Mitch Report

date generated: 2024-03-16

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch

	ADOS	diagnosis	iIQ	iLang	motor
A1BG	-0.2102058	0.0652946	-0.7367748	-0.7417465	-0.5370327
A1BG-AS1	-0.1444174	0.1810133	-0.9832567	-0.9587371	-0.4536532
A1CF	-0.4174745	-0.2956526	-0.4555659	-0.4473704	0.2081326
A2M	-0.9043933	-0.2004846	-2.2335124	-2.5472337	-0.6020613
A2M-AS1	1.1209844	1.3650347	-0.4557539	-0.6895200	0.0049048
A2ML1	-0.4512646	-0.2944681	-0.8175737	-0.7709556	-0.1342367

Here are some metrics about the input data profile:

Profiling data metrics

	Profile metrics
num_genes_in_profile	22285
duplicated_genes_present	0
num_profile_genes_in_sets	16322
num_profile_genes_not_in_sets	5963

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:

Gene set metrics

	Gene sets metrics
num_genesets	7647
num_genesets_excluded	2159
num_genesets_included	5488

Genes by sector

ADOS	diagnosis	iIQ	iLang	motor	Count
-1	-1	-1	-1	-1	13744
1	-1	-1	-1	-1	150
-1	1	-1	-1	-1	3118
1	1	-1	-1	-1	1018
-1	-1	1	-1	-1	83
1	-1	1	-1	-1	10
-1	1	1	-1	-1	12
1	1	1	-1	-1	28
1	-1	-1	0	-1	1
-1	-1	-1	1	-1	75
1	-1	-1	1	-1	33
-1	1	-1	1	-1	17
1	1	-1	1	-1	142
-1	-1	1	1	-1	316
1	-1	1	1	-1	276
-1	1	1	1	-1	41
1	1	1	1	-1	877
-1	-1	-1	-1	0	1
-1	-1	-1	-1	1	1088
1	-1	-1	-1	1	33
-1	0	-1	-1	1	1
-1	1	-1	-1	1	106
1	1	-1	-1	1	72
-1	-1	0	-1	1	1
-1	-1	1	-1	1	51
1	-1	1	-1	1	10
-1	1	1	-1	1	2
1	1	1	-1	1	8
-1	-1	-1	1	1	20
1	-1	-1	1	1	6
-1	1	-1	1	1	7
1	1	-1	1	1	16
-1	-1	1	1	1	283
1	-1	1	1	1	222
-1	1	1	1	1	30
0	1	1	1	1	1
1	1	1	1	1	386

Number of significant gene sets (FDR<0.05)= 392

Gene sets by sector

Gene sets by sector

s.ADOS	s.diagnosis	s.iIQ	s.iLang	s.motor	Count
-1	-1	-1	-1	-1	22
-1	1	-1	-1	-1	4
1	1	-1	-1	-1	2
1	-1	1	-1	-1	1
1	-1	1	1	-1	18
1	1	1	1	-1	32
-1	-1	-1	-1	1	36
1	-1	-1	-1	1	4
-1	1	-1	-1	1	7
1	1	-1	-1	1	13
-1	-1	1	-1	1	7
1	-1	1	-1	1	6
-1	1	-1	1	1	1
1	1	-1	1	1	3
-1	-1	1	1	1	7
1	-1	1	1	1	167
1	1	1	1	1	62

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results

A plot of effect size versus significance

Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets

## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.ADOS	s.diagnosis	s.iIQ	s.iLang	s.motor	p.ADOS	p.diagnosis	p.iIQ	p.iLang	p.motor
CELLULAR RESPONSE TO NITROSATIVE STRESS	6	3.08e-02	0.264000	1.340	0.619	0.27300	0.691	0.668	0.6460	0.008590	0.24700	0.00337	0.004610	0.00613
PROTEIN POLYUFMYLATION	5	2.66e-02	0.244000	1.340	0.670	0.22200	0.804	0.798	0.0550	0.009480	0.38900	0.00184	0.002000	0.83100
MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE	5	1.11e-02	0.137000	1.300	-0.565	0.11100	-0.740	-0.767	-0.4740	0.028700	0.66600	0.00416	0.002970	0.06620
TELOMERE TETHERING AT NUCLEAR PERIPHERY	6	7.89e-03	0.110000	1.270	-0.539	0.08630	-0.742	-0.759	-0.4340	0.022300	0.71400	0.00165	0.001290	0.06550
MRNA 3 SPLICE SITE RECOGNITION	6	5.34e-02	0.362000	1.270	0.616	0.16800	0.694	0.692	0.4890	0.009020	0.47700	0.00323	0.003320	0.03800
NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	6	6.07e-02	0.394000	1.260	-0.656	-0.66500	-0.589	-0.604	-0.1090	0.005410	0.00479	0.01250	0.010400	0.64400
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C	6	1.11e-01	0.534000	1.260	0.656	0.40000	0.670	0.674	0.3110	0.005420	0.08980	0.00447	0.004250	0.18700
RESPONSE TO YEAST	7	2.02e-03	0.041000	1.220	-0.486	-0.56400	-0.678	-0.681	-0.0316	0.025800	0.00982	0.00189	0.001810	0.88500
DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY	6	1.83e-02	0.192000	1.210	0.536	-0.00841	0.629	0.657	0.5870	0.022900	0.97200	0.00760	0.005340	0.01270
INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY	6	6.94e-02	0.422000	1.190	-0.607	-0.53500	-0.609	-0.626	0.0454	0.010000	0.02320	0.00982	0.007950	0.84700
POSITIVE REGULATION OF HYPERSENSITIVITY	5	9.02e-02	0.478000	1.170	0.528	0.60700	0.519	0.543	0.3950	0.040700	0.01870	0.04450	0.035500	0.12600
FUSED ANTRUM STAGE	6	4.20e-02	0.314000	1.160	-0.609	-0.73500	-0.409	-0.460	-0.2230	0.009830	0.00182	0.08250	0.050900	0.34400
INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY	6	4.19e-02	0.313000	1.130	-0.565	-0.66500	-0.487	-0.494	0.1840	0.016500	0.00477	0.03900	0.036300	0.43500
RESPONSE TO PROSTAGLANDIN D	5	1.37e-01	0.589000	1.110	-0.591	-0.30600	-0.526	-0.508	-0.5110	0.022000	0.23600	0.04160	0.049200	0.04770
RNA GUANINE N7 METHYLATION	6	1.52e-01	0.613000	1.110	0.557	0.37200	0.625	0.613	0.0995	0.018100	0.11500	0.00804	0.009290	0.67300
NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	6	6.91e-02	0.421000	1.110	-0.569	-0.66300	-0.417	-0.466	-0.2610	0.015800	0.00490	0.07720	0.048000	0.26800
PROTEIN UFMYLATION	6	4.76e-02	0.341000	1.110	0.567	0.10900	0.670	0.651	0.1230	0.016200	0.64500	0.00448	0.005730	0.60100
PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY	6	3.96e-03	0.067900	1.100	0.394	0.61600	0.428	0.474	0.5120	0.094200	0.00897	0.06920	0.044500	0.02990
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	7	2.97e-02	0.260000	1.100	0.469	0.55000	0.498	0.508	0.4140	0.031600	0.01180	0.02260	0.019900	0.05790
NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	5	1.59e-01	0.620000	1.090	-0.598	-0.15000	-0.595	-0.607	-0.2840	0.020600	0.56100	0.02120	0.018800	0.27100
NEGATIVE REGULATION OF MYOBLAST PROLIFERATION	9	1.30e-02	0.153000	1.060	-0.504	-0.09050	-0.597	-0.640	-0.3200	0.008860	0.63800	0.00193	0.000876	0.09640
U4 SNRNA 3 END PROCESSING	8	1.87e-03	0.039000	1.060	0.591	0.18700	0.614	0.579	-0.1340	0.003780	0.35900	0.00265	0.004590	0.51200
ANTRAL OVARIAN FOLLICLE GROWTH	11	1.36e-02	0.157000	1.050	-0.549	-0.52400	-0.444	-0.472	-0.3350	0.001600	0.00263	0.01080	0.006660	0.05430
POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	5	9.13e-02	0.481000	1.050	0.377	0.29200	0.454	0.428	0.6950	0.144000	0.25800	0.07860	0.097700	0.00709
REGULATION OF FEMALE RECEPTIVITY	7	1.06e-02	0.133000	1.050	-0.463	-0.53300	-0.510	-0.580	0.0621	0.034000	0.01460	0.01940	0.007900	0.77600
SENSORY PERCEPTION OF SWEET TASTE	7	6.35e-02	0.403000	1.040	-0.351	-0.05320	-0.556	-0.513	-0.6230	0.108000	0.80800	0.01090	0.018700	0.00431
NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	5	3.16e-01	0.788000	1.030	0.436	0.12400	0.564	0.555	0.4870	0.091500	0.63200	0.02890	0.031600	0.05940
PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	7	1.54e-01	0.616000	1.030	0.547	0.24800	0.534	0.564	0.3010	0.012100	0.25700	0.01440	0.009700	0.16900
PROTEIN UNFOLDING	5	9.00e-02	0.477000	1.020	0.314	0.08690	0.635	0.659	0.3260	0.225000	0.73700	0.01390	0.010700	0.20700
POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	12	6.04e-04	0.016400	1.020	0.406	0.51000	0.458	0.486	0.4170	0.015000	0.00220	0.00605	0.003590	0.01240
LIMB JOINT MORPHOGENESIS	5	2.20e-01	0.700000	1.020	-0.461	-0.51700	-0.513	-0.504	-0.2150	0.074300	0.04540	0.04720	0.050900	0.40500
CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE	7	7.77e-02	0.450000	1.020	-0.398	0.00730	-0.623	-0.618	-0.3230	0.068200	0.97300	0.00431	0.004610	0.13800
NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	5	7.28e-02	0.434000	1.020	0.546	0.08830	0.577	0.625	0.0358	0.034400	0.73200	0.02540	0.015500	0.89000
LEUKOTRIENE B4 METABOLIC PROCESS	5	1.17e-01	0.546000	1.010	0.563	0.64900	0.295	0.382	-0.2250	0.029400	0.01200	0.25400	0.139000	0.38400
NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION	5	3.68e-01	0.831000	1.000	0.504	0.19800	0.552	0.575	0.2800	0.051000	0.44300	0.03260	0.026000	0.27800
POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION	5	2.36e-01	0.719000	1.000	0.458	0.17400	0.565	0.509	0.4330	0.076400	0.49900	0.02870	0.048600	0.09370
DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM	6	5.33e-02	0.362000	1.000	-0.441	-0.55200	-0.486	-0.496	0.1500	0.061400	0.01930	0.03920	0.035300	0.52500
THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION	6	9.07e-02	0.480000	0.999	-0.552	-0.59000	-0.331	-0.371	0.3130	0.019200	0.01230	0.16000	0.116000	0.18500
PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	5	2.84e-01	0.762000	0.994	0.546	0.20800	0.557	0.571	0.0975	0.034500	0.42000	0.03090	0.026900	0.70600
VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	5	3.87e-01	0.840000	0.989	0.462	0.23000	0.511	0.537	0.4030	0.073300	0.37300	0.04800	0.037700	0.11800
INDUCTION OF BACTERIAL AGGLUTINATION	6	1.45e-01	0.603000	0.989	-0.545	-0.56600	-0.425	-0.414	0.0908	0.020700	0.01640	0.07130	0.079100	0.70000
REGULATION OF MACROPHAGE FUSION	5	1.56e-01	0.618000	0.988	-0.476	-0.50900	-0.514	-0.466	-0.0975	0.065200	0.04890	0.04640	0.070900	0.70600
REGULATION OF LIPID TRANSPORTER ACTIVITY	6	6.46e-03	0.096500	0.984	-0.482	-0.21400	-0.555	-0.435	-0.4390	0.040700	0.36400	0.01860	0.064900	0.06260
EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY	6	2.80e-01	0.758000	0.983	0.543	0.50600	0.418	0.444	0.2070	0.021200	0.03170	0.07610	0.059600	0.38100
PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN	16	1.65e-05	0.000866	0.981	0.546	0.35400	0.446	0.485	-0.3230	0.000157	0.01410	0.00202	0.000775	0.02510
MELANOCYTE PROLIFERATION	5	1.72e-01	0.644000	0.980	-0.438	-0.57000	-0.435	-0.477	-0.1670	0.089800	0.02740	0.09230	0.065000	0.51800
POSITIVE REGULATION OF DNA LIGATION	5	1.36e-01	0.586000	0.979	0.409	0.04390	0.601	0.637	0.1510	0.114000	0.86500	0.01990	0.013600	0.56000
SENSORY PERCEPTION OF UMAMI TASTE	7	7.38e-02	0.437000	0.979	-0.356	0.06240	-0.537	-0.497	-0.5410	0.103000	0.77500	0.01390	0.022700	0.01320
PROTEIN IMPORT INTO PEROXISOME MEMBRANE	6	1.09e-01	0.529000	0.976	0.616	0.39900	0.440	0.451	-0.1310	0.008990	0.09050	0.06180	0.055600	0.57700
NEGATIVE REGULATION OF MIRNA PROCESSING	9	6.17e-02	0.397000	0.976	0.602	0.34900	0.467	0.493	0.0918	0.001770	0.07020	0.01520	0.010500	0.63300

---

Results (complete table)

Click HERE to show results for all gene sets

Complete results

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.ADOS	s.diagnosis	s.iIQ	s.iLang	s.motor	p.ADOS	p.diagnosis	p.iIQ	p.iLang	p.motor
CELLULAR RESPONSE TO NITROSATIVE STRESS	6	3.08e-02	2.64e-01	1.3400	6.19e-01	2.73e-01	6.91e-01	6.68e-01	6.46e-01	8.59e-03	2.47e-01	3.37e-03	4.61e-03	6.13e-03
PROTEIN POLYUFMYLATION	5	2.66e-02	2.44e-01	1.3400	6.70e-01	2.22e-01	8.04e-01	7.98e-01	5.50e-02	9.48e-03	3.89e-01	1.84e-03	2.00e-03	8.31e-01
MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE	5	1.11e-02	1.37e-01	1.3000	-5.65e-01	1.11e-01	-7.40e-01	-7.67e-01	-4.74e-01	2.87e-02	6.66e-01	4.16e-03	2.97e-03	6.62e-02
TELOMERE TETHERING AT NUCLEAR PERIPHERY	6	7.89e-03	1.10e-01	1.2700	-5.39e-01	8.63e-02	-7.42e-01	-7.59e-01	-4.34e-01	2.23e-02	7.14e-01	1.65e-03	1.29e-03	6.55e-02
MRNA 3 SPLICE SITE RECOGNITION	6	5.34e-02	3.62e-01	1.2700	6.16e-01	1.68e-01	6.94e-01	6.92e-01	4.89e-01	9.02e-03	4.77e-01	3.23e-03	3.32e-03	3.80e-02
NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	6	6.07e-02	3.94e-01	1.2600	-6.56e-01	-6.65e-01	-5.89e-01	-6.04e-01	-1.09e-01	5.41e-03	4.79e-03	1.25e-02	1.04e-02	6.44e-01
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C	6	1.11e-01	5.34e-01	1.2600	6.56e-01	4.00e-01	6.70e-01	6.74e-01	3.11e-01	5.42e-03	8.98e-02	4.47e-03	4.25e-03	1.87e-01
RESPONSE TO YEAST	7	2.02e-03	4.10e-02	1.2200	-4.86e-01	-5.64e-01	-6.78e-01	-6.81e-01	-3.16e-02	2.58e-02	9.82e-03	1.89e-03	1.81e-03	8.85e-01
DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY	6	1.83e-02	1.92e-01	1.2100	5.36e-01	-8.41e-03	6.29e-01	6.57e-01	5.87e-01	2.29e-02	9.72e-01	7.60e-03	5.34e-03	1.27e-02
INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY	6	6.94e-02	4.22e-01	1.1900	-6.07e-01	-5.35e-01	-6.09e-01	-6.26e-01	4.54e-02	1.00e-02	2.32e-02	9.82e-03	7.95e-03	8.47e-01
POSITIVE REGULATION OF HYPERSENSITIVITY	5	9.02e-02	4.78e-01	1.1700	5.28e-01	6.07e-01	5.19e-01	5.43e-01	3.95e-01	4.07e-02	1.87e-02	4.45e-02	3.55e-02	1.26e-01
FUSED ANTRUM STAGE	6	4.20e-02	3.14e-01	1.1600	-6.09e-01	-7.35e-01	-4.09e-01	-4.60e-01	-2.23e-01	9.83e-03	1.82e-03	8.25e-02	5.09e-02	3.44e-01
INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY	6	4.19e-02	3.13e-01	1.1300	-5.65e-01	-6.65e-01	-4.87e-01	-4.94e-01	1.84e-01	1.65e-02	4.77e-03	3.90e-02	3.63e-02	4.35e-01
RESPONSE TO PROSTAGLANDIN D	5	1.37e-01	5.89e-01	1.1100	-5.91e-01	-3.06e-01	-5.26e-01	-5.08e-01	-5.11e-01	2.20e-02	2.36e-01	4.16e-02	4.92e-02	4.77e-02
RNA GUANINE N7 METHYLATION	6	1.52e-01	6.13e-01	1.1100	5.57e-01	3.72e-01	6.25e-01	6.13e-01	9.95e-02	1.81e-02	1.15e-01	8.04e-03	9.29e-03	6.73e-01
NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	6	6.91e-02	4.21e-01	1.1100	-5.69e-01	-6.63e-01	-4.17e-01	-4.66e-01	-2.61e-01	1.58e-02	4.90e-03	7.72e-02	4.80e-02	2.68e-01
PROTEIN UFMYLATION	6	4.76e-02	3.41e-01	1.1100	5.67e-01	1.09e-01	6.70e-01	6.51e-01	1.23e-01	1.62e-02	6.45e-01	4.48e-03	5.73e-03	6.01e-01
PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY	6	3.96e-03	6.79e-02	1.1000	3.94e-01	6.16e-01	4.28e-01	4.74e-01	5.12e-01	9.42e-02	8.97e-03	6.92e-02	4.45e-02	2.99e-02
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	7	2.97e-02	2.60e-01	1.1000	4.69e-01	5.50e-01	4.98e-01	5.08e-01	4.14e-01	3.16e-02	1.18e-02	2.26e-02	1.99e-02	5.79e-02
NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	5	1.59e-01	6.20e-01	1.0900	-5.98e-01	-1.50e-01	-5.95e-01	-6.07e-01	-2.84e-01	2.06e-02	5.61e-01	2.12e-02	1.88e-02	2.71e-01
NEGATIVE REGULATION OF MYOBLAST PROLIFERATION	9	1.30e-02	1.53e-01	1.0600	-5.04e-01	-9.05e-02	-5.97e-01	-6.40e-01	-3.20e-01	8.86e-03	6.38e-01	1.93e-03	8.76e-04	9.64e-02
U4 SNRNA 3 END PROCESSING	8	1.87e-03	3.90e-02	1.0600	5.91e-01	1.87e-01	6.14e-01	5.79e-01	-1.34e-01	3.78e-03	3.59e-01	2.65e-03	4.59e-03	5.12e-01
ANTRAL OVARIAN FOLLICLE GROWTH	11	1.36e-02	1.57e-01	1.0500	-5.49e-01	-5.24e-01	-4.44e-01	-4.72e-01	-3.35e-01	1.60e-03	2.63e-03	1.08e-02	6.66e-03	5.43e-02
POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	5	9.13e-02	4.81e-01	1.0500	3.77e-01	2.92e-01	4.54e-01	4.28e-01	6.95e-01	1.44e-01	2.58e-01	7.86e-02	9.77e-02	7.09e-03
REGULATION OF FEMALE RECEPTIVITY	7	1.06e-02	1.33e-01	1.0500	-4.63e-01	-5.33e-01	-5.10e-01	-5.80e-01	6.21e-02	3.40e-02	1.46e-02	1.94e-02	7.90e-03	7.76e-01
SENSORY PERCEPTION OF SWEET TASTE	7	6.35e-02	4.03e-01	1.0400	-3.51e-01	-5.32e-02	-5.56e-01	-5.13e-01	-6.23e-01	1.08e-01	8.08e-01	1.09e-02	1.87e-02	4.31e-03
NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	5	3.16e-01	7.88e-01	1.0300	4.36e-01	1.24e-01	5.64e-01	5.55e-01	4.87e-01	9.15e-02	6.32e-01	2.89e-02	3.16e-02	5.94e-02
PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	7	1.54e-01	6.16e-01	1.0300	5.47e-01	2.48e-01	5.34e-01	5.64e-01	3.01e-01	1.21e-02	2.57e-01	1.44e-02	9.70e-03	1.69e-01
PROTEIN UNFOLDING	5	9.00e-02	4.77e-01	1.0200	3.14e-01	8.69e-02	6.35e-01	6.59e-01	3.26e-01	2.25e-01	7.37e-01	1.39e-02	1.07e-02	2.07e-01
POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	12	6.04e-04	1.64e-02	1.0200	4.06e-01	5.10e-01	4.58e-01	4.86e-01	4.17e-01	1.50e-02	2.20e-03	6.05e-03	3.59e-03	1.24e-02
LIMB JOINT MORPHOGENESIS	5	2.20e-01	7.00e-01	1.0200	-4.61e-01	-5.17e-01	-5.13e-01	-5.04e-01	-2.15e-01	7.43e-02	4.54e-02	4.72e-02	5.09e-02	4.05e-01
CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE	7	7.77e-02	4.50e-01	1.0200	-3.98e-01	7.30e-03	-6.23e-01	-6.18e-01	-3.23e-01	6.82e-02	9.73e-01	4.31e-03	4.61e-03	1.38e-01
NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	5	7.28e-02	4.34e-01	1.0200	5.46e-01	8.83e-02	5.77e-01	6.25e-01	3.58e-02	3.44e-02	7.32e-01	2.54e-02	1.55e-02	8.90e-01
LEUKOTRIENE B4 METABOLIC PROCESS	5	1.17e-01	5.46e-01	1.0100	5.63e-01	6.49e-01	2.95e-01	3.82e-01	-2.25e-01	2.94e-02	1.20e-02	2.54e-01	1.39e-01	3.84e-01
NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION	5	3.68e-01	8.31e-01	1.0000	5.04e-01	1.98e-01	5.52e-01	5.75e-01	2.80e-01	5.10e-02	4.43e-01	3.26e-02	2.60e-02	2.78e-01
POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION	5	2.36e-01	7.19e-01	1.0000	4.58e-01	1.74e-01	5.65e-01	5.09e-01	4.33e-01	7.64e-02	4.99e-01	2.87e-02	4.86e-02	9.37e-02
DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM	6	5.33e-02	3.62e-01	1.0000	-4.41e-01	-5.52e-01	-4.86e-01	-4.96e-01	1.50e-01	6.14e-02	1.93e-02	3.92e-02	3.53e-02	5.25e-01
THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION	6	9.07e-02	4.80e-01	0.9990	-5.52e-01	-5.90e-01	-3.31e-01	-3.71e-01	3.13e-01	1.92e-02	1.23e-02	1.60e-01	1.16e-01	1.85e-01
PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	5	2.84e-01	7.62e-01	0.9940	5.46e-01	2.08e-01	5.57e-01	5.71e-01	9.75e-02	3.45e-02	4.20e-01	3.09e-02	2.69e-02	7.06e-01
VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	5	3.87e-01	8.40e-01	0.9890	4.62e-01	2.30e-01	5.11e-01	5.37e-01	4.03e-01	7.33e-02	3.73e-01	4.80e-02	3.77e-02	1.18e-01
INDUCTION OF BACTERIAL AGGLUTINATION	6	1.45e-01	6.03e-01	0.9890	-5.45e-01	-5.66e-01	-4.25e-01	-4.14e-01	9.08e-02	2.07e-02	1.64e-02	7.13e-02	7.91e-02	7.00e-01
REGULATION OF MACROPHAGE FUSION	5	1.56e-01	6.18e-01	0.9880	-4.76e-01	-5.09e-01	-5.14e-01	-4.66e-01	-9.75e-02	6.52e-02	4.89e-02	4.64e-02	7.09e-02	7.06e-01
REGULATION OF LIPID TRANSPORTER ACTIVITY	6	6.46e-03	9.65e-02	0.9840	-4.82e-01	-2.14e-01	-5.55e-01	-4.35e-01	-4.39e-01	4.07e-02	3.64e-01	1.86e-02	6.49e-02	6.26e-02
EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY	6	2.80e-01	7.58e-01	0.9830	5.43e-01	5.06e-01	4.18e-01	4.44e-01	2.07e-01	2.12e-02	3.17e-02	7.61e-02	5.96e-02	3.81e-01
PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN	16	1.65e-05	8.66e-04	0.9810	5.46e-01	3.54e-01	4.46e-01	4.85e-01	-3.23e-01	1.57e-04	1.41e-02	2.02e-03	7.75e-04	2.51e-02
MELANOCYTE PROLIFERATION	5	1.72e-01	6.44e-01	0.9800	-4.38e-01	-5.70e-01	-4.35e-01	-4.77e-01	-1.67e-01	8.98e-02	2.74e-02	9.23e-02	6.50e-02	5.18e-01
POSITIVE REGULATION OF DNA LIGATION	5	1.36e-01	5.86e-01	0.9790	4.09e-01	4.39e-02	6.01e-01	6.37e-01	1.51e-01	1.14e-01	8.65e-01	1.99e-02	1.36e-02	5.60e-01
SENSORY PERCEPTION OF UMAMI TASTE	7	7.38e-02	4.37e-01	0.9790	-3.56e-01	6.24e-02	-5.37e-01	-4.97e-01	-5.41e-01	1.03e-01	7.75e-01	1.39e-02	2.27e-02	1.32e-02
PROTEIN IMPORT INTO PEROXISOME MEMBRANE	6	1.09e-01	5.29e-01	0.9760	6.16e-01	3.99e-01	4.40e-01	4.51e-01	-1.31e-01	8.99e-03	9.05e-02	6.18e-02	5.56e-02	5.77e-01
NEGATIVE REGULATION OF MIRNA PROCESSING	9	6.17e-02	3.97e-01	0.9760	6.02e-01	3.49e-01	4.67e-01	4.93e-01	9.18e-02	1.77e-03	7.02e-02	1.52e-02	1.05e-02	6.33e-01
NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	7	7.96e-02	4.53e-01	0.9760	-3.58e-01	-1.78e-01	-4.81e-01	-5.18e-01	-5.42e-01	1.01e-01	4.16e-01	2.76e-02	1.77e-02	1.30e-02
GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT	5	2.75e-01	7.56e-01	0.9710	6.12e-01	3.47e-01	4.46e-01	4.86e-01	1.14e-01	1.78e-02	1.78e-01	8.42e-02	5.97e-02	6.59e-01
MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C	12	5.81e-03	9.11e-02	0.9700	5.61e-01	2.90e-01	5.28e-01	5.12e-01	-2.58e-02	7.58e-04	8.16e-02	1.55e-03	2.15e-03	8.77e-01
NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	5	2.91e-01	7.67e-01	0.9690	3.72e-01	-2.15e-03	5.59e-01	5.24e-01	4.61e-01	1.50e-01	9.93e-01	3.05e-02	4.24e-02	7.40e-02
ZYMOGEN INHIBITION	7	8.86e-03	1.18e-01	0.9650	1.66e-02	-3.54e-01	4.14e-01	4.13e-01	6.81e-01	9.39e-01	1.05e-01	5.76e-02	5.82e-02	1.81e-03
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION	5	2.90e-01	7.67e-01	0.9640	4.72e-01	5.34e-01	4.02e-01	4.37e-01	2.63e-01	6.76e-02	3.86e-02	1.19e-01	9.07e-02	3.08e-01
ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	6.18e-02	3.97e-01	0.9610	3.87e-01	5.20e-01	4.65e-01	5.10e-01	-1.62e-01	1.34e-01	4.41e-02	7.15e-02	4.83e-02	5.30e-01
MITOCHONDRIAL RIBOSOME ASSEMBLY	10	3.50e-03	6.18e-02	0.9530	3.78e-01	6.39e-02	6.11e-01	6.22e-01	1.75e-02	3.83e-02	7.27e-01	8.18e-04	6.61e-04	9.24e-01
STRAND INVASION	6	1.23e-01	5.62e-01	0.9480	4.31e-01	1.06e-01	5.88e-01	5.96e-01	3.60e-02	6.78e-02	6.52e-01	1.26e-02	1.14e-02	8.79e-01
POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	7	2.42e-02	2.30e-01	0.9480	-3.98e-01	-5.06e-01	-4.89e-01	-4.76e-01	1.40e-01	6.84e-02	2.05e-02	2.51e-02	2.92e-02	5.22e-01
AXON CHOICE POINT RECOGNITION	7	8.03e-02	4.53e-01	0.9470	-4.93e-01	-5.77e-01	-3.54e-01	-4.27e-01	-1.16e-01	2.39e-02	8.15e-03	1.05e-01	5.03e-02	5.96e-01
NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	5	3.91e-01	8.41e-01	0.9460	-4.81e-01	-4.90e-01	-4.42e-01	-4.36e-01	-1.97e-01	6.23e-02	5.79e-02	8.69e-02	9.14e-02	4.46e-01
PROTEIN K27 LINKED UBIQUITINATION	7	9.31e-02	4.86e-01	0.9450	2.78e-01	-6.52e-02	5.16e-01	5.24e-01	5.21e-01	2.03e-01	7.65e-01	1.82e-02	1.63e-02	1.70e-02
CONSTITUTIVE SECRETORY PATHWAY	7	7.34e-02	4.35e-01	0.9440	4.08e-01	-3.27e-02	5.91e-01	5.75e-01	2.07e-01	6.17e-02	8.81e-01	6.73e-03	8.46e-03	3.43e-01
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION	6	4.38e-02	3.23e-01	0.9420	4.44e-01	5.06e-01	4.58e-01	4.18e-01	-2.22e-01	5.97e-02	3.19e-02	5.19e-02	7.60e-02	3.46e-01
RESPONSE TO OZONE	5	1.45e-02	1.63e-01	0.9400	6.00e-01	5.38e-01	1.55e-01	1.54e-01	-4.31e-01	2.02e-02	3.71e-02	5.47e-01	5.52e-01	9.53e-02
LOBAR BRONCHUS EPITHELIUM DEVELOPMENT	5	2.17e-01	6.99e-01	0.9390	-4.35e-01	-1.39e-01	-5.61e-01	-4.92e-01	-3.40e-01	9.22e-02	5.90e-01	2.97e-02	5.69e-02	1.88e-01
NECROPTOTIC SIGNALING PATHWAY	8	8.58e-02	4.67e-01	0.9380	4.24e-01	4.18e-01	4.21e-01	4.61e-01	3.69e-01	3.76e-02	4.05e-02	3.92e-02	2.41e-02	7.09e-02
RESPONSE TO ZINC ION STARVATION	9	8.58e-02	4.67e-01	0.9360	-5.10e-01	-5.36e-01	-4.03e-01	-4.07e-01	2.43e-02	8.12e-03	5.40e-03	3.64e-02	3.43e-02	9.00e-01
POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	6	1.21e-01	5.55e-01	0.9320	-6.03e-01	-3.96e-01	-3.53e-01	-3.96e-01	-2.59e-01	1.06e-02	9.30e-02	1.34e-01	9.31e-02	2.72e-01
MESENCHYMAL EPITHELIAL CELL SIGNALING	7	3.02e-01	7.74e-01	0.9290	-4.38e-01	-2.84e-01	-4.78e-01	-4.77e-01	-3.68e-01	4.50e-02	1.94e-01	2.86e-02	2.88e-02	9.19e-02
REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	10	5.22e-02	3.58e-01	0.9240	-4.78e-01	-4.86e-01	-4.19e-01	-4.59e-01	6.21e-02	8.84e-03	7.76e-03	2.18e-02	1.20e-02	7.34e-01
POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	5	1.30e-01	5.74e-01	0.9210	-5.84e-01	-5.04e-01	-2.79e-01	-3.66e-01	-2.03e-01	2.37e-02	5.08e-02	2.81e-01	1.56e-01	4.32e-01
REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	5	3.82e-01	8.38e-01	0.9200	-4.31e-01	-1.52e-01	-4.51e-01	-4.67e-01	-4.64e-01	9.49e-02	5.57e-01	8.11e-02	7.03e-02	7.21e-02
HISTAMINE METABOLIC PROCESS	6	1.65e-01	6.31e-01	0.9190	-3.21e-01	-2.30e-02	-4.41e-01	-4.62e-01	-5.77e-01	1.73e-01	9.22e-01	6.17e-02	4.98e-02	1.43e-02
LEUKOTRIENE CATABOLIC PROCESS	6	1.42e-01	6.00e-01	0.9180	5.21e-01	6.13e-01	2.39e-01	3.01e-01	-2.19e-01	2.70e-02	9.27e-03	3.10e-01	2.02e-01	3.54e-01
REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	7	6.14e-02	3.97e-01	0.9170	2.42e-01	-2.23e-01	4.87e-01	4.60e-01	5.32e-01	2.68e-01	3.07e-01	2.56e-02	3.49e-02	1.48e-02
REGULATION OF EXCRETION	11	6.92e-02	4.22e-01	0.9150	4.82e-01	4.80e-01	4.22e-01	4.42e-01	2.53e-02	5.65e-03	5.86e-03	1.53e-02	1.12e-02	8.84e-01
CELLULAR RESPONSE TO TEMPERATURE STIMULUS	5	4.76e-01	8.86e-01	0.9120	-5.04e-01	-2.41e-01	-4.98e-01	-5.03e-01	-1.37e-01	5.12e-02	3.51e-01	5.36e-02	5.14e-02	5.96e-01
NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	5	4.03e-02	3.07e-01	0.9110	-3.70e-01	-4.68e-01	-4.46e-01	-4.06e-01	3.33e-01	1.52e-01	6.99e-02	8.38e-02	1.16e-01	1.97e-01
RENAL SODIUM EXCRETION	11	2.74e-02	2.47e-01	0.9090	4.84e-01	5.09e-01	3.79e-01	3.98e-01	-1.74e-01	5.42e-03	3.46e-03	2.94e-02	2.21e-02	3.17e-01
OPTIC NERVE MORPHOGENESIS	6	2.89e-01	7.66e-01	0.9070	4.18e-01	4.31e-01	4.29e-01	4.25e-01	3.12e-01	7.60e-02	6.74e-02	6.89e-02	7.15e-02	1.86e-01
REGULATION OF RENAL SODIUM EXCRETION	8	1.60e-01	6.22e-01	0.9060	4.79e-01	5.06e-01	3.99e-01	4.15e-01	-4.31e-02	1.88e-02	1.31e-02	5.05e-02	4.19e-02	8.33e-01
ELASTIN CATABOLIC PROCESS	5	3.02e-01	7.74e-01	0.9060	-5.16e-01	-5.39e-01	-3.06e-01	-3.47e-01	2.21e-01	4.58e-02	3.68e-02	2.36e-01	1.78e-01	3.92e-01
INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS	7	2.66e-01	7.47e-01	0.8970	-5.21e-01	-4.80e-01	-3.68e-01	-3.83e-01	-1.42e-01	1.69e-02	2.77e-02	9.15e-02	7.95e-02	5.14e-01
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	5	1.68e-01	6.36e-01	0.8960	5.37e-01	2.05e-01	4.85e-01	4.76e-01	-1.08e-01	3.76e-02	4.28e-01	6.05e-02	6.53e-02	6.76e-01
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS	6	1.41e-01	5.99e-01	0.8940	-4.17e-01	-3.06e-01	-4.89e-01	-5.30e-01	1.09e-01	7.72e-02	1.95e-01	3.80e-02	2.46e-02	6.43e-01
REGULATION OF NEUTROPHIL DEGRANULATION	8	1.23e-01	5.62e-01	0.8900	-4.31e-01	-5.21e-01	-3.71e-01	-3.91e-01	-2.12e-01	3.47e-02	1.07e-02	6.90e-02	5.56e-02	3.00e-01
AMINOPHOSPHOLIPID TRANSPORT	8	1.43e-01	6.00e-01	0.8880	-3.89e-01	-1.57e-01	-5.19e-01	-5.51e-01	-2.02e-01	5.66e-02	4.41e-01	1.11e-02	7.00e-03	3.23e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	5	8.22e-02	4.58e-01	0.8850	-1.55e-01	-5.05e-01	2.65e-01	2.17e-01	6.22e-01	5.48e-01	5.06e-02	3.04e-01	4.00e-01	1.61e-02
CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION	5	2.21e-01	7.01e-01	0.8840	4.94e-01	1.14e-01	5.22e-01	4.80e-01	1.50e-01	5.56e-02	6.58e-01	4.34e-02	6.32e-02	5.60e-01
RENAL TUBULAR SECRETION	19	4.08e-03	6.97e-02	0.8820	4.84e-01	4.71e-01	3.87e-01	4.12e-01	-5.53e-02	2.58e-04	3.80e-04	3.51e-03	1.89e-03	6.77e-01
ADHESION OF SYMBIONT TO HOST CELL	8	2.68e-01	7.48e-01	0.8790	4.89e-01	4.17e-01	4.13e-01	4.33e-01	3.07e-02	1.66e-02	4.09e-02	4.29e-02	3.38e-02	8.81e-01
CARDIAC FIBROBLAST CELL DIFFERENTIATION	5	4.64e-01	8.81e-01	0.8790	5.16e-01	4.48e-01	3.74e-01	3.74e-01	1.63e-01	4.58e-02	8.30e-02	1.48e-01	1.47e-01	5.29e-01
ARTICULAR CARTILAGE DEVELOPMENT	5	2.51e-01	7.35e-01	0.8790	-2.84e-01	-3.02e-02	-3.85e-01	-3.63e-01	-6.40e-01	2.71e-01	9.07e-01	1.36e-01	1.60e-01	1.31e-02
ADHESION OF SYMBIONT TO HOST	12	1.02e-01	5.10e-01	0.8750	4.80e-01	3.82e-01	4.12e-01	4.44e-01	1.53e-01	3.98e-03	2.19e-02	1.35e-02	7.79e-03	3.58e-01
AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS	6	2.66e-02	2.44e-01	0.8750	-3.45e-01	-4.52e-01	-4.76e-01	-4.29e-01	1.81e-01	1.44e-01	5.51e-02	4.35e-02	6.90e-02	4.43e-01
PEPTIDYL ARGININE MODIFICATION	10	1.65e-01	6.31e-01	0.8730	4.90e-01	3.00e-01	4.48e-01	4.70e-01	1.04e-01	7.29e-03	1.01e-01	1.41e-02	1.00e-02	5.70e-01
POSITIVE REGULATION OF NECROPTOTIC PROCESS	7	1.79e-01	6.52e-01	0.8720	-4.81e-01	-1.62e-01	-4.21e-01	-4.46e-01	-3.57e-01	2.76e-02	4.58e-01	5.39e-02	4.08e-02	1.02e-01
REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	6	4.60e-01	8.80e-01	0.8710	-4.53e-01	-3.41e-01	-4.10e-01	-4.35e-01	-2.82e-01	5.48e-02	1.47e-01	8.17e-02	6.52e-02	2.32e-01
VITAMIN E METABOLIC PROCESS	6	3.19e-01	7.91e-01	0.8700	5.03e-01	4.35e-01	3.62e-01	4.25e-01	4.59e-02	3.29e-02	6.48e-02	1.24e-01	7.13e-02	8.46e-01
SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	11	2.98e-02	2.60e-01	0.8700	-3.38e-01	7.26e-02	-4.87e-01	-4.76e-01	-4.16e-01	5.23e-02	6.77e-01	5.19e-03	6.21e-03	1.68e-02
TRANSLOCATION OF MOLECULES INTO HOST	7	1.80e-01	6.52e-01	0.8650	3.48e-01	2.89e-02	4.42e-01	4.15e-01	5.08e-01	1.11e-01	8.95e-01	4.27e-02	5.75e-02	1.99e-02
POSITIVE REGULATION OF NEURON PROJECTION REGENERATION	10	1.96e-01	6.73e-01	0.8650	-4.17e-01	-2.27e-01	-4.57e-01	-4.53e-01	-3.29e-01	2.25e-02	2.14e-01	1.23e-02	1.31e-02	7.17e-02
REGULATION OF MITOCHONDRIAL MRNA STABILITY	7	1.57e-01	6.19e-01	0.8640	4.72e-01	2.49e-01	4.69e-01	4.80e-01	-1.12e-01	3.07e-02	2.53e-01	3.18e-02	2.79e-02	6.07e-01
NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	6	3.37e-01	8.08e-01	0.8640	-4.53e-01	-1.18e-01	-4.70e-01	-4.62e-01	-3.06e-01	5.45e-02	6.18e-01	4.61e-02	5.02e-02	1.95e-01
REGULATION OF HOMOPHILIC CELL ADHESION	5	2.63e-01	7.46e-01	0.8640	-5.39e-01	-2.79e-01	-4.40e-01	-4.04e-01	-1.45e-01	3.70e-02	2.80e-01	8.85e-02	1.17e-01	5.74e-01
REGULATION OF COLLAGEN FIBRIL ORGANIZATION	8	2.58e-01	7.41e-01	0.8610	-4.00e-01	-1.61e-01	-4.86e-01	-4.60e-01	-3.28e-01	4.98e-02	4.31e-01	1.72e-02	2.43e-02	1.08e-01
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN	17	1.37e-03	3.14e-02	0.8610	-4.59e-01	-6.52e-02	-4.63e-01	-4.50e-01	-3.32e-01	1.06e-03	6.42e-01	9.51e-04	1.32e-03	1.79e-02
REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	3.50e-02	2.83e-01	0.8590	4.25e-01	-1.14e-02	5.39e-01	5.11e-01	8.08e-02	3.75e-02	9.56e-01	8.27e-03	1.24e-02	6.92e-01
ETHANOL CATABOLIC PROCESS	10	2.46e-02	2.33e-01	0.8520	-4.39e-01	-3.57e-01	-4.76e-01	-4.23e-01	2.27e-03	1.62e-02	5.07e-02	9.12e-03	2.05e-02	9.90e-01
MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY	25	1.51e-03	3.36e-02	0.8500	3.67e-01	1.21e-01	4.62e-01	4.69e-01	3.74e-01	1.47e-03	2.96e-01	6.34e-05	4.99e-05	1.20e-03
NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS	12	1.17e-01	5.47e-01	0.8490	-4.72e-01	-3.62e-01	-4.04e-01	-4.05e-01	-1.99e-01	4.60e-03	2.99e-02	1.54e-02	1.50e-02	2.33e-01
SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS	9	7.98e-02	4.53e-01	0.8480	3.90e-01	-3.91e-03	5.14e-01	5.12e-01	2.03e-01	4.28e-02	9.84e-01	7.57e-03	7.80e-03	2.91e-01
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA	10	1.19e-01	5.51e-01	0.8480	3.30e-01	8.87e-02	5.24e-01	5.03e-01	2.75e-01	7.09e-02	6.27e-01	4.12e-03	5.90e-03	1.32e-01
AXON MIDLINE CHOICE POINT RECOGNITION	5	1.50e-01	6.11e-01	0.8480	-4.25e-01	-5.56e-01	-2.74e-01	-3.67e-01	-1.38e-01	1.00e-01	3.13e-02	2.89e-01	1.55e-01	5.93e-01
POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	10	1.59e-01	6.21e-01	0.8460	-4.52e-01	-2.46e-01	-4.06e-01	-4.21e-01	-3.29e-01	1.34e-02	1.77e-01	2.60e-02	2.10e-02	7.16e-02
MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION	5	1.54e-01	6.16e-01	0.8400	-3.22e-01	2.08e-01	-4.98e-01	-4.68e-01	-3.03e-01	2.13e-01	4.20e-01	5.37e-02	6.99e-02	2.41e-01
POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION	5	4.81e-01	8.91e-01	0.8360	-3.79e-01	-4.51e-02	-5.01e-01	-4.79e-01	-2.70e-01	1.42e-01	8.61e-01	5.22e-02	6.38e-02	2.96e-01
VITAMIN D BIOSYNTHETIC PROCESS	10	2.29e-02	2.22e-01	0.8360	1.95e-01	4.93e-02	3.86e-01	3.99e-01	5.91e-01	2.87e-01	7.87e-01	3.44e-02	2.87e-02	1.20e-03
STEM CELL FATE SPECIFICATION	6	2.50e-03	4.85e-02	0.8320	-2.28e-01	-6.98e-01	4.52e-03	-1.19e-01	3.72e-01	3.33e-01	3.07e-03	9.85e-01	6.13e-01	1.15e-01
POSITIVE REGULATION OF MITOPHAGY	7	4.30e-01	8.67e-01	0.8310	-3.92e-01	-2.59e-01	-4.30e-01	-4.49e-01	-2.90e-01	7.26e-02	2.36e-01	4.90e-02	3.96e-02	1.84e-01
HINDBRAIN TANGENTIAL CELL MIGRATION	5	4.19e-01	8.59e-01	0.8280	4.27e-01	4.93e-01	3.03e-01	3.25e-01	2.49e-01	9.84e-02	5.61e-02	2.41e-01	2.08e-01	3.34e-01
EXCRETION	29	3.06e-04	9.75e-03	0.8250	4.29e-01	4.40e-01	3.73e-01	4.03e-01	5.54e-03	6.35e-05	4.08e-05	4.99e-04	1.69e-04	9.59e-01
POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	5	4.70e-01	8.84e-01	0.8230	-4.38e-01	-5.32e-01	-3.09e-01	-3.25e-01	3.86e-02	8.97e-02	3.95e-02	2.31e-01	2.08e-01	8.81e-01
MACROPHAGE FUSION	6	4.18e-01	8.58e-01	0.8230	-4.54e-01	-3.49e-01	-4.26e-01	-4.01e-01	-8.13e-02	5.39e-02	1.39e-01	7.08e-02	8.87e-02	7.30e-01
SENSORY PERCEPTION OF BITTER TASTE	44	2.98e-07	2.39e-05	0.8230	-3.69e-01	-7.10e-02	-4.68e-01	-4.35e-01	-3.57e-01	2.23e-05	4.15e-01	7.63e-08	5.96e-07	4.12e-05
NEGATIVE REGULATION OF SYNAPSE ASSEMBLY	8	8.15e-02	4.56e-01	0.8220	-3.97e-01	-5.15e-01	-3.15e-01	-3.77e-01	1.00e-01	5.16e-02	1.16e-02	1.23e-01	6.46e-02	6.24e-01
GASTRIC MOTILITY	5	2.19e-01	7.00e-01	0.8210	-4.04e-01	-6.68e-01	-1.14e-01	-1.53e-01	1.71e-01	1.17e-01	9.72e-03	6.59e-01	5.55e-01	5.09e-01
NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	18	8.29e-05	3.28e-03	0.8210	5.13e-01	3.39e-01	3.04e-01	3.57e-01	-2.76e-01	1.64e-04	1.28e-02	2.57e-02	8.70e-03	4.28e-02
NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION	6	3.02e-01	7.74e-01	0.8190	-4.43e-01	-4.26e-01	-3.23e-01	-3.90e-01	-1.90e-01	6.01e-02	7.06e-02	1.71e-01	9.81e-02	4.20e-01
POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION	8	1.63e-01	6.28e-01	0.8180	3.23e-01	2.39e-01	3.62e-01	3.77e-01	4.85e-01	1.13e-01	2.42e-01	7.65e-02	6.50e-02	1.75e-02
NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION	6	4.86e-01	8.92e-01	0.8170	4.46e-01	4.09e-01	3.88e-01	3.86e-01	3.29e-02	5.83e-02	8.28e-02	1.00e-01	1.02e-01	8.89e-01
REGULATION OF PRIMARY MIRNA PROCESSING	5	4.82e-01	8.91e-01	0.8160	2.96e-01	1.78e-02	4.28e-01	4.05e-01	4.81e-01	2.51e-01	9.45e-01	9.75e-02	1.17e-01	6.27e-02
POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	7	3.94e-01	8.43e-01	0.8150	3.97e-01	1.13e-01	4.58e-01	4.67e-01	2.55e-01	6.91e-02	6.04e-01	3.57e-02	3.24e-02	2.43e-01
7 METHYLGUANOSINE CAP HYPERMETHYLATION	8	8.58e-02	4.67e-01	0.8140	2.66e-01	-3.24e-02	5.21e-01	5.30e-01	1.98e-01	1.93e-01	8.74e-01	1.08e-02	9.47e-03	3.31e-01
OTIC VESICLE FORMATION	8	3.23e-01	7.96e-01	0.8140	-3.75e-01	-3.47e-01	-4.14e-01	-4.19e-01	-2.34e-01	6.59e-02	8.95e-02	4.25e-02	4.04e-02	2.52e-01
PREVENTION OF POLYSPERMY	7	3.37e-02	2.78e-01	0.8140	2.51e-01	4.33e-01	3.88e-01	3.73e-01	3.50e-01	2.50e-01	4.74e-02	7.56e-02	8.73e-02	1.09e-01
RESPIRATORY CHAIN COMPLEX IV ASSEMBLY	29	7.09e-04	1.87e-02	0.8130	3.52e-01	7.99e-02	4.67e-01	4.67e-01	3.08e-01	1.03e-03	4.57e-01	1.36e-05	1.32e-05	4.14e-03
POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	5	2.29e-01	7.13e-01	0.8110	5.58e-02	-3.14e-01	3.84e-01	3.54e-01	5.33e-01	8.29e-01	2.23e-01	1.37e-01	1.71e-01	3.90e-02
PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY	15	5.37e-02	3.63e-01	0.8110	4.57e-01	2.39e-01	4.19e-01	4.46e-01	1.34e-01	2.19e-03	1.10e-01	4.97e-03	2.75e-03	3.70e-01
GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION	10	2.30e-01	7.14e-01	0.8100	4.51e-01	2.33e-01	4.26e-01	4.26e-01	1.89e-01	1.35e-02	2.02e-01	1.97e-02	1.97e-02	3.00e-01
REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	5	4.15e-01	8.55e-01	0.8090	-3.91e-01	-3.92e-01	-3.20e-01	-3.65e-01	-3.37e-01	1.30e-01	1.29e-01	2.15e-01	1.58e-01	1.92e-01
FUCOSE CATABOLIC PROCESS	9	1.21e-01	5.56e-01	0.8090	-3.15e-01	-1.94e-01	-5.11e-01	-4.82e-01	-1.57e-01	1.01e-01	3.12e-01	7.99e-03	1.23e-02	4.16e-01
CELLULAR RESPONSE TO INTERFERON ALPHA	7	2.37e-01	7.20e-01	0.8090	3.03e-01	2.76e-01	4.48e-01	4.19e-01	3.32e-01	1.65e-01	2.06e-01	4.00e-02	5.50e-02	1.28e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	10	2.05e-01	6.84e-01	0.8090	4.37e-01	2.19e-01	4.34e-01	4.18e-01	2.29e-01	1.67e-02	2.32e-01	1.76e-02	2.21e-02	2.11e-01
MICTURITION	8	1.28e-01	5.70e-01	0.8080	4.17e-01	5.00e-01	3.04e-01	3.70e-01	-2.58e-02	4.12e-02	1.43e-02	1.37e-01	7.00e-02	9.00e-01
POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION	16	1.88e-03	3.90e-02	0.8060	4.08e-01	7.26e-02	4.96e-01	4.82e-01	-9.59e-03	4.71e-03	6.15e-01	5.96e-04	8.40e-04	9.47e-01
VENTRAL MIDLINE DEVELOPMENT	6	2.26e-01	7.08e-01	0.8060	5.50e-01	3.91e-01	3.05e-01	3.17e-01	-1.85e-02	1.97e-02	9.68e-02	1.96e-01	1.78e-01	9.37e-01
NUCLEAR MIGRATION ALONG MICROTUBULE	5	5.50e-01	9.15e-01	0.8030	-4.26e-01	-1.48e-01	-4.56e-01	-4.35e-01	-2.09e-01	9.88e-02	5.65e-01	7.72e-02	9.22e-02	4.17e-01
BRONCHIOLE DEVELOPMENT	5	3.85e-01	8.39e-01	0.8030	-4.74e-01	-4.27e-01	-2.95e-01	-3.64e-01	1.35e-01	6.64e-02	9.81e-02	2.54e-01	1.59e-01	6.02e-01
SINOATRIAL NODE CELL DEVELOPMENT	5	1.00e-01	5.08e-01	0.8030	2.55e-02	-4.79e-01	3.43e-01	2.79e-01	4.68e-01	9.21e-01	6.36e-02	1.84e-01	2.80e-01	7.02e-02
PENETRATION OF ZONA PELLUCIDA	9	2.19e-01	7.00e-01	0.8010	4.27e-01	3.38e-01	3.80e-01	4.31e-01	1.16e-01	2.65e-02	7.88e-02	4.85e-02	2.50e-02	5.46e-01
MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE	6	1.29e-01	5.72e-01	0.7990	9.64e-02	-1.92e-01	4.87e-01	4.63e-01	3.74e-01	6.82e-01	4.15e-01	3.90e-02	4.93e-02	1.12e-01
AMMONIUM HOMEOSTASIS	5	2.88e-01	7.66e-01	0.7980	-4.14e-01	-5.95e-01	-2.19e-01	-2.25e-01	-1.10e-01	1.09e-01	2.11e-02	3.97e-01	3.83e-01	6.70e-01
REGULATION OF ADHERENS JUNCTION ORGANIZATION	5	2.83e-01	7.62e-01	0.7970	-4.83e-01	-5.85e-01	-1.37e-01	-1.85e-01	8.37e-02	6.16e-02	2.36e-02	5.95e-01	4.73e-01	7.46e-01
CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION	10	9.30e-03	1.23e-01	0.7930	2.56e-01	-2.55e-01	4.00e-01	3.95e-01	4.27e-01	1.62e-01	1.62e-01	2.84e-02	3.05e-02	1.93e-02
PROTEIN LOCALIZATION TO NUCLEAR BODY	11	1.64e-02	1.77e-01	0.7930	4.56e-01	1.33e-01	4.28e-01	4.61e-01	-8.07e-02	8.75e-03	4.44e-01	1.39e-02	8.12e-03	6.43e-01
MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION	5	4.56e-01	8.78e-01	0.7910	-3.87e-01	-4.22e-01	-3.62e-01	-3.95e-01	1.05e-01	1.34e-01	1.02e-01	1.61e-01	1.26e-01	6.84e-01
RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	15	4.47e-03	7.51e-02	0.7900	-2.43e-01	1.77e-01	-4.32e-01	-4.05e-01	-4.26e-01	1.03e-01	2.34e-01	3.78e-03	6.58e-03	4.24e-03
RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS	8	1.13e-02	1.39e-01	0.7880	1.92e-01	-7.64e-02	5.55e-01	5.20e-01	1.78e-02	3.47e-01	7.08e-01	6.58e-03	1.09e-02	9.30e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	5	5.02e-01	8.98e-01	0.7870	-2.43e-01	-7.22e-02	-4.77e-01	-4.58e-01	-3.41e-01	3.46e-01	7.80e-01	6.46e-02	7.60e-02	1.86e-01
NATURAL KILLER CELL CYTOKINE PRODUCTION	9	4.94e-02	3.47e-01	0.7860	2.73e-01	3.61e-01	3.70e-01	3.52e-01	3.90e-01	1.56e-01	6.08e-02	5.44e-02	6.72e-02	4.28e-02
TRNA 5 LEADER REMOVAL	13	1.24e-01	5.62e-01	0.7860	3.98e-01	1.87e-01	4.51e-01	4.55e-01	1.15e-01	1.30e-02	2.42e-01	4.84e-03	4.47e-03	4.71e-01
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	6	3.39e-01	8.08e-01	0.7860	2.62e-01	7.50e-02	4.39e-01	3.88e-01	4.48e-01	2.67e-01	7.50e-01	6.27e-02	9.96e-02	5.76e-02
NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	6	4.10e-01	8.52e-01	0.7860	-3.79e-01	-3.09e-01	-4.47e-01	-4.20e-01	-4.47e-02	1.08e-01	1.91e-01	5.78e-02	7.47e-02	8.50e-01
PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE	7	2.81e-01	7.60e-01	0.7860	3.00e-01	-2.59e-02	4.64e-01	4.25e-01	3.62e-01	1.69e-01	9.05e-01	3.37e-02	5.15e-02	9.69e-02
DETECTION OF VIRUS	6	1.92e-01	6.66e-01	0.7840	4.42e-01	3.14e-01	4.19e-01	3.71e-01	-8.18e-02	6.06e-02	1.83e-01	7.56e-02	1.16e-01	7.29e-01
POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	16	3.56e-02	2.87e-01	0.7830	3.48e-01	2.99e-01	4.17e-01	4.42e-01	1.81e-01	1.58e-02	3.82e-02	3.85e-03	2.18e-03	2.09e-01
REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	6	2.72e-01	7.53e-01	0.7830	-2.82e-01	1.30e-01	-4.44e-01	-4.19e-01	-3.80e-01	2.32e-01	5.81e-01	5.94e-02	7.57e-02	1.07e-01
DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING	8	1.45e-01	6.03e-01	0.7830	4.50e-01	2.18e-01	4.25e-01	4.17e-01	-9.61e-02	2.74e-02	2.86e-01	3.76e-02	4.13e-02	6.38e-01
REGULATION OF FOREBRAIN NEURON DIFFERENTIATION	5	3.33e-01	8.05e-01	0.7830	3.42e-01	2.48e-02	3.64e-01	3.37e-01	4.99e-01	1.86e-01	9.23e-01	1.59e-01	1.92e-01	5.33e-02
PROTEIN C LINKED GLYCOSYLATION	6	8.23e-02	4.58e-01	0.7810	-2.11e-01	-4.56e-01	3.40e-02	-1.85e-02	5.98e-01	3.72e-01	5.32e-02	8.85e-01	9.38e-01	1.12e-02
NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	6	4.66e-01	8.83e-01	0.7810	3.22e-01	1.50e-01	3.86e-01	4.07e-01	4.12e-01	1.72e-01	5.25e-01	1.01e-01	8.45e-02	8.05e-02
REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS	8	2.96e-01	7.72e-01	0.7810	3.37e-01	8.34e-02	4.04e-01	4.23e-01	3.84e-01	9.90e-02	6.83e-01	4.77e-02	3.84e-02	5.98e-02
MITOCHONDRIAL RNA 3 END PROCESSING	5	3.40e-02	2.79e-01	0.7810	3.67e-01	1.93e-01	1.59e-01	1.83e-01	-6.15e-01	1.55e-01	4.55e-01	5.39e-01	4.80e-01	1.72e-02
PULMONARY ARTERY MORPHOGENESIS	6	4.58e-01	8.79e-01	0.7770	3.76e-01	1.20e-01	4.11e-01	4.46e-01	2.82e-01	1.10e-01	6.10e-01	8.09e-02	5.85e-02	2.32e-01
PERICENTRIC HETEROCHROMATIN FORMATION	5	1.31e-01	5.76e-01	0.7750	2.40e-01	-2.54e-01	4.98e-01	4.50e-01	1.69e-01	3.53e-01	3.26e-01	5.36e-02	8.15e-02	5.13e-01
CEREBRAL CORTEX TANGENTIAL MIGRATION	5	1.99e-01	6.79e-01	0.7750	-3.95e-01	-6.29e-01	-1.13e-01	-1.09e-01	1.54e-01	1.26e-01	1.48e-02	6.62e-01	6.73e-01	5.50e-01
RESPONSE TO GRAM POSITIVE BACTERIUM	5	1.24e-01	5.62e-01	0.7750	3.10e-02	-4.25e-01	2.23e-01	2.05e-01	5.72e-01	9.04e-01	1.00e-01	3.87e-01	4.28e-01	2.68e-02
TRANSLATIONAL TERMINATION	15	3.03e-02	2.62e-01	0.7740	3.28e-01	7.40e-03	4.63e-01	4.70e-01	2.36e-01	2.79e-02	9.60e-01	1.89e-03	1.62e-03	1.13e-01
REGULATION OF CYTOCHROME C OXIDASE ACTIVITY	5	3.78e-01	8.36e-01	0.7740	2.48e-01	-1.36e-01	4.59e-01	4.14e-01	3.69e-01	3.37e-01	5.98e-01	7.55e-02	1.09e-01	1.53e-01
NEGATIVE REGULATION OF LIPASE ACTIVITY	16	7.07e-02	4.27e-01	0.7720	-3.20e-01	-1.70e-01	-4.20e-01	-4.12e-01	-3.45e-01	2.67e-02	2.39e-01	3.63e-03	4.35e-03	1.70e-02
REGULATION OF MONOCYTE EXTRAVASATION	7	3.19e-01	7.91e-01	0.7710	-4.08e-01	-2.87e-01	-3.96e-01	-4.21e-01	1.05e-01	6.18e-02	1.88e-01	6.97e-02	5.38e-02	6.29e-01
FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION	7	1.81e-01	6.56e-01	0.7700	4.39e-01	2.85e-01	4.22e-01	3.76e-01	-1.20e-02	4.42e-02	1.91e-01	5.34e-02	8.51e-02	9.56e-01
CYTOPLASMIC TRANSLATIONAL ELONGATION	5	7.11e-01	9.67e-01	0.7680	3.93e-01	2.31e-01	4.28e-01	4.27e-01	1.27e-01	1.28e-01	3.72e-01	9.74e-02	9.80e-02	6.22e-01
LOBAR BRONCHUS DEVELOPMENT	6	2.77e-01	7.57e-01	0.7660	-3.19e-01	-4.43e-02	-4.32e-01	-3.71e-01	-3.98e-01	1.75e-01	8.51e-01	6.67e-02	1.15e-01	9.11e-02
AMINOPHOSPHOLIPID TRANSLOCATION	6	3.24e-01	7.96e-01	0.7660	-3.42e-01	-8.95e-02	-4.60e-01	-4.93e-01	-8.50e-02	1.47e-01	7.04e-01	5.12e-02	3.66e-02	7.19e-01
TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE	5	5.16e-01	9.02e-01	0.7650	-4.52e-01	-5.10e-01	-2.28e-01	-2.59e-01	3.97e-02	8.00e-02	4.82e-02	3.77e-01	3.17e-01	8.78e-01
REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	7	5.95e-02	3.88e-01	0.7650	4.25e-01	9.45e-02	3.19e-01	2.98e-01	4.53e-01	5.17e-02	6.65e-01	1.44e-01	1.73e-01	3.79e-02
INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY	6	4.83e-01	8.91e-01	0.7630	-3.01e-01	-1.55e-01	-4.03e-01	-3.73e-01	-4.06e-01	2.01e-01	5.11e-01	8.73e-02	1.13e-01	8.51e-02
REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME	5	2.76e-01	7.57e-01	0.7620	-4.64e-01	-4.32e-01	-2.43e-01	-3.38e-01	-7.47e-02	7.22e-02	9.40e-02	3.47e-01	1.91e-01	7.72e-01
RESPONSE TO SORBITOL	6	5.04e-01	8.98e-01	0.7600	-3.85e-01	-3.57e-01	-3.19e-01	-3.34e-01	-2.98e-01	1.02e-01	1.30e-01	1.76e-01	1.56e-01	2.07e-01
PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	10	2.44e-01	7.29e-01	0.7580	4.67e-01	3.45e-01	3.26e-01	3.51e-01	8.70e-02	1.05e-02	5.90e-02	7.39e-02	5.49e-02	6.34e-01
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	8	3.04e-01	7.76e-01	0.7570	-4.04e-01	-3.06e-01	-3.79e-01	-4.09e-01	7.62e-02	4.78e-02	1.34e-01	6.31e-02	4.54e-02	7.09e-01
FATTY ACID ELONGATION SATURATED FATTY ACID	7	2.36e-01	7.19e-01	0.7570	2.11e-01	-1.41e-01	3.94e-01	3.66e-01	4.69e-01	3.34e-01	5.19e-01	7.12e-02	9.34e-02	3.17e-02
POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	5	6.85e-01	9.61e-01	0.7560	3.52e-01	1.06e-01	4.31e-01	4.38e-01	2.44e-01	1.73e-01	6.82e-01	9.54e-02	9.00e-02	3.46e-01
REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE	6	6.60e-01	9.54e-01	0.7550	-4.03e-01	-3.09e-01	-3.72e-01	-3.79e-01	-1.77e-01	8.74e-02	1.90e-01	1.15e-01	1.08e-01	4.52e-01
THROMBOPOIETIN MEDIATED SIGNALING PATHWAY	5	4.13e-01	8.54e-01	0.7550	3.77e-01	3.93e-01	2.55e-01	2.73e-01	3.66e-01	1.45e-01	1.28e-01	3.23e-01	2.90e-01	1.57e-01
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	18	4.83e-03	7.91e-02	0.7530	-3.68e-01	-4.22e-01	-3.26e-01	-3.35e-01	1.89e-01	6.91e-03	1.93e-03	1.67e-02	1.39e-02	1.65e-01
MHC CLASS I BIOSYNTHETIC PROCESS	8	2.90e-02	2.55e-01	0.7520	-4.02e-01	-2.13e-01	-2.23e-01	-2.37e-01	-5.03e-01	4.92e-02	2.96e-01	2.74e-01	2.47e-01	1.38e-02
FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	13	3.58e-02	2.88e-01	0.7510	2.25e-01	9.09e-02	3.51e-01	3.63e-01	5.01e-01	1.61e-01	5.70e-01	2.84e-02	2.34e-02	1.77e-03
REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	5	3.82e-01	8.38e-01	0.7510	-2.45e-01	-2.18e-01	-4.43e-01	-4.58e-01	-2.24e-01	3.42e-01	3.99e-01	8.62e-02	7.59e-02	3.85e-01
CYTOCHROME COMPLEX ASSEMBLY	38	8.97e-05	3.49e-03	0.7500	2.96e-01	2.18e-02	4.46e-01	4.32e-01	2.99e-01	1.60e-03	8.16e-01	1.95e-06	4.00e-06	1.44e-03
DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM	10	2.00e-02	2.03e-01	0.7490	-3.87e-01	-3.86e-01	-3.13e-01	-2.82e-01	2.92e-01	3.41e-02	3.44e-02	8.68e-02	1.23e-01	1.10e-01
ANTIMICROBIAL PEPTIDE PRODUCTION	11	2.83e-02	2.52e-01	0.7490	-3.46e-01	-8.71e-02	-4.91e-01	-4.30e-01	-8.77e-02	4.71e-02	6.17e-01	4.84e-03	1.34e-02	6.15e-01
REGULATION OF PROTEIN FOLDING	8	1.19e-01	5.50e-01	0.7480	1.72e-01	-2.24e-01	4.33e-01	4.01e-01	3.64e-01	3.99e-01	2.73e-01	3.41e-02	4.94e-02	7.49e-02
FOREBRAIN NEURON FATE COMMITMENT	7	9.76e-03	1.27e-01	0.7480	3.31e-01	-2.31e-01	4.02e-01	3.40e-01	3.45e-01	1.29e-01	2.90e-01	6.53e-02	1.19e-01	1.13e-01
REGULATION OF PROTEIN MONOUBIQUITINATION	6	2.65e-01	7.47e-01	0.7470	3.20e-01	9.06e-02	4.55e-01	3.84e-01	3.05e-01	1.75e-01	7.01e-01	5.34e-02	1.04e-01	1.96e-01
REGULATION OF ODONTOBLAST DIFFERENTIATION	5	4.60e-01	8.80e-01	0.7470	-3.60e-01	-3.36e-01	-2.95e-01	-3.48e-01	-3.27e-01	1.64e-01	1.94e-01	2.53e-01	1.78e-01	2.05e-01
SYNAPTIC SIGNALING VIA NEUROPEPTIDE	6	2.77e-03	5.23e-02	0.7450	-3.76e-02	-5.28e-01	1.89e-02	-6.21e-02	5.21e-01	8.73e-01	2.52e-02	9.36e-01	7.92e-01	2.72e-02
COMMA SHAPED BODY MORPHOGENESIS	5	3.31e-02	2.76e-01	0.7450	3.80e-01	3.61e-02	4.11e-01	2.98e-01	3.89e-01	1.41e-01	8.89e-01	1.11e-01	2.49e-01	1.32e-01
CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION	19	1.57e-02	1.72e-01	0.7450	-3.62e-01	-2.83e-01	-3.97e-01	-4.31e-01	-2.40e-02	6.33e-03	3.26e-02	2.76e-03	1.13e-03	8.56e-01
GLYCINE IMPORT ACROSS PLASMA MEMBRANE	5	2.45e-01	7.30e-01	0.7450	5.00e-01	3.75e-01	2.38e-01	2.42e-01	-2.21e-01	5.28e-02	1.47e-01	3.56e-01	3.48e-01	3.92e-01
MAMMALIAN OOGENESIS STAGE	12	1.09e-02	1.35e-01	0.7450	-3.78e-01	-5.10e-01	-1.79e-01	-2.09e-01	-2.77e-01	2.35e-02	2.23e-03	2.82e-01	2.09e-01	9.69e-02
POSITIVE REGULATION OF RRNA PROCESSING	10	2.04e-01	6.84e-01	0.7420	3.77e-01	1.43e-01	4.45e-01	4.17e-01	1.30e-01	3.88e-02	4.34e-01	1.48e-02	2.25e-02	4.77e-01
SKELETAL MUSCLE THIN FILAMENT ASSEMBLY	7	1.16e-01	5.45e-01	0.7400	-2.35e-01	-2.49e-01	-4.60e-01	-4.58e-01	-9.43e-02	2.81e-01	2.53e-01	3.50e-02	3.59e-02	6.66e-01
T HELPER 2 CELL CYTOKINE PRODUCTION	13	1.55e-01	6.17e-01	0.7390	-3.84e-01	-2.50e-01	-4.01e-01	-4.18e-01	-2.44e-02	1.66e-02	1.19e-01	1.22e-02	8.99e-03	8.79e-01
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	6	5.31e-01	9.07e-01	0.7390	3.74e-01	9.99e-02	3.99e-01	4.23e-01	2.40e-01	1.12e-01	6.72e-01	9.01e-02	7.30e-02	3.08e-01
B 1 B CELL DIFFERENTIATION	5	5.33e-01	9.09e-01	0.7360	4.88e-01	3.71e-01	2.72e-01	3.04e-01	1.19e-02	5.90e-02	1.50e-01	2.92e-01	2.40e-01	9.63e-01
REGULATION OF CONNECTIVE TISSUE REPLACEMENT	15	1.36e-01	5.87e-01	0.7360	-3.76e-01	-2.58e-01	-3.95e-01	-3.79e-01	-1.81e-01	1.16e-02	8.34e-02	8.02e-03	1.10e-02	2.25e-01
NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	9	1.47e-01	6.06e-01	0.7350	3.42e-01	-4.19e-02	4.28e-01	4.29e-01	2.33e-01	7.55e-02	8.28e-01	2.60e-02	2.60e-02	2.26e-01
CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	15	1.51e-01	6.13e-01	0.7350	3.34e-01	2.08e-01	4.16e-01	4.12e-01	2.06e-01	2.49e-02	1.62e-01	5.29e-03	5.77e-03	1.67e-01
REGULATION OF BASEMENT MEMBRANE ORGANIZATION	11	2.70e-01	7.50e-01	0.7350	-4.16e-01	-2.73e-01	-3.75e-01	-3.88e-01	-2.80e-02	1.70e-02	1.16e-01	3.12e-02	2.59e-02	8.72e-01
PYRIMIDINE CONTAINING COMPOUND SALVAGE	7	1.74e-02	1.85e-01	0.7330	-2.33e-01	-4.49e-01	-2.95e-01	-2.67e-01	3.51e-01	2.86e-01	3.96e-02	1.76e-01	2.21e-01	1.08e-01
NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	14	5.50e-02	3.68e-01	0.7310	2.06e-01	-3.32e-02	4.07e-01	4.05e-01	4.00e-01	1.82e-01	8.30e-01	8.32e-03	8.64e-03	9.48e-03
REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	8	7.13e-02	4.29e-01	0.7300	-3.14e-01	-1.76e-01	-3.77e-01	-4.57e-01	-2.30e-01	1.24e-01	3.89e-01	6.46e-02	2.53e-02	2.60e-01
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE	46	2.44e-06	1.56e-04	0.7300	-2.90e-01	-9.71e-03	-4.37e-01	-4.00e-01	-3.13e-01	6.66e-04	9.09e-01	2.95e-07	2.65e-06	2.43e-04
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	9	3.34e-02	2.76e-01	0.7290	3.90e-01	5.80e-02	4.08e-01	4.40e-01	-1.26e-01	4.25e-02	7.63e-01	3.41e-02	2.24e-02	5.13e-01
REGULATION OF PHENOTYPIC SWITCHING	6	6.85e-02	4.20e-01	0.7290	-2.44e-01	-3.39e-01	-3.19e-01	-3.22e-01	3.88e-01	3.00e-01	1.50e-01	1.76e-01	1.72e-01	9.94e-02
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	22	1.03e-02	1.30e-01	0.7290	-3.14e-01	-6.75e-02	-4.43e-01	-4.09e-01	-2.55e-01	1.08e-02	5.84e-01	3.25e-04	9.04e-04	3.86e-02
CILIARY BODY MORPHOGENESIS	5	7.15e-01	9.68e-01	0.7280	3.57e-01	3.08e-01	3.63e-01	3.91e-01	1.51e-01	1.67e-01	2.33e-01	1.59e-01	1.30e-01	5.58e-01
REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS	7	5.54e-01	9.16e-01	0.7280	-3.57e-01	-3.38e-01	-3.51e-01	-3.56e-01	-1.94e-01	1.02e-01	1.22e-01	1.08e-01	1.02e-01	3.74e-01
CYTOPLASMIC TRANSLATION	141	2.91e-21	1.82e-18	0.7270	3.32e-01	1.04e-01	4.44e-01	4.54e-01	6.25e-02	9.24e-12	3.36e-02	8.00e-20	1.29e-20	2.00e-01
REGULATION OF URINE VOLUME	20	6.14e-03	9.37e-02	0.7260	4.13e-01	2.21e-01	3.96e-01	3.84e-01	-6.10e-02	1.37e-03	8.73e-02	2.16e-03	2.96e-03	6.37e-01
ENDOCARDIAL CELL DIFFERENTIATION	6	4.29e-01	8.66e-01	0.7260	-4.12e-01	-4.84e-01	-2.14e-01	-2.67e-01	7.84e-02	8.04e-02	4.01e-02	3.64e-01	2.57e-01	7.39e-01
SINOATRIAL NODE CELL DIFFERENTIATION	6	1.60e-01	6.21e-01	0.7250	1.60e-01	-3.05e-01	3.64e-01	3.26e-01	4.11e-01	4.97e-01	1.96e-01	1.22e-01	1.67e-01	8.10e-02
POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN	5	2.00e-01	6.80e-01	0.7250	4.80e-01	1.83e-01	2.65e-01	3.13e-01	3.06e-01	6.33e-02	4.79e-01	3.04e-01	2.25e-01	2.35e-01
NEUTROPHIL DIFFERENTIATION	11	1.59e-01	6.21e-01	0.7250	3.80e-01	2.02e-01	3.19e-01	3.33e-01	3.57e-01	2.89e-02	2.47e-01	6.70e-02	5.57e-02	4.01e-02
REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	7	4.56e-02	3.33e-01	0.7240	1.85e-01	1.74e-01	3.16e-01	3.78e-01	4.65e-01	3.96e-01	4.25e-01	1.48e-01	8.32e-02	3.31e-02
ASPARTATE METABOLIC PROCESS	8	1.54e-01	6.16e-01	0.7220	-1.69e-01	7.15e-02	-3.14e-01	-2.79e-01	-5.58e-01	4.07e-01	7.26e-01	1.24e-01	1.72e-01	6.28e-03
POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY	6	1.77e-01	6.47e-01	0.7220	-3.00e-01	-4.45e-01	-1.77e-01	-1.79e-01	4.12e-01	2.02e-01	5.91e-02	4.53e-01	4.49e-01	8.07e-02
NEURONAL DENSE CORE VESICLE EXOCYTOSIS	7	4.11e-01	8.53e-01	0.7210	2.94e-01	3.56e-02	3.95e-01	4.19e-01	3.18e-01	1.78e-01	8.71e-01	7.04e-02	5.48e-02	1.45e-01
MESENCHYMAL STEM CELL PROLIFERATION	10	3.23e-01	7.96e-01	0.7210	-3.83e-01	-2.37e-01	-3.41e-01	-3.43e-01	-2.90e-01	3.61e-02	1.95e-01	6.22e-02	6.03e-02	1.13e-01
SYNAPTIC VESICLE DOCKING	10	9.59e-02	4.94e-01	0.7210	2.93e-01	3.17e-01	3.96e-01	4.20e-01	3.24e-02	1.09e-01	8.25e-02	3.03e-02	2.16e-02	8.59e-01
ER OVERLOAD RESPONSE	11	2.05e-01	6.84e-01	0.7200	3.56e-01	9.29e-02	3.80e-01	3.70e-01	3.19e-01	4.09e-02	5.94e-01	2.89e-02	3.37e-02	6.67e-02
POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	6	5.92e-01	9.32e-01	0.7200	-4.46e-01	-3.56e-01	-2.96e-01	-3.21e-01	-4.85e-02	5.87e-02	1.31e-01	2.09e-01	1.73e-01	8.37e-01
MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION	5	4.03e-01	8.48e-01	0.7190	-3.34e-01	-4.07e-01	-3.31e-01	-3.15e-01	1.78e-01	1.96e-01	1.15e-01	2.00e-01	2.22e-01	4.92e-01
HIS PURKINJE SYSTEM DEVELOPMENT	7	1.46e-02	1.64e-01	0.7170	2.98e-01	-2.72e-01	3.39e-01	3.10e-01	3.73e-01	1.73e-01	2.12e-01	1.20e-01	1.55e-01	8.72e-02
TELOMERASE HOLOENZYME COMPLEX ASSEMBLY	6	4.35e-01	8.69e-01	0.7160	3.44e-01	2.58e-01	4.23e-01	3.83e-01	4.73e-02	1.45e-01	2.74e-01	7.29e-02	1.04e-01	8.41e-01
ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	10	3.16e-01	7.88e-01	0.7150	4.15e-01	3.20e-01	3.43e-01	3.45e-01	-9.84e-03	2.30e-02	7.95e-02	6.05e-02	5.91e-02	9.57e-01
POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	5	4.14e-01	8.54e-01	0.7150	3.90e-01	8.96e-02	3.47e-01	4.01e-01	2.64e-01	1.31e-01	7.29e-01	1.79e-01	1.20e-01	3.06e-01
RESPONSE TO NITROSATIVE STRESS	10	2.69e-01	7.49e-01	0.7140	3.87e-01	1.43e-01	4.08e-01	3.91e-01	1.41e-01	3.39e-02	4.33e-01	2.55e-02	3.21e-02	4.41e-01
REGULATION OF DNA LIGATION	6	1.46e-01	6.04e-01	0.7140	2.67e-01	-3.05e-02	4.48e-01	4.86e-01	1.36e-02	2.58e-01	8.97e-01	5.72e-02	3.93e-02	9.54e-01
REGULATION OF MYOFIBROBLAST DIFFERENTIATION	9	4.12e-02	3.10e-01	0.7100	1.68e-01	1.66e-01	3.69e-01	3.09e-01	4.64e-01	3.82e-01	3.89e-01	5.49e-02	1.08e-01	1.59e-02
NEGATIVE REGULATION OF CHROMATIN ORGANIZATION	5	7.69e-01	9.76e-01	0.7090	-3.34e-01	-1.43e-01	-3.81e-01	-3.87e-01	-2.77e-01	1.96e-01	5.81e-01	1.40e-01	1.34e-01	2.84e-01
POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	8	8.27e-02	4.59e-01	0.7090	-3.64e-01	-2.76e-01	-2.79e-01	-2.87e-01	3.66e-01	7.43e-02	1.76e-01	1.72e-01	1.60e-01	7.32e-02
CHONDROBLAST DIFFERENTIATION	5	2.31e-01	7.14e-01	0.7090	-1.96e-01	-5.11e-01	-4.11e-03	-3.88e-02	4.49e-01	4.47e-01	4.78e-02	9.87e-01	8.81e-01	8.22e-02
NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM	6	1.60e-02	1.74e-01	0.7080	-1.67e-01	-4.12e-01	-3.43e-01	-3.52e-01	2.49e-01	4.80e-01	8.07e-02	1.46e-01	1.35e-01	2.91e-01
POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS	7	1.98e-01	6.77e-01	0.7070	-4.48e-01	-3.84e-01	-1.96e-01	-2.23e-01	2.52e-01	4.00e-02	7.89e-02	3.70e-01	3.06e-01	2.48e-01
POSITIVE REGULATION OF PLATELET ACTIVATION	9	4.58e-01	8.79e-01	0.7060	-3.66e-01	-2.25e-01	-3.81e-01	-4.01e-01	-9.21e-02	5.76e-02	2.42e-01	4.78e-02	3.73e-02	6.32e-01
POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION	9	1.69e-01	6.37e-01	0.7040	-3.32e-01	-2.91e-01	-3.61e-01	-3.86e-01	1.48e-01	8.46e-02	1.31e-01	6.07e-02	4.50e-02	4.41e-01
PROTEIN RETENTION IN GOLGI APPARATUS	5	6.85e-01	9.61e-01	0.7040	-3.16e-01	-1.41e-01	-4.35e-01	-4.21e-01	-1.04e-01	2.21e-01	5.86e-01	9.24e-02	1.03e-01	6.89e-01
KETONE BODY METABOLIC PROCESS	10	8.67e-02	4.68e-01	0.7040	-1.98e-01	-5.04e-02	-4.30e-01	-4.50e-01	-2.58e-01	2.78e-01	7.83e-01	1.85e-02	1.38e-02	1.57e-01
LEUKOTRIENE D4 BIOSYNTHETIC PROCESS	6	6.23e-02	3.99e-01	0.7030	-1.50e-01	5.86e-02	-4.20e-01	-3.05e-01	-4.47e-01	5.25e-01	8.04e-01	7.51e-02	1.96e-01	5.81e-02
TRNA 5 END PROCESSING	15	6.17e-02	3.97e-01	0.7030	3.47e-01	1.13e-01	4.26e-01	4.23e-01	3.34e-02	2.00e-02	4.49e-01	4.28e-03	4.59e-03	8.23e-01
RESPONSE TO SODIUM PHOSPHATE	7	4.49e-01	8.75e-01	0.7020	4.31e-01	2.85e-01	3.41e-01	3.32e-01	4.69e-03	4.81e-02	1.92e-01	1.18e-01	1.28e-01	9.83e-01
REGULATION OF T CELL COSTIMULATION	5	2.98e-01	7.72e-01	0.7020	3.32e-01	4.01e-01	2.83e-01	2.36e-01	2.92e-01	1.99e-01	1.20e-01	2.73e-01	3.62e-01	2.58e-01
REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	5	2.88e-01	7.66e-01	0.7020	1.17e-01	-3.57e-03	4.61e-01	4.41e-01	2.66e-01	6.51e-01	9.89e-01	7.39e-02	8.73e-02	3.03e-01
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	10	2.63e-01	7.46e-01	0.7020	-4.45e-01	-3.17e-01	-3.00e-01	-3.22e-01	8.32e-03	1.48e-02	8.31e-02	1.01e-01	7.79e-02	9.64e-01
ANTIFUNGAL INNATE IMMUNE RESPONSE	19	2.69e-02	2.46e-01	0.7010	-3.30e-01	-1.17e-01	-3.96e-01	-3.58e-01	-2.89e-01	1.28e-02	3.79e-01	2.81e-03	6.86e-03	2.89e-02
NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS	8	1.65e-01	6.31e-01	0.7010	3.05e-01	4.95e-01	2.67e-01	2.77e-01	6.56e-02	1.36e-01	1.53e-02	1.90e-01	1.74e-01	7.48e-01
ELASTIC FIBER ASSEMBLY	9	3.98e-01	8.45e-01	0.7010	-2.93e-01	-2.26e-01	-3.58e-01	-3.54e-01	-3.18e-01	1.28e-01	2.41e-01	6.31e-02	6.59e-02	9.88e-02
NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	1.91e-01	6.64e-01	0.7000	2.97e-01	3.94e-02	4.56e-01	4.33e-01	7.01e-02	1.22e-01	8.38e-01	1.78e-02	2.45e-02	7.16e-01
BUD ELONGATION INVOLVED IN LUNG BRANCHING	7	1.50e-01	6.11e-01	0.7000	3.83e-01	1.38e-01	4.20e-01	3.76e-01	-7.85e-02	7.93e-02	5.28e-01	5.41e-02	8.50e-02	7.19e-01
REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION	9	1.01e-02	1.29e-01	0.7000	-3.68e-01	5.33e-02	-4.40e-01	-3.67e-01	-1.51e-01	5.56e-02	7.82e-01	2.22e-02	5.67e-02	4.34e-01
PROTEIN TO MEMBRANE DOCKING	5	2.77e-01	7.57e-01	0.7000	4.60e-01	8.77e-02	3.66e-01	3.70e-01	-4.42e-03	7.52e-02	7.34e-01	1.56e-01	1.52e-01	9.86e-01
RESPONSE TO ACTINOMYCIN D	5	3.86e-01	8.40e-01	0.6990	3.69e-01	2.27e-01	3.28e-01	3.50e-01	-2.65e-01	1.53e-01	3.79e-01	2.03e-01	1.75e-01	3.04e-01
SNRNA MODIFICATION	6	2.35e-01	7.19e-01	0.6990	3.92e-01	1.49e-01	3.74e-01	3.68e-01	-1.93e-01	9.67e-02	5.28e-01	1.12e-01	1.18e-01	4.14e-01
POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	1.97e-01	6.75e-01	0.6990	-3.54e-01	-1.78e-01	-4.09e-01	-3.39e-01	-2.22e-01	1.05e-01	4.15e-01	6.12e-02	1.20e-01	3.10e-01
MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	16	1.27e-01	5.69e-01	0.6970	3.10e-01	1.13e-01	4.19e-01	4.05e-01	1.92e-01	3.17e-02	4.34e-01	3.70e-03	5.01e-03	1.83e-01
CORTICOSPINAL TRACT MORPHOGENESIS	8	4.45e-01	8.73e-01	0.6970	-3.52e-01	-3.87e-01	-2.96e-01	-3.08e-01	-1.70e-01	8.43e-02	5.79e-02	1.47e-01	1.31e-01	4.05e-01
REGULATION OF MITOCHONDRIAL TRANSCRIPTION	5	1.77e-01	6.47e-01	0.6960	-4.17e-03	-2.38e-01	3.93e-01	3.01e-01	4.27e-01	9.87e-01	3.56e-01	1.28e-01	2.44e-01	9.79e-02
NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	9	2.88e-01	7.66e-01	0.6960	2.21e-01	-4.54e-02	3.74e-01	3.54e-01	4.10e-01	2.52e-01	8.14e-01	5.18e-02	6.61e-02	3.33e-02
THYROID HORMONE MEDIATED SIGNALING PATHWAY	8	1.24e-01	5.63e-01	0.6960	-3.07e-01	-1.70e-01	-3.96e-01	-4.29e-01	1.44e-01	1.33e-01	4.06e-01	5.25e-02	3.58e-02	4.81e-01
GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY	8	3.14e-01	7.86e-01	0.6940	3.89e-01	4.41e-01	2.19e-01	2.53e-01	1.53e-01	5.64e-02	3.07e-02	2.84e-01	2.16e-01	4.54e-01
ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS	12	5.13e-02	3.55e-01	0.6940	1.09e-01	-2.14e-01	3.71e-01	3.47e-01	4.06e-01	5.13e-01	1.99e-01	2.60e-02	3.72e-02	1.48e-02
GOLGI TO ENDOSOME TRANSPORT	17	1.15e-01	5.44e-01	0.6930	-3.51e-01	-2.75e-01	-3.18e-01	-3.35e-01	-2.60e-01	1.21e-02	4.98e-02	2.31e-02	1.67e-02	6.34e-02
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN	6	1.46e-01	6.03e-01	0.6920	1.81e-01	3.04e-01	-1.40e-01	-9.57e-02	-5.70e-01	4.43e-01	1.97e-01	5.53e-01	6.85e-01	1.56e-02
NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE	6	3.02e-01	7.74e-01	0.6920	-2.83e-01	-1.47e-01	-4.25e-01	-4.31e-01	1.01e-01	2.30e-01	5.34e-01	7.13e-02	6.73e-02	6.69e-01
APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY	7	2.03e-01	6.82e-01	0.6920	-2.19e-01	9.75e-02	-3.14e-01	-2.74e-01	-4.98e-01	3.17e-01	6.55e-01	1.51e-01	2.09e-01	2.26e-02
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	6	1.76e-01	6.47e-01	0.6910	-2.44e-01	-5.46e-01	-6.80e-02	-1.15e-01	3.20e-01	3.00e-01	2.06e-02	7.73e-01	6.25e-01	1.75e-01
AIM2 INFLAMMASOME COMPLEX ASSEMBLY	5	4.89e-02	3.45e-01	0.6900	-3.59e-01	-2.96e-01	-2.73e-01	-1.98e-01	3.82e-01	1.64e-01	2.52e-01	2.91e-01	4.43e-01	1.39e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	5	2.24e-01	7.06e-01	0.6900	-2.44e-01	-4.61e-01	-3.02e-01	-3.32e-01	5.34e-02	3.45e-01	7.43e-02	2.43e-01	1.99e-01	8.36e-01
CELLULAR RESPONSE TO L GLUTAMATE	5	7.39e-01	9.73e-01	0.6890	2.74e-01	1.87e-01	3.88e-01	3.87e-01	2.55e-01	2.88e-01	4.69e-01	1.33e-01	1.34e-01	3.23e-01
POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	6	3.98e-01	8.45e-01	0.6890	-4.22e-01	-2.92e-01	-2.55e-01	-3.11e-01	-2.22e-01	7.32e-02	2.16e-01	2.79e-01	1.86e-01	3.46e-01
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION	13	1.51e-01	6.13e-01	0.6890	3.38e-01	4.41e-02	3.95e-01	3.88e-01	2.29e-01	3.50e-02	7.83e-01	1.37e-02	1.55e-02	1.54e-01
GLUTATHIONE TRANSMEMBRANE TRANSPORT	7	4.47e-01	8.74e-01	0.6880	-3.28e-01	-3.74e-01	-3.00e-01	-3.38e-01	-1.46e-01	1.33e-01	8.66e-02	1.69e-01	1.21e-01	5.05e-01
L SERINE CATABOLIC PROCESS	5	1.05e-01	5.17e-01	0.6870	3.86e-01	5.66e-01	-4.83e-02	-2.15e-02	2.82e-02	1.35e-01	2.85e-02	8.52e-01	9.34e-01	9.13e-01
LEUKOTRIENE D4 METABOLIC PROCESS	8	5.08e-02	3.53e-01	0.6870	-1.22e-01	9.90e-02	-4.06e-01	-3.10e-01	-4.32e-01	5.52e-01	6.28e-01	4.70e-02	1.29e-01	3.43e-02
PROGESTERONE BIOSYNTHETIC PROCESS	6	3.98e-01	8.45e-01	0.6870	3.33e-01	2.69e-01	3.51e-01	3.57e-01	-1.93e-01	1.58e-01	2.54e-01	1.37e-01	1.29e-01	4.12e-01
RIBOSOMAL SMALL SUBUNIT BIOGENESIS	101	1.98e-12	3.63e-10	0.6860	3.22e-01	1.21e-01	4.15e-01	4.21e-01	5.23e-02	2.17e-08	3.53e-02	5.63e-13	2.60e-13	3.64e-01
MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE	5	3.71e-01	8.31e-01	0.6850	4.63e-01	1.60e-01	2.98e-01	3.34e-01	1.69e-01	7.29e-02	5.34e-01	2.49e-01	1.96e-01	5.12e-01
DUCTUS ARTERIOSUS CLOSURE	5	4.86e-01	8.92e-01	0.6850	2.88e-01	6.09e-02	2.77e-01	2.91e-01	4.70e-01	2.64e-01	8.14e-01	2.84e-01	2.60e-01	6.87e-02
CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION	8	1.47e-01	6.05e-01	0.6840	-2.75e-01	1.50e-01	-4.00e-01	-3.94e-01	-2.37e-01	1.79e-01	4.64e-01	5.03e-02	5.37e-02	2.46e-01
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	8	1.45e-01	6.03e-01	0.6840	3.74e-01	3.55e-03	4.00e-01	4.08e-01	3.45e-02	6.67e-02	9.86e-01	5.02e-02	4.55e-02	8.66e-01
ONCOGENE INDUCED CELL SENESCENCE	6	3.49e-01	8.18e-01	0.6830	-3.84e-01	-4.64e-01	-1.70e-01	-2.23e-01	-1.59e-01	1.03e-01	4.91e-02	4.72e-01	3.45e-01	4.99e-01
RRNA TRANSPORT	5	2.63e-01	7.46e-01	0.6830	2.96e-01	2.55e-03	4.15e-01	4.37e-01	-1.25e-01	2.51e-01	9.92e-01	1.08e-01	9.06e-02	6.27e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK	5	6.30e-01	9.46e-01	0.6830	3.46e-01	3.17e-01	2.61e-01	2.78e-01	3.17e-01	1.81e-01	2.19e-01	3.13e-01	2.82e-01	2.19e-01
DTMP METABOLIC PROCESS	6	2.70e-01	7.50e-01	0.6830	2.22e-01	-1.46e-01	2.99e-01	3.10e-01	4.58e-01	3.46e-01	5.34e-01	2.04e-01	1.88e-01	5.21e-02
POST EMBRYONIC EYE MORPHOGENESIS	7	1.64e-01	6.28e-01	0.6820	-3.05e-01	-4.54e-01	-7.46e-02	-8.06e-02	3.94e-01	1.63e-01	3.77e-02	7.32e-01	7.12e-01	7.14e-02
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS	32	6.34e-03	9.56e-02	0.6820	3.10e-01	1.15e-01	4.07e-01	3.92e-01	1.93e-01	2.42e-03	2.60e-01	6.87e-05	1.23e-04	5.94e-02
MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION	6	4.20e-03	7.14e-02	0.6820	3.31e-01	2.34e-01	1.46e-01	2.84e-01	4.46e-01	1.60e-01	3.22e-01	5.37e-01	2.28e-01	5.85e-02
REGULATION OF MESONEPHROS DEVELOPMENT	5	3.78e-01	8.36e-01	0.6820	9.72e-02	-2.80e-01	3.73e-01	3.28e-01	3.61e-01	7.07e-01	2.78e-01	1.48e-01	2.04e-01	1.62e-01
REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC	9	4.55e-01	8.78e-01	0.6810	2.77e-01	6.28e-02	3.99e-01	3.95e-01	2.62e-01	1.51e-01	7.44e-01	3.83e-02	4.03e-02	1.74e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS	17	8.03e-02	4.53e-01	0.6810	3.10e-01	6.81e-02	4.17e-01	4.05e-01	1.56e-01	2.67e-02	6.27e-01	2.88e-03	3.86e-03	2.67e-01
NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION	7	5.14e-01	9.01e-01	0.6800	4.12e-01	2.84e-01	3.07e-01	3.42e-01	-3.27e-02	5.92e-02	1.93e-01	1.59e-01	1.17e-01	8.81e-01
TRNA PSEUDOURIDINE SYNTHESIS	6	5.09e-01	9.00e-01	0.6800	3.68e-01	1.50e-01	3.79e-01	4.00e-01	-3.43e-02	1.19e-01	5.24e-01	1.08e-01	9.01e-02	8.84e-01
REGULATION OF DEFENSE RESPONSE TO FUNGUS	5	8.03e-01	9.82e-01	0.6790	-3.80e-01	-2.54e-01	-3.25e-01	-3.42e-01	-1.73e-01	1.41e-01	3.26e-01	2.08e-01	1.85e-01	5.02e-01
POSITIVE THYMIC T CELL SELECTION	14	4.55e-02	3.33e-01	0.6790	3.42e-01	4.96e-01	1.66e-01	1.94e-01	-1.81e-01	2.66e-02	1.32e-03	2.81e-01	2.09e-01	2.42e-01
NEURAL CREST CELL FATE COMMITMENT	6	6.18e-01	9.42e-01	0.6760	3.35e-01	1.81e-01	3.85e-01	4.04e-01	2.05e-02	1.55e-01	4.42e-01	1.03e-01	8.67e-02	9.31e-01
REGULATION OF ELECTRON TRANSFER ACTIVITY	6	2.46e-01	7.32e-01	0.6760	1.65e-01	-2.27e-01	3.80e-01	3.22e-01	3.60e-01	4.84e-01	3.36e-01	1.07e-01	1.72e-01	1.27e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB	18	8.31e-02	4.59e-01	0.6750	2.95e-01	1.99e-01	3.67e-01	3.91e-01	2.04e-01	3.04e-02	1.43e-01	7.05e-03	4.08e-03	1.34e-01
FATTY ACID ALPHA OXIDATION	8	2.73e-01	7.55e-01	0.6740	3.14e-01	4.40e-01	2.70e-01	2.64e-01	1.44e-01	1.24e-01	3.13e-02	1.87e-01	1.96e-01	4.81e-01
REGULATION OF T CIRCLE FORMATION	5	1.59e-01	6.20e-01	0.6740	-2.44e-01	-3.91e-01	-1.96e-01	-1.60e-01	4.23e-01	3.46e-01	1.30e-01	4.47e-01	5.36e-01	1.02e-01
ACTIVATION OF MEIOSIS	6	4.23e-01	8.61e-01	0.6740	-2.02e-01	-1.22e-01	-3.64e-01	-3.88e-01	-3.40e-01	3.92e-01	6.05e-01	1.23e-01	9.95e-02	1.49e-01
INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY	8	1.11e-01	5.34e-01	0.6740	3.67e-01	5.10e-01	1.08e-01	1.48e-01	1.60e-01	7.25e-02	1.24e-02	5.97e-01	4.67e-01	4.33e-01
CELLULAR RESPONSE TO NICOTINE	8	2.13e-02	2.12e-01	0.6740	2.19e-01	2.18e-01	2.21e-01	3.01e-01	4.67e-01	2.83e-01	2.86e-01	2.78e-01	1.40e-01	2.21e-02
REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	7	6.74e-02	4.16e-01	0.6730	-2.64e-01	-5.22e-01	1.52e-01	1.27e-01	2.68e-01	2.27e-01	1.68e-02	4.87e-01	5.61e-01	2.20e-01
NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	12	1.28e-01	5.72e-01	0.6720	4.35e-01	1.98e-01	3.20e-01	3.36e-01	8.96e-02	9.00e-03	2.35e-01	5.49e-02	4.41e-02	5.91e-01
T FOLLICULAR HELPER CELL DIFFERENTIATION	7	7.52e-02	4.40e-01	0.6720	-4.37e-01	-2.02e-01	-2.03e-01	-2.38e-01	-3.49e-01	4.53e-02	3.54e-01	3.53e-01	2.76e-01	1.10e-01
OMEGA HYDROXYLASE P450 PATHWAY	11	1.37e-01	5.87e-01	0.6710	3.57e-01	3.74e-01	2.50e-01	2.61e-01	-2.30e-01	4.04e-02	3.15e-02	1.52e-01	1.35e-01	1.86e-01
REGULATION OF MYELOID DENDRITIC CELL ACTIVATION	5	5.02e-01	8.98e-01	0.6710	4.28e-01	3.84e-01	2.04e-01	2.72e-01	6.02e-02	9.73e-02	1.37e-01	4.29e-01	2.91e-01	8.16e-01
NATURAL KILLER CELL CHEMOTAXIS	10	1.37e-02	1.57e-01	0.6710	2.02e-01	3.88e-01	2.34e-01	2.14e-01	3.98e-01	2.69e-01	3.37e-02	2.00e-01	2.42e-01	2.94e-02
CHROMATIN LOOPING	11	1.49e-01	6.10e-01	0.6710	2.51e-01	3.03e-02	3.20e-01	2.92e-01	4.45e-01	1.50e-01	8.62e-01	6.59e-02	9.33e-02	1.06e-02
ROUNDABOUT SIGNALING PATHWAY	5	6.45e-01	9.50e-01	0.6700	-3.65e-01	-3.48e-01	-2.82e-01	-2.93e-01	1.71e-01	1.57e-01	1.78e-01	2.75e-01	2.56e-01	5.08e-01
NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	10	1.66e-01	6.32e-01	0.6700	3.20e-01	-1.77e-02	4.08e-01	4.05e-01	1.24e-01	7.93e-02	9.23e-01	2.56e-02	2.66e-02	4.97e-01
ECTODERMAL CELL DIFFERENTIATION	6	1.52e-01	6.14e-01	0.6690	-2.31e-01	-5.22e-01	-1.62e-01	-1.62e-01	2.65e-01	3.28e-01	2.69e-02	4.92e-01	4.93e-01	2.62e-01
NUCLEAR PORE LOCALIZATION	5	3.58e-01	8.23e-01	0.6690	-2.77e-01	-3.84e-01	-1.45e-01	-1.56e-01	4.22e-01	2.84e-01	1.37e-01	5.73e-01	5.45e-01	1.03e-01
REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL	12	5.00e-02	3.50e-01	0.6690	3.02e-01	-9.70e-02	3.86e-01	3.87e-01	2.19e-01	6.99e-02	5.61e-01	2.05e-02	2.03e-02	1.90e-01
MONOCYTE EXTRAVASATION	10	3.08e-01	7.82e-01	0.6690	-3.56e-01	-2.72e-01	-3.45e-01	-3.48e-01	8.17e-02	5.11e-02	1.37e-01	5.87e-02	5.70e-02	6.55e-01
PRIMARY ALCOHOL CATABOLIC PROCESS	13	2.64e-02	2.43e-01	0.6680	-3.38e-01	-2.34e-01	-3.91e-01	-3.25e-01	-1.37e-01	3.47e-02	1.44e-01	1.46e-02	4.23e-02	3.94e-01
RESPONSE TO INTERLEUKIN 2	9	7.98e-02	4.53e-01	0.6680	3.77e-01	4.69e-01	1.23e-01	1.61e-01	2.08e-01	5.01e-02	1.48e-02	5.24e-01	4.04e-01	2.79e-01
CHIASMA ASSEMBLY	6	1.63e-01	6.27e-01	0.6680	3.27e-01	5.13e-01	-5.03e-02	-3.35e-02	-2.68e-01	1.65e-01	2.95e-02	8.31e-01	8.87e-01	2.56e-01
POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS	5	7.21e-01	9.70e-01	0.6670	-3.86e-01	-2.40e-01	-3.13e-01	-3.57e-01	-1.13e-01	1.35e-01	3.52e-01	2.25e-01	1.67e-01	6.63e-01
CELLULAR GLUCURONIDATION	21	1.16e-04	4.41e-03	0.6660	-4.63e-01	-1.46e-01	-3.19e-01	-3.01e-01	-1.28e-01	2.42e-04	2.47e-01	1.15e-02	1.69e-02	3.10e-01
TRNA 3 END PROCESSING	6	6.91e-02	4.21e-01	0.6660	2.00e-03	1.11e-01	-5.35e-02	-8.10e-02	-6.50e-01	9.93e-01	6.38e-01	8.21e-01	7.31e-01	5.85e-03
PLATELET ACTIVATING FACTOR METABOLIC PROCESS	8	5.49e-01	9.15e-01	0.6650	-3.49e-01	-1.85e-01	-3.76e-01	-3.79e-01	-4.59e-02	8.76e-02	3.64e-01	6.57e-02	6.37e-02	8.22e-01
PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER	7	1.87e-01	6.58e-01	0.6640	3.32e-01	6.63e-02	3.88e-01	3.92e-01	-1.51e-01	1.28e-01	7.61e-01	7.53e-02	7.27e-02	4.90e-01
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION	6	1.39e-01	5.94e-01	0.6640	-2.20e-01	-5.75e-01	-5.86e-02	-1.07e-01	2.18e-01	3.51e-01	1.47e-02	8.04e-01	6.50e-01	3.56e-01
TYPE II HYPERSENSITIVITY	5	5.24e-01	9.04e-01	0.6640	3.31e-01	3.78e-01	2.73e-01	3.37e-01	-1.04e-02	2.00e-01	1.43e-01	2.90e-01	1.92e-01	9.68e-01
ISOLEUCINE METABOLIC PROCESS	6	4.48e-01	8.74e-01	0.6640	3.15e-01	1.59e-01	2.58e-01	2.66e-01	4.23e-01	1.82e-01	5.01e-01	2.73e-01	2.59e-01	7.31e-02
RESPONSE TO LECTIN	22	3.62e-03	6.33e-02	0.6630	-3.73e-01	-3.56e-02	-3.78e-01	-3.75e-01	-1.28e-01	2.46e-03	7.73e-01	2.15e-03	2.33e-03	3.00e-01
VOLUNTARY SKELETAL MUSCLE CONTRACTION	5	1.17e-01	5.46e-01	0.6630	3.75e-01	4.91e-01	8.52e-02	2.02e-01	9.96e-02	1.47e-01	5.72e-02	7.41e-01	4.34e-01	7.00e-01
AGGRESOME ASSEMBLY	5	7.04e-01	9.65e-01	0.6630	2.43e-01	1.96e-01	3.76e-01	3.69e-01	2.55e-01	3.47e-01	4.49e-01	1.46e-01	1.53e-01	3.24e-01
FATTY ACID ELONGATION	12	5.95e-02	3.88e-01	0.6630	8.76e-02	-2.25e-01	3.05e-01	2.91e-01	4.50e-01	5.99e-01	1.77e-01	6.69e-02	8.10e-02	6.90e-03
REGULATION OF ANGIOTENSIN LEVELS IN BLOOD	8	6.69e-02	4.13e-01	0.6630	-2.29e-01	-3.41e-01	-3.60e-01	-3.47e-01	1.41e-01	2.62e-01	9.45e-02	7.75e-02	8.92e-02	4.91e-01
PROTEIN SIALYLATION	5	2.59e-01	7.42e-01	0.6620	-2.33e-01	-4.29e-01	-1.97e-01	-2.29e-01	-3.29e-01	3.66e-01	9.64e-02	4.44e-01	3.75e-01	2.03e-01
ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	17	1.32e-01	5.77e-01	0.6620	3.74e-01	2.47e-01	3.44e-01	3.44e-01	1.03e-02	7.55e-03	7.77e-02	1.40e-02	1.40e-02	9.42e-01
PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS	65	2.24e-07	1.83e-05	0.6620	3.50e-01	9.64e-02	3.85e-01	3.91e-01	7.24e-02	1.05e-06	1.79e-01	7.73e-08	5.04e-08	3.13e-01
NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	8	4.24e-01	8.62e-01	0.6620	-3.30e-01	-8.45e-02	-3.78e-01	-3.47e-01	-2.44e-01	1.06e-01	6.79e-01	6.43e-02	8.94e-02	2.33e-01
FATTY ACYL COA CATABOLIC PROCESS	5	3.69e-01	8.31e-01	0.6610	2.19e-02	-1.23e-01	2.86e-01	2.31e-01	5.35e-01	9.32e-01	6.33e-01	2.68e-01	3.71e-01	3.82e-02
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION	26	3.52e-03	6.19e-02	0.6610	3.06e-01	3.03e-02	3.67e-01	3.35e-01	3.10e-01	6.89e-03	7.89e-01	1.21e-03	3.08e-03	6.26e-03
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	21	2.11e-04	7.41e-03	0.6610	2.35e-01	4.09e-01	2.33e-01	2.54e-01	3.10e-01	6.18e-02	1.18e-03	6.42e-02	4.38e-02	1.40e-02
NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	8	2.87e-01	7.66e-01	0.6600	-3.30e-01	-4.23e-01	-1.95e-01	-2.18e-01	2.50e-01	1.06e-01	3.83e-02	3.40e-01	2.85e-01	2.20e-01
REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY	5	6.01e-01	9.33e-01	0.6600	-3.41e-01	-3.46e-01	-2.66e-01	-3.03e-01	1.93e-01	1.86e-01	1.81e-01	3.03e-01	2.41e-01	4.55e-01
RESPONSE TO L GLUTAMATE	14	2.42e-01	7.26e-01	0.6600	3.19e-01	1.77e-01	3.83e-01	3.87e-01	8.11e-02	3.87e-02	2.52e-01	1.31e-02	1.22e-02	5.99e-01
TONIC SMOOTH MUSCLE CONTRACTION	11	1.45e-01	6.03e-01	0.6600	3.64e-01	4.24e-01	1.81e-01	2.31e-01	-1.93e-01	3.66e-02	1.49e-02	2.99e-01	1.86e-01	2.68e-01
2FE 2S CLUSTER ASSEMBLY	9	1.88e-01	6.59e-01	0.6590	2.77e-01	-9.95e-02	3.63e-01	3.59e-01	2.95e-01	1.50e-01	6.05e-01	5.94e-02	6.22e-02	1.26e-01
PROTEIN LOCALIZATION TO NUCLEOPLASM	13	1.30e-02	1.54e-01	0.6590	3.87e-01	1.52e-01	3.12e-01	3.58e-01	-1.91e-01	1.58e-02	3.43e-01	5.17e-02	2.55e-02	2.33e-01
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS	8	5.92e-01	9.32e-01	0.6590	2.76e-01	1.17e-01	3.74e-01	3.59e-01	2.74e-01	1.76e-01	5.66e-01	6.69e-02	7.83e-02	1.80e-01
WYBUTOSINE METABOLIC PROCESS	6	1.83e-01	6.56e-01	0.6590	4.36e-01	9.67e-02	2.71e-01	3.01e-01	2.66e-01	6.47e-02	6.82e-01	2.50e-01	2.02e-01	2.59e-01
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	5	3.31e-01	8.03e-01	0.6590	3.41e-01	-9.55e-02	3.53e-01	3.46e-01	2.54e-01	1.86e-01	7.12e-01	1.72e-01	1.80e-01	3.25e-01
SPERMIDINE METABOLIC PROCESS	6	4.50e-01	8.76e-01	0.6590	2.18e-01	2.76e-02	4.44e-01	4.09e-01	1.47e-01	3.55e-01	9.07e-01	5.96e-02	8.31e-02	5.34e-01
INTESTINAL STEM CELL HOMEOSTASIS	6	4.68e-01	8.84e-01	0.6580	-3.16e-01	-3.79e-01	-2.70e-01	-2.78e-01	1.98e-01	1.80e-01	1.08e-01	2.53e-01	2.38e-01	4.00e-01
REGULATION OF OSTEOCLAST PROLIFERATION	6	1.38e-01	5.90e-01	0.6580	-2.96e-01	-4.99e-01	-8.24e-02	-1.12e-01	-2.76e-01	2.10e-01	3.41e-02	7.27e-01	6.34e-01	2.42e-01
RETINAL BLOOD VESSEL MORPHOGENESIS	5	6.34e-01	9.48e-01	0.6570	3.11e-01	2.89e-01	2.52e-01	2.61e-01	3.47e-01	2.29e-01	2.63e-01	3.29e-01	3.12e-01	1.79e-01
REGULATION OF PROTEIN OLIGOMERIZATION	5	4.12e-01	8.53e-01	0.6570	3.33e-01	2.63e-01	3.13e-01	3.92e-01	7.24e-03	1.97e-01	3.09e-01	2.25e-01	1.29e-01	9.78e-01
REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	5	5.67e-01	9.24e-01	0.6570	-3.32e-01	1.11e-02	-3.63e-01	-3.48e-01	-2.61e-01	1.98e-01	9.66e-01	1.60e-01	1.78e-01	3.12e-01
EPINEPHRINE TRANSPORT	11	7.96e-02	4.53e-01	0.6560	-1.89e-01	9.77e-02	-3.62e-01	-3.92e-01	-3.17e-01	2.77e-01	5.75e-01	3.75e-02	2.45e-02	6.91e-02
REGULATION OF AMACRINE CELL DIFFERENTIATION	6	9.77e-03	1.27e-01	0.6560	2.44e-01	-3.90e-01	3.37e-01	3.01e-01	1.20e-01	3.01e-01	9.84e-02	1.53e-01	2.02e-01	6.09e-01
REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	5	7.82e-01	9.81e-01	0.6560	2.85e-01	9.24e-02	3.69e-01	3.85e-01	2.35e-01	2.70e-01	7.21e-01	1.52e-01	1.36e-01	3.63e-01
PEPTIDYL ARGININE METHYLATION	7	5.53e-01	9.16e-01	0.6550	3.77e-01	2.85e-01	3.01e-01	3.30e-01	-8.32e-02	8.43e-02	1.91e-01	1.69e-01	1.31e-01	7.03e-01
RNA IMPORT INTO MITOCHONDRION	5	7.71e-01	9.76e-01	0.6550	3.70e-01	2.50e-01	3.29e-01	3.47e-01	-2.64e-02	1.52e-01	3.33e-01	2.02e-01	1.79e-01	9.18e-01
OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION	15	2.40e-01	7.24e-01	0.6550	3.02e-01	1.06e-01	3.81e-01	3.72e-01	2.06e-01	4.32e-02	4.76e-01	1.06e-02	1.25e-02	1.67e-01
POST ANAL TAIL MORPHOGENESIS	18	3.37e-02	2.78e-01	0.6540	-3.57e-01	-4.65e-01	-1.88e-01	-2.04e-01	8.48e-02	8.74e-03	6.30e-04	1.68e-01	1.33e-01	5.34e-01
NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	9.36e-02	4.88e-01	0.6530	1.90e-01	-6.30e-02	8.66e-02	9.78e-02	6.08e-01	4.62e-01	8.07e-01	7.37e-01	7.05e-01	1.85e-02
CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY	5	7.72e-01	9.76e-01	0.6530	-3.89e-01	-2.13e-01	-3.35e-01	-3.38e-01	-6.06e-02	1.32e-01	4.10e-01	1.95e-01	1.91e-01	8.14e-01
POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	8	7.86e-02	4.52e-01	0.6520	8.28e-03	-3.16e-01	1.60e-01	1.65e-01	5.22e-01	9.68e-01	1.22e-01	4.34e-01	4.19e-01	1.05e-02
REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	6	7.09e-01	9.66e-01	0.6520	-2.88e-01	-6.16e-02	-3.65e-01	-3.72e-01	-2.59e-01	2.21e-01	7.94e-01	1.22e-01	1.14e-01	2.73e-01
DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS	6	1.25e-01	5.64e-01	0.6520	-2.88e-02	-4.43e-01	1.61e-01	1.06e-01	4.37e-01	9.03e-01	6.03e-02	4.95e-01	6.52e-01	6.36e-02
ICOSANOID CATABOLIC PROCESS	9	3.36e-01	8.06e-01	0.6510	3.75e-01	3.19e-01	2.66e-01	3.06e-01	-1.33e-01	5.16e-02	9.76e-02	1.66e-01	1.12e-01	4.90e-01
REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS	6	5.62e-01	9.21e-01	0.6510	3.01e-01	3.00e-01	2.55e-01	2.69e-01	3.24e-01	2.01e-01	2.03e-01	2.80e-01	2.53e-01	1.69e-01
INTRACELLULAR SPHINGOLIPID HOMEOSTASIS	5	6.98e-01	9.62e-01	0.6500	3.57e-01	2.72e-01	2.69e-01	3.14e-01	2.25e-01	1.67e-01	2.93e-01	2.97e-01	2.24e-01	3.84e-01
ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS	9	3.20e-01	7.93e-01	0.6500	-2.93e-01	8.18e-03	-3.44e-01	-3.54e-01	-3.05e-01	1.28e-01	9.66e-01	7.43e-02	6.59e-02	1.13e-01
REGULATION OF STRESS GRANULE ASSEMBLY	8	1.39e-01	5.93e-01	0.6500	7.82e-02	-2.92e-01	2.73e-01	2.34e-01	4.48e-01	7.02e-01	1.53e-01	1.81e-01	2.51e-01	2.81e-02
EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA	13	2.62e-02	2.42e-01	0.6490	3.26e-01	1.12e-01	3.99e-01	3.64e-01	-9.88e-02	4.16e-02	4.84e-01	1.26e-02	2.30e-02	5.37e-01
POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	16	8.63e-02	4.67e-01	0.6470	-3.95e-01	-1.98e-01	-3.38e-01	-3.30e-01	-2.68e-02	6.28e-03	1.69e-01	1.94e-02	2.23e-02	8.53e-01
REGULATION OF ENAMEL MINERALIZATION	7	7.46e-02	4.40e-01	0.6460	-2.34e-01	1.31e-01	-2.05e-01	-2.21e-01	-5.05e-01	2.83e-01	5.50e-01	3.47e-01	3.11e-01	2.07e-02
ASCENDING AORTA DEVELOPMENT	5	4.97e-02	3.49e-01	0.6460	2.71e-01	-2.88e-01	3.67e-01	3.52e-01	-5.18e-02	2.94e-01	2.65e-01	1.56e-01	1.72e-01	8.41e-01
POINTED END ACTIN FILAMENT CAPPING	7	6.48e-01	9.51e-01	0.6460	-3.85e-01	-3.47e-01	-2.60e-01	-2.79e-01	-6.22e-02	7.78e-02	1.12e-01	2.34e-01	2.01e-01	7.76e-01
MITOCHONDRIAL RNA PROCESSING	20	3.77e-03	6.50e-02	0.6460	3.53e-01	2.28e-01	2.97e-01	3.05e-01	-2.43e-01	6.20e-03	7.76e-02	2.16e-02	1.82e-02	5.98e-02
POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE	8	4.77e-02	3.41e-01	0.6460	1.97e-01	4.81e-01	-1.81e-01	-9.48e-02	-3.25e-01	3.35e-01	1.85e-02	3.76e-01	6.42e-01	1.12e-01
POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE	8	1.99e-02	2.03e-01	0.6460	-2.67e-01	1.12e-01	-4.21e-01	-3.23e-01	-2.26e-01	1.90e-01	5.84e-01	3.92e-02	1.13e-01	2.68e-01
T HELPER 1 CELL CYTOKINE PRODUCTION	8	1.25e-01	5.65e-01	0.6450	-2.78e-01	-2.81e-01	-3.07e-01	-3.61e-01	1.87e-01	1.74e-01	1.69e-01	1.32e-01	7.69e-02	3.61e-01
OVULATION	15	5.20e-03	8.38e-02	0.6450	-1.77e-01	-1.77e-01	-3.29e-01	-3.72e-01	-3.26e-01	2.37e-01	2.35e-01	2.72e-02	1.26e-02	2.88e-02
REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL	7	5.57e-01	9.19e-01	0.6450	2.61e-01	1.29e-01	3.67e-01	3.30e-01	2.94e-01	2.31e-01	5.54e-01	9.23e-02	1.30e-01	1.78e-01
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION	5	2.54e-01	7.37e-01	0.6440	-8.52e-02	1.71e-01	-4.34e-01	-3.50e-01	-2.60e-01	7.42e-01	5.07e-01	9.32e-02	1.75e-01	3.13e-01
MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY	8	5.28e-01	9.06e-01	0.6440	3.77e-01	2.31e-01	3.18e-01	3.43e-01	-1.22e-02	6.47e-02	2.58e-01	1.19e-01	9.31e-02	9.52e-01
HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY	5	2.93e-01	7.69e-01	0.6420	-3.99e-01	-4.86e-01	-2.35e-02	-9.68e-02	8.44e-02	1.23e-01	6.00e-02	9.27e-01	7.08e-01	7.44e-01
CELLULAR RESPONSE TO IRON ION	8	3.22e-01	7.96e-01	0.6420	1.71e-01	8.05e-02	4.00e-01	3.75e-01	2.73e-01	4.02e-01	6.93e-01	4.98e-02	6.60e-02	1.81e-01
U2 TYPE PRESPLICEOSOME ASSEMBLY	22	5.66e-04	1.57e-02	0.6410	2.72e-01	-2.35e-02	4.06e-01	4.13e-01	-3.90e-02	2.70e-02	8.48e-01	9.83e-04	7.99e-04	7.52e-01
MUSCULAR SEPTUM MORPHOGENESIS	5	4.67e-01	8.83e-01	0.6410	4.76e-02	-2.81e-01	3.24e-01	2.90e-01	3.74e-01	8.54e-01	2.76e-01	2.09e-01	2.62e-01	1.47e-01
POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT	12	2.42e-01	7.27e-01	0.6410	-3.32e-01	-1.58e-01	-3.55e-01	-3.22e-01	-2.11e-01	4.62e-02	3.42e-01	3.31e-02	5.32e-02	2.05e-01
NUCLEAR MRNA SURVEILLANCE	10	2.63e-01	7.46e-01	0.6400	3.75e-01	2.09e-01	3.46e-01	3.25e-01	-1.55e-02	3.98e-02	2.53e-01	5.83e-02	7.53e-02	9.32e-01
L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE	5	1.49e-01	6.10e-01	0.6390	-2.19e-01	-5.96e-01	5.49e-02	2.78e-02	-3.37e-02	3.97e-01	2.09e-02	8.32e-01	9.14e-01	8.96e-01
NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS	6	6.08e-01	9.35e-01	0.6380	3.72e-01	1.15e-01	3.40e-01	3.32e-01	1.72e-01	1.15e-01	6.25e-01	1.49e-01	1.59e-01	4.65e-01
MODULATION BY VIRUS OF HOST PROCESS	7	6.64e-01	9.54e-01	0.6380	-3.34e-01	-1.56e-01	-3.60e-01	-3.42e-01	-1.59e-01	1.26e-01	4.76e-01	9.90e-02	1.17e-01	4.68e-01
RIBOSOMAL SMALL SUBUNIT ASSEMBLY	18	3.97e-02	3.05e-01	0.6380	2.57e-01	1.22e-01	3.92e-01	4.09e-01	7.22e-02	5.91e-02	3.71e-01	4.00e-03	2.69e-03	5.96e-01
GLYCOSYLCERAMIDE CATABOLIC PROCESS	6	3.89e-01	8.40e-01	0.6360	-2.35e-01	-1.86e-01	-4.12e-01	-3.79e-01	-1.90e-02	3.19e-01	4.29e-01	8.04e-02	1.08e-01	9.36e-01
INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	8	3.43e-01	8.14e-01	0.6360	-3.25e-01	-4.11e-02	-3.21e-01	-3.54e-01	-2.62e-01	1.12e-01	8.41e-01	1.15e-01	8.31e-02	2.00e-01
NEGATIVE REGULATION OF FIBROBLAST MIGRATION	10	2.24e-01	7.06e-01	0.6350	-3.52e-01	-4.36e-01	-1.92e-01	-1.92e-01	1.26e-01	5.42e-02	1.69e-02	2.92e-01	2.93e-01	4.90e-01
MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL	7	4.14e-02	3.11e-01	0.6350	-2.70e-01	8.53e-02	-3.64e-01	-3.68e-01	2.36e-01	2.16e-01	6.96e-01	9.53e-02	9.18e-02	2.80e-01
SERINE PHOSPHORYLATION OF STAT PROTEIN	21	3.02e-02	2.61e-01	0.6350	-3.72e-01	-1.31e-01	-3.17e-01	-3.18e-01	-2.14e-01	3.13e-03	2.97e-01	1.20e-02	1.17e-02	8.98e-02
PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE	8	4.00e-01	8.45e-01	0.6350	4.08e-01	3.76e-01	1.97e-01	2.27e-01	6.43e-02	4.56e-02	6.56e-02	3.34e-01	2.66e-01	7.53e-01
LIPOXIN METABOLIC PROCESS	5	4.90e-01	8.93e-01	0.6340	-9.41e-02	1.97e-01	-3.89e-01	-3.51e-01	-2.83e-01	7.15e-01	4.46e-01	1.32e-01	1.74e-01	2.73e-01
CELLULAR RESPONSE TO DSRNA	22	3.21e-02	2.71e-01	0.6340	2.85e-01	1.73e-03	3.77e-01	3.70e-01	2.04e-01	2.08e-02	9.89e-01	2.22e-03	2.66e-03	9.83e-02
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	19	9.13e-02	4.81e-01	0.6330	3.02e-01	5.74e-02	3.51e-01	3.39e-01	2.62e-01	2.26e-02	6.65e-01	8.15e-03	1.06e-02	4.82e-02
FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION	5	1.93e-01	6.67e-01	0.6330	-2.42e-01	-4.49e-01	2.12e-01	1.46e-01	2.72e-01	3.48e-01	8.22e-02	4.11e-01	5.72e-01	2.92e-01
NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	5	5.02e-01	8.98e-01	0.6330	3.40e-01	4.01e-01	1.49e-01	1.49e-01	-2.83e-01	1.89e-01	1.20e-01	5.64e-01	5.64e-01	2.74e-01
NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	8	5.81e-02	3.83e-01	0.6330	2.53e-01	4.06e-01	2.09e-01	2.83e-01	2.18e-01	2.16e-01	4.66e-02	3.07e-01	1.65e-01	2.85e-01
EXOCYST LOCALIZATION	5	5.74e-01	9.26e-01	0.6330	-1.50e-01	1.83e-01	-3.58e-01	-3.30e-01	-3.28e-01	5.61e-01	4.79e-01	1.66e-01	2.01e-01	2.04e-01
POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING	8	2.12e-02	2.11e-01	0.6330	3.50e-01	5.94e-02	3.12e-01	2.88e-01	-3.07e-01	8.66e-02	7.71e-01	1.26e-01	1.59e-01	1.32e-01
REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	6	3.70e-01	8.31e-01	0.6320	5.15e-02	-2.70e-01	2.56e-01	2.36e-01	4.50e-01	8.27e-01	2.52e-01	2.77e-01	3.17e-01	5.64e-02
POSITIVE REGULATION OF ERAD PATHWAY	13	7.99e-02	4.53e-01	0.6320	9.44e-02	-1.72e-01	2.97e-01	2.86e-01	4.36e-01	5.56e-01	2.83e-01	6.36e-02	7.41e-02	6.45e-03
NEGATIVE REGULATION OF NEUTROPHIL MIGRATION	5	3.84e-01	8.39e-01	0.6310	-1.99e-01	-1.99e-01	-4.16e-01	-3.70e-01	-9.67e-02	4.41e-01	4.40e-01	1.07e-01	1.52e-01	7.08e-01
MEIOTIC SPINDLE ASSEMBLY	12	1.19e-01	5.50e-01	0.6310	3.37e-01	2.92e-02	3.73e-01	3.77e-01	5.18e-02	4.32e-02	8.61e-01	2.52e-02	2.37e-02	7.56e-01
CITRATE TRANSPORT	5	7.23e-01	9.70e-01	0.6310	3.17e-01	3.45e-01	2.80e-01	3.12e-01	-6.28e-02	2.20e-01	1.82e-01	2.78e-01	2.27e-01	8.08e-01
SPHINGOLIPID TRANSLOCATION	5	3.89e-01	8.40e-01	0.6310	-3.98e-01	-2.13e-01	-3.36e-01	-2.83e-01	-3.48e-02	1.23e-01	4.10e-01	1.93e-01	2.73e-01	8.93e-01
CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE	7	4.22e-01	8.60e-01	0.6310	2.53e-01	-1.62e-02	3.70e-01	3.22e-01	3.05e-01	2.47e-01	9.41e-01	9.00e-02	1.40e-01	1.62e-01
PHOSPHAGEN METABOLIC PROCESS	5	2.79e-01	7.58e-01	0.6310	1.97e-01	4.91e-01	-3.73e-02	-4.94e-02	-3.38e-01	4.46e-01	5.74e-02	8.85e-01	8.48e-01	1.90e-01
RESPONSE TO SELENIUM ION	8	9.50e-02	4.92e-01	0.6300	2.60e-01	-8.92e-02	2.44e-01	2.74e-01	4.31e-01	2.03e-01	6.62e-01	2.31e-01	1.79e-01	3.47e-02
REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION	5	8.15e-01	9.82e-01	0.6290	3.21e-01	1.59e-01	3.65e-01	3.46e-01	1.24e-01	2.14e-01	5.39e-01	1.58e-01	1.80e-01	6.32e-01
PEPTIDE MODIFICATION	5	4.36e-01	8.69e-01	0.6290	-2.50e-01	-2.79e-02	-3.54e-01	-4.13e-01	-1.93e-01	3.34e-01	9.14e-01	1.70e-01	1.10e-01	4.55e-01
REGULATION OF CORTICOTROPIN SECRETION	5	4.84e-01	8.91e-01	0.6290	-2.71e-01	-1.08e-01	-3.64e-01	-4.18e-01	-6.35e-02	2.93e-01	6.76e-01	1.59e-01	1.06e-01	8.06e-01
POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE	6	1.17e-01	5.46e-01	0.6290	3.14e-01	4.27e-02	3.20e-01	3.13e-01	-3.08e-01	1.83e-01	8.56e-01	1.74e-01	1.84e-01	1.91e-01
POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	10	3.80e-01	8.37e-01	0.6290	-3.19e-01	-2.14e-01	-3.46e-01	-3.55e-01	4.76e-02	8.08e-02	2.41e-01	5.79e-02	5.20e-02	7.94e-01
NAD TRANSPORT	5	3.08e-01	7.82e-01	0.6280	-2.14e-02	7.77e-02	-3.83e-01	-3.27e-01	-3.66e-01	9.34e-01	7.64e-01	1.38e-01	2.05e-01	1.57e-01
ELASTIN METABOLIC PROCESS	8	3.75e-01	8.36e-01	0.6280	-3.08e-01	-4.04e-01	-2.16e-01	-2.48e-01	1.68e-01	1.31e-01	4.81e-02	2.90e-01	2.25e-01	4.12e-01
CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	8	4.01e-01	8.46e-01	0.6270	4.12e-01	3.20e-01	2.20e-01	2.45e-01	1.13e-01	4.34e-02	1.17e-01	2.82e-01	2.30e-01	5.79e-01
POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE	6	4.74e-01	8.86e-01	0.6270	2.97e-01	4.23e-01	1.99e-01	2.15e-01	2.02e-01	2.08e-01	7.29e-02	3.99e-01	3.62e-01	3.92e-01
POSITIVE REGULATION OF FEEDING BEHAVIOR	10	1.35e-01	5.83e-01	0.6270	-2.67e-01	-4.30e-01	-2.19e-01	-2.45e-01	-1.70e-01	1.44e-01	1.85e-02	2.31e-01	1.80e-01	3.53e-01
EOSINOPHIL DIFFERENTIATION	6	5.65e-01	9.23e-01	0.6270	-3.18e-01	-3.16e-01	-2.86e-01	-2.87e-01	1.66e-01	1.77e-01	1.80e-01	2.25e-01	2.24e-01	4.81e-01
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	8	5.11e-01	9.00e-01	0.6260	2.77e-01	2.22e-03	3.57e-01	3.44e-01	2.64e-01	1.75e-01	9.91e-01	8.03e-02	9.16e-02	1.96e-01
MITOCHONDRIAL PROTEIN CATABOLIC PROCESS	6	5.36e-01	9.11e-01	0.6260	-2.88e-01	-4.23e-01	-2.45e-01	-2.64e-01	2.87e-02	2.22e-01	7.27e-02	2.98e-01	2.63e-01	9.03e-01
POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	5	7.52e-01	9.75e-01	0.6260	-2.63e-01	7.02e-03	-3.66e-01	-3.68e-01	-2.33e-01	3.09e-01	9.78e-01	1.57e-01	1.54e-01	3.67e-01
POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	4.28e-01	8.65e-01	0.6260	4.12e-01	9.74e-02	3.00e-01	3.43e-01	7.22e-02	1.10e-01	7.06e-01	2.45e-01	1.84e-01	7.80e-01
POSITIVE REGULATION OF ENAMEL MINERALIZATION	5	4.59e-01	8.79e-01	0.6260	-1.52e-01	-3.80e-02	-2.00e-01	-1.98e-01	-5.37e-01	5.56e-01	8.83e-01	4.39e-01	4.44e-01	3.75e-02
RESPONSE TO STILBENOID	8	6.01e-01	9.33e-01	0.6260	2.96e-01	2.89e-01	3.11e-01	3.29e-01	1.26e-01	1.47e-01	1.57e-01	1.28e-01	1.07e-01	5.37e-01
PANCREATIC JUICE SECRETION	11	4.75e-01	8.86e-01	0.6260	-3.33e-01	-2.88e-01	-3.00e-01	-3.24e-01	-5.35e-02	5.58e-02	9.79e-02	8.48e-02	6.29e-02	7.59e-01
POSITIVE REGULATION OF GROWTH HORMONE SECRETION	9	2.49e-01	7.33e-01	0.6260	2.87e-01	3.10e-01	2.18e-01	2.51e-01	3.20e-01	1.35e-01	1.08e-01	2.57e-01	1.92e-01	9.63e-02
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN	32	1.21e-02	1.45e-01	0.6260	2.74e-01	2.34e-01	3.40e-01	3.50e-01	1.52e-01	7.34e-03	2.20e-02	8.60e-04	5.99e-04	1.36e-01
POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY	5	7.72e-01	9.76e-01	0.6250	3.34e-01	2.59e-01	3.27e-01	3.21e-01	-4.68e-02	1.96e-01	3.15e-01	2.06e-01	2.14e-01	8.56e-01
POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	19	3.69e-02	2.93e-01	0.6250	1.97e-01	-5.43e-02	3.82e-01	3.43e-01	2.92e-01	1.37e-01	6.82e-01	3.94e-03	9.56e-03	2.74e-02
REGULATION OF TRANSLATIONAL TERMINATION	8	1.77e-01	6.47e-01	0.6250	1.00e-01	-2.57e-01	3.14e-01	3.20e-01	3.38e-01	6.24e-01	2.08e-01	1.24e-01	1.17e-01	9.81e-02
PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS	5	3.73e-02	2.94e-01	0.6250	-4.10e-01	1.26e-01	-3.37e-01	-2.93e-01	-8.31e-02	1.12e-01	6.26e-01	1.91e-01	2.57e-01	7.47e-01
ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO	6	2.54e-01	7.37e-01	0.6230	3.91e-01	3.69e-01	1.93e-01	1.64e-01	1.89e-01	9.71e-02	1.18e-01	4.13e-01	4.86e-01	4.24e-01
REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS	7	1.22e-01	5.57e-01	0.6230	-3.86e-01	-3.39e-01	-2.78e-01	-2.15e-01	-2.57e-02	7.68e-02	1.20e-01	2.02e-01	3.24e-01	9.06e-01
CELLULAR RESPONSE TO HYDROPEROXIDE	8	9.63e-02	4.94e-01	0.6230	-4.17e-01	-1.74e-01	-2.57e-01	-3.24e-01	1.17e-01	4.09e-02	3.95e-01	2.09e-01	1.13e-01	5.68e-01
NEGATIVE REGULATION OF GONADOTROPIN SECRETION	7	8.49e-02	4.65e-01	0.6230	-2.27e-01	-3.62e-01	-2.66e-01	-3.31e-01	1.60e-01	2.98e-01	9.71e-02	2.23e-01	1.30e-01	4.63e-01
PROTEIN HEXAMERIZATION	9	1.56e-01	6.17e-01	0.6230	2.43e-01	3.09e-04	4.23e-01	3.88e-01	1.04e-02	2.08e-01	9.99e-01	2.79e-02	4.41e-02	9.57e-01
REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	5	4.55e-01	8.78e-01	0.6230	1.55e-01	5.00e-02	3.73e-01	3.04e-01	3.61e-01	5.48e-01	8.47e-01	1.49e-01	2.40e-01	1.62e-01
LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	11	4.86e-01	8.92e-01	0.6230	2.72e-01	1.15e-01	3.48e-01	3.55e-01	2.32e-01	1.18e-01	5.09e-01	4.59e-02	4.14e-02	1.83e-01
REGULATION OF PROTEIN K48 LINKED UBIQUITINATION	6	7.38e-01	9.73e-01	0.6230	3.18e-01	1.99e-01	3.46e-01	3.57e-01	1.02e-02	1.77e-01	4.00e-01	1.42e-01	1.30e-01	9.65e-01
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY	92	8.64e-11	1.30e-08	0.6230	2.68e-01	-3.12e-02	3.77e-01	3.76e-01	1.76e-01	8.64e-06	6.05e-01	3.88e-10	4.39e-10	3.60e-03
SKIN MORPHOGENESIS	13	3.95e-01	8.44e-01	0.6230	-2.99e-01	-1.83e-01	-3.42e-01	-3.27e-01	-2.01e-01	6.23e-02	2.53e-01	3.26e-02	4.09e-02	2.09e-01
CAP DEPENDENT TRANSLATIONAL INITIATION	7	3.91e-01	8.41e-01	0.6220	1.18e-01	-1.69e-01	3.68e-01	3.37e-01	3.10e-01	5.90e-01	4.40e-01	9.14e-02	1.23e-01	1.56e-01
BONE MARROW DEVELOPMENT	9	4.72e-01	8.85e-01	0.6220	3.43e-01	1.22e-01	3.42e-01	3.61e-01	8.23e-02	7.49e-02	5.25e-01	7.56e-02	6.04e-02	6.69e-01
CELLULAR RESPONSE TO SODIUM ARSENITE	5	3.49e-01	8.18e-01	0.6220	2.84e-01	2.23e-01	3.75e-01	3.18e-01	-1.19e-01	2.71e-01	3.88e-01	1.46e-01	2.18e-01	6.45e-01
MHC CLASS II BIOSYNTHETIC PROCESS	20	8.01e-02	4.53e-01	0.6220	-3.47e-01	-3.82e-01	-2.42e-01	-2.48e-01	4.00e-03	7.18e-03	3.09e-03	6.13e-02	5.49e-02	9.75e-01
LYSOSOMAL MICROAUTOPHAGY	13	1.49e-01	6.11e-01	0.6220	-2.26e-01	-3.01e-02	-4.05e-01	-3.97e-01	-1.13e-01	1.59e-01	8.51e-01	1.15e-02	1.31e-02	4.80e-01
POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	6	3.87e-01	8.40e-01	0.6210	-2.58e-01	-4.72e-01	-1.38e-01	-1.56e-01	2.32e-01	2.73e-01	4.54e-02	5.58e-01	5.09e-01	3.25e-01
POSITIVE REGULATION OF CELLULAR RESPIRATION	13	5.67e-02	3.77e-01	0.6210	7.90e-02	-7.82e-03	3.19e-01	2.99e-01	4.35e-01	6.22e-01	9.61e-01	4.66e-02	6.20e-02	6.65e-03
SUCCINYL COA METABOLIC PROCESS	10	5.26e-01	9.05e-01	0.6190	3.21e-01	3.00e-01	2.98e-01	2.93e-01	1.24e-01	7.86e-02	1.00e-01	1.03e-01	1.08e-01	4.96e-01
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT	5	7.60e-01	9.75e-01	0.6190	-3.55e-01	-3.92e-01	-2.11e-01	-2.30e-01	-8.22e-02	1.70e-01	1.29e-01	4.15e-01	3.73e-01	7.50e-01
REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	5	3.06e-02	2.63e-01	0.6190	-1.53e-03	1.66e-02	-4.30e-01	-4.43e-01	-3.50e-02	9.95e-01	9.49e-01	9.57e-02	8.62e-02	8.92e-01
PURINE NUCLEOBASE BIOSYNTHETIC PROCESS	9	5.25e-01	9.05e-01	0.6190	3.15e-01	1.76e-01	3.19e-01	3.54e-01	1.61e-01	1.02e-01	3.61e-01	9.77e-02	6.62e-02	4.03e-01
REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL	5	4.67e-01	8.83e-01	0.6180	-3.66e-01	-3.50e-01	-1.93e-01	-2.74e-01	-1.15e-01	1.56e-01	1.75e-01	4.55e-01	2.88e-01	6.57e-01
NEGATIVE REGULATION OF VASCULAR WOUND HEALING	7	4.39e-04	1.31e-02	0.6180	2.77e-01	4.11e-01	1.22e-01	2.94e-01	-1.89e-01	2.05e-01	5.99e-02	5.76e-01	1.78e-01	3.87e-01
APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS	7	1.50e-01	6.11e-01	0.6180	2.94e-01	-9.14e-02	3.51e-01	2.96e-01	2.77e-01	1.78e-01	6.75e-01	1.08e-01	1.75e-01	2.05e-01
POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS	5	8.34e-01	9.85e-01	0.6180	-2.96e-01	-1.50e-01	-3.63e-01	-3.63e-01	-8.76e-02	2.52e-01	5.61e-01	1.60e-01	1.60e-01	7.34e-01
NADH DEHYDROGENASE COMPLEX ASSEMBLY	52	1.45e-06	9.73e-05	0.6180	2.98e-01	-7.20e-03	3.71e-01	3.81e-01	1.02e-01	2.03e-04	9.28e-01	3.68e-06	2.04e-06	2.03e-01
PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE	12	3.26e-02	2.73e-01	0.6180	2.60e-01	-7.39e-02	3.80e-01	4.04e-01	2.56e-02	1.19e-01	6.58e-01	2.27e-02	1.53e-02	8.78e-01
NEPHRIC DUCT FORMATION	5	3.71e-01	8.31e-01	0.6170	9.21e-02	-1.32e-01	4.02e-01	3.25e-01	2.96e-01	7.21e-01	6.09e-01	1.20e-01	2.08e-01	2.51e-01
NUCLEAR RNA SURVEILLANCE	14	6.59e-02	4.10e-01	0.6170	3.31e-01	1.29e-01	3.66e-01	3.41e-01	-5.90e-02	3.18e-02	4.05e-01	1.77e-02	2.72e-02	7.02e-01
RIBOSOME ASSEMBLY	58	1.27e-08	1.37e-06	0.6160	2.18e-01	2.37e-02	4.00e-01	4.11e-01	4.89e-02	4.05e-03	7.55e-01	1.34e-07	6.16e-08	5.19e-01
POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS	11	6.04e-02	3.93e-01	0.6150	-2.87e-01	-3.01e-01	-1.84e-01	-1.85e-01	3.71e-01	9.97e-02	8.37e-02	2.90e-01	2.89e-01	3.31e-02
RNA 5 END PROCESSING	21	6.16e-02	3.97e-01	0.6150	3.32e-01	1.65e-01	3.48e-01	3.45e-01	-7.24e-03	8.38e-03	1.90e-01	5.76e-03	6.16e-03	9.54e-01
KETONE BODY BIOSYNTHETIC PROCESS	6	2.34e-01	7.18e-01	0.6150	-1.30e-01	6.11e-02	-3.75e-01	-4.13e-01	-2.16e-01	5.81e-01	7.96e-01	1.12e-01	7.99e-02	3.60e-01
REGULATION OF MITOCHONDRIAL TRANSLATION	25	7.20e-03	1.05e-01	0.6150	3.15e-01	8.14e-02	3.73e-01	3.64e-01	-6.45e-03	6.48e-03	4.81e-01	1.23e-03	1.61e-03	9.55e-01
ASPARAGINE METABOLIC PROCESS	5	6.46e-01	9.50e-01	0.6150	2.47e-01	6.45e-02	4.03e-01	3.87e-01	2.75e-02	3.39e-01	8.03e-01	1.19e-01	1.34e-01	9.15e-01
INTERLEUKIN 23 PRODUCTION	9	1.52e-02	1.68e-01	0.6140	-3.32e-01	-2.67e-03	-3.61e-01	-3.17e-01	1.88e-01	8.43e-02	9.89e-01	6.08e-02	9.92e-02	3.28e-01
HEAT ACCLIMATION	5	2.91e-01	7.67e-01	0.6140	2.26e-01	-1.58e-01	3.39e-01	3.87e-01	1.91e-01	3.82e-01	5.42e-01	1.89e-01	1.34e-01	4.60e-01
REGULATION OF ERAD PATHWAY	19	3.24e-02	2.72e-01	0.6140	1.86e-01	-1.06e-01	3.14e-01	2.98e-01	3.79e-01	1.62e-01	4.22e-01	1.79e-02	2.47e-02	4.21e-03
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION	11	3.88e-01	8.40e-01	0.6130	-3.48e-01	-1.87e-01	-3.12e-01	-3.45e-01	-5.96e-02	4.57e-02	2.82e-01	7.30e-02	4.75e-02	7.32e-01
REGULATION OF LUNG BLOOD PRESSURE	5	4.58e-01	8.79e-01	0.6130	-3.98e-01	-2.47e-01	-2.36e-01	-3.15e-01	-3.76e-02	1.23e-01	3.39e-01	3.60e-01	2.23e-01	8.84e-01
RESPONSE TO INTERFERON ALPHA	17	3.89e-02	3.02e-01	0.6130	3.16e-01	2.07e-01	3.36e-01	2.86e-01	1.94e-01	2.40e-02	1.40e-01	1.64e-02	4.10e-02	1.65e-01
RETINAL BIPOLAR NEURON DIFFERENTIATION	7	3.82e-01	8.38e-01	0.6120	3.32e-01	3.56e-01	2.20e-01	2.90e-01	7.68e-02	1.28e-01	1.03e-01	3.13e-01	1.84e-01	7.25e-01
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	6	3.64e-02	2.90e-01	0.6120	1.02e-01	-3.90e-01	3.40e-01	3.07e-01	-5.20e-02	6.65e-01	9.82e-02	1.49e-01	1.93e-01	8.25e-01
TRANSEPITHELIAL CHLORIDE TRANSPORT	8	1.96e-01	6.74e-01	0.6120	-1.65e-02	2.99e-01	-3.16e-01	-2.85e-01	-3.23e-01	9.36e-01	1.44e-01	1.22e-01	1.63e-01	1.14e-01
GENERAL ADAPTATION SYNDROME	6	1.65e-01	6.31e-01	0.6110	-2.26e-01	-2.35e-01	-2.54e-01	-3.07e-01	3.29e-01	3.37e-01	3.18e-01	2.80e-01	1.93e-01	1.63e-01
REGULATION OF EPINEPHRINE SECRETION	7	3.35e-01	8.05e-01	0.6100	-2.17e-01	-6.67e-02	-3.12e-01	-3.63e-01	-3.03e-01	3.21e-01	7.60e-01	1.53e-01	9.67e-02	1.65e-01
MYOSIN FILAMENT ORGANIZATION	6	7.81e-01	9.81e-01	0.6090	-2.70e-01	-1.19e-01	-3.67e-01	-3.55e-01	-1.52e-01	2.52e-01	6.15e-01	1.19e-01	1.32e-01	5.18e-01
PROTEIN O LINKED GLYCOSYLATION VIA THREONINE	10	5.02e-01	8.98e-01	0.6090	-2.92e-01	-2.14e-01	-3.16e-01	-3.46e-01	-1.42e-01	1.10e-01	2.42e-01	8.32e-02	5.82e-02	4.38e-01
REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	9	5.62e-01	9.20e-01	0.6090	-2.78e-01	-5.42e-02	-3.61e-01	-3.55e-01	-1.84e-01	1.48e-01	7.78e-01	6.08e-02	6.54e-02	3.39e-01
RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING	7	5.31e-01	9.07e-01	0.6080	2.07e-01	-5.19e-02	3.14e-01	2.91e-01	3.75e-01	3.43e-01	8.12e-01	1.50e-01	1.82e-01	8.55e-02
REGULATION OF PLASMA MEMBRANE REPAIR	6	4.98e-01	8.96e-01	0.6080	4.23e-01	2.35e-01	2.47e-01	2.73e-01	-1.77e-02	7.28e-02	3.19e-01	2.95e-01	2.47e-01	9.40e-01
MITOTIC DNA REPLICATION	15	2.77e-02	2.49e-01	0.6080	2.79e-01	1.41e-02	3.83e-01	3.77e-01	-5.85e-02	6.18e-02	9.25e-01	1.03e-02	1.15e-02	6.95e-01
GLUTATHIONE TRANSPORT	9	3.95e-01	8.43e-01	0.6070	-2.94e-01	-3.89e-01	-2.35e-01	-2.66e-01	-7.16e-02	1.26e-01	4.34e-02	2.23e-01	1.67e-01	7.10e-01
CYTOLYSIS BY HOST OF SYMBIONT CELLS	7	5.22e-02	3.58e-01	0.6070	-4.41e-01	-2.54e-01	-2.21e-01	-1.84e-01	1.63e-01	4.33e-02	2.44e-01	3.12e-01	3.99e-01	4.56e-01
ENDOCARDIUM DEVELOPMENT	12	1.60e-01	6.23e-01	0.6070	-3.16e-01	-4.33e-01	-1.31e-01	-1.70e-01	1.89e-01	5.83e-02	9.46e-03	4.32e-01	3.09e-01	2.57e-01
RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION	14	2.98e-01	7.72e-01	0.6070	2.29e-01	7.02e-02	3.47e-01	3.28e-01	2.88e-01	1.39e-01	6.49e-01	2.44e-02	3.37e-02	6.18e-02
RESPONSE TO GONADOTROPIN RELEASING HORMONE	7	6.10e-01	9.36e-01	0.6070	-2.58e-01	-2.65e-01	-2.99e-01	-3.21e-01	-1.96e-01	2.36e-01	2.25e-01	1.70e-01	1.42e-01	3.68e-01
MRNA CIS SPLICING VIA SPLICEOSOME	26	3.34e-02	2.76e-01	0.6060	3.37e-01	2.15e-01	3.30e-01	3.15e-01	2.11e-02	2.96e-03	5.75e-02	3.62e-03	5.50e-03	8.52e-01
REGULATION OF T HELPER 2 CELL DIFFERENTIATION	12	1.26e-01	5.67e-01	0.6060	-2.64e-01	-4.14e-01	-2.50e-01	-2.52e-01	-1.65e-02	1.13e-01	1.30e-02	1.33e-01	1.31e-01	9.21e-01
VITAMIN BIOSYNTHETIC PROCESS	24	3.76e-02	2.96e-01	0.6060	2.23e-01	1.93e-03	3.19e-01	3.22e-01	3.35e-01	5.85e-02	9.87e-01	6.91e-03	6.37e-03	4.47e-03
NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME	7	3.90e-01	8.41e-01	0.6050	2.99e-01	4.15e-01	1.83e-01	2.32e-01	1.33e-01	1.70e-01	5.73e-02	4.03e-01	2.87e-01	5.42e-01
INTESTINAL HEXOSE ABSORPTION	5	1.70e-01	6.41e-01	0.6050	-2.82e-01	-5.37e-02	-3.20e-01	-2.82e-01	3.19e-01	2.75e-01	8.35e-01	2.16e-01	2.75e-01	2.16e-01
THYMIC T CELL SELECTION	23	1.66e-02	1.79e-01	0.6050	3.09e-01	4.36e-01	1.75e-01	2.06e-01	-8.54e-02	1.03e-02	2.94e-04	1.46e-01	8.68e-02	4.78e-01
NEUROENDOCRINE CELL DIFFERENTIATION	16	8.81e-03	1.18e-01	0.6050	-9.93e-02	-3.82e-01	1.09e-01	8.11e-02	4.38e-01	4.92e-01	8.17e-03	4.50e-01	5.74e-01	2.43e-03
NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION	6	5.59e-01	9.19e-01	0.6050	3.24e-01	3.48e-01	2.55e-01	2.38e-01	-1.34e-01	1.69e-01	1.40e-01	2.80e-01	3.12e-01	5.69e-01
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS	37	7.66e-03	1.09e-01	0.6040	2.59e-01	4.77e-02	3.62e-01	3.52e-01	2.03e-01	6.36e-03	6.15e-01	1.38e-04	2.13e-04	3.27e-02
CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING	5	6.90e-01	9.61e-01	0.6040	-2.84e-01	6.19e-03	-3.41e-01	-3.15e-01	-2.62e-01	2.71e-01	9.81e-01	1.87e-01	2.23e-01	3.11e-01
CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION	7	5.45e-01	9.15e-01	0.6030	-3.75e-01	-3.78e-01	-1.88e-01	-1.99e-01	7.71e-02	8.61e-02	8.36e-02	3.89e-01	3.61e-01	7.24e-01
REGULATION OF ADIPONECTIN SECRETION	7	3.49e-01	8.18e-01	0.6030	-2.40e-01	-1.19e-01	-3.65e-01	-3.99e-01	4.09e-03	2.72e-01	5.86e-01	9.42e-02	6.79e-02	9.85e-01
NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION	6	7.95e-02	4.53e-01	0.6020	1.54e-01	2.21e-01	3.10e-01	2.19e-01	3.82e-01	5.12e-01	3.50e-01	1.88e-01	3.54e-01	1.05e-01
CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION	5	3.26e-01	7.98e-01	0.6020	1.71e-01	6.51e-02	4.28e-01	3.51e-01	1.50e-01	5.08e-01	8.01e-01	9.72e-02	1.74e-01	5.63e-01
FORMATION OF TRANSLATION PREINITIATION COMPLEX	7	5.73e-01	9.26e-01	0.6020	2.14e-01	2.00e-02	3.85e-01	3.81e-01	1.50e-01	3.26e-01	9.27e-01	7.81e-02	8.06e-02	4.92e-01
REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL	8	4.25e-01	8.62e-01	0.6020	-2.88e-01	-2.93e-01	-2.71e-01	-3.22e-01	-1.27e-01	1.58e-01	1.51e-01	1.85e-01	1.15e-01	5.35e-01
CYCLIC NUCLEOTIDE TRANSPORT	9	3.67e-01	8.30e-01	0.6010	-2.38e-01	-2.20e-01	-2.69e-01	-2.98e-01	-3.10e-01	2.17e-01	2.53e-01	1.63e-01	1.22e-01	1.07e-01
GLANDULAR EPITHELIAL CELL MATURATION	9	1.05e-01	5.18e-01	0.6010	-2.39e-01	-3.74e-01	-1.82e-01	-2.36e-01	2.76e-01	2.15e-01	5.21e-02	3.44e-01	2.21e-01	1.52e-01
REGULATION OF LENS FIBER CELL DIFFERENTIATION	9	6.31e-01	9.46e-01	0.6010	2.87e-01	9.91e-02	3.45e-01	3.36e-01	1.93e-01	1.36e-01	6.07e-01	7.28e-02	8.06e-02	3.17e-01
REGULATION OF HISTONE H3 K4 METHYLATION	11	4.98e-01	8.96e-01	0.6010	-2.69e-01	-2.10e-01	-3.38e-01	-3.31e-01	-1.47e-01	1.23e-01	2.28e-01	5.24e-02	5.74e-02	4.00e-01
TRICUSPID VALVE MORPHOGENESIS	5	6.30e-01	9.46e-01	0.6010	-2.64e-01	-1.34e-01	-2.34e-01	-2.67e-01	-3.83e-01	3.06e-01	6.04e-01	3.65e-01	3.00e-01	1.38e-01
POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	9	4.95e-01	8.96e-01	0.6000	-2.22e-01	-1.13e-01	-3.48e-01	-3.62e-01	-2.16e-01	2.49e-01	5.57e-01	7.07e-02	6.02e-02	2.62e-01
DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM	8	5.42e-01	9.14e-01	0.6000	3.75e-01	3.12e-01	2.25e-01	2.67e-01	2.69e-02	6.62e-02	1.26e-01	2.71e-01	1.91e-01	8.95e-01
ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS	5	4.80e-01	8.91e-01	0.6000	3.57e-01	2.76e-01	1.73e-01	1.90e-01	-3.01e-01	1.66e-01	2.86e-01	5.04e-01	4.61e-01	2.43e-01
REGULATION OF POTASSIUM ION IMPORT	5	6.78e-01	9.60e-01	0.6000	-3.29e-01	-3.41e-01	-2.27e-01	-2.87e-01	4.04e-02	2.03e-01	1.87e-01	3.79e-01	2.66e-01	8.76e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	12	2.42e-01	7.26e-01	0.5990	3.02e-01	2.85e-01	2.31e-01	2.69e-01	2.48e-01	7.03e-02	8.75e-02	1.66e-01	1.07e-01	1.37e-01
NEURON GLIAL CELL SIGNALING	5	2.61e-01	7.44e-01	0.5990	1.06e-01	2.43e-01	1.98e-01	2.10e-01	4.53e-01	6.81e-01	3.46e-01	4.42e-01	4.16e-01	7.94e-02
DENSE CORE GRANULE EXOCYTOSIS	10	3.82e-01	8.38e-01	0.5990	2.02e-01	-7.24e-03	2.98e-01	3.03e-01	3.71e-01	2.70e-01	9.68e-01	1.03e-01	9.66e-02	4.21e-02
CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT	6	4.51e-01	8.76e-01	0.5990	1.10e-01	-1.67e-01	3.28e-01	3.39e-01	3.10e-01	6.41e-01	4.78e-01	1.64e-01	1.51e-01	1.88e-01
REGULATION OF RRNA PROCESSING	16	3.83e-02	2.99e-01	0.5990	2.89e-01	2.95e-02	3.80e-01	3.60e-01	-1.12e-02	4.54e-02	8.38e-01	8.46e-03	1.26e-02	9.38e-01
PROTEIN LOCALIZATION TO ADHERENS JUNCTION	6	8.37e-01	9.85e-01	0.5990	-3.25e-01	-2.25e-01	-3.07e-01	-3.05e-01	-1.22e-01	1.68e-01	3.39e-01	1.93e-01	1.95e-01	6.06e-01
METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE	5	5.73e-01	9.26e-01	0.5990	3.11e-01	3.26e-01	2.76e-01	2.32e-01	1.59e-01	2.28e-01	2.07e-01	2.85e-01	3.69e-01	5.39e-01
GUANINE NUCLEOTIDE TRANSPORT	9	4.39e-01	8.70e-01	0.5980	-2.38e-01	-2.10e-01	-2.87e-01	-3.12e-01	-2.79e-01	2.15e-01	2.76e-01	1.36e-01	1.05e-01	1.48e-01
URETERIC BUD FORMATION	7	1.98e-01	6.76e-01	0.5980	5.21e-02	-2.78e-01	3.66e-01	3.22e-01	2.00e-01	8.11e-01	2.03e-01	9.40e-02	1.40e-01	3.59e-01
HARD PALATE DEVELOPMENT	8	1.54e-01	6.16e-01	0.5980	-2.08e-01	-4.66e-01	8.48e-02	2.27e-02	2.98e-01	3.08e-01	2.24e-02	6.78e-01	9.11e-01	1.44e-01
MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL	6	1.17e-01	5.46e-01	0.5970	1.96e-01	5.53e-01	-9.70e-02	-4.33e-02	-6.79e-03	4.06e-01	1.89e-02	6.81e-01	8.54e-01	9.77e-01
POSITIVE REGULATION OF PROTEIN NEDDYLATION	5	5.94e-01	9.32e-01	0.5960	-2.70e-01	-3.46e-01	-2.22e-01	-2.05e-01	-2.68e-01	2.96e-01	1.81e-01	3.91e-01	4.27e-01	2.98e-01
MATURATION OF SSU RRNA	51	8.72e-05	3.42e-03	0.5960	3.02e-01	1.08e-01	3.54e-01	3.57e-01	7.58e-03	1.88e-04	1.81e-01	1.22e-05	1.05e-05	9.25e-01
NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	5	4.41e-01	8.71e-01	0.5960	-2.13e-01	-1.59e-01	-4.03e-01	-3.47e-01	-4.00e-02	4.10e-01	5.38e-01	1.19e-01	1.79e-01	8.77e-01
PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT	7	4.57e-01	8.78e-01	0.5960	3.82e-01	3.80e-01	1.64e-01	1.78e-01	7.99e-02	8.01e-02	8.20e-02	4.52e-01	4.15e-01	7.14e-01
NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION	8	5.96e-01	9.33e-01	0.5950	3.14e-01	3.77e-01	2.29e-01	2.44e-01	4.68e-02	1.24e-01	6.51e-02	2.62e-01	2.33e-01	8.19e-01
ENDOCARDIUM MORPHOGENESIS	6	5.58e-01	9.19e-01	0.5950	-3.44e-01	-4.16e-01	-1.25e-01	-1.77e-01	1.22e-01	1.44e-01	7.73e-02	5.96e-01	4.52e-01	6.04e-01
MICROGLIAL CELL MEDIATED CYTOTOXICITY	5	6.06e-01	9.34e-01	0.5940	-2.54e-01	-3.84e-01	-2.10e-01	-2.32e-01	-2.08e-01	3.24e-01	1.37e-01	4.16e-01	3.70e-01	4.21e-01
EPITHELIAL MESENCHYMAL CELL SIGNALING	6	2.64e-01	7.47e-01	0.5940	2.00e-01	-2.33e-01	3.43e-01	3.10e-01	2.13e-01	3.97e-01	3.23e-01	1.46e-01	1.89e-01	3.66e-01
CRANIAL SUTURE MORPHOGENESIS	8	1.52e-01	6.14e-01	0.5940	2.22e-01	-8.09e-02	3.17e-01	2.52e-01	3.64e-01	2.76e-01	6.92e-01	1.20e-01	2.17e-01	7.43e-02
NEGATIVE REGULATION OF FEEDING BEHAVIOR	6	9.63e-02	4.94e-01	0.5940	6.86e-02	3.88e-01	-2.50e-01	-2.80e-01	-2.37e-01	7.71e-01	9.96e-02	2.89e-01	2.36e-01	3.15e-01
REGULATION OF PROTEIN ADP RIBOSYLATION	8	5.22e-02	3.58e-01	0.5930	7.64e-02	-2.93e-01	2.70e-01	3.14e-01	2.98e-01	7.08e-01	1.52e-01	1.86e-01	1.25e-01	1.45e-01
THREONINE METABOLIC PROCESS	5	2.03e-01	6.82e-01	0.5920	2.05e-01	-9.48e-02	1.32e-01	1.35e-01	5.14e-01	4.27e-01	7.13e-01	6.10e-01	6.02e-01	4.65e-02
OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE	5	8.72e-01	9.88e-01	0.5920	-2.85e-01	-1.81e-01	-3.11e-01	-3.31e-01	-1.73e-01	2.69e-01	4.82e-01	2.29e-01	2.00e-01	5.03e-01
SECRETION OF LYSOSOMAL ENZYMES	7	2.06e-01	6.84e-01	0.5920	2.35e-01	-4.71e-03	3.61e-01	4.05e-01	-1.06e-02	2.82e-01	9.83e-01	9.80e-02	6.33e-02	9.61e-01
NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	7	1.84e-01	6.56e-01	0.5910	-2.13e-01	-4.04e-01	-1.51e-01	-1.65e-01	-3.01e-01	3.29e-01	6.43e-02	4.89e-01	4.51e-01	1.67e-01
RIBOSOMAL LARGE SUBUNIT BIOGENESIS	70	2.18e-08	2.13e-06	0.5910	2.20e-01	2.90e-02	3.83e-01	3.86e-01	6.25e-02	1.44e-03	6.75e-01	2.96e-08	2.29e-08	3.66e-01
REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY	6	2.83e-01	7.62e-01	0.5910	2.21e-01	4.77e-01	-9.13e-04	6.91e-02	-2.62e-01	3.49e-01	4.32e-02	9.97e-01	7.70e-01	2.67e-01
REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION	7	3.60e-01	8.25e-01	0.5910	-1.71e-01	1.90e-02	-3.61e-01	-3.90e-01	-1.94e-01	4.34e-01	9.31e-01	9.86e-02	7.43e-02	3.75e-01
SUCCINYL COA CATABOLIC PROCESS	6	6.10e-01	9.36e-01	0.5900	2.42e-01	2.73e-01	2.64e-01	2.48e-01	2.90e-01	3.06e-01	2.47e-01	2.63e-01	2.93e-01	2.18e-01
NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	6	7.38e-01	9.73e-01	0.5900	2.94e-01	1.61e-01	3.50e-01	3.23e-01	8.97e-02	2.13e-01	4.94e-01	1.37e-01	1.70e-01	7.04e-01
ISG15 PROTEIN CONJUGATION	6	7.92e-01	9.81e-01	0.5900	-3.15e-01	-3.13e-01	-2.70e-01	-2.78e-01	1.05e-02	1.81e-01	1.84e-01	2.52e-01	2.38e-01	9.64e-01
ANTIBACTERIAL PEPTIDE PRODUCTION	9	1.05e-01	5.17e-01	0.5890	-2.43e-01	-1.10e-01	-4.02e-01	-3.39e-01	1.61e-02	2.08e-01	5.69e-01	3.69e-02	7.82e-02	9.33e-01
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE	19	1.74e-04	6.34e-03	0.5890	-1.74e-01	-1.18e-01	-4.22e-01	-3.53e-01	-1.60e-02	1.88e-01	3.72e-01	1.44e-03	7.78e-03	9.04e-01
VESICLE TETHERING INVOLVED IN EXOCYTOSIS	9	4.15e-01	8.55e-01	0.5890	-2.63e-01	-4.52e-02	-2.80e-01	-3.05e-01	-3.23e-01	1.72e-01	8.14e-01	1.45e-01	1.13e-01	9.29e-02
INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY	9	1.37e-01	5.89e-01	0.5890	-3.02e-01	7.08e-04	-2.99e-01	-3.55e-01	-2.02e-01	1.16e-01	9.97e-01	1.21e-01	6.55e-02	2.94e-01
REGULATION OF PHOSPHATE TRANSPORT	6	6.90e-01	9.61e-01	0.5890	2.29e-01	1.60e-01	3.13e-01	2.82e-01	3.02e-01	3.31e-01	4.98e-01	1.84e-01	2.31e-01	2.00e-01
REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	5	1.30e-01	5.74e-01	0.5890	-2.60e-01	-2.12e-01	-3.88e-01	-2.87e-01	3.50e-02	3.14e-01	4.11e-01	1.33e-01	2.66e-01	8.92e-01
APOPTOTIC CHROMOSOME CONDENSATION	6	1.33e-01	5.79e-01	0.5890	2.45e-01	2.47e-01	-8.18e-02	-7.45e-02	-4.62e-01	3.00e-01	2.95e-01	7.29e-01	7.52e-01	5.00e-02
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	6	6.40e-01	9.49e-01	0.5880	3.01e-01	2.97e-01	2.92e-01	2.59e-01	1.21e-01	2.02e-01	2.07e-01	2.16e-01	2.72e-01	6.07e-01
NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	7	1.22e-01	5.56e-01	0.5880	-9.61e-02	1.25e-01	-3.35e-01	-2.38e-01	-3.90e-01	6.60e-01	5.68e-01	1.25e-01	2.76e-01	7.36e-02
INTESTINAL EPITHELIAL CELL MATURATION	6	7.52e-01	9.75e-01	0.5880	-2.84e-01	-2.81e-01	-2.85e-01	-3.14e-01	-7.60e-02	2.28e-01	2.33e-01	2.27e-01	1.82e-01	7.47e-01
CORNIFICATION	9	3.13e-01	7.86e-01	0.5870	-1.06e-01	8.89e-02	-3.59e-01	-3.21e-01	-3.06e-01	5.83e-01	6.44e-01	6.23e-02	9.52e-02	1.11e-01
ENDOTHELIAL CELL ACTIVATION	11	1.32e-02	1.54e-01	0.5870	-1.05e-01	-4.82e-01	6.23e-02	5.15e-03	3.12e-01	5.48e-01	5.59e-03	7.20e-01	9.76e-01	7.34e-02
GALACTOSE CATABOLIC PROCESS	5	3.76e-01	8.36e-01	0.5870	2.84e-01	2.79e-01	1.16e-01	1.85e-01	-3.72e-01	2.72e-01	2.79e-01	6.52e-01	4.74e-01	1.50e-01
POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING	13	8.41e-02	4.62e-01	0.5870	-2.39e-01	-3.46e-01	-2.85e-01	-2.84e-01	7.94e-02	1.36e-01	3.08e-02	7.53e-02	7.67e-02	6.20e-01
DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX	5	4.35e-01	8.69e-01	0.5870	-8.57e-02	-3.76e-01	2.39e-01	2.08e-01	3.09e-01	7.40e-01	1.45e-01	3.55e-01	4.21e-01	2.32e-01
GROWTH PLATE CARTILAGE DEVELOPMENT	20	1.19e-01	5.51e-01	0.5870	2.86e-01	6.31e-02	3.12e-01	3.06e-01	2.60e-01	2.65e-02	6.25e-01	1.57e-02	1.79e-02	4.44e-02
EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION	5	6.68e-01	9.56e-01	0.5870	3.06e-01	3.23e-02	2.98e-01	2.81e-01	2.87e-01	2.36e-01	9.00e-01	2.49e-01	2.77e-01	2.67e-01
ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT	27	1.18e-02	1.42e-01	0.5860	2.25e-01	-6.12e-02	3.56e-01	3.45e-01	2.08e-01	4.34e-02	5.82e-01	1.34e-03	1.90e-03	6.12e-02
ESTABLISHMENT OF BLOOD BRAIN BARRIER	14	2.29e-01	7.13e-01	0.5860	3.11e-01	3.12e-01	2.46e-01	2.73e-01	-1.18e-01	4.36e-02	4.31e-02	1.11e-01	7.66e-02	4.45e-01
NEGATIVE REGULATION OF ACTIN NUCLEATION	9	5.00e-01	8.98e-01	0.5860	1.92e-01	9.35e-02	3.18e-01	2.95e-01	3.31e-01	3.19e-01	6.27e-01	9.84e-02	1.25e-01	8.52e-02
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA	5	5.23e-01	9.04e-01	0.5860	1.41e-01	-1.59e-01	3.88e-01	3.56e-01	1.45e-01	5.84e-01	5.39e-01	1.33e-01	1.68e-01	5.76e-01
MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	21	9.42e-02	4.90e-01	0.5860	-3.04e-01	-2.37e-01	-3.17e-01	-2.91e-01	-9.48e-02	1.58e-02	6.06e-02	1.19e-02	2.09e-02	4.52e-01
REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA	5	3.40e-01	8.09e-01	0.5850	2.02e-01	4.87e-01	1.76e-01	1.74e-01	-6.00e-02	4.34e-01	5.94e-02	4.96e-01	5.00e-01	8.16e-01
HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	14	1.28e-01	5.70e-01	0.5850	2.80e-01	1.63e-02	2.89e-01	2.74e-01	3.25e-01	7.01e-02	9.16e-01	6.10e-02	7.57e-02	3.53e-02
RIBOSOME BIOGENESIS	304	1.07e-31	4.01e-28	0.5850	2.67e-01	5.95e-02	3.66e-01	3.62e-01	4.79e-02	1.03e-15	7.45e-02	4.19e-28	1.52e-27	1.51e-01
REGULATION OF ADIPOSE TISSUE DEVELOPMENT	16	3.53e-01	8.21e-01	0.5850	-2.99e-01	-2.42e-01	-3.06e-01	-3.10e-01	-6.46e-02	3.85e-02	9.32e-02	3.39e-02	3.18e-02	6.55e-01
RRNA METHYLATION	24	1.47e-03	3.30e-02	0.5850	1.19e-01	-1.92e-01	3.64e-01	3.16e-01	2.41e-01	3.12e-01	1.03e-01	2.01e-03	7.38e-03	4.09e-02
REGULATION OF SKELETAL MUSCLE ADAPTATION	14	4.47e-02	3.29e-01	0.5840	2.60e-01	4.71e-01	1.34e-01	1.78e-01	-4.56e-02	9.24e-02	2.27e-03	3.85e-01	2.48e-01	7.68e-01
FEMALE MEIOSIS I	13	3.99e-01	8.45e-01	0.5840	2.47e-01	1.31e-01	2.91e-01	2.90e-01	3.07e-01	1.23e-01	4.15e-01	6.94e-02	7.02e-02	5.50e-02
PANCREATIC A CELL DIFFERENTIATION	11	9.90e-03	1.28e-01	0.5840	2.63e-01	-1.71e-01	2.95e-01	2.47e-01	3.08e-01	1.31e-01	3.26e-01	9.01e-02	1.56e-01	7.72e-02
SEROTONIN SECRETION	9	2.46e-01	7.31e-01	0.5840	-3.75e-01	-3.60e-01	-1.48e-01	-2.09e-01	-6.85e-02	5.14e-02	6.11e-02	4.43e-01	2.77e-01	7.22e-01
BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS	5	5.52e-01	9.16e-01	0.5840	3.25e-01	1.45e-01	2.26e-01	2.14e-01	3.42e-01	2.08e-01	5.73e-01	3.82e-01	4.08e-01	1.85e-01
URONIC ACID METABOLIC PROCESS	26	2.87e-03	5.34e-02	0.5840	-3.96e-01	-1.75e-01	-2.70e-01	-2.66e-01	-9.85e-02	4.75e-04	1.22e-01	1.70e-02	1.91e-02	3.85e-01
REGULATION OF MITOCHONDRIAL GENE EXPRESSION	30	3.88e-03	6.68e-02	0.5840	2.61e-01	2.81e-02	3.77e-01	3.54e-01	6.59e-02	1.32e-02	7.90e-01	3.54e-04	7.92e-04	5.32e-01
REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE	12	2.22e-02	2.17e-01	0.5830	-2.54e-01	9.29e-02	-3.61e-01	-2.93e-01	-2.25e-01	1.28e-01	5.77e-01	3.03e-02	7.90e-02	1.77e-01
NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	11	9.66e-02	4.95e-01	0.5830	1.83e-01	-1.56e-01	3.69e-01	3.19e-01	2.11e-01	2.92e-01	3.72e-01	3.42e-02	6.74e-02	2.26e-01
NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	20	1.99e-01	6.78e-01	0.5830	-2.92e-01	-1.32e-01	-3.34e-01	-3.40e-01	-9.62e-02	2.37e-02	3.07e-01	9.64e-03	8.44e-03	4.56e-01
CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE	20	6.79e-03	1.00e-01	0.5820	-2.50e-01	-2.12e-01	-3.45e-01	-3.14e-01	1.18e-01	5.29e-02	1.00e-01	7.64e-03	1.50e-02	3.62e-01
GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT	6	5.87e-01	9.29e-01	0.5820	3.03e-01	4.22e-01	1.64e-01	1.75e-01	1.06e-01	1.98e-01	7.37e-02	4.87e-01	4.57e-01	6.54e-01
MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	7	6.44e-02	4.05e-01	0.5810	-1.91e-01	-4.61e-01	-1.72e-01	-2.39e-01	-4.51e-02	3.81e-01	3.46e-02	4.31e-01	2.74e-01	8.36e-01
PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE	8	6.92e-01	9.61e-01	0.5810	3.03e-01	2.54e-01	3.05e-01	2.95e-01	4.40e-02	1.38e-01	2.14e-01	1.36e-01	1.48e-01	8.29e-01
SMOOTH MUSCLE CELL MATRIX ADHESION	6	2.08e-01	6.85e-01	0.5810	-3.27e-01	-1.69e-01	-1.86e-01	-2.66e-01	-3.11e-01	1.66e-01	4.74e-01	4.30e-01	2.59e-01	1.88e-01
SPERM MITOCHONDRIAL SHEATH ASSEMBLY	6	1.51e-01	6.13e-01	0.5800	2.33e-01	3.04e-01	2.44e-01	3.33e-01	1.41e-01	3.24e-01	1.97e-01	3.00e-01	1.58e-01	5.51e-01
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	11	2.69e-01	7.49e-01	0.5800	3.66e-01	1.41e-01	2.78e-01	3.10e-01	9.46e-02	3.54e-02	4.20e-01	1.11e-01	7.50e-02	5.87e-01
MODULATION OF PROCESS OF ANOTHER ORGANISM	19	2.55e-02	2.37e-01	0.5790	-3.01e-01	-2.37e-01	-3.18e-01	-2.84e-01	8.32e-02	2.33e-02	7.43e-02	1.64e-02	3.20e-02	5.30e-01
HIPPOCAMPAL NEURON APOPTOTIC PROCESS	6	1.32e-01	5.79e-01	0.5780	3.17e-01	3.56e-01	1.65e-01	2.79e-01	-4.53e-02	1.79e-01	1.31e-01	4.85e-01	2.37e-01	8.47e-01
NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	7	6.93e-01	9.61e-01	0.5770	2.10e-01	8.74e-02	3.57e-01	3.38e-01	2.01e-01	3.37e-01	6.89e-01	1.02e-01	1.22e-01	3.58e-01
NEGATIVE REGULATION OF MACROPHAGE MIGRATION	14	2.53e-01	7.37e-01	0.5770	-2.41e-01	-2.28e-01	-3.05e-01	-3.27e-01	-1.51e-01	1.18e-01	1.39e-01	4.80e-02	3.42e-02	3.27e-01
TOOTH ERUPTION	5	3.96e-01	8.45e-01	0.5760	-8.40e-02	4.92e-02	-4.05e-01	-3.78e-01	-1.27e-01	7.45e-01	8.49e-01	1.17e-01	1.43e-01	6.22e-01
THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY	13	3.23e-01	7.96e-01	0.5760	-3.12e-01	-3.29e-01	-2.33e-01	-2.47e-01	1.03e-01	5.16e-02	4.00e-02	1.45e-01	1.24e-01	5.20e-01
REGULATION OF ENDODERMAL CELL DIFFERENTIATION	7	5.23e-01	9.04e-01	0.5750	-2.31e-01	-3.20e-01	-2.71e-01	-2.84e-01	-1.44e-01	2.90e-01	1.42e-01	2.14e-01	1.94e-01	5.09e-01
CELLULAR RESPONSE TO GAMMA RADIATION	26	3.41e-02	2.79e-01	0.5750	2.74e-01	1.66e-01	3.37e-01	3.02e-01	1.50e-01	1.55e-02	1.43e-01	2.91e-03	7.68e-03	1.84e-01
MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	34	9.96e-03	1.28e-01	0.5740	3.09e-01	2.16e-01	3.10e-01	3.01e-01	-3.77e-02	1.85e-03	2.91e-02	1.75e-03	2.41e-03	7.04e-01
XENOBIOTIC GLUCURONIDATION	7	1.42e-02	1.60e-01	0.5740	-4.31e-01	-7.17e-02	-2.85e-01	-2.21e-01	-9.13e-02	4.81e-02	7.43e-01	1.92e-01	3.11e-01	6.76e-01
ACYLGLYCEROL TRANSPORT	8	4.35e-01	8.69e-01	0.5740	-3.41e-01	-7.39e-02	-3.12e-01	-2.97e-01	-1.52e-01	9.50e-02	7.17e-01	1.27e-01	1.46e-01	4.57e-01
TRANSITION BETWEEN FAST AND SLOW FIBER	9	1.46e-01	6.03e-01	0.5740	2.39e-01	4.70e-01	1.35e-01	1.82e-01	4.59e-04	2.14e-01	1.46e-02	4.83e-01	3.45e-01	9.98e-01
REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	11	3.30e-01	8.02e-01	0.5740	3.35e-01	1.29e-01	2.76e-01	2.69e-01	2.28e-01	5.46e-02	4.58e-01	1.13e-01	1.23e-01	1.90e-01
PROTEIN LOCALIZATION TO EARLY ENDOSOME	11	3.39e-01	8.08e-01	0.5740	-3.37e-01	-3.06e-01	-2.14e-01	-2.67e-01	-7.29e-02	5.31e-02	7.93e-02	2.19e-01	1.25e-01	6.76e-01
REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	8	4.53e-02	3.31e-01	0.5740	1.31e-01	3.45e-01	1.53e-01	1.29e-01	3.91e-01	5.22e-01	9.12e-02	4.55e-01	5.26e-01	5.54e-02
MITOCHONDRIAL TRNA PROCESSING	13	6.14e-02	3.97e-01	0.5730	2.99e-01	2.32e-01	2.39e-01	2.30e-01	-2.75e-01	6.19e-02	1.48e-01	1.36e-01	1.51e-01	8.56e-02
BOX C D SNORNP ASSEMBLY	10	4.22e-01	8.61e-01	0.5730	3.50e-01	1.69e-01	2.96e-01	2.99e-01	-1.87e-02	5.56e-02	3.56e-01	1.05e-01	1.02e-01	9.19e-01
PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT	5	1.98e-03	4.04e-02	0.5720	1.55e-01	-2.94e-01	1.38e-01	6.62e-03	4.45e-01	5.49e-01	2.55e-01	5.94e-01	9.80e-01	8.47e-02
REGULATION OF HEXOKINASE ACTIVITY	7	5.72e-01	9.26e-01	0.5720	2.90e-01	8.49e-03	3.01e-01	3.01e-01	2.50e-01	1.83e-01	9.69e-01	1.68e-01	1.69e-01	2.53e-01
SNRNA 3 END PROCESSING	20	1.50e-02	1.66e-01	0.5720	2.94e-01	4.82e-02	3.60e-01	3.30e-01	-2.26e-03	2.28e-02	7.09e-01	5.27e-03	1.07e-02	9.86e-01
CARDIAC PACEMAKER CELL DEVELOPMENT	9	1.70e-02	1.82e-01	0.5720	-2.13e-02	-4.76e-01	1.80e-01	1.15e-01	2.35e-01	9.12e-01	1.35e-02	3.51e-01	5.52e-01	2.22e-01
SNRNA CATABOLIC PROCESS	5	3.98e-01	8.45e-01	0.5720	-3.14e-01	-4.45e-01	-4.89e-02	-1.11e-01	-1.26e-01	2.24e-01	8.46e-02	8.50e-01	6.68e-01	6.26e-01
REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	18	4.73e-02	3.40e-01	0.5720	1.86e-01	-5.96e-02	3.78e-01	3.40e-01	1.73e-01	1.71e-01	6.62e-01	5.44e-03	1.25e-02	2.03e-01
NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	8	6.34e-02	4.02e-01	0.5720	-3.59e-01	-3.36e-01	-1.22e-01	-8.77e-02	2.51e-01	7.88e-02	1.00e-01	5.51e-01	6.68e-01	2.20e-01
CARDIAC PACEMAKER CELL DIFFERENTIATION	11	6.64e-03	9.84e-02	0.5720	8.91e-02	-3.99e-01	2.41e-01	1.99e-01	2.49e-01	6.09e-01	2.19e-02	1.67e-01	2.52e-01	1.53e-01
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN	25	1.31e-01	5.77e-01	0.5710	2.54e-01	1.86e-01	3.13e-01	3.17e-01	1.69e-01	2.77e-02	1.08e-01	6.69e-03	6.06e-03	1.43e-01
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	6	6.19e-01	9.42e-01	0.5710	-2.63e-01	-3.33e-01	-2.47e-01	-2.56e-01	1.42e-01	2.65e-01	1.58e-01	2.94e-01	2.77e-01	5.48e-01
REGULATION OF PROTEIN AUTOUBIQUITINATION	5	8.04e-01	9.82e-01	0.5710	-2.93e-01	-3.23e-01	-2.25e-01	-2.60e-01	-1.34e-01	2.57e-01	2.11e-01	3.84e-01	3.14e-01	6.03e-01
REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT	5	7.37e-01	9.73e-01	0.5710	1.31e-01	2.19e-02	3.14e-01	2.86e-01	3.58e-01	6.11e-01	9.32e-01	2.24e-01	2.68e-01	1.66e-01
PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE	10	2.20e-01	7.00e-01	0.5710	1.82e-01	-5.41e-02	3.88e-01	3.42e-01	1.49e-01	3.19e-01	7.67e-01	3.35e-02	6.11e-02	4.15e-01
MITOCHONDRIAL TRANSLATION	130	1.11e-17	3.99e-15	0.5700	2.59e-01	-2.34e-03	3.59e-01	3.58e-01	-1.02e-02	3.34e-07	9.63e-01	1.47e-12	1.65e-12	8.41e-01
ISOTYPE SWITCHING TO IGG ISOTYPES	15	3.26e-01	7.98e-01	0.5700	2.32e-01	1.83e-01	3.21e-01	3.17e-01	1.83e-01	1.20e-01	2.20e-01	3.14e-02	3.33e-02	2.20e-01
POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	40	1.51e-02	1.67e-01	0.5690	2.63e-01	2.20e-01	2.85e-01	3.00e-01	1.87e-01	3.94e-03	1.62e-02	1.80e-03	1.03e-03	4.02e-02
REGULATION OF ASYMMETRIC CELL DIVISION	5	4.60e-01	8.80e-01	0.5690	2.56e-01	2.68e-01	2.20e-01	1.98e-01	-3.14e-01	3.21e-01	2.99e-01	3.95e-01	4.42e-01	2.24e-01
RNA SURVEILLANCE	17	1.44e-02	1.62e-01	0.5690	3.04e-01	1.13e-01	3.11e-01	2.97e-01	-1.84e-01	3.00e-02	4.18e-01	2.65e-02	3.39e-02	1.90e-01
TELOMERIC LOOP DISASSEMBLY	9	6.19e-01	9.42e-01	0.5680	-2.82e-01	-2.17e-01	-2.82e-01	-3.15e-01	-1.31e-01	1.43e-01	2.60e-01	1.44e-01	1.02e-01	4.95e-01
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY	6	7.71e-01	9.76e-01	0.5670	-2.26e-01	-3.95e-02	-3.38e-01	-3.09e-01	-2.45e-01	3.37e-01	8.67e-01	1.52e-01	1.90e-01	2.99e-01
POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION	9	2.12e-01	6.91e-01	0.5670	2.18e-01	2.26e-01	1.70e-01	1.69e-01	4.07e-01	2.58e-01	2.39e-01	3.76e-01	3.80e-01	3.46e-02
NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	4.38e-01	8.69e-01	0.5660	2.85e-01	1.60e-01	3.21e-01	2.93e-01	1.59e-01	8.78e-02	3.37e-01	5.44e-02	7.86e-02	3.40e-01
SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION	5	6.73e-01	9.59e-01	0.5660	1.12e-01	-1.78e-01	2.71e-01	2.58e-01	3.69e-01	6.66e-01	4.92e-01	2.93e-01	3.17e-01	1.53e-01
MATURATION OF LSU RRNA	27	2.98e-02	2.60e-01	0.5660	2.21e-01	8.74e-03	3.60e-01	3.49e-01	1.41e-01	4.64e-02	9.37e-01	1.21e-03	1.67e-03	2.04e-01
NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	13	2.55e-01	7.38e-01	0.5660	-2.80e-01	-2.36e-01	-2.81e-01	-2.49e-01	-2.13e-01	7.99e-02	1.41e-01	7.99e-02	1.21e-01	1.84e-01
RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE	10	3.26e-01	7.98e-01	0.5650	3.16e-01	1.73e-01	3.20e-01	2.79e-01	9.63e-02	8.34e-02	3.43e-01	7.97e-02	1.27e-01	5.98e-01
NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	7	2.50e-01	7.33e-01	0.5650	2.67e-01	3.75e-01	1.14e-01	1.68e-01	2.57e-01	2.21e-01	8.61e-02	6.01e-01	4.43e-01	2.39e-01
POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	26	4.61e-02	3.35e-01	0.5640	2.38e-01	1.98e-01	3.30e-01	3.29e-01	6.73e-02	3.54e-02	8.01e-02	3.61e-03	3.70e-03	5.53e-01
TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	15	1.33e-01	5.80e-01	0.5630	-3.14e-01	-1.45e-01	-3.30e-01	-2.98e-01	-2.32e-02	3.52e-02	3.32e-01	2.70e-02	4.60e-02	8.76e-01
ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB	25	2.65e-02	2.43e-01	0.5630	2.41e-01	2.37e-01	3.01e-01	3.28e-01	6.22e-02	3.68e-02	4.04e-02	9.15e-03	4.50e-03	5.90e-01
PROTEIN LOCALIZATION TO GOLGI MEMBRANE	5	6.39e-01	9.49e-01	0.5630	2.14e-01	-1.32e-01	3.14e-01	2.99e-01	2.55e-01	4.07e-01	6.09e-01	2.24e-01	2.46e-01	3.23e-01
RIBOSOMAL LARGE SUBUNIT ASSEMBLY	24	5.00e-04	1.45e-02	0.5620	1.47e-01	-2.57e-02	3.75e-01	3.89e-01	3.56e-02	2.12e-01	8.28e-01	1.46e-03	9.57e-04	7.63e-01
ENDOSOMAL LUMEN ACIDIFICATION	12	3.49e-01	8.18e-01	0.5620	3.08e-01	2.48e-01	2.79e-01	2.72e-01	-8.72e-02	6.44e-02	1.37e-01	9.39e-02	1.03e-01	6.01e-01
POSITIVE REGULATION OF CENTRIOLE REPLICATION	9	5.65e-01	9.23e-01	0.5620	2.71e-01	7.51e-02	3.28e-01	3.47e-01	9.27e-02	1.59e-01	6.96e-01	8.83e-02	7.18e-02	6.30e-01
REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	10	3.61e-01	8.25e-01	0.5620	3.19e-01	3.58e-01	1.87e-01	1.83e-01	-1.33e-01	8.07e-02	5.02e-02	3.07e-01	3.17e-01	4.67e-01
ADIPONECTIN ACTIVATED SIGNALING PATHWAY	7	2.18e-01	7.00e-01	0.5620	-2.63e-01	-4.96e-01	-1.26e-02	-1.92e-02	4.75e-04	2.27e-01	2.32e-02	9.54e-01	9.30e-01	9.98e-01
ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS	6	8.23e-01	9.83e-01	0.5610	-2.46e-01	-1.28e-01	-3.02e-01	-2.83e-01	-2.59e-01	2.98e-01	5.89e-01	2.00e-01	2.29e-01	2.72e-01
POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS	5	3.86e-01	8.40e-01	0.5610	-1.88e-01	2.47e-01	-2.88e-01	-2.76e-01	-2.44e-01	4.66e-01	3.39e-01	2.65e-01	2.86e-01	3.45e-01
ADENINE TRANSPORT	5	2.60e-01	7.43e-01	0.5610	9.57e-02	-1.72e-01	2.04e-01	1.24e-01	4.68e-01	7.11e-01	5.05e-01	4.30e-01	6.30e-01	7.00e-02
GALACTOSE TRANSMEMBRANE TRANSPORT	5	8.25e-02	4.59e-01	0.5610	2.31e-01	4.98e-01	-8.16e-02	4.45e-02	-6.52e-02	3.71e-01	5.37e-02	7.52e-01	8.63e-01	8.01e-01
MITOCHONDRIAL RNA MODIFICATION	9	2.99e-01	7.73e-01	0.5600	2.86e-01	2.04e-01	3.03e-01	2.78e-01	-1.47e-01	1.38e-01	2.89e-01	1.16e-01	1.48e-01	4.45e-01
REGULATION OF RIBONUCLEASE ACTIVITY	9	6.37e-01	9.48e-01	0.5600	2.19e-01	6.43e-02	3.34e-01	3.38e-01	1.89e-01	2.55e-01	7.38e-01	8.31e-02	7.89e-02	3.27e-01
PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION	38	6.67e-05	2.80e-03	0.5600	2.73e-01	7.33e-02	3.30e-01	3.32e-01	-1.18e-01	3.55e-03	4.35e-01	4.34e-04	3.91e-04	2.07e-01
REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY	9	3.44e-01	8.14e-01	0.5590	2.25e-01	8.26e-02	3.75e-01	3.37e-01	4.20e-02	2.42e-01	6.68e-01	5.16e-02	8.03e-02	8.27e-01
RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY	10	2.90e-01	7.67e-01	0.5590	2.92e-01	3.08e-01	2.23e-01	2.82e-01	-6.04e-02	1.10e-01	9.16e-02	2.22e-01	1.23e-01	7.41e-01
DNA DEAMINATION	13	5.26e-02	3.59e-01	0.5590	2.80e-01	2.24e-01	1.69e-01	2.04e-01	-3.37e-01	8.04e-02	1.63e-01	2.91e-01	2.03e-01	3.52e-02
TETRAHYDROFOLATE BIOSYNTHETIC PROCESS	5	5.59e-01	9.19e-01	0.5590	1.98e-01	1.14e-01	3.64e-01	3.49e-01	-7.69e-02	4.42e-01	6.58e-01	1.59e-01	1.77e-01	7.66e-01
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	15	3.88e-01	8.40e-01	0.5590	2.71e-01	8.82e-02	2.98e-01	3.07e-01	2.20e-01	6.96e-02	5.54e-01	4.59e-02	3.94e-02	1.41e-01
REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS	5	1.56e-01	6.17e-01	0.5580	2.82e-01	3.93e-01	1.23e-01	2.44e-01	-5.87e-02	2.74e-01	1.28e-01	6.34e-01	3.45e-01	8.20e-01
CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP	6	5.48e-01	9.15e-01	0.5580	-3.38e-01	-1.89e-01	-2.61e-01	-2.58e-01	1.64e-01	1.52e-01	4.22e-01	2.69e-01	2.73e-01	4.85e-01
REGULATION OF MESODERMAL CELL FATE SPECIFICATION	5	2.66e-01	7.47e-01	0.5580	-1.62e-01	-3.44e-01	-2.66e-01	-3.10e-01	-1.97e-02	5.30e-01	1.83e-01	3.03e-01	2.31e-01	9.39e-01
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	8	4.89e-01	8.92e-01	0.5580	-3.38e-01	-2.93e-01	-2.03e-01	-2.60e-01	4.35e-02	9.78e-02	1.51e-01	3.20e-01	2.02e-01	8.31e-01
REGULATION OF BONE DEVELOPMENT	9	2.76e-01	7.56e-01	0.5580	-1.43e-01	-8.65e-02	-3.67e-01	-3.55e-01	-1.49e-01	4.57e-01	6.53e-01	5.64e-02	6.51e-02	4.38e-01
LATERAL MESODERM DEVELOPMENT	15	1.72e-01	6.44e-01	0.5580	3.58e-01	1.66e-01	2.58e-01	2.90e-01	6.73e-02	1.64e-02	2.65e-01	8.39e-02	5.17e-02	6.52e-01
NEGATIVE REGULATION BY HOST OF VIRAL PROCESS	14	2.58e-01	7.41e-01	0.5570	2.17e-01	-3.15e-02	3.37e-01	3.12e-01	2.27e-01	1.59e-01	8.38e-01	2.89e-02	4.32e-02	1.42e-01
RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS	14	1.06e-02	1.33e-01	0.5570	1.29e-01	-1.32e-01	3.81e-01	3.60e-01	-2.64e-02	4.04e-01	3.91e-01	1.35e-02	1.95e-02	8.64e-01
POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE	6	1.84e-01	6.56e-01	0.5570	-2.07e-01	-2.23e-01	1.24e-01	1.10e-01	4.35e-01	3.79e-01	3.44e-01	5.98e-01	6.40e-01	6.48e-02
REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	7	2.12e-02	2.11e-01	0.5560	1.34e-01	1.37e-01	1.09e-01	2.03e-01	4.68e-01	5.39e-01	5.30e-01	6.16e-01	3.52e-01	3.19e-02
PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	5	3.97e-01	8.45e-01	0.5560	-1.05e-02	2.91e-01	-9.79e-02	-7.59e-02	-4.57e-01	9.68e-01	2.59e-01	7.05e-01	7.69e-01	7.68e-02
REGULATION OF TRANSLATIONAL ELONGATION	12	6.88e-02	4.21e-01	0.5560	1.51e-01	-6.96e-02	3.94e-01	3.47e-01	7.27e-02	3.66e-01	6.76e-01	1.81e-02	3.72e-02	6.63e-01
GLYCEROL 3 PHOSPHATE METABOLIC PROCESS	7	1.62e-01	6.26e-01	0.5560	-1.34e-01	2.34e-01	-3.63e-01	-3.10e-01	-8.71e-02	5.38e-01	2.83e-01	9.62e-02	1.55e-01	6.90e-01
3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS	15	2.27e-01	7.10e-01	0.5550	-2.86e-01	-3.55e-01	-2.14e-01	-2.12e-01	-9.60e-02	5.48e-02	1.72e-02	1.51e-01	1.55e-01	5.20e-01
QUINOLINATE METABOLIC PROCESS	5	7.24e-01	9.70e-01	0.5550	-1.33e-01	-7.45e-02	-3.26e-01	-3.08e-01	-2.90e-01	6.07e-01	7.73e-01	2.07e-01	2.33e-01	2.61e-01
REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	7	2.18e-01	7.00e-01	0.5550	2.57e-01	1.82e-01	2.02e-01	1.92e-01	-3.63e-01	2.39e-01	4.05e-01	3.54e-01	3.79e-01	9.66e-02
NEGATIVE REGULATION OF PROTEIN ACETYLATION	8	6.42e-01	9.50e-01	0.5550	2.33e-01	1.29e-01	2.52e-01	2.63e-01	3.24e-01	2.55e-01	5.28e-01	2.18e-01	1.97e-01	1.13e-01
NEGATIVE REGULATION OF GLUTAMATE SECRETION	6	3.55e-01	8.22e-01	0.5550	-2.90e-02	-2.66e-01	2.49e-01	1.78e-01	3.78e-01	9.02e-01	2.60e-01	2.91e-01	4.51e-01	1.08e-01
POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	8	4.19e-01	8.59e-01	0.5550	3.50e-01	1.51e-01	2.78e-01	2.52e-01	1.49e-01	8.68e-02	4.60e-01	1.74e-01	2.16e-01	4.66e-01
POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION	16	7.30e-02	4.34e-01	0.5550	-3.04e-01	-3.76e-01	-1.96e-01	-1.75e-01	6.82e-02	3.51e-02	9.25e-03	1.74e-01	2.25e-01	6.37e-01
RECEPTOR DIFFUSION TRAPPING	10	3.47e-01	8.18e-01	0.5540	3.09e-01	3.46e-01	1.69e-01	2.17e-01	1.27e-01	9.03e-02	5.79e-02	3.56e-01	2.35e-01	4.86e-01
PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	16	2.71e-01	7.50e-01	0.5540	3.48e-01	2.61e-01	2.40e-01	2.46e-01	2.50e-03	1.59e-02	7.10e-02	9.61e-02	8.86e-02	9.86e-01
POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE	15	1.37e-01	5.89e-01	0.5540	1.87e-01	-5.71e-02	2.64e-01	2.44e-01	3.74e-01	2.09e-01	7.02e-01	7.69e-02	1.02e-01	1.21e-02
PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING	11	2.28e-01	7.12e-01	0.5540	3.34e-01	4.13e-01	9.91e-02	1.19e-01	-2.36e-02	5.51e-02	1.76e-02	5.69e-01	4.93e-01	8.92e-01
POSITIVE REGULATION OF RECEPTOR BINDING	6	6.99e-01	9.63e-01	0.5540	2.56e-01	9.94e-02	3.48e-01	3.08e-01	1.24e-01	2.78e-01	6.73e-01	1.39e-01	1.91e-01	5.98e-01
TELOMERIC D LOOP DISASSEMBLY	7	7.66e-01	9.75e-01	0.5540	-3.00e-01	-2.40e-01	-2.56e-01	-2.91e-01	-9.53e-02	1.69e-01	2.71e-01	2.41e-01	1.82e-01	6.62e-01
REGULATION OF ASTROCYTE ACTIVATION	8	2.37e-01	7.20e-01	0.5540	3.07e-01	2.41e-01	1.70e-01	2.37e-01	2.64e-01	1.33e-01	2.39e-01	4.04e-01	2.46e-01	1.95e-01
MAINTENANCE OF ANIMAL ORGAN IDENTITY	5	4.68e-01	8.83e-01	0.5540	-1.81e-01	-2.61e-01	1.15e-02	-3.80e-02	4.52e-01	4.83e-01	3.12e-01	9.65e-01	8.83e-01	8.00e-02
NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	8	6.91e-01	9.61e-01	0.5540	-2.54e-01	-5.80e-02	-2.88e-01	-2.83e-01	-2.75e-01	2.14e-01	7.76e-01	1.58e-01	1.65e-01	1.78e-01
PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	5	8.04e-01	9.82e-01	0.5540	3.21e-01	3.04e-01	2.26e-01	2.23e-01	-1.02e-01	2.14e-01	2.40e-01	3.82e-01	3.88e-01	6.91e-01
REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES	6	3.23e-01	7.96e-01	0.5530	-1.74e-01	-3.48e-01	-2.27e-01	-2.55e-01	-1.96e-01	4.61e-01	1.40e-01	3.35e-01	2.80e-01	4.06e-01
REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE	12	1.15e-01	5.43e-01	0.5530	-2.70e-01	6.36e-02	-3.21e-01	-2.90e-01	-2.05e-01	1.06e-01	7.03e-01	5.40e-02	8.23e-02	2.18e-01
POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	10	6.05e-01	9.34e-01	0.5530	-2.66e-01	-2.78e-01	-2.69e-01	-2.67e-01	-1.20e-01	1.46e-01	1.28e-01	1.41e-01	1.43e-01	5.11e-01
INTERLEUKIN 18 PRODUCTION	14	7.76e-02	4.50e-01	0.5530	-2.66e-01	-2.24e-01	-2.23e-01	-2.42e-01	2.76e-01	8.45e-02	1.46e-01	1.48e-01	1.17e-01	7.41e-02
TELOMERE LOCALIZATION	12	4.71e-02	3.39e-01	0.5520	-1.71e-01	1.85e-01	-3.01e-01	-3.30e-01	-2.05e-01	3.04e-01	2.67e-01	7.14e-02	4.77e-02	2.18e-01
REGULATION OF NEUTROPHIL ACTIVATION	15	3.54e-01	8.22e-01	0.5520	-3.10e-01	-3.35e-01	-2.09e-01	-2.28e-01	-4.20e-02	3.76e-02	2.49e-02	1.62e-01	1.27e-01	7.78e-01
PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING	9	5.10e-02	3.54e-01	0.5520	2.00e-01	5.08e-01	-5.76e-02	-4.42e-02	2.53e-02	3.00e-01	8.26e-03	7.65e-01	8.18e-01	8.95e-01
NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	6	3.52e-01	8.19e-01	0.5520	8.56e-02	2.46e-02	1.22e-01	1.14e-01	5.18e-01	7.17e-01	9.17e-01	6.04e-01	6.30e-01	2.80e-02
NUCLEOSOME ORGANIZATION	119	4.38e-11	6.72e-09	0.5510	3.10e-01	1.98e-01	2.71e-01	2.87e-01	-1.16e-01	5.15e-09	1.96e-04	3.40e-07	6.36e-08	2.91e-02
XYLULOSE 5 PHOSPHATE METABOLIC PROCESS	6	5.00e-01	8.98e-01	0.5510	-2.37e-01	-4.09e-01	-1.76e-01	-2.19e-01	3.46e-02	3.14e-01	8.29e-02	4.54e-01	3.53e-01	8.83e-01
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	6	1.16e-01	5.45e-01	0.5510	1.27e-01	4.38e-01	-1.40e-01	-3.68e-02	-2.73e-01	5.91e-01	6.32e-02	5.52e-01	8.76e-01	2.47e-01
PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS	10	2.23e-01	7.04e-01	0.5510	-1.56e-01	3.65e-02	-3.69e-01	-3.68e-01	-7.91e-02	3.93e-01	8.42e-01	4.36e-02	4.39e-02	6.65e-01
COP9 SIGNALOSOME ASSEMBLY	5	4.06e-01	8.50e-01	0.5500	6.78e-02	-1.86e-01	3.64e-01	2.89e-01	2.17e-01	7.93e-01	4.71e-01	1.58e-01	2.63e-01	4.00e-01
VESICLE TETHERING TO GOLGI	5	2.71e-02	2.47e-01	0.5500	-1.62e-01	-4.74e-01	-8.48e-02	-2.09e-01	-9.87e-03	5.30e-01	6.64e-02	7.43e-01	4.18e-01	9.69e-01
POSITIVE REGULATION OF TISSUE REMODELING	23	8.26e-02	4.59e-01	0.5490	-3.14e-01	-1.31e-01	-3.08e-01	-2.91e-01	-8.25e-02	9.14e-03	2.78e-01	1.06e-02	1.57e-02	4.93e-01
CITRATE METABOLIC PROCESS	5	3.03e-01	7.75e-01	0.5490	-1.86e-01	-2.71e-01	-6.01e-02	-8.91e-02	-4.27e-01	4.71e-01	2.95e-01	8.16e-01	7.30e-01	9.82e-02
CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	15	2.91e-01	7.67e-01	0.5490	3.40e-01	1.87e-01	2.72e-01	2.77e-01	9.47e-03	2.25e-02	2.10e-01	6.79e-02	6.32e-02	9.49e-01
PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE	6	9.65e-02	4.95e-01	0.5490	1.95e-02	-4.65e-01	1.43e-01	1.45e-01	2.09e-01	9.34e-01	4.88e-02	5.44e-01	5.40e-01	3.74e-01
REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	13	2.62e-01	7.45e-01	0.5490	1.64e-01	-3.96e-02	2.60e-01	2.65e-01	3.68e-01	3.07e-01	8.05e-01	1.05e-01	9.79e-02	2.16e-02
LEUKOTRIENE BIOSYNTHETIC PROCESS	17	1.28e-01	5.72e-01	0.5490	-2.96e-01	-1.83e-01	-3.02e-01	-2.64e-01	-1.36e-01	3.43e-02	1.90e-01	3.09e-02	5.95e-02	3.33e-01
MICROGLIA DIFFERENTIATION	11	2.46e-01	7.32e-01	0.5490	-2.71e-01	-3.83e-01	-1.17e-01	-1.24e-01	2.28e-01	1.20e-01	2.80e-02	5.01e-01	4.75e-01	1.90e-01
MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS	6	3.82e-01	8.38e-01	0.5480	-1.33e-01	-4.30e-01	1.27e-01	8.10e-02	2.74e-01	5.73e-01	6.80e-02	5.90e-01	7.31e-01	2.45e-01
ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY	5	7.94e-01	9.81e-01	0.5480	3.15e-01	1.45e-01	3.09e-01	2.92e-01	2.51e-04	2.22e-01	5.75e-01	2.32e-01	2.59e-01	9.99e-01
CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS	5	1.27e-01	5.68e-01	0.5480	4.42e-01	2.74e-01	4.52e-02	7.49e-02	-1.48e-01	8.68e-02	2.88e-01	8.61e-01	7.72e-01	5.65e-01
POSITIVE REGULATION OF URINE VOLUME	13	2.36e-01	7.19e-01	0.5480	2.93e-01	6.66e-02	3.27e-01	2.96e-01	1.25e-01	6.72e-02	6.78e-01	4.11e-02	6.49e-02	4.37e-01
REGULATION OF RELAXATION OF CARDIAC MUSCLE	6	4.29e-01	8.66e-01	0.5480	-6.40e-02	1.24e-01	-3.40e-01	-3.43e-01	-2.18e-01	7.86e-01	5.99e-01	1.49e-01	1.45e-01	3.55e-01
RENAL WATER HOMEOSTASIS	24	7.80e-02	4.50e-01	0.5480	2.90e-01	3.46e-01	2.08e-01	2.20e-01	-6.63e-02	1.39e-02	3.32e-03	7.76e-02	6.22e-02	5.74e-01
POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	5	7.73e-01	9.77e-01	0.5470	2.38e-01	2.86e-01	2.87e-01	2.81e-01	3.73e-03	3.57e-01	2.67e-01	2.66e-01	2.77e-01	9.88e-01
RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION	13	3.34e-03	6.01e-02	0.5470	2.56e-01	4.69e-01	-8.45e-02	1.16e-02	-7.92e-02	1.10e-01	3.39e-03	5.98e-01	9.42e-01	6.21e-01
NORADRENERGIC NEURON DIFFERENTIATION	10	3.25e-02	2.73e-01	0.5470	3.07e-01	-1.29e-01	2.91e-01	3.05e-01	1.05e-01	9.26e-02	4.80e-01	1.12e-01	9.48e-02	5.67e-01
PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT	5	1.88e-01	6.59e-01	0.5470	-3.60e-02	5.41e-02	-4.72e-02	-3.61e-02	5.40e-01	8.89e-01	8.34e-01	8.55e-01	8.89e-01	3.65e-02
POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	9	3.39e-01	8.08e-01	0.5470	-1.70e-01	9.46e-02	-2.90e-01	-3.14e-01	-2.80e-01	3.76e-01	6.23e-01	1.32e-01	1.02e-01	1.46e-01
HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION	9	1.34e-01	5.82e-01	0.5460	-3.11e-01	3.78e-02	-3.15e-01	-2.78e-01	-1.53e-01	1.06e-01	8.44e-01	1.01e-01	1.48e-01	4.27e-01
T HELPER 17 CELL LINEAGE COMMITMENT	16	1.07e-01	5.24e-01	0.5460	2.76e-01	3.44e-01	1.81e-01	1.78e-01	2.00e-01	5.64e-02	1.73e-02	2.11e-01	2.17e-01	1.66e-01
CORTICOSTERONE SECRETION	5	3.39e-01	8.08e-01	0.5460	-2.22e-01	9.83e-02	-3.11e-01	-2.36e-01	-2.95e-01	3.90e-01	7.03e-01	2.28e-01	3.61e-01	2.54e-01
INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY	11	2.17e-01	7.00e-01	0.5460	-1.33e-01	1.38e-01	-2.75e-01	-2.34e-01	-3.62e-01	4.46e-01	4.28e-01	1.14e-01	1.79e-01	3.77e-02
NEGATIVE REGULATION OF T CELL MIGRATION	6	5.52e-01	9.16e-01	0.5460	-3.45e-01	-2.42e-01	-2.03e-01	-2.69e-01	-8.12e-02	1.43e-01	3.05e-01	3.89e-01	2.53e-01	7.31e-01
PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK	6	1.77e-01	6.47e-01	0.5460	3.65e-01	2.33e-02	2.11e-01	2.11e-01	2.74e-01	1.22e-01	9.21e-01	3.70e-01	3.70e-01	2.46e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE	37	4.17e-03	7.09e-02	0.5460	2.14e-01	-1.55e-03	3.31e-01	3.44e-01	1.56e-01	2.44e-02	9.87e-01	4.97e-04	2.88e-04	1.01e-01
NEGATIVE REGULATION OF NUCLEASE ACTIVITY	7	5.21e-01	9.03e-01	0.5460	2.23e-01	-2.20e-02	3.58e-01	3.14e-01	1.45e-01	3.07e-01	9.20e-01	1.01e-01	1.50e-01	5.06e-01
CORTICOTROPIN SECRETION	7	5.63e-01	9.22e-01	0.5460	-2.15e-01	4.41e-02	-3.36e-01	-3.49e-01	-1.24e-01	3.25e-01	8.40e-01	1.24e-01	1.10e-01	5.70e-01
PONS DEVELOPMENT	11	3.67e-01	8.30e-01	0.5460	2.75e-01	2.70e-02	3.11e-01	3.33e-01	1.18e-01	1.14e-01	8.77e-01	7.41e-02	5.61e-02	4.97e-01
CELLULAR RESPONSE TO EXOGENOUS DSRNA	16	2.38e-01	7.21e-01	0.5460	2.90e-01	4.87e-02	3.01e-01	2.99e-01	1.78e-01	4.46e-02	7.36e-01	3.72e-02	3.85e-02	2.19e-01
REGULATION OF NAD P H OXIDASE ACTIVITY	7	2.58e-01	7.40e-01	0.5460	3.56e-01	4.07e-01	2.44e-02	6.97e-02	-1.41e-02	1.03e-01	6.25e-02	9.11e-01	7.50e-01	9.48e-01
AMINO ACID BETAINE BIOSYNTHETIC PROCESS	5	7.06e-01	9.65e-01	0.5450	3.26e-01	2.07e-01	2.36e-01	2.46e-01	-1.78e-01	2.07e-01	4.23e-01	3.61e-01	3.40e-01	4.90e-01
NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	7	2.14e-01	6.95e-01	0.5450	-2.17e-01	-3.33e-01	-2.14e-01	-1.77e-01	2.49e-01	3.19e-01	1.27e-01	3.26e-01	4.16e-01	2.54e-01
PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT	8	2.42e-03	4.75e-02	0.5450	2.04e-01	-1.23e-01	2.14e-01	1.06e-01	4.29e-01	3.18e-01	5.46e-01	2.96e-01	6.05e-01	3.57e-02
POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	14	2.20e-01	7.00e-01	0.5450	2.78e-01	9.23e-02	2.45e-01	2.38e-01	3.07e-01	7.21e-02	5.50e-01	1.12e-01	1.22e-01	4.65e-02
POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY	8	3.75e-01	8.36e-01	0.5450	-2.73e-01	-4.17e-01	-1.18e-01	-1.58e-01	-9.80e-02	1.81e-01	4.13e-02	5.63e-01	4.38e-01	6.31e-01
INHIBITORY POSTSYNAPTIC POTENTIAL	16	8.85e-02	4.73e-01	0.5450	-2.45e-01	2.68e-02	-3.42e-01	-3.42e-01	-4.28e-02	9.00e-02	8.53e-01	1.78e-02	1.78e-02	7.67e-01
REGULATION OF NEUTROPHIL EXTRAVASATION	5	5.75e-01	9.26e-01	0.5440	-2.91e-01	-1.99e-01	-1.99e-01	-2.14e-01	2.95e-01	2.60e-01	4.40e-01	4.41e-01	4.08e-01	2.53e-01
NEGATIVE REGULATION OF ERAD PATHWAY	6	4.87e-01	8.92e-01	0.5440	3.13e-01	-5.01e-03	2.85e-01	2.69e-01	2.11e-01	1.84e-01	9.83e-01	2.27e-01	2.53e-01	3.71e-01
GENITALIA MORPHOGENESIS	11	2.00e-01	6.80e-01	0.5430	-1.10e-01	-9.72e-02	-2.50e-01	-2.52e-01	-3.84e-01	5.29e-01	5.77e-01	1.50e-01	1.48e-01	2.74e-02
MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION	6	3.63e-01	8.26e-01	0.5430	7.93e-02	-2.19e-01	3.37e-01	3.34e-01	1.25e-01	7.37e-01	3.52e-01	1.53e-01	1.57e-01	5.97e-01
MEIOTIC SPINDLE ORGANIZATION	18	3.59e-02	2.88e-01	0.5430	3.37e-01	1.11e-01	2.75e-01	2.91e-01	-9.22e-02	1.32e-02	4.16e-01	4.36e-02	3.25e-02	4.98e-01
RESPONSE TO ISOQUINOLINE ALKALOID	11	4.62e-02	3.35e-01	0.5430	1.43e-01	-5.89e-03	1.77e-01	1.24e-01	4.77e-01	4.10e-01	9.73e-01	3.09e-01	4.78e-01	6.20e-03
NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	5	3.08e-01	7.82e-01	0.5420	-2.07e-01	-2.19e-01	1.13e-01	4.63e-02	4.34e-01	4.22e-01	3.97e-01	6.63e-01	8.58e-01	9.27e-02
MITOCHONDRIAL GENE EXPRESSION	162	1.29e-18	5.70e-16	0.5420	2.51e-01	1.38e-02	3.42e-01	3.38e-01	-2.94e-03	3.35e-08	7.62e-01	5.92e-14	1.15e-13	9.49e-01
MITOCHONDRIAL TRANSLATIONAL ELONGATION	5	3.37e-01	8.08e-01	0.5420	3.56e-01	1.13e-01	2.03e-01	2.24e-01	-2.52e-01	1.68e-01	6.61e-01	4.32e-01	3.85e-01	3.30e-01
CENP A CONTAINING CHROMATIN ASSEMBLY	9	1.14e-01	5.39e-01	0.5420	3.16e-01	8.46e-02	3.34e-01	2.74e-01	1.21e-02	1.00e-01	6.60e-01	8.27e-02	1.55e-01	9.50e-01
MRNA ALTERNATIVE POLYADENYLATION	5	8.05e-01	9.82e-01	0.5420	2.28e-01	5.14e-02	3.20e-01	3.45e-01	1.32e-01	3.78e-01	8.42e-01	2.15e-01	1.81e-01	6.08e-01
REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	7	7.50e-01	9.75e-01	0.5420	-3.00e-01	-2.28e-01	-2.37e-01	-2.74e-01	-1.44e-01	1.70e-01	2.97e-01	2.78e-01	2.09e-01	5.09e-01
GLYCINE TRANSPORT	14	3.93e-01	8.42e-01	0.5420	3.33e-01	2.75e-01	2.27e-01	2.35e-01	-2.56e-02	3.12e-02	7.45e-02	1.42e-01	1.28e-01	8.68e-01
POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION	6	4.01e-01	8.46e-01	0.5420	-2.97e-01	-9.80e-02	-1.82e-01	-1.82e-01	-3.59e-01	2.07e-01	6.77e-01	4.41e-01	4.39e-01	1.27e-01
OXYGEN METABOLIC PROCESS	5	2.99e-01	7.73e-01	0.5420	-2.35e-02	-3.22e-01	2.80e-01	2.94e-01	1.57e-01	9.28e-01	2.13e-01	2.78e-01	2.55e-01	5.42e-01
G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	21	7.26e-02	4.33e-01	0.5410	-2.72e-01	-2.09e-01	-2.75e-01	-3.05e-01	8.16e-02	3.07e-02	9.80e-02	2.93e-02	1.54e-02	5.17e-01
NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION	8	4.96e-01	8.96e-01	0.5410	-3.53e-01	-2.50e-01	-2.00e-01	-2.52e-01	-5.14e-02	8.39e-02	2.22e-01	3.28e-01	2.17e-01	8.01e-01
GLYCOSIDE TRANSPORT	5	1.35e-01	5.85e-01	0.5410	-7.30e-02	-1.48e-01	-2.22e-01	-1.90e-01	4.25e-01	7.77e-01	5.67e-01	3.89e-01	4.63e-01	1.00e-01
PLATELET DEGRANULATION	7	6.17e-01	9.41e-01	0.5410	-3.44e-01	-3.19e-01	-1.58e-01	-2.00e-01	8.86e-02	1.15e-01	1.44e-01	4.70e-01	3.59e-01	6.85e-01
CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	10	8.09e-02	4.55e-01	0.5410	3.01e-01	1.72e-02	1.93e-01	2.20e-01	3.40e-01	9.91e-02	9.25e-01	2.90e-01	2.28e-01	6.25e-02
REGULATION OF RECEPTOR CATABOLIC PROCESS	11	3.20e-01	7.93e-01	0.5410	-3.44e-01	-3.07e-01	-1.58e-01	-1.83e-01	1.48e-01	4.84e-02	7.80e-02	3.63e-01	2.94e-01	3.96e-01
NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	15	2.69e-01	7.50e-01	0.5410	-2.90e-01	-6.65e-02	-3.14e-01	-2.98e-01	-1.27e-01	5.17e-02	6.56e-01	3.50e-02	4.55e-02	3.95e-01
REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	12	2.30e-02	2.23e-01	0.5400	2.77e-01	-1.45e-02	2.92e-01	3.01e-01	-1.98e-01	9.63e-02	9.31e-01	8.02e-02	7.08e-02	2.35e-01
NEGATIVE REGULATION OF P38MAPK CASCADE	8	3.71e-01	8.31e-01	0.5400	-2.73e-01	-4.29e-01	-1.55e-02	-5.23e-02	1.76e-01	1.82e-01	3.57e-02	9.39e-01	7.98e-01	3.89e-01
GLUCOSE IMPORT ACROSS PLASMA MEMBRANE	5	3.50e-02	2.83e-01	0.5400	2.31e-01	2.91e-01	5.91e-02	1.91e-01	3.38e-01	3.71e-01	2.60e-01	8.19e-01	4.60e-01	1.90e-01
ADP BIOSYNTHETIC PROCESS	5	7.97e-01	9.81e-01	0.5400	-1.68e-01	-3.84e-02	-3.14e-01	-3.29e-01	-2.36e-01	5.15e-01	8.82e-01	2.25e-01	2.03e-01	3.60e-01
NEGATIVE REGULATION OF B CELL PROLIFERATION	16	4.31e-01	8.67e-01	0.5400	-3.08e-01	-1.98e-01	-2.76e-01	-2.80e-01	-5.29e-02	3.26e-02	1.71e-01	5.55e-02	5.25e-02	7.14e-01
VESTIBULOCOCHLEAR NERVE FORMATION	5	5.70e-01	9.26e-01	0.5400	3.06e-01	2.43e-01	1.88e-01	1.63e-01	2.78e-01	2.37e-01	3.47e-01	4.66e-01	5.29e-01	2.81e-01
NEGATIVE T CELL SELECTION	13	2.65e-01	7.47e-01	0.5400	2.48e-01	3.53e-01	2.07e-01	2.25e-01	1.10e-01	1.22e-01	2.77e-02	1.96e-01	1.60e-01	4.93e-01
PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	9	2.44e-01	7.29e-01	0.5400	-2.06e-01	-3.22e-01	-1.61e-01	-1.79e-01	2.94e-01	2.84e-01	9.40e-02	4.03e-01	3.52e-01	1.26e-01
ESCRT COMPLEX DISASSEMBLY	10	4.76e-02	3.41e-01	0.5400	2.82e-01	6.40e-02	2.74e-01	3.44e-01	-1.19e-01	1.22e-01	7.26e-01	1.33e-01	5.99e-02	5.13e-01
NEGATIVE REGULATION OF ACTION POTENTIAL	6	4.56e-01	8.78e-01	0.5390	1.32e-01	3.32e-01	-4.33e-02	-4.53e-03	-4.02e-01	5.76e-01	1.59e-01	8.54e-01	9.85e-01	8.84e-02
VITAMIN D3 METABOLIC PROCESS	6	8.12e-01	9.82e-01	0.5390	1.81e-01	8.93e-02	3.01e-01	2.88e-01	2.76e-01	4.42e-01	7.05e-01	2.01e-01	2.21e-01	2.42e-01
ESTABLISHMENT OF LEFT RIGHT ASYMMETRY	6	1.51e-01	6.13e-01	0.5390	1.71e-01	-7.87e-02	3.00e-01	3.00e-01	-2.73e-01	4.69e-01	7.39e-01	2.03e-01	2.03e-01	2.46e-01
POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	31	1.55e-02	1.71e-01	0.5380	2.31e-01	2.83e-03	3.28e-01	3.38e-01	1.21e-01	2.60e-02	9.78e-01	1.59e-03	1.11e-03	2.44e-01
NEGATIVE REGULATION OF CELL KILLING	29	7.62e-04	1.98e-02	0.5380	1.92e-01	2.99e-01	1.90e-01	2.12e-01	2.87e-01	7.41e-02	5.33e-03	7.70e-02	4.79e-02	7.48e-03
POSITIVE REGULATION OF PODOSOME ASSEMBLY	10	1.27e-01	5.69e-01	0.5380	-2.14e-01	2.69e-02	-3.72e-01	-3.23e-01	8.45e-03	2.41e-01	8.83e-01	4.18e-02	7.65e-02	9.63e-01
DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS	9	1.40e-01	5.95e-01	0.5380	-2.49e-02	-3.39e-01	1.38e-01	9.00e-02	3.82e-01	8.97e-01	7.78e-02	4.74e-01	6.40e-01	4.70e-02
POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION	5	7.56e-01	9.75e-01	0.5370	-3.01e-01	-2.77e-01	-2.06e-01	-2.56e-01	1.18e-01	2.45e-01	2.83e-01	4.25e-01	3.22e-01	6.48e-01
NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	12	2.84e-01	7.62e-01	0.5370	-3.02e-01	-3.30e-01	-1.70e-01	-2.23e-01	1.01e-01	7.04e-02	4.78e-02	3.07e-01	1.81e-01	5.45e-01
BLOOD COAGULATION INTRINSIC PATHWAY	6	7.05e-01	9.65e-01	0.5370	-2.01e-01	-1.71e-01	-2.23e-01	-2.37e-01	-3.36e-01	3.94e-01	4.69e-01	3.45e-01	3.14e-01	1.54e-01
REGULATION OF TRANSCRIPTION BY GLUCOSE	8	1.01e-01	5.08e-01	0.5370	2.45e-01	3.56e-02	2.56e-01	2.51e-01	-3.14e-01	2.29e-01	8.61e-01	2.10e-01	2.19e-01	1.24e-01
REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	18	3.45e-01	8.16e-01	0.5370	-2.59e-01	-2.10e-01	-2.80e-01	-2.69e-01	-1.61e-01	5.70e-02	1.23e-01	3.95e-02	4.82e-02	2.36e-01
POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	5	7.85e-01	9.81e-01	0.5370	2.88e-01	3.58e-01	2.01e-01	1.89e-01	-2.78e-02	2.64e-01	1.66e-01	4.36e-01	4.63e-01	9.14e-01
CONNECTIVE TISSUE REPLACEMENT	20	2.42e-01	7.27e-01	0.5350	-2.38e-01	-1.78e-01	-2.86e-01	-2.69e-01	-2.11e-01	6.49e-02	1.69e-01	2.70e-02	3.75e-02	1.03e-01
NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS	5	2.46e-01	7.31e-01	0.5340	9.24e-02	3.78e-01	-2.38e-01	-1.41e-01	-2.41e-01	7.21e-01	1.44e-01	3.56e-01	5.86e-01	3.52e-01
POSITIVE REGULATION OF MUCUS SECRETION	5	2.88e-01	7.66e-01	0.5340	-1.06e-01	-4.81e-02	1.06e-03	-3.60e-02	5.20e-01	6.81e-01	8.52e-01	9.97e-01	8.89e-01	4.40e-02
VIRAL TRANSLATIONAL TERMINATION REINITIATION	5	4.09e-01	8.52e-01	0.5340	2.90e-01	3.84e-01	1.34e-01	9.78e-02	1.63e-01	2.61e-01	1.37e-01	6.04e-01	7.05e-01	5.28e-01
REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	9	5.14e-01	9.01e-01	0.5340	2.43e-01	4.51e-02	3.39e-01	3.02e-01	1.35e-01	2.08e-01	8.15e-01	7.83e-02	1.16e-01	4.84e-01
REGULATION OF ARACHIDONIC ACID SECRETION	7	2.54e-01	7.37e-01	0.5340	-3.14e-01	-2.60e-01	-5.12e-02	-8.51e-02	3.31e-01	1.51e-01	2.34e-01	8.15e-01	6.97e-01	1.30e-01
REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	36	2.86e-03	5.34e-02	0.5340	1.93e-01	-5.17e-02	3.45e-01	3.16e-01	1.62e-01	4.47e-02	5.92e-01	3.40e-04	1.03e-03	9.35e-02
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	8	4.73e-01	8.86e-01	0.5340	3.27e-01	6.10e-02	2.88e-01	2.97e-01	5.49e-02	1.09e-01	7.65e-01	1.59e-01	1.45e-01	7.88e-01
CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY	7	5.25e-01	9.05e-01	0.5340	2.79e-01	1.43e-01	2.29e-01	2.83e-01	2.32e-01	2.01e-01	5.12e-01	2.93e-01	1.95e-01	2.87e-01
CELL PROLIFERATION IN MIDBRAIN	8	2.91e-01	7.67e-01	0.5340	-2.02e-01	-3.70e-01	-1.54e-01	-1.90e-01	2.18e-01	3.22e-01	7.01e-02	4.51e-01	3.53e-01	2.85e-01
TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX	6	6.95e-01	9.61e-01	0.5340	-3.01e-01	-2.03e-01	-2.59e-01	-2.57e-01	1.40e-01	2.01e-01	3.90e-01	2.71e-01	2.75e-01	5.52e-01
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME	13	3.33e-01	8.05e-01	0.5340	2.96e-01	3.68e-01	1.56e-01	1.92e-01	-1.89e-02	6.49e-02	2.15e-02	3.30e-01	2.30e-01	9.06e-01
AUTOPHAGOSOME MEMBRANE DOCKING	7	2.79e-01	7.58e-01	0.5340	1.41e-01	-1.14e-01	2.60e-01	1.93e-01	3.84e-01	5.19e-01	6.03e-01	2.34e-01	3.78e-01	7.85e-02
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	16	2.70e-01	7.50e-01	0.5330	-3.42e-01	-2.01e-01	-2.49e-01	-2.53e-01	-4.01e-02	1.80e-02	1.64e-01	8.45e-02	7.99e-02	7.81e-01
HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	13	8.25e-02	4.59e-01	0.5330	-3.01e-01	-2.22e-01	-2.19e-01	-1.80e-01	-2.53e-01	5.99e-02	1.67e-01	1.71e-01	2.60e-01	1.14e-01
NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	43	5.59e-03	8.89e-02	0.5330	2.76e-01	5.17e-02	2.89e-01	2.88e-01	1.97e-01	1.72e-03	5.57e-01	1.02e-03	1.09e-03	2.56e-02
REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION	7	6.08e-01	9.35e-01	0.5330	-2.66e-01	-1.66e-01	-2.39e-01	-2.13e-01	-2.89e-01	2.23e-01	4.48e-01	2.74e-01	3.29e-01	1.85e-01
PROTEIN RETENTION IN ER LUMEN	8	6.37e-01	9.48e-01	0.5330	2.05e-01	2.16e-01	2.68e-01	2.78e-01	2.13e-01	3.15e-01	2.90e-01	1.89e-01	1.73e-01	2.96e-01
NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	9	4.18e-01	8.58e-01	0.5320	-3.19e-01	-2.14e-01	-2.29e-01	-2.88e-01	-2.54e-02	9.79e-02	2.67e-01	2.34e-01	1.34e-01	8.95e-01
RNA CAPPING	35	1.18e-02	1.42e-01	0.5320	2.35e-01	7.54e-02	3.35e-01	3.30e-01	3.71e-02	1.60e-02	4.40e-01	5.99e-04	7.41e-04	7.04e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME	8	2.97e-01	7.72e-01	0.5320	-3.18e-01	-3.54e-01	-1.17e-01	-1.88e-01	-9.13e-02	1.20e-01	8.32e-02	5.66e-01	3.58e-01	6.55e-01
SENSORY PERCEPTION OF SOUR TASTE	9	4.03e-01	8.48e-01	0.5320	3.06e-01	3.39e-01	1.42e-01	1.55e-01	1.73e-01	1.11e-01	7.81e-02	4.61e-01	4.21e-01	3.68e-01
REGULATION OF LYSOSOME SIZE	8	2.66e-01	7.47e-01	0.5320	1.42e-01	-1.96e-01	2.37e-01	2.05e-01	3.55e-01	4.87e-01	3.36e-01	2.45e-01	3.16e-01	8.20e-02
OBSERVATIONAL LEARNING	7	4.40e-01	8.70e-01	0.5320	-2.05e-01	1.08e-01	-3.44e-01	-3.12e-01	-1.16e-01	3.48e-01	6.20e-01	1.15e-01	1.53e-01	5.96e-01
RETINAL PIGMENT EPITHELIUM DEVELOPMENT	6	1.93e-01	6.67e-01	0.5310	-2.84e-01	-3.44e-01	-7.41e-02	-1.61e-01	-2.26e-01	2.28e-01	1.44e-01	7.53e-01	4.94e-01	3.37e-01
FEMALE MEIOSIS CHROMOSOME SEGREGATION	6	6.69e-01	9.56e-01	0.5310	2.34e-01	1.53e-01	3.08e-01	2.60e-01	2.04e-01	3.22e-01	5.17e-01	1.92e-01	2.71e-01	3.87e-01
MITOCHONDRIAL RNA CATABOLIC PROCESS	6	5.73e-01	9.26e-01	0.5310	2.49e-01	7.35e-03	3.19e-01	3.43e-01	-5.49e-03	2.91e-01	9.75e-01	1.76e-01	1.46e-01	9.81e-01
BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	6	6.12e-01	9.37e-01	0.5310	3.41e-01	3.36e-01	1.59e-01	1.52e-01	6.57e-02	1.49e-01	1.54e-01	5.00e-01	5.18e-01	7.81e-01
PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS	29	1.57e-03	3.41e-02	0.5300	6.05e-03	-2.04e-01	1.85e-01	1.83e-01	4.15e-01	9.55e-01	5.69e-02	8.52e-02	8.81e-02	1.11e-04
CHOLINE METABOLIC PROCESS	6	3.15e-01	7.88e-01	0.5300	1.49e-02	1.02e-01	-3.30e-01	-2.97e-01	-2.71e-01	9.49e-01	6.64e-01	1.62e-01	2.07e-01	2.51e-01
REGULATION OF ESTABLISHMENT OF T CELL POLARITY	6	7.45e-01	9.75e-01	0.5300	-2.50e-01	-3.20e-01	-2.26e-01	-2.54e-01	6.75e-03	2.88e-01	1.74e-01	3.38e-01	2.81e-01	9.77e-01
POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT	18	2.81e-03	5.27e-02	0.5300	-1.84e-01	-2.60e-01	-1.34e-01	-1.09e-01	3.87e-01	1.76e-01	5.63e-02	3.27e-01	4.25e-01	4.49e-03
REGULATION OF FEMALE GONAD DEVELOPMENT	7	6.97e-01	9.62e-01	0.5290	-1.83e-01	1.64e-02	-2.73e-01	-2.86e-01	-3.00e-01	4.02e-01	9.40e-01	2.11e-01	1.90e-01	1.70e-01
PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT	8	3.33e-02	2.76e-01	0.5290	-1.20e-01	-7.12e-02	-2.09e-01	-1.69e-01	4.34e-01	5.57e-01	7.27e-01	3.06e-01	4.09e-01	3.35e-02
ACINAR CELL DIFFERENTIATION	5	8.26e-01	9.83e-01	0.5290	-1.56e-01	2.44e-02	-3.25e-01	-3.22e-01	-2.13e-01	5.47e-01	9.25e-01	2.08e-01	2.12e-01	4.09e-01
ENDOCANNABINOID SIGNALING PATHWAY	5	2.05e-01	6.84e-01	0.5290	1.24e-01	4.74e-01	1.25e-01	1.49e-01	4.18e-02	6.31e-01	6.65e-02	6.28e-01	5.65e-01	8.71e-01
MAST CELL PROLIFERATION	7	3.40e-01	8.09e-01	0.5280	-1.78e-01	-2.16e-01	-3.02e-01	-3.17e-01	9.43e-02	4.15e-01	3.22e-01	1.67e-01	1.46e-01	6.66e-01
FOREBRAIN DORSAL VENTRAL PATTERN FORMATION	7	4.56e-02	3.33e-01	0.5280	2.46e-01	-9.31e-02	2.58e-01	1.74e-01	3.37e-01	2.60e-01	6.70e-01	2.38e-01	4.25e-01	1.23e-01
RESPONSE TO BACTERIAL LIPOPROTEIN	10	5.49e-01	9.15e-01	0.5280	-3.09e-01	-3.08e-01	-1.88e-01	-2.30e-01	-1.25e-02	9.05e-02	9.19e-02	3.03e-01	2.08e-01	9.45e-01
RESPONSE TO INTERLEUKIN 9	5	6.49e-01	9.51e-01	0.5280	3.15e-01	3.89e-01	9.19e-02	1.07e-01	8.88e-02	2.23e-01	1.32e-01	7.22e-01	6.78e-01	7.31e-01
POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	5	4.30e-02	3.19e-01	0.5280	-1.44e-01	-4.92e-01	2.28e-02	-9.25e-02	-8.01e-02	5.78e-01	5.67e-02	9.30e-01	7.20e-01	7.56e-01
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES	11	5.73e-01	9.26e-01	0.5270	2.02e-01	1.55e-01	2.94e-01	2.85e-01	2.14e-01	2.46e-01	3.73e-01	9.17e-02	1.01e-01	2.20e-01
TENDON DEVELOPMENT	5	4.08e-01	8.51e-01	0.5270	2.46e-02	-1.94e-01	2.45e-01	1.60e-01	3.93e-01	9.24e-01	4.52e-01	3.44e-01	5.35e-01	1.28e-01
TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	15	2.22e-01	7.02e-01	0.5270	1.60e-01	-5.08e-02	3.40e-01	3.17e-01	1.83e-01	2.83e-01	7.34e-01	2.25e-02	3.37e-02	2.21e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5	12	5.31e-02	3.62e-01	0.5270	2.81e-01	3.48e-02	3.21e-01	2.85e-01	-1.12e-01	9.14e-02	8.35e-01	5.39e-02	8.70e-02	5.01e-01
ACTIVATION OF PROTEIN KINASE C ACTIVITY	5	5.60e-01	9.19e-01	0.5270	3.38e-01	4.76e-02	2.31e-01	2.51e-01	2.11e-01	1.90e-01	8.54e-01	3.71e-01	3.32e-01	4.13e-01
REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY	10	3.82e-01	8.38e-01	0.5270	-2.36e-01	-3.22e-01	-1.89e-01	-2.16e-01	-1.88e-01	1.96e-01	7.75e-02	3.01e-01	2.36e-01	3.04e-01
POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION	7	7.91e-02	4.52e-01	0.5270	-1.59e-01	1.40e-01	-7.81e-02	-9.74e-02	-4.66e-01	4.65e-01	5.21e-01	7.20e-01	6.55e-01	3.29e-02
L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE	6	7.88e-01	9.81e-01	0.5260	2.98e-01	9.77e-02	2.67e-01	2.92e-01	1.47e-01	2.06e-01	6.79e-01	2.57e-01	2.15e-01	5.34e-01
REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	6	3.74e-01	8.35e-01	0.5260	-1.88e-01	-2.16e-01	-2.42e-01	-2.31e-01	2.88e-01	4.26e-01	3.60e-01	3.05e-01	3.27e-01	2.21e-01
COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION	13	1.38e-01	5.89e-01	0.5260	-2.35e-01	-3.29e-01	-1.96e-01	-2.43e-01	1.26e-01	1.43e-01	4.01e-02	2.20e-01	1.29e-01	4.30e-01
REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	14	2.15e-01	6.95e-01	0.5260	2.08e-01	-2.04e-02	3.31e-01	3.40e-01	8.79e-02	1.78e-01	8.95e-01	3.20e-02	2.76e-02	5.69e-01
CARDIAC SEPTUM CELL DIFFERENTIATION	5	6.65e-02	4.12e-01	0.5260	4.09e-03	-5.12e-01	9.20e-02	4.78e-02	5.37e-02	9.87e-01	4.72e-02	7.22e-01	8.53e-01	8.35e-01
POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY	6	1.68e-01	6.35e-01	0.5260	4.27e-01	1.25e-01	1.87e-01	2.06e-01	3.67e-02	7.04e-02	5.95e-01	4.28e-01	3.82e-01	8.76e-01
CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT	16	2.68e-01	7.48e-01	0.5250	2.57e-01	2.01e-02	2.89e-01	3.00e-01	1.92e-01	7.53e-02	8.89e-01	4.56e-02	3.80e-02	1.84e-01
MAMMARY GLAND INVOLUTION	8	5.04e-01	8.98e-01	0.5250	3.03e-01	4.49e-02	2.63e-01	2.59e-01	2.13e-01	1.38e-01	8.26e-01	1.98e-01	2.04e-01	2.98e-01
CHONDROCYTE HYPERTROPHY	6	3.54e-01	8.22e-01	0.5240	3.41e-01	1.07e-02	2.65e-01	2.96e-01	4.53e-03	1.49e-01	9.64e-01	2.60e-01	2.09e-01	9.85e-01
REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	11	1.77e-01	6.47e-01	0.5230	-1.07e-02	1.87e-01	-2.63e-01	-2.63e-01	-3.17e-01	9.51e-01	2.82e-01	1.31e-01	1.31e-01	6.88e-02
C TERMINAL PROTEIN LIPIDATION	5	7.54e-01	9.75e-01	0.5230	-3.41e-01	-1.87e-01	-2.05e-01	-2.17e-01	-1.83e-01	1.87e-01	4.69e-01	4.27e-01	4.00e-01	4.79e-01
METANEPHRIC PART OF URETERIC BUD DEVELOPMENT	6	2.12e-01	6.91e-01	0.5230	-2.00e-01	-2.01e-01	-2.57e-01	-3.40e-01	-1.10e-01	3.97e-01	3.94e-01	2.76e-01	1.50e-01	6.40e-01
POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	8	6.78e-01	9.60e-01	0.5230	1.47e-01	3.50e-02	2.82e-01	2.76e-01	3.09e-01	4.70e-01	8.64e-01	1.68e-01	1.77e-01	1.30e-01
G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY	10	3.05e-01	7.76e-01	0.5230	7.78e-02	1.85e-02	2.94e-01	2.73e-01	3.26e-01	6.70e-01	9.19e-01	1.07e-01	1.35e-01	7.46e-02
N TERMINAL PROTEIN LIPIDATION	6	8.27e-01	9.83e-01	0.5230	2.69e-01	2.65e-01	2.44e-01	2.30e-01	1.36e-01	2.53e-01	2.61e-01	3.01e-01	3.30e-01	5.63e-01
REGULATION OF LYMPHANGIOGENESIS	6	8.41e-01	9.85e-01	0.5230	2.11e-01	1.67e-01	2.95e-01	3.01e-01	1.54e-01	3.71e-01	4.79e-01	2.11e-01	2.02e-01	5.14e-01
RESPONSE TO MUSCLE INACTIVITY	9	2.20e-02	2.16e-01	0.5230	1.56e-01	4.64e-01	-1.62e-01	-7.85e-02	-2.29e-02	4.17e-01	1.59e-02	3.99e-01	6.84e-01	9.05e-01
FAT PAD DEVELOPMENT	8	6.99e-01	9.62e-01	0.5220	2.18e-01	4.99e-02	2.69e-01	2.50e-01	2.97e-01	2.86e-01	8.07e-01	1.88e-01	2.20e-01	1.46e-01
DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	5	8.38e-01	9.85e-01	0.5220	-2.78e-01	-3.39e-01	-1.93e-01	-1.91e-01	-8.22e-02	2.82e-01	1.89e-01	4.54e-01	4.60e-01	7.50e-01
SYNAPTIC TRANSMISSION GLYCINERGIC	5	2.20e-01	7.00e-01	0.5220	-9.76e-02	-3.23e-02	-3.14e-01	-3.26e-01	2.39e-01	7.06e-01	9.00e-01	2.24e-01	2.07e-01	3.56e-01
RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY	53	4.84e-05	2.15e-03	0.5220	2.49e-01	1.05e-01	3.07e-01	3.11e-01	-8.80e-02	1.68e-03	1.84e-01	1.10e-04	8.98e-05	2.68e-01
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION	7	3.67e-01	8.30e-01	0.5210	2.19e-01	3.38e-01	4.49e-04	6.39e-02	-3.25e-01	3.15e-01	1.21e-01	9.98e-01	7.70e-01	1.37e-01
PROTEIN DNA COMPLEX ASSEMBLY	203	5.64e-19	2.83e-16	0.5210	2.82e-01	1.62e-01	2.73e-01	2.78e-01	-1.18e-01	4.00e-12	7.07e-05	1.84e-11	8.07e-12	3.89e-03
FLAVONOID METABOLIC PROCESS	11	9.41e-03	1.24e-01	0.5210	-3.29e-01	-1.01e-01	-2.74e-01	-2.16e-01	1.77e-01	5.87e-02	5.61e-01	1.16e-01	2.14e-01	3.09e-01
DE NOVO PROTEIN FOLDING	41	1.89e-03	3.91e-02	0.5210	2.35e-01	1.06e-02	3.23e-01	3.29e-01	5.59e-02	9.18e-03	9.07e-01	3.42e-04	2.61e-04	5.36e-01
POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	12	2.31e-01	7.14e-01	0.5210	2.18e-01	3.19e-01	2.11e-01	2.45e-01	1.31e-01	1.90e-01	5.56e-02	2.06e-01	1.42e-01	4.31e-01
RECEPTOR TRANSACTIVATION	5	4.61e-01	8.80e-01	0.5200	-2.67e-01	-1.69e-01	-2.34e-01	-3.18e-01	-1.20e-01	3.01e-01	5.12e-01	3.64e-01	2.18e-01	6.43e-01
PYRIMIDINE NUCLEOSIDE TRANSPORT	6	3.65e-02	2.91e-01	0.5200	2.18e-02	1.73e-01	-1.32e-01	-6.95e-02	4.67e-01	9.26e-01	4.64e-01	5.77e-01	7.68e-01	4.76e-02
SULFATION	20	2.61e-01	7.44e-01	0.5200	-2.52e-01	-2.33e-01	-2.71e-01	-2.81e-01	-1.76e-02	5.13e-02	7.15e-02	3.61e-02	2.97e-02	8.91e-01
CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE	5	2.51e-01	7.35e-01	0.5200	3.50e-01	3.69e-01	-2.09e-02	4.19e-02	9.59e-02	1.75e-01	1.53e-01	9.36e-01	8.71e-01	7.11e-01
RRNA MODIFICATION	32	2.91e-04	9.43e-03	0.5200	1.41e-01	-1.64e-01	3.40e-01	3.10e-01	1.08e-01	1.67e-01	1.09e-01	8.63e-04	2.43e-03	2.88e-01
MAGNESIUM ION HOMEOSTASIS	10	3.58e-01	8.23e-01	0.5200	-2.07e-01	-2.30e-01	-2.92e-01	-2.56e-01	-1.53e-01	2.57e-01	2.08e-01	1.09e-01	1.61e-01	4.02e-01
POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION	5	8.90e-01	9.91e-01	0.5190	2.17e-01	1.44e-01	2.99e-01	2.76e-01	1.92e-01	4.01e-01	5.77e-01	2.48e-01	2.85e-01	4.58e-01
REGULATION OF SUPEROXIDE ANION GENERATION	19	7.78e-02	4.50e-01	0.5190	-2.93e-01	-3.67e-01	-1.50e-01	-1.42e-01	7.93e-02	2.73e-02	5.59e-03	2.56e-01	2.82e-01	5.50e-01
REGULATION OF DNA TEMPLATED DNA REPLICATION	46	5.70e-04	1.57e-02	0.5190	1.73e-01	-4.50e-02	3.41e-01	3.21e-01	1.35e-01	4.26e-02	5.98e-01	6.30e-05	1.67e-04	1.13e-01
REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	8	3.47e-01	8.18e-01	0.5190	2.19e-01	6.94e-02	3.08e-01	3.39e-01	-8.02e-02	2.84e-01	7.34e-01	1.32e-01	9.64e-02	6.94e-01
CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING	32	1.27e-03	2.97e-02	0.5190	2.00e-01	-3.14e-02	3.29e-01	3.45e-01	2.87e-02	5.04e-02	7.59e-01	1.26e-03	7.36e-04	7.79e-01
POSITIVE REGULATION OF MIRNA PROCESSING	5	8.02e-01	9.82e-01	0.5190	-2.94e-01	-9.32e-02	-2.36e-01	-2.41e-01	-2.45e-01	2.55e-01	7.18e-01	3.60e-01	3.51e-01	3.43e-01
CERAMIDE 1 PHOSPHATE TRANSPORT	7	2.01e-01	6.81e-01	0.5180	1.75e-01	-2.09e-01	2.40e-01	1.97e-01	3.13e-01	4.23e-01	3.39e-01	2.71e-01	3.67e-01	1.51e-01
PSEUDOURIDINE SYNTHESIS	17	1.01e-02	1.29e-01	0.5180	2.27e-01	-4.78e-03	3.00e-01	3.17e-01	-1.63e-01	1.05e-01	9.73e-01	3.24e-02	2.38e-02	2.43e-01
REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION	13	5.50e-01	9.15e-01	0.5180	2.68e-01	8.52e-02	2.88e-01	2.83e-01	1.63e-01	9.48e-02	5.95e-01	7.20e-02	7.72e-02	3.10e-01
RESPONSE TO FRUCTOSE	8	7.25e-01	9.70e-01	0.5180	3.11e-01	2.13e-01	2.23e-01	2.57e-01	1.00e-01	1.28e-01	2.97e-01	2.74e-01	2.08e-01	6.23e-01
INOSITOL TRISPHOSPHATE METABOLIC PROCESS	12	2.19e-01	7.00e-01	0.5180	-2.66e-01	-6.37e-03	-2.51e-01	-2.83e-01	-2.33e-01	1.10e-01	9.70e-01	1.32e-01	9.00e-02	1.62e-01
POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY	10	5.01e-01	8.98e-01	0.5180	2.39e-01	1.53e-01	2.96e-01	3.13e-01	-3.98e-02	1.90e-01	4.01e-01	1.05e-01	8.66e-02	8.28e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA	9	4.47e-01	8.74e-01	0.5180	2.53e-01	-2.00e-04	3.18e-01	3.20e-01	2.36e-02	1.89e-01	9.99e-01	9.86e-02	9.67e-02	9.02e-01
TRNA SURVEILLANCE	8	2.25e-01	7.08e-01	0.5170	3.23e-01	2.55e-01	2.26e-01	1.82e-01	-1.19e-01	1.14e-01	2.12e-01	2.68e-01	3.73e-01	5.61e-01
GAMMA DELTA T CELL DIFFERENTIATION	13	3.70e-01	8.31e-01	0.5170	3.11e-01	2.84e-01	2.19e-01	2.05e-01	1.18e-02	5.22e-02	7.64e-02	1.71e-01	2.01e-01	9.41e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	10	3.84e-01	8.39e-01	0.5170	1.89e-01	-8.60e-02	3.30e-01	3.06e-01	1.47e-01	3.01e-01	6.38e-01	7.08e-02	9.35e-02	4.21e-01
REGULATION OF MITOTIC SPINDLE ASSEMBLY	22	1.57e-03	3.41e-02	0.5170	1.85e-01	-2.00e-01	2.97e-01	3.00e-01	1.20e-01	1.33e-01	1.04e-01	1.58e-02	1.47e-02	3.31e-01
PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX	19	3.27e-02	2.73e-01	0.5170	1.19e-01	-1.35e-01	3.15e-01	2.61e-01	2.60e-01	3.67e-01	3.08e-01	1.76e-02	4.93e-02	4.99e-02
PROTEIN DNA COVALENT CROSS LINKING REPAIR	6	2.78e-01	7.58e-01	0.5160	-1.14e-01	-3.48e-01	2.49e-01	2.15e-01	1.55e-01	6.28e-01	1.40e-01	2.91e-01	3.61e-01	5.11e-01
NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	8	5.35e-01	9.09e-01	0.5160	-1.09e-01	6.52e-02	-2.70e-01	-2.83e-01	-3.12e-01	5.94e-01	7.49e-01	1.86e-01	1.66e-01	1.27e-01
SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION	8	5.42e-01	9.14e-01	0.5150	-2.39e-01	-2.91e-01	-2.16e-01	-2.20e-01	1.69e-01	2.42e-01	1.54e-01	2.89e-01	2.81e-01	4.08e-01
STRESS GRANULE DISASSEMBLY	5	2.91e-01	7.67e-01	0.5150	-2.08e-01	-2.70e-01	1.12e-01	1.90e-02	3.69e-01	4.21e-01	2.96e-01	6.64e-01	9.41e-01	1.53e-01
REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY	5	8.54e-01	9.88e-01	0.5150	2.91e-01	3.20e-01	1.73e-01	2.10e-01	6.19e-02	2.61e-01	2.15e-01	5.03e-01	4.15e-01	8.11e-01
REGULATION OF EXIT FROM MITOSIS	18	8.32e-02	4.59e-01	0.5150	2.62e-01	2.22e-02	3.23e-01	2.91e-01	8.13e-02	5.41e-02	8.70e-01	1.75e-02	3.28e-02	5.50e-01
PUTRESCINE METABOLIC PROCESS	7	5.81e-01	9.28e-01	0.5140	1.46e-01	2.79e-02	2.60e-01	2.16e-01	3.58e-01	5.03e-01	8.98e-01	2.33e-01	3.22e-01	1.01e-01
REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY	7	9.92e-02	5.04e-01	0.5140	1.35e-01	4.40e-01	1.04e-01	1.44e-01	1.46e-01	5.35e-01	4.38e-02	6.34e-01	5.09e-01	5.05e-01
POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY	7	1.48e-01	6.10e-01	0.5140	5.63e-02	-3.44e-01	1.24e-01	1.08e-01	3.41e-01	7.97e-01	1.15e-01	5.70e-01	6.21e-01	1.18e-01
DNA UNWINDING INVOLVED IN DNA REPLICATION	21	4.08e-02	3.08e-01	0.5140	1.86e-01	2.09e-02	3.45e-01	3.32e-01	1.25e-02	1.39e-01	8.68e-01	6.23e-03	8.39e-03	9.21e-01
LIPID GLYCOSYLATION	12	3.97e-01	8.45e-01	0.5140	-2.31e-01	-2.66e-01	-2.57e-01	-2.70e-01	3.77e-02	1.66e-01	1.10e-01	1.24e-01	1.05e-01	8.21e-01
MESENCHYME MIGRATION	5	1.46e-01	6.03e-01	0.5140	3.28e-01	-3.50e-02	1.63e-01	1.49e-01	3.26e-01	2.03e-01	8.92e-01	5.28e-01	5.63e-01	2.06e-01
INTERCELLULAR TRANSPORT	10	1.73e-01	6.44e-01	0.5140	2.47e-01	4.41e-01	3.77e-02	5.84e-02	6.34e-02	1.76e-01	1.58e-02	8.36e-01	7.49e-01	7.28e-01
ALCOHOL CATABOLIC PROCESS	33	1.81e-02	1.91e-01	0.5140	-2.70e-01	-2.31e-01	-2.70e-01	-2.51e-01	4.31e-02	7.22e-03	2.19e-02	7.20e-03	1.25e-02	6.68e-01
CYTOPLASMIC SEQUESTERING OF NF KAPPAB	5	3.66e-01	8.30e-01	0.5140	-2.72e-01	-4.01e-01	8.65e-02	7.47e-02	1.28e-01	2.92e-01	1.21e-01	7.38e-01	7.72e-01	6.19e-01
MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN	19	1.62e-01	6.26e-01	0.5140	2.74e-01	2.86e-01	1.96e-01	2.11e-01	-1.56e-01	3.87e-02	3.11e-02	1.39e-01	1.11e-01	2.38e-01
PROLACTIN SECRETION	5	9.03e-01	9.94e-01	0.5140	-2.56e-01	-5.74e-02	-2.84e-01	-2.84e-01	-1.85e-01	3.22e-01	8.24e-01	2.72e-01	2.72e-01	4.74e-01
SUBTELOMERIC HETEROCHROMATIN FORMATION	8	4.52e-01	8.76e-01	0.5130	1.92e-01	-1.21e-01	3.14e-01	2.92e-01	1.67e-01	3.47e-01	5.54e-01	1.24e-01	1.52e-01	4.14e-01
NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	6	5.78e-01	9.27e-01	0.5130	1.45e-01	-1.62e-01	2.72e-01	2.84e-01	2.48e-01	5.40e-01	4.91e-01	2.49e-01	2.28e-01	2.92e-01
INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION	5	4.05e-01	8.50e-01	0.5130	3.88e-01	1.50e-01	1.66e-01	2.10e-01	1.36e-01	1.33e-01	5.62e-01	5.21e-01	4.16e-01	5.98e-01
RESPIRATORY CHAIN COMPLEX III ASSEMBLY	12	2.67e-01	7.48e-01	0.5130	9.21e-02	-1.72e-01	2.92e-01	2.74e-01	2.55e-01	5.81e-01	3.03e-01	7.99e-02	1.01e-01	1.26e-01
D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE	5	6.27e-01	9.45e-01	0.5130	2.70e-01	3.06e-01	1.31e-01	1.87e-01	2.09e-01	2.95e-01	2.36e-01	6.12e-01	4.68e-01	4.18e-01
POSITIVE REGULATION OF GLUCONEOGENESIS	21	2.10e-01	6.87e-01	0.5130	-1.76e-01	-2.19e-02	-3.14e-01	-3.04e-01	-2.00e-01	1.62e-01	8.62e-01	1.27e-02	1.59e-02	1.12e-01
VALINE METABOLIC PROCESS	7	3.69e-01	8.31e-01	0.5120	-2.93e-02	-3.20e-01	2.03e-01	1.50e-01	3.09e-01	8.93e-01	1.43e-01	3.52e-01	4.91e-01	1.56e-01
GAMMA DELTA T CELL ACTIVATION	23	9.24e-02	4.84e-01	0.5120	2.99e-01	3.19e-01	1.82e-01	1.80e-01	-7.91e-02	1.32e-02	8.12e-03	1.31e-01	1.35e-01	5.11e-01
CELLULAR RESPONSE TO CHOLESTEROL	20	8.46e-03	1.15e-01	0.5120	-7.86e-02	-1.38e-02	-3.51e-01	-3.24e-01	-1.67e-01	5.43e-01	9.15e-01	6.58e-03	1.20e-02	1.97e-01
REGULATION OF RESPONSE TO DRUG	15	1.56e-01	6.18e-01	0.5120	-1.82e-01	8.68e-02	-2.99e-01	-2.61e-01	-2.52e-01	2.22e-01	5.61e-01	4.49e-02	7.98e-02	9.07e-02
PRIMITIVE HEMOPOIESIS	8	3.14e-01	7.86e-01	0.5120	-1.17e-01	-3.21e-01	1.04e-01	4.92e-02	3.63e-01	5.66e-01	1.16e-01	6.12e-01	8.10e-01	7.51e-02
ATP BIOSYNTHETIC PROCESS	89	2.82e-06	1.77e-04	0.5110	2.58e-01	4.60e-02	3.02e-01	3.09e-01	7.61e-02	2.59e-05	4.54e-01	8.35e-07	4.53e-07	2.15e-01
NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS	7	4.56e-01	8.78e-01	0.5110	7.13e-02	-2.23e-01	2.92e-01	2.50e-01	2.43e-01	7.44e-01	3.08e-01	1.81e-01	2.53e-01	2.66e-01
NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION	8	7.87e-01	9.81e-01	0.5110	3.07e-01	2.29e-01	2.29e-01	2.31e-01	9.49e-02	1.33e-01	2.62e-01	2.62e-01	2.59e-01	6.42e-01
RESPONSE TO PHEROMONE	7	7.43e-01	9.74e-01	0.5110	-2.97e-01	-3.42e-01	-1.51e-01	-1.79e-01	-2.61e-02	1.73e-01	1.17e-01	4.89e-01	4.12e-01	9.05e-01
CEREBRAL CORTEX REGIONALIZATION	7	1.58e-01	6.20e-01	0.5110	2.70e-01	-1.44e-01	2.97e-01	2.78e-01	4.28e-02	2.16e-01	5.11e-01	1.74e-01	2.03e-01	8.45e-01
PROTEIN K6 LINKED UBIQUITINATION	11	5.90e-01	9.30e-01	0.5110	1.80e-01	2.45e-02	2.64e-01	2.64e-01	2.97e-01	3.02e-01	8.88e-01	1.29e-01	1.29e-01	8.84e-02
SNRNA TRANSPORT	6	3.10e-01	7.83e-01	0.5100	-3.09e-01	-4.05e-01	-2.55e-02	-1.67e-02	-3.47e-03	1.90e-01	8.59e-02	9.14e-01	9.43e-01	9.88e-01
NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	5	6.28e-01	9.45e-01	0.5100	-2.36e-01	1.66e-02	-2.98e-01	-3.37e-01	-4.09e-02	3.61e-01	9.49e-01	2.48e-01	1.92e-01	8.74e-01
GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS	5	3.81e-01	8.38e-01	0.5100	-1.66e-01	-1.09e-01	-2.00e-01	-2.31e-01	3.57e-01	5.21e-01	6.73e-01	4.39e-01	3.70e-01	1.67e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	18	8.15e-02	4.56e-01	0.5090	-7.91e-02	1.29e-01	-2.13e-01	-2.17e-01	-3.80e-01	5.61e-01	3.44e-01	1.17e-01	1.11e-01	5.29e-03
COMMON BILE DUCT DEVELOPMENT	5	1.94e-03	3.99e-02	0.5090	2.36e-01	-2.44e-01	8.52e-02	-8.26e-03	3.70e-01	3.61e-01	3.45e-01	7.41e-01	9.74e-01	1.52e-01
CENTROMERIC SISTER CHROMATID COHESION	10	4.82e-01	8.91e-01	0.5090	2.82e-01	2.54e-01	2.16e-01	2.13e-01	-1.50e-01	1.22e-01	1.64e-01	2.36e-01	2.44e-01	4.12e-01
AMMONIUM ION METABOLIC PROCESS	22	9.54e-02	4.93e-01	0.5090	-1.19e-01	8.72e-03	-2.76e-01	-2.76e-01	-3.04e-01	3.35e-01	9.44e-01	2.52e-02	2.48e-02	1.35e-02
POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS	8	4.58e-01	8.79e-01	0.5090	3.09e-01	1.62e-01	2.71e-01	2.31e-01	9.96e-02	1.30e-01	4.27e-01	1.84e-01	2.57e-01	6.26e-01
OUTER EAR MORPHOGENESIS	7	5.41e-01	9.14e-01	0.5090	1.88e-01	3.21e-02	3.50e-01	3.04e-01	8.53e-02	3.90e-01	8.83e-01	1.09e-01	1.63e-01	6.96e-01
RESPONSE TO OXYGEN GLUCOSE DEPRIVATION	11	3.44e-01	8.14e-01	0.5090	1.86e-01	-3.83e-02	3.25e-01	2.80e-01	1.96e-01	2.86e-01	8.26e-01	6.21e-02	1.08e-01	2.59e-01
POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	14	2.43e-01	7.27e-01	0.5090	-2.78e-01	-3.24e-01	-1.61e-01	-1.58e-01	1.59e-01	7.22e-02	3.56e-02	2.96e-01	3.06e-01	3.02e-01
SENSORY PERCEPTION OF TASTE	66	2.58e-05	1.28e-03	0.5090	-1.81e-01	5.69e-02	-3.08e-01	-2.77e-01	-2.26e-01	1.12e-02	4.24e-01	1.51e-05	9.76e-05	1.51e-03
ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	85	1.37e-06	9.35e-05	0.5080	2.84e-01	6.50e-02	2.89e-01	2.98e-01	3.94e-02	6.08e-06	3.01e-01	4.08e-06	2.10e-06	5.30e-01
POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	3.34e-01	8.05e-01	0.5080	7.50e-02	-1.59e-01	3.01e-01	2.46e-01	2.77e-01	6.97e-01	4.10e-01	1.19e-01	2.00e-01	1.51e-01
NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	14	6.09e-02	3.95e-01	0.5080	-9.19e-03	-3.18e-01	1.88e-01	1.44e-01	3.18e-01	9.53e-01	3.95e-02	2.24e-01	3.51e-01	3.93e-02
ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB	7	1.34e-01	5.81e-01	0.5080	1.03e-01	3.33e-01	1.32e-01	1.66e-01	-3.02e-01	6.36e-01	1.27e-01	5.46e-01	4.46e-01	1.66e-01
CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY	21	1.02e-01	5.10e-01	0.5080	1.99e-01	-6.73e-02	3.01e-01	2.96e-01	1.89e-01	1.15e-01	5.93e-01	1.69e-02	1.90e-02	1.34e-01
POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	6	1.74e-01	6.46e-01	0.5070	2.01e-01	-2.05e-01	1.66e-01	1.75e-01	3.42e-01	3.95e-01	3.84e-01	4.82e-01	4.57e-01	1.47e-01
IRON ION IMPORT ACROSS PLASMA MEMBRANE	5	4.88e-01	8.92e-01	0.5070	-5.25e-02	-1.38e-01	1.88e-01	2.00e-01	4.00e-01	8.39e-01	5.93e-01	4.67e-01	4.38e-01	1.21e-01
POST EMBRYONIC ANIMAL MORPHOGENESIS	16	3.93e-02	3.05e-01	0.5070	-2.08e-01	-2.47e-01	-1.21e-01	-1.19e-01	3.52e-01	1.50e-01	8.68e-02	4.00e-01	4.09e-01	1.48e-02
RRNA BASE METHYLATION	9	3.49e-01	8.18e-01	0.5070	9.75e-02	-1.52e-01	3.15e-01	2.65e-01	2.34e-01	6.12e-01	4.31e-01	1.02e-01	1.68e-01	2.25e-01
POSITIVE REGULATION OF MONOCYTE EXTRAVASATION	5	9.17e-01	9.95e-01	0.5060	-2.70e-01	-1.40e-01	-2.81e-01	-2.90e-01	-3.40e-02	2.96e-01	5.87e-01	2.77e-01	2.61e-01	8.95e-01
REGULATION OF GERM CELL PROLIFERATION	7	4.00e-01	8.45e-01	0.5060	-1.73e-01	-2.18e-01	-2.83e-01	-3.14e-01	-5.90e-03	4.28e-01	3.18e-01	1.95e-01	1.50e-01	9.78e-01
TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE	5	1.08e-01	5.25e-01	0.5060	-7.36e-02	3.69e-01	-2.60e-01	-2.00e-01	8.37e-02	7.76e-01	1.53e-01	3.15e-01	4.38e-01	7.46e-01
REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	11	6.57e-02	4.09e-01	0.5060	-3.39e-01	-2.93e-01	-2.48e-02	-7.91e-02	2.20e-01	5.14e-02	9.20e-02	8.87e-01	6.50e-01	2.07e-01
PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER	15	4.52e-02	3.31e-01	0.5060	2.18e-01	-7.12e-02	3.23e-01	3.12e-01	-4.10e-02	1.45e-01	6.33e-01	3.02e-02	3.62e-02	7.83e-01
POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS	6	1.08e-01	5.26e-01	0.5060	-3.08e-01	-1.73e-01	-3.70e-02	-6.25e-02	-3.55e-01	1.91e-01	4.62e-01	8.75e-01	7.91e-01	1.33e-01
RRNA PSEUDOURIDINE SYNTHESIS	7	1.45e-01	6.03e-01	0.5060	2.19e-01	-4.18e-02	2.52e-01	2.77e-01	-2.57e-01	3.17e-01	8.48e-01	2.48e-01	2.04e-01	2.40e-01
REGULATION OF CARDIAC MUSCLE ADAPTATION	17	3.79e-01	8.36e-01	0.5060	-2.06e-01	-2.30e-02	-2.74e-01	-2.75e-01	-2.49e-01	1.42e-01	8.70e-01	5.01e-02	4.97e-02	7.57e-02
POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	15	1.57e-01	6.19e-01	0.5060	-2.44e-01	-2.84e-01	-2.56e-01	-2.23e-01	-1.04e-02	1.01e-01	5.68e-02	8.63e-02	1.35e-01	9.45e-01
MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION	8	4.73e-01	8.86e-01	0.5060	-2.93e-01	-1.75e-01	-2.34e-01	-2.30e-01	1.77e-01	1.51e-01	3.91e-01	2.52e-01	2.60e-01	3.86e-01
POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	12	3.33e-01	8.05e-01	0.5050	1.43e-01	-3.86e-02	3.18e-01	3.24e-01	1.65e-01	3.90e-01	8.17e-01	5.67e-02	5.21e-02	3.21e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN	14	1.12e-01	5.35e-01	0.5050	-1.94e-01	-3.44e-01	-2.13e-01	-2.24e-01	6.22e-02	2.09e-01	2.59e-02	1.68e-01	1.46e-01	6.87e-01
REGULATION OF CHROMOSOME CONDENSATION	13	2.34e-01	7.18e-01	0.5050	8.38e-02	-1.72e-01	2.57e-01	2.53e-01	2.98e-01	6.01e-01	2.83e-01	1.09e-01	1.15e-01	6.31e-02
POLE PLASM ASSEMBLY	6	4.45e-01	8.73e-01	0.5050	-2.07e-01	1.47e-01	-3.06e-01	-3.03e-01	-6.41e-02	3.79e-01	5.32e-01	1.94e-01	1.98e-01	7.86e-01
MRNA 5 SPLICE SITE RECOGNITION	10	1.56e-01	6.18e-01	0.5050	2.64e-01	2.42e-01	2.02e-01	1.69e-01	-2.39e-01	1.48e-01	1.86e-01	2.69e-01	3.55e-01	1.90e-01
SPERMIDINE TRANSPORT	5	4.52e-01	8.76e-01	0.5050	1.94e-01	3.90e-01	-1.56e-01	-1.23e-01	-1.60e-01	4.52e-01	1.31e-01	5.46e-01	6.33e-01	5.36e-01
PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY	6	4.10e-01	8.52e-01	0.5040	4.19e-02	-6.64e-02	2.24e-01	2.58e-01	3.62e-01	8.59e-01	7.78e-01	3.41e-01	2.74e-01	1.24e-01
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	22	5.03e-02	3.50e-01	0.5040	3.33e-01	1.61e-01	2.29e-01	2.47e-01	-6.65e-02	6.87e-03	1.92e-01	6.35e-02	4.51e-02	5.89e-01
EOSINOPHIL ACTIVATION	8	2.88e-01	7.66e-01	0.5040	5.03e-02	-2.55e-01	1.49e-01	1.31e-01	3.84e-01	8.05e-01	2.13e-01	4.66e-01	5.20e-01	6.01e-02
GERM CELL MIGRATION	8	7.17e-01	9.68e-01	0.5040	2.67e-01	3.42e-01	1.71e-01	1.91e-01	3.58e-03	1.91e-01	9.41e-02	4.02e-01	3.50e-01	9.86e-01
REGULATION OF CORE PROMOTER BINDING	5	7.69e-01	9.75e-01	0.5040	2.58e-01	3.85e-01	1.39e-01	1.38e-01	3.21e-02	3.17e-01	1.36e-01	5.91e-01	5.94e-01	9.01e-01
MITOCHONDRIAL TRANSCRIPTION	19	9.18e-02	4.83e-01	0.5030	1.42e-01	-7.48e-02	2.96e-01	2.51e-01	2.78e-01	2.83e-01	5.72e-01	2.57e-02	5.80e-02	3.62e-02
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	6	4.89e-01	8.92e-01	0.5030	2.86e-01	-1.46e-02	2.32e-01	2.64e-01	2.18e-01	2.25e-01	9.50e-01	3.24e-01	2.62e-01	3.55e-01
NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	25	1.11e-01	5.34e-01	0.5030	-1.69e-01	-7.68e-02	-3.11e-01	-3.03e-01	-1.73e-01	1.43e-01	5.06e-01	7.08e-03	8.70e-03	1.34e-01
NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS	7	2.78e-01	7.58e-01	0.5030	1.24e-01	-3.41e-02	1.86e-01	1.26e-01	4.31e-01	5.69e-01	8.76e-01	3.95e-01	5.63e-01	4.84e-02
POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION	6	6.45e-02	4.05e-01	0.5020	1.96e-01	4.49e-01	-5.85e-03	1.09e-01	6.88e-03	4.06e-01	5.66e-02	9.80e-01	6.43e-01	9.77e-01
RECOGNITION OF APOPTOTIC CELL	7	1.44e-02	1.62e-01	0.5020	2.39e-01	3.93e-01	-1.10e-01	2.72e-03	1.70e-01	2.74e-01	7.21e-02	6.13e-01	9.90e-01	4.36e-01
SINOATRIAL NODE DEVELOPMENT	12	2.44e-01	7.29e-01	0.5020	1.59e-01	-1.42e-01	2.56e-01	2.37e-01	2.91e-01	3.40e-01	3.95e-01	1.25e-01	1.54e-01	8.07e-02
POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	11	4.59e-01	8.79e-01	0.5020	2.74e-01	1.64e-01	2.49e-01	2.21e-01	1.96e-01	1.15e-01	3.45e-01	1.52e-01	2.05e-01	2.59e-01
XENOBIOTIC EXPORT FROM CELL	26	5.75e-02	3.80e-01	0.5010	-2.28e-01	-8.28e-03	-2.88e-01	-2.60e-01	-2.21e-01	4.38e-02	9.42e-01	1.11e-02	2.20e-02	5.11e-02
N ACYLETHANOLAMINE METABOLIC PROCESS	5	6.39e-01	9.49e-01	0.5010	-2.04e-01	-2.41e-01	-2.20e-01	-2.09e-01	2.43e-01	4.29e-01	3.51e-01	3.95e-01	4.17e-01	3.47e-01
NEGATIVE REGULATION OF CHOLESTEROL EFFLUX	22	1.10e-01	5.30e-01	0.5010	-2.20e-01	-8.85e-02	-3.22e-01	-2.90e-01	-8.09e-02	7.43e-02	4.73e-01	8.87e-03	1.84e-02	5.11e-01
POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION	7	1.33e-02	1.55e-01	0.5010	-2.23e-01	2.13e-01	-3.00e-01	-2.28e-01	1.15e-01	3.06e-01	3.29e-01	1.69e-01	2.96e-01	5.98e-01
ADHERENS JUNCTION MAINTENANCE	7	7.92e-01	9.81e-01	0.5010	-2.37e-01	-2.44e-02	-2.99e-01	-3.00e-01	-1.21e-01	2.78e-01	9.11e-01	1.70e-01	1.70e-01	5.79e-01
LUNG LOBE DEVELOPMENT	7	6.11e-01	9.37e-01	0.5010	3.24e-01	1.12e-01	2.52e-01	2.63e-01	-2.88e-02	1.38e-01	6.07e-01	2.49e-01	2.28e-01	8.95e-01
MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	25	1.57e-01	6.19e-01	0.5010	2.72e-01	1.22e-01	2.87e-01	2.80e-01	3.36e-02	1.86e-02	2.90e-01	1.30e-02	1.54e-02	7.71e-01
POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	8	3.76e-01	8.36e-01	0.5010	-1.54e-01	-3.15e-01	1.05e-01	6.29e-02	3.36e-01	4.50e-01	1.23e-01	6.07e-01	7.58e-01	1.00e-01
GROWTH INVOLVED IN HEART MORPHOGENESIS	5	4.06e-01	8.50e-01	0.5000	2.06e-01	4.43e-01	-3.71e-02	3.57e-03	1.01e-01	4.25e-01	8.61e-02	8.86e-01	9.89e-01	6.97e-01
REGULATION OF G2 MI TRANSITION OF MEIOTIC CELL CYCLE	5	7.91e-01	9.81e-01	0.5000	2.64e-01	2.73e-01	2.28e-01	2.08e-01	-1.04e-01	3.06e-01	2.91e-01	3.77e-01	4.22e-01	6.86e-01
CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS	8	6.79e-01	9.60e-01	0.5000	1.44e-01	-6.21e-02	2.60e-01	2.43e-01	3.15e-01	4.81e-01	7.61e-01	2.03e-01	2.34e-01	1.23e-01
CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS	8	7.68e-01	9.75e-01	0.5000	2.77e-01	2.39e-01	2.26e-01	2.50e-01	-5.57e-02	1.75e-01	2.42e-01	2.68e-01	2.22e-01	7.85e-01
TESTOSTERONE BIOSYNTHETIC PROCESS	11	7.47e-01	9.75e-01	0.5000	-2.43e-01	-1.47e-01	-2.72e-01	-2.65e-01	-1.60e-01	1.63e-01	3.98e-01	1.19e-01	1.29e-01	3.59e-01
OXIDATIVE PHOSPHORYLATION	126	4.17e-09	4.99e-07	0.5000	2.59e-01	6.76e-02	2.97e-01	3.00e-01	2.02e-02	5.26e-07	1.90e-01	8.57e-09	6.10e-09	6.95e-01
OVULATION FROM OVARIAN FOLLICLE	8	1.83e-01	6.56e-01	0.5000	-5.81e-02	-1.84e-02	-2.77e-01	-3.09e-01	-2.72e-01	7.76e-01	9.28e-01	1.76e-01	1.30e-01	1.82e-01
ALPHA LINOLENIC ACID METABOLIC PROCESS	9	5.22e-01	9.04e-01	0.5000	1.22e-01	-1.17e-01	2.92e-01	2.60e-01	2.61e-01	5.26e-01	5.42e-01	1.30e-01	1.77e-01	1.74e-01
NEUTROPHIL DEGRANULATION	13	1.66e-01	6.33e-01	0.4990	-2.15e-01	-3.87e-01	-1.38e-01	-1.61e-01	-9.06e-02	1.80e-01	1.56e-02	3.88e-01	3.15e-01	5.72e-01
RRNA METABOLIC PROCESS	254	2.33e-18	9.22e-16	0.4990	2.41e-01	5.36e-02	3.08e-01	3.01e-01	4.72e-02	3.41e-11	1.41e-01	2.56e-17	1.28e-16	1.95e-01
NOTOCHORD MORPHOGENESIS	8	3.94e-01	8.43e-01	0.4990	8.50e-02	-1.98e-01	3.02e-01	2.91e-01	1.63e-01	6.77e-01	3.32e-01	1.39e-01	1.55e-01	4.25e-01
NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION	6	6.30e-01	9.46e-01	0.4990	-2.23e-01	-1.47e-01	-2.34e-01	-2.89e-01	-1.98e-01	3.44e-01	5.33e-01	3.22e-01	2.20e-01	4.01e-01
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS	448	2.30e-36	1.73e-32	0.4980	2.29e-01	5.06e-02	3.13e-01	3.09e-01	1.87e-02	1.04e-16	6.62e-02	5.36e-30	3.42e-29	4.96e-01
CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE	5	7.25e-01	9.70e-01	0.4980	-1.91e-01	-2.67e-01	-2.05e-01	-2.37e-01	-2.07e-01	4.61e-01	3.01e-01	4.28e-01	3.60e-01	4.23e-01
NEGATIVE REGULATION OF MAST CELL DEGRANULATION	5	6.36e-01	9.48e-01	0.4980	-1.33e-01	-3.40e-01	-4.11e-03	-3.13e-02	3.37e-01	6.06e-01	1.88e-01	9.87e-01	9.04e-01	1.92e-01
DESMOSOME ORGANIZATION	10	3.51e-01	8.18e-01	0.4980	-3.02e-01	-2.98e-01	-1.13e-01	-1.21e-01	2.02e-01	9.82e-02	1.03e-01	5.37e-01	5.06e-01	2.70e-01
CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS	5	8.41e-01	9.85e-01	0.4980	2.34e-01	9.37e-02	3.12e-01	2.95e-01	-6.71e-03	3.65e-01	7.17e-01	2.27e-01	2.53e-01	9.79e-01
RRNA 5 END PROCESSING	5	6.77e-01	9.60e-01	0.4980	2.70e-01	3.86e-01	1.02e-01	8.82e-02	-8.80e-02	2.95e-01	1.35e-01	6.92e-01	7.33e-01	7.33e-01
POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	8	4.67e-01	8.83e-01	0.4980	2.19e-01	3.52e-01	4.11e-02	8.49e-02	-2.59e-01	2.83e-01	8.48e-02	8.40e-01	6.77e-01	2.05e-01
PHAGOSOME ACIDIFICATION	7	1.16e-01	5.45e-01	0.4980	-2.72e-02	6.24e-02	-3.52e-01	-3.45e-01	3.59e-03	9.01e-01	7.75e-01	1.06e-01	1.14e-01	9.87e-01
HEME TRANSPORT	9	2.40e-01	7.24e-01	0.4980	-1.71e-01	-3.33e-01	-1.57e-01	-1.77e-01	-2.26e-01	3.75e-01	8.33e-02	4.15e-01	3.57e-01	2.40e-01
SUGAR MEDIATED SIGNALING PATHWAY	9	3.44e-01	8.14e-01	0.4980	3.05e-01	2.42e-01	1.44e-01	1.49e-01	-2.31e-01	1.13e-01	2.09e-01	4.54e-01	4.38e-01	2.30e-01
POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING	8	4.74e-01	8.86e-01	0.4980	-3.11e-01	-2.88e-01	-1.45e-01	-2.07e-01	-6.34e-02	1.27e-01	1.58e-01	4.79e-01	3.12e-01	7.56e-01
TERMINATION OF RNA POLYMERASE II TRANSCRIPTION	10	4.60e-01	8.80e-01	0.4980	2.64e-01	2.39e-01	1.94e-01	2.06e-01	-2.01e-01	1.48e-01	1.91e-01	2.88e-01	2.59e-01	2.70e-01
RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE	6	1.35e-01	5.83e-01	0.4980	-7.60e-02	-4.27e-01	1.64e-01	1.81e-01	-4.08e-03	7.47e-01	7.01e-02	4.88e-01	4.43e-01	9.86e-01
AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION	14	5.60e-02	3.73e-01	0.4970	2.49e-01	4.27e-01	-2.04e-02	-4.16e-03	-5.24e-02	1.06e-01	5.71e-03	8.95e-01	9.78e-01	7.34e-01
SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION	5	4.96e-01	8.96e-01	0.4970	6.76e-02	-2.49e-01	1.42e-01	1.57e-01	3.69e-01	7.94e-01	3.35e-01	5.83e-01	5.44e-01	1.54e-01
MACROPINOCYTOSIS	10	4.68e-01	8.84e-01	0.4970	-2.62e-01	-3.16e-01	-1.56e-01	-1.58e-01	-1.70e-01	1.51e-01	8.37e-02	3.92e-01	3.87e-01	3.52e-01
AGGREPHAGY	10	2.49e-01	7.33e-01	0.4960	-1.55e-01	-2.67e-01	6.47e-02	2.67e-02	3.82e-01	3.96e-01	1.43e-01	7.23e-01	8.84e-01	3.64e-02
MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL	5	2.32e-01	7.15e-01	0.4960	1.27e-01	4.43e-01	9.83e-02	1.54e-01	1.44e-02	6.24e-01	8.59e-02	7.04e-01	5.51e-01	9.55e-01
MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS	5	4.45e-01	8.73e-01	0.4960	-1.32e-01	-4.65e-01	-3.50e-03	-2.55e-02	1.11e-01	6.10e-01	7.20e-02	9.89e-01	9.21e-01	6.68e-01
REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP	5	6.27e-01	9.45e-01	0.4960	-2.85e-01	-1.71e-01	-1.81e-01	-1.87e-01	2.61e-01	2.70e-01	5.08e-01	4.84e-01	4.68e-01	3.12e-01
COPI COATED VESICLE BUDDING	6	3.34e-01	8.05e-01	0.4960	2.23e-01	4.40e-02	2.54e-01	3.02e-01	-1.96e-01	3.43e-01	8.52e-01	2.80e-01	2.00e-01	4.06e-01
MYOFIBROBLAST DIFFERENTIATION	14	4.61e-02	3.35e-01	0.4960	3.58e-03	-4.25e-02	1.91e-01	1.37e-01	4.35e-01	9.82e-01	7.83e-01	2.16e-01	3.75e-01	4.84e-03
L LYSINE TRANSPORT	7	2.92e-01	7.68e-01	0.4960	-8.20e-02	8.60e-02	-3.19e-01	-3.44e-01	-1.09e-01	7.07e-01	6.94e-01	1.43e-01	1.16e-01	6.17e-01
CYTOLYSIS	7	6.55e-01	9.53e-01	0.4960	-2.23e-01	-3.16e-02	-3.25e-01	-2.91e-01	-6.66e-02	3.07e-01	8.85e-01	1.36e-01	1.82e-01	7.60e-01
POLY A PLUS MRNA EXPORT FROM NUCLEUS	18	1.14e-01	5.39e-01	0.4960	2.87e-01	5.69e-02	2.75e-01	2.51e-01	1.46e-01	3.49e-02	6.76e-01	4.31e-02	6.53e-02	2.83e-01
SKELETAL MUSCLE TISSUE GROWTH	9	4.09e-01	8.52e-01	0.4960	3.35e-01	3.11e-01	1.24e-01	1.29e-01	-6.92e-02	8.16e-02	1.06e-01	5.20e-01	5.03e-01	7.19e-01
MYELOID DENDRITIC CELL CHEMOTAXIS	5	6.57e-01	9.53e-01	0.4950	-1.82e-01	6.75e-02	-3.40e-01	-2.96e-01	-6.81e-02	4.82e-01	7.94e-01	1.88e-01	2.52e-01	7.92e-01
RENAL SODIUM ION ABSORPTION	12	1.42e-01	5.99e-01	0.4950	7.61e-02	2.74e-01	-7.64e-02	-7.61e-02	-3.91e-01	6.48e-01	1.01e-01	6.47e-01	6.48e-01	1.90e-02
NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	5	8.77e-01	9.88e-01	0.4950	2.92e-01	2.87e-01	1.89e-01	1.85e-01	8.59e-02	2.58e-01	2.66e-01	4.63e-01	4.74e-01	7.39e-01
THIAMINE CONTAINING COMPOUND METABOLIC PROCESS	6	2.60e-01	7.43e-01	0.4950	-1.84e-01	-4.40e-01	3.31e-03	6.87e-03	-1.32e-01	4.35e-01	6.20e-02	9.89e-01	9.77e-01	5.75e-01
NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	5	5.37e-01	9.12e-01	0.4940	3.26e-01	1.19e-01	2.29e-01	1.92e-01	1.85e-01	2.07e-01	6.46e-01	3.74e-01	4.56e-01	4.73e-01
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	12	1.42e-01	5.99e-01	0.4940	3.43e-01	7.19e-02	2.29e-01	2.41e-01	1.04e-01	3.97e-02	6.66e-01	1.70e-01	1.47e-01	5.35e-01
ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE	8	3.91e-01	8.41e-01	0.4940	3.51e-01	1.34e-01	2.19e-01	2.29e-01	-4.61e-02	8.52e-02	5.11e-01	2.84e-01	2.61e-01	8.22e-01
REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	10	3.27e-01	7.99e-01	0.4940	-3.19e-01	-3.20e-01	-9.97e-02	-1.58e-01	6.93e-02	8.03e-02	7.98e-02	5.85e-01	3.87e-01	7.04e-01
NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION	8	3.85e-01	8.40e-01	0.4940	-8.27e-02	3.01e-02	-3.39e-01	-2.96e-01	-1.82e-01	6.85e-01	8.83e-01	9.66e-02	1.47e-01	3.73e-01
POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION	7	3.33e-01	8.04e-01	0.4940	-9.27e-02	-1.95e-01	-1.02e-02	-4.31e-02	4.42e-01	6.71e-01	3.73e-01	9.63e-01	8.44e-01	4.29e-02
PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH	6	3.12e-01	7.85e-01	0.4930	-1.27e-01	-1.49e-01	-2.85e-01	-3.33e-01	-1.15e-01	5.91e-01	5.28e-01	2.26e-01	1.58e-01	6.27e-01
TYPE I PNEUMOCYTE DIFFERENTIATION	8	4.92e-01	8.94e-01	0.4930	-1.50e-01	-2.19e-01	-2.35e-01	-2.29e-01	-2.55e-01	4.62e-01	2.83e-01	2.49e-01	2.62e-01	2.12e-01
INTRACELLULAR TRANSPORT OF VIRUS	10	5.77e-01	9.26e-01	0.4930	2.15e-01	1.78e-01	2.86e-01	2.88e-01	-1.84e-02	2.39e-01	3.28e-01	1.18e-01	1.15e-01	9.20e-01
POSITIVE REGULATION OF NEUTROPHIL ACTIVATION	6	8.21e-01	9.83e-01	0.4930	-2.57e-01	-2.45e-01	-2.45e-01	-2.32e-01	5.01e-02	2.75e-01	2.98e-01	2.98e-01	3.25e-01	8.32e-01
POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION	9	7.52e-01	9.75e-01	0.4930	-2.72e-01	-2.98e-01	-1.92e-01	-2.01e-01	-4.86e-02	1.58e-01	1.22e-01	3.18e-01	2.95e-01	8.01e-01
MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	9	3.16e-01	7.89e-01	0.4920	-2.95e-01	-3.86e-01	-2.83e-02	-7.18e-02	2.22e-02	1.26e-01	4.50e-02	8.83e-01	7.09e-01	9.08e-01
REGULATION OF REGULATORY NCRNA PROCESSING	16	2.49e-01	7.33e-01	0.4920	2.76e-01	1.53e-01	2.50e-01	2.63e-01	-1.05e-01	5.59e-02	2.88e-01	8.36e-02	6.88e-02	4.65e-01
PROTEIN REFOLDING	27	7.34e-02	4.35e-01	0.4920	1.91e-01	-3.91e-02	2.96e-01	2.96e-01	1.71e-01	8.56e-02	7.25e-01	7.86e-03	7.84e-03	1.25e-01
LUTEOLYSIS	6	8.60e-01	9.88e-01	0.4920	-3.07e-01	-2.25e-01	-2.03e-01	-2.33e-01	-4.10e-02	1.93e-01	3.40e-01	3.90e-01	3.23e-01	8.62e-01
SEPTUM PRIMUM DEVELOPMENT	5	4.34e-01	8.69e-01	0.4920	-8.21e-02	-2.33e-01	-1.71e-01	-1.78e-01	-3.46e-01	7.50e-01	3.68e-01	5.07e-01	4.90e-01	1.81e-01
POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION	11	7.29e-01	9.71e-01	0.4910	-2.72e-01	-2.37e-01	-2.29e-01	-2.28e-01	-8.12e-02	1.19e-01	1.73e-01	1.88e-01	1.90e-01	6.41e-01
ADHERENS JUNCTION ASSEMBLY	13	3.72e-01	8.32e-01	0.4910	-2.60e-01	-1.41e-01	-2.12e-01	-2.00e-01	-2.63e-01	1.05e-01	3.77e-01	1.86e-01	2.12e-01	1.01e-01
PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT	5	2.35e-01	7.19e-01	0.4910	1.98e-01	-2.44e-01	2.15e-01	2.52e-01	1.79e-01	4.42e-01	3.46e-01	4.05e-01	3.29e-01	4.88e-01
DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY	6	7.08e-01	9.65e-01	0.4900	2.63e-01	1.47e-01	1.96e-01	1.83e-01	2.79e-01	2.65e-01	5.34e-01	4.05e-01	4.39e-01	2.37e-01
NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY	8	4.22e-01	8.60e-01	0.4900	3.45e-01	2.68e-01	1.32e-01	1.45e-01	1.05e-01	9.14e-02	1.90e-01	5.19e-01	4.78e-01	6.07e-01
NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	14	4.39e-01	8.69e-01	0.4900	-2.76e-01	-2.65e-01	-1.81e-01	-1.87e-01	-1.59e-01	7.35e-02	8.61e-02	2.40e-01	2.26e-01	3.03e-01
NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	9	8.23e-01	9.83e-01	0.4890	-2.65e-01	-2.17e-01	-2.45e-01	-2.45e-01	-4.87e-02	1.69e-01	2.59e-01	2.04e-01	2.03e-01	8.00e-01
GOLGI TO VACUOLE TRANSPORT	20	4.42e-01	8.72e-01	0.4890	-2.73e-01	-1.62e-01	-2.55e-01	-2.57e-01	-8.82e-02	3.46e-02	2.11e-01	4.84e-02	4.65e-02	4.95e-01
NEGATIVE REGULATION OF JUN KINASE ACTIVITY	14	2.00e-01	6.80e-01	0.4890	3.07e-01	1.56e-01	2.14e-01	2.42e-01	-1.28e-01	4.67e-02	3.11e-01	1.65e-01	1.18e-01	4.08e-01
HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	4.32e-01	8.68e-01	0.4890	-2.33e-01	-9.27e-02	-2.93e-01	-2.98e-01	4.01e-02	1.62e-01	5.78e-01	7.91e-02	7.34e-02	8.10e-01
DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION	12	4.24e-01	8.61e-01	0.4890	1.47e-01	-8.06e-03	3.24e-01	3.02e-01	1.47e-01	3.76e-01	9.61e-01	5.22e-02	7.02e-02	3.79e-01
T CELL MEDIATED CYTOTOXICITY	59	2.25e-03	4.49e-02	0.4890	2.12e-01	2.17e-01	2.44e-01	2.57e-01	1.47e-01	4.93e-03	3.88e-03	1.21e-03	6.29e-04	5.10e-02
PEPTIDYL HISTIDINE MODIFICATION	8	1.26e-01	5.67e-01	0.4890	-8.81e-02	-4.57e-01	9.90e-02	8.50e-02	7.19e-02	6.66e-01	2.51e-02	6.28e-01	6.77e-01	7.25e-01
NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION	24	2.20e-01	7.00e-01	0.4890	-2.94e-01	-2.34e-01	-2.11e-01	-2.27e-01	3.51e-02	1.26e-02	4.72e-02	7.31e-02	5.37e-02	7.66e-01
REGULATION OF MEMBRANE TUBULATION	5	8.35e-01	9.85e-01	0.4890	-1.70e-01	-1.37e-01	-2.64e-01	-2.32e-01	-2.61e-01	5.11e-01	5.97e-01	3.08e-01	3.68e-01	3.12e-01
NEURON FATE DETERMINATION	10	1.69e-02	1.81e-01	0.4890	-6.18e-02	-4.52e-01	1.22e-01	4.99e-02	1.13e-01	7.35e-01	1.32e-02	5.03e-01	7.85e-01	5.35e-01
REGULATION OF APOPTOTIC CELL CLEARANCE	10	1.75e-01	6.47e-01	0.4890	2.02e-01	3.96e-01	-5.63e-02	1.02e-02	-1.96e-01	2.69e-01	3.03e-02	7.58e-01	9.55e-01	2.83e-01
NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	24	9.82e-02	5.01e-01	0.4880	1.34e-01	-4.54e-02	2.81e-01	2.50e-01	2.77e-01	2.56e-01	7.01e-01	1.70e-02	3.41e-02	1.87e-02
LYSOSOMAL LUMEN ACIDIFICATION	20	7.92e-02	4.52e-01	0.4880	2.45e-01	9.98e-02	2.86e-01	2.77e-01	-1.00e-01	5.82e-02	4.40e-01	2.66e-02	3.21e-02	4.38e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	13	8.51e-02	4.66e-01	0.4880	-1.73e-01	-2.06e-01	-2.28e-01	-2.82e-01	-1.86e-01	2.80e-01	1.98e-01	1.55e-01	7.87e-02	2.45e-01
ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	24	7.75e-02	4.49e-01	0.4880	1.75e-01	-5.00e-02	2.76e-01	2.46e-01	2.62e-01	1.38e-01	6.72e-01	1.91e-02	3.73e-02	2.66e-02
DNA DEALKYLATION INVOLVED IN DNA REPAIR	9	7.71e-01	9.76e-01	0.4880	-2.00e-01	-1.35e-01	-2.63e-01	-2.74e-01	-1.89e-01	2.99e-01	4.85e-01	1.72e-01	1.54e-01	3.27e-01
FUCOSE METABOLIC PROCESS	16	3.54e-01	8.22e-01	0.4880	-2.10e-01	-1.75e-01	-2.88e-01	-2.82e-01	-2.81e-02	1.46e-01	2.25e-01	4.60e-02	5.09e-02	8.46e-01
REGULATION OF DEVELOPMENT HETEROCHRONIC	12	1.15e-01	5.42e-01	0.4880	2.97e-01	-2.91e-02	2.46e-01	2.64e-01	1.36e-01	7.51e-02	8.61e-01	1.40e-01	1.13e-01	4.13e-01
REGULATION OF PRE MIRNA PROCESSING	6	6.66e-01	9.55e-01	0.4880	3.43e-01	2.83e-01	1.25e-01	1.53e-01	2.48e-02	1.46e-01	2.29e-01	5.95e-01	5.16e-01	9.16e-01
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	15	5.50e-02	3.68e-01	0.4870	-9.29e-02	-3.85e-01	8.10e-02	6.17e-02	2.65e-01	5.33e-01	9.79e-03	5.87e-01	6.79e-01	7.54e-02
RRNA 3 END PROCESSING	10	3.29e-01	8.02e-01	0.4870	2.26e-01	-3.22e-02	3.08e-01	2.64e-01	1.44e-01	2.15e-01	8.60e-01	9.22e-02	1.48e-01	4.29e-01
MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION	35	6.69e-02	4.13e-01	0.4870	1.92e-01	1.05e-02	2.75e-01	2.64e-01	2.35e-01	4.94e-02	9.14e-01	4.85e-03	6.93e-03	1.60e-02
RESPONSE TO MISFOLDED PROTEIN	23	2.79e-02	2.50e-01	0.4870	3.62e-02	-1.94e-01	2.08e-01	2.08e-01	3.35e-01	7.64e-01	1.07e-01	8.46e-02	8.41e-02	5.46e-03
POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	5	3.87e-01	8.40e-01	0.4870	-7.11e-02	9.62e-02	-1.69e-01	-9.32e-02	-4.31e-01	7.83e-01	7.10e-01	5.13e-01	7.18e-01	9.52e-02
GLIAL CELL FATE SPECIFICATION	7	1.83e-02	1.92e-01	0.4870	1.33e-01	-4.01e-01	1.43e-01	1.34e-01	1.44e-01	5.43e-01	6.63e-02	5.14e-01	5.40e-01	5.10e-01
CHOLESTEROL CATABOLIC PROCESS	9	5.21e-01	9.03e-01	0.4870	-2.45e-01	-3.05e-01	-1.63e-01	-1.59e-01	1.79e-01	2.03e-01	1.13e-01	3.96e-01	4.08e-01	3.53e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	8	6.32e-01	9.47e-01	0.4870	-2.44e-01	-2.89e-02	-2.66e-01	-2.39e-01	-2.20e-01	2.31e-01	8.87e-01	1.93e-01	2.41e-01	2.81e-01
PEXOPHAGY	6	1.46e-01	6.03e-01	0.4870	3.21e-01	1.21e-01	2.02e-01	1.56e-01	-2.33e-01	1.74e-01	6.08e-01	3.91e-01	5.09e-01	3.22e-01
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY	14	2.70e-02	2.46e-01	0.4860	2.62e-01	-3.37e-02	2.74e-01	2.70e-01	-1.36e-01	8.99e-02	8.27e-01	7.58e-02	7.98e-02	3.77e-01
FLAVONE METABOLIC PROCESS	6	1.14e-03	2.76e-02	0.4860	-2.32e-01	1.99e-01	-1.11e-01	-3.97e-02	3.60e-01	3.26e-01	3.98e-01	6.38e-01	8.66e-01	1.27e-01
KERATINOCYTE APOPTOTIC PROCESS	7	7.39e-01	9.73e-01	0.4860	1.13e-01	-9.55e-02	2.55e-01	2.45e-01	2.99e-01	6.04e-01	6.62e-01	2.42e-01	2.61e-01	1.71e-01
SNO S RNA METABOLIC PROCESS	15	1.50e-03	3.36e-02	0.4860	2.44e-01	3.25e-02	2.08e-01	1.73e-01	-3.20e-01	1.02e-01	8.28e-01	1.64e-01	2.46e-01	3.17e-02
PROTEIN LOCALIZATION TO CILIARY MEMBRANE	11	4.58e-01	8.79e-01	0.4860	2.26e-01	1.78e-01	2.61e-01	2.74e-01	-1.02e-01	1.95e-01	3.07e-01	1.33e-01	1.16e-01	5.57e-01
MONOCYTE ACTIVATION	12	6.21e-01	9.43e-01	0.4860	-2.45e-01	-2.41e-01	-2.17e-01	-2.44e-01	-1.10e-01	1.42e-01	1.49e-01	1.93e-01	1.44e-01	5.11e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	6	5.46e-01	9.15e-01	0.4860	-2.19e-01	-3.80e-01	-1.12e-01	-1.70e-01	4.28e-02	3.52e-01	1.07e-01	6.35e-01	4.71e-01	8.56e-01
GLUTAMATE CATABOLIC PROCESS	7	3.75e-01	8.36e-01	0.4850	-2.00e-01	-3.64e-01	-9.91e-02	-1.63e-01	1.64e-01	3.59e-01	9.58e-02	6.50e-01	4.55e-01	4.53e-01
RESPONSE TO INTERLEUKIN 18	11	8.86e-02	4.73e-01	0.4850	-1.85e-01	5.33e-02	-2.33e-01	-2.93e-01	-2.41e-01	2.88e-01	7.60e-01	1.82e-01	9.22e-02	1.67e-01
SOFT PALATE DEVELOPMENT	5	8.05e-01	9.82e-01	0.4850	-2.26e-01	-2.11e-01	-2.30e-01	-2.50e-01	1.54e-01	3.81e-01	4.13e-01	3.72e-01	3.33e-01	5.51e-01
SPERM EJACULATION	5	4.33e-01	8.69e-01	0.4850	1.63e-03	-3.64e-01	1.96e-01	1.42e-01	2.10e-01	9.95e-01	1.59e-01	4.47e-01	5.84e-01	4.16e-01
RESPONSE TO IRON II ION	6	2.08e-01	6.85e-01	0.4850	-1.05e-01	-3.45e-01	1.97e-01	2.18e-01	1.35e-01	6.55e-01	1.43e-01	4.03e-01	3.55e-01	5.68e-01
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES	13	2.35e-01	7.19e-01	0.4850	1.96e-01	2.94e-01	2.42e-01	2.26e-01	1.80e-02	2.21e-01	6.64e-02	1.31e-01	1.58e-01	9.11e-01
URETER MORPHOGENESIS	7	7.70e-02	4.48e-01	0.4840	2.92e-01	-5.57e-02	3.02e-01	2.31e-01	4.76e-02	1.81e-01	7.99e-01	1.67e-01	2.90e-01	8.27e-01
REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	6	6.47e-01	9.51e-01	0.4840	-2.97e-01	-9.91e-02	-2.39e-01	-2.78e-01	4.68e-02	2.07e-01	6.74e-01	3.11e-01	2.38e-01	8.43e-01
REGULATION OF MEMBRANE INVAGINATION	15	2.42e-01	7.26e-01	0.4840	-2.63e-01	-2.51e-01	-1.92e-01	-1.87e-01	1.74e-01	7.83e-02	9.18e-02	1.98e-01	2.09e-01	2.43e-01
NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS	5	1.64e-01	6.28e-01	0.4840	-1.53e-01	3.38e-01	-2.23e-01	-2.12e-01	-3.76e-02	5.52e-01	1.90e-01	3.87e-01	4.12e-01	8.84e-01
4FE 4S CLUSTER ASSEMBLY	5	4.37e-01	8.69e-01	0.4840	-8.19e-03	-3.35e-01	7.29e-02	8.58e-02	3.30e-01	9.75e-01	1.94e-01	7.78e-01	7.40e-01	2.01e-01
BILE ACID AND BILE SALT TRANSPORT	28	1.77e-01	6.47e-01	0.4830	-2.86e-01	-1.55e-01	-2.42e-01	-2.57e-01	-5.33e-02	8.76e-03	1.55e-01	2.66e-02	1.86e-02	6.26e-01
REGULATION OF MESODERMAL CELL DIFFERENTIATION	9	3.72e-02	2.94e-01	0.4830	-1.24e-01	-3.28e-01	-2.05e-01	-2.61e-01	1.84e-02	5.18e-01	8.87e-02	2.87e-01	1.75e-01	9.24e-01
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	11	6.06e-01	9.34e-01	0.4830	-2.83e-01	-2.47e-01	-2.17e-01	-2.09e-01	3.54e-02	1.04e-01	1.57e-01	2.12e-01	2.30e-01	8.39e-01
TELENCEPHALON REGIONALIZATION	13	1.47e-03	3.30e-02	0.4830	2.01e-01	-2.53e-01	2.70e-01	2.14e-01	1.02e-01	2.09e-01	1.14e-01	9.23e-02	1.82e-01	5.24e-01
TRICUSPID VALVE DEVELOPMENT	6	6.19e-01	9.42e-01	0.4830	-1.28e-01	-9.95e-02	-1.75e-01	-2.00e-01	-3.69e-01	5.86e-01	6.73e-01	4.57e-01	3.95e-01	1.18e-01
POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	34	1.25e-01	5.64e-01	0.4830	2.31e-01	2.07e-01	2.56e-01	2.52e-01	8.72e-02	1.96e-02	3.71e-02	9.82e-03	1.08e-02	3.79e-01
ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY	7	4.85e-01	8.92e-01	0.4830	-2.15e-01	-6.86e-02	-3.07e-01	-2.77e-01	1.05e-01	3.24e-01	7.53e-01	1.60e-01	2.04e-01	6.31e-01
POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION	7	6.56e-01	9.53e-01	0.4830	-2.78e-01	-2.18e-01	-2.03e-01	-2.59e-01	-1.80e-04	2.03e-01	3.19e-01	3.53e-01	2.35e-01	9.99e-01
RESPONSE TO ERYTHROPOIETIN	7	1.15e-02	1.40e-01	0.4830	1.99e-01	-1.87e-01	1.36e-01	1.20e-01	-3.54e-01	3.62e-01	3.92e-01	5.34e-01	5.84e-01	1.05e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	16	1.84e-01	6.56e-01	0.4820	9.62e-02	-1.43e-01	2.69e-01	2.68e-01	2.43e-01	5.05e-01	3.23e-01	6.26e-02	6.39e-02	9.19e-02
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	26	3.89e-03	6.68e-02	0.4820	-1.50e-01	-4.07e-01	9.70e-03	-1.99e-02	2.10e-01	1.84e-01	3.31e-04	9.32e-01	8.61e-01	6.43e-02
MEMBRANOUS SEPTUM MORPHOGENESIS	8	4.46e-01	8.73e-01	0.4820	1.40e-01	-1.20e-01	3.21e-01	2.80e-01	1.30e-01	4.93e-01	5.55e-01	1.16e-01	1.70e-01	5.24e-01
PROTEIN MATURATION BY PROTEIN FOLDING	7	7.86e-01	9.81e-01	0.4820	2.84e-01	9.84e-02	2.49e-01	2.43e-01	1.45e-01	1.93e-01	6.52e-01	2.54e-01	2.66e-01	5.07e-01
SOMATOSTATIN RECEPTOR SIGNALING PATHWAY	5	6.61e-01	9.54e-01	0.4820	-3.10e-02	1.86e-01	-2.81e-01	-2.79e-01	-1.99e-01	9.04e-01	4.71e-01	2.76e-01	2.80e-01	4.41e-01
NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	6	4.62e-01	8.80e-01	0.4820	-3.14e-02	2.17e-01	-2.92e-01	-2.88e-01	-1.25e-01	8.94e-01	3.57e-01	2.15e-01	2.22e-01	5.95e-01
POSITIVE REGULATION OF RIG I SIGNALING PATHWAY	10	2.83e-01	7.62e-01	0.4810	-1.14e-01	1.64e-01	-2.56e-01	-2.76e-01	-2.25e-01	5.32e-01	3.68e-01	1.62e-01	1.31e-01	2.19e-01
REGULATION OF BLOOD VESSEL REMODELING	12	7.15e-01	9.68e-01	0.4810	-2.64e-01	-1.96e-01	-2.20e-01	-2.31e-01	-1.47e-01	1.13e-01	2.39e-01	1.87e-01	1.66e-01	3.79e-01
TOXIN METABOLIC PROCESS	14	3.83e-01	8.39e-01	0.4810	1.38e-01	-3.50e-02	3.02e-01	2.73e-01	2.13e-01	3.73e-01	8.20e-01	5.02e-02	7.67e-02	1.68e-01
WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	11	2.54e-01	7.37e-01	0.4810	2.21e-01	-1.03e-01	2.80e-01	2.72e-01	1.39e-01	2.05e-01	5.53e-01	1.08e-01	1.18e-01	4.24e-01
NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	31	9.18e-02	4.83e-01	0.4810	-2.47e-01	-7.33e-02	-2.53e-01	-2.43e-01	-2.04e-01	1.71e-02	4.80e-01	1.47e-02	1.93e-02	4.93e-02
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	12	5.09e-01	9.00e-01	0.4810	-2.68e-01	-1.97e-01	-2.36e-01	-2.35e-01	9.85e-02	1.08e-01	2.38e-01	1.57e-01	1.58e-01	5.55e-01
VESTIBULOCOCHLEAR NERVE MORPHOGENESIS	7	4.27e-01	8.65e-01	0.4810	2.58e-01	2.47e-01	1.35e-01	1.15e-01	2.69e-01	2.38e-01	2.58e-01	5.36e-01	5.97e-01	2.19e-01
REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	21	2.02e-01	6.82e-01	0.4810	-2.39e-01	-2.88e-01	-1.85e-01	-1.88e-01	-1.45e-01	5.75e-02	2.23e-02	1.42e-01	1.35e-01	2.50e-01
PURINE RIBONUCLEOTIDE SALVAGE	7	8.54e-01	9.88e-01	0.4810	-2.30e-01	-2.20e-01	-2.53e-01	-2.42e-01	-8.38e-02	2.91e-01	3.13e-01	2.47e-01	2.67e-01	7.01e-01
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE	6	7.75e-01	9.77e-01	0.4810	-2.08e-01	-1.57e-01	-1.81e-01	-2.02e-01	-2.99e-01	3.77e-01	5.06e-01	4.43e-01	3.92e-01	2.04e-01
CELLULAR RESPONSE TO PROGESTERONE STIMULUS	7	5.60e-01	9.19e-01	0.4800	-4.18e-02	2.06e-01	-1.85e-01	-1.85e-01	-3.44e-01	8.48e-01	3.46e-01	3.97e-01	3.97e-01	1.15e-01
NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	5	5.78e-01	9.27e-01	0.4800	-1.36e-01	-2.28e-01	-9.51e-02	-1.21e-01	3.69e-01	6.00e-01	3.77e-01	7.13e-01	6.39e-01	1.52e-01
NEGATIVE REGULATION OF CELL VOLUME	5	7.92e-01	9.81e-01	0.4800	-1.93e-01	3.50e-02	-3.10e-01	-2.69e-01	-1.54e-01	4.55e-01	8.92e-01	2.30e-01	2.97e-01	5.50e-01
NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	6	6.04e-01	9.34e-01	0.4800	2.41e-02	-4.32e-02	2.10e-01	1.71e-01	3.94e-01	9.19e-01	8.55e-01	3.73e-01	4.69e-01	9.50e-02
POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE	6	5.03e-01	8.98e-01	0.4800	-1.73e-01	-2.43e-01	-1.73e-02	-1.14e-02	3.76e-01	4.64e-01	3.02e-01	9.41e-01	9.61e-01	1.11e-01
NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	8	6.15e-01	9.39e-01	0.4800	1.78e-01	-9.77e-02	2.78e-01	2.63e-01	2.07e-01	3.84e-01	6.32e-01	1.73e-01	1.98e-01	3.11e-01
DETECTION OF CELL DENSITY	9	5.41e-01	9.14e-01	0.4790	-1.90e-01	-1.75e-01	-2.97e-01	-2.70e-01	-4.37e-02	3.24e-01	3.63e-01	1.23e-01	1.60e-01	8.20e-01
OXALOACETATE METABOLIC PROCESS	9	2.07e-01	6.84e-01	0.4790	2.02e-01	2.57e-02	2.82e-01	2.64e-01	-1.95e-01	2.93e-01	8.94e-01	1.42e-01	1.69e-01	3.10e-01
REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS	13	5.93e-01	9.32e-01	0.4790	2.75e-01	1.10e-01	2.59e-01	2.58e-01	8.86e-02	8.55e-02	4.93e-01	1.07e-01	1.07e-01	5.80e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA	11	3.14e-01	7.86e-01	0.4790	9.47e-02	-1.27e-01	2.36e-01	2.54e-01	2.90e-01	5.87e-01	4.65e-01	1.76e-01	1.44e-01	9.61e-02
SCHWANN CELL PROLIFERATION	9	7.10e-01	9.67e-01	0.4790	-3.00e-01	-1.43e-01	-2.29e-01	-2.48e-01	-6.97e-02	1.20e-01	4.57e-01	2.34e-01	1.97e-01	7.17e-01
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	24	3.43e-01	8.14e-01	0.4790	2.07e-01	9.14e-02	2.62e-01	2.61e-01	2.03e-01	7.93e-02	4.38e-01	2.61e-02	2.71e-02	8.50e-02
GLYCINE BIOSYNTHETIC PROCESS	7	4.75e-01	8.86e-01	0.4790	1.72e-01	2.92e-01	2.49e-01	2.30e-01	7.05e-04	4.32e-01	1.82e-01	2.55e-01	2.93e-01	9.97e-01
CARNITINE METABOLIC PROCESS	11	2.02e-01	6.82e-01	0.4790	-8.33e-02	-1.36e-01	-2.03e-01	-1.89e-01	-3.56e-01	6.32e-01	4.34e-01	2.44e-01	2.78e-01	4.09e-02
ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	9	3.39e-01	8.08e-01	0.4780	1.74e-01	3.63e-01	-8.38e-02	-6.25e-02	-2.37e-01	3.66e-01	5.96e-02	6.63e-01	7.46e-01	2.18e-01
DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	5	7.63e-01	9.75e-01	0.4780	2.58e-01	3.18e-01	5.13e-02	7.07e-02	-2.32e-01	3.17e-01	2.19e-01	8.43e-01	7.84e-01	3.69e-01
GLUTAMATE SECRETION NEUROTRANSMISSION	8	8.33e-01	9.85e-01	0.4780	2.02e-01	6.26e-02	2.66e-01	2.51e-01	2.24e-01	3.23e-01	7.59e-01	1.92e-01	2.19e-01	2.72e-01
RESPONSE TO HEPATOCYTE GROWTH FACTOR	17	3.72e-01	8.32e-01	0.4780	-2.36e-01	-2.65e-01	-2.23e-01	-2.12e-01	-8.95e-02	9.15e-02	5.85e-02	1.12e-01	1.30e-01	5.23e-01
SNO S RNA PROCESSING	12	5.15e-03	8.32e-02	0.4780	2.50e-01	4.84e-02	2.04e-01	1.58e-01	-3.12e-01	1.34e-01	7.72e-01	2.20e-01	3.43e-01	6.14e-02
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	14	4.84e-01	8.91e-01	0.4780	-2.39e-01	-2.88e-01	-1.98e-01	-2.22e-01	-2.21e-02	1.22e-01	6.23e-02	2.00e-01	1.50e-01	8.86e-01
TRICARBOXYLIC ACID CYCLE	29	7.07e-03	1.03e-01	0.4780	2.33e-01	9.44e-03	2.94e-01	2.90e-01	-5.88e-02	2.96e-02	9.30e-01	6.16e-03	6.83e-03	5.84e-01
NOTOCHORD DEVELOPMENT	19	2.64e-01	7.47e-01	0.4780	2.47e-01	3.65e-02	2.79e-01	2.85e-01	8.32e-02	6.25e-02	7.83e-01	3.52e-02	3.14e-02	5.30e-01
RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS	7	5.36e-02	3.63e-01	0.4780	-2.26e-02	-2.30e-01	1.89e-01	1.61e-01	-3.37e-01	9.18e-01	2.93e-01	3.86e-01	4.61e-01	1.23e-01
POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION	61	7.45e-05	3.00e-03	0.4780	-2.31e-01	-2.76e-01	-1.76e-01	-1.81e-01	1.87e-01	1.77e-03	1.96e-04	1.76e-02	1.45e-02	1.14e-02
POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	14	3.84e-01	8.39e-01	0.4780	-2.26e-01	1.45e-02	-2.73e-01	-2.59e-01	-1.88e-01	1.43e-01	9.25e-01	7.70e-02	9.28e-02	2.24e-01
CMP METABOLIC PROCESS	8	5.53e-01	9.16e-01	0.4780	-1.75e-01	-2.23e-01	-2.69e-01	-2.74e-01	-1.78e-02	3.93e-01	2.75e-01	1.88e-01	1.79e-01	9.31e-01
TERMINAL BUTTON ORGANIZATION	6	8.45e-01	9.86e-01	0.4770	2.82e-01	2.33e-01	1.83e-01	1.86e-01	1.61e-01	2.31e-01	3.23e-01	4.38e-01	4.30e-01	4.95e-01
POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	11	1.67e-01	6.33e-01	0.4770	-3.23e-02	-2.24e-01	1.11e-01	1.27e-01	3.85e-01	8.53e-01	1.99e-01	5.25e-01	4.65e-01	2.70e-02
MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER	5	3.99e-01	8.45e-01	0.4770	-1.66e-01	-2.10e-02	-2.07e-01	-1.99e-01	3.42e-01	5.20e-01	9.35e-01	4.23e-01	4.41e-01	1.85e-01
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	32	2.80e-02	2.51e-01	0.4770	1.18e-01	-1.09e-01	2.72e-01	2.53e-01	2.52e-01	2.47e-01	2.88e-01	7.85e-03	1.32e-02	1.35e-02
PEPTIDYL THREONINE DEPHOSPHORYLATION	18	1.77e-01	6.47e-01	0.4760	2.39e-01	4.68e-02	2.57e-01	2.27e-01	2.23e-01	7.86e-02	7.31e-01	5.88e-02	9.59e-02	1.01e-01
THORAX AND ANTERIOR ABDOMEN DETERMINATION	5	3.54e-01	8.21e-01	0.4760	3.05e-01	2.66e-01	1.35e-01	8.79e-02	1.93e-01	2.38e-01	3.03e-01	6.02e-01	7.33e-01	4.55e-01
POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY	39	6.30e-02	4.02e-01	0.4760	2.39e-01	1.85e-01	2.63e-01	2.49e-01	6.30e-02	9.69e-03	4.51e-02	4.45e-03	7.22e-03	4.96e-01
FOLLICLE STIMULATING HORMONE SECRETION	8	3.88e-02	3.01e-01	0.4760	-9.40e-02	-3.53e-01	-1.90e-01	-2.36e-01	-3.51e-02	6.45e-01	8.37e-02	3.52e-01	2.47e-01	8.63e-01
EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS	5	8.04e-01	9.82e-01	0.4760	2.62e-01	3.00e-02	2.41e-01	2.71e-01	1.59e-01	3.09e-01	9.07e-01	3.51e-01	2.94e-01	5.37e-01
NCRNA EXPORT FROM NUCLEUS	9	1.10e-01	5.32e-01	0.4760	-2.55e-01	-3.82e-01	8.83e-02	7.07e-02	5.51e-02	1.86e-01	4.73e-02	6.46e-01	7.13e-01	7.75e-01
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION	8	8.67e-01	9.88e-01	0.4760	2.25e-01	1.83e-01	2.47e-01	2.44e-01	1.47e-01	2.70e-01	3.69e-01	2.26e-01	2.33e-01	4.71e-01
LATERAL VENTRICLE DEVELOPMENT	12	3.50e-01	8.18e-01	0.4760	7.83e-02	-6.91e-02	1.83e-01	1.72e-01	3.91e-01	6.39e-01	6.79e-01	2.73e-01	3.03e-01	1.91e-02
POSITIVE REGULATION OF DOPAMINE SECRETION	6	4.61e-01	8.80e-01	0.4760	1.84e-02	-1.27e-02	2.86e-01	2.38e-01	2.96e-01	9.38e-01	9.57e-01	2.25e-01	3.12e-01	2.10e-01
AMINO ACID NEUROTRANSMITTER REUPTAKE	10	2.23e-01	7.04e-01	0.4760	1.98e-01	4.22e-01	4.38e-02	7.59e-02	3.19e-02	2.77e-01	2.07e-02	8.11e-01	6.78e-01	8.61e-01
CELL PROLIFERATION IN HINDBRAIN	16	2.34e-01	7.18e-01	0.4760	2.19e-01	4.37e-03	2.25e-01	2.15e-01	2.86e-01	1.30e-01	9.76e-01	1.19e-01	1.37e-01	4.77e-02
REGULATION OF IRON ION TRANSPORT	7	4.87e-01	8.92e-01	0.4760	1.31e-01	1.71e-01	1.97e-01	2.27e-01	2.99e-01	5.49e-01	4.33e-01	3.66e-01	2.98e-01	1.71e-01
ROSTROCAUDAL NEURAL TUBE PATTERNING	10	1.25e-02	1.49e-01	0.4760	2.68e-03	-3.16e-01	3.93e-02	-3.00e-02	3.52e-01	9.88e-01	8.39e-02	8.29e-01	8.70e-01	5.38e-02
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION	5	7.15e-01	9.68e-01	0.4750	-1.86e-01	-2.80e-01	-1.14e-02	-2.40e-02	3.35e-01	4.71e-01	2.78e-01	9.65e-01	9.26e-01	1.95e-01
POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION	6	6.01e-01	9.33e-01	0.4750	7.80e-03	-1.84e-01	1.68e-01	1.21e-01	3.86e-01	9.74e-01	4.35e-01	4.76e-01	6.07e-01	1.02e-01
INTRACILIARY ANTEROGRADE TRANSPORT	17	1.54e-01	6.16e-01	0.4750	3.19e-01	1.94e-01	2.15e-01	1.98e-01	3.07e-02	2.27e-02	1.66e-01	1.25e-01	1.58e-01	8.27e-01
REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	8	4.68e-01	8.83e-01	0.4750	-2.31e-01	-2.82e-01	-4.31e-02	-5.48e-02	2.96e-01	2.57e-01	1.67e-01	8.33e-01	7.89e-01	1.48e-01
AGGRESSIVE BEHAVIOR	7	3.31e-01	8.03e-01	0.4750	-1.91e-01	-3.33e-01	-1.64e-01	-2.26e-01	-1.10e-02	3.83e-01	1.27e-01	4.54e-01	3.00e-01	9.60e-01
MESONEPHRIC TUBULE FORMATION	10	1.83e-01	6.56e-01	0.4750	-3.52e-02	-3.04e-01	2.45e-01	2.04e-01	1.73e-01	8.47e-01	9.64e-02	1.79e-01	2.63e-01	3.42e-01
REGULATION OF T CELL MEDIATED CYTOTOXICITY	50	7.78e-03	1.09e-01	0.4740	2.07e-01	2.39e-01	2.27e-01	2.36e-01	1.36e-01	1.14e-02	3.50e-03	5.56e-03	3.95e-03	9.61e-02
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	7	1.78e-02	1.88e-01	0.4740	1.82e-01	3.19e-01	9.00e-02	2.11e-01	1.94e-01	4.05e-01	1.44e-01	6.80e-01	3.33e-01	3.73e-01
MYOBLAST FATE COMMITMENT	6	5.14e-01	9.01e-01	0.4740	-2.63e-01	-2.43e-01	-1.72e-01	-2.49e-01	-7.57e-02	2.65e-01	3.02e-01	4.67e-01	2.92e-01	7.48e-01
AXIAL MESODERM DEVELOPMENT	8	5.12e-01	9.00e-01	0.4740	-2.15e-01	-4.01e-01	-4.54e-02	-6.01e-02	1.11e-01	2.92e-01	4.96e-02	8.24e-01	7.68e-01	5.88e-01
MONOCYTE AGGREGATION	5	4.96e-01	8.96e-01	0.4740	-1.37e-01	-4.43e-01	6.25e-02	4.96e-02	6.15e-02	5.95e-01	8.64e-02	8.09e-01	8.48e-01	8.12e-01
POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	14	2.96e-01	7.71e-01	0.4740	-2.16e-01	-3.51e-01	-1.59e-01	-1.70e-01	-2.30e-02	1.61e-01	2.29e-02	3.03e-01	2.70e-01	8.81e-01
RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	7	6.25e-01	9.44e-01	0.4740	-1.36e-01	-1.60e-01	-2.66e-01	-2.40e-01	-2.29e-01	5.34e-01	4.63e-01	2.23e-01	2.71e-01	2.95e-01
REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY	8	8.24e-01	9.83e-01	0.4740	-2.34e-01	-1.66e-01	-2.46e-01	-2.72e-01	-9.02e-02	2.52e-01	4.16e-01	2.29e-01	1.83e-01	6.59e-01
SMOOTH MUSCLE ADAPTATION	5	4.11e-01	8.53e-01	0.4740	1.88e-01	5.24e-02	1.25e-01	1.33e-01	-3.91e-01	4.66e-01	8.39e-01	6.28e-01	6.07e-01	1.30e-01
POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION	17	7.89e-02	4.52e-01	0.4740	-2.06e-01	8.43e-02	-2.38e-01	-2.62e-01	-2.23e-01	1.42e-01	5.48e-01	8.88e-02	6.14e-02	1.12e-01
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	23	1.08e-01	5.25e-01	0.4730	-2.82e-01	-1.77e-01	-2.25e-01	-2.26e-01	1.10e-01	1.94e-02	1.43e-01	6.22e-02	6.06e-02	3.60e-01
WHITE FAT CELL DIFFERENTIATION	17	5.10e-01	9.00e-01	0.4730	-2.36e-01	-1.69e-01	-2.19e-01	-2.23e-01	-2.05e-01	9.16e-02	2.29e-01	1.17e-01	1.12e-01	1.44e-01
ORNITHINE TRANSPORT	6	5.14e-01	9.01e-01	0.4730	-9.54e-02	1.12e-01	-2.92e-01	-3.16e-01	-1.31e-01	6.86e-01	6.35e-01	2.16e-01	1.80e-01	5.78e-01
MATURATION OF 5 8S RRNA	35	7.52e-02	4.40e-01	0.4730	2.36e-01	5.40e-02	2.80e-01	2.69e-01	1.20e-01	1.57e-02	5.81e-01	4.10e-03	5.88e-03	2.19e-01
NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	11	5.95e-01	9.33e-01	0.4730	2.37e-01	1.32e-01	2.26e-01	2.07e-01	2.37e-01	1.74e-01	4.47e-01	1.94e-01	2.34e-01	1.74e-01
METANEPHRIC PROXIMAL TUBULE DEVELOPMENT	5	2.08e-01	6.85e-01	0.4730	-1.64e-01	1.59e-01	-2.31e-01	-2.11e-01	2.71e-01	5.26e-01	5.37e-01	3.70e-01	4.14e-01	2.94e-01
BRUSH BORDER ASSEMBLY	7	1.59e-01	6.21e-01	0.4730	4.02e-02	3.69e-01	-2.28e-01	-1.83e-01	1.03e-03	8.54e-01	9.07e-02	2.97e-01	4.01e-01	9.96e-01
GDP MANNOSE METABOLIC PROCESS	7	1.57e-01	6.19e-01	0.4720	2.19e-01	-1.54e-01	2.60e-01	2.75e-01	-9.00e-02	3.17e-01	4.81e-01	2.34e-01	2.07e-01	6.80e-01
POSITIVE REGULATION OF VASCULAR WOUND HEALING	5	1.50e-01	6.11e-01	0.4720	4.25e-02	-2.94e-01	2.29e-01	2.86e-01	4.09e-03	8.69e-01	2.55e-01	3.74e-01	2.68e-01	9.87e-01
NEGATIVE REGULATION OF PHAGOCYTOSIS	21	2.09e-01	6.86e-01	0.4720	-2.42e-01	-3.31e-01	-1.56e-01	-1.73e-01	1.56e-02	5.50e-02	8.63e-03	2.16e-01	1.69e-01	9.01e-01
POSITIVE REGULATION OF RECEPTOR CLUSTERING	6	8.84e-01	9.91e-01	0.4720	-2.28e-01	-2.22e-01	-2.14e-01	-2.40e-01	-1.34e-01	3.33e-01	3.46e-01	3.64e-01	3.09e-01	5.70e-01
CEREBRAL CORTEX NEURON DIFFERENTIATION	24	7.76e-03	1.09e-01	0.4720	2.02e-01	-1.27e-01	2.37e-01	2.23e-01	2.45e-01	8.72e-02	2.82e-01	4.44e-02	5.88e-02	3.79e-02
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN	9	5.37e-01	9.12e-01	0.4720	3.15e-01	1.88e-01	2.11e-01	1.96e-01	7.22e-02	1.02e-01	3.29e-01	2.72e-01	3.10e-01	7.07e-01
NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	9	7.27e-01	9.71e-01	0.4720	2.64e-01	1.85e-01	1.93e-01	1.99e-01	2.04e-01	1.71e-01	3.36e-01	3.15e-01	3.01e-01	2.90e-01
REGULATION OF DENDRITIC SPINE MAINTENANCE	13	2.45e-01	7.30e-01	0.4720	-2.13e-01	-2.17e-01	-1.35e-01	-1.53e-01	-2.97e-01	1.84e-01	1.75e-01	3.98e-01	3.40e-01	6.37e-02
REGULATION OF GLUCOCORTICOID SECRETION	10	6.79e-01	9.60e-01	0.4710	-2.39e-01	-2.94e-01	-1.86e-01	-2.09e-01	7.53e-03	1.91e-01	1.07e-01	3.08e-01	2.52e-01	9.67e-01
HYPEROSMOTIC SALINITY RESPONSE	10	7.63e-01	9.75e-01	0.4710	2.53e-01	2.33e-01	2.18e-01	2.11e-01	1.08e-01	1.65e-01	2.03e-01	2.32e-01	2.47e-01	5.56e-01
REGULATION OF I KAPPAB PHOSPHORYLATION	8	1.30e-01	5.74e-01	0.4710	1.62e-01	3.81e-01	3.37e-02	8.87e-02	2.05e-01	4.27e-01	6.22e-02	8.69e-01	6.64e-01	3.16e-01
POSITIVE REGULATION OF SARCOMERE ORGANIZATION	6	5.14e-01	9.01e-01	0.4710	-1.32e-01	1.73e-01	-1.72e-01	-1.74e-01	-3.39e-01	5.75e-01	4.63e-01	4.67e-01	4.62e-01	1.50e-01
DETECTION OF CALCIUM ION	13	2.32e-01	7.16e-01	0.4710	8.86e-02	-8.76e-02	1.80e-01	1.49e-01	3.90e-01	5.80e-01	5.85e-01	2.61e-01	3.52e-01	1.50e-02
REGULATION OF SARCOMERE ORGANIZATION	9	9.55e-02	4.93e-01	0.4710	-1.20e-01	2.53e-01	-1.39e-01	-1.51e-01	-3.18e-01	5.34e-01	1.89e-01	4.71e-01	4.32e-01	9.81e-02
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL	7	7.46e-01	9.75e-01	0.4710	-2.24e-01	-8.89e-02	-2.74e-01	-2.36e-01	-1.80e-01	3.04e-01	6.84e-01	2.09e-01	2.80e-01	4.09e-01
POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE	5	8.17e-01	9.83e-01	0.4710	-1.59e-01	-8.42e-02	-1.88e-01	-2.11e-01	-3.30e-01	5.38e-01	7.44e-01	4.65e-01	4.13e-01	2.01e-01
ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	8	6.68e-01	9.56e-01	0.4710	2.74e-01	3.11e-01	1.64e-01	1.52e-01	-8.42e-04	1.79e-01	1.28e-01	4.23e-01	4.57e-01	9.97e-01
MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION	62	2.10e-03	4.24e-02	0.4710	-2.25e-01	-4.46e-02	-2.88e-01	-2.70e-01	-1.14e-01	2.14e-03	5.44e-01	8.93e-05	2.37e-04	1.20e-01
POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION	15	3.47e-01	8.18e-01	0.4710	2.51e-01	4.35e-02	2.74e-01	2.52e-01	1.35e-01	9.23e-02	7.71e-01	6.62e-02	9.17e-02	3.66e-01
DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT	8	3.91e-01	8.41e-01	0.4700	-1.65e-01	-2.71e-02	-3.14e-01	-2.94e-01	9.10e-02	4.20e-01	8.94e-01	1.24e-01	1.50e-01	6.56e-01
CDP CHOLINE PATHWAY	6	3.00e-01	7.73e-01	0.4700	-1.04e-01	-2.56e-01	1.18e-02	-6.40e-02	3.75e-01	6.58e-01	2.78e-01	9.60e-01	7.86e-01	1.12e-01
REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	15	1.63e-01	6.27e-01	0.4700	1.13e-01	3.65e-02	1.51e-01	1.55e-01	4.00e-01	4.50e-01	8.06e-01	3.10e-01	2.97e-01	7.33e-03
TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY	11	3.71e-01	8.31e-01	0.4700	2.87e-01	4.12e-02	2.57e-01	2.66e-01	1.72e-02	9.99e-02	8.13e-01	1.40e-01	1.26e-01	9.21e-01
CRANIOFACIAL SUTURE MORPHOGENESIS	18	7.56e-02	4.42e-01	0.4700	2.56e-01	7.71e-02	2.49e-01	2.07e-01	2.10e-01	6.00e-02	5.71e-01	6.70e-02	1.29e-01	1.22e-01
NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	7	3.84e-02	3.00e-01	0.4700	-8.59e-02	2.10e-01	4.83e-02	3.54e-02	-4.07e-01	6.94e-01	3.36e-01	8.25e-01	8.71e-01	6.22e-02
RETINAL CELL PROGRAMMED CELL DEATH	6	5.29e-01	9.06e-01	0.4700	-1.49e-01	-2.51e-01	-2.74e-02	-1.79e-02	3.66e-01	5.27e-01	2.86e-01	9.08e-01	9.40e-01	1.20e-01
FLOOR PLATE DEVELOPMENT	11	1.01e-01	5.10e-01	0.4700	3.50e-01	1.42e-01	1.85e-01	1.69e-01	1.22e-01	4.43e-02	4.15e-01	2.88e-01	3.31e-01	4.84e-01
NEGATIVE REGULATION OF EPINEPHRINE SECRETION	5	4.61e-01	8.80e-01	0.4700	-1.26e-01	8.87e-02	-2.23e-01	-2.83e-01	-2.59e-01	6.26e-01	7.31e-01	3.88e-01	2.73e-01	3.17e-01
MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION	91	2.56e-04	8.61e-03	0.4690	-2.56e-01	-1.23e-01	-2.63e-01	-2.63e-01	-3.43e-02	2.45e-05	4.33e-02	1.39e-05	1.42e-05	5.71e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC	20	1.38e-02	1.57e-01	0.4690	2.52e-01	8.38e-02	2.61e-01	2.33e-01	-1.65e-01	5.13e-02	5.17e-01	4.33e-02	7.15e-02	2.03e-01
POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION	8	1.45e-01	6.03e-01	0.4690	2.84e-01	1.49e-01	1.16e-01	1.03e-01	-3.04e-01	1.64e-01	4.64e-01	5.68e-01	6.16e-01	1.36e-01
MITOCHONDRION MORPHOGENESIS	20	2.88e-01	7.66e-01	0.4690	2.80e-01	1.01e-01	2.39e-01	2.44e-01	1.22e-01	3.04e-02	4.34e-01	6.45e-02	5.90e-02	3.46e-01
MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL	6	1.87e-01	6.58e-01	0.4680	7.99e-02	2.08e-01	-1.93e-01	-2.35e-01	-2.77e-01	7.35e-01	3.78e-01	4.12e-01	3.18e-01	2.39e-01
POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	14	4.85e-01	8.91e-01	0.4680	-2.13e-01	-1.94e-01	-2.27e-01	-2.57e-01	-1.37e-01	1.68e-01	2.08e-01	1.41e-01	9.65e-02	3.75e-01
CYSTEINE METABOLIC PROCESS	11	2.33e-01	7.16e-01	0.4680	-2.18e-01	-6.89e-02	-1.92e-01	-1.57e-01	-3.25e-01	2.12e-01	6.92e-01	2.71e-01	3.68e-01	6.17e-02
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	29	3.02e-02	2.61e-01	0.4680	8.90e-02	-1.51e-01	2.39e-01	2.23e-01	2.86e-01	4.07e-01	1.59e-01	2.58e-02	3.76e-02	7.76e-03
REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH	12	2.22e-01	7.03e-01	0.4680	5.67e-03	-2.43e-01	1.75e-01	1.35e-01	3.34e-01	9.73e-01	1.45e-01	2.95e-01	4.18e-01	4.54e-02
MITOCHONDRIAL DNA METABOLIC PROCESS	23	1.74e-01	6.46e-01	0.4680	2.50e-01	9.39e-02	2.70e-01	2.73e-01	-1.83e-02	3.79e-02	4.35e-01	2.51e-02	2.33e-02	8.79e-01
PUTRESCINE BIOSYNTHETIC PROCESS	5	9.21e-01	9.95e-01	0.4680	2.06e-01	1.68e-01	2.61e-01	2.40e-01	1.51e-01	4.26e-01	5.16e-01	3.13e-01	3.52e-01	5.59e-01
REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION	9	2.02e-01	6.82e-01	0.4680	9.15e-02	-2.13e-01	1.44e-01	1.16e-01	3.62e-01	6.35e-01	2.68e-01	4.54e-01	5.45e-01	6.03e-02
MITOCHONDRIAL RNA METABOLIC PROCESS	51	1.53e-03	3.39e-02	0.4680	2.31e-01	6.22e-02	2.91e-01	2.77e-01	-5.98e-03	4.31e-03	4.42e-01	3.21e-04	6.18e-04	9.41e-01
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	12	5.14e-01	9.01e-01	0.4670	-1.20e-01	2.39e-02	-2.76e-01	-2.46e-01	-2.59e-01	4.71e-01	8.86e-01	9.84e-02	1.40e-01	1.21e-01
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	5	7.82e-01	9.81e-01	0.4670	9.28e-02	-7.82e-02	2.52e-01	2.03e-01	3.15e-01	7.19e-01	7.62e-01	3.30e-01	4.31e-01	2.23e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	6	5.66e-01	9.23e-01	0.4670	1.96e-01	3.72e-02	1.89e-01	1.51e-01	3.46e-01	4.05e-01	8.75e-01	4.22e-01	5.22e-01	1.42e-01
L SERINE BIOSYNTHETIC PROCESS	5	5.72e-01	9.26e-01	0.4670	2.81e-02	-2.78e-01	2.02e-01	1.45e-01	2.79e-01	9.13e-01	2.81e-01	4.35e-01	5.73e-01	2.80e-01
TRNA WOBBLE BASE MODIFICATION	20	1.05e-01	5.18e-01	0.4670	1.46e-01	-4.41e-02	3.09e-01	3.05e-01	7.64e-02	2.58e-01	7.33e-01	1.67e-02	1.81e-02	5.54e-01
RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE	9	7.06e-01	9.65e-01	0.4670	2.79e-01	2.59e-01	1.58e-01	1.77e-01	1.28e-01	1.47e-01	1.78e-01	4.12e-01	3.58e-01	5.04e-01
BASOLATERAL PROTEIN SECRETION	5	4.82e-01	8.91e-01	0.4670	2.04e-01	2.61e-02	1.97e-01	1.39e-01	3.43e-01	4.29e-01	9.20e-01	4.46e-01	5.92e-01	1.85e-01
REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME	12	9.48e-02	4.92e-01	0.4660	-2.94e-01	-3.35e-01	-4.97e-02	-1.25e-01	-2.38e-02	7.76e-02	4.43e-02	7.66e-01	4.55e-01	8.87e-01
REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT	7	3.89e-01	8.40e-01	0.4660	1.65e-01	2.45e-01	8.14e-02	9.98e-02	3.36e-01	4.50e-01	2.61e-01	7.09e-01	6.48e-01	1.23e-01
MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	43	3.19e-03	5.79e-02	0.4660	2.42e-01	-1.26e-02	2.59e-01	2.69e-01	1.37e-01	5.98e-03	8.86e-01	3.30e-03	2.30e-03	1.20e-01
COMMON MYELOID PROGENITOR CELL PROLIFERATION	9	2.26e-01	7.08e-01	0.4650	8.00e-02	-2.38e-01	2.83e-01	2.61e-01	7.35e-02	6.78e-01	2.17e-01	1.41e-01	1.76e-01	7.03e-01
TRIGEMINAL NERVE DEVELOPMENT	10	2.60e-01	7.43e-01	0.4650	3.06e-01	1.46e-01	1.98e-01	1.71e-01	1.82e-01	9.42e-02	4.24e-01	2.77e-01	3.50e-01	3.19e-01
MEIOTIC TELOMERE CLUSTERING	10	8.62e-02	4.67e-01	0.4650	-1.71e-01	1.56e-01	-2.26e-01	-2.77e-01	-1.87e-01	3.48e-01	3.93e-01	2.15e-01	1.30e-01	3.06e-01
GROWTH HORMONE SECRETION	13	4.45e-01	8.73e-01	0.4650	2.14e-01	1.46e-01	1.78e-01	1.90e-01	2.86e-01	1.82e-01	3.63e-01	2.66e-01	2.36e-01	7.46e-02
THYROID HORMONE METABOLIC PROCESS	28	4.86e-02	3.44e-01	0.4650	-2.33e-01	-2.78e-01	-1.42e-01	-1.63e-01	1.95e-01	3.25e-02	1.09e-02	1.94e-01	1.35e-01	7.46e-02
TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION	8	3.14e-01	7.86e-01	0.4650	1.91e-01	4.37e-03	2.68e-01	2.75e-01	-1.80e-01	3.50e-01	9.83e-01	1.89e-01	1.78e-01	3.79e-01
REGULATION OF GLUCAGON SECRETION	8	7.01e-02	4.24e-01	0.4650	2.36e-01	2.78e-01	-1.05e-01	-1.20e-01	-2.40e-01	2.47e-01	1.73e-01	6.09e-01	5.57e-01	2.40e-01
CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS	11	2.37e-01	7.20e-01	0.4650	1.57e-01	2.48e-01	2.87e-02	6.84e-02	-3.52e-01	3.67e-01	1.54e-01	8.69e-01	6.94e-01	4.30e-02
ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION	6	8.65e-01	9.88e-01	0.4650	2.48e-01	1.31e-01	2.28e-01	2.63e-01	1.24e-01	2.92e-01	5.79e-01	3.33e-01	2.64e-01	5.98e-01
SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION	12	4.81e-02	3.42e-01	0.4640	5.03e-02	-2.75e-01	2.38e-01	1.69e-01	2.29e-01	7.63e-01	9.94e-02	1.53e-01	3.12e-01	1.70e-01
REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION	15	3.68e-01	8.30e-01	0.4640	1.53e-01	-3.43e-02	3.03e-01	2.85e-01	1.35e-01	3.04e-01	8.18e-01	4.25e-02	5.61e-02	3.67e-01
PROTEIN INSERTION INTO MEMBRANE	73	4.65e-04	1.38e-02	0.4640	2.08e-01	1.68e-02	2.81e-01	2.86e-01	1.06e-01	2.12e-03	8.04e-01	3.38e-05	2.39e-05	1.18e-01
NEGATIVE REGULATION OF CHEMOKINE PRODUCTION	29	4.80e-03	7.91e-02	0.4640	-1.89e-01	-1.43e-01	-3.04e-01	-2.58e-01	5.39e-04	7.83e-02	1.83e-01	4.65e-03	1.61e-02	9.96e-01
MODULATION BY HOST OF VIRAL GENOME REPLICATION	23	2.62e-02	2.42e-01	0.4630	1.97e-01	-5.71e-02	2.51e-01	2.12e-01	2.54e-01	1.02e-01	6.36e-01	3.70e-02	7.89e-02	3.47e-02
REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION	7	9.98e-02	5.06e-01	0.4630	-2.42e-01	6.44e-02	-3.12e-01	-2.31e-01	-3.52e-02	2.67e-01	7.68e-01	1.53e-01	2.90e-01	8.72e-01
REGULATION OF GLUTAMATE RECEPTOR CLUSTERING	6	7.63e-01	9.75e-01	0.4630	-2.29e-01	-1.51e-01	-2.09e-01	-2.58e-01	-1.70e-01	3.31e-01	5.22e-01	3.74e-01	2.74e-01	4.71e-01
POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	8	6.05e-01	9.34e-01	0.4630	-2.29e-01	-3.41e-01	-7.49e-02	-1.17e-01	1.62e-01	2.61e-01	9.48e-02	7.14e-01	5.65e-01	4.28e-01
CELLULAR RESPONSE TO ESTROGEN STIMULUS	18	1.42e-01	6.00e-01	0.4630	-2.37e-01	-3.71e-01	-9.20e-02	-9.43e-02	6.22e-02	8.22e-02	6.49e-03	4.99e-01	4.88e-01	6.48e-01
ER TO GOLGI CERAMIDE TRANSPORT	5	9.24e-01	9.95e-01	0.4630	2.21e-01	4.48e-02	2.49e-01	2.38e-01	2.13e-01	3.92e-01	8.62e-01	3.36e-01	3.57e-01	4.11e-01
NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	18	7.79e-02	4.50e-01	0.4630	1.20e-01	1.22e-01	1.86e-01	1.57e-01	3.54e-01	3.77e-01	3.70e-01	1.72e-01	2.48e-01	9.22e-03
POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	9	6.92e-01	9.61e-01	0.4630	1.40e-01	-3.80e-02	2.24e-01	2.19e-01	3.08e-01	4.67e-01	8.43e-01	2.45e-01	2.54e-01	1.10e-01
L PROLINE BIOSYNTHETIC PROCESS	6	1.76e-01	6.47e-01	0.4630	-8.59e-02	-4.27e-01	5.42e-02	5.72e-02	-1.36e-01	7.15e-01	7.03e-02	8.18e-01	8.08e-01	5.65e-01
CHRONIC INFLAMMATORY RESPONSE	18	6.81e-04	1.81e-02	0.4620	-1.24e-01	-1.99e-01	-5.46e-02	-1.63e-03	3.95e-01	3.61e-01	1.44e-01	6.88e-01	9.90e-01	3.74e-03
NEGATIVE REGULATION OF CELL MATRIX ADHESION	37	1.65e-01	6.31e-01	0.4620	-2.50e-01	-1.71e-01	-2.32e-01	-2.48e-01	-8.32e-02	8.52e-03	7.26e-02	1.47e-02	9.04e-03	3.81e-01
EPITHELIAL FLUID TRANSPORT	11	3.77e-01	8.36e-01	0.4620	2.82e-01	3.09e-01	1.03e-01	1.52e-01	6.97e-02	1.06e-01	7.55e-02	5.55e-01	3.83e-01	6.89e-01
ENDODERMAL CELL FATE SPECIFICATION	8	2.14e-01	6.94e-01	0.4620	-1.88e-01	-3.65e-01	-1.10e-01	-1.81e-01	1.09e-02	3.58e-01	7.38e-02	5.89e-01	3.75e-01	9.58e-01
MYCOTOXIN METABOLIC PROCESS	6	8.02e-01	9.82e-01	0.4620	1.16e-01	2.44e-03	2.95e-01	2.63e-01	2.09e-01	6.22e-01	9.92e-01	2.11e-01	2.64e-01	3.75e-01
SMOOTH MUSCLE CELL CHEMOTAXIS	9	1.71e-01	6.41e-01	0.4620	-2.75e-01	-1.79e-01	-2.55e-01	-1.94e-01	5.57e-02	1.53e-01	3.52e-01	1.86e-01	3.14e-01	7.72e-01
ESTROGEN METABOLIC PROCESS	39	1.03e-01	5.13e-01	0.4620	-2.67e-01	-1.65e-01	-2.29e-01	-2.27e-01	-1.04e-01	3.89e-03	7.45e-02	1.31e-02	1.43e-02	2.63e-01
ALDITOL BIOSYNTHETIC PROCESS	5	7.59e-01	9.75e-01	0.4620	3.32e-01	2.10e-01	1.72e-01	1.69e-01	-5.55e-03	1.98e-01	4.16e-01	5.04e-01	5.12e-01	9.83e-01
N TERMINAL PROTEIN AMINO ACID ACETYLATION	15	2.95e-01	7.71e-01	0.4610	2.64e-01	1.74e-01	2.03e-01	2.20e-01	-1.52e-01	7.64e-02	2.44e-01	1.74e-01	1.39e-01	3.07e-01
MEIOTIC CELL CYCLE PHASE TRANSITION	13	5.45e-01	9.15e-01	0.4610	2.48e-01	2.44e-01	2.03e-01	2.04e-01	-9.25e-02	1.21e-01	1.27e-01	2.04e-01	2.03e-01	5.64e-01
POSITIVE REGULATION OF SYNAPTIC PLASTICITY	10	7.44e-01	9.74e-01	0.4610	1.97e-01	5.11e-02	2.48e-01	2.31e-01	2.38e-01	2.81e-01	7.80e-01	1.75e-01	2.06e-01	1.93e-01
FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS	7	5.44e-01	9.15e-01	0.4610	1.39e-01	-1.84e-02	3.28e-01	2.88e-01	4.62e-02	5.25e-01	9.33e-01	1.33e-01	1.87e-01	8.32e-01
MITOCHONDRIAL DNA REPLICATION	14	1.77e-01	6.47e-01	0.4610	2.30e-01	7.25e-02	2.56e-01	2.56e-01	-1.53e-01	1.37e-01	6.38e-01	9.71e-02	9.70e-02	3.23e-01
NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	8	4.56e-01	8.78e-01	0.4610	2.88e-02	-1.67e-01	1.21e-01	1.26e-01	3.92e-01	8.88e-01	4.15e-01	5.53e-01	5.38e-01	5.51e-02
OOCYTE CONSTRUCTION	8	6.70e-01	9.56e-01	0.4610	-2.49e-01	-7.40e-03	-2.45e-01	-2.58e-01	-1.52e-01	2.22e-01	9.71e-01	2.30e-01	2.06e-01	4.56e-01
PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	6	7.53e-01	9.75e-01	0.4600	2.63e-01	3.05e-01	1.11e-01	1.29e-01	1.44e-01	2.64e-01	1.96e-01	6.37e-01	5.85e-01	5.41e-01
TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	29	1.15e-02	1.40e-01	0.4600	2.11e-01	-8.57e-02	2.52e-01	2.42e-01	1.93e-01	4.91e-02	4.24e-01	1.88e-02	2.38e-02	7.18e-02
DEPYRIMIDINATION	8	4.21e-01	8.60e-01	0.4600	1.89e-01	-8.69e-02	2.91e-01	2.89e-01	-8.44e-03	3.55e-01	6.70e-01	1.54e-01	1.57e-01	9.67e-01
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS	7	7.95e-01	9.81e-01	0.4600	2.02e-01	1.57e-01	2.80e-01	2.58e-01	3.21e-02	3.54e-01	4.72e-01	2.00e-01	2.37e-01	8.83e-01
CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION	6	7.75e-01	9.77e-01	0.4600	-1.64e-01	1.02e-01	-2.66e-01	-2.47e-01	-2.06e-01	4.87e-01	6.66e-01	2.60e-01	2.94e-01	3.83e-01
REGULATION OF EOSINOPHIL MIGRATION	6	8.12e-01	9.82e-01	0.4590	-2.20e-01	-2.70e-01	-1.80e-01	-1.89e-01	1.46e-01	3.52e-01	2.51e-01	4.44e-01	4.22e-01	5.35e-01
REACTIVE GLIOSIS	6	7.29e-01	9.71e-01	0.4590	2.92e-01	2.19e-01	1.64e-01	2.19e-01	-4.98e-02	2.15e-01	3.52e-01	4.86e-01	3.53e-01	8.33e-01
NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION	5	2.12e-01	6.91e-01	0.4590	-1.38e-01	-2.49e-01	-6.92e-02	-1.55e-01	-3.18e-01	5.93e-01	3.35e-01	7.89e-01	5.49e-01	2.18e-01
FATTY ACID TRANSMEMBRANE TRANSPORT	19	3.04e-01	7.76e-01	0.4590	-2.13e-01	-8.53e-02	-2.13e-01	-2.36e-01	-2.39e-01	1.08e-01	5.20e-01	1.09e-01	7.47e-02	7.10e-02
MRNA PSEUDOURIDINE SYNTHESIS	8	4.28e-01	8.65e-01	0.4590	1.93e-01	1.19e-01	2.29e-01	2.50e-01	-2.11e-01	3.45e-01	5.60e-01	2.62e-01	2.21e-01	3.02e-01
DETECTION OF MUSCLE STRETCH	7	6.64e-01	9.54e-01	0.4590	-2.38e-01	-5.55e-03	-2.16e-01	-2.09e-01	-2.51e-01	2.75e-01	9.80e-01	3.23e-01	3.38e-01	2.50e-01
D AMINO ACID TRANSPORT	6	4.11e-01	8.53e-01	0.4580	1.79e-01	2.42e-01	6.76e-02	1.14e-01	3.19e-01	4.47e-01	3.05e-01	7.74e-01	6.28e-01	1.76e-01
NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION	7	2.20e-01	7.00e-01	0.4580	-9.71e-02	-2.65e-01	-2.62e-01	-2.38e-01	-7.05e-02	6.56e-01	2.24e-01	2.31e-01	2.76e-01	7.47e-01
CELLULAR RESPONSE TO AMMONIUM ION	5	4.97e-01	8.96e-01	0.4580	-1.71e-01	-2.90e-01	1.83e-01	1.44e-01	2.05e-01	5.08e-01	2.61e-01	4.78e-01	5.76e-01	4.28e-01
COMPLEMENT ACTIVATION LECTIN PATHWAY	11	1.17e-02	1.41e-01	0.4580	-1.58e-01	1.76e-01	-3.12e-01	-2.25e-01	-7.78e-02	3.64e-01	3.12e-01	7.34e-02	1.97e-01	6.55e-01
NEUTROPHIL EXTRAVASATION	11	2.44e-01	7.29e-01	0.4580	-2.11e-01	-1.91e-01	-1.66e-01	-1.56e-01	2.77e-01	2.26e-01	2.74e-01	3.39e-01	3.71e-01	1.11e-01
POSITIVE REGULATION OF GLIAL CELL MIGRATION	11	2.99e-02	2.60e-01	0.4580	1.09e-01	2.60e-02	8.87e-02	1.55e-01	4.06e-01	5.33e-01	8.81e-01	6.10e-01	3.72e-01	1.97e-02
CRD MEDIATED MRNA STABILIZATION	11	4.45e-01	8.73e-01	0.4580	9.60e-02	-9.11e-02	1.81e-01	1.72e-01	3.60e-01	5.82e-01	6.01e-01	2.98e-01	3.24e-01	3.87e-02
POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	11	2.76e-01	7.56e-01	0.4570	1.80e-01	-9.33e-02	2.72e-01	2.27e-01	2.07e-01	3.02e-01	5.92e-01	1.18e-01	1.92e-01	2.35e-01
MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE	7	3.46e-01	8.17e-01	0.4570	1.15e-01	2.47e-01	-9.40e-02	-2.03e-02	-3.54e-01	5.97e-01	2.57e-01	6.67e-01	9.26e-01	1.05e-01
VITAMIN K METABOLIC PROCESS	10	4.38e-01	8.69e-01	0.4570	2.99e-01	8.38e-02	2.33e-01	2.20e-01	9.75e-02	1.01e-01	6.46e-01	2.01e-01	2.27e-01	5.93e-01
RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION	6	4.97e-01	8.96e-01	0.4570	-2.68e-01	-5.00e-02	-2.25e-01	-2.87e-01	-4.56e-02	2.56e-01	8.32e-01	3.40e-01	2.24e-01	8.47e-01
NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	5	5.31e-01	9.07e-01	0.4570	2.08e-01	1.97e-01	1.98e-01	2.76e-01	1.05e-01	4.20e-01	4.44e-01	4.43e-01	2.86e-01	6.84e-01
POSITIVE REGULATION OF PYROPTOSIS	5	1.48e-01	6.08e-01	0.4570	-3.56e-01	-2.19e-01	-2.98e-02	-8.98e-03	1.81e-01	1.68e-01	3.96e-01	9.08e-01	9.72e-01	4.83e-01
CRISTAE FORMATION	15	8.12e-02	4.56e-01	0.4570	-1.44e-02	-2.27e-01	2.56e-01	2.04e-01	2.22e-01	9.23e-01	1.27e-01	8.56e-02	1.71e-01	1.36e-01
RESPONSE TO SALT STRESS	24	3.08e-01	7.82e-01	0.4570	2.09e-01	1.70e-01	2.19e-01	2.36e-01	1.80e-01	7.67e-02	1.49e-01	6.34e-02	4.56e-02	1.27e-01
FATTY ACID OMEGA OXIDATION	5	2.91e-01	7.67e-01	0.4560	4.66e-02	6.80e-02	1.56e-01	1.22e-01	-4.03e-01	8.57e-01	7.92e-01	5.46e-01	6.37e-01	1.19e-01
REGULATION OF MYOBLAST PROLIFERATION	25	2.53e-01	7.37e-01	0.4560	-2.25e-01	-8.01e-02	-2.43e-01	-2.64e-01	-1.50e-01	5.15e-02	4.88e-01	3.56e-02	2.23e-02	1.94e-01
MITOTIC NUCLEAR MEMBRANE DISASSEMBLY	7	7.97e-01	9.81e-01	0.4560	-2.59e-01	-3.15e-01	-1.14e-01	-1.44e-01	8.62e-02	2.36e-01	1.48e-01	6.00e-01	5.09e-01	6.93e-01
NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION	5	6.83e-01	9.61e-01	0.4560	-2.97e-01	-2.47e-01	-1.56e-01	-1.30e-01	-1.31e-01	2.50e-01	3.38e-01	5.45e-01	6.15e-01	6.13e-01
REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	9	4.42e-01	8.72e-01	0.4550	-1.19e-01	-2.72e-01	3.78e-02	1.16e-02	3.43e-01	5.36e-01	1.58e-01	8.44e-01	9.52e-01	7.48e-02
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	11	1.16e-01	5.45e-01	0.4550	2.25e-01	-4.16e-02	2.52e-01	2.65e-01	-1.44e-01	1.97e-01	8.11e-01	1.48e-01	1.29e-01	4.07e-01
REGULATION OF COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY	5	2.19e-01	7.00e-01	0.4540	-2.41e-01	-3.17e-01	1.79e-01	1.26e-01	2.07e-02	3.51e-01	2.20e-01	4.89e-01	6.26e-01	9.36e-01
GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS	8	1.31e-01	5.76e-01	0.4540	-5.83e-02	-1.72e-01	1.95e-01	1.01e-01	3.54e-01	7.75e-01	4.00e-01	3.40e-01	6.21e-01	8.30e-02
AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING	11	1.93e-01	6.67e-01	0.4540	2.21e-01	3.96e-01	-1.93e-02	-1.68e-03	-7.46e-03	2.04e-01	2.29e-02	9.12e-01	9.92e-01	9.66e-01
DEFENSE RESPONSE TO FUNGUS	52	5.90e-04	1.62e-02	0.4540	-1.46e-01	-1.20e-01	-2.92e-01	-2.66e-01	-1.18e-01	6.76e-02	1.34e-01	2.66e-04	8.95e-04	1.39e-01
SIGNAL COMPLEX ASSEMBLY	8	5.96e-01	9.33e-01	0.4540	-2.19e-01	6.33e-03	-2.47e-01	-2.81e-01	-1.34e-01	2.83e-01	9.75e-01	2.26e-01	1.69e-01	5.10e-01
NEGATIVE REGULATION OF SYNAPSE ORGANIZATION	11	2.36e-01	7.19e-01	0.4540	-1.67e-01	-2.75e-01	-2.07e-01	-2.43e-01	2.52e-02	3.37e-01	1.14e-01	2.35e-01	1.63e-01	8.85e-01
DNA REPLICATION SYNTHESIS OF RNA PRIMER	6	7.05e-01	9.65e-01	0.4540	2.39e-01	2.26e-01	2.40e-01	1.98e-01	3.21e-02	3.12e-01	3.37e-01	3.08e-01	4.01e-01	8.92e-01
VOLUNTARY MUSCULOSKELETAL MOVEMENT	7	6.94e-01	9.61e-01	0.4540	-1.68e-01	-2.43e-01	-2.24e-01	-2.10e-01	-1.57e-01	4.41e-01	2.66e-01	3.05e-01	3.37e-01	4.73e-01
REGULATION OF SPINDLE ASSEMBLY	32	2.39e-03	4.73e-02	0.4540	1.97e-01	-1.23e-01	2.64e-01	2.57e-01	1.27e-01	5.44e-02	2.28e-01	9.76e-03	1.18e-02	2.13e-01
CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	19	2.14e-02	2.12e-01	0.4540	-1.21e-01	-2.72e-01	-5.74e-02	-4.50e-02	3.34e-01	3.60e-01	4.02e-02	6.65e-01	7.34e-01	1.16e-02
INTESTINAL EPITHELIAL CELL DEVELOPMENT	17	4.34e-01	8.69e-01	0.4530	-2.20e-01	-9.19e-02	-2.50e-01	-2.76e-01	-1.00e-01	1.16e-01	5.12e-01	7.47e-02	4.89e-02	4.73e-01
REGULATION OF OVARIAN FOLLICLE DEVELOPMENT	6	6.58e-01	9.54e-01	0.4530	4.05e-02	1.58e-01	-1.23e-01	-8.91e-02	-3.95e-01	8.64e-01	5.02e-01	6.03e-01	7.05e-01	9.41e-02
NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	10	3.99e-01	8.45e-01	0.4530	-2.57e-01	-2.83e-01	-1.36e-01	-2.00e-01	1.96e-02	1.59e-01	1.21e-01	4.55e-01	2.73e-01	9.15e-01
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	6	1.44e-01	6.01e-01	0.4530	-1.56e-01	1.84e-01	-2.57e-01	-1.67e-01	-2.31e-01	5.08e-01	4.36e-01	2.75e-01	4.79e-01	3.28e-01
RHOMBOMERE DEVELOPMENT	8	2.17e-01	6.99e-01	0.4530	-1.19e-01	-4.11e-01	-4.97e-02	-8.59e-02	1.11e-01	5.62e-01	4.42e-02	8.07e-01	6.74e-01	5.88e-01
NETRIN ACTIVATED SIGNALING PATHWAY	9	2.78e-01	7.58e-01	0.4520	-2.05e-01	-1.31e-01	-1.29e-01	-1.37e-01	3.32e-01	2.88e-01	4.97e-01	5.01e-01	4.76e-01	8.48e-02
ERBB2 ERBB4 SIGNALING PATHWAY	5	6.60e-01	9.54e-01	0.4520	-1.55e-01	-4.12e-01	1.61e-02	-1.37e-02	1.00e-01	5.49e-01	1.11e-01	9.50e-01	9.58e-01	6.97e-01
RESPONSE TO AMMONIUM ION	6	4.91e-01	8.94e-01	0.4520	-2.59e-01	-3.64e-01	3.26e-02	1.66e-02	5.69e-02	2.72e-01	1.22e-01	8.90e-01	9.44e-01	8.09e-01
NEURAL FOLD FORMATION	7	8.16e-01	9.83e-01	0.4520	-2.38e-01	-2.63e-01	-1.97e-01	-1.89e-01	5.98e-02	2.75e-01	2.28e-01	3.66e-01	3.88e-01	7.84e-01
CHAPERONE MEDIATED PROTEIN FOLDING	74	2.59e-08	2.50e-06	0.4520	1.93e-01	-6.42e-02	2.81e-01	2.88e-01	-2.51e-02	4.01e-03	3.39e-01	2.92e-05	1.83e-05	7.09e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	5.56e-01	9.18e-01	0.4510	2.72e-01	8.19e-02	2.30e-01	2.30e-01	1.33e-01	1.03e-01	6.23e-01	1.68e-01	1.68e-01	4.25e-01
DNA PROTECTION	6	7.12e-01	9.67e-01	0.4510	2.93e-01	1.49e-01	1.69e-01	2.12e-01	1.49e-01	2.14e-01	5.28e-01	4.73e-01	3.68e-01	5.26e-01
POSITIVE REGULATION OF RNA SPLICING	37	3.31e-02	2.76e-01	0.4510	2.05e-01	2.78e-03	2.85e-01	2.70e-01	8.64e-02	3.11e-02	9.77e-01	2.74e-03	4.42e-03	3.63e-01
RIBOFLAVIN TRANSPORT	6	6.58e-01	9.54e-01	0.4510	-2.00e-01	-2.03e-01	-1.07e-01	-1.24e-01	3.09e-01	3.97e-01	3.90e-01	6.49e-01	5.98e-01	1.90e-01
SCHWANN CELL MIGRATION	5	6.18e-01	9.41e-01	0.4510	-1.67e-01	-3.36e-01	2.63e-02	-4.29e-02	2.45e-01	5.18e-01	1.93e-01	9.19e-01	8.68e-01	3.43e-01
REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE	5	6.01e-01	9.33e-01	0.4510	-1.56e-01	-3.55e-01	-1.29e-01	-1.71e-01	8.67e-02	5.47e-01	1.70e-01	6.18e-01	5.09e-01	7.37e-01
NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	5	1.87e-01	6.57e-01	0.4510	-2.58e-01	-2.74e-01	1.82e-01	1.27e-01	1.11e-01	3.17e-01	2.89e-01	4.81e-01	6.24e-01	6.69e-01
V D J RECOMBINATION	19	3.71e-02	2.93e-01	0.4500	2.19e-01	1.36e-01	2.88e-01	2.32e-01	1.27e-02	9.86e-02	3.06e-01	2.99e-02	8.04e-02	9.24e-01
REGULATION OF MICROTUBULE NUCLEATION	17	2.48e-01	7.33e-01	0.4500	2.32e-01	-1.75e-02	2.48e-01	2.43e-01	1.68e-01	9.74e-02	9.01e-01	7.66e-02	8.33e-02	2.31e-01
AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS	10	1.52e-01	6.13e-01	0.4500	1.21e-01	3.86e-01	4.33e-02	8.64e-02	-1.73e-01	5.06e-01	3.47e-02	8.12e-01	6.36e-01	3.42e-01
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	6	3.98e-01	8.45e-01	0.4500	2.24e-01	-5.70e-03	2.32e-01	2.24e-01	-2.21e-01	3.43e-01	9.81e-01	3.25e-01	3.41e-01	3.50e-01
TOXIN TRANSPORT	11	3.84e-01	8.39e-01	0.4500	-8.85e-02	1.71e-01	-2.15e-01	-2.20e-01	-2.65e-01	6.11e-01	3.25e-01	2.16e-01	2.07e-01	1.28e-01
NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS	24	8.85e-02	4.73e-01	0.4490	1.12e-01	8.04e-02	2.57e-01	2.32e-01	2.52e-01	3.44e-01	4.95e-01	2.92e-02	4.96e-02	3.28e-02
ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY	17	2.66e-01	7.47e-01	0.4490	-2.36e-01	-3.45e-01	-1.13e-01	-1.18e-01	2.66e-02	9.19e-02	1.39e-02	4.19e-01	4.00e-01	8.49e-01
GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION	5	2.47e-01	7.32e-01	0.4490	-6.66e-02	-3.97e-01	6.39e-03	-6.60e-02	1.88e-01	7.96e-01	1.24e-01	9.80e-01	7.98e-01	4.67e-01
PROLINE TRANSMEMBRANE TRANSPORT	9	5.69e-01	9.25e-01	0.4490	2.41e-01	2.12e-01	1.51e-01	1.77e-01	-2.11e-01	2.11e-01	2.71e-01	4.34e-01	3.57e-01	2.72e-01
NEGATIVE REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY	5	4.41e-01	8.71e-01	0.4490	-2.78e-01	-2.69e-01	-1.04e-01	-2.01e-01	2.83e-02	2.82e-01	2.97e-01	6.87e-01	4.37e-01	9.13e-01
REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	16	4.71e-01	8.85e-01	0.4490	2.70e-01	1.92e-01	1.95e-01	1.90e-01	1.34e-01	6.19e-02	1.83e-01	1.76e-01	1.89e-01	3.55e-01
SKELETAL MYOFIBRIL ASSEMBLY	10	3.07e-01	7.81e-01	0.4490	-1.09e-01	-1.15e-01	-3.02e-01	-2.78e-01	-8.89e-02	5.50e-01	5.30e-01	9.80e-02	1.28e-01	6.27e-01
T CELL EXTRAVASATION	10	3.39e-01	8.08e-01	0.4490	1.96e-01	2.78e-02	2.88e-01	2.65e-01	-9.55e-02	2.82e-01	8.79e-01	1.15e-01	1.47e-01	6.01e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	7	5.25e-01	9.05e-01	0.4490	-1.39e-02	-3.94e-02	1.58e-01	1.42e-01	3.93e-01	9.49e-01	8.57e-01	4.69e-01	5.14e-01	7.19e-02
SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING	8	7.53e-01	9.75e-01	0.4490	2.53e-01	1.45e-01	2.23e-01	2.57e-01	-2.09e-02	2.16e-01	4.76e-01	2.75e-01	2.08e-01	9.19e-01
PLASMA MEMBRANE TUBULATION	19	5.31e-01	9.07e-01	0.4490	-2.29e-01	-2.18e-01	-2.19e-01	-2.17e-01	-7.74e-02	8.35e-02	9.99e-02	9.84e-02	1.01e-01	5.59e-01
REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	17	4.47e-01	8.74e-01	0.4490	-2.35e-01	-3.92e-02	-2.53e-01	-2.48e-01	-1.37e-01	9.40e-02	7.80e-01	7.06e-02	7.61e-02	3.29e-01
AMACRINE CELL DIFFERENTIATION	12	8.65e-03	1.17e-01	0.4480	2.47e-01	-1.70e-01	2.05e-01	1.78e-01	1.94e-01	1.39e-01	3.07e-01	2.19e-01	2.85e-01	2.45e-01
GAMMA AMINOBUTYRIC ACID SECRETION	12	4.34e-01	8.69e-01	0.4480	-2.59e-01	-1.81e-01	-1.82e-01	-1.98e-01	1.70e-01	1.21e-01	2.78e-01	2.75e-01	2.34e-01	3.08e-01
IMMUNOLOGICAL MEMORY PROCESS	17	1.36e-01	5.85e-01	0.4480	1.80e-01	2.44e-01	1.97e-01	1.68e-01	2.05e-01	1.99e-01	8.18e-02	1.60e-01	2.31e-01	1.44e-01
MAINTENANCE OF SISTER CHROMATID COHESION	11	5.41e-01	9.14e-01	0.4480	-1.84e-01	-2.27e-01	-2.02e-01	-1.87e-01	-1.98e-01	2.92e-01	1.93e-01	2.46e-01	2.82e-01	2.55e-01
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	29	5.94e-02	3.88e-01	0.4480	-1.45e-01	3.55e-02	-2.89e-01	-2.88e-01	-1.08e-01	1.78e-01	7.41e-01	7.03e-03	7.25e-03	3.15e-01
TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS	15	2.04e-01	6.84e-01	0.4480	1.66e-01	-2.16e-02	2.98e-01	2.88e-01	-1.32e-02	2.66e-01	8.85e-01	4.54e-02	5.32e-02	9.29e-01
SKELETAL MUSCLE FIBER DIFFERENTIATION	8	6.76e-01	9.59e-01	0.4470	1.13e-01	-9.49e-02	1.98e-01	1.99e-01	3.15e-01	5.81e-01	6.42e-01	3.31e-01	3.30e-01	1.22e-01
NEGATIVE REGULATION OF ATP METABOLIC PROCESS	7	4.04e-01	8.49e-01	0.4470	-1.97e-01	1.01e-01	-2.79e-01	-2.66e-01	4.58e-02	3.67e-01	6.43e-01	2.01e-01	2.23e-01	8.34e-01
REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	8	8.09e-01	9.82e-01	0.4470	1.82e-01	1.04e-01	2.70e-01	2.79e-01	6.97e-02	3.74e-01	6.10e-01	1.85e-01	1.71e-01	7.33e-01
POSITIVE REGULATION OF MUSCLE ADAPTATION	13	2.90e-01	7.67e-01	0.4470	-1.02e-01	1.55e-01	-2.32e-01	-2.41e-01	-2.30e-01	5.26e-01	3.32e-01	1.47e-01	1.32e-01	1.51e-01
NEGATIVE REGULATION OF MUSCLE ADAPTATION	10	6.66e-01	9.55e-01	0.4470	-1.31e-01	5.39e-02	-2.40e-01	-2.17e-01	-2.73e-01	4.73e-01	7.68e-01	1.89e-01	2.35e-01	1.34e-01
RNA SECONDARY STRUCTURE UNWINDING	8	2.19e-01	7.00e-01	0.4470	-1.62e-01	-1.80e-02	-2.61e-01	-3.23e-01	-2.61e-02	4.29e-01	9.30e-01	2.01e-01	1.14e-01	8.98e-01
POSITIVE REGULATION OF AMINE METABOLIC PROCESS	6	8.91e-01	9.92e-01	0.4470	2.08e-01	1.16e-01	1.94e-01	2.04e-01	2.52e-01	3.77e-01	6.24e-01	4.11e-01	3.88e-01	2.84e-01
AMMONIUM TRANSMEMBRANE TRANSPORT	12	7.04e-01	9.65e-01	0.4470	-2.32e-01	-2.48e-01	-2.05e-01	-2.03e-01	-1.69e-02	1.63e-01	1.36e-01	2.18e-01	2.24e-01	9.19e-01
REGULATION OF SKELETAL MUSCLE CONTRACTION	15	6.22e-02	3.98e-01	0.4470	2.61e-01	2.34e-01	9.36e-02	1.53e-01	2.11e-01	8.06e-02	1.17e-01	5.30e-01	3.06e-01	1.56e-01
REGULATION OF CHAPERONE MEDIATED AUTOPHAGY	8	5.99e-01	9.33e-01	0.4460	1.02e-01	-4.10e-02	2.02e-01	2.25e-01	3.10e-01	6.18e-01	8.41e-01	3.24e-01	2.70e-01	1.29e-01
GOLGI DISASSEMBLY	6	5.57e-01	9.19e-01	0.4460	1.68e-03	-2.49e-01	7.86e-02	7.37e-02	3.55e-01	9.94e-01	2.92e-01	7.39e-01	7.55e-01	1.32e-01
DETOXIFICATION OF NITROGEN COMPOUND	5	3.46e-01	8.17e-01	0.4460	-1.32e-01	-3.08e-01	2.22e-01	1.39e-01	1.33e-01	6.08e-01	2.33e-01	3.89e-01	5.91e-01	6.05e-01
NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	8	3.61e-01	8.25e-01	0.4460	8.52e-02	3.13e-01	-1.94e-01	-1.72e-01	-1.64e-01	6.76e-01	1.26e-01	3.42e-01	4.01e-01	4.22e-01
POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	5	6.10e-01	9.36e-01	0.4460	-9.69e-03	-5.17e-03	1.68e-01	1.76e-01	3.74e-01	9.70e-01	9.84e-01	5.14e-01	4.96e-01	1.48e-01
PIRNA PROCESSING	24	7.81e-02	4.50e-01	0.4460	-1.02e-01	1.18e-01	-2.80e-01	-2.64e-01	-1.61e-01	3.86e-01	3.19e-01	1.74e-02	2.50e-02	1.72e-01
AEROBIC RESPIRATION	170	1.56e-11	2.50e-09	0.4460	2.31e-01	4.92e-02	2.67e-01	2.67e-01	-1.06e-02	1.95e-07	2.69e-01	1.79e-09	1.89e-09	8.12e-01
POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION	15	5.06e-01	8.99e-01	0.4460	-2.82e-01	-1.32e-01	-2.15e-01	-2.27e-01	-6.12e-02	5.86e-02	3.74e-01	1.49e-01	1.28e-01	6.81e-01
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION	13	4.76e-01	8.86e-01	0.4450	-2.81e-01	-1.33e-01	-2.20e-01	-2.06e-01	-1.04e-01	7.96e-02	4.08e-01	1.69e-01	1.98e-01	5.15e-01
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	20	1.13e-01	5.39e-01	0.4450	8.78e-02	-5.94e-02	2.99e-01	2.76e-01	1.46e-01	4.96e-01	6.45e-01	2.06e-02	3.24e-02	2.57e-01
MAMMARY GLAND ALVEOLUS DEVELOPMENT	19	7.42e-02	4.39e-01	0.4450	-1.22e-01	-3.02e-01	2.16e-03	-1.42e-02	3.03e-01	3.58e-01	2.26e-02	9.87e-01	9.15e-01	2.22e-02
POSITIVE REGULATION OF INTERFERON BETA PRODUCTION	37	5.26e-02	3.59e-01	0.4450	1.87e-01	-2.00e-02	2.45e-01	2.35e-01	2.17e-01	4.87e-02	8.33e-01	1.00e-02	1.33e-02	2.22e-02
SKELETAL MUSCLE ATROPHY	5	8.69e-01	9.88e-01	0.4450	2.19e-01	1.14e-01	2.45e-01	2.77e-01	-1.95e-02	3.97e-01	6.59e-01	3.44e-01	2.84e-01	9.40e-01
RADIAL GLIAL CELL DIFFERENTIATION	14	1.87e-01	6.57e-01	0.4440	2.11e-01	4.73e-02	2.96e-01	2.51e-01	1.20e-02	1.73e-01	7.59e-01	5.50e-02	1.04e-01	9.38e-01
DIACYLGLYCEROL CATABOLIC PROCESS	5	6.70e-01	9.57e-01	0.4440	-2.47e-01	-1.16e-01	-2.54e-01	-1.97e-01	-1.39e-01	3.39e-01	6.54e-01	3.24e-01	4.46e-01	5.89e-01
ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	21	2.54e-01	7.37e-01	0.4440	2.27e-01	8.91e-02	2.51e-01	2.74e-01	1.03e-02	7.18e-02	4.80e-01	4.65e-02	2.99e-02	9.35e-01
MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS	6	7.48e-01	9.75e-01	0.4440	1.74e-01	1.24e-01	2.85e-01	2.41e-01	1.11e-01	4.61e-01	5.98e-01	2.26e-01	3.07e-01	6.38e-01
NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	7	4.54e-01	8.78e-01	0.4440	-2.31e-02	-1.26e-01	3.38e-02	1.19e-02	4.24e-01	9.16e-01	5.63e-01	8.77e-01	9.57e-01	5.23e-02
GLUTATHIONE CATABOLIC PROCESS	7	4.27e-01	8.65e-01	0.4440	2.07e-01	3.16e-01	1.37e-02	8.81e-02	-2.16e-01	3.43e-01	1.48e-01	9.50e-01	6.87e-01	3.23e-01
SYNAPTIC VESICLE ENDOSOMAL PROCESSING	8	5.46e-01	9.15e-01	0.4440	-1.77e-01	-2.90e-01	-1.05e-01	-1.41e-01	2.24e-01	3.85e-01	1.55e-01	6.06e-01	4.91e-01	2.72e-01
REGULATION OF REMOVAL OF SUPEROXIDE RADICALS	9	1.70e-01	6.40e-01	0.4430	9.40e-02	2.66e-01	2.19e-01	2.01e-01	1.68e-01	6.25e-01	1.66e-01	2.55e-01	2.97e-01	3.83e-01
NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	10	8.63e-02	4.67e-01	0.4430	1.14e-01	4.13e-01	6.57e-02	6.44e-02	6.33e-02	5.32e-01	2.36e-02	7.19e-01	7.24e-01	7.29e-01
REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	9	5.63e-01	9.22e-01	0.4430	1.39e-01	8.81e-02	1.63e-01	1.82e-01	3.31e-01	4.70e-01	6.47e-01	3.98e-01	3.45e-01	8.52e-02
RESPONSE TO FOLIC ACID	10	1.01e-01	5.08e-01	0.4430	-9.07e-02	-3.53e-01	2.15e-02	5.50e-02	2.45e-01	6.19e-01	5.34e-02	9.06e-01	7.63e-01	1.79e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	11	2.79e-01	7.58e-01	0.4430	6.69e-02	-8.92e-02	2.74e-01	2.13e-01	2.52e-01	7.01e-01	6.08e-01	1.16e-01	2.21e-01	1.48e-01
TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	66	6.02e-05	2.59e-03	0.4430	2.08e-01	1.15e-01	2.54e-01	2.50e-01	-1.12e-01	3.53e-03	1.07e-01	3.50e-04	4.39e-04	1.15e-01
CHORIO ALLANTOIC FUSION	7	7.88e-01	9.81e-01	0.4430	1.96e-01	1.83e-01	2.41e-01	2.46e-01	-7.11e-02	3.68e-01	4.01e-01	2.69e-01	2.60e-01	7.45e-01
BEHAVIORAL RESPONSE TO NICOTINE	9	2.87e-01	7.66e-01	0.4430	1.81e-01	3.32e-01	1.44e-01	1.13e-01	-1.39e-01	3.47e-01	8.45e-02	4.53e-01	5.59e-01	4.71e-01
NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	5	6.76e-01	9.59e-01	0.4420	-1.16e-01	-2.00e-01	2.03e-03	-4.00e-02	3.75e-01	6.53e-01	4.39e-01	9.94e-01	8.77e-01	1.46e-01
PLASMA MEMBRANE TO ENDOSOME TRANSPORT	8	5.23e-01	9.04e-01	0.4420	-1.94e-01	-2.98e-01	-1.28e-01	-1.69e-01	-1.56e-01	3.43e-01	1.44e-01	5.30e-01	4.08e-01	4.44e-01
THYROID HORMONE GENERATION	22	6.57e-02	4.09e-01	0.4420	-1.82e-01	-2.51e-01	-9.74e-02	-1.13e-01	2.77e-01	1.39e-01	4.16e-02	4.29e-01	3.57e-01	2.44e-02
POLYAMINE BIOSYNTHETIC PROCESS	12	5.75e-01	9.26e-01	0.4410	1.46e-01	5.52e-02	2.88e-01	2.72e-01	1.15e-01	3.80e-01	7.40e-01	8.36e-02	1.03e-01	4.91e-01
SEQUESTERING OF ACTIN MONOMERS	6	3.47e-01	8.18e-01	0.4410	1.84e-01	-1.89e-01	2.04e-01	1.75e-01	2.31e-01	4.35e-01	4.24e-01	3.86e-01	4.59e-01	3.28e-01
NEGATIVE REGULATION OF MITOCHONDRIAL FUSION	7	4.07e-01	8.51e-01	0.4410	1.17e-02	-1.76e-01	3.48e-02	2.62e-02	4.02e-01	9.57e-01	4.19e-01	8.73e-01	9.05e-01	6.55e-02
PHENYLPROPANOID METABOLIC PROCESS	7	3.51e-04	1.08e-02	0.4410	-3.70e-01	1.79e-01	-1.17e-01	-1.08e-01	2.59e-02	9.05e-02	4.13e-01	5.92e-01	6.22e-01	9.05e-01
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	15	2.07e-01	6.84e-01	0.4410	1.80e-01	1.50e-01	1.64e-01	2.05e-01	2.65e-01	2.27e-01	3.14e-01	2.72e-01	1.69e-01	7.51e-02
NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	8	5.48e-01	9.15e-01	0.4410	-1.89e-01	-2.05e-01	-1.50e-01	-1.76e-01	2.51e-01	3.54e-01	3.15e-01	4.62e-01	3.89e-01	2.19e-01
PROTEIN FOLDING IN ENDOPLASMIC RETICULUM	12	8.71e-02	4.68e-01	0.4410	-1.04e-01	-4.11e-01	6.38e-03	4.71e-03	1.20e-01	5.32e-01	1.37e-02	9.69e-01	9.77e-01	4.72e-01
NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	15	3.66e-01	8.29e-01	0.4410	-1.45e-01	1.69e-02	-2.88e-01	-2.87e-01	-8.56e-02	3.32e-01	9.10e-01	5.32e-02	5.42e-02	5.66e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	7	5.03e-01	8.98e-01	0.4410	2.71e-01	3.35e-01	5.27e-02	5.21e-02	5.61e-02	2.14e-01	1.25e-01	8.09e-01	8.11e-01	7.97e-01
RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY	9	1.19e-01	5.50e-01	0.4400	1.67e-02	3.32e-01	-5.18e-02	-7.94e-02	-2.73e-01	9.31e-01	8.43e-02	7.88e-01	6.80e-01	1.57e-01
MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM	12	6.29e-01	9.46e-01	0.4400	1.95e-01	6.31e-02	2.10e-01	2.30e-01	2.34e-01	2.42e-01	7.05e-01	2.08e-01	1.67e-01	1.60e-01
NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION	5	3.98e-01	8.45e-01	0.4400	2.21e-02	-1.94e-01	3.08e-01	2.47e-01	-8.62e-04	9.32e-01	4.53e-01	2.33e-01	3.39e-01	9.97e-01
SPHINGOMYELIN BIOSYNTHETIC PROCESS	11	4.90e-01	8.93e-01	0.4400	-2.45e-01	-3.45e-01	-7.34e-02	-9.68e-02	-9.89e-03	1.59e-01	4.77e-02	6.74e-01	5.78e-01	9.55e-01
ACTOMYOSIN CONTRACTILE RING ORGANIZATION	10	3.60e-01	8.25e-01	0.4400	-8.38e-02	-7.02e-02	-2.90e-01	-2.72e-01	-1.54e-01	6.46e-01	7.00e-01	1.12e-01	1.37e-01	4.00e-01
NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY	12	3.26e-01	7.98e-01	0.4400	5.49e-02	-1.33e-01	1.68e-01	1.33e-01	3.56e-01	7.42e-01	4.24e-01	3.13e-01	4.24e-01	3.28e-02
PROTEIN DE ADP RIBOSYLATION	5	5.26e-01	9.05e-01	0.4400	8.24e-02	-5.93e-02	2.26e-01	2.79e-01	2.33e-01	7.50e-01	8.18e-01	3.82e-01	2.80e-01	3.67e-01
MDA 5 SIGNALING PATHWAY	11	3.75e-01	8.36e-01	0.4400	2.85e-01	2.81e-01	1.28e-01	1.15e-01	6.29e-02	1.02e-01	1.07e-01	4.61e-01	5.08e-01	7.18e-01
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY	14	2.14e-01	6.94e-01	0.4400	2.05e-01	2.58e-01	1.44e-01	1.93e-01	1.65e-01	1.85e-01	9.51e-02	3.52e-01	2.11e-01	2.86e-01
REGULATION OF MITOCHONDRIAL FUSION	11	4.34e-01	8.69e-01	0.4400	1.01e-01	3.18e-02	1.52e-01	1.42e-01	3.73e-01	5.63e-01	8.55e-01	3.84e-01	4.14e-01	3.24e-02
RESPONSE TO CGMP	8	8.37e-01	9.85e-01	0.4390	-2.14e-01	-5.20e-02	-2.69e-01	-2.55e-01	-8.28e-02	2.94e-01	7.99e-01	1.88e-01	2.11e-01	6.85e-01
NEGATIVE REGULATION OF TUBULIN DEACETYLATION	5	6.86e-01	9.61e-01	0.4390	-1.62e-01	-2.08e-01	-1.81e-02	-6.55e-02	3.45e-01	5.31e-01	4.21e-01	9.44e-01	8.00e-01	1.82e-01
PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	5	5.01e-01	8.98e-01	0.4390	-9.78e-02	-1.99e-01	6.29e-02	9.74e-02	3.61e-01	7.05e-01	4.41e-01	8.08e-01	7.06e-01	1.63e-01
MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS	33	1.14e-01	5.41e-01	0.4390	2.41e-01	2.83e-01	1.49e-01	1.73e-01	-4.86e-02	1.66e-02	4.89e-03	1.39e-01	8.56e-02	6.29e-01
URINARY BLADDER SMOOTH MUSCLE CONTRACTION	7	6.46e-01	9.50e-01	0.4390	1.77e-01	3.38e-01	-1.80e-04	9.17e-03	-2.15e-01	4.17e-01	1.21e-01	9.99e-01	9.66e-01	3.24e-01
GOLGI RIBBON FORMATION	10	3.66e-01	8.29e-01	0.4390	1.50e-01	-1.29e-01	2.16e-01	2.37e-01	2.24e-01	4.12e-01	4.78e-01	2.36e-01	1.94e-01	2.20e-01
NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY	5	6.89e-01	9.61e-01	0.4380	-4.22e-02	2.53e-01	-1.84e-01	-1.91e-01	-2.37e-01	8.70e-01	3.27e-01	4.77e-01	4.60e-01	3.59e-01
MESODERMAL CELL MIGRATION	5	6.41e-01	9.49e-01	0.4380	2.15e-01	9.31e-02	1.09e-01	1.45e-01	3.23e-01	4.06e-01	7.18e-01	6.74e-01	5.74e-01	2.11e-01
REGULATION OF GAP JUNCTION ASSEMBLY	9	2.84e-01	7.63e-01	0.4380	3.32e-01	1.30e-01	1.81e-01	1.75e-01	-3.91e-02	8.50e-02	4.98e-01	3.46e-01	3.63e-01	8.39e-01
REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION	10	5.13e-01	9.01e-01	0.4380	-2.45e-01	-2.86e-01	-6.04e-02	-9.99e-02	1.91e-01	1.80e-01	1.17e-01	7.41e-01	5.85e-01	2.97e-01
BILE ACID SIGNALING PATHWAY	11	5.22e-01	9.04e-01	0.4380	-1.73e-01	-2.47e-03	-2.68e-01	-2.26e-01	-1.97e-01	3.21e-01	9.89e-01	1.24e-01	1.94e-01	2.58e-01
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	65	7.24e-05	2.98e-03	0.4380	1.81e-01	5.64e-02	2.73e-01	2.81e-01	-4.49e-02	1.16e-02	4.31e-01	1.42e-04	8.78e-05	5.31e-01
REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	10	3.55e-01	8.22e-01	0.4370	1.45e-01	1.45e-01	2.12e-01	2.56e-01	1.97e-01	4.28e-01	4.26e-01	2.45e-01	1.62e-01	2.81e-01
REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY	9	3.92e-01	8.41e-01	0.4370	8.28e-04	-1.85e-02	1.90e-01	1.83e-01	3.48e-01	9.97e-01	9.23e-01	3.24e-01	3.42e-01	7.02e-02
SYNAPTONEMAL COMPLEX ORGANIZATION	25	8.13e-02	4.56e-01	0.4370	-2.56e-01	-5.43e-02	-2.37e-01	-2.58e-01	1.01e-04	2.69e-02	6.38e-01	4.00e-02	2.55e-02	9.99e-01
NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL	12	2.81e-02	2.51e-01	0.4370	-7.44e-02	-1.94e-01	-2.74e-01	-2.62e-01	6.39e-02	6.55e-01	2.44e-01	1.00e-01	1.17e-01	7.02e-01
MITOTIC DNA REPLICATION CHECKPOINT SIGNALING	10	4.75e-02	3.41e-01	0.4370	2.00e-01	9.39e-02	2.75e-01	2.02e-01	-1.61e-01	2.74e-01	6.07e-01	1.33e-01	2.68e-01	3.79e-01
REGULATION OF THYROID HORMONE GENERATION	7	6.22e-01	9.43e-01	0.4370	2.78e-02	-9.24e-02	1.20e-01	9.81e-02	3.97e-01	8.99e-01	6.72e-01	5.84e-01	6.53e-01	6.91e-02
PROSTHETIC GROUP METABOLIC PROCESS	6	5.88e-01	9.29e-01	0.4370	1.25e-01	-1.99e-01	2.53e-01	2.42e-01	1.14e-01	5.95e-01	3.99e-01	2.84e-01	3.04e-01	6.30e-01
PEPTIDYL SERINE DEPHOSPHORYLATION	14	1.76e-01	6.47e-01	0.4370	-1.10e-02	-1.54e-01	1.88e-01	1.35e-01	3.36e-01	9.43e-01	3.19e-01	2.23e-01	3.82e-01	2.93e-02
MAINTENANCE OF DNA REPEAT ELEMENTS	7	6.38e-01	9.49e-01	0.4370	2.05e-01	-8.09e-02	2.62e-01	2.49e-01	1.06e-01	3.47e-01	7.11e-01	2.30e-01	2.54e-01	6.26e-01
PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE	15	3.49e-01	8.18e-01	0.4360	-2.22e-01	-1.65e-01	-2.54e-01	-2.22e-01	-2.24e-03	1.36e-01	2.69e-01	8.83e-02	1.37e-01	9.88e-01
NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	10	8.00e-01	9.82e-01	0.4360	-2.18e-01	-1.50e-01	-2.48e-01	-2.30e-01	-7.82e-02	2.32e-01	4.13e-01	1.75e-01	2.09e-01	6.69e-01
NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION	6	6.25e-01	9.44e-01	0.4360	1.41e-02	-1.75e-01	8.21e-02	8.35e-02	3.82e-01	9.52e-01	4.59e-01	7.28e-01	7.23e-01	1.05e-01
OVULATION CYCLE PROCESS	50	1.29e-02	1.52e-01	0.4360	-1.72e-01	-1.43e-01	-2.13e-01	-2.33e-01	-2.01e-01	3.59e-02	8.11e-02	9.10e-03	4.31e-03	1.39e-02
MITOTIC SPINDLE ELONGATION	11	4.80e-01	8.91e-01	0.4360	-7.71e-02	4.83e-02	-1.74e-01	-1.83e-01	-3.44e-01	6.58e-01	7.82e-01	3.19e-01	2.94e-01	4.85e-02
OSMOSENSORY SIGNALING PATHWAY	5	5.55e-01	9.17e-01	0.4360	-1.71e-01	-2.98e-01	-2.07e-01	-1.60e-01	5.32e-02	5.08e-01	2.48e-01	4.22e-01	5.36e-01	8.37e-01
OTIC VESICLE MORPHOGENESIS	10	8.34e-01	9.85e-01	0.4350	-2.03e-01	-1.81e-01	-2.19e-01	-2.31e-01	-1.18e-01	2.66e-01	3.21e-01	2.30e-01	2.05e-01	5.18e-01
CELL ADHESION MOLECULE PRODUCTION	18	1.22e-01	5.56e-01	0.4350	-1.81e-01	-2.41e-01	-3.00e-02	-4.88e-02	3.09e-01	1.85e-01	7.70e-02	8.25e-01	7.20e-01	2.30e-02
CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION	12	3.53e-01	8.21e-01	0.4350	1.12e-01	-6.22e-02	3.00e-01	2.59e-01	1.29e-01	5.02e-01	7.09e-01	7.23e-02	1.21e-01	4.40e-01
NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	10	5.92e-01	9.32e-01	0.4350	-2.06e-01	2.96e-02	-2.47e-01	-2.28e-01	-1.81e-01	2.58e-01	8.71e-01	1.76e-01	2.12e-01	3.21e-01
PYRAMIDAL NEURON DEVELOPMENT	9	7.29e-01	9.71e-01	0.4350	-2.41e-01	-2.87e-01	-1.18e-01	-1.48e-01	1.13e-01	2.10e-01	1.36e-01	5.40e-01	4.41e-01	5.57e-01
MEIOTIC DNA DOUBLE STRAND BREAK FORMATION	6	2.50e-01	7.35e-01	0.4350	-1.66e-01	1.56e-01	-2.23e-01	-2.83e-01	-8.78e-02	4.80e-01	5.08e-01	3.45e-01	2.31e-01	7.09e-01
NK T CELL DIFFERENTIATION	11	6.36e-01	9.48e-01	0.4350	1.90e-01	2.34e-01	2.12e-01	2.29e-01	2.97e-02	2.75e-01	1.80e-01	2.23e-01	1.88e-01	8.65e-01
REGULATION OF FEAR RESPONSE	9	5.16e-02	3.57e-01	0.4350	-7.39e-02	6.58e-02	1.24e-01	6.99e-02	3.99e-01	7.01e-01	7.33e-01	5.20e-01	7.16e-01	3.82e-02
REGULATION OF VASCULAR WOUND HEALING	13	5.61e-04	1.56e-02	0.4350	1.85e-01	1.02e-01	2.05e-01	3.17e-01	-4.33e-02	2.48e-01	5.23e-01	2.01e-01	4.76e-02	7.87e-01
IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY	9	6.52e-02	4.07e-01	0.4350	1.86e-03	3.72e-01	-1.70e-01	-1.39e-01	4.80e-02	9.92e-01	5.33e-02	3.77e-01	4.69e-01	8.03e-01
EXOCRINE PANCREAS DEVELOPMENT	7	5.94e-01	9.33e-01	0.4350	3.07e-01	8.91e-02	2.07e-01	2.09e-01	3.32e-03	1.59e-01	6.83e-01	3.42e-01	3.38e-01	9.88e-01
FOREBRAIN NEURON DEVELOPMENT	23	8.62e-02	4.67e-01	0.4350	-2.01e-01	-1.97e-01	-1.92e-01	-2.21e-01	1.54e-01	9.49e-02	1.02e-01	1.11e-01	6.63e-02	2.00e-01
CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE	6	2.53e-02	2.37e-01	0.4340	1.15e-01	2.12e-01	-4.86e-02	6.57e-02	3.52e-01	6.25e-01	3.69e-01	8.37e-01	7.80e-01	1.35e-01
RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE	16	6.83e-01	9.61e-01	0.4340	2.16e-01	1.76e-01	2.26e-01	2.37e-01	6.13e-02	1.35e-01	2.23e-01	1.17e-01	1.01e-01	6.71e-01
POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION	9	8.72e-01	9.88e-01	0.4340	2.05e-01	7.51e-02	2.28e-01	2.29e-01	1.88e-01	2.87e-01	6.96e-01	2.36e-01	2.33e-01	3.28e-01
REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	10	1.02e-01	5.10e-01	0.4330	-7.45e-02	1.23e-01	-3.17e-01	-2.40e-01	-9.04e-02	6.83e-01	5.00e-01	8.21e-02	1.88e-01	6.21e-01
C TERMINAL PROTEIN AMINO ACID MODIFICATION	12	5.73e-01	9.26e-01	0.4330	-2.76e-01	-2.09e-01	-1.61e-01	-1.78e-01	1.00e-01	9.82e-02	2.10e-01	3.33e-01	2.85e-01	5.47e-01
NEUTROPHIL APOPTOTIC PROCESS	8	6.45e-01	9.50e-01	0.4330	-1.26e-01	-8.33e-02	-2.74e-01	-2.83e-01	-9.70e-02	5.38e-01	6.83e-01	1.79e-01	1.66e-01	6.35e-01
DORSAL AORTA DEVELOPMENT	10	4.52e-01	8.76e-01	0.4330	2.32e-01	2.46e-02	2.55e-01	2.51e-01	-6.97e-02	2.04e-01	8.93e-01	1.63e-01	1.69e-01	7.03e-01
POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	5	4.97e-01	8.96e-01	0.4330	-8.42e-02	-6.97e-02	-1.35e-01	-1.48e-01	3.67e-01	7.44e-01	7.87e-01	6.00e-01	5.66e-01	1.55e-01
LENS MORPHOGENESIS IN CAMERA TYPE EYE	21	3.56e-01	8.22e-01	0.4320	-2.08e-01	-2.30e-01	-2.09e-01	-2.15e-01	2.94e-02	9.89e-02	6.75e-02	9.77e-02	8.82e-02	8.15e-01
RESPONSE TO NEMATODE	7	6.40e-01	9.49e-01	0.4320	1.59e-01	-6.28e-02	2.27e-01	2.60e-01	1.96e-01	4.65e-01	7.74e-01	2.98e-01	2.34e-01	3.69e-01
MORPHOGENESIS OF AN ENDOTHELIUM	17	5.85e-01	9.28e-01	0.4320	2.46e-01	1.05e-01	2.25e-01	2.37e-01	9.18e-02	7.90e-02	4.54e-01	1.08e-01	9.10e-02	5.12e-01
MAINTENANCE OF ORGANELLE LOCATION	13	7.52e-01	9.75e-01	0.4320	-2.12e-01	-1.99e-01	-2.01e-01	-2.09e-01	-1.35e-01	1.85e-01	2.15e-01	2.10e-01	1.91e-01	4.01e-01
NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	7	8.59e-01	9.88e-01	0.4320	2.52e-01	2.01e-01	1.97e-01	1.96e-01	-7.53e-02	2.48e-01	3.58e-01	3.66e-01	3.70e-01	7.30e-01
RESPONSE TO GAMMA RADIATION	50	1.39e-02	1.58e-01	0.4320	1.98e-01	5.02e-02	2.50e-01	2.22e-01	1.83e-01	1.54e-02	5.39e-01	2.22e-03	6.73e-03	2.53e-02
SODIUM ION HOMEOSTASIS	46	1.51e-02	1.67e-01	0.4320	2.28e-01	3.09e-01	1.12e-01	1.33e-01	-9.49e-02	7.38e-03	2.92e-04	1.90e-01	1.17e-01	2.66e-01
GLOMERULAR MESANGIAL CELL DEVELOPMENT	5	6.52e-01	9.52e-01	0.4320	2.63e-01	-4.74e-02	2.31e-01	2.20e-01	1.17e-01	3.09e-01	8.54e-01	3.72e-01	3.94e-01	6.52e-01
TELOMERASE RNA LOCALIZATION	18	3.98e-02	3.05e-01	0.4320	2.40e-01	7.84e-03	2.37e-01	2.33e-01	-1.35e-01	7.79e-02	9.54e-01	8.18e-02	8.64e-02	3.22e-01
ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	8	3.48e-01	8.18e-01	0.4320	-1.20e-01	-8.86e-02	-2.93e-01	-2.65e-01	9.16e-02	5.58e-01	6.64e-01	1.52e-01	1.94e-01	6.54e-01
REGULATION OF TRANSMISSION OF NERVE IMPULSE	15	2.62e-01	7.44e-01	0.4310	-1.72e-01	-1.95e-01	-2.26e-01	-2.35e-01	1.11e-01	2.50e-01	1.92e-01	1.29e-01	1.15e-01	4.58e-01
POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	6	6.25e-01	9.44e-01	0.4310	1.64e-01	3.66e-01	9.16e-02	1.11e-01	6.50e-02	4.86e-01	1.20e-01	6.98e-01	6.37e-01	7.83e-01
MITOTIC CHROMOSOME CONDENSATION	19	2.51e-01	7.35e-01	0.4310	1.74e-01	-2.42e-02	2.54e-01	2.73e-01	1.29e-01	1.90e-01	8.55e-01	5.57e-02	3.97e-02	3.32e-01
POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION	8	6.79e-01	9.60e-01	0.4310	1.80e-01	2.27e-01	2.35e-01	2.10e-01	5.02e-02	3.78e-01	2.67e-01	2.50e-01	3.03e-01	8.06e-01
CYTOPLASM ORGANIZATION	15	3.04e-01	7.76e-01	0.4310	-2.52e-01	-4.63e-02	-2.45e-01	-2.44e-01	2.29e-02	9.08e-02	7.56e-01	9.97e-02	1.02e-01	8.78e-01
POSITIVE REGULATION OF KIDNEY DEVELOPMENT	9	7.86e-01	9.81e-01	0.4310	1.43e-01	-1.38e-02	2.47e-01	2.23e-01	2.33e-01	4.57e-01	9.43e-01	2.00e-01	2.46e-01	2.26e-01
MARGINAL ZONE B CELL DIFFERENTIATION	8	7.25e-01	9.70e-01	0.4310	-6.93e-02	1.17e-01	-2.03e-01	-1.98e-01	-2.95e-01	7.34e-01	5.66e-01	3.21e-01	3.33e-01	1.49e-01
REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION	12	2.65e-01	7.47e-01	0.4310	1.75e-02	-1.90e-02	2.08e-01	2.08e-01	3.13e-01	9.17e-01	9.09e-01	2.12e-01	2.11e-01	6.03e-02
ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS	8	3.76e-01	8.36e-01	0.4300	-1.96e-01	-1.30e-01	-2.44e-01	-2.05e-01	1.68e-01	3.37e-01	5.24e-01	2.31e-01	3.16e-01	4.11e-01
REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS	10	3.41e-01	8.11e-01	0.4300	-7.70e-02	-6.06e-02	-2.90e-01	-2.73e-01	-1.28e-01	6.73e-01	7.40e-01	1.12e-01	1.34e-01	4.82e-01
NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	32	7.46e-02	4.40e-01	0.4300	-2.09e-01	-2.25e-01	-1.91e-01	-1.98e-01	1.21e-01	4.10e-02	2.75e-02	6.20e-02	5.20e-02	2.36e-01
CENTRIOLE CENTRIOLE COHESION	15	5.16e-01	9.02e-01	0.4290	-1.56e-01	-9.84e-02	-2.10e-01	-2.27e-01	-2.35e-01	2.94e-01	5.10e-01	1.60e-01	1.29e-01	1.16e-01
REGULATION OF NK T CELL PROLIFERATION	7	1.00e-01	5.06e-01	0.4290	-4.12e-02	2.31e-02	-3.38e-01	-2.59e-01	2.50e-02	8.50e-01	9.16e-01	1.21e-01	2.35e-01	9.09e-01
LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS	9	5.75e-01	9.26e-01	0.4290	-1.69e-01	-2.02e-01	-2.26e-01	-2.36e-01	9.11e-02	3.81e-01	2.93e-01	2.41e-01	2.21e-01	6.36e-01
PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	26	1.02e-01	5.10e-01	0.4290	-2.10e-01	2.60e-02	-2.33e-01	-2.43e-01	-1.60e-01	6.34e-02	8.19e-01	3.94e-02	3.19e-02	1.57e-01
NEURAL CREST FORMATION	15	5.76e-01	9.26e-01	0.4290	2.18e-01	7.91e-02	2.54e-01	2.33e-01	1.07e-01	1.44e-01	5.96e-01	8.81e-02	1.19e-01	4.74e-01
POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS	20	6.06e-02	3.94e-01	0.4290	2.19e-01	2.44e-01	8.69e-02	9.75e-02	2.43e-01	8.96e-02	5.91e-02	5.01e-01	4.51e-01	5.94e-02
DOLICHYL DIPHOSPHATE METABOLIC PROCESS	5	7.46e-01	9.75e-01	0.4290	1.60e-01	-8.52e-02	1.64e-01	1.77e-01	3.04e-01	5.35e-01	7.41e-01	5.26e-01	4.93e-01	2.39e-01
LIPID DROPLET DISASSEMBLY	6	4.76e-01	8.86e-01	0.4290	3.48e-02	-3.01e-01	2.12e-01	1.76e-01	1.26e-01	8.83e-01	2.01e-01	3.68e-01	4.55e-01	5.94e-01
ISOCITRATE METABOLIC PROCESS	5	6.27e-01	9.45e-01	0.4290	9.25e-02	-2.25e-01	2.47e-01	2.43e-01	6.65e-02	7.20e-01	3.84e-01	3.39e-01	3.47e-01	7.97e-01
REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING	10	5.89e-01	9.30e-01	0.4280	1.96e-01	2.59e-01	1.38e-01	1.50e-01	-1.92e-01	2.83e-01	1.57e-01	4.51e-01	4.13e-01	2.93e-01
NEGATIVE REGULATION OF MRNA PROCESSING	22	2.28e-01	7.11e-01	0.4280	2.00e-01	8.18e-02	2.47e-01	2.73e-01	3.05e-02	1.05e-01	5.07e-01	4.50e-02	2.67e-02	8.04e-01
REGULATION OF PRO B CELL DIFFERENTIATION	8	4.97e-01	8.96e-01	0.4280	-1.36e-01	-2.28e-01	-9.38e-02	-1.12e-01	3.02e-01	5.07e-01	2.65e-01	6.46e-01	5.85e-01	1.39e-01
NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY	12	2.50e-01	7.33e-01	0.4280	-4.25e-02	1.30e-01	-2.89e-01	-2.55e-01	-1.26e-01	7.99e-01	4.35e-01	8.33e-02	1.27e-01	4.49e-01
INOSITOL PHOSPHATE METABOLIC PROCESS	42	4.11e-02	3.10e-01	0.4280	-2.67e-01	-1.08e-01	-2.11e-01	-2.26e-01	-6.82e-02	2.79e-03	2.27e-01	1.79e-02	1.14e-02	4.44e-01
REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	78	1.46e-03	3.29e-02	0.4280	1.92e-01	3.10e-03	2.56e-01	2.51e-01	1.31e-01	3.30e-03	9.62e-01	9.18e-05	1.26e-04	4.54e-02
REGULATION OF PROSTATIC BUD FORMATION	5	4.24e-01	8.61e-01	0.4280	2.09e-01	-4.65e-02	2.80e-01	2.03e-01	1.32e-01	4.17e-01	8.57e-01	2.79e-01	4.32e-01	6.10e-01
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	5	1.35e-01	5.85e-01	0.4270	-2.79e-01	-1.53e-01	-2.35e-01	-1.39e-01	8.17e-02	2.79e-01	5.54e-01	3.62e-01	5.91e-01	7.52e-01
CEREBELLAR GRANULAR LAYER FORMATION	6	9.13e-01	9.94e-01	0.4270	-2.03e-01	-1.31e-01	-2.55e-01	-2.42e-01	-1.80e-02	3.90e-01	5.78e-01	2.79e-01	3.04e-01	9.39e-01
MITOTIC NUCLEAR MEMBRANE ORGANIZATION	10	2.24e-01	7.05e-01	0.4270	1.17e-01	-1.59e-01	2.60e-01	2.75e-01	2.12e-02	5.23e-01	3.85e-01	1.55e-01	1.32e-01	9.08e-01
REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION	8	6.94e-01	9.61e-01	0.4270	-2.35e-01	-1.80e-01	-1.65e-01	-1.90e-01	1.77e-01	2.50e-01	3.79e-01	4.18e-01	3.53e-01	3.86e-01
CELLULAR RESPONSE TO INDOLE 3 METHANOL	5	7.39e-01	9.73e-01	0.4270	-1.35e-01	1.57e-01	-2.64e-01	-2.32e-01	-1.26e-01	6.01e-01	5.43e-01	3.07e-01	3.69e-01	6.26e-01
PROPIONATE METABOLIC PROCESS	5	9.35e-01	9.97e-01	0.4260	2.30e-01	1.37e-01	1.84e-01	1.85e-01	2.05e-01	3.74e-01	5.96e-01	4.75e-01	4.75e-01	4.27e-01
REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	5	7.93e-01	9.81e-01	0.4260	-1.90e-01	-7.11e-02	-1.90e-01	-2.39e-01	-2.17e-01	4.63e-01	7.83e-01	4.61e-01	3.54e-01	4.01e-01
DETECTION OF MOLECULE OF BACTERIAL ORIGIN	13	3.23e-01	7.96e-01	0.4260	-1.14e-01	8.11e-02	-2.92e-01	-2.63e-01	-8.38e-02	4.75e-01	6.13e-01	6.80e-02	1.00e-01	6.01e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	43	4.04e-02	3.07e-01	0.4260	1.92e-01	2.21e-02	2.64e-01	2.65e-01	6.48e-02	2.97e-02	8.02e-01	2.78e-03	2.59e-03	4.62e-01
ESTROUS CYCLE	16	2.00e-01	6.80e-01	0.4250	-2.22e-01	-3.24e-01	7.33e-03	-2.11e-02	1.62e-01	1.24e-01	2.48e-02	9.60e-01	8.84e-01	2.63e-01
POSITIVE REGULATION OF GASTRULATION	6	1.46e-01	6.03e-01	0.4250	3.05e-01	-1.88e-02	1.87e-01	1.64e-01	-1.61e-01	1.96e-01	9.36e-01	4.27e-01	4.88e-01	4.95e-01
REGULATION OF TYPE 2 IMMUNE RESPONSE	34	1.75e-01	6.47e-01	0.4250	-2.43e-01	-2.53e-01	-1.69e-01	-1.72e-01	-7.43e-03	1.42e-02	1.07e-02	8.82e-02	8.33e-02	9.40e-01
POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	8	3.63e-01	8.26e-01	0.4250	1.10e-01	3.04e-01	6.13e-02	1.01e-01	-2.50e-01	5.89e-01	1.37e-01	7.64e-01	6.22e-01	2.20e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	6	2.90e-01	7.67e-01	0.4250	-1.99e-01	-3.25e-01	1.47e-01	1.19e-01	-6.19e-03	3.99e-01	1.68e-01	5.34e-01	6.13e-01	9.79e-01
MANCHETTE ASSEMBLY	6	6.26e-01	9.44e-01	0.4250	-1.29e-01	-2.19e-01	-1.18e-01	-1.30e-01	2.92e-01	5.84e-01	3.52e-01	6.18e-01	5.81e-01	2.16e-01
CENTRAL NERVOUS SYSTEM MYELIN FORMATION	8	3.25e-01	7.98e-01	0.4250	-1.63e-01	1.06e-01	-2.57e-01	-2.61e-01	8.95e-02	4.24e-01	6.02e-01	2.07e-01	2.01e-01	6.61e-01
TRNA THIO MODIFICATION	5	5.26e-01	9.05e-01	0.4250	1.42e-01	-4.28e-02	2.43e-01	2.75e-01	-1.53e-01	5.81e-01	8.68e-01	3.46e-01	2.87e-01	5.53e-01
DNA METHYLATION ON CYTOSINE	6	5.17e-01	9.02e-01	0.4250	-2.14e-01	1.21e-01	-2.46e-01	-2.25e-01	-9.52e-02	3.65e-01	6.07e-01	2.97e-01	3.41e-01	6.86e-01
REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II	5	5.63e-01	9.22e-01	0.4240	3.12e-01	1.94e-02	1.99e-01	2.06e-01	1.96e-02	2.27e-01	9.40e-01	4.42e-01	4.24e-01	9.40e-01
ORNITHINE METABOLIC PROCESS	9	7.83e-01	9.81e-01	0.4240	1.89e-01	1.03e-01	2.07e-01	2.35e-01	1.89e-01	3.26e-01	5.92e-01	2.82e-01	2.22e-01	3.26e-01
REGULATION OF SOMITOGENESIS	6	7.71e-01	9.76e-01	0.4240	-1.09e-01	1.22e-01	-2.65e-01	-2.61e-01	-1.20e-01	6.42e-01	6.04e-01	2.61e-01	2.67e-01	6.11e-01
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS	77	1.95e-03	3.99e-02	0.4240	1.89e-01	1.56e-02	2.59e-01	2.42e-01	1.36e-01	4.20e-03	8.12e-01	8.71e-05	2.36e-04	3.86e-02
NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	9	7.41e-01	9.73e-01	0.4240	2.07e-01	1.21e-02	2.11e-01	2.09e-01	2.20e-01	2.82e-01	9.50e-01	2.73e-01	2.78e-01	2.53e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	34	1.55e-01	6.17e-01	0.4240	1.72e-01	-4.30e-03	2.53e-01	2.48e-01	1.56e-01	8.30e-02	9.65e-01	1.06e-02	1.24e-02	1.15e-01
REGULATION OF PROTEIN KINASE C ACTIVITY	5	5.49e-01	9.15e-01	0.4230	2.69e-01	2.62e-02	2.15e-01	1.97e-01	-1.45e-01	2.98e-01	9.19e-01	4.05e-01	4.45e-01	5.76e-01
REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	15	4.72e-01	8.85e-01	0.4230	-1.75e-01	-5.34e-02	-2.03e-01	-1.81e-01	-2.68e-01	2.41e-01	7.21e-01	1.74e-01	2.25e-01	7.28e-02
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	5	7.99e-01	9.81e-01	0.4230	2.44e-01	3.13e-01	6.66e-02	1.14e-01	6.47e-02	3.46e-01	2.26e-01	7.97e-01	6.60e-01	8.02e-01
TROPHOBLAST GIANT CELL DIFFERENTIATION	12	5.80e-01	9.27e-01	0.4230	1.55e-01	-3.24e-02	2.76e-01	2.62e-01	9.30e-02	3.52e-01	8.46e-01	9.76e-02	1.16e-01	5.77e-01
REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	5	5.89e-01	9.30e-01	0.4220	2.04e-01	2.81e-01	1.24e-01	2.02e-01	-4.27e-02	4.30e-01	2.77e-01	6.30e-01	4.34e-01	8.69e-01
ERBB2 EGFR SIGNALING PATHWAY	8	2.19e-01	7.00e-01	0.4220	-5.47e-02	-2.64e-01	-7.52e-02	-9.97e-02	3.00e-01	7.89e-01	1.96e-01	7.13e-01	6.25e-01	1.42e-01
SUCCINATE METABOLIC PROCESS	5	6.16e-01	9.40e-01	0.4220	2.38e-01	3.41e-01	-5.57e-02	-3.27e-02	-3.74e-02	3.57e-01	1.87e-01	8.29e-01	8.99e-01	8.85e-01
DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING	8	5.13e-01	9.01e-01	0.4220	-1.05e-02	-9.76e-02	1.21e-01	8.11e-02	3.84e-01	9.59e-01	6.33e-01	5.54e-01	6.91e-01	6.02e-02
MACROPHAGE APOPTOTIC PROCESS	14	1.48e-01	6.10e-01	0.4220	4.22e-02	-2.31e-01	1.40e-01	1.10e-01	3.02e-01	7.85e-01	1.34e-01	3.64e-01	4.75e-01	5.07e-02
REGULATION OF OSTEOCLAST DEVELOPMENT	11	5.78e-01	9.27e-01	0.4220	-2.40e-01	-1.73e-02	-2.21e-01	-2.25e-01	-1.45e-01	1.68e-01	9.21e-01	2.05e-01	1.97e-01	4.06e-01
OXALATE TRANSPORT	12	5.02e-01	8.98e-01	0.4220	-2.79e-01	-1.08e-01	-2.10e-01	-2.10e-01	3.89e-03	9.41e-02	5.19e-01	2.07e-01	2.07e-01	9.81e-01
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	37	1.77e-01	6.47e-01	0.4220	2.13e-01	1.02e-01	2.15e-01	2.07e-01	1.83e-01	2.52e-02	2.84e-01	2.39e-02	2.94e-02	5.45e-02
HEMOGLOBIN BIOSYNTHETIC PROCESS	13	1.64e-02	1.77e-01	0.4220	-8.50e-02	-3.16e-01	-1.65e-01	-1.97e-01	6.79e-02	5.95e-01	4.84e-02	3.04e-01	2.19e-01	6.72e-01
POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE	7	1.82e-01	6.56e-01	0.4220	-1.01e-01	-4.02e-02	-2.30e-01	-1.82e-01	2.83e-01	6.43e-01	8.54e-01	2.93e-01	4.05e-01	1.95e-01
PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	7.98e-01	9.81e-01	0.4210	-8.04e-02	8.18e-02	-1.92e-01	-2.07e-01	-2.91e-01	7.33e-01	7.29e-01	4.15e-01	3.79e-01	2.18e-01
POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	9	8.55e-01	9.88e-01	0.4210	2.39e-01	2.50e-01	1.65e-01	1.70e-01	4.45e-02	2.15e-01	1.95e-01	3.91e-01	3.78e-01	8.17e-01
NK T CELL PROLIFERATION	8	2.06e-01	6.84e-01	0.4210	-9.92e-02	-2.52e-02	-3.14e-01	-2.55e-01	5.27e-02	6.27e-01	9.02e-01	1.24e-01	2.11e-01	7.96e-01
HEPARIN BIOSYNTHETIC PROCESS	11	7.84e-01	9.81e-01	0.4200	-2.23e-01	-6.16e-02	-2.40e-01	-2.42e-01	-8.42e-02	2.00e-01	7.24e-01	1.68e-01	1.65e-01	6.29e-01
ADENOSINE METABOLIC PROCESS	10	8.16e-01	9.83e-01	0.4200	-1.68e-01	-5.89e-02	-2.13e-01	-2.04e-01	-2.42e-01	3.58e-01	7.47e-01	2.44e-01	2.65e-01	1.86e-01
COPPER ION HOMEOSTASIS	17	8.37e-02	4.61e-01	0.4200	-3.69e-02	-3.05e-01	1.52e-01	1.45e-01	1.95e-01	7.92e-01	2.94e-02	2.79e-01	3.00e-01	1.64e-01
AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY	13	6.16e-02	3.97e-01	0.4200	8.70e-02	1.15e-02	2.28e-02	3.95e-02	-4.08e-01	5.87e-01	9.43e-01	8.87e-01	8.05e-01	1.09e-02
PROTEASOME ASSEMBLY	11	7.90e-01	9.81e-01	0.4200	2.18e-01	1.41e-01	2.30e-01	2.36e-01	-1.55e-02	2.11e-01	4.19e-01	1.86e-01	1.76e-01	9.29e-01
UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	5	6.08e-01	9.35e-01	0.4200	-1.43e-01	-3.87e-01	5.77e-02	4.55e-02	-8.42e-03	5.79e-01	1.34e-01	8.23e-01	8.60e-01	9.74e-01
NEGATIVE REGULATION OF STEROL TRANSPORT	31	6.24e-02	3.99e-01	0.4200	-2.13e-01	-7.49e-02	-2.51e-01	-2.15e-01	-1.26e-01	4.03e-02	4.71e-01	1.55e-02	3.83e-02	2.26e-01
PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER	35	1.91e-01	6.66e-01	0.4190	-1.94e-01	-2.02e-01	-2.11e-01	-2.11e-01	-8.93e-02	4.64e-02	3.83e-02	3.05e-02	3.07e-02	3.61e-01
LOCOMOTORY EXPLORATION BEHAVIOR	14	4.64e-01	8.81e-01	0.4190	-2.52e-01	-1.97e-01	-1.69e-01	-1.69e-01	1.30e-01	1.03e-01	2.03e-01	2.75e-01	2.74e-01	4.00e-01
PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE	8	2.96e-01	7.72e-01	0.4190	-4.19e-02	-3.31e-01	9.16e-02	1.12e-01	2.10e-01	8.38e-01	1.05e-01	6.54e-01	5.85e-01	3.04e-01
CELLULAR RESPONSE TO STEROL	25	3.44e-03	6.14e-02	0.4190	-4.00e-02	4.86e-03	-3.01e-01	-2.74e-01	-9.00e-02	7.29e-01	9.66e-01	9.09e-03	1.76e-02	4.36e-01
CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	9	3.97e-01	8.45e-01	0.4190	-3.19e-02	-1.88e-01	2.42e-01	2.17e-01	1.83e-01	8.68e-01	3.29e-01	2.08e-01	2.59e-01	3.41e-01
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	22	2.45e-01	7.29e-01	0.4190	1.09e-01	-9.73e-02	2.32e-01	2.19e-01	2.29e-01	3.78e-01	4.29e-01	5.99e-02	7.48e-02	6.27e-02
PIGMENT GRANULE LOCALIZATION	23	4.66e-01	8.83e-01	0.4190	2.18e-01	1.36e-01	1.99e-01	1.97e-01	1.76e-01	7.06e-02	2.58e-01	9.83e-02	1.01e-01	1.43e-01
TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER	95	2.99e-05	1.44e-03	0.4190	1.81e-01	3.80e-02	2.66e-01	2.65e-01	1.18e-02	2.28e-03	5.22e-01	7.22e-06	7.97e-06	8.43e-01
CELL CYCLE DNA REPLICATION	42	1.27e-03	2.97e-02	0.4190	9.76e-02	-1.31e-01	2.76e-01	2.57e-01	7.97e-02	2.74e-01	1.43e-01	1.94e-03	3.93e-03	3.71e-01
DETECTION OF LIPOPOLYSACCHARIDE	5	7.46e-01	9.75e-01	0.4190	-1.26e-01	6.93e-02	-2.88e-01	-2.67e-01	1.91e-02	6.27e-01	7.88e-01	2.64e-01	3.01e-01	9.41e-01
REGULATION OF NK T CELL DIFFERENTIATION	6	6.11e-01	9.36e-01	0.4190	1.40e-01	3.53e-01	1.06e-01	1.03e-01	-9.62e-02	5.54e-01	1.34e-01	6.53e-01	6.62e-01	6.83e-01
POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	8	4.46e-01	8.73e-01	0.4190	-2.27e-01	-3.46e-01	5.27e-04	-5.79e-02	2.31e-02	2.67e-01	8.98e-02	9.98e-01	7.77e-01	9.10e-01
NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	5	6.98e-01	9.62e-01	0.4190	-2.29e-01	-1.68e-01	-1.72e-01	-1.45e-01	2.10e-01	3.76e-01	5.16e-01	5.05e-01	5.74e-01	4.16e-01
PROTEIN K63 LINKED DEUBIQUITINATION	27	4.50e-01	8.76e-01	0.4180	-1.95e-01	-9.53e-02	-2.22e-01	-2.25e-01	-1.67e-01	7.89e-02	3.92e-01	4.59e-02	4.26e-02	1.34e-01
MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	8	9.57e-02	4.94e-01	0.4180	1.53e-01	-2.08e-01	2.06e-01	2.14e-01	-1.41e-01	4.54e-01	3.08e-01	3.13e-01	2.95e-01	4.89e-01
LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	10	7.68e-01	9.75e-01	0.4180	-2.32e-01	-6.96e-02	-2.12e-01	-2.31e-01	-1.32e-01	2.04e-01	7.03e-01	2.45e-01	2.05e-01	4.68e-01
REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	8	7.17e-01	9.68e-01	0.4180	1.17e-01	9.78e-02	2.61e-01	2.56e-01	1.35e-01	5.68e-01	6.32e-01	2.01e-01	2.10e-01	5.09e-01
PARACRINE SIGNALING	7	5.77e-01	9.26e-01	0.4180	-1.35e-01	-3.66e-01	6.46e-02	3.64e-02	1.30e-01	5.37e-01	9.35e-02	7.67e-01	8.68e-01	5.51e-01
MRNA SPLICE SITE RECOGNITION	35	1.44e-01	6.02e-01	0.4180	2.05e-01	8.00e-02	2.50e-01	2.51e-01	1.89e-02	3.61e-02	4.13e-01	1.05e-02	1.00e-02	8.47e-01
POSITIVE REGULATION OF CELLULAR PH REDUCTION	5	2.30e-01	7.14e-01	0.4170	1.20e-03	-1.62e-01	-2.22e-01	-2.47e-01	-1.94e-01	9.96e-01	5.31e-01	3.91e-01	3.38e-01	4.52e-01
PERK MEDIATED UNFOLDED PROTEIN RESPONSE	18	4.53e-01	8.77e-01	0.4170	1.87e-01	1.96e-03	2.33e-01	2.45e-01	1.58e-01	1.69e-01	9.89e-01	8.76e-02	7.20e-02	2.47e-01
IMMUNOLOGICAL MEMORY FORMATION PROCESS	14	4.95e-01	8.96e-01	0.4170	1.79e-01	1.87e-01	1.88e-01	1.69e-01	2.08e-01	2.47e-01	2.27e-01	2.24e-01	2.74e-01	1.77e-01
NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	15	2.28e-01	7.11e-01	0.4170	1.35e-01	-9.37e-02	2.80e-01	2.57e-01	4.89e-02	3.66e-01	5.30e-01	6.07e-02	8.48e-02	7.43e-01
MOTOR NEURON AXON GUIDANCE	23	1.57e-01	6.19e-01	0.4170	-2.56e-01	-2.60e-01	-8.79e-02	-1.17e-01	1.38e-01	3.34e-02	3.09e-02	4.65e-01	3.32e-01	2.52e-01
CHAPERONE MEDIATED AUTOPHAGY	14	4.56e-01	8.78e-01	0.4160	9.67e-02	-5.50e-02	1.86e-01	1.95e-01	2.97e-01	5.31e-01	7.22e-01	2.28e-01	2.07e-01	5.41e-02
INTERLEUKIN 10 PRODUCTION	59	9.93e-03	1.28e-01	0.4160	-2.12e-01	-1.97e-01	-2.02e-01	-2.05e-01	8.04e-02	4.85e-03	8.72e-03	7.28e-03	6.43e-03	2.85e-01
THYMOCYTE MIGRATION	7	8.62e-02	4.67e-01	0.4160	1.26e-02	2.13e-01	-2.00e-01	-1.41e-01	2.59e-01	9.54e-01	3.28e-01	3.60e-01	5.17e-01	2.35e-01
REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT	8	6.04e-01	9.34e-01	0.4150	-1.86e-01	7.19e-02	-2.48e-01	-2.60e-01	-5.94e-02	3.62e-01	7.25e-01	2.24e-01	2.03e-01	7.71e-01
DELAMINATION	7	4.14e-01	8.54e-01	0.4150	-5.68e-03	-3.01e-02	-1.25e-01	-7.89e-02	-3.87e-01	9.79e-01	8.90e-01	5.67e-01	7.18e-01	7.64e-02
TYPE 2 IMMUNE RESPONSE	42	7.11e-02	4.28e-01	0.4150	-2.15e-01	-2.66e-01	-1.63e-01	-1.65e-01	-3.59e-02	1.58e-02	2.81e-03	6.72e-02	6.49e-02	6.87e-01
TETRAHYDROBIOPTERIN METABOLIC PROCESS	8	4.34e-01	8.69e-01	0.4150	-7.45e-02	-3.42e-01	1.39e-01	1.11e-01	1.34e-01	7.15e-01	9.42e-02	4.97e-01	5.87e-01	5.11e-01
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS	31	1.48e-01	6.10e-01	0.4150	-1.39e-01	-5.99e-03	-2.17e-01	-1.95e-01	-2.60e-01	1.80e-01	9.54e-01	3.66e-02	6.03e-02	1.24e-02
POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	11	5.41e-01	9.14e-01	0.4140	-2.75e-01	-2.37e-01	-1.07e-01	-1.46e-01	8.44e-02	1.14e-01	1.73e-01	5.39e-01	4.03e-01	6.28e-01
NEURAL PLATE MORPHOGENESIS	5	8.09e-01	9.82e-01	0.4140	-2.42e-02	-2.37e-01	1.06e-01	8.60e-02	3.09e-01	9.25e-01	3.58e-01	6.80e-01	7.39e-01	2.31e-01
NEPHRON TUBULE FORMATION	20	1.68e-02	1.81e-01	0.4140	9.93e-03	-2.37e-01	1.89e-01	1.23e-01	2.53e-01	9.39e-01	6.63e-02	1.44e-01	3.42e-01	4.98e-02
MIDGUT DEVELOPMENT	10	4.30e-01	8.66e-01	0.4140	1.79e-01	1.91e-01	1.26e-01	1.20e-01	-2.69e-01	3.27e-01	2.95e-01	4.90e-01	5.09e-01	1.41e-01
POLYOL CATABOLIC PROCESS	9	3.01e-01	7.74e-01	0.4140	-2.05e-01	-1.48e-01	-9.34e-02	-1.48e-01	2.77e-01	2.88e-01	4.41e-01	6.27e-01	4.41e-01	1.51e-01
POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	5	9.40e-01	9.97e-01	0.4130	-1.98e-01	-2.54e-01	-1.68e-01	-1.82e-01	-7.52e-02	4.43e-01	3.26e-01	5.16e-01	4.80e-01	7.71e-01
PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE	7	8.73e-01	9.88e-01	0.4130	-2.50e-01	-2.64e-01	-1.19e-01	-1.43e-01	6.13e-02	2.51e-01	2.27e-01	5.85e-01	5.12e-01	7.79e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	42	2.53e-02	2.37e-01	0.4130	1.67e-01	-4.72e-03	2.49e-01	2.16e-01	1.85e-01	6.17e-02	9.58e-01	5.27e-03	1.55e-02	3.77e-02
NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION	18	3.30e-01	8.02e-01	0.4130	-1.86e-01	-2.58e-01	-1.52e-01	-1.52e-01	-1.52e-01	1.71e-01	5.80e-02	2.66e-01	2.64e-01	2.64e-01
NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	14	2.01e-03	4.09e-02	0.4130	1.44e-01	-2.16e-01	1.68e-01	9.85e-02	2.55e-01	3.51e-01	1.62e-01	2.77e-01	5.23e-01	9.83e-02
POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	10	6.61e-01	9.54e-01	0.4130	-1.64e-01	-2.26e-01	-2.12e-01	-2.14e-01	-3.81e-02	3.69e-01	2.16e-01	2.45e-01	2.41e-01	8.35e-01
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE	18	5.19e-01	9.03e-01	0.4120	2.27e-01	2.60e-01	1.48e-01	1.55e-01	7.06e-02	9.52e-02	5.60e-02	2.78e-01	2.56e-01	6.04e-01
POSITIVE REGULATION OF INTEGRIN ACTIVATION	11	1.69e-01	6.39e-01	0.4120	-1.94e-01	2.01e-02	-2.28e-01	-2.73e-01	7.34e-02	2.65e-01	9.08e-01	1.91e-01	1.17e-01	6.73e-01
MEIOTIC CYTOKINESIS	8	8.68e-01	9.88e-01	0.4120	-2.61e-01	-1.92e-01	-1.66e-01	-1.91e-01	-2.43e-02	2.01e-01	3.46e-01	4.17e-01	3.49e-01	9.05e-01
REGULATION OF MICROGLIAL CELL ACTIVATION	20	5.82e-01	9.28e-01	0.4110	1.96e-01	1.03e-01	2.21e-01	2.09e-01	1.66e-01	1.28e-01	4.24e-01	8.66e-02	1.06e-01	1.98e-01
ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	6.70e-01	9.57e-01	0.4110	-1.82e-01	-9.46e-02	-2.18e-01	-2.74e-01	6.46e-02	4.80e-01	7.14e-01	3.98e-01	2.88e-01	8.03e-01
OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT	7	2.16e-01	6.98e-01	0.4110	-1.13e-01	-3.16e-01	-1.36e-01	-1.94e-01	6.07e-03	6.04e-01	1.47e-01	5.33e-01	3.73e-01	9.78e-01
NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	18	1.02e-01	5.10e-01	0.4110	-2.47e-01	-1.60e-01	-2.24e-01	-1.79e-01	-1.70e-02	6.98e-02	2.40e-01	1.00e-01	1.88e-01	9.01e-01
REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN	6	7.53e-01	9.75e-01	0.4110	1.23e-01	2.40e-01	7.96e-03	2.53e-02	-3.09e-01	6.01e-01	3.08e-01	9.73e-01	9.14e-01	1.91e-01
GLUCOCORTICOID SECRETION	12	8.41e-01	9.85e-01	0.4110	-2.34e-01	-1.56e-01	-2.03e-01	-2.04e-01	-8.37e-02	1.60e-01	3.50e-01	2.24e-01	2.22e-01	6.15e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY	6	7.59e-01	9.75e-01	0.4110	-1.14e-01	-2.62e-01	8.78e-02	5.62e-02	2.76e-01	6.29e-01	2.66e-01	7.09e-01	8.12e-01	2.42e-01
RESPONSE TO SODIUM ARSENITE	6	5.40e-01	9.13e-01	0.4110	2.03e-01	1.14e-01	2.40e-01	1.93e-01	-1.40e-01	3.89e-01	6.29e-01	3.09e-01	4.13e-01	5.51e-01
ACTIVATION INDUCED CELL DEATH OF T CELLS	8	5.66e-01	9.23e-01	0.4110	9.55e-02	-3.61e-02	2.74e-01	2.83e-01	5.65e-02	6.40e-01	8.60e-01	1.79e-01	1.66e-01	7.82e-01
ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION	21	4.50e-01	8.76e-01	0.4110	2.15e-01	1.54e-01	1.80e-01	1.77e-01	1.87e-01	8.76e-02	2.22e-01	1.54e-01	1.61e-01	1.37e-01
REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION	12	3.80e-01	8.37e-01	0.4110	-1.26e-01	-2.79e-01	4.19e-03	-2.79e-03	2.74e-01	4.51e-01	9.43e-02	9.80e-01	9.87e-01	1.01e-01
NEGATIVE REGULATION OF RNA SPLICING	25	5.34e-02	3.62e-01	0.4100	2.00e-01	7.37e-02	2.24e-01	2.58e-01	-7.86e-02	8.28e-02	5.24e-01	5.22e-02	2.57e-02	4.96e-01
FOREBRAIN REGIONALIZATION	24	6.74e-05	2.82e-03	0.4100	1.90e-01	-1.80e-01	2.28e-01	1.73e-01	1.35e-01	1.07e-01	1.27e-01	5.31e-02	1.43e-01	2.54e-01
RESPONSE TO HYDROSTATIC PRESSURE	7	6.82e-01	9.61e-01	0.4100	2.12e-01	3.42e-01	7.89e-03	2.04e-02	-7.96e-02	3.32e-01	1.18e-01	9.71e-01	9.25e-01	7.15e-01
PROTEIN INSERTION INTO ER MEMBRANE	28	2.73e-02	2.47e-01	0.4100	8.36e-02	-1.78e-01	2.42e-01	2.16e-01	1.56e-01	4.44e-01	1.02e-01	2.70e-02	4.82e-02	1.54e-01
POSITIVE REGULATION OF SPINDLE ASSEMBLY	8	5.25e-01	9.05e-01	0.4090	2.85e-01	7.80e-02	1.96e-01	1.80e-01	9.64e-02	1.63e-01	7.02e-01	3.37e-01	3.78e-01	6.37e-01
XMP METABOLIC PROCESS	7	8.69e-01	9.88e-01	0.4090	1.84e-01	1.69e-01	2.14e-01	2.39e-01	4.78e-02	4.00e-01	4.39e-01	3.27e-01	2.73e-01	8.27e-01
REGULATION OF SULFUR METABOLIC PROCESS	12	3.73e-01	8.34e-01	0.4090	-2.98e-01	-2.11e-01	-1.09e-01	-1.47e-01	2.87e-02	7.43e-02	2.07e-01	5.13e-01	3.77e-01	8.63e-01
CELLULAR RESPONSE TO UNFOLDED PROTEIN	88	1.64e-03	3.51e-02	0.4090	1.87e-01	3.05e-02	2.52e-01	2.45e-01	8.78e-02	2.41e-03	6.21e-01	4.44e-05	7.10e-05	1.55e-01
3 UTR MEDIATED MRNA STABILIZATION	20	2.45e-01	7.29e-01	0.4090	1.66e-01	7.82e-02	1.84e-01	1.58e-01	2.72e-01	1.98e-01	5.45e-01	1.54e-01	2.20e-01	3.50e-02
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	106	2.01e-04	7.12e-03	0.4090	1.70e-01	-8.25e-04	2.50e-01	2.46e-01	1.22e-01	2.51e-03	9.88e-01	8.58e-06	1.17e-05	3.01e-02
LUNG GROWTH	6	3.30e-01	8.02e-01	0.4080	6.50e-02	-1.10e-02	2.95e-02	-1.17e-03	-4.02e-01	7.83e-01	9.63e-01	9.00e-01	9.96e-01	8.81e-02
TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION	5	4.20e-01	8.59e-01	0.4080	3.78e-02	-2.55e-01	2.04e-01	2.39e-01	3.95e-02	8.83e-01	3.24e-01	4.30e-01	3.54e-01	8.78e-01
GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS	6	6.54e-01	9.53e-01	0.4080	1.40e-01	1.92e-01	8.66e-02	1.23e-01	-2.95e-01	5.52e-01	4.15e-01	7.13e-01	6.01e-01	2.10e-01
POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	26	1.83e-01	6.56e-01	0.4080	-1.91e-01	-2.63e-01	-1.57e-01	-1.83e-01	-5.18e-02	9.17e-02	2.03e-02	1.65e-01	1.07e-01	6.47e-01
CARDIAC LEFT VENTRICLE MORPHOGENESIS	16	5.41e-02	3.65e-01	0.4080	-2.06e-02	-3.32e-01	1.29e-01	9.19e-02	1.75e-01	8.86e-01	2.15e-02	3.72e-01	5.24e-01	2.25e-01
REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	16	4.36e-01	8.69e-01	0.4080	-9.31e-02	3.08e-02	-2.58e-01	-2.31e-01	-1.92e-01	5.19e-01	8.31e-01	7.45e-02	1.09e-01	1.83e-01
NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY	10	5.47e-01	9.15e-01	0.4080	1.95e-01	2.72e-01	3.61e-02	4.24e-02	-2.27e-01	2.86e-01	1.37e-01	8.43e-01	8.16e-01	2.14e-01
INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY	6	4.73e-01	8.86e-01	0.4080	9.19e-02	3.44e-01	-1.23e-01	-1.32e-01	-8.43e-02	6.97e-01	1.44e-01	6.03e-01	5.76e-01	7.21e-01
PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE	35	6.76e-02	4.17e-01	0.4080	1.53e-01	-3.14e-02	2.59e-01	2.32e-01	1.45e-01	1.17e-01	7.48e-01	7.96e-03	1.77e-02	1.38e-01
TYPE III INTERFERON PRODUCTION	5	7.88e-01	9.81e-01	0.4080	-3.02e-02	1.95e-01	-1.12e-01	-1.11e-01	-3.20e-01	9.07e-01	4.51e-01	6.64e-01	6.68e-01	2.15e-01
PROTEIN TRANSMEMBRANE TRANSPORT	64	7.48e-03	1.07e-01	0.4080	1.92e-01	2.84e-02	2.52e-01	2.33e-01	1.01e-01	7.78e-03	6.94e-01	4.80e-04	1.25e-03	1.62e-01
CORTISOL SECRETION	5	7.73e-01	9.77e-01	0.4070	-1.82e-01	-2.69e-01	-1.46e-01	-1.99e-01	-9.53e-03	4.82e-01	2.98e-01	5.73e-01	4.42e-01	9.71e-01
REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	11	5.53e-01	9.16e-01	0.4070	-1.89e-01	-1.81e-01	-2.34e-01	-2.05e-01	2.20e-02	2.77e-01	2.98e-01	1.79e-01	2.39e-01	8.99e-01
LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE	8	8.56e-01	9.88e-01	0.4070	-1.55e-01	-1.06e-01	-2.52e-01	-2.34e-01	-1.11e-01	4.48e-01	6.04e-01	2.17e-01	2.51e-01	5.85e-01
ERROR PRONE TRANSLESION SYNTHESIS	11	5.54e-01	9.16e-01	0.4070	-1.98e-01	-2.93e-01	-1.04e-01	-1.18e-01	-1.27e-01	2.55e-01	9.27e-02	5.49e-01	4.97e-01	4.65e-01
NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION	15	4.16e-01	8.56e-01	0.4070	-2.79e-01	-1.79e-01	-1.49e-01	-1.76e-01	5.34e-02	6.15e-02	2.30e-01	3.17e-01	2.37e-01	7.20e-01
REGULATION OF MDA 5 SIGNALING PATHWAY	7	3.84e-01	8.39e-01	0.4070	1.64e-01	3.32e-01	-6.29e-02	-8.24e-02	-1.32e-01	4.52e-01	1.28e-01	7.73e-01	7.06e-01	5.44e-01
CELLULAR RESPONSE TO ETHANOL	11	3.35e-01	8.05e-01	0.4070	-1.32e-01	-2.48e-01	-1.12e-01	-1.37e-01	2.35e-01	4.48e-01	1.54e-01	5.19e-01	4.31e-01	1.77e-01
PROTEIN REPAIR	7	7.27e-01	9.71e-01	0.4070	-1.66e-01	-1.58e-01	-2.10e-01	-2.18e-01	1.46e-01	4.46e-01	4.70e-01	3.36e-01	3.17e-01	5.03e-01
REGULATION OF CELLULAR RESPONSE TO HYPOXIA	20	1.20e-01	5.52e-01	0.4070	3.62e-03	-2.22e-01	1.72e-01	1.69e-01	2.41e-01	9.78e-01	8.57e-02	1.83e-01	1.90e-01	6.22e-02
RESPONSE TO INTERLEUKIN 7	12	2.56e-01	7.39e-01	0.4070	9.91e-02	8.32e-02	2.65e-01	2.78e-01	3.98e-02	5.52e-01	6.18e-01	1.13e-01	9.59e-02	8.11e-01
CELLULAR RESPONSE TO GLUCAGON STIMULUS	11	6.64e-01	9.54e-01	0.4060	1.70e-01	2.15e-01	2.03e-01	1.88e-01	1.16e-01	3.29e-01	2.16e-01	2.44e-01	2.80e-01	5.06e-01
UBIQUINONE METABOLIC PROCESS	19	1.65e-01	6.29e-01	0.4060	1.23e-01	-1.32e-01	2.52e-01	2.38e-01	1.12e-01	3.52e-01	3.21e-01	5.74e-02	7.25e-02	3.97e-01
TELOMERE ORGANIZATION	178	7.79e-09	8.75e-07	0.4060	1.99e-01	4.25e-02	2.52e-01	2.44e-01	2.51e-02	4.66e-06	3.28e-01	6.23e-09	2.01e-08	5.63e-01
SNRNA PROCESSING	25	3.32e-02	2.76e-01	0.4060	1.96e-01	2.25e-02	2.70e-01	2.30e-01	-9.18e-03	9.00e-02	8.46e-01	1.94e-02	4.61e-02	9.37e-01
REGULATION OF MUCUS SECRETION	8	4.96e-02	3.49e-01	0.4060	-1.54e-01	1.19e-01	-4.65e-02	-5.37e-02	3.49e-01	4.49e-01	5.61e-01	8.20e-01	7.93e-01	8.71e-02
NEURONAL SIGNAL TRANSDUCTION	7	8.48e-01	9.87e-01	0.4060	2.33e-01	2.04e-01	1.37e-01	1.46e-01	1.71e-01	2.86e-01	3.50e-01	5.30e-01	5.05e-01	4.34e-01
MICROGLIAL CELL MIGRATION	8	1.83e-01	6.56e-01	0.4060	7.14e-02	-3.90e-02	3.21e-02	8.38e-02	3.88e-01	7.26e-01	8.49e-01	8.75e-01	6.81e-01	5.77e-02
CILIARY BASAL BODY ORGANIZATION	5	8.27e-01	9.83e-01	0.4060	-6.28e-02	-4.57e-02	-2.30e-01	-2.31e-01	-2.29e-01	8.08e-01	8.60e-01	3.72e-01	3.71e-01	3.75e-01
COPPER ION TRANSMEMBRANE TRANSPORT	7	5.89e-01	9.30e-01	0.4060	6.74e-02	-1.92e-01	2.10e-01	1.63e-01	2.30e-01	7.57e-01	3.79e-01	3.36e-01	4.56e-01	2.92e-01
ECTODERMAL PLACODE DEVELOPMENT	13	3.09e-01	7.82e-01	0.4060	-1.59e-01	-3.20e-01	-4.59e-03	-5.05e-02	1.85e-01	3.20e-01	4.55e-02	9.77e-01	7.53e-01	2.48e-01
INTRACELLULAR NITROGEN HOMEOSTASIS	5	7.34e-01	9.73e-01	0.4060	-2.30e-01	-1.59e-01	-1.31e-01	-1.07e-01	-2.41e-01	3.73e-01	5.38e-01	6.12e-01	6.79e-01	3.51e-01
POSITIVE REGULATION OF HELICASE ACTIVITY	6	9.18e-01	9.95e-01	0.4060	1.85e-01	5.16e-02	2.22e-01	1.99e-01	1.97e-01	4.32e-01	8.27e-01	3.47e-01	3.98e-01	4.03e-01
NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	5	1.59e-01	6.21e-01	0.4060	1.45e-01	2.41e-01	-7.91e-02	1.46e-02	2.81e-01	5.74e-01	3.50e-01	7.59e-01	9.55e-01	2.77e-01
THIAMINE DIPHOSPHATE METABOLIC PROCESS	5	3.71e-01	8.32e-01	0.4060	-4.72e-02	-3.44e-01	1.06e-01	1.13e-01	-1.42e-01	8.55e-01	1.83e-01	6.81e-01	6.61e-01	5.82e-01
CHORIONIC TROPHOBLAST CELL DIFFERENTIATION	7	3.49e-01	8.18e-01	0.4060	-2.88e-01	-2.81e-01	-4.17e-02	-2.64e-02	1.53e-02	1.87e-01	1.98e-01	8.48e-01	9.04e-01	9.44e-01
EOSINOPHIL MIGRATION	31	3.00e-02	2.60e-01	0.4060	9.99e-02	6.83e-02	1.32e-01	1.34e-01	3.39e-01	3.36e-01	5.10e-01	2.05e-01	1.97e-01	1.10e-03
AMINO ACID BETAINE METABOLIC PROCESS	16	1.26e-01	5.67e-01	0.4060	1.59e-03	-5.46e-03	-1.80e-01	-1.62e-01	-3.25e-01	9.91e-01	9.70e-01	2.12e-01	2.62e-01	2.44e-02
SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY	19	2.95e-03	5.44e-02	0.4050	1.23e-01	-5.70e-02	1.32e-01	1.28e-01	-3.35e-01	3.52e-01	6.67e-01	3.20e-01	3.34e-01	1.15e-02
PARENTAL BEHAVIOR	10	2.37e-01	7.21e-01	0.4050	-1.88e-01	-3.51e-01	5.14e-02	-1.28e-02	5.29e-02	3.04e-01	5.43e-02	7.78e-01	9.44e-01	7.72e-01
TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING	7	5.85e-01	9.28e-01	0.4050	1.44e-01	-7.89e-03	2.61e-01	2.51e-01	-1.11e-01	5.10e-01	9.71e-01	2.32e-01	2.50e-01	6.10e-01
REGULATION OF SEROTONIN SECRETION	6	4.88e-01	8.92e-01	0.4050	-2.50e-01	-2.18e-01	-6.61e-02	-1.45e-01	1.71e-01	2.90e-01	3.55e-01	7.79e-01	5.39e-01	4.69e-01
REGULATION OF SPINDLE ORGANIZATION	46	4.59e-03	7.65e-02	0.4050	1.99e-01	-5.02e-02	2.38e-01	2.32e-01	1.06e-01	1.93e-02	5.56e-01	5.18e-03	6.40e-03	2.14e-01
SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT	18	5.95e-01	9.33e-01	0.4050	1.46e-01	2.06e-02	2.15e-01	2.11e-01	2.28e-01	2.82e-01	8.80e-01	1.15e-01	1.22e-01	9.45e-02
MELANOSOME ASSEMBLY	18	3.81e-02	2.98e-01	0.4050	-1.64e-01	-2.97e-01	-9.64e-02	-1.60e-01	1.19e-01	2.28e-01	2.92e-02	4.79e-01	2.41e-01	3.82e-01
PROTEIN LOCALIZATION TO ENDOSOME	26	2.09e-01	6.86e-01	0.4050	-2.27e-01	-2.24e-01	-1.40e-01	-1.75e-01	-1.10e-01	4.48e-02	4.84e-02	2.16e-01	1.23e-01	3.33e-01
DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS	6	8.89e-01	9.91e-01	0.4050	-2.15e-01	-7.08e-02	-2.33e-01	-2.39e-01	3.49e-02	3.61e-01	7.64e-01	3.23e-01	3.11e-01	8.82e-01
SKELETAL MUSCLE ADAPTATION	25	1.04e-01	5.17e-01	0.4050	1.78e-01	3.27e-01	8.34e-02	1.07e-01	-8.33e-02	1.23e-01	4.69e-03	4.70e-01	3.56e-01	4.71e-01
LIPOPROTEIN LOCALIZATION	21	2.76e-01	7.56e-01	0.4050	-1.73e-01	-1.72e-01	-2.19e-01	-2.34e-01	3.62e-02	1.71e-01	1.73e-01	8.18e-02	6.30e-02	7.74e-01
PEROXISOMAL TRANSPORT	22	4.42e-01	8.72e-01	0.4050	2.25e-01	2.04e-01	1.93e-01	1.84e-01	-1.09e-02	6.82e-02	9.69e-02	1.17e-01	1.34e-01	9.30e-01
VOCALIZATION BEHAVIOR	15	4.37e-01	8.69e-01	0.4040	2.26e-01	2.93e-01	9.32e-02	1.10e-01	7.77e-02	1.30e-01	4.95e-02	5.32e-01	4.60e-01	6.02e-01
N TERMINAL PROTEIN AMINO ACID MODIFICATION	27	1.63e-01	6.27e-01	0.4040	2.26e-01	7.13e-02	2.31e-01	2.30e-01	-3.18e-02	4.24e-02	5.21e-01	3.75e-02	3.83e-02	7.75e-01
REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	8	6.67e-01	9.55e-01	0.4040	1.58e-01	-3.00e-02	2.57e-01	2.67e-01	2.35e-03	4.39e-01	8.83e-01	2.08e-01	1.91e-01	9.91e-01
REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	15	3.81e-01	8.38e-01	0.4040	1.08e-01	-8.14e-02	2.67e-01	2.39e-01	1.28e-01	4.68e-01	5.85e-01	7.29e-02	1.09e-01	3.90e-01
OLFACTORY BULB INTERNEURON DEVELOPMENT	7	8.87e-01	9.91e-01	0.4040	-2.47e-01	-2.15e-01	-1.49e-01	-1.63e-01	8.66e-02	2.58e-01	3.25e-01	4.95e-01	4.55e-01	6.91e-01
POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	9	5.31e-01	9.07e-01	0.4040	1.05e-01	1.84e-01	1.86e-01	1.75e-01	2.30e-01	5.86e-01	3.38e-01	3.33e-01	3.64e-01	2.31e-01
NOREPINEPHRINE BIOSYNTHETIC PROCESS	8	7.18e-01	9.69e-01	0.4040	1.33e-01	-1.09e-02	1.56e-01	1.72e-01	3.02e-01	5.14e-01	9.57e-01	4.45e-01	4.01e-01	1.38e-01
RETINAL ROD CELL DEVELOPMENT	8	6.39e-01	9.49e-01	0.4040	1.97e-01	8.21e-03	1.58e-01	1.58e-01	2.73e-01	3.34e-01	9.68e-01	4.40e-01	4.40e-01	1.81e-01
POSITIVE REGULATION OF BLOOD VESSEL REMODELING	6	8.77e-01	9.88e-01	0.4040	-2.48e-01	-2.60e-01	-1.02e-01	-1.40e-01	6.42e-02	2.93e-01	2.71e-01	6.64e-01	5.53e-01	7.85e-01
NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	12	4.45e-01	8.73e-01	0.4040	-2.23e-01	-2.81e-01	-9.54e-02	-9.37e-02	-1.27e-01	1.82e-01	9.14e-02	5.67e-01	5.74e-01	4.44e-01
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	8	6.80e-01	9.60e-01	0.4040	5.48e-02	-1.68e-01	1.73e-01	1.48e-01	2.82e-01	7.88e-01	4.11e-01	3.96e-01	4.68e-01	1.67e-01
POSITIVE REGULATION OF BONE RESORPTION	18	5.23e-01	9.04e-01	0.4030	-1.74e-01	-1.18e-01	-2.47e-01	-2.27e-01	-7.76e-02	2.01e-01	3.85e-01	6.98e-02	9.57e-02	5.68e-01
NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	9	5.82e-01	9.28e-01	0.4030	6.91e-02	6.64e-02	1.49e-01	1.37e-01	3.35e-01	7.20e-01	7.30e-01	4.38e-01	4.77e-01	8.15e-02
RENAL SODIUM ION TRANSPORT	15	2.25e-01	7.06e-01	0.4030	7.83e-02	2.20e-01	-1.66e-02	-3.11e-03	-3.29e-01	5.99e-01	1.41e-01	9.12e-01	9.83e-01	2.75e-02
TRNA TRANSPORT	6	5.84e-01	9.28e-01	0.4030	6.62e-02	2.57e-02	2.95e-01	2.56e-01	6.98e-02	7.79e-01	9.13e-01	2.11e-01	2.77e-01	7.67e-01
COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY	12	2.49e-02	2.34e-01	0.4030	-1.43e-02	-1.02e-01	-1.22e-02	4.57e-02	3.87e-01	9.31e-01	5.40e-01	9.42e-01	7.84e-01	2.04e-02
REGULATION OF CILIUM MOVEMENT	38	1.61e-01	6.25e-01	0.4030	2.55e-01	1.95e-01	1.66e-01	1.79e-01	1.30e-03	6.54e-03	3.79e-02	7.68e-02	5.68e-02	9.89e-01
ENDOTHELIAL CELL MATRIX ADHESION	8	1.27e-01	5.68e-01	0.4030	1.23e-01	-9.20e-02	5.21e-03	2.26e-02	3.72e-01	5.48e-01	6.52e-01	9.80e-01	9.12e-01	6.87e-02
REGULATION OF T HELPER 1 CELL DIFFERENTIATION	11	6.91e-01	9.61e-01	0.4030	-1.69e-01	-2.25e-01	-2.01e-01	-1.99e-01	-5.33e-02	3.32e-01	1.95e-01	2.50e-01	2.52e-01	7.60e-01
REGULATION OF RIBOSOME BIOGENESIS	9	2.19e-01	7.00e-01	0.4030	1.05e-01	-3.22e-02	2.20e-01	2.28e-01	-2.23e-01	5.85e-01	8.67e-01	2.53e-01	2.36e-01	2.48e-01
BRAINSTEM DEVELOPMENT	7	4.35e-01	8.69e-01	0.4030	1.92e-01	3.07e-01	7.79e-02	1.53e-01	-3.71e-02	3.79e-01	1.59e-01	7.21e-01	4.84e-01	8.65e-01
CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS	14	2.09e-01	6.86e-01	0.4030	-8.16e-02	-1.81e-01	-1.54e-02	-2.14e-02	3.49e-01	5.97e-01	2.41e-01	9.21e-01	8.90e-01	2.36e-02
DTTP METABOLIC PROCESS	5	8.95e-01	9.93e-01	0.4030	2.51e-01	5.97e-02	1.97e-01	2.18e-01	9.59e-02	3.31e-01	8.17e-01	4.46e-01	3.99e-01	7.10e-01
REGULATION OF FLAGELLATED SPERM MOTILITY	18	4.66e-01	8.83e-01	0.4020	2.32e-01	1.86e-01	1.71e-01	2.09e-01	2.40e-02	8.89e-02	1.71e-01	2.09e-01	1.25e-01	8.60e-01
RESPONSE TO L PHENYLALANINE DERIVATIVE	6	7.99e-01	9.82e-01	0.4020	1.50e-01	-1.11e-01	2.34e-01	2.16e-01	1.60e-01	5.23e-01	6.38e-01	3.21e-01	3.60e-01	4.97e-01
CELLULAR RESPONSE TO ACIDIC PH	16	3.35e-01	8.05e-01	0.4020	1.63e-01	2.07e-01	1.46e-01	1.72e-01	2.03e-01	2.58e-01	1.52e-01	3.12e-01	2.33e-01	1.60e-01
MICROTUBULE ANCHORING	23	2.06e-01	6.84e-01	0.4020	-2.00e-01	-1.82e-01	-1.84e-01	-2.15e-01	9.11e-02	9.67e-02	1.32e-01	1.27e-01	7.38e-02	4.50e-01
PRIMITIVE STREAK FORMATION	10	6.99e-03	1.02e-01	0.4020	2.59e-01	-4.79e-03	7.34e-02	5.06e-02	-2.94e-01	1.57e-01	9.79e-01	6.88e-01	7.82e-01	1.07e-01
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE	16	1.82e-01	6.56e-01	0.4010	-2.48e-01	-2.55e-01	-4.12e-02	-9.28e-02	1.56e-01	8.54e-02	7.77e-02	7.75e-01	5.21e-01	2.81e-01
ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	74	5.95e-03	9.21e-02	0.4010	1.90e-01	3.42e-02	2.47e-01	2.41e-01	6.88e-02	4.61e-03	6.11e-01	2.44e-04	3.43e-04	3.06e-01
MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	17	2.56e-01	7.39e-01	0.4010	-1.62e-01	-2.40e-01	-1.79e-01	-2.09e-01	-3.63e-02	2.47e-01	8.61e-02	2.02e-01	1.36e-01	7.96e-01
GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY	5	6.00e-01	9.33e-01	0.4010	1.40e-02	-3.39e-02	-2.16e-02	-1.84e-02	3.98e-01	9.57e-01	8.95e-01	9.33e-01	9.43e-01	1.23e-01
POSITIVE REGULATION OF DNA DEMETHYLATION	8	1.55e-01	6.17e-01	0.4010	-2.84e-01	-1.50e-01	-3.10e-02	-3.36e-02	2.35e-01	1.64e-01	4.63e-01	8.79e-01	8.69e-01	2.50e-01
REGULATION OF ENDOSOME SIZE	13	8.53e-02	4.67e-01	0.4010	2.51e-02	-3.07e-01	1.51e-01	1.11e-01	1.75e-01	8.75e-01	5.54e-02	3.46e-01	4.89e-01	2.74e-01
NK T CELL ACTIVATION	12	3.20e-01	7.93e-01	0.4000	-1.77e-01	-1.41e-01	-2.27e-01	-1.97e-01	1.37e-01	2.89e-01	3.98e-01	1.73e-01	2.36e-01	4.10e-01
RETICULOPHAGY	18	2.76e-01	7.57e-01	0.4000	2.68e-01	1.25e-01	1.79e-01	1.89e-01	-6.77e-02	4.89e-02	3.58e-01	1.87e-01	1.64e-01	6.19e-01
SENSORY PERCEPTION OF CHEMICAL STIMULUS	458	5.11e-29	7.69e-26	0.4000	-2.44e-01	-4.55e-02	-2.18e-01	-2.22e-01	-3.88e-02	3.14e-19	9.51e-02	1.27e-15	3.56e-16	1.55e-01
TRANSFORMING GROWTH FACTOR BETA ACTIVATION	13	2.88e-01	7.66e-01	0.4000	-1.69e-01	9.43e-02	-2.54e-01	-2.39e-01	-3.24e-02	2.92e-01	5.56e-01	1.13e-01	1.36e-01	8.40e-01
REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	12	4.43e-01	8.72e-01	0.4000	-2.09e-01	-7.45e-02	-2.52e-01	-2.12e-01	-4.46e-02	2.09e-01	6.55e-01	1.30e-01	2.04e-01	7.89e-01
REGULATION OF FIBROBLAST APOPTOTIC PROCESS	19	2.55e-01	7.38e-01	0.4000	2.05e-01	2.91e-01	1.15e-01	1.05e-01	-9.35e-02	1.22e-01	2.80e-02	3.86e-01	4.28e-01	4.80e-01
ACTIN FILAMENT NETWORK FORMATION	8	4.05e-01	8.50e-01	0.4000	-1.61e-01	3.83e-02	-2.28e-01	-2.32e-01	1.62e-01	4.31e-01	8.51e-01	2.63e-01	2.56e-01	4.27e-01
NEGATIVE REGULATION OF CYCLASE ACTIVITY	15	4.07e-01	8.50e-01	0.3990	2.39e-01	1.06e-01	1.57e-01	1.61e-01	2.02e-01	1.09e-01	4.78e-01	2.92e-01	2.81e-01	1.76e-01
SIGNAL PEPTIDE PROCESSING	13	4.10e-01	8.52e-01	0.3990	1.25e-01	-1.12e-01	2.44e-01	2.11e-01	1.66e-01	4.36e-01	4.85e-01	1.28e-01	1.88e-01	3.01e-01
POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	18	3.00e-01	7.73e-01	0.3990	-2.15e-01	-2.09e-01	-1.18e-01	-1.48e-01	1.84e-01	1.14e-01	1.25e-01	3.87e-01	2.76e-01	1.77e-01
MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION	8	5.34e-01	9.09e-01	0.3990	-2.71e-01	-1.14e-01	-1.62e-01	-2.15e-01	-7.83e-03	1.84e-01	5.75e-01	4.28e-01	2.92e-01	9.69e-01
NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS	10	2.82e-01	7.60e-01	0.3990	7.80e-02	1.45e-01	2.36e-01	1.94e-01	1.97e-01	6.69e-01	4.27e-01	1.97e-01	2.87e-01	2.81e-01
NEGATIVE REGULATION OF VIRAL LIFE CYCLE	26	2.67e-01	7.48e-01	0.3990	1.96e-01	1.12e-01	1.78e-01	1.68e-01	2.20e-01	8.36e-02	3.24e-01	1.15e-01	1.39e-01	5.21e-02
POSITIVE REGULATION OF CGMP MEDIATED SIGNALING	5	5.45e-01	9.15e-01	0.3990	-1.02e-01	-2.04e-01	1.90e-01	1.96e-01	1.81e-01	6.93e-01	4.29e-01	4.62e-01	4.47e-01	4.84e-01
NEGATIVE REGULATION OF DOPAMINE SECRETION	5	4.89e-01	8.92e-01	0.3990	-5.91e-02	7.28e-02	7.22e-02	5.63e-02	3.77e-01	8.19e-01	7.78e-01	7.80e-01	8.27e-01	1.45e-01
ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION	6	6.17e-01	9.40e-01	0.3990	9.72e-02	-2.04e-01	2.10e-01	2.21e-01	1.23e-01	6.80e-01	3.88e-01	3.73e-01	3.48e-01	6.02e-01
POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	11	1.70e-01	6.39e-01	0.3990	1.07e-01	-4.21e-02	2.51e-01	2.83e-01	-5.13e-02	5.40e-01	8.09e-01	1.49e-01	1.04e-01	7.68e-01
NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	12	2.59e-01	7.43e-01	0.3990	2.69e-01	4.88e-02	1.79e-01	1.67e-01	1.58e-01	1.07e-01	7.70e-01	2.83e-01	3.18e-01	3.44e-01
INTERLEUKIN 5 PRODUCTION	19	5.98e-01	9.33e-01	0.3990	-2.01e-01	-1.33e-01	-1.79e-01	-1.84e-01	-1.87e-01	1.30e-01	3.16e-01	1.77e-01	1.64e-01	1.57e-01
REGULATION OF PROSTAGLANDIN SECRETION	13	2.64e-01	7.47e-01	0.3990	-1.63e-01	-1.88e-01	-2.33e-01	-1.97e-01	6.63e-02	3.10e-01	2.40e-01	1.47e-01	2.19e-01	6.79e-01
ALPHA KETOGLUTARATE TRANSPORT	7	4.76e-02	3.41e-01	0.3990	-1.64e-02	2.95e-01	6.32e-02	9.93e-02	2.40e-01	9.40e-01	1.76e-01	7.72e-01	6.49e-01	2.71e-01
FERMENTATION	5	6.46e-01	9.50e-01	0.3990	-3.43e-02	-3.12e-01	8.62e-02	1.02e-01	2.06e-01	8.94e-01	2.26e-01	7.39e-01	6.92e-01	4.26e-01
PROTEIN K29 LINKED UBIQUITINATION	7	6.86e-01	9.61e-01	0.3990	3.06e-02	1.85e-02	1.75e-01	1.50e-01	3.23e-01	8.88e-01	9.32e-01	4.23e-01	4.91e-01	1.38e-01
NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION	6	9.09e-01	9.94e-01	0.3980	1.74e-01	6.68e-02	1.71e-01	1.85e-01	2.45e-01	4.59e-01	7.77e-01	4.68e-01	4.33e-01	2.98e-01
POSITIVE REGULATION OF COMPLEMENT ACTIVATION	7	4.33e-01	8.69e-01	0.3980	-1.39e-01	-2.65e-01	1.15e-01	1.26e-01	2.00e-01	5.24e-01	2.25e-01	6.00e-01	5.65e-01	3.59e-01
LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS	6	5.49e-01	9.15e-01	0.3980	-2.62e-01	-1.37e-01	-2.11e-01	-1.62e-01	1.21e-02	2.66e-01	5.61e-01	3.71e-01	4.93e-01	9.59e-01
NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	9	7.24e-01	9.70e-01	0.3980	-2.28e-01	-2.42e-01	-1.14e-01	-1.19e-01	-1.44e-01	2.37e-01	2.08e-01	5.55e-01	5.36e-01	4.56e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	13	3.95e-02	3.05e-01	0.3980	-1.05e-01	-3.56e-01	6.45e-02	7.33e-02	-1.05e-01	5.13e-01	2.63e-02	6.87e-01	6.47e-01	5.12e-01
NEGATIVE REGULATION OF CYTOKINESIS	7	1.44e-01	6.02e-01	0.3980	-7.64e-02	-2.67e-01	1.04e-01	1.27e-01	-2.33e-01	7.26e-01	2.21e-01	6.35e-01	5.60e-01	2.87e-01
NUCLEOPHAGY	18	5.24e-01	9.05e-01	0.3970	-1.45e-01	-1.82e-02	-2.56e-01	-2.49e-01	-9.62e-02	2.87e-01	8.93e-01	6.03e-02	6.79e-02	4.80e-01
PROTEIN RNA COMPLEX DISASSEMBLY	8	3.86e-01	8.40e-01	0.3970	-1.61e-01	-3.25e-01	3.93e-02	-3.21e-02	1.54e-01	4.31e-01	1.11e-01	8.47e-01	8.75e-01	4.52e-01
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	37	3.30e-02	2.75e-01	0.3970	2.51e-01	7.22e-02	2.11e-01	2.11e-01	-9.99e-03	8.20e-03	4.47e-01	2.61e-02	2.60e-02	9.16e-01
POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	10	4.14e-01	8.54e-01	0.3970	-1.35e-01	-2.84e-01	-1.55e-01	-1.43e-01	-1.20e-01	4.59e-01	1.20e-01	3.97e-01	4.32e-01	5.12e-01
MAMMARY GLAND FORMATION	7	3.01e-01	7.73e-01	0.3970	1.09e-02	-2.37e-01	2.42e-01	1.65e-01	1.24e-01	9.60e-01	2.77e-01	2.68e-01	4.50e-01	5.69e-01
PROTEIN O LINKED GLYCOSYLATION VIA SERINE	10	6.44e-01	9.50e-01	0.3970	-2.21e-01	-2.15e-01	-1.48e-01	-1.96e-01	4.28e-02	2.27e-01	2.38e-01	4.18e-01	2.83e-01	8.15e-01
POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	5	5.13e-01	9.01e-01	0.3960	2.08e-01	5.01e-03	1.67e-01	1.51e-01	-2.51e-01	4.21e-01	9.85e-01	5.17e-01	5.59e-01	3.30e-01
VESICLE FUSION WITH GOLGI APPARATUS	9	3.48e-01	8.18e-01	0.3960	1.51e-01	-1.65e-01	1.90e-01	2.06e-01	1.68e-01	4.34e-01	3.90e-01	3.24e-01	2.83e-01	3.82e-01
NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	6	2.92e-01	7.67e-01	0.3960	-1.64e-01	2.06e-01	-2.23e-01	-1.92e-01	2.54e-02	4.86e-01	3.82e-01	3.45e-01	4.15e-01	9.14e-01
IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION	10	8.05e-01	9.82e-01	0.3950	2.22e-01	4.91e-02	2.22e-01	2.23e-01	7.72e-02	2.25e-01	7.88e-01	2.24e-01	2.22e-01	6.72e-01
RESPONSE TO GRAVITY	9	4.00e-01	8.45e-01	0.3950	-2.33e-01	-3.08e-01	7.71e-03	-5.38e-02	6.76e-02	2.27e-01	1.10e-01	9.68e-01	7.80e-01	7.25e-01
ATP METABOLIC PROCESS	124	3.58e-06	2.15e-04	0.3950	1.96e-01	6.58e-03	2.33e-01	2.42e-01	6.73e-02	1.58e-04	8.99e-01	7.16e-06	3.10e-06	1.95e-01
VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS	8	3.24e-01	7.96e-01	0.3950	-1.65e-01	-3.50e-01	3.52e-02	-1.98e-02	-6.97e-02	4.18e-01	8.65e-02	8.63e-01	9.23e-01	7.33e-01
PROTEIN K11 LINKED UBIQUITINATION	28	1.29e-01	5.72e-01	0.3950	1.72e-01	-4.06e-02	2.22e-01	2.02e-01	1.88e-01	1.15e-01	7.10e-01	4.23e-02	6.48e-02	8.51e-02
NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING	16	5.34e-01	9.09e-01	0.3950	-2.51e-01	-2.12e-01	-1.36e-01	-1.70e-01	3.00e-02	8.20e-02	1.43e-01	3.46e-01	2.40e-01	8.35e-01
CHOLESTEROL IMPORT	9	3.81e-01	8.38e-01	0.3950	-3.09e-02	-6.26e-02	2.07e-01	2.01e-01	2.60e-01	8.72e-01	7.45e-01	2.81e-01	2.96e-01	1.77e-01
FRUCTOSE TRANSMEMBRANE TRANSPORT	10	6.86e-01	9.61e-01	0.3950	-1.80e-01	-1.19e-01	-2.47e-01	-2.20e-01	4.75e-03	3.23e-01	5.13e-01	1.77e-01	2.29e-01	9.79e-01
UTERINE SMOOTH MUSCLE CONTRACTION	9	8.90e-01	9.91e-01	0.3950	-2.19e-01	-2.20e-01	-1.62e-01	-1.83e-01	-2.44e-03	2.55e-01	2.53e-01	4.01e-01	3.42e-01	9.90e-01
RESPONSE TO LIPOTEICHOIC ACID	10	6.85e-01	9.61e-01	0.3950	-2.07e-01	-1.05e-01	-2.19e-01	-2.13e-01	9.39e-02	2.57e-01	5.65e-01	2.30e-01	2.44e-01	6.07e-01
DAMP METABOLIC PROCESS	7	8.20e-01	9.83e-01	0.3950	2.31e-01	2.91e-01	7.06e-02	7.94e-02	-7.88e-02	2.89e-01	1.82e-01	7.46e-01	7.16e-01	7.18e-01
RESPONSE TO ETHER	11	6.93e-01	9.61e-01	0.3950	7.17e-02	-5.74e-02	2.03e-01	2.01e-01	2.56e-01	6.80e-01	7.42e-01	2.44e-01	2.48e-01	1.41e-01
ZINC ION IMPORT INTO ORGANELLE	9	5.96e-01	9.33e-01	0.3950	2.54e-02	-1.44e-01	2.38e-01	2.25e-01	1.65e-01	8.95e-01	4.54e-01	2.17e-01	2.43e-01	3.92e-01
S SHAPED BODY MORPHOGENESIS	7	3.15e-02	2.68e-01	0.3940	1.97e-01	-3.94e-02	2.19e-01	1.09e-01	2.35e-01	3.67e-01	8.57e-01	3.16e-01	6.16e-01	2.81e-01
MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT	7	2.37e-01	7.21e-01	0.3940	6.09e-02	-2.11e-01	3.53e-02	4.41e-03	3.26e-01	7.80e-01	3.34e-01	8.71e-01	9.84e-01	1.36e-01
NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	7	3.69e-01	8.31e-01	0.3940	7.87e-02	6.36e-02	1.50e-01	2.05e-01	2.84e-01	7.18e-01	7.71e-01	4.91e-01	3.47e-01	1.94e-01
POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	14	8.33e-01	9.85e-01	0.3940	-2.01e-01	-1.17e-01	-2.05e-01	-2.04e-01	-1.34e-01	1.93e-01	4.48e-01	1.85e-01	1.86e-01	3.86e-01
NUCLEOSIDE TRANSPORT	10	1.59e-02	1.74e-01	0.3940	-1.43e-01	1.93e-01	-1.76e-01	-1.37e-01	2.19e-01	4.34e-01	2.91e-01	3.34e-01	4.52e-01	2.31e-01
PERICYTE CELL DIFFERENTIATION	11	1.93e-01	6.67e-01	0.3940	-1.11e-01	-3.45e-01	-1.00e-01	-1.17e-01	-9.88e-03	5.24e-01	4.74e-02	5.65e-01	5.01e-01	9.55e-01
POSITIVE REGULATION OF CAMP MEDIATED SIGNALING	15	5.80e-01	9.27e-01	0.3940	-1.77e-01	-2.14e-01	-1.98e-01	-1.86e-01	-6.74e-02	2.36e-01	1.51e-01	1.84e-01	2.14e-01	6.51e-01
PEPTIDYL LYSINE HYDROXYLATION	8	2.79e-01	7.58e-01	0.3940	7.27e-02	9.43e-03	1.16e-01	1.31e-01	-3.45e-01	7.22e-01	9.63e-01	5.68e-01	5.22e-01	9.09e-02
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION	7	5.47e-01	9.15e-01	0.3940	3.47e-02	2.32e-02	7.29e-02	4.79e-02	3.82e-01	8.74e-01	9.15e-01	7.38e-01	8.26e-01	8.01e-02
REGULATION OF LEUKOCYTE DEGRANULATION	43	8.35e-03	1.14e-01	0.3940	-1.57e-01	-2.51e-01	-1.83e-01	-1.79e-01	4.07e-02	7.44e-02	4.39e-03	3.73e-02	4.24e-02	6.45e-01
B CELL LINEAGE COMMITMENT	6	7.81e-01	9.81e-01	0.3940	1.89e-01	3.08e-01	-2.36e-02	-6.16e-03	-1.55e-01	4.24e-01	1.91e-01	9.20e-01	9.79e-01	5.12e-01
MYOBLAST PROLIFERATION	34	3.36e-01	8.06e-01	0.3940	-1.69e-01	-1.16e-01	-2.17e-01	-2.22e-01	-1.28e-01	8.80e-02	2.43e-01	2.86e-02	2.47e-02	1.97e-01
REGULATION OF MACROPHAGE APOPTOTIC PROCESS	11	3.19e-01	7.91e-01	0.3930	1.59e-02	-2.05e-01	1.17e-01	7.54e-02	3.05e-01	9.27e-01	2.38e-01	5.01e-01	6.65e-01	7.99e-02
POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION	5	5.47e-01	9.15e-01	0.3930	4.77e-02	-1.26e-01	1.07e-01	4.41e-02	3.51e-01	8.53e-01	6.25e-01	6.77e-01	8.64e-01	1.74e-01
BASEMENT MEMBRANE ORGANIZATION	36	2.76e-01	7.57e-01	0.3930	-2.19e-01	-1.84e-01	-1.81e-01	-2.00e-01	-5.02e-04	2.32e-02	5.57e-02	5.96e-02	3.78e-02	9.96e-01
NEGATIVE REGULATION OF COMPLEMENT ACTIVATION	12	2.21e-01	7.01e-01	0.3930	-1.84e-01	-2.33e-01	4.02e-02	-2.07e-02	2.54e-01	2.70e-01	1.62e-01	8.09e-01	9.01e-01	1.28e-01
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	25	7.91e-03	1.10e-01	0.3930	6.65e-02	-2.58e-01	1.93e-01	1.72e-01	1.29e-01	5.65e-01	2.56e-02	9.46e-02	1.36e-01	2.65e-01
CELLULAR RESPONSE TO SALT STRESS	14	5.07e-01	8.99e-01	0.3930	1.72e-01	2.39e-01	1.65e-01	1.53e-01	1.31e-01	2.66e-01	1.21e-01	2.87e-01	3.22e-01	3.95e-01
NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	9	6.48e-01	9.51e-01	0.3930	1.67e-01	1.51e-01	1.96e-01	2.01e-01	-1.58e-01	3.86e-01	4.34e-01	3.09e-01	2.98e-01	4.11e-01
PARAXIAL MESODERM FORMATION	7	7.92e-01	9.81e-01	0.3930	1.53e-01	1.07e-01	2.51e-01	2.11e-01	1.09e-01	4.83e-01	6.24e-01	2.51e-01	3.33e-01	6.18e-01
OPSONIZATION	16	4.19e-02	3.13e-01	0.3920	-6.04e-02	2.42e-01	-1.82e-01	-1.27e-01	-2.06e-01	6.76e-01	9.41e-02	2.08e-01	3.78e-01	1.53e-01
BERGMANN GLIAL CELL DIFFERENTIATION	11	7.35e-01	9.73e-01	0.3920	2.20e-01	1.30e-01	1.55e-01	1.74e-01	1.85e-01	2.07e-01	4.54e-01	3.72e-01	3.17e-01	2.89e-01
CHORION DEVELOPMENT	10	8.95e-02	4.76e-01	0.3920	-2.65e-01	-2.79e-01	-5.78e-02	-1.60e-02	5.00e-02	1.47e-01	1.27e-01	7.52e-01	9.30e-01	7.84e-01
SEQUESTERING OF TRIGLYCERIDE	18	2.76e-01	7.56e-01	0.3920	-1.78e-01	-2.15e-01	-2.06e-01	-1.81e-01	2.47e-02	1.90e-01	1.15e-01	1.30e-01	1.84e-01	8.56e-01
RESPONSE TO VASOPRESSIN	8	7.36e-01	9.73e-01	0.3920	2.20e-01	1.84e-01	1.24e-01	1.34e-01	-1.94e-01	2.81e-01	3.66e-01	5.42e-01	5.11e-01	3.41e-01
PH REDUCTION	6	8.21e-01	9.83e-01	0.3920	1.73e-01	3.20e-01	4.81e-02	5.27e-02	-1.27e-01	4.64e-01	1.74e-01	8.38e-01	8.23e-01	5.91e-01
GOLGI TO LYSOSOME TRANSPORT	12	8.14e-01	9.82e-01	0.3920	-1.95e-01	-4.66e-02	-2.30e-01	-2.26e-01	-9.62e-02	2.42e-01	7.80e-01	1.67e-01	1.75e-01	5.64e-01
INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY	9	5.29e-01	9.07e-01	0.3920	-1.79e-01	-5.68e-02	-2.10e-01	-2.34e-01	1.39e-01	3.53e-01	7.68e-01	2.75e-01	2.24e-01	4.69e-01
NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	5	4.50e-01	8.76e-01	0.3920	-7.72e-02	-2.85e-01	8.35e-02	6.26e-02	-2.35e-01	7.65e-01	2.69e-01	7.46e-01	8.08e-01	3.62e-01
C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY	5	3.08e-01	7.82e-01	0.3920	9.78e-02	-7.04e-02	-5.87e-03	5.36e-02	3.69e-01	7.05e-01	7.85e-01	9.82e-01	8.36e-01	1.53e-01
POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	13	5.75e-02	3.80e-01	0.3920	-9.67e-02	-3.37e-01	-6.60e-02	-5.02e-02	-1.53e-01	5.46e-01	3.52e-02	6.80e-01	7.54e-01	3.39e-01
REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL	6	6.00e-01	9.33e-01	0.3920	-6.61e-02	-3.31e-02	-2.86e-01	-2.55e-01	-3.31e-02	7.79e-01	8.88e-01	2.26e-01	2.79e-01	8.88e-01
BONE CELL DEVELOPMENT	17	2.77e-01	7.57e-01	0.3910	-1.31e-01	1.23e-01	-2.02e-01	-1.99e-01	-2.01e-01	3.48e-01	3.79e-01	1.50e-01	1.56e-01	1.51e-01
CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	13	6.40e-01	9.49e-01	0.3910	-1.51e-01	-9.44e-02	-2.46e-01	-2.45e-01	-2.16e-02	3.44e-01	5.56e-01	1.24e-01	1.26e-01	8.93e-01
CUT CATABOLIC PROCESS	5	6.42e-01	9.50e-01	0.3910	1.62e-01	9.94e-02	9.79e-02	8.08e-02	-3.17e-01	5.31e-01	7.00e-01	7.05e-01	7.54e-01	2.19e-01
G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY	22	3.35e-01	8.06e-01	0.3910	-1.51e-01	-2.56e-02	-2.41e-01	-2.55e-01	-8.10e-02	2.20e-01	8.35e-01	5.07e-02	3.85e-02	5.10e-01
REGULATION OF GUANYLATE CYCLASE ACTIVITY	6	1.19e-01	5.51e-01	0.3910	1.59e-01	3.26e-01	-1.35e-01	-1.93e-02	-5.40e-02	5.00e-01	1.67e-01	5.66e-01	9.35e-01	8.19e-01
NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	5	6.43e-01	9.50e-01	0.3910	-8.64e-02	-2.11e-01	-2.29e-01	-2.16e-01	-3.97e-02	7.38e-01	4.14e-01	3.76e-01	4.02e-01	8.78e-01
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION	5	1.84e-01	6.56e-01	0.3910	-1.58e-01	1.86e-01	-2.55e-01	-1.66e-01	-2.32e-02	5.40e-01	4.71e-01	3.24e-01	5.20e-01	9.28e-01
REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY	8	2.18e-01	7.00e-01	0.3910	1.41e-01	3.30e-01	-5.60e-02	5.16e-04	1.43e-01	4.88e-01	1.06e-01	7.84e-01	9.98e-01	4.85e-01
PLASMA MEMBRANE FUSION	30	5.15e-03	8.32e-02	0.3910	1.33e-02	2.71e-01	-1.43e-01	-9.61e-02	-2.22e-01	9.00e-01	1.02e-02	1.75e-01	3.62e-01	3.54e-02
TYPE B PANCREATIC CELL APOPTOTIC PROCESS	10	6.74e-01	9.59e-01	0.3910	2.28e-01	7.96e-02	1.92e-01	1.72e-01	1.67e-01	2.12e-01	6.63e-01	2.94e-01	3.45e-01	3.62e-01
NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	7	4.50e-01	8.76e-01	0.3910	-3.20e-02	-7.50e-02	1.99e-01	2.13e-01	2.47e-01	8.83e-01	7.31e-01	3.62e-01	3.30e-01	2.58e-01
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION	472	4.51e-31	1.13e-27	0.3900	-2.41e-01	-3.88e-02	-2.14e-01	-2.14e-01	-3.58e-02	2.35e-19	1.48e-01	1.74e-15	1.64e-15	1.82e-01
POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	8	8.04e-01	9.82e-01	0.3900	2.30e-01	1.91e-01	1.34e-01	1.51e-01	-1.49e-01	2.60e-01	3.49e-01	5.11e-01	4.60e-01	4.65e-01
NOREPINEPHRINE UPTAKE	8	5.52e-01	9.16e-01	0.3900	7.37e-02	3.19e-01	-5.41e-02	-4.41e-02	-2.00e-01	7.18e-01	1.18e-01	7.91e-01	8.29e-01	3.27e-01
POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	40	6.35e-03	9.56e-02	0.3900	-1.63e-01	-2.13e-01	-1.55e-01	-1.45e-01	1.88e-01	7.45e-02	1.96e-02	8.94e-02	1.13e-01	4.00e-02
REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY	5	4.46e-01	8.73e-01	0.3900	2.59e-01	3.70e-02	2.23e-01	1.69e-01	-7.49e-02	3.16e-01	8.86e-01	3.88e-01	5.13e-01	7.72e-01
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	7.47e-01	9.75e-01	0.3900	1.35e-01	6.11e-02	2.38e-01	2.42e-01	1.22e-01	4.17e-01	7.14e-01	1.54e-01	1.46e-01	4.63e-01
CELLULAR RESPONSE TO GLUCOSE STARVATION	49	7.51e-02	4.40e-01	0.3900	2.00e-01	4.79e-02	2.30e-01	2.32e-01	5.85e-02	1.55e-02	5.62e-01	5.38e-03	4.97e-03	4.79e-01
REGULATION OF INTESTINAL ABSORPTION	12	5.19e-01	9.03e-01	0.3900	-1.06e-02	1.43e-01	-1.91e-01	-1.58e-01	-2.66e-01	9.49e-01	3.92e-01	2.53e-01	3.45e-01	1.11e-01
CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS	6	7.38e-01	9.73e-01	0.3900	1.52e-01	2.04e-01	-3.45e-02	4.47e-03	-2.93e-01	5.19e-01	3.86e-01	8.83e-01	9.85e-01	2.13e-01
VIRION ASSEMBLY	34	2.24e-02	2.19e-01	0.3900	9.19e-02	-1.52e-01	2.05e-01	2.10e-01	1.86e-01	3.54e-01	1.25e-01	3.89e-02	3.44e-02	6.00e-02
NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	11	4.67e-01	8.83e-01	0.3900	5.95e-02	7.34e-02	1.73e-01	1.51e-01	3.00e-01	7.33e-01	6.73e-01	3.20e-01	3.84e-01	8.46e-02
REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	16	4.46e-02	3.28e-01	0.3900	-1.37e-01	6.47e-02	-2.37e-01	-1.66e-01	-2.13e-01	3.41e-01	6.54e-01	1.01e-01	2.52e-01	1.40e-01
CARTILAGE MORPHOGENESIS	10	2.51e-01	7.35e-01	0.3900	9.23e-02	-2.02e-01	2.37e-01	1.89e-01	1.02e-01	6.13e-01	2.69e-01	1.94e-01	3.00e-01	5.78e-01
NEGATIVE REGULATION OF B CELL DIFFERENTIATION	6	2.74e-01	7.56e-01	0.3890	2.21e-01	-1.47e-01	1.89e-01	1.55e-01	1.46e-01	3.48e-01	5.33e-01	4.24e-01	5.10e-01	5.35e-01
RAP PROTEIN SIGNAL TRANSDUCTION	12	2.55e-01	7.38e-01	0.3890	4.55e-02	-9.57e-02	2.04e-01	1.41e-01	2.81e-01	7.85e-01	5.66e-01	2.20e-01	3.98e-01	9.23e-02
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	17	4.01e-02	3.06e-01	0.3890	-2.31e-01	-2.93e-01	-2.06e-02	-9.17e-02	-5.77e-02	9.96e-02	3.62e-02	8.83e-01	5.13e-01	6.81e-01
PROTEIN DENEDDYLATION	11	2.78e-01	7.58e-01	0.3890	5.75e-02	-1.52e-01	2.10e-01	1.48e-01	2.43e-01	7.41e-01	3.82e-01	2.28e-01	3.96e-01	1.64e-01
PROTEIN TRANSPORT WITHIN LIPID BILAYER	6	5.85e-01	9.28e-01	0.3890	1.57e-01	4.87e-02	1.34e-01	1.44e-01	-2.93e-01	5.05e-01	8.36e-01	5.71e-01	5.40e-01	2.15e-01
REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	19	2.28e-01	7.11e-01	0.3890	-1.68e-01	-2.19e-01	-6.60e-02	-7.92e-02	2.54e-01	2.05e-01	9.88e-02	6.19e-01	5.50e-01	5.55e-02
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	5	6.38e-01	9.49e-01	0.3890	2.66e-02	-2.84e-02	-1.46e-02	-1.88e-02	-3.86e-01	9.18e-01	9.12e-01	9.55e-01	9.42e-01	1.35e-01
ANTERIOR POSTERIOR AXON GUIDANCE	7	6.56e-01	9.53e-01	0.3880	1.57e-01	3.35e-02	1.73e-01	1.31e-01	2.79e-01	4.71e-01	8.78e-01	4.28e-01	5.48e-01	2.01e-01
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	14	1.03e-01	5.13e-01	0.3880	-2.16e-01	-3.09e-01	-1.23e-02	-8.01e-02	-4.65e-02	1.63e-01	4.52e-02	9.37e-01	6.04e-01	7.63e-01
HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	15	5.40e-01	9.13e-01	0.3880	-2.38e-01	-1.42e-01	-1.73e-01	-2.09e-01	9.40e-04	1.10e-01	3.41e-01	2.45e-01	1.60e-01	9.95e-01
UBIQUITIN DEPENDENT ENDOCYTOSIS	7	6.53e-01	9.52e-01	0.3880	7.46e-02	1.13e-01	1.16e-01	1.05e-01	3.28e-01	7.33e-01	6.04e-01	5.96e-01	6.31e-01	1.32e-01
POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE	5	7.20e-01	9.69e-01	0.3880	-5.50e-02	-1.11e-01	1.39e-01	1.51e-01	3.05e-01	8.31e-01	6.67e-01	5.91e-01	5.59e-01	2.37e-01
ORGANELLE INHERITANCE	15	3.88e-01	8.40e-01	0.3880	6.32e-02	-1.12e-01	1.38e-01	1.31e-01	3.12e-01	6.72e-01	4.52e-01	3.53e-01	3.82e-01	3.63e-02
DNA REPLICATION INITIATION	35	9.53e-02	4.92e-01	0.3880	1.73e-01	3.17e-03	2.50e-01	2.34e-01	5.17e-02	7.69e-02	9.74e-01	1.03e-02	1.65e-02	5.96e-01
POLARIZED EPITHELIAL CELL DIFFERENTIATION	25	4.18e-01	8.58e-01	0.3870	-2.16e-01	-2.35e-01	-1.55e-01	-1.55e-01	1.47e-02	6.14e-02	4.23e-02	1.79e-01	1.80e-01	8.98e-01
RESPONSE TO INACTIVITY	12	5.48e-02	3.68e-01	0.3870	1.38e-01	3.07e-01	-1.42e-01	-9.63e-02	8.29e-02	4.07e-01	6.52e-02	3.93e-01	5.64e-01	6.19e-01
REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	10	8.32e-01	9.85e-01	0.3870	-2.00e-01	-2.43e-01	-1.59e-01	-1.56e-01	-2.93e-02	2.72e-01	1.83e-01	3.85e-01	3.92e-01	8.72e-01
VITAMIN D METABOLIC PROCESS	20	1.61e-01	6.25e-01	0.3870	8.05e-02	5.27e-02	1.68e-01	1.88e-01	2.78e-01	5.33e-01	6.83e-01	1.95e-01	1.44e-01	3.17e-02
ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	17	6.83e-02	4.19e-01	0.3870	1.71e-01	-1.01e-01	2.11e-01	2.45e-01	7.58e-02	2.21e-01	4.70e-01	1.33e-01	8.01e-02	5.88e-01
TAURINE METABOLIC PROCESS	9	4.95e-01	8.96e-01	0.3870	7.53e-02	-5.05e-02	1.97e-01	1.41e-01	2.87e-01	6.96e-01	7.93e-01	3.05e-01	4.64e-01	1.35e-01
ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION	12	4.69e-01	8.84e-01	0.3870	-1.55e-01	-2.37e-01	-8.32e-02	-8.33e-02	2.36e-01	3.53e-01	1.55e-01	6.18e-01	6.17e-01	1.57e-01
REGULATION OF PROTON TRANSPORT	16	3.72e-01	8.32e-01	0.3870	2.14e-01	6.82e-02	2.32e-01	2.10e-01	-2.87e-02	1.37e-01	6.37e-01	1.08e-01	1.45e-01	8.42e-01
TRYPTOPHAN CATABOLIC PROCESS	9	8.07e-01	9.82e-01	0.3860	-1.93e-01	-2.71e-01	-1.40e-01	-1.38e-01	5.07e-03	3.15e-01	1.59e-01	4.67e-01	4.74e-01	9.79e-01
MODIFICATION OF SYNAPTIC STRUCTURE	27	4.82e-01	8.91e-01	0.3860	1.49e-01	6.17e-02	2.21e-01	2.14e-01	1.69e-01	1.80e-01	5.79e-01	4.72e-02	5.39e-02	1.28e-01
REGULATION OF HETEROCHROMATIN ORGANIZATION	23	2.01e-01	6.81e-01	0.3860	-2.14e-01	-2.20e-01	-1.06e-01	-1.34e-01	-1.60e-01	7.58e-02	6.74e-02	3.78e-01	2.65e-01	1.85e-01
PROTEIN OXIDATION	13	7.64e-01	9.75e-01	0.3860	2.25e-01	1.35e-01	1.97e-01	2.02e-01	-2.90e-02	1.60e-01	4.00e-01	2.19e-01	2.08e-01	8.56e-01
SOMATIC MOTOR NEURON DIFFERENTIATION	5	4.83e-01	8.91e-01	0.3860	-7.26e-02	-3.18e-01	-1.50e-01	-1.40e-01	2.07e-02	7.79e-01	2.18e-01	5.61e-01	5.88e-01	9.36e-01
MODIFICATION OF POSTSYNAPTIC STRUCTURE	21	5.61e-01	9.20e-01	0.3860	1.46e-01	9.45e-02	2.01e-01	1.94e-01	2.01e-01	2.47e-01	4.53e-01	1.10e-01	1.24e-01	1.10e-01
POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	8	6.08e-01	9.35e-01	0.3860	8.62e-02	-1.59e-01	1.52e-01	1.30e-01	2.76e-01	6.73e-01	4.37e-01	4.57e-01	5.25e-01	1.76e-01
PROTEIN LIPID COMPLEX ASSEMBLY	30	6.89e-02	4.21e-01	0.3860	-1.89e-01	-1.42e-01	-1.36e-01	-1.24e-01	-2.44e-01	7.39e-02	1.79e-01	1.97e-01	2.40e-01	2.09e-02
CHEMOREPULSION OF AXON	6	9.11e-01	9.94e-01	0.3860	1.99e-01	2.22e-01	1.37e-01	1.36e-01	1.50e-01	3.98e-01	3.46e-01	5.62e-01	5.63e-01	5.25e-01
SENSORY PERCEPTION OF SMELL	383	1.41e-26	1.77e-23	0.3860	-2.52e-01	-5.73e-02	-1.97e-01	-2.07e-01	-7.52e-03	2.47e-17	5.42e-02	3.31e-11	3.14e-12	8.01e-01
ANTERIOR COMMISSURE MORPHOGENESIS	7	2.65e-01	7.47e-01	0.3860	-9.85e-02	-2.94e-01	6.61e-02	1.12e-01	1.88e-01	6.52e-01	1.77e-01	7.62e-01	6.08e-01	3.89e-01
APOPTOTIC DNA FRAGMENTATION	19	1.42e-01	6.00e-01	0.3850	-3.84e-02	-2.43e-01	6.76e-02	6.10e-02	2.82e-01	7.72e-01	6.67e-02	6.10e-01	6.45e-01	3.31e-02
NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT	11	4.33e-01	8.69e-01	0.3850	2.53e-02	-2.04e-01	2.00e-01	2.00e-01	1.62e-01	8.84e-01	2.42e-01	2.51e-01	2.50e-01	3.53e-01
REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	17	7.20e-02	4.31e-01	0.3850	1.63e-01	-1.06e-01	1.96e-01	1.56e-01	2.18e-01	2.45e-01	4.48e-01	1.61e-01	2.65e-01	1.20e-01
REGULATION OF CHLORIDE TRANSPORT	6	8.07e-01	9.82e-01	0.3850	-1.58e-01	-1.44e-01	-2.28e-01	-2.07e-01	8.66e-02	5.04e-01	5.42e-01	3.33e-01	3.80e-01	7.14e-01
DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION	14	3.36e-01	8.06e-01	0.3850	1.43e-01	-5.72e-02	2.48e-01	2.51e-01	-8.42e-03	3.53e-01	7.11e-01	1.09e-01	1.04e-01	9.56e-01
NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	9	8.08e-01	9.82e-01	0.3840	-2.28e-01	-1.28e-01	-1.55e-01	-1.79e-01	-1.54e-01	2.37e-01	5.07e-01	4.22e-01	3.53e-01	4.23e-01
G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	10	6.90e-01	9.61e-01	0.3840	-2.20e-01	-1.81e-01	-1.44e-01	-1.45e-01	1.58e-01	2.29e-01	3.23e-01	4.31e-01	4.26e-01	3.86e-01
RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	6	6.10e-01	9.36e-01	0.3840	-1.47e-01	-3.47e-01	-1.56e-02	-6.07e-02	-4.25e-02	5.33e-01	1.41e-01	9.47e-01	7.97e-01	8.57e-01
NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION	5	5.56e-01	9.18e-01	0.3840	-1.69e-02	-2.31e-01	2.17e-01	2.12e-01	-4.15e-02	9.48e-01	3.71e-01	4.00e-01	4.11e-01	8.72e-01
FAT SOLUBLE VITAMIN CATABOLIC PROCESS	11	2.06e-01	6.84e-01	0.3840	2.22e-01	2.04e-01	1.48e-01	9.92e-02	1.59e-01	2.02e-01	2.42e-01	3.97e-01	5.69e-01	3.63e-01
REGULATION OF THE FORCE OF HEART CONTRACTION	26	2.30e-01	7.13e-01	0.3840	1.91e-01	2.70e-01	1.06e-01	1.33e-01	-9.65e-02	9.14e-02	1.72e-02	3.48e-01	2.42e-01	3.94e-01
REGULATION OF MRNA PROCESSING	116	1.40e-04	5.21e-03	0.3840	1.73e-01	4.71e-02	2.44e-01	2.33e-01	4.37e-02	1.31e-03	3.80e-01	5.64e-06	1.50e-05	4.17e-01
INTRACILIARY RETROGRADE TRANSPORT	14	4.87e-01	8.92e-01	0.3840	1.82e-01	2.56e-01	6.30e-02	7.17e-02	-1.99e-01	2.38e-01	9.76e-02	6.83e-01	6.42e-01	1.96e-01
POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION	5	1.14e-02	1.40e-01	0.3840	9.08e-02	-1.11e-01	-1.68e-01	-2.57e-01	-1.81e-01	7.25e-01	6.66e-01	5.16e-01	3.20e-01	4.83e-01
ANDROGEN BIOSYNTHETIC PROCESS	10	1.08e-01	5.26e-01	0.3840	8.40e-02	3.32e-01	-4.84e-02	-9.78e-03	1.66e-01	6.46e-01	6.90e-02	7.91e-01	9.57e-01	3.63e-01
RELAXATION OF SMOOTH MUSCLE	9	3.41e-01	8.11e-01	0.3840	-1.15e-01	-3.46e-01	6.94e-02	7.56e-02	6.53e-02	5.52e-01	7.26e-02	7.18e-01	6.94e-01	7.34e-01
RHODOPSIN MEDIATED SIGNALING PATHWAY	12	4.10e-01	8.52e-01	0.3840	4.51e-02	2.49e-01	-1.51e-01	-1.15e-01	-2.16e-01	7.87e-01	1.35e-01	3.64e-01	4.89e-01	1.94e-01
RESPONSE TO WATER DEPRIVATION	5	3.70e-01	8.31e-01	0.3840	3.21e-01	4.53e-02	1.06e-01	1.34e-01	1.12e-01	2.13e-01	8.61e-01	6.80e-01	6.03e-01	6.64e-01
PROLINE TRANSPORT	11	7.58e-01	9.75e-01	0.3840	2.10e-01	8.09e-02	2.27e-01	2.12e-01	1.45e-02	2.27e-01	6.42e-01	1.93e-01	2.24e-01	9.34e-01
REGULATION OF BILE ACID SECRETION	6	2.93e-01	7.69e-01	0.3840	-1.18e-01	-8.90e-02	-1.34e-01	-7.86e-02	3.18e-01	6.16e-01	7.06e-01	5.68e-01	7.39e-01	1.78e-01
PLASMA MEMBRANE REPAIR	27	1.05e-01	5.18e-01	0.3830	2.40e-01	5.71e-02	1.97e-01	2.18e-01	-9.39e-03	3.11e-02	6.08e-01	7.67e-02	4.99e-02	9.33e-01
TRANSPOSITION	38	3.76e-02	2.96e-01	0.3830	-8.53e-02	9.13e-02	-2.48e-01	-2.27e-01	-1.36e-01	3.63e-01	3.30e-01	8.20e-03	1.55e-02	1.48e-01
CERAMIDE TRANSPORT	17	2.91e-01	7.67e-01	0.3830	-1.42e-01	-2.98e-01	1.93e-02	1.39e-03	1.93e-01	3.09e-01	3.33e-02	8.91e-01	9.92e-01	1.69e-01
LEUKOTRIENE METABOLIC PROCESS	30	5.86e-02	3.85e-01	0.3830	-1.38e-01	-1.70e-02	-2.43e-01	-1.96e-01	-1.72e-01	1.89e-01	8.72e-01	2.13e-02	6.28e-02	1.02e-01
POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	46	1.03e-02	1.31e-01	0.3830	1.81e-01	1.21e-01	2.36e-01	1.97e-01	7.13e-02	3.35e-02	1.56e-01	5.69e-03	2.10e-02	4.03e-01
ETHANOL METABOLIC PROCESS	19	1.67e-01	6.34e-01	0.3830	-1.89e-01	-1.38e-01	-2.33e-01	-1.93e-01	2.65e-02	1.54e-01	2.97e-01	7.90e-02	1.46e-01	8.42e-01
ADHERENS JUNCTION ORGANIZATION	57	5.35e-02	3.63e-01	0.3830	-2.15e-01	-1.14e-01	-1.76e-01	-1.95e-01	-1.35e-01	4.94e-03	1.38e-01	2.13e-02	1.08e-02	7.78e-02
CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION	11	2.13e-01	6.91e-01	0.3830	2.39e-01	-2.02e-02	1.45e-01	1.67e-01	2.00e-01	1.69e-01	9.08e-01	4.05e-01	3.39e-01	2.50e-01
POSITIVE REGULATION OF CELL FATE COMMITMENT	13	2.16e-01	6.98e-01	0.3830	-1.85e-01	3.36e-02	-2.16e-01	-2.35e-01	9.77e-02	2.49e-01	8.34e-01	1.78e-01	1.43e-01	5.42e-01
LONG CHAIN FATTY ACID CATABOLIC PROCESS	8	5.98e-01	9.33e-01	0.3830	2.02e-01	2.77e-01	2.90e-02	8.85e-02	-1.42e-01	3.22e-01	1.75e-01	8.87e-01	6.65e-01	4.88e-01
INTRACELLULAR POTASSIUM ION HOMEOSTASIS	15	7.35e-01	9.73e-01	0.3830	1.59e-01	1.50e-01	2.05e-01	2.07e-01	1.19e-01	2.87e-01	3.16e-01	1.69e-01	1.66e-01	4.27e-01
MIDBODY ABSCISSION	17	4.33e-02	3.20e-01	0.3820	1.92e-01	-5.51e-02	2.05e-01	2.36e-01	-9.27e-02	1.70e-01	6.94e-01	1.44e-01	9.16e-02	5.08e-01
POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	15	3.45e-01	8.16e-01	0.3820	-1.83e-01	-6.25e-02	-2.10e-01	-2.31e-01	1.06e-01	2.19e-01	6.75e-01	1.58e-01	1.22e-01	4.78e-01
THERMOCEPTION	8	8.23e-01	9.83e-01	0.3820	-1.55e-01	-2.94e-02	-2.56e-01	-2.31e-01	-5.18e-02	4.48e-01	8.86e-01	2.10e-01	2.59e-01	8.00e-01
POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS	7	8.00e-01	9.82e-01	0.3820	-1.34e-02	1.32e-01	-2.07e-01	-1.81e-01	-2.30e-01	9.51e-01	5.44e-01	3.42e-01	4.06e-01	2.93e-01
NEGATIVE REGULATION OF VIRAL TRANSCRIPTION	14	4.66e-01	8.83e-01	0.3820	2.41e-01	1.46e-01	1.94e-01	1.68e-01	2.89e-02	1.18e-01	3.43e-01	2.09e-01	2.77e-01	8.51e-01
LIPID HYDROXYLATION	7	6.45e-01	9.50e-01	0.3820	-1.49e-01	-1.50e-01	-9.91e-02	-1.37e-01	-2.70e-01	4.95e-01	4.91e-01	6.50e-01	5.30e-01	2.17e-01
POSITIVE T CELL SELECTION	39	5.08e-02	3.53e-01	0.3820	1.89e-01	2.93e-01	1.08e-01	1.09e-01	-3.10e-02	4.16e-02	1.53e-03	2.44e-01	2.37e-01	7.38e-01
DISACCHARIDE METABOLIC PROCESS	11	1.71e-01	6.41e-01	0.3820	1.71e-01	2.99e-01	-1.20e-02	3.80e-02	1.61e-01	3.25e-01	8.65e-02	9.45e-01	8.27e-01	3.55e-01
RESPONSE TO MERCURY ION	10	3.28e-01	8.01e-01	0.3820	1.08e-01	1.05e-01	7.32e-02	1.08e-01	3.26e-01	5.55e-01	5.64e-01	6.88e-01	5.53e-01	7.44e-02
POSITIVE REGULATION OF NUCLEASE ACTIVITY	7	6.78e-01	9.60e-01	0.3820	2.43e-01	3.80e-03	1.96e-01	2.17e-01	3.67e-02	2.65e-01	9.86e-01	3.68e-01	3.21e-01	8.67e-01
FUCOSYLATION	17	2.63e-01	7.46e-01	0.3820	-1.17e-01	-9.41e-02	-2.59e-01	-2.35e-01	-3.38e-02	4.05e-01	5.02e-01	6.48e-02	9.28e-02	8.09e-01
RESPONSE TO EPIDERMAL GROWTH FACTOR	44	2.02e-01	6.82e-01	0.3820	1.50e-01	3.93e-02	2.24e-01	2.23e-01	1.48e-01	8.44e-02	6.52e-01	1.02e-02	1.06e-02	8.91e-02
SIRNA PROCESSING	9	3.38e-01	8.08e-01	0.3820	3.25e-02	6.41e-02	-9.30e-03	2.69e-02	-3.74e-01	8.66e-01	7.39e-01	9.61e-01	8.89e-01	5.22e-02
EXPLORATION BEHAVIOR	28	3.61e-01	8.25e-01	0.3820	-2.01e-01	-2.22e-01	-1.59e-01	-1.67e-01	5.47e-02	6.55e-02	4.20e-02	1.46e-01	1.27e-01	6.16e-01
NEGATIVE REGULATION OF CENTROSOME DUPLICATION	12	5.67e-01	9.24e-01	0.3820	1.39e-01	1.49e-01	2.13e-01	1.81e-01	1.61e-01	4.03e-01	3.72e-01	2.02e-01	2.77e-01	3.34e-01
ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY	7	1.32e-01	5.77e-01	0.3820	1.96e-02	-2.68e-02	-2.68e-01	-2.62e-01	6.21e-02	9.28e-01	9.02e-01	2.19e-01	2.30e-01	7.76e-01
MAST CELL DIFFERENTIATION	6	7.18e-01	9.69e-01	0.3810	2.43e-01	2.33e-01	5.80e-02	7.62e-02	1.51e-01	3.03e-01	3.23e-01	8.06e-01	7.47e-01	5.21e-01
PROTEIN IMPORT	7	5.14e-01	9.01e-01	0.3810	-7.09e-02	-2.78e-02	5.57e-02	3.19e-02	3.68e-01	7.45e-01	8.98e-01	7.99e-01	8.84e-01	9.18e-02
POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION	7	9.08e-01	9.94e-01	0.3810	-2.22e-01	-1.68e-01	-1.66e-01	-1.84e-01	8.14e-02	3.10e-01	4.42e-01	4.48e-01	3.99e-01	7.09e-01
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION	6	4.98e-01	8.97e-01	0.3810	1.49e-01	3.36e-01	-3.68e-02	1.64e-02	9.20e-02	5.27e-01	1.54e-01	8.76e-01	9.44e-01	6.96e-01
ANTIBACTERIAL INNATE IMMUNE RESPONSE	6	6.04e-01	9.34e-01	0.3810	2.66e-01	1.02e-01	1.23e-01	1.76e-01	1.34e-01	2.59e-01	6.65e-01	6.03e-01	4.56e-01	5.69e-01
MAINTENANCE OF LENS TRANSPARENCY	7	7.53e-01	9.75e-01	0.3810	-1.50e-01	-1.90e-01	-1.75e-01	-1.96e-01	1.32e-01	4.91e-01	3.85e-01	4.22e-01	3.69e-01	5.47e-01
REGULATION OF NK T CELL ACTIVATION	11	2.80e-01	7.58e-01	0.3810	-1.47e-01	-1.21e-01	-2.34e-01	-1.95e-01	1.27e-01	4.00e-01	4.89e-01	1.79e-01	2.64e-01	4.65e-01
T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	9	7.99e-01	9.81e-01	0.3800	1.52e-01	1.89e-01	2.08e-01	2.03e-01	3.87e-02	4.28e-01	3.25e-01	2.81e-01	2.93e-01	8.41e-01
DIAPEDESIS	6	7.34e-01	9.73e-01	0.3800	-1.66e-01	5.46e-02	-1.98e-01	-1.60e-01	-2.22e-01	4.83e-01	8.17e-01	4.00e-01	4.97e-01	3.47e-01
REGULATION OF ALDOSTERONE METABOLIC PROCESS	8	3.88e-01	8.40e-01	0.3800	-2.89e-01	-2.40e-01	-2.87e-02	-4.65e-02	-1.15e-02	1.57e-01	2.39e-01	8.88e-01	8.20e-01	9.55e-01
REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	15	1.92e-01	6.66e-01	0.3800	-2.84e-01	-1.85e-01	-8.72e-02	-1.29e-01	7.49e-02	5.72e-02	2.15e-01	5.59e-01	3.88e-01	6.16e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	101	2.49e-03	4.85e-02	0.3800	1.91e-01	3.49e-02	2.14e-01	2.15e-01	1.22e-01	9.16e-04	5.45e-01	2.02e-04	1.93e-04	3.46e-02
UREA TRANSMEMBRANE TRANSPORT	9	4.00e-01	8.45e-01	0.3800	2.77e-02	-2.27e-03	2.13e-01	2.33e-01	2.10e-01	8.85e-01	9.91e-01	2.70e-01	2.26e-01	2.76e-01
POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	13	1.74e-01	6.46e-01	0.3800	-1.36e-01	-3.20e-01	-5.79e-02	-3.12e-02	1.39e-01	3.96e-01	4.60e-02	7.18e-01	8.45e-01	3.87e-01
SOMATOTROPIN SECRETING CELL DIFFERENTIATION	5	3.84e-01	8.39e-01	0.3800	-1.91e-01	-1.60e-01	-2.37e-01	-1.49e-01	-6.07e-02	4.59e-01	5.35e-01	3.60e-01	5.63e-01	8.14e-01
INNER MITOCHONDRIAL MEMBRANE ORGANIZATION	36	4.52e-03	7.54e-02	0.3800	4.41e-02	-1.87e-01	2.35e-01	2.10e-01	8.77e-02	6.47e-01	5.22e-02	1.45e-02	2.91e-02	3.62e-01
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION	14	6.00e-01	9.33e-01	0.3800	-1.91e-01	-2.58e-01	-9.20e-02	-1.14e-01	1.39e-01	2.16e-01	9.41e-02	5.51e-01	4.60e-01	3.68e-01
TROPHECTODERMAL CELL DIFFERENTIATION	19	7.08e-01	9.65e-01	0.3790	2.05e-01	1.01e-01	1.99e-01	2.12e-01	8.30e-02	1.22e-01	4.47e-01	1.33e-01	1.09e-01	5.31e-01
POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS	7	2.18e-01	7.00e-01	0.3790	-4.41e-02	-2.78e-01	-1.61e-01	-1.70e-01	-9.80e-02	8.40e-01	2.03e-01	4.60e-01	4.35e-01	6.53e-01
REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY	5	6.82e-01	9.61e-01	0.3790	2.01e-01	1.14e-02	1.88e-01	2.48e-01	7.83e-02	4.35e-01	9.65e-01	4.67e-01	3.37e-01	7.62e-01
GLUTAMATE REUPTAKE	6	6.05e-01	9.34e-01	0.3790	1.00e-01	3.50e-01	-5.21e-02	-6.79e-03	-9.13e-02	6.71e-01	1.38e-01	8.25e-01	9.77e-01	6.98e-01
POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION	25	3.70e-02	2.93e-01	0.3790	-1.45e-01	-1.60e-01	-1.25e-01	-1.58e-01	2.37e-01	2.09e-01	1.65e-01	2.81e-01	1.71e-01	4.00e-02
FLAVONOID GLUCURONIDATION	5	1.75e-03	3.68e-02	0.3790	-2.08e-01	2.21e-01	-3.86e-03	8.49e-02	2.11e-01	4.21e-01	3.92e-01	9.88e-01	7.42e-01	4.14e-01
POSITIVE REGULATION OF PINOCYTOSIS	7	3.18e-01	7.90e-01	0.3790	-6.76e-02	-3.18e-01	1.16e-01	1.07e-01	-1.13e-01	7.57e-01	1.45e-01	5.95e-01	6.23e-01	6.06e-01
REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS	6	7.29e-01	9.71e-01	0.3790	5.09e-02	2.59e-01	-2.87e-02	-2.12e-02	-2.69e-01	8.29e-01	2.71e-01	9.03e-01	9.28e-01	2.54e-01
REGULATION OF CILIUM DEPENDENT CELL MOTILITY	27	3.12e-01	7.86e-01	0.3790	2.49e-01	1.80e-01	1.46e-01	1.66e-01	-1.82e-02	2.52e-02	1.06e-01	1.88e-01	1.35e-01	8.70e-01
CHORIONIC TROPHOBLAST CELL PROLIFERATION	5	1.21e-01	5.54e-01	0.3790	2.25e-01	1.55e-01	-2.08e-01	-1.39e-01	-8.10e-02	3.84e-01	5.49e-01	4.20e-01	5.91e-01	7.54e-01
DENTINOGENESIS	6	6.38e-01	9.49e-01	0.3780	3.23e-02	2.64e-01	-1.51e-01	-9.41e-02	-2.02e-01	8.91e-01	2.63e-01	5.22e-01	6.90e-01	3.92e-01
NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION	17	3.38e-01	8.08e-01	0.3780	-2.07e-01	-2.27e-01	-1.23e-01	-1.71e-01	6.79e-02	1.40e-01	1.06e-01	3.81e-01	2.22e-01	6.28e-01
NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION	9	4.73e-01	8.86e-01	0.3780	2.40e-01	2.78e-01	-1.76e-02	1.10e-02	-8.72e-02	2.13e-01	1.48e-01	9.27e-01	9.54e-01	6.51e-01
CELLULAR RESPONSE TO UV C	5	4.17e-01	8.57e-01	0.3780	3.05e-03	-1.13e-02	7.99e-02	1.20e-01	-3.49e-01	9.91e-01	9.65e-01	7.57e-01	6.42e-01	1.76e-01
NOTCH RECEPTOR PROCESSING	9	7.24e-02	4.33e-01	0.3780	9.44e-02	-9.27e-02	2.11e-01	1.13e-01	2.61e-01	6.24e-01	6.30e-01	2.73e-01	5.56e-01	1.75e-01
NEGATIVE REGULATION OF HEART RATE	11	1.75e-01	6.47e-01	0.3780	1.97e-01	2.97e-01	-6.51e-03	5.51e-02	1.14e-01	2.58e-01	8.85e-02	9.70e-01	7.52e-01	5.12e-01
REGULATION OF HYPERSENSITIVITY	9	5.05e-01	8.99e-01	0.3780	1.31e-01	8.56e-02	1.16e-01	1.56e-01	2.84e-01	4.95e-01	6.57e-01	5.48e-01	4.18e-01	1.40e-01
REGULATION OF T CELL CHEMOTAXIS	16	3.86e-02	3.01e-01	0.3780	1.58e-01	1.76e-01	-2.90e-03	1.94e-02	2.94e-01	2.73e-01	2.23e-01	9.84e-01	8.93e-01	4.18e-02
ALDITOL CATABOLIC PROCESS	6	5.00e-01	8.97e-01	0.3780	-2.32e-01	-2.35e-01	-4.16e-03	-8.30e-02	1.62e-01	3.24e-01	3.18e-01	9.86e-01	7.25e-01	4.91e-01
FUNGIFORM PAPILLA MORPHOGENESIS	5	7.22e-01	9.70e-01	0.3770	-1.23e-01	-2.01e-01	9.94e-02	3.77e-02	2.75e-01	6.35e-01	4.37e-01	7.00e-01	8.84e-01	2.86e-01
NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	5	3.23e-01	7.96e-01	0.3770	2.90e-02	3.74e-01	2.68e-02	2.50e-03	2.71e-02	9.11e-01	1.48e-01	9.17e-01	9.92e-01	9.16e-01
RESPONSE TO FUNGUS	62	1.41e-02	1.60e-01	0.3770	-1.54e-01	-1.28e-01	-2.31e-01	-2.16e-01	-4.59e-02	3.64e-02	8.20e-02	1.64e-03	3.24e-03	5.32e-01
TAURINE TRANSPORT	8	8.48e-01	9.87e-01	0.3770	2.12e-01	1.50e-01	1.81e-01	1.79e-01	-1.00e-01	3.00e-01	4.63e-01	3.74e-01	3.81e-01	6.23e-01
POSITIVE REGULATION OF NK T CELL ACTIVATION	9	4.81e-01	8.91e-01	0.3770	-1.09e-01	1.31e-02	-2.70e-01	-2.36e-01	3.43e-02	5.70e-01	9.46e-01	1.61e-01	2.20e-01	8.58e-01
L KYNURENINE METABOLIC PROCESS	7	3.20e-01	7.93e-01	0.3770	-1.18e-01	-7.70e-02	1.73e-02	-1.21e-02	-3.49e-01	5.88e-01	7.24e-01	9.37e-01	9.56e-01	1.10e-01
GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	9	4.51e-01	8.76e-01	0.3770	1.62e-01	2.61e-01	6.52e-02	3.86e-02	-2.05e-01	4.01e-01	1.75e-01	7.35e-01	8.41e-01	2.88e-01
WOUND HEALING SPREADING OF EPIDERMAL CELLS	21	4.30e-01	8.66e-01	0.3760	-1.64e-01	-1.52e-01	-2.01e-01	-2.23e-01	-4.22e-02	1.94e-01	2.29e-01	1.11e-01	7.71e-02	7.38e-01
POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION	13	4.63e-01	8.80e-01	0.3760	1.77e-01	2.85e-01	7.83e-02	1.21e-01	-9.07e-02	2.69e-01	7.53e-02	6.25e-01	4.48e-01	5.71e-01
S ADENOSYLMETHIONINE CYCLE	7	2.00e-01	6.80e-01	0.3760	4.65e-02	-3.07e-01	1.37e-01	1.52e-01	-5.55e-02	8.31e-01	1.59e-01	5.30e-01	4.87e-01	7.99e-01
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	50	8.28e-02	4.59e-01	0.3760	1.70e-01	3.30e-02	2.03e-01	1.88e-01	1.87e-01	3.77e-02	6.86e-01	1.29e-02	2.12e-02	2.22e-02
T HELPER 2 CELL DIFFERENTIATION	19	6.82e-02	4.19e-01	0.3760	-1.17e-01	-2.96e-01	-1.40e-01	-1.30e-01	-6.46e-02	3.76e-01	2.57e-02	2.92e-01	3.28e-01	6.26e-01
TYROSINE CATABOLIC PROCESS	6	5.86e-01	9.29e-01	0.3760	-5.75e-03	-2.45e-01	1.73e-02	1.83e-02	2.84e-01	9.81e-01	2.98e-01	9.41e-01	9.38e-01	2.28e-01
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY	30	2.97e-01	7.72e-01	0.3760	-1.82e-01	-1.96e-01	-1.78e-01	-1.94e-01	2.18e-02	8.45e-02	6.33e-02	9.23e-02	6.55e-02	8.36e-01
CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	13	3.68e-01	8.31e-01	0.3760	1.98e-01	-6.16e-02	2.00e-01	2.12e-01	1.15e-01	2.17e-01	7.01e-01	2.11e-01	1.86e-01	4.71e-01
MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING	17	8.91e-02	4.74e-01	0.3760	1.52e-01	7.59e-02	2.54e-01	2.06e-01	-7.24e-02	2.77e-01	5.88e-01	7.00e-02	1.41e-01	6.05e-01
NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION	12	2.96e-01	7.72e-01	0.3760	-1.67e-01	-1.63e-01	-7.75e-02	-6.62e-02	-2.76e-01	3.15e-01	3.27e-01	6.42e-01	6.91e-01	9.83e-02
REGULATION OF MICROTUBULE BINDING	7	8.39e-01	9.85e-01	0.3760	-1.64e-01	-4.76e-02	-1.81e-01	-2.15e-01	-1.82e-01	4.53e-01	8.27e-01	4.07e-01	3.25e-01	4.05e-01
POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	18	3.13e-01	7.86e-01	0.3760	-2.01e-01	-1.57e-01	-1.64e-01	-2.06e-01	8.05e-02	1.39e-01	2.48e-01	2.29e-01	1.31e-01	5.54e-01
RESPONSE TO HYDROXYUREA	11	5.87e-01	9.29e-01	0.3750	1.72e-01	1.13e-01	1.19e-01	1.16e-01	2.67e-01	3.24e-01	5.17e-01	4.93e-01	5.04e-01	1.26e-01
PERICARDIUM DEVELOPMENT	19	2.96e-01	7.72e-01	0.3750	-9.71e-02	-1.11e-01	-1.62e-01	-1.69e-01	-2.53e-01	4.64e-01	4.02e-01	2.22e-01	2.02e-01	5.58e-02
PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	15	5.06e-01	8.99e-01	0.3750	-1.79e-01	-2.81e-01	-4.60e-02	-6.54e-02	1.52e-01	2.31e-01	5.91e-02	7.58e-01	6.61e-01	3.07e-01
STOMACH DEVELOPMENT	5	7.08e-01	9.65e-01	0.3750	-5.01e-03	-1.71e-01	2.38e-02	4.48e-02	3.30e-01	9.85e-01	5.09e-01	9.27e-01	8.62e-01	2.01e-01
REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	12	5.90e-01	9.31e-01	0.3750	1.32e-01	-3.62e-02	2.52e-01	2.40e-01	3.37e-02	4.30e-01	8.28e-01	1.31e-01	1.50e-01	8.40e-01
REGULATION OF MRNA SPLICING VIA SPLICEOSOME	95	4.26e-03	7.21e-02	0.3750	1.81e-01	5.40e-02	2.29e-01	2.22e-01	5.63e-02	2.31e-03	3.63e-01	1.14e-04	1.84e-04	3.43e-01
VAGINA DEVELOPMENT	10	1.08e-01	5.26e-01	0.3750	1.32e-01	-4.64e-02	2.35e-01	1.83e-01	-1.80e-01	4.69e-01	8.00e-01	1.98e-01	3.17e-01	3.24e-01
BASEMENT MEMBRANE ASSEMBLY	9	8.57e-01	9.88e-01	0.3750	-1.88e-01	-7.85e-02	-1.69e-01	-1.65e-01	-2.08e-01	3.29e-01	6.83e-01	3.81e-01	3.92e-01	2.79e-01
CELLULAR RESPONSE TO IONIZING RADIATION	68	1.48e-02	1.65e-01	0.3750	1.94e-01	6.52e-02	2.13e-01	1.93e-01	1.26e-01	5.69e-03	3.52e-01	2.38e-03	6.01e-03	7.19e-02
NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT	24	2.07e-01	6.84e-01	0.3740	2.68e-02	-9.22e-02	2.06e-01	1.88e-01	2.30e-01	8.20e-01	4.34e-01	8.00e-02	1.11e-01	5.08e-02
DETOXIFICATION OF INORGANIC COMPOUND	21	3.94e-01	8.43e-01	0.3740	1.69e-01	-3.83e-03	2.09e-01	1.88e-01	1.81e-01	1.80e-01	9.76e-01	9.78e-02	1.36e-01	1.51e-01
LIPID DIGESTION	21	2.14e-02	2.12e-01	0.3740	-1.06e-01	1.67e-01	-1.53e-01	-1.13e-01	-2.54e-01	4.01e-01	1.85e-01	2.24e-01	3.70e-01	4.36e-02
DETECTION OF BIOTIC STIMULUS	37	2.32e-01	7.15e-01	0.3740	-1.64e-01	-8.40e-02	-2.31e-01	-2.13e-01	-8.63e-02	8.45e-02	3.77e-01	1.50e-02	2.50e-02	3.63e-01
DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	8	2.88e-01	7.66e-01	0.3740	1.50e-01	-1.02e-01	2.06e-01	1.91e-01	-1.68e-01	4.63e-01	6.16e-01	3.12e-01	3.49e-01	4.12e-01
POSITIVE REGULATION OF MRNA PROCESSING	28	1.04e-01	5.17e-01	0.3740	1.47e-01	9.63e-03	2.52e-01	2.34e-01	-1.40e-02	1.77e-01	9.30e-01	2.12e-02	3.24e-02	8.98e-01
REGULATION OF RESTING MEMBRANE POTENTIAL	10	3.42e-01	8.12e-01	0.3740	3.17e-03	7.75e-03	2.07e-02	1.13e-02	3.73e-01	9.86e-01	9.66e-01	9.10e-01	9.51e-01	4.10e-02
NUCLEOSIDE TRANSMEMBRANE TRANSPORT	8	8.57e-02	4.67e-01	0.3740	-6.67e-02	1.82e-01	-1.43e-01	-9.66e-02	2.69e-01	7.44e-01	3.74e-01	4.85e-01	6.36e-01	1.87e-01
TRANSFORMING GROWTH FACTOR BETA PRODUCTION	42	1.44e-01	6.02e-01	0.3740	-2.06e-01	-1.72e-01	-1.87e-01	-1.78e-01	2.82e-02	2.07e-02	5.33e-02	3.61e-02	4.61e-02	7.52e-01
CHITIN METABOLIC PROCESS	6	5.46e-01	9.15e-01	0.3730	2.00e-01	2.38e-01	-4.07e-02	3.25e-02	-2.01e-01	3.97e-01	3.13e-01	8.63e-01	8.90e-01	3.95e-01
REGULATION OF FATTY ACID BETA OXIDATION	19	3.23e-01	7.96e-01	0.3730	-9.31e-02	1.05e-02	-1.41e-01	-1.54e-01	-2.95e-01	4.82e-01	9.37e-01	2.86e-01	2.46e-01	2.60e-02
XENOBIOTIC TRANSMEMBRANE TRANSPORT	16	3.78e-01	8.36e-01	0.3730	-1.42e-01	-1.15e-01	-2.42e-01	-2.18e-01	7.99e-03	3.27e-01	4.27e-01	9.34e-02	1.31e-01	9.56e-01
PROTEIN TARGETING TO PEROXISOME	19	6.95e-01	9.61e-01	0.3730	2.09e-01	1.58e-01	1.89e-01	1.81e-01	4.52e-02	1.15e-01	2.33e-01	1.53e-01	1.71e-01	7.33e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	8	7.23e-02	4.33e-01	0.3730	-9.62e-02	2.26e-01	-8.65e-02	-8.57e-02	2.53e-01	6.37e-01	2.68e-01	6.72e-01	6.75e-01	2.15e-01
MICROTUBULE BASED PROTEIN TRANSPORT	14	3.14e-01	7.86e-01	0.3730	-2.05e-01	-2.19e-01	-7.26e-02	-6.18e-02	2.01e-01	1.84e-01	1.56e-01	6.38e-01	6.89e-01	1.93e-01
C 5 METHYLATION OF CYTOSINE	5	6.28e-01	9.45e-01	0.3730	-2.25e-01	8.95e-02	-2.05e-01	-1.94e-01	-3.06e-02	3.84e-01	7.29e-01	4.27e-01	4.52e-01	9.06e-01
MITOCHONDRIAL DNA REPAIR	5	4.39e-01	8.70e-01	0.3730	8.42e-03	-1.41e-02	1.28e-01	9.03e-02	-3.38e-01	9.74e-01	9.57e-01	6.19e-01	7.26e-01	1.91e-01
FOREBRAIN NEUROBLAST DIVISION	5	8.66e-01	9.88e-01	0.3730	1.28e-01	1.04e-01	2.46e-01	2.25e-01	-2.78e-02	6.21e-01	6.86e-01	3.41e-01	3.83e-01	9.14e-01
PROTEIN DEMETHYLATION	9	8.96e-01	9.93e-01	0.3720	-1.47e-01	-1.35e-01	-1.90e-01	-1.90e-01	-1.62e-01	4.45e-01	4.82e-01	3.23e-01	3.23e-01	4.00e-01
GASTRIC ACID SECRETION	13	7.06e-01	9.65e-01	0.3720	-2.02e-01	-4.49e-02	-2.01e-01	-2.21e-01	-8.13e-02	2.07e-01	7.79e-01	2.10e-01	1.67e-01	6.12e-01
MRNA METHYLATION	17	1.85e-01	6.56e-01	0.3720	1.51e-01	7.30e-02	1.88e-01	1.97e-01	-1.91e-01	2.82e-01	6.02e-01	1.80e-01	1.59e-01	1.74e-01
PRO B CELL DIFFERENTIATION	12	3.04e-01	7.76e-01	0.3720	4.68e-02	-1.59e-01	8.77e-02	6.37e-02	3.15e-01	7.79e-01	3.41e-01	5.99e-01	7.02e-01	5.85e-02
REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL	7	3.43e-01	8.14e-01	0.3720	-2.47e-02	2.54e-01	-2.00e-01	-1.31e-01	-1.28e-01	9.10e-01	2.44e-01	3.60e-01	5.50e-01	5.58e-01
RESPONSE TO CORTICOSTERONE	12	4.30e-01	8.67e-01	0.3720	3.31e-02	-1.47e-01	1.00e-01	7.90e-02	3.15e-01	8.43e-01	3.77e-01	5.48e-01	6.36e-01	5.85e-02
REGULATION OF CORTICOSTEROID HORMONE SECRETION	16	8.01e-01	9.82e-01	0.3720	-1.93e-01	-1.83e-01	-1.80e-01	-1.84e-01	-3.97e-02	1.82e-01	2.06e-01	2.12e-01	2.03e-01	7.83e-01
REGULATION OF FEEDING BEHAVIOR	27	4.84e-01	8.91e-01	0.3720	-1.89e-01	-1.01e-01	-2.00e-01	-2.18e-01	-6.91e-02	8.91e-02	3.63e-01	7.23e-02	4.95e-02	5.34e-01
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY	5	3.50e-01	8.18e-01	0.3720	-5.83e-02	2.99e-01	-1.71e-01	-1.21e-01	3.68e-02	8.22e-01	2.46e-01	5.08e-01	6.39e-01	8.87e-01
CARDIOBLAST DIFFERENTIATION	17	2.48e-01	7.33e-01	0.3720	9.80e-02	-9.49e-02	2.55e-01	2.21e-01	7.59e-02	4.84e-01	4.98e-01	6.91e-02	1.14e-01	5.88e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	13	3.45e-01	8.16e-01	0.3720	-1.47e-01	-2.16e-01	-3.26e-02	-2.24e-02	2.61e-01	3.59e-01	1.77e-01	8.39e-01	8.89e-01	1.03e-01
REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS	5	7.57e-01	9.75e-01	0.3720	-1.51e-01	1.00e-01	-2.18e-01	-1.72e-01	-1.68e-01	5.59e-01	6.98e-01	3.99e-01	5.05e-01	5.16e-01
NEURON NEURON SYNAPTIC TRANSMISSION	6	8.79e-01	9.89e-01	0.3720	-1.84e-01	-1.95e-01	-1.09e-01	-1.26e-01	1.96e-01	4.34e-01	4.09e-01	6.45e-01	5.92e-01	4.05e-01
POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	9	4.90e-01	8.93e-01	0.3720	-2.44e-01	-2.51e-01	-4.65e-02	-1.08e-01	4.16e-02	2.05e-01	1.93e-01	8.09e-01	5.74e-01	8.29e-01
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	155	7.90e-07	5.72e-05	0.3720	1.32e-01	-4.53e-02	2.29e-01	2.29e-01	1.17e-01	4.65e-03	3.30e-01	8.15e-07	8.64e-07	1.23e-02
NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	7	7.66e-01	9.75e-01	0.3720	-2.46e-01	-2.04e-01	-9.73e-02	-1.02e-01	-1.26e-01	2.59e-01	3.49e-01	6.56e-01	6.41e-01	5.65e-01
POSITIVE REGULATION OF FERTILIZATION	5	2.66e-01	7.47e-01	0.3710	-1.24e-01	2.74e-01	-1.77e-01	-1.25e-01	-2.32e-02	6.32e-01	2.89e-01	4.94e-01	6.28e-01	9.28e-01
CELLULAR RESPONSE TO OXYGEN RADICAL	23	6.11e-01	9.37e-01	0.3710	2.21e-01	1.28e-01	1.84e-01	1.93e-01	4.16e-02	6.67e-02	2.89e-01	1.27e-01	1.09e-01	7.30e-01
HYPEROSMOTIC RESPONSE	26	3.78e-01	8.36e-01	0.3710	1.87e-01	1.77e-01	1.68e-01	1.55e-01	1.39e-01	9.93e-02	1.17e-01	1.39e-01	1.72e-01	2.20e-01
NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	7	6.00e-01	9.33e-01	0.3710	1.21e-01	3.07e-01	-2.46e-02	-4.08e-02	-1.62e-01	5.78e-01	1.59e-01	9.10e-01	8.52e-01	4.58e-01
ATRIAL SEPTUM MORPHOGENESIS	15	6.56e-02	4.09e-01	0.3710	-8.16e-02	-2.62e-01	-8.40e-02	-1.09e-01	-2.08e-01	5.84e-01	7.88e-02	5.73e-01	4.66e-01	1.62e-01
REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS	5	7.43e-01	9.74e-01	0.3710	1.52e-01	-7.03e-02	2.17e-01	2.50e-01	2.84e-03	5.55e-01	7.85e-01	4.02e-01	3.33e-01	9.91e-01
CELLULAR RESPONSE TO UV A	10	2.40e-01	7.24e-01	0.3710	4.04e-02	-8.38e-02	2.04e-01	1.28e-01	2.66e-01	8.25e-01	6.46e-01	2.64e-01	4.82e-01	1.45e-01
REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	5	1.42e-01	5.99e-01	0.3710	-2.39e-02	3.25e-01	-1.63e-02	4.03e-02	1.71e-01	9.26e-01	2.08e-01	9.50e-01	8.76e-01	5.08e-01
REGULATION OF SNARE COMPLEX ASSEMBLY	14	4.09e-01	8.52e-01	0.3710	-1.88e-01	-2.90e-01	1.34e-02	-4.25e-03	1.33e-01	2.23e-01	6.02e-02	9.31e-01	9.78e-01	3.88e-01
DNA REPLICATION CHECKPOINT SIGNALING	18	1.97e-01	6.75e-01	0.3710	1.84e-01	1.28e-01	2.23e-01	1.85e-01	-5.80e-02	1.77e-01	3.46e-01	1.02e-01	1.74e-01	6.70e-01
CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	8	5.25e-02	3.59e-01	0.3710	-9.07e-02	1.82e-01	-1.66e-01	-1.06e-01	2.40e-01	6.57e-01	3.74e-01	4.17e-01	6.05e-01	2.40e-01
DNA TEMPLATED TRANSCRIPTION INITIATION	135	1.40e-05	7.61e-04	0.3710	1.59e-01	3.84e-02	2.34e-01	2.35e-01	1.97e-02	1.41e-03	4.41e-01	2.64e-06	2.33e-06	6.93e-01
NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	8	1.42e-01	5.99e-01	0.3710	-2.18e-01	-2.14e-01	-3.37e-02	1.49e-02	2.07e-01	2.85e-01	2.96e-01	8.69e-01	9.42e-01	3.11e-01
REGULATION OF ISOTYPE SWITCHING	37	8.79e-02	4.72e-01	0.3700	1.49e-01	-3.83e-02	2.31e-01	2.33e-01	7.71e-02	1.18e-01	6.87e-01	1.51e-02	1.41e-02	4.17e-01
POSITIVE REGULATION OF DNA RECOMBINATION	67	1.13e-01	5.37e-01	0.3700	1.74e-01	1.10e-01	2.05e-01	2.08e-01	9.84e-02	1.38e-02	1.20e-01	3.70e-03	3.29e-03	1.63e-01
TRANSLATIONAL READTHROUGH	9	8.32e-01	9.85e-01	0.3700	-2.09e-01	-2.67e-01	-8.91e-02	-1.17e-01	2.11e-02	2.77e-01	1.65e-01	6.43e-01	5.43e-01	9.13e-01
POSITIVE REGULATION OF G0 TO G1 TRANSITION	5	5.34e-01	9.09e-01	0.3700	4.34e-02	-1.00e-01	1.55e-02	7.77e-03	-3.53e-01	8.66e-01	6.98e-01	9.52e-01	9.76e-01	1.71e-01
REGULATION OF SEQUESTERING OF TRIGLYCERIDE	15	5.86e-01	9.29e-01	0.3700	-1.76e-01	-1.86e-01	-1.97e-01	-1.79e-01	1.13e-02	2.37e-01	2.11e-01	1.86e-01	2.31e-01	9.40e-01
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS	65	2.04e-02	2.05e-01	0.3700	1.71e-01	-5.99e-03	2.11e-01	2.03e-01	1.47e-01	1.73e-02	9.33e-01	3.19e-03	4.56e-03	4.04e-02
POLYAMINE METABOLIC PROCESS	15	7.06e-01	9.65e-01	0.3700	1.34e-01	5.54e-02	2.36e-01	2.21e-01	1.06e-01	3.71e-01	7.10e-01	1.13e-01	1.38e-01	4.76e-01
OLFACTORY BULB INTERNEURON DIFFERENTIATION	12	5.03e-01	8.98e-01	0.3700	-1.69e-01	-3.20e-01	-2.72e-02	-5.80e-02	3.88e-02	3.11e-01	5.48e-02	8.70e-01	7.28e-01	8.16e-01
G2 MI TRANSITION OF MEIOTIC CELL CYCLE	7	6.96e-01	9.61e-01	0.3700	1.40e-01	1.06e-01	1.91e-01	1.85e-01	-1.88e-01	5.22e-01	6.28e-01	3.83e-01	3.97e-01	3.88e-01
ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY	7	7.39e-01	9.73e-01	0.3700	-1.98e-03	-1.54e-01	1.88e-01	1.42e-01	2.40e-01	9.93e-01	4.80e-01	3.89e-01	5.15e-01	2.72e-01
REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS	9	1.62e-01	6.26e-01	0.3690	-2.74e-01	-1.91e-01	2.55e-02	-3.00e-02	1.52e-01	1.54e-01	3.22e-01	8.95e-01	8.76e-01	4.29e-01
PHOSPHATIDYLCHOLINE CATABOLIC PROCESS	16	3.68e-01	8.31e-01	0.3690	-2.07e-01	-1.29e-01	-2.08e-01	-1.78e-01	4.24e-02	1.51e-01	3.70e-01	1.50e-01	2.19e-01	7.69e-01
TRANSCRIPTION BY RNA POLYMERASE I	68	4.51e-03	7.54e-02	0.3690	1.89e-01	9.78e-02	2.03e-01	2.08e-01	-8.12e-02	7.07e-03	1.63e-01	3.87e-03	2.95e-03	2.47e-01
TELENCEPHALON GLIAL CELL MIGRATION	27	4.61e-01	8.80e-01	0.3690	-1.96e-01	-7.50e-02	-2.09e-01	-2.18e-01	-3.82e-02	7.86e-02	5.00e-01	6.07e-02	5.00e-02	7.31e-01
REGULATION OF MELANOCYTE DIFFERENTIATION	6	6.30e-01	9.46e-01	0.3690	-1.97e-02	-6.45e-02	1.68e-03	-2.58e-02	3.62e-01	9.33e-01	7.84e-01	9.94e-01	9.13e-01	1.25e-01
HEMATOPOIETIC STEM CELL DIFFERENTIATION	36	1.29e-02	1.53e-01	0.3690	1.88e-01	2.14e-02	2.35e-01	1.91e-01	9.34e-02	5.12e-02	8.24e-01	1.47e-02	4.73e-02	3.32e-01
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	13	2.77e-01	7.57e-01	0.3690	-1.16e-01	-1.52e-01	-1.54e-01	-1.47e-01	2.32e-01	4.67e-01	3.42e-01	3.37e-01	3.58e-01	1.47e-01
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	77	2.76e-04	9.11e-03	0.3690	1.48e-01	3.93e-02	2.33e-01	2.38e-01	-4.29e-02	2.47e-02	5.51e-01	4.19e-04	3.12e-04	5.15e-01
MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	11	5.50e-01	9.15e-01	0.3690	9.23e-02	1.37e-01	1.45e-01	1.35e-01	2.63e-01	5.96e-01	4.31e-01	4.05e-01	4.39e-01	1.31e-01
NCRNA PROCESSING	419	1.26e-17	4.31e-15	0.3680	1.75e-01	3.45e-02	2.31e-01	2.24e-01	2.39e-02	7.74e-10	2.26e-01	5.41e-16	3.54e-15	4.02e-01
NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	113	3.46e-05	1.65e-03	0.3680	1.71e-01	-8.44e-03	2.30e-01	2.27e-01	4.18e-02	1.67e-03	8.77e-01	2.35e-05	3.04e-05	4.42e-01
OVIDUCT DEVELOPMENT	5	6.75e-01	9.59e-01	0.3680	1.78e-01	3.21e-01	1.78e-02	-8.56e-03	-1.91e-02	4.90e-01	2.14e-01	9.45e-01	9.74e-01	9.41e-01
XENOBIOTIC TRANSPORT	59	6.67e-02	4.13e-01	0.3680	-1.72e-01	-3.69e-02	-2.26e-01	-2.16e-01	-8.41e-02	2.26e-02	6.24e-01	2.66e-03	4.14e-03	2.64e-01
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION	14	6.12e-01	9.37e-01	0.3680	6.28e-02	-7.45e-02	1.76e-01	1.55e-01	2.66e-01	6.84e-01	6.29e-01	2.53e-01	3.17e-01	8.44e-02
REGULATION OF INTESTINAL LIPID ABSORPTION	10	4.01e-01	8.46e-01	0.3680	1.21e-02	2.46e-01	-1.12e-01	-6.68e-02	-2.40e-01	9.47e-01	1.77e-01	5.38e-01	7.14e-01	1.89e-01
BRANCHING MORPHOGENESIS OF A NERVE	10	3.92e-01	8.41e-01	0.3680	-9.83e-02	-3.26e-01	1.57e-02	-2.48e-02	1.36e-01	5.90e-01	7.44e-02	9.32e-01	8.92e-01	4.55e-01
RNA SPLICING VIA TRANSESTERIFICATION REACTIONS	286	2.48e-13	5.19e-11	0.3680	1.76e-01	2.97e-02	2.29e-01	2.25e-01	-5.57e-04	2.89e-07	3.87e-01	2.41e-11	5.54e-11	9.87e-01
PROTEIN POLYGLUTAMYLATION	12	7.59e-01	9.75e-01	0.3680	1.05e-01	-3.20e-02	1.96e-01	2.02e-01	2.10e-01	5.31e-01	8.48e-01	2.40e-01	2.25e-01	2.08e-01
REGULATION OF CELL PROJECTION SIZE	12	3.11e-01	7.85e-01	0.3680	1.12e-01	3.08e-01	-1.11e-01	-7.41e-02	-9.79e-02	5.00e-01	6.44e-02	5.04e-01	6.57e-01	5.57e-01
INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA	7	6.93e-01	9.61e-01	0.3680	-6.61e-02	1.08e-01	-2.17e-01	-2.37e-01	-1.25e-01	7.62e-01	6.21e-01	3.20e-01	2.77e-01	5.67e-01
PROTEIN PEPTIDYL PROLYL ISOMERIZATION	19	1.01e-01	5.09e-01	0.3670	-1.61e-04	-2.49e-01	1.88e-01	1.61e-01	1.08e-01	9.99e-01	6.02e-02	1.56e-01	2.23e-01	4.14e-01
REPLICATIVE SENESCENCE	17	4.65e-01	8.82e-01	0.3670	1.21e-01	-3.28e-02	2.42e-01	2.11e-01	1.28e-01	3.90e-01	8.15e-01	8.37e-02	1.33e-01	3.62e-01
HISTIDINE CATABOLIC PROCESS	8	5.57e-01	9.19e-01	0.3670	1.40e-01	1.67e-01	-7.42e-02	-6.14e-02	-2.79e-01	4.92e-01	4.13e-01	7.16e-01	7.64e-01	1.71e-01
RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR	17	4.49e-01	8.76e-01	0.3670	-1.27e-01	-9.77e-02	-2.41e-01	-2.20e-01	-5.57e-02	3.64e-01	4.86e-01	8.60e-02	1.17e-01	6.91e-01
RETINAL CONE CELL DEVELOPMENT	11	5.93e-01	9.32e-01	0.3670	1.71e-01	2.97e-01	7.11e-02	9.66e-02	5.29e-02	3.25e-01	8.76e-02	6.83e-01	5.79e-01	7.61e-01
TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	11	7.17e-02	4.31e-01	0.3670	-5.25e-02	-3.61e-01	-1.98e-03	-3.70e-02	-2.56e-02	7.63e-01	3.83e-02	9.91e-01	8.32e-01	8.83e-01
SEROTONIN RECEPTOR SIGNALING PATHWAY	27	2.57e-01	7.39e-01	0.3670	-1.52e-01	7.84e-03	-2.23e-01	-2.36e-01	-7.82e-02	1.71e-01	9.44e-01	4.47e-02	3.37e-02	4.82e-01
UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY	12	2.27e-01	7.10e-01	0.3670	1.57e-01	-1.18e-01	2.26e-01	1.84e-01	1.07e-01	3.47e-01	4.79e-01	1.75e-01	2.71e-01	5.21e-01
DETECTION OF EXTERNAL BIOTIC STIMULUS	26	4.04e-01	8.49e-01	0.3670	-1.39e-01	2.90e-03	-2.27e-01	-2.06e-01	-1.46e-01	2.21e-01	9.80e-01	4.54e-02	6.84e-02	1.97e-01
INTEGRATED STRESS RESPONSE SIGNALING	42	2.32e-02	2.25e-01	0.3670	6.31e-02	-1.48e-01	1.80e-01	1.79e-01	2.10e-01	4.79e-01	9.76e-02	4.31e-02	4.47e-02	1.85e-02
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	18	2.78e-01	7.58e-01	0.3670	-1.69e-01	-1.18e-03	-2.21e-01	-2.35e-01	4.67e-02	2.15e-01	9.93e-01	1.05e-01	8.49e-02	7.32e-01
NEGATIVE REGULATION OF LIPID TRANSPORT	48	2.88e-02	2.54e-01	0.3670	-1.87e-01	-7.21e-02	-2.15e-01	-1.83e-01	-1.21e-01	2.49e-02	3.88e-01	1.01e-02	2.85e-02	1.46e-01
REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY	9	6.39e-01	9.49e-01	0.3670	8.87e-02	2.78e-01	-9.14e-02	-7.31e-02	-1.88e-01	6.45e-01	1.48e-01	6.35e-01	7.04e-01	3.30e-01
REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	31	2.60e-01	7.43e-01	0.3670	-1.95e-01	-2.49e-01	-1.17e-01	-1.42e-01	-1.71e-02	6.03e-02	1.63e-02	2.58e-01	1.72e-01	8.69e-01
REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY	7	2.40e-01	7.24e-01	0.3670	1.51e-01	2.94e-01	3.15e-02	1.16e-01	1.03e-01	4.88e-01	1.78e-01	8.85e-01	5.96e-01	6.37e-01
CELLULAR RESPONSE TO MAGNESIUM ION	7	4.27e-01	8.64e-01	0.3660	-1.14e-01	-2.17e-01	-3.92e-03	-7.60e-02	2.62e-01	6.02e-01	3.20e-01	9.86e-01	7.28e-01	2.31e-01
REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY	9	2.77e-01	7.57e-01	0.3660	2.83e-01	1.66e-01	9.68e-02	8.00e-02	-1.03e-01	1.42e-01	3.88e-01	6.15e-01	6.78e-01	5.94e-01
REGULATION OF LIGASE ACTIVITY	7	4.19e-01	8.59e-01	0.3660	8.61e-02	9.06e-02	1.41e-01	1.10e-01	-2.94e-01	6.93e-01	6.78e-01	5.17e-01	6.13e-01	1.79e-01
RNA SPLICING	421	6.28e-18	2.36e-15	0.3660	1.75e-01	4.14e-02	2.28e-01	2.23e-01	8.44e-03	7.21e-10	1.45e-01	9.84e-16	4.27e-15	7.67e-01
REGULATION OF P38MAPK CASCADE	47	4.88e-02	3.45e-01	0.3660	-1.81e-01	-2.74e-01	-1.03e-01	-1.21e-01	3.02e-02	3.22e-02	1.14e-03	2.22e-01	1.52e-01	7.20e-01
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS	8	8.09e-01	9.82e-01	0.3660	-1.42e-01	5.46e-02	-2.07e-01	-2.22e-01	-1.36e-01	4.87e-01	7.89e-01	3.12e-01	2.76e-01	5.04e-01
REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY	11	3.22e-01	7.96e-01	0.3660	-1.28e-01	-1.56e-01	-1.23e-01	-1.64e-01	2.25e-01	4.61e-01	3.69e-01	4.80e-01	3.45e-01	1.96e-01
IMMUNE COMPLEX CLEARANCE	5	5.06e-01	8.99e-01	0.3660	-5.12e-03	-1.61e-01	-9.30e-02	-1.05e-01	2.97e-01	9.84e-01	5.32e-01	7.19e-01	6.85e-01	2.51e-01
HISTONE MRNA METABOLIC PROCESS	24	1.34e-02	1.56e-01	0.3660	1.31e-02	-1.55e-01	2.53e-01	2.09e-01	4.25e-02	9.11e-01	1.89e-01	3.21e-02	7.59e-02	7.19e-01
REGULATION OF ENDOCRINE PROCESS	39	4.33e-02	3.20e-01	0.3650	-1.42e-01	-2.09e-01	-1.77e-01	-1.93e-01	-3.05e-02	1.25e-01	2.38e-02	5.56e-02	3.69e-02	7.42e-01
NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE	11	5.78e-02	3.82e-01	0.3650	1.66e-01	2.35e-01	4.42e-02	1.30e-01	1.78e-01	3.42e-01	1.76e-01	8.00e-01	4.56e-01	3.06e-01
IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION	11	8.81e-02	4.72e-01	0.3650	5.64e-02	2.55e-01	-1.29e-01	-1.06e-01	1.93e-01	7.46e-01	1.43e-01	4.57e-01	5.44e-01	2.68e-01
ACETATE ESTER TRANSPORT	9	4.96e-01	8.96e-01	0.3650	6.95e-02	2.95e-01	-1.32e-01	-1.16e-01	-1.03e-01	7.18e-01	1.25e-01	4.93e-01	5.48e-01	5.93e-01
VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS	6	6.61e-01	9.54e-01	0.3650	1.47e-01	2.13e-01	2.04e-01	1.57e-01	1.87e-02	5.33e-01	3.67e-01	3.87e-01	5.07e-01	9.37e-01
RESPONSE TO HEPARIN	7	5.69e-01	9.25e-01	0.3650	-1.06e-01	-1.80e-01	-1.60e-01	-1.40e-01	2.11e-01	6.26e-01	4.09e-01	4.65e-01	5.21e-01	3.34e-01
NEGATIVE REGULATION OF GTPASE ACTIVITY	21	2.82e-01	7.62e-01	0.3650	-2.60e-01	-1.49e-01	-1.34e-01	-1.59e-01	1.54e-02	3.93e-02	2.36e-01	2.86e-01	2.08e-01	9.03e-01
FLAVIN CONTAINING COMPOUND METABOLIC PROCESS	6	7.25e-01	9.71e-01	0.3650	-1.69e-01	-2.63e-01	8.62e-03	2.08e-02	1.87e-01	4.72e-01	2.65e-01	9.71e-01	9.30e-01	4.27e-01
ANATOMICAL STRUCTURE ARRANGEMENT	15	3.06e-01	7.79e-01	0.3650	1.21e-01	-6.79e-02	1.25e-01	1.15e-01	2.92e-01	4.19e-01	6.49e-01	4.01e-01	4.40e-01	5.05e-02
METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION	5	7.53e-01	9.75e-01	0.3650	-2.12e-01	-1.56e-01	-9.54e-02	-1.55e-01	1.74e-01	4.12e-01	5.45e-01	7.12e-01	5.47e-01	5.01e-01
REGULATION OF BARBED END ACTIN FILAMENT CAPPING	5	9.06e-01	9.94e-01	0.3640	-9.07e-02	8.07e-02	-2.22e-01	-2.32e-01	-1.22e-01	7.25e-01	7.55e-01	3.90e-01	3.69e-01	6.36e-01
REGULATION OF AUTOPHAGOSOME MATURATION	16	3.69e-01	8.31e-01	0.3640	1.34e-01	1.44e-01	2.16e-01	2.08e-01	-6.49e-02	3.54e-01	3.17e-01	1.34e-01	1.51e-01	6.53e-01
CORTICAL ACTIN CYTOSKELETON ORGANIZATION	42	6.45e-02	4.05e-01	0.3640	-1.70e-01	-1.72e-01	-2.02e-01	-1.77e-01	-4.65e-02	5.72e-02	5.43e-02	2.34e-02	4.66e-02	6.02e-01
CELLULAR RESPONSE TO ALDOSTERONE	7	8.25e-01	9.83e-01	0.3640	1.76e-01	2.75e-01	2.18e-04	2.53e-02	-1.60e-01	4.20e-01	2.08e-01	9.99e-01	9.08e-01	4.64e-01
SELF PROTEOLYSIS	12	4.63e-01	8.80e-01	0.3640	1.19e-03	-9.97e-02	6.50e-02	5.95e-02	3.39e-01	9.94e-01	5.50e-01	6.97e-01	7.21e-01	4.20e-02
CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE	6	6.75e-01	9.59e-01	0.3640	-1.18e-01	-1.43e-01	-8.21e-02	-1.22e-01	-2.77e-01	6.17e-01	5.44e-01	7.28e-01	6.04e-01	2.41e-01
INTRACELLULAR SODIUM ION HOMEOSTASIS	22	5.75e-01	9.26e-01	0.3640	2.16e-01	2.26e-01	1.24e-01	1.40e-01	-1.24e-02	7.99e-02	6.70e-02	3.16e-01	2.55e-01	9.20e-01
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	37	1.87e-02	1.95e-01	0.3640	-1.66e-01	2.77e-02	-2.40e-01	-2.04e-01	-6.87e-02	8.12e-02	7.71e-01	1.14e-02	3.14e-02	4.69e-01
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE	19	2.46e-01	7.31e-01	0.3640	4.40e-02	-1.63e-01	2.16e-01	1.91e-01	1.45e-01	7.40e-01	2.19e-01	1.03e-01	1.50e-01	2.75e-01
POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION	5	2.71e-02	2.46e-01	0.3640	-8.24e-02	1.47e-01	-2.86e-01	-1.41e-01	4.73e-02	7.50e-01	5.70e-01	2.68e-01	5.85e-01	8.55e-01
CELLULAR RESPONSE TO CGMP	7	9.06e-01	9.94e-01	0.3640	-1.56e-01	2.80e-02	-2.21e-01	-2.21e-01	-9.83e-02	4.76e-01	8.98e-01	3.11e-01	3.12e-01	6.52e-01
REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS	7	7.47e-01	9.75e-01	0.3640	-2.00e-01	2.77e-02	-1.79e-01	-2.01e-01	-1.38e-01	3.59e-01	8.99e-01	4.13e-01	3.56e-01	5.27e-01
PROTEIN DNA COMPLEX DISASSEMBLY	21	5.83e-01	9.28e-01	0.3640	1.82e-01	8.27e-02	2.19e-01	2.10e-01	1.65e-02	1.48e-01	5.12e-01	8.28e-02	9.53e-02	8.96e-01
REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	32	3.79e-01	8.37e-01	0.3640	1.85e-01	4.51e-02	2.09e-01	2.01e-01	1.08e-01	6.94e-02	6.58e-01	4.08e-02	4.87e-02	2.93e-01
LYSINE METABOLIC PROCESS	8	2.84e-01	7.62e-01	0.3640	4.12e-02	-1.05e-01	-1.71e-02	-7.11e-03	-3.45e-01	8.40e-01	6.08e-01	9.33e-01	9.72e-01	9.09e-02
O GLYCAN PROCESSING	42	2.86e-01	7.65e-01	0.3630	-2.19e-01	-1.64e-01	-1.59e-01	-1.73e-01	-4.76e-02	1.40e-02	6.64e-02	7.53e-02	5.23e-02	5.93e-01
EXTRAEMBRYONIC MEMBRANE DEVELOPMENT	13	2.26e-02	2.20e-01	0.3630	-2.24e-01	-2.63e-01	3.26e-02	6.61e-02	8.51e-02	1.63e-01	1.00e-01	8.39e-01	6.80e-01	5.95e-01
REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	35	5.25e-04	1.49e-02	0.3630	2.12e-01	7.47e-02	8.43e-02	1.19e-01	-2.46e-01	2.99e-02	4.44e-01	3.88e-01	2.25e-01	1.19e-02
POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM	8	1.72e-01	6.44e-01	0.3630	-2.69e-01	-1.50e-02	-1.78e-01	-1.42e-01	8.54e-02	1.87e-01	9.41e-01	3.82e-01	4.87e-01	6.76e-01
FC EPSILON RECEPTOR SIGNALING PATHWAY	24	3.74e-01	8.35e-01	0.3630	-2.36e-01	-1.28e-01	-1.59e-01	-1.84e-01	-3.06e-02	4.54e-02	2.79e-01	1.79e-01	1.18e-01	7.95e-01
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST	18	1.47e-01	6.06e-01	0.3630	1.45e-01	-4.48e-02	2.51e-01	2.14e-01	-9.34e-03	2.86e-01	7.42e-01	6.57e-02	1.15e-01	9.45e-01
PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE	9	8.91e-01	9.92e-01	0.3630	-1.42e-01	1.45e-02	-2.23e-01	-2.13e-01	-1.28e-01	4.60e-01	9.40e-01	2.47e-01	2.68e-01	5.07e-01
PRIMARY MIRNA PROCESSING	18	4.62e-01	8.80e-01	0.3630	1.40e-01	5.96e-02	2.40e-01	2.25e-01	7.31e-03	3.05e-01	6.62e-01	7.74e-02	9.81e-02	9.57e-01
GLOSSOPHARYNGEAL NERVE DEVELOPMENT	5	6.32e-01	9.47e-01	0.3630	1.44e-01	2.82e-01	-1.27e-01	-5.87e-02	-1.09e-01	5.77e-01	2.75e-01	6.22e-01	8.20e-01	6.74e-01
EOSINOPHIL MEDIATED IMMUNITY	8	3.51e-01	8.18e-01	0.3630	5.75e-02	-2.54e-01	9.01e-02	7.45e-02	2.23e-01	7.78e-01	2.13e-01	6.59e-01	7.15e-01	2.74e-01
REGULATION OF HEPATIC STELLATE CELL ACTIVATION	7	8.04e-01	9.82e-01	0.3630	-1.35e-01	-2.48e-01	-1.54e-01	-1.59e-01	-5.11e-02	5.36e-01	2.55e-01	4.81e-01	4.66e-01	8.15e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	6	8.99e-01	9.93e-01	0.3620	-1.02e-01	6.74e-02	-1.66e-01	-1.48e-01	-2.59e-01	6.65e-01	7.75e-01	4.81e-01	5.31e-01	2.73e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	37	1.26e-01	5.67e-01	0.3620	7.31e-02	-8.98e-02	1.89e-01	1.82e-01	2.22e-01	4.41e-01	3.44e-01	4.69e-02	5.59e-02	1.96e-02
DETECTION OF OTHER ORGANISM	19	7.63e-01	9.75e-01	0.3620	-1.85e-01	-1.52e-01	-1.82e-01	-1.78e-01	-9.65e-02	1.63e-01	2.52e-01	1.69e-01	1.80e-01	4.67e-01
NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	14	5.03e-01	8.98e-01	0.3620	-2.17e-01	-2.23e-01	-1.12e-01	-1.00e-01	1.10e-01	1.60e-01	1.49e-01	4.69e-01	5.16e-01	4.77e-01
CELL REDOX HOMEOSTASIS	38	1.29e-01	5.73e-01	0.3620	1.76e-01	-1.85e-03	1.86e-01	1.87e-01	1.75e-01	5.99e-02	9.84e-01	4.77e-02	4.61e-02	6.19e-02
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	7	6.38e-01	9.49e-01	0.3620	2.55e-02	-1.04e-03	1.46e-01	9.82e-02	3.16e-01	9.07e-01	9.96e-01	5.04e-01	6.53e-01	1.48e-01
OUTFLOW TRACT SEPTUM MORPHOGENESIS	26	9.45e-02	4.91e-01	0.3620	-1.64e-01	-2.53e-01	-1.17e-01	-1.61e-01	1.38e-02	1.47e-01	2.53e-02	3.00e-01	1.56e-01	9.03e-01
TRANSLATIONAL INITIATION	109	6.16e-04	1.66e-02	0.3620	1.35e-01	-1.54e-02	2.31e-01	2.17e-01	1.12e-01	1.49e-02	7.81e-01	3.19e-05	9.21e-05	4.41e-02
TRNA PROCESSING	128	3.57e-06	2.15e-04	0.3620	1.44e-01	-2.60e-02	2.36e-01	2.28e-01	4.11e-02	4.84e-03	6.11e-01	3.81e-06	8.36e-06	4.22e-01
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	9	6.28e-01	9.45e-01	0.3620	2.20e-01	8.21e-02	1.36e-01	1.27e-01	2.04e-01	2.54e-01	6.70e-01	4.81e-01	5.10e-01	2.90e-01
POST GOLGI VESICLE MEDIATED TRANSPORT	101	2.59e-02	2.40e-01	0.3620	-1.88e-01	-1.14e-01	-1.83e-01	-1.90e-01	-1.14e-01	1.07e-03	4.85e-02	1.45e-03	9.80e-04	4.78e-02
ENDOTHELIN RECEPTOR SIGNALING PATHWAY	10	6.63e-01	9.54e-01	0.3620	1.52e-01	1.70e-01	1.43e-01	1.54e-01	-1.86e-01	4.05e-01	3.51e-01	4.35e-01	3.98e-01	3.08e-01
GLYCOLIPID TRANSPORT	8	6.82e-01	9.61e-01	0.3620	-2.62e-02	-1.74e-01	1.86e-01	1.78e-01	1.83e-01	8.98e-01	3.93e-01	3.61e-01	3.84e-01	3.70e-01
T HELPER CELL LINEAGE COMMITMENT	20	3.96e-01	8.44e-01	0.3620	1.74e-01	2.47e-01	1.16e-01	1.17e-01	1.12e-01	1.78e-01	5.59e-02	3.69e-01	3.64e-01	3.88e-01
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	7	8.11e-01	9.82e-01	0.3620	-2.05e-01	-2.48e-01	-8.14e-02	-1.24e-01	-7.33e-02	3.47e-01	2.56e-01	7.09e-01	5.71e-01	7.37e-01
BICARBONATE TRANSPORT	35	2.01e-01	6.80e-01	0.3610	-1.82e-01	-7.35e-02	-2.22e-01	-2.06e-01	-1.46e-02	6.18e-02	4.52e-01	2.29e-02	3.50e-02	8.81e-01
REGULATION OF RENAL SYSTEM PROCESS	21	3.78e-01	8.36e-01	0.3610	1.79e-01	2.15e-01	1.29e-01	1.60e-01	-9.92e-02	1.54e-01	8.80e-02	3.05e-01	2.05e-01	4.31e-01
REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	6	7.00e-01	9.63e-01	0.3610	1.43e-01	3.11e-01	-6.09e-02	-6.10e-02	-7.61e-02	5.45e-01	1.87e-01	7.96e-01	7.96e-01	7.47e-01
NEGATIVE REGULATION OF AMINE METABOLIC PROCESS	6	8.57e-01	9.88e-01	0.3610	1.72e-01	1.71e-01	1.56e-01	2.00e-01	8.49e-02	4.66e-01	4.68e-01	5.09e-01	3.95e-01	7.19e-01
SYMPATHETIC NEURON PROJECTION EXTENSION	5	4.37e-01	8.69e-01	0.3610	-1.50e-01	4.55e-02	-1.72e-01	-2.36e-01	1.44e-01	5.61e-01	8.60e-01	5.05e-01	3.61e-01	5.78e-01
REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	30	3.49e-01	8.18e-01	0.3610	1.71e-01	2.52e-02	2.24e-01	2.14e-01	6.76e-02	1.05e-01	8.11e-01	3.40e-02	4.21e-02	5.21e-01
CDC42 PROTEIN SIGNAL TRANSDUCTION	16	4.14e-01	8.54e-01	0.3610	7.93e-02	-8.14e-02	1.99e-01	2.16e-01	1.77e-01	5.83e-01	5.73e-01	1.67e-01	1.36e-01	2.21e-01
AXONEMAL CENTRAL APPARATUS ASSEMBLY	6	3.62e-01	8.26e-01	0.3610	-3.83e-02	-9.57e-02	-1.97e-01	-2.18e-01	1.83e-01	8.71e-01	6.85e-01	4.05e-01	3.55e-01	4.38e-01
CHEMOSENSORY BEHAVIOR	18	5.83e-01	9.28e-01	0.3610	1.96e-01	2.41e-01	1.11e-01	1.25e-01	7.69e-02	1.51e-01	7.62e-02	4.16e-01	3.60e-01	5.72e-01
RESPONSE TO MITOCHONDRIAL DEPOLARISATION	19	2.74e-01	7.56e-01	0.3610	5.39e-02	-1.22e-01	1.64e-01	1.78e-01	2.32e-01	6.84e-01	3.57e-01	2.15e-01	1.79e-01	8.04e-02
POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	6	7.44e-01	9.74e-01	0.3610	-1.21e-01	-2.64e-01	5.90e-02	6.79e-02	1.94e-01	6.09e-01	2.63e-01	8.02e-01	7.73e-01	4.10e-01
OVULATION CYCLE	72	3.12e-02	2.66e-01	0.3610	-1.80e-01	-1.77e-01	-1.55e-01	-1.75e-01	-1.08e-01	8.33e-03	9.46e-03	2.28e-02	1.01e-02	1.14e-01
REGULATION OF RNA SPLICING	163	3.54e-05	1.66e-03	0.3610	1.79e-01	6.49e-02	2.18e-01	2.14e-01	2.68e-02	8.09e-05	1.53e-01	1.60e-06	2.52e-06	5.55e-01
DETOXIFICATION OF COPPER ION	15	7.06e-01	9.65e-01	0.3600	1.25e-01	5.53e-02	2.22e-01	1.99e-01	1.50e-01	4.03e-01	7.11e-01	1.37e-01	1.82e-01	3.16e-01
VIRAL TRANSCRIPTION	50	8.12e-02	4.56e-01	0.3600	1.73e-01	8.02e-02	2.21e-01	1.97e-01	7.73e-02	3.44e-02	3.26e-01	6.94e-03	1.59e-02	3.44e-01
CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	33	2.35e-01	7.19e-01	0.3600	2.14e-01	6.72e-02	1.75e-01	1.86e-01	1.18e-01	3.33e-02	5.04e-01	8.12e-02	6.46e-02	2.40e-01
NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS	6	7.25e-01	9.70e-01	0.3600	-8.92e-02	-1.67e-01	-2.03e-01	-1.71e-01	-1.53e-01	7.05e-01	4.80e-01	3.90e-01	4.68e-01	5.16e-01
NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL	22	3.24e-01	7.96e-01	0.3600	1.62e-01	1.32e-01	1.55e-01	1.34e-01	2.10e-01	1.88e-01	2.84e-01	2.09e-01	2.78e-01	8.85e-02
GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS	9	4.89e-01	8.92e-01	0.3600	1.98e-01	2.52e-01	-2.21e-02	3.73e-02	-1.57e-01	3.02e-01	1.90e-01	9.09e-01	8.46e-01	4.16e-01
TRACHEA DEVELOPMENT	18	5.39e-01	9.13e-01	0.3600	2.24e-01	7.14e-02	1.92e-01	1.91e-01	3.27e-02	1.00e-01	6.00e-01	1.58e-01	1.62e-01	8.10e-01
REGULATION OF RESPONSE TO TYPE II INTERFERON	14	6.59e-01	9.54e-01	0.3600	-2.38e-01	-2.18e-01	-1.03e-01	-1.18e-01	-2.83e-02	1.23e-01	1.58e-01	5.06e-01	4.43e-01	8.55e-01
MONOTERPENOID METABOLIC PROCESS	6	6.36e-02	4.03e-01	0.3600	-2.84e-01	-2.41e-03	-5.98e-04	-2.02e-02	-2.20e-01	2.29e-01	9.92e-01	9.98e-01	9.32e-01	3.50e-01
POSITIVE REGULATION OF MAST CELL CHEMOTAXIS	5	8.30e-01	9.84e-01	0.3600	-2.28e-01	-2.15e-01	-2.78e-02	-7.37e-02	1.59e-01	3.78e-01	4.05e-01	9.14e-01	7.75e-01	5.39e-01
SEX DETERMINATION	18	1.84e-01	6.56e-01	0.3600	1.83e-01	-6.27e-02	1.89e-01	1.69e-01	1.66e-01	1.78e-01	6.45e-01	1.65e-01	2.14e-01	2.24e-01
RESPONSE TO BLUE LIGHT	6	6.40e-01	9.49e-01	0.3600	-7.17e-02	-1.27e-01	-5.59e-02	-9.03e-02	3.11e-01	7.61e-01	5.91e-01	8.12e-01	7.02e-01	1.87e-01
NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	18	2.48e-01	7.33e-01	0.3590	5.11e-02	-1.09e-01	9.52e-02	8.67e-02	3.13e-01	7.08e-01	4.22e-01	4.85e-01	5.24e-01	2.14e-02
IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE	56	2.66e-02	2.44e-01	0.3590	1.37e-01	-5.75e-02	2.08e-01	2.03e-01	1.50e-01	7.53e-02	4.57e-01	7.03e-03	8.75e-03	5.23e-02
POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION	23	1.78e-01	6.49e-01	0.3590	-1.49e-01	-2.60e-01	-1.22e-01	-1.13e-01	1.07e-01	2.15e-01	3.10e-02	3.11e-01	3.47e-01	3.75e-01
ESTABLISHMENT OF CENTROSOME LOCALIZATION	10	4.85e-01	8.92e-01	0.3590	-2.77e-01	-1.49e-01	-1.04e-01	-1.31e-01	4.63e-02	1.29e-01	4.15e-01	5.70e-01	4.73e-01	8.00e-01
LIVER REGENERATION	28	2.25e-01	7.08e-01	0.3590	6.16e-02	-1.11e-01	1.98e-01	1.81e-01	2.03e-01	5.73e-01	3.10e-01	7.03e-02	9.82e-02	6.29e-02
INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	82	7.70e-03	1.09e-01	0.3590	1.65e-01	2.20e-02	2.25e-01	2.20e-01	5.01e-02	9.92e-03	7.31e-01	4.32e-04	5.81e-04	4.33e-01
T CELL SELECTION	52	1.80e-02	1.90e-01	0.3590	1.65e-01	2.73e-01	1.12e-01	1.14e-01	-3.96e-02	3.97e-02	6.56e-04	1.62e-01	1.55e-01	6.21e-01
REGULATION OF MITOTIC RECOMBINATION	7	6.92e-01	9.61e-01	0.3590	-1.05e-01	-1.12e-01	2.23e-02	4.92e-03	3.24e-01	6.31e-01	6.08e-01	9.18e-01	9.82e-01	1.38e-01
NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING	12	8.21e-02	4.58e-01	0.3590	-9.12e-02	-3.18e-01	-3.26e-03	-5.28e-02	-1.29e-01	5.85e-01	5.64e-02	9.84e-01	7.51e-01	4.41e-01
POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	21	1.14e-01	5.41e-01	0.3590	2.34e-01	1.58e-01	7.42e-02	1.05e-01	-1.80e-01	6.31e-02	2.09e-01	5.56e-01	4.04e-01	1.54e-01
NEGATIVE REGULATION OF PINOCYTOSIS	5	6.52e-01	9.52e-01	0.3590	1.91e-01	1.46e-01	1.22e-01	1.95e-01	-1.35e-01	4.60e-01	5.72e-01	6.36e-01	4.51e-01	6.01e-01
NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS	15	5.28e-01	9.06e-01	0.3590	-2.00e-01	-1.79e-01	-1.22e-01	-1.24e-01	1.63e-01	1.79e-01	2.31e-01	4.13e-01	4.07e-01	2.74e-01
KYNURENINE METABOLIC PROCESS	11	3.61e-01	8.25e-01	0.3590	-2.04e-01	-2.50e-01	-1.82e-02	-4.97e-02	-1.48e-01	2.40e-01	1.52e-01	9.17e-01	7.75e-01	3.95e-01
S ADENOSYLMETHIONINE METABOLIC PROCESS	15	2.39e-01	7.24e-01	0.3590	1.76e-01	-7.58e-02	2.16e-01	2.13e-01	-8.44e-03	2.38e-01	6.11e-01	1.47e-01	1.54e-01	9.55e-01
REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME	9	6.59e-01	9.54e-01	0.3590	-1.39e-01	-2.01e-01	-1.69e-01	-2.00e-01	1.91e-02	4.70e-01	2.96e-01	3.80e-01	2.99e-01	9.21e-01
LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING	9	7.49e-01	9.75e-01	0.3590	1.85e-02	-1.61e-01	1.42e-01	1.36e-01	2.52e-01	9.23e-01	4.03e-01	4.60e-01	4.80e-01	1.90e-01
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION	18	2.92e-01	7.68e-01	0.3590	1.57e-01	2.79e-02	2.22e-01	2.14e-01	-8.89e-02	2.49e-01	8.37e-01	1.03e-01	1.15e-01	5.14e-01
CARBON CATABOLITE REGULATION OF TRANSCRIPTION	7	5.77e-01	9.26e-01	0.3580	1.69e-01	2.14e-02	1.71e-01	1.61e-01	-2.11e-01	4.39e-01	9.22e-01	4.35e-01	4.61e-01	3.34e-01
REGULATION OF MICROVILLUS LENGTH	7	5.23e-01	9.04e-01	0.3580	-2.45e-02	2.36e-01	-2.01e-01	-1.78e-01	-7.19e-03	9.11e-01	2.80e-01	3.57e-01	4.14e-01	9.74e-01
UDP GLUCOSE METABOLIC PROCESS	6	3.57e-01	8.22e-01	0.3580	2.09e-01	-1.08e-01	1.67e-01	1.73e-01	-1.25e-01	3.76e-01	6.48e-01	4.79e-01	4.64e-01	5.96e-01
RESPONSE TO HYDROPEROXIDE	18	3.69e-01	8.31e-01	0.3580	-2.54e-01	-1.60e-01	-1.23e-01	-1.37e-01	6.57e-02	6.24e-02	2.39e-01	3.66e-01	3.13e-01	6.29e-01
HISTONE H3 ACETYLATION	6	6.83e-01	9.61e-01	0.3580	1.92e-01	1.37e-01	1.62e-01	1.28e-01	-1.71e-01	4.14e-01	5.60e-01	4.91e-01	5.86e-01	4.68e-01
NEGATIVE REGULATION OF CALCIUM ION IMPORT	10	8.31e-01	9.85e-01	0.3580	1.42e-01	2.99e-02	2.06e-01	2.25e-01	1.17e-01	4.37e-01	8.70e-01	2.60e-01	2.17e-01	5.21e-01
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING	16	2.42e-01	7.26e-01	0.3580	2.67e-01	8.26e-02	1.46e-01	1.58e-01	5.57e-02	6.40e-02	5.67e-01	3.11e-01	2.72e-01	7.00e-01
CELLULAR RESPONSE TO NITROGEN STARVATION	12	7.23e-02	4.33e-01	0.3570	1.00e-01	2.26e-02	1.65e-01	2.17e-01	-2.07e-01	5.48e-01	8.92e-01	3.23e-01	1.93e-01	2.14e-01
POSITIVE REGULATION OF MAST CELL ACTIVATION	18	5.70e-02	3.79e-01	0.3570	-5.98e-02	-2.89e-01	5.57e-02	7.99e-02	1.77e-01	6.60e-01	3.39e-02	6.83e-01	5.58e-01	1.93e-01
REGULATION OF GLIAL CELL APOPTOTIC PROCESS	10	4.64e-01	8.81e-01	0.3570	1.70e-01	2.51e-01	5.80e-02	1.04e-01	1.47e-01	3.51e-01	1.69e-01	7.51e-01	5.69e-01	4.22e-01
CORTICOSTEROID HORMONE SECRETION	19	7.30e-01	9.71e-01	0.3570	-1.81e-01	-5.93e-02	-2.05e-01	-1.97e-01	-1.03e-01	1.73e-01	6.55e-01	1.22e-01	1.37e-01	4.37e-01
NUCLEAR PORE COMPLEX ASSEMBLY	11	4.88e-01	8.92e-01	0.3570	-1.41e-01	-1.61e-01	-1.32e-01	-1.64e-01	1.93e-01	4.20e-01	3.54e-01	4.47e-01	3.46e-01	2.68e-01
MONOACYLGLYCEROL CATABOLIC PROCESS	7	7.30e-01	9.71e-01	0.3570	-3.53e-02	3.14e-02	-1.04e-01	-1.23e-01	-3.15e-01	8.71e-01	8.86e-01	6.35e-01	5.73e-01	1.49e-01
NEUROTRANSMITTER UPTAKE	44	1.72e-01	6.44e-01	0.3570	1.93e-01	2.18e-01	1.30e-01	1.37e-01	8.22e-02	2.68e-02	1.22e-02	1.35e-01	1.15e-01	3.45e-01
REGULATION OF ODONTOGENESIS	18	5.56e-02	3.71e-01	0.3570	2.79e-02	-2.50e-01	1.43e-01	9.58e-02	1.86e-01	8.38e-01	6.66e-02	2.93e-01	4.82e-01	1.73e-01
NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	8	7.39e-01	9.73e-01	0.3570	1.37e-01	3.83e-02	2.48e-01	2.07e-01	5.12e-02	5.02e-01	8.51e-01	2.25e-01	3.10e-01	8.02e-01
EMBRYONIC BRAIN DEVELOPMENT	16	1.65e-02	1.78e-01	0.3570	2.75e-01	2.09e-01	4.67e-02	2.11e-02	-7.46e-02	5.72e-02	1.48e-01	7.46e-01	8.84e-01	6.05e-01
N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	9	6.00e-01	9.33e-01	0.3570	1.84e-01	2.07e-01	5.32e-02	1.05e-01	-1.91e-01	3.39e-01	2.83e-01	7.82e-01	5.84e-01	3.21e-01
DNA CYTOSINE DEAMINATION	9	5.32e-01	9.07e-01	0.3570	9.24e-02	2.46e-01	-6.07e-02	-6.91e-03	-2.33e-01	6.31e-01	2.02e-01	7.53e-01	9.71e-01	2.26e-01
LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING	10	5.42e-01	9.14e-01	0.3560	1.89e-01	3.00e-01	-1.95e-02	7.18e-03	-1.86e-02	2.99e-01	1.00e-01	9.15e-01	9.69e-01	9.19e-01
FREE UBIQUITIN CHAIN POLYMERIZATION	9	7.52e-01	9.75e-01	0.3560	2.48e-01	1.67e-01	1.37e-01	1.29e-01	4.75e-02	1.97e-01	3.86e-01	4.78e-01	5.04e-01	8.05e-01
PROSTAGLANDIN SECRETION	17	1.97e-01	6.74e-01	0.3560	-1.16e-01	-1.38e-01	-2.33e-01	-2.01e-01	7.92e-03	4.10e-01	3.26e-01	9.65e-02	1.52e-01	9.55e-01
PEPTIDYL PROLINE MODIFICATION	33	4.81e-03	7.91e-02	0.3560	-1.09e-03	-2.75e-01	1.39e-01	1.35e-01	1.18e-01	9.91e-01	6.31e-03	1.68e-01	1.80e-01	2.40e-01
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE	89	8.45e-03	1.15e-01	0.3560	1.26e-01	9.84e-02	1.88e-01	1.84e-01	1.79e-01	4.03e-02	1.08e-01	2.19e-03	2.63e-03	3.52e-03
LIVER MORPHOGENESIS	25	3.80e-01	8.37e-01	0.3560	-1.96e-01	-2.47e-01	-8.63e-02	-1.01e-01	9.84e-02	8.95e-02	3.25e-02	4.55e-01	3.84e-01	3.94e-01
PEROXISOME FISSION	9	5.10e-01	9.00e-01	0.3560	1.47e-01	1.51e-01	5.55e-02	4.15e-02	-2.78e-01	4.45e-01	4.31e-01	7.73e-01	8.29e-01	1.49e-01
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	6	5.60e-01	9.19e-01	0.3560	-4.12e-02	-1.37e-01	8.24e-02	1.43e-02	3.15e-01	8.61e-01	5.62e-01	7.27e-01	9.52e-01	1.81e-01
MRNA MODIFICATION	31	3.47e-02	2.82e-01	0.3560	1.21e-01	7.01e-02	2.16e-01	2.24e-01	-9.95e-02	2.43e-01	4.99e-01	3.73e-02	3.06e-02	3.38e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I	37	4.28e-01	8.65e-01	0.3560	1.80e-01	6.75e-02	1.94e-01	1.95e-01	1.17e-01	5.87e-02	4.77e-01	4.06e-02	3.99e-02	2.16e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS	17	1.07e-01	5.25e-01	0.3560	1.36e-01	-1.36e-01	2.12e-01	2.10e-01	-1.38e-02	3.33e-01	3.31e-01	1.30e-01	1.33e-01	9.22e-01
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	27	3.95e-01	8.44e-01	0.3560	-1.72e-01	-2.28e-02	-2.17e-01	-2.17e-01	-4.50e-02	1.23e-01	8.38e-01	5.07e-02	5.06e-02	6.86e-01
REGULATION OF SREBP SIGNALING PATHWAY	8	5.08e-01	9.00e-01	0.3550	-3.04e-02	-2.29e-01	3.07e-02	5.18e-02	2.63e-01	8.82e-01	2.61e-01	8.80e-01	8.00e-01	1.98e-01
POSITIVE REGULATION OF VESICLE FUSION	11	3.57e-01	8.22e-01	0.3550	-2.77e-01	-1.56e-01	-9.12e-02	-1.03e-01	7.70e-02	1.11e-01	3.70e-01	6.01e-01	5.56e-01	6.59e-01
MITOCHONDRIAL RESPIRASOME ASSEMBLY	10	4.34e-01	8.69e-01	0.3550	-5.02e-02	-1.38e-01	-1.09e-01	-1.01e-01	-2.87e-01	7.84e-01	4.51e-01	5.49e-01	5.80e-01	1.16e-01
CHEMOKINE PRODUCTION	101	4.80e-04	1.41e-02	0.3550	-1.66e-01	-1.87e-01	-1.84e-01	-1.71e-01	1.59e-02	3.91e-03	1.16e-03	1.37e-03	2.96e-03	7.83e-01
FIBROBLAST APOPTOTIC PROCESS	25	3.92e-01	8.41e-01	0.3550	1.80e-01	1.66e-01	1.90e-01	1.68e-01	4.32e-02	1.19e-01	1.52e-01	1.01e-01	1.46e-01	7.09e-01
XENOPHAGY	14	7.62e-01	9.75e-01	0.3550	-1.04e-01	2.21e-02	-1.91e-01	-1.92e-01	-2.04e-01	5.00e-01	8.86e-01	2.17e-01	2.14e-01	1.87e-01
CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	12	7.12e-01	9.67e-01	0.3550	1.62e-01	1.58e-03	1.85e-01	1.65e-01	1.95e-01	3.31e-01	9.92e-01	2.66e-01	3.22e-01	2.42e-01
MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	16	1.37e-01	5.89e-01	0.3550	-1.18e-01	-2.99e-01	-8.27e-02	-1.22e-01	3.18e-02	4.15e-01	3.85e-02	5.67e-01	3.99e-01	8.26e-01
VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	12	5.40e-01	9.13e-01	0.3550	-1.16e-01	-1.39e-01	-1.06e-01	-1.21e-01	-2.59e-01	4.85e-01	4.05e-01	5.27e-01	4.66e-01	1.20e-01
POSITIVE REGULATION OF CATECHOLAMINE SECRETION	12	5.70e-01	9.26e-01	0.3550	-1.83e-01	-2.57e-01	-3.79e-03	-4.18e-02	1.56e-01	2.72e-01	1.23e-01	9.82e-01	8.02e-01	3.50e-01
NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	12	7.93e-01	9.81e-01	0.3540	8.03e-02	-4.62e-02	1.84e-01	1.75e-01	2.29e-01	6.30e-01	7.82e-01	2.69e-01	2.95e-01	1.69e-01
SEQUESTERING OF METAL ION	10	1.49e-01	6.10e-01	0.3540	-8.14e-02	-3.12e-01	-7.77e-02	-3.83e-02	1.20e-01	6.56e-01	8.79e-02	6.71e-01	8.34e-01	5.12e-01
OTOLITH MORPHOGENESIS	5	7.14e-01	9.68e-01	0.3540	8.48e-02	2.15e-01	-1.84e-01	-1.70e-01	-9.73e-02	7.43e-01	4.05e-01	4.77e-01	5.10e-01	7.06e-01
CENTRAL NERVOUS SYSTEM MATURATION	6	7.63e-01	9.75e-01	0.3540	2.67e-01	1.54e-01	1.26e-01	1.17e-01	-2.83e-02	2.57e-01	5.14e-01	5.93e-01	6.20e-01	9.04e-01
GALACTOSE METABOLIC PROCESS	8	7.15e-01	9.68e-01	0.3540	1.74e-01	2.59e-01	9.57e-03	5.84e-02	-1.56e-01	3.93e-01	2.04e-01	9.63e-01	7.75e-01	4.45e-01
REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	7	8.66e-01	9.88e-01	0.3540	-2.52e-01	-1.67e-01	-1.19e-01	-1.40e-01	-4.85e-03	2.48e-01	4.44e-01	5.87e-01	5.20e-01	9.82e-01
PROTEIN LOCALIZATION TO CELL CELL JUNCTION	21	4.21e-01	8.60e-01	0.3540	-2.15e-01	-8.54e-02	-1.75e-01	-1.62e-01	-1.22e-01	8.80e-02	4.98e-01	1.64e-01	1.99e-01	3.35e-01
FOREGUT MORPHOGENESIS	10	8.19e-01	9.83e-01	0.3540	-1.49e-01	-1.59e-01	-1.81e-01	-2.03e-01	-6.44e-02	4.16e-01	3.85e-01	3.22e-01	2.67e-01	7.24e-01
REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM	11	2.58e-01	7.40e-01	0.3540	-2.20e-01	-9.04e-02	-1.35e-01	-1.14e-01	1.93e-01	2.06e-01	6.04e-01	4.37e-01	5.11e-01	2.69e-01
GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE	19	3.48e-02	2.83e-01	0.3540	-1.22e-01	-1.36e-01	-2.12e-01	-1.66e-01	1.38e-01	3.58e-01	3.06e-01	1.09e-01	2.09e-01	2.96e-01
SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY	12	4.76e-01	8.86e-01	0.3540	2.40e-01	7.71e-02	1.79e-01	1.66e-01	-4.49e-02	1.50e-01	6.44e-01	2.83e-01	3.19e-01	7.88e-01
REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR	9	2.48e-01	7.33e-01	0.3540	-2.40e-01	-2.27e-01	-5.07e-02	-1.81e-02	1.15e-01	2.13e-01	2.39e-01	7.92e-01	9.25e-01	5.50e-01
POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	6	5.95e-01	9.33e-01	0.3530	-3.36e-02	1.54e-01	-2.47e-01	-1.90e-01	-5.63e-02	8.87e-01	5.15e-01	2.95e-01	4.20e-01	8.11e-01
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	12	7.60e-01	9.75e-01	0.3530	-1.43e-01	-1.83e-01	-1.84e-01	-1.77e-01	-7.39e-02	3.90e-01	2.71e-01	2.69e-01	2.88e-01	6.57e-01
METHIONINE BIOSYNTHETIC PROCESS	12	4.36e-01	8.69e-01	0.3530	-1.61e-01	-3.13e-01	1.90e-02	6.88e-03	2.42e-02	3.35e-01	6.03e-02	9.09e-01	9.67e-01	8.85e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION	6	8.21e-01	9.83e-01	0.3530	-1.19e-01	1.77e-02	-1.22e-01	-1.02e-01	-2.92e-01	6.13e-01	9.40e-01	6.06e-01	6.66e-01	2.16e-01
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	8	7.41e-01	9.73e-01	0.3530	-1.87e-01	-1.60e-01	-1.87e-01	-1.48e-01	-8.53e-02	3.59e-01	4.34e-01	3.59e-01	4.69e-01	6.76e-01
REGULATION OF HISTONE METHYLATION	16	7.77e-01	9.79e-01	0.3530	-1.41e-01	-8.31e-02	-2.15e-01	-2.08e-01	-8.98e-02	3.28e-01	5.65e-01	1.36e-01	1.49e-01	5.34e-01
RIBOSOME DISASSEMBLY	12	6.08e-01	9.35e-01	0.3530	1.37e-01	-9.55e-02	1.95e-01	1.90e-01	1.51e-01	4.11e-01	5.67e-01	2.43e-01	2.54e-01	3.66e-01
POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	7	4.74e-01	8.86e-01	0.3530	6.54e-02	-9.06e-02	2.26e-01	1.51e-01	1.96e-01	7.64e-01	6.78e-01	3.00e-01	4.89e-01	3.70e-01
INTESTINAL CHOLESTEROL ABSORPTION	18	4.59e-02	3.35e-01	0.3530	-4.83e-02	2.20e-01	-9.75e-02	-6.03e-02	-2.47e-01	7.23e-01	1.07e-01	4.74e-01	6.58e-01	7.00e-02
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	8	6.01e-01	9.33e-01	0.3530	1.85e-01	-7.66e-02	1.74e-01	1.92e-01	1.32e-01	3.64e-01	7.08e-01	3.95e-01	3.48e-01	5.17e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	63	1.32e-01	5.77e-01	0.3530	1.81e-01	7.48e-02	1.92e-01	1.87e-01	1.21e-01	1.30e-02	3.04e-01	8.42e-03	1.05e-02	9.71e-02
MEIOTIC CHROMOSOME CONDENSATION	6	9.25e-01	9.95e-01	0.3530	1.19e-01	5.07e-02	2.16e-01	2.30e-01	9.11e-02	6.14e-01	8.30e-01	3.59e-01	3.30e-01	6.99e-01
N TERMINAL PEPTIDYL METHIONINE ACETYLATION	6	7.42e-01	9.73e-01	0.3530	1.39e-01	9.96e-02	1.59e-01	1.43e-01	-2.23e-01	5.55e-01	6.73e-01	5.01e-01	5.43e-01	3.45e-01
IRON SULFUR CLUSTER ASSEMBLY	27	2.07e-01	6.85e-01	0.3530	2.10e-01	2.89e-02	1.95e-01	2.03e-01	1.49e-02	5.86e-02	7.95e-01	8.00e-02	6.74e-02	8.93e-01
ISOLEUCINE TRANSPORT	5	7.32e-01	9.72e-01	0.3530	2.64e-01	1.35e-01	8.25e-02	9.30e-02	-1.45e-01	3.07e-01	6.01e-01	7.49e-01	7.19e-01	5.74e-01
TYPE II PNEUMOCYTE DIFFERENTIATION	6	8.71e-01	9.88e-01	0.3530	1.90e-01	-2.76e-02	1.93e-01	1.82e-01	1.32e-01	4.21e-01	9.07e-01	4.13e-01	4.39e-01	5.77e-01
REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	6	2.81e-01	7.60e-01	0.3530	2.06e-01	1.17e-01	-2.57e-02	-2.10e-02	2.59e-01	3.81e-01	6.19e-01	9.13e-01	9.29e-01	2.72e-01
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	110	4.44e-06	2.65e-04	0.3530	7.79e-02	-1.44e-01	1.95e-01	1.80e-01	1.65e-01	1.58e-01	9.09e-03	4.21e-04	1.11e-03	2.73e-03
RESPIRATORY ELECTRON TRANSPORT CHAIN	107	4.86e-05	2.15e-03	0.3530	2.05e-01	2.54e-02	1.97e-01	2.06e-01	2.01e-02	2.41e-04	6.49e-01	4.28e-04	2.37e-04	7.19e-01
ANAGEN	5	6.01e-02	3.91e-01	0.3520	-7.91e-02	1.21e-01	-5.64e-02	-1.77e-01	-2.63e-01	7.59e-01	6.40e-01	8.27e-01	4.94e-01	3.09e-01
POSITIVE REGULATION OF THYROID HORMONE GENERATION	5	8.53e-01	9.88e-01	0.3520	-1.92e-03	-1.64e-02	9.74e-02	7.53e-02	3.30e-01	9.94e-01	9.49e-01	7.06e-01	7.71e-01	2.02e-01
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	13	6.69e-01	9.56e-01	0.3520	1.55e-01	1.39e-02	2.27e-01	2.19e-01	-4.43e-03	3.34e-01	9.31e-01	1.56e-01	1.72e-01	9.78e-01
RNA 3 URIDYLATION	5	3.17e-01	7.89e-01	0.3520	-4.94e-02	6.85e-02	-1.99e-01	-2.62e-01	9.20e-02	8.48e-01	7.91e-01	4.42e-01	3.10e-01	7.22e-01
AMELOBLAST DIFFERENTIATION	5	8.05e-01	9.82e-01	0.3520	-6.71e-02	-2.76e-01	1.13e-01	6.55e-02	1.61e-01	7.95e-01	2.85e-01	6.62e-01	8.00e-01	5.33e-01
PHOTOTRANSDUCTION VISIBLE LIGHT	18	6.33e-02	4.02e-01	0.3520	-1.38e-03	2.54e-01	-1.85e-01	-1.40e-01	-7.15e-02	9.92e-01	6.16e-02	1.75e-01	3.02e-01	6.00e-01
DIRECT OSSIFICATION	7	5.96e-01	9.33e-01	0.3520	-1.26e-01	2.69e-02	-2.56e-01	-2.00e-01	-3.86e-02	5.64e-01	9.02e-01	2.40e-01	3.60e-01	8.60e-01
DETERMINATION OF ADULT LIFESPAN	35	1.34e-01	5.81e-01	0.3520	1.44e-01	-3.77e-02	1.74e-01	1.84e-01	1.93e-01	1.41e-01	6.99e-01	7.43e-02	5.94e-02	4.79e-02
BIOLOGICAL PHASE	11	6.45e-02	4.05e-01	0.3520	-1.88e-01	-1.83e-01	-7.46e-02	-1.66e-01	-1.47e-01	2.81e-01	2.92e-01	6.68e-01	3.41e-01	3.98e-01
POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	24	6.43e-01	9.50e-01	0.3520	-2.07e-01	-1.19e-01	-1.73e-01	-1.73e-01	-8.17e-02	7.97e-02	3.11e-01	1.42e-01	1.42e-01	4.89e-01
KINETOCHORE ORGANIZATION	20	2.29e-01	7.13e-01	0.3520	1.78e-01	5.40e-02	2.25e-01	1.93e-01	-3.02e-02	1.68e-01	6.76e-01	8.11e-02	1.35e-01	8.15e-01
NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	5	8.79e-01	9.89e-01	0.3510	-3.89e-02	-2.51e-01	1.02e-01	8.45e-02	2.04e-01	8.80e-01	3.31e-01	6.92e-01	7.44e-01	4.31e-01
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION	7	8.53e-01	9.88e-01	0.3510	2.36e-01	7.08e-02	1.65e-01	1.84e-01	4.19e-02	2.80e-01	7.46e-01	4.50e-01	3.98e-01	8.48e-01
POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	28	4.14e-01	8.54e-01	0.3510	-1.83e-01	-1.87e-01	-1.50e-01	-1.65e-01	7.13e-02	9.34e-02	8.64e-02	1.71e-01	1.30e-01	5.14e-01
PROTEIN LIPOYLATION	5	1.54e-01	6.16e-01	0.3510	6.11e-02	-2.88e-01	7.03e-02	1.37e-01	-1.15e-01	8.13e-01	2.65e-01	7.85e-01	5.96e-01	6.57e-01
DEFINITIVE HEMOPOIESIS	19	5.49e-02	3.68e-01	0.3510	-1.26e-01	-3.05e-01	-5.08e-02	-9.95e-02	-4.33e-02	3.43e-01	2.13e-02	7.02e-01	4.53e-01	7.44e-01
CORTICAL CYTOSKELETON ORGANIZATION	50	4.82e-02	3.42e-01	0.3510	-1.73e-01	-1.69e-01	-1.90e-01	-1.67e-01	-2.59e-02	3.39e-02	3.89e-02	2.02e-02	4.10e-02	7.51e-01
ADENOSINE TO INOSINE EDITING	7	7.87e-01	9.81e-01	0.3510	1.51e-01	2.99e-01	7.47e-02	7.18e-02	1.42e-02	4.88e-01	1.71e-01	7.32e-01	7.42e-01	9.48e-01
AXO DENDRITIC PROTEIN TRANSPORT	9	5.27e-01	9.06e-01	0.3510	-1.30e-01	-2.10e-01	5.91e-02	6.74e-02	2.33e-01	5.00e-01	2.76e-01	7.59e-01	7.26e-01	2.26e-01
POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	10	6.82e-01	9.61e-01	0.3510	-2.17e-01	-6.05e-02	-1.57e-01	-1.91e-01	-1.05e-01	2.34e-01	7.40e-01	3.89e-01	2.95e-01	5.66e-01
INTRACILIARY TRANSPORT	45	2.01e-02	2.04e-01	0.3510	2.05e-01	2.15e-01	1.24e-01	1.07e-01	-8.70e-02	1.71e-02	1.24e-02	1.49e-01	2.15e-01	3.12e-01
POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II	48	4.63e-03	7.70e-02	0.3510	1.09e-01	-5.97e-02	2.41e-01	2.22e-01	5.08e-03	1.90e-01	4.74e-01	3.79e-03	7.84e-03	9.51e-01
DENDRITIC TRANSPORT	12	2.72e-01	7.54e-01	0.3510	-1.37e-01	-1.96e-01	1.00e-01	9.98e-02	2.15e-01	4.12e-01	2.41e-01	5.47e-01	5.49e-01	1.98e-01
NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS	41	2.60e-01	7.43e-01	0.3510	-1.12e-01	-2.16e-02	-1.96e-01	-1.93e-01	-1.85e-01	2.13e-01	8.11e-01	3.02e-02	3.23e-02	4.01e-02
PHOSPHATE ION TRANSMEMBRANE TRANSPORT	17	6.30e-01	9.46e-01	0.3500	1.85e-01	2.11e-01	1.18e-01	1.42e-01	9.92e-02	1.86e-01	1.31e-01	4.00e-01	3.10e-01	4.79e-01
PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS	8	9.84e-02	5.01e-01	0.3500	-6.62e-02	-1.76e-01	-1.72e-01	-2.39e-01	3.02e-02	7.46e-01	3.88e-01	4.01e-01	2.42e-01	8.83e-01
EPIBOLY	37	3.05e-01	7.77e-01	0.3500	-1.68e-01	-1.36e-01	-1.86e-01	-2.02e-01	-1.87e-02	7.73e-02	1.51e-01	5.00e-02	3.31e-02	8.44e-01
BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	12	2.20e-01	7.00e-01	0.3500	2.33e-01	1.89e-02	1.93e-01	1.65e-01	-6.16e-02	1.63e-01	9.10e-01	2.48e-01	3.21e-01	7.12e-01
POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	5	7.94e-01	9.81e-01	0.3500	1.35e-01	2.77e-01	1.30e-01	1.02e-01	1.62e-02	6.01e-01	2.83e-01	6.14e-01	6.93e-01	9.50e-01
DNA CATABOLIC PROCESS	29	1.31e-01	5.76e-01	0.3500	5.42e-02	-1.36e-01	1.39e-01	1.25e-01	2.57e-01	6.14e-01	2.06e-01	1.94e-01	2.44e-01	1.64e-02
ACTIN FILAMENT BASED TRANSPORT	21	3.95e-01	8.43e-01	0.3500	-1.27e-01	6.66e-02	-2.08e-01	-1.87e-01	-1.54e-01	3.14e-01	5.97e-01	9.84e-02	1.39e-01	2.20e-01
PROTEIN SIDE CHAIN DEGLUTAMYLATION	5	7.37e-01	9.73e-01	0.3500	4.76e-02	1.03e-01	1.24e-01	8.36e-02	2.95e-01	8.54e-01	6.90e-01	6.30e-01	7.46e-01	2.53e-01
REGULATION OF TOOTH MINERALIZATION	10	5.73e-01	9.26e-01	0.3500	-2.24e-01	-5.48e-02	-1.30e-01	-1.51e-01	-1.72e-01	2.20e-01	7.64e-01	4.78e-01	4.09e-01	3.46e-01
CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING	6	6.80e-01	9.61e-01	0.3500	-1.01e-01	-2.27e-01	-5.43e-02	-4.80e-02	-2.35e-01	6.69e-01	3.36e-01	8.18e-01	8.39e-01	3.18e-01
FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX	14	2.68e-01	7.48e-01	0.3500	1.33e-01	9.59e-02	2.32e-01	1.93e-01	-6.71e-02	3.91e-01	5.34e-01	1.33e-01	2.12e-01	6.64e-01
ACETATE ESTER METABOLIC PROCESS	6	5.47e-01	9.15e-01	0.3490	3.44e-02	6.82e-02	-2.27e-01	-2.24e-01	-1.21e-01	8.84e-01	7.72e-01	3.36e-01	3.42e-01	6.09e-01
PHOSPHATIDYLSERINE ACYL CHAIN REMODELING	9	1.82e-01	6.56e-01	0.3490	-4.98e-02	1.57e-01	-1.78e-01	-2.06e-01	1.45e-01	7.96e-01	4.16e-01	3.56e-01	2.85e-01	4.53e-01
PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING	6	9.76e-01	9.97e-01	0.3490	1.64e-01	5.64e-02	2.09e-01	2.04e-01	8.06e-02	4.87e-01	8.11e-01	3.75e-01	3.87e-01	7.32e-01
CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE	17	3.23e-02	2.72e-01	0.3490	6.10e-02	-1.96e-02	2.62e-01	2.11e-01	-6.81e-02	6.63e-01	8.89e-01	6.15e-02	1.33e-01	6.27e-01
POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	5	7.18e-01	9.69e-01	0.3490	-1.95e-01	7.25e-02	-1.39e-01	-1.38e-01	-2.00e-01	4.51e-01	7.79e-01	5.89e-01	5.94e-01	4.38e-01
POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET	7	9.51e-01	9.97e-01	0.3490	1.54e-01	4.04e-02	1.88e-01	1.74e-01	1.75e-01	4.80e-01	8.53e-01	3.88e-01	4.26e-01	4.23e-01
PROTEIN POLY ADP RIBOSYLATION	10	4.15e-01	8.55e-01	0.3490	-1.03e-01	-2.25e-01	1.17e-01	1.24e-01	1.77e-01	5.74e-01	2.18e-01	5.22e-01	4.98e-01	3.31e-01
CENTROMERE COMPLEX ASSEMBLY	28	4.51e-02	3.31e-01	0.3490	1.73e-01	-8.63e-04	2.31e-01	1.87e-01	5.88e-02	1.13e-01	9.94e-01	3.47e-02	8.64e-02	5.90e-01
RETINAL CELL APOPTOTIC PROCESS	7	5.73e-01	9.26e-01	0.3490	-1.09e-01	-1.08e-01	6.71e-02	1.61e-02	3.05e-01	6.16e-01	6.19e-01	7.59e-01	9.41e-01	1.62e-01
REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	7	6.93e-01	9.61e-01	0.3490	9.69e-02	2.56e-01	8.12e-02	7.80e-02	-1.85e-01	6.57e-01	2.42e-01	7.10e-01	7.21e-01	3.97e-01
CELLULAR RESPONSE TO PEPTIDOGLYCAN	6	3.32e-01	8.04e-01	0.3490	1.97e-01	2.69e-01	-6.93e-02	1.24e-02	7.07e-02	4.03e-01	2.53e-01	7.69e-01	9.58e-01	7.64e-01
REGULATION OF CHRONIC INFLAMMATORY RESPONSE	9	2.64e-01	7.47e-01	0.3490	-8.48e-02	-5.91e-02	-3.22e-02	2.71e-03	3.31e-01	6.60e-01	7.59e-01	8.67e-01	9.89e-01	8.52e-02
CELL FATE DETERMINATION	42	3.83e-04	1.16e-02	0.3490	5.91e-02	-2.12e-01	1.19e-01	8.89e-02	2.25e-01	5.07e-01	1.72e-02	1.81e-01	3.19e-01	1.15e-02
CELL CELL JUNCTION MAINTENANCE	18	3.75e-01	8.36e-01	0.3480	-1.38e-01	-7.73e-02	-2.20e-01	-2.08e-01	6.86e-02	3.11e-01	5.70e-01	1.06e-01	1.27e-01	6.14e-01
GLYCEROL ETHER METABOLIC PROCESS	21	6.57e-01	9.54e-01	0.3480	-1.43e-01	-9.22e-02	-2.12e-01	-2.05e-01	-7.13e-02	2.58e-01	4.65e-01	9.21e-02	1.03e-01	5.72e-01
REGULATION OF HEART MORPHOGENESIS	10	3.87e-01	8.40e-01	0.3480	-1.62e-01	-2.96e-01	-2.03e-02	-8.03e-02	-1.32e-02	3.75e-01	1.05e-01	9.11e-01	6.60e-01	9.42e-01
GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE	5	7.20e-01	9.69e-01	0.3480	-1.15e-01	-2.99e-01	-6.79e-02	-1.16e-01	2.59e-02	6.57e-01	2.47e-01	7.93e-01	6.54e-01	9.20e-01
PROTEIN NEDDYLATION	28	1.44e-01	6.01e-01	0.3480	1.28e-01	-1.58e-03	2.42e-01	2.11e-01	4.14e-02	2.43e-01	9.88e-01	2.67e-02	5.34e-02	7.05e-01
MITOCHONDRIAL MEMBRANE ORGANIZATION	113	1.42e-04	5.27e-03	0.3480	1.09e-01	-6.51e-02	2.15e-01	2.10e-01	1.20e-01	4.45e-02	2.32e-01	8.02e-05	1.12e-04	2.73e-02
REGULATION OF TISSUE REMODELING	86	4.16e-02	3.12e-01	0.3480	-1.67e-01	-1.16e-01	-2.00e-01	-1.94e-01	-4.62e-02	7.44e-03	6.36e-02	1.37e-03	1.87e-03	4.58e-01
CONSTITUTIVE HETEROCHROMATIN FORMATION	11	4.63e-01	8.81e-01	0.3480	9.86e-02	-9.91e-02	2.39e-01	1.95e-01	7.91e-02	5.71e-01	5.69e-01	1.70e-01	2.63e-01	6.50e-01
REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS	14	4.61e-01	8.80e-01	0.3470	-1.56e-01	-2.27e-01	-9.21e-03	-5.04e-02	2.06e-01	3.13e-01	1.42e-01	9.52e-01	7.44e-01	1.82e-01
PROTEIN LOCALIZATION TO MEMBRANE RAFT	9	5.28e-01	9.06e-01	0.3470	-5.06e-02	-2.93e-01	1.03e-01	9.68e-02	1.11e-01	7.93e-01	1.28e-01	5.93e-01	6.15e-01	5.64e-01
NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE	20	2.65e-01	7.47e-01	0.3470	-1.50e-01	-2.81e-01	-7.79e-02	-1.02e-01	-5.40e-02	2.47e-01	2.97e-02	5.47e-01	4.31e-01	6.76e-01
INHIBITORY SYNAPSE ASSEMBLY	19	6.41e-01	9.50e-01	0.3470	-1.71e-01	-6.95e-02	-2.12e-01	-2.04e-01	-3.07e-03	1.98e-01	6.00e-01	1.10e-01	1.23e-01	9.81e-01
POSITIVE REGULATION OF DNA BINDING	41	1.33e-01	5.79e-01	0.3470	2.05e-01	4.43e-02	1.92e-01	1.93e-01	4.72e-02	2.31e-02	6.24e-01	3.32e-02	3.24e-02	6.01e-01
REGULATION OF LYMPHOCYTE CHEMOTAXIS	26	3.40e-02	2.79e-01	0.3470	1.38e-01	1.98e-01	3.95e-02	4.43e-02	2.42e-01	2.24e-01	8.05e-02	7.27e-01	6.96e-01	3.26e-02
NEGATIVE REGULATION OF DNA RECOMBINATION	45	8.96e-02	4.76e-01	0.3470	2.25e-01	8.62e-02	1.73e-01	1.74e-01	4.47e-02	9.03e-03	3.17e-01	4.44e-02	4.35e-02	6.04e-01
NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	19	2.89e-01	7.67e-01	0.3470	-1.79e-01	-2.70e-01	-1.79e-03	-7.91e-03	1.23e-01	1.77e-01	4.14e-02	9.89e-01	9.52e-01	3.53e-01
GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS	6	4.42e-01	8.72e-01	0.3470	1.28e-01	-1.59e-01	6.93e-02	7.00e-02	2.63e-01	5.88e-01	5.01e-01	7.69e-01	7.67e-01	2.65e-01
B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	6	2.54e-01	7.37e-01	0.3470	-9.58e-02	-1.64e-01	-7.96e-02	-1.63e-01	-2.27e-01	6.84e-01	4.88e-01	7.36e-01	4.89e-01	3.37e-01
POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	6	5.26e-01	9.05e-01	0.3470	-6.39e-03	5.89e-03	4.02e-02	6.78e-02	-3.37e-01	9.78e-01	9.80e-01	8.65e-01	7.74e-01	1.52e-01
NUCLEOTIDE SALVAGE	17	2.05e-01	6.84e-01	0.3470	-1.11e-01	-2.30e-01	-1.54e-01	-1.45e-01	1.02e-01	4.30e-01	1.01e-01	2.73e-01	3.00e-01	4.66e-01
RESPONSE TO HUMAN CHORIONIC GONADOTROPIN	5	7.15e-01	9.68e-01	0.3470	7.41e-02	3.12e-03	2.09e-01	2.18e-01	-1.53e-01	7.74e-01	9.90e-01	4.18e-01	3.99e-01	5.54e-01
POSITIVE REGULATION OF HAIR FOLLICLE MATURATION	5	4.48e-02	3.30e-01	0.3460	4.59e-02	-1.12e-01	1.47e-01	2.73e-02	-2.88e-01	8.59e-01	6.64e-01	5.70e-01	9.16e-01	2.64e-01
REGULATION OF GLOMERULUS DEVELOPMENT	5	7.11e-01	9.67e-01	0.3460	-6.14e-02	-1.89e-01	1.85e-01	1.19e-01	1.79e-01	8.12e-01	4.64e-01	4.74e-01	6.44e-01	4.88e-01
UBIQUITIN DEPENDENT ERAD PATHWAY	82	1.14e-04	4.38e-03	0.3460	1.03e-01	-1.33e-01	1.93e-01	1.84e-01	1.44e-01	1.07e-01	3.78e-02	2.55e-03	4.01e-03	2.42e-02
KIDNEY MESENCHYME DEVELOPMENT	16	1.93e-01	6.67e-01	0.3460	1.19e-01	-7.53e-02	1.84e-01	1.34e-01	2.19e-01	4.09e-01	6.02e-01	2.03e-01	3.52e-01	1.30e-01
PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE	23	4.85e-02	3.43e-01	0.3460	1.30e-01	-1.46e-01	2.09e-01	1.89e-01	4.63e-02	2.81e-01	2.27e-01	8.29e-02	1.16e-01	7.01e-01
STABILIZATION OF MEMBRANE POTENTIAL	17	2.29e-01	7.13e-01	0.3460	1.54e-02	1.50e-02	1.11e-01	1.22e-01	3.03e-01	9.12e-01	9.15e-01	4.28e-01	3.85e-01	3.03e-02
SUCCINATE TRANSMEMBRANE TRANSPORT	6	7.64e-01	9.75e-01	0.3460	1.19e-01	2.79e-01	1.14e-01	1.00e-01	-6.66e-02	6.12e-01	2.37e-01	6.28e-01	6.70e-01	7.77e-01
METANEPHRIC NEPHRON TUBULE MORPHOGENESIS	8	3.22e-01	7.96e-01	0.3450	1.06e-01	-5.35e-02	7.98e-02	3.44e-02	3.13e-01	6.03e-01	7.93e-01	6.96e-01	8.66e-01	1.26e-01
NEGATIVE REGULATION OF CELLULAR SENESCENCE	25	1.48e-01	6.10e-01	0.3450	1.25e-01	-1.00e-01	2.08e-01	1.81e-01	1.32e-01	2.78e-01	3.86e-01	7.20e-02	1.17e-01	2.52e-01
INTRACELLULAR GLUTAMATE HOMEOSTASIS	5	6.17e-01	9.40e-01	0.3450	3.42e-02	2.87e-02	-2.00e-02	-5.93e-02	-3.37e-01	8.95e-01	9.12e-01	9.38e-01	8.18e-01	1.92e-01
POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY	16	2.38e-01	7.22e-01	0.3450	-2.46e-01	-1.18e-01	-1.21e-01	-1.71e-01	-3.18e-02	8.84e-02	4.14e-01	4.02e-01	2.38e-01	8.26e-01
REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	54	1.21e-03	2.88e-02	0.3450	9.78e-02	5.60e-03	2.35e-01	2.29e-01	-4.44e-02	2.14e-01	9.43e-01	2.84e-03	3.59e-03	5.72e-01
COBALT ION TRANSPORT	6	4.66e-01	8.83e-01	0.3450	-5.44e-02	-2.60e-01	-1.22e-01	-1.44e-01	-1.13e-01	8.17e-01	2.69e-01	6.06e-01	5.43e-01	6.30e-01
SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING	36	2.05e-01	6.84e-01	0.3450	-1.63e-01	-2.34e-01	-1.34e-01	-1.38e-01	2.79e-02	9.03e-02	1.51e-02	1.66e-01	1.51e-01	7.72e-01
INSEMINATION	12	4.58e-01	8.79e-01	0.3450	1.26e-01	-1.07e-01	2.07e-01	1.72e-01	1.39e-01	4.51e-01	5.22e-01	2.14e-01	3.03e-01	4.04e-01
POSITIVE REGULATION OF CHEMOKINE PRODUCTION	70	2.75e-02	2.47e-01	0.3450	-1.66e-01	-2.15e-01	-1.49e-01	-1.50e-01	8.66e-03	1.64e-02	1.85e-03	3.09e-02	2.95e-02	9.00e-01
PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	29	3.93e-01	8.42e-01	0.3450	-1.67e-01	-1.50e-01	-1.84e-01	-1.81e-01	4.15e-02	1.19e-01	1.63e-01	8.58e-02	9.24e-02	6.99e-01
REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	12	3.39e-01	8.08e-01	0.3450	3.03e-02	-1.30e-01	3.33e-02	3.57e-02	3.14e-01	8.56e-01	4.35e-01	8.41e-01	8.31e-01	5.98e-02
ADULT FEEDING BEHAVIOR	9	3.44e-03	6.14e-02	0.3440	1.71e-01	8.99e-02	-1.65e-01	-2.10e-01	-1.00e-01	3.74e-01	6.41e-01	3.92e-01	2.76e-01	6.02e-01
REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	5	9.08e-01	9.94e-01	0.3440	-2.90e-02	-1.13e-03	-1.85e-01	-1.74e-01	-2.31e-01	9.10e-01	9.97e-01	4.73e-01	5.00e-01	3.72e-01
EARLY ENDOSOME TO GOLGI TRANSPORT	13	5.05e-01	8.99e-01	0.3440	3.21e-02	-1.52e-01	1.94e-01	1.55e-01	1.81e-01	8.41e-01	3.44e-01	2.26e-01	3.32e-01	2.59e-01
CARDIAC MUSCLE CELL FATE COMMITMENT	11	2.49e-01	7.33e-01	0.3440	-7.08e-02	-3.29e-01	6.04e-02	3.62e-02	-1.86e-02	6.84e-01	5.89e-02	7.29e-01	8.35e-01	9.15e-01
REGULATION OF SYNAPSE STRUCTURAL PLASTICITY	7	8.74e-01	9.88e-01	0.3440	1.95e-01	2.67e-01	5.35e-02	7.52e-02	2.42e-02	3.73e-01	2.22e-01	8.06e-01	7.30e-01	9.12e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	6	5.70e-01	9.26e-01	0.3440	1.24e-01	2.67e-01	-6.03e-02	-3.74e-02	1.62e-01	6.00e-01	2.57e-01	7.98e-01	8.74e-01	4.91e-01
COPPER ION IMPORT	6	9.04e-01	9.94e-01	0.3430	7.91e-02	-6.53e-02	1.73e-01	1.89e-01	2.04e-01	7.37e-01	7.82e-01	4.62e-01	4.23e-01	3.87e-01
CARBON DIOXIDE TRANSPORT	15	5.12e-02	3.55e-01	0.3430	-2.45e-01	-8.75e-02	-4.51e-02	-7.34e-02	2.07e-01	1.01e-01	5.57e-01	7.63e-01	6.23e-01	1.66e-01
STEM CELL FATE COMMITMENT	10	3.82e-01	8.38e-01	0.3430	3.80e-02	-1.91e-01	1.77e-01	1.20e-01	1.84e-01	8.35e-01	2.95e-01	3.32e-01	5.10e-01	3.14e-01
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	5	8.68e-01	9.88e-01	0.3430	7.78e-02	1.24e-01	2.10e-01	2.04e-01	1.02e-01	7.63e-01	6.32e-01	4.15e-01	4.30e-01	6.93e-01
NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	6	8.53e-01	9.88e-01	0.3430	-1.47e-01	-1.27e-02	-2.06e-01	-2.19e-01	7.26e-02	5.33e-01	9.57e-01	3.82e-01	3.52e-01	7.58e-01
HEMOGLOBIN METABOLIC PROCESS	17	1.88e-02	1.95e-01	0.3430	-4.54e-02	-2.16e-01	-1.77e-01	-1.81e-01	6.71e-02	7.46e-01	1.23e-01	2.05e-01	1.96e-01	6.32e-01
DICARBOXYLIC ACID BIOSYNTHETIC PROCESS	12	6.38e-01	9.49e-01	0.3430	-5.68e-02	9.83e-03	-2.17e-01	-2.15e-01	-1.44e-01	7.33e-01	9.53e-01	1.93e-01	1.98e-01	3.86e-01
RESPONSE TO L ASCORBIC ACID	6	9.07e-04	2.26e-02	0.3430	2.51e-01	-8.59e-02	-1.11e-01	-1.55e-01	1.04e-01	2.88e-01	7.16e-01	6.38e-01	5.10e-01	6.59e-01
DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS	6	9.13e-01	9.94e-01	0.3430	-1.74e-01	-2.32e-01	-1.36e-01	-1.20e-01	1.63e-02	4.61e-01	3.24e-01	5.63e-01	6.10e-01	9.45e-01
NEGATIVE REGULATION OF MEIOTIC CELL CYCLE	17	4.41e-01	8.71e-01	0.3430	1.60e-01	9.26e-02	1.79e-01	1.83e-01	-1.33e-01	2.54e-01	5.09e-01	2.00e-01	1.92e-01	3.43e-01
ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY	25	5.97e-01	9.33e-01	0.3430	-1.85e-01	-2.12e-01	-1.33e-01	-1.43e-01	9.18e-03	1.09e-01	6.67e-02	2.50e-01	2.17e-01	9.37e-01
ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY	15	3.60e-01	8.25e-01	0.3420	1.81e-01	-2.30e-02	1.41e-01	1.54e-01	2.01e-01	2.25e-01	8.77e-01	3.45e-01	3.01e-01	1.79e-01
CRANIAL NERVE STRUCTURAL ORGANIZATION	9	6.89e-01	9.61e-01	0.3420	3.95e-02	-6.82e-02	8.55e-02	6.72e-02	3.15e-01	8.37e-01	7.23e-01	6.57e-01	7.27e-01	1.02e-01
SPINAL CORD PATTERNING	21	1.86e-01	6.57e-01	0.3420	1.44e-01	-9.41e-02	1.59e-01	1.62e-01	1.89e-01	2.52e-01	4.55e-01	2.07e-01	1.98e-01	1.33e-01
FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY	5	2.87e-01	7.66e-01	0.3420	-3.85e-02	2.85e-01	4.27e-03	-2.36e-02	1.84e-01	8.82e-01	2.70e-01	9.87e-01	9.27e-01	4.76e-01
HYPOTONIC RESPONSE	13	7.20e-01	9.69e-01	0.3420	-1.49e-01	-1.26e-01	-2.07e-01	-1.89e-01	7.10e-03	3.52e-01	4.31e-01	1.96e-01	2.37e-01	9.65e-01
NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION	8	5.16e-01	9.02e-01	0.3420	-7.90e-02	-1.93e-01	-1.68e-01	-1.90e-01	-9.44e-02	6.99e-01	3.44e-01	4.11e-01	3.52e-01	6.44e-01
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION	15	1.20e-02	1.45e-01	0.3420	1.50e-01	-1.65e-01	2.02e-01	1.39e-01	8.51e-02	3.13e-01	2.70e-01	1.76e-01	3.53e-01	5.68e-01
RESPONSE TO HYPEROXIA	18	2.86e-02	2.53e-01	0.3420	1.89e-01	-6.21e-02	1.38e-01	1.06e-01	2.16e-01	1.65e-01	6.48e-01	3.12e-01	4.34e-01	1.12e-01
PROTEIN TARGETING TO MITOCHONDRION	101	7.52e-04	1.96e-02	0.3420	1.34e-01	-4.56e-02	2.09e-01	1.94e-01	1.23e-01	1.96e-02	4.28e-01	2.80e-04	7.65e-04	3.21e-02
CYTOPLASMIC SEQUESTERING OF PROTEIN	18	5.07e-01	8.99e-01	0.3420	-2.29e-01	-1.76e-01	-1.04e-01	-1.29e-01	7.43e-02	9.20e-02	1.97e-01	4.43e-01	3.43e-01	5.85e-01
ERK5 CASCADE	5	5.25e-01	9.05e-01	0.3410	-1.39e-01	-1.69e-01	-3.64e-02	-1.20e-01	2.30e-01	5.92e-01	5.13e-01	8.88e-01	6.41e-01	3.73e-01
LYMPHOID PROGENITOR CELL DIFFERENTIATION	24	1.56e-01	6.17e-01	0.3410	8.69e-02	-1.40e-01	1.51e-01	1.35e-01	2.20e-01	4.61e-01	2.34e-01	2.01e-01	2.53e-01	6.21e-02
T CELL APOPTOTIC PROCESS	57	4.13e-02	3.10e-01	0.3410	1.04e-01	5.81e-02	2.13e-01	1.93e-01	1.40e-01	1.74e-01	4.48e-01	5.32e-03	1.19e-02	6.73e-02
NEURON PROJECTION MAINTENANCE	11	6.13e-01	9.38e-01	0.3410	1.71e-01	1.88e-01	1.38e-02	3.93e-02	-2.24e-01	3.27e-01	2.81e-01	9.37e-01	8.22e-01	1.98e-01
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS	21	3.24e-01	7.96e-01	0.3410	-1.99e-01	-1.43e-01	-1.43e-01	-1.88e-01	-3.08e-04	1.14e-01	2.57e-01	2.55e-01	1.35e-01	9.98e-01
MINERALOCORTICOID BIOSYNTHETIC PROCESS	12	4.68e-01	8.83e-01	0.3410	-2.52e-01	-1.11e-01	-1.45e-01	-1.36e-01	2.99e-02	1.31e-01	5.07e-01	3.85e-01	4.13e-01	8.58e-01
SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION	5	8.14e-01	9.82e-01	0.3410	-1.52e-01	-1.56e-01	-1.07e-01	-1.57e-01	1.82e-01	5.57e-01	5.47e-01	6.79e-01	5.44e-01	4.82e-01
REGULATION OF LEUKOCYTE TETHERING OR ROLLING	18	2.75e-01	7.56e-01	0.3410	-1.17e-01	-2.03e-01	-1.55e-01	-1.54e-01	1.14e-01	3.88e-01	1.35e-01	2.54e-01	2.57e-01	4.03e-01
DENDRITIC CELL CHEMOTAXIS	25	2.73e-02	2.47e-01	0.3410	1.65e-01	1.19e-01	4.10e-02	6.47e-02	2.62e-01	1.53e-01	3.03e-01	7.23e-01	5.76e-01	2.33e-02
DETECTION OF STIMULUS	592	2.47e-29	4.64e-26	0.3400	-2.03e-01	-2.44e-02	-1.92e-01	-1.92e-01	-2.08e-02	3.46e-17	3.10e-01	1.18e-15	1.43e-15	3.87e-01
POSITIVE REGULATION OF ATP METABOLIC PROCESS	10	3.04e-01	7.76e-01	0.3400	1.24e-01	3.21e-03	8.22e-02	1.33e-01	2.76e-01	4.96e-01	9.86e-01	6.53e-01	4.68e-01	1.31e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	9	5.79e-01	9.27e-01	0.3400	6.28e-02	1.50e-01	1.29e-01	1.36e-01	2.33e-01	7.44e-01	4.37e-01	5.01e-01	4.81e-01	2.26e-01
NEGATIVE REGULATION OF MYELINATION	9	4.85e-01	8.91e-01	0.3400	-1.45e-01	-2.00e-01	8.02e-02	8.13e-02	2.04e-01	4.52e-01	2.99e-01	6.77e-01	6.73e-01	2.88e-01
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	14	4.96e-01	8.96e-01	0.3400	-1.34e-01	-2.57e-01	-7.75e-02	-7.21e-02	1.42e-01	3.85e-01	9.56e-02	6.16e-01	6.40e-01	3.56e-01
MINERALOCORTICOID SECRETION	7	8.67e-01	9.88e-01	0.3400	-8.90e-02	1.06e-01	-2.09e-01	-1.85e-01	-1.36e-01	6.84e-01	6.26e-01	3.39e-01	3.97e-01	5.33e-01
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	58	1.06e-01	5.23e-01	0.3400	1.36e-01	-1.09e-02	1.99e-01	1.97e-01	1.34e-01	7.32e-02	8.86e-01	8.60e-03	9.31e-03	7.73e-02
NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION	27	1.65e-02	1.78e-01	0.3400	1.75e-01	-7.03e-02	1.48e-01	1.28e-01	2.04e-01	1.16e-01	5.27e-01	1.82e-01	2.51e-01	6.69e-02
SLEEP	22	6.10e-02	3.95e-01	0.3400	-1.23e-01	-3.25e-02	-1.39e-01	-1.49e-01	2.40e-01	3.17e-01	7.92e-01	2.59e-01	2.28e-01	5.13e-02
REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	11	6.68e-01	9.56e-01	0.3400	-9.06e-02	-8.01e-02	-2.25e-01	-2.04e-01	-9.00e-02	6.03e-01	6.46e-01	1.95e-01	2.41e-01	6.05e-01
POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION	10	2.80e-01	7.58e-01	0.3400	-1.22e-01	-2.50e-01	1.04e-01	1.21e-01	1.11e-01	5.02e-01	1.71e-01	5.69e-01	5.08e-01	5.42e-01
VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION	13	2.98e-01	7.72e-01	0.3390	1.17e-01	-1.39e-01	1.23e-01	1.28e-01	2.25e-01	4.67e-01	3.84e-01	4.42e-01	4.23e-01	1.60e-01
REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	13	5.56e-01	9.18e-01	0.3390	1.60e-01	2.48e-01	-8.32e-03	2.97e-02	-1.65e-01	3.19e-01	1.21e-01	9.59e-01	8.53e-01	3.03e-01
PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS	8	7.04e-01	9.65e-01	0.3390	9.66e-02	-1.59e-01	1.79e-01	1.61e-01	1.50e-01	6.36e-01	4.35e-01	3.82e-01	4.31e-01	4.61e-01
LYSOSOMAL MEMBRANE ORGANIZATION	14	3.19e-01	7.92e-01	0.3390	1.98e-01	-1.48e-02	1.68e-01	2.04e-01	7.57e-02	2.00e-01	9.24e-01	2.76e-01	1.86e-01	6.24e-01
POSITIVE REGULATION OF ODONTOGENESIS	7	2.41e-01	7.26e-01	0.3390	-2.88e-02	-2.52e-01	8.42e-02	3.34e-02	-2.06e-01	8.95e-01	2.49e-01	7.00e-01	8.78e-01	3.45e-01
REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	19	2.66e-01	7.47e-01	0.3390	1.99e-01	-1.99e-02	1.95e-01	1.84e-01	5.32e-02	1.32e-01	8.80e-01	1.41e-01	1.66e-01	6.88e-01
REGULATION OF FAS SIGNALING PATHWAY	6	2.61e-01	7.44e-01	0.3390	-1.41e-01	-5.15e-02	-2.56e-01	-1.64e-01	2.47e-03	5.50e-01	8.27e-01	2.78e-01	4.88e-01	9.92e-01
POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	24	1.73e-01	6.45e-01	0.3390	-1.25e-01	-1.82e-01	-9.27e-02	-9.33e-02	2.20e-01	2.88e-01	1.23e-01	4.32e-01	4.29e-01	6.17e-02
REGULATION OF DNA STRAND ELONGATION	17	1.92e-01	6.66e-01	0.3380	2.19e-01	2.97e-02	1.96e-01	1.66e-01	9.64e-03	1.19e-01	8.32e-01	1.62e-01	2.37e-01	9.45e-01
RESPONSE TO WATER	13	5.06e-01	8.99e-01	0.3380	2.50e-01	1.78e-01	8.99e-02	1.00e-01	4.66e-02	1.19e-01	2.66e-01	5.75e-01	5.31e-01	7.71e-01
N GLYCAN PROCESSING	17	4.71e-01	8.85e-01	0.3380	-7.48e-02	-6.90e-02	-1.52e-01	-1.61e-01	-2.35e-01	5.93e-01	6.23e-01	2.78e-01	2.51e-01	9.35e-02
IRON COORDINATION ENTITY TRANSPORT	12	2.24e-01	7.05e-01	0.3380	-2.13e-02	-1.30e-01	-1.52e-01	-1.55e-01	-2.23e-01	8.98e-01	4.35e-01	3.62e-01	3.52e-01	1.80e-01
REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS	18	7.60e-01	9.75e-01	0.3380	-1.74e-01	-1.02e-01	-1.74e-01	-1.95e-01	-7.46e-02	2.01e-01	4.53e-01	2.02e-01	1.53e-01	5.84e-01
TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION	9	5.36e-01	9.11e-01	0.3380	-1.34e-01	-2.96e-01	4.55e-02	-7.29e-03	8.26e-02	4.86e-01	1.24e-01	8.13e-01	9.70e-01	6.68e-01
FOLIC ACID METABOLIC PROCESS	15	7.97e-01	9.81e-01	0.3380	1.34e-01	5.28e-02	1.67e-01	1.56e-01	2.03e-01	3.68e-01	7.23e-01	2.63e-01	2.95e-01	1.73e-01
REGULATION OF APOPTOTIC DNA FRAGMENTATION	10	6.37e-01	9.49e-01	0.3380	-3.47e-02	-2.12e-01	4.97e-02	3.83e-02	2.53e-01	8.49e-01	2.45e-01	7.85e-01	8.34e-01	1.65e-01
REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	39	2.98e-01	7.72e-01	0.3380	1.35e-01	9.96e-02	1.59e-01	1.55e-01	1.92e-01	1.44e-01	2.82e-01	8.62e-02	9.49e-02	3.77e-02
AMINE CATABOLIC PROCESS	15	5.15e-01	9.01e-01	0.3380	1.95e-01	2.53e-01	1.28e-02	3.86e-02	-1.04e-01	1.91e-01	9.04e-02	9.32e-01	7.96e-01	4.87e-01
OXIDATIVE RNA DEMETHYLATION	5	8.46e-01	9.87e-01	0.3380	1.17e-01	4.48e-02	8.29e-02	6.62e-02	2.95e-01	6.51e-01	8.62e-01	7.48e-01	7.98e-01	2.53e-01
PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS	8	8.04e-01	9.82e-01	0.3380	-1.19e-01	-1.31e-01	-1.97e-01	-2.09e-01	1.96e-02	5.60e-01	5.21e-01	3.35e-01	3.06e-01	9.24e-01
CELLULAR RESPIRATION	216	7.54e-09	8.60e-07	0.3380	1.72e-01	2.49e-02	2.04e-01	2.05e-01	-8.68e-03	1.26e-05	5.28e-01	2.25e-07	2.13e-07	8.26e-01
NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	10	3.86e-01	8.40e-01	0.3380	-1.25e-01	-1.23e-01	-1.75e-01	-2.25e-01	4.59e-02	4.93e-01	4.99e-01	3.39e-01	2.19e-01	8.01e-01
GLYOXYLATE METABOLIC PROCESS	8	9.42e-01	9.97e-01	0.3380	1.60e-01	7.93e-02	2.02e-01	2.03e-01	7.34e-03	4.33e-01	6.98e-01	3.22e-01	3.20e-01	9.71e-01
COMPARTMENT PATTERN SPECIFICATION	5	7.85e-01	9.81e-01	0.3380	-7.28e-02	-1.25e-02	-2.36e-01	-2.16e-01	7.92e-02	7.78e-01	9.61e-01	3.61e-01	4.04e-01	7.59e-01
NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	7	7.07e-01	9.65e-01	0.3380	3.64e-02	-1.95e-01	1.59e-01	1.17e-01	1.89e-01	8.67e-01	3.72e-01	4.66e-01	5.92e-01	3.87e-01
NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	24	6.92e-01	9.61e-01	0.3380	1.90e-01	1.05e-01	1.80e-01	1.84e-01	2.17e-02	1.08e-01	3.71e-01	1.26e-01	1.19e-01	8.54e-01
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	13	5.45e-01	9.15e-01	0.3380	-1.17e-01	-2.36e-01	-6.60e-02	-8.51e-02	1.81e-01	4.64e-01	1.41e-01	6.80e-01	5.95e-01	2.58e-01
ORGAN INDUCTION	22	2.50e-01	7.35e-01	0.3370	-1.59e-01	-2.40e-01	-9.90e-02	-1.40e-01	3.97e-02	1.97e-01	5.11e-02	4.21e-01	2.56e-01	7.47e-01
REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	43	1.86e-01	6.57e-01	0.3370	1.62e-01	2.38e-02	1.64e-01	1.68e-01	1.78e-01	6.56e-02	7.87e-01	6.22e-02	5.64e-02	4.38e-02
SYNAPTIC VESICLE MATURATION	23	5.38e-01	9.12e-01	0.3370	1.86e-01	5.20e-02	1.98e-01	1.89e-01	3.63e-02	1.22e-01	6.66e-01	1.00e-01	1.17e-01	7.63e-01
POSITIVE REGULATION OF OPSONIZATION	8	2.47e-01	7.32e-01	0.3370	7.20e-02	2.73e-01	-1.55e-01	-7.51e-02	-6.55e-02	7.24e-01	1.81e-01	4.48e-01	7.13e-01	7.48e-01
NEURAL PLATE DEVELOPMENT	8	8.39e-01	9.85e-01	0.3370	-1.36e-01	-2.31e-01	-4.89e-02	-6.52e-02	1.88e-01	5.06e-01	2.58e-01	8.11e-01	7.50e-01	3.58e-01
GALACTOLIPID METABOLIC PROCESS	9	6.87e-01	9.61e-01	0.3370	-2.05e-01	-2.38e-01	-1.57e-02	-6.06e-02	1.04e-01	2.87e-01	2.15e-01	9.35e-01	7.53e-01	5.89e-01
PROTEIN RNA COMPLEX ORGANIZATION	205	1.42e-09	1.91e-07	0.3370	1.37e-01	8.67e-03	2.20e-01	2.15e-01	-1.60e-02	7.09e-04	8.31e-01	5.81e-08	1.15e-07	6.93e-01
PROTEIN NITROSYLATION	15	1.18e-01	5.49e-01	0.3370	1.11e-01	8.89e-03	9.82e-02	1.52e-01	2.61e-01	4.57e-01	9.52e-01	5.10e-01	3.08e-01	7.99e-02
CGMP CATABOLIC PROCESS	5	8.98e-01	9.93e-01	0.3370	-4.38e-02	1.87e-01	-1.59e-01	-1.49e-01	-1.70e-01	8.65e-01	4.69e-01	5.39e-01	5.64e-01	5.10e-01
TRUNK SEGMENTATION	5	6.45e-01	9.50e-01	0.3360	6.26e-02	2.88e-01	-7.47e-02	-6.70e-02	1.27e-01	8.09e-01	2.64e-01	7.72e-01	7.95e-01	6.23e-01
ATRIOVENTRICULAR NODE DEVELOPMENT	9	2.73e-01	7.56e-01	0.3360	-6.00e-02	-2.86e-01	-7.93e-02	-1.00e-01	-1.08e-01	7.55e-01	1.38e-01	6.80e-01	6.02e-01	5.75e-01
REGULATION OF LYSOSOMAL LUMEN PH	27	2.72e-01	7.54e-01	0.3360	1.47e-01	5.20e-02	2.12e-01	2.05e-01	-4.43e-02	1.87e-01	6.40e-01	5.60e-02	6.57e-02	6.90e-01
PHOTOTRANSDUCTION	42	1.25e-03	2.95e-02	0.3360	3.04e-02	2.54e-01	-1.63e-01	-1.29e-01	-6.77e-02	7.33e-01	4.39e-03	6.84e-02	1.47e-01	4.48e-01
REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	15	8.23e-01	9.83e-01	0.3360	1.64e-01	1.34e-01	1.66e-01	1.87e-01	7.67e-02	2.71e-01	3.69e-01	2.66e-01	2.11e-01	6.07e-01
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE	14	2.00e-01	6.80e-01	0.3360	-7.68e-02	2.21e-01	-1.59e-01	-1.52e-01	-9.88e-02	6.19e-01	1.52e-01	3.02e-01	3.24e-01	5.22e-01
INTESTINAL LIPID ABSORPTION	22	9.57e-02	4.94e-01	0.3360	-1.10e-01	1.29e-01	-1.48e-01	-1.21e-01	-2.19e-01	3.71e-01	2.95e-01	2.31e-01	3.26e-01	7.59e-02
POSITIVE REGULATION OF FEAR RESPONSE	6	4.23e-01	8.61e-01	0.3360	-3.04e-02	3.92e-02	-1.00e-02	-6.39e-02	3.26e-01	8.97e-01	8.68e-01	9.66e-01	7.86e-01	1.67e-01
RRNA CATABOLIC PROCESS	21	3.21e-02	2.71e-01	0.3360	1.66e-01	-2.35e-02	1.68e-01	1.54e-01	-1.81e-01	1.87e-01	8.52e-01	1.83e-01	2.22e-01	1.51e-01
EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION	10	7.50e-01	9.75e-01	0.3360	1.49e-01	2.47e-01	1.26e-01	1.15e-01	1.05e-02	4.14e-01	1.75e-01	4.89e-01	5.28e-01	9.54e-01
CELL CELL RECOGNITION	72	1.12e-03	2.74e-02	0.3360	1.49e-01	2.75e-01	5.10e-02	8.26e-02	-7.54e-02	2.90e-02	5.50e-05	4.55e-01	2.26e-01	2.69e-01
SPLICEOSOMAL COMPLEX ASSEMBLY	75	1.34e-02	1.56e-01	0.3360	1.50e-01	2.91e-02	2.10e-01	2.12e-01	9.30e-03	2.47e-02	6.63e-01	1.66e-03	1.46e-03	8.89e-01
CELLULAR RESPONSE TO THYROID HORMONE STIMULUS	16	2.44e-01	7.29e-01	0.3350	-1.14e-01	-2.90e-01	-7.35e-02	-7.32e-02	-6.61e-02	4.30e-01	4.43e-02	6.11e-01	6.12e-01	6.47e-01
REGULATORY NCRNA MEDIATED GENE SILENCING	610	8.21e-25	8.82e-22	0.3350	-1.47e-01	2.46e-02	-2.01e-01	-1.82e-01	-1.29e-01	6.11e-10	2.99e-01	2.12e-17	1.58e-14	4.71e-08
MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER	13	4.69e-01	8.84e-01	0.3350	-1.27e-01	-1.18e-01	-1.85e-01	-2.17e-01	3.67e-02	4.29e-01	4.61e-01	2.49e-01	1.76e-01	8.19e-01
REGULATION OF MIRNA CATABOLIC PROCESS	9	9.57e-01	9.97e-01	0.3350	1.48e-01	9.00e-02	1.80e-01	1.87e-01	1.22e-01	4.43e-01	6.40e-01	3.49e-01	3.31e-01	5.25e-01
DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	65	2.88e-02	2.54e-01	0.3350	1.58e-01	5.39e-03	2.01e-01	1.81e-01	1.18e-01	2.74e-02	9.40e-01	5.01e-03	1.15e-02	1.01e-01
INTERKINETIC NUCLEAR MIGRATION	5	8.12e-01	9.82e-01	0.3350	-1.44e-02	5.51e-03	-1.60e-01	-1.81e-01	-2.32e-01	9.56e-01	9.83e-01	5.37e-01	4.84e-01	3.69e-01
AMINO ACID SALVAGE	7	5.75e-01	9.26e-01	0.3350	-7.72e-02	-3.15e-01	6.87e-02	4.38e-02	-1.75e-02	7.23e-01	1.49e-01	7.53e-01	8.41e-01	9.36e-01
REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	17	5.19e-01	9.03e-01	0.3350	-1.72e-01	-2.63e-01	-6.34e-02	-9.54e-02	1.40e-02	2.19e-01	6.05e-02	6.51e-01	4.96e-01	9.20e-01
AUTOPHAGY OF PEROXISOME	10	1.38e-01	5.90e-01	0.3350	2.34e-01	1.46e-01	1.42e-01	8.63e-02	-8.97e-02	1.99e-01	4.23e-01	4.36e-01	6.37e-01	6.23e-01
INTESTINAL EPITHELIAL CELL DIFFERENTIATION	27	1.73e-01	6.44e-01	0.3350	-1.35e-01	-1.02e-01	-1.83e-01	-2.17e-01	-5.03e-02	2.25e-01	3.59e-01	9.89e-02	5.08e-02	6.51e-01
CELL CELL ADHESION INVOLVED IN GASTRULATION	11	3.61e-01	8.25e-01	0.3350	-7.93e-02	-2.98e-01	-1.60e-02	-1.98e-03	1.29e-01	6.49e-01	8.70e-02	9.27e-01	9.91e-01	4.59e-01
NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	15	8.08e-01	9.82e-01	0.3350	-1.52e-01	-9.36e-02	-1.95e-01	-2.04e-01	-1.74e-02	3.08e-01	5.30e-01	1.90e-01	1.72e-01	9.07e-01
RESPONSE TO INCREASED OXYGEN LEVELS	24	8.66e-03	1.17e-01	0.3350	2.05e-01	-3.89e-02	1.55e-01	1.22e-01	1.71e-01	8.16e-02	7.42e-01	1.89e-01	3.01e-01	1.46e-01
GLYCOSIDE CATABOLIC PROCESS	8	9.45e-01	9.97e-01	0.3340	-2.02e-01	-1.84e-01	-1.24e-01	-1.47e-01	1.03e-03	3.22e-01	3.68e-01	5.42e-01	4.72e-01	9.96e-01
REGULATION OF MACROPHAGE DIFFERENTIATION	24	2.74e-01	7.56e-01	0.3340	-1.00e-01	-8.37e-02	-2.19e-01	-1.92e-01	-1.01e-01	3.96e-01	4.78e-01	6.38e-02	1.03e-01	3.94e-01
NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	38	3.51e-01	8.18e-01	0.3340	1.20e-01	4.58e-02	2.03e-01	1.88e-01	1.38e-01	1.99e-01	6.25e-01	3.06e-02	4.54e-02	1.42e-01
NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT	6	7.22e-01	9.70e-01	0.3340	1.05e-01	-1.33e-02	1.97e-01	1.88e-01	-1.63e-01	6.58e-01	9.55e-01	4.04e-01	4.26e-01	4.88e-01
MYELIN ASSEMBLY	24	1.13e-01	5.39e-01	0.3340	-1.96e-01	-4.02e-02	-1.65e-01	-1.99e-01	6.76e-02	9.59e-02	7.33e-01	1.61e-01	9.13e-02	5.66e-01
REGULATION OF CENTRIOLE REPLICATION	23	4.04e-01	8.49e-01	0.3340	1.01e-01	-6.82e-03	2.08e-01	1.75e-01	1.65e-01	4.00e-01	9.55e-01	8.42e-02	1.46e-01	1.70e-01
REGULATION OF NODAL SIGNALING PATHWAY	9	7.54e-01	9.75e-01	0.3340	1.37e-01	1.64e-01	1.18e-01	1.51e-01	1.70e-01	4.75e-01	3.93e-01	5.39e-01	4.32e-01	3.78e-01
WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE	8	6.23e-01	9.43e-01	0.3340	-1.13e-01	-2.29e-01	-4.11e-02	-5.18e-02	-2.05e-01	5.80e-01	2.62e-01	8.40e-01	8.00e-01	3.16e-01
PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	9.28e-01	9.95e-01	0.3340	1.75e-01	1.61e-01	1.12e-01	1.50e-01	1.42e-01	4.99e-01	5.34e-01	6.66e-01	5.61e-01	5.83e-01
MEIOTIC CELL CYCLE CHECKPOINT SIGNALING	8	7.14e-01	9.68e-01	0.3340	-1.82e-01	-2.18e-02	-1.31e-01	-1.66e-01	-1.81e-01	3.73e-01	9.15e-01	5.20e-01	4.15e-01	3.75e-01
UBIQUITIN RECYCLING	13	4.69e-01	8.84e-01	0.3340	2.17e-01	1.02e-01	1.57e-01	1.29e-01	1.12e-01	1.76e-01	5.22e-01	3.28e-01	4.22e-01	4.83e-01
REGULATION OF LIPOPHAGY	5	7.27e-01	9.71e-01	0.3340	-2.10e-02	-1.10e-01	-1.72e-02	-4.13e-03	-3.14e-01	9.35e-01	6.70e-01	9.47e-01	9.87e-01	2.24e-01
REGULATION OF MACROPHAGE PROLIFERATION	7	8.16e-01	9.83e-01	0.3340	-2.09e-01	-7.50e-02	-1.89e-01	-1.61e-01	-1.61e-02	3.37e-01	7.31e-01	3.86e-01	4.62e-01	9.41e-01
NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	7	1.85e-01	6.56e-01	0.3340	-4.26e-02	1.71e-01	1.03e-01	9.01e-02	-2.48e-01	8.45e-01	4.34e-01	6.37e-01	6.80e-01	2.55e-01
CIRCADIAN SLEEP WAKE CYCLE	21	1.24e-01	5.62e-01	0.3340	-1.34e-01	-8.08e-02	-8.24e-02	-9.32e-02	2.67e-01	2.89e-01	5.22e-01	5.13e-01	4.60e-01	3.41e-02
NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT	5	1.50e-01	6.11e-01	0.3340	-1.85e-01	2.29e-01	-7.57e-02	-1.09e-01	8.27e-02	4.74e-01	3.74e-01	7.69e-01	6.72e-01	7.49e-01
GABAERGIC NEURON DIFFERENTIATION	19	3.25e-02	2.73e-01	0.3330	1.15e-01	-2.00e-01	1.64e-01	1.35e-01	1.14e-01	3.88e-01	1.31e-01	2.17e-01	3.08e-01	3.91e-01
NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	19	2.83e-01	7.62e-01	0.3330	2.12e-01	6.16e-02	1.84e-01	1.56e-01	6.12e-02	1.09e-01	6.42e-01	1.65e-01	2.38e-01	6.44e-01
CAMP CATABOLIC PROCESS	9	8.80e-01	9.89e-01	0.3330	-1.89e-01	-7.60e-02	-1.79e-01	-1.89e-01	4.47e-02	3.27e-01	6.93e-01	3.53e-01	3.27e-01	8.16e-01
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS	26	5.74e-01	9.26e-01	0.3330	-1.63e-01	-7.75e-02	-1.60e-01	-1.53e-01	-1.70e-01	1.50e-01	4.94e-01	1.57e-01	1.76e-01	1.32e-01
POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	6	9.51e-01	9.97e-01	0.3330	-1.14e-01	-1.25e-01	-1.65e-01	-1.62e-01	-1.69e-01	6.30e-01	5.97e-01	4.83e-01	4.91e-01	4.72e-01
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	52	3.49e-06	2.14e-04	0.3330	5.18e-02	2.50e-01	6.67e-02	7.37e-02	1.90e-01	5.18e-01	1.84e-03	4.05e-01	3.58e-01	1.79e-02
PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE	13	4.33e-01	8.69e-01	0.3330	1.64e-01	-5.60e-02	1.96e-01	2.06e-01	-1.68e-02	3.06e-01	7.27e-01	2.21e-01	2.00e-01	9.16e-01
POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	6	4.92e-01	8.94e-01	0.3330	-5.04e-02	-2.63e-01	-1.24e-01	-1.06e-01	1.12e-01	8.31e-01	2.64e-01	6.00e-01	6.54e-01	6.34e-01
URETER DEVELOPMENT	18	3.02e-02	2.61e-01	0.3330	1.15e-01	-1.61e-01	1.72e-01	1.18e-01	1.68e-01	3.98e-01	2.38e-01	2.07e-01	3.84e-01	2.17e-01
BONE GROWTH	32	4.92e-01	8.94e-01	0.3330	1.44e-01	3.82e-02	1.71e-01	1.66e-01	1.78e-01	1.57e-01	7.08e-01	9.37e-02	1.05e-01	8.15e-02
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	11	1.78e-01	6.48e-01	0.3330	-1.49e-01	-1.05e-01	-3.80e-02	-1.06e-01	2.55e-01	3.93e-01	5.47e-01	8.27e-01	5.42e-01	1.44e-01
POSITIVE REGULATION OF DNA CATABOLIC PROCESS	5	9.72e-01	9.97e-01	0.3330	9.84e-02	-1.82e-02	1.73e-01	1.56e-01	2.16e-01	7.03e-01	9.44e-01	5.04e-01	5.47e-01	4.03e-01
IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	20	2.95e-01	7.71e-01	0.3330	1.49e-01	-5.09e-02	2.08e-01	2.06e-01	8.53e-04	2.47e-01	6.94e-01	1.08e-01	1.10e-01	9.95e-01
HEMIDESMOSOME ASSEMBLY	6	3.92e-01	8.41e-01	0.3320	-1.24e-01	2.12e-01	-1.69e-01	-1.42e-01	3.40e-02	5.99e-01	3.68e-01	4.73e-01	5.47e-01	8.85e-01
REGULATION OF MYOTUBE DIFFERENTIATION	48	1.40e-01	5.96e-01	0.3320	-1.12e-01	3.33e-02	-2.08e-01	-2.01e-01	-1.16e-01	1.78e-01	6.90e-01	1.29e-02	1.61e-02	1.66e-01
SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	10	7.71e-01	9.76e-01	0.3320	3.26e-03	-1.21e-01	1.35e-01	1.32e-01	2.45e-01	9.86e-01	5.07e-01	4.61e-01	4.71e-01	1.79e-01
NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS	7	8.72e-01	9.88e-01	0.3320	-1.07e-01	-9.81e-02	-2.12e-01	-1.84e-01	-1.01e-01	6.25e-01	6.53e-01	3.30e-01	3.98e-01	6.42e-01
REGULATION OF COMPLEMENT ACTIVATION	22	2.64e-01	7.47e-01	0.3320	-4.81e-02	-1.39e-01	1.29e-01	1.06e-01	2.46e-01	6.96e-01	2.58e-01	2.94e-01	3.91e-01	4.54e-02
SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION	5	4.46e-01	8.73e-01	0.3320	-6.10e-02	-2.53e-01	-1.67e-01	-1.13e-01	-4.11e-02	8.13e-01	3.27e-01	5.17e-01	6.62e-01	8.74e-01
DORSAL SPINAL CORD DEVELOPMENT	20	7.26e-02	4.33e-01	0.3320	2.91e-02	-2.39e-01	1.45e-01	1.06e-01	1.42e-01	8.22e-01	6.46e-02	2.62e-01	4.11e-01	2.72e-01
REGULATION OF ACROSOME REACTION	17	1.08e-01	5.25e-01	0.3320	8.06e-02	2.41e-01	3.86e-02	5.38e-02	2.04e-01	5.65e-01	8.59e-02	7.83e-01	7.01e-01	1.46e-01
NEGATIVE REGULATION OF CHEMOTAXIS	65	1.04e-01	5.17e-01	0.3320	-1.68e-01	-9.41e-02	-1.89e-01	-1.93e-01	2.63e-03	1.88e-02	1.90e-01	8.38e-03	7.13e-03	9.71e-01
POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	8	7.69e-01	9.75e-01	0.3320	1.52e-01	1.85e-01	-1.49e-02	1.03e-02	-2.29e-01	4.56e-01	3.66e-01	9.42e-01	9.60e-01	2.61e-01
NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	10	6.65e-01	9.54e-01	0.3320	-1.22e-01	-2.35e-01	-1.38e-01	-1.31e-01	6.19e-02	5.03e-01	1.99e-01	4.49e-01	4.74e-01	7.35e-01
REGULATION OF CHOLESTEROL EFFLUX	54	1.16e-02	1.40e-01	0.3320	-1.81e-01	-1.44e-01	-1.83e-01	-1.52e-01	2.07e-03	2.15e-02	6.78e-02	1.97e-02	5.34e-02	9.79e-01
NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	169	1.32e-07	1.11e-05	0.3320	1.56e-01	-2.63e-02	2.05e-01	2.05e-01	3.04e-02	4.52e-04	5.55e-01	4.19e-06	4.34e-06	4.96e-01
AMP CATABOLIC PROCESS	5	7.24e-01	9.70e-01	0.3320	6.59e-03	2.54e-01	-1.53e-01	-1.48e-01	1.06e-02	9.80e-01	3.25e-01	5.52e-01	5.68e-01	9.67e-01
PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	12	5.24e-01	9.04e-01	0.3320	9.02e-02	-1.17e-01	2.19e-01	1.94e-01	5.17e-02	5.88e-01	4.83e-01	1.89e-01	2.45e-01	7.57e-01
KILLING BY HOST OF SYMBIONT CELLS	28	5.55e-02	3.71e-01	0.3320	-1.14e-01	-1.23e-01	-1.36e-01	-1.27e-01	2.17e-01	2.97e-01	2.59e-01	2.14e-01	2.44e-01	4.66e-02
EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI	8	8.76e-01	9.88e-01	0.3310	1.77e-01	2.57e-01	4.77e-02	7.55e-02	-6.53e-02	3.86e-01	2.08e-01	8.15e-01	7.12e-01	7.49e-01
POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY	8	6.23e-01	9.43e-01	0.3310	1.49e-01	-8.83e-02	2.11e-01	1.77e-01	5.97e-02	4.65e-01	6.65e-01	3.00e-01	3.85e-01	7.70e-01
XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	8.67e-01	9.88e-01	0.3310	-1.08e-01	3.01e-02	-2.19e-01	-2.21e-01	2.19e-02	6.48e-01	8.98e-01	3.52e-01	3.50e-01	9.26e-01
DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION	11	4.43e-01	8.72e-01	0.3310	5.25e-02	2.67e-01	-7.56e-02	-8.59e-02	-1.50e-01	7.63e-01	1.25e-01	6.64e-01	6.22e-01	3.90e-01
TERPENOID CATABOLIC PROCESS	8	3.46e-01	8.17e-01	0.3310	-2.95e-02	-1.96e-01	-6.84e-02	-9.24e-02	-2.39e-01	8.85e-01	3.37e-01	7.38e-01	6.51e-01	2.42e-01
SPERM DNA CONDENSATION	17	7.43e-02	4.40e-01	0.3310	7.69e-02	3.05e-01	-8.68e-02	-4.71e-02	2.62e-02	5.83e-01	2.93e-02	5.36e-01	7.37e-01	8.52e-01
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	104	2.66e-05	1.30e-03	0.3310	1.20e-01	-5.14e-02	2.24e-01	2.03e-01	3.51e-02	3.42e-02	3.65e-01	8.08e-05	3.57e-04	5.36e-01
REGULATION OF STEROID HORMONE SECRETION	22	5.77e-01	9.26e-01	0.3310	-1.42e-01	-1.84e-01	-1.59e-01	-1.62e-01	-6.29e-02	2.50e-01	1.36e-01	1.96e-01	1.88e-01	6.09e-01
NUCLEAR MEMBRANE REASSEMBLY	25	2.58e-03	4.96e-02	0.3310	1.14e-01	-1.47e-01	1.68e-01	1.99e-01	-8.33e-02	3.24e-01	2.04e-01	1.47e-01	8.43e-02	4.71e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	6	4.48e-01	8.74e-01	0.3310	-2.57e-01	-2.02e-01	-1.91e-02	-4.88e-03	-4.58e-02	2.76e-01	3.91e-01	9.36e-01	9.83e-01	8.46e-01
PROTEIN LOCALIZATION TO MITOCHONDRION	126	2.13e-04	7.43e-03	0.3300	1.19e-01	-5.22e-02	1.96e-01	1.81e-01	1.46e-01	2.14e-02	3.11e-01	1.43e-04	4.64e-04	4.65e-03
ARGININE METABOLIC PROCESS	19	7.41e-01	9.73e-01	0.3300	2.00e-01	1.56e-01	1.31e-01	1.49e-01	7.34e-02	1.31e-01	2.39e-01	3.24e-01	2.59e-01	5.80e-01
REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	10	3.40e-01	8.10e-01	0.3300	1.15e-01	2.68e-01	-8.03e-03	3.18e-02	1.52e-01	5.31e-01	1.42e-01	9.65e-01	8.62e-01	4.06e-01
NEURAL PLATE REGIONALIZATION	6	6.22e-01	9.43e-01	0.3300	-1.30e-01	-2.51e-01	4.51e-02	3.61e-02	-1.60e-01	5.80e-01	2.86e-01	8.48e-01	8.78e-01	4.98e-01
DNA TEMPLATED TRANSCRIPTION TERMINATION	24	2.66e-01	7.47e-01	0.3300	1.04e-01	-1.22e-02	2.21e-01	2.21e-01	8.68e-03	3.78e-01	9.18e-01	6.03e-02	6.05e-02	9.41e-01
REGULATION OF DNA CATABOLIC PROCESS	11	6.80e-01	9.61e-01	0.3300	4.60e-02	-1.41e-01	1.20e-01	1.07e-01	2.47e-01	7.92e-01	4.18e-01	4.91e-01	5.38e-01	1.56e-01
POSITIVE REGULATION OF MACROPHAGE ACTIVATION	30	2.43e-01	7.27e-01	0.3300	-1.55e-01	-2.37e-01	-9.43e-02	-9.36e-02	1.05e-01	1.41e-01	2.47e-02	3.71e-01	3.75e-01	3.20e-01
MORPHOGENESIS OF AN EPITHELIAL FOLD	23	3.23e-01	7.96e-01	0.3300	-1.64e-01	-2.61e-01	-6.51e-02	-9.77e-02	5.92e-03	1.72e-01	3.04e-02	5.89e-01	4.17e-01	9.61e-01
AMELOGENESIS	24	5.53e-01	9.16e-01	0.3300	-1.32e-01	-6.74e-03	-1.81e-01	-1.95e-01	-1.43e-01	2.64e-01	9.54e-01	1.24e-01	9.85e-02	2.24e-01
ECTODERM DEVELOPMENT	21	8.16e-02	4.56e-01	0.3300	-9.11e-02	-2.52e-01	-1.24e-01	-1.41e-01	-3.83e-02	4.70e-01	4.54e-02	3.24e-01	2.64e-01	7.61e-01
UMP CATABOLIC PROCESS	5	9.51e-01	9.97e-01	0.3300	-1.08e-01	-9.40e-02	-2.10e-01	-2.05e-01	-4.49e-02	6.77e-01	7.16e-01	4.15e-01	4.27e-01	8.62e-01
REGULATION OF OOCYTE MATURATION	7	4.73e-01	8.86e-01	0.3300	7.40e-03	-1.33e-01	2.01e-01	2.04e-01	-9.46e-02	9.73e-01	5.43e-01	3.57e-01	3.50e-01	6.65e-01
MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT	6	8.12e-01	9.82e-01	0.3300	2.09e-01	1.96e-01	3.16e-02	3.38e-02	-1.57e-01	3.76e-01	4.07e-01	8.93e-01	8.86e-01	5.05e-01
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	44	3.27e-03	5.91e-02	0.3300	-3.02e-02	-2.67e-01	1.07e-01	9.90e-02	1.22e-01	7.29e-01	2.14e-03	2.20e-01	2.56e-01	1.60e-01
DNA INTEGRATION	8	4.41e-01	8.71e-01	0.3290	1.53e-01	7.98e-02	-4.07e-02	-2.82e-02	-2.76e-01	4.54e-01	6.96e-01	8.42e-01	8.90e-01	1.76e-01
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	9	2.59e-01	7.43e-01	0.3290	3.63e-02	2.51e-01	-1.35e-01	-1.56e-01	3.96e-02	8.50e-01	1.92e-01	4.84e-01	4.19e-01	8.37e-01
REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE	21	3.09e-01	7.83e-01	0.3290	2.76e-02	1.36e-02	1.56e-01	1.40e-01	2.51e-01	8.27e-01	9.14e-01	2.17e-01	2.65e-01	4.60e-02
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	5	8.49e-01	9.87e-01	0.3290	1.32e-01	5.27e-02	1.91e-01	1.38e-01	1.80e-01	6.10e-01	8.38e-01	4.60e-01	5.92e-01	4.86e-01
LONG CHAIN FATTY ACYL COA METABOLIC PROCESS	24	5.28e-01	9.06e-01	0.3290	-1.69e-01	-2.13e-01	-1.08e-01	-1.20e-01	9.01e-02	1.53e-01	7.03e-02	3.61e-01	3.10e-01	4.45e-01
NEGATIVE REGULATION OF MAST CELL ACTIVATION	12	7.98e-01	9.81e-01	0.3290	-1.69e-01	-1.45e-01	-1.44e-01	-1.57e-01	1.13e-01	3.10e-01	3.85e-01	3.87e-01	3.46e-01	4.96e-01
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	61	7.86e-04	2.03e-02	0.3290	8.85e-02	-8.86e-02	2.25e-01	2.03e-01	1.34e-02	2.32e-01	2.31e-01	2.34e-03	6.00e-03	8.56e-01
NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS	11	6.38e-01	9.49e-01	0.3280	-1.40e-02	-9.72e-02	1.45e-01	1.07e-01	2.57e-01	9.36e-01	5.77e-01	4.06e-01	5.38e-01	1.41e-01
AUTOPHAGOSOME LYSOSOME FUSION	9	1.27e-01	5.68e-01	0.3280	-1.82e-01	-2.03e-01	9.25e-02	3.46e-02	-1.54e-01	3.45e-01	2.91e-01	6.31e-01	8.57e-01	4.24e-01
INSULIN PROCESSING	8	7.90e-01	9.81e-01	0.3280	-1.15e-01	-2.84e-01	1.27e-02	-6.49e-03	1.18e-01	5.74e-01	1.65e-01	9.51e-01	9.75e-01	5.63e-01
NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION	10	6.53e-01	9.52e-01	0.3280	-2.29e-01	-8.44e-02	-1.19e-01	-1.42e-01	-1.18e-01	2.10e-01	6.44e-01	5.16e-01	4.38e-01	5.17e-01
SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING	10	6.66e-01	9.55e-01	0.3280	1.33e-01	7.11e-02	1.30e-01	1.69e-01	1.99e-01	4.65e-01	6.97e-01	4.78e-01	3.55e-01	2.77e-01
ERBB2 SIGNALING PATHWAY	18	6.29e-01	9.45e-01	0.3280	-1.52e-01	-1.61e-01	-1.57e-01	-1.63e-01	8.53e-02	2.64e-01	2.36e-01	2.49e-01	2.33e-01	5.31e-01
MOTOR NEURON MIGRATION	13	6.56e-01	9.53e-01	0.3280	1.78e-01	1.19e-01	1.08e-01	1.06e-01	1.97e-01	2.67e-01	4.56e-01	5.00e-01	5.08e-01	2.19e-01
HEART FIELD SPECIFICATION	17	7.36e-02	4.36e-01	0.3280	-1.25e-01	-2.92e-01	-5.34e-04	-6.60e-02	4.57e-02	3.71e-01	3.71e-02	9.97e-01	6.37e-01	7.44e-01
REGULATION OF COLLAGEN METABOLIC PROCESS	41	3.57e-01	8.22e-01	0.3280	-1.67e-01	-1.72e-01	-1.57e-01	-1.58e-01	1.22e-02	6.39e-02	5.64e-02	8.22e-02	8.02e-02	8.93e-01
REGULATION OF PODOSOME ASSEMBLY	13	3.49e-01	8.18e-01	0.3270	-1.31e-01	-1.56e-02	-2.23e-01	-1.86e-01	7.24e-02	4.14e-01	9.22e-01	1.63e-01	2.45e-01	6.51e-01
ASTROCYTE CELL MIGRATION	9	6.01e-01	9.33e-01	0.3270	1.13e-01	2.83e-01	1.25e-02	-2.79e-03	-1.19e-01	5.56e-01	1.42e-01	9.48e-01	9.88e-01	5.36e-01
MEMBRANE HYPERPOLARIZATION	10	8.99e-01	9.93e-01	0.3270	1.80e-01	5.72e-02	1.73e-01	1.92e-01	6.78e-02	3.26e-01	7.54e-01	3.42e-01	2.93e-01	7.10e-01
LEUKOCYTE AGGREGATION	12	5.04e-01	8.98e-01	0.3270	-1.21e-01	-2.38e-01	-1.43e-01	-1.23e-01	-1.94e-02	4.70e-01	1.54e-01	3.90e-01	4.60e-01	9.08e-01
REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	8	4.97e-01	8.96e-01	0.3270	-7.51e-02	-2.36e-01	-1.28e-01	-1.47e-01	8.67e-02	7.13e-01	2.47e-01	5.31e-01	4.71e-01	6.71e-01
POSITIVE REGULATION OF TELOMERE CAPPING	17	5.74e-01	9.26e-01	0.3270	1.92e-02	-1.23e-01	1.51e-01	1.32e-01	2.26e-01	8.91e-01	3.81e-01	2.80e-01	3.45e-01	1.07e-01
HINDBRAIN MORPHOGENESIS	44	1.86e-01	6.57e-01	0.3270	1.56e-01	1.65e-02	1.59e-01	1.65e-01	1.73e-01	7.41e-02	8.50e-01	6.78e-02	5.78e-02	4.76e-02
PLASMA CELL DIFFERENTIATION	8	5.79e-01	9.27e-01	0.3270	1.02e-01	-1.56e-01	2.01e-01	1.72e-01	3.95e-02	6.16e-01	4.44e-01	3.24e-01	3.99e-01	8.46e-01
VIRAL GENOME REPLICATION	124	5.95e-03	9.21e-02	0.3270	1.87e-01	1.01e-01	1.74e-01	1.65e-01	6.27e-02	3.24e-04	5.11e-02	8.21e-04	1.49e-03	2.28e-01
POSITIVE REGULATION OF TELOMERE MAINTENANCE	66	1.58e-02	1.73e-01	0.3270	1.48e-01	-2.94e-02	2.01e-01	1.84e-01	9.82e-02	3.82e-02	6.80e-01	4.67e-03	9.77e-03	1.68e-01
NEGATIVE REGULATION OF CELL SIZE	9	1.90e-01	6.64e-01	0.3270	4.04e-02	3.31e-02	1.19e-01	6.93e-02	-2.92e-01	8.34e-01	8.63e-01	5.38e-01	7.19e-01	1.30e-01
HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS	52	9.99e-03	1.28e-01	0.3270	-1.62e-01	2.61e-02	-1.80e-01	-2.04e-01	-7.44e-02	4.29e-02	7.44e-01	2.50e-02	1.08e-02	3.53e-01
CANNABINOID SIGNALING PATHWAY	9	4.09e-01	8.52e-01	0.3270	2.88e-02	2.99e-01	-9.72e-02	-8.10e-02	-1.53e-02	8.81e-01	1.20e-01	6.14e-01	6.74e-01	9.37e-01
REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	13	8.73e-01	9.88e-01	0.3260	1.58e-01	1.21e-01	1.58e-01	1.47e-01	1.44e-01	3.25e-01	4.49e-01	3.25e-01	3.59e-01	3.70e-01
OSTEOCLAST PROLIFERATION	11	3.60e-01	8.25e-01	0.3260	-7.58e-02	-3.15e-01	2.64e-02	2.31e-02	1.77e-02	6.63e-01	7.04e-02	8.80e-01	8.94e-01	9.19e-01
SEQUESTERING OF IRON ION	6	5.83e-01	9.28e-01	0.3260	1.71e-02	-2.08e-01	1.61e-01	1.89e-01	3.68e-02	9.42e-01	3.78e-01	4.94e-01	4.23e-01	8.76e-01
POSITIVE REGULATION OF CHROMATIN ORGANIZATION	14	4.24e-01	8.62e-01	0.3260	-1.70e-01	-2.60e-01	-2.63e-02	-6.44e-02	-7.19e-02	2.70e-01	9.24e-02	8.65e-01	6.76e-01	6.41e-01
NEGATIVE REGULATION OF LYASE ACTIVITY	18	6.13e-01	9.38e-01	0.3260	1.46e-01	3.53e-03	1.54e-01	1.45e-01	2.01e-01	2.85e-01	9.79e-01	2.57e-01	2.86e-01	1.40e-01
RESPONSE TO GLYCOPROTEIN	11	5.15e-01	9.01e-01	0.3260	8.96e-02	-1.49e-01	2.01e-01	1.72e-01	7.86e-02	6.07e-01	3.92e-01	2.50e-01	3.22e-01	6.52e-01
REGULATION OF FIBROBLAST MIGRATION	38	1.18e-01	5.47e-01	0.3260	-2.05e-01	-1.76e-01	-1.09e-01	-1.06e-01	1.02e-01	2.91e-02	6.11e-02	2.43e-01	2.58e-01	2.75e-01
ADENOHYPOPHYSIS DEVELOPMENT	16	5.07e-01	8.99e-01	0.3260	-1.21e-01	-2.38e-01	-6.69e-02	-7.50e-02	1.58e-01	4.02e-01	9.99e-02	6.43e-01	6.03e-01	2.73e-01
PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	6	6.86e-01	9.61e-01	0.3260	1.83e-01	-5.83e-02	1.19e-01	1.38e-01	1.90e-01	4.39e-01	8.05e-01	6.13e-01	5.58e-01	4.20e-01
POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	11	6.04e-01	9.34e-01	0.3260	-1.37e-01	-2.11e-01	-6.08e-02	-7.93e-02	-1.81e-01	4.33e-01	2.25e-01	7.27e-01	6.49e-01	2.98e-01
INTERLEUKIN 21 PRODUCTION	5	6.69e-01	9.56e-01	0.3260	-1.24e-01	1.33e-01	-1.73e-01	-2.06e-01	3.04e-02	6.31e-01	6.08e-01	5.03e-01	4.26e-01	9.06e-01
GLIAL CELL APOPTOTIC PROCESS	15	7.56e-01	9.75e-01	0.3260	1.39e-01	1.46e-01	1.53e-01	1.74e-01	1.08e-01	3.51e-01	3.28e-01	3.04e-01	2.45e-01	4.68e-01
AUTOPHAGIC CELL DEATH	9	7.23e-01	9.70e-01	0.3250	1.34e-03	-1.20e-01	1.84e-01	1.83e-01	1.55e-01	9.94e-01	5.32e-01	3.39e-01	3.42e-01	4.21e-01
ADP METABOLIC PROCESS	8	9.13e-01	9.94e-01	0.3250	-1.06e-01	1.32e-02	-1.66e-01	-1.80e-01	-1.86e-01	6.04e-01	9.49e-01	4.17e-01	3.79e-01	3.61e-01
PERIPHERAL NERVOUS SYSTEM AXON REGENERATION	8	7.95e-01	9.81e-01	0.3250	-9.10e-02	7.45e-03	-8.88e-02	-9.06e-02	-2.85e-01	6.56e-01	9.71e-01	6.63e-01	6.57e-01	1.62e-01
LENS FIBER CELL MORPHOGENESIS	6	8.72e-01	9.88e-01	0.3250	-2.21e-01	-2.10e-01	-8.10e-02	-7.24e-02	3.33e-02	3.48e-01	3.74e-01	7.31e-01	7.59e-01	8.88e-01
PROTEIN AUTOPROCESSING	28	3.14e-01	7.86e-01	0.3250	-1.61e-01	-1.95e-01	-1.33e-01	-1.24e-01	9.08e-02	1.40e-01	7.35e-02	2.22e-01	2.56e-01	4.06e-01
MOTOR NEURON APOPTOTIC PROCESS	21	7.58e-01	9.75e-01	0.3250	1.57e-01	6.87e-02	1.82e-01	1.95e-01	7.10e-02	2.14e-01	5.86e-01	1.48e-01	1.22e-01	5.73e-01
PHOTORECEPTOR CELL MORPHOGENESIS	5	8.98e-01	9.93e-01	0.3250	1.80e-01	1.97e-01	1.23e-01	9.71e-02	-9.87e-02	4.87e-01	4.45e-01	6.34e-01	7.07e-01	7.02e-01
REGULATION OF MITOPHAGY	15	7.79e-01	9.79e-01	0.3250	-1.35e-01	-6.61e-02	-1.57e-01	-1.77e-01	-1.64e-01	3.67e-01	6.58e-01	2.91e-01	2.35e-01	2.72e-01
REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	28	1.34e-01	5.81e-01	0.3240	-1.17e-01	-2.19e-01	-1.19e-01	-1.18e-01	1.24e-01	2.84e-01	4.48e-02	2.76e-01	2.79e-01	2.55e-01
OXYGEN TRANSPORT	15	2.21e-01	7.01e-01	0.3240	2.45e-02	6.14e-02	2.00e-01	1.64e-01	1.84e-01	8.69e-01	6.81e-01	1.80e-01	2.70e-01	2.18e-01
RENAL ABSORPTION	32	1.72e-01	6.44e-01	0.3240	-4.30e-02	1.17e-01	-1.33e-01	-1.14e-01	-2.43e-01	6.74e-01	2.50e-01	1.93e-01	2.66e-01	1.75e-02
REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	7	4.70e-01	8.84e-01	0.3240	8.37e-03	-1.47e-01	-5.82e-02	-5.60e-02	-2.77e-01	9.69e-01	5.00e-01	7.90e-01	7.98e-01	2.04e-01
POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	7	7.26e-01	9.71e-01	0.3240	8.26e-02	-5.84e-03	4.72e-02	5.36e-02	3.05e-01	7.05e-01	9.79e-01	8.29e-01	8.06e-01	1.62e-01
ACETYLCHOLINE SECRETION	5	8.91e-01	9.92e-01	0.3240	2.16e-02	2.34e-01	-9.11e-02	-8.69e-02	-1.85e-01	9.33e-01	3.66e-01	7.24e-01	7.37e-01	4.74e-01
PURINE RIBONUCLEOSIDE SALVAGE	6	7.46e-01	9.75e-01	0.3240	6.42e-02	-1.73e-01	1.97e-01	1.79e-01	8.14e-03	7.85e-01	4.63e-01	4.03e-01	4.49e-01	9.72e-01
OPTIC NERVE DEVELOPMENT	20	5.18e-01	9.03e-01	0.3240	1.44e-01	3.98e-02	1.26e-01	1.38e-01	2.19e-01	2.66e-01	7.58e-01	3.29e-01	2.87e-01	9.04e-02
NEURAL PLATE PATTERN SPECIFICATION	8	6.62e-01	9.54e-01	0.3240	-1.44e-01	-2.82e-01	1.52e-02	2.13e-03	-6.74e-02	4.81e-01	1.67e-01	9.41e-01	9.92e-01	7.41e-01
MATERNAL PROCESS INVOLVED IN PARTURITION	5	6.99e-01	9.62e-01	0.3240	1.17e-01	-6.16e-02	1.77e-01	1.53e-01	-1.81e-01	6.51e-01	8.11e-01	4.93e-01	5.54e-01	4.84e-01
PROTEIN FOLDING	209	7.82e-10	1.07e-07	0.3240	1.42e-01	-4.12e-02	2.05e-01	2.01e-01	2.51e-02	3.99e-04	3.05e-01	3.34e-07	5.45e-07	5.31e-01
NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	6	4.87e-01	8.92e-01	0.3240	-1.84e-01	-1.78e-01	1.24e-01	9.00e-02	1.26e-01	4.35e-01	4.51e-01	6.00e-01	7.03e-01	5.93e-01
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	6	7.22e-01	9.70e-01	0.3230	-1.74e-01	-2.44e-01	7.12e-02	5.85e-02	7.73e-02	4.59e-01	3.00e-01	7.63e-01	8.04e-01	7.43e-01
PYRUVATE TRANSPORT	7	1.84e-01	6.56e-01	0.3230	-1.07e-01	-2.00e-01	-3.02e-02	-1.17e-01	-1.96e-01	6.24e-01	3.59e-01	8.90e-01	5.91e-01	3.70e-01
NITRIC OXIDE TRANSPORT	5	1.67e-01	6.34e-01	0.3230	-7.59e-02	1.37e-01	2.14e-01	1.84e-01	8.01e-03	7.69e-01	5.95e-01	4.08e-01	4.75e-01	9.75e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	6	9.63e-01	9.97e-01	0.3230	-1.96e-01	-1.77e-01	-1.07e-01	-1.23e-01	-9.10e-02	4.06e-01	4.54e-01	6.50e-01	6.01e-01	7.00e-01
PEROXISOME ORGANIZATION	34	1.03e-01	5.13e-01	0.3230	1.81e-01	1.59e-01	1.26e-01	1.12e-01	-1.33e-01	6.78e-02	1.08e-01	2.04e-01	2.58e-01	1.79e-01
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	49	3.86e-02	3.01e-01	0.3230	1.15e-01	-2.60e-02	2.11e-01	2.14e-01	1.92e-02	1.64e-01	7.53e-01	1.08e-02	9.62e-03	8.16e-01
SYNAPTIC VESICLE COATING	5	4.93e-01	8.95e-01	0.3230	-1.54e-01	-9.39e-02	-3.01e-02	1.44e-02	2.66e-01	5.52e-01	7.16e-01	9.07e-01	9.55e-01	3.03e-01
POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY	8	2.80e-01	7.58e-01	0.3230	1.41e-01	4.43e-03	1.66e-01	2.37e-01	-2.71e-02	4.90e-01	9.83e-01	4.16e-01	2.47e-01	8.94e-01
AMYLIN RECEPTOR SIGNALING PATHWAY	6	6.39e-01	9.49e-01	0.3230	-5.65e-02	-2.34e-02	1.32e-02	2.40e-02	-3.16e-01	8.11e-01	9.21e-01	9.56e-01	9.19e-01	1.81e-01
MEIOTIC SISTER CHROMATID COHESION	13	5.85e-01	9.28e-01	0.3220	-7.86e-02	1.75e-02	-1.14e-01	-1.36e-01	-2.57e-01	6.24e-01	9.13e-01	4.75e-01	3.95e-01	1.09e-01
REGULATION OF PIGMENT CELL DIFFERENTIATION	8	6.29e-01	9.45e-01	0.3220	1.06e-01	7.83e-02	9.55e-02	6.10e-02	2.71e-01	6.02e-01	7.01e-01	6.40e-01	7.65e-01	1.84e-01
POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	21	5.85e-01	9.28e-01	0.3220	1.99e-01	1.89e-01	9.69e-02	1.18e-01	7.31e-02	1.15e-01	1.34e-01	4.42e-01	3.49e-01	5.62e-01
POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	71	7.34e-03	1.06e-01	0.3220	-1.48e-01	-1.90e-01	-1.11e-01	-1.11e-01	1.46e-01	3.14e-02	5.68e-03	1.05e-01	1.04e-01	3.37e-02
NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION	14	7.92e-01	9.81e-01	0.3220	2.17e-01	1.59e-01	1.21e-01	1.28e-01	1.75e-02	1.59e-01	3.04e-01	4.34e-01	4.06e-01	9.10e-01
RESPONSE TO INTERLEUKIN 12	12	2.88e-01	7.66e-01	0.3220	-1.06e-01	-2.82e-02	-1.82e-01	-2.20e-01	1.02e-01	5.27e-01	8.66e-01	2.75e-01	1.87e-01	5.41e-01
PERICARDIUM MORPHOGENESIS	8	8.90e-01	9.91e-01	0.3220	-5.20e-02	-2.50e-03	-1.50e-01	-1.49e-01	-2.37e-01	7.99e-01	9.90e-01	4.62e-01	4.66e-01	2.45e-01
NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION	12	6.49e-01	9.51e-01	0.3220	-1.25e-01	-2.26e-01	-1.32e-01	-1.26e-01	6.12e-02	4.52e-01	1.76e-01	4.27e-01	4.51e-01	7.14e-01
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	34	4.80e-01	8.91e-01	0.3220	-1.97e-01	-1.23e-01	-1.50e-01	-1.65e-01	-7.77e-03	4.66e-02	2.13e-01	1.31e-01	9.66e-02	9.37e-01
ATTACHMENT OF GPI ANCHOR TO PROTEIN	6	9.74e-01	9.97e-01	0.3220	1.85e-01	6.65e-02	1.79e-01	1.79e-01	3.18e-02	4.33e-01	7.78e-01	4.48e-01	4.48e-01	8.93e-01
PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES	19	6.68e-01	9.56e-01	0.3220	-1.65e-01	-1.43e-01	-1.55e-01	-1.37e-01	-1.14e-01	2.13e-01	2.82e-01	2.41e-01	3.00e-01	3.90e-01
REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	18	4.40e-01	8.71e-01	0.3220	-1.61e-01	-1.99e-01	-7.06e-02	-9.13e-02	-1.56e-01	2.36e-01	1.44e-01	6.04e-01	5.02e-01	2.51e-01
POSITIVE REGULATION OF ACROSOME REACTION	11	1.51e-01	6.13e-01	0.3220	-6.23e-03	1.67e-01	8.88e-03	2.98e-02	2.73e-01	9.71e-01	3.39e-01	9.59e-01	8.64e-01	1.17e-01
UTP METABOLIC PROCESS	12	1.98e-02	2.03e-01	0.3220	-1.87e-01	-2.21e-01	8.42e-02	-3.46e-03	-1.11e-01	2.61e-01	1.85e-01	6.14e-01	9.83e-01	5.07e-01
NON LYTIC VIRAL RELEASE	14	8.31e-02	4.59e-01	0.3210	1.34e-01	-9.84e-02	1.60e-01	1.99e-01	-1.04e-01	3.86e-01	5.24e-01	3.01e-01	1.98e-01	5.02e-01
PROTEIN LOCALIZATION TO CELL CORTEX	11	6.21e-01	9.43e-01	0.3210	-5.75e-02	-2.13e-01	1.03e-01	6.37e-02	2.00e-01	7.41e-01	2.21e-01	5.54e-01	7.14e-01	2.51e-01
POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION	5	7.74e-01	9.77e-01	0.3210	1.36e-01	1.60e-01	1.22e-01	1.81e-01	1.07e-01	5.99e-01	5.36e-01	6.38e-01	4.82e-01	6.79e-01
POLYKETIDE METABOLIC PROCESS	10	6.51e-01	9.52e-01	0.3210	3.33e-02	2.17e-01	-5.48e-02	-3.04e-02	-2.26e-01	8.55e-01	2.35e-01	7.64e-01	8.68e-01	2.16e-01
PROTEIN TARGETING TO VACUOLE	46	2.74e-01	7.56e-01	0.3210	-1.69e-01	-1.96e-01	-1.25e-01	-1.43e-01	-1.96e-02	4.80e-02	2.17e-02	1.43e-01	9.35e-02	8.18e-01
REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	43	4.38e-01	8.69e-01	0.3210	1.35e-01	9.82e-02	1.74e-01	1.72e-01	1.22e-01	1.25e-01	2.65e-01	4.79e-02	5.05e-02	1.68e-01
NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION	15	5.86e-01	9.29e-01	0.3210	1.62e-01	8.42e-03	1.36e-01	1.55e-01	1.84e-01	2.77e-01	9.55e-01	3.61e-01	2.99e-01	2.17e-01
EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	10	1.07e-01	5.23e-01	0.3200	8.01e-02	-2.50e-01	1.13e-01	1.08e-01	-9.58e-02	6.61e-01	1.70e-01	5.37e-01	5.54e-01	6.00e-01
HEMATOPOIETIC STEM CELL PROLIFERATION	33	2.83e-02	2.52e-01	0.3200	7.45e-02	-1.65e-01	1.64e-01	1.32e-01	1.59e-01	4.59e-01	1.01e-01	1.02e-01	1.88e-01	1.13e-01
LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	6	2.57e-01	7.40e-01	0.3200	-9.55e-02	-1.35e-01	-2.23e-01	-1.40e-01	7.65e-02	6.85e-01	5.68e-01	3.43e-01	5.53e-01	7.45e-01
POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY	9	5.71e-02	3.79e-01	0.3200	-5.27e-02	9.69e-02	-1.73e-01	-6.78e-02	-2.37e-01	7.84e-01	6.15e-01	3.70e-01	7.25e-01	2.19e-01
DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	14	8.39e-01	9.85e-01	0.3200	-1.58e-01	-1.28e-01	-1.81e-01	-1.67e-01	-1.74e-02	3.05e-01	4.06e-01	2.40e-01	2.79e-01	9.10e-01
REGULATION OF CHROMATIN ORGANIZATION	44	5.40e-02	3.65e-01	0.3200	-1.73e-01	-2.40e-01	-6.62e-02	-1.04e-01	-8.15e-03	4.77e-02	5.94e-03	4.47e-01	2.32e-01	9.26e-01
NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	10	6.58e-01	9.54e-01	0.3200	3.35e-02	3.05e-02	2.00e-01	1.79e-01	1.69e-01	8.55e-01	8.67e-01	2.75e-01	3.26e-01	3.55e-01
NUCLEUS LOCALIZATION	33	4.35e-01	8.69e-01	0.3200	-1.27e-01	2.48e-03	-2.02e-01	-1.90e-01	-9.74e-02	2.08e-01	9.80e-01	4.48e-02	5.86e-02	3.33e-01
EGG ACTIVATION	11	1.32e-01	5.79e-01	0.3200	1.02e-02	2.12e-01	6.80e-02	4.20e-02	2.26e-01	9.53e-01	2.24e-01	6.96e-01	8.09e-01	1.94e-01
REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	54	8.03e-03	1.11e-01	0.3200	-2.02e-01	-1.85e-01	-1.09e-01	-9.01e-02	-8.73e-02	1.02e-02	1.89e-02	1.68e-01	2.52e-01	2.67e-01
POSITIVE REGULATION OF P38MAPK CASCADE	31	1.74e-01	6.46e-01	0.3200	-1.32e-01	-2.56e-01	-8.42e-02	-9.98e-02	4.92e-02	2.03e-01	1.36e-02	4.17e-01	3.36e-01	6.35e-01
TRYPTOPHAN METABOLIC PROCESS	10	7.59e-01	9.75e-01	0.3200	-1.32e-01	-2.62e-01	-6.10e-02	-6.13e-02	9.30e-02	4.71e-01	1.51e-01	7.39e-01	7.37e-01	6.10e-01
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION	9	1.58e-01	6.20e-01	0.3200	2.43e-01	1.66e-01	-4.89e-02	1.82e-02	-1.12e-01	2.06e-01	3.87e-01	8.00e-01	9.25e-01	5.60e-01
POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION	5	3.96e-01	8.45e-01	0.3200	4.43e-02	-2.62e-01	-3.98e-02	-3.66e-02	1.70e-01	8.64e-01	3.11e-01	8.78e-01	8.87e-01	5.11e-01
NEGATIVE REGULATION OF TELOMERE CAPPING	8	7.06e-01	9.65e-01	0.3200	-6.14e-02	-1.28e-01	-5.57e-03	5.35e-03	2.86e-01	7.63e-01	5.29e-01	9.78e-01	9.79e-01	1.61e-01
NEGATIVE REGULATION OF LIPID LOCALIZATION	66	7.57e-03	1.08e-01	0.3200	-1.65e-01	-4.54e-02	-2.03e-01	-1.73e-01	-4.37e-02	2.03e-02	5.23e-01	4.38e-03	1.53e-02	5.39e-01
PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE	7	1.59e-01	6.20e-01	0.3200	-1.79e-01	-2.75e-02	3.78e-03	-7.85e-02	2.51e-01	4.12e-01	9.00e-01	9.86e-01	7.19e-01	2.50e-01
POLYOL TRANSMEMBRANE TRANSPORT	10	3.66e-01	8.29e-01	0.3190	7.41e-02	2.65e-01	7.82e-03	1.50e-02	1.62e-01	6.85e-01	1.47e-01	9.66e-01	9.34e-01	3.76e-01
REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE	6	8.38e-01	9.85e-01	0.3190	-1.34e-01	-1.34e-01	-5.65e-02	-5.01e-02	2.46e-01	5.70e-01	5.69e-01	8.11e-01	8.32e-01	2.97e-01
HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	17	3.63e-02	2.90e-01	0.3190	-1.49e-01	-3.19e-02	-2.29e-01	-1.55e-01	-4.93e-02	2.88e-01	8.20e-01	1.03e-01	2.67e-01	7.25e-01
FORMATION OF ANATOMICAL BOUNDARY	7	1.50e-01	6.11e-01	0.3190	1.97e-01	-3.57e-02	6.69e-03	5.48e-03	-2.49e-01	3.68e-01	8.70e-01	9.76e-01	9.80e-01	2.54e-01
ANTEROGRADE DENDRITIC TRANSPORT	9	2.81e-01	7.60e-01	0.3190	-2.00e-01	-1.54e-01	1.41e-02	3.01e-02	1.93e-01	3.00e-01	4.24e-01	9.42e-01	8.76e-01	3.16e-01
NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	22	5.15e-01	9.01e-01	0.3190	1.00e-01	4.01e-02	1.30e-01	1.40e-01	2.32e-01	4.16e-01	7.45e-01	2.92e-01	2.57e-01	5.97e-02
ESTABLISHMENT OF LYMPHOCYTE POLARITY	16	8.58e-01	9.88e-01	0.3190	-1.54e-01	-1.25e-01	-1.72e-01	-1.80e-01	-1.92e-02	2.87e-01	3.86e-01	2.34e-01	2.11e-01	8.94e-01
NEGATIVE REGULATION OF FATTY ACID TRANSPORT	7	9.30e-01	9.96e-01	0.3190	-1.78e-01	-8.44e-02	-1.41e-01	-1.70e-01	-1.19e-01	4.15e-01	6.99e-01	5.18e-01	4.36e-01	5.87e-01
REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	10	5.77e-01	9.26e-01	0.3190	1.03e-01	-1.43e-01	1.32e-01	1.31e-01	1.90e-01	5.71e-01	4.32e-01	4.70e-01	4.74e-01	2.99e-01
PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME	15	3.12e-01	7.85e-01	0.3190	6.86e-02	-8.65e-02	2.23e-01	1.99e-01	-2.37e-02	6.46e-01	5.62e-01	1.36e-01	1.83e-01	8.74e-01
REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	5	8.65e-01	9.88e-01	0.3190	-1.93e-01	3.20e-03	-1.87e-01	-1.69e-01	2.85e-02	4.54e-01	9.90e-01	4.69e-01	5.14e-01	9.12e-01
GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS	8	2.78e-01	7.58e-01	0.3190	1.86e-01	-1.05e-01	9.08e-02	1.02e-01	1.93e-01	3.62e-01	6.07e-01	6.57e-01	6.17e-01	3.44e-01
RNA METHYLATION	86	1.81e-04	6.53e-03	0.3190	1.07e-01	-5.38e-02	2.16e-01	2.02e-01	2.19e-04	8.59e-02	3.89e-01	5.40e-04	1.22e-03	9.97e-01
NEGATIVE REGULATION OF TELOMERE MAINTENANCE	32	1.67e-01	6.33e-01	0.3190	-3.44e-04	-1.69e-01	1.38e-01	1.23e-01	1.97e-01	9.97e-01	9.87e-02	1.78e-01	2.27e-01	5.34e-02
REGULATION OF AXON GUIDANCE	13	4.83e-01	8.91e-01	0.3180	-1.39e-01	-2.52e-01	-6.93e-02	-1.14e-01	3.15e-02	3.86e-01	1.16e-01	6.65e-01	4.78e-01	8.44e-01
POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	13	8.09e-01	9.82e-01	0.3180	-1.97e-01	-2.06e-01	-7.84e-02	-9.57e-02	6.92e-02	2.19e-01	1.98e-01	6.24e-01	5.50e-01	6.66e-01
NEGATIVE REGULATION OF NUCLEAR DIVISION	63	8.99e-04	2.26e-02	0.3180	9.11e-02	3.57e-02	2.17e-01	2.05e-01	-5.31e-02	2.11e-01	6.24e-01	2.93e-03	4.90e-03	4.66e-01
DNA LIGATION	16	3.45e-01	8.16e-01	0.3180	1.21e-01	-2.56e-02	2.00e-01	1.94e-01	-9.25e-02	4.02e-01	8.59e-01	1.66e-01	1.80e-01	5.22e-01
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	89	1.64e-02	1.77e-01	0.3180	-1.82e-01	-1.79e-01	-1.39e-01	-1.29e-01	5.80e-03	3.01e-03	3.52e-03	2.31e-02	3.50e-02	9.25e-01
RESPONSE TO CHEMOKINE	96	5.24e-04	1.49e-02	0.3180	1.54e-01	1.45e-01	9.14e-02	1.03e-01	1.94e-01	9.27e-03	1.42e-02	1.22e-01	8.25e-02	9.99e-04
REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	50	2.60e-01	7.43e-01	0.3180	1.42e-01	1.93e-02	1.94e-01	1.85e-01	9.42e-02	8.25e-02	8.13e-01	1.76e-02	2.39e-02	2.49e-01
CALCIUM IMPORT INTO THE MITOCHONDRION	12	4.27e-01	8.64e-01	0.3180	-9.21e-02	-1.45e-01	1.12e-01	6.50e-02	2.34e-01	5.81e-01	3.85e-01	5.00e-01	6.96e-01	1.61e-01
NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION	8	7.82e-01	9.81e-01	0.3180	-1.46e-01	-2.02e-01	-1.51e-01	-1.22e-01	3.12e-02	4.73e-01	3.23e-01	4.60e-01	5.49e-01	8.78e-01
PROSTATE GLANDULAR ACINUS DEVELOPMENT	10	3.57e-01	8.22e-01	0.3180	-9.47e-02	-7.06e-02	-5.43e-02	-1.03e-01	-2.71e-01	6.04e-01	6.99e-01	7.66e-01	5.74e-01	1.38e-01
REGULATION OF LUTEINIZING HORMONE SECRETION	6	9.04e-01	9.94e-01	0.3180	1.95e-01	6.94e-03	1.76e-01	1.68e-01	5.98e-02	4.08e-01	9.77e-01	4.56e-01	4.76e-01	8.00e-01
POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY	5	3.79e-01	8.36e-01	0.3170	2.04e-01	2.93e-03	5.22e-02	2.72e-02	-2.36e-01	4.29e-01	9.91e-01	8.40e-01	9.16e-01	3.61e-01
NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY	10	1.31e-01	5.77e-01	0.3170	8.78e-03	1.38e-01	-2.34e-01	-1.52e-01	-6.24e-02	9.62e-01	4.51e-01	2.00e-01	4.05e-01	7.33e-01
PROTEIN DEGLUTAMYLATION	6	7.53e-01	9.75e-01	0.3170	-1.17e-01	-7.55e-02	-4.94e-02	-8.47e-02	2.68e-01	6.20e-01	7.49e-01	8.34e-01	7.19e-01	2.56e-01
NEGATIVE REGULATION OF MEMBRANE POTENTIAL	12	5.10e-01	9.00e-01	0.3170	-6.37e-02	-1.63e-01	1.44e-01	1.38e-01	1.74e-01	7.03e-01	3.29e-01	3.86e-01	4.08e-01	2.96e-01
THIAMINE TRANSPORT	8	7.15e-01	9.68e-01	0.3170	1.10e-01	1.23e-01	6.27e-02	9.36e-02	-2.47e-01	5.91e-01	5.48e-01	7.59e-01	6.47e-01	2.27e-01
PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	48	9.14e-02	4.81e-01	0.3170	1.52e-01	-1.94e-02	1.87e-01	1.95e-01	6.70e-02	6.88e-02	8.16e-01	2.52e-02	1.97e-02	4.22e-01
SEMICIRCULAR CANAL MORPHOGENESIS	7	2.45e-01	7.29e-01	0.3170	-1.51e-01	-2.24e-01	1.37e-02	-7.28e-02	-1.49e-01	4.89e-01	3.05e-01	9.50e-01	7.39e-01	4.96e-01
SNARE COMPLEX ASSEMBLY	22	1.60e-01	6.22e-01	0.3170	-3.50e-02	-2.51e-01	1.09e-01	1.02e-01	1.17e-01	7.76e-01	4.12e-02	3.74e-01	4.06e-01	3.44e-01
URATE TRANSPORT	11	8.06e-01	9.82e-01	0.3170	-7.62e-02	9.05e-02	-1.95e-01	-1.86e-01	-1.19e-01	6.62e-01	6.03e-01	2.63e-01	2.87e-01	4.96e-01
NEGATIVE REGULATION OF RUFFLE ASSEMBLY	7	3.99e-01	8.45e-01	0.3170	2.02e-01	1.83e-01	1.35e-01	7.37e-02	4.79e-02	3.54e-01	4.01e-01	5.38e-01	7.36e-01	8.26e-01
INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY	7	4.74e-01	8.86e-01	0.3170	-9.61e-02	1.17e-01	-3.97e-02	-2.57e-02	-2.74e-01	6.60e-01	5.90e-01	8.56e-01	9.06e-01	2.09e-01
REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	24	3.03e-01	7.75e-01	0.3170	-8.14e-02	-2.93e-02	-2.20e-01	-2.05e-01	-5.18e-02	4.90e-01	8.04e-01	6.25e-02	8.26e-02	6.61e-01
VACUOLE FUSION	12	2.54e-01	7.37e-01	0.3170	1.75e-01	-1.44e-02	1.46e-01	1.86e-01	-1.18e-01	2.95e-01	9.31e-01	3.82e-01	2.66e-01	4.79e-01
SPLICEOSOMAL SNRNP ASSEMBLY	43	2.35e-02	2.26e-01	0.3170	1.24e-01	-9.30e-03	1.98e-01	2.01e-01	-7.26e-02	1.58e-01	9.16e-01	2.47e-02	2.28e-02	4.10e-01
REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	40	9.00e-03	1.20e-01	0.3160	-6.58e-02	-2.58e-01	-1.82e-03	-2.85e-02	1.69e-01	4.71e-01	4.75e-03	9.84e-01	7.56e-01	6.48e-02
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	17	4.97e-01	8.96e-01	0.3160	1.04e-01	1.55e-01	1.09e-01	1.19e-01	1.98e-01	4.56e-01	2.68e-01	4.37e-01	3.94e-01	1.58e-01
DNA STRAND ELONGATION	36	1.71e-01	6.42e-01	0.3160	1.77e-01	2.40e-02	1.91e-01	1.73e-01	4.22e-02	6.58e-02	8.04e-01	4.76e-02	7.19e-02	6.61e-01
POSITIVE REGULATION OF DNA REPAIR	124	9.92e-03	1.28e-01	0.3160	1.38e-01	4.40e-02	1.93e-01	1.80e-01	9.69e-02	7.79e-03	3.97e-01	2.04e-04	5.39e-04	6.23e-02
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	45	1.76e-01	6.47e-01	0.3160	1.75e-01	1.17e-01	1.54e-01	1.59e-01	-8.30e-02	4.24e-02	1.75e-01	7.35e-02	6.54e-02	3.35e-01
MIDDLE EAR MORPHOGENESIS	20	1.73e-01	6.44e-01	0.3160	-1.96e-02	-2.25e-01	1.58e-01	1.37e-01	7.18e-02	8.80e-01	8.14e-02	2.20e-01	2.90e-01	5.78e-01
POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	7	8.45e-01	9.86e-01	0.3160	-5.40e-02	-1.42e-01	1.32e-01	1.04e-01	2.21e-01	8.04e-01	5.16e-01	5.45e-01	6.34e-01	3.12e-01
RESPONSE TO UV C	14	3.67e-01	8.30e-01	0.3160	-1.37e-01	-2.75e-01	5.16e-02	4.49e-02	3.07e-02	3.76e-01	7.49e-02	7.38e-01	7.71e-01	8.42e-01
CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS	9	7.20e-01	9.69e-01	0.3160	6.00e-02	9.52e-02	-2.10e-02	-6.16e-03	-2.94e-01	7.55e-01	6.21e-01	9.13e-01	9.74e-01	1.26e-01
LATE NUCLEOPHAGY	8	4.76e-01	8.86e-01	0.3160	1.97e-02	1.22e-01	-2.20e-01	-1.90e-01	5.20e-03	9.23e-01	5.51e-01	2.81e-01	3.52e-01	9.80e-01
RETINAL GANGLION CELL AXON GUIDANCE	22	6.92e-01	9.61e-01	0.3160	-1.87e-01	-1.86e-01	-1.11e-01	-1.21e-01	5.49e-02	1.28e-01	1.30e-01	3.69e-01	3.24e-01	6.56e-01
PLATELET DENSE GRANULE ORGANIZATION	24	3.12e-01	7.85e-01	0.3160	-1.44e-01	-2.47e-01	-2.86e-02	-6.25e-02	1.14e-01	2.21e-01	3.58e-02	8.09e-01	5.96e-01	3.35e-01
NUCLEOBASE TRANSPORT	12	1.50e-01	6.11e-01	0.3160	-3.12e-03	5.26e-03	-1.43e-01	-1.34e-01	2.47e-01	9.85e-01	9.75e-01	3.91e-01	4.21e-01	1.38e-01
GLYCINE METABOLIC PROCESS	15	6.81e-01	9.61e-01	0.3160	8.94e-02	6.40e-02	1.87e-01	1.96e-01	1.20e-01	5.49e-01	6.68e-01	2.11e-01	1.89e-01	4.21e-01
NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	39	9.90e-03	1.28e-01	0.3160	-1.63e-01	-1.63e-01	-1.72e-01	-1.29e-01	1.72e-02	7.81e-02	7.88e-02	6.26e-02	1.63e-01	8.52e-01
REGULATION OF SKELETAL MUSCLE TISSUE GROWTH	6	8.26e-01	9.83e-01	0.3160	2.33e-01	1.19e-01	8.75e-02	1.12e-01	1.05e-01	3.23e-01	6.13e-01	7.11e-01	6.34e-01	6.57e-01
VESICLE UNCOATING	8	8.62e-01	9.88e-01	0.3160	2.14e-01	1.01e-01	1.53e-01	1.42e-01	-6.73e-03	2.94e-01	6.19e-01	4.54e-01	4.88e-01	9.74e-01
TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER	8	8.50e-01	9.88e-01	0.3160	3.13e-02	-1.27e-01	1.86e-01	1.76e-01	1.30e-01	8.78e-01	5.35e-01	3.62e-01	3.89e-01	5.23e-01
REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS	6	4.30e-01	8.67e-01	0.3160	-5.45e-02	-1.01e-01	-2.23e-01	-1.67e-01	9.35e-02	8.17e-01	6.67e-01	3.44e-01	4.80e-01	6.92e-01
CORNIFIED ENVELOPE ASSEMBLY	6	9.24e-01	9.95e-01	0.3150	8.74e-02	-8.99e-02	2.02e-01	1.89e-01	8.34e-02	7.11e-01	7.03e-01	3.91e-01	4.22e-01	7.24e-01
LUNG SECRETORY CELL DIFFERENTIATION	11	6.24e-01	9.44e-01	0.3150	-1.44e-01	-2.29e-01	-1.26e-01	-1.00e-01	7.70e-03	4.09e-01	1.88e-01	4.68e-01	5.65e-01	9.65e-01
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	37	2.73e-02	2.47e-01	0.3150	1.94e-02	-1.74e-01	1.87e-01	1.57e-01	9.36e-02	8.38e-01	6.68e-02	4.87e-02	9.75e-02	3.24e-01
COCHLEA MORPHOGENESIS	23	1.56e-01	6.17e-01	0.3150	2.24e-01	7.28e-02	1.56e-01	1.36e-01	2.71e-02	6.29e-02	5.46e-01	1.94e-01	2.57e-01	8.22e-01
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	21	1.17e-01	5.46e-01	0.3150	-1.52e-01	-1.86e-01	2.59e-02	3.48e-02	1.99e-01	2.29e-01	1.40e-01	8.37e-01	7.83e-01	1.14e-01
MESODERMAL CELL FATE COMMITMENT	17	9.33e-02	4.87e-01	0.3150	1.56e-01	-1.18e-01	1.52e-01	1.26e-01	1.48e-01	2.65e-01	4.00e-01	2.77e-01	3.68e-01	2.92e-01
NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	22	4.45e-01	8.73e-01	0.3150	-1.42e-01	-2.11e-01	-9.32e-02	-1.01e-01	-1.25e-01	2.48e-01	8.71e-02	4.49e-01	4.11e-01	3.11e-01
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT	10	9.12e-01	9.94e-01	0.3150	-1.70e-01	-1.81e-01	-1.23e-01	-1.26e-01	7.86e-02	3.53e-01	3.21e-01	4.99e-01	4.89e-01	6.67e-01
REGULATION OF ATP DEPENDENT ACTIVITY	61	7.84e-02	4.51e-01	0.3150	1.52e-01	1.35e-01	1.76e-01	1.63e-01	-1.54e-02	4.03e-02	6.80e-02	1.75e-02	2.77e-02	8.35e-01
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	33	4.73e-04	1.39e-02	0.3150	1.48e-02	2.05e-01	8.45e-02	8.35e-02	2.07e-01	8.83e-01	4.16e-02	4.01e-01	4.07e-01	4.00e-02
POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	30	3.27e-01	7.99e-01	0.3150	1.37e-01	4.09e-02	2.00e-01	1.95e-01	-2.53e-02	1.95e-01	6.98e-01	5.79e-02	6.48e-02	8.11e-01
2 OXOGLUTARATE METABOLIC PROCESS	15	3.65e-01	8.29e-01	0.3140	-4.39e-02	-2.28e-01	1.14e-01	7.00e-02	1.64e-01	7.68e-01	1.25e-01	4.46e-01	6.39e-01	2.71e-01
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY	7	6.49e-01	9.51e-01	0.3140	-2.88e-02	-5.90e-02	-3.86e-02	-6.19e-02	2.99e-01	8.95e-01	7.87e-01	8.60e-01	7.77e-01	1.71e-01
CELLULAR HYPEROSMOTIC RESPONSE	19	6.34e-01	9.48e-01	0.3140	1.40e-01	7.39e-02	1.55e-01	1.33e-01	1.79e-01	2.91e-01	5.77e-01	2.42e-01	3.14e-01	1.77e-01
PEPTIDYL PROLINE HYDROXYLATION	11	1.79e-01	6.50e-01	0.3140	-4.16e-02	-2.87e-01	-5.63e-04	3.42e-02	1.17e-01	8.11e-01	9.97e-02	9.97e-01	8.44e-01	5.01e-01
BRONCHUS DEVELOPMENT	11	6.03e-01	9.34e-01	0.3140	-5.84e-02	-7.54e-02	-1.18e-01	-9.02e-02	-2.60e-01	7.37e-01	6.65e-01	4.99e-01	6.05e-01	1.36e-01
REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	6	5.93e-01	9.32e-01	0.3140	-1.29e-01	1.11e-01	-1.56e-01	-1.77e-01	1.18e-01	5.85e-01	6.37e-01	5.08e-01	4.52e-01	6.18e-01
NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	33	2.66e-01	7.47e-01	0.3140	-1.32e-01	-1.96e-01	-1.34e-01	-1.49e-01	-5.35e-02	1.91e-01	5.13e-02	1.84e-01	1.39e-01	5.94e-01
NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	14	4.96e-01	8.96e-01	0.3140	-1.59e-01	-1.28e-01	-6.31e-02	-6.69e-02	2.20e-01	3.03e-01	4.06e-01	6.83e-01	6.65e-01	1.55e-01
NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	20	4.75e-01	8.86e-01	0.3140	3.97e-02	-5.53e-02	1.08e-01	9.39e-02	2.71e-01	7.59e-01	6.68e-01	4.03e-01	4.67e-01	3.62e-02
NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	26	5.24e-01	9.05e-01	0.3130	9.45e-02	2.12e-02	1.42e-01	1.46e-01	2.18e-01	4.04e-01	8.51e-01	2.11e-01	1.98e-01	5.43e-02
LUTEINIZATION	12	5.84e-01	9.28e-01	0.3130	-2.57e-02	4.81e-02	-2.01e-01	-2.01e-01	-1.18e-01	8.77e-01	7.73e-01	2.27e-01	2.27e-01	4.78e-01
POSITIVE REGULATION OF RNA BINDING	5	9.86e-01	9.98e-01	0.3130	1.52e-01	2.46e-02	1.78e-01	1.83e-01	9.66e-02	5.55e-01	9.24e-01	4.92e-01	4.80e-01	7.08e-01
ENTRAINMENT OF CIRCADIAN CLOCK	30	5.82e-01	9.28e-01	0.3130	-1.65e-01	-1.86e-01	-1.22e-01	-1.30e-01	-6.76e-02	1.18e-01	7.81e-02	2.49e-01	2.17e-01	5.22e-01
REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT	14	6.25e-01	9.44e-01	0.3130	1.91e-01	1.78e-01	9.26e-02	1.37e-01	-4.84e-02	2.15e-01	2.48e-01	5.49e-01	3.76e-01	7.54e-01
RESPONSE TO THYROXINE	5	8.72e-01	9.88e-01	0.3130	2.58e-02	-2.17e-01	1.43e-01	1.29e-01	1.13e-01	9.20e-01	4.00e-01	5.79e-01	6.17e-01	6.62e-01
CARDIAC ATRIUM MORPHOGENESIS	29	7.81e-02	4.50e-01	0.3130	-7.54e-02	-1.64e-01	-1.20e-01	-1.30e-01	-1.84e-01	4.82e-01	1.27e-01	2.64e-01	2.24e-01	8.56e-02
TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	17	2.54e-01	7.37e-01	0.3130	-6.67e-02	-1.74e-01	-7.83e-02	-8.47e-02	2.23e-01	6.34e-01	2.15e-01	5.76e-01	5.46e-01	1.11e-01
NEURONAL ACTION POTENTIAL PROPAGATION	9	3.83e-01	8.39e-01	0.3130	1.03e-02	1.55e-01	-2.15e-01	-1.66e-01	1.68e-03	9.58e-01	4.20e-01	2.65e-01	3.89e-01	9.93e-01
MITOCHONDRIAL TRANSPORT	181	6.05e-06	3.53e-04	0.3130	1.26e-01	-4.22e-02	1.91e-01	1.79e-01	1.07e-01	3.35e-03	3.27e-01	9.67e-06	3.28e-05	1.26e-02
POLY N ACETYLLACTOSAMINE METABOLIC PROCESS	7	4.70e-01	8.85e-01	0.3120	-2.58e-02	-1.39e-01	-1.39e-01	-1.68e-01	-1.73e-01	9.06e-01	5.26e-01	5.23e-01	4.42e-01	4.27e-01
POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	4.43e-01	8.72e-01	0.3120	1.20e-01	-1.06e-01	1.75e-01	1.97e-01	4.95e-02	4.71e-01	5.24e-01	2.95e-01	2.37e-01	7.66e-01
ASYMMETRIC NEUROBLAST DIVISION	5	7.72e-01	9.77e-01	0.3120	-4.60e-02	-1.02e-01	-3.36e-02	-6.38e-02	-2.82e-01	8.59e-01	6.93e-01	8.96e-01	8.05e-01	2.74e-01
NEUTROPHIL MEDIATED IMMUNITY	36	7.63e-02	4.46e-01	0.3120	-1.13e-01	-2.24e-01	-1.21e-01	-1.30e-01	5.20e-02	2.42e-01	1.98e-02	2.07e-01	1.77e-01	5.89e-01
MOTOR LEARNING	7	2.17e-01	6.99e-01	0.3120	-3.65e-02	-9.19e-02	3.53e-02	-3.53e-02	-2.92e-01	8.67e-01	6.74e-01	8.71e-01	8.71e-01	1.81e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	16	3.91e-01	8.41e-01	0.3120	-1.52e-01	-2.42e-01	-9.84e-02	-7.39e-02	-1.95e-02	2.93e-01	9.39e-02	4.95e-01	6.09e-01	8.93e-01
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	18	1.83e-01	6.56e-01	0.3120	-1.49e-01	-2.68e-01	5.01e-03	-4.44e-02	-3.37e-02	2.74e-01	4.91e-02	9.71e-01	7.44e-01	8.04e-01
REGULATION OF NOREPINEPHRINE SECRETION	13	5.62e-02	3.74e-01	0.3120	-1.47e-01	-2.63e-01	2.35e-02	-6.17e-02	-4.24e-02	3.60e-01	1.00e-01	8.84e-01	7.00e-01	7.91e-01
POSITIVE REGULATION OF VIRAL GENOME REPLICATION	30	5.73e-01	9.26e-01	0.3120	1.69e-01	7.14e-02	1.79e-01	1.68e-01	5.53e-02	1.08e-01	4.99e-01	8.97e-02	1.11e-01	6.00e-01
NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION	10	1.17e-01	5.47e-01	0.3110	-1.84e-01	-2.00e-03	-4.10e-02	-9.90e-02	2.28e-01	3.15e-01	9.91e-01	8.22e-01	5.88e-01	2.13e-01
POSITIVE REGULATION OF STEROID HORMONE SECRETION	11	6.70e-01	9.56e-01	0.3110	-1.15e-01	-1.77e-01	-1.47e-01	-1.75e-01	-1.98e-02	5.08e-01	3.10e-01	3.99e-01	3.16e-01	9.09e-01
CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT	24	7.63e-01	9.75e-01	0.3110	1.39e-01	8.12e-02	1.56e-01	1.63e-01	1.42e-01	2.39e-01	4.91e-01	1.87e-01	1.67e-01	2.30e-01
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	168	3.12e-07	2.47e-05	0.3110	1.22e-01	-3.01e-02	2.10e-01	1.90e-01	2.89e-02	6.56e-03	5.01e-01	2.67e-06	2.08e-05	5.17e-01
DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	28	3.89e-01	8.40e-01	0.3110	1.78e-01	1.92e-02	1.61e-01	1.72e-01	9.27e-02	1.02e-01	8.60e-01	1.40e-01	1.14e-01	3.96e-01
IMMUNE RESPONSE TO TUMOR CELL	26	2.30e-01	7.14e-01	0.3110	9.50e-02	1.51e-01	1.77e-01	1.63e-01	8.36e-02	4.02e-01	1.82e-01	1.19e-01	1.51e-01	4.61e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN	20	2.40e-01	7.24e-01	0.3110	-9.21e-02	-1.88e-01	-1.66e-01	-1.59e-01	-5.25e-03	4.76e-01	1.46e-01	1.98e-01	2.19e-01	9.68e-01
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS	46	2.89e-01	7.67e-01	0.3110	1.05e-01	-1.71e-02	1.73e-01	1.73e-01	1.59e-01	2.17e-01	8.41e-01	4.29e-02	4.22e-02	6.15e-02
REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	66	1.63e-01	6.28e-01	0.3110	1.55e-01	6.33e-02	1.82e-01	1.69e-01	8.09e-02	2.96e-02	3.74e-01	1.04e-02	1.74e-02	2.55e-01
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	14	8.84e-02	4.73e-01	0.3100	6.65e-02	-2.16e-01	4.28e-02	5.42e-02	2.01e-01	6.67e-01	1.62e-01	7.82e-01	7.26e-01	1.92e-01
PROXIMAL TUBULE DEVELOPMENT	10	2.87e-01	7.66e-01	0.3100	-1.17e-02	1.58e-01	-1.62e-01	-1.42e-01	1.57e-01	9.49e-01	3.88e-01	3.75e-01	4.35e-01	3.89e-01
NEGATIVE REGULATION OF DEPHOSPHORYLATION	35	1.27e-01	5.68e-01	0.3100	-1.24e-01	-1.95e-01	-1.04e-02	-3.87e-02	2.03e-01	2.05e-01	4.55e-02	9.16e-01	6.92e-01	3.80e-02
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION	53	2.43e-01	7.28e-01	0.3100	-1.88e-01	-1.41e-01	-1.33e-01	-1.49e-01	2.50e-02	1.77e-02	7.49e-02	9.29e-02	6.00e-02	7.53e-01
REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	13	3.58e-01	8.23e-01	0.3100	-3.36e-02	-1.16e-01	1.24e-01	1.46e-01	2.12e-01	8.34e-01	4.71e-01	4.38e-01	3.64e-01	1.85e-01
RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	8	8.94e-01	9.93e-01	0.3100	-5.36e-02	4.80e-02	-1.13e-01	-1.04e-01	-2.59e-01	7.93e-01	8.14e-01	5.82e-01	6.09e-01	2.04e-01
TRACHEA CARTILAGE DEVELOPMENT	7	3.11e-01	7.85e-01	0.3100	2.10e-01	2.21e-02	1.81e-02	3.57e-02	-2.23e-01	3.36e-01	9.19e-01	9.34e-01	8.70e-01	3.07e-01
MAST CELL CYTOKINE PRODUCTION	6	6.96e-01	9.62e-01	0.3100	4.51e-02	-2.11e-01	1.55e-01	1.59e-01	5.22e-03	8.48e-01	3.71e-01	5.10e-01	5.00e-01	9.82e-01
TRANSCRIPTION BY RNA POLYMERASE III	59	2.05e-02	2.06e-01	0.3100	1.34e-01	-1.35e-02	1.99e-01	1.95e-01	-1.40e-02	7.52e-02	8.57e-01	8.07e-03	9.66e-03	8.53e-01
REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	8	2.49e-01	7.33e-01	0.3100	1.26e-01	2.35e-01	5.12e-02	1.33e-01	6.71e-02	5.37e-01	2.50e-01	8.02e-01	5.15e-01	7.42e-01
ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	6	6.31e-01	9.47e-01	0.3100	-2.12e-01	-1.74e-01	-1.02e-01	-6.04e-02	-8.12e-02	3.68e-01	4.62e-01	6.66e-01	7.98e-01	7.31e-01
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	55	1.14e-03	2.77e-02	0.3100	4.22e-02	-1.98e-01	1.30e-01	1.34e-01	1.41e-01	5.88e-01	1.10e-02	9.65e-02	8.46e-02	7.03e-02
REGULATION OF RESPIRATORY SYSTEM PROCESS	13	6.51e-01	9.52e-01	0.3100	-8.75e-02	-8.49e-03	-2.20e-01	-1.88e-01	-6.80e-02	5.85e-01	9.58e-01	1.71e-01	2.41e-01	6.71e-01
NEGATIVE REGULATION OF CHOLESTEROL STORAGE	11	5.47e-01	9.15e-01	0.3100	-8.13e-02	-1.29e-01	-1.87e-02	-4.55e-03	2.69e-01	6.40e-01	4.58e-01	9.14e-01	9.79e-01	1.23e-01
TRNA METABOLIC PROCESS	190	7.38e-08	6.54e-06	0.3090	1.32e-01	-2.46e-02	2.01e-01	1.93e-01	7.79e-03	1.76e-03	5.59e-01	1.70e-06	4.45e-06	8.53e-01
TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING	38	1.85e-01	6.56e-01	0.3090	1.94e-01	7.76e-02	1.65e-01	1.56e-01	-2.33e-02	3.88e-02	4.08e-01	7.91e-02	9.55e-02	8.04e-01
REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	10	9.63e-01	9.97e-01	0.3090	1.54e-01	1.21e-01	1.47e-01	1.50e-01	1.13e-01	3.99e-01	5.07e-01	4.20e-01	4.10e-01	5.36e-01
PROTEIN GERANYLGERANYLATION	6	1.86e-01	6.57e-01	0.3090	-2.62e-01	-4.41e-02	1.32e-02	6.73e-04	1.58e-01	2.67e-01	8.52e-01	9.55e-01	9.98e-01	5.02e-01
ETHER METABOLIC PROCESS	26	5.50e-01	9.15e-01	0.3090	-1.13e-01	-5.91e-02	-1.97e-01	-1.95e-01	-4.82e-02	3.17e-01	6.02e-01	8.15e-02	8.55e-02	6.70e-01
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	3.65e-01	8.29e-01	0.3090	-8.16e-02	4.17e-02	-1.40e-01	-1.86e-01	-1.81e-01	6.25e-01	8.03e-01	4.00e-01	2.65e-01	2.77e-01
REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	9	4.23e-01	8.61e-01	0.3080	-9.21e-02	-2.24e-01	-7.03e-02	-1.17e-01	-1.34e-01	6.32e-01	2.46e-01	7.15e-01	5.42e-01	4.86e-01
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	26	1.21e-01	5.56e-01	0.3080	7.96e-02	1.06e-01	8.91e-02	1.14e-01	2.38e-01	4.82e-01	3.50e-01	4.32e-01	3.13e-01	3.58e-02
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE	5	4.94e-01	8.95e-01	0.3080	-1.48e-01	-1.17e-01	-3.39e-02	-1.14e-01	-2.13e-01	5.67e-01	6.51e-01	8.96e-01	6.58e-01	4.11e-01
INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT	52	4.46e-02	3.28e-01	0.3080	1.11e-01	-5.12e-02	1.91e-01	1.62e-01	1.30e-01	1.66e-01	5.23e-01	1.70e-02	4.27e-02	1.04e-01
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY	41	1.45e-01	6.03e-01	0.3080	1.09e-01	2.86e-02	1.47e-01	1.70e-01	1.78e-01	2.27e-01	7.51e-01	1.04e-01	5.94e-02	4.84e-02
POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	5	8.82e-01	9.91e-01	0.3080	-1.58e-01	-1.33e-01	-4.48e-02	-3.99e-02	2.20e-01	5.41e-01	6.05e-01	8.62e-01	8.77e-01	3.94e-01
INDOLALKYLAMINE METABOLIC PROCESS	11	7.39e-01	9.73e-01	0.3080	-1.29e-01	-2.39e-01	-6.20e-02	-5.64e-02	1.19e-01	4.59e-01	1.70e-01	7.22e-01	7.46e-01	4.94e-01
REGULATION OF TELOMERE MAINTENANCE	98	2.38e-03	4.71e-02	0.3080	1.13e-01	-4.85e-02	1.88e-01	1.66e-01	1.29e-01	5.30e-02	4.06e-01	1.28e-03	4.43e-03	2.77e-02
REGULATION OF GONADOTROPIN SECRETION	11	1.76e-01	6.47e-01	0.3080	-5.54e-02	-2.16e-01	-1.28e-01	-1.65e-01	3.81e-02	7.50e-01	2.15e-01	4.62e-01	3.44e-01	8.27e-01
PYRAMIDAL NEURON DIFFERENTIATION	12	6.84e-01	9.61e-01	0.3080	-1.13e-01	-2.49e-01	-2.59e-02	-5.18e-02	1.29e-01	4.99e-01	1.35e-01	8.77e-01	7.56e-01	4.40e-01
CELLULAR RESPONSE TO TESTOSTERONE STIMULUS	9	3.69e-01	8.31e-01	0.3080	-1.15e-01	-2.02e-01	-1.75e-02	-7.35e-02	-1.87e-01	5.50e-01	2.93e-01	9.28e-01	7.03e-01	3.32e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	10	7.81e-01	9.81e-01	0.3080	-1.58e-01	-1.81e-01	-1.43e-01	-1.15e-01	-5.66e-02	3.87e-01	3.21e-01	4.34e-01	5.28e-01	7.57e-01
REGULATION OF VIRAL GENOME REPLICATION	84	1.20e-01	5.53e-01	0.3080	1.83e-01	1.35e-01	1.45e-01	1.47e-01	2.04e-02	3.79e-03	3.22e-02	2.17e-02	1.98e-02	7.46e-01
CYTIDINE METABOLIC PROCESS	12	4.74e-01	8.86e-01	0.3080	-1.01e-01	9.32e-02	-2.02e-01	-1.57e-01	-1.00e-01	5.43e-01	5.76e-01	2.25e-01	3.46e-01	5.47e-01
REGULATION OF METAPHASE PLATE CONGRESSION	13	5.59e-01	9.19e-01	0.3080	1.62e-01	7.34e-02	1.22e-01	1.42e-01	-1.66e-01	3.11e-01	6.47e-01	4.45e-01	3.74e-01	3.00e-01
SPERM EGG RECOGNITION	51	9.16e-03	1.22e-01	0.3070	1.35e-01	2.47e-01	3.61e-02	7.92e-02	-8.66e-02	9.46e-02	2.25e-03	6.55e-01	3.28e-01	2.85e-01
NEGATIVE REGULATION OF NEURON MIGRATION	9	7.63e-01	9.75e-01	0.3070	-1.50e-01	-1.99e-02	-2.03e-01	-1.73e-01	1.67e-02	4.36e-01	9.18e-01	2.91e-01	3.68e-01	9.31e-01
NEPHRIC DUCT MORPHOGENESIS	10	2.03e-01	6.82e-01	0.3070	-6.52e-02	-2.53e-01	1.34e-01	5.77e-02	6.88e-02	7.21e-01	1.65e-01	4.63e-01	7.52e-01	7.07e-01
CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING	5	4.88e-01	8.92e-01	0.3070	8.56e-02	-2.32e-01	4.91e-02	2.75e-02	1.74e-01	7.40e-01	3.69e-01	8.49e-01	9.15e-01	5.01e-01
RESPONSE TO LITHIUM ION	15	8.48e-01	9.87e-01	0.3070	1.38e-01	3.11e-02	1.47e-01	1.52e-01	1.72e-01	3.55e-01	8.35e-01	3.24e-01	3.08e-01	2.48e-01
REGULATION OF DNA REPLICATION	121	5.26e-04	1.49e-02	0.3070	1.34e-01	-6.64e-03	1.99e-01	1.89e-01	2.61e-02	1.08e-02	9.00e-01	1.52e-04	3.18e-04	6.19e-01
NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION	16	6.26e-01	9.44e-01	0.3070	-1.45e-01	-2.34e-01	-7.25e-02	-1.03e-01	5.23e-02	3.17e-01	1.05e-01	6.16e-01	4.76e-01	7.17e-01
METANEPHRIC MESENCHYME DEVELOPMENT	14	2.91e-01	7.67e-01	0.3070	8.99e-03	-1.60e-01	1.12e-01	5.85e-02	2.29e-01	9.54e-01	3.00e-01	4.68e-01	7.05e-01	1.38e-01
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS	11	7.92e-02	4.52e-01	0.3070	-4.36e-02	2.46e-01	-5.82e-02	-4.23e-02	1.63e-01	8.02e-01	1.58e-01	7.38e-01	8.08e-01	3.48e-01
RNA MODIFICATION	170	1.41e-06	9.57e-05	0.3070	1.11e-01	-2.49e-02	2.05e-01	1.97e-01	2.01e-02	1.29e-02	5.75e-01	3.90e-06	9.47e-06	6.52e-01
CLATHRIN DEPENDENT ENDOCYTOSIS	47	3.59e-01	8.25e-01	0.3070	-1.40e-01	-1.02e-01	-1.63e-01	-1.78e-01	-7.63e-02	9.59e-02	2.25e-01	5.35e-02	3.51e-02	3.65e-01
RESPONSE TO INTERLEUKIN 15	11	6.84e-01	9.61e-01	0.3070	1.52e-01	1.56e-01	8.82e-02	7.42e-02	1.83e-01	3.82e-01	3.72e-01	6.12e-01	6.70e-01	2.94e-01
DORSAL AORTA MORPHOGENESIS	8	7.05e-01	9.65e-01	0.3060	1.32e-01	3.77e-03	1.58e-01	1.74e-01	-1.47e-01	5.18e-01	9.85e-01	4.40e-01	3.95e-01	4.72e-01
POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR	82	1.10e-01	5.32e-01	0.3060	1.40e-01	8.58e-02	1.69e-01	1.57e-01	1.18e-01	2.89e-02	1.79e-01	8.18e-03	1.42e-02	6.40e-02
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT	18	5.07e-01	8.99e-01	0.3060	-2.48e-02	-1.46e-01	8.76e-02	8.49e-02	2.39e-01	8.55e-01	2.82e-01	5.20e-01	5.33e-01	7.96e-02
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT	12	4.81e-01	8.91e-01	0.3060	1.16e-01	-8.76e-02	1.97e-01	1.81e-01	-3.80e-02	4.88e-01	5.99e-01	2.38e-01	2.79e-01	8.20e-01
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT	33	4.55e-01	8.78e-01	0.3060	8.04e-02	-3.68e-02	1.78e-01	1.69e-01	1.60e-01	4.24e-01	7.14e-01	7.67e-02	9.26e-02	1.11e-01
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	8	8.88e-01	9.91e-01	0.3060	-1.47e-01	-1.95e-01	-9.23e-02	-8.68e-02	1.36e-01	4.73e-01	3.40e-01	6.51e-01	6.71e-01	5.06e-01
LACTATION	37	1.94e-01	6.71e-01	0.3060	-1.42e-01	-2.09e-01	-8.01e-02	-8.05e-02	1.30e-01	1.34e-01	2.77e-02	3.99e-01	3.97e-01	1.72e-01
SNRNA METABOLIC PROCESS	53	2.88e-03	5.36e-02	0.3060	1.44e-01	-2.57e-02	1.98e-01	1.75e-01	-4.84e-02	6.91e-02	7.46e-01	1.25e-02	2.77e-02	5.42e-01
GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT	10	5.87e-01	9.29e-01	0.3060	1.38e-01	8.01e-02	4.92e-02	5.75e-02	2.50e-01	4.49e-01	6.61e-01	7.87e-01	7.53e-01	1.71e-01
INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	29	7.03e-02	4.24e-01	0.3060	-2.25e-01	-3.63e-02	-1.36e-01	-1.51e-01	-2.13e-02	3.60e-02	7.35e-01	2.05e-01	1.60e-01	8.43e-01
POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	42	9.72e-02	4.97e-01	0.3060	-1.91e-01	-1.13e-01	-1.27e-01	-1.28e-01	1.09e-01	3.22e-02	2.05e-01	1.54e-01	1.52e-01	2.23e-01
AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS	16	3.33e-01	8.05e-01	0.3060	-9.39e-02	-2.59e-01	-8.88e-02	-8.67e-02	4.55e-02	5.16e-01	7.24e-02	5.38e-01	5.48e-01	7.53e-01
NADPH OXIDATION	5	8.95e-01	9.93e-01	0.3060	1.17e-01	8.25e-02	1.05e-01	1.23e-01	-2.16e-01	6.51e-01	7.49e-01	6.83e-01	6.34e-01	4.02e-01
LIPID DROPLET FORMATION	13	4.06e-01	8.50e-01	0.3060	-4.91e-02	-1.05e-01	3.73e-02	-6.06e-03	2.81e-01	7.59e-01	5.14e-01	8.16e-01	9.70e-01	7.98e-02
NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION	15	7.97e-01	9.81e-01	0.3060	1.02e-01	9.06e-02	1.81e-01	1.68e-01	1.17e-01	4.92e-01	5.43e-01	2.25e-01	2.59e-01	4.33e-01
EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION	13	8.43e-01	9.86e-01	0.3060	-1.82e-01	-1.94e-01	-9.64e-02	-9.75e-02	6.20e-02	2.55e-01	2.27e-01	5.47e-01	5.43e-01	6.99e-01
ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	9	5.00e-01	8.98e-01	0.3060	-2.58e-02	3.36e-02	-2.21e-01	-2.03e-01	3.96e-02	8.93e-01	8.61e-01	2.50e-01	2.93e-01	8.37e-01
REGULATION OF EATING BEHAVIOR	7	3.51e-01	8.19e-01	0.3060	-1.15e-01	-1.34e-01	-1.30e-01	-2.06e-01	5.26e-02	5.97e-01	5.38e-01	5.51e-01	3.46e-01	8.09e-01
REGULATION OF TELOMERE CAPPING	26	3.48e-01	8.18e-01	0.3060	-1.36e-02	-1.26e-01	1.05e-01	9.13e-02	2.41e-01	9.04e-01	2.67e-01	3.53e-01	4.21e-01	3.37e-02
REGULATION OF NUCLEASE ACTIVITY	22	5.65e-01	9.23e-01	0.3060	1.01e-01	-6.06e-02	1.89e-01	1.83e-01	1.00e-01	4.12e-01	6.23e-01	1.24e-01	1.36e-01	4.16e-01
NEUROTRANSMITTER REUPTAKE	34	3.12e-01	7.85e-01	0.3060	1.55e-01	2.25e-01	8.86e-02	9.31e-02	4.63e-02	1.19e-01	2.30e-02	3.71e-01	3.48e-01	6.40e-01
NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	15	8.21e-01	9.83e-01	0.3060	1.01e-01	4.79e-02	1.82e-01	1.88e-01	1.11e-01	5.00e-01	7.48e-01	2.23e-01	2.07e-01	4.55e-01
POSITIVE REGULATION OF TOOTH MINERALIZATION	7	6.27e-01	9.45e-01	0.3050	-7.17e-02	-2.12e-01	7.73e-03	-5.67e-03	-2.08e-01	7.43e-01	3.32e-01	9.72e-01	9.79e-01	3.41e-01
ANDROGEN CATABOLIC PROCESS	5	7.97e-01	9.81e-01	0.3050	2.00e-01	2.28e-01	-2.23e-02	-2.01e-02	-1.74e-02	4.39e-01	3.77e-01	9.31e-01	9.38e-01	9.46e-01
DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	11	2.94e-01	7.71e-01	0.3050	1.20e-01	-9.56e-02	1.74e-01	1.52e-01	-1.27e-01	4.91e-01	5.83e-01	3.18e-01	3.82e-01	4.66e-01
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	27	9.03e-02	4.78e-01	0.3050	8.75e-02	-6.88e-02	1.19e-01	8.42e-02	2.44e-01	4.31e-01	5.36e-01	2.86e-01	4.49e-01	2.83e-02
REGULATION OF TRANSLATIONAL FIDELITY	18	1.89e-01	6.61e-01	0.3050	1.23e-01	1.88e-03	1.33e-01	1.42e-01	-2.00e-01	3.65e-01	9.89e-01	3.29e-01	2.97e-01	1.42e-01
RESPONSE TO CORTISOL	6	8.91e-01	9.92e-01	0.3050	9.21e-02	-2.86e-02	2.04e-01	2.03e-01	-2.77e-02	6.96e-01	9.03e-01	3.86e-01	3.90e-01	9.06e-01
POSITIVE REGULATION BY HOST OF VIRAL PROCESS	20	1.84e-01	6.56e-01	0.3050	-8.58e-02	-2.10e-01	9.59e-03	-3.84e-02	1.99e-01	5.06e-01	1.03e-01	9.41e-01	7.66e-01	1.23e-01
COMPLEMENT DEPENDENT CYTOTOXICITY	13	3.84e-01	8.39e-01	0.3050	-7.26e-02	-1.19e-01	-3.91e-02	-7.55e-02	2.57e-01	6.51e-01	4.57e-01	8.07e-01	6.37e-01	1.08e-01
REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION	7	9.52e-01	9.97e-01	0.3050	-1.63e-01	-1.85e-01	-1.10e-01	-1.38e-01	3.34e-02	4.56e-01	3.97e-01	6.16e-01	5.28e-01	8.78e-01
PENILE ERECTION	7	6.00e-01	9.33e-01	0.3050	-1.85e-01	-1.54e-01	-3.11e-02	-2.06e-02	-1.83e-01	3.97e-01	4.80e-01	8.87e-01	9.25e-01	4.02e-01
CRANIAL NERVE FORMATION	10	4.87e-01	8.92e-01	0.3050	1.56e-01	-4.63e-02	1.91e-01	1.46e-01	9.13e-02	3.93e-01	8.00e-01	2.95e-01	4.23e-01	6.17e-01
LIPOXYGENASE PATHWAY	11	5.38e-01	9.12e-01	0.3040	7.74e-02	2.56e-02	3.49e-02	3.91e-02	2.89e-01	6.56e-01	8.83e-01	8.41e-01	8.22e-01	9.74e-02
NUCLEAR BODY ORGANIZATION	15	7.86e-01	9.81e-01	0.3040	1.60e-01	1.69e-01	1.06e-01	1.30e-01	1.01e-01	2.83e-01	2.57e-01	4.78e-01	3.82e-01	4.99e-01
PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY	29	3.78e-01	8.36e-01	0.3040	-8.55e-02	-8.39e-02	-1.59e-01	-1.45e-01	-1.79e-01	4.25e-01	4.34e-01	1.37e-01	1.77e-01	9.61e-02
RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	9	6.30e-01	9.46e-01	0.3040	9.72e-02	1.31e-01	1.69e-01	1.45e-01	-1.28e-01	6.14e-01	4.97e-01	3.80e-01	4.51e-01	5.07e-01
DENTATE GYRUS DEVELOPMENT	23	2.02e-01	6.82e-01	0.3040	7.77e-02	-1.17e-01	2.00e-01	1.77e-01	3.59e-02	5.19e-01	3.31e-01	9.67e-02	1.41e-01	7.66e-01
SKELETAL MUSCLE CONTRACTION	43	2.51e-02	2.36e-01	0.3040	1.40e-01	2.61e-01	1.77e-02	4.38e-02	5.28e-02	1.13e-01	3.11e-03	8.40e-01	6.19e-01	5.49e-01
SYMPATHETIC GANGLION DEVELOPMENT	9	7.90e-01	9.81e-01	0.3040	-1.17e-01	-1.40e-01	-8.78e-02	-8.81e-02	2.08e-01	5.42e-01	4.66e-01	6.48e-01	6.47e-01	2.79e-01
POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	21	8.28e-01	9.83e-01	0.3040	1.40e-01	9.32e-02	1.77e-01	1.70e-01	6.41e-02	2.68e-01	4.60e-01	1.61e-01	1.78e-01	6.11e-01
TELOMERE MAINTENANCE	149	6.52e-05	2.76e-03	0.3040	1.21e-01	-3.14e-02	1.97e-01	1.78e-01	7.90e-02	1.11e-02	5.08e-01	3.42e-05	1.69e-04	9.62e-02
REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	38	1.55e-01	6.17e-01	0.3040	-1.29e-01	-1.39e-01	-1.58e-01	-1.52e-01	9.21e-02	1.70e-01	1.38e-01	9.25e-02	1.06e-01	3.26e-01
CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS	5	7.94e-01	9.81e-01	0.3040	-1.04e-02	1.60e-01	-2.03e-01	-1.58e-01	-2.25e-02	9.68e-01	5.36e-01	4.33e-01	5.40e-01	9.31e-01
BLOOD VESSEL MATURATION	8	9.43e-01	9.97e-01	0.3040	1.72e-01	1.72e-01	1.27e-01	1.15e-01	6.13e-02	4.00e-01	4.00e-01	5.35e-01	5.72e-01	7.64e-01
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS	20	8.92e-02	4.75e-01	0.3040	2.09e-01	1.17e-01	9.55e-02	1.59e-01	-1.74e-02	1.05e-01	3.64e-01	4.60e-01	2.19e-01	8.93e-01
FATTY ACID DERIVATIVE CATABOLIC PROCESS	17	8.84e-01	9.91e-01	0.3040	1.83e-01	1.28e-01	1.42e-01	1.47e-01	2.33e-02	1.92e-01	3.61e-01	3.11e-01	2.95e-01	8.68e-01
INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	25	2.69e-01	7.50e-01	0.3030	-1.76e-02	1.06e-01	-1.78e-01	-1.77e-01	-1.33e-01	8.79e-01	3.58e-01	1.23e-01	1.26e-01	2.50e-01
CELLULAR DETOXIFICATION OF ALDEHYDE	9	7.10e-01	9.67e-01	0.3030	-4.67e-02	-1.01e-01	-1.09e-01	-9.28e-02	-2.43e-01	8.08e-01	5.98e-01	5.72e-01	6.30e-01	2.06e-01
PROTEIN O LINKED GLYCOSYLATION	96	8.65e-02	4.68e-01	0.3030	-1.72e-01	-1.21e-01	-1.38e-01	-1.50e-01	-7.78e-02	3.49e-03	4.00e-02	1.98e-02	1.09e-02	1.88e-01
BINDING OF SPERM TO ZONA PELLUCIDA	38	1.06e-01	5.23e-01	0.3030	1.28e-01	1.97e-01	9.40e-02	1.22e-01	-1.13e-01	1.71e-01	3.54e-02	3.16e-01	1.92e-01	2.26e-01
NEGATIVE REGULATION OF VIRAL GENOME REPLICATION	55	2.93e-01	7.69e-01	0.3030	1.80e-01	1.75e-01	1.15e-01	1.22e-01	2.33e-02	2.06e-02	2.47e-02	1.42e-01	1.16e-01	7.65e-01
REGULATION OF CARDIOCYTE DIFFERENTIATION	32	4.21e-01	8.60e-01	0.3030	-1.58e-01	-1.79e-01	-1.08e-01	-1.28e-01	8.36e-02	1.23e-01	8.00e-02	2.92e-01	2.09e-01	4.13e-01
REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	30	7.41e-01	9.73e-01	0.3030	-1.37e-01	-6.16e-02	-1.70e-01	-1.70e-01	-1.08e-01	1.94e-01	5.59e-01	1.08e-01	1.07e-01	3.06e-01
CELLULAR RESPONSE TO UV B	12	5.79e-01	9.27e-01	0.3030	-1.07e-01	-1.83e-01	-1.36e-01	-1.66e-01	-2.69e-02	5.20e-01	2.72e-01	4.16e-01	3.20e-01	8.72e-01
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT	31	5.95e-01	9.33e-01	0.3030	-1.43e-01	-1.22e-01	-1.44e-01	-1.36e-01	-1.32e-01	1.69e-01	2.41e-01	1.66e-01	1.90e-01	2.03e-01
POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION	16	1.83e-01	6.56e-01	0.3030	6.19e-02	-2.14e-01	1.07e-01	9.53e-02	1.47e-01	6.68e-01	1.39e-01	4.57e-01	5.09e-01	3.07e-01
POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING	9	7.06e-01	9.65e-01	0.3030	9.73e-02	3.21e-02	1.85e-01	1.80e-01	-1.21e-01	6.13e-01	8.68e-01	3.36e-01	3.51e-01	5.30e-01
SPERMATID NUCLEUS DIFFERENTIATION	27	3.52e-01	8.20e-01	0.3030	1.54e-01	2.31e-01	6.28e-02	7.95e-02	6.59e-02	1.66e-01	3.76e-02	5.72e-01	4.75e-01	5.54e-01
NEUROBLAST DIFFERENTIATION	8	1.34e-01	5.81e-01	0.3030	1.37e-01	-2.18e-01	7.94e-02	5.92e-02	1.25e-01	5.02e-01	2.87e-01	6.97e-01	7.72e-01	5.40e-01
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	19	4.57e-01	8.79e-01	0.3030	1.60e-01	9.56e-02	1.67e-01	1.47e-01	-8.68e-02	2.27e-01	4.71e-01	2.08e-01	2.68e-01	5.13e-01
GAP JUNCTION ASSEMBLY	16	1.34e-01	5.81e-01	0.3030	2.42e-01	1.73e-01	4.00e-02	3.54e-02	3.24e-03	9.31e-02	2.31e-01	7.82e-01	8.07e-01	9.82e-01
PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	23	6.33e-01	9.48e-01	0.3020	-9.56e-02	-7.87e-02	-1.66e-01	-1.69e-01	-1.42e-01	4.28e-01	5.14e-01	1.68e-01	1.61e-01	2.39e-01
PULMONARY VALVE MORPHOGENESIS	19	5.96e-01	9.33e-01	0.3020	-7.27e-02	-3.82e-02	-1.94e-01	-1.87e-01	-1.09e-01	5.83e-01	7.73e-01	1.42e-01	1.58e-01	4.12e-01
REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	7	6.74e-01	9.59e-01	0.3020	-6.63e-02	-2.08e-01	-1.45e-01	-1.29e-01	-7.73e-02	7.61e-01	3.42e-01	5.06e-01	5.54e-01	7.23e-01
PROSTATIC BUD FORMATION	8	2.73e-01	7.54e-01	0.3020	1.17e-02	-2.32e-01	1.63e-01	9.04e-02	4.95e-02	9.54e-01	2.55e-01	4.25e-01	6.58e-01	8.08e-01
ACTIVATION OF JANUS KINASE ACTIVITY	13	2.55e-01	7.38e-01	0.3020	-1.09e-01	9.11e-02	-1.87e-01	-1.60e-01	1.02e-01	4.95e-01	5.69e-01	2.43e-01	3.18e-01	5.26e-01
RENAL VESICLE FORMATION	8	8.99e-01	9.93e-01	0.3020	-1.89e-01	-1.33e-01	-1.46e-01	-1.27e-01	1.27e-02	3.54e-01	5.15e-01	4.75e-01	5.34e-01	9.50e-01
REGULATION OF HEART RATE BY CHEMICAL SIGNAL	7	9.11e-01	9.94e-01	0.3020	-2.09e-01	-1.13e-01	-1.07e-01	-1.21e-01	-9.05e-02	3.38e-01	6.04e-01	6.24e-01	5.79e-01	6.79e-01
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS	17	5.30e-01	9.07e-01	0.3020	1.30e-01	2.30e-01	-3.73e-02	-1.77e-02	-1.39e-01	3.53e-01	1.00e-01	7.90e-01	8.99e-01	3.22e-01
POSITIVE REGULATION OF MICROTUBULE NUCLEATION	7	5.84e-01	9.28e-01	0.3020	2.18e-01	6.25e-02	6.38e-02	7.98e-02	1.70e-01	3.18e-01	7.75e-01	7.70e-01	7.15e-01	4.35e-01
SUPEROXIDE ANION GENERATION	37	4.82e-01	8.91e-01	0.3010	-1.65e-01	-1.77e-01	-1.29e-01	-1.24e-01	-1.88e-02	8.23e-02	6.30e-02	1.76e-01	1.90e-01	8.43e-01
REGULATION OF B CELL MEDIATED IMMUNITY	61	9.44e-02	4.91e-01	0.3010	9.64e-02	3.15e-03	1.67e-01	1.79e-01	1.47e-01	1.93e-01	9.66e-01	2.43e-02	1.54e-02	4.73e-02
POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	10	8.62e-01	9.88e-01	0.3010	6.67e-02	-1.70e-02	1.49e-01	1.23e-01	2.20e-01	7.15e-01	9.26e-01	4.13e-01	5.00e-01	2.28e-01
GRANULOCYTE ACTIVATION	49	4.12e-02	3.10e-01	0.3010	-1.13e-01	-1.98e-01	-1.02e-01	-1.10e-01	1.28e-01	1.70e-01	1.67e-02	2.15e-01	1.83e-01	1.22e-01
THALAMUS DEVELOPMENT	11	8.10e-01	9.82e-01	0.3010	9.95e-02	-2.44e-02	2.08e-01	1.86e-01	5.06e-02	5.68e-01	8.89e-01	2.32e-01	2.86e-01	7.71e-01
DICARBOXYLIC ACID CATABOLIC PROCESS	18	4.33e-01	8.69e-01	0.3010	-7.61e-02	-9.09e-02	-1.68e-01	-1.85e-01	-1.19e-01	5.76e-01	5.04e-01	2.17e-01	1.74e-01	3.83e-01
MANGANESE ION TRANSPORT	11	7.29e-01	9.71e-01	0.3010	-7.59e-02	-3.30e-02	-1.77e-01	-1.98e-01	-1.15e-01	6.63e-01	8.50e-01	3.08e-01	2.56e-01	5.08e-01
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	12	1.42e-01	6.00e-01	0.3010	2.05e-02	-1.63e-01	-6.35e-02	-5.35e-02	-2.38e-01	9.02e-01	3.28e-01	7.03e-01	7.48e-01	1.53e-01
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	18	7.31e-01	9.72e-01	0.3010	5.64e-02	-1.77e-02	1.57e-01	1.49e-01	2.01e-01	6.79e-01	8.97e-01	2.50e-01	2.75e-01	1.39e-01
REGULATION OF DNA RECOMBINATION	128	2.85e-02	2.53e-01	0.3010	1.53e-01	6.41e-02	1.74e-01	1.72e-01	5.66e-02	2.75e-03	2.11e-01	6.81e-04	7.81e-04	2.69e-01
METANEPHRIC TUBULE MORPHOGENESIS	11	3.89e-01	8.40e-01	0.3010	4.47e-02	-7.30e-02	7.19e-03	-7.98e-03	2.88e-01	7.98e-01	6.75e-01	9.67e-01	9.63e-01	9.78e-02
BRANCH ELONGATION OF AN EPITHELIUM	19	1.77e-01	6.47e-01	0.3010	1.09e-01	-1.14e-01	1.95e-01	1.64e-01	1.96e-02	4.12e-01	3.88e-01	1.40e-01	2.15e-01	8.83e-01
NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	21	6.61e-01	9.54e-01	0.3010	1.55e-01	2.05e-01	7.95e-02	9.39e-02	-9.74e-02	2.20e-01	1.04e-01	5.28e-01	4.56e-01	4.40e-01
POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	6	8.58e-01	9.88e-01	0.3010	1.23e-01	1.58e-01	1.68e-01	1.37e-01	-5.57e-02	6.01e-01	5.01e-01	4.76e-01	5.61e-01	8.13e-01
NEGATIVE REGULATION OF PROTEIN UBIQUITINATION	69	4.66e-02	3.37e-01	0.3010	8.66e-02	-6.76e-02	1.78e-01	1.73e-01	1.29e-01	2.14e-01	3.31e-01	1.03e-02	1.31e-02	6.32e-02
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	24	2.32e-01	7.15e-01	0.3010	-2.63e-02	-1.90e-01	1.49e-01	1.21e-01	1.30e-01	8.24e-01	1.07e-01	2.08e-01	3.04e-01	2.71e-01
REGULATION OF OPSONIZATION	10	2.39e-01	7.23e-01	0.3010	7.74e-02	2.76e-01	-8.62e-02	-2.25e-02	2.33e-02	6.72e-01	1.31e-01	6.37e-01	9.02e-01	8.99e-01
T CELL RECEPTOR SIGNALING PATHWAY	133	1.52e-03	3.38e-02	0.3010	1.24e-01	1.40e-01	1.67e-01	1.60e-01	4.75e-02	1.38e-02	5.44e-03	8.76e-04	1.47e-03	3.44e-01
MESENCHYMAL CELL DEVELOPMENT	6	9.36e-01	9.97e-01	0.3010	2.11e-01	1.16e-01	1.13e-01	1.41e-01	1.44e-03	3.71e-01	6.23e-01	6.33e-01	5.51e-01	9.95e-01
CARDIOLIPIN METABOLIC PROCESS	14	2.12e-01	6.91e-01	0.3010	8.67e-02	-1.92e-01	1.01e-01	9.85e-02	1.61e-01	5.74e-01	2.12e-01	5.12e-01	5.24e-01	2.97e-01
EPHRIN RECEPTOR SIGNALING PATHWAY	49	3.35e-01	8.05e-01	0.3010	-1.79e-01	-1.28e-01	-1.34e-01	-1.54e-01	-1.38e-02	3.01e-02	1.21e-01	1.04e-01	6.19e-02	8.68e-01
SPHINGOLIPID MEDIATED SIGNALING PATHWAY	18	3.13e-01	7.86e-01	0.3010	3.68e-03	-2.03e-01	6.45e-02	5.98e-02	2.04e-01	9.78e-01	1.36e-01	6.36e-01	6.61e-01	1.35e-01
NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	12	8.02e-01	9.82e-01	0.3010	-1.07e-01	4.27e-03	-1.16e-01	-1.12e-01	-2.30e-01	5.22e-01	9.80e-01	4.87e-01	5.02e-01	1.67e-01
ENTRY OF BACTERIUM INTO HOST CELL	9	4.61e-01	8.80e-01	0.3000	-4.94e-02	1.93e-01	-1.74e-01	-1.26e-01	-6.93e-02	7.98e-01	3.17e-01	3.67e-01	5.14e-01	7.19e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	6	9.82e-01	9.97e-01	0.3000	-1.19e-01	-7.85e-02	-1.63e-01	-1.50e-01	-1.45e-01	6.13e-01	7.39e-01	4.89e-01	5.25e-01	5.39e-01
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	45	3.84e-01	8.39e-01	0.3000	1.15e-01	-6.72e-03	1.73e-01	1.68e-01	1.38e-01	1.83e-01	9.38e-01	4.46e-02	5.16e-02	1.09e-01
MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS	6	5.18e-01	9.03e-01	0.3000	-1.86e-01	-1.67e-01	9.60e-02	8.52e-02	1.06e-01	4.30e-01	4.78e-01	6.84e-01	7.18e-01	6.54e-01
UTP BIOSYNTHETIC PROCESS	10	3.74e-02	2.95e-01	0.3000	-1.33e-01	-1.92e-01	1.46e-01	5.84e-02	-1.05e-01	4.66e-01	2.94e-01	4.24e-01	7.49e-01	5.64e-01
CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT	9	9.13e-01	9.94e-01	0.3000	1.57e-01	2.93e-02	1.50e-01	1.39e-01	1.52e-01	4.16e-01	8.79e-01	4.37e-01	4.71e-01	4.29e-01
REGULATION OF CORTISOL BIOSYNTHETIC PROCESS	7	4.75e-01	8.86e-01	0.3000	-2.43e-01	-1.55e-01	1.57e-02	-1.62e-02	8.15e-02	2.65e-01	4.78e-01	9.43e-01	9.41e-01	7.09e-01
OSTEOBLAST PROLIFERATION	36	5.65e-01	9.23e-01	0.3000	1.69e-01	1.41e-01	1.29e-01	1.29e-01	8.97e-02	7.84e-02	1.44e-01	1.79e-01	1.79e-01	3.52e-01
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION	36	5.56e-01	9.18e-01	0.3000	-1.85e-01	-1.32e-01	-1.29e-01	-1.44e-01	-3.31e-02	5.51e-02	1.71e-01	1.80e-01	1.35e-01	7.31e-01
ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	44	3.09e-01	7.83e-01	0.3000	1.06e-01	6.39e-03	1.72e-01	1.52e-01	1.61e-01	2.23e-01	9.42e-01	4.84e-02	8.01e-02	6.52e-02
ENDOCARDIAL CUSHION FORMATION	31	1.03e-01	5.13e-01	0.3000	-1.09e-01	-2.66e-01	3.63e-02	4.60e-03	7.88e-02	2.96e-01	1.05e-02	7.27e-01	9.65e-01	4.47e-01
REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	10	6.36e-01	9.48e-01	0.3000	6.98e-02	-1.47e-01	1.69e-01	1.77e-01	5.83e-02	7.02e-01	4.19e-01	3.55e-01	3.33e-01	7.49e-01
NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	22	4.34e-01	8.69e-01	0.3000	1.06e-01	-6.45e-02	1.97e-01	1.77e-01	6.55e-02	3.91e-01	6.00e-01	1.09e-01	1.51e-01	5.95e-01
NEGATIVE REGULATION OF RECEPTOR RECYCLING	5	6.52e-01	9.52e-01	0.3000	3.53e-02	2.18e-01	1.50e-01	1.37e-01	-6.68e-03	8.91e-01	3.99e-01	5.62e-01	5.96e-01	9.79e-01
TRANSDIFFERENTIATION	7	1.44e-01	6.01e-01	0.2990	1.19e-01	-2.50e-01	9.19e-02	6.33e-02	-2.41e-02	5.85e-01	2.52e-01	6.74e-01	7.72e-01	9.12e-01
REGULATION OF ENDOSOME ORGANIZATION	5	5.16e-01	9.02e-01	0.2990	-4.30e-02	-1.17e-01	-1.26e-01	-1.87e-01	-1.53e-01	8.68e-01	6.52e-01	6.26e-01	4.69e-01	5.53e-01
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	32	2.58e-01	7.40e-01	0.2990	-9.68e-02	-3.37e-02	-1.67e-01	-1.35e-01	-1.82e-01	3.43e-01	7.41e-01	1.02e-01	1.87e-01	7.54e-02
T CELL HOMEOSTASIS	44	5.20e-01	9.03e-01	0.2990	1.30e-01	8.20e-02	1.65e-01	1.70e-01	9.84e-02	1.37e-01	3.47e-01	5.76e-02	5.06e-02	2.59e-01
REGULATION OF VESICLE FUSION	24	2.85e-01	7.64e-01	0.2990	-4.05e-02	-8.69e-02	1.04e-01	9.27e-02	2.47e-01	7.31e-01	4.61e-01	3.79e-01	4.32e-01	3.62e-02
COMMISSURAL NEURON AXON GUIDANCE	12	6.69e-01	9.56e-01	0.2990	-1.59e-01	-1.48e-01	-4.59e-02	-4.97e-02	1.94e-01	3.40e-01	3.75e-01	7.83e-01	7.66e-01	2.45e-01
T CELL CHEMOTAXIS	27	2.35e-02	2.26e-01	0.2990	6.86e-02	9.40e-02	-1.85e-02	-4.22e-03	2.75e-01	5.37e-01	3.98e-01	8.68e-01	9.70e-01	1.35e-02
MRNA EXPORT FROM NUCLEUS	62	3.99e-02	3.06e-01	0.2990	1.31e-01	-2.42e-02	1.85e-01	1.62e-01	1.05e-01	7.37e-02	7.42e-01	1.19e-02	2.72e-02	1.54e-01
NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	28	2.79e-01	7.58e-01	0.2990	-7.84e-02	-1.84e-01	4.71e-02	2.76e-02	2.15e-01	4.73e-01	9.15e-02	6.66e-01	8.01e-01	4.91e-02
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	21	6.54e-02	4.08e-01	0.2990	-1.16e-02	5.87e-02	4.19e-02	6.21e-02	2.83e-01	9.26e-01	6.41e-01	7.40e-01	6.22e-01	2.49e-02
NEGATIVE REGULATION OF RIBOSOME BIOGENESIS	7	7.74e-01	9.77e-01	0.2990	1.56e-01	-2.80e-03	1.57e-01	1.86e-01	-7.57e-02	4.76e-01	9.90e-01	4.73e-01	3.93e-01	7.29e-01
CLATHRIN COATED VESICLE CARGO LOADING	7	7.37e-01	9.73e-01	0.2980	-1.91e-01	-1.42e-01	-7.47e-02	-5.69e-02	1.54e-01	3.83e-01	5.14e-01	7.32e-01	7.94e-01	4.81e-01
REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH	14	9.10e-01	9.94e-01	0.2980	-1.61e-01	-1.59e-01	-1.25e-01	-1.26e-01	-8.15e-02	2.98e-01	3.03e-01	4.19e-01	4.15e-01	5.97e-01
INNER CELL MASS CELL PROLIFERATION	14	8.61e-01	9.88e-01	0.2980	1.33e-01	1.40e-02	1.75e-01	1.58e-01	1.24e-01	3.88e-01	9.28e-01	2.56e-01	3.07e-01	4.22e-01
HYDROGEN PEROXIDE METABOLIC PROCESS	49	2.27e-02	2.21e-01	0.2980	1.02e-01	-5.05e-02	1.16e-01	9.72e-02	2.30e-01	2.18e-01	5.41e-01	1.58e-01	2.39e-01	5.33e-03
UREA METABOLIC PROCESS	12	6.57e-01	9.54e-01	0.2980	1.16e-01	2.36e-01	6.56e-02	7.53e-02	9.80e-02	4.88e-01	1.56e-01	6.94e-01	6.52e-01	5.57e-01
ERBB4 ERBB4 SIGNALING PATHWAY	6	6.74e-01	9.59e-01	0.2980	-3.93e-03	-2.68e-01	8.19e-02	4.71e-02	8.78e-02	9.87e-01	2.55e-01	7.28e-01	8.42e-01	7.10e-01
GONADOTROPIN SECRETION	17	9.37e-02	4.88e-01	0.2980	-8.88e-02	-1.98e-01	-1.14e-01	-1.64e-01	-4.24e-02	5.26e-01	1.58e-01	4.18e-01	2.43e-01	7.62e-01
MALE GENITALIA DEVELOPMENT	23	6.39e-01	9.49e-01	0.2970	-1.50e-01	-1.73e-01	-1.20e-01	-1.45e-01	-3.17e-02	2.14e-01	1.52e-01	3.21e-01	2.30e-01	7.92e-01
FATTY ACYL COA METABOLIC PROCESS	37	2.33e-01	7.18e-01	0.2970	-1.44e-01	-2.24e-01	-2.80e-02	-4.33e-02	1.22e-01	1.30e-01	1.82e-02	7.68e-01	6.49e-01	2.00e-01
HEPATIC STELLATE CELL ACTIVATION	9	8.34e-01	9.85e-01	0.2970	-1.26e-01	-2.47e-01	-7.43e-02	-7.59e-02	-2.33e-02	5.14e-01	2.00e-01	7.00e-01	6.93e-01	9.04e-01
NEGATIVE REGULATION OF GLIAL CELL MIGRATION	6	7.80e-02	4.50e-01	0.2970	-6.36e-02	-2.01e-01	1.60e-01	2.82e-02	1.33e-01	7.87e-01	3.94e-01	4.98e-01	9.05e-01	5.72e-01
MRNA PROCESSING	450	9.91e-15	2.33e-12	0.2970	1.36e-01	2.18e-02	1.90e-01	1.82e-01	-6.29e-03	7.02e-07	4.29e-01	4.67e-12	3.42e-11	8.19e-01
ADENOSINE TRANSPORT	5	6.71e-01	9.57e-01	0.2970	8.04e-02	1.84e-01	-1.10e-01	-8.03e-02	1.72e-01	7.56e-01	4.77e-01	6.69e-01	7.56e-01	5.06e-01
NEGATIVE REGULATION OF MACROAUTOPHAGY	31	5.52e-01	9.16e-01	0.2970	1.52e-01	1.32e-01	1.52e-01	1.50e-01	-4.45e-02	1.42e-01	2.03e-01	1.42e-01	1.48e-01	6.68e-01
REGULATION OF GLIAL CELL MIGRATION	19	5.41e-01	9.14e-01	0.2970	5.09e-02	3.57e-02	1.11e-01	1.07e-01	2.47e-01	7.01e-01	7.87e-01	4.04e-01	4.21e-01	6.26e-02
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION	17	2.74e-01	7.56e-01	0.2970	-8.27e-02	-2.25e-01	4.70e-02	-4.47e-03	1.68e-01	5.55e-01	1.07e-01	7.37e-01	9.75e-01	2.30e-01
PITUITARY GLAND DEVELOPMENT	40	2.81e-03	5.27e-02	0.2970	-5.89e-02	-2.61e-01	1.91e-02	-2.45e-02	1.25e-01	5.20e-01	4.31e-03	8.34e-01	7.88e-01	1.71e-01
CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY	5	4.44e-01	8.73e-01	0.2970	-1.34e-01	-1.72e-01	1.07e-01	3.90e-02	-1.65e-01	6.03e-01	5.05e-01	6.77e-01	8.80e-01	5.23e-01
CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS	10	4.15e-01	8.55e-01	0.2960	2.04e-01	-2.55e-02	1.51e-01	1.28e-01	8.00e-02	2.64e-01	8.89e-01	4.08e-01	4.84e-01	6.61e-01
NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	33	7.56e-02	4.42e-01	0.2960	-2.25e-02	-2.32e-01	8.63e-02	7.60e-02	1.43e-01	8.23e-01	2.12e-02	3.91e-01	4.50e-01	1.56e-01
REGULATION OF HISTAMINE SECRETION BY MAST CELL	6	5.20e-01	9.03e-01	0.2960	1.97e-01	-9.11e-02	1.24e-01	1.55e-01	3.66e-02	4.02e-01	6.99e-01	6.00e-01	5.12e-01	8.77e-01
CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS	49	2.37e-01	7.20e-01	0.2960	1.89e-01	1.03e-01	1.45e-01	1.43e-01	-4.77e-04	2.22e-02	2.13e-01	7.87e-02	8.33e-02	9.95e-01
POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION	9	4.23e-01	8.61e-01	0.2960	1.02e-01	-8.67e-02	1.42e-01	8.61e-02	2.06e-01	5.96e-01	6.52e-01	4.62e-01	6.55e-01	2.86e-01
URETERIC BUD ELONGATION	8	9.20e-01	9.95e-01	0.2960	5.18e-02	-8.76e-02	1.78e-01	1.60e-01	1.41e-01	8.00e-01	6.68e-01	3.84e-01	4.32e-01	4.90e-01
NADH METABOLIC PROCESS	11	5.08e-01	9.00e-01	0.2960	1.73e-01	2.17e-01	5.78e-02	3.41e-02	7.72e-02	3.21e-01	2.12e-01	7.40e-01	8.45e-01	6.58e-01
COBALAMIN TRANSPORT	8	7.99e-01	9.81e-01	0.2960	-1.09e-01	-1.61e-01	-1.39e-01	-1.72e-01	-2.66e-02	5.93e-01	4.29e-01	4.95e-01	4.01e-01	8.96e-01
FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE	12	6.19e-01	9.42e-01	0.2960	-7.31e-02	-2.48e-01	7.61e-02	4.70e-02	1.13e-01	6.61e-01	1.37e-01	6.48e-01	7.78e-01	4.98e-01
NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	11	5.94e-01	9.33e-01	0.2960	-7.72e-02	-2.50e-01	7.21e-02	3.13e-02	1.14e-01	6.57e-01	1.52e-01	6.79e-01	8.57e-01	5.13e-01
AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS	8	5.32e-01	9.08e-01	0.2960	3.74e-02	1.72e-01	1.20e-01	1.37e-01	1.52e-01	8.55e-01	3.98e-01	5.55e-01	5.03e-01	4.56e-01
INTRACELLULAR WATER HOMEOSTASIS	6	8.56e-01	9.88e-01	0.2960	5.98e-02	5.44e-02	2.11e-01	1.87e-01	3.96e-02	8.00e-01	8.18e-01	3.71e-01	4.28e-01	8.66e-01
HISTONE UBIQUITINATION	8	6.63e-01	9.54e-01	0.2960	-1.29e-01	-1.59e-01	-8.56e-02	-1.39e-01	1.37e-01	5.26e-01	4.35e-01	6.75e-01	4.96e-01	5.04e-01
CELLULAR RESPONSE TO HISTAMINE	7	6.80e-01	9.61e-01	0.2960	-5.17e-02	-1.26e-01	-8.66e-02	-6.60e-02	2.38e-01	8.13e-01	5.63e-01	6.92e-01	7.63e-01	2.75e-01
REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	6	8.77e-01	9.88e-01	0.2960	-1.65e-01	-1.65e-01	9.47e-03	-1.42e-02	1.80e-01	4.83e-01	4.84e-01	9.68e-01	9.52e-01	4.44e-01
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION	17	4.92e-01	8.94e-01	0.2950	-5.41e-02	7.70e-02	-2.05e-01	-1.79e-01	-6.64e-02	6.99e-01	5.83e-01	1.43e-01	2.03e-01	6.36e-01
INTRACELLULAR ZINC ION HOMEOSTASIS	36	3.14e-01	7.86e-01	0.2950	1.07e-01	-5.84e-02	1.61e-01	1.60e-01	1.44e-01	2.67e-01	5.45e-01	9.43e-02	9.57e-02	1.35e-01
CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR	11	7.08e-01	9.65e-01	0.2950	-1.99e-01	-1.82e-01	-2.86e-02	-4.84e-02	1.07e-01	2.54e-01	2.96e-01	8.69e-01	7.81e-01	5.39e-01
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION	50	3.35e-03	6.01e-02	0.2950	6.76e-02	1.66e-02	2.03e-01	1.90e-01	-7.11e-02	4.08e-01	8.39e-01	1.31e-02	2.00e-02	3.84e-01
B CELL CHEMOTAXIS	7	9.11e-01	9.94e-01	0.2950	-1.29e-01	-1.44e-01	-9.13e-02	-1.07e-01	1.74e-01	5.56e-01	5.09e-01	6.76e-01	6.25e-01	4.26e-01
INTERFERON BETA PRODUCTION	56	1.92e-01	6.67e-01	0.2950	1.16e-01	-2.23e-02	1.61e-01	1.55e-01	1.52e-01	1.32e-01	7.73e-01	3.72e-02	4.50e-02	4.91e-02
CHROMOSOME CONDENSATION	46	1.41e-01	5.97e-01	0.2950	2.02e-01	9.97e-02	1.23e-01	1.45e-01	1.48e-02	1.79e-02	2.42e-01	1.49e-01	8.96e-02	8.62e-01
REGULATION OF MICROTUBULE BASED MOVEMENT	50	2.99e-01	7.73e-01	0.2950	1.92e-01	1.35e-01	1.22e-01	1.29e-01	9.31e-03	1.90e-02	9.74e-02	1.34e-01	1.14e-01	9.09e-01
GERMINAL CENTER B CELL DIFFERENTIATION	9	4.56e-01	8.78e-01	0.2950	5.69e-03	1.58e-01	5.22e-02	6.29e-02	-2.34e-01	9.76e-01	4.10e-01	7.86e-01	7.44e-01	2.23e-01
RETINAL CONE CELL DIFFERENTIATION	13	4.58e-01	8.79e-01	0.2950	9.67e-02	2.76e-01	-3.12e-02	2.20e-03	-2.10e-02	5.46e-01	8.53e-02	8.46e-01	9.89e-01	8.96e-01
POSITIVE REGULATION OF CHROMOSOME SEGREGATION	27	8.08e-02	4.55e-01	0.2940	3.33e-02	-1.03e-01	1.90e-01	1.96e-01	1.34e-02	7.64e-01	3.53e-01	8.69e-02	7.75e-02	9.04e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	5	7.72e-01	9.77e-01	0.2940	-1.38e-01	3.28e-02	-5.52e-02	-5.22e-02	-2.46e-01	5.93e-01	8.99e-01	8.31e-01	8.40e-01	3.40e-01
PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	7	8.59e-01	9.88e-01	0.2940	-1.35e-01	-2.03e-01	-4.27e-02	-5.51e-02	-1.50e-01	5.36e-01	3.53e-01	8.45e-01	8.01e-01	4.92e-01
DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	28	1.30e-01	5.74e-01	0.2940	-2.11e-01	-1.93e-01	-2.91e-02	-6.11e-02	4.58e-03	5.29e-02	7.76e-02	7.90e-01	5.76e-01	9.67e-01
GENOMIC IMPRINTING	18	6.34e-01	9.48e-01	0.2940	1.43e-01	2.19e-01	5.79e-02	5.68e-02	-1.07e-01	2.93e-01	1.08e-01	6.71e-01	6.76e-01	4.32e-01
RESPONSE TO REDOX STATE	14	2.67e-01	7.48e-01	0.2930	1.26e-01	2.35e-01	7.70e-02	3.94e-02	-8.64e-02	4.15e-01	1.27e-01	6.18e-01	7.99e-01	5.76e-01
ACTIVATION OF PROTEIN KINASE B ACTIVITY	25	4.88e-01	8.92e-01	0.2930	8.71e-02	-3.18e-02	1.23e-01	1.12e-01	2.23e-01	4.51e-01	7.83e-01	2.87e-01	3.33e-01	5.33e-02
POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION	5	5.10e-01	9.00e-01	0.2930	-1.40e-02	-1.27e-01	-1.68e-01	-2.04e-01	-1.01e-02	9.57e-01	6.23e-01	5.15e-01	4.31e-01	9.69e-01
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	8	3.78e-01	8.36e-01	0.2930	7.32e-02	7.53e-02	1.14e-01	4.85e-02	2.44e-01	7.20e-01	7.12e-01	5.77e-01	8.12e-01	2.32e-01
LIPID EXPORT FROM CELL	47	1.58e-01	6.20e-01	0.2930	-9.77e-02	-1.03e-01	-1.78e-01	-1.65e-01	-8.45e-02	2.46e-01	2.22e-01	3.52e-02	5.04e-02	3.16e-01
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	68	6.99e-02	4.23e-01	0.2930	1.20e-01	2.26e-04	1.86e-01	1.64e-01	9.97e-02	8.82e-02	9.97e-01	7.84e-03	1.91e-02	1.55e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM	7	7.55e-01	9.75e-01	0.2930	9.63e-02	2.64e-01	-7.03e-02	-3.28e-02	-2.67e-02	6.59e-01	2.26e-01	7.47e-01	8.81e-01	9.03e-01
CELLULAR RESPONSE TO ANTIBIOTIC	11	7.76e-01	9.78e-01	0.2930	1.45e-01	3.80e-02	1.61e-01	1.78e-01	-7.59e-02	4.07e-01	8.27e-01	3.54e-01	3.07e-01	6.63e-01
CAMKK AMPK SIGNALING CASCADE	9	6.75e-01	9.59e-01	0.2930	-1.42e-01	-2.53e-01	-3.56e-02	-1.72e-02	-1.56e-02	4.62e-01	1.89e-01	8.53e-01	9.29e-01	9.35e-01
ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	66	5.24e-02	3.59e-01	0.2930	1.28e-01	8.27e-03	1.93e-01	1.74e-01	3.99e-02	7.13e-02	9.07e-01	6.66e-03	1.44e-02	5.76e-01
REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS	19	2.99e-01	7.73e-01	0.2930	1.19e-01	-8.81e-02	1.73e-01	1.41e-01	1.18e-01	3.69e-01	5.06e-01	1.91e-01	2.87e-01	3.74e-01
REGULATION OF CAMP MEDIATED SIGNALING	29	6.34e-01	9.48e-01	0.2930	-1.47e-01	-1.42e-01	-1.51e-01	-1.44e-01	6.86e-03	1.69e-01	1.85e-01	1.60e-01	1.79e-01	9.49e-01
REGULATION OF RESPONSE TO OSMOTIC STRESS	16	7.24e-01	9.70e-01	0.2930	1.95e-01	8.19e-02	1.31e-01	1.52e-01	2.28e-02	1.76e-01	5.71e-01	3.65e-01	2.93e-01	8.74e-01
PEPTIDYL L CYSTEINE S PALMITOYLATION	20	5.79e-01	9.27e-01	0.2920	-1.40e-01	-1.87e-01	-1.13e-01	-9.95e-02	-9.17e-02	2.80e-01	1.48e-01	3.81e-01	4.41e-01	4.78e-01
FAT SOLUBLE VITAMIN METABOLIC PROCESS	45	3.99e-01	8.45e-01	0.2920	1.21e-01	5.15e-02	1.36e-01	1.40e-01	1.74e-01	1.61e-01	5.50e-01	1.13e-01	1.05e-01	4.37e-02
CELL MIGRATION INVOLVED IN GASTRULATION	13	4.91e-01	8.93e-01	0.2920	9.85e-02	3.56e-02	6.15e-02	4.56e-02	2.62e-01	5.39e-01	8.24e-01	7.01e-01	7.76e-01	1.02e-01
RESPONSE TO NITRIC OXIDE	19	8.67e-01	9.88e-01	0.2920	1.14e-01	5.13e-02	1.54e-01	1.50e-01	1.53e-01	3.88e-01	6.99e-01	2.47e-01	2.57e-01	2.47e-01
RESPONSE TO LEUCINE	15	1.89e-01	6.61e-01	0.2920	1.77e-01	3.18e-02	1.46e-01	1.16e-01	-1.35e-01	2.35e-01	8.31e-01	3.27e-01	4.36e-01	3.66e-01
POSITIVE REGULATION OF CELL MATURATION	7	6.84e-01	9.61e-01	0.2920	1.15e-01	-1.75e-02	1.32e-01	1.21e-01	-1.99e-01	5.98e-01	9.36e-01	5.46e-01	5.79e-01	3.61e-01
POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	10	2.56e-01	7.39e-01	0.2920	7.38e-02	-1.53e-01	1.69e-01	1.03e-01	1.32e-01	6.86e-01	4.03e-01	3.54e-01	5.74e-01	4.70e-01
POSITIVE REGULATION OF DNA REPLICATION	37	4.43e-01	8.72e-01	0.2920	1.07e-01	2.41e-02	1.76e-01	1.85e-01	8.92e-02	2.59e-01	8.00e-01	6.35e-02	5.16e-02	3.48e-01
HYPOTHALAMUS CELL MIGRATION	6	5.72e-01	9.26e-01	0.2920	-7.00e-02	-5.40e-02	-1.08e-01	-1.59e-01	2.02e-01	7.67e-01	8.19e-01	6.48e-01	5.01e-01	3.92e-01
CELLULAR HYPOTONIC RESPONSE	11	7.55e-01	9.75e-01	0.2920	-1.09e-01	-8.20e-02	-1.97e-01	-1.66e-01	-1.95e-02	5.32e-01	6.38e-01	2.59e-01	3.39e-01	9.11e-01
PRENYLATION	11	4.83e-01	8.91e-01	0.2920	-2.25e-01	-1.80e-01	-1.49e-02	-4.26e-02	-2.61e-04	1.96e-01	3.01e-01	9.32e-01	8.07e-01	9.99e-01
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	36	6.10e-01	9.36e-01	0.2920	-1.45e-01	-1.44e-01	-1.44e-01	-1.50e-01	-1.36e-02	1.32e-01	1.34e-01	1.36e-01	1.18e-01	8.88e-01
MATING BEHAVIOR	36	2.52e-01	7.37e-01	0.2920	-1.64e-01	-2.05e-01	-7.18e-02	-1.04e-01	-2.24e-02	8.85e-02	3.36e-02	4.56e-01	2.80e-01	8.16e-01
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY	55	3.19e-01	7.91e-01	0.2920	-1.70e-01	-1.77e-01	-1.05e-01	-1.17e-01	1.22e-02	2.92e-02	2.28e-02	1.78e-01	1.34e-01	8.76e-01
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS	7	9.46e-01	9.97e-01	0.2920	-1.41e-01	-1.81e-01	-1.15e-01	-1.09e-01	8.56e-02	5.18e-01	4.08e-01	5.98e-01	6.16e-01	6.95e-01
REGULATION OF RNA BINDING	7	9.53e-01	9.97e-01	0.2920	1.34e-01	7.02e-02	1.58e-01	1.83e-01	6.02e-02	5.39e-01	7.48e-01	4.70e-01	4.01e-01	7.83e-01
RENAL SYSTEM PROCESS	117	6.90e-03	1.01e-01	0.2920	1.51e-01	2.07e-01	8.35e-02	9.86e-02	-5.11e-02	4.67e-03	1.10e-04	1.19e-01	6.54e-02	3.40e-01
REGULATION OF GRANULOCYTE DIFFERENTIATION	16	7.51e-01	9.75e-01	0.2920	-5.95e-02	6.60e-02	-1.27e-01	-1.26e-01	-2.12e-01	6.80e-01	6.48e-01	3.79e-01	3.82e-01	1.41e-01
PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS	16	5.18e-01	9.03e-01	0.2910	-1.18e-01	1.29e-02	-2.03e-01	-1.70e-01	-2.65e-02	4.13e-01	9.29e-01	1.59e-01	2.40e-01	8.54e-01
REGULATION OF NADP METABOLIC PROCESS	9	7.74e-01	9.77e-01	0.2910	9.06e-02	2.01e-02	1.02e-01	7.46e-02	2.46e-01	6.38e-01	9.17e-01	5.96e-01	6.98e-01	2.02e-01
POSITIVE REGULATION OF ISOTYPE SWITCHING	28	4.41e-01	8.71e-01	0.2910	1.02e-01	-6.34e-02	1.75e-01	1.74e-01	9.81e-02	3.49e-01	5.62e-01	1.10e-01	1.12e-01	3.69e-01
COBALAMIN METABOLIC PROCESS	9	4.87e-01	8.92e-01	0.2910	-1.44e-01	-1.73e-01	1.06e-02	-3.05e-02	-1.82e-01	4.54e-01	3.70e-01	9.56e-01	8.74e-01	3.44e-01
CELLULAR RESPONSE TO LEUCINE STARVATION	12	3.32e-01	8.04e-01	0.2910	8.97e-02	7.60e-02	1.30e-01	9.68e-02	-2.11e-01	5.91e-01	6.49e-01	4.35e-01	5.62e-01	2.05e-01
MANNOSYLATION	23	4.60e-01	8.80e-01	0.2910	-1.78e-01	-2.20e-01	-4.35e-02	-4.87e-02	1.84e-02	1.40e-01	6.74e-02	7.18e-01	6.86e-01	8.78e-01
APOPTOTIC PROCESS IN BONE MARROW CELL	6	6.86e-01	9.61e-01	0.2910	-1.97e-01	-1.92e-01	-2.35e-02	-9.23e-02	1.95e-04	4.04e-01	4.15e-01	9.20e-01	6.95e-01	9.99e-01
RESPONSE TO LEPTIN	21	6.99e-01	9.62e-01	0.2910	1.48e-01	8.84e-03	1.67e-01	1.55e-01	1.05e-01	2.42e-01	9.44e-01	1.85e-01	2.19e-01	4.04e-01
REGULATION OF PANCREATIC JUICE SECRETION	7	9.63e-01	9.97e-01	0.2910	-1.57e-01	-1.88e-01	-8.71e-02	-1.09e-01	7.42e-02	4.73e-01	3.90e-01	6.90e-01	6.18e-01	7.34e-01
MACROPHAGE DIFFERENTIATION	61	1.14e-01	5.39e-01	0.2910	-1.47e-01	-1.83e-01	-1.19e-01	-1.14e-01	4.89e-02	4.67e-02	1.33e-02	1.09e-01	1.25e-01	5.09e-01
NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	14	3.90e-01	8.40e-01	0.2910	4.32e-02	-1.71e-01	1.13e-01	7.78e-02	1.86e-01	7.80e-01	2.69e-01	4.63e-01	6.14e-01	2.27e-01
POSITIVE REGULATION OF CELL SIZE	10	4.28e-01	8.65e-01	0.2910	-1.24e-01	-2.92e-02	-3.22e-02	-6.84e-02	-2.50e-01	4.97e-01	8.73e-01	8.60e-01	7.08e-01	1.71e-01
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	13	8.05e-01	9.82e-01	0.2910	6.21e-02	-8.26e-02	1.80e-01	1.71e-01	1.11e-01	6.98e-01	6.06e-01	2.61e-01	2.86e-01	4.89e-01
MESANGIAL CELL DEVELOPMENT	6	5.35e-01	9.10e-01	0.2910	1.43e-01	-1.65e-01	1.05e-01	1.00e-01	1.25e-01	5.45e-01	4.84e-01	6.55e-01	6.70e-01	5.96e-01
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	14	5.05e-01	8.99e-01	0.2910	-7.32e-02	2.11e-02	-1.23e-01	-8.33e-02	-2.38e-01	6.35e-01	8.91e-01	4.25e-01	5.90e-01	1.23e-01
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	11	2.95e-01	7.71e-01	0.2910	-7.23e-03	-2.49e-01	-1.78e-02	-1.12e-02	1.48e-01	9.67e-01	1.53e-01	9.18e-01	9.49e-01	3.94e-01
OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS	20	4.45e-01	8.73e-01	0.2900	1.21e-01	-4.02e-02	1.88e-01	1.80e-01	-1.53e-02	3.48e-01	7.56e-01	1.46e-01	1.63e-01	9.05e-01
POST CHAPERONIN TUBULIN FOLDING PATHWAY	6	9.48e-01	9.97e-01	0.2900	-1.17e-01	6.85e-02	-1.58e-01	-1.53e-01	-1.32e-01	6.19e-01	7.71e-01	5.02e-01	5.16e-01	5.75e-01
HEPARIN METABOLIC PROCESS	17	7.95e-01	9.81e-01	0.2900	-1.60e-01	-2.32e-02	-1.50e-01	-1.55e-01	-1.07e-01	2.52e-01	8.69e-01	2.83e-01	2.69e-01	4.45e-01
CERAMIDE CATABOLIC PROCESS	20	8.60e-01	9.88e-01	0.2900	-1.29e-01	-9.38e-02	-1.66e-01	-1.58e-01	-7.96e-02	3.19e-01	4.68e-01	1.99e-01	2.21e-01	5.38e-01
POSITIVE REGULATION OF CILIUM MOVEMENT	11	7.50e-01	9.75e-01	0.2900	1.38e-01	1.26e-01	1.01e-01	1.38e-01	1.42e-01	4.28e-01	4.71e-01	5.63e-01	4.29e-01	4.14e-01
AZOLE TRANSMEMBRANE TRANSPORT	13	6.23e-01	9.43e-01	0.2900	1.33e-01	2.51e-01	1.81e-02	5.42e-02	-1.39e-02	4.06e-01	1.17e-01	9.10e-01	7.35e-01	9.31e-01
REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY	6	9.56e-01	9.97e-01	0.2900	-1.19e-01	-1.86e-01	-1.07e-01	-1.11e-01	-1.08e-01	6.15e-01	4.30e-01	6.51e-01	6.38e-01	6.46e-01
REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY	14	4.80e-01	8.91e-01	0.2900	2.24e-02	-1.71e-01	6.02e-02	5.99e-02	2.17e-01	8.85e-01	2.68e-01	6.97e-01	6.98e-01	1.60e-01
VITAMIN TRANSMEMBRANE TRANSPORT	21	5.80e-01	9.28e-01	0.2900	-7.23e-02	-6.44e-02	-1.65e-01	-1.47e-01	-1.60e-01	5.66e-01	6.10e-01	1.90e-01	2.44e-01	2.03e-01
POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY	66	1.62e-01	6.27e-01	0.2900	1.13e-01	6.60e-02	1.31e-01	1.30e-01	1.81e-01	1.13e-01	3.54e-01	6.51e-02	6.83e-02	1.10e-02
REGULATION OF COA TRANSFERASE ACTIVITY	10	3.79e-01	8.36e-01	0.2900	1.03e-01	8.63e-02	1.45e-01	2.04e-01	5.78e-02	5.72e-01	6.36e-01	4.27e-01	2.65e-01	7.52e-01
CRANIAL NERVE MORPHOGENESIS	29	5.01e-01	8.98e-01	0.2900	1.79e-01	1.04e-01	1.27e-01	1.20e-01	1.01e-01	9.47e-02	3.32e-01	2.36e-01	2.62e-01	3.45e-01
CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	52	6.29e-03	9.54e-02	0.2900	1.04e-01	2.53e-01	4.85e-02	7.43e-02	3.28e-02	1.93e-01	1.59e-03	5.45e-01	3.54e-01	6.82e-01
AUTOPHAGOSOME MATURATION	60	4.02e-02	3.07e-01	0.2890	9.93e-02	-1.33e-02	1.94e-01	1.89e-01	5.80e-03	1.83e-01	8.58e-01	9.21e-03	1.11e-02	9.38e-01
REVERSIBLE DIFFERENTIATION	11	7.01e-01	9.63e-01	0.2890	-6.68e-02	-1.92e-02	-2.09e-01	-1.77e-01	-6.26e-02	7.01e-01	9.12e-01	2.30e-01	3.10e-01	7.19e-01
REGULATION OF FERTILIZATION	17	2.18e-02	2.14e-01	0.2890	-7.23e-03	2.50e-01	3.04e-02	3.27e-02	1.38e-01	9.59e-01	7.38e-02	8.28e-01	8.15e-01	3.26e-01
REGULATION OF DENDRITIC CELL CHEMOTAXIS	11	4.05e-02	3.07e-01	0.2890	1.08e-01	4.50e-02	-1.96e-01	-1.77e-01	1.99e-02	5.36e-01	7.96e-01	2.60e-01	3.10e-01	9.09e-01
REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS	5	8.66e-01	9.88e-01	0.2890	-1.49e-01	-2.31e-01	6.72e-02	2.65e-02	5.14e-02	5.63e-01	3.70e-01	7.95e-01	9.18e-01	8.42e-01
RESPONSE TO INTERFERON BETA	33	2.60e-01	7.43e-01	0.2890	1.61e-01	1.81e-01	1.20e-01	1.00e-01	-2.00e-02	1.09e-01	7.16e-02	2.34e-01	3.19e-01	8.43e-01
POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	8	9.41e-01	9.97e-01	0.2890	6.74e-02	1.53e-02	1.65e-01	1.45e-01	1.75e-01	7.41e-01	9.40e-01	4.18e-01	4.78e-01	3.92e-01
LYMPHOCYTE COSTIMULATION	46	5.43e-02	3.66e-01	0.2890	1.12e-01	2.54e-01	3.84e-02	4.51e-02	-5.36e-02	1.90e-01	2.84e-03	6.52e-01	5.97e-01	5.30e-01
POSITIVE REGULATION OF HISTONE METHYLATION	14	8.65e-01	9.88e-01	0.2890	-1.13e-01	-1.14e-01	-1.68e-01	-1.67e-01	-4.43e-02	4.65e-01	4.61e-01	2.78e-01	2.80e-01	7.74e-01
NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	13	5.90e-01	9.30e-01	0.2890	-5.00e-02	-4.53e-02	-5.93e-02	-7.08e-02	-2.65e-01	7.55e-01	7.78e-01	7.11e-01	6.59e-01	9.77e-02
NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	5	7.52e-01	9.75e-01	0.2890	4.49e-03	-4.36e-02	6.29e-02	1.07e-01	2.57e-01	9.86e-01	8.66e-01	8.07e-01	6.78e-01	3.20e-01
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	72	2.21e-01	7.01e-01	0.2890	1.18e-01	1.66e-02	1.66e-01	1.66e-01	1.19e-01	8.38e-02	8.08e-01	1.49e-02	1.50e-02	8.13e-02
DECIDUALIZATION	24	4.75e-01	8.86e-01	0.2890	1.94e-01	6.84e-02	1.38e-01	1.46e-01	-2.12e-02	1.00e-01	5.62e-01	2.41e-01	2.14e-01	8.57e-01
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	34	2.73e-01	7.55e-01	0.2880	4.86e-02	-8.77e-02	1.81e-01	1.67e-01	1.11e-01	6.24e-01	3.76e-01	6.77e-02	9.18e-02	2.62e-01
SYNAPTIC TRANSMISSION DOPAMINERGIC	28	4.60e-01	8.80e-01	0.2880	8.69e-02	-2.84e-02	1.41e-01	1.21e-01	2.00e-01	4.26e-01	7.95e-01	1.95e-01	2.70e-01	6.66e-02
RRNA TRANSCRIPTION	37	4.56e-01	8.78e-01	0.2880	1.36e-01	2.61e-02	1.80e-01	1.76e-01	2.49e-02	1.54e-01	7.84e-01	5.86e-02	6.41e-02	7.93e-01
HISTIDINE METABOLIC PROCESS	10	7.71e-01	9.76e-01	0.2880	6.97e-02	1.12e-01	-7.72e-02	-6.48e-02	-2.35e-01	7.03e-01	5.39e-01	6.73e-01	7.23e-01	1.98e-01
REGULATION OF T HELPER 17 CELL DIFFERENTIATION	21	7.86e-01	9.81e-01	0.2880	1.04e-01	4.72e-02	1.45e-01	1.54e-01	1.58e-01	4.09e-01	7.08e-01	2.49e-01	2.23e-01	2.10e-01
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	9	7.85e-02	4.51e-01	0.2880	-9.04e-02	-2.48e-02	-2.07e-01	-1.20e-01	1.30e-01	6.39e-01	8.97e-01	2.83e-01	5.33e-01	4.99e-01
G PROTEIN COUPLED RECEPTOR INTERNALIZATION	10	5.78e-01	9.27e-01	0.2880	2.21e-01	1.10e-01	7.96e-02	7.82e-02	9.64e-02	2.26e-01	5.47e-01	6.63e-01	6.68e-01	5.97e-01
NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	57	2.39e-02	2.29e-01	0.2880	8.66e-02	1.46e-01	1.22e-01	1.33e-01	1.46e-01	2.58e-01	5.67e-02	1.12e-01	8.23e-02	5.59e-02
INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX	7	7.99e-01	9.81e-01	0.2870	1.42e-02	-1.98e-01	1.17e-01	1.26e-01	1.17e-01	9.48e-01	3.65e-01	5.93e-01	5.63e-01	5.91e-01
PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE	8	3.71e-01	8.31e-01	0.2870	-4.01e-02	-2.76e-01	-5.42e-02	-2.27e-02	3.91e-02	8.44e-01	1.77e-01	7.91e-01	9.12e-01	8.48e-01
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER	54	3.00e-01	7.73e-01	0.2870	-1.17e-01	-1.44e-03	-1.75e-01	-1.75e-01	-8.61e-02	1.38e-01	9.85e-01	2.57e-02	2.60e-02	2.74e-01
RNA TEMPLATED DNA BIOSYNTHETIC PROCESS	68	8.54e-02	4.67e-01	0.2870	1.17e-01	-6.71e-03	1.87e-01	1.72e-01	6.45e-02	9.39e-02	9.24e-01	7.67e-03	1.42e-02	3.58e-01
REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	13	8.92e-01	9.92e-01	0.2870	1.57e-01	1.11e-01	1.20e-01	1.43e-01	1.02e-01	3.26e-01	4.88e-01	4.54e-01	3.72e-01	5.26e-01
POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	15	5.69e-01	9.25e-01	0.2870	-1.83e-01	-9.05e-03	-1.57e-01	-1.54e-01	1.22e-02	2.20e-01	9.52e-01	2.92e-01	3.01e-01	9.35e-01
CHONDROITIN SULFATE METABOLIC PROCESS	26	1.89e-01	6.61e-01	0.2870	-1.42e-01	-1.89e-01	-8.60e-02	-1.33e-01	3.03e-02	2.09e-01	9.46e-02	4.48e-01	2.39e-01	7.89e-01
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	32	6.49e-01	9.51e-01	0.2870	-1.48e-01	-1.66e-01	-1.28e-01	-1.27e-01	-1.86e-02	1.48e-01	1.05e-01	2.10e-01	2.13e-01	8.55e-01
REGULATION OF PLASMA CELL DIFFERENTIATION	5	7.91e-01	9.81e-01	0.2870	-5.29e-02	-1.93e-01	-6.57e-02	-9.31e-02	-1.70e-01	8.38e-01	4.54e-01	7.99e-01	7.18e-01	5.10e-01
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	57	2.65e-01	7.47e-01	0.2860	1.08e-01	6.05e-02	1.58e-01	1.43e-01	1.46e-01	1.59e-01	4.29e-01	3.91e-02	6.11e-02	5.70e-02
CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	77	4.50e-03	7.54e-02	0.2860	-1.37e-01	-4.50e-03	-1.90e-01	-1.64e-01	-1.75e-02	3.76e-02	9.46e-01	3.93e-03	1.30e-02	7.90e-01
NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	35	3.84e-01	8.39e-01	0.2860	4.79e-02	-7.18e-02	1.62e-01	1.51e-01	1.59e-01	6.24e-01	4.62e-01	9.69e-02	1.22e-01	1.03e-01
PENTOSE METABOLIC PROCESS	11	3.03e-01	7.75e-01	0.2860	1.21e-02	-1.71e-01	1.14e-01	5.02e-02	1.92e-01	9.45e-01	3.25e-01	5.12e-01	7.73e-01	2.70e-01
PARANODAL JUNCTION ASSEMBLY	6	7.87e-01	9.81e-01	0.2860	-8.62e-02	-1.14e-01	1.30e-01	8.62e-02	1.93e-01	7.15e-01	6.28e-01	5.82e-01	7.15e-01	4.13e-01
PRONEPHROS DEVELOPMENT	9	8.05e-01	9.82e-01	0.2860	-1.65e-01	-2.01e-01	-5.75e-02	-1.04e-01	1.56e-02	3.91e-01	2.97e-01	7.65e-01	5.89e-01	9.35e-01
DUMP CATABOLIC PROCESS	6	9.73e-01	9.97e-01	0.2860	-1.06e-01	-9.08e-02	-1.75e-01	-1.75e-01	-3.36e-02	6.52e-01	7.00e-01	4.57e-01	4.59e-01	8.87e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	35	3.71e-01	8.31e-01	0.2860	-1.46e-01	-7.66e-02	-1.75e-01	-1.54e-01	-2.00e-02	1.35e-01	4.33e-01	7.30e-02	1.16e-01	8.37e-01
NEGATIVE REGULATION OF VASOCONSTRICTION	8	9.82e-01	9.97e-01	0.2860	-1.49e-01	-5.54e-02	-1.60e-01	-1.61e-01	-7.09e-02	4.65e-01	7.86e-01	4.32e-01	4.32e-01	7.29e-01
GLUCOCORTICOID BIOSYNTHETIC PROCESS	16	1.30e-01	5.74e-01	0.2860	-1.98e-01	1.47e-02	-1.18e-01	-1.21e-01	1.18e-01	1.71e-01	9.19e-01	4.14e-01	4.01e-01	4.14e-01
SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY	15	6.29e-01	9.46e-01	0.2860	-9.34e-02	-2.42e-01	6.59e-04	-9.38e-03	1.19e-01	5.31e-01	1.04e-01	9.96e-01	9.50e-01	4.23e-01
POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION	12	5.69e-01	9.25e-01	0.2860	1.43e-01	2.39e-01	-4.40e-02	-3.59e-02	-3.37e-02	3.91e-01	1.52e-01	7.92e-01	8.30e-01	8.40e-01
NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I	21	7.88e-01	9.81e-01	0.2860	1.57e-01	1.52e-01	1.23e-01	1.25e-01	-5.62e-02	2.13e-01	2.26e-01	3.30e-01	3.22e-01	6.56e-01
AMYGDALA DEVELOPMENT	5	6.43e-01	9.50e-01	0.2860	3.14e-02	-1.66e-01	8.83e-02	5.98e-02	-2.04e-01	9.03e-01	5.20e-01	7.32e-01	8.17e-01	4.29e-01
POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION	74	5.95e-03	9.21e-02	0.2860	-1.65e-01	-8.01e-03	-1.59e-01	-1.69e-01	2.57e-02	1.41e-02	9.05e-01	1.83e-02	1.20e-02	7.02e-01
CELLULAR RESPONSE TO ELECTRICAL STIMULUS	13	8.35e-01	9.85e-01	0.2850	-1.13e-01	-1.27e-01	-1.61e-01	-1.42e-01	-8.08e-02	4.81e-01	4.27e-01	3.16e-01	3.75e-01	6.14e-01
TELOMERE CAPPING	39	1.77e-01	6.47e-01	0.2850	-1.06e-02	-1.48e-01	1.22e-01	1.03e-01	1.85e-01	9.09e-01	1.10e-01	1.88e-01	2.68e-01	4.60e-02
POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING	9	9.13e-01	9.94e-01	0.2850	-1.84e-01	-1.85e-01	-6.67e-02	-9.19e-02	-1.85e-02	3.39e-01	3.36e-01	7.29e-01	6.33e-01	9.24e-01
CELLULAR RESPONSE TO CADMIUM ION	35	3.15e-01	7.87e-01	0.2850	1.12e-01	1.37e-02	1.92e-01	1.78e-01	1.03e-02	2.53e-01	8.88e-01	4.89e-02	6.87e-02	9.16e-01
IODIDE TRANSPORT	9	7.60e-01	9.75e-01	0.2850	2.06e-02	5.61e-02	1.15e-01	1.16e-01	2.26e-01	9.15e-01	7.71e-01	5.51e-01	5.47e-01	2.40e-01
OSTEOBLAST DEVELOPMENT	17	5.11e-01	9.00e-01	0.2850	1.97e-01	5.13e-02	1.13e-01	1.27e-01	1.04e-01	1.60e-01	7.14e-01	4.18e-01	3.63e-01	4.57e-01
N ACETYLGLUCOSAMINE METABOLIC PROCESS	16	7.29e-01	9.71e-01	0.2850	1.10e-01	1.72e-01	1.33e-01	1.28e-01	7.70e-02	4.48e-01	2.35e-01	3.58e-01	3.77e-01	5.94e-01
REGULATION OF GASTRIC ACID SECRETION	6	5.91e-01	9.31e-01	0.2850	-2.31e-01	-7.32e-02	-6.67e-02	-1.24e-01	-5.28e-02	3.28e-01	7.56e-01	7.77e-01	5.99e-01	8.23e-01
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	29	4.38e-01	8.69e-01	0.2850	-1.56e-01	-8.79e-02	-1.67e-01	-1.43e-01	-3.05e-02	1.46e-01	4.13e-01	1.20e-01	1.83e-01	7.76e-01
ACROSOMAL VESICLE EXOCYTOSIS	9	8.76e-01	9.88e-01	0.2850	1.20e-02	-4.13e-02	9.44e-02	8.86e-02	2.50e-01	9.50e-01	8.30e-01	6.24e-01	6.45e-01	1.94e-01
ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT	11	8.20e-01	9.83e-01	0.2850	3.79e-02	1.59e-02	1.20e-01	1.03e-01	2.34e-01	8.28e-01	9.27e-01	4.92e-01	5.54e-01	1.80e-01
MITOTIC METAPHASE CHROMOSOME ALIGNMENT	58	1.70e-02	1.82e-01	0.2850	1.22e-01	-3.15e-02	1.75e-01	1.85e-01	-2.03e-02	1.08e-01	6.78e-01	2.12e-02	1.48e-02	7.89e-01
NEGATIVE REGULATION OF CELLULAR EXTRAVASATION	9	8.74e-01	9.88e-01	0.2850	5.36e-02	2.99e-05	9.73e-02	8.22e-02	2.49e-01	7.81e-01	1.00e+00	6.13e-01	6.69e-01	1.96e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	43	1.85e-01	6.56e-01	0.2850	-1.38e-01	-2.08e-01	-8.83e-02	-8.20e-02	6.42e-02	1.17e-01	1.81e-02	3.16e-01	3.52e-01	4.67e-01
MYELOID PROGENITOR CELL DIFFERENTIATION	9	4.52e-01	8.76e-01	0.2850	-4.28e-02	-2.04e-01	-1.14e-01	-1.26e-01	9.37e-02	8.24e-01	2.88e-01	5.55e-01	5.14e-01	6.27e-01
LATE ENDOSOME TO LYSOSOME TRANSPORT	21	2.83e-02	2.52e-01	0.2850	2.29e-02	-1.58e-01	8.15e-02	9.50e-02	-2.00e-01	8.56e-01	2.10e-01	5.18e-01	4.51e-01	1.13e-01
MACROPHAGE CYTOKINE PRODUCTION	36	1.92e-01	6.66e-01	0.2850	-1.35e-01	-1.26e-01	-9.88e-02	-1.21e-01	1.51e-01	1.62e-01	1.90e-01	3.05e-01	2.11e-01	1.18e-01
REGULATION OF PROTEIN POLYUBIQUITINATION	26	7.68e-01	9.75e-01	0.2850	1.61e-01	6.37e-02	1.49e-01	1.57e-01	6.37e-02	1.56e-01	5.74e-01	1.87e-01	1.65e-01	5.74e-01
REGULATION OF MESODERM DEVELOPMENT	6	6.94e-01	9.61e-01	0.2850	-1.88e-02	8.70e-02	3.51e-02	6.78e-03	2.68e-01	9.37e-01	7.12e-01	8.82e-01	9.77e-01	2.56e-01
OLIGODENDROCYTE PROGENITOR PROLIFERATION	8	8.18e-01	9.83e-01	0.2850	-1.46e-01	-1.41e-01	-6.07e-02	-9.40e-02	-1.65e-01	4.74e-01	4.91e-01	7.66e-01	6.45e-01	4.18e-01
NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL	5	6.77e-01	9.59e-01	0.2850	-2.08e-01	-9.31e-02	-9.82e-02	-5.83e-02	-1.26e-01	4.20e-01	7.18e-01	7.04e-01	8.21e-01	6.26e-01
POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT	5	9.61e-01	9.97e-01	0.2840	-6.30e-02	5.30e-02	-1.96e-01	-1.74e-01	-7.26e-02	8.07e-01	8.37e-01	4.48e-01	5.00e-01	7.79e-01
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING	7	7.35e-01	9.73e-01	0.2840	1.76e-01	1.69e-01	-4.37e-02	-6.71e-03	-1.38e-01	4.19e-01	4.38e-01	8.41e-01	9.75e-01	5.28e-01
PROTEIN LOCALIZATION TO PRESYNAPSE	11	6.36e-01	9.48e-01	0.2840	-1.49e-02	-6.18e-02	6.62e-02	8.41e-02	2.55e-01	9.32e-01	7.23e-01	7.04e-01	6.29e-01	1.43e-01
SUBSTRATE DEPENDENT CELL MIGRATION	25	6.04e-01	9.34e-01	0.2840	-1.47e-01	-1.59e-01	-9.82e-02	-1.06e-01	1.14e-01	2.03e-01	1.70e-01	3.96e-01	3.59e-01	3.23e-01
NEURON CELL CELL ADHESION	13	5.10e-01	9.00e-01	0.2840	-1.42e-01	-1.80e-02	-1.52e-01	-1.37e-01	1.35e-01	3.74e-01	9.11e-01	3.43e-01	3.91e-01	4.01e-01
CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS	146	6.38e-03	9.58e-02	0.2840	8.68e-02	-1.47e-02	1.63e-01	1.53e-01	1.51e-01	7.01e-02	7.59e-01	6.70e-04	1.38e-03	1.64e-03
REGULATION OF T CELL APOPTOTIC PROCESS	39	1.85e-01	6.56e-01	0.2840	7.13e-02	5.60e-02	1.69e-01	1.43e-01	1.53e-01	4.41e-01	5.45e-01	6.83e-02	1.22e-01	9.83e-02
POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	25	3.56e-01	8.22e-01	0.2840	-1.21e-01	-1.40e-01	-1.43e-01	-1.27e-01	9.81e-02	2.93e-01	2.25e-01	2.17e-01	2.71e-01	3.96e-01
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS	20	8.46e-01	9.87e-01	0.2840	-1.61e-01	-1.16e-01	-1.35e-01	-1.51e-01	5.02e-03	2.12e-01	3.71e-01	2.96e-01	2.42e-01	9.69e-01
PROSTATE GLANDULAR ACINUS MORPHOGENESIS	6	7.86e-01	9.81e-01	0.2840	-2.69e-02	4.35e-02	-1.64e-02	-4.43e-02	-2.75e-01	9.09e-01	8.54e-01	9.44e-01	8.51e-01	2.44e-01
IMP CATABOLIC PROCESS	5	6.63e-01	9.54e-01	0.2830	1.29e-01	1.56e-01	-5.55e-02	-8.84e-02	-1.69e-01	6.19e-01	5.45e-01	8.30e-01	7.32e-01	5.13e-01
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	25	1.76e-01	6.47e-01	0.2830	-1.20e-01	-1.54e-01	-1.19e-01	-1.61e-01	4.79e-02	3.01e-01	1.82e-01	3.03e-01	1.64e-01	6.78e-01
REGULATION OF HISTONE DEACETYLATION	5	9.81e-01	9.97e-01	0.2830	1.72e-01	1.67e-01	7.85e-02	1.01e-01	-8.10e-02	5.06e-01	5.18e-01	7.61e-01	6.96e-01	7.54e-01
SULFUR AMINO ACID METABOLIC PROCESS	32	2.30e-01	7.13e-01	0.2830	-1.79e-01	-1.33e-01	-1.00e-01	-8.83e-02	-1.13e-01	7.98e-02	1.94e-01	3.26e-01	3.87e-01	2.69e-01
ANIMAL ORGAN REGENERATION	60	7.93e-02	4.52e-01	0.2830	3.41e-02	-9.35e-02	1.56e-01	1.38e-01	1.64e-01	6.48e-01	2.10e-01	3.66e-02	6.39e-02	2.82e-02
CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION	7	3.99e-01	8.45e-01	0.2830	2.41e-01	1.44e-01	-2.96e-02	2.24e-03	-1.76e-02	2.70e-01	5.09e-01	8.92e-01	9.92e-01	9.36e-01
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	21	7.29e-01	9.71e-01	0.2830	-1.53e-01	-3.84e-02	-1.70e-01	-1.61e-01	-2.03e-02	2.24e-01	7.60e-01	1.78e-01	2.02e-01	8.72e-01
PSEUDOPODIUM ORGANIZATION	16	3.38e-01	8.08e-01	0.2830	3.01e-02	5.01e-02	-1.64e-01	-1.57e-01	-1.58e-01	8.35e-01	7.29e-01	2.55e-01	2.76e-01	2.75e-01
DNA TOPOLOGICAL CHANGE	9	2.58e-01	7.41e-01	0.2830	-6.61e-02	-2.53e-01	1.03e-01	2.88e-02	9.11e-03	7.31e-01	1.88e-01	5.94e-01	8.81e-01	9.62e-01
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	15	8.82e-02	4.73e-01	0.2830	-9.41e-02	-1.47e-01	-6.27e-02	-1.31e-01	1.68e-01	5.28e-01	3.24e-01	6.74e-01	3.80e-01	2.59e-01
POSITIVE REGULATION OF MEMBRANE PERMEABILITY	49	3.68e-01	8.31e-01	0.2830	9.70e-02	-1.63e-02	1.55e-01	1.48e-01	1.55e-01	2.40e-01	8.44e-01	6.01e-02	7.31e-02	5.99e-02
RESPONSE TO VITAMIN E	8	3.00e-01	7.73e-01	0.2820	1.82e-01	1.62e-01	-8.39e-02	-6.21e-02	9.77e-02	3.72e-01	4.28e-01	6.81e-01	7.61e-01	6.32e-01
POSITIVE REGULATION OF NEURON MIGRATION	18	6.62e-01	9.54e-01	0.2820	-1.70e-01	-9.99e-02	-9.50e-02	-1.12e-01	-1.38e-01	2.12e-01	4.63e-01	4.85e-01	4.09e-01	3.09e-01
FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS	44	2.84e-01	7.62e-01	0.2820	-1.02e-01	-9.30e-02	-1.73e-01	-1.70e-01	-4.05e-02	2.40e-01	2.86e-01	4.71e-02	5.07e-02	6.42e-01
MODULATION BY HOST OF VIRAL PROCESS	45	2.62e-02	2.42e-01	0.2820	5.31e-02	-1.33e-01	1.33e-01	9.97e-02	1.77e-01	5.38e-01	1.22e-01	1.23e-01	2.47e-01	3.94e-02
POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION	16	7.15e-01	9.68e-01	0.2820	-1.09e-01	-1.40e-01	-1.58e-01	-1.40e-01	-5.97e-02	4.51e-01	3.31e-01	2.74e-01	3.33e-01	6.79e-01
TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	9	8.10e-01	9.82e-01	0.2820	-1.88e-01	-5.32e-02	-1.26e-01	-1.47e-01	6.26e-02	3.28e-01	7.82e-01	5.14e-01	4.45e-01	7.45e-01
NEUROBLAST MIGRATION	6	3.32e-01	8.04e-01	0.2820	1.85e-01	2.68e-02	1.65e-01	8.78e-02	9.87e-02	4.32e-01	9.09e-01	4.85e-01	7.10e-01	6.75e-01
NATURAL KILLER CELL MEDIATED IMMUNITY	78	5.81e-05	2.52e-03	0.2820	5.24e-02	1.52e-01	1.06e-01	1.17e-01	1.70e-01	4.24e-01	2.04e-02	1.06e-01	7.32e-02	9.61e-03
SNRNA TRANSCRIPTION	19	4.81e-01	8.91e-01	0.2820	1.83e-01	1.87e-02	1.47e-01	1.55e-01	-1.56e-02	1.68e-01	8.88e-01	2.69e-01	2.42e-01	9.06e-01
ZINC ION TRANSPORT	28	3.55e-01	8.22e-01	0.2820	7.09e-02	-1.07e-01	1.34e-01	1.22e-01	1.74e-01	5.16e-01	3.29e-01	2.21e-01	2.64e-01	1.10e-01
CARDIAC VENTRICLE FORMATION	8	4.63e-01	8.81e-01	0.2820	7.48e-02	-2.19e-01	1.14e-01	1.13e-01	1.41e-02	7.14e-01	2.84e-01	5.76e-01	5.80e-01	9.45e-01
T CELL DIFFERENTIATION IN THYMUS	84	1.75e-01	6.47e-01	0.2820	1.31e-01	1.05e-01	1.46e-01	1.39e-01	1.02e-01	3.83e-02	9.50e-02	2.03e-02	2.78e-02	1.06e-01
THYMOCYTE APOPTOTIC PROCESS	20	3.59e-01	8.25e-01	0.2820	7.36e-02	3.91e-02	1.74e-01	1.31e-01	1.58e-01	5.69e-01	7.62e-01	1.79e-01	3.10e-01	2.21e-01
NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	11	3.13e-01	7.86e-01	0.2820	-1.59e-02	-1.21e-01	1.70e-01	1.88e-01	-1.30e-02	9.27e-01	4.87e-01	3.28e-01	2.81e-01	9.40e-01
PROTEIN DESUMOYLATION	8	6.76e-01	9.59e-01	0.2810	-1.09e-01	-2.03e-01	1.72e-02	9.85e-03	-1.60e-01	5.95e-01	3.19e-01	9.33e-01	9.62e-01	4.33e-01
SKELETAL MUSCLE SATELLITE CELL ACTIVATION	8	7.51e-01	9.75e-01	0.2810	4.48e-02	8.32e-02	5.36e-02	3.56e-02	2.57e-01	8.26e-01	6.84e-01	7.93e-01	8.62e-01	2.08e-01
REGULATION OF PENTOSE PHOSPHATE SHUNT	7	8.83e-01	9.91e-01	0.2810	1.21e-01	1.31e-01	1.16e-01	8.77e-02	1.62e-01	5.78e-01	5.48e-01	5.97e-01	6.88e-01	4.59e-01
EPOXYGENASE P450 PATHWAY	18	4.56e-02	3.33e-01	0.2810	2.42e-02	1.99e-01	1.30e-01	1.34e-01	-6.07e-02	8.59e-01	1.43e-01	3.39e-01	3.24e-01	6.55e-01
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	35	1.63e-01	6.27e-01	0.2810	2.35e-02	6.52e-04	7.57e-02	7.11e-02	2.60e-01	8.10e-01	9.95e-01	4.38e-01	4.67e-01	7.74e-03
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION	89	1.71e-03	3.60e-02	0.2810	5.44e-02	-7.04e-02	1.92e-01	1.77e-01	5.40e-02	3.75e-01	2.51e-01	1.74e-03	3.94e-03	3.78e-01
RESPONSE TO SYMBIONT	6	8.62e-01	9.88e-01	0.2810	-8.39e-02	-9.94e-02	9.14e-02	8.23e-02	2.16e-01	7.22e-01	6.73e-01	6.98e-01	7.27e-01	3.58e-01
MEGAKARYOCYTE DIFFERENTIATION	61	4.15e-04	1.25e-02	0.2810	1.78e-01	7.36e-02	6.28e-02	7.18e-02	-1.81e-01	1.61e-02	3.20e-01	3.96e-01	3.32e-01	1.47e-02
REGULATION OF PROTEIN DEUBIQUITINATION	10	9.22e-01	9.95e-01	0.2810	7.66e-02	4.18e-03	1.58e-01	1.67e-01	1.41e-01	6.75e-01	9.82e-01	3.86e-01	3.59e-01	4.39e-01
REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	8	7.07e-01	9.65e-01	0.2810	2.01e-02	-1.80e-01	9.90e-02	5.93e-02	1.80e-01	9.21e-01	3.77e-01	6.28e-01	7.72e-01	3.77e-01
REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION	12	5.59e-02	3.73e-01	0.2810	4.34e-02	-1.39e-01	-1.69e-02	-6.73e-02	2.30e-01	7.95e-01	4.05e-01	9.19e-01	6.86e-01	1.68e-01
POSITIVE REGULATION OF HIPPO SIGNALING	10	9.35e-01	9.97e-01	0.2810	-1.46e-01	-5.32e-02	-1.62e-01	-1.67e-01	2.09e-02	4.24e-01	7.71e-01	3.75e-01	3.60e-01	9.09e-01
METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	6	8.28e-01	9.83e-01	0.2810	2.50e-02	2.36e-01	-7.31e-02	-8.21e-02	-1.02e-01	9.15e-01	3.17e-01	7.56e-01	7.28e-01	6.64e-01
HOMOCYSTEINE METABOLIC PROCESS	13	5.00e-01	8.98e-01	0.2810	-1.80e-01	-3.02e-02	-1.54e-01	-1.22e-01	-8.34e-02	2.62e-01	8.50e-01	3.36e-01	4.48e-01	6.03e-01
FACULTATIVE HETEROCHROMATIN FORMATION	40	1.19e-01	5.50e-01	0.2800	-1.90e-01	-1.59e-01	-6.17e-02	-8.75e-02	-7.53e-02	3.74e-02	8.18e-02	4.99e-01	3.38e-01	4.10e-01
ERBB4 SIGNALING PATHWAY	10	5.34e-01	9.09e-01	0.2800	2.22e-02	-2.31e-01	8.40e-02	8.18e-02	1.04e-01	9.03e-01	2.05e-01	6.45e-01	6.54e-01	5.70e-01
POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	8	9.19e-01	9.95e-01	0.2800	-7.83e-02	-5.19e-02	-1.26e-01	-1.05e-01	-2.07e-01	7.01e-01	7.99e-01	5.37e-01	6.08e-01	3.11e-01
GANGLION DEVELOPMENT	17	5.17e-01	9.03e-01	0.2800	-4.21e-02	-1.88e-01	7.07e-02	3.80e-02	1.87e-01	7.64e-01	1.80e-01	6.14e-01	7.86e-01	1.82e-01
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	72	8.57e-02	4.67e-01	0.2800	-1.27e-01	-1.57e-01	-1.37e-01	-1.35e-01	2.77e-02	6.23e-02	2.12e-02	4.47e-02	4.81e-02	6.85e-01
NEUTROPHIL MEDIATED CYTOTOXICITY	14	1.81e-01	6.56e-01	0.2800	-2.85e-02	-1.27e-01	-1.75e-01	-1.69e-01	4.76e-02	8.54e-01	4.09e-01	2.58e-01	2.74e-01	7.58e-01
NEGATIVE REGULATION OF B CELL ACTIVATION	31	4.34e-01	8.69e-01	0.2800	-1.27e-01	-1.74e-01	-9.74e-02	-1.04e-01	1.09e-01	2.23e-01	9.35e-02	3.48e-01	3.16e-01	2.95e-01
POSITIVE REGULATION OF FATTY ACID BETA OXIDATION	10	8.14e-01	9.82e-01	0.2800	2.07e-02	1.36e-01	-4.99e-02	-5.02e-02	-2.33e-01	9.10e-01	4.55e-01	7.85e-01	7.83e-01	2.02e-01
CELLULAR RESPONSE TO FLUID SHEAR STRESS	21	5.44e-01	9.15e-01	0.2800	-1.23e-01	-2.29e-01	-4.72e-02	-7.17e-02	5.92e-02	3.29e-01	6.96e-02	7.08e-01	5.70e-01	6.39e-01
INTERLEUKIN 13 PRODUCTION	21	6.44e-01	9.50e-01	0.2800	-1.58e-01	-1.77e-01	-7.16e-02	-8.36e-02	-9.81e-02	2.09e-01	1.60e-01	5.70e-01	5.07e-01	4.36e-01
REPRODUCTIVE BEHAVIOR	42	1.26e-01	5.68e-01	0.2800	-1.65e-01	-2.05e-01	-4.68e-02	-8.36e-02	2.90e-03	6.45e-02	2.17e-02	6.00e-01	3.49e-01	9.74e-01
LEUCINE METABOLIC PROCESS	8	8.14e-01	9.82e-01	0.2800	4.53e-02	-1.12e-01	1.89e-01	1.61e-01	4.44e-02	8.25e-01	5.83e-01	3.55e-01	4.30e-01	8.28e-01
NEUROMUSCULAR SYNAPTIC TRANSMISSION	28	1.86e-01	6.57e-01	0.2800	1.18e-01	1.85e-01	-4.38e-02	-4.32e-02	-1.62e-01	2.79e-01	9.03e-02	6.89e-01	6.92e-01	1.38e-01
REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	44	6.91e-02	4.21e-01	0.2800	-3.01e-02	-2.03e-01	7.89e-02	6.94e-02	1.58e-01	7.30e-01	1.98e-02	3.65e-01	4.25e-01	6.93e-02
REGULATION OF DNA DEMETHYLATION	11	2.08e-01	6.85e-01	0.2790	-2.30e-01	-1.51e-01	5.45e-03	7.43e-03	5.05e-02	1.87e-01	3.87e-01	9.75e-01	9.66e-01	7.72e-01
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	27	3.31e-01	8.03e-01	0.2790	1.24e-01	2.16e-01	6.11e-02	8.32e-02	7.31e-02	2.64e-01	5.24e-02	5.83e-01	4.54e-01	5.11e-01
POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION	5	7.20e-01	9.69e-01	0.2790	-6.19e-02	7.26e-02	6.13e-02	4.89e-02	2.50e-01	8.11e-01	7.78e-01	8.12e-01	8.50e-01	3.32e-01
REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	64	2.05e-01	6.84e-01	0.2790	9.46e-02	5.56e-02	1.70e-01	1.67e-01	9.49e-02	1.91e-01	4.42e-01	1.88e-02	2.06e-02	1.89e-01
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	28	2.82e-01	7.60e-01	0.2790	-9.57e-02	-1.75e-01	-1.21e-01	-1.36e-01	-6.97e-02	3.81e-01	1.08e-01	2.69e-01	2.13e-01	5.23e-01
REGULATION OF STEM CELL DIVISION	11	2.80e-01	7.58e-01	0.2790	-2.83e-02	-1.28e-01	-3.72e-02	-8.52e-02	2.28e-01	8.71e-01	4.63e-01	8.31e-01	6.25e-01	1.90e-01
POSTSYNAPTIC MEMBRANE ASSEMBLY	7	6.87e-01	9.61e-01	0.2790	-7.67e-02	-6.16e-03	-2.48e-02	-1.10e-02	2.67e-01	7.25e-01	9.77e-01	9.10e-01	9.60e-01	2.22e-01
DEVELOPMENTAL INDUCTION	33	1.21e-01	5.55e-01	0.2790	-9.84e-02	-2.16e-01	-4.76e-02	-7.94e-02	1.13e-01	3.28e-01	3.17e-02	6.36e-01	4.30e-01	2.60e-01
CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	29	2.70e-01	7.50e-01	0.2790	8.43e-02	1.35e-01	1.43e-01	1.25e-01	1.28e-01	4.32e-01	2.09e-01	1.82e-01	2.45e-01	2.31e-01
NEGATIVE REGULATION OF TELOMERASE ACTIVITY	10	8.11e-01	9.82e-01	0.2790	-6.24e-02	-5.60e-02	-8.03e-02	-9.15e-02	-2.36e-01	7.33e-01	7.59e-01	6.60e-01	6.16e-01	1.95e-01
RESPONSE TO LIGHT INTENSITY	16	2.68e-01	7.48e-01	0.2790	-1.50e-03	1.31e-01	-1.91e-01	-1.45e-01	-5.55e-02	9.92e-01	3.63e-01	1.86e-01	3.17e-01	7.01e-01
HISTAMINE TRANSPORT	15	3.51e-01	8.18e-01	0.2790	1.15e-01	8.70e-02	-6.14e-02	-3.69e-02	-2.28e-01	4.41e-01	5.59e-01	6.80e-01	8.05e-01	1.27e-01
REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	18	2.90e-01	7.67e-01	0.2790	-1.11e-01	1.05e-01	-1.21e-01	-1.02e-01	-1.71e-01	4.14e-01	4.38e-01	3.76e-01	4.55e-01	2.09e-01
POSITIVE REGULATION OF STEM CELL PROLIFERATION	53	2.13e-01	6.93e-01	0.2790	-1.39e-01	-2.08e-01	-8.09e-02	-8.82e-02	2.76e-02	7.91e-02	8.88e-03	3.08e-01	2.67e-01	7.28e-01
COENZYME A METABOLIC PROCESS	19	3.74e-01	8.36e-01	0.2790	1.58e-01	5.27e-02	1.44e-01	1.10e-01	1.31e-01	2.34e-01	6.91e-01	2.76e-01	4.06e-01	3.24e-01
REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	17	2.02e-01	6.82e-01	0.2790	1.82e-01	-2.41e-02	1.09e-01	1.01e-01	1.47e-01	1.93e-01	8.63e-01	4.36e-01	4.71e-01	2.93e-01
NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION	6	2.23e-01	7.05e-01	0.2790	4.92e-02	-2.53e-01	-6.61e-02	-8.20e-02	-1.50e-02	8.35e-01	2.84e-01	7.79e-01	7.28e-01	9.49e-01
NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	10	9.35e-01	9.97e-01	0.2780	-1.38e-01	-1.31e-01	-1.39e-01	-1.35e-01	5.93e-02	4.49e-01	4.73e-01	4.45e-01	4.58e-01	7.46e-01
NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	35	7.34e-01	9.73e-01	0.2780	1.59e-01	1.16e-01	1.35e-01	1.42e-01	1.88e-02	1.03e-01	2.34e-01	1.67e-01	1.46e-01	8.48e-01
REGULATION OF PROTEIN UBIQUITINATION	180	8.80e-06	4.95e-04	0.2780	8.02e-02	-8.44e-02	1.70e-01	1.54e-01	1.07e-01	6.34e-02	5.07e-02	8.70e-05	3.65e-04	1.31e-02
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS	44	3.77e-01	8.36e-01	0.2780	-7.82e-02	-1.86e-02	-1.62e-01	-1.64e-01	-1.34e-01	3.69e-01	8.31e-01	6.30e-02	6.01e-02	1.24e-01
COMPLEMENT ACTIVATION CLASSICAL PATHWAY	34	2.73e-02	2.47e-01	0.2780	6.34e-02	1.76e-01	2.25e-02	3.07e-02	2.02e-01	5.23e-01	7.56e-02	8.20e-01	7.57e-01	4.12e-02
NCRNA METABOLIC PROCESS	607	1.37e-18	5.71e-16	0.2780	1.29e-01	-2.92e-03	1.78e-01	1.70e-01	1.09e-02	5.41e-08	9.02e-01	7.05e-14	7.64e-13	6.46e-01
NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	13	7.87e-01	9.81e-01	0.2780	1.84e-01	4.77e-02	1.28e-01	1.45e-01	6.19e-02	2.51e-01	7.66e-01	4.25e-01	3.64e-01	6.99e-01
POSITIVE REGULATION OF MITOTIC CYTOKINESIS	8	8.66e-01	9.88e-01	0.2780	1.18e-01	1.78e-01	1.37e-01	1.13e-01	-3.41e-03	5.64e-01	3.83e-01	5.03e-01	5.78e-01	9.87e-01
G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY	12	8.92e-01	9.92e-01	0.2780	-1.69e-01	-5.21e-02	-1.50e-01	-1.41e-01	-5.67e-02	3.10e-01	7.55e-01	3.67e-01	3.97e-01	7.34e-01
FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS	11	2.75e-01	7.56e-01	0.2780	-5.65e-02	-8.21e-02	-1.50e-01	-1.92e-01	8.89e-02	7.46e-01	6.37e-01	3.88e-01	2.71e-01	6.10e-01
GAMMA AMINOBUTYRIC ACID TRANSPORT	19	5.89e-01	9.30e-01	0.2780	-1.57e-01	-9.28e-02	-1.20e-01	-1.19e-01	1.23e-01	2.35e-01	4.84e-01	3.64e-01	3.69e-01	3.54e-01
SPHINGOSINE BIOSYNTHETIC PROCESS	14	8.84e-01	9.91e-01	0.2780	-1.48e-01	-1.52e-01	-1.21e-01	-1.10e-01	-7.29e-02	3.38e-01	3.26e-01	4.31e-01	4.75e-01	6.37e-01
SULFUR AMINO ACID BIOSYNTHETIC PROCESS	16	3.82e-01	8.38e-01	0.2780	-1.38e-01	-2.27e-01	-1.22e-02	-4.28e-03	-7.96e-02	3.41e-01	1.16e-01	9.33e-01	9.76e-01	5.81e-01
REGULATION OF FOCAL ADHESION DISASSEMBLY	6	5.61e-01	9.20e-01	0.2780	-1.67e-01	-1.95e-01	7.50e-02	1.06e-03	7.51e-02	4.79e-01	4.09e-01	7.50e-01	9.96e-01	7.50e-01
REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION	10	7.88e-01	9.81e-01	0.2770	-8.71e-02	9.91e-02	-1.78e-01	-1.58e-01	-5.49e-02	6.33e-01	5.87e-01	3.30e-01	3.87e-01	7.64e-01
INTRACELLULAR OXYGEN HOMEOSTASIS	7	5.84e-01	9.28e-01	0.2770	2.23e-01	6.57e-02	9.07e-02	7.75e-02	-9.26e-02	3.07e-01	7.64e-01	6.78e-01	7.22e-01	6.71e-01
POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	11	4.97e-01	8.96e-01	0.2770	-1.37e-01	3.44e-02	-1.89e-01	-1.44e-01	-2.83e-02	4.33e-01	8.44e-01	2.79e-01	4.09e-01	8.71e-01
CARDIAC CHAMBER FORMATION	12	2.67e-01	7.48e-01	0.2770	4.66e-02	-2.36e-01	1.01e-01	8.93e-02	2.78e-02	7.80e-01	1.57e-01	5.45e-01	5.92e-01	8.68e-01
RESPONSE TO IRON ION	28	4.50e-01	8.76e-01	0.2770	1.09e-02	-1.09e-01	1.35e-01	1.16e-01	1.82e-01	9.20e-01	3.16e-01	2.17e-01	2.89e-01	9.51e-02
TYPE B PANCREATIC CELL PROLIFERATION	27	9.78e-02	5.00e-01	0.2770	1.36e-01	-1.03e-01	1.45e-01	1.48e-01	7.02e-02	2.20e-01	3.56e-01	1.94e-01	1.83e-01	5.28e-01
REGULATION OF TRANSLATIONAL INITIATION	76	2.39e-02	2.28e-01	0.2770	5.25e-02	-9.70e-02	1.67e-01	1.53e-01	1.15e-01	4.29e-01	1.44e-01	1.20e-02	2.07e-02	8.24e-02
POSITIVE REGULATION OF SISTER CHROMATID COHESION	9	4.91e-01	8.94e-01	0.2770	8.92e-02	-1.83e-01	1.14e-01	1.28e-01	7.71e-02	6.43e-01	3.42e-01	5.54e-01	5.06e-01	6.89e-01
PIGMENT GRANULE ORGANIZATION	37	1.51e-02	1.67e-01	0.2770	7.79e-02	-1.00e-01	1.31e-01	8.62e-02	1.90e-01	4.12e-01	2.92e-01	1.68e-01	3.64e-01	4.55e-02
GLYCOSYL COMPOUND CATABOLIC PROCESS	34	4.73e-01	8.86e-01	0.2770	-1.47e-01	-1.05e-01	-1.55e-01	-1.40e-01	1.77e-02	1.38e-01	2.88e-01	1.18e-01	1.57e-01	8.59e-01
EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY	12	4.45e-01	8.73e-01	0.2770	1.38e-01	-5.77e-02	1.10e-01	8.73e-02	1.85e-01	4.07e-01	7.29e-01	5.08e-01	6.01e-01	2.66e-01
ERYTHROCYTE MATURATION	17	6.62e-01	9.54e-01	0.2770	-1.10e-01	-1.32e-01	-1.28e-01	-1.35e-01	1.11e-01	4.31e-01	3.44e-01	3.60e-01	3.37e-01	4.28e-01
POLYAMINE TRANSPORT	16	7.61e-01	9.75e-01	0.2770	-2.10e-02	1.01e-01	-1.44e-01	-1.35e-01	-1.64e-01	8.84e-01	4.85e-01	3.20e-01	3.49e-01	2.55e-01
CITRULLINE METABOLIC PROCESS	7	6.95e-01	9.61e-01	0.2760	4.27e-02	5.34e-02	1.63e-01	1.51e-01	-1.49e-01	8.45e-01	8.07e-01	4.54e-01	4.88e-01	4.96e-01
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	123	3.48e-03	6.16e-02	0.2760	9.02e-02	9.25e-02	1.24e-01	1.31e-01	1.65e-01	8.40e-02	7.65e-02	1.78e-02	1.22e-02	1.55e-03
REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	15	6.88e-01	9.61e-01	0.2760	7.48e-02	2.10e-01	-4.98e-02	-3.02e-02	-1.52e-01	6.16e-01	1.59e-01	7.38e-01	8.39e-01	3.08e-01
POSITIVE REGULATION OF JUN KINASE ACTIVITY	31	2.31e-01	7.14e-01	0.2760	-3.46e-02	-3.01e-02	-1.68e-01	-1.56e-01	-1.47e-01	7.39e-01	7.72e-01	1.06e-01	1.33e-01	1.56e-01
REGULATION OF KETONE BIOSYNTHETIC PROCESS	21	5.43e-01	9.15e-01	0.2760	-1.61e-01	-2.11e-01	-3.44e-02	-5.50e-02	-3.83e-02	2.03e-01	9.39e-02	7.85e-01	6.63e-01	7.61e-01
REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	10	8.60e-01	9.88e-01	0.2760	-7.16e-02	-4.12e-02	-8.90e-02	-9.92e-02	-2.27e-01	6.95e-01	8.21e-01	6.26e-01	5.87e-01	2.14e-01
REGULATION OF TRANSLATION AT SYNAPSE	6	5.44e-01	9.15e-01	0.2760	1.08e-01	1.75e-01	-1.21e-01	-1.34e-01	3.04e-02	6.46e-01	4.58e-01	6.08e-01	5.68e-01	8.97e-01
REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	6	6.85e-01	9.61e-01	0.2760	4.22e-02	3.23e-02	-4.02e-02	-5.79e-02	2.61e-01	8.58e-01	8.91e-01	8.64e-01	8.06e-01	2.68e-01
SEROTONIN METABOLIC PROCESS	10	9.33e-01	9.97e-01	0.2760	-7.70e-02	-2.85e-02	-1.44e-01	-1.52e-01	-1.60e-01	6.73e-01	8.76e-01	4.31e-01	4.06e-01	3.82e-01
NEGATIVE REGULATION OF DNA REPLICATION	24	3.91e-01	8.41e-01	0.2760	1.03e-01	-5.13e-02	1.84e-01	1.70e-01	4.09e-03	3.84e-01	6.64e-01	1.19e-01	1.49e-01	9.72e-01
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	39	3.33e-01	8.05e-01	0.2750	-8.92e-02	-1.01e-01	-1.60e-01	-1.57e-01	-8.71e-02	3.35e-01	2.75e-01	8.40e-02	9.04e-02	3.46e-01
NEGATIVE REGULATION OF BLOOD CIRCULATION	24	9.59e-02	4.94e-01	0.2750	9.55e-02	2.26e-01	-1.01e-01	-7.27e-02	1.19e-02	4.18e-01	5.56e-02	3.90e-01	5.37e-01	9.20e-01
NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	5	4.14e-01	8.54e-01	0.2750	-6.27e-02	-1.44e-01	-3.11e-02	4.33e-02	2.19e-01	8.08e-01	5.77e-01	9.04e-01	8.67e-01	3.95e-01
MAMMARY GLAND DUCT MORPHOGENESIS	28	6.16e-01	9.39e-01	0.2750	-1.35e-01	-1.89e-01	-9.53e-02	-1.11e-01	-1.52e-02	2.16e-01	8.31e-02	3.83e-01	3.08e-01	8.89e-01
ERAD PATHWAY	108	1.84e-04	6.64e-03	0.2750	7.02e-02	-1.31e-01	1.43e-01	1.35e-01	1.22e-01	2.07e-01	1.88e-02	9.98e-03	1.55e-02	2.86e-02
POSITIVE REGULATION OF PROTEIN UBIQUITINATION	100	1.59e-03	3.43e-02	0.2750	7.44e-02	-1.03e-01	1.58e-01	1.39e-01	1.24e-01	1.99e-01	7.50e-02	6.38e-03	1.65e-02	3.20e-02
TRNA TRANSCRIPTION	11	9.23e-01	9.95e-01	0.2750	1.54e-01	6.89e-02	1.48e-01	1.53e-01	-4.04e-02	3.76e-01	6.92e-01	3.95e-01	3.78e-01	8.16e-01
URINARY TRACT SMOOTH MUSCLE CONTRACTION	9	8.77e-01	9.88e-01	0.2750	1.70e-01	1.57e-01	1.09e-01	9.06e-02	-4.58e-02	3.78e-01	4.14e-01	5.73e-01	6.38e-01	8.12e-01
RESPONSE TO UV A	13	3.91e-01	8.41e-01	0.2750	-4.97e-04	-8.16e-02	1.38e-01	7.90e-02	2.09e-01	9.98e-01	6.11e-01	3.90e-01	6.22e-01	1.92e-01
VIRAL BUDDING	25	1.49e-01	6.10e-01	0.2750	4.51e-02	-1.77e-01	1.28e-01	1.35e-01	8.74e-02	6.96e-01	1.25e-01	2.69e-01	2.43e-01	4.49e-01
REGULATION OF KERATINOCYTE MIGRATION	14	7.78e-01	9.79e-01	0.2750	-1.63e-01	-1.71e-01	-6.72e-02	-9.55e-02	-7.87e-02	2.90e-01	2.69e-01	6.63e-01	5.36e-01	6.10e-01
NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT	11	1.15e-01	5.43e-01	0.2750	-4.80e-02	-2.57e-01	-4.21e-02	8.75e-03	-7.27e-02	7.83e-01	1.40e-01	8.09e-01	9.60e-01	6.76e-01
RESPONSE TO X RAY	28	1.95e-01	6.73e-01	0.2750	1.01e-01	-7.75e-02	1.71e-01	1.38e-01	1.04e-01	3.53e-01	4.78e-01	1.16e-01	2.06e-01	3.41e-01
NEUROEPITHELIAL CELL DIFFERENTIATION	38	4.83e-02	3.42e-01	0.2750	9.08e-03	-2.04e-01	8.76e-02	7.17e-02	1.44e-01	9.23e-01	2.92e-02	3.50e-01	4.44e-01	1.24e-01
CORNEA DEVELOPMENT IN CAMERA TYPE EYE	12	8.54e-01	9.88e-01	0.2750	-1.32e-01	-2.08e-01	-7.01e-02	-7.83e-02	-6.27e-02	4.30e-01	2.13e-01	6.74e-01	6.39e-01	7.07e-01
ABSCISSION	6	5.63e-01	9.21e-01	0.2750	1.15e-03	-1.91e-01	-8.02e-02	-5.61e-02	-1.71e-01	9.96e-01	4.17e-01	7.34e-01	8.12e-01	4.68e-01
REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	8	8.11e-01	9.82e-01	0.2750	-8.89e-02	-7.62e-02	-1.62e-01	-1.87e-01	2.46e-02	6.63e-01	7.09e-01	4.29e-01	3.59e-01	9.04e-01
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS	14	6.26e-01	9.44e-01	0.2750	-8.83e-02	-1.56e-01	-9.24e-02	-1.14e-01	-1.48e-01	5.67e-01	3.12e-01	5.49e-01	4.61e-01	3.38e-01
REGULATION OF CELL FATE SPECIFICATION	24	2.83e-01	7.62e-01	0.2750	-5.71e-02	-1.73e-01	9.70e-03	-2.00e-02	2.04e-01	6.28e-01	1.42e-01	9.34e-01	8.65e-01	8.30e-02
ENDOTHELIAL CELL CHEMOTAXIS	27	2.77e-01	7.57e-01	0.2750	-1.52e-01	-1.69e-01	-7.39e-04	-9.70e-03	1.54e-01	1.72e-01	1.28e-01	9.95e-01	9.30e-01	1.66e-01
LEUKOTRIENE TRANSPORT	7	8.74e-01	9.88e-01	0.2750	-8.71e-02	9.41e-02	-1.73e-01	-1.71e-01	-5.75e-03	6.90e-01	6.66e-01	4.29e-01	4.34e-01	9.79e-01
POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	15	5.80e-01	9.28e-01	0.2750	9.52e-02	2.86e-02	7.80e-02	6.18e-02	2.36e-01	5.23e-01	8.48e-01	6.01e-01	6.79e-01	1.14e-01
NEGATIVE REGULATION OF RECEPTOR BINDING	12	4.99e-01	8.97e-01	0.2740	-2.17e-01	-1.25e-01	-4.45e-02	-6.10e-02	8.29e-02	1.93e-01	4.52e-01	7.89e-01	7.15e-01	6.19e-01
NEGATIVE REGULATION OF RESPIRATORY BURST	6	8.77e-01	9.88e-01	0.2740	1.94e-01	1.76e-01	5.88e-02	4.73e-02	3.13e-02	4.10e-01	4.56e-01	8.03e-01	8.41e-01	8.94e-01
DGMP METABOLIC PROCESS	5	7.92e-01	9.81e-01	0.2740	1.33e-01	2.10e-01	-7.16e-02	-8.27e-02	-3.62e-02	6.06e-01	4.15e-01	7.82e-01	7.49e-01	8.88e-01
T CELL CYTOKINE PRODUCTION	36	2.04e-01	6.84e-01	0.2740	-1.54e-01	-9.58e-02	-1.12e-01	-1.40e-01	1.02e-01	1.11e-01	3.20e-01	2.46e-01	1.47e-01	2.89e-01
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS	58	2.13e-01	6.91e-01	0.2740	1.74e-01	1.17e-01	1.20e-01	1.23e-01	-4.40e-02	2.21e-02	1.25e-01	1.14e-01	1.06e-01	5.62e-01
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	45	1.05e-01	5.18e-01	0.2740	-1.21e-01	-1.06e-01	-1.19e-01	-1.39e-01	1.25e-01	1.59e-01	2.19e-01	1.66e-01	1.06e-01	1.48e-01
PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS	6	9.22e-01	9.95e-01	0.2740	4.02e-02	1.96e-01	-3.26e-02	-2.86e-02	-1.82e-01	8.65e-01	4.06e-01	8.90e-01	9.03e-01	4.39e-01
CELLULAR PIGMENTATION	60	1.84e-02	1.92e-01	0.2740	8.71e-02	-6.46e-02	1.33e-01	1.05e-01	1.87e-01	2.43e-01	3.87e-01	7.55e-02	1.61e-01	1.25e-02
CORONARY VASCULATURE MORPHOGENESIS	19	6.48e-01	9.51e-01	0.2740	-1.51e-01	-1.81e-01	-4.89e-02	-8.10e-02	1.03e-01	2.54e-01	1.73e-01	7.12e-01	5.41e-01	4.39e-01
DETECTION OF VISIBLE LIGHT	46	1.20e-02	1.44e-01	0.2740	1.11e-02	2.02e-01	-1.35e-01	-1.04e-01	-7.03e-02	8.96e-01	1.78e-02	1.12e-01	2.23e-01	4.10e-01
MANNOSE METABOLIC PROCESS	9	7.29e-01	9.71e-01	0.2740	3.33e-02	3.53e-03	-9.20e-02	-8.31e-02	-2.42e-01	8.63e-01	9.85e-01	6.33e-01	6.66e-01	2.09e-01
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	68	1.84e-01	6.56e-01	0.2740	1.18e-01	5.19e-03	1.72e-01	1.68e-01	5.47e-02	9.20e-02	9.41e-01	1.40e-02	1.65e-02	4.35e-01
ENAMEL MINERALIZATION	19	5.92e-01	9.32e-01	0.2740	-1.35e-01	-1.67e-02	-1.40e-01	-1.69e-01	-9.05e-02	3.07e-01	8.99e-01	2.92e-01	2.02e-01	4.95e-01
AMPA GLUTAMATE RECEPTOR CLUSTERING	10	9.15e-01	9.94e-01	0.2740	-1.87e-01	-1.35e-01	-8.94e-02	-1.10e-01	-3.85e-02	3.06e-01	4.59e-01	6.25e-01	5.48e-01	8.33e-01
CATECHOLAMINE UPTAKE	18	7.22e-01	9.70e-01	0.2740	1.64e-01	1.73e-01	9.81e-02	8.61e-02	3.22e-02	2.29e-01	2.04e-01	4.71e-01	5.27e-01	8.13e-01
APOPTOTIC MITOCHONDRIAL CHANGES	105	8.23e-04	2.11e-02	0.2730	7.83e-02	-9.75e-02	1.41e-01	1.49e-01	1.30e-01	1.66e-01	8.42e-02	1.23e-02	8.29e-03	2.12e-02
MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING	29	1.54e-01	6.16e-01	0.2730	8.81e-02	-5.20e-02	1.95e-01	1.62e-01	1.50e-02	4.11e-01	6.28e-01	6.93e-02	1.32e-01	8.89e-01
REGULATION OF CILIUM BEAT FREQUENCY	17	5.30e-01	9.07e-01	0.2730	2.04e-01	1.01e-01	1.11e-01	1.03e-01	-1.06e-02	1.46e-01	4.70e-01	4.29e-01	4.61e-01	9.40e-01
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	21	6.74e-01	9.59e-01	0.2730	-1.53e-01	-1.41e-01	-8.81e-02	-1.10e-01	1.07e-01	2.24e-01	2.63e-01	4.85e-01	3.81e-01	3.98e-01
NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	13	8.47e-01	9.87e-01	0.2730	-8.88e-02	4.22e-02	-1.77e-01	-1.54e-01	-1.00e-01	5.79e-01	7.92e-01	2.70e-01	3.36e-01	5.31e-01
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	79	1.40e-03	3.19e-02	0.2730	-1.02e-01	-1.18e-01	-8.84e-02	-1.13e-01	1.73e-01	1.16e-01	7.04e-02	1.74e-01	8.30e-02	7.91e-03
VESICLE TARGETING ROUGH ER TO CIS GOLGI	25	5.11e-01	9.00e-01	0.2730	8.71e-02	-3.78e-02	1.83e-01	1.77e-01	3.16e-02	4.51e-01	7.44e-01	1.14e-01	1.26e-01	7.85e-01
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS	20	4.67e-01	8.83e-01	0.2730	-1.06e-01	-2.33e-01	-5.47e-02	-7.73e-02	1.32e-02	4.11e-01	7.14e-02	6.72e-01	5.50e-01	9.18e-01
REGULATION OF ASTROCYTE DIFFERENTIATION	31	3.95e-01	8.44e-01	0.2730	1.69e-01	4.81e-02	1.17e-01	1.27e-01	1.19e-01	1.03e-01	6.43e-01	2.61e-01	2.23e-01	2.52e-01
PLASMINOGEN ACTIVATION	26	6.91e-01	9.61e-01	0.2730	-1.49e-01	-1.83e-01	-8.95e-02	-9.17e-02	5.22e-02	1.89e-01	1.07e-01	4.30e-01	4.18e-01	6.45e-01
INTRACELLULAR AMINO ACID HOMEOSTASIS	8	6.01e-01	9.33e-01	0.2730	1.79e-02	4.39e-02	-1.23e-01	-1.53e-01	-1.84e-01	9.30e-01	8.30e-01	5.46e-01	4.54e-01	3.68e-01
NEGATIVE REGULATION OF VIRAL PROCESS	91	1.60e-01	6.22e-01	0.2730	1.58e-01	1.43e-01	1.10e-01	1.16e-01	5.94e-02	9.05e-03	1.85e-02	6.94e-02	5.60e-02	3.27e-01
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES	6	9.00e-01	9.94e-01	0.2730	-1.73e-01	-2.09e-01	-1.88e-02	-1.78e-02	-4.26e-03	4.63e-01	3.75e-01	9.37e-01	9.40e-01	9.86e-01
NEGATIVE REGULATION OF CENTRIOLE REPLICATION	7	6.91e-01	9.61e-01	0.2730	1.31e-01	1.69e-01	8.50e-02	4.42e-02	1.40e-01	5.47e-01	4.40e-01	6.97e-01	8.39e-01	5.22e-01
COLLAGEN BIOSYNTHETIC PROCESS	46	6.44e-02	4.05e-01	0.2730	-1.59e-01	-1.63e-01	-1.13e-01	-8.87e-02	4.43e-02	6.21e-02	5.60e-02	1.85e-01	2.98e-01	6.03e-01
RNA EXPORT FROM NUCLEUS	83	5.92e-02	3.87e-01	0.2730	1.15e-01	-1.69e-02	1.73e-01	1.61e-01	7.27e-02	7.09e-02	7.91e-01	6.48e-03	1.15e-02	2.52e-01
STEROL HOMEOSTASIS	99	1.58e-02	1.73e-01	0.2730	-1.53e-01	-7.84e-02	-1.58e-01	-1.39e-01	-2.09e-02	8.48e-03	1.78e-01	6.52e-03	1.69e-02	7.19e-01
PEPTIDYL METHIONINE MODIFICATION	12	4.48e-01	8.75e-01	0.2730	6.40e-02	-1.23e-01	1.62e-01	1.49e-01	-8.02e-02	7.01e-01	4.60e-01	3.30e-01	3.71e-01	6.31e-01
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	31	1.22e-01	5.57e-01	0.2730	-1.50e-01	-1.68e-01	-7.42e-02	-5.35e-02	-1.24e-01	1.49e-01	1.06e-01	4.74e-01	6.06e-01	2.33e-01
BONE RESORPTION	65	1.26e-01	5.67e-01	0.2720	-9.46e-02	-8.06e-02	-1.70e-01	-1.64e-01	-5.40e-02	1.87e-01	2.61e-01	1.76e-02	2.21e-02	4.51e-01
TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY	7	9.40e-01	9.97e-01	0.2720	2.47e-02	-6.62e-02	1.63e-01	1.38e-01	1.54e-01	9.10e-01	7.62e-01	4.56e-01	5.28e-01	4.80e-01
UREA CYCLE	10	8.01e-01	9.82e-01	0.2720	1.18e-01	1.95e-01	4.56e-02	5.19e-02	1.33e-01	5.20e-01	2.86e-01	8.03e-01	7.76e-01	4.67e-01
ANTIBACTERIAL HUMORAL RESPONSE	60	9.44e-04	2.33e-02	0.2720	1.74e-01	8.93e-02	7.42e-02	1.20e-01	1.27e-01	1.97e-02	2.32e-01	3.20e-01	1.09e-01	8.88e-02
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS	17	1.67e-01	6.33e-01	0.2720	5.10e-02	-1.61e-01	1.65e-01	1.14e-01	7.47e-02	7.16e-01	2.50e-01	2.40e-01	4.17e-01	5.94e-01
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	16	8.33e-01	9.85e-01	0.2720	-1.77e-01	-1.28e-01	-9.97e-02	-1.03e-01	-7.74e-02	2.21e-01	3.74e-01	4.90e-01	4.76e-01	5.92e-01
EMBRYONIC CAMERA TYPE EYE FORMATION	11	2.62e-01	7.45e-01	0.2720	-2.98e-02	-1.41e-01	-1.44e-01	-1.67e-01	7.01e-02	8.64e-01	4.18e-01	4.09e-01	3.39e-01	6.87e-01
CELL CELL JUNCTION DISASSEMBLY	5	8.49e-01	9.87e-01	0.2720	-1.20e-02	2.94e-03	6.48e-03	-2.53e-02	2.71e-01	9.63e-01	9.91e-01	9.80e-01	9.22e-01	2.94e-01
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	10	7.19e-01	9.69e-01	0.2720	-2.89e-02	-1.58e-02	1.04e-01	8.16e-02	2.36e-01	8.74e-01	9.31e-01	5.70e-01	6.55e-01	1.97e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	57	1.27e-01	5.69e-01	0.2720	-8.44e-02	-3.17e-02	-1.75e-01	-1.50e-01	-1.13e-01	2.70e-01	6.79e-01	2.20e-02	5.00e-02	1.41e-01
PHAGOCYTOSIS RECOGNITION	28	2.56e-03	4.93e-02	0.2720	2.11e-02	2.52e-01	-9.01e-02	-3.56e-02	3.08e-02	8.47e-01	2.12e-02	4.09e-01	7.44e-01	7.78e-01
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	74	2.75e-02	2.48e-01	0.2720	-1.55e-01	-1.50e-01	-1.24e-01	-1.05e-01	3.49e-02	2.13e-02	2.53e-02	6.61e-02	1.18e-01	6.04e-01
GLUCOCORTICOID METABOLIC PROCESS	24	2.55e-01	7.38e-01	0.2720	-1.31e-01	-9.34e-02	-3.47e-02	-4.09e-02	2.13e-01	2.67e-01	4.28e-01	7.69e-01	7.29e-01	7.12e-02
RESPONSE TO BILE ACID	7	5.66e-01	9.23e-01	0.2720	3.35e-02	1.86e-01	-1.62e-01	-9.77e-02	-4.90e-02	8.78e-01	3.94e-01	4.58e-01	6.55e-01	8.22e-01
RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE	5	6.84e-01	9.61e-01	0.2720	-4.45e-02	-4.71e-02	1.94e-01	1.78e-01	-1.74e-02	8.63e-01	8.55e-01	4.52e-01	4.90e-01	9.46e-01
POSITIVE REGULATION OF BEHAVIOR	24	6.08e-01	9.35e-01	0.2720	-1.32e-01	-1.79e-01	-9.33e-02	-1.19e-01	4.26e-02	2.62e-01	1.30e-01	4.29e-01	3.15e-01	7.18e-01
VITAMIN D RECEPTOR SIGNALING PATHWAY	12	8.15e-01	9.82e-01	0.2720	1.68e-02	-1.30e-01	1.19e-01	9.60e-02	1.83e-01	9.20e-01	4.37e-01	4.75e-01	5.65e-01	2.72e-01
REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE	6	7.76e-01	9.78e-01	0.2720	5.75e-02	2.93e-02	1.29e-01	1.06e-01	-2.05e-01	8.07e-01	9.01e-01	5.85e-01	6.52e-01	3.85e-01
NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	10	8.85e-01	9.91e-01	0.2720	1.23e-01	1.63e-01	6.08e-02	8.33e-02	-1.47e-01	4.99e-01	3.74e-01	7.39e-01	6.48e-01	4.20e-01
REGULATION OF FATTY ACID TRANSPORT	31	6.95e-01	9.61e-01	0.2720	-1.38e-01	-1.14e-01	-1.39e-01	-1.49e-01	2.11e-02	1.83e-01	2.71e-01	1.81e-01	1.52e-01	8.39e-01
RESPONSE TO OXYGEN RADICAL	27	8.44e-01	9.86e-01	0.2720	1.47e-01	1.24e-01	1.33e-01	1.38e-01	1.46e-02	1.87e-01	2.67e-01	2.30e-01	2.14e-01	8.95e-01
RIBOFLAVIN METABOLIC PROCESS	5	9.03e-01	9.94e-01	0.2720	-1.15e-01	-1.55e-01	-1.39e-01	-1.06e-01	7.61e-02	6.56e-01	5.47e-01	5.89e-01	6.81e-01	7.68e-01
RESPONSE TO INDOLE 3 METHANOL	6	9.07e-01	9.94e-01	0.2720	-2.55e-02	1.69e-01	-1.44e-01	-1.21e-01	-9.49e-02	9.14e-01	4.73e-01	5.42e-01	6.06e-01	6.87e-01
TRNA MODIFICATION	89	2.13e-03	4.29e-02	0.2710	9.70e-02	-6.12e-02	1.79e-01	1.69e-01	8.87e-03	1.14e-01	3.18e-01	3.58e-03	5.89e-03	8.85e-01
ASYMMETRIC CELL DIVISION	18	8.14e-01	9.82e-01	0.2710	1.38e-01	8.46e-02	1.61e-01	1.46e-01	-1.05e-03	3.09e-01	5.34e-01	2.36e-01	2.84e-01	9.94e-01
REGULATION OF GLUCONEOGENESIS	51	2.60e-01	7.43e-01	0.2710	-7.32e-02	2.14e-02	-1.74e-01	-1.69e-01	-9.53e-02	3.66e-01	7.92e-01	3.19e-02	3.71e-02	2.39e-01
LACTATE TRANSMEMBRANE TRANSPORT	7	3.85e-01	8.40e-01	0.2710	-1.28e-01	-1.78e-01	-2.64e-02	-1.07e-01	-1.14e-01	5.58e-01	4.14e-01	9.04e-01	6.24e-01	6.00e-01
PHENOTYPIC SWITCHING	16	3.47e-01	8.18e-01	0.2710	-7.14e-02	-4.82e-02	-1.93e-01	-1.60e-01	5.52e-02	6.21e-01	7.39e-01	1.82e-01	2.66e-01	7.02e-01
RESPONSE TO CORTICOTROPIN RELEASING HORMONE	5	9.27e-01	9.95e-01	0.2710	-2.01e-01	-1.36e-01	-5.67e-02	-9.39e-02	4.85e-02	4.36e-01	5.98e-01	8.26e-01	7.16e-01	8.51e-01
KINETOCHORE ASSEMBLY	16	3.72e-01	8.32e-01	0.2710	1.65e-01	3.18e-02	1.68e-01	1.30e-01	5.94e-03	2.53e-01	8.26e-01	2.46e-01	3.67e-01	9.67e-01
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	32	3.34e-01	8.05e-01	0.2710	9.60e-02	1.10e-02	9.77e-02	8.74e-02	2.16e-01	3.47e-01	9.14e-01	3.39e-01	3.92e-01	3.42e-02
PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	10	9.21e-01	9.95e-01	0.2700	1.76e-01	1.55e-01	9.81e-02	9.16e-02	1.55e-02	3.36e-01	3.96e-01	5.91e-01	6.16e-01	9.32e-01
REGULATION OF VIRAL TRANSCRIPTION	18	6.06e-01	9.34e-01	0.2700	1.57e-01	8.09e-02	1.58e-01	1.30e-01	7.76e-03	2.49e-01	5.52e-01	2.46e-01	3.38e-01	9.55e-01
PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY	8	9.33e-01	9.97e-01	0.2700	-1.72e-01	-1.74e-01	-5.44e-02	-8.39e-02	5.84e-02	4.00e-01	3.94e-01	7.90e-01	6.81e-01	7.75e-01
PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE	103	8.33e-02	4.59e-01	0.2700	-1.42e-01	-6.17e-02	-1.56e-01	-1.44e-01	-6.30e-02	1.30e-02	2.80e-01	6.22e-03	1.14e-02	2.69e-01
BASE EXCISION REPAIR AP SITE FORMATION	12	2.91e-01	7.67e-01	0.2700	0.00e+00	-2.18e-01	1.01e-01	7.80e-02	-9.40e-02	1.00e+00	1.90e-01	5.43e-01	6.40e-01	5.73e-01
MAINTENANCE OF APICAL BASAL CELL POLARITY	10	8.58e-01	9.88e-01	0.2700	6.91e-02	-2.18e-02	1.92e-01	1.69e-01	4.92e-02	7.05e-01	9.05e-01	2.94e-01	3.56e-01	7.88e-01
MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING	34	5.02e-02	3.50e-01	0.2700	1.66e-01	4.98e-02	1.55e-01	1.15e-01	7.55e-02	9.43e-02	6.16e-01	1.19e-01	2.44e-01	4.46e-01
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	45	2.74e-01	7.56e-01	0.2700	-1.88e-01	-1.41e-01	-8.80e-02	-9.87e-02	-5.07e-04	2.89e-02	1.01e-01	3.07e-01	2.52e-01	9.95e-01
REGULATION OF GAMMA DELTA T CELL ACTIVATION	11	8.34e-01	9.85e-01	0.2700	1.14e-01	2.62e-02	1.72e-01	1.38e-01	1.02e-01	5.14e-01	8.80e-01	3.22e-01	4.28e-01	5.57e-01
POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	26	2.56e-01	7.39e-01	0.2700	-1.47e-01	-5.57e-02	-1.42e-01	-1.26e-01	1.10e-01	1.96e-01	6.23e-01	2.09e-01	2.67e-01	3.31e-01
POSITIVE REGULATION OF MYELINATION	17	2.93e-01	7.69e-01	0.2700	1.03e-01	2.36e-01	-4.50e-03	3.45e-02	7.04e-02	4.61e-01	9.15e-02	9.74e-01	8.05e-01	6.15e-01
REGULATION OF MICROVILLUS ORGANIZATION	13	5.21e-01	9.03e-01	0.2700	-3.27e-02	1.16e-01	-1.74e-01	-1.65e-01	2.68e-02	8.38e-01	4.70e-01	2.78e-01	3.02e-01	8.67e-01
HYALURONAN CATABOLIC PROCESS	16	8.13e-01	9.82e-01	0.2700	-1.49e-01	-1.37e-01	-9.91e-02	-1.01e-01	1.09e-01	3.04e-01	3.43e-01	4.92e-01	4.85e-01	4.51e-01
NEGATIVE REGULATION OF COLLATERAL SPROUTING	10	2.16e-01	6.97e-01	0.2700	6.48e-02	-5.83e-02	3.51e-03	-4.02e-02	2.52e-01	7.23e-01	7.50e-01	9.85e-01	8.26e-01	1.68e-01
NUCLEOLUS ORGANIZATION	16	8.43e-01	9.86e-01	0.2690	1.28e-01	6.53e-02	1.56e-01	1.61e-01	-3.83e-02	3.77e-01	6.51e-01	2.79e-01	2.64e-01	7.91e-01
BASE EXCISION REPAIR GAP FILLING	14	4.20e-01	8.59e-01	0.2690	6.09e-02	-1.15e-01	1.33e-01	1.64e-01	1.05e-01	6.93e-01	4.55e-01	3.89e-01	2.89e-01	4.98e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	22	6.87e-01	9.61e-01	0.2690	-1.62e-01	-9.00e-02	-1.27e-01	-1.30e-01	7.00e-02	1.88e-01	4.65e-01	3.02e-01	2.91e-01	5.70e-01
POSITIVE REGULATION OF CHROMATIN BINDING	9	8.54e-01	9.88e-01	0.2690	4.75e-02	-1.06e-01	1.74e-01	1.47e-01	8.55e-02	8.05e-01	5.83e-01	3.67e-01	4.46e-01	6.57e-01
TRICARBOXYLIC ACID METABOLIC PROCESS	14	8.73e-01	9.88e-01	0.2690	1.05e-01	2.62e-02	1.73e-01	1.75e-01	1.41e-02	4.97e-01	8.65e-01	2.62e-01	2.58e-01	9.27e-01
MORPHOGENESIS OF AN EPITHELIAL SHEET	59	1.08e-01	5.26e-01	0.2690	-1.01e-01	-1.17e-01	-1.40e-01	-1.57e-01	-6.53e-02	1.81e-01	1.21e-01	6.20e-02	3.73e-02	3.85e-01
HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION	7	3.88e-01	8.40e-01	0.2690	-2.55e-03	8.30e-02	9.63e-03	-4.94e-02	2.51e-01	9.91e-01	7.04e-01	9.65e-01	8.21e-01	2.51e-01
UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY	7	7.15e-01	9.68e-01	0.2690	8.99e-02	-1.59e-01	1.49e-01	1.28e-01	2.55e-02	6.80e-01	4.67e-01	4.96e-01	5.58e-01	9.07e-01
VENOUS BLOOD VESSEL MORPHOGENESIS	9	8.03e-01	9.82e-01	0.2690	6.49e-02	7.44e-02	-4.96e-02	-4.61e-02	-2.41e-01	7.36e-01	6.99e-01	7.97e-01	8.11e-01	2.11e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE	8	5.03e-01	8.98e-01	0.2690	-8.54e-02	-1.71e-01	1.93e-02	6.13e-02	1.77e-01	6.76e-01	4.01e-01	9.25e-01	7.64e-01	3.86e-01
MULTIVESICULAR BODY SORTING PATHWAY	46	3.49e-02	2.83e-01	0.2690	-6.87e-03	-2.02e-01	8.67e-02	8.44e-02	1.29e-01	9.36e-01	1.76e-02	3.09e-01	3.22e-01	1.31e-01
ATRIOVENTRICULAR CANAL DEVELOPMENT	13	4.03e-01	8.48e-01	0.2690	-4.35e-02	-2.52e-01	7.11e-02	4.05e-02	8.59e-03	7.86e-01	1.16e-01	6.57e-01	8.00e-01	9.57e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	9	9.75e-01	9.97e-01	0.2690	-1.11e-01	-6.39e-02	-1.47e-01	-1.35e-01	-1.26e-01	5.66e-01	7.40e-01	4.45e-01	4.84e-01	5.11e-01
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	11	3.78e-01	8.36e-01	0.2690	-1.01e-01	1.88e-02	-1.51e-01	-1.15e-01	1.59e-01	5.60e-01	9.14e-01	3.86e-01	5.09e-01	3.60e-01
RNA DECAPPING	19	4.31e-01	8.67e-01	0.2680	1.00e-01	-6.17e-02	1.79e-01	1.44e-01	7.36e-02	4.49e-01	6.42e-01	1.77e-01	2.77e-01	5.79e-01
RESPONSE TO COBALT ION	9	9.50e-01	9.97e-01	0.2680	1.37e-01	1.36e-02	1.65e-01	1.53e-01	5.07e-02	4.76e-01	9.44e-01	3.91e-01	4.28e-01	7.92e-01
MALE SEX DETERMINATION	11	4.01e-01	8.46e-01	0.2680	1.18e-01	-1.46e-01	1.19e-01	1.04e-01	1.09e-01	4.97e-01	4.03e-01	4.94e-01	5.51e-01	5.33e-01
RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	9	7.23e-01	9.70e-01	0.2680	-1.78e-02	-7.78e-02	-1.16e-01	-1.21e-01	-1.94e-01	9.26e-01	6.86e-01	5.47e-01	5.29e-01	3.14e-01
NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	10	8.87e-01	9.91e-01	0.2680	2.36e-02	-1.18e-01	1.05e-01	1.01e-01	1.90e-01	8.97e-01	5.18e-01	5.67e-01	5.79e-01	2.97e-01
NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING	6	4.17e-01	8.58e-01	0.2680	-1.02e-02	1.93e-01	1.94e-02	6.25e-02	1.74e-01	9.66e-01	4.12e-01	9.34e-01	7.91e-01	4.61e-01
CELLULAR RESPONSE TO PH	26	4.91e-02	3.46e-01	0.2680	7.72e-02	1.75e-01	3.09e-02	7.12e-02	1.72e-01	4.96e-01	1.23e-01	7.85e-01	5.30e-01	1.29e-01
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	10	8.85e-01	9.91e-01	0.2680	1.74e-01	1.86e-01	4.82e-02	5.23e-02	-4.43e-02	3.41e-01	3.08e-01	7.92e-01	7.75e-01	8.08e-01
CELLULAR RESPONSE TO FATTY ACID	33	3.50e-01	8.18e-01	0.2680	-1.42e-01	-9.68e-02	-8.50e-02	-1.05e-01	-1.55e-01	1.58e-01	3.36e-01	3.98e-01	2.97e-01	1.22e-01
INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY	7	7.24e-01	9.70e-01	0.2680	-1.62e-01	-2.06e-01	5.36e-02	1.02e-02	1.23e-03	4.57e-01	3.44e-01	8.06e-01	9.63e-01	9.95e-01
NUCLEAR MIGRATION	25	6.68e-01	9.56e-01	0.2680	-9.39e-02	-4.58e-03	-1.77e-01	-1.56e-01	-8.64e-02	4.17e-01	9.68e-01	1.26e-01	1.77e-01	4.55e-01
POSITIVE REGULATION OF MRNA 3 END PROCESSING	6	4.95e-01	8.96e-01	0.2680	-5.52e-02	-6.42e-02	1.56e-01	1.17e-01	-1.64e-01	8.15e-01	7.86e-01	5.09e-01	6.20e-01	4.87e-01
MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS	13	4.54e-01	8.78e-01	0.2680	1.16e-01	-3.40e-02	1.70e-01	1.21e-01	1.17e-01	4.69e-01	8.32e-01	2.88e-01	4.50e-01	4.66e-01
RESOLUTION OF RECOMBINATION INTERMEDIATES	6	9.26e-01	9.95e-01	0.2680	-8.09e-02	-1.29e-01	-1.58e-01	-1.53e-01	1.67e-02	7.32e-01	5.84e-01	5.03e-01	5.16e-01	9.44e-01
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	22	1.53e-01	6.16e-01	0.2680	-1.27e-01	-4.31e-02	-1.79e-01	-1.26e-01	-7.74e-02	3.04e-01	7.26e-01	1.47e-01	3.05e-01	5.30e-01
CAMP METABOLIC PROCESS	23	8.18e-01	9.83e-01	0.2680	-1.41e-01	-5.65e-02	-1.58e-01	-1.53e-01	-1.74e-02	2.42e-01	6.39e-01	1.89e-01	2.05e-01	8.85e-01
POSITIVE REGULATION OF CHROMOSOME CONDENSATION	8	9.03e-01	9.94e-01	0.2680	3.43e-02	-2.63e-02	1.55e-01	1.63e-01	1.38e-01	8.67e-01	8.98e-01	4.47e-01	4.23e-01	5.00e-01
SYNAPTIC VESICLE TRANSPORT	40	3.74e-01	8.35e-01	0.2680	4.96e-02	-6.68e-02	1.25e-01	1.14e-01	1.90e-01	5.87e-01	4.65e-01	1.71e-01	2.11e-01	3.80e-02
REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	31	4.80e-01	8.91e-01	0.2670	-1.19e-01	-1.22e-01	-1.30e-01	-1.34e-01	8.62e-02	2.51e-01	2.39e-01	2.11e-01	1.95e-01	4.06e-01
REGULATION OF PEPTIDYL LYSINE ACETYLATION	28	1.96e-01	6.73e-01	0.2670	1.24e-02	-1.76e-01	6.65e-02	5.62e-02	1.81e-01	9.10e-01	1.06e-01	5.42e-01	6.07e-01	9.81e-02
REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY	95	6.37e-04	1.71e-02	0.2670	8.01e-02	1.61e-01	9.09e-02	1.00e-01	1.45e-01	1.77e-01	6.82e-03	1.26e-01	9.14e-02	1.48e-02
PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	11	6.23e-01	9.43e-01	0.2670	-1.48e-02	-1.68e-01	5.17e-03	1.69e-02	2.07e-01	9.32e-01	3.36e-01	9.76e-01	9.22e-01	2.35e-01
POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION	6	9.56e-01	9.97e-01	0.2670	-2.63e-02	2.33e-02	-8.92e-02	-9.24e-02	-2.32e-01	9.11e-01	9.21e-01	7.05e-01	6.95e-01	3.26e-01
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	27	6.65e-01	9.54e-01	0.2670	-1.65e-01	-8.05e-02	-1.19e-01	-1.18e-01	-9.87e-02	1.39e-01	4.69e-01	2.86e-01	2.88e-01	3.75e-01
REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	5	7.51e-01	9.75e-01	0.2670	-3.16e-02	-9.04e-02	1.24e-01	1.08e-01	-1.88e-01	9.03e-01	7.26e-01	6.32e-01	6.75e-01	4.68e-01
T HELPER 17 CELL DIFFERENTIATION	32	6.19e-01	9.42e-01	0.2670	1.17e-01	1.22e-01	1.10e-01	1.12e-01	1.35e-01	2.52e-01	2.33e-01	2.82e-01	2.75e-01	1.86e-01
POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	6	8.52e-01	9.88e-01	0.2670	1.26e-01	8.15e-02	3.33e-02	2.54e-02	-2.17e-01	5.93e-01	7.30e-01	8.88e-01	9.14e-01	3.58e-01
ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL	12	7.16e-01	9.68e-01	0.2670	-5.91e-02	-1.49e-02	-1.23e-01	-1.50e-01	-1.73e-01	7.23e-01	9.29e-01	4.61e-01	3.69e-01	2.99e-01
GLYCOLIPID CATABOLIC PROCESS	16	8.90e-01	9.91e-01	0.2670	-1.49e-01	-1.52e-01	-1.18e-01	-1.09e-01	-1.89e-02	3.03e-01	2.94e-01	4.15e-01	4.50e-01	8.96e-01
PEPTIDYL LYSINE DIMETHYLATION	11	9.05e-01	9.94e-01	0.2670	-1.44e-01	-3.69e-02	-1.61e-01	-1.40e-01	-6.12e-02	4.10e-01	8.32e-01	3.56e-01	4.21e-01	7.25e-01
REGULATION OF CELLULAR PH REDUCTION	7	3.45e-01	8.16e-01	0.2670	5.05e-02	-6.49e-02	-1.49e-01	-1.65e-01	-1.24e-01	8.17e-01	7.66e-01	4.96e-01	4.51e-01	5.71e-01
ISOPRENOID TRANSPORT	5	8.53e-01	9.88e-01	0.2670	1.79e-01	1.88e-01	4.15e-03	5.99e-02	1.00e-02	4.87e-01	4.67e-01	9.87e-01	8.17e-01	9.69e-01
POSITIVE REGULATION OF CELL KILLING	75	8.21e-04	2.11e-02	0.2670	6.30e-02	1.54e-01	1.01e-01	1.14e-01	1.42e-01	3.45e-01	2.08e-02	1.30e-01	8.90e-02	3.32e-02
L ARGININE TRANSMEMBRANE TRANSPORT	14	7.60e-01	9.75e-01	0.2670	-1.07e-02	1.22e-01	-1.33e-01	-1.34e-01	-1.44e-01	9.45e-01	4.30e-01	3.88e-01	3.87e-01	3.52e-01
GLYCOSPHINGOLIPID CATABOLIC PROCESS	13	9.26e-01	9.95e-01	0.2670	-1.32e-01	-1.22e-01	-1.43e-01	-1.35e-01	1.36e-02	4.09e-01	4.45e-01	3.73e-01	4.01e-01	9.32e-01
NUCLEOBASE BIOSYNTHETIC PROCESS	16	8.05e-01	9.82e-01	0.2670	1.18e-01	1.03e-02	1.61e-01	1.75e-01	2.51e-02	4.14e-01	9.43e-01	2.66e-01	2.26e-01	8.62e-01
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	10	6.14e-01	9.38e-01	0.2670	-3.68e-04	1.83e-01	-1.33e-01	-1.40e-01	-1.88e-02	9.98e-01	3.17e-01	4.67e-01	4.43e-01	9.18e-01
TUBULIN COMPLEX ASSEMBLY	8	8.51e-01	9.88e-01	0.2660	3.83e-02	1.48e-01	-4.42e-02	-1.06e-02	-2.13e-01	8.51e-01	4.67e-01	8.28e-01	9.58e-01	2.96e-01
REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS	13	8.13e-01	9.82e-01	0.2660	9.77e-02	1.65e-01	1.01e-01	1.08e-01	1.10e-01	5.42e-01	3.02e-01	5.30e-01	4.99e-01	4.91e-01
INTESTINAL ABSORPTION	41	1.79e-01	6.52e-01	0.2660	-8.02e-02	8.87e-02	-1.26e-01	-1.13e-01	-1.67e-01	3.74e-01	3.26e-01	1.62e-01	2.10e-01	6.47e-02
MOTOR BEHAVIOR	22	6.89e-01	9.61e-01	0.2660	9.07e-02	-6.23e-02	1.45e-01	1.44e-01	1.31e-01	4.61e-01	6.13e-01	2.39e-01	2.43e-01	2.89e-01
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	14	6.57e-01	9.54e-01	0.2660	7.89e-02	1.34e-01	7.67e-02	8.39e-02	-1.84e-01	6.09e-01	3.86e-01	6.19e-01	5.87e-01	2.34e-01
SERINE TRANSPORT	9	6.46e-01	9.50e-01	0.2660	3.51e-02	-1.95e-01	8.38e-02	5.97e-02	1.45e-01	8.55e-01	3.11e-01	6.63e-01	7.56e-01	4.53e-01
NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	12	7.48e-01	9.75e-01	0.2660	1.12e-02	-5.18e-02	1.50e-01	1.14e-01	1.80e-01	9.46e-01	7.56e-01	3.69e-01	4.94e-01	2.80e-01
REGULATION OF AMYLOID FIBRIL FORMATION	16	5.71e-01	9.26e-01	0.2660	-1.28e-01	-1.10e-01	-5.11e-02	-5.46e-02	-1.91e-01	3.74e-01	4.48e-01	7.24e-01	7.06e-01	1.85e-01
DENDRITIC SPINE MAINTENANCE	22	6.11e-01	9.37e-01	0.2660	-1.55e-01	-1.01e-01	-8.63e-02	-9.11e-02	-1.44e-01	2.07e-01	4.13e-01	4.84e-01	4.60e-01	2.44e-01
SYNAPSE MATURATION	33	7.51e-01	9.75e-01	0.2660	1.62e-01	1.09e-01	1.23e-01	1.30e-01	2.07e-02	1.07e-01	2.80e-01	2.20e-01	1.96e-01	8.37e-01
HYDROGEN PEROXIDE CATABOLIC PROCESS	30	1.29e-01	5.72e-01	0.2660	-9.95e-03	-1.33e-01	4.19e-02	1.01e-02	2.26e-01	9.25e-01	2.08e-01	6.91e-01	9.24e-01	3.23e-02
ARGININE CATABOLIC PROCESS	11	8.90e-01	9.91e-01	0.2660	1.71e-01	1.72e-01	5.89e-02	7.76e-02	4.55e-02	3.25e-01	3.23e-01	7.35e-01	6.56e-01	7.94e-01
REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	8	9.63e-01	9.97e-01	0.2660	1.25e-01	1.21e-01	1.33e-01	1.35e-01	-6.70e-02	5.40e-01	5.54e-01	5.15e-01	5.10e-01	7.43e-01
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	83	8.77e-04	2.24e-02	0.2660	1.44e-01	-2.70e-02	1.67e-01	1.45e-01	1.65e-02	2.37e-02	6.70e-01	8.54e-03	2.23e-02	7.95e-01
NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	145	5.02e-02	3.50e-01	0.2660	1.08e-01	6.35e-02	1.47e-01	1.44e-01	1.11e-01	2.51e-02	1.87e-01	2.23e-03	2.68e-03	2.05e-02
REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	13	7.71e-01	9.76e-01	0.2660	9.79e-02	2.61e-02	1.61e-01	1.84e-01	2.18e-02	5.41e-01	8.70e-01	3.13e-01	2.52e-01	8.92e-01
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	82	7.74e-02	4.49e-01	0.2650	1.35e-01	3.48e-03	1.57e-01	1.60e-01	4.44e-02	3.51e-02	9.57e-01	1.38e-02	1.22e-02	4.87e-01
CD40 SIGNALING PATHWAY	15	4.57e-01	8.78e-01	0.2650	1.73e-01	-2.29e-02	1.26e-01	1.48e-01	4.68e-02	2.47e-01	8.78e-01	3.97e-01	3.20e-01	7.54e-01
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	54	4.59e-01	8.79e-01	0.2650	-1.25e-01	-3.29e-02	-1.61e-01	-1.58e-01	-5.29e-02	1.12e-01	6.76e-01	4.05e-02	4.45e-02	5.01e-01
HOMOLOGOUS CHROMOSOME SEGREGATION	64	4.97e-02	3.49e-01	0.2650	-1.27e-01	-7.67e-03	-1.42e-01	-1.68e-01	-7.79e-02	7.96e-02	9.15e-01	4.92e-02	2.04e-02	2.81e-01
VIRAL TRANSLATION	20	6.42e-01	9.50e-01	0.2650	5.60e-02	1.89e-02	1.47e-01	1.20e-01	1.75e-01	6.65e-01	8.84e-01	2.55e-01	3.51e-01	1.74e-01
DORSAL VENTRAL AXIS SPECIFICATION	12	8.75e-01	9.88e-01	0.2650	-4.02e-02	5.79e-02	-9.87e-02	-9.11e-02	-2.18e-01	8.10e-01	7.29e-01	5.54e-01	5.85e-01	1.92e-01
RESPONSE TO DISACCHARIDE	7	4.77e-01	8.87e-01	0.2650	-1.84e-01	-1.77e-01	-5.81e-02	-1.17e-02	-3.99e-02	4.00e-01	4.16e-01	7.90e-01	9.57e-01	8.55e-01
RENAL WATER TRANSPORT	9	8.70e-01	9.88e-01	0.2650	7.79e-02	1.28e-01	9.22e-02	8.43e-02	1.80e-01	6.86e-01	5.07e-01	6.32e-01	6.61e-01	3.51e-01
DENSE CORE GRANULE LOCALIZATION	10	7.18e-01	9.69e-01	0.2650	-1.42e-01	-7.76e-02	-1.46e-01	-1.17e-01	9.58e-02	4.38e-01	6.71e-01	4.23e-01	5.23e-01	6.00e-01
CIRCADIAN SLEEP WAKE CYCLE SLEEP	16	3.02e-01	7.74e-01	0.2650	-7.20e-02	1.76e-02	-6.10e-02	-7.36e-02	2.36e-01	6.18e-01	9.03e-01	6.73e-01	6.10e-01	1.03e-01
KERATINOCYTE DEVELOPMENT	13	4.04e-01	8.49e-01	0.2650	6.98e-03	1.70e-01	-1.61e-01	-1.15e-01	-4.38e-02	9.65e-01	2.88e-01	3.14e-01	4.73e-01	7.85e-01
SPINDLE ELONGATION	13	7.04e-01	9.65e-01	0.2650	1.17e-02	6.55e-02	-5.22e-02	-6.08e-02	-2.44e-01	9.42e-01	6.83e-01	7.45e-01	7.04e-01	1.28e-01
EXTRACELLULAR MATRIX ASSEMBLY	42	5.54e-01	9.16e-01	0.2650	-1.10e-01	-7.68e-02	-1.56e-01	-1.43e-01	-8.59e-02	2.16e-01	3.89e-01	8.02e-02	1.10e-01	3.36e-01
EPITHELIAL CELL MATURATION	24	1.60e-02	1.75e-01	0.2650	-1.40e-02	-1.69e-01	5.20e-04	-5.25e-02	1.96e-01	9.05e-01	1.51e-01	9.96e-01	6.56e-01	9.60e-02
POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	7	6.04e-01	9.34e-01	0.2650	-5.18e-02	3.75e-02	-2.00e-01	-1.48e-01	6.52e-02	8.12e-01	8.64e-01	3.60e-01	4.98e-01	7.65e-01
REGULATION OF CHONDROCYTE DEVELOPMENT	6	8.75e-01	9.88e-01	0.2650	-3.48e-02	-8.35e-02	-7.52e-02	-5.23e-02	-2.31e-01	8.82e-01	7.23e-01	7.50e-01	8.24e-01	3.27e-01
FORMATE METABOLIC PROCESS	6	6.26e-01	9.45e-01	0.2650	6.16e-02	9.13e-02	-1.77e-01	-1.61e-01	2.64e-02	7.94e-01	6.99e-01	4.53e-01	4.95e-01	9.11e-01
SEMINIFEROUS TUBULE DEVELOPMENT	14	1.92e-01	6.66e-01	0.2650	-1.19e-01	-9.93e-02	-1.12e-01	-1.78e-01	-4.22e-02	4.42e-01	5.20e-01	4.68e-01	2.48e-01	7.84e-01
MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING	84	5.05e-04	1.46e-02	0.2640	1.25e-01	1.08e-03	1.81e-01	1.45e-01	1.94e-02	4.70e-02	9.86e-01	4.08e-03	2.16e-02	7.59e-01
SMOOTH MUSCLE TISSUE DEVELOPMENT	27	1.51e-01	6.13e-01	0.2640	-7.50e-02	-2.06e-01	-8.57e-02	-7.33e-02	9.58e-02	5.00e-01	6.45e-02	4.41e-01	5.09e-01	3.89e-01
METAPHASE CHROMOSOME ALIGNMENT	97	6.75e-03	9.98e-02	0.2640	1.20e-01	-1.12e-02	1.66e-01	1.65e-01	-1.34e-02	4.15e-02	8.48e-01	4.62e-03	4.85e-03	8.20e-01
POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	8	3.23e-01	7.96e-01	0.2640	3.43e-02	1.03e-01	2.24e-02	-3.55e-02	2.37e-01	8.67e-01	6.12e-01	9.13e-01	8.62e-01	2.46e-01
NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	20	3.45e-01	8.16e-01	0.2640	-9.80e-02	1.28e-02	-1.91e-01	-1.49e-01	-3.72e-02	4.48e-01	9.21e-01	1.40e-01	2.49e-01	7.73e-01
REGULATION OF WNT PROTEIN SECRETION	5	8.74e-01	9.88e-01	0.2640	1.12e-02	4.58e-02	1.45e-01	1.59e-01	1.45e-01	9.65e-01	8.59e-01	5.73e-01	5.38e-01	5.75e-01
WNT PROTEIN SECRETION	5	8.74e-01	9.88e-01	0.2640	1.12e-02	4.58e-02	1.45e-01	1.59e-01	1.45e-01	9.65e-01	8.59e-01	5.73e-01	5.38e-01	5.75e-01
NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	11	7.27e-01	9.71e-01	0.2640	5.21e-02	-9.82e-02	1.40e-01	1.01e-01	1.66e-01	7.65e-01	5.73e-01	4.21e-01	5.64e-01	3.41e-01
POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	19	2.05e-01	6.84e-01	0.2640	-7.09e-02	-1.08e-01	-1.69e-01	-1.22e-01	-9.78e-02	5.93e-01	4.16e-01	2.03e-01	3.57e-01	4.60e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	12	7.75e-01	9.77e-01	0.2640	-8.59e-02	-1.72e-01	-1.24e-01	-1.21e-01	-4.81e-02	6.06e-01	3.01e-01	4.56e-01	4.67e-01	7.73e-01
GALACTOLIPID BIOSYNTHETIC PROCESS	6	5.98e-01	9.33e-01	0.2640	-7.77e-02	-7.44e-02	9.47e-02	2.31e-02	2.20e-01	7.42e-01	7.52e-01	6.88e-01	9.22e-01	3.50e-01
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION	66	1.85e-01	6.56e-01	0.2640	1.00e-01	-2.64e-02	1.62e-01	1.49e-01	1.01e-01	1.59e-01	7.11e-01	2.30e-02	3.62e-02	1.54e-01
SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR	11	8.64e-01	9.88e-01	0.2630	-1.38e-01	-1.69e-01	-1.73e-02	-2.76e-02	1.44e-01	4.28e-01	3.33e-01	9.21e-01	8.74e-01	4.08e-01
SEBACEOUS GLAND DEVELOPMENT	10	8.27e-01	9.83e-01	0.2630	-4.60e-02	1.91e-02	-9.45e-02	-6.69e-02	-2.31e-01	8.01e-01	9.17e-01	6.05e-01	7.14e-01	2.05e-01
POLYPRENOL METABOLIC PROCESS	23	4.37e-01	8.69e-01	0.2630	1.29e-01	-4.11e-03	1.52e-01	1.61e-01	-5.89e-02	2.83e-01	9.73e-01	2.06e-01	1.82e-01	6.25e-01
PERISTALSIS	12	4.43e-01	8.72e-01	0.2630	1.19e-01	-7.17e-02	1.06e-01	7.61e-02	1.82e-01	4.75e-01	6.67e-01	5.25e-01	6.48e-01	2.76e-01
NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION	8	5.39e-01	9.13e-01	0.2630	-1.55e-01	-2.07e-01	-4.64e-02	-5.80e-03	-2.41e-03	4.47e-01	3.10e-01	8.20e-01	9.77e-01	9.91e-01
GTP METABOLIC PROCESS	24	2.10e-02	2.10e-01	0.2630	-8.25e-02	-1.53e-01	7.77e-02	3.69e-02	-1.78e-01	4.84e-01	1.94e-01	5.10e-01	7.55e-01	1.31e-01
BONE MATURATION	26	3.24e-01	7.96e-01	0.2630	-8.32e-02	1.03e-01	-1.35e-01	-1.14e-01	-1.43e-01	4.62e-01	3.65e-01	2.33e-01	3.15e-01	2.05e-01
POSITIVE REGULATION OF FIBROBLAST MIGRATION	15	3.06e-01	7.79e-01	0.2630	-1.61e-01	-1.56e-02	-1.04e-01	-9.37e-02	1.53e-01	2.82e-01	9.17e-01	4.85e-01	5.30e-01	3.04e-01
REGULATION OF HELICASE ACTIVITY	10	9.63e-01	9.97e-01	0.2630	1.32e-01	6.08e-02	1.43e-01	1.29e-01	1.05e-01	4.71e-01	7.39e-01	4.32e-01	4.82e-01	5.65e-01
CYTOPLASMIC TRANSLATIONAL INITIATION	34	1.84e-01	6.56e-01	0.2630	6.17e-02	-3.53e-02	1.90e-01	1.66e-01	2.16e-02	5.34e-01	7.21e-01	5.53e-02	9.38e-02	8.27e-01
ATRIOVENTRICULAR VALVE FORMATION	8	7.89e-01	9.81e-01	0.2630	-1.81e-01	1.10e-02	-1.20e-01	-1.22e-01	-8.30e-02	3.76e-01	9.57e-01	5.55e-01	5.50e-01	6.84e-01
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS	26	3.86e-01	8.40e-01	0.2630	-4.18e-02	8.13e-02	-8.71e-02	-6.71e-02	-2.21e-01	7.12e-01	4.73e-01	4.42e-01	5.54e-01	5.15e-02
MESANGIAL CELL DIFFERENTIATION	7	2.63e-01	7.46e-01	0.2630	9.01e-02	-2.39e-01	4.04e-02	2.63e-02	3.96e-02	6.80e-01	2.74e-01	8.53e-01	9.04e-01	8.56e-01
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	17	8.73e-01	9.88e-01	0.2630	1.35e-01	6.42e-02	1.59e-01	1.44e-01	2.60e-02	3.36e-01	6.47e-01	2.57e-01	3.03e-01	8.53e-01
POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	13	6.75e-01	9.59e-01	0.2620	1.30e-01	1.41e-01	4.57e-02	4.40e-02	1.68e-01	4.18e-01	3.80e-01	7.76e-01	7.84e-01	2.94e-01
EMBRYONIC HEMOPOIESIS	23	4.21e-01	8.60e-01	0.2620	-1.95e-02	-1.50e-01	5.10e-02	2.82e-02	2.06e-01	8.71e-01	2.12e-01	6.72e-01	8.15e-01	8.73e-02
NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT	36	4.97e-01	8.96e-01	0.2620	-1.22e-01	-3.38e-02	-1.64e-01	-1.43e-01	-7.38e-02	2.04e-01	7.26e-01	8.88e-02	1.39e-01	4.43e-01
DETECTION OF LIGHT STIMULUS	61	3.45e-03	6.14e-02	0.2620	1.82e-02	1.93e-01	-1.31e-01	-1.07e-01	-4.89e-02	8.05e-01	8.99e-03	7.63e-02	1.49e-01	5.09e-01
FOCAL ADHESION ASSEMBLY	83	1.68e-01	6.36e-01	0.2620	-1.41e-01	-1.17e-01	-1.22e-01	-1.42e-01	-1.35e-02	2.62e-02	6.54e-02	5.50e-02	2.58e-02	8.32e-01
POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	23	4.01e-01	8.46e-01	0.2620	-9.99e-02	-7.16e-02	-1.18e-01	-1.24e-01	1.56e-01	4.07e-01	5.52e-01	3.29e-01	3.03e-01	1.96e-01
SINGLE STRAND BREAK REPAIR	11	6.67e-01	9.55e-01	0.2620	-5.78e-02	-1.76e-01	3.60e-02	5.53e-02	1.73e-01	7.40e-01	3.13e-01	8.36e-01	7.51e-01	3.20e-01
SEMAPHORIN PLEXIN SIGNALING PATHWAY	41	2.16e-01	6.98e-01	0.2620	-1.12e-01	2.78e-02	-1.65e-01	-1.67e-01	1.86e-03	2.15e-01	7.58e-01	6.72e-02	6.43e-02	9.84e-01
PHOTOPERIODISM	28	7.84e-01	9.81e-01	0.2620	-1.15e-01	-1.05e-01	-1.24e-01	-1.22e-01	-1.19e-01	2.92e-01	3.37e-01	2.57e-01	2.65e-01	2.76e-01
MITOCHONDRIAL CALCIUM ION HOMEOSTASIS	24	3.39e-01	8.08e-01	0.2620	-1.78e-02	-4.49e-02	6.18e-02	3.56e-02	2.47e-01	8.80e-01	7.04e-01	6.00e-01	7.63e-01	3.62e-02
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	17	6.62e-01	9.54e-01	0.2610	5.03e-02	-5.38e-03	6.64e-02	6.30e-02	2.40e-01	7.20e-01	9.69e-01	6.36e-01	6.53e-01	8.71e-02
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	22	4.09e-01	8.52e-01	0.2610	1.54e-01	1.27e-01	6.55e-02	5.86e-02	1.44e-01	2.11e-01	3.01e-01	5.95e-01	6.34e-01	2.42e-01
FEMALE MEIOTIC NUCLEAR DIVISION	38	5.96e-01	9.33e-01	0.2610	1.23e-01	4.63e-02	1.53e-01	1.36e-01	9.61e-02	1.91e-01	6.21e-01	1.03e-01	1.46e-01	3.05e-01
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	67	5.88e-02	3.86e-01	0.2610	9.15e-02	1.24e-01	1.01e-01	1.14e-01	1.46e-01	1.95e-01	7.95e-02	1.51e-01	1.06e-01	3.91e-02
REGULATION OF AMYLOID BETA CLEARANCE	20	5.19e-02	3.58e-01	0.2610	7.42e-02	1.14e-01	2.15e-02	7.66e-02	2.09e-01	5.66e-01	3.78e-01	8.68e-01	5.53e-01	1.06e-01
LENS FIBER CELL DIFFERENTIATION	37	3.15e-01	7.87e-01	0.2610	4.02e-02	-9.88e-02	1.38e-01	1.15e-01	1.57e-01	6.72e-01	2.98e-01	1.48e-01	2.26e-01	9.76e-02
POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	22	5.59e-01	9.19e-01	0.2610	5.98e-02	9.18e-02	1.20e-01	1.14e-01	1.70e-01	6.27e-01	4.56e-01	3.32e-01	3.53e-01	1.67e-01
AMYLOID BETA CLEARANCE BY TRANSCYTOSIS	7	8.30e-01	9.84e-01	0.2610	1.09e-01	-8.88e-02	1.48e-01	1.63e-01	-4.44e-03	6.19e-01	6.84e-01	4.97e-01	4.55e-01	9.84e-01
BONE REMODELING	89	1.18e-01	5.49e-01	0.2610	-1.16e-01	-1.07e-01	-1.46e-01	-1.48e-01	-4.13e-04	5.81e-02	8.07e-02	1.71e-02	1.60e-02	9.95e-01
AUDITORY RECEPTOR CELL DEVELOPMENT	24	2.54e-01	7.37e-01	0.2610	-1.25e-01	6.24e-02	-1.60e-01	-1.32e-01	-7.47e-02	2.88e-01	5.97e-01	1.75e-01	2.63e-01	5.27e-01
CARDIAC RIGHT VENTRICLE MORPHOGENESIS	21	9.62e-02	4.94e-01	0.2610	-4.34e-02	-2.40e-01	-7.76e-03	-2.86e-02	-8.75e-02	7.30e-01	5.68e-02	9.51e-01	8.20e-01	4.88e-01
POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	7	9.32e-01	9.97e-01	0.2610	1.61e-01	3.14e-02	1.31e-01	1.16e-01	1.03e-01	4.61e-01	8.86e-01	5.48e-01	5.96e-01	6.37e-01
CARDIAC CELL FATE COMMITMENT	16	3.53e-01	8.21e-01	0.2610	-3.29e-02	-2.32e-01	5.44e-02	1.92e-02	9.80e-02	8.20e-01	1.08e-01	7.06e-01	8.94e-01	4.98e-01
REGULATION OF MYELOID CELL APOPTOTIC PROCESS	31	3.30e-01	8.02e-01	0.2610	-9.44e-02	-1.84e-01	-7.19e-02	-8.50e-02	1.13e-01	3.63e-01	7.59e-02	4.88e-01	4.13e-01	2.77e-01
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	33	3.62e-01	8.26e-01	0.2610	1.21e-01	1.11e-01	1.30e-01	1.20e-01	-9.77e-02	2.30e-01	2.70e-01	1.95e-01	2.31e-01	3.32e-01
POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION	10	2.19e-01	7.00e-01	0.2610	2.52e-02	1.62e-01	-9.53e-02	-3.92e-02	1.74e-01	8.90e-01	3.74e-01	6.02e-01	8.30e-01	3.40e-01
REGULATION OF RECEPTOR CLUSTERING	13	9.00e-01	9.94e-01	0.2610	-1.22e-01	-1.53e-01	-9.76e-02	-1.16e-01	-8.23e-02	4.48e-01	3.38e-01	5.42e-01	4.71e-01	6.07e-01
BLASTOCYST FORMATION	45	5.44e-01	9.15e-01	0.2610	1.62e-01	1.13e-01	1.10e-01	1.14e-01	6.30e-02	6.05e-02	1.92e-01	2.01e-01	1.86e-01	4.64e-01
EXIT FROM MITOSIS	32	1.41e-01	5.99e-01	0.2600	7.26e-02	-1.07e-01	1.70e-01	1.46e-01	2.83e-02	4.77e-01	2.93e-01	9.68e-02	1.52e-01	7.82e-01
PYRIMIDINE DIMER REPAIR	9	6.44e-01	9.50e-01	0.2600	-7.91e-02	-2.16e-01	-7.54e-02	-4.95e-02	-8.32e-02	6.81e-01	2.63e-01	6.95e-01	7.97e-01	6.66e-01
MITOTIC SISTER CHROMATID SEGREGATION	180	2.26e-04	7.75e-03	0.2600	1.06e-01	-1.04e-02	1.69e-01	1.66e-01	1.89e-02	1.37e-02	8.09e-01	9.46e-05	1.26e-04	6.62e-01
NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	21	7.41e-01	9.73e-01	0.2600	-1.17e-01	2.55e-02	-1.35e-01	-1.33e-01	-1.32e-01	3.53e-01	8.39e-01	2.86e-01	2.90e-01	2.95e-01
FORELIMB MORPHOGENESIS	39	3.46e-04	1.08e-02	0.2600	1.89e-01	-5.85e-02	1.16e-01	9.67e-02	7.44e-02	4.09e-02	5.28e-01	2.09e-01	2.96e-01	4.21e-01
NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	7	4.62e-01	8.80e-01	0.2600	-5.10e-02	1.63e-01	-1.73e-02	-3.99e-02	1.91e-01	8.15e-01	4.55e-01	9.37e-01	8.55e-01	3.82e-01
GLOMERULAR MESANGIAL CELL PROLIFERATION	13	9.42e-01	9.97e-01	0.2600	1.64e-01	1.35e-01	1.03e-01	1.04e-01	3.12e-02	3.07e-01	3.98e-01	5.19e-01	5.16e-01	8.45e-01
WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	12	9.46e-01	9.97e-01	0.2600	-1.21e-01	-1.41e-01	-1.23e-01	-1.33e-01	-1.34e-02	4.69e-01	3.97e-01	4.62e-01	4.23e-01	9.36e-01
CELLULAR RESPONSE TO ATP	16	9.26e-01	9.95e-01	0.2600	-1.24e-01	-1.40e-01	-1.23e-01	-1.30e-01	-2.76e-02	3.91e-01	3.33e-01	3.96e-01	3.69e-01	8.49e-01
GERMINAL CENTER FORMATION	14	7.19e-01	9.69e-01	0.2600	-1.27e-01	-2.21e-01	-3.58e-02	-2.80e-02	2.28e-02	4.10e-01	1.53e-01	8.16e-01	8.56e-01	8.83e-01
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	70	1.56e-03	3.41e-02	0.2600	4.45e-02	-1.31e-01	1.66e-01	1.36e-01	4.73e-02	5.20e-01	5.82e-02	1.60e-02	4.98e-02	4.94e-01
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	32	4.31e-01	8.68e-01	0.2600	-1.27e-01	-4.50e-02	-1.03e-01	-1.23e-01	-1.53e-01	2.14e-01	6.60e-01	3.15e-01	2.27e-01	1.34e-01
ISOPRENOID CATABOLIC PROCESS	10	2.64e-01	7.47e-01	0.2590	6.32e-02	-6.12e-02	-1.11e-01	-1.13e-01	-1.86e-01	7.29e-01	7.38e-01	5.44e-01	5.35e-01	3.09e-01
MODULATION BY HOST OF SYMBIONT PROCESS	81	9.43e-02	4.90e-01	0.2590	6.56e-02	-3.05e-02	1.43e-01	1.25e-01	1.61e-01	3.08e-01	6.35e-01	2.60e-02	5.18e-02	1.22e-02
CELL MIGRATION IN HINDBRAIN	16	6.92e-01	9.61e-01	0.2590	1.15e-01	1.31e-01	1.12e-01	8.81e-02	1.29e-01	4.27e-01	3.64e-01	4.39e-01	5.42e-01	3.72e-01
POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	11	3.40e-01	8.09e-01	0.2590	-3.33e-02	-1.67e-01	-9.70e-02	-1.26e-01	1.15e-01	8.48e-01	3.39e-01	5.77e-01	4.70e-01	5.10e-01
GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS	6	9.38e-01	9.97e-01	0.2590	-1.10e-01	-2.26e-01	-2.86e-02	-5.31e-02	-1.44e-02	6.40e-01	3.37e-01	9.03e-01	8.22e-01	9.51e-01
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	38	2.56e-01	7.39e-01	0.2590	2.89e-02	-1.27e-01	1.35e-01	1.16e-01	1.37e-01	7.58e-01	1.77e-01	1.50e-01	2.18e-01	1.44e-01
NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	21	6.02e-01	9.33e-01	0.2590	-1.25e-01	-1.95e-01	-5.92e-02	-5.04e-02	8.56e-02	3.20e-01	1.22e-01	6.39e-01	6.89e-01	4.97e-01
EXTRACELLULAR MATRIX CONSTITUENT SECRETION	13	8.12e-01	9.82e-01	0.2590	1.63e-01	1.53e-01	6.59e-02	1.02e-01	-4.73e-02	3.08e-01	3.39e-01	6.81e-01	5.25e-01	7.68e-01
POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	10	7.98e-01	9.81e-01	0.2590	1.16e-01	1.98e-01	9.24e-02	7.04e-02	3.14e-02	5.26e-01	2.78e-01	6.13e-01	7.00e-01	8.64e-01
SECRETORY GRANULE LOCALIZATION	13	7.23e-01	9.70e-01	0.2590	-1.31e-02	-5.17e-02	5.28e-02	5.94e-02	2.41e-01	9.35e-01	7.47e-01	7.42e-01	7.11e-01	1.33e-01
MITOCHONDRIAL FUSION	32	5.01e-01	8.98e-01	0.2590	2.74e-02	-7.23e-02	1.13e-01	9.89e-02	1.96e-01	7.89e-01	4.79e-01	2.69e-01	3.33e-01	5.48e-02
LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	16	1.85e-01	6.56e-01	0.2590	-8.44e-02	-1.32e-01	-1.42e-01	-9.66e-02	1.15e-01	5.59e-01	3.61e-01	3.27e-01	5.04e-01	4.27e-01
CELLULAR RESPONSE TO OXYGEN LEVELS	160	7.77e-03	1.09e-01	0.2590	8.44e-02	-2.72e-02	1.47e-01	1.38e-01	1.36e-01	6.53e-02	5.52e-01	1.35e-03	2.64e-03	2.93e-03
MONOATOMIC ANION HOMEOSTASIS	20	5.69e-01	9.25e-01	0.2590	-8.31e-02	9.98e-02	-1.39e-01	-1.42e-01	-1.03e-01	5.20e-01	4.40e-01	2.81e-01	2.72e-01	4.26e-01
KERATAN SULFATE METABOLIC PROCESS	18	7.55e-01	9.75e-01	0.2590	-1.46e-01	-1.00e-01	-1.11e-01	-1.43e-01	-5.50e-02	2.85e-01	4.61e-01	4.16e-01	2.95e-01	6.86e-01
REGULATION OF PINOCYTOSIS	12	3.01e-01	7.74e-01	0.2590	4.01e-02	-1.25e-01	1.19e-01	1.44e-01	-1.22e-01	8.10e-01	4.54e-01	4.76e-01	3.89e-01	4.64e-01
CELLULAR RESPONSE TO WATER STIMULUS	6	1.61e-01	6.24e-01	0.2590	1.75e-01	2.02e-02	-4.62e-02	-8.06e-02	1.64e-01	4.57e-01	9.32e-01	8.44e-01	7.32e-01	4.86e-01
FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA	13	8.41e-01	9.85e-01	0.2580	-1.16e-01	-2.02e-01	-5.06e-02	-7.46e-02	6.67e-02	4.68e-01	2.08e-01	7.52e-01	6.42e-01	6.77e-01
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT	8	9.03e-01	9.94e-01	0.2580	-7.07e-02	-2.17e-01	3.31e-02	2.22e-02	1.13e-01	7.29e-01	2.87e-01	8.71e-01	9.13e-01	5.78e-01
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS	31	2.94e-01	7.71e-01	0.2580	-1.36e-01	-1.62e-01	-8.11e-02	-1.20e-01	-3.31e-02	1.91e-01	1.19e-01	4.35e-01	2.47e-01	7.50e-01
VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	5.59e-01	9.19e-01	0.2580	1.50e-02	-3.55e-02	1.36e-01	1.82e-01	1.16e-01	9.45e-01	8.71e-01	5.34e-01	4.03e-01	5.95e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT	5	9.39e-01	9.97e-01	0.2580	-1.15e-01	-2.29e-01	2.66e-02	2.50e-03	-1.61e-02	6.55e-01	3.76e-01	9.18e-01	9.92e-01	9.50e-01
G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	14	3.24e-01	7.96e-01	0.2580	-2.69e-02	1.83e-01	-1.19e-01	-1.28e-01	3.86e-02	8.62e-01	2.35e-01	4.39e-01	4.06e-01	8.03e-01
REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	11	9.45e-01	9.97e-01	0.2580	1.15e-01	2.87e-03	1.29e-01	1.23e-01	1.47e-01	5.10e-01	9.87e-01	4.60e-01	4.81e-01	3.97e-01
DNA TEMPLATED DNA REPLICATION	158	2.62e-05	1.29e-03	0.2580	6.39e-02	-5.47e-02	1.79e-01	1.60e-01	4.08e-02	1.65e-01	2.35e-01	1.01e-04	5.14e-04	3.76e-01
POSITIVE REGULATION OF MEIOTIC CELL CYCLE	27	4.30e-01	8.66e-01	0.2580	1.21e-01	2.12e-01	-1.49e-02	-4.68e-03	-8.10e-02	2.77e-01	5.62e-02	8.93e-01	9.66e-01	4.66e-01
REGULATION OF INTEGRIN ACTIVATION	17	1.75e-01	6.47e-01	0.2580	-7.37e-02	9.37e-02	-1.28e-01	-1.55e-01	1.09e-01	5.99e-01	5.03e-01	3.59e-01	2.69e-01	4.38e-01
SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	17	6.99e-01	9.62e-01	0.2580	-7.22e-03	-4.94e-02	1.20e-01	1.08e-01	1.94e-01	9.59e-01	7.25e-01	3.90e-01	4.41e-01	1.65e-01
GOLGI LUMEN ACIDIFICATION	10	7.46e-01	9.75e-01	0.2580	1.04e-01	5.60e-02	1.34e-01	1.15e-01	-1.46e-01	5.71e-01	7.59e-01	4.64e-01	5.29e-01	4.23e-01
NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	21	8.06e-01	9.82e-01	0.2580	-1.13e-01	-5.70e-02	-1.63e-01	-1.55e-01	7.36e-04	3.72e-01	6.51e-01	1.97e-01	2.18e-01	9.95e-01
REGULATION OF GTP BINDING	11	9.26e-01	9.95e-01	0.2580	-1.45e-01	-1.93e-02	-1.27e-01	-1.36e-01	-1.03e-01	4.06e-01	9.12e-01	4.67e-01	4.36e-01	5.52e-01
PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	23	4.71e-01	8.85e-01	0.2580	1.02e-01	-7.88e-02	1.32e-01	1.40e-01	1.13e-01	3.95e-01	5.13e-01	2.74e-01	2.46e-01	3.49e-01
NEURONAL ION CHANNEL CLUSTERING	12	6.73e-01	9.59e-01	0.2580	6.19e-02	1.64e-01	1.16e-01	1.15e-01	9.46e-02	7.11e-01	3.26e-01	4.85e-01	4.90e-01	5.71e-01
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	20	1.54e-01	6.16e-01	0.2570	-1.86e-02	-2.15e-01	-2.45e-02	-1.48e-02	1.38e-01	8.85e-01	9.67e-02	8.50e-01	9.09e-01	2.85e-01
BENZENE CONTAINING COMPOUND METABOLIC PROCESS	26	1.77e-01	6.47e-01	0.2570	-1.71e-01	-1.90e-01	2.12e-02	1.30e-03	1.71e-02	1.32e-01	9.27e-02	8.51e-01	9.91e-01	8.80e-01
POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	16	5.60e-01	9.20e-01	0.2570	-9.77e-02	-1.31e-01	-1.77e-02	-5.45e-02	1.90e-01	4.99e-01	3.65e-01	9.03e-01	7.06e-01	1.87e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	33	7.19e-01	9.69e-01	0.2570	-1.18e-01	-1.18e-01	-1.23e-01	-1.18e-01	-9.67e-02	2.42e-01	2.41e-01	2.21e-01	2.40e-01	3.37e-01
POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	5	8.74e-01	9.88e-01	0.2570	1.60e-03	-5.64e-02	-9.47e-02	-6.06e-02	-2.24e-01	9.95e-01	8.27e-01	7.14e-01	8.15e-01	3.85e-01
MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS	23	7.77e-01	9.79e-01	0.2570	1.24e-01	1.27e-02	1.61e-01	1.49e-01	5.04e-02	3.03e-01	9.16e-01	1.82e-01	2.16e-01	6.76e-01
CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS	18	9.04e-01	9.94e-01	0.2570	1.15e-01	7.73e-02	1.18e-01	1.15e-01	1.41e-01	3.97e-01	5.70e-01	3.87e-01	3.99e-01	3.02e-01
HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING	16	2.86e-01	7.66e-01	0.2570	-1.46e-01	-1.51e-01	-1.12e-01	-7.03e-02	6.66e-02	3.12e-01	2.96e-01	4.36e-01	6.26e-01	6.45e-01
REGULATION OF METALLOPEPTIDASE ACTIVITY	22	7.43e-01	9.74e-01	0.2570	1.54e-01	1.79e-01	5.69e-02	8.02e-02	-2.46e-02	2.11e-01	1.45e-01	6.44e-01	5.15e-01	8.42e-01
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	25	4.89e-01	8.92e-01	0.2570	-1.71e-01	-1.33e-01	-9.76e-02	-8.54e-02	4.76e-02	1.39e-01	2.50e-01	3.98e-01	4.60e-01	6.80e-01
POSITIVE REGULATION OF HORMONE METABOLIC PROCESS	15	4.67e-01	8.83e-01	0.2570	-1.18e-01	-1.77e-01	3.55e-02	-1.59e-02	1.39e-01	4.31e-01	2.35e-01	8.12e-01	9.15e-01	3.51e-01
AMIDE CATABOLIC PROCESS	20	4.92e-01	8.94e-01	0.2570	3.36e-02	1.29e-01	-1.21e-01	-8.53e-02	-1.62e-01	7.95e-01	3.19e-01	3.50e-01	5.09e-01	2.09e-01
HYPOTHALAMUS DEVELOPMENT	24	2.13e-01	6.93e-01	0.2570	-9.81e-02	-1.93e-01	2.61e-02	-2.39e-02	1.33e-01	4.05e-01	1.02e-01	8.25e-01	8.39e-01	2.59e-01
CARDIAC MUSCLE MYOBLAST PROLIFERATION	7	7.18e-01	9.69e-01	0.2570	2.08e-01	4.95e-02	8.41e-02	7.94e-02	8.21e-02	3.41e-01	8.21e-01	7.00e-01	7.16e-01	7.07e-01
MULTIVESICULAR BODY ORGANIZATION	32	1.23e-01	5.62e-01	0.2570	4.34e-03	-1.86e-01	1.06e-01	1.11e-01	8.70e-02	9.66e-01	6.90e-02	2.98e-01	2.76e-01	3.94e-01
MITOTIC SISTER CHROMATID SEPARATION	62	8.73e-03	1.17e-01	0.2560	5.82e-02	3.28e-04	1.82e-01	1.67e-01	-3.38e-02	4.28e-01	9.96e-01	1.30e-02	2.30e-02	6.45e-01
REGULATION OF STORE OPERATED CALCIUM ENTRY	15	4.39e-01	8.70e-01	0.2560	5.46e-02	1.14e-01	1.43e-02	6.50e-03	2.22e-01	7.14e-01	4.44e-01	9.24e-01	9.65e-01	1.37e-01
ENDOCRINE HORMONE SECRETION	56	1.56e-01	6.18e-01	0.2560	-9.83e-02	-7.98e-02	-1.48e-01	-1.64e-01	-2.22e-02	2.03e-01	3.02e-01	5.54e-02	3.32e-02	7.74e-01
CELL SUBSTRATE JUNCTION DISASSEMBLY	8	5.23e-01	9.04e-01	0.2560	-1.01e-01	-1.57e-01	1.16e-01	4.89e-02	1.21e-01	6.21e-01	4.42e-01	5.69e-01	8.11e-01	5.52e-01
RESPONSE TO COPPER ION	35	4.55e-01	8.78e-01	0.2560	1.24e-01	3.71e-02	1.28e-01	1.52e-01	9.47e-02	2.04e-01	7.04e-01	1.89e-01	1.19e-01	3.32e-01
PEPTIDE CATABOLIC PROCESS	22	4.82e-01	8.91e-01	0.2560	-6.34e-02	9.26e-02	-1.46e-01	-1.58e-01	-8.15e-02	6.06e-01	4.52e-01	2.37e-01	2.00e-01	5.08e-01
SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION	9	8.64e-01	9.88e-01	0.2560	-1.47e-02	-1.88e-01	7.43e-02	6.51e-02	1.42e-01	9.39e-01	3.30e-01	6.99e-01	7.35e-01	4.61e-01
BONE MINERALIZATION INVOLVED IN BONE MATURATION	13	6.33e-01	9.48e-01	0.2560	-3.81e-02	-5.38e-02	-1.03e-01	-7.14e-02	-2.13e-01	8.12e-01	7.37e-01	5.20e-01	6.56e-01	1.84e-01
REGULATION OF DNA BINDING	82	9.10e-02	4.81e-01	0.2560	1.44e-01	2.37e-02	1.48e-01	1.47e-01	2.18e-02	2.42e-02	7.11e-01	2.04e-02	2.14e-02	7.33e-01
DOPAMINERGIC NEURON DIFFERENTIATION	40	8.95e-04	2.26e-02	0.2550	3.49e-03	-2.32e-01	2.61e-02	-7.98e-03	1.04e-01	9.70e-01	1.12e-02	7.75e-01	9.30e-01	2.56e-01
REGULATION OF SUPEROXIDE METABOLIC PROCESS	30	2.17e-01	6.99e-01	0.2550	-1.55e-01	-1.24e-01	-2.64e-02	-3.33e-02	1.55e-01	1.42e-01	2.38e-01	8.02e-01	7.52e-01	1.43e-01
MICROGLIAL CELL PROLIFERATION	8	4.70e-02	3.39e-01	0.2550	-1.44e-03	5.64e-03	-2.09e-01	-1.06e-01	1.02e-01	9.94e-01	9.78e-01	3.06e-01	6.04e-01	6.19e-01
POSITIVE REGULATION OF JNK CASCADE	85	1.02e-01	5.10e-01	0.2550	-9.18e-02	-5.34e-02	-1.60e-01	-1.62e-01	-4.39e-02	1.43e-01	3.95e-01	1.06e-02	9.74e-03	4.84e-01
ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE	9	3.69e-01	8.31e-01	0.2550	-3.09e-02	-1.95e-01	1.42e-01	7.75e-02	-8.12e-03	8.72e-01	3.11e-01	4.61e-01	6.87e-01	9.66e-01
NEGATIVE REGULATION OF CELLULAR RESPIRATION	10	5.10e-01	9.00e-01	0.2550	-1.53e-01	-1.26e-01	-1.28e-01	-7.82e-02	-5.87e-02	4.02e-01	4.91e-01	4.83e-01	6.69e-01	7.48e-01
ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	21	1.69e-01	6.37e-01	0.2550	-4.98e-02	-2.20e-01	7.40e-02	5.89e-02	-7.17e-02	6.93e-01	8.04e-02	5.57e-01	6.40e-01	5.70e-01
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS	305	7.37e-08	6.54e-06	0.2550	1.40e-01	1.85e-02	1.51e-01	1.48e-01	-1.03e-02	2.49e-05	5.79e-01	5.54e-06	8.18e-06	7.57e-01
PROXIMAL DISTAL PATTERN FORMATION	34	6.91e-05	2.88e-03	0.2550	1.89e-01	-7.21e-02	1.25e-01	8.67e-02	3.39e-02	5.71e-02	4.67e-01	2.08e-01	3.81e-01	7.32e-01
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	5	7.14e-01	9.68e-01	0.2550	9.81e-02	-1.07e-01	5.70e-02	6.66e-02	-1.90e-01	7.04e-01	6.78e-01	8.25e-01	7.97e-01	4.62e-01
LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	5.84e-01	9.28e-01	0.2550	-1.03e-01	-8.03e-02	1.63e-01	1.27e-01	7.35e-02	6.64e-01	7.33e-01	4.91e-01	5.89e-01	7.55e-01
REGULATION OF DENDRITE EXTENSION	26	4.68e-01	8.84e-01	0.2550	-1.15e-01	-1.23e-01	-6.82e-02	-9.04e-02	1.54e-01	3.11e-01	2.78e-01	5.47e-01	4.25e-01	1.73e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	17	1.86e-01	6.56e-01	0.2550	6.26e-02	-1.18e-01	1.23e-01	1.09e-01	-1.41e-01	6.55e-01	3.99e-01	3.79e-01	4.37e-01	3.13e-01
AMINO ACID IMPORT ACROSS PLASMA MEMBRANE	44	2.37e-01	7.21e-01	0.2550	1.56e-01	1.74e-01	3.09e-02	5.64e-02	-7.85e-02	7.39e-02	4.56e-02	7.23e-01	5.17e-01	3.68e-01
HYALOID VASCULAR PLEXUS REGRESSION	7	7.90e-01	9.81e-01	0.2550	7.11e-02	2.21e-01	-5.34e-02	-4.00e-02	8.11e-02	7.45e-01	3.12e-01	8.07e-01	8.55e-01	7.10e-01
CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	118	1.31e-03	3.04e-02	0.2550	-1.21e-01	-1.07e-01	-9.73e-02	-1.19e-01	1.23e-01	2.34e-02	4.40e-02	6.79e-02	2.58e-02	2.10e-02
REGULATION OF CHOLESTEROL STORAGE	19	5.45e-01	9.15e-01	0.2540	-1.17e-01	-1.20e-01	-4.44e-02	-3.87e-02	1.82e-01	3.76e-01	3.64e-01	7.38e-01	7.70e-01	1.70e-01
KETONE CATABOLIC PROCESS	14	7.81e-01	9.81e-01	0.2540	1.10e-01	2.24e-01	1.32e-02	3.17e-02	-3.21e-02	4.76e-01	1.46e-01	9.32e-01	8.37e-01	8.35e-01
INOSITOL METABOLIC PROCESS	8	4.86e-01	8.92e-01	0.2540	-8.93e-02	8.13e-02	-1.26e-01	-1.73e-01	6.47e-02	6.62e-01	6.90e-01	5.37e-01	3.97e-01	7.51e-01
COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY	8	6.56e-01	9.53e-01	0.2540	-4.06e-02	5.86e-02	4.75e-02	4.94e-02	2.34e-01	8.42e-01	7.74e-01	8.16e-01	8.09e-01	2.52e-01
REGULATION OF AUTOPHAGY OF MITOCHONDRION	38	2.53e-01	7.37e-01	0.2540	-9.71e-02	-1.16e-01	-1.14e-01	-1.39e-01	-9.70e-02	3.00e-01	2.17e-01	2.26e-01	1.37e-01	3.01e-01
CARNITINE TRANSPORT	8	5.60e-01	9.19e-01	0.2540	3.83e-02	5.27e-04	-1.75e-01	-1.59e-01	-8.54e-02	8.51e-01	9.98e-01	3.92e-01	4.37e-01	6.76e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	184	2.25e-05	1.13e-03	0.2540	4.14e-02	-1.13e-01	1.41e-01	1.32e-01	1.12e-01	3.33e-01	7.99e-03	9.76e-04	2.03e-03	8.56e-03
AXIS ELONGATION	28	3.67e-01	8.30e-01	0.2540	8.95e-02	-7.04e-02	1.66e-01	1.44e-01	5.51e-02	4.12e-01	5.19e-01	1.28e-01	1.87e-01	6.14e-01
POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	19	2.38e-01	7.22e-01	0.2540	1.70e-02	9.46e-02	-8.50e-03	-1.65e-02	2.34e-01	8.98e-01	4.75e-01	9.49e-01	9.01e-01	7.72e-02
DERMATAN SULFATE BIOSYNTHETIC PROCESS	5	5.96e-01	9.33e-01	0.2540	1.69e-01	-3.60e-02	9.99e-02	6.70e-02	-1.41e-01	5.12e-01	8.89e-01	6.99e-01	7.95e-01	5.84e-01
SENSORY PERCEPTION	884	2.06e-22	1.41e-19	0.2540	-1.46e-01	-1.48e-02	-1.46e-01	-1.45e-01	-2.08e-02	1.67e-13	4.54e-01	1.63e-13	2.52e-13	2.93e-01
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	15	3.80e-01	8.37e-01	0.2540	-5.39e-02	-2.08e-01	-9.22e-02	-8.41e-02	4.98e-02	7.18e-01	1.63e-01	5.36e-01	5.73e-01	7.39e-01
CARDIAC MYOFIBRIL ASSEMBLY	19	7.03e-01	9.65e-01	0.2540	-2.47e-02	1.19e-01	-1.10e-01	-1.07e-01	-1.61e-01	8.52e-01	3.69e-01	4.08e-01	4.18e-01	2.24e-01
L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	17	7.49e-01	9.75e-01	0.2530	1.17e-01	1.43e-01	7.68e-02	9.98e-02	1.20e-01	4.04e-01	3.08e-01	5.84e-01	4.76e-01	3.93e-01
MONOACYLGLYCEROL METABOLIC PROCESS	12	8.74e-01	9.88e-01	0.2530	-4.13e-02	5.91e-02	-8.53e-02	-8.47e-02	-2.11e-01	8.04e-01	7.23e-01	6.09e-01	6.11e-01	2.06e-01
POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE	48	3.39e-01	8.08e-01	0.2530	-9.56e-02	-1.80e-02	-1.37e-01	-1.54e-01	-1.11e-01	2.52e-01	8.29e-01	1.01e-01	6.55e-02	1.81e-01
NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	26	1.10e-01	5.30e-01	0.2530	3.35e-02	1.45e-02	1.70e-01	1.72e-01	-6.60e-02	7.67e-01	8.98e-01	1.33e-01	1.30e-01	5.61e-01
MYOBLAST MIGRATION	13	4.54e-01	8.78e-01	0.2530	-1.04e-01	-2.24e-01	4.33e-02	-1.51e-03	-3.44e-02	5.14e-01	1.62e-01	7.87e-01	9.92e-01	8.30e-01
PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY	7	8.99e-01	9.93e-01	0.2530	-1.61e-01	-9.95e-02	-6.97e-02	-1.04e-01	1.13e-01	4.61e-01	6.48e-01	7.49e-01	6.34e-01	6.06e-01
INTERLEUKIN 17 PRODUCTION	46	1.46e-01	6.03e-01	0.2530	-1.42e-01	-1.24e-01	-1.07e-01	-9.15e-02	9.36e-02	9.58e-02	1.47e-01	2.09e-01	2.83e-01	2.72e-01
POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS	31	1.35e-02	1.56e-01	0.2530	-8.76e-03	1.48e-01	-1.18e-01	-9.16e-02	1.40e-01	9.33e-01	1.54e-01	2.56e-01	3.77e-01	1.76e-01
IMMUNOLOGICAL SYNAPSE FORMATION	15	3.58e-01	8.23e-01	0.2530	5.91e-02	2.43e-01	1.63e-02	4.96e-03	3.19e-02	6.92e-01	1.03e-01	9.13e-01	9.73e-01	8.31e-01
PEPTIDYL LYSINE TRIMETHYLATION	9	8.58e-01	9.88e-01	0.2530	8.63e-02	-1.40e-02	1.66e-01	1.57e-01	-6.28e-02	6.54e-01	9.42e-01	3.88e-01	4.14e-01	7.44e-01
REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	8	8.66e-01	9.88e-01	0.2530	-9.04e-02	6.68e-02	-1.30e-01	-1.55e-01	-1.02e-01	6.58e-01	7.43e-01	5.23e-01	4.48e-01	6.18e-01
CARDIAC ATRIUM DEVELOPMENT	37	1.74e-01	6.46e-01	0.2530	-4.73e-02	-7.58e-02	-1.01e-01	-1.13e-01	-1.82e-01	6.18e-01	4.25e-01	2.89e-01	2.36e-01	5.56e-02
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION	17	3.13e-01	7.86e-01	0.2530	4.67e-02	1.46e-01	-1.40e-01	-1.40e-01	-3.54e-02	7.39e-01	2.97e-01	3.19e-01	3.17e-01	8.01e-01
DNA RECOMBINATION	318	3.48e-05	1.65e-03	0.2530	1.26e-01	3.90e-02	1.53e-01	1.41e-01	5.66e-02	1.15e-04	2.32e-01	2.63e-06	1.54e-05	8.27e-02
MITOCHONDRION ORGANIZATION	523	4.29e-14	9.22e-12	0.2530	1.04e-01	-5.24e-02	1.49e-01	1.48e-01	7.92e-02	4.99e-05	4.01e-02	5.42e-09	7.35e-09	1.94e-03
ATRIAL SEPTUM DEVELOPMENT	23	1.25e-01	5.65e-01	0.2520	-2.36e-02	-9.61e-02	-5.43e-02	-8.08e-02	-2.11e-01	8.44e-01	4.25e-01	6.52e-01	5.02e-01	8.00e-02
AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	67	1.11e-01	5.34e-01	0.2520	-1.51e-01	-1.68e-01	-6.97e-02	-6.84e-02	-5.53e-02	3.24e-02	1.73e-02	3.24e-01	3.33e-01	4.34e-01
INTESTINE SMOOTH MUSCLE CONTRACTION	8	7.68e-01	9.75e-01	0.2520	1.28e-01	1.69e-01	-6.32e-02	-1.69e-02	-1.20e-01	5.30e-01	4.08e-01	7.57e-01	9.34e-01	5.56e-01
POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	13	2.03e-01	6.82e-01	0.2520	1.11e-01	1.07e-01	-1.49e-02	3.99e-02	1.95e-01	4.87e-01	5.02e-01	9.26e-01	8.03e-01	2.24e-01
PROTEOGLYCAN CATABOLIC PROCESS	9	7.17e-01	9.68e-01	0.2520	-2.81e-03	5.95e-02	1.12e-01	8.87e-02	1.99e-01	9.88e-01	7.57e-01	5.61e-01	6.45e-01	3.01e-01
POSITIVE REGULATION OF BONE MINERALIZATION	43	3.14e-01	7.86e-01	0.2520	-1.06e-01	-1.74e-01	-9.63e-02	-9.51e-02	-6.08e-02	2.28e-01	4.82e-02	2.75e-01	2.81e-01	4.91e-01
UV DAMAGE EXCISION REPAIR	12	8.10e-01	9.82e-01	0.2520	-2.16e-02	-3.11e-02	-1.09e-01	-1.06e-01	-1.98e-01	8.97e-01	8.52e-01	5.13e-01	5.26e-01	2.36e-01
LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	26	4.00e-01	8.45e-01	0.2520	-4.53e-02	-2.00e-01	4.51e-02	3.78e-02	1.35e-01	6.89e-01	7.81e-02	6.90e-01	7.39e-01	2.33e-01
REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	21	2.61e-01	7.44e-01	0.2520	5.05e-02	-1.30e-01	1.45e-01	1.51e-01	-1.89e-02	6.88e-01	3.04e-01	2.51e-01	2.30e-01	8.81e-01
MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT	6	8.84e-01	9.91e-01	0.2520	-1.48e-01	-1.83e-01	-2.50e-02	-7.74e-02	3.59e-02	5.29e-01	4.37e-01	9.15e-01	7.43e-01	8.79e-01
POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION	8	9.02e-01	9.94e-01	0.2520	9.33e-02	1.19e-02	9.61e-02	7.40e-02	2.00e-01	6.48e-01	9.54e-01	6.38e-01	7.17e-01	3.28e-01
PROTEIN DEPALMITOYLATION	8	5.78e-01	9.27e-01	0.2520	-5.39e-02	-1.50e-01	2.56e-02	-1.50e-02	-1.93e-01	7.92e-01	4.63e-01	9.00e-01	9.42e-01	3.45e-01
TRANSEPITHELIAL TRANSPORT	34	2.51e-01	7.35e-01	0.2520	1.60e-01	1.79e-01	2.55e-02	6.15e-02	-3.65e-02	1.06e-01	7.15e-02	7.97e-01	5.35e-01	7.12e-01
GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS	21	4.32e-01	8.68e-01	0.2520	1.20e-01	-5.51e-02	1.17e-01	1.36e-01	1.18e-01	3.41e-01	6.62e-01	3.55e-01	2.82e-01	3.50e-01
NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS	16	8.09e-01	9.82e-01	0.2520	1.51e-01	3.35e-02	1.35e-01	1.44e-01	-2.48e-02	2.97e-01	8.17e-01	3.49e-01	3.20e-01	8.64e-01
CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	27	2.49e-01	7.33e-01	0.2520	1.88e-01	9.37e-02	8.95e-02	8.06e-02	6.79e-02	9.05e-02	4.00e-01	4.21e-01	4.68e-01	5.41e-01
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION	21	2.39e-01	7.23e-01	0.2520	-5.27e-02	-2.21e-01	-5.97e-02	-6.43e-02	6.28e-02	6.76e-01	7.93e-02	6.36e-01	6.10e-01	6.18e-01
INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY	6	2.79e-01	7.58e-01	0.2520	4.21e-02	1.86e-01	-2.53e-02	-1.02e-01	-1.26e-01	8.58e-01	4.31e-01	9.15e-01	6.65e-01	5.92e-01
SEGMENT SPECIFICATION	16	7.98e-02	4.53e-01	0.2520	6.02e-02	-1.38e-01	5.42e-02	6.00e-03	1.94e-01	6.77e-01	3.38e-01	7.08e-01	9.67e-01	1.79e-01
REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	10	8.47e-01	9.87e-01	0.2510	-3.31e-02	-1.81e-01	4.18e-02	2.30e-02	1.65e-01	8.56e-01	3.22e-01	8.19e-01	9.00e-01	3.67e-01
REGULATION OF RIG I SIGNALING PATHWAY	20	5.84e-01	9.28e-01	0.2510	1.14e-01	2.17e-01	-1.04e-02	-5.28e-03	-5.30e-02	3.76e-01	9.29e-02	9.36e-01	9.67e-01	6.81e-01
NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	14	2.98e-01	7.72e-01	0.2510	9.48e-02	1.71e-01	-6.94e-02	-6.73e-02	1.25e-01	5.39e-01	2.68e-01	6.53e-01	6.63e-01	4.19e-01
VACUOLAR ACIDIFICATION	32	1.56e-01	6.18e-01	0.2510	1.28e-01	2.08e-02	1.42e-01	1.25e-01	-1.03e-01	2.12e-01	8.39e-01	1.65e-01	2.22e-01	3.12e-01
NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	26	2.80e-01	7.58e-01	0.2510	-1.10e-01	1.54e-02	-1.44e-01	-1.65e-01	5.19e-02	3.33e-01	8.92e-01	2.04e-01	1.44e-01	6.47e-01
LABYRINTHINE LAYER MORPHOGENESIS	22	5.44e-01	9.15e-01	0.2510	6.39e-02	1.02e-01	1.42e-01	1.45e-01	8.53e-02	6.04e-01	4.07e-01	2.47e-01	2.40e-01	4.89e-01
POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	6	8.68e-01	9.88e-01	0.2510	-1.90e-02	-7.38e-02	1.75e-01	1.48e-01	6.87e-02	9.36e-01	7.54e-01	4.59e-01	5.29e-01	7.71e-01
STEROID HORMONE SECRETION	27	7.85e-01	9.81e-01	0.2510	-8.80e-02	-5.99e-02	-1.52e-01	-1.47e-01	-8.28e-02	4.29e-01	5.90e-01	1.71e-01	1.87e-01	4.56e-01
TROPHOBLAST CELL MIGRATION	17	3.38e-01	8.08e-01	0.2510	-4.12e-02	-1.31e-01	-9.99e-02	-9.49e-02	1.58e-01	7.69e-01	3.50e-01	4.76e-01	4.98e-01	2.59e-01
MORPHOGENESIS OF AN EPITHELIAL BUD	14	3.99e-01	8.45e-01	0.2500	-8.53e-02	-2.17e-01	-1.56e-02	-5.75e-02	-7.10e-02	5.80e-01	1.61e-01	9.20e-01	7.10e-01	6.46e-01
REGULATION OF SYNAPTIC VESICLE TRANSPORT	5	9.52e-01	9.97e-01	0.2500	-5.22e-02	-7.22e-02	-2.23e-02	-3.01e-02	2.31e-01	8.40e-01	7.80e-01	9.31e-01	9.07e-01	3.71e-01
LEUKOCYTE MEDIATED CYTOTOXICITY	135	8.84e-04	2.25e-02	0.2500	9.24e-02	1.33e-01	9.45e-02	1.10e-01	1.23e-01	6.38e-02	7.44e-03	5.81e-02	2.67e-02	1.32e-02
APICAL JUNCTION ASSEMBLY	73	2.85e-01	7.65e-01	0.2500	-1.47e-01	-8.44e-02	-1.33e-01	-1.25e-01	-2.31e-02	2.98e-02	2.12e-01	4.96e-02	6.38e-02	7.33e-01
AMINOGLYCAN BIOSYNTHETIC PROCESS	73	1.29e-01	5.72e-01	0.2500	-1.00e-01	-1.15e-01	-1.32e-01	-1.44e-01	-3.46e-02	1.40e-01	8.79e-02	5.11e-02	3.35e-02	6.09e-01
MICROVILLUS ASSEMBLY	20	5.12e-01	9.01e-01	0.2500	-9.78e-02	-1.24e-01	-3.42e-02	-6.51e-02	1.80e-01	4.49e-01	3.36e-01	7.91e-01	6.14e-01	1.65e-01
CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND	14	6.89e-01	9.61e-01	0.2500	-1.40e-02	-7.02e-03	-4.62e-02	-5.21e-02	-2.40e-01	9.28e-01	9.64e-01	7.65e-01	7.36e-01	1.20e-01
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY	67	2.95e-01	7.71e-01	0.2500	-1.21e-01	-1.14e-01	-1.25e-01	-1.40e-01	-3.91e-03	8.71e-02	1.06e-01	7.77e-02	4.82e-02	9.56e-01
MISMATCH REPAIR	34	2.81e-01	7.60e-01	0.2500	1.56e-02	-1.17e-01	1.49e-01	1.23e-01	1.06e-01	8.75e-01	2.37e-01	1.33e-01	2.13e-01	2.85e-01
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	16	7.04e-01	9.65e-01	0.2500	1.15e-01	2.17e-01	2.30e-02	1.95e-02	-3.54e-02	4.27e-01	1.32e-01	8.74e-01	8.92e-01	8.06e-01
LUNG CELL DIFFERENTIATION	28	2.16e-01	6.97e-01	0.2500	-6.64e-02	-1.76e-01	-1.11e-01	-1.08e-01	-5.63e-02	5.43e-01	1.07e-01	3.09e-01	3.22e-01	6.06e-01
POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	29	8.48e-01	9.87e-01	0.2500	-1.36e-01	-1.06e-01	-1.11e-01	-1.21e-01	-7.63e-02	2.05e-01	3.21e-01	3.03e-01	2.60e-01	4.77e-01
REGULATION OF BEHAVIOR	73	4.65e-02	3.36e-01	0.2500	-1.41e-01	-1.13e-01	-7.17e-02	-9.03e-02	1.29e-01	3.74e-02	9.56e-02	2.90e-01	1.82e-01	5.68e-02
POSITIVE REGULATION OF OSSIFICATION	52	3.00e-01	7.73e-01	0.2500	-1.07e-01	-1.59e-01	-1.00e-01	-1.06e-01	-6.50e-02	1.82e-01	4.66e-02	2.10e-01	1.85e-01	4.18e-01
DIENCEPHALON DEVELOPMENT	73	3.04e-04	9.73e-03	0.2500	-5.94e-02	-2.15e-01	2.50e-02	-1.80e-02	1.09e-01	3.80e-01	1.51e-03	7.12e-01	7.91e-01	1.07e-01
STRIATED MUSCLE ADAPTATION	55	9.86e-02	5.02e-01	0.2500	4.85e-03	1.45e-01	-8.89e-02	-6.95e-02	-1.69e-01	9.50e-01	6.29e-02	2.54e-01	3.73e-01	2.97e-02
SHORT CHAIN FATTY ACID CATABOLIC PROCESS	7	9.06e-01	9.94e-01	0.2500	-1.97e-02	-5.36e-02	1.08e-01	7.47e-02	2.05e-01	9.28e-01	8.06e-01	6.22e-01	7.32e-01	3.48e-01
FC GAMMA RECEPTOR SIGNALING PATHWAY	33	3.60e-01	8.25e-01	0.2500	-6.14e-02	4.18e-02	-1.20e-01	-9.29e-02	-1.84e-01	5.42e-01	6.78e-01	2.31e-01	3.56e-01	6.75e-02
GLYCOSYLCERAMIDE METABOLIC PROCESS	16	8.07e-01	9.82e-01	0.2500	-1.26e-01	-1.21e-01	-9.59e-02	-1.20e-01	9.19e-02	3.82e-01	4.04e-01	5.07e-01	4.07e-01	5.24e-01
NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	8	7.36e-01	9.73e-01	0.2500	1.40e-01	1.50e-01	1.19e-02	3.83e-03	1.42e-01	4.92e-01	4.62e-01	9.54e-01	9.85e-01	4.88e-01
ACTIN MYOSIN FILAMENT SLIDING	16	3.62e-01	8.26e-01	0.2500	9.89e-02	2.22e-01	-4.58e-02	4.51e-03	-3.57e-02	4.93e-01	1.25e-01	7.51e-01	9.75e-01	8.05e-01
PHARYNGEAL SYSTEM DEVELOPMENT	30	3.53e-01	8.21e-01	0.2500	6.52e-03	-1.59e-01	1.00e-01	8.45e-02	1.41e-01	9.51e-01	1.32e-01	3.43e-01	4.23e-01	1.82e-01
RECOMBINATIONAL REPAIR	169	2.57e-03	4.95e-02	0.2500	1.18e-01	1.10e-02	1.52e-01	1.35e-01	8.32e-02	7.98e-03	8.05e-01	6.51e-04	2.47e-03	6.21e-02
GLUCOSE CATABOLIC PROCESS	25	2.27e-01	7.10e-01	0.2500	-7.57e-02	-8.40e-02	-1.39e-01	-1.19e-01	1.27e-01	5.12e-01	4.67e-01	2.30e-01	3.03e-01	2.72e-01
L SERINE TRANSPORT	7	7.97e-01	9.81e-01	0.2500	-3.52e-02	-2.08e-01	3.03e-02	-8.76e-03	1.29e-01	8.72e-01	3.40e-01	8.89e-01	9.68e-01	5.53e-01
RESPONSE TO TUMOR CELL	42	4.11e-01	8.53e-01	0.2500	8.59e-02	8.91e-02	1.45e-01	1.30e-01	9.43e-02	3.36e-01	3.18e-01	1.04e-01	1.43e-01	2.90e-01
HYALURONAN BIOSYNTHETIC PROCESS	14	4.82e-01	8.91e-01	0.2490	-5.67e-03	-1.65e-02	-1.74e-01	-1.63e-01	-7.10e-02	9.71e-01	9.15e-01	2.60e-01	2.90e-01	6.46e-01
PROTEIN LOCALIZATION TO CHROMOSOME	113	2.70e-04	8.98e-03	0.2490	9.70e-02	-3.38e-02	1.68e-01	1.51e-01	-2.94e-02	7.49e-02	5.35e-01	2.06e-03	5.69e-03	5.89e-01
MITOCHONDRIAL TRANSMEMBRANE TRANSPORT	59	3.07e-02	2.63e-01	0.2490	2.10e-02	-1.25e-01	1.53e-01	1.26e-01	8.36e-02	7.80e-01	9.80e-02	4.19e-02	9.48e-02	2.67e-01
FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	32	7.75e-01	9.77e-01	0.2490	-1.43e-01	-7.13e-02	-1.23e-01	-1.21e-01	-8.28e-02	1.60e-01	4.85e-01	2.30e-01	2.37e-01	4.18e-01
EXTRACELLULAR MATRIX DISASSEMBLY	61	1.83e-01	6.56e-01	0.2490	-1.16e-01	-6.25e-02	-1.45e-01	-1.44e-01	5.54e-02	1.16e-01	3.98e-01	5.04e-02	5.23e-02	4.54e-01
REGULATION OF CENTROMERE COMPLEX ASSEMBLY	6	9.79e-01	9.97e-01	0.2490	6.52e-02	-6.40e-02	1.34e-01	1.17e-01	1.49e-01	7.82e-01	7.86e-01	5.69e-01	6.20e-01	5.29e-01
REGULATION OF DNA BIOSYNTHETIC PROCESS	117	1.20e-02	1.44e-01	0.2490	1.01e-01	-2.36e-02	1.59e-01	1.58e-01	3.22e-02	5.86e-02	6.60e-01	3.02e-03	3.08e-03	5.47e-01
POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	7	8.48e-01	9.87e-01	0.2490	6.28e-02	9.30e-02	1.15e-01	1.31e-01	-1.38e-01	7.74e-01	6.70e-01	5.98e-01	5.47e-01	5.27e-01
L CYSTINE TRANSPORT	6	7.60e-01	9.75e-01	0.2490	-5.57e-02	9.83e-03	-1.94e-01	-1.43e-01	2.59e-02	8.13e-01	9.67e-01	4.10e-01	5.44e-01	9.13e-01
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	18	4.41e-01	8.71e-01	0.2490	-3.39e-02	-2.23e-01	6.62e-02	4.48e-02	6.96e-02	8.03e-01	1.02e-01	6.27e-01	7.42e-01	6.09e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT	25	5.89e-01	9.30e-01	0.2490	9.61e-02	1.19e-01	1.19e-01	1.40e-01	6.92e-02	4.06e-01	3.03e-01	3.03e-01	2.25e-01	5.50e-01
EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	10	5.93e-01	9.32e-01	0.2490	-3.53e-02	-1.83e-01	-4.62e-02	-5.59e-02	-1.49e-01	8.47e-01	3.17e-01	8.00e-01	7.59e-01	4.16e-01
CYTIDINE TO URIDINE EDITING	12	4.83e-01	8.91e-01	0.2490	-1.03e-01	1.11e-01	-1.54e-01	-1.22e-01	-2.58e-02	5.38e-01	5.07e-01	3.55e-01	4.66e-01	8.77e-01
RESPONSE TO IONIZING RADIATION	136	5.42e-03	8.68e-02	0.2490	9.91e-02	-2.14e-02	1.53e-01	1.33e-01	1.04e-01	4.59e-02	6.67e-01	2.13e-03	7.57e-03	3.62e-02
RESPONSE TO MANGANESE ION	17	2.90e-01	7.67e-01	0.2490	-4.93e-02	-2.24e-01	-4.62e-02	-5.90e-02	-6.16e-02	7.25e-01	1.10e-01	7.42e-01	6.74e-01	6.60e-01
PARATHYROID GLAND DEVELOPMENT	7	9.67e-01	9.97e-01	0.2490	9.21e-02	-5.11e-02	1.58e-01	1.47e-01	6.30e-02	6.73e-01	8.15e-01	4.69e-01	4.99e-01	7.73e-01
REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	55	5.32e-02	3.62e-01	0.2490	-8.31e-02	-1.81e-01	-9.34e-02	-1.02e-01	5.59e-02	2.86e-01	2.04e-02	2.31e-01	1.92e-01	4.73e-01
ACID SECRETION	43	3.86e-01	8.40e-01	0.2480	-1.38e-01	-5.69e-02	-1.36e-01	-1.35e-01	5.17e-02	1.18e-01	5.18e-01	1.22e-01	1.25e-01	5.57e-01
MYELOID DENDRITIC CELL DIFFERENTIATION	20	5.77e-01	9.26e-01	0.2480	8.24e-02	9.82e-02	2.04e-02	3.06e-02	-2.10e-01	5.24e-01	4.47e-01	8.74e-01	8.13e-01	1.05e-01
REGULATION OF CELLULAR EXTRAVASATION	38	3.03e-01	7.75e-01	0.2480	-9.63e-02	-1.43e-01	-8.07e-02	-8.40e-02	1.36e-01	3.04e-01	1.27e-01	3.90e-01	3.70e-01	1.48e-01
REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	9	7.59e-01	9.75e-01	0.2480	-4.04e-02	-2.15e-01	7.52e-02	3.85e-02	8.22e-02	8.34e-01	2.65e-01	6.96e-01	8.41e-01	6.69e-01
PEPTIDYL LYSINE MONOMETHYLATION	9	6.82e-01	9.61e-01	0.2480	-1.01e-01	-2.15e-01	4.46e-02	5.72e-02	-6.28e-04	6.00e-01	2.64e-01	8.17e-01	7.66e-01	9.97e-01
FOREBRAIN NEURON DIFFERENTIATION	42	1.19e-03	2.84e-02	0.2480	2.31e-02	-1.27e-01	1.12e-02	-2.71e-02	2.10e-01	7.96e-01	1.54e-01	9.00e-01	7.61e-01	1.86e-02
ELECTRON TRANSPORT CHAIN	156	3.16e-04	1.00e-02	0.2480	1.45e-01	7.82e-03	1.37e-01	1.47e-01	1.06e-02	1.78e-03	8.66e-01	3.17e-03	1.52e-03	8.19e-01
NEGATIVE REGULATION OF BEHAVIOR	12	2.64e-01	7.47e-01	0.2480	6.84e-02	2.13e-01	-5.56e-02	-8.97e-02	1.29e-02	6.82e-01	2.01e-01	7.39e-01	5.90e-01	9.38e-01
CELLULAR METABOLIC COMPOUND SALVAGE	29	1.11e-01	5.34e-01	0.2480	-5.50e-02	-2.27e-01	-4.76e-02	-4.43e-02	5.10e-02	6.08e-01	3.42e-02	6.57e-01	6.80e-01	6.35e-01
COLLAGEN ACTIVATED SIGNALING PATHWAY	13	5.24e-01	9.05e-01	0.2480	-1.21e-01	-3.78e-02	-7.16e-02	-6.03e-02	1.92e-01	4.52e-01	8.13e-01	6.55e-01	7.06e-01	2.32e-01
POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION	13	7.94e-01	9.81e-01	0.2480	-8.43e-02	-8.71e-02	-1.43e-01	-1.53e-01	5.37e-02	5.99e-01	5.87e-01	3.72e-01	3.40e-01	7.37e-01
VIRAL PROTEIN PROCESSING	31	3.37e-01	8.08e-01	0.2480	-1.12e-01	-2.05e-01	-3.28e-02	-4.06e-02	-6.46e-02	2.82e-01	4.81e-02	7.52e-01	6.95e-01	5.34e-01
INTERMEDIATE FILAMENT BUNDLE ASSEMBLY	8	9.48e-01	9.97e-01	0.2480	-7.58e-02	-1.10e-01	-1.17e-01	-1.25e-01	-1.19e-01	7.10e-01	5.90e-01	5.65e-01	5.40e-01	5.61e-01
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS	28	2.23e-01	7.04e-01	0.2480	-6.79e-02	-1.16e-02	-1.57e-01	-1.49e-01	9.89e-02	5.34e-01	9.16e-01	1.51e-01	1.72e-01	3.65e-01
P38MAPK CASCADE	58	9.21e-02	4.84e-01	0.2480	-1.04e-01	-2.18e-01	-2.26e-02	-3.52e-02	3.22e-02	1.70e-01	4.04e-03	7.66e-01	6.43e-01	6.72e-01
POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY	12	3.59e-01	8.25e-01	0.2480	2.04e-01	7.64e-02	4.55e-02	4.50e-02	-9.90e-02	2.21e-01	6.47e-01	7.85e-01	7.87e-01	5.52e-01
POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	5	6.05e-01	9.34e-01	0.2470	-1.00e-01	-1.33e-01	1.10e-01	1.34e-01	-5.71e-02	6.98e-01	6.07e-01	6.69e-01	6.03e-01	8.25e-01
PML BODY ORGANIZATION	7	8.12e-01	9.82e-01	0.2470	1.49e-01	1.55e-01	-2.22e-03	5.08e-02	-1.11e-01	4.94e-01	4.78e-01	9.92e-01	8.16e-01	6.11e-01
REVERSE CHOLESTEROL TRANSPORT	20	4.61e-01	8.80e-01	0.2470	-1.58e-01	-1.02e-01	-1.26e-01	-9.55e-02	-2.92e-02	2.23e-01	4.30e-01	3.28e-01	4.60e-01	8.21e-01
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION	52	3.50e-02	2.83e-01	0.2470	9.60e-02	-1.02e-01	1.42e-01	1.39e-01	4.55e-02	2.31e-01	2.05e-01	7.66e-02	8.31e-02	5.70e-01
PROTOPORPHYRINOGEN IX METABOLIC PROCESS	10	5.98e-01	9.33e-01	0.2470	4.75e-02	-1.59e-01	1.15e-01	7.43e-02	1.22e-01	7.95e-01	3.85e-01	5.30e-01	6.84e-01	5.03e-01
B CELL MEDIATED IMMUNITY	130	2.96e-02	2.59e-01	0.2470	1.12e-01	7.84e-02	1.04e-01	1.18e-01	1.32e-01	2.73e-02	1.23e-01	3.96e-02	2.01e-02	9.24e-03
REGULATION OF NEUROTRANSMITTER UPTAKE	18	8.28e-01	9.83e-01	0.2470	1.62e-01	1.36e-01	7.52e-02	9.82e-02	3.25e-02	2.34e-01	3.18e-01	5.81e-01	4.71e-01	8.11e-01
RESPONSE TO INTERLEUKIN 3	6	9.76e-01	9.97e-01	0.2470	-1.14e-01	-1.93e-01	-6.41e-02	-6.29e-02	5.33e-02	6.30e-01	4.13e-01	7.86e-01	7.90e-01	8.21e-01
REGULATION OF NEUTROPHIL CHEMOTAXIS	31	8.31e-02	4.59e-01	0.2470	-5.41e-02	-1.18e-01	-1.03e-01	-8.57e-02	1.62e-01	6.02e-01	2.57e-01	3.20e-01	4.09e-01	1.19e-01
NEUTROPHIL CLEARANCE	6	6.69e-01	9.56e-01	0.2470	6.79e-02	-1.62e-01	1.04e-01	1.37e-01	-1.89e-02	7.73e-01	4.92e-01	6.58e-01	5.60e-01	9.36e-01
REGULATION OF NATURAL KILLER CELL PROLIFERATION	12	2.81e-01	7.60e-01	0.2470	4.18e-02	1.68e-01	-1.31e-01	-8.27e-02	8.28e-02	8.02e-01	3.14e-01	4.30e-01	6.20e-01	6.19e-01
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	120	1.02e-02	1.30e-01	0.2470	-9.11e-02	-6.98e-02	-1.51e-01	-1.58e-01	-4.36e-03	8.46e-02	1.87e-01	4.31e-03	2.83e-03	9.34e-01
REGULATION OF CELL PROLIFERATION IN BONE MARROW	8	6.99e-01	9.62e-01	0.2470	-1.24e-01	-1.31e-01	-4.65e-02	-1.00e-01	-1.27e-01	5.42e-01	5.22e-01	8.20e-01	6.24e-01	5.35e-01
REGULATION OF COLLATERAL SPROUTING	20	2.02e-01	6.82e-01	0.2470	1.06e-02	-7.58e-02	9.82e-03	-2.37e-02	2.33e-01	9.35e-01	5.57e-01	9.39e-01	8.54e-01	7.12e-02
NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	20	5.85e-01	9.28e-01	0.2470	-1.79e-01	-1.29e-01	-7.24e-02	-6.95e-02	-4.73e-02	1.66e-01	3.19e-01	5.75e-01	5.91e-01	7.14e-01
DCMP CATABOLIC PROCESS	6	9.73e-01	9.97e-01	0.2470	-9.97e-02	-1.13e-01	-1.40e-01	-1.30e-01	4.36e-02	6.72e-01	6.33e-01	5.54e-01	5.82e-01	8.53e-01
RESPONSE TO ARSENIC CONTAINING SUBSTANCE	31	1.86e-02	1.94e-01	0.2470	2.87e-02	-7.78e-02	1.88e-01	1.36e-01	-1.22e-02	7.82e-01	4.53e-01	7.08e-02	1.89e-01	9.06e-01
POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	38	5.33e-01	9.08e-01	0.2460	-1.37e-01	-1.05e-01	-1.19e-01	-1.14e-01	6.25e-02	1.45e-01	2.61e-01	2.05e-01	2.24e-01	5.05e-01
REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS	8	9.26e-01	9.95e-01	0.2460	7.17e-02	-8.32e-02	1.05e-01	1.13e-01	1.58e-01	7.26e-01	6.84e-01	6.07e-01	5.81e-01	4.39e-01
SOMATIC STEM CELL DIVISION	11	5.34e-01	9.09e-01	0.2460	4.62e-02	-1.54e-01	1.02e-01	6.14e-02	1.44e-01	7.91e-01	3.75e-01	5.59e-01	7.25e-01	4.10e-01
REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	11	8.22e-01	9.83e-01	0.2460	7.60e-02	1.70e-01	1.02e-01	1.04e-01	6.96e-02	6.62e-01	3.30e-01	5.58e-01	5.49e-01	6.89e-01
DE NOVO NAD BIOSYNTHETIC PROCESS	8	9.39e-01	9.97e-01	0.2460	-8.82e-02	-1.61e-01	-3.29e-02	-3.54e-02	1.57e-01	6.66e-01	4.31e-01	8.72e-01	8.62e-01	4.41e-01
FACIAL NERVE STRUCTURAL ORGANIZATION	7	9.18e-01	9.95e-01	0.2460	4.70e-02	-4.55e-02	4.66e-02	4.50e-02	2.28e-01	8.30e-01	8.35e-01	8.31e-01	8.37e-01	2.95e-01
POSITIVE REGULATION OF DNA METABOLIC PROCESS	286	7.84e-04	2.03e-02	0.2460	1.02e-01	2.07e-02	1.52e-01	1.48e-01	6.90e-02	3.04e-03	5.47e-01	9.20e-06	1.70e-05	4.47e-02
MITOTIC G2 M TRANSITION CHECKPOINT	50	3.68e-03	6.42e-02	0.2460	9.34e-02	-3.47e-02	1.64e-01	1.12e-01	1.06e-01	2.53e-01	6.71e-01	4.49e-02	1.71e-01	1.95e-01
COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY	16	4.87e-01	8.92e-01	0.2460	-1.06e-01	-1.11e-01	7.17e-02	5.74e-02	1.69e-01	4.63e-01	4.41e-01	6.19e-01	6.91e-01	2.42e-01
7 METHYLGUANOSINE RNA CAPPING	8	7.96e-01	9.81e-01	0.2460	4.37e-02	6.22e-03	1.73e-01	1.55e-01	-6.73e-02	8.30e-01	9.76e-01	3.97e-01	4.46e-01	7.42e-01
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	19	2.89e-01	7.66e-01	0.2460	-1.34e-01	-7.89e-02	-1.55e-01	-1.10e-01	1.28e-02	3.11e-01	5.51e-01	2.43e-01	4.05e-01	9.23e-01
CALCIUM ION REGULATED EXOCYTOSIS	64	1.92e-01	6.67e-01	0.2460	7.30e-02	7.73e-02	1.16e-01	1.18e-01	1.48e-01	3.13e-01	2.85e-01	1.08e-01	1.03e-01	4.09e-02
POSITIVE REGULATION OF PROTEIN SUMOYLATION	12	9.02e-01	9.94e-01	0.2460	8.23e-02	1.05e-02	1.65e-01	1.62e-01	8.95e-03	6.22e-01	9.50e-01	3.23e-01	3.30e-01	9.57e-01
POSITIVE REGULATION OF FATTY ACID TRANSPORT	23	5.50e-01	9.15e-01	0.2460	-8.39e-02	-5.47e-02	-1.53e-01	-1.53e-01	5.98e-02	4.86e-01	6.50e-01	2.04e-01	2.04e-01	6.19e-01
SECONDARY HEART FIELD SPECIFICATION	11	3.75e-01	8.36e-01	0.2460	8.47e-02	-1.22e-01	1.52e-01	9.98e-02	7.26e-02	6.27e-01	4.85e-01	3.81e-01	5.67e-01	6.77e-01
POSITIVE REGULATION OF HISTONE ACETYLATION	10	4.69e-01	8.84e-01	0.2460	1.12e-01	-1.25e-01	6.91e-02	8.24e-02	1.43e-01	5.39e-01	4.92e-01	7.05e-01	6.52e-01	4.33e-01
DEFENSE RESPONSE TO TUMOR CELL	13	8.95e-01	9.93e-01	0.2460	5.04e-02	-7.34e-02	1.15e-01	1.01e-01	1.70e-01	7.53e-01	6.47e-01	4.73e-01	5.28e-01	2.88e-01
ENDOCARDIAL CUSHION FUSION	5	9.42e-01	9.97e-01	0.2460	2.80e-03	-5.04e-02	1.71e-01	1.41e-01	9.31e-02	9.91e-01	8.45e-01	5.09e-01	5.85e-01	7.18e-01
ALKALOID METABOLIC PROCESS	7	9.01e-01	9.94e-01	0.2460	-1.23e-01	4.74e-02	-1.11e-01	-1.31e-01	-1.16e-01	5.72e-01	8.28e-01	6.11e-01	5.50e-01	5.95e-01
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	19	1.92e-01	6.66e-01	0.2450	6.22e-02	1.86e-01	-6.40e-02	-6.80e-02	1.14e-01	6.39e-01	1.60e-01	6.29e-01	6.08e-01	3.89e-01
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	22	6.68e-01	9.56e-01	0.2450	1.55e-01	1.48e-01	5.69e-02	8.74e-02	-5.81e-02	2.08e-01	2.29e-01	6.44e-01	4.78e-01	6.37e-01
THYMUS DEVELOPMENT	49	2.05e-01	6.84e-01	0.2450	5.74e-02	-5.96e-02	1.59e-01	1.34e-01	1.02e-01	4.87e-01	4.71e-01	5.45e-02	1.06e-01	2.17e-01
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	23	2.07e-01	6.84e-01	0.2450	-9.58e-02	-2.21e-01	4.54e-02	1.18e-03	1.42e-02	4.26e-01	6.68e-02	7.06e-01	9.92e-01	9.06e-01
POSITIVE REGULATION OF CALCIUM ION IMPORT	14	9.49e-01	9.97e-01	0.2450	1.47e-01	1.44e-01	8.96e-02	9.19e-02	3.59e-02	3.40e-01	3.52e-01	5.62e-01	5.52e-01	8.16e-01
REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	12	6.51e-01	9.52e-01	0.2450	-3.66e-03	-1.50e-01	4.15e-02	1.06e-02	1.89e-01	9.82e-01	3.69e-01	8.03e-01	9.50e-01	2.57e-01
CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE	63	2.00e-02	2.04e-01	0.2450	-1.21e-01	4.16e-02	-1.27e-01	-1.49e-01	-7.33e-02	9.66e-02	5.68e-01	8.19e-02	4.09e-02	3.15e-01
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	80	2.95e-01	7.71e-01	0.2450	-1.04e-01	-2.50e-02	-1.43e-01	-1.50e-01	-7.44e-02	1.06e-01	6.99e-01	2.69e-02	2.06e-02	2.50e-01
RECEPTOR CATABOLIC PROCESS	27	5.61e-01	9.20e-01	0.2450	-1.54e-01	-1.41e-01	-5.29e-02	-5.89e-02	1.00e-01	1.66e-01	2.05e-01	6.34e-01	5.96e-01	3.67e-01
POSITIVE REGULATION OF GONADOTROPIN SECRETION	7	1.32e-01	5.77e-01	0.2450	1.01e-01	-1.17e-01	-9.60e-02	-1.20e-01	-1.11e-01	6.45e-01	5.93e-01	6.60e-01	5.81e-01	6.11e-01
GLIAL CELL FATE COMMITMENT	13	4.82e-02	3.42e-01	0.2450	6.78e-02	-1.88e-01	8.63e-02	2.27e-02	1.10e-01	6.72e-01	2.41e-01	5.90e-01	8.88e-01	4.94e-01
PROTEIN K48 LINKED DEUBIQUITINATION	25	8.30e-01	9.84e-01	0.2450	-1.25e-01	-1.45e-01	-1.07e-01	-1.06e-01	1.52e-02	2.78e-01	2.08e-01	3.52e-01	3.61e-01	8.95e-01
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING	10	8.19e-01	9.83e-01	0.2450	-6.24e-02	-1.66e-01	-6.27e-02	-6.72e-02	1.41e-01	7.32e-01	3.62e-01	7.32e-01	7.13e-01	4.42e-01
PHAGOCYTOSIS ENGULFMENT	48	1.83e-01	6.56e-01	0.2440	-1.52e-01	-1.62e-01	-6.79e-02	-5.79e-02	4.78e-02	6.82e-02	5.16e-02	4.16e-01	4.87e-01	5.67e-01
REGULATION OF MEIOTIC CELL CYCLE	66	2.40e-01	7.24e-01	0.2440	1.50e-01	1.19e-01	1.09e-01	1.02e-01	-2.70e-02	3.52e-02	9.44e-02	1.25e-01	1.51e-01	7.04e-01
REGULATION OF MONOCYTE DIFFERENTIATION	20	8.36e-01	9.85e-01	0.2440	1.59e-01	1.51e-01	7.37e-02	7.78e-02	7.19e-05	2.17e-01	2.43e-01	5.68e-01	5.47e-01	1.00e+00
PEPTIDYL GLUTAMIC ACID MODIFICATION	26	7.14e-01	9.68e-01	0.2440	4.15e-02	-4.86e-02	1.07e-01	1.02e-01	1.84e-01	7.14e-01	6.68e-01	3.46e-01	3.69e-01	1.05e-01
PIGMENT CATABOLIC PROCESS	11	6.04e-01	9.34e-01	0.2440	1.04e-01	1.16e-01	2.11e-03	5.32e-02	-1.80e-01	5.49e-01	5.05e-01	9.90e-01	7.60e-01	3.01e-01
VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	8.96e-01	9.93e-01	0.2440	-1.83e-01	-5.31e-02	-7.18e-02	-6.91e-02	-1.16e-01	4.79e-01	8.37e-01	7.81e-01	7.89e-01	6.55e-01
RESPONSE TO PEPTIDOGLYCAN	13	2.34e-01	7.19e-01	0.2440	1.17e-02	-1.74e-02	-1.62e-01	-1.42e-01	1.13e-01	9.42e-01	9.14e-01	3.12e-01	3.76e-01	4.81e-01
CORTICOSTEROID RECEPTOR SIGNALING PATHWAY	14	8.04e-01	9.82e-01	0.2440	-7.45e-02	-1.80e-01	1.49e-02	-8.52e-03	1.46e-01	6.29e-01	2.45e-01	9.23e-01	9.56e-01	3.43e-01
DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION	20	4.33e-01	8.69e-01	0.2440	4.29e-03	1.34e-01	-1.38e-01	-9.79e-02	-1.14e-01	9.74e-01	3.01e-01	2.86e-01	4.49e-01	3.76e-01
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	19	1.84e-01	6.56e-01	0.2440	4.24e-02	1.61e-01	-7.19e-02	-5.18e-02	1.54e-01	7.49e-01	2.24e-01	5.87e-01	6.96e-01	2.44e-01
SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION	10	4.71e-01	8.85e-01	0.2440	1.15e-01	-8.60e-02	1.18e-01	7.71e-02	1.37e-01	5.27e-01	6.38e-01	5.17e-01	6.73e-01	4.54e-01
FUNGIFORM PAPILLA DEVELOPMENT	6	7.20e-01	9.69e-01	0.2440	6.76e-03	-6.87e-02	1.80e-01	1.15e-01	9.62e-02	9.77e-01	7.71e-01	4.46e-01	6.26e-01	6.83e-01
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	7	8.66e-01	9.88e-01	0.2440	1.03e-01	-5.18e-02	1.64e-01	1.26e-01	5.75e-02	6.38e-01	8.12e-01	4.53e-01	5.63e-01	7.92e-01
PROTEIN LOCALIZATION TO CHROMATIN	56	3.93e-02	3.04e-01	0.2440	1.04e-01	3.84e-02	1.34e-01	1.22e-01	-1.19e-01	1.80e-01	6.19e-01	8.33e-02	1.13e-01	1.23e-01
FATTY ACID HOMEOSTASIS	16	7.32e-01	9.72e-01	0.2430	-1.71e-01	-1.46e-01	-6.63e-02	-6.12e-02	-2.34e-02	2.35e-01	3.13e-01	6.46e-01	6.72e-01	8.71e-01
POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS	5	8.67e-01	9.88e-01	0.2430	-1.65e-02	-1.53e-01	1.47e-01	1.13e-01	-3.50e-02	9.49e-01	5.53e-01	5.69e-01	6.63e-01	8.92e-01
DIACYLGLYCEROL METABOLIC PROCESS	26	5.04e-01	8.98e-01	0.2430	-1.10e-01	2.69e-03	-1.64e-01	-1.38e-01	-3.29e-02	3.32e-01	9.81e-01	1.47e-01	2.23e-01	7.71e-01
EMBRYONIC FORELIMB MORPHOGENESIS	33	4.73e-04	1.39e-02	0.2430	1.62e-01	-1.06e-01	1.15e-01	8.57e-02	3.56e-02	1.08e-01	2.90e-01	2.55e-01	3.94e-01	7.23e-01
PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	28	1.54e-01	6.16e-01	0.2430	6.06e-02	-1.32e-01	1.47e-01	1.28e-01	8.02e-06	5.79e-01	2.25e-01	1.78e-01	2.41e-01	1.00e+00
LEUCINE CATABOLIC PROCESS	6	9.74e-01	9.97e-01	0.2430	1.10e-01	3.01e-02	1.60e-01	1.43e-01	-1.77e-02	6.42e-01	8.98e-01	4.98e-01	5.45e-01	9.40e-01
POSITIVE REGULATION OF BLOOD CIRCULATION	38	3.06e-01	7.79e-01	0.2430	1.37e-01	5.64e-02	1.15e-01	1.34e-01	-7.85e-02	1.45e-01	5.47e-01	2.20e-01	1.53e-01	4.02e-01
REGULATION OF T CELL DIFFERENTIATION IN THYMUS	26	6.11e-01	9.37e-01	0.2430	-1.40e-01	-1.08e-01	-7.60e-02	-8.77e-02	1.19e-01	2.16e-01	3.39e-01	5.03e-01	4.39e-01	2.93e-01
RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE	5	8.71e-01	9.88e-01	0.2430	-4.28e-02	-2.60e-02	-6.73e-02	-9.71e-02	2.06e-01	8.68e-01	9.20e-01	7.94e-01	7.07e-01	4.24e-01
DNA REPLICATION	272	2.18e-06	1.41e-04	0.2430	9.37e-02	-2.82e-02	1.61e-01	1.51e-01	3.15e-02	7.78e-03	4.23e-01	5.16e-06	1.86e-05	3.71e-01
ICOSANOID BIOSYNTHETIC PROCESS	56	2.17e-01	6.99e-01	0.2430	-1.04e-01	-1.44e-01	-1.19e-01	-1.06e-01	-4.78e-02	1.79e-01	6.25e-02	1.25e-01	1.70e-01	5.36e-01
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	9	3.61e-01	8.25e-01	0.2430	-1.61e-01	6.27e-02	-6.55e-02	-4.99e-02	-1.50e-01	4.03e-01	7.44e-01	7.34e-01	7.96e-01	4.36e-01
DIPEPTIDE TRANSMEMBRANE TRANSPORT	7	7.85e-01	9.81e-01	0.2430	-2.46e-02	4.13e-02	-1.32e-01	-1.65e-01	-1.09e-01	9.10e-01	8.50e-01	5.45e-01	4.49e-01	6.17e-01
CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT	6	6.25e-01	9.44e-01	0.2430	-2.90e-03	-9.57e-02	-1.14e-01	-5.86e-02	-1.82e-01	9.90e-01	6.85e-01	6.27e-01	8.04e-01	4.39e-01
GOLGI VESICLE FUSION TO TARGET MEMBRANE	5	8.40e-01	9.85e-01	0.2430	-4.20e-02	-1.51e-01	6.83e-02	4.21e-02	-1.67e-01	8.71e-01	5.58e-01	7.91e-01	8.70e-01	5.18e-01
POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	34	5.99e-01	9.33e-01	0.2430	-1.47e-01	-1.44e-01	-6.66e-02	-7.56e-02	8.08e-02	1.38e-01	1.47e-01	5.02e-01	4.46e-01	4.15e-01
GLYCEROL TRANSMEMBRANE TRANSPORT	7	4.85e-01	8.91e-01	0.2430	-1.16e-01	1.10e-01	-7.81e-02	-6.18e-02	1.53e-01	5.96e-01	6.13e-01	7.21e-01	7.77e-01	4.83e-01
REGULATION OF METANEPHROS DEVELOPMENT	5	9.75e-01	9.97e-01	0.2430	-1.55e-01	-7.91e-02	-9.32e-02	-1.25e-01	-6.49e-02	5.47e-01	7.59e-01	7.18e-01	6.29e-01	8.02e-01
MUSCLE HYPERTROPHY	103	2.07e-01	6.84e-01	0.2430	-1.06e-01	-3.96e-02	-1.37e-01	-1.27e-01	-1.06e-01	6.41e-02	4.87e-01	1.63e-02	2.60e-02	6.25e-02
SEMICIRCULAR CANAL DEVELOPMENT	9	3.56e-01	8.22e-01	0.2430	-1.10e-01	-1.96e-01	2.16e-02	-5.08e-02	-7.18e-02	5.66e-01	3.08e-01	9.11e-01	7.92e-01	7.09e-01
CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER	21	4.93e-01	8.95e-01	0.2430	-1.54e-03	1.18e-02	9.99e-02	9.80e-02	1.98e-01	9.90e-01	9.25e-01	4.28e-01	4.37e-01	1.16e-01
NEGATIVE REGULATION OF CELL FATE COMMITMENT	11	2.75e-01	7.56e-01	0.2430	3.38e-02	-1.79e-01	1.62e-02	-2.05e-02	1.58e-01	8.46e-01	3.03e-01	9.26e-01	9.06e-01	3.65e-01
POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY	26	7.75e-01	9.77e-01	0.2430	-1.36e-01	-1.36e-01	-9.15e-02	-1.15e-01	1.32e-02	2.29e-01	2.29e-01	4.20e-01	3.12e-01	9.07e-01
DIOL METABOLIC PROCESS	30	5.46e-01	9.15e-01	0.2420	-1.26e-01	-2.01e-01	-2.98e-02	-3.78e-02	1.76e-02	2.32e-01	5.71e-02	7.78e-01	7.20e-01	8.68e-01
REGULATION OF CGMP MEDIATED SIGNALING	11	2.81e-01	7.60e-01	0.2420	-5.18e-02	1.26e-02	9.69e-02	1.23e-01	1.77e-01	7.66e-01	9.42e-01	5.78e-01	4.79e-01	3.09e-01
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION	104	5.91e-03	9.21e-02	0.2420	8.83e-02	-6.77e-02	1.53e-01	1.39e-01	5.91e-02	1.20e-01	2.33e-01	6.85e-03	1.43e-02	2.98e-01
RESPONSE TO UV B	21	5.61e-01	9.20e-01	0.2420	-8.60e-02	-1.99e-01	-3.76e-02	-6.07e-02	7.98e-02	4.95e-01	1.14e-01	7.65e-01	6.30e-01	5.27e-01
SKELETAL MUSCLE CELL PROLIFERATION	24	5.33e-01	9.09e-01	0.2420	-1.61e-02	-1.57e-01	7.55e-02	5.48e-02	1.58e-01	8.92e-01	1.83e-01	5.22e-01	6.42e-01	1.80e-01
GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	12	9.10e-01	9.94e-01	0.2420	1.19e-01	1.94e-01	3.81e-02	4.11e-02	-6.14e-02	4.74e-01	2.46e-01	8.19e-01	8.06e-01	7.12e-01
SARCOMERE ORGANIZATION	45	3.77e-03	6.50e-02	0.2420	-1.18e-02	2.07e-01	-6.39e-02	-3.14e-02	-1.03e-01	8.91e-01	1.62e-02	4.59e-01	7.16e-01	2.34e-01
THYROID HORMONE TRANSPORT	10	6.81e-01	9.61e-01	0.2420	-1.17e-01	-1.36e-01	-5.25e-02	-2.67e-02	-1.52e-01	5.22e-01	4.58e-01	7.74e-01	8.84e-01	4.06e-01
POSITIVE REGULATION OF ACTIN NUCLEATION	14	8.34e-01	9.85e-01	0.2420	-9.44e-02	-1.49e-01	-1.20e-01	-1.06e-01	-4.43e-02	5.41e-01	3.35e-01	4.39e-01	4.93e-01	7.74e-01
POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	34	5.38e-01	9.12e-01	0.2420	5.84e-02	-6.46e-02	1.42e-01	1.23e-01	1.26e-01	5.56e-01	5.15e-01	1.53e-01	2.14e-01	2.05e-01
ENDOCARDIAL CUSHION MORPHOGENESIS	44	6.28e-02	4.00e-01	0.2420	-7.09e-02	-2.20e-01	3.06e-02	-9.32e-04	6.37e-02	4.16e-01	1.15e-02	7.26e-01	9.91e-01	4.65e-01
NEGATIVE REGULATION OF AMINO ACID TRANSPORT	16	7.43e-01	9.74e-01	0.2420	8.18e-02	-6.69e-02	1.01e-01	9.14e-02	1.70e-01	5.71e-01	6.43e-01	4.84e-01	5.27e-01	2.40e-01
MALATE METABOLIC PROCESS	9	8.88e-01	9.91e-01	0.2420	1.15e-01	7.70e-02	8.25e-02	1.04e-01	-1.48e-01	5.51e-01	6.89e-01	6.68e-01	5.90e-01	4.44e-01
ZINC ION IMPORT ACROSS PLASMA MEMBRANE	9	9.21e-01	9.95e-01	0.2420	-9.05e-02	-1.81e-01	-7.96e-02	-8.13e-02	6.76e-02	6.38e-01	3.47e-01	6.79e-01	6.73e-01	7.26e-01
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	17	2.83e-01	7.62e-01	0.2420	-1.83e-02	-1.31e-01	-1.22e-01	-1.19e-01	-1.09e-01	8.96e-01	3.51e-01	3.84e-01	3.94e-01	4.37e-01
POSITIVE REGULATION OF CELL MORPHOGENESIS	31	1.98e-01	6.77e-01	0.2420	-1.10e-01	6.38e-02	-1.45e-01	-1.43e-01	3.00e-02	2.91e-01	5.38e-01	1.63e-01	1.68e-01	7.73e-01
NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	7	9.44e-01	9.97e-01	0.2420	-5.67e-02	-1.49e-01	1.40e-02	1.61e-02	1.80e-01	7.95e-01	4.95e-01	9.49e-01	9.41e-01	4.08e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	18	5.84e-01	9.28e-01	0.2410	-1.55e-02	-1.12e-02	-9.03e-02	-1.03e-01	-1.98e-01	9.10e-01	9.35e-01	5.07e-01	4.49e-01	1.46e-01
CELLULAR DEFENSE RESPONSE	50	4.01e-02	3.06e-01	0.2410	1.23e-01	1.88e-01	1.83e-02	5.35e-02	6.93e-02	1.34e-01	2.17e-02	8.23e-01	5.13e-01	3.97e-01
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL	122	3.41e-03	6.11e-02	0.2410	6.36e-02	-9.11e-02	1.42e-01	1.29e-01	9.60e-02	2.25e-01	8.21e-02	6.88e-03	1.39e-02	6.69e-02
ACTIN CROSSLINK FORMATION	12	9.10e-01	9.94e-01	0.2410	-5.79e-02	6.21e-02	-1.49e-01	-1.49e-01	-8.26e-02	7.28e-01	7.09e-01	3.73e-01	3.73e-01	6.20e-01
NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	48	3.34e-01	8.05e-01	0.2410	9.74e-02	-3.03e-02	1.56e-01	1.43e-01	5.52e-02	2.43e-01	7.16e-01	6.19e-02	8.64e-02	5.08e-01
ENDOTHELIAL CELL MORPHOGENESIS	9	6.96e-01	9.61e-01	0.2410	1.41e-01	8.61e-02	-2.52e-02	-9.85e-03	-1.74e-01	4.63e-01	6.55e-01	8.96e-01	9.59e-01	3.67e-01
DETECTION OF TEMPERATURE STIMULUS	24	3.09e-01	7.83e-01	0.2410	4.99e-02	1.25e-01	4.58e-02	5.60e-02	1.86e-01	6.72e-01	2.88e-01	6.98e-01	6.35e-01	1.14e-01
HISTONE H4 K16 ACETYLATION	6	7.83e-01	9.81e-01	0.2410	-2.78e-02	-1.28e-01	3.21e-02	-2.21e-02	1.99e-01	9.06e-01	5.87e-01	8.92e-01	9.25e-01	4.00e-01
REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	9	9.08e-01	9.94e-01	0.2410	3.51e-02	1.51e-01	-3.73e-02	-1.79e-02	-1.79e-01	8.55e-01	4.32e-01	8.46e-01	9.26e-01	3.51e-01
POSITIVE REGULATION OF HEART GROWTH	38	3.48e-01	8.18e-01	0.2410	-8.03e-02	-1.22e-01	-1.13e-01	-1.26e-01	-8.97e-02	3.92e-01	1.95e-01	2.27e-01	1.79e-01	3.38e-01
FAT CELL PROLIFERATION	14	8.62e-01	9.88e-01	0.2410	3.38e-02	-8.49e-02	8.86e-02	8.54e-02	1.86e-01	8.27e-01	5.82e-01	5.66e-01	5.80e-01	2.29e-01
NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION	5	7.91e-01	9.81e-01	0.2410	-5.02e-02	-1.88e-01	-8.90e-03	-5.34e-02	-1.31e-01	8.46e-01	4.68e-01	9.72e-01	8.36e-01	6.11e-01
EMBRYO IMPLANTATION	58	2.01e-01	6.80e-01	0.2410	1.26e-01	3.93e-04	1.18e-01	1.31e-01	1.05e-01	9.78e-02	9.96e-01	1.21e-01	8.54e-02	1.65e-01
CGMP BIOSYNTHETIC PROCESS	10	9.44e-01	9.97e-01	0.2400	9.35e-02	1.41e-02	1.61e-01	1.51e-01	1.64e-03	6.09e-01	9.39e-01	3.77e-01	4.08e-01	9.93e-01
RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT	8	6.59e-01	9.54e-01	0.2400	-1.57e-01	5.89e-02	-9.07e-02	-1.14e-01	-9.18e-02	4.41e-01	7.73e-01	6.57e-01	5.77e-01	6.53e-01
POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION	13	7.77e-01	9.79e-01	0.2400	1.83e-01	6.84e-02	9.67e-02	9.96e-02	2.06e-02	2.54e-01	6.69e-01	5.46e-01	5.34e-01	8.98e-01
REGULATION OF SISTER CHROMATID SEGREGATION	104	7.63e-03	1.09e-01	0.2400	8.62e-02	6.70e-03	1.67e-01	1.50e-01	-5.27e-03	1.29e-01	9.06e-01	3.26e-03	8.36e-03	9.26e-01
MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	5	4.56e-01	8.78e-01	0.2400	-1.01e-01	-1.41e-01	8.30e-02	1.32e-01	-5.60e-02	6.95e-01	5.84e-01	7.48e-01	6.09e-01	8.28e-01
REGULATION OF PHOSPHOLIPASE C ACTIVITY	39	5.71e-01	9.26e-01	0.2400	-1.22e-01	-1.07e-01	-1.12e-01	-1.16e-01	7.21e-02	1.86e-01	2.46e-01	2.25e-01	2.11e-01	4.36e-01
MAGNESIUM ION TRANSPORT	16	8.94e-01	9.92e-01	0.2400	-1.48e-01	-8.01e-02	-1.10e-01	-1.31e-01	5.07e-03	3.04e-01	5.79e-01	4.45e-01	3.66e-01	9.72e-01
GLOMERULAR MESANGIUM DEVELOPMENT	18	7.68e-01	9.75e-01	0.2400	1.64e-01	6.19e-02	1.16e-01	1.08e-01	4.15e-02	2.29e-01	6.50e-01	3.93e-01	4.26e-01	7.60e-01
REGULATION OF HEART RATE BY CARDIAC CONDUCTION	37	2.65e-01	7.47e-01	0.2400	-9.81e-02	-7.71e-02	-9.67e-02	-1.02e-01	1.49e-01	3.02e-01	4.17e-01	3.09e-01	2.82e-01	1.16e-01
ANTEROGRADE AXONAL TRANSPORT	49	2.48e-01	7.33e-01	0.2400	-1.28e-02	-9.92e-02	9.02e-02	8.43e-02	1.80e-01	8.77e-01	2.30e-01	2.75e-01	3.08e-01	2.94e-02
CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	22	7.00e-01	9.63e-01	0.2400	1.42e-01	7.46e-02	1.02e-01	9.03e-02	1.15e-01	2.49e-01	5.45e-01	4.06e-01	4.63e-01	3.51e-01
MITOTIC CELL CYCLE CHECKPOINT SIGNALING	139	1.58e-05	8.38e-04	0.2400	7.28e-02	-2.67e-02	1.75e-01	1.45e-01	5.34e-03	1.38e-01	5.86e-01	3.74e-04	3.20e-03	9.13e-01
GTP BIOSYNTHETIC PROCESS	11	1.28e-01	5.72e-01	0.2400	-8.74e-02	-1.32e-01	1.50e-01	8.00e-02	-5.95e-02	6.16e-01	4.47e-01	3.89e-01	6.46e-01	7.33e-01
FC RECEPTOR SIGNALING PATHWAY	54	4.28e-01	8.65e-01	0.2400	-8.28e-02	2.65e-02	-1.30e-01	-1.21e-01	-1.36e-01	2.93e-01	7.36e-01	9.85e-02	1.24e-01	8.39e-02
INFLAMMATORY CELL APOPTOTIC PROCESS	24	2.60e-01	7.43e-01	0.2400	4.23e-02	-1.27e-01	6.18e-02	4.14e-02	1.85e-01	7.20e-01	2.82e-01	6.00e-01	7.25e-01	1.17e-01
PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	10	9.09e-01	9.94e-01	0.2400	1.11e-01	7.47e-02	9.86e-02	7.94e-02	1.53e-01	5.42e-01	6.83e-01	5.89e-01	6.64e-01	4.01e-01
PURINE NUCLEOTIDE SALVAGE	10	7.81e-01	9.81e-01	0.2400	1.10e-02	-1.66e-02	-1.20e-01	-1.09e-01	-1.76e-01	9.52e-01	9.27e-01	5.13e-01	5.50e-01	3.36e-01
ANATOMICAL STRUCTURE REGRESSION	16	5.32e-01	9.07e-01	0.2400	6.63e-02	1.42e-01	-1.20e-01	-1.07e-01	-8.48e-02	6.46e-01	3.25e-01	4.07e-01	4.61e-01	5.57e-01
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	45	2.08e-01	6.85e-01	0.2400	-8.92e-02	-1.80e-01	-8.52e-02	-9.37e-02	-3.32e-02	3.00e-01	3.68e-02	3.23e-01	2.77e-01	7.00e-01
FOLATE TRANSMEMBRANE TRANSPORT	5	9.19e-01	9.95e-01	0.2400	-8.38e-02	-1.53e-01	-9.56e-02	-1.33e-01	1.07e-02	7.46e-01	5.53e-01	7.11e-01	6.07e-01	9.67e-01
RESPONSE TO TESTOSTERONE	42	1.35e-02	1.56e-01	0.2400	-3.98e-02	-1.84e-01	-6.27e-02	-7.47e-02	-1.11e-01	6.56e-01	3.86e-02	4.82e-01	4.02e-01	2.13e-01
HYPERSENSITIVITY	12	4.47e-01	8.74e-01	0.2400	6.96e-02	3.44e-02	6.30e-02	1.11e-01	1.87e-01	6.76e-01	8.37e-01	7.06e-01	5.04e-01	2.62e-01
CARDIAC CONDUCTION SYSTEM DEVELOPMENT	37	8.82e-03	1.18e-01	0.2400	1.20e-01	-1.26e-01	1.17e-01	1.01e-01	5.69e-02	2.07e-01	1.85e-01	2.19e-01	2.86e-01	5.49e-01
PLASMA MEMBRANE RAFT ORGANIZATION	11	9.50e-01	9.97e-01	0.2390	6.35e-02	5.13e-02	1.22e-01	1.16e-01	1.49e-01	7.16e-01	7.68e-01	4.84e-01	5.04e-01	3.92e-01
REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION	9	8.12e-01	9.82e-01	0.2390	1.19e-01	1.98e-01	1.68e-02	6.10e-02	1.12e-03	5.35e-01	3.05e-01	9.31e-01	7.51e-01	9.95e-01
LYMPHOCYTE APOPTOTIC PROCESS	80	9.50e-02	4.92e-01	0.2390	6.71e-02	1.31e-03	1.61e-01	1.40e-01	8.59e-02	2.99e-01	9.84e-01	1.31e-02	3.03e-02	1.84e-01
POSITIVE REGULATION OF AXON GUIDANCE	5	6.46e-01	9.50e-01	0.2390	1.86e-01	1.22e-01	7.11e-02	2.21e-02	4.64e-02	4.70e-01	6.37e-01	7.83e-01	9.32e-01	8.57e-01
TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	77	1.14e-01	5.39e-01	0.2390	9.56e-02	-1.14e-02	1.59e-01	1.42e-01	4.97e-02	1.47e-01	8.62e-01	1.58e-02	3.12e-02	4.51e-01
N ACETYLNEURAMINATE CATABOLIC PROCESS	6	9.73e-01	9.97e-01	0.2390	1.71e-01	9.00e-02	8.89e-02	9.31e-02	5.66e-02	4.68e-01	7.03e-01	7.06e-01	6.93e-01	8.10e-01
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT	41	2.17e-01	6.99e-01	0.2390	-7.75e-03	-2.29e-02	6.65e-02	5.59e-02	2.21e-01	9.32e-01	8.00e-01	4.61e-01	5.36e-01	1.42e-02
NEPHRIC DUCT DEVELOPMENT	14	4.50e-01	8.76e-01	0.2390	-9.46e-02	-1.92e-01	4.01e-02	-1.60e-02	9.75e-02	5.40e-01	2.14e-01	7.95e-01	9.18e-01	5.28e-01
REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II	85	3.18e-03	5.78e-02	0.2390	5.96e-02	-8.59e-02	1.63e-01	1.37e-01	2.91e-02	3.42e-01	1.71e-01	9.58e-03	2.87e-02	6.42e-01
POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	9	7.86e-01	9.81e-01	0.2390	1.46e-02	2.30e-02	-1.55e-01	-1.29e-01	-1.25e-01	9.40e-01	9.05e-01	4.20e-01	5.04e-01	5.16e-01
SODIUM ION IMPORT ACROSS PLASMA MEMBRANE	23	1.05e-01	5.17e-01	0.2390	6.25e-02	2.20e-01	-2.53e-02	1.60e-02	6.25e-02	6.04e-01	6.81e-02	8.34e-01	8.94e-01	6.04e-01
CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION	9	5.70e-01	9.26e-01	0.2390	1.15e-01	1.27e-01	3.19e-02	-5.99e-04	1.64e-01	5.52e-01	5.10e-01	8.69e-01	9.98e-01	3.95e-01
REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY	13	8.52e-01	9.88e-01	0.2390	-6.39e-03	-1.47e-01	9.03e-02	7.69e-02	1.45e-01	9.68e-01	3.58e-01	5.73e-01	6.31e-01	3.64e-01
LEUCINE IMPORT ACROSS PLASMA MEMBRANE	5	8.10e-01	9.82e-01	0.2390	1.88e-01	5.32e-02	2.49e-02	4.43e-02	-1.28e-01	4.67e-01	8.37e-01	9.23e-01	8.64e-01	6.21e-01
POSITIVE REGULATION OF CHOLESTEROL STORAGE	8	9.51e-01	9.97e-01	0.2390	-1.66e-01	-1.08e-01	-7.97e-02	-8.55e-02	6.19e-02	4.15e-01	5.96e-01	6.96e-01	6.75e-01	7.62e-01
GLUTAMINE METABOLIC PROCESS	25	7.34e-01	9.73e-01	0.2380	5.58e-02	-7.02e-02	1.21e-01	1.18e-01	1.43e-01	6.29e-01	5.44e-01	2.96e-01	3.07e-01	2.17e-01
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	26	5.72e-01	9.26e-01	0.2380	-7.75e-02	-1.20e-01	-1.31e-01	-1.19e-01	-7.07e-02	4.94e-01	2.88e-01	2.48e-01	2.93e-01	5.33e-01
NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	28	5.07e-01	8.99e-01	0.2380	1.11e-01	1.64e-01	7.59e-02	6.49e-02	8.73e-02	3.08e-01	1.34e-01	4.87e-01	5.52e-01	4.24e-01
ETHER BIOSYNTHETIC PROCESS	12	9.02e-01	9.94e-01	0.2380	-1.06e-01	-8.70e-02	-1.22e-01	-1.20e-01	9.27e-02	5.25e-01	6.02e-01	4.65e-01	4.70e-01	5.78e-01
POSITIVE REGULATION OF COLLATERAL SPROUTING	10	8.60e-01	9.88e-01	0.2380	-4.36e-02	-9.33e-02	1.61e-02	-7.18e-03	2.14e-01	8.11e-01	6.09e-01	9.30e-01	9.69e-01	2.42e-01
SPECIFICATION OF ANIMAL ORGAN IDENTITY	35	4.03e-02	3.07e-01	0.2380	-9.55e-02	-1.98e-01	-1.99e-02	-7.17e-02	5.20e-02	3.28e-01	4.25e-02	8.38e-01	4.63e-01	5.94e-01
RIBONUCLEOPROTEIN COMPLEX LOCALIZATION	9	9.50e-01	9.97e-01	0.2380	1.23e-01	-1.68e-02	1.42e-01	1.33e-01	5.77e-02	5.22e-01	9.30e-01	4.61e-01	4.90e-01	7.64e-01
MAMMARY GLAND EPITHELIUM DEVELOPMENT	65	7.88e-02	4.52e-01	0.2380	-9.77e-02	-2.00e-01	-3.35e-02	-5.45e-02	5.54e-02	1.73e-01	5.36e-03	6.40e-01	4.48e-01	4.40e-01
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	43	6.43e-02	4.05e-01	0.2380	-4.18e-05	-1.65e-01	1.28e-01	1.10e-01	3.08e-02	1.00e+00	6.08e-02	1.47e-01	2.13e-01	7.27e-01
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION	22	5.17e-01	9.02e-01	0.2380	1.14e-01	-2.05e-02	1.56e-01	1.28e-01	5.00e-02	3.57e-01	8.68e-01	2.04e-01	3.00e-01	6.85e-01
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE	182	3.83e-07	2.98e-05	0.2380	7.30e-02	-7.48e-02	1.62e-01	1.33e-01	4.35e-02	8.93e-02	8.18e-02	1.69e-04	2.02e-03	3.11e-01
REGULATION OF DENDRITIC SPINE DEVELOPMENT	52	1.54e-01	6.16e-01	0.2380	-1.57e-01	-2.31e-02	-1.26e-01	-1.21e-01	-3.02e-02	5.02e-02	7.73e-01	1.17e-01	1.31e-01	7.06e-01
NEGATIVE REGULATION OF PROTEIN MATURATION	27	4.39e-01	8.70e-01	0.2380	3.84e-03	-1.13e-01	9.42e-02	1.05e-01	1.55e-01	9.72e-01	3.11e-01	3.97e-01	3.45e-01	1.64e-01
REGULATION OF VITAMIN METABOLIC PROCESS	12	8.08e-01	9.82e-01	0.2380	4.23e-02	-1.15e-02	1.28e-01	1.48e-01	1.27e-01	8.00e-01	9.45e-01	4.42e-01	3.74e-01	4.46e-01
FATTY ACYL COA BIOSYNTHETIC PROCESS	25	4.38e-01	8.69e-01	0.2380	-3.39e-02	-1.78e-01	1.82e-02	1.05e-02	1.52e-01	7.69e-01	1.24e-01	8.75e-01	9.28e-01	1.88e-01
LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION	8	9.57e-01	9.97e-01	0.2380	1.06e-01	1.30e-01	8.58e-02	8.38e-02	-1.17e-01	6.02e-01	5.24e-01	6.74e-01	6.82e-01	5.65e-01
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	51	6.46e-02	4.05e-01	0.2370	-1.28e-02	-1.95e-02	-1.43e-01	-1.27e-01	-1.39e-01	8.75e-01	8.10e-01	7.70e-02	1.17e-01	8.62e-02
REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	12	8.43e-01	9.86e-01	0.2370	-1.23e-01	-1.02e-01	-1.35e-01	-1.05e-01	-3.64e-02	4.59e-01	5.40e-01	4.19e-01	5.27e-01	8.27e-01
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	179	3.01e-04	9.69e-03	0.2370	8.10e-02	1.01e-01	1.43e-01	1.36e-01	2.50e-02	6.15e-02	2.02e-02	9.39e-04	1.74e-03	5.63e-01
PYRIMIDINE NUCLEOBASE METABOLIC PROCESS	20	7.24e-01	9.70e-01	0.2370	-1.25e-01	-1.97e-01	-2.83e-02	-3.10e-02	8.04e-03	3.32e-01	1.28e-01	8.27e-01	8.10e-01	9.50e-01
REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	66	2.67e-01	7.48e-01	0.2370	-1.38e-01	-1.23e-01	-9.19e-02	-1.17e-01	-7.84e-03	5.32e-02	8.43e-02	1.97e-01	1.01e-01	9.12e-01
METHIONINE METABOLIC PROCESS	15	7.94e-01	9.81e-01	0.2370	-1.16e-01	-2.03e-01	-2.79e-03	-7.22e-03	3.86e-02	4.37e-01	1.74e-01	9.85e-01	9.61e-01	7.96e-01
CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS	26	3.11e-01	7.85e-01	0.2370	1.37e-01	9.69e-02	1.09e-01	8.44e-02	-9.52e-02	2.26e-01	3.93e-01	3.38e-01	4.57e-01	4.01e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	19	9.15e-01	9.94e-01	0.2370	1.30e-01	7.27e-02	1.07e-01	1.21e-01	8.93e-02	3.26e-01	5.83e-01	4.21e-01	3.62e-01	5.00e-01
REGULATION OF HISTONE ACETYLATION	18	3.78e-01	8.36e-01	0.2370	1.79e-02	-1.35e-01	6.22e-03	9.86e-03	1.93e-01	8.95e-01	3.20e-01	9.64e-01	9.42e-01	1.56e-01
L ALANINE TRANSPORT	10	9.59e-01	9.97e-01	0.2370	1.29e-01	1.57e-01	5.32e-02	7.18e-02	-8.18e-02	4.79e-01	3.89e-01	7.71e-01	6.94e-01	6.54e-01
AMINO ACID ACTIVATION	43	8.16e-02	4.56e-01	0.2370	7.77e-02	-7.17e-02	1.49e-01	1.44e-01	-4.35e-02	3.78e-01	4.16e-01	9.02e-02	1.03e-01	6.21e-01
REGULATION OF TRANSLATION IN RESPONSE TO STRESS	19	7.49e-01	9.75e-01	0.2370	-7.94e-02	-1.57e-01	1.36e-02	-5.12e-03	1.58e-01	5.49e-01	2.36e-01	9.18e-01	9.69e-01	2.34e-01
ESTABLISHMENT OF GOLGI LOCALIZATION	8	6.15e-01	9.39e-01	0.2370	-5.59e-02	-2.02e-01	-4.45e-02	-1.10e-02	-1.01e-01	7.84e-01	3.23e-01	8.27e-01	9.57e-01	6.22e-01
CELLULAR RESPONSE TO COCAINE	8	7.13e-01	9.67e-01	0.2370	6.68e-02	-8.01e-02	2.93e-02	5.64e-02	2.03e-01	7.44e-01	6.95e-01	8.86e-01	7.82e-01	3.21e-01
REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	19	1.91e-01	6.64e-01	0.2370	4.53e-02	-7.59e-02	-1.39e-02	-7.50e-03	-2.19e-01	7.32e-01	5.67e-01	9.16e-01	9.55e-01	9.85e-02
TISSUE REGENERATION	73	4.45e-01	8.73e-01	0.2370	-1.20e-01	-3.18e-02	-1.33e-01	-1.33e-01	-7.18e-02	7.56e-02	6.39e-01	4.93e-02	4.98e-02	2.89e-01
HEPATOCYTE DIFFERENTIATION	15	8.26e-01	9.83e-01	0.2370	9.53e-02	-6.43e-02	1.35e-01	1.36e-01	7.76e-02	5.23e-01	6.67e-01	3.65e-01	3.62e-01	6.03e-01
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	8	8.28e-01	9.83e-01	0.2370	1.25e-01	1.63e-01	2.72e-02	5.52e-03	-1.14e-01	5.40e-01	4.25e-01	8.94e-01	9.78e-01	5.77e-01
REGULATION OF BILE ACID METABOLIC PROCESS	15	8.86e-01	9.91e-01	0.2370	-5.23e-02	2.79e-02	-1.57e-01	-1.42e-01	-8.83e-02	7.26e-01	8.52e-01	2.93e-01	3.42e-01	5.54e-01
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	1160	3.40e-23	2.56e-20	0.2360	-1.32e-01	-2.53e-02	-1.38e-01	-1.37e-01	-9.15e-04	3.57e-14	1.47e-01	1.75e-15	4.11e-15	9.58e-01
REGULATION OF CHROMOSOME ORGANIZATION	239	2.86e-06	1.78e-04	0.2360	7.28e-02	-4.63e-02	1.60e-01	1.38e-01	5.96e-02	5.24e-02	2.18e-01	2.00e-05	2.26e-04	1.12e-01
ENTEROENDOCRINE CELL DIFFERENTIATION	36	1.13e-01	5.39e-01	0.2360	1.33e-02	-1.78e-01	7.89e-02	5.82e-02	1.19e-01	8.90e-01	6.39e-02	4.12e-01	5.46e-01	2.16e-01
IMMUNE SYSTEM DEVELOPMENT	198	1.66e-03	3.54e-02	0.2360	8.85e-02	-1.93e-02	1.48e-01	1.31e-01	9.28e-02	3.18e-02	6.39e-01	3.42e-04	1.46e-03	2.43e-02
DE NOVO CENTRIOLE ASSEMBLY	6	9.65e-01	9.97e-01	0.2360	-1.05e-01	-2.05e-01	-3.61e-02	-3.64e-02	-1.29e-02	6.57e-01	3.84e-01	8.78e-01	8.77e-01	9.56e-01
BARBED END ACTIN FILAMENT CAPPING	25	8.82e-01	9.91e-01	0.2360	-8.91e-02	-4.08e-02	-1.24e-01	-1.29e-01	-1.19e-01	4.40e-01	7.24e-01	2.83e-01	2.64e-01	3.03e-01
CELLULAR RESPONSE TO INTERFERON BETA	26	7.92e-01	9.81e-01	0.2360	1.19e-01	1.45e-01	9.73e-02	9.10e-02	5.25e-02	2.93e-01	2.00e-01	3.90e-01	4.22e-01	6.43e-01
BRANCHED CHAIN AMINO ACID TRANSPORT	13	8.07e-01	9.82e-01	0.2360	1.69e-01	1.15e-01	7.89e-02	7.20e-02	-4.98e-02	2.91e-01	4.71e-01	6.22e-01	6.53e-01	7.56e-01
NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	86	1.12e-01	5.37e-01	0.2360	7.82e-02	-4.02e-02	1.41e-01	1.44e-01	8.62e-02	2.10e-01	5.19e-01	2.39e-02	2.10e-02	1.67e-01
MACROPHAGE PROLIFERATION	12	1.02e-01	5.10e-01	0.2360	-5.89e-02	-8.07e-03	-1.68e-01	-9.66e-02	1.21e-01	7.24e-01	9.61e-01	3.13e-01	5.62e-01	4.69e-01
TRYPTOPHAN TRANSPORT	5	9.36e-01	9.97e-01	0.2360	-5.08e-02	-1.32e-01	1.28e-01	1.20e-01	7.12e-02	8.44e-01	6.09e-01	6.21e-01	6.43e-01	7.83e-01
SISTER CHROMATID SEGREGATION	221	2.82e-04	9.24e-03	0.2360	1.02e-01	-5.08e-03	1.54e-01	1.45e-01	2.46e-02	9.24e-03	8.96e-01	7.85e-05	2.05e-04	5.29e-01
GOLGI VESICLE BUDDING	10	8.10e-01	9.82e-01	0.2360	1.23e-01	1.56e-02	1.23e-01	1.59e-01	7.53e-03	5.02e-01	9.32e-01	5.00e-01	3.85e-01	9.67e-01
PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS	21	5.54e-01	9.16e-01	0.2360	6.22e-02	-1.16e-01	1.05e-01	1.06e-01	1.27e-01	6.22e-01	3.59e-01	4.06e-01	3.98e-01	3.14e-01
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	61	2.97e-01	7.72e-01	0.2360	-1.11e-01	-1.16e-02	-1.45e-01	-1.48e-01	-8.15e-03	1.34e-01	8.76e-01	4.98e-02	4.50e-02	9.12e-01
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION	15	8.93e-01	9.92e-01	0.2360	-1.15e-01	-1.51e-01	-1.00e-01	-9.15e-02	3.42e-02	4.41e-01	3.10e-01	5.03e-01	5.39e-01	8.19e-01
MYELOID CELL APOPTOTIC PROCESS	38	1.85e-01	6.56e-01	0.2360	-4.51e-02	-1.77e-01	-7.77e-03	-1.87e-02	1.47e-01	6.30e-01	5.83e-02	9.34e-01	8.42e-01	1.16e-01
REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	6	2.18e-01	7.00e-01	0.2360	-5.50e-02	1.88e-01	-6.09e-02	2.08e-02	-1.14e-01	8.16e-01	4.25e-01	7.96e-01	9.30e-01	6.29e-01
REGULATION OF GROWTH RATE	5	9.57e-01	9.97e-01	0.2360	-9.01e-02	1.48e-02	-1.36e-01	-1.40e-01	9.58e-02	7.27e-01	9.54e-01	5.99e-01	5.88e-01	7.11e-01
GPI ANCHOR METABOLIC PROCESS	31	1.52e-01	6.14e-01	0.2350	3.69e-02	-1.26e-01	1.32e-01	1.43e-01	1.92e-02	7.22e-01	2.24e-01	2.05e-01	1.68e-01	8.53e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	44	6.04e-01	9.34e-01	0.2350	-1.30e-01	-7.54e-02	-1.33e-01	-1.21e-01	-2.23e-02	1.37e-01	3.87e-01	1.26e-01	1.64e-01	7.98e-01
PODOCYTE CELL MIGRATION	7	9.39e-01	9.97e-01	0.2350	8.39e-02	5.74e-02	1.35e-01	1.49e-01	-6.87e-02	7.01e-01	7.93e-01	5.38e-01	4.95e-01	7.53e-01
GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE	22	8.67e-02	4.68e-01	0.2350	-6.48e-02	-7.28e-02	-1.65e-01	-1.17e-01	7.15e-02	5.99e-01	5.55e-01	1.81e-01	3.43e-01	5.62e-01
NEUROTRANSMITTER CATABOLIC PROCESS	8	5.41e-01	9.14e-01	0.2350	5.70e-03	-1.03e-02	-9.42e-02	-1.21e-01	1.78e-01	9.78e-01	9.60e-01	6.44e-01	5.53e-01	3.83e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	32	5.58e-01	9.19e-01	0.2350	9.46e-02	1.28e-01	1.01e-01	1.18e-01	7.71e-02	3.55e-01	2.11e-01	3.25e-01	2.47e-01	4.50e-01
NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY	17	2.66e-01	7.47e-01	0.2350	-7.12e-02	-1.91e-02	1.64e-02	-9.68e-03	-2.22e-01	6.11e-01	8.91e-01	9.07e-01	9.45e-01	1.12e-01
CELLULAR RESPONSE TO MURAMYL DIPEPTIDE	8	5.15e-01	9.01e-01	0.2350	2.10e-01	9.83e-02	-1.12e-03	2.81e-02	2.82e-02	3.04e-01	6.30e-01	9.96e-01	8.90e-01	8.90e-01
HYALURONAN METABOLIC PROCESS	33	4.28e-01	8.65e-01	0.2350	-9.01e-02	-4.40e-02	-1.52e-01	-1.41e-01	4.97e-02	3.70e-01	6.62e-01	1.32e-01	1.62e-01	6.21e-01
REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	12	7.50e-01	9.75e-01	0.2350	9.48e-02	1.80e-02	1.68e-01	1.33e-01	-6.42e-03	5.70e-01	9.14e-01	3.15e-01	4.24e-01	9.69e-01
METANEPHRIC LOOP OF HENLE DEVELOPMENT	6	9.85e-01	9.98e-01	0.2350	-3.53e-02	1.16e-02	-1.03e-01	-1.01e-01	-1.82e-01	8.81e-01	9.61e-01	6.63e-01	6.70e-01	4.40e-01
ER NUCLEUS SIGNALING PATHWAY	45	3.42e-01	8.13e-01	0.2350	1.31e-01	-6.47e-03	1.24e-01	1.21e-01	8.95e-02	1.29e-01	9.40e-01	1.51e-01	1.59e-01	2.99e-01
DNA INTEGRITY CHECKPOINT SIGNALING	131	1.19e-04	4.52e-03	0.2350	9.72e-02	-1.27e-02	1.65e-01	1.35e-01	1.47e-02	5.46e-02	8.02e-01	1.13e-03	7.73e-03	7.71e-01
POSITIVE REGULATION OF TRANSLATION	127	1.00e-02	1.29e-01	0.2350	7.78e-02	-5.31e-02	1.47e-01	1.45e-01	6.01e-02	1.30e-01	3.02e-01	4.21e-03	4.85e-03	2.42e-01
EMBRYONIC DIGIT MORPHOGENESIS	57	1.78e-03	3.71e-02	0.2350	-5.96e-02	-1.74e-01	-7.34e-02	-1.07e-01	6.53e-02	4.37e-01	2.29e-02	3.38e-01	1.62e-01	3.94e-01
CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT	25	6.75e-01	9.59e-01	0.2350	1.14e-01	1.50e-01	7.80e-02	7.03e-02	9.16e-02	3.23e-01	1.94e-01	5.00e-01	5.43e-01	4.28e-01
MAINTENANCE OF GASTROINTESTINAL EPITHELIUM	23	7.06e-01	9.65e-01	0.2350	-5.77e-02	8.45e-02	-1.28e-01	-1.28e-01	-1.08e-01	6.32e-01	4.83e-01	2.88e-01	2.87e-01	3.69e-01
NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION	8	6.35e-01	9.48e-01	0.2340	1.27e-01	1.42e-01	5.65e-02	1.21e-01	2.59e-02	5.33e-01	4.86e-01	7.82e-01	5.53e-01	8.99e-01
VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS	46	2.78e-02	2.50e-01	0.2340	-1.37e-01	-1.71e-01	2.76e-02	-1.87e-02	7.65e-02	1.07e-01	4.51e-02	7.46e-01	8.26e-01	3.70e-01
NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT	14	5.39e-01	9.13e-01	0.2340	-7.71e-02	-5.38e-02	-1.32e-01	-1.68e-01	1.62e-02	6.18e-01	7.28e-01	3.91e-01	2.76e-01	9.16e-01
ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS	52	3.67e-01	8.30e-01	0.2340	-1.17e-01	-6.87e-02	-1.41e-01	-1.28e-01	1.90e-02	1.45e-01	3.92e-01	7.88e-02	1.11e-01	8.13e-01
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	9	9.27e-01	9.95e-01	0.2340	-1.22e-01	-1.24e-01	-5.65e-02	-5.61e-02	-1.35e-01	5.27e-01	5.18e-01	7.69e-01	7.71e-01	4.83e-01
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	94	1.68e-01	6.36e-01	0.2340	-8.57e-02	-4.95e-02	-1.40e-01	-1.46e-01	-6.42e-02	1.51e-01	4.07e-01	1.89e-02	1.45e-02	2.82e-01
LOOP OF HENLE DEVELOPMENT	12	1.63e-01	6.27e-01	0.2340	1.58e-01	-1.95e-02	9.35e-02	4.67e-02	1.36e-01	3.44e-01	9.07e-01	5.75e-01	7.79e-01	4.14e-01
CELLULAR RESPONSE TO ALDEHYDE	16	6.94e-01	9.61e-01	0.2340	5.08e-02	6.31e-02	-6.11e-02	-4.11e-02	-2.07e-01	7.25e-01	6.62e-01	6.72e-01	7.76e-01	1.52e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	6	9.65e-01	9.97e-01	0.2340	-1.21e-02	6.82e-03	-6.43e-02	-5.32e-02	-2.18e-01	9.59e-01	9.77e-01	7.85e-01	8.22e-01	3.55e-01
VIRAL RNA GENOME REPLICATION	29	6.75e-01	9.59e-01	0.2340	1.52e-01	9.76e-02	1.08e-01	1.00e-01	-2.40e-02	1.58e-01	3.63e-01	3.16e-01	3.50e-01	8.23e-01
AMP METABOLIC PROCESS	22	9.00e-01	9.94e-01	0.2340	-8.01e-02	3.41e-03	-1.30e-01	-1.22e-01	-1.28e-01	5.15e-01	9.78e-01	2.90e-01	3.23e-01	2.97e-01
RESPONSE TO DEXAMETHASONE	38	3.14e-01	7.86e-01	0.2340	1.28e-01	4.77e-02	1.43e-01	1.22e-01	-2.82e-02	1.72e-01	6.11e-01	1.28e-01	1.94e-01	7.64e-01
DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	14	7.28e-01	9.71e-01	0.2340	1.71e-01	4.00e-02	1.02e-01	1.11e-01	-3.33e-02	2.68e-01	7.95e-01	5.08e-01	4.72e-01	8.29e-01
NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	15	6.96e-01	9.61e-01	0.2340	8.91e-02	6.50e-02	1.30e-01	1.59e-01	-1.73e-02	5.50e-01	6.63e-01	3.82e-01	2.87e-01	9.08e-01
CORONARY ARTERY MORPHOGENESIS	9	5.59e-01	9.19e-01	0.2340	-2.75e-02	-1.78e-01	-8.98e-03	-5.47e-02	1.39e-01	8.86e-01	3.56e-01	9.63e-01	7.76e-01	4.71e-01
DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING	6	8.60e-01	9.88e-01	0.2340	7.57e-02	1.53e-02	1.14e-01	8.86e-02	-1.67e-01	7.48e-01	9.48e-01	6.30e-01	7.07e-01	4.79e-01
DNA TEMPLATED TRANSCRIPTION ELONGATION	132	2.96e-04	9.57e-03	0.2340	6.95e-02	-4.92e-02	1.64e-01	1.42e-01	1.36e-02	1.68e-01	3.29e-01	1.14e-03	4.78e-03	7.87e-01
MITOCHONDRIAL PROTEIN PROCESSING	13	9.28e-01	9.95e-01	0.2340	6.13e-02	8.35e-03	1.10e-01	9.46e-02	1.72e-01	7.02e-01	9.58e-01	4.92e-01	5.55e-01	2.82e-01
CELL COMMUNICATION BY ELECTRICAL COUPLING	34	3.77e-01	8.36e-01	0.2340	1.56e-01	7.92e-02	8.46e-02	8.10e-02	1.01e-01	1.15e-01	4.24e-01	3.93e-01	4.14e-01	3.08e-01
BEHAVIORAL RESPONSE TO PAIN	19	6.45e-01	9.50e-01	0.2330	-1.18e-01	2.85e-02	-1.43e-01	-1.37e-01	2.20e-02	3.75e-01	8.30e-01	2.79e-01	3.01e-01	8.68e-01
POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	24	8.54e-01	9.88e-01	0.2330	7.45e-02	2.35e-02	1.39e-01	1.25e-01	1.16e-01	5.28e-01	8.42e-01	2.39e-01	2.90e-01	3.25e-01
ADULT HEART DEVELOPMENT	13	9.23e-01	9.95e-01	0.2330	-7.75e-02	5.13e-02	-1.44e-01	-1.33e-01	-8.51e-02	6.29e-01	7.49e-01	3.67e-01	4.08e-01	5.95e-01
MAINTENANCE OF CENTROSOME LOCATION	6	7.45e-01	9.75e-01	0.2330	-7.32e-02	-1.64e-01	3.76e-02	-9.77e-03	-1.43e-01	7.56e-01	4.87e-01	8.73e-01	9.67e-01	5.43e-01
CENTROSOME SEPARATION	15	8.39e-01	9.85e-01	0.2330	6.20e-02	-9.26e-02	1.25e-01	1.14e-01	1.15e-01	6.77e-01	5.35e-01	4.01e-01	4.43e-01	4.42e-01
RESPONSE TO STEROL DEPLETION	18	5.42e-01	9.14e-01	0.2330	-4.60e-02	-1.71e-01	-2.53e-02	-1.70e-02	1.48e-01	7.35e-01	2.09e-01	8.53e-01	9.01e-01	2.76e-01
KERATINIZATION	80	1.89e-08	1.90e-06	0.2330	-3.27e-03	2.14e-01	-7.54e-02	-2.09e-02	-4.89e-02	9.60e-01	9.46e-04	2.43e-01	7.47e-01	4.49e-01
MUSCLE CELL FATE COMMITMENT	20	2.83e-01	7.62e-01	0.2330	-4.97e-02	-2.25e-01	-1.63e-03	-2.37e-02	-2.63e-02	7.00e-01	8.20e-02	9.90e-01	8.54e-01	8.39e-01
CALCINEURIN MEDIATED SIGNALING	48	4.51e-01	8.76e-01	0.2330	1.18e-01	1.32e-01	7.44e-02	8.51e-02	1.00e-01	1.59e-01	1.13e-01	3.72e-01	3.08e-01	2.29e-01
ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS	17	7.30e-01	9.71e-01	0.2330	-3.62e-02	-6.33e-02	-1.19e-01	-1.14e-01	-1.47e-01	7.96e-01	6.51e-01	3.95e-01	4.15e-01	2.94e-01
NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	33	2.51e-01	7.35e-01	0.2330	-4.10e-02	-9.87e-02	1.24e-01	1.01e-01	1.31e-01	6.83e-01	3.26e-01	2.17e-01	3.16e-01	1.93e-01
NEURON FATE COMMITMENT	73	1.51e-09	1.99e-07	0.2330	1.20e-01	-1.56e-01	9.73e-02	6.46e-02	4.18e-02	7.69e-02	2.09e-02	1.51e-01	3.40e-01	5.37e-01
SODIUM DEPENDENT PHOSPHATE TRANSPORT	12	6.07e-01	9.35e-01	0.2330	5.16e-02	1.93e-01	1.64e-02	1.18e-02	1.17e-01	7.57e-01	2.46e-01	9.22e-01	9.43e-01	4.84e-01
REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	7	5.84e-01	9.28e-01	0.2330	-5.47e-02	-1.14e-01	-7.88e-02	-2.81e-02	1.76e-01	8.02e-01	6.01e-01	7.18e-01	8.97e-01	4.19e-01
REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	11	6.74e-01	9.59e-01	0.2330	6.36e-02	1.91e-01	1.67e-02	7.74e-03	1.15e-01	7.15e-01	2.72e-01	9.24e-01	9.65e-01	5.09e-01
AXONEMAL DYNEIN COMPLEX ASSEMBLY	39	3.56e-01	8.22e-01	0.2330	1.41e-01	1.57e-01	1.64e-02	2.85e-02	-9.35e-02	1.29e-01	9.06e-02	8.60e-01	7.58e-01	3.12e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II	29	7.69e-01	9.76e-01	0.2330	-8.63e-02	9.32e-03	-1.51e-01	-1.41e-01	-6.25e-02	4.21e-01	9.31e-01	1.59e-01	1.90e-01	5.60e-01
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION	44	1.02e-01	5.10e-01	0.2330	1.80e-01	6.67e-02	8.87e-02	8.79e-02	4.08e-02	3.89e-02	4.44e-01	3.09e-01	3.13e-01	6.39e-01
LYMPHOCYTE MEDIATED IMMUNITY	282	7.63e-05	3.05e-03	0.2320	9.93e-02	1.10e-01	9.57e-02	1.09e-01	1.05e-01	4.09e-03	1.47e-03	5.65e-03	1.68e-03	2.39e-03
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION	108	1.57e-03	3.41e-02	0.2320	-1.34e-01	-1.36e-01	-9.58e-02	-7.36e-02	5.52e-02	1.61e-02	1.49e-02	8.55e-02	1.86e-01	3.21e-01
FARNESYL DIPHOSPHATE METABOLIC PROCESS	6	6.43e-01	9.50e-01	0.2320	7.55e-02	-1.52e-01	7.47e-02	5.81e-02	-1.27e-01	7.49e-01	5.18e-01	7.51e-01	8.05e-01	5.91e-01
POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	19	4.35e-01	8.69e-01	0.2320	1.15e-01	-7.03e-02	9.77e-02	8.99e-02	1.34e-01	3.85e-01	5.96e-01	4.61e-01	4.98e-01	3.11e-01
SPLEEN DEVELOPMENT	38	5.20e-02	3.58e-01	0.2320	-3.91e-02	-2.13e-01	6.93e-02	3.73e-02	2.73e-02	6.77e-01	2.31e-02	4.60e-01	6.91e-01	7.71e-01
STORE OPERATED CALCIUM ENTRY	21	1.79e-01	6.52e-01	0.2320	3.31e-02	1.43e-01	7.92e-02	4.91e-02	1.54e-01	7.93e-01	2.58e-01	5.30e-01	6.97e-01	2.22e-01
NUCLEAR MEMBRANE ORGANIZATION	42	1.37e-02	1.57e-01	0.2320	2.87e-02	-1.56e-01	1.10e-01	1.17e-01	-5.39e-02	7.48e-01	8.11e-02	2.18e-01	1.89e-01	5.45e-01
NEURAL TUBE PATTERNING	39	6.62e-03	9.83e-02	0.2320	3.05e-02	-1.63e-01	7.21e-02	2.88e-02	1.41e-01	7.42e-01	7.73e-02	4.36e-01	7.55e-01	1.26e-01
TRANSLESION SYNTHESIS	25	3.24e-01	7.96e-01	0.2320	4.18e-02	-1.32e-01	1.31e-01	1.31e-01	1.38e-02	7.17e-01	2.54e-01	2.56e-01	2.57e-01	9.05e-01
POSITIVE REGULATION OF MEMBRANE POTENTIAL	15	7.17e-01	9.68e-01	0.2320	7.61e-02	8.24e-02	7.89e-02	9.34e-02	-1.62e-01	6.10e-01	5.80e-01	5.97e-01	5.31e-01	2.78e-01
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	89	2.72e-01	7.54e-01	0.2320	-1.33e-01	-5.50e-02	-1.28e-01	-1.28e-01	-1.26e-02	3.07e-02	3.69e-01	3.67e-02	3.62e-02	8.37e-01
MATERNAL PLACENTA DEVELOPMENT	33	4.99e-01	8.97e-01	0.2320	1.48e-01	2.87e-02	1.24e-01	1.24e-01	-9.02e-03	1.42e-01	7.75e-01	2.18e-01	2.16e-01	9.29e-01
POSITIVE REGULATION OF B CELL ACTIVATION	79	1.93e-01	6.67e-01	0.2320	5.55e-02	-2.15e-02	1.47e-01	1.39e-01	9.51e-02	3.94e-01	7.41e-01	2.38e-02	3.25e-02	1.44e-01
RAB PROTEIN SIGNAL TRANSDUCTION	16	8.32e-01	9.85e-01	0.2310	-1.88e-02	9.74e-02	-1.04e-01	-1.07e-01	-1.47e-01	8.96e-01	5.00e-01	4.71e-01	4.59e-01	3.10e-01
PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	17	3.15e-01	7.88e-01	0.2310	1.02e-01	-9.55e-02	6.12e-02	6.79e-02	1.60e-01	4.65e-01	4.95e-01	6.62e-01	6.28e-01	2.53e-01
CHOLESTEROL EFFLUX	73	1.82e-02	1.92e-01	0.2310	-1.26e-01	-7.63e-02	-1.37e-01	-1.04e-01	-4.82e-02	6.27e-02	2.60e-01	4.33e-02	1.24e-01	4.77e-01
SNORNA LOCALIZATION	6	6.35e-01	9.48e-01	0.2310	9.21e-02	2.17e-02	1.71e-01	9.94e-02	7.51e-02	6.96e-01	9.27e-01	4.70e-01	6.73e-01	7.50e-01
POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	42	4.06e-01	8.50e-01	0.2310	-1.31e-01	-9.71e-02	-7.92e-02	-7.54e-02	-1.22e-01	1.41e-01	2.76e-01	3.75e-01	3.98e-01	1.71e-01
HYPOTHALAMUS CELL DIFFERENTIATION	12	5.70e-01	9.26e-01	0.2310	-1.07e-01	-1.66e-01	8.10e-02	3.25e-02	8.28e-02	5.20e-01	3.20e-01	6.27e-01	8.45e-01	6.20e-01
CELLULAR RESPONSE TO COPPER ION	25	5.45e-01	9.15e-01	0.2310	5.56e-02	-5.25e-02	1.13e-01	1.32e-01	1.31e-01	6.30e-01	6.49e-01	3.26e-01	2.52e-01	2.55e-01
CELLULAR RESPONSE TO HEPARIN	5	6.64e-01	9.54e-01	0.2310	6.11e-02	-1.42e-01	-4.56e-02	-4.33e-02	1.60e-01	8.13e-01	5.82e-01	8.60e-01	8.67e-01	5.37e-01
NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION	7	9.74e-01	9.97e-01	0.2310	1.13e-01	2.93e-02	1.32e-01	1.49e-01	-1.09e-02	6.06e-01	8.93e-01	5.45e-01	4.95e-01	9.60e-01
NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE	7	7.27e-01	9.71e-01	0.2310	-1.52e-02	1.09e-01	-1.01e-02	-3.23e-02	2.00e-01	9.44e-01	6.16e-01	9.63e-01	8.82e-01	3.59e-01
POSITIVE REGULATION OF CENTRIOLE ELONGATION	5	9.05e-01	9.94e-01	0.2310	2.44e-02	-6.75e-02	9.55e-02	1.31e-01	1.48e-01	9.25e-01	7.94e-01	7.11e-01	6.13e-01	5.66e-01
IP 10 PRODUCTION	5	3.96e-01	8.44e-01	0.2310	9.24e-02	1.75e-01	1.49e-02	1.14e-01	-2.98e-02	7.20e-01	4.98e-01	9.54e-01	6.58e-01	9.08e-01
ADP TRANSPORT	10	7.23e-01	9.70e-01	0.2310	1.48e-01	5.98e-02	4.66e-02	4.71e-02	-1.53e-01	4.16e-01	7.43e-01	7.99e-01	7.96e-01	4.03e-01
NEGATIVE REGULATION OF GLIOGENESIS	44	9.30e-03	1.23e-01	0.2310	1.01e-02	-1.60e-01	5.14e-02	1.22e-02	1.58e-01	9.08e-01	6.71e-02	5.55e-01	8.89e-01	6.99e-02
REGULATION OF VIRAL PROCESS	164	8.65e-02	4.68e-01	0.2310	1.31e-01	9.00e-02	1.18e-01	1.15e-01	2.80e-02	3.81e-03	4.67e-02	8.89e-03	1.11e-02	5.36e-01
SPERM AXONEME ASSEMBLY	27	7.84e-01	9.81e-01	0.2310	-1.20e-01	-6.74e-02	-1.27e-01	-1.10e-01	-7.85e-02	2.79e-01	5.45e-01	2.55e-01	3.24e-01	4.80e-01
RELAXATION OF CARDIAC MUSCLE	17	7.72e-01	9.77e-01	0.2310	-5.68e-02	-7.14e-02	-1.10e-01	-1.22e-01	-1.34e-01	6.85e-01	6.10e-01	4.34e-01	3.83e-01	3.40e-01
RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM	70	2.32e-01	7.15e-01	0.2310	-3.08e-02	5.64e-02	-1.13e-01	-1.04e-01	-1.59e-01	6.56e-01	4.14e-01	1.03e-01	1.31e-01	2.10e-02
GLYCOSAMINOGLYCAN CATABOLIC PROCESS	27	8.33e-01	9.85e-01	0.2310	-1.41e-01	-1.16e-01	-1.02e-01	-9.70e-02	-3.18e-03	2.04e-01	2.99e-01	3.58e-01	3.83e-01	9.77e-01
MITOTIC SPINDLE ASSEMBLY	67	1.54e-01	6.16e-01	0.2300	8.80e-02	-3.15e-02	1.50e-01	1.46e-01	2.16e-02	2.13e-01	6.56e-01	3.35e-02	3.88e-02	7.60e-01
REGULATION OF STEM CELL DIFFERENTIATION	78	7.53e-03	1.08e-01	0.2300	8.28e-02	-8.36e-02	1.10e-01	8.99e-02	1.38e-01	2.06e-01	2.02e-01	9.16e-02	1.70e-01	3.56e-02
NUCLEOTIDE TRANSMEMBRANE TRANSPORT	26	2.11e-01	6.90e-01	0.2300	1.39e-02	4.67e-02	-4.70e-02	-7.22e-02	-2.08e-01	9.02e-01	6.80e-01	6.78e-01	5.24e-01	6.64e-02
SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION	10	8.03e-01	9.82e-01	0.2300	-4.15e-02	-1.32e-01	3.44e-02	5.32e-02	1.73e-01	8.20e-01	4.71e-01	8.51e-01	7.71e-01	3.43e-01
NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	12	2.06e-01	6.84e-01	0.2300	8.10e-02	-1.22e-01	5.85e-03	7.09e-03	-1.77e-01	6.27e-01	4.63e-01	9.72e-01	9.66e-01	2.88e-01
COLLATERAL SPROUTING	26	1.41e-01	5.98e-01	0.2300	-2.08e-02	-6.72e-02	-4.92e-02	-7.35e-02	2.00e-01	8.55e-01	5.53e-01	6.64e-01	5.17e-01	7.68e-02
PODOSOME ASSEMBLY	19	3.86e-01	8.40e-01	0.2300	-4.29e-02	8.28e-02	-1.58e-01	-1.32e-01	4.49e-02	7.46e-01	5.32e-01	2.34e-01	3.20e-01	7.35e-01
REGULATION OF PROTEIN LOCALIZATION TO CILIUM	11	8.40e-01	9.85e-01	0.2300	8.50e-02	1.40e-01	1.01e-01	1.27e-01	-6.75e-03	6.25e-01	4.23e-01	5.62e-01	4.67e-01	9.69e-01
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS	10	7.48e-01	9.75e-01	0.2300	2.70e-02	-1.19e-01	5.54e-02	2.59e-02	1.85e-01	8.82e-01	5.15e-01	7.62e-01	8.87e-01	3.10e-01
PHOSPHATIDYLSERINE METABOLIC PROCESS	23	1.97e-01	6.75e-01	0.2300	-3.57e-02	6.02e-02	-1.42e-01	-1.67e-01	9.85e-03	7.67e-01	6.17e-01	2.39e-01	1.67e-01	9.35e-01
POSITIVE REGULATION OF VIRAL LIFE CYCLE	23	6.75e-01	9.59e-01	0.2300	1.35e-01	8.05e-02	9.62e-02	1.22e-01	-6.35e-02	2.62e-01	5.04e-01	4.25e-01	3.12e-01	5.98e-01
NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	15	3.63e-01	8.26e-01	0.2300	-8.64e-02	-5.26e-02	2.34e-02	1.86e-02	-2.04e-01	5.62e-01	7.24e-01	8.75e-01	9.01e-01	1.71e-01
NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	13	8.03e-01	9.82e-01	0.2300	-7.15e-02	-8.23e-02	-1.35e-01	-1.50e-01	1.02e-02	6.55e-01	6.08e-01	4.00e-01	3.48e-01	9.49e-01
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	8	8.33e-01	9.85e-01	0.2300	8.89e-02	3.68e-02	1.66e-01	1.23e-01	2.56e-02	6.63e-01	8.57e-01	4.15e-01	5.47e-01	9.00e-01
DIOL BIOSYNTHETIC PROCESS	21	6.16e-01	9.40e-01	0.2290	-9.86e-02	-2.04e-01	-2.09e-02	-2.20e-02	-1.68e-02	4.34e-01	1.05e-01	8.68e-01	8.62e-01	8.94e-01
PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS	22	4.23e-01	8.61e-01	0.2290	-6.93e-02	-2.08e-01	2.19e-02	-1.12e-02	6.37e-02	5.74e-01	9.17e-02	8.59e-01	9.28e-01	6.05e-01
PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS	10	8.26e-01	9.83e-01	0.2290	1.87e-02	-1.00e-01	1.37e-01	1.46e-01	4.35e-02	9.18e-01	5.83e-01	4.52e-01	4.23e-01	8.12e-01
CELL CELL ADHESION MEDIATED BY CADHERIN	47	2.94e-01	7.70e-01	0.2290	-1.07e-01	-4.56e-02	-1.28e-01	-1.49e-01	1.74e-02	2.05e-01	5.88e-01	1.28e-01	7.68e-02	8.36e-01
PHENOL CONTAINING COMPOUND CATABOLIC PROCESS	7	9.53e-01	9.97e-01	0.2290	-1.08e-01	-1.05e-01	-7.08e-02	-6.37e-02	1.44e-01	6.20e-01	6.30e-01	7.46e-01	7.70e-01	5.10e-01
PLACENTA BLOOD VESSEL DEVELOPMENT	30	4.94e-01	8.96e-01	0.2290	1.59e-02	-1.07e-01	6.80e-02	6.83e-02	1.77e-01	8.80e-01	3.10e-01	5.19e-01	5.18e-01	9.25e-02
CELLULAR OXIDANT DETOXIFICATION	95	8.02e-02	4.53e-01	0.2290	8.51e-02	-1.56e-02	1.19e-01	1.03e-01	1.43e-01	1.52e-01	7.92e-01	4.57e-02	8.41e-02	1.62e-02
NEURON FATE SPECIFICATION	34	3.78e-04	1.16e-02	0.2290	1.44e-01	-1.16e-01	1.02e-01	6.87e-02	5.48e-02	1.46e-01	2.41e-01	3.01e-01	4.88e-01	5.81e-01
QUINONE METABOLIC PROCESS	39	4.34e-01	8.69e-01	0.2290	1.09e-01	-3.22e-02	1.40e-01	1.33e-01	4.72e-02	2.38e-01	7.28e-01	1.31e-01	1.52e-01	6.10e-01
POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS	9	2.08e-01	6.85e-01	0.2290	8.72e-02	-2.84e-02	-1.13e-01	-1.11e-01	1.37e-01	6.51e-01	8.83e-01	5.59e-01	5.64e-01	4.75e-01
LATE ENDOSOME TO VACUOLE TRANSPORT	36	1.57e-01	6.19e-01	0.2290	4.05e-02	-1.28e-01	1.19e-01	1.29e-01	5.73e-02	6.74e-01	1.82e-01	2.18e-01	1.79e-01	5.52e-01
POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	12	8.41e-01	9.85e-01	0.2290	1.47e-01	1.27e-02	1.06e-01	1.00e-01	9.56e-02	3.78e-01	9.39e-01	5.24e-01	5.48e-01	5.66e-01
REGULATION OF BONE REMODELING	49	3.44e-01	8.14e-01	0.2290	-8.36e-02	-7.93e-02	-1.43e-01	-1.36e-01	5.14e-03	3.12e-01	3.37e-01	8.34e-02	9.92e-02	9.50e-01
PROTEIN N LINKED GLYCOSYLATION	68	1.83e-02	1.92e-01	0.2290	8.19e-02	-8.53e-02	1.46e-01	1.28e-01	2.53e-02	2.43e-01	2.24e-01	3.74e-02	6.85e-02	7.18e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	38	6.61e-01	9.54e-01	0.2280	1.43e-01	5.24e-02	1.10e-01	1.16e-01	5.68e-02	1.26e-01	5.76e-01	2.40e-01	2.14e-01	5.44e-01
REGULATION OF ATP BIOSYNTHETIC PROCESS	17	7.96e-01	9.81e-01	0.2280	7.90e-02	1.20e-01	7.99e-02	9.30e-02	1.29e-01	5.73e-01	3.92e-01	5.68e-01	5.07e-01	3.58e-01
DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	42	3.31e-01	8.03e-01	0.2280	1.48e-01	1.64e-02	1.19e-01	1.24e-01	2.34e-02	9.66e-02	8.54e-01	1.83e-01	1.65e-01	7.93e-01
SOMATIC STEM CELL POPULATION MAINTENANCE	65	1.36e-02	1.57e-01	0.2280	8.92e-02	-8.82e-02	1.40e-01	1.30e-01	-1.62e-03	2.14e-01	2.19e-01	5.15e-02	6.95e-02	9.82e-01
GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS	23	8.31e-01	9.84e-01	0.2280	1.12e-01	1.65e-01	6.66e-02	8.12e-02	-3.36e-02	3.50e-01	1.70e-01	5.80e-01	5.00e-01	7.81e-01
REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	11	8.93e-01	9.92e-01	0.2280	-4.18e-02	-1.30e-01	9.21e-03	4.17e-03	1.82e-01	8.10e-01	4.56e-01	9.58e-01	9.81e-01	2.95e-01
REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	24	5.77e-01	9.26e-01	0.2280	1.22e-01	-3.72e-02	1.30e-01	1.32e-01	3.46e-02	3.00e-01	7.53e-01	2.70e-01	2.62e-01	7.69e-01
STRIATED MUSCLE ATROPHY	7	9.82e-01	9.97e-01	0.2280	1.44e-01	1.12e-01	8.28e-02	1.08e-01	-5.36e-03	5.11e-01	6.06e-01	7.04e-01	6.19e-01	9.80e-01
PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS	5	9.01e-01	9.94e-01	0.2280	-5.59e-02	-1.47e-01	-1.11e-01	-8.41e-02	8.86e-02	8.29e-01	5.69e-01	6.68e-01	7.45e-01	7.32e-01
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING	9	7.04e-01	9.65e-01	0.2280	7.79e-02	4.86e-02	1.15e-01	1.61e-01	6.64e-02	6.86e-01	8.01e-01	5.50e-01	4.03e-01	7.30e-01
CELLULAR RESPONSE TO TOXIC SUBSTANCE	124	3.58e-02	2.88e-01	0.2280	8.90e-02	-1.66e-02	1.13e-01	1.03e-01	1.42e-01	8.69e-02	7.50e-01	2.93e-02	4.68e-02	6.28e-03
OLFACTORY NERVE DEVELOPMENT	6	8.78e-01	9.88e-01	0.2280	-8.59e-02	8.04e-02	-1.20e-01	-1.33e-01	7.67e-02	7.16e-01	7.33e-01	6.11e-01	5.72e-01	7.45e-01
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	27	7.67e-01	9.75e-01	0.2280	1.20e-01	4.08e-02	9.82e-02	9.70e-02	1.30e-01	2.81e-01	7.13e-01	3.77e-01	3.83e-01	2.43e-01
ALLANTOIN METABOLIC PROCESS	9	7.29e-01	9.71e-01	0.2280	1.25e-01	1.73e-01	-5.96e-02	-5.35e-02	5.46e-03	5.17e-01	3.69e-01	7.57e-01	7.81e-01	9.77e-01
SMOOTH MUSCLE CELL APOPTOTIC PROCESS	32	7.94e-01	9.81e-01	0.2280	-1.26e-01	-1.07e-01	-1.03e-01	-1.07e-01	5.01e-02	2.18e-01	2.94e-01	3.15e-01	2.94e-01	6.24e-01
POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	41	4.51e-01	8.76e-01	0.2280	6.98e-02	-2.93e-02	1.35e-01	1.46e-01	8.13e-02	4.40e-01	7.45e-01	1.35e-01	1.06e-01	3.67e-01
PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE	7	9.61e-01	9.97e-01	0.2280	9.89e-02	7.29e-02	1.22e-01	1.45e-01	-2.83e-02	6.50e-01	7.38e-01	5.78e-01	5.06e-01	8.97e-01
GOLGI LOCALIZATION	14	8.23e-01	9.83e-01	0.2280	-4.52e-02	-7.81e-02	-9.09e-02	-8.18e-02	-1.69e-01	7.70e-01	6.13e-01	5.56e-01	5.96e-01	2.73e-01
NEGATIVE REGULATION OF MUSCLE HYPERTROPHY	36	8.16e-01	9.83e-01	0.2270	-9.12e-02	-3.92e-02	-1.28e-01	-1.19e-01	-1.06e-01	3.44e-01	6.84e-01	1.83e-01	2.16e-01	2.71e-01
PULMONARY VALVE DEVELOPMENT	23	7.25e-01	9.70e-01	0.2270	-3.62e-02	5.63e-03	-1.43e-01	-1.40e-01	-1.01e-01	7.64e-01	9.63e-01	2.34e-01	2.45e-01	4.01e-01
IMMUNOGLOBULIN PRODUCTION	104	1.27e-01	5.68e-01	0.2270	8.05e-02	-2.76e-02	1.31e-01	1.32e-01	9.96e-02	1.56e-01	6.27e-01	2.13e-02	1.98e-02	7.93e-02
SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	19	7.59e-01	9.75e-01	0.2270	7.05e-02	2.04e-02	1.61e-01	1.42e-01	2.02e-02	5.94e-01	8.78e-01	2.25e-01	2.85e-01	8.79e-01
MAINTENANCE OF CELL POLARITY	17	8.58e-01	9.88e-01	0.2270	1.23e-02	-8.77e-02	1.13e-01	1.08e-01	1.40e-01	9.30e-01	5.31e-01	4.21e-01	4.42e-01	3.18e-01
INNER EAR RECEPTOR CELL FATE COMMITMENT	5	9.05e-01	9.94e-01	0.2270	8.95e-02	7.71e-02	-6.71e-02	-7.22e-02	-1.67e-01	7.29e-01	7.65e-01	7.95e-01	7.80e-01	5.17e-01
REGULATION OF CELL KILLING	113	2.32e-04	7.95e-03	0.2270	4.84e-02	1.32e-01	6.92e-02	7.51e-02	1.47e-01	3.75e-01	1.56e-02	2.04e-01	1.68e-01	7.00e-03
GLANDULAR EPITHELIAL CELL DIFFERENTIATION	72	2.84e-02	2.52e-01	0.2270	-7.09e-02	-1.81e-01	-5.89e-02	-6.60e-02	7.73e-02	2.98e-01	7.84e-03	3.87e-01	3.33e-01	2.57e-01
REGULATION OF SYNAPSE PRUNING	6	9.51e-01	9.97e-01	0.2270	-1.47e-01	-7.07e-02	-6.75e-02	-7.63e-02	1.21e-01	5.33e-01	7.64e-01	7.75e-01	7.46e-01	6.08e-01
BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT	115	1.47e-02	1.64e-01	0.2270	3.26e-02	-5.17e-02	7.79e-02	6.63e-02	1.93e-01	5.46e-01	3.39e-01	1.49e-01	2.20e-01	3.41e-04
TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION	9	9.44e-01	9.97e-01	0.2270	-1.10e-01	-7.38e-02	-8.12e-02	-1.06e-01	-1.27e-01	5.67e-01	7.01e-01	6.73e-01	5.82e-01	5.10e-01
METANEPHRIC DISTAL TUBULE DEVELOPMENT	7	8.23e-01	9.83e-01	0.2270	-5.72e-02	-7.04e-02	-1.14e-01	-1.52e-01	-8.41e-02	7.93e-01	7.47e-01	6.00e-01	4.86e-01	7.00e-01
POSITIVE REGULATION OF CIRCADIAN RHYTHM	18	6.78e-01	9.60e-01	0.2270	-1.06e-01	-4.98e-02	-1.06e-01	-1.28e-01	1.01e-01	4.36e-01	7.14e-01	4.35e-01	3.48e-01	4.58e-01
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	81	4.07e-01	8.51e-01	0.2270	-1.00e-01	-7.78e-02	-1.26e-01	-1.32e-01	-4.54e-02	1.19e-01	2.26e-01	5.00e-02	3.94e-02	4.80e-01
REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	52	3.67e-01	8.30e-01	0.2270	-9.28e-02	-1.29e-01	-1.15e-01	-1.06e-01	-4.17e-02	2.47e-01	1.08e-01	1.51e-01	1.85e-01	6.03e-01
REGULATION OF MACROPHAGE ACTIVATION	61	8.99e-02	4.77e-01	0.2270	-5.51e-02	-1.42e-01	-3.55e-03	-1.84e-03	1.68e-01	4.56e-01	5.47e-02	9.62e-01	9.80e-01	2.32e-02
ARACHIDONIC ACID SECRETION	31	3.34e-01	8.05e-01	0.2270	6.50e-02	1.30e-01	6.96e-02	8.48e-02	1.35e-01	5.31e-01	2.12e-01	5.02e-01	4.14e-01	1.92e-01
POSITIVE REGULATION OF ACTION POTENTIAL	8	3.54e-02	2.86e-01	0.2270	-4.24e-02	8.12e-02	-1.93e-01	-7.56e-02	1.52e-02	8.36e-01	6.91e-01	3.46e-01	7.11e-01	9.41e-01
PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM	9	9.63e-01	9.97e-01	0.2270	-8.93e-02	-3.01e-02	-9.51e-02	-1.12e-01	-1.44e-01	6.43e-01	8.76e-01	6.21e-01	5.60e-01	4.53e-01
CILIUM DISASSEMBLY	5	9.20e-01	9.95e-01	0.2270	1.67e-01	9.02e-02	9.42e-02	6.63e-02	4.70e-02	5.19e-01	7.27e-01	7.15e-01	7.97e-01	8.56e-01
REGULATION OF MAST CELL ACTIVATION	38	2.60e-01	7.43e-01	0.2260	-6.84e-02	-1.76e-01	-5.12e-02	-5.21e-02	1.02e-01	4.65e-01	6.08e-02	5.85e-01	5.79e-01	2.77e-01
MECHANOSENSORY BEHAVIOR	14	6.63e-01	9.54e-01	0.2260	5.83e-02	2.03e-01	-6.33e-02	-5.17e-02	-1.92e-05	7.06e-01	1.89e-01	6.82e-01	7.38e-01	1.00e+00
URATE METABOLIC PROCESS	12	6.84e-01	9.61e-01	0.2260	9.13e-02	1.84e-01	-3.53e-02	-1.92e-02	8.71e-02	5.84e-01	2.71e-01	8.32e-01	9.08e-01	6.01e-01
G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION	6	7.32e-01	9.72e-01	0.2260	-1.89e-01	-4.75e-02	-9.15e-02	-6.36e-02	2.87e-02	4.23e-01	8.40e-01	6.98e-01	7.87e-01	9.03e-01
EMBRYONIC CLEAVAGE	8	9.36e-01	9.97e-01	0.2260	-5.45e-02	-4.52e-02	-1.30e-01	-1.01e-01	-1.38e-01	7.89e-01	8.25e-01	5.25e-01	6.20e-01	4.99e-01
REGULATION OF HEPATOCYTE PROLIFERATION	16	5.95e-01	9.33e-01	0.2260	-1.54e-01	-1.62e-01	-2.00e-02	-1.16e-02	2.53e-02	2.87e-01	2.61e-01	8.90e-01	9.36e-01	8.61e-01
NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	20	7.11e-01	9.67e-01	0.2260	8.07e-03	-1.06e-01	6.00e-02	6.19e-02	1.80e-01	9.50e-01	4.12e-01	6.42e-01	6.32e-01	1.63e-01
TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE	7	1.01e-01	5.09e-01	0.2260	-7.35e-02	2.53e-03	6.98e-02	1.45e-01	1.41e-01	7.36e-01	9.91e-01	7.49e-01	5.07e-01	5.18e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	49	8.77e-02	4.71e-01	0.2260	-1.04e-01	-7.56e-02	-9.28e-02	-1.23e-01	1.04e-01	2.09e-01	3.60e-01	2.61e-01	1.36e-01	2.08e-01
MUSCLE CELL APOPTOTIC PROCESS	91	1.83e-01	6.56e-01	0.2260	-1.01e-01	-1.05e-01	-1.21e-01	-1.22e-01	2.09e-02	9.64e-02	8.45e-02	4.63e-02	4.39e-02	7.30e-01
CEREBELLAR CORTEX MORPHOGENESIS	34	8.38e-01	9.85e-01	0.2260	1.11e-01	4.51e-02	1.11e-01	1.16e-01	1.05e-01	2.63e-01	6.49e-01	2.63e-01	2.41e-01	2.91e-01
REGULATION OF AMPA RECEPTOR ACTIVITY	23	6.49e-01	9.51e-01	0.2260	8.27e-02	1.39e-01	8.83e-02	1.06e-01	7.69e-02	4.92e-01	2.48e-01	4.63e-01	3.80e-01	5.23e-01
PROTEIN IMPORT INTO PEROXISOME MATRIX	14	9.73e-01	9.97e-01	0.2260	1.36e-01	9.29e-02	1.08e-01	1.10e-01	-1.10e-03	3.77e-01	5.47e-01	4.84e-01	4.74e-01	9.94e-01
SNRNA TRANSCRIPTION BY RNA POLYMERASE II	16	4.10e-01	8.52e-01	0.2260	1.64e-01	-3.29e-02	1.04e-01	1.10e-01	1.57e-02	2.57e-01	8.20e-01	4.72e-01	4.45e-01	9.13e-01
HISTAMINE SECRETION	12	2.75e-01	7.56e-01	0.2260	1.79e-01	6.08e-03	3.14e-02	5.05e-02	-1.23e-01	2.82e-01	9.71e-01	8.50e-01	7.62e-01	4.59e-01
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	72	2.43e-04	8.20e-03	0.2260	-1.26e-01	-1.24e-01	-1.09e-01	-6.78e-02	5.78e-02	6.46e-02	6.95e-02	1.10e-01	3.20e-01	3.96e-01
INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS	10	7.72e-01	9.77e-01	0.2260	5.88e-02	1.82e-01	-8.59e-02	-8.42e-02	-1.18e-02	7.48e-01	3.20e-01	6.38e-01	6.45e-01	9.48e-01
NEGATIVE REGULATION OF BONE MINERALIZATION	18	4.62e-01	8.80e-01	0.2260	-2.54e-02	-9.92e-02	-1.28e-01	-1.17e-01	-1.02e-01	8.52e-01	4.66e-01	3.48e-01	3.91e-01	4.53e-01
L PHENYLALANINE METABOLIC PROCESS	8	4.09e-01	8.52e-01	0.2260	4.30e-02	-2.07e-01	-2.26e-02	-7.26e-03	7.56e-02	8.33e-01	3.11e-01	9.12e-01	9.72e-01	7.11e-01
MICROTUBULE SEVERING	8	9.64e-01	9.97e-01	0.2260	-1.29e-01	-1.17e-01	-6.30e-02	-8.74e-02	9.48e-02	5.28e-01	5.67e-01	7.58e-01	6.69e-01	6.42e-01
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY	93	2.05e-01	6.84e-01	0.2250	-1.02e-01	-6.52e-03	-1.39e-01	-1.28e-01	-6.90e-02	8.94e-02	9.13e-01	2.03e-02	3.34e-02	2.50e-01
CYTOPLASMIC MICROTUBULE ORGANIZATION	59	3.11e-01	7.85e-01	0.2250	-9.16e-02	1.76e-03	-1.47e-01	-1.44e-01	-8.47e-03	2.24e-01	9.81e-01	5.07e-02	5.59e-02	9.10e-01
REGULATION OF NITRIC OXIDE METABOLIC PROCESS	57	3.35e-01	8.06e-01	0.2250	-1.17e-01	-1.28e-01	-8.35e-02	-8.06e-02	8.43e-02	1.25e-01	9.42e-02	2.76e-01	2.93e-01	2.71e-01
VESICLE COATING	38	5.52e-01	9.16e-01	0.2250	8.87e-02	2.47e-02	1.40e-01	1.50e-01	1.34e-02	3.44e-01	7.92e-01	1.36e-01	1.09e-01	8.86e-01
RIG I SIGNALING PATHWAY	28	5.86e-01	9.29e-01	0.2250	1.34e-01	1.72e-01	4.19e-02	3.75e-02	-1.11e-02	2.21e-01	1.15e-01	7.01e-01	7.31e-01	9.19e-01
NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	32	3.97e-01	8.45e-01	0.2250	-1.13e-01	4.45e-02	-1.37e-01	-1.29e-01	-2.37e-02	2.70e-01	6.63e-01	1.80e-01	2.05e-01	8.16e-01
NUCLEAR PORE ORGANIZATION	15	5.89e-01	9.30e-01	0.2250	-6.50e-03	-1.15e-01	1.32e-02	-1.35e-02	1.93e-01	9.65e-01	4.42e-01	9.30e-01	9.28e-01	1.96e-01
MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	18	4.86e-01	8.92e-01	0.2250	-2.48e-02	-7.58e-02	1.63e-02	-1.77e-02	2.09e-01	8.56e-01	5.78e-01	9.05e-01	8.97e-01	1.25e-01
ANTIVIRAL INNATE IMMUNE RESPONSE	48	4.53e-01	8.77e-01	0.2250	1.54e-01	9.12e-02	9.13e-02	9.80e-02	-2.65e-02	6.55e-02	2.75e-01	2.74e-01	2.40e-01	7.51e-01
COPII COATED VESICLE CARGO LOADING	16	4.81e-01	8.91e-01	0.2250	-3.91e-02	-1.32e-01	-9.52e-02	-7.12e-02	-1.32e-01	7.86e-01	3.61e-01	5.10e-01	6.22e-01	3.60e-01
MITOTIC SPINDLE ORGANIZATION	125	1.37e-02	1.57e-01	0.2250	9.62e-02	-1.48e-02	1.47e-01	1.39e-01	7.03e-03	6.33e-02	7.75e-01	4.44e-03	7.25e-03	8.92e-01
CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY	6	5.48e-01	9.15e-01	0.2250	-1.60e-01	-7.86e-02	2.10e-02	-4.08e-02	-1.29e-01	4.98e-01	7.39e-01	9.29e-01	8.63e-01	5.83e-01
PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX	14	3.22e-01	7.96e-01	0.2250	-1.35e-01	1.01e-01	-9.82e-02	-9.02e-02	-6.42e-02	3.81e-01	5.11e-01	5.25e-01	5.59e-01	6.77e-01
ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION	6	9.48e-01	9.97e-01	0.2250	-1.64e-01	-1.37e-01	-1.79e-02	-3.24e-02	5.75e-02	4.86e-01	5.61e-01	9.40e-01	8.91e-01	8.07e-01
REGULATION OF KIDNEY SIZE	5	9.06e-01	9.94e-01	0.2250	-1.45e-01	-8.98e-02	-1.62e-02	-1.96e-02	-1.44e-01	5.75e-01	7.28e-01	9.50e-01	9.39e-01	5.76e-01
FIBRINOLYSIS	27	7.41e-01	9.73e-01	0.2250	-1.12e-01	-1.56e-01	-7.04e-02	-9.19e-02	1.43e-02	3.14e-01	1.61e-01	5.26e-01	4.08e-01	8.97e-01
3 UTR MEDIATED MRNA DESTABILIZATION	19	9.68e-01	9.97e-01	0.2250	1.05e-01	5.93e-02	1.26e-01	1.28e-01	6.15e-02	4.27e-01	6.55e-01	3.44e-01	3.35e-01	6.43e-01
POSITIVE REGULATION OF DENDRITE DEVELOPMENT	15	7.84e-01	9.81e-01	0.2250	-9.82e-02	4.93e-02	-1.45e-01	-1.30e-01	-1.98e-02	5.10e-01	7.41e-01	3.30e-01	3.85e-01	8.94e-01
ALDEHYDE CATABOLIC PROCESS	14	8.78e-01	9.88e-01	0.2250	-1.21e-01	-8.87e-02	-6.64e-02	-6.70e-02	-1.38e-01	4.34e-01	5.66e-01	6.67e-01	6.64e-01	3.71e-01
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	35	1.99e-01	6.80e-01	0.2250	1.94e-02	7.70e-02	-8.64e-02	-1.02e-01	-1.62e-01	8.42e-01	4.31e-01	3.76e-01	2.99e-01	9.67e-02
HIPPOCAMPUS DEVELOPMENT	90	7.93e-03	1.11e-01	0.2250	6.78e-02	-7.13e-02	1.51e-01	1.26e-01	4.46e-02	2.66e-01	2.43e-01	1.32e-02	3.87e-02	4.64e-01
REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT	9	6.56e-01	9.53e-01	0.2240	-2.11e-02	-1.80e-01	-6.81e-02	-6.61e-02	-9.11e-02	9.13e-01	3.49e-01	7.23e-01	7.31e-01	6.36e-01
NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY	32	8.72e-01	9.88e-01	0.2240	1.30e-01	6.61e-02	1.15e-01	1.22e-01	3.10e-02	2.05e-01	5.18e-01	2.59e-01	2.34e-01	7.62e-01
SPINDLE MIDZONE ASSEMBLY	13	6.65e-01	9.54e-01	0.2240	2.83e-02	8.23e-02	-1.40e-02	-3.65e-02	-2.03e-01	8.60e-01	6.07e-01	9.30e-01	8.20e-01	2.06e-01
NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE	6	9.22e-01	9.95e-01	0.2240	-1.00e-01	-9.81e-02	-4.20e-02	-7.70e-02	-1.51e-01	6.70e-01	6.77e-01	8.59e-01	7.44e-01	5.23e-01
HEXOSE CATABOLIC PROCESS	42	1.40e-01	5.96e-01	0.2240	-5.73e-02	-3.42e-02	-1.64e-01	-1.37e-01	-8.26e-03	5.21e-01	7.01e-01	6.66e-02	1.24e-01	9.26e-01
EXTRACELLULAR VESICLE BIOGENESIS	25	7.68e-01	9.75e-01	0.2240	4.31e-02	-5.68e-02	1.29e-01	1.29e-01	1.08e-01	7.09e-01	6.23e-01	2.65e-01	2.63e-01	3.49e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	6	9.29e-01	9.95e-01	0.2240	-7.05e-02	-1.52e-01	-8.25e-02	-1.09e-01	-5.73e-02	7.65e-01	5.19e-01	7.26e-01	6.43e-01	8.08e-01
INTEGRIN ACTIVATION	26	3.97e-01	8.45e-01	0.2240	-7.95e-02	6.80e-02	-1.39e-01	-1.37e-01	3.26e-02	4.83e-01	5.48e-01	2.21e-01	2.26e-01	7.74e-01
REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	20	4.39e-01	8.70e-01	0.2240	1.28e-02	-6.18e-02	1.39e-02	-7.46e-03	2.14e-01	9.21e-01	6.32e-01	9.14e-01	9.54e-01	9.74e-02
REGULATION OF POSITIVE CHEMOTAXIS	25	7.22e-01	9.70e-01	0.2240	-9.85e-02	-1.30e-01	-5.23e-02	-5.83e-02	1.32e-01	3.94e-01	2.60e-01	6.51e-01	6.14e-01	2.55e-01
POSITIVE REGULATION OF GONAD DEVELOPMENT	8	7.31e-01	9.72e-01	0.2240	8.21e-02	1.22e-02	-6.45e-02	-3.97e-02	-1.93e-01	6.88e-01	9.52e-01	7.52e-01	8.46e-01	3.43e-01
AMINO SUGAR CATABOLIC PROCESS	14	6.46e-01	9.50e-01	0.2240	1.74e-01	1.15e-01	3.55e-02	7.05e-02	-7.86e-03	2.59e-01	4.55e-01	8.18e-01	6.48e-01	9.59e-01
REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION	9	1.84e-01	6.56e-01	0.2240	1.73e-01	-1.66e-02	9.11e-02	3.72e-02	9.95e-02	3.67e-01	9.31e-01	6.36e-01	8.47e-01	6.05e-01
5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III	6	9.76e-01	9.97e-01	0.2230	1.24e-01	4.01e-02	1.00e-01	8.52e-02	1.25e-01	5.98e-01	8.65e-01	6.71e-01	7.18e-01	5.97e-01
MITOTIC CYTOKINETIC PROCESS	26	1.62e-01	6.26e-01	0.2230	5.89e-02	-1.31e-01	1.13e-01	1.29e-01	-1.95e-03	6.03e-01	2.49e-01	3.20e-01	2.54e-01	9.86e-01
POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	17	8.01e-01	9.82e-01	0.2230	5.31e-02	1.59e-01	-6.62e-02	-5.13e-02	-1.22e-01	7.04e-01	2.57e-01	6.36e-01	7.14e-01	3.83e-01
RESPONSE TO ACIDIC PH	28	6.67e-01	9.55e-01	0.2230	1.19e-01	1.39e-01	5.31e-02	6.46e-02	9.68e-02	2.76e-01	2.02e-01	6.27e-01	5.54e-01	3.75e-01
PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	5	8.23e-01	9.83e-01	0.2230	-6.80e-02	4.20e-03	-1.75e-01	-1.19e-01	2.19e-02	7.92e-01	9.87e-01	4.98e-01	6.46e-01	9.32e-01
C4 DICARBOXYLATE TRANSPORT	27	7.76e-01	9.78e-01	0.2230	1.16e-01	1.60e-01	6.04e-02	8.00e-02	-3.01e-02	2.99e-01	1.51e-01	5.87e-01	4.72e-01	7.87e-01
PROTEIN TARGETING TO LYSOSOME	31	3.55e-01	8.22e-01	0.2230	-9.34e-02	-1.95e-01	-2.18e-02	-4.90e-02	-1.24e-02	3.68e-01	6.02e-02	8.33e-01	6.37e-01	9.05e-01
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	18	1.09e-01	5.28e-01	0.2230	-4.14e-02	3.21e-03	8.99e-02	1.01e-01	-1.72e-01	7.61e-01	9.81e-01	5.09e-01	4.59e-01	2.05e-01
MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE	41	5.97e-01	9.33e-01	0.2230	6.98e-02	-4.66e-02	1.17e-01	1.16e-01	1.23e-01	4.39e-01	6.05e-01	1.93e-01	1.97e-01	1.71e-01
POSITIVE REGULATION OF PROTEIN BINDING	59	2.31e-01	7.14e-01	0.2230	-1.20e-01	-1.39e-01	-6.06e-02	-8.41e-02	-7.23e-02	1.12e-01	6.45e-02	4.21e-01	2.64e-01	3.37e-01
ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE	24	6.45e-01	9.50e-01	0.2230	-1.31e-01	-9.93e-02	-7.32e-02	-1.03e-01	-8.11e-02	2.67e-01	4.00e-01	5.35e-01	3.80e-01	4.91e-01
PROTEIN HYDROXYLATION	23	3.34e-02	2.76e-01	0.2230	-1.54e-02	-1.85e-01	3.10e-02	6.72e-02	-9.80e-02	8.98e-01	1.24e-01	7.97e-01	5.77e-01	4.16e-01
LINOLEIC ACID METABOLIC PROCESS	20	7.48e-01	9.75e-01	0.2230	8.95e-02	1.26e-02	1.52e-01	1.34e-01	-1.30e-02	4.88e-01	9.22e-01	2.38e-01	2.98e-01	9.20e-01
EPOXIDE METABOLIC PROCESS	5	8.58e-01	9.88e-01	0.2230	1.05e-02	7.99e-02	-1.34e-01	-1.51e-01	4.88e-02	9.68e-01	7.57e-01	6.03e-01	5.60e-01	8.50e-01
NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	19	9.47e-01	9.97e-01	0.2230	-1.30e-01	-1.17e-01	-9.33e-02	-9.24e-02	-3.91e-02	3.25e-01	3.76e-01	4.81e-01	4.86e-01	7.68e-01
REGULATION OF CYTOPLASMIC TRANSLATION	30	7.27e-01	9.71e-01	0.2230	3.72e-02	-4.65e-02	1.07e-01	9.33e-02	1.61e-01	7.24e-01	6.59e-01	3.11e-01	3.76e-01	1.27e-01
POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	12	9.07e-01	9.94e-01	0.2220	-1.45e-01	-2.27e-02	-1.04e-01	-1.11e-01	-6.72e-02	3.83e-01	8.92e-01	5.32e-01	5.04e-01	6.87e-01
REGULATION OF MICROVILLUS ASSEMBLY	6	9.15e-01	9.94e-01	0.2220	-4.23e-02	-2.41e-02	-1.42e-01	-1.50e-01	6.65e-02	8.58e-01	9.19e-01	5.48e-01	5.24e-01	7.78e-01
REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY	13	9.01e-01	9.94e-01	0.2220	-1.37e-01	-7.75e-03	-1.12e-01	-1.18e-01	-6.30e-02	3.91e-01	9.61e-01	4.84e-01	4.62e-01	6.94e-01
REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	76	1.41e-01	5.99e-01	0.2220	-8.72e-02	-8.36e-02	-9.53e-02	-8.13e-02	-1.38e-01	1.89e-01	2.08e-01	1.51e-01	2.20e-01	3.72e-02
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	46	4.28e-02	3.18e-01	0.2220	-7.03e-02	-2.02e-01	1.48e-02	3.07e-02	4.76e-02	4.09e-01	1.75e-02	8.62e-01	7.19e-01	5.76e-01
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	20	8.21e-01	9.83e-01	0.2220	-9.48e-02	-7.01e-02	-1.41e-01	-1.20e-01	-3.26e-02	4.63e-01	5.88e-01	2.75e-01	3.53e-01	8.00e-01
REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	34	2.87e-01	7.66e-01	0.2220	8.06e-02	-8.41e-02	1.36e-01	1.15e-01	6.22e-02	4.16e-01	3.96e-01	1.70e-01	2.45e-01	5.30e-01
EXCITATORY SYNAPSE ASSEMBLY	32	1.91e-01	6.64e-01	0.2220	-9.60e-02	-3.40e-02	-1.18e-01	-1.52e-01	4.12e-02	3.47e-01	7.40e-01	2.48e-01	1.36e-01	6.86e-01
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	11	8.02e-01	9.82e-01	0.2220	-1.12e-01	-1.22e-01	4.55e-02	1.69e-02	1.40e-01	5.22e-01	4.84e-01	7.94e-01	9.23e-01	4.22e-01
LYMPHOCYTE CHEMOTAXIS	62	9.39e-03	1.24e-01	0.2220	8.22e-02	1.32e-01	-5.19e-03	1.22e-02	1.57e-01	2.63e-01	7.17e-02	9.44e-01	8.68e-01	3.22e-02
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS	18	7.60e-01	9.75e-01	0.2220	-1.05e-01	-1.75e-01	-7.05e-03	-3.77e-02	7.70e-02	4.41e-01	1.98e-01	9.59e-01	7.82e-01	5.72e-01
MRNA TRANSPORT	113	2.75e-01	7.56e-01	0.2220	1.04e-01	2.21e-02	1.28e-01	1.27e-01	7.39e-02	5.68e-02	6.85e-01	1.91e-02	1.96e-02	1.75e-01
LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS	18	7.54e-01	9.75e-01	0.2220	-3.23e-02	-1.51e-01	2.69e-02	2.13e-02	1.55e-01	8.12e-01	2.67e-01	8.43e-01	8.76e-01	2.55e-01
REGULATION OF DENDRITIC SPINE MORPHOGENESIS	39	4.89e-01	8.92e-01	0.2210	-1.45e-01	-3.82e-02	-1.16e-01	-1.14e-01	-7.01e-03	1.17e-01	6.80e-01	2.09e-01	2.19e-01	9.40e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	15	6.58e-01	9.54e-01	0.2210	-3.79e-02	-4.27e-02	-5.31e-02	-5.71e-02	1.99e-01	8.00e-01	7.74e-01	7.22e-01	7.02e-01	1.81e-01
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	181	2.71e-03	5.16e-02	0.2210	7.36e-02	8.92e-02	9.59e-02	1.03e-01	1.26e-01	8.77e-02	3.85e-02	2.60e-02	1.68e-02	3.47e-03
REGULATION OF DNA REPAIR	205	5.33e-04	1.51e-02	0.2210	9.85e-02	5.92e-03	1.47e-01	1.32e-01	1.30e-02	1.50e-02	8.84e-01	2.78e-04	1.12e-03	7.48e-01
POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	18	4.82e-01	8.91e-01	0.2210	-4.16e-02	1.17e-02	-1.34e-01	-1.36e-01	1.04e-01	7.60e-01	9.31e-01	3.26e-01	3.17e-01	4.46e-01
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	57	2.04e-01	6.83e-01	0.2210	4.86e-02	-6.44e-02	1.42e-01	1.18e-01	9.16e-02	5.25e-01	4.01e-01	6.42e-02	1.22e-01	2.32e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY	7	9.17e-01	9.95e-01	0.2210	9.14e-02	-2.54e-02	1.21e-01	1.30e-01	-9.14e-02	6.75e-01	9.07e-01	5.78e-01	5.51e-01	6.75e-01
REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT	18	8.87e-01	9.91e-01	0.2210	-6.34e-02	-6.03e-02	-9.69e-02	-9.75e-02	-1.50e-01	6.41e-01	6.58e-01	4.76e-01	4.74e-01	2.71e-01
EYELID DEVELOPMENT IN CAMERA TYPE EYE	13	2.01e-01	6.81e-01	0.2210	1.57e-01	-4.92e-02	9.29e-02	5.92e-02	9.90e-02	3.28e-01	7.59e-01	5.62e-01	7.12e-01	5.36e-01
RESPONSE TO INTERLEUKIN 4	33	7.38e-01	9.73e-01	0.2210	1.35e-01	4.81e-02	1.02e-01	1.07e-01	8.09e-02	1.80e-01	6.32e-01	3.09e-01	2.88e-01	4.21e-01
ENDOCRINE PROCESS	87	1.05e-02	1.32e-01	0.2210	-6.11e-02	-8.79e-02	-1.31e-01	-1.42e-01	-1.07e-02	3.24e-01	1.56e-01	3.47e-02	2.20e-02	8.63e-01
NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	44	7.03e-01	9.65e-01	0.2210	-1.17e-01	-1.16e-01	-9.39e-02	-1.11e-01	-2.46e-02	1.78e-01	1.83e-01	2.81e-01	2.04e-01	7.78e-01
AMINE BIOSYNTHETIC PROCESS	37	5.59e-01	9.19e-01	0.2210	3.91e-02	-1.60e-02	1.19e-01	1.25e-01	1.32e-01	6.81e-01	8.66e-01	2.10e-01	1.88e-01	1.66e-01
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	27	2.86e-02	2.53e-01	0.2210	-9.53e-02	-9.20e-02	-1.49e-01	-9.19e-02	2.33e-02	3.91e-01	4.08e-01	1.79e-01	4.09e-01	8.34e-01
MITOTIC NUCLEAR DIVISION	270	1.88e-05	9.69e-04	0.2210	9.12e-02	-2.98e-02	1.42e-01	1.37e-01	2.36e-02	9.85e-03	4.00e-01	5.76e-05	1.03e-04	5.05e-01
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE	36	1.83e-01	6.56e-01	0.2210	-1.12e-01	1.44e-02	-1.14e-01	-1.29e-01	8.06e-02	2.43e-01	8.81e-01	2.37e-01	1.82e-01	4.03e-01
REGULATION OF NEURON MIGRATION	45	6.73e-01	9.59e-01	0.2210	-1.23e-01	-5.82e-02	-1.01e-01	-1.13e-01	-8.60e-02	1.53e-01	4.99e-01	2.42e-01	1.90e-01	3.18e-01
DISTAL TUBULE DEVELOPMENT	12	5.85e-01	9.28e-01	0.2210	6.01e-02	1.19e-01	-1.07e-01	-1.18e-01	-7.56e-02	7.19e-01	4.77e-01	5.20e-01	4.79e-01	6.50e-01
PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	29	2.96e-01	7.71e-01	0.2210	-4.65e-02	-2.00e-01	1.10e-02	-1.10e-02	8.10e-02	6.64e-01	6.29e-02	9.18e-01	9.18e-01	4.50e-01
REGULATION OF CHROMATIN BINDING	11	8.70e-01	9.88e-01	0.2210	-7.83e-02	-1.69e-01	3.26e-02	-4.49e-04	1.13e-01	6.53e-01	3.31e-01	8.52e-01	9.98e-01	5.15e-01
GOLGI TO PLASMA MEMBRANE TRANSPORT	57	6.70e-01	9.56e-01	0.2210	-1.12e-01	-5.26e-02	-1.08e-01	-1.10e-01	-9.78e-02	1.42e-01	4.92e-01	1.60e-01	1.49e-01	2.01e-01
REGULATION OF CALCIUM MEDIATED SIGNALING	81	2.33e-01	7.18e-01	0.2210	9.85e-02	9.51e-02	9.02e-02	1.05e-01	1.04e-01	1.25e-01	1.39e-01	1.61e-01	1.03e-01	1.04e-01
PURINE NUCLEOTIDE TRANSPORT	34	5.37e-01	9.12e-01	0.2210	-1.88e-02	3.49e-02	-8.15e-02	-8.60e-02	-1.82e-01	8.50e-01	7.24e-01	4.11e-01	3.85e-01	6.63e-02
PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	18	7.60e-01	9.75e-01	0.2210	-7.88e-02	1.25e-02	-7.44e-02	-8.94e-02	-1.70e-01	5.63e-01	9.27e-01	5.85e-01	5.12e-01	2.13e-01
TRANSLATIONAL ELONGATION	68	1.63e-02	1.77e-01	0.2210	6.99e-02	-7.80e-02	1.41e-01	1.30e-01	-2.93e-02	3.19e-01	2.66e-01	4.41e-02	6.35e-02	6.77e-01
DNA DOUBLE STRAND BREAK PROCESSING	19	1.25e-02	1.49e-01	0.2210	1.34e-01	1.30e-01	7.31e-02	7.29e-03	-9.21e-02	3.12e-01	3.27e-01	5.81e-01	9.56e-01	4.87e-01
VITAMIN CATABOLIC PROCESS	14	1.82e-01	6.56e-01	0.2210	1.31e-01	6.59e-02	1.11e-01	5.13e-02	1.11e-01	3.98e-01	6.69e-01	4.74e-01	7.40e-01	4.70e-01
INTERNEURON MIGRATION	14	3.77e-01	8.36e-01	0.2210	1.20e-01	-9.08e-02	6.77e-02	6.68e-02	1.30e-01	4.36e-01	5.57e-01	6.61e-01	6.65e-01	4.00e-01
REGULATION OF BILE ACID BIOSYNTHETIC PROCESS	12	9.17e-01	9.95e-01	0.2210	-7.07e-02	5.61e-02	-1.38e-01	-1.40e-01	-4.31e-02	6.71e-01	7.37e-01	4.07e-01	4.02e-01	7.96e-01
XENOBIOTIC CATABOLIC PROCESS	25	4.70e-01	8.84e-01	0.2200	6.97e-02	9.95e-02	1.12e-01	1.02e-01	-1.05e-01	5.47e-01	3.89e-01	3.34e-01	3.79e-01	3.63e-01
REGULATION OF GOLGI ORGANIZATION	17	7.30e-01	9.71e-01	0.2200	-4.88e-02	-1.10e-01	8.42e-02	5.47e-02	1.55e-01	7.28e-01	4.33e-01	5.48e-01	6.96e-01	2.68e-01
NEGATIVE REGULATION OF DNA METABOLIC PROCESS	135	8.08e-03	1.12e-01	0.2200	9.28e-02	-3.36e-02	1.41e-01	1.37e-01	2.09e-02	6.26e-02	5.00e-01	4.81e-03	6.13e-03	6.75e-01
REGULATION OF ARTERY MORPHOGENESIS	11	6.87e-02	4.21e-01	0.2200	-1.11e-01	-8.35e-03	8.29e-02	1.11e-01	-1.30e-01	5.24e-01	9.62e-01	6.34e-01	5.25e-01	4.54e-01
INSULIN RECEPTOR SIGNALING PATHWAY	123	1.52e-01	6.14e-01	0.2200	-1.18e-01	-1.22e-01	-9.13e-02	-1.05e-01	2.13e-02	2.37e-02	1.97e-02	8.03e-02	4.51e-02	6.83e-01
RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS	211	7.40e-04	1.93e-02	0.2200	9.58e-02	-3.13e-02	1.36e-01	1.32e-01	4.84e-02	1.64e-02	4.33e-01	6.38e-04	9.62e-04	2.25e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY	310	2.02e-05	1.04e-03	0.2200	7.34e-02	-5.02e-02	1.34e-01	1.25e-01	8.34e-02	2.62e-02	1.29e-01	4.86e-05	1.53e-04	1.15e-02
PRIMARY AMINO COMPOUND METABOLIC PROCESS	13	8.34e-01	9.85e-01	0.2200	-2.31e-02	-1.59e-02	-1.14e-01	-1.23e-01	-1.41e-01	8.85e-01	9.21e-01	4.78e-01	4.44e-01	3.80e-01
EXTRACELLULAR EXOSOME ASSEMBLY	7	8.25e-01	9.83e-01	0.2200	-3.07e-02	-2.08e-01	4.10e-02	2.02e-02	-4.56e-02	8.88e-01	3.40e-01	8.51e-01	9.26e-01	8.34e-01
VITAMIN B6 METABOLIC PROCESS	5	8.97e-01	9.93e-01	0.2200	5.80e-02	-1.40e-01	1.22e-01	8.62e-02	5.69e-02	8.22e-01	5.88e-01	6.37e-01	7.39e-01	8.26e-01
NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	44	7.45e-01	9.75e-01	0.2200	-1.03e-01	-3.81e-02	-1.22e-01	-1.32e-01	-6.51e-02	2.36e-01	6.62e-01	1.63e-01	1.31e-01	4.55e-01
ONE CARBON COMPOUND TRANSPORT	60	7.11e-02	4.28e-01	0.2200	-1.46e-01	-4.80e-02	-1.02e-01	-9.68e-02	6.98e-02	5.00e-02	5.20e-01	1.70e-01	1.95e-01	3.50e-01
DETERMINATION OF DORSAL VENTRAL ASYMMETRY	11	9.16e-01	9.94e-01	0.2200	-8.20e-02	-1.59e-01	-8.21e-02	-7.94e-02	-5.78e-02	6.38e-01	3.61e-01	6.37e-01	6.48e-01	7.40e-01
HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	47	2.59e-02	2.40e-01	0.2200	4.81e-02	1.58e-01	2.43e-02	4.51e-02	1.36e-01	5.69e-01	6.10e-02	7.73e-01	5.93e-01	1.07e-01
TELOMERE MAINTENANCE VIA RECOMBINATION	14	8.64e-01	9.88e-01	0.2200	2.03e-02	-1.01e-01	1.18e-01	1.20e-01	9.63e-02	8.95e-01	5.12e-01	4.43e-01	4.37e-01	5.33e-01
COLLECTING DUCT DEVELOPMENT	15	7.98e-01	9.81e-01	0.2200	1.41e-01	1.61e-01	-4.85e-04	1.80e-02	-4.44e-02	3.43e-01	2.79e-01	9.97e-01	9.04e-01	7.66e-01
NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	63	2.29e-01	7.13e-01	0.2200	-1.09e-01	-9.94e-02	-1.09e-01	-9.93e-02	6.92e-02	1.35e-01	1.73e-01	1.34e-01	1.73e-01	3.42e-01
POSITIVE REGULATION OF RESPONSE TO WOUNDING	73	4.45e-01	8.73e-01	0.2200	-1.33e-01	-1.29e-01	-7.95e-02	-8.45e-02	2.21e-02	4.87e-02	5.73e-02	2.40e-01	2.12e-01	7.44e-01
REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	30	5.62e-01	9.21e-01	0.2200	-2.09e-02	1.20e-01	-9.21e-02	-8.70e-02	-1.32e-01	8.43e-01	2.57e-01	3.83e-01	4.10e-01	2.10e-01
PHARYNGEAL ARCH ARTERY MORPHOGENESIS	10	9.44e-01	9.97e-01	0.2200	9.41e-02	-1.86e-02	1.38e-01	1.41e-01	-5.78e-03	6.06e-01	9.19e-01	4.49e-01	4.40e-01	9.75e-01
RESPONSE TO ENDOPLASMIC RETICULUM STRESS	258	1.83e-05	9.52e-04	0.2200	8.22e-02	-6.18e-02	1.27e-01	1.21e-01	8.23e-02	2.30e-02	8.71e-02	4.42e-04	7.81e-04	2.27e-02
PHASIC SMOOTH MUSCLE CONTRACTION	24	3.77e-01	8.36e-01	0.2200	1.75e-01	9.12e-02	5.19e-02	5.94e-02	-5.48e-02	1.37e-01	4.39e-01	6.60e-01	6.14e-01	6.42e-01
UREA TRANSPORT	11	8.22e-01	9.83e-01	0.2200	2.79e-02	4.06e-03	1.25e-01	1.42e-01	1.08e-01	8.73e-01	9.81e-01	4.74e-01	4.13e-01	5.36e-01
PEPTIDE CROSS LINKING	27	1.09e-02	1.36e-01	0.2200	-4.20e-02	1.90e-01	-7.76e-02	-3.14e-02	-5.66e-02	7.06e-01	8.68e-02	4.85e-01	7.77e-01	6.11e-01
PORE COMPLEX ASSEMBLY	19	4.67e-01	8.83e-01	0.2190	-5.30e-02	-1.40e-01	-6.19e-02	-8.67e-02	1.20e-01	6.89e-01	2.91e-01	6.41e-01	5.13e-01	3.65e-01
GLUCOSYLCERAMIDE METABOLIC PROCESS	7	8.99e-01	9.93e-01	0.2190	-2.20e-02	-1.05e-01	-3.20e-02	-2.04e-02	1.87e-01	9.20e-01	6.30e-01	8.83e-01	9.26e-01	3.91e-01
NUCLEAR EXPORT	157	7.66e-03	1.09e-01	0.2190	9.23e-02	-3.44e-02	1.36e-01	1.27e-01	5.99e-02	4.60e-02	4.57e-01	3.21e-03	5.94e-03	1.95e-01
ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	26	8.10e-01	9.82e-01	0.2190	-1.34e-01	-7.85e-02	-9.88e-02	-1.19e-01	4.22e-04	2.38e-01	4.88e-01	3.83e-01	2.92e-01	9.97e-01
TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	26	6.90e-01	9.61e-01	0.2190	2.70e-02	-7.32e-03	8.22e-02	8.63e-02	1.82e-01	8.12e-01	9.48e-01	4.68e-01	4.46e-01	1.09e-01
RESPONSE TO ATP	31	5.78e-01	9.27e-01	0.2190	-1.02e-01	-1.30e-01	-8.33e-02	-1.09e-01	-4.03e-02	3.26e-01	2.09e-01	4.22e-01	2.92e-01	6.98e-01
IRON IMPORT INTO CELL	10	9.21e-01	9.95e-01	0.2190	-1.17e-01	-9.19e-02	-4.39e-02	-5.96e-02	1.42e-01	5.22e-01	6.15e-01	8.10e-01	7.44e-01	4.35e-01
REGULATION OF CELLULAR SENESCENCE	52	3.89e-01	8.40e-01	0.2190	4.20e-02	-6.95e-02	1.09e-01	9.41e-02	1.44e-01	6.01e-01	3.86e-01	1.76e-01	2.40e-01	7.31e-02
MESENCHYME MORPHOGENESIS	60	2.33e-02	2.25e-01	0.2190	-5.75e-03	-1.71e-01	7.54e-02	4.68e-02	1.04e-01	9.39e-01	2.22e-02	3.13e-01	5.31e-01	1.64e-01
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	7	5.30e-01	9.07e-01	0.2190	-2.66e-02	-1.82e-01	-4.84e-02	-9.78e-02	-4.35e-02	9.03e-01	4.03e-01	8.25e-01	6.54e-01	8.42e-01
FATTY ACID DERIVATIVE METABOLIC PROCESS	69	5.82e-01	9.28e-01	0.2180	-9.15e-02	-6.82e-02	-1.24e-01	-1.20e-01	-7.03e-02	1.89e-01	3.27e-01	7.49e-02	8.49e-02	3.12e-01
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY	69	3.10e-01	7.83e-01	0.2180	-9.92e-02	-1.24e-01	-1.04e-01	-1.02e-01	3.74e-02	1.54e-01	7.58e-02	1.36e-01	1.42e-01	5.91e-01
T CELL MEDIATED IMMUNITY	123	1.50e-01	6.11e-01	0.2180	8.62e-02	7.55e-02	1.04e-01	1.08e-01	1.10e-01	9.86e-02	1.48e-01	4.64e-02	3.83e-02	3.54e-02
SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	47	7.76e-02	4.50e-01	0.2180	1.22e-02	-1.01e-01	9.75e-02	5.83e-02	1.56e-01	8.85e-01	2.29e-01	2.48e-01	4.89e-01	6.42e-02
NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	36	5.07e-01	8.99e-01	0.2180	-1.15e-01	-1.06e-01	-4.96e-02	-5.89e-02	1.31e-01	2.31e-01	2.73e-01	6.06e-01	5.41e-01	1.72e-01
CELL CELL JUNCTION ORGANIZATION	208	4.20e-02	3.14e-01	0.2180	-1.25e-01	-7.21e-02	-1.13e-01	-1.18e-01	-5.27e-03	1.83e-03	7.29e-02	5.04e-03	3.30e-03	8.96e-01
POSITIVE REGULATION OF NEURON DIFFERENTIATION	91	2.91e-06	1.79e-04	0.2180	2.74e-02	-1.65e-01	5.12e-02	1.69e-02	1.29e-01	6.51e-01	6.45e-03	3.99e-01	7.81e-01	3.33e-02
POSITIVE REGULATION OF PHAGOCYTOSIS	68	1.59e-02	1.74e-01	0.2180	-9.20e-02	-7.28e-02	-1.41e-01	-1.11e-01	4.07e-02	1.90e-01	2.99e-01	4.39e-02	1.15e-01	5.62e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	7	9.80e-01	9.97e-01	0.2180	-1.42e-01	-1.53e-01	-3.85e-02	-4.69e-02	1.27e-02	5.14e-01	4.83e-01	8.60e-01	8.30e-01	9.54e-01
POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE	15	8.85e-01	9.91e-01	0.2180	1.20e-01	5.84e-02	1.28e-01	1.12e-01	-2.70e-02	4.20e-01	6.95e-01	3.90e-01	4.53e-01	8.56e-01
RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID	5	7.65e-01	9.75e-01	0.2180	-1.03e-02	1.86e-01	6.38e-02	4.55e-02	-8.22e-02	9.68e-01	4.72e-01	8.05e-01	8.60e-01	7.50e-01
NEURAL NUCLEUS DEVELOPMENT	61	3.17e-01	7.89e-01	0.2180	9.33e-02	-2.12e-02	1.31e-01	1.16e-01	8.84e-02	2.07e-01	7.75e-01	7.67e-02	1.18e-01	2.32e-01
BLEB ASSEMBLY	11	8.40e-01	9.85e-01	0.2180	-8.21e-02	-1.82e-01	-5.79e-02	-4.25e-02	4.86e-02	6.37e-01	2.95e-01	7.40e-01	8.07e-01	7.80e-01
CELLULAR RESPONSE TO INTERLEUKIN 1	107	1.46e-01	6.04e-01	0.2180	1.11e-01	1.30e-01	7.45e-02	8.16e-02	7.82e-02	4.74e-02	2.04e-02	1.83e-01	1.45e-01	1.62e-01
NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	36	1.89e-01	6.61e-01	0.2180	3.76e-02	-9.75e-02	1.36e-01	1.33e-01	-2.11e-02	6.96e-01	3.11e-01	1.58e-01	1.69e-01	8.27e-01
NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	15	3.65e-01	8.29e-01	0.2180	-1.16e-01	3.64e-02	-1.35e-01	-1.01e-01	6.46e-02	4.35e-01	8.07e-01	3.65e-01	4.99e-01	6.65e-01
10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS	6	9.80e-01	9.97e-01	0.2180	-1.03e-01	-1.32e-01	-1.07e-01	-8.89e-02	-1.20e-03	6.63e-01	5.74e-01	6.50e-01	7.06e-01	9.96e-01
PLASMA MEMBRANE RAFT ASSEMBLY	7	9.52e-01	9.97e-01	0.2180	-8.87e-03	-6.78e-02	2.67e-02	1.04e-02	2.05e-01	9.68e-01	7.56e-01	9.03e-01	9.62e-01	3.48e-01
PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS	30	4.04e-01	8.49e-01	0.2180	-9.46e-02	-1.81e-01	-3.18e-02	-6.38e-02	2.53e-02	3.70e-01	8.66e-02	7.63e-01	5.45e-01	8.11e-01
HISTONE MRNA CATABOLIC PROCESS	15	2.53e-01	7.37e-01	0.2180	4.57e-02	-4.85e-02	1.70e-01	1.15e-01	-2.65e-02	7.60e-01	7.45e-01	2.54e-01	4.41e-01	8.59e-01
REGULATION OF NEUTROPHIL MIGRATION	40	2.10e-02	2.10e-01	0.2170	-2.51e-02	-7.56e-02	-1.13e-01	-9.22e-02	1.40e-01	7.83e-01	4.08e-01	2.14e-01	3.13e-01	1.26e-01
CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	22	7.58e-01	9.75e-01	0.2170	-8.53e-04	6.73e-02	-5.80e-02	-4.91e-02	-1.92e-01	9.94e-01	5.84e-01	6.38e-01	6.90e-01	1.19e-01
POSTSYNAPTIC SIGNAL TRANSDUCTION	38	1.85e-01	6.56e-01	0.2170	-7.68e-02	-5.36e-02	-7.28e-02	-9.34e-02	1.56e-01	4.13e-01	5.67e-01	4.37e-01	3.19e-01	9.54e-02
ACTIVATION OF PHOSPHOLIPASE C ACTIVITY	27	4.89e-01	8.92e-01	0.2170	-8.54e-02	-7.40e-02	-8.43e-02	-7.71e-02	1.46e-01	4.42e-01	5.06e-01	4.48e-01	4.88e-01	1.88e-01
NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	12	8.20e-01	9.83e-01	0.2170	1.30e-01	6.76e-02	8.69e-02	1.22e-01	-5.91e-02	4.37e-01	6.85e-01	6.02e-01	4.66e-01	7.23e-01
PIGMENT GRANULE MATURATION	10	1.74e-01	6.46e-01	0.2170	1.14e-01	-4.19e-02	1.35e-01	6.01e-02	1.03e-01	5.31e-01	8.18e-01	4.61e-01	7.42e-01	5.74e-01
POSITIVE REGULATION OF MITOCHONDRIAL FISSION	21	1.33e-01	5.80e-01	0.2170	-2.13e-02	-1.75e-01	-6.03e-02	-8.61e-02	7.16e-02	8.66e-01	1.66e-01	6.32e-01	4.94e-01	5.70e-01
REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	11	6.54e-01	9.53e-01	0.2170	1.41e-01	-2.50e-02	9.98e-02	7.86e-02	1.02e-01	4.18e-01	8.86e-01	5.67e-01	6.52e-01	5.57e-01
REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE	9	9.45e-01	9.97e-01	0.2170	-8.85e-02	-1.88e-01	-2.00e-02	-1.97e-02	5.75e-02	6.46e-01	3.30e-01	9.17e-01	9.18e-01	7.65e-01
SPHINGOMYELIN METABOLIC PROCESS	20	8.29e-01	9.83e-01	0.2170	-1.04e-01	-1.73e-01	-5.41e-02	-5.12e-02	2.90e-02	4.19e-01	1.81e-01	6.76e-01	6.92e-01	8.22e-01
MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT	18	2.29e-01	7.13e-01	0.2170	-6.00e-02	2.36e-02	5.61e-02	2.00e-02	1.98e-01	6.59e-01	8.63e-01	6.80e-01	8.83e-01	1.45e-01
FIBROBLAST MIGRATION	52	3.59e-01	8.25e-01	0.2170	-1.41e-01	-8.64e-02	-9.30e-02	-9.01e-02	5.30e-02	7.80e-02	2.81e-01	2.46e-01	2.61e-01	5.08e-01
OOCYTE MATURATION	33	2.11e-01	6.89e-01	0.2170	-3.43e-02	-1.96e-01	6.50e-02	4.84e-02	2.46e-02	7.33e-01	5.08e-02	5.18e-01	6.30e-01	8.07e-01
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER	32	3.38e-02	2.78e-01	0.2170	7.61e-02	-1.32e-01	9.74e-02	6.31e-02	1.01e-01	4.57e-01	1.97e-01	3.40e-01	5.36e-01	3.21e-01
CELL ADHESION INVOLVED IN HEART MORPHOGENESIS	6	9.66e-01	9.97e-01	0.2170	-1.18e-01	-1.75e-01	2.02e-02	-6.45e-03	4.23e-02	6.17e-01	4.57e-01	9.32e-01	9.78e-01	8.58e-01
REGULATION OF STEROL TRANSPORT	80	1.78e-02	1.88e-01	0.2170	-1.26e-01	-7.55e-02	-1.25e-01	-9.75e-02	1.77e-02	5.23e-02	2.43e-01	5.35e-02	1.31e-01	7.84e-01
CEREBELLAR CORTEX DEVELOPMENT	49	4.76e-01	8.86e-01	0.2160	6.51e-02	-5.68e-02	1.24e-01	1.14e-01	1.05e-01	4.30e-01	4.92e-01	1.34e-01	1.68e-01	2.02e-01
POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	10	2.33e-01	7.18e-01	0.2160	-5.93e-02	-1.05e-02	1.05e-01	5.19e-02	-1.72e-01	7.45e-01	9.54e-01	5.66e-01	7.76e-01	3.46e-01
NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	12	7.03e-01	9.65e-01	0.2160	1.92e-02	-7.97e-02	1.35e-01	1.48e-01	-6.74e-03	9.08e-01	6.33e-01	4.17e-01	3.76e-01	9.68e-01
REGULATION OF MEMBRANE PERMEABILITY	72	3.49e-01	8.18e-01	0.2160	7.24e-02	-3.51e-02	1.22e-01	1.14e-01	1.11e-01	2.88e-01	6.06e-01	7.27e-02	9.40e-02	1.04e-01
REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS	10	8.57e-01	9.88e-01	0.2160	-3.85e-03	7.07e-02	-1.46e-01	-1.12e-01	-8.90e-02	9.83e-01	6.99e-01	4.25e-01	5.39e-01	6.26e-01
NEGATIVE REGULATION OF BONE REMODELING	18	6.36e-01	9.48e-01	0.2160	1.26e-01	9.28e-03	7.09e-02	7.05e-02	1.44e-01	3.56e-01	9.46e-01	6.03e-01	6.05e-01	2.89e-01
LATERAL SPROUTING FROM AN EPITHELIUM	10	4.75e-01	8.86e-01	0.2160	4.19e-02	-9.36e-02	1.59e-01	1.03e-01	-2.00e-02	8.19e-01	6.08e-01	3.85e-01	5.73e-01	9.13e-01
SPINDLE ASSEMBLY	127	3.06e-02	2.63e-01	0.2160	1.04e-01	-1.79e-02	1.33e-01	1.25e-01	4.81e-02	4.34e-02	7.28e-01	9.56e-03	1.53e-02	3.49e-01
INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY	9	8.36e-01	9.85e-01	0.2160	-4.82e-02	-1.01e-01	-1.25e-01	-1.14e-01	7.42e-02	8.02e-01	5.99e-01	5.16e-01	5.55e-01	7.00e-01
MEMBRANE INVAGINATION	64	3.00e-01	7.73e-01	0.2160	-1.33e-01	-1.45e-01	-5.69e-02	-5.56e-02	3.85e-02	6.61e-02	4.41e-02	4.31e-01	4.42e-01	5.94e-01
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	135	1.69e-03	3.58e-02	0.2160	3.30e-02	-1.11e-01	1.26e-01	1.12e-01	6.86e-02	5.07e-01	2.57e-02	1.16e-02	2.43e-02	1.68e-01
REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION	6	6.89e-01	9.61e-01	0.2160	-8.09e-02	1.55e-01	-7.71e-02	-4.30e-02	-9.07e-02	7.31e-01	5.11e-01	7.44e-01	8.55e-01	7.00e-01
T TUBULE ORGANIZATION	6	8.62e-01	9.88e-01	0.2160	-1.24e-02	-4.62e-03	7.01e-02	7.23e-02	-1.90e-01	9.58e-01	9.84e-01	7.66e-01	7.59e-01	4.19e-01
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	36	5.47e-01	9.15e-01	0.2160	7.13e-02	-1.96e-02	1.47e-01	1.25e-01	6.19e-02	4.59e-01	8.39e-01	1.26e-01	1.94e-01	5.20e-01
ADRENAL GLAND DEVELOPMENT	27	4.26e-01	8.64e-01	0.2160	-4.58e-02	-8.10e-02	7.55e-02	7.97e-02	1.61e-01	6.80e-01	4.66e-01	4.97e-01	4.73e-01	1.48e-01
NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	27	5.23e-01	9.04e-01	0.2160	-9.06e-02	-1.71e-01	-2.65e-02	-3.80e-02	-8.25e-02	4.15e-01	1.23e-01	8.11e-01	7.33e-01	4.58e-01
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	182	1.67e-03	3.54e-02	0.2160	6.77e-02	-6.27e-02	1.33e-01	1.27e-01	6.54e-02	1.15e-01	1.45e-01	2.02e-03	3.15e-03	1.28e-01
PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	9.93e-01	9.99e-01	0.2160	-1.08e-01	-1.16e-01	-1.07e-01	-9.50e-02	3.07e-02	6.77e-01	6.53e-01	6.79e-01	7.13e-01	9.05e-01
CARDIOBLAST PROLIFERATION	11	1.55e-01	6.17e-01	0.2160	1.52e-01	-2.75e-02	1.22e-01	6.08e-02	6.48e-02	3.84e-01	8.75e-01	4.84e-01	7.27e-01	7.10e-01
CELLULAR RESPONSE TO ZINC ION	23	7.42e-01	9.74e-01	0.2160	1.13e-02	-6.78e-02	7.94e-02	6.01e-02	1.78e-01	9.25e-01	5.73e-01	5.10e-01	6.18e-01	1.38e-01
CELLULAR RESPONSE TO X RAY	11	6.40e-01	9.49e-01	0.2160	1.30e-01	6.80e-02	1.29e-01	8.51e-02	3.06e-02	4.54e-01	6.96e-01	4.58e-01	6.25e-01	8.61e-01
BILE ACID METABOLIC PROCESS	49	9.76e-02	4.99e-01	0.2150	-5.50e-02	8.80e-02	-1.28e-01	-1.38e-01	-1.55e-02	5.06e-01	2.87e-01	1.22e-01	9.44e-02	8.51e-01
NERVE DEVELOPMENT	94	1.45e-01	6.03e-01	0.2150	9.74e-02	-7.61e-03	1.07e-01	1.01e-01	1.24e-01	1.03e-01	8.98e-01	7.37e-02	9.06e-02	3.84e-02
CELL PROLIFERATION IN FOREBRAIN	26	5.87e-01	9.29e-01	0.2150	5.59e-02	-2.38e-02	1.38e-01	1.06e-01	1.12e-01	6.22e-01	8.34e-01	2.24e-01	3.51e-01	3.22e-01
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS	49	4.50e-01	8.76e-01	0.2150	1.43e-01	4.40e-02	1.03e-01	1.11e-01	3.31e-02	8.36e-02	5.94e-01	2.12e-01	1.80e-01	6.88e-01
ESTABLISHMENT OF RNA LOCALIZATION	147	1.34e-01	5.81e-01	0.2150	1.05e-01	2.20e-02	1.28e-01	1.25e-01	5.19e-02	2.80e-02	6.45e-01	7.38e-03	8.70e-03	2.78e-01
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	20	9.06e-01	9.94e-01	0.2150	-9.61e-02	-3.46e-02	-1.37e-01	-1.31e-01	2.83e-04	4.57e-01	7.89e-01	2.89e-01	3.12e-01	9.98e-01
NATURAL KILLER CELL DIFFERENTIATION	24	4.99e-01	8.97e-01	0.2150	1.20e-01	5.65e-02	1.32e-01	1.04e-01	-2.18e-02	3.10e-01	6.32e-01	2.61e-01	3.79e-01	8.53e-01
ACROSOME ASSEMBLY	27	2.22e-01	7.03e-01	0.2150	8.22e-02	1.73e-01	-7.25e-02	-5.30e-02	3.96e-02	4.60e-01	1.20e-01	5.15e-01	6.34e-01	7.21e-01
SENSORY PERCEPTION OF LIGHT STIMULUS	208	1.13e-03	2.76e-02	0.2150	-6.79e-02	2.82e-02	-1.44e-01	-1.36e-01	-3.71e-02	9.13e-02	4.83e-01	3.36e-04	6.91e-04	3.56e-01
REGULATION OF HETEROTYPIC CELL CELL ADHESION	24	3.91e-01	8.41e-01	0.2150	-7.23e-02	-1.72e-01	-6.66e-02	-4.67e-02	6.92e-02	5.40e-01	1.45e-01	5.72e-01	6.92e-01	5.58e-01
PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	39	2.09e-01	6.86e-01	0.2150	-5.50e-02	-2.02e-01	2.74e-02	1.20e-02	3.82e-02	5.52e-01	2.91e-02	7.67e-01	8.97e-01	6.80e-01
ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE	13	4.99e-01	8.97e-01	0.2150	1.80e-01	1.12e-01	2.74e-02	2.07e-02	9.73e-03	2.62e-01	4.85e-01	8.64e-01	8.97e-01	9.52e-01
FRUCTOSE METABOLIC PROCESS	13	5.08e-01	9.00e-01	0.2150	6.81e-02	-9.60e-03	1.40e-01	1.04e-01	-1.04e-01	6.71e-01	9.52e-01	3.81e-01	5.18e-01	5.14e-01
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	9	8.59e-01	9.88e-01	0.2140	-4.96e-02	-1.54e-01	1.07e-01	8.67e-02	3.02e-02	7.97e-01	4.24e-01	5.79e-01	6.52e-01	8.76e-01
POSITIVE REGULATION OF VIRAL PROCESS	62	4.47e-01	8.74e-01	0.2140	1.11e-01	2.85e-02	1.32e-01	1.21e-01	2.66e-02	1.30e-01	6.98e-01	7.24e-02	9.86e-02	7.17e-01
LIPOPROTEIN CATABOLIC PROCESS	15	7.75e-01	9.77e-01	0.2140	-8.98e-02	-1.19e-01	-2.77e-02	-4.02e-02	-1.47e-01	5.47e-01	4.26e-01	8.52e-01	7.88e-01	3.26e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	27	2.27e-01	7.10e-01	0.2140	1.20e-01	-3.97e-02	1.23e-01	1.08e-01	-5.65e-02	2.80e-01	7.21e-01	2.70e-01	3.30e-01	6.11e-01
NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	44	6.53e-01	9.52e-01	0.2140	7.00e-02	-2.86e-02	1.23e-01	1.11e-01	1.14e-01	4.22e-01	7.43e-01	1.60e-01	2.02e-01	1.93e-01
SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX	5	7.51e-01	9.75e-01	0.2140	-5.97e-02	1.28e-01	-1.12e-01	-6.81e-02	9.35e-02	8.17e-01	6.20e-01	6.63e-01	7.92e-01	7.17e-01
CARNITINE TRANSMEMBRANE TRANSPORT	6	5.42e-01	9.14e-01	0.2140	4.65e-02	-1.10e-01	-1.32e-01	-1.05e-01	-5.52e-02	8.44e-01	6.40e-01	5.74e-01	6.55e-01	8.15e-01
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY	27	4.21e-01	8.60e-01	0.2140	-1.03e-01	-1.27e-01	5.23e-02	3.34e-02	1.24e-01	3.53e-01	2.55e-01	6.38e-01	7.64e-01	2.65e-01
SYNAPTIC TRANSMISSION GABAERGIC	56	1.93e-01	6.67e-01	0.2140	-1.24e-01	-1.28e-01	-9.04e-03	-2.49e-02	1.16e-01	1.09e-01	9.67e-02	9.07e-01	7.47e-01	1.34e-01
TYPE B PANCREATIC CELL DEVELOPMENT	24	5.33e-01	9.09e-01	0.2140	-5.16e-02	-1.82e-01	-2.00e-03	-2.09e-02	9.82e-02	6.62e-01	1.23e-01	9.87e-01	8.60e-01	4.05e-01
RESPONSE TO CADMIUM ION	57	1.64e-01	6.28e-01	0.2140	9.84e-02	-5.55e-02	1.19e-01	1.23e-01	6.08e-02	1.99e-01	4.69e-01	1.19e-01	1.08e-01	4.27e-01
EMBRYONIC VISCEROCRANIUM MORPHOGENESIS	10	7.52e-01	9.75e-01	0.2140	-1.31e-02	-5.27e-02	-1.28e-01	-1.39e-01	-8.54e-02	9.43e-01	7.73e-01	4.84e-01	4.48e-01	6.40e-01
R LOOP PROCESSING	6	9.41e-01	9.97e-01	0.2140	-3.30e-02	-1.61e-02	-1.60e-02	-3.13e-02	-2.08e-01	8.89e-01	9.45e-01	9.46e-01	8.94e-01	3.78e-01
POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING	42	3.76e-01	8.36e-01	0.2140	9.63e-02	1.41e-01	4.70e-02	6.24e-02	1.02e-01	2.80e-01	1.13e-01	5.98e-01	4.84e-01	2.53e-01
POSITIVE REGULATION OF HEAT GENERATION	9	9.15e-01	9.94e-01	0.2140	-8.90e-02	-1.54e-01	-8.91e-02	-7.04e-02	3.64e-02	6.44e-01	4.25e-01	6.44e-01	7.15e-01	8.50e-01
MESENDODERM DEVELOPMENT	9	8.72e-01	9.88e-01	0.2140	1.31e-01	6.18e-03	9.73e-02	7.88e-02	1.13e-01	4.95e-01	9.74e-01	6.13e-01	6.82e-01	5.57e-01
L AMINO ACID TRANSPORT	84	1.65e-01	6.31e-01	0.2140	1.31e-01	1.56e-01	3.62e-02	5.17e-02	-1.12e-02	3.80e-02	1.33e-02	5.66e-01	4.12e-01	8.60e-01
RESPONSE TO OXYGEN LEVELS	321	1.15e-03	2.79e-02	0.2140	8.24e-02	-8.58e-03	1.17e-01	1.12e-01	1.12e-01	1.11e-02	7.92e-01	3.17e-04	5.39e-04	5.67e-04
POSITIVE REGULATION OF BLOOD PRESSURE	32	6.84e-01	9.61e-01	0.2140	3.69e-02	-6.17e-02	9.13e-02	8.02e-02	1.60e-01	7.18e-01	5.46e-01	3.72e-01	4.32e-01	1.16e-01
VENTRICULAR SEPTUM MORPHOGENESIS	43	1.76e-01	6.47e-01	0.2140	-8.79e-02	-1.92e-01	4.04e-04	-2.91e-02	6.80e-03	3.18e-01	2.90e-02	9.96e-01	7.42e-01	9.39e-01
PROTEIN STABILIZATION	202	7.40e-05	3.00e-03	0.2140	7.53e-02	-7.23e-02	1.26e-01	1.27e-01	5.17e-02	6.50e-02	7.66e-02	1.95e-03	1.88e-03	2.05e-01
MONOCYTE CHEMOTAXIS	69	1.14e-02	1.39e-01	0.2140	1.55e-01	9.66e-02	3.68e-02	6.36e-02	8.25e-02	2.58e-02	1.65e-01	5.97e-01	3.61e-01	2.36e-01
BRAIN MORPHOGENESIS	37	2.61e-01	7.44e-01	0.2140	-8.48e-02	-1.18e-01	-7.70e-02	-1.08e-01	-8.28e-02	3.72e-01	2.13e-01	4.18e-01	2.56e-01	3.83e-01
REGULATION OF MRNA 3 END PROCESSING	12	3.37e-01	8.08e-01	0.2140	-6.79e-02	-8.70e-02	1.44e-01	1.06e-01	-3.68e-02	6.84e-01	6.02e-01	3.87e-01	5.25e-01	8.25e-01
ENDOCARDIAL CUSHION DEVELOPMENT	54	2.35e-02	2.26e-01	0.2140	-5.14e-03	-1.84e-01	7.43e-02	4.88e-02	6.05e-02	9.48e-01	1.91e-02	3.45e-01	5.35e-01	4.42e-01
POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	31	5.34e-01	9.09e-01	0.2130	-1.27e-01	-1.47e-01	-4.01e-02	-7.30e-02	3.07e-02	2.20e-01	1.58e-01	6.99e-01	4.82e-01	7.67e-01
REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	102	1.50e-03	3.35e-02	0.2130	3.73e-02	-9.70e-02	1.43e-01	1.16e-01	2.92e-02	5.15e-01	9.03e-02	1.27e-02	4.26e-02	6.10e-01
PARAXIAL MESODERM DEVELOPMENT	17	7.66e-01	9.75e-01	0.2130	-2.69e-02	-1.26e-01	6.67e-02	3.75e-02	1.52e-01	8.48e-01	3.68e-01	6.34e-01	7.89e-01	2.78e-01
ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING	6	9.65e-01	9.97e-01	0.2130	5.10e-02	7.22e-02	3.19e-02	3.95e-02	-1.87e-01	8.29e-01	7.59e-01	8.92e-01	8.67e-01	4.26e-01
HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS	8	8.13e-01	9.82e-01	0.2130	-4.92e-02	5.32e-03	7.10e-02	4.46e-02	1.90e-01	8.10e-01	9.79e-01	7.28e-01	8.27e-01	3.52e-01
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	77	3.95e-01	8.44e-01	0.2130	-7.42e-02	1.08e-02	-1.30e-01	-1.31e-01	-7.62e-02	2.60e-01	8.70e-01	4.78e-02	4.76e-02	2.48e-01
REGULATION OF DNA METABOLIC PROCESS	506	3.99e-08	3.75e-06	0.2130	8.68e-02	-7.68e-03	1.40e-01	1.33e-01	2.50e-02	8.27e-04	7.67e-01	6.56e-08	3.20e-07	3.35e-01
ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX	5	3.97e-01	8.45e-01	0.2130	-8.24e-02	9.77e-02	4.74e-02	9.43e-02	1.34e-01	7.50e-01	7.05e-01	8.54e-01	7.15e-01	6.04e-01
MITOTIC RECOMBINATION	25	7.81e-01	9.81e-01	0.2130	1.43e-02	-9.06e-02	9.40e-02	8.42e-02	1.45e-01	9.02e-01	4.33e-01	4.16e-01	4.66e-01	2.09e-01
INNER DYNEIN ARM ASSEMBLY	16	5.61e-01	9.20e-01	0.2130	1.14e-01	1.23e-01	-6.70e-02	-4.18e-02	-1.05e-01	4.31e-01	3.93e-01	6.43e-01	7.72e-01	4.67e-01
GROOMING BEHAVIOR	17	2.56e-01	7.39e-01	0.2130	2.43e-02	-1.09e-01	-5.78e-02	-4.14e-02	-1.67e-01	8.62e-01	4.37e-01	6.80e-01	7.68e-01	2.33e-01
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS	13	7.35e-01	9.73e-01	0.2130	-5.73e-03	1.53e-02	1.28e-01	1.17e-01	1.22e-01	9.71e-01	9.24e-01	4.23e-01	4.66e-01	4.44e-01
STRESS GRANULE ASSEMBLY	29	3.08e-01	7.82e-01	0.2130	-2.81e-03	-1.61e-01	7.87e-02	4.91e-02	1.04e-01	9.79e-01	1.34e-01	4.63e-01	6.47e-01	3.31e-01
ENDOCRINE PANCREAS DEVELOPMENT	46	3.20e-03	5.79e-02	0.2130	2.29e-02	-1.93e-01	4.42e-02	1.73e-02	7.27e-02	7.88e-01	2.35e-02	6.04e-01	8.39e-01	3.93e-01
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	28	3.56e-01	8.22e-01	0.2130	-5.32e-02	-2.03e-01	-1.11e-02	-1.99e-02	3.06e-02	6.26e-01	6.36e-02	9.19e-01	8.55e-01	7.79e-01
POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION	14	9.18e-01	9.95e-01	0.2130	-9.28e-02	-1.12e-01	-1.10e-01	-1.01e-01	4.42e-02	5.48e-01	4.69e-01	4.76e-01	5.14e-01	7.75e-01
SKELETAL MUSCLE CELL DIFFERENTIATION	71	3.59e-01	8.25e-01	0.2130	7.37e-02	2.02e-02	1.09e-01	9.43e-02	1.37e-01	2.83e-01	7.69e-01	1.14e-01	1.70e-01	4.59e-02
REGULATION OF OSTEOBLAST PROLIFERATION	30	8.67e-01	9.88e-01	0.2130	1.16e-01	1.23e-01	8.95e-02	8.58e-02	3.67e-02	2.73e-01	2.43e-01	3.96e-01	4.16e-01	7.28e-01
REGULATION OF MITOTIC NUCLEAR DIVISION	118	3.12e-02	2.66e-01	0.2130	8.66e-02	6.65e-03	1.41e-01	1.32e-01	-1.23e-02	1.04e-01	9.01e-01	7.95e-03	1.31e-02	8.18e-01
REGULATION OF ACUTE INFLAMMATORY RESPONSE	48	2.03e-01	6.83e-01	0.2130	1.63e-02	-8.67e-02	4.49e-02	3.20e-02	1.85e-01	8.45e-01	2.99e-01	5.91e-01	7.01e-01	2.62e-02
RESPONSE TO IMMOBILIZATION STRESS	21	5.55e-01	9.17e-01	0.2130	-4.68e-03	-1.30e-01	3.80e-02	1.39e-02	1.63e-01	9.70e-01	3.02e-01	7.63e-01	9.12e-01	1.96e-01
CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS	7	8.19e-01	9.83e-01	0.2130	-4.78e-02	-1.85e-01	-3.06e-02	-6.73e-02	5.66e-02	8.27e-01	3.97e-01	8.89e-01	7.58e-01	7.95e-01
EPIDERMAL CELL FATE SPECIFICATION	5	9.05e-01	9.94e-01	0.2120	6.83e-02	-1.29e-01	1.06e-01	9.91e-02	-5.16e-02	7.91e-01	6.18e-01	6.81e-01	7.01e-01	8.42e-01
POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	27	7.35e-01	9.73e-01	0.2120	1.32e-01	1.56e-01	3.10e-02	4.78e-02	-1.77e-03	2.34e-01	1.62e-01	7.81e-01	6.67e-01	9.87e-01
REGULATION OF HORMONE METABOLIC PROCESS	39	1.58e-01	6.20e-01	0.2120	-8.44e-02	-1.50e-01	5.62e-02	1.61e-02	1.09e-01	3.61e-01	1.05e-01	5.43e-01	8.62e-01	2.38e-01
REGULATION OF MEIOTIC NUCLEAR DIVISION	33	5.75e-01	9.26e-01	0.2120	1.75e-02	9.52e-02	-6.61e-02	-6.56e-02	-1.64e-01	8.62e-01	3.44e-01	5.11e-01	5.14e-01	1.03e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	21	7.73e-01	9.77e-01	0.2120	-9.45e-02	-4.82e-02	-1.25e-01	-9.84e-02	-9.11e-02	4.54e-01	7.02e-01	3.21e-01	4.35e-01	4.70e-01
POSITIVE REGULATION OF AXONOGENESIS	72	1.49e-01	6.10e-01	0.2120	-8.83e-02	7.65e-04	-1.32e-01	-1.39e-01	1.69e-02	1.95e-01	9.91e-01	5.32e-02	4.08e-02	8.04e-01
LIPID PHOSPHORYLATION	10	8.88e-01	9.91e-01	0.2120	-6.59e-02	1.07e-01	-1.06e-01	-9.57e-02	-9.34e-02	7.18e-01	5.58e-01	5.63e-01	6.00e-01	6.09e-01
NEGATIVE REGULATION OF CYTOKINE PRODUCTION	359	1.36e-03	3.13e-02	0.2120	-1.14e-01	-8.50e-02	-1.13e-01	-1.09e-01	2.22e-03	2.18e-04	5.64e-03	2.34e-04	3.89e-04	9.42e-01
ALDITOL PHOSPHATE METABOLIC PROCESS	10	6.93e-01	9.61e-01	0.2120	-2.71e-02	1.79e-01	-8.44e-02	-6.80e-02	-6.64e-03	8.82e-01	3.26e-01	6.44e-01	7.10e-01	9.71e-01
SERTOLI CELL PROLIFERATION	5	9.40e-01	9.97e-01	0.2110	7.72e-02	-1.83e-02	1.17e-01	1.46e-01	-5.83e-02	7.65e-01	9.43e-01	6.49e-01	5.72e-01	8.22e-01
EMBRYONIC PLACENTA MORPHOGENESIS	27	6.00e-01	9.33e-01	0.2110	4.81e-02	6.36e-02	1.32e-01	1.32e-01	5.89e-02	6.65e-01	5.67e-01	2.35e-01	2.35e-01	5.96e-01
HINDGUT DEVELOPMENT	8	9.43e-01	9.97e-01	0.2110	1.58e-01	4.96e-02	9.16e-02	9.35e-02	-8.99e-03	4.39e-01	8.08e-01	6.54e-01	6.47e-01	9.65e-01
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	6	9.42e-01	9.97e-01	0.2110	5.73e-02	1.52e-01	-9.10e-02	-5.48e-02	-8.38e-02	8.08e-01	5.20e-01	7.00e-01	8.16e-01	7.22e-01
NEGATIVE REGULATION OF PROTEIN POLYMERIZATION	75	6.34e-01	9.48e-01	0.2110	-1.14e-01	-7.41e-02	-1.07e-01	-1.15e-01	-3.60e-02	8.76e-02	2.67e-01	1.08e-01	8.37e-02	5.89e-01
GLOMERULAR EPITHELIAL CELL DEVELOPMENT	12	6.09e-01	9.36e-01	0.2110	-1.15e-01	-2.12e-02	-1.07e-01	-6.60e-02	-1.23e-01	4.90e-01	8.99e-01	5.22e-01	6.92e-01	4.60e-01
REGULATION OF CALCINEURIN MEDIATED SIGNALING	41	7.46e-01	9.75e-01	0.2110	1.04e-01	9.31e-02	8.64e-02	9.92e-02	8.80e-02	2.48e-01	3.02e-01	3.38e-01	2.72e-01	3.29e-01
CELLULAR RESPONSE TO POTASSIUM ION	12	6.43e-01	9.50e-01	0.2110	5.31e-02	1.08e-01	-2.68e-02	-4.12e-03	1.72e-01	7.50e-01	5.19e-01	8.72e-01	9.80e-01	3.03e-01
DNA BIOSYNTHETIC PROCESS	188	1.61e-03	3.45e-02	0.2110	8.76e-02	-3.03e-02	1.34e-01	1.33e-01	1.98e-02	3.82e-02	4.73e-01	1.53e-03	1.71e-03	6.39e-01
RHYTHMIC BEHAVIOR	44	2.41e-01	7.25e-01	0.2110	-7.77e-02	-6.70e-02	-4.15e-02	-5.41e-02	1.71e-01	3.72e-01	4.42e-01	6.34e-01	5.35e-01	4.94e-02
NATURAL KILLER CELL PROLIFERATION	14	4.50e-01	8.76e-01	0.2110	2.37e-02	1.18e-01	-1.25e-01	-9.36e-02	7.51e-02	8.78e-01	4.45e-01	4.18e-01	5.44e-01	6.27e-01
ACUTE PHASE RESPONSE	47	2.47e-02	2.33e-01	0.2110	5.24e-03	1.92e-01	-6.72e-02	-4.09e-02	-3.67e-02	9.50e-01	2.27e-02	4.26e-01	6.27e-01	6.63e-01
REGULATION OF LIPID TRANSPORT	153	1.94e-02	2.00e-01	0.2110	-1.13e-01	-7.94e-02	-1.21e-01	-1.04e-01	-7.55e-03	1.60e-02	9.02e-02	1.00e-02	2.62e-02	8.72e-01
SEROTONIN UPTAKE	12	7.96e-01	9.81e-01	0.2110	4.42e-02	1.96e-01	7.68e-03	1.07e-02	-6.12e-02	7.91e-01	2.39e-01	9.63e-01	9.49e-01	7.14e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	61	1.29e-01	5.72e-01	0.2110	-3.77e-02	-1.71e-01	4.73e-02	3.81e-02	1.01e-01	6.11e-01	2.10e-02	5.23e-01	6.07e-01	1.75e-01
DNA DAMAGE RESPONSE	835	3.69e-14	8.16e-12	0.2110	8.64e-02	-2.14e-02	1.36e-01	1.23e-01	5.23e-02	2.22e-05	2.94e-01	2.22e-11	1.41e-09	1.02e-02
RETINOL METABOLIC PROCESS	50	2.53e-01	7.37e-01	0.2110	-5.70e-02	-3.87e-02	-1.00e-01	-7.62e-02	-1.54e-01	4.86e-01	6.36e-01	2.19e-01	3.51e-01	5.94e-02
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	6	3.13e-01	7.86e-01	0.2100	-1.20e-01	5.84e-02	-1.08e-01	-2.89e-02	-1.18e-01	6.10e-01	8.04e-01	6.46e-01	9.02e-01	6.17e-01
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	110	6.30e-03	9.54e-02	0.2100	7.37e-02	-5.30e-02	1.43e-01	1.20e-01	3.64e-02	1.82e-01	3.36e-01	9.72e-03	2.99e-02	5.09e-01
REGULATION OF DOUBLE STRAND BREAK REPAIR	125	8.91e-02	4.74e-01	0.2100	1.01e-01	2.88e-02	1.33e-01	1.17e-01	4.39e-02	5.06e-02	5.78e-01	1.05e-02	2.36e-02	3.97e-01
POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	21	2.21e-01	7.01e-01	0.2100	2.37e-02	-7.47e-02	-2.52e-02	1.31e-03	-1.94e-01	8.51e-01	5.53e-01	8.42e-01	9.92e-01	1.25e-01
PIGMENT ACCUMULATION	11	3.03e-01	7.75e-01	0.2100	8.08e-02	-3.93e-02	1.24e-01	5.71e-02	1.33e-01	6.43e-01	8.21e-01	4.77e-01	7.43e-01	4.47e-01
NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY	24	1.31e-02	1.54e-01	0.2100	1.36e-01	-1.07e-01	9.64e-02	6.77e-02	-1.80e-02	2.48e-01	3.63e-01	4.14e-01	5.66e-01	8.79e-01
STRIATED MUSCLE CELL APOPTOTIC PROCESS	58	5.64e-01	9.22e-01	0.2100	-9.55e-02	-1.01e-01	-1.10e-01	-1.12e-01	1.25e-02	2.08e-01	1.83e-01	1.47e-01	1.39e-01	8.69e-01
MUCOPOLYSACCHARIDE METABOLIC PROCESS	89	3.47e-01	8.18e-01	0.2100	-1.05e-01	-8.13e-02	-1.08e-01	-1.22e-01	-1.03e-02	8.65e-02	1.85e-01	7.88e-02	4.72e-02	8.66e-01
SPERM CAPACITATION	30	1.88e-01	6.59e-01	0.2100	1.09e-01	1.55e-01	-1.35e-02	2.09e-02	8.72e-02	3.00e-01	1.42e-01	8.98e-01	8.43e-01	4.08e-01
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	7.07e-01	9.65e-01	0.2100	6.81e-02	-1.38e-01	3.20e-02	3.13e-02	-1.36e-01	7.73e-01	5.57e-01	8.92e-01	8.94e-01	5.65e-01
RESPONSE TO FUNGICIDE	7	9.47e-01	9.97e-01	0.2100	-5.35e-02	-7.13e-02	-3.07e-02	-3.91e-02	-1.84e-01	8.06e-01	7.44e-01	8.88e-01	8.58e-01	4.00e-01
NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	155	7.92e-02	4.52e-01	0.2100	-1.09e-01	-1.42e-01	-7.38e-02	-7.95e-02	1.86e-02	1.88e-02	2.34e-03	1.13e-01	8.77e-02	6.89e-01
SYNAPTIC VESICLE PRIMING	18	8.28e-01	9.83e-01	0.2100	3.86e-02	-6.20e-02	1.18e-01	1.27e-01	9.40e-02	7.77e-01	6.49e-01	3.87e-01	3.52e-01	4.90e-01
GLUTAMATE SECRETION	28	4.97e-01	8.96e-01	0.2100	4.84e-03	-6.49e-02	6.25e-02	3.54e-02	1.86e-01	9.65e-01	5.52e-01	5.67e-01	7.46e-01	8.80e-02
MEMBRANE FISSION	42	2.18e-01	7.00e-01	0.2100	-8.52e-02	-1.85e-01	4.43e-04	-1.37e-02	-5.00e-02	3.39e-01	3.84e-02	9.96e-01	8.78e-01	5.75e-01
METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT	9	7.55e-01	9.75e-01	0.2100	-5.16e-02	-1.26e-01	-9.62e-02	-1.27e-01	6.38e-04	7.89e-01	5.13e-01	6.17e-01	5.08e-01	9.97e-01
CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT	27	7.87e-01	9.81e-01	0.2100	7.71e-02	-2.85e-02	1.10e-01	9.64e-02	1.26e-01	4.88e-01	7.97e-01	3.24e-01	3.86e-01	2.57e-01
GASTRULATION WITH MOUTH FORMING SECOND	26	9.27e-02	4.85e-01	0.2100	1.12e-01	3.16e-02	-1.80e-02	-2.36e-02	-1.72e-01	3.22e-01	7.81e-01	8.74e-01	8.35e-01	1.30e-01
REGULATION OF GONAD DEVELOPMENT	12	9.37e-01	9.97e-01	0.2100	1.63e-02	7.81e-02	-6.60e-02	-5.61e-02	-1.73e-01	9.22e-01	6.40e-01	6.92e-01	7.36e-01	2.98e-01
PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	14	8.27e-01	9.83e-01	0.2090	1.32e-01	1.36e-01	3.12e-03	9.49e-03	-8.82e-02	3.92e-01	3.78e-01	9.84e-01	9.51e-01	5.68e-01
MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE	6	9.98e-01	1.00e+00	0.2090	8.86e-02	5.84e-02	1.23e-01	1.18e-01	5.94e-02	7.07e-01	8.04e-01	6.02e-01	6.16e-01	8.01e-01
ACROSOME REACTION	40	6.25e-02	3.99e-01	0.2090	4.00e-02	1.90e-01	-4.36e-02	-2.42e-02	5.97e-02	6.62e-01	3.74e-02	6.33e-01	7.91e-01	5.13e-01
NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	11	9.90e-01	9.98e-01	0.2090	1.02e-01	6.93e-02	1.08e-01	1.18e-01	5.49e-02	5.58e-01	6.91e-01	5.36e-01	4.97e-01	7.52e-01
POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	8	3.83e-01	8.39e-01	0.2090	7.80e-02	-1.30e-01	-2.21e-02	-3.07e-02	-1.39e-01	7.02e-01	5.23e-01	9.14e-01	8.80e-01	4.96e-01
NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	24	6.61e-01	9.54e-01	0.2090	7.64e-02	9.15e-02	8.66e-02	9.84e-02	-1.11e-01	5.17e-01	4.38e-01	4.62e-01	4.04e-01	3.45e-01
AMINOGLYCAN METABOLIC PROCESS	118	2.20e-01	7.00e-01	0.2090	-8.64e-02	-6.83e-02	-1.22e-01	-1.25e-01	-3.44e-02	1.05e-01	2.00e-01	2.21e-02	1.92e-02	5.19e-01
RESPONSE TO DIETARY EXCESS	34	7.41e-01	9.73e-01	0.2090	-6.59e-02	-1.27e-02	-1.15e-01	-9.77e-02	-1.28e-01	5.06e-01	8.98e-01	2.44e-01	3.24e-01	1.97e-01
NEGATIVE REGULATION OF TORC1 SIGNALING	46	2.07e-01	6.84e-01	0.2090	1.02e-01	-2.96e-02	1.34e-01	1.20e-01	-1.37e-02	2.32e-01	7.29e-01	1.16e-01	1.60e-01	8.72e-01
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	10	6.26e-01	9.44e-01	0.2090	2.51e-03	3.73e-02	-5.69e-02	-9.54e-02	-1.73e-01	9.89e-01	8.38e-01	7.55e-01	6.01e-01	3.43e-01
CELLULAR LIPID BIOSYNTHETIC PROCESS	12	8.76e-01	9.88e-01	0.2090	-6.48e-02	-1.08e-01	-8.21e-02	-8.13e-02	1.21e-01	6.98e-01	5.18e-01	6.22e-01	6.26e-01	4.69e-01
DENDRITIC CELL APOPTOTIC PROCESS	11	6.96e-01	9.61e-01	0.2090	3.15e-02	2.03e-01	-3.30e-03	-5.13e-03	3.46e-02	8.56e-01	2.43e-01	9.85e-01	9.76e-01	8.42e-01
CELL CYCLE G2 M PHASE TRANSITION	148	6.12e-03	9.37e-02	0.2090	7.45e-02	-3.94e-02	1.38e-01	1.20e-01	5.51e-02	1.18e-01	4.08e-01	3.66e-03	1.20e-02	2.48e-01
PROTON TRANSMEMBRANE TRANSPORT	141	4.26e-02	3.17e-01	0.2090	1.01e-01	4.19e-02	1.27e-01	1.22e-01	-2.61e-02	3.85e-02	3.90e-01	9.18e-03	1.27e-02	5.93e-01
PHOSPHOLIPID DEPHOSPHORYLATION	37	5.54e-01	9.16e-01	0.2090	-7.91e-02	-9.83e-02	-1.00e-01	-1.18e-01	-6.11e-02	4.05e-01	3.01e-01	2.92e-01	2.15e-01	5.20e-01
NEGATIVE REGULATION OF LIPID STORAGE	22	2.44e-01	7.29e-01	0.2090	-5.40e-02	5.22e-02	-1.36e-01	-1.04e-01	9.34e-02	6.61e-01	6.72e-01	2.71e-01	4.00e-01	4.48e-01
RESPONSE TO POTASSIUM ION	17	2.70e-01	7.50e-01	0.2080	1.08e-02	1.67e-01	-7.09e-02	-3.70e-02	9.44e-02	9.39e-01	2.32e-01	6.13e-01	7.92e-01	5.00e-01
MYELOID LEUKOCYTE CYTOKINE PRODUCTION	50	3.54e-01	8.22e-01	0.2080	-9.38e-02	-1.24e-01	-4.71e-02	-6.79e-02	1.12e-01	2.51e-01	1.30e-01	5.65e-01	4.06e-01	1.71e-01
MESENCHYMAL CELL APOPTOTIC PROCESS	15	1.75e-01	6.47e-01	0.2080	-8.34e-03	-1.85e-01	-3.43e-02	-7.31e-02	5.07e-02	9.55e-01	2.14e-01	8.18e-01	6.24e-01	7.34e-01
NUCLEOLAR CHROMATIN ORGANIZATION	9	8.99e-01	9.93e-01	0.2080	5.55e-02	3.77e-02	4.03e-02	4.04e-02	-1.89e-01	7.73e-01	8.45e-01	8.34e-01	8.34e-01	3.26e-01
POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	18	8.40e-01	9.85e-01	0.2080	-3.52e-02	-1.40e-01	6.43e-02	5.21e-02	1.25e-01	7.96e-01	3.04e-01	6.37e-01	7.02e-01	3.57e-01
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES	16	9.08e-01	9.94e-01	0.2080	8.92e-02	-1.86e-02	1.09e-01	9.52e-02	1.19e-01	5.37e-01	8.97e-01	4.52e-01	5.10e-01	4.08e-01
NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	11	7.00e-01	9.63e-01	0.2080	-1.79e-02	-2.22e-02	-9.25e-02	-9.95e-02	1.55e-01	9.18e-01	8.99e-01	5.95e-01	5.68e-01	3.72e-01
LUTEINIZING HORMONE SECRETION	10	5.93e-01	9.32e-01	0.2080	1.25e-01	-2.71e-02	1.32e-01	9.35e-02	-2.55e-02	4.92e-01	8.82e-01	4.68e-01	6.09e-01	8.89e-01
SALIVA SECRETION	13	8.47e-01	9.87e-01	0.2080	-8.40e-02	8.68e-03	-1.23e-01	-1.37e-01	4.80e-02	6.00e-01	9.57e-01	4.42e-01	3.92e-01	7.65e-01
ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM	16	5.20e-01	9.03e-01	0.2080	1.45e-01	1.42e-01	-1.98e-03	-1.05e-02	-4.37e-02	3.14e-01	3.26e-01	9.89e-01	9.42e-01	7.62e-01
CELL CYCLE CHECKPOINT SIGNALING	188	4.68e-06	2.78e-04	0.2080	5.94e-02	-2.84e-02	1.52e-01	1.26e-01	-3.66e-03	1.60e-01	5.02e-01	3.23e-04	2.94e-03	9.31e-01
MEMBRANE BIOGENESIS	59	3.55e-02	2.86e-01	0.2080	8.14e-02	-7.16e-02	1.19e-01	1.29e-01	-2.43e-02	2.79e-01	3.41e-01	1.14e-01	8.56e-02	7.46e-01
REGULATION OF GLUTAMATE SECRETION	20	4.10e-01	8.52e-01	0.2080	-6.40e-03	-1.01e-01	5.46e-02	1.24e-02	1.73e-01	9.60e-01	4.35e-01	6.72e-01	9.24e-01	1.81e-01
PHOTORECEPTOR CELL MAINTENANCE	43	1.34e-01	5.81e-01	0.2080	8.26e-02	1.58e-01	2.60e-02	1.52e-02	1.02e-01	3.49e-01	7.23e-02	7.68e-01	8.63e-01	2.49e-01
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION	34	7.83e-01	9.81e-01	0.2080	1.26e-01	3.87e-02	1.12e-01	1.09e-01	3.53e-02	2.03e-01	6.96e-01	2.57e-01	2.72e-01	7.21e-01
REGULATION OF CARDIOBLAST DIFFERENTIATION	5	8.65e-01	9.88e-01	0.2080	9.93e-02	-1.00e-01	9.08e-02	8.43e-02	-8.88e-02	7.00e-01	6.98e-01	7.25e-01	7.44e-01	7.31e-01
OTIC VESICLE DEVELOPMENT	15	8.62e-01	9.88e-01	0.2070	-8.32e-02	-6.75e-02	-9.74e-02	-1.23e-01	-8.27e-02	5.77e-01	6.51e-01	5.14e-01	4.08e-01	5.79e-01
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION	24	2.04e-01	6.84e-01	0.2070	-4.08e-02	-1.71e-01	-2.47e-02	3.46e-03	1.07e-01	7.29e-01	1.47e-01	8.34e-01	9.77e-01	3.63e-01
CRANIAL GANGLION DEVELOPMENT	5	9.88e-01	9.98e-01	0.2070	9.25e-02	3.45e-02	1.01e-01	7.92e-02	1.30e-01	7.20e-01	8.94e-01	6.95e-01	7.59e-01	6.16e-01
NEGATIVE REGULATION OF DNA BINDING	33	6.04e-01	9.34e-01	0.2070	7.09e-02	-4.23e-02	1.39e-01	1.27e-01	2.76e-02	4.81e-01	6.74e-01	1.67e-01	2.07e-01	7.84e-01
ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE	79	1.25e-03	2.94e-02	0.2070	1.14e-01	1.09e-01	2.66e-02	6.79e-02	1.13e-01	7.85e-02	9.47e-02	6.82e-01	2.97e-01	8.28e-02
CAMP MEDIATED SIGNALING	53	4.91e-01	8.94e-01	0.2070	-1.03e-01	-1.32e-01	-8.23e-02	-7.68e-02	4.66e-02	1.93e-01	9.61e-02	3.00e-01	3.34e-01	5.57e-01
NEURON PROJECTION REGENERATION	54	2.27e-01	7.10e-01	0.2070	-1.92e-02	7.82e-02	-1.21e-01	-9.38e-02	-1.14e-01	8.08e-01	3.20e-01	1.24e-01	2.33e-01	1.47e-01
CELL DIFFERENTIATION IN SPINAL CORD	49	5.22e-03	8.40e-02	0.2070	1.19e-01	-8.65e-02	1.06e-01	8.42e-02	5.47e-02	1.51e-01	2.95e-01	1.99e-01	3.08e-01	5.08e-01
ASTRAL MICROTUBULE ORGANIZATION	10	8.44e-01	9.86e-01	0.2070	-4.47e-02	-7.20e-02	-1.05e-01	-1.07e-01	1.14e-01	8.07e-01	6.93e-01	5.64e-01	5.56e-01	5.32e-01
P BODY ASSEMBLY	20	8.47e-01	9.87e-01	0.2070	-1.09e-01	-1.64e-01	-2.04e-02	-4.22e-02	4.36e-02	3.99e-01	2.05e-01	8.74e-01	7.44e-01	7.35e-01
NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	59	3.00e-01	7.73e-01	0.2070	1.03e-01	-1.77e-02	1.28e-01	1.17e-01	4.01e-02	1.69e-01	8.14e-01	8.83e-02	1.19e-01	5.94e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE	63	4.51e-01	8.76e-01	0.2070	-1.04e-01	-1.47e-01	-5.68e-02	-7.06e-02	4.57e-02	1.52e-01	4.34e-02	4.35e-01	3.33e-01	5.31e-01
CORTISOL BIOSYNTHETIC PROCESS	10	4.37e-01	8.69e-01	0.2070	-1.54e-01	3.89e-02	-6.90e-02	-5.98e-02	9.62e-02	3.99e-01	8.31e-01	7.06e-01	7.43e-01	5.99e-01
POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	7	8.50e-01	9.88e-01	0.2070	-1.54e-01	-3.98e-02	-4.04e-02	-5.34e-02	1.15e-01	4.82e-01	8.55e-01	8.53e-01	8.07e-01	5.99e-01
NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS	12	6.62e-01	9.54e-01	0.2070	-8.55e-02	-1.04e-01	1.04e-01	7.66e-02	9.01e-02	6.08e-01	5.35e-01	5.33e-01	6.46e-01	5.89e-01
ESTABLISHMENT OF EPITHELIAL CELL POLARITY	33	4.94e-01	8.95e-01	0.2070	-5.53e-02	-1.32e-01	-3.05e-02	-3.41e-02	1.42e-01	5.83e-01	1.88e-01	7.62e-01	7.35e-01	1.58e-01
CELLULAR RESPONSE TO HEAT	62	6.79e-01	9.60e-01	0.2070	9.71e-02	5.04e-02	1.06e-01	1.16e-01	7.76e-02	1.86e-01	4.92e-01	1.47e-01	1.15e-01	2.91e-01
INTERLEUKIN 1 ALPHA PRODUCTION	11	7.59e-01	9.75e-01	0.2070	1.35e-01	1.54e-01	-1.78e-02	2.05e-02	9.31e-03	4.39e-01	3.76e-01	9.19e-01	9.06e-01	9.57e-01
POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	27	3.93e-02	3.04e-01	0.2070	-6.12e-02	-1.25e-01	-7.47e-02	-1.28e-01	-3.81e-02	5.82e-01	2.61e-01	5.02e-01	2.50e-01	7.32e-01
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS	25	7.63e-01	9.75e-01	0.2070	8.35e-02	-1.00e-02	8.76e-02	7.81e-02	1.48e-01	4.70e-01	9.31e-01	4.49e-01	4.99e-01	2.01e-01
RESPONSE TO EPINEPHRINE	14	9.39e-01	9.97e-01	0.2070	-7.39e-02	-1.62e-02	-1.31e-01	-1.39e-01	-2.31e-02	6.32e-01	9.17e-01	3.97e-01	3.68e-01	8.81e-01
POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	7	9.89e-01	9.98e-01	0.2070	5.64e-02	-1.16e-02	1.21e-01	1.02e-01	1.20e-01	7.96e-01	9.58e-01	5.79e-01	6.41e-01	5.83e-01
NEURONAL ACTION POTENTIAL	32	6.94e-01	9.61e-01	0.2060	-1.09e-01	-9.24e-02	-9.63e-02	-8.84e-02	7.08e-02	2.84e-01	3.66e-01	3.46e-01	3.87e-01	4.88e-01
POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	15	2.08e-01	6.85e-01	0.2060	1.53e-01	-8.00e-02	7.64e-02	7.49e-02	3.62e-02	3.05e-01	5.92e-01	6.08e-01	6.15e-01	8.08e-01
MITOCHONDRIAL GENOME MAINTENANCE	31	7.04e-01	9.65e-01	0.2060	8.26e-02	-1.15e-02	1.39e-01	1.25e-01	2.48e-02	4.26e-01	9.12e-01	1.79e-01	2.29e-01	8.11e-01
CHROMOSOME SEPARATION	81	5.80e-03	9.11e-02	0.2060	5.22e-02	1.02e-03	1.39e-01	1.21e-01	-7.67e-02	4.16e-01	9.87e-01	3.02e-02	6.03e-02	2.33e-01
ARF PROTEIN SIGNAL TRANSDUCTION	21	6.21e-01	9.43e-01	0.2060	-3.96e-02	1.29e-01	-9.37e-02	-8.17e-02	-9.41e-02	7.54e-01	3.05e-01	4.57e-01	5.17e-01	4.55e-01
CHROMOSOME ORGANIZATION	606	3.44e-12	6.03e-10	0.2060	9.49e-02	6.57e-03	1.35e-01	1.23e-01	-1.24e-02	6.57e-05	7.82e-01	1.23e-08	2.49e-07	6.03e-01
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT	51	2.55e-01	7.38e-01	0.2060	-7.93e-02	-1.29e-01	-7.35e-02	-9.25e-02	7.57e-02	3.27e-01	1.12e-01	3.64e-01	2.53e-01	3.49e-01
CENTRIOLE ELONGATION	8	9.32e-01	9.97e-01	0.2060	7.63e-03	-1.43e-01	7.14e-02	7.71e-02	1.05e-01	9.70e-01	4.83e-01	7.26e-01	7.06e-01	6.08e-01
PLACENTA DEVELOPMENT	146	1.16e-01	5.45e-01	0.2060	8.00e-02	-4.78e-03	1.19e-01	1.10e-01	9.96e-02	9.52e-02	9.21e-01	1.30e-02	2.23e-02	3.78e-02
ASPARTATE TRANSMEMBRANE TRANSPORT	19	7.87e-01	9.81e-01	0.2060	1.18e-01	1.32e-01	4.03e-02	7.25e-02	-6.42e-02	3.72e-01	3.18e-01	7.61e-01	5.85e-01	6.28e-01
REGULATION OF PROTEIN KINASE C SIGNALING	18	9.40e-01	9.97e-01	0.2060	8.85e-02	9.58e-02	1.08e-01	1.17e-01	1.22e-02	5.16e-01	4.82e-01	4.26e-01	3.92e-01	9.28e-01
NEGATIVE REGULATION OF MRNA METABOLIC PROCESS	90	2.88e-01	7.66e-01	0.2060	5.23e-02	-3.38e-02	1.11e-01	1.10e-01	1.19e-01	3.91e-01	5.80e-01	6.92e-02	7.17e-02	5.06e-02
TRACHEA FORMATION	7	9.85e-01	9.98e-01	0.2060	5.89e-02	6.80e-02	1.23e-01	1.16e-01	7.56e-02	7.87e-01	7.55e-01	5.73e-01	5.95e-01	7.29e-01
PEPTIDOGLYCAN METABOLIC PROCESS	6	8.36e-01	9.85e-01	0.2060	6.13e-04	3.68e-02	-7.15e-02	-1.79e-02	-1.89e-01	9.98e-01	8.76e-01	7.62e-01	9.39e-01	4.24e-01
RESPONSE TO FOLLICLE STIMULATING HORMONE	15	8.55e-01	9.88e-01	0.2060	1.17e-01	1.15e-01	4.21e-02	3.71e-02	-1.11e-01	4.32e-01	4.42e-01	7.78e-01	8.03e-01	4.56e-01
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR	10	9.42e-01	9.97e-01	0.2060	-9.95e-02	-1.65e-01	-3.00e-02	-3.31e-02	-5.78e-02	5.86e-01	3.67e-01	8.69e-01	8.56e-01	7.52e-01
AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	25	1.15e-01	5.43e-01	0.2060	-8.10e-02	1.08e-02	1.69e-02	1.49e-02	-1.87e-01	4.83e-01	9.25e-01	8.84e-01	8.98e-01	1.05e-01
NEGATIVE REGULATION OF PLATELET AGGREGATION	10	7.71e-01	9.76e-01	0.2060	9.89e-02	1.35e-01	-8.40e-02	-6.98e-02	-4.83e-02	5.88e-01	4.59e-01	6.46e-01	7.02e-01	7.92e-01
RESPONSE TO TYPE III INTERFERON	12	3.50e-01	8.18e-01	0.2060	-1.10e-01	1.28e-01	-8.09e-02	-6.23e-02	-5.67e-02	5.08e-01	4.41e-01	6.28e-01	7.09e-01	7.34e-01
MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS	25	7.97e-01	9.81e-01	0.2060	-9.78e-02	-1.40e-01	-6.98e-02	-9.07e-02	6.35e-03	3.97e-01	2.26e-01	5.46e-01	4.32e-01	9.56e-01
VIRAL RELEASE FROM HOST CELL	28	2.98e-01	7.72e-01	0.2060	7.57e-02	-1.10e-01	1.05e-01	1.10e-01	3.41e-02	4.88e-01	3.12e-01	3.36e-01	3.13e-01	7.55e-01
POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	34	3.04e-01	7.76e-01	0.2050	-1.38e-01	-2.70e-03	-1.14e-01	-1.01e-01	-1.30e-03	1.65e-01	9.78e-01	2.50e-01	3.06e-01	9.90e-01
CELL FATE SPECIFICATION	107	3.80e-07	2.98e-05	0.2050	7.13e-02	-1.31e-01	1.00e-01	6.57e-02	7.43e-02	2.02e-01	1.89e-02	7.35e-02	2.40e-01	1.84e-01
HYDROGEN SULFIDE METABOLIC PROCESS	6	5.14e-01	9.01e-01	0.2050	2.12e-02	7.63e-02	9.96e-02	1.60e-01	1.78e-02	9.28e-01	7.46e-01	6.73e-01	4.97e-01	9.40e-01
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT	21	8.67e-01	9.88e-01	0.2050	5.37e-02	-6.19e-02	1.05e-01	9.46e-02	1.25e-01	6.70e-01	6.23e-01	4.06e-01	4.53e-01	3.23e-01
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	33	4.08e-01	8.51e-01	0.2050	-9.38e-02	-1.05e-01	-6.86e-02	-9.92e-02	8.82e-02	3.51e-01	2.97e-01	4.95e-01	3.24e-01	3.81e-01
PROTEIN K11 LINKED DEUBIQUITINATION	9	6.38e-01	9.49e-01	0.2050	1.82e-01	7.92e-02	3.95e-02	2.91e-02	1.33e-02	3.44e-01	6.81e-01	8.37e-01	8.80e-01	9.45e-01
ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS	47	1.64e-01	6.28e-01	0.2050	-4.70e-02	-1.04e-01	-4.44e-02	-3.96e-02	-1.60e-01	5.77e-01	2.16e-01	5.99e-01	6.39e-01	5.82e-02
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	31	1.24e-01	5.63e-01	0.2050	-1.64e-02	-3.80e-02	-1.26e-02	1.61e-02	2.00e-01	8.75e-01	7.14e-01	9.03e-01	8.77e-01	5.41e-02
REGULATION OF LIPID LOCALIZATION	183	1.06e-02	1.33e-01	0.2050	-1.08e-01	-6.08e-02	-1.22e-01	-1.08e-01	-1.80e-03	1.14e-02	1.56e-01	4.26e-03	1.20e-02	9.66e-01
RESPONSE TO MAGNESIUM ION	20	7.24e-01	9.70e-01	0.2050	-2.40e-02	-5.01e-02	5.18e-02	2.97e-02	1.88e-01	8.53e-01	6.98e-01	6.88e-01	8.18e-01	1.46e-01
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	5	9.73e-01	9.97e-01	0.2050	-1.03e-01	-1.23e-01	4.58e-02	2.23e-02	1.17e-01	6.90e-01	6.34e-01	8.59e-01	9.31e-01	6.52e-01
GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY	27	3.55e-01	8.22e-01	0.2050	-1.16e-01	-1.18e-01	-3.24e-02	-1.51e-02	1.14e-01	2.96e-01	2.88e-01	7.71e-01	8.92e-01	3.03e-01
CEREBRAL CORTEX CELL MIGRATION	46	6.21e-01	9.43e-01	0.2050	-1.17e-01	-1.14e-01	-7.50e-02	-9.74e-02	-8.32e-03	1.71e-01	1.79e-01	3.79e-01	2.53e-01	9.22e-01
REGULATION OF NMDA RECEPTOR ACTIVITY	17	4.18e-01	8.58e-01	0.2050	-1.52e-01	-1.83e-02	-6.37e-02	-6.50e-02	1.00e-01	2.77e-01	8.96e-01	6.49e-01	6.43e-01	4.75e-01
NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	7	9.70e-01	9.97e-01	0.2050	8.85e-02	-4.02e-02	1.31e-01	1.12e-01	5.25e-02	6.85e-01	8.54e-01	5.48e-01	6.09e-01	8.10e-01
NEGATIVE REGULATION OF FATTY ACID OXIDATION	14	7.23e-01	9.70e-01	0.2050	-5.99e-02	-1.07e-01	-2.72e-02	-5.09e-02	-1.53e-01	6.98e-01	4.89e-01	8.60e-01	7.42e-01	3.20e-01
REGULATION OF PLATELET ACTIVATION	47	4.60e-01	8.80e-01	0.2040	-6.55e-02	-6.83e-02	-1.23e-01	-1.29e-01	-3.37e-02	4.37e-01	4.18e-01	1.46e-01	1.25e-01	6.89e-01
PEPTIDE BIOSYNTHETIC PROCESS	806	5.21e-17	1.51e-14	0.2040	7.87e-02	-3.07e-02	1.31e-01	1.32e-01	2.75e-03	1.45e-04	1.38e-01	2.67e-10	1.58e-10	8.94e-01
POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION	19	8.28e-01	9.83e-01	0.2040	-9.39e-02	-1.23e-01	4.90e-03	-1.29e-02	1.33e-01	4.79e-01	3.55e-01	9.71e-01	9.22e-01	3.14e-01
NODAL SIGNALING PATHWAY	16	8.83e-01	9.91e-01	0.2040	1.43e-01	1.10e-01	5.28e-02	7.61e-02	-2.52e-02	3.21e-01	4.47e-01	7.14e-01	5.98e-01	8.62e-01
RESPONSE TO HISTAMINE	11	5.80e-01	9.27e-01	0.2040	1.17e-01	2.67e-02	2.35e-03	5.53e-03	1.65e-01	5.01e-01	8.78e-01	9.89e-01	9.75e-01	3.43e-01
RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES	15	3.53e-01	8.21e-01	0.2040	7.74e-02	-6.78e-02	8.98e-02	4.49e-02	1.45e-01	6.04e-01	6.50e-01	5.47e-01	7.64e-01	3.30e-01
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	58	1.12e-01	5.37e-01	0.2040	-4.91e-02	-1.35e-01	5.94e-02	6.55e-02	1.15e-01	5.18e-01	7.44e-02	4.34e-01	3.88e-01	1.31e-01
RESPONSE TO AUDITORY STIMULUS	31	4.09e-01	8.52e-01	0.2040	5.76e-02	1.88e-01	-1.95e-02	2.67e-03	-5.14e-02	5.79e-01	7.03e-02	8.51e-01	9.79e-01	6.20e-01
RESPONSE TO STEROL	35	7.51e-02	4.40e-01	0.2040	2.96e-02	4.19e-02	-1.48e-01	-1.24e-01	-4.28e-02	7.62e-01	6.68e-01	1.31e-01	2.05e-01	6.61e-01
LUNG ASSOCIATED MESENCHYME DEVELOPMENT	8	9.72e-01	9.97e-01	0.2040	-2.17e-03	6.50e-02	-8.85e-02	-9.20e-02	-1.45e-01	9.92e-01	7.50e-01	6.65e-01	6.52e-01	4.77e-01
AUTOCRINE SIGNALING	7	8.06e-02	4.54e-01	0.2040	2.28e-03	-1.28e-01	4.76e-02	1.47e-01	3.70e-02	9.92e-01	5.57e-01	8.27e-01	5.02e-01	8.65e-01
POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS	34	1.13e-01	5.37e-01	0.2040	-4.05e-02	-1.88e-01	2.58e-02	-1.16e-02	6.04e-02	6.83e-01	5.74e-02	7.95e-01	9.07e-01	5.42e-01
RESPONSE TO PROGESTERONE	40	4.42e-01	8.72e-01	0.2040	-6.38e-02	-1.59e-01	-1.74e-02	-1.95e-02	1.07e-01	4.85e-01	8.16e-02	8.49e-01	8.31e-01	2.42e-01
VESICLE TARGETING TO FROM OR WITHIN GOLGI	32	5.18e-01	9.03e-01	0.2040	8.02e-02	-2.97e-02	1.30e-01	1.28e-01	-3.12e-02	4.32e-01	7.71e-01	2.04e-01	2.10e-01	7.60e-01
CELL SUBSTRATE JUNCTION ORGANIZATION	100	3.27e-01	7.99e-01	0.2040	-1.12e-01	-8.73e-02	-9.45e-02	-1.10e-01	-9.78e-03	5.20e-02	1.32e-01	1.02e-01	5.62e-02	8.66e-01
RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	28	6.06e-01	9.34e-01	0.2040	-5.08e-02	-7.02e-02	-5.87e-02	-6.80e-02	-1.61e-01	6.42e-01	5.20e-01	5.91e-01	5.33e-01	1.41e-01
SPHINGOID METABOLIC PROCESS	22	9.39e-01	9.97e-01	0.2040	-1.19e-01	-1.15e-01	-8.34e-02	-8.03e-02	-2.56e-02	3.33e-01	3.52e-01	4.98e-01	5.14e-01	8.35e-01
PROTEIN SULFATION	6	3.90e-01	8.40e-01	0.2030	-3.74e-02	1.25e-01	4.67e-02	-2.22e-02	-1.47e-01	8.74e-01	5.95e-01	8.43e-01	9.25e-01	5.33e-01
STEROID CATABOLIC PROCESS	24	8.72e-01	9.88e-01	0.2030	-1.16e-01	-1.09e-01	-6.44e-02	-7.37e-02	8.11e-02	3.26e-01	3.57e-01	5.85e-01	5.32e-01	4.92e-01
REELIN MEDIATED SIGNALING PATHWAY	7	9.79e-01	9.97e-01	0.2030	-8.29e-02	-1.38e-01	-6.23e-02	-7.97e-02	7.25e-02	7.04e-01	5.28e-01	7.75e-01	7.15e-01	7.40e-01
ERBB3 SIGNALING PATHWAY	5	9.79e-01	9.97e-01	0.2030	-1.28e-01	-5.44e-02	-1.08e-01	-8.41e-02	-5.61e-02	6.20e-01	8.33e-01	6.74e-01	7.45e-01	8.28e-01
NOREPINEPHRINE METABOLIC PROCESS	12	8.89e-01	9.91e-01	0.2030	-3.08e-03	-4.60e-02	2.24e-02	2.69e-02	1.95e-01	9.85e-01	7.82e-01	8.93e-01	8.72e-01	2.43e-01
REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	35	3.03e-01	7.75e-01	0.2030	-9.77e-02	-9.52e-02	3.28e-02	9.68e-03	1.47e-01	3.17e-01	3.30e-01	7.37e-01	9.21e-01	1.33e-01
TETRAPYRROLE CATABOLIC PROCESS	13	7.44e-01	9.74e-01	0.2030	1.14e-01	1.09e-01	5.01e-02	9.38e-02	-7.01e-02	4.75e-01	4.95e-01	7.55e-01	5.58e-01	6.62e-01
POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION	10	6.84e-01	9.61e-01	0.2030	-2.45e-03	5.15e-02	-4.62e-03	-3.47e-02	1.93e-01	9.89e-01	7.78e-01	9.80e-01	8.49e-01	2.90e-01
REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION	8	9.08e-01	9.94e-01	0.2030	-6.56e-02	2.45e-02	-6.08e-02	-3.82e-02	-1.77e-01	7.48e-01	9.04e-01	7.66e-01	8.52e-01	3.87e-01
POSITIVE REGULATION OF FEVER GENERATION	7	9.32e-01	9.97e-01	0.2030	-6.96e-02	-1.64e-01	-6.15e-02	-4.33e-02	6.04e-02	7.50e-01	4.51e-01	7.78e-01	8.43e-01	7.82e-01
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	48	6.71e-01	9.57e-01	0.2030	-8.16e-02	-1.37e-02	-1.20e-01	-1.05e-01	-9.47e-02	3.28e-01	8.70e-01	1.50e-01	2.10e-01	2.56e-01
FOREBRAIN MORPHOGENESIS	13	7.77e-01	9.79e-01	0.2030	-6.49e-02	-1.86e-01	2.99e-02	1.32e-02	-3.59e-02	6.85e-01	2.45e-01	8.52e-01	9.34e-01	8.23e-01
T CELL TOLERANCE INDUCTION	14	4.03e-01	8.48e-01	0.2030	2.48e-02	1.31e-01	1.19e-01	8.56e-02	4.23e-02	8.73e-01	3.95e-01	4.42e-01	5.79e-01	7.84e-01
NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	8	7.91e-01	9.81e-01	0.2030	-7.72e-02	1.25e-01	-8.22e-02	-1.00e-01	-5.06e-02	7.06e-01	5.39e-01	6.87e-01	6.24e-01	8.04e-01
REGULATION OF TETRAPYRROLE METABOLIC PROCESS	8	9.48e-01	9.97e-01	0.2020	-1.38e-01	-1.03e-01	-5.64e-02	-9.08e-02	7.62e-03	5.00e-01	6.14e-01	7.82e-01	6.57e-01	9.70e-01
HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT	98	1.07e-01	5.25e-01	0.2020	7.03e-02	-3.80e-02	1.30e-01	1.13e-01	7.10e-02	2.29e-01	5.16e-01	2.65e-02	5.36e-02	2.25e-01
DUMP METABOLIC PROCESS	7	8.45e-01	9.86e-01	0.2020	-2.53e-02	-1.33e-01	-9.20e-02	-7.86e-02	8.94e-02	9.08e-01	5.42e-01	6.74e-01	7.19e-01	6.82e-01
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	28	8.80e-01	9.89e-01	0.2020	9.03e-02	-1.00e-02	1.18e-01	1.15e-01	7.47e-02	4.08e-01	9.27e-01	2.79e-01	2.93e-01	4.94e-01
ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT	15	9.25e-01	9.95e-01	0.2020	9.39e-02	1.46e-01	1.41e-02	3.19e-02	-9.80e-02	5.29e-01	3.28e-01	9.25e-01	8.31e-01	5.11e-01
TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION	10	8.37e-01	9.85e-01	0.2020	-3.09e-02	-7.14e-02	-6.44e-02	-7.51e-02	1.58e-01	8.66e-01	6.96e-01	7.24e-01	6.81e-01	3.86e-01
REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	18	3.29e-01	8.02e-01	0.2020	2.47e-03	4.96e-02	6.28e-02	9.25e-02	1.61e-01	9.86e-01	7.15e-01	6.45e-01	4.97e-01	2.37e-01
CELLULAR RESPONSE TO CAFFEINE	11	7.96e-01	9.81e-01	0.2020	6.94e-02	1.35e-02	7.64e-02	6.32e-02	-1.61e-01	6.90e-01	9.38e-01	6.61e-01	7.16e-01	3.54e-01
REGULATION OF PROTEIN STABILITY	305	2.18e-06	1.41e-04	0.2020	6.51e-02	-6.28e-02	1.27e-01	1.24e-01	3.32e-02	5.07e-02	5.92e-02	1.33e-04	1.89e-04	3.18e-01
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS	158	8.60e-03	1.16e-01	0.2020	7.75e-02	-2.70e-02	1.34e-01	1.27e-01	1.21e-02	9.28e-02	5.58e-01	3.67e-03	5.95e-03	7.93e-01
ACYLGLYCEROL HOMEOSTASIS	42	6.80e-03	1.00e-01	0.2020	-1.45e-01	-1.13e-02	-1.12e-01	-7.16e-02	-4.51e-02	1.04e-01	8.99e-01	2.10e-01	4.22e-01	6.13e-01
REGULATION OF PRESYNAPSE ORGANIZATION	28	6.64e-01	9.54e-01	0.2020	-6.26e-02	-1.36e-01	-3.02e-02	-3.89e-02	1.27e-01	5.67e-01	2.14e-01	7.82e-01	7.22e-01	2.45e-01
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	40	1.22e-01	5.58e-01	0.2020	1.56e-03	2.95e-02	7.28e-03	2.34e-02	1.98e-01	9.86e-01	7.46e-01	9.36e-01	7.98e-01	2.98e-02
REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT	10	3.88e-01	8.40e-01	0.2020	7.21e-02	4.85e-02	4.18e-02	-8.17e-03	-1.77e-01	6.93e-01	7.90e-01	8.19e-01	9.64e-01	3.31e-01
COLLAGEN METABOLIC PROCESS	103	1.38e-01	5.91e-01	0.2020	-1.25e-01	-9.95e-02	-8.96e-02	-8.11e-02	2.85e-02	2.90e-02	8.10e-02	1.16e-01	1.55e-01	6.18e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	8	3.39e-01	8.08e-01	0.2020	8.38e-03	-1.30e-01	-5.53e-02	-1.08e-01	9.64e-02	9.67e-01	5.26e-01	7.86e-01	5.98e-01	6.37e-01
L ASPARTATE TRANSMEMBRANE TRANSPORT	11	8.51e-01	9.88e-01	0.2020	1.31e-01	4.85e-02	8.39e-02	1.19e-01	-1.06e-02	4.53e-01	7.81e-01	6.30e-01	4.94e-01	9.52e-01
NCRNA CATABOLIC PROCESS	54	2.45e-02	2.32e-01	0.2020	9.19e-02	-5.06e-02	1.23e-01	1.03e-01	-6.38e-02	2.43e-01	5.20e-01	1.18e-01	1.90e-01	4.17e-01
RENAL SYSTEM VASCULATURE MORPHOGENESIS	8	7.37e-01	9.73e-01	0.2020	-7.38e-02	-2.70e-02	-9.95e-02	-1.45e-01	5.92e-02	7.18e-01	8.95e-01	6.26e-01	4.77e-01	7.72e-01
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS	102	2.20e-01	7.00e-01	0.2020	7.28e-02	-1.01e-02	1.21e-01	1.06e-01	9.63e-02	2.04e-01	8.60e-01	3.42e-02	6.35e-02	9.29e-02
POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	14	3.07e-01	7.80e-01	0.2020	5.01e-02	1.52e-01	-1.11e-01	-5.11e-02	-1.56e-02	7.45e-01	3.26e-01	4.72e-01	7.40e-01	9.19e-01
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION	18	7.63e-01	9.75e-01	0.2020	8.45e-02	6.77e-02	1.00e-01	8.69e-02	-1.07e-01	5.35e-01	6.19e-01	4.62e-01	5.23e-01	4.34e-01
MEMBRANE PROTEIN PROTEOLYSIS	56	1.67e-01	6.34e-01	0.2020	-7.61e-02	-5.74e-02	-6.60e-02	-7.43e-02	1.47e-01	3.25e-01	4.57e-01	3.93e-01	3.36e-01	5.67e-02
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	5	9.97e-01	1.00e+00	0.2020	-1.12e-01	-9.98e-02	-8.33e-02	-1.03e-01	-2.38e-02	6.64e-01	6.99e-01	7.47e-01	6.90e-01	9.26e-01
INTERMEDIATE FILAMENT ORGANIZATION	72	5.66e-06	3.33e-04	0.2020	2.51e-02	1.81e-01	-7.80e-02	-2.37e-02	2.35e-02	7.12e-01	7.87e-03	2.52e-01	7.28e-01	7.30e-01
SPONTANEOUS NEUROTRANSMITTER SECRETION	8	5.48e-01	9.15e-01	0.2010	-9.04e-02	7.64e-02	2.22e-02	3.73e-03	1.62e-01	6.58e-01	7.08e-01	9.13e-01	9.85e-01	4.29e-01
POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY	26	6.77e-01	9.59e-01	0.2010	-1.29e-01	-6.21e-02	-1.09e-01	-9.01e-02	-1.18e-02	2.55e-01	5.84e-01	3.36e-01	4.27e-01	9.17e-01
REGULATION OF MEMBRANE REPOLARIZATION	36	5.11e-01	9.00e-01	0.2010	-1.02e-01	2.81e-02	-1.25e-01	-1.17e-01	-1.43e-02	2.89e-01	7.71e-01	1.96e-01	2.25e-01	8.82e-01
STEROL TRANSPORT	141	2.29e-02	2.22e-01	0.2010	-1.09e-01	-5.10e-02	-1.22e-01	-1.04e-01	-1.31e-02	2.52e-02	2.96e-01	1.20e-02	3.27e-02	7.88e-01
PROTEIN KINASE C SIGNALING	35	5.95e-01	9.33e-01	0.2010	-2.50e-02	8.35e-02	-7.96e-02	-6.47e-02	-1.50e-01	7.98e-01	3.93e-01	4.15e-01	5.08e-01	1.25e-01
EMBRYONIC PLACENTA DEVELOPMENT	86	2.99e-01	7.73e-01	0.2010	6.12e-02	-2.08e-02	1.16e-01	1.01e-01	1.12e-01	3.27e-01	7.38e-01	6.21e-02	1.05e-01	7.24e-02
REGULATION OF IMMUNOGLOBULIN PRODUCTION	72	1.20e-01	5.53e-01	0.2010	6.26e-02	-2.56e-02	1.20e-01	1.36e-01	5.47e-02	3.59e-01	7.07e-01	7.84e-02	4.55e-02	4.22e-01
NADH OXIDATION	6	9.81e-01	9.97e-01	0.2010	1.20e-01	1.54e-01	1.46e-02	3.11e-02	3.44e-02	6.11e-01	5.13e-01	9.51e-01	8.95e-01	8.84e-01
REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	21	5.20e-01	9.03e-01	0.2010	2.40e-02	8.93e-02	9.47e-02	7.66e-02	1.31e-01	8.49e-01	4.79e-01	4.52e-01	5.43e-01	2.99e-01
SHORT CHAIN FATTY ACID METABOLIC PROCESS	16	9.17e-01	9.95e-01	0.2010	5.00e-04	-6.95e-02	7.93e-02	6.57e-02	1.58e-01	9.97e-01	6.30e-01	5.83e-01	6.49e-01	2.73e-01
VESICLE DOCKING INVOLVED IN EXOCYTOSIS	42	3.26e-01	7.98e-01	0.2010	7.40e-02	4.30e-02	1.04e-01	1.02e-01	-1.10e-01	4.07e-01	6.30e-01	2.45e-01	2.54e-01	2.19e-01
DIACYLGLYCEROL BIOSYNTHETIC PROCESS	9	7.12e-01	9.67e-01	0.2010	9.46e-02	1.50e-01	-8.47e-02	-4.10e-02	3.37e-03	6.23e-01	4.35e-01	6.60e-01	8.31e-01	9.86e-01
MESONEPHRIC DUCT DEVELOPMENT	8	9.24e-01	9.95e-01	0.2010	-1.08e-01	-1.06e-01	-5.58e-02	-9.42e-02	7.45e-02	5.96e-01	6.04e-01	7.85e-01	6.44e-01	7.15e-01
ERROR FREE TRANSLESION SYNTHESIS	5	9.01e-01	9.94e-01	0.2010	1.36e-01	1.27e-03	7.08e-02	5.95e-02	-1.16e-01	5.99e-01	9.96e-01	7.84e-01	8.18e-01	6.54e-01
ENUCLEATE ERYTHROCYTE DIFFERENTIATION	10	7.27e-01	9.71e-01	0.2010	-2.50e-02	-1.97e-01	-2.14e-02	-1.78e-02	-1.66e-02	8.91e-01	2.81e-01	9.07e-01	9.22e-01	9.27e-01
POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	10	8.73e-01	9.88e-01	0.2010	6.53e-02	1.13e-01	1.02e-01	8.28e-02	-7.79e-02	7.20e-01	5.36e-01	5.77e-01	6.50e-01	6.70e-01
VASCULAR WOUND HEALING	22	9.53e-02	4.92e-01	0.2010	4.58e-02	-1.13e-01	8.53e-02	1.29e-01	3.80e-02	7.10e-01	3.57e-01	4.88e-01	2.95e-01	7.57e-01
REGULATION OF NEURON PROJECTION REGENERATION	29	7.37e-01	9.73e-01	0.2010	-3.54e-02	-1.63e-02	-1.13e-01	-9.71e-02	-1.29e-01	7.41e-01	8.80e-01	2.91e-01	3.65e-01	2.30e-01
T CELL LINEAGE COMMITMENT	31	6.84e-01	9.61e-01	0.2010	8.76e-02	1.32e-01	7.31e-02	6.47e-02	7.61e-02	3.99e-01	2.04e-01	4.81e-01	5.33e-01	4.64e-01
AMINO SUGAR BIOSYNTHETIC PROCESS	11	8.04e-01	9.82e-01	0.2010	-3.23e-02	3.72e-02	-1.13e-01	-1.39e-01	-7.59e-02	8.53e-01	8.31e-01	5.16e-01	4.25e-01	6.63e-01
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS	93	1.45e-01	6.03e-01	0.2010	-1.24e-01	-1.30e-01	-4.86e-02	-5.33e-02	-5.20e-02	3.81e-02	3.01e-02	4.18e-01	3.74e-01	3.86e-01
POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	5	9.29e-01	9.95e-01	0.2010	4.02e-02	1.36e-01	-9.80e-02	-7.67e-02	6.88e-02	8.76e-01	5.99e-01	7.04e-01	7.67e-01	7.90e-01
TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	105	1.77e-01	6.47e-01	0.2010	8.28e-02	8.65e-02	1.01e-01	1.14e-01	5.40e-02	1.43e-01	1.26e-01	7.51e-02	4.38e-02	3.39e-01
POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	146	2.69e-03	5.14e-02	0.2010	5.06e-02	-9.74e-02	1.10e-01	1.00e-01	7.84e-02	2.91e-01	4.22e-02	2.18e-02	3.69e-02	1.02e-01
L SERINE METABOLIC PROCESS	12	8.71e-01	9.88e-01	0.2010	8.78e-02	7.07e-02	6.00e-02	4.31e-02	1.49e-01	5.98e-01	6.72e-01	7.19e-01	7.96e-01	3.72e-01
REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	28	6.56e-01	9.53e-01	0.2010	1.89e-02	-6.03e-02	6.86e-02	4.87e-02	1.71e-01	8.63e-01	5.81e-01	5.30e-01	6.56e-01	1.18e-01
NUCLEOTIDE TRANSPORT	40	5.09e-01	9.00e-01	0.2010	-3.88e-02	-4.37e-03	-7.07e-02	-8.10e-02	-1.65e-01	6.71e-01	9.62e-01	4.39e-01	3.75e-01	7.13e-02
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	52	2.69e-01	7.50e-01	0.2000	-7.74e-02	-1.65e-01	-4.72e-02	-5.04e-02	-4.69e-02	3.35e-01	3.95e-02	5.56e-01	5.29e-01	5.59e-01
B CELL HOMEOSTASIS	31	6.56e-01	9.53e-01	0.2000	-8.63e-02	-1.75e-01	-2.25e-02	-3.62e-02	2.11e-02	4.06e-01	9.25e-02	8.29e-01	7.27e-01	8.39e-01
DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	6	9.36e-01	9.97e-01	0.2000	-6.44e-02	-1.48e-01	2.30e-02	1.31e-02	-1.15e-01	7.85e-01	5.29e-01	9.22e-01	9.56e-01	6.25e-01
POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	7	9.75e-01	9.97e-01	0.2000	-7.38e-02	-1.40e-01	-7.96e-02	-9.37e-02	-1.95e-03	7.35e-01	5.21e-01	7.15e-01	6.68e-01	9.93e-01
REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION	5	9.68e-01	9.97e-01	0.2000	1.39e-01	1.12e-01	7.57e-02	5.28e-02	-4.13e-04	5.92e-01	6.66e-01	7.70e-01	8.38e-01	9.99e-01
ENDOPLASMIC RETICULUM LOCALIZATION	10	8.32e-01	9.85e-01	0.2000	7.83e-02	4.70e-02	7.19e-02	1.03e-01	-1.27e-01	6.68e-01	7.97e-01	6.94e-01	5.74e-01	4.87e-01
NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY	15	8.74e-01	9.88e-01	0.2000	6.22e-03	-7.34e-02	1.27e-01	1.16e-01	7.23e-02	9.67e-01	6.23e-01	3.96e-01	4.37e-01	6.28e-01
NEUTRAL LIPID BIOSYNTHETIC PROCESS	46	7.08e-01	9.65e-01	0.2000	-9.38e-02	-8.48e-02	-1.11e-01	-9.83e-02	-4.70e-02	2.71e-01	3.20e-01	1.94e-01	2.49e-01	5.81e-01
VERY LONG CHAIN FATTY ACID METABOLIC PROCESS	34	8.93e-01	9.92e-01	0.2000	9.99e-02	4.61e-02	1.08e-01	1.01e-01	7.83e-02	3.13e-01	6.41e-01	2.74e-01	3.10e-01	4.30e-01
BASE CONVERSION OR SUBSTITUTION EDITING	19	4.06e-01	8.50e-01	0.2000	-9.00e-03	1.80e-01	-6.99e-02	-5.04e-02	-1.11e-02	9.46e-01	1.74e-01	5.98e-01	7.04e-01	9.33e-01
RESPONSE TO HEAT	99	3.70e-01	8.31e-01	0.2000	1.21e-01	7.17e-02	9.26e-02	1.06e-01	2.40e-02	3.81e-02	2.18e-01	1.11e-01	6.88e-02	6.80e-01
REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	262	8.99e-05	3.49e-03	0.2000	5.25e-02	-7.64e-02	1.18e-01	1.08e-01	7.68e-02	1.44e-01	3.33e-02	1.05e-03	2.55e-03	3.24e-02
NEGATIVE REGULATION OF FAT CELL PROLIFERATION	5	5.30e-01	9.07e-01	0.2000	-3.04e-02	5.48e-02	-3.67e-02	3.32e-02	1.83e-01	9.06e-01	8.32e-01	8.87e-01	8.98e-01	4.78e-01
INTERLEUKIN 12 PRODUCTION	62	3.08e-02	2.64e-01	0.2000	-1.02e-01	-3.29e-02	-3.21e-02	-4.51e-02	1.59e-01	1.63e-01	6.54e-01	6.62e-01	5.39e-01	3.01e-02
NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	14	7.11e-01	9.67e-01	0.2000	-4.47e-02	-1.74e-01	-5.82e-02	-5.30e-02	3.86e-02	7.72e-01	2.59e-01	7.06e-01	7.32e-01	8.03e-01
SUCKLING BEHAVIOR	12	6.71e-01	9.57e-01	0.2000	1.58e-02	-1.60e-01	7.89e-02	8.37e-02	-2.99e-02	9.25e-01	3.37e-01	6.36e-01	6.16e-01	8.58e-01
REGULATION OF RELAXATION OF MUSCLE	14	5.05e-01	8.99e-01	0.2000	1.10e-01	1.46e-01	-5.36e-02	-5.99e-02	1.54e-02	4.78e-01	3.45e-01	7.28e-01	6.98e-01	9.21e-01
REGULATION OF FIBROBLAST PROLIFERATION	87	4.68e-02	3.38e-01	0.2000	9.63e-02	-4.93e-02	1.19e-01	1.15e-01	2.91e-02	1.20e-01	4.27e-01	5.60e-02	6.32e-02	6.39e-01
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL	141	2.98e-02	2.60e-01	0.2000	-1.20e-01	-1.97e-02	-1.09e-01	-1.16e-01	1.44e-03	1.41e-02	6.86e-01	2.61e-02	1.78e-02	9.77e-01
NEGATIVE REGULATION OF CELL DIVISION	17	6.34e-01	9.48e-01	0.2000	8.37e-02	2.77e-02	6.43e-03	1.84e-02	-1.78e-01	5.50e-01	8.43e-01	9.63e-01	8.95e-01	2.04e-01
POSITIVE REGULATION OF VASCULAR PERMEABILITY	18	7.03e-01	9.65e-01	0.1990	-1.12e-01	-1.34e-01	-3.68e-02	-2.07e-02	8.52e-02	4.09e-01	3.23e-01	7.87e-01	8.79e-01	5.31e-01
REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS	7	2.40e-01	7.24e-01	0.1990	5.74e-02	6.29e-02	-3.91e-02	5.76e-02	-1.66e-01	7.93e-01	7.73e-01	8.58e-01	7.92e-01	4.46e-01
NEGATIVE REGULATION OF ANOIKIS	18	6.80e-01	9.61e-01	0.1990	1.58e-01	1.08e-01	3.90e-02	4.08e-02	-1.06e-02	2.47e-01	4.28e-01	7.75e-01	7.64e-01	9.38e-01
METHYLGUANOSINE CAP DECAPPING	16	6.47e-01	9.51e-01	0.1990	7.75e-02	-4.83e-02	1.39e-01	1.04e-01	3.76e-02	5.91e-01	7.38e-01	3.37e-01	4.73e-01	7.95e-01
CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	11	7.39e-01	9.73e-01	0.1990	1.11e-01	-7.47e-02	9.73e-02	1.10e-01	1.25e-02	5.22e-01	6.68e-01	5.76e-01	5.28e-01	9.43e-01
NEUROTROPHIN SIGNALING PATHWAY	38	6.65e-01	9.54e-01	0.1990	8.15e-02	5.05e-02	1.23e-01	1.20e-01	-3.38e-02	3.84e-01	5.90e-01	1.91e-01	2.02e-01	7.19e-01
PURINE NUCLEOSIDE CATABOLIC PROCESS	8	8.26e-01	9.83e-01	0.1990	1.12e-02	-9.65e-02	3.81e-02	6.97e-02	1.55e-01	9.56e-01	6.37e-01	8.52e-01	7.33e-01	4.49e-01
NEUROTRANSMITTER RECEPTOR INTERNALIZATION	30	7.59e-01	9.75e-01	0.1990	1.13e-01	1.16e-01	6.06e-02	5.79e-02	8.07e-02	2.85e-01	2.72e-01	5.66e-01	5.83e-01	4.44e-01
RESPONSE TO ZINC ION	48	3.53e-01	8.21e-01	0.1990	-4.90e-02	-1.08e-01	8.91e-03	9.64e-03	1.60e-01	5.57e-01	1.97e-01	9.15e-01	9.08e-01	5.56e-02
MESODERMAL CELL FATE SPECIFICATION	12	3.29e-01	8.02e-01	0.1990	1.44e-01	-5.36e-02	9.54e-02	6.25e-02	5.45e-02	3.87e-01	7.48e-01	5.67e-01	7.08e-01	7.44e-01
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE	193	1.76e-02	1.88e-01	0.1990	-9.31e-02	-6.77e-02	-1.21e-01	-1.08e-01	-1.03e-02	2.58e-02	1.05e-01	3.71e-03	9.85e-03	8.05e-01
REGULATION OF PHOSPHOLIPID TRANSPORT	15	1.43e-01	6.00e-01	0.1990	-8.34e-02	-7.64e-02	6.70e-02	1.04e-01	1.08e-01	5.76e-01	6.08e-01	6.53e-01	4.86e-01	4.71e-01
REGULATION OF GASTRULATION	16	2.57e-01	7.40e-01	0.1990	9.57e-02	-5.91e-03	-2.90e-02	-3.76e-02	-1.68e-01	5.07e-01	9.67e-01	8.41e-01	7.95e-01	2.45e-01
SULFUR AMINO ACID CATABOLIC PROCESS	10	1.62e-01	6.26e-01	0.1990	-2.60e-02	1.65e-01	-3.33e-02	3.49e-02	-9.65e-02	8.87e-01	3.66e-01	8.55e-01	8.48e-01	5.97e-01
DITERPENOID BIOSYNTHETIC PROCESS	10	4.84e-01	8.91e-01	0.1990	-9.19e-03	-1.46e-01	-4.41e-02	-7.92e-02	-1.00e-01	9.60e-01	4.25e-01	8.09e-01	6.65e-01	5.84e-01
HAIR CYCLE PHASE	9	3.47e-02	2.82e-01	0.1990	-1.19e-01	-7.43e-02	1.80e-02	-9.38e-02	-1.03e-01	5.35e-01	6.99e-01	9.26e-01	6.26e-01	5.92e-01
TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	55	5.54e-01	9.17e-01	0.1990	-1.07e-01	-1.36e-01	-5.80e-02	-7.69e-02	1.71e-02	1.71e-01	8.04e-02	4.57e-01	3.24e-01	8.26e-01
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND	15	7.97e-01	9.81e-01	0.1990	-1.83e-02	9.78e-02	-3.16e-02	-2.37e-02	-1.68e-01	9.02e-01	5.12e-01	8.32e-01	8.74e-01	2.61e-01
CELLULAR SENESCENCE	106	2.54e-02	2.37e-01	0.1990	1.60e-02	-1.17e-01	8.83e-02	7.16e-02	1.12e-01	7.76e-01	3.72e-02	1.16e-01	2.03e-01	4.56e-02
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	7	9.52e-01	9.97e-01	0.1990	-9.14e-02	-1.71e-01	1.69e-02	6.87e-03	-4.02e-02	6.75e-01	4.34e-01	9.38e-01	9.75e-01	8.54e-01
HAIR FOLLICLE MATURATION	15	7.72e-02	4.49e-01	0.1990	-1.08e-01	-1.21e-02	-6.74e-02	-1.43e-01	-5.22e-02	4.69e-01	9.35e-01	6.52e-01	3.38e-01	7.26e-01
POSTREPLICATION REPAIR	33	4.07e-01	8.51e-01	0.1990	2.92e-02	-1.14e-01	1.11e-01	1.10e-01	3.29e-02	7.72e-01	2.56e-01	2.69e-01	2.74e-01	7.44e-01
RNA LOCALIZATION	183	4.07e-02	3.08e-01	0.1990	9.53e-02	3.27e-03	1.23e-01	1.18e-01	3.66e-02	2.61e-02	9.39e-01	4.14e-03	5.85e-03	3.93e-01
REGULATION OF FATTY ACID METABOLIC PROCESS	95	1.80e-01	6.52e-01	0.1990	-4.50e-02	-3.77e-02	-1.08e-01	-1.04e-01	-1.16e-01	4.48e-01	5.25e-01	6.81e-02	7.90e-02	5.10e-02
PROSTAGLANDIN TRANSPORT	28	3.19e-02	2.70e-01	0.1990	-2.13e-02	6.48e-02	-1.50e-01	-9.63e-02	5.48e-02	8.46e-01	5.53e-01	1.70e-01	3.78e-01	6.16e-01
RESPONSE TO ACETYLCHOLINE	36	4.23e-01	8.61e-01	0.1990	-8.17e-02	-5.12e-03	-1.17e-01	-1.34e-01	3.24e-02	3.96e-01	9.58e-01	2.26e-01	1.63e-01	7.37e-01
MONOCYTE DIFFERENTIATION	34	7.50e-01	9.75e-01	0.1990	1.22e-01	1.07e-01	6.86e-02	6.55e-02	6.33e-02	2.17e-01	2.81e-01	4.89e-01	5.09e-01	5.23e-01
REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	15	8.71e-01	9.88e-01	0.1980	7.79e-02	7.35e-02	6.54e-02	6.60e-02	-1.39e-01	6.01e-01	6.22e-01	6.61e-01	6.58e-01	3.52e-01
DORSAL ROOT GANGLION DEVELOPMENT	7	8.78e-01	9.88e-01	0.1980	-1.03e-01	-7.18e-02	-7.55e-02	-1.21e-01	5.60e-02	6.36e-01	7.42e-01	7.30e-01	5.78e-01	7.98e-01
POSITIVE REGULATION OF MAP KINASE ACTIVITY	86	2.39e-01	7.24e-01	0.1980	-8.19e-02	-1.10e-01	-1.04e-01	-9.78e-02	-1.27e-02	1.89e-01	7.86e-02	9.42e-02	1.17e-01	8.39e-01
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	18	3.39e-01	8.09e-01	0.1980	6.58e-02	1.03e-01	-5.22e-02	-2.22e-02	1.46e-01	6.29e-01	4.51e-01	7.01e-01	8.70e-01	2.84e-01
DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY	54	3.14e-01	7.86e-01	0.1980	1.13e-02	-6.26e-02	1.07e-01	8.25e-02	1.30e-01	8.86e-01	4.26e-01	1.72e-01	2.94e-01	9.82e-02
DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY	5	7.01e-01	9.63e-01	0.1980	3.56e-02	3.62e-02	-2.82e-02	-7.92e-02	1.72e-01	8.90e-01	8.89e-01	9.13e-01	7.59e-01	5.05e-01
ALDEHYDE BIOSYNTHETIC PROCESS	16	7.27e-01	9.71e-01	0.1980	-1.40e-01	-1.12e-01	-6.23e-02	-4.51e-02	3.65e-02	3.33e-01	4.40e-01	6.66e-01	7.55e-01	8.01e-01
ANGIOTENSIN ACTIVATED SIGNALING PATHWAY	18	3.90e-01	8.40e-01	0.1980	-2.82e-02	-3.47e-02	-1.46e-01	-1.14e-01	5.49e-02	8.36e-01	7.99e-01	2.85e-01	4.02e-01	6.87e-01
REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	20	7.00e-01	9.63e-01	0.1980	6.25e-03	-6.07e-02	1.29e-01	9.90e-02	9.50e-02	9.61e-01	6.39e-01	3.17e-01	4.43e-01	4.62e-01
PHOSPHATE ION TRANSPORT	28	6.58e-01	9.54e-01	0.1980	8.44e-02	1.68e-01	3.27e-02	3.61e-02	3.86e-02	4.39e-01	1.24e-01	7.65e-01	7.41e-01	7.24e-01
FIBROBLAST PROLIFERATION	104	2.01e-02	2.04e-01	0.1980	9.55e-02	-4.93e-02	1.18e-01	1.13e-01	2.97e-02	9.25e-02	3.85e-01	3.72e-02	4.68e-02	6.00e-01
OVARIAN FOLLICLE DEVELOPMENT	54	6.25e-02	3.99e-01	0.1980	-7.32e-02	-1.74e-01	-1.73e-02	-4.84e-02	-2.60e-02	3.52e-01	2.65e-02	8.26e-01	5.38e-01	7.41e-01
PROTEASOMAL PROTEIN CATABOLIC PROCESS	509	1.99e-10	2.83e-08	0.1980	8.60e-02	-4.65e-02	1.21e-01	1.10e-01	5.30e-02	8.87e-04	7.22e-02	2.93e-06	2.17e-05	4.05e-02
VIRAL GENE EXPRESSION	99	1.08e-01	5.26e-01	0.1980	6.97e-02	-1.71e-02	1.35e-01	1.16e-01	4.98e-02	2.31e-01	7.69e-01	2.07e-02	4.67e-02	3.92e-01
LUNG ALVEOLUS DEVELOPMENT	47	4.89e-01	8.92e-01	0.1980	-6.50e-02	-8.48e-02	-9.86e-02	-1.10e-01	-7.66e-02	4.41e-01	3.15e-01	2.42e-01	1.92e-01	3.63e-01
SYNAPTIC VESICLE LOCALIZATION	53	5.74e-01	9.26e-01	0.1980	3.42e-02	-2.34e-02	9.56e-02	8.43e-02	1.45e-01	6.67e-01	7.69e-01	2.29e-01	2.89e-01	6.71e-02
DERMATAN SULFATE METABOLIC PROCESS	8	5.54e-01	9.16e-01	0.1980	1.21e-01	-5.16e-02	9.55e-02	6.01e-02	-9.54e-02	5.54e-01	8.01e-01	6.40e-01	7.68e-01	6.40e-01
NEUROTRANSMITTER BIOSYNTHETIC PROCESS	14	4.68e-01	8.84e-01	0.1980	1.48e-01	9.50e-02	-3.57e-02	-3.55e-03	-8.22e-02	3.37e-01	5.38e-01	8.17e-01	9.82e-01	5.94e-01
ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT	21	6.90e-01	9.61e-01	0.1980	-5.58e-03	-1.51e-01	5.03e-02	4.00e-02	1.09e-01	9.65e-01	2.30e-01	6.90e-01	7.51e-01	3.86e-01
SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION	10	3.97e-01	8.45e-01	0.1980	1.21e-01	-7.48e-02	1.14e-01	6.76e-02	3.68e-02	5.09e-01	6.82e-01	5.33e-01	7.11e-01	8.40e-01
REGULATION OF CELL FATE COMMITMENT	41	2.87e-01	7.66e-01	0.1970	-7.44e-02	-7.96e-02	-6.19e-02	-8.52e-02	1.27e-01	4.10e-01	3.78e-01	4.93e-01	3.45e-01	1.61e-01
PROTEOGLYCAN BIOSYNTHETIC PROCESS	63	3.78e-01	8.36e-01	0.1970	-9.25e-02	-7.25e-02	-8.38e-02	-1.05e-01	-8.46e-02	2.04e-01	3.20e-01	2.50e-01	1.51e-01	2.45e-01
PHOSPHATE ION HOMEOSTASIS	20	8.15e-01	9.82e-01	0.1970	7.61e-02	1.73e-01	-1.49e-02	-4.41e-03	-5.36e-02	5.56e-01	1.80e-01	9.08e-01	9.73e-01	6.78e-01
SYNAPTIC VESICLE LUMEN ACIDIFICATION	14	6.05e-01	9.34e-01	0.1970	1.11e-01	-2.05e-02	1.04e-01	8.54e-02	-8.94e-02	4.72e-01	8.94e-01	4.99e-01	5.80e-01	5.62e-01
CARBOHYDRATE MEDIATED SIGNALING	11	8.82e-01	9.91e-01	0.1970	1.29e-01	8.54e-02	3.27e-02	3.50e-02	-1.12e-01	4.58e-01	6.24e-01	8.51e-01	8.41e-01	5.19e-01
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	67	1.17e-01	5.47e-01	0.1970	2.41e-02	-1.04e-01	5.71e-02	5.86e-02	1.44e-01	7.33e-01	1.40e-01	4.19e-01	4.06e-01	4.14e-02
NEGATIVE REGULATION OF ASTROCYTE ACTIVATION	5	1.86e-01	6.56e-01	0.1970	1.16e-01	9.25e-02	-2.40e-02	9.66e-02	8.27e-02	6.52e-01	7.20e-01	9.26e-01	7.08e-01	7.49e-01
NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS	30	5.39e-01	9.13e-01	0.1970	-9.47e-02	-9.39e-02	-1.14e-01	-8.91e-02	4.42e-03	3.69e-01	3.73e-01	2.78e-01	3.98e-01	9.67e-01
MONOATOMIC ANION TRANSPORT	161	2.42e-03	4.75e-02	0.1970	-8.85e-02	1.73e-02	-1.31e-01	-1.16e-01	3.92e-03	5.25e-02	7.05e-01	4.15e-03	1.08e-02	9.32e-01
DENDRITIC CELL CYTOKINE PRODUCTION	19	3.89e-01	8.40e-01	0.1970	3.80e-03	3.54e-02	-1.28e-01	-1.28e-01	6.91e-02	9.77e-01	7.89e-01	3.34e-01	3.34e-01	6.02e-01
LYMPHANGIOGENESIS	18	9.53e-01	9.97e-01	0.1970	8.97e-02	1.11e-01	9.31e-02	9.88e-02	-1.05e-02	5.10e-01	4.17e-01	4.94e-01	4.68e-01	9.39e-01
BONE MORPHOGENESIS	98	8.49e-02	4.65e-01	0.1970	9.59e-02	-1.09e-02	9.90e-02	8.72e-02	1.10e-01	1.01e-01	8.53e-01	9.04e-02	1.36e-01	6.00e-02
DIGESTIVE SYSTEM PROCESS	102	2.45e-01	7.29e-01	0.1970	-9.59e-02	4.55e-03	-1.10e-01	-1.14e-01	-6.79e-02	9.42e-02	9.37e-01	5.60e-02	4.71e-02	2.36e-01
POSITIVE REGULATION OF CHROMOSOME SEPARATION	29	7.15e-01	9.68e-01	0.1970	9.35e-02	7.57e-02	1.09e-01	9.60e-02	-5.75e-02	3.84e-01	4.80e-01	3.12e-01	3.71e-01	5.92e-01
REGULATION OF RESPIRATORY GASEOUS EXCHANGE	21	7.15e-01	9.68e-01	0.1970	-1.38e-02	-1.20e-02	-1.21e-01	-1.18e-01	-9.89e-02	9.13e-01	9.24e-01	3.37e-01	3.48e-01	4.33e-01
DENDRITE EXTENSION	35	5.09e-01	9.00e-01	0.1970	-8.31e-02	-7.36e-02	-4.12e-02	-5.50e-02	1.47e-01	3.95e-01	4.51e-01	6.74e-01	5.74e-01	1.32e-01
L GLUTAMATE IMPORT	38	5.72e-01	9.26e-01	0.1970	1.19e-01	1.25e-01	3.99e-02	5.91e-02	6.20e-02	2.03e-01	1.84e-01	6.70e-01	5.29e-01	5.08e-01
MAMMARY GLAND DEVELOPMENT	126	5.09e-03	8.25e-02	0.1970	-5.37e-02	-1.48e-01	-1.87e-02	-3.64e-02	1.11e-01	2.98e-01	4.19e-03	7.17e-01	4.80e-01	3.15e-02
POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	20	3.93e-01	8.42e-01	0.1970	-3.63e-02	-1.53e-01	-9.08e-02	-7.44e-02	9.52e-03	7.79e-01	2.36e-01	4.82e-01	5.65e-01	9.41e-01
POSITIVE CHEMOTAXIS	63	2.10e-01	6.87e-01	0.1970	-6.93e-02	-8.91e-02	-4.53e-02	-5.10e-02	1.46e-01	3.41e-01	2.21e-01	5.34e-01	4.84e-01	4.55e-02
REGULATION OF PHAGOCYTOSIS	96	1.33e-02	1.55e-01	0.1960	-8.41e-02	-9.91e-02	-1.01e-01	-8.02e-02	7.04e-02	1.54e-01	9.33e-02	8.65e-02	1.74e-01	2.33e-01
CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS	6	8.07e-01	9.82e-01	0.1960	-5.15e-02	1.54e-01	-5.53e-02	-2.62e-02	-9.14e-02	8.27e-01	5.13e-01	8.15e-01	9.11e-01	6.98e-01
L ASCORBIC ACID METABOLIC PROCESS	9	4.93e-01	8.95e-01	0.1960	8.79e-02	-5.11e-02	-1.12e-03	4.24e-02	-1.62e-01	6.48e-01	7.91e-01	9.95e-01	8.26e-01	3.99e-01
RESPONSE TO INTERLEUKIN 6	41	2.98e-01	7.72e-01	0.1960	1.09e-01	1.61e-01	-1.54e-02	2.30e-03	1.80e-02	2.26e-01	7.41e-02	8.64e-01	9.80e-01	8.42e-01
TYPE II INTERFERON PRODUCTION	113	7.19e-02	4.31e-01	0.1960	-1.06e-01	-4.49e-03	-1.12e-01	-1.21e-01	-1.74e-03	5.12e-02	9.34e-01	3.96e-02	2.63e-02	9.75e-01
BILE ACID BIOSYNTHETIC PROCESS	36	5.25e-01	9.05e-01	0.1960	-7.98e-02	4.66e-03	-1.19e-01	-1.33e-01	1.36e-02	4.07e-01	9.61e-01	2.15e-01	1.68e-01	8.88e-01
POSITIVE REGULATION OF BMP SIGNALING PATHWAY	40	3.14e-02	2.67e-01	0.1960	3.76e-02	-1.08e-02	-4.32e-02	-6.47e-02	-1.76e-01	6.81e-01	9.06e-01	6.37e-01	4.79e-01	5.45e-02
POSITIVE REGULATION OF GLYCOLYTIC PROCESS	22	9.04e-01	9.94e-01	0.1960	-1.25e-01	-9.55e-02	-7.10e-02	-9.03e-02	1.73e-02	3.08e-01	4.38e-01	5.64e-01	4.63e-01	8.89e-01
MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY	7	7.96e-01	9.81e-01	0.1960	2.99e-02	4.63e-02	-1.01e-01	-7.88e-02	1.38e-01	8.91e-01	8.32e-01	6.44e-01	7.18e-01	5.28e-01
REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY	11	8.87e-01	9.91e-01	0.1960	-1.34e-01	-4.19e-02	-7.31e-02	-1.01e-01	-5.39e-02	4.41e-01	8.10e-01	6.75e-01	5.60e-01	7.57e-01
NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING	11	8.61e-01	9.88e-01	0.1960	-4.70e-02	5.16e-02	-1.33e-01	-1.17e-01	4.34e-02	7.87e-01	7.67e-01	4.43e-01	5.01e-01	8.03e-01
REGULATION OF EXCITATORY SYNAPSE ASSEMBLY	15	8.78e-01	9.88e-01	0.1960	-1.13e-01	-1.85e-02	-1.00e-01	-1.15e-01	4.20e-02	4.48e-01	9.01e-01	5.02e-01	4.39e-01	7.78e-01
REGULATION OF MAST CELL CHEMOTAXIS	7	9.59e-01	9.97e-01	0.1950	-1.03e-01	-8.05e-02	-6.57e-02	-9.70e-02	8.60e-02	6.38e-01	7.12e-01	7.63e-01	6.57e-01	6.94e-01
AUDITORY RECEPTOR CELL MORPHOGENESIS	20	4.14e-01	8.54e-01	0.1950	-7.26e-02	7.29e-02	-1.27e-01	-8.80e-02	-6.16e-02	5.74e-01	5.72e-01	3.26e-01	4.96e-01	6.33e-01
POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	60	2.24e-01	7.05e-01	0.1950	-8.31e-02	-1.10e-01	-8.53e-02	-1.09e-01	1.82e-03	2.66e-01	1.41e-01	2.53e-01	1.43e-01	9.81e-01
CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC	111	4.81e-02	3.42e-01	0.1950	-1.08e-01	9.86e-03	-1.12e-01	-1.17e-01	-6.84e-03	4.97e-02	8.58e-01	4.08e-02	3.28e-02	9.01e-01
LACRIMAL GLAND DEVELOPMENT	7	9.67e-01	9.97e-01	0.1950	1.38e-01	4.69e-02	8.24e-02	8.36e-02	-5.49e-02	5.27e-01	8.30e-01	7.06e-01	7.02e-01	8.01e-01
POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION	22	4.75e-01	8.86e-01	0.1950	-7.19e-03	-4.99e-02	-3.57e-02	-2.33e-02	1.84e-01	9.53e-01	6.85e-01	7.72e-01	8.50e-01	1.36e-01
POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	16	6.88e-01	9.61e-01	0.1950	2.64e-02	6.77e-02	1.88e-02	3.45e-02	1.77e-01	8.55e-01	6.39e-01	8.96e-01	8.11e-01	2.21e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC	6	6.70e-01	9.56e-01	0.1950	-9.37e-02	-6.44e-02	1.48e-03	-6.23e-02	-1.46e-01	6.91e-01	7.85e-01	9.95e-01	7.92e-01	5.37e-01
NEGATIVE REGULATION OF RELAXATION OF MUSCLE	7	6.64e-01	9.54e-01	0.1950	7.81e-02	4.93e-02	-9.72e-02	-9.45e-02	1.05e-01	7.20e-01	8.21e-01	6.56e-01	6.65e-01	6.30e-01
ANTERIOR POSTERIOR AXIS SPECIFICATION	54	3.70e-02	2.93e-01	0.1950	1.42e-01	3.71e-02	8.72e-02	6.58e-02	6.70e-02	7.12e-02	6.37e-01	2.68e-01	4.03e-01	3.95e-01
INTERLEUKIN 8 PRODUCTION	97	6.41e-02	4.05e-01	0.1950	-7.78e-02	-1.13e-01	-9.76e-02	-8.68e-02	4.46e-02	1.86e-01	5.42e-02	9.67e-02	1.39e-01	4.47e-01
POSITIVE REGULATION OF RECEPTOR INTERNALIZATION	26	6.45e-01	9.50e-01	0.1950	-1.16e-01	-1.25e-01	9.15e-03	-3.00e-03	9.32e-02	3.08e-01	2.68e-01	9.36e-01	9.79e-01	4.11e-01
ODONTOBLAST DIFFERENTIATION	11	9.43e-01	9.97e-01	0.1950	-8.16e-02	-1.15e-01	-4.88e-02	-4.56e-02	-1.16e-01	6.39e-01	5.10e-01	7.79e-01	7.93e-01	5.04e-01
UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	35	2.49e-01	7.33e-01	0.1950	2.28e-02	-1.44e-01	6.44e-02	7.20e-02	8.56e-02	8.15e-01	1.41e-01	5.09e-01	4.61e-01	3.81e-01
PRIMARY ALCOHOL METABOLIC PROCESS	101	1.40e-01	5.96e-01	0.1950	-9.93e-02	-4.79e-02	-1.17e-01	-9.78e-02	-4.85e-02	8.47e-02	4.05e-01	4.15e-02	8.93e-02	4.00e-01
CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT	5	7.30e-01	9.71e-01	0.1950	9.24e-02	-3.23e-02	-4.62e-02	5.13e-03	-1.62e-01	7.20e-01	9.00e-01	8.58e-01	9.84e-01	5.32e-01
CELL KILLING	220	1.11e-05	6.14e-04	0.1940	6.07e-02	1.11e-01	5.24e-02	6.93e-02	1.19e-01	1.21e-01	4.54e-03	1.80e-01	7.65e-02	2.26e-03
SYNAPTIC VESICLE BUDDING	10	9.50e-01	9.97e-01	0.1940	3.88e-02	6.13e-02	6.74e-02	7.16e-02	1.51e-01	8.32e-01	7.37e-01	7.12e-01	6.95e-01	4.08e-01
EQUILIBRIOCEPTION	7	9.80e-01	9.97e-01	0.1940	-9.93e-02	-3.14e-03	-1.09e-01	-1.26e-01	-3.41e-03	6.49e-01	9.89e-01	6.17e-01	5.63e-01	9.88e-01
COLLAGEN CATABOLIC PROCESS	44	4.97e-01	8.96e-01	0.1940	-1.34e-01	-5.68e-02	-8.13e-02	-9.15e-02	4.01e-02	1.24e-01	5.14e-01	3.51e-01	2.94e-01	6.46e-01
PEPTIDYL LYSINE OXIDATION	5	9.74e-01	9.97e-01	0.1940	1.24e-01	8.27e-02	1.64e-02	2.18e-02	-1.22e-01	6.32e-01	7.49e-01	9.50e-01	9.33e-01	6.37e-01
DNA REPAIR DEPENDENT CHROMATIN REMODELING	19	7.33e-01	9.73e-01	0.1940	3.93e-02	-5.00e-02	1.26e-01	1.34e-01	5.15e-03	7.67e-01	7.06e-01	3.43e-01	3.13e-01	9.69e-01
REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	11	9.16e-01	9.94e-01	0.1940	-1.09e-01	-1.32e-01	2.41e-02	4.45e-03	8.87e-02	5.31e-01	4.50e-01	8.90e-01	9.80e-01	6.10e-01
REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	35	1.36e-01	5.86e-01	0.1940	-6.32e-02	7.01e-02	-1.33e-01	-9.34e-02	-4.84e-02	5.18e-01	4.73e-01	1.73e-01	3.39e-01	6.20e-01
POSITIVE REGULATION OF MIRNA TRANSCRIPTION	50	3.41e-02	2.79e-01	0.1940	8.16e-03	-1.73e-01	2.87e-02	1.84e-02	7.99e-02	9.20e-01	3.40e-02	7.26e-01	8.22e-01	3.28e-01
MITOTIC SISTER CHROMATID COHESION	26	2.62e-01	7.44e-01	0.1940	2.81e-02	-1.06e-01	8.68e-02	8.79e-02	-1.02e-01	8.04e-01	3.51e-01	4.43e-01	4.38e-01	3.68e-01
PROTEIN MATURATION	517	2.03e-06	1.33e-04	0.1940	9.28e-02	-7.58e-03	1.17e-01	1.18e-01	3.62e-02	3.01e-04	7.68e-01	4.88e-06	4.60e-06	1.59e-01
REGULATION OF SECONDARY METABOLIC PROCESS	15	8.84e-01	9.91e-01	0.1940	-8.46e-02	-9.66e-02	-4.70e-02	-6.88e-02	1.19e-01	5.71e-01	5.17e-01	7.53e-01	6.45e-01	4.24e-01
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	50	6.17e-01	9.40e-01	0.1940	-9.76e-02	-9.61e-02	-8.71e-02	-1.06e-01	-2.86e-04	2.33e-01	2.40e-01	2.87e-01	1.94e-01	9.97e-01
POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	25	3.57e-01	8.22e-01	0.1940	4.39e-02	1.73e-01	-5.55e-02	-3.23e-02	4.11e-02	7.04e-01	1.35e-01	6.31e-01	7.80e-01	7.22e-01
MALE MATING BEHAVIOR	6	3.62e-01	8.26e-01	0.1940	-1.27e-01	-1.25e-01	3.80e-02	-5.95e-02	3.02e-02	5.91e-01	5.96e-01	8.72e-01	8.01e-01	8.98e-01
NEGATIVE REGULATION OF DNA REPAIR	33	1.57e-01	6.19e-01	0.1940	1.00e-01	-5.58e-02	1.09e-01	9.49e-02	-5.85e-02	3.19e-01	5.79e-01	2.77e-01	3.46e-01	5.61e-01
PHOSPHATIDIC ACID METABOLIC PROCESS	35	6.64e-01	9.54e-01	0.1940	-8.23e-02	2.98e-02	-1.25e-01	-1.12e-01	-3.92e-02	4.00e-01	7.60e-01	1.99e-01	2.50e-01	6.88e-01
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	26	2.24e-01	7.05e-01	0.1940	-4.14e-03	-1.72e-01	5.20e-02	1.83e-02	6.89e-02	9.71e-01	1.28e-01	6.46e-01	8.71e-01	5.43e-01
NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION	11	7.55e-01	9.75e-01	0.1940	-1.28e-02	-6.08e-02	-1.35e-01	-1.20e-01	-3.20e-02	9.41e-01	7.27e-01	4.37e-01	4.92e-01	8.54e-01
ACTIVATION OF ADENYLATE CYCLASE ACTIVITY	25	6.81e-01	9.61e-01	0.1940	-7.58e-02	-1.68e-01	-3.04e-02	-4.72e-02	-1.90e-02	5.12e-01	1.46e-01	7.92e-01	6.83e-01	8.70e-01
REGULATION OF PROTEIN KINASE A SIGNALING	20	4.51e-01	8.76e-01	0.1940	2.90e-02	7.89e-02	1.01e-01	1.11e-01	-8.85e-02	8.23e-01	5.41e-01	4.35e-01	3.89e-01	4.93e-01
NEGATIVE REGULATION OF RESPONSE TO FOOD	10	1.43e-01	6.00e-01	0.1930	1.38e-01	9.15e-02	8.89e-02	1.58e-02	4.14e-02	4.49e-01	6.16e-01	6.26e-01	9.31e-01	8.21e-01
TNFSF11 MEDIATED SIGNALING PATHWAY	5	9.49e-01	9.97e-01	0.1930	-1.35e-01	-4.17e-02	-7.13e-02	-5.78e-02	9.41e-02	6.00e-01	8.72e-01	7.82e-01	8.23e-01	7.16e-01
NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	18	8.09e-01	9.82e-01	0.1930	-1.32e-02	-6.58e-02	1.59e-02	3.39e-03	1.81e-01	9.23e-01	6.29e-01	9.07e-01	9.80e-01	1.85e-01
POSITIVE REGULATION OF CELLULAR SENESCENCE	17	6.30e-01	9.46e-01	0.1930	-5.23e-02	-3.30e-02	-2.37e-02	-8.13e-03	1.81e-01	7.09e-01	8.14e-01	8.66e-01	9.54e-01	1.95e-01
REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	11	8.73e-01	9.88e-01	0.1930	-3.47e-02	-1.35e-01	8.83e-02	5.51e-02	8.48e-02	8.42e-01	4.40e-01	6.12e-01	7.52e-01	6.26e-01
CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	18	5.77e-01	9.26e-01	0.1930	4.04e-02	1.68e-01	-7.13e-02	-3.66e-02	-3.28e-02	7.67e-01	2.18e-01	6.00e-01	7.88e-01	8.09e-01
ESTABLISHMENT OF SISTER CHROMATID COHESION	9	8.26e-01	9.83e-01	0.1930	-1.49e-01	-8.50e-02	-2.35e-02	-2.01e-02	8.35e-02	4.40e-01	6.59e-01	9.03e-01	9.17e-01	6.64e-01
NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	6	9.78e-01	9.97e-01	0.1930	-3.85e-02	-1.45e-01	6.65e-02	4.17e-02	9.20e-02	8.70e-01	5.37e-01	7.78e-01	8.60e-01	6.96e-01
PROTEIN LOCALIZATION TO CYTOSKELETON	57	2.85e-01	7.64e-01	0.1930	-5.28e-02	-7.89e-02	-1.02e-01	-1.12e-01	-7.32e-02	4.91e-01	3.03e-01	1.82e-01	1.45e-01	3.39e-01
LIPOPHAGY	7	9.43e-01	9.97e-01	0.1930	8.99e-02	-3.17e-03	9.36e-02	8.80e-02	-1.13e-01	6.81e-01	9.88e-01	6.68e-01	6.87e-01	6.06e-01
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	25	7.12e-01	9.67e-01	0.1930	5.35e-02	-8.12e-02	7.99e-02	7.57e-02	1.25e-01	6.43e-01	4.82e-01	4.89e-01	5.12e-01	2.79e-01
NUCLEAR ENVELOPE ORGANIZATION	52	2.38e-02	2.28e-01	0.1930	2.38e-02	-1.37e-01	8.59e-02	9.39e-02	-4.17e-02	7.67e-01	8.75e-02	2.84e-01	2.42e-01	6.03e-01
INTERMEDIATE FILAMENT BASED PROCESS	94	6.28e-05	2.67e-03	0.1930	5.78e-03	1.55e-01	-9.70e-02	-5.48e-02	-2.81e-02	9.23e-01	9.40e-03	1.04e-01	3.58e-01	6.38e-01
ALANINE TRANSPORT	16	9.66e-01	9.97e-01	0.1930	1.08e-01	1.40e-01	4.84e-02	5.77e-02	-1.72e-02	4.53e-01	3.33e-01	7.38e-01	6.89e-01	9.05e-01
RNA PROCESSING	1257	3.01e-14	6.87e-12	0.1930	8.82e-02	3.24e-02	1.21e-01	1.17e-01	-3.27e-03	1.43e-07	5.31e-02	5.53e-13	2.42e-12	8.45e-01
AMYLOID BETA CLEARANCE	39	5.35e-01	9.09e-01	0.1930	5.39e-02	2.91e-02	7.71e-02	9.38e-02	1.37e-01	5.60e-01	7.53e-01	4.04e-01	3.11e-01	1.40e-01
REGULATION OF LIPOPROTEIN METABOLIC PROCESS	17	3.84e-01	8.39e-01	0.1930	6.88e-02	9.90e-02	-1.21e-01	-8.79e-02	-1.90e-02	6.24e-01	4.80e-01	3.89e-01	5.30e-01	8.92e-01
CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	22	8.48e-01	9.87e-01	0.1930	3.71e-02	-3.58e-02	8.76e-02	9.78e-02	1.31e-01	7.63e-01	7.71e-01	4.77e-01	4.27e-01	2.86e-01
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION	74	3.69e-02	2.93e-01	0.1930	1.57e-02	-1.43e-01	5.82e-02	5.30e-02	1.01e-01	8.16e-01	3.30e-02	3.86e-01	4.31e-01	1.33e-01
PHENOL CONTAINING COMPOUND METABOLIC PROCESS	105	1.61e-01	6.24e-01	0.1930	-9.04e-02	-1.17e-01	-5.23e-02	-6.21e-02	9.36e-02	1.09e-01	3.87e-02	3.54e-01	2.72e-01	9.75e-02
SIALYLATION	8	5.39e-01	9.13e-01	0.1930	-3.83e-02	-1.71e-01	2.32e-02	-3.50e-02	-6.80e-02	8.51e-01	4.02e-01	9.09e-01	8.64e-01	7.39e-01
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS	128	8.84e-03	1.18e-01	0.1930	-5.63e-02	8.15e-02	-1.17e-01	-1.10e-01	-3.70e-02	2.72e-01	1.11e-01	2.20e-02	3.13e-02	4.69e-01
POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	27	4.52e-01	8.76e-01	0.1930	-5.56e-02	-1.80e-01	7.57e-03	-6.18e-03	-3.72e-02	6.17e-01	1.05e-01	9.46e-01	9.56e-01	7.38e-01
DNA METABOLIC PROCESS	986	3.28e-13	6.49e-11	0.1930	8.53e-02	-4.06e-03	1.25e-01	1.17e-01	2.27e-02	5.68e-06	8.29e-01	2.85e-11	5.46e-10	2.28e-01
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	125	1.23e-01	5.61e-01	0.1930	7.08e-02	4.21e-02	8.26e-02	9.36e-02	1.21e-01	1.71e-01	4.16e-01	1.11e-01	7.06e-02	1.93e-02
PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	35	5.28e-01	9.06e-01	0.1920	-1.86e-02	7.67e-02	-1.17e-01	-1.19e-01	-5.47e-02	8.49e-01	4.32e-01	2.30e-01	2.25e-01	5.76e-01
TIGHT JUNCTION ORGANIZATION	78	5.43e-01	9.14e-01	0.1920	-1.16e-01	-6.05e-02	-1.01e-01	-9.86e-02	-5.28e-03	7.71e-02	3.56e-01	1.22e-01	1.32e-01	9.36e-01
MUSCLE ORGAN MORPHOGENESIS	82	3.70e-01	8.31e-01	0.1920	-9.25e-02	-1.40e-01	-6.40e-02	-6.65e-02	2.12e-02	1.47e-01	2.88e-02	3.16e-01	2.98e-01	7.40e-01
MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	30	4.72e-01	8.85e-01	0.1920	-8.96e-02	-2.28e-04	-4.92e-02	-6.27e-02	-1.50e-01	3.95e-01	9.98e-01	6.41e-01	5.52e-01	1.54e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH	27	2.31e-01	7.14e-01	0.1920	-3.25e-02	-1.77e-01	-1.81e-02	-6.24e-03	-6.47e-02	7.70e-01	1.11e-01	8.70e-01	9.55e-01	5.61e-01
REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	8	4.43e-01	8.72e-01	0.1920	-1.08e-01	-1.22e-02	2.59e-03	-6.02e-02	-1.47e-01	5.97e-01	9.53e-01	9.90e-01	7.68e-01	4.73e-01
N ACETYLNEURAMINATE METABOLIC PROCESS	11	9.63e-01	9.97e-01	0.1920	7.67e-02	-3.10e-02	1.20e-01	1.03e-01	7.12e-02	6.59e-01	8.59e-01	4.90e-01	5.55e-01	6.83e-01
NUCLEOSIDE SALVAGE	8	8.08e-01	9.82e-01	0.1920	-1.01e-02	-1.92e-01	-3.19e-03	2.69e-04	-2.92e-03	9.61e-01	3.47e-01	9.88e-01	9.99e-01	9.89e-01
REGULATION OF MITOCHONDRIAL FISSION	30	1.87e-01	6.57e-01	0.1920	-3.97e-02	-1.29e-01	-8.21e-02	-1.06e-01	-2.54e-02	7.06e-01	2.21e-01	4.36e-01	3.15e-01	8.10e-01
CARTILAGE CONDENSATION	19	5.82e-01	9.28e-01	0.1920	-6.05e-02	-1.60e-01	-7.00e-02	-4.98e-02	-1.29e-02	6.48e-01	2.27e-01	5.97e-01	7.07e-01	9.23e-01
HISTONE DEACETYLATION	19	9.71e-01	9.97e-01	0.1920	7.32e-02	4.33e-02	1.09e-01	1.13e-01	7.05e-02	5.81e-01	7.44e-01	4.09e-01	3.94e-01	5.95e-01
NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY	24	7.78e-01	9.79e-01	0.1920	-4.38e-02	-1.23e-01	9.15e-03	-3.66e-03	1.40e-01	7.10e-01	2.96e-01	9.38e-01	9.75e-01	2.34e-01
RESPONSE TO GLUCAGON	20	9.52e-01	9.97e-01	0.1920	1.07e-01	3.17e-02	1.12e-01	1.07e-01	2.08e-02	4.07e-01	8.06e-01	3.87e-01	4.07e-01	8.72e-01
LIMBIC SYSTEM DEVELOPMENT	117	1.28e-03	2.99e-02	0.1920	3.53e-02	-8.96e-02	1.27e-01	9.71e-02	4.46e-02	5.09e-01	9.41e-02	1.75e-02	6.95e-02	4.04e-01
TYPE II INTERFERON MEDIATED SIGNALING PATHWAY	26	5.97e-01	9.33e-01	0.1920	-1.47e-01	-7.40e-02	-6.02e-02	-6.08e-02	-5.00e-02	1.95e-01	5.14e-01	5.95e-01	5.92e-01	6.59e-01
REGULATION OF FIBRINOLYSIS	18	8.70e-01	9.88e-01	0.1920	-6.44e-02	-1.62e-01	-1.73e-03	-1.36e-02	7.85e-02	6.36e-01	2.33e-01	9.90e-01	9.21e-01	5.64e-01
NEGATIVE REGULATION OF COAGULATION	52	7.52e-01	9.75e-01	0.1920	-9.04e-02	-1.07e-01	-8.24e-02	-8.91e-02	-4.90e-02	2.59e-01	1.81e-01	3.04e-01	2.66e-01	5.41e-01
ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	20	3.67e-01	8.30e-01	0.1920	1.12e-02	-1.46e-01	8.07e-02	4.03e-02	8.56e-02	9.31e-01	2.59e-01	5.32e-01	7.55e-01	5.08e-01
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	231	8.64e-05	3.40e-03	0.1920	1.96e-02	-1.10e-01	1.01e-01	8.54e-02	8.24e-02	6.07e-01	3.84e-03	8.44e-03	2.53e-02	3.09e-02
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	21	3.13e-01	7.86e-01	0.1920	-1.44e-03	1.59e-01	-6.10e-02	-4.26e-02	7.68e-02	9.91e-01	2.07e-01	6.28e-01	7.36e-01	5.42e-01
MESENCHYMAL CELL MIGRATION	61	2.51e-01	7.35e-01	0.1910	-7.64e-02	-7.14e-02	-9.60e-02	-1.11e-01	6.44e-02	3.02e-01	3.35e-01	1.95e-01	1.33e-01	3.85e-01
VENTRAL SPINAL CORD DEVELOPMENT	45	2.38e-02	2.28e-01	0.1910	1.33e-01	-5.09e-02	9.36e-02	8.09e-02	3.29e-02	1.23e-01	5.55e-01	2.77e-01	3.48e-01	7.03e-01
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	10	8.69e-01	9.88e-01	0.1910	4.43e-02	1.33e-01	5.83e-02	4.42e-02	-1.08e-01	8.08e-01	4.68e-01	7.50e-01	8.09e-01	5.54e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	61	6.63e-01	9.54e-01	0.1910	-8.10e-02	-7.54e-02	-1.11e-01	-1.07e-01	-2.52e-02	2.74e-01	3.08e-01	1.34e-01	1.50e-01	7.34e-01
CORTISOL METABOLIC PROCESS	12	4.47e-01	8.74e-01	0.1910	-7.85e-02	6.55e-02	-1.61e-02	-4.74e-03	1.61e-01	6.38e-01	6.94e-01	9.23e-01	9.77e-01	3.35e-01
EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE	6	8.95e-01	9.93e-01	0.1910	7.13e-02	-4.96e-02	4.46e-02	4.22e-02	-1.59e-01	7.62e-01	8.33e-01	8.50e-01	8.58e-01	5.01e-01
PROTEIN LOCALIZATION TO NON MOTILE CILIUM	12	9.09e-01	9.94e-01	0.1910	1.28e-01	5.79e-02	9.71e-02	7.83e-02	3.33e-02	4.42e-01	7.28e-01	5.60e-01	6.39e-01	8.42e-01
HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION	8	6.19e-01	9.42e-01	0.1910	-8.66e-02	-3.56e-02	1.60e-02	-4.32e-02	1.60e-01	6.71e-01	8.62e-01	9.38e-01	8.32e-01	4.33e-01
B CELL APOPTOTIC PROCESS	26	5.73e-01	9.26e-01	0.1910	-5.18e-05	-1.39e-01	9.25e-02	7.29e-02	5.70e-02	1.00e+00	2.20e-01	4.14e-01	5.20e-01	6.15e-01
RESPONSE TO AMYLOID BETA	55	1.05e-01	5.17e-01	0.1910	-7.30e-02	-8.08e-02	-5.94e-02	-4.22e-02	1.39e-01	3.49e-01	3.00e-01	4.46e-01	5.88e-01	7.50e-02
SPINAL CORD DEVELOPMENT	99	5.98e-04	1.63e-02	0.1910	8.85e-02	-8.43e-02	8.58e-02	7.03e-02	9.58e-02	1.28e-01	1.47e-01	1.40e-01	2.26e-01	9.96e-02
CELLULAR RESPONSE TO INSULIN STIMULUS	203	1.01e-01	5.08e-01	0.1910	-9.53e-02	-1.06e-01	-8.53e-02	-9.26e-02	-1.16e-02	1.92e-02	8.94e-03	3.61e-02	2.29e-02	7.76e-01
DOPAMINE RECEPTOR SIGNALING PATHWAY	37	4.47e-01	8.74e-01	0.1910	1.01e-01	-3.11e-04	7.01e-02	6.57e-02	1.30e-01	2.87e-01	9.97e-01	4.61e-01	4.89e-01	1.71e-01
DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA	11	6.90e-01	9.61e-01	0.1910	-2.00e-02	-9.27e-02	1.18e-01	6.76e-02	9.39e-02	9.08e-01	5.95e-01	4.97e-01	6.98e-01	5.90e-01
NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	19	9.14e-01	9.94e-01	0.1910	8.27e-02	5.97e-02	1.11e-01	1.07e-01	-4.60e-02	5.33e-01	6.52e-01	4.02e-01	4.18e-01	7.28e-01
HEXOSE PHOSPHATE TRANSPORT	7	8.50e-01	9.88e-01	0.1910	-1.66e-02	7.01e-02	5.36e-03	3.35e-02	-1.73e-01	9.39e-01	7.48e-01	9.80e-01	8.78e-01	4.27e-01
POSITIVE REGULATION OF ORGAN GROWTH	47	3.49e-01	8.18e-01	0.1910	-7.24e-02	-1.36e-01	-6.26e-02	-8.13e-02	-4.41e-02	3.90e-01	1.06e-01	4.58e-01	3.35e-01	6.01e-01
KERATINOCYTE MIGRATION	20	9.74e-01	9.97e-01	0.1910	-9.72e-02	-9.55e-02	-8.91e-02	-8.72e-02	-4.71e-02	4.52e-01	4.60e-01	4.90e-01	5.00e-01	7.15e-01
MACROMOLECULE DEPALMITOYLATION	11	2.98e-01	7.72e-01	0.1910	-1.60e-02	-7.50e-02	1.51e-02	-4.33e-02	-1.68e-01	9.27e-01	6.67e-01	9.31e-01	8.03e-01	3.34e-01
CHLORIDE TRANSPORT	116	1.13e-02	1.39e-01	0.1910	-8.24e-02	1.56e-02	-1.31e-01	-1.10e-01	6.05e-03	1.25e-01	7.71e-01	1.51e-02	4.02e-02	9.10e-01
TRNA CATABOLIC PROCESS	16	4.51e-01	8.76e-01	0.1910	1.25e-01	8.11e-02	5.56e-02	2.67e-02	-1.01e-01	3.85e-01	5.74e-01	7.00e-01	8.53e-01	4.84e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	15	8.77e-01	9.88e-01	0.1900	-1.08e-01	-1.14e-01	7.03e-03	-8.64e-03	1.08e-01	4.70e-01	4.46e-01	9.62e-01	9.54e-01	4.69e-01
REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	19	4.36e-01	8.69e-01	0.1900	-7.21e-02	-1.41e-01	6.31e-02	3.57e-02	-7.79e-02	5.86e-01	2.89e-01	6.34e-01	7.87e-01	5.57e-01
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	21	5.67e-01	9.23e-01	0.1900	-6.63e-02	-9.67e-02	-1.14e-01	-8.75e-02	4.30e-02	5.99e-01	4.43e-01	3.66e-01	4.87e-01	7.33e-01
RETINA HOMEOSTASIS	75	5.31e-02	3.62e-01	0.1900	7.42e-02	1.33e-01	1.81e-02	3.44e-02	1.08e-01	2.66e-01	4.72e-02	7.87e-01	6.07e-01	1.06e-01
PRESYNAPSE ORGANIZATION	44	4.41e-01	8.71e-01	0.1900	-6.74e-02	-1.50e-01	-2.60e-02	-4.42e-02	8.12e-02	4.39e-01	8.55e-02	7.65e-01	6.12e-01	3.51e-01
POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	35	6.48e-01	9.51e-01	0.1900	-7.36e-02	-1.01e-01	-5.63e-02	-6.48e-02	1.15e-01	4.51e-01	3.01e-01	5.64e-01	5.07e-01	2.40e-01
PEPTIDYL LYSINE METHYLATION	48	7.41e-01	9.73e-01	0.1900	-8.86e-02	-1.10e-01	-8.10e-02	-9.18e-02	-3.30e-02	2.88e-01	1.86e-01	3.31e-01	2.71e-01	6.92e-01
NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	14	8.20e-01	9.83e-01	0.1900	-6.94e-02	2.67e-02	-1.08e-01	-1.17e-01	7.15e-02	6.53e-01	8.62e-01	4.83e-01	4.47e-01	6.43e-01
REGULATION OF PROTEIN LIPIDATION	11	2.93e-01	7.69e-01	0.1900	9.90e-02	-4.77e-02	-2.89e-02	1.05e-02	1.52e-01	5.70e-01	7.84e-01	8.68e-01	9.52e-01	3.83e-01
POSITIVE REGULATION OF RESPONSE TO TUMOR CELL	15	6.28e-01	9.45e-01	0.1900	6.35e-02	1.22e-01	9.95e-02	6.57e-02	5.32e-02	6.70e-01	4.12e-01	5.05e-01	6.60e-01	7.21e-01
VITAMIN A METABOLIC PROCESS	8	9.13e-01	9.94e-01	0.1900	2.46e-02	8.39e-02	3.42e-02	1.90e-02	1.64e-01	9.04e-01	6.81e-01	8.67e-01	9.26e-01	4.22e-01
RIGHTING REFLEX	8	6.21e-01	9.43e-01	0.1900	6.83e-02	-4.38e-02	-2.10e-02	-4.21e-02	1.65e-01	7.38e-01	8.30e-01	9.18e-01	8.37e-01	4.19e-01
NEURON APOPTOTIC PROCESS	265	1.32e-03	3.05e-02	0.1900	9.28e-02	-1.40e-02	9.98e-02	9.48e-02	9.06e-02	9.26e-03	6.95e-01	5.17e-03	7.87e-03	1.11e-02
APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS	5	9.76e-01	9.97e-01	0.1900	7.09e-03	-2.39e-02	1.38e-01	1.23e-01	3.54e-02	9.78e-01	9.26e-01	5.93e-01	6.35e-01	8.91e-01
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	18	9.68e-01	9.97e-01	0.1900	-1.21e-01	-8.74e-02	-8.27e-02	-8.29e-02	3.88e-03	3.75e-01	5.21e-01	5.44e-01	5.43e-01	9.77e-01
REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	6	9.71e-01	9.97e-01	0.1900	1.53e-02	2.73e-02	1.39e-02	1.47e-02	1.86e-01	9.48e-01	9.08e-01	9.53e-01	9.50e-01	4.30e-01
UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS	9	6.99e-01	9.62e-01	0.1900	-2.49e-04	8.17e-02	-1.05e-01	-1.35e-01	8.90e-03	9.99e-01	6.71e-01	5.85e-01	4.84e-01	9.63e-01
REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY	7	7.46e-01	9.75e-01	0.1900	-7.16e-02	-9.64e-02	-2.42e-02	-8.28e-02	1.19e-01	7.43e-01	6.59e-01	9.12e-01	7.05e-01	5.87e-01
PROSTANOID BIOSYNTHETIC PROCESS	31	3.54e-01	8.22e-01	0.1890	-4.38e-02	-1.46e-01	-7.67e-02	-7.52e-02	3.32e-02	6.73e-01	1.59e-01	4.60e-01	4.69e-01	7.49e-01
ANTIMICROBIAL HUMORAL RESPONSE	119	2.88e-04	9.39e-03	0.1890	1.04e-01	9.60e-02	3.65e-02	7.46e-02	9.40e-02	4.91e-02	7.03e-02	4.92e-01	1.60e-01	7.65e-02
LIPID DROPLET ORGANIZATION	34	2.91e-01	7.67e-01	0.1890	4.06e-02	-8.52e-02	6.76e-02	4.11e-02	1.44e-01	6.82e-01	3.90e-01	4.95e-01	6.78e-01	1.47e-01
POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY	42	2.18e-01	7.00e-01	0.1890	-3.19e-02	-1.37e-01	-3.71e-02	-3.37e-02	1.16e-01	7.20e-01	1.25e-01	6.77e-01	7.06e-01	1.92e-01
RESPONSE TO CAFFEINE	15	3.84e-01	8.39e-01	0.1890	2.26e-02	-6.06e-02	1.20e-01	7.97e-02	-1.04e-01	8.79e-01	6.85e-01	4.20e-01	5.93e-01	4.87e-01
OLFACTORY BEHAVIOR	10	9.33e-01	9.97e-01	0.1890	1.19e-01	1.35e-01	4.12e-02	2.88e-02	-2.82e-02	5.13e-01	4.61e-01	8.22e-01	8.75e-01	8.77e-01
DNA REPAIR	565	1.49e-08	1.54e-06	0.1890	8.30e-02	-5.74e-03	1.26e-01	1.12e-01	2.33e-02	7.46e-04	8.16e-01	3.19e-07	5.71e-06	3.44e-01
REGULATION OF PROTEIN COMPLEX STABILITY	14	4.66e-01	8.83e-01	0.1890	-4.60e-02	-1.70e-01	6.55e-02	1.65e-02	-5.32e-03	7.66e-01	2.70e-01	6.71e-01	9.15e-01	9.73e-01
TETRAHYDROFOLATE METABOLIC PROCESS	15	8.88e-01	9.91e-01	0.1890	6.62e-02	-1.80e-02	1.27e-01	1.18e-01	-2.99e-02	6.57e-01	9.04e-01	3.94e-01	4.29e-01	8.41e-01
REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	26	5.71e-01	9.26e-01	0.1890	-5.03e-02	2.09e-02	-1.16e-01	-1.36e-01	-2.49e-02	6.57e-01	8.54e-01	3.04e-01	2.31e-01	8.26e-01
RNA 3 END PROCESSING	90	1.55e-03	3.40e-02	0.1890	4.70e-02	-4.79e-02	1.22e-01	9.89e-02	-7.98e-02	4.41e-01	4.32e-01	4.52e-02	1.05e-01	1.91e-01
REGULATION OF CHROMOSOME SEGREGATION	129	1.85e-02	1.94e-01	0.1890	6.47e-02	-4.08e-03	1.33e-01	1.17e-01	-4.17e-03	2.04e-01	9.36e-01	8.98e-03	2.21e-02	9.35e-01
T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	5	9.95e-01	9.99e-01	0.1880	-6.39e-02	1.15e-02	-6.88e-02	-6.91e-02	-1.48e-01	8.05e-01	9.64e-01	7.90e-01	7.89e-01	5.67e-01
MEDIUM CHAIN FATTY ACID METABOLIC PROCESS	15	8.72e-01	9.88e-01	0.1880	6.76e-02	3.87e-02	1.16e-01	1.05e-01	-7.04e-02	6.51e-01	7.95e-01	4.37e-01	4.81e-01	6.37e-01
AXONAL FASCICULATION	21	7.10e-01	9.67e-01	0.1880	-6.18e-02	-7.70e-02	5.25e-02	4.89e-02	1.44e-01	6.24e-01	5.41e-01	6.77e-01	6.98e-01	2.55e-01
PYROPTOSIS	36	9.48e-02	4.92e-01	0.1880	-5.64e-02	2.57e-02	-1.12e-01	-8.31e-02	1.10e-01	5.58e-01	7.90e-01	2.44e-01	3.88e-01	2.52e-01
REGULATION OF SYNAPTIC VESICLE CLUSTERING	6	9.46e-01	9.97e-01	0.1880	-6.96e-02	3.34e-02	-1.05e-01	-1.29e-01	4.28e-02	7.68e-01	8.87e-01	6.55e-01	5.84e-01	8.56e-01
VIRAL LIFE CYCLE	309	1.48e-02	1.65e-01	0.1880	9.42e-02	2.25e-02	1.13e-01	1.08e-01	4.04e-02	4.39e-03	4.97e-01	6.42e-04	1.05e-03	2.22e-01
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS	15	7.03e-01	9.65e-01	0.1880	-1.75e-02	-5.21e-02	-4.63e-03	-3.20e-02	1.77e-01	9.06e-01	7.27e-01	9.75e-01	8.30e-01	2.35e-01
CELLULAR RESPONSE TO VIRUS	81	2.92e-01	7.67e-01	0.1880	-1.24e-01	-4.32e-02	-9.67e-02	-9.45e-02	6.36e-04	5.41e-02	5.02e-01	1.32e-01	1.41e-01	9.92e-01
POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	26	3.57e-01	8.23e-01	0.1880	3.38e-02	9.42e-02	-1.15e-01	-1.10e-01	-1.10e-02	7.66e-01	4.06e-01	3.12e-01	3.30e-01	9.22e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE	10	8.94e-01	9.93e-01	0.1880	8.87e-02	1.47e-01	3.31e-02	6.97e-02	-8.12e-03	6.27e-01	4.21e-01	8.56e-01	7.03e-01	9.65e-01
INTRA GOLGI VESICLE MEDIATED TRANSPORT	33	1.81e-01	6.56e-01	0.1880	-6.18e-02	-1.26e-01	4.01e-02	1.87e-02	-1.17e-01	5.39e-01	2.10e-01	6.90e-01	8.53e-01	2.43e-01
REGULATION OF CELL MATRIX ADHESION	121	2.34e-01	7.19e-01	0.1880	-9.06e-02	-6.96e-02	-9.97e-02	-1.11e-01	7.62e-03	8.52e-02	1.86e-01	5.81e-02	3.47e-02	8.85e-01
DNA CONFORMATION CHANGE	88	3.16e-03	5.76e-02	0.1880	6.84e-02	1.69e-02	1.25e-01	9.67e-02	-7.32e-02	2.67e-01	7.84e-01	4.21e-02	1.17e-01	2.35e-01
POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	10	6.44e-01	9.50e-01	0.1880	2.18e-02	1.29e-02	-1.03e-01	-1.11e-01	1.09e-01	9.05e-01	9.44e-01	5.71e-01	5.45e-01	5.52e-01
CAVEOLA ASSEMBLY	5	9.79e-01	9.97e-01	0.1880	-3.50e-02	-1.34e-01	4.62e-02	1.39e-02	1.17e-01	8.92e-01	6.03e-01	8.58e-01	9.57e-01	6.50e-01
TRACHEA MORPHOGENESIS	11	9.81e-01	9.97e-01	0.1880	1.00e-01	4.71e-02	1.12e-01	1.02e-01	-7.00e-03	5.64e-01	7.87e-01	5.19e-01	5.59e-01	9.68e-01
PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	32	5.21e-01	9.03e-01	0.1880	-8.21e-02	-1.60e-01	4.08e-02	2.31e-02	2.98e-02	4.22e-01	1.18e-01	6.90e-01	8.21e-01	7.70e-01
GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	15	7.56e-01	9.75e-01	0.1880	-5.51e-02	-1.65e-01	-8.12e-03	-2.54e-02	-6.56e-02	7.12e-01	2.68e-01	9.57e-01	8.65e-01	6.60e-01
REGULATION OF CENTROSOME CYCLE	54	3.69e-01	8.31e-01	0.1880	4.39e-02	-5.36e-02	1.24e-01	1.20e-01	2.39e-02	5.76e-01	4.96e-01	1.14e-01	1.28e-01	7.61e-01
LYSOSOMAL PROTEIN CATABOLIC PROCESS	19	9.61e-01	9.97e-01	0.1880	9.31e-02	5.63e-03	1.06e-01	1.10e-01	5.74e-02	4.83e-01	9.66e-01	4.26e-01	4.07e-01	6.65e-01
NEGATIVE REGULATION OF HIPPO SIGNALING	12	7.56e-01	9.75e-01	0.1880	-8.93e-02	3.61e-03	-1.32e-01	-9.70e-02	1.63e-02	5.92e-01	9.83e-01	4.27e-01	5.61e-01	9.22e-01
CARDIAC MUSCLE TISSUE MORPHOGENESIS	61	6.37e-01	9.48e-01	0.1880	-1.04e-01	-1.14e-01	-6.01e-02	-6.93e-02	-5.45e-02	1.61e-01	1.23e-01	4.17e-01	3.49e-01	4.61e-01
REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS	38	6.73e-01	9.59e-01	0.1880	4.30e-02	-6.21e-02	8.37e-02	7.36e-02	1.31e-01	6.46e-01	5.07e-01	3.72e-01	4.32e-01	1.64e-01
POSITIVE REGULATION OF ENDOCYTOSIS	149	6.80e-02	4.18e-01	0.1880	-1.03e-01	-8.73e-02	-9.40e-02	-8.41e-02	3.10e-02	2.94e-02	6.60e-02	4.76e-02	7.63e-02	5.14e-01
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	14	4.29e-01	8.66e-01	0.1880	-1.17e-01	8.28e-02	-9.46e-02	-7.54e-02	-1.25e-03	4.49e-01	5.92e-01	5.40e-01	6.25e-01	9.94e-01
GLANDULAR EPITHELIAL CELL DEVELOPMENT	36	3.31e-01	8.03e-01	0.1870	-1.90e-02	-1.23e-01	-1.01e-02	-2.31e-02	1.38e-01	8.44e-01	2.00e-01	9.16e-01	8.10e-01	1.53e-01
POSITIVE REGULATION OF GLUCOSE IMPORT	35	6.12e-01	9.37e-01	0.1870	-9.72e-02	-7.86e-02	-4.41e-02	-4.92e-02	-1.23e-01	3.20e-01	4.21e-01	6.51e-01	6.14e-01	2.08e-01
REGULATION OF MITOTIC CYTOKINESIS	11	7.01e-01	9.63e-01	0.1870	1.08e-01	9.87e-02	9.15e-02	5.07e-02	5.22e-02	5.35e-01	5.71e-01	5.99e-01	7.71e-01	7.65e-01
PEPTIDYL THREONINE MODIFICATION	107	2.46e-01	7.31e-01	0.1870	-5.73e-02	-4.33e-02	-1.00e-01	-1.06e-01	-9.34e-02	3.05e-01	4.38e-01	7.36e-02	5.87e-02	9.52e-02
REGULATION OF RECEPTOR INTERNALIZATION	60	4.53e-01	8.77e-01	0.1870	-9.47e-02	-1.41e-01	-2.25e-02	-4.15e-02	6.29e-02	2.05e-01	5.86e-02	7.63e-01	5.78e-01	3.99e-01
REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	43	5.95e-01	9.33e-01	0.1870	-7.75e-02	-6.00e-02	-1.12e-01	-1.04e-01	4.52e-02	3.79e-01	4.96e-01	2.04e-01	2.37e-01	6.08e-01
REGULATION OF LIPID STORAGE	54	2.18e-01	7.00e-01	0.1870	-7.76e-02	-2.20e-03	-1.26e-01	-1.07e-01	4.15e-02	3.24e-01	9.78e-01	1.10e-01	1.72e-01	5.98e-01
NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	52	5.26e-01	9.05e-01	0.1870	-1.18e-01	-3.25e-02	-9.29e-02	-8.66e-02	-6.23e-02	1.40e-01	6.86e-01	2.46e-01	2.80e-01	4.37e-01
NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	15	8.23e-01	9.83e-01	0.1870	-3.39e-02	-1.72e-01	3.89e-02	2.93e-02	4.25e-02	8.20e-01	2.48e-01	7.94e-01	8.44e-01	7.76e-01
REGULATION OF B CELL DIFFERENTIATION	31	8.90e-01	9.91e-01	0.1870	9.38e-02	8.24e-03	1.09e-01	1.13e-01	3.93e-02	3.66e-01	9.37e-01	2.95e-01	2.76e-01	7.05e-01
PROTEIN AUTOUBIQUITINATION	67	1.01e-01	5.09e-01	0.1870	-7.78e-02	-1.06e-01	4.33e-02	1.55e-02	1.24e-01	2.71e-01	1.32e-01	5.40e-01	8.27e-01	7.82e-02
POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	9	8.42e-01	9.86e-01	0.1870	8.45e-02	8.45e-02	1.81e-02	-4.61e-03	-1.42e-01	6.61e-01	6.61e-01	9.25e-01	9.81e-01	4.60e-01
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	28	6.58e-01	9.54e-01	0.1870	-5.96e-02	-1.69e-01	-1.16e-03	-1.64e-02	5.16e-02	5.85e-01	1.23e-01	9.92e-01	8.81e-01	6.37e-01
PHAGOCYTOSIS	230	3.20e-02	2.70e-01	0.1870	-9.05e-02	-7.34e-02	-1.07e-01	-9.69e-02	-1.91e-02	1.81e-02	5.53e-02	5.05e-03	1.13e-02	6.17e-01
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	112	2.15e-02	2.13e-01	0.1870	3.41e-02	-9.54e-02	1.01e-01	1.05e-01	5.83e-02	5.33e-01	8.13e-02	6.44e-02	5.58e-02	2.87e-01
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT	58	1.65e-01	6.29e-01	0.1870	3.27e-03	-1.28e-01	9.76e-02	8.44e-02	4.18e-02	9.66e-01	9.14e-02	1.99e-01	2.66e-01	5.82e-01
REGULATION OF PROTEIN TARGETING	76	4.19e-01	8.59e-01	0.1860	8.95e-02	5.55e-03	1.02e-01	9.06e-02	9.01e-02	1.77e-01	9.33e-01	1.24e-01	1.72e-01	1.74e-01
PROTEIN K48 LINKED UBIQUITINATION	64	1.94e-01	6.69e-01	0.1860	2.95e-02	-5.91e-02	1.10e-01	8.19e-02	1.08e-01	6.83e-01	4.14e-01	1.28e-01	2.57e-01	1.36e-01
OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT	9	9.47e-01	9.97e-01	0.1860	-1.89e-02	4.98e-02	-1.01e-01	-1.16e-01	-9.09e-02	9.22e-01	7.96e-01	5.98e-01	5.48e-01	6.37e-01
REGULATION OF NEURON MATURATION	8	7.78e-01	9.79e-01	0.1860	-3.58e-02	-1.34e-01	1.06e-01	6.19e-02	-2.07e-02	8.61e-01	5.12e-01	6.02e-01	7.62e-01	9.19e-01
IMP METABOLIC PROCESS	17	9.51e-01	9.97e-01	0.1860	-4.10e-02	-2.34e-02	-9.94e-02	-9.14e-02	-1.20e-01	7.70e-01	8.67e-01	4.78e-01	5.14e-01	3.93e-01
MITRAL VALVE DEVELOPMENT	13	9.22e-01	9.95e-01	0.1860	-3.03e-02	-3.19e-02	-9.17e-02	-1.01e-01	-1.19e-01	8.50e-01	8.42e-01	5.67e-01	5.28e-01	4.57e-01
L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT	65	3.60e-01	8.25e-01	0.1860	1.07e-01	1.47e-01	1.29e-02	2.89e-02	-2.48e-02	1.35e-01	4.04e-02	8.57e-01	6.87e-01	7.30e-01
SECRETION BY TISSUE	44	4.33e-01	8.69e-01	0.1860	-1.10e-01	-5.34e-03	-9.98e-02	-1.05e-01	3.78e-02	2.05e-01	9.51e-01	2.52e-01	2.26e-01	6.64e-01
CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS	8	8.41e-01	9.85e-01	0.1860	1.13e-01	-1.49e-02	3.39e-02	5.01e-02	1.34e-01	5.78e-01	9.42e-01	8.68e-01	8.06e-01	5.12e-01
WALKING BEHAVIOR	35	3.50e-01	8.18e-01	0.1860	1.09e-01	5.29e-02	5.92e-02	4.38e-02	1.20e-01	2.62e-01	5.88e-01	5.45e-01	6.54e-01	2.18e-01
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION	20	8.73e-01	9.88e-01	0.1860	9.99e-02	1.16e-01	5.27e-02	4.54e-02	-8.06e-02	4.39e-01	3.71e-01	6.84e-01	7.25e-01	5.33e-01
PEPTIDYL TYROSINE DEPHOSPHORYLATION	30	7.56e-01	9.75e-01	0.1860	1.12e-01	6.51e-02	5.93e-02	6.30e-02	1.02e-01	2.90e-01	5.37e-01	5.74e-01	5.51e-01	3.33e-01
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION	61	7.39e-01	9.73e-01	0.1860	-9.06e-02	-3.85e-02	-1.11e-01	-1.11e-01	-1.00e-02	2.21e-01	6.03e-01	1.32e-01	1.33e-01	8.92e-01
CALCIUM ION IMPORT	46	4.99e-01	8.97e-01	0.1860	7.50e-02	1.39e-01	5.67e-02	7.03e-02	3.83e-02	3.79e-01	1.03e-01	5.06e-01	4.09e-01	6.53e-01
MONOUBIQUITINATED PROTEIN DEUBIQUITINATION	7	6.97e-01	9.62e-01	0.1860	-1.16e-01	6.77e-02	-2.13e-02	-4.63e-02	-1.18e-01	5.95e-01	7.56e-01	9.22e-01	8.32e-01	5.90e-01
EPITHELIAL CELL FATE COMMITMENT	14	3.34e-01	8.05e-01	0.1860	3.09e-02	-8.41e-02	-1.05e-01	-1.04e-01	-6.84e-02	8.41e-01	5.86e-01	4.98e-01	5.00e-01	6.58e-01
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	90	3.10e-02	2.65e-01	0.1850	2.09e-03	-1.41e-01	7.60e-02	7.20e-02	5.91e-02	9.73e-01	2.05e-02	2.13e-01	2.38e-01	3.32e-01
PROTEIN DEGLYCOSYLATION	15	5.11e-01	9.00e-01	0.1850	1.57e-01	4.75e-02	5.58e-02	4.40e-02	-5.00e-02	2.93e-01	7.50e-01	7.08e-01	7.68e-01	7.38e-01
ATP TRANSPORT	17	9.07e-01	9.94e-01	0.1850	6.20e-02	1.24e-01	-1.22e-02	-1.01e-02	-1.23e-01	6.58e-01	3.78e-01	9.31e-01	9.42e-01	3.82e-01
TYPE B PANCREATIC CELL DIFFERENTIATION	30	3.61e-01	8.25e-01	0.1850	-1.04e-03	-1.50e-01	3.02e-02	1.23e-02	1.04e-01	9.92e-01	1.55e-01	7.75e-01	9.07e-01	3.25e-01
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	14	8.24e-01	9.83e-01	0.1850	1.66e-02	-7.34e-03	-2.32e-03	2.80e-03	1.84e-01	9.15e-01	9.62e-01	9.88e-01	9.86e-01	2.32e-01
REGULATION OF PLASMINOGEN ACTIVATION	18	8.17e-01	9.83e-01	0.1850	-5.22e-02	-1.52e-01	-3.75e-02	-3.94e-02	7.43e-02	7.02e-01	2.65e-01	7.83e-01	7.72e-01	5.85e-01
VENOUS BLOOD VESSEL DEVELOPMENT	16	7.39e-01	9.73e-01	0.1850	6.82e-02	3.51e-02	6.06e-03	9.99e-04	-1.68e-01	6.37e-01	8.08e-01	9.67e-01	9.94e-01	2.44e-01
TRIGLYCERIDE BIOSYNTHETIC PROCESS	40	7.93e-01	9.81e-01	0.1850	-9.09e-02	-9.63e-02	-8.63e-02	-7.65e-02	-5.82e-02	3.20e-01	2.92e-01	3.45e-01	4.03e-01	5.24e-01
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	85	2.15e-01	6.97e-01	0.1850	6.46e-02	-1.64e-02	1.27e-01	1.17e-01	8.65e-03	3.03e-01	7.93e-01	4.36e-02	6.24e-02	8.90e-01
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION	35	5.03e-01	8.98e-01	0.1850	6.32e-02	1.30e-01	6.59e-02	8.30e-02	4.70e-02	5.17e-01	1.85e-01	5.00e-01	3.96e-01	6.31e-01
NEGATIVE REGULATION OF SODIUM ION TRANSPORT	17	8.17e-01	9.83e-01	0.1850	-4.87e-02	7.52e-02	-1.14e-01	-1.15e-01	-2.84e-03	7.28e-01	5.91e-01	4.17e-01	4.11e-01	9.84e-01
POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	41	7.10e-01	9.67e-01	0.1850	-8.94e-02	-1.40e-01	-3.13e-02	-3.41e-02	6.70e-02	3.22e-01	1.21e-01	7.28e-01	7.06e-01	4.58e-01
MESONEPHRIC TUBULE MORPHOGENESIS	64	2.41e-01	7.25e-01	0.1850	3.09e-02	-5.59e-02	9.37e-02	6.86e-02	1.29e-01	6.69e-01	4.39e-01	1.95e-01	3.42e-01	7.47e-02
PROTEIN LOCALIZATION TO NUCLEOLUS	18	5.14e-01	9.01e-01	0.1850	3.46e-02	-1.98e-02	1.22e-01	9.51e-02	-9.25e-02	7.99e-01	8.84e-01	3.69e-01	4.85e-01	4.97e-01
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	146	4.89e-02	3.45e-01	0.1850	5.06e-02	5.01e-02	7.03e-02	7.32e-02	1.37e-01	2.91e-01	2.96e-01	1.43e-01	1.27e-01	4.28e-03
ENDOTHELIAL CELL FATE COMMITMENT	8	4.37e-01	8.69e-01	0.1850	1.79e-01	-1.83e-02	2.62e-02	2.57e-02	-1.81e-02	3.80e-01	9.28e-01	8.98e-01	9.00e-01	9.30e-01
LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	55	1.64e-01	6.28e-01	0.1850	-6.35e-02	-1.05e-01	-9.67e-02	-7.94e-02	5.81e-02	4.15e-01	1.78e-01	2.15e-01	3.08e-01	4.56e-01
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	47	6.84e-01	9.61e-01	0.1850	9.53e-02	2.77e-02	1.11e-01	1.07e-01	-1.92e-02	2.59e-01	7.43e-01	1.87e-01	2.03e-01	8.20e-01
POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	7	9.62e-01	9.97e-01	0.1850	-9.16e-02	-9.03e-02	2.77e-02	2.03e-02	1.28e-01	6.75e-01	6.79e-01	8.99e-01	9.26e-01	5.58e-01
ESTABLISHMENT OF ENDOTHELIAL BARRIER	51	5.18e-01	9.03e-01	0.1850	-7.54e-02	-1.44e-01	1.48e-04	-5.48e-03	8.72e-02	3.51e-01	7.50e-02	9.99e-01	9.46e-01	2.81e-01
REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	45	1.47e-01	6.06e-01	0.1850	-2.62e-03	-1.61e-01	5.10e-02	3.13e-02	6.83e-02	9.76e-01	6.22e-02	5.54e-01	7.17e-01	4.28e-01
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	90	1.43e-01	6.00e-01	0.1850	-8.46e-02	-1.53e-01	-2.92e-02	-4.21e-02	-2.84e-02	1.66e-01	1.20e-02	6.32e-01	4.90e-01	6.42e-01
ESTROGEN BIOSYNTHETIC PROCESS	11	7.79e-01	9.79e-01	0.1840	9.67e-02	1.54e-01	-2.71e-02	1.60e-02	2.17e-03	5.79e-01	3.77e-01	8.76e-01	9.27e-01	9.90e-01
REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY	45	1.36e-02	1.57e-01	0.1840	1.43e-02	1.48e-01	2.25e-02	4.91e-02	9.54e-02	8.68e-01	8.67e-02	7.94e-01	5.69e-01	2.68e-01
NEGATIVE REGULATION OF ORGAN GROWTH	35	3.51e-01	8.18e-01	0.1840	-6.03e-02	-1.69e-01	-2.98e-02	-2.03e-02	-2.58e-02	5.37e-01	8.44e-02	7.60e-01	8.35e-01	7.92e-01
SINGLE FERTILIZATION	158	5.71e-03	9.04e-02	0.1840	8.64e-02	1.56e-01	1.72e-02	4.06e-02	-1.23e-02	6.10e-02	6.99e-04	7.09e-01	3.79e-01	7.89e-01
BLASTOCYST GROWTH	22	8.37e-01	9.85e-01	0.1840	9.96e-02	1.15e-02	1.16e-01	1.02e-01	-8.80e-03	4.19e-01	9.25e-01	3.48e-01	4.07e-01	9.43e-01
SULFUR AMINO ACID TRANSPORT	12	5.69e-01	9.25e-01	0.1840	5.13e-03	-3.42e-02	-8.04e-02	-5.10e-02	1.54e-01	9.75e-01	8.37e-01	6.30e-01	7.60e-01	3.56e-01
STRIATED MUSCLE CELL DEVELOPMENT	73	7.25e-02	4.33e-01	0.1840	-1.79e-02	1.29e-01	-7.96e-02	-6.29e-02	-8.22e-02	7.91e-01	5.73e-02	2.39e-01	3.53e-01	2.25e-01
INTRACELLULAR PH ELEVATION	7	8.10e-01	9.82e-01	0.1840	-1.09e-02	1.81e-01	6.28e-04	1.08e-02	-2.82e-02	9.60e-01	4.06e-01	9.98e-01	9.61e-01	8.97e-01
REGULATION OF POSTSYNAPSE ORGANIZATION	97	6.00e-01	9.33e-01	0.1840	-9.98e-02	-5.31e-02	-8.88e-02	-9.35e-02	-6.70e-02	8.93e-02	3.66e-01	1.31e-01	1.11e-01	2.54e-01
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS	44	4.82e-01	8.91e-01	0.1840	4.92e-02	-6.94e-02	8.55e-02	7.08e-02	1.20e-01	5.72e-01	4.26e-01	3.26e-01	4.17e-01	1.70e-01
CELLULAR RESPONSE TO CAMP	49	1.97e-01	6.75e-01	0.1840	-8.20e-02	-3.61e-02	-3.20e-02	-4.76e-02	1.50e-01	3.21e-01	6.62e-01	6.98e-01	5.64e-01	6.91e-02
SENSORY PERCEPTION OF PAIN	76	1.96e-01	6.73e-01	0.1840	2.55e-02	1.42e-02	5.03e-02	5.14e-02	1.67e-01	7.01e-01	8.31e-01	4.48e-01	4.39e-01	1.19e-02
ARTERY DEVELOPMENT	111	2.35e-01	7.19e-01	0.1840	9.83e-02	2.31e-03	9.91e-02	9.76e-02	6.93e-02	7.37e-02	9.66e-01	7.12e-02	7.55e-02	2.07e-01
BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS	20	7.64e-01	9.75e-01	0.1840	-5.80e-03	-1.34e-01	7.56e-02	5.42e-02	8.38e-02	9.64e-01	2.98e-01	5.58e-01	6.75e-01	5.16e-01
BASIC AMINO ACID TRANSPORT	21	7.46e-01	9.75e-01	0.1840	1.29e-02	1.41e-01	-7.87e-02	-7.09e-02	-4.93e-02	9.18e-01	2.63e-01	5.32e-01	5.74e-01	6.96e-01
MOLTING CYCLE PROCESS	93	1.61e-01	6.25e-01	0.1840	-7.96e-02	-1.18e-01	-7.13e-02	-8.90e-02	2.35e-02	1.85e-01	4.97e-02	2.35e-01	1.38e-01	6.95e-01
RESPONSE TO FOOD	35	2.23e-01	7.04e-01	0.1840	1.15e-01	1.64e-02	7.21e-02	5.16e-02	1.11e-01	2.38e-01	8.67e-01	4.60e-01	5.97e-01	2.56e-01
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS	54	8.36e-01	9.85e-01	0.1840	1.02e-01	4.17e-02	9.90e-02	9.78e-02	4.77e-02	1.96e-01	5.96e-01	2.08e-01	2.14e-01	5.44e-01
MAINTENANCE OF BLOOD BRAIN BARRIER	36	4.95e-01	8.96e-01	0.1840	-4.19e-02	-1.34e-01	7.66e-02	5.55e-02	7.10e-02	6.64e-01	1.64e-01	4.26e-01	5.65e-01	4.61e-01
NEGATIVE REGULATION OF PLATELET ACTIVATION	17	6.61e-01	9.54e-01	0.1840	1.15e-01	8.68e-02	-2.74e-02	-6.86e-03	-1.11e-01	4.12e-01	5.35e-01	8.45e-01	9.61e-01	4.30e-01
ICOSANOID TRANSPORT	63	6.36e-02	4.03e-01	0.1840	7.33e-02	1.58e-01	5.13e-04	2.80e-02	5.02e-02	3.14e-01	3.00e-02	9.94e-01	7.00e-01	4.90e-01
AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM	25	3.18e-01	7.91e-01	0.1840	8.17e-02	1.46e-01	-3.42e-02	-4.49e-02	5.01e-02	4.80e-01	2.06e-01	7.67e-01	6.98e-01	6.65e-01
OUTER DYNEIN ARM ASSEMBLY	23	7.92e-01	9.81e-01	0.1830	1.02e-01	9.25e-02	1.76e-02	2.48e-02	-1.18e-01	3.98e-01	4.42e-01	8.84e-01	8.37e-01	3.29e-01
MEGAKARYOCYTE DEVELOPMENT	22	5.18e-01	9.03e-01	0.1830	5.97e-02	5.33e-02	-3.41e-02	-4.55e-02	-1.55e-01	6.28e-01	6.65e-01	7.82e-01	7.12e-01	2.09e-01
TRANSFERRIN TRANSPORT	10	9.50e-01	9.97e-01	0.1830	-8.65e-02	-9.16e-02	-1.04e-01	-8.08e-02	-1.44e-02	6.36e-01	6.16e-01	5.68e-01	6.58e-01	9.37e-01
CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	20	3.62e-02	2.89e-01	0.1830	2.47e-02	-1.42e-01	7.36e-03	-3.88e-02	-1.05e-01	8.49e-01	2.70e-01	9.55e-01	7.64e-01	4.16e-01
CYCLOOXYGENASE PATHWAY	9	4.99e-01	8.97e-01	0.1830	7.41e-02	-1.26e-01	4.03e-02	2.00e-02	-1.00e-01	7.00e-01	5.13e-01	8.34e-01	9.17e-01	6.02e-01
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	22	6.25e-01	9.44e-01	0.1830	-9.09e-02	4.90e-02	-1.05e-01	-1.02e-01	3.42e-02	4.60e-01	6.91e-01	3.92e-01	4.06e-01	7.82e-01
GLYCEROPHOSPHOLIPID CATABOLIC PROCESS	34	3.89e-01	8.40e-01	0.1830	-8.28e-02	2.29e-02	-1.25e-01	-1.01e-01	1.29e-02	4.03e-01	8.17e-01	2.06e-01	3.08e-01	8.96e-01
POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	27	6.35e-01	9.48e-01	0.1830	1.45e-02	2.51e-02	-1.02e-01	-8.88e-02	-1.20e-01	8.96e-01	8.21e-01	3.60e-01	4.24e-01	2.82e-01
EPIDERMIS MORPHOGENESIS	36	5.19e-01	9.03e-01	0.1830	-5.68e-02	-1.25e-01	-7.83e-02	-8.06e-02	4.28e-02	5.55e-01	1.93e-01	4.16e-01	4.03e-01	6.57e-01
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT	139	1.30e-01	5.74e-01	0.1830	-8.87e-02	5.20e-03	-1.06e-01	-9.72e-02	-6.95e-02	7.10e-02	9.16e-01	3.12e-02	4.77e-02	1.57e-01
CHONDROCYTE DIFFERENTIATION	113	2.06e-01	6.84e-01	0.1830	-9.50e-02	-1.20e-01	-6.07e-02	-7.90e-02	-7.17e-03	8.11e-02	2.78e-02	2.65e-01	1.47e-01	8.95e-01
REGULATION OF DNA DAMAGE CHECKPOINT	23	6.76e-01	9.59e-01	0.1830	4.49e-02	-8.45e-02	1.17e-01	9.69e-02	3.16e-02	7.09e-01	4.83e-01	3.29e-01	4.21e-01	7.93e-01
REGULATION OF LONG TERM SYNAPTIC DEPRESSION	12	8.39e-01	9.85e-01	0.1830	-3.40e-02	-2.42e-02	5.07e-02	2.17e-02	1.69e-01	8.38e-01	8.85e-01	7.61e-01	8.97e-01	3.11e-01
RESPONSE TO MUSCLE ACTIVITY	28	5.61e-01	9.20e-01	0.1830	-2.06e-02	1.20e-01	-9.95e-02	-8.83e-02	-2.93e-02	8.50e-01	2.73e-01	3.62e-01	4.19e-01	7.89e-01
NEGATIVE REGULATION OF MEMBRANE PERMEABILITY	20	5.32e-01	9.07e-01	0.1830	8.47e-02	-6.72e-02	1.05e-01	7.81e-02	6.63e-02	5.12e-01	6.03e-01	4.14e-01	5.45e-01	6.08e-01
LEUKOCYTE DEGRANULATION	78	3.07e-02	2.63e-01	0.1820	-3.82e-02	-1.51e-01	-3.92e-02	-3.51e-02	7.96e-02	5.60e-01	2.13e-02	5.50e-01	5.92e-01	2.24e-01
BONE TRABECULA MORPHOGENESIS	13	6.81e-01	9.61e-01	0.1820	-6.27e-02	8.93e-02	-8.82e-02	-1.15e-01	-2.25e-02	6.96e-01	5.77e-01	5.82e-01	4.75e-01	8.88e-01
AMYLOID BETA METABOLIC PROCESS	64	1.09e-01	5.28e-01	0.1820	-1.16e-01	-1.29e-01	-1.70e-02	-1.43e-02	-5.14e-02	1.08e-01	7.38e-02	8.14e-01	8.43e-01	4.77e-01
REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	12	8.20e-01	9.83e-01	0.1820	2.25e-02	-1.37e-01	9.06e-02	7.12e-02	2.69e-02	8.93e-01	4.11e-01	5.87e-01	6.69e-01	8.72e-01
LIPID HOMEOSTASIS	170	3.00e-02	2.60e-01	0.1820	-1.15e-01	-9.12e-02	-8.09e-02	-7.07e-02	1.05e-02	9.48e-03	4.02e-02	6.87e-02	1.12e-01	8.14e-01
DOUBLE STRAND BREAK REPAIR	294	3.39e-04	1.06e-02	0.1820	8.78e-02	6.27e-03	1.17e-01	9.91e-02	4.43e-02	9.59e-03	8.53e-01	5.63e-04	3.47e-03	1.91e-01
FOREBRAIN GENERATION OF NEURONS	51	6.34e-03	9.56e-02	0.1820	4.49e-02	-8.46e-02	3.66e-02	1.35e-03	1.50e-01	5.79e-01	2.96e-01	6.51e-01	9.87e-01	6.31e-02
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	23	8.06e-01	9.82e-01	0.1820	-1.04e-01	-1.41e-01	-1.75e-02	-4.04e-02	-1.86e-02	3.87e-01	2.42e-01	8.84e-01	7.37e-01	8.77e-01
REGULATION OF PROTEIN ACETYLATION	38	4.82e-01	8.91e-01	0.1820	4.02e-02	-8.41e-02	5.96e-02	6.27e-02	1.30e-01	6.68e-01	3.69e-01	5.25e-01	5.03e-01	1.66e-01
REGULATION OF CARTILAGE DEVELOPMENT	70	8.05e-01	9.82e-01	0.1820	-8.61e-02	-5.83e-02	-9.46e-02	-9.89e-02	-5.90e-02	2.13e-01	3.99e-01	1.71e-01	1.53e-01	3.94e-01
REGULATION OF MACROPHAGE MIGRATION	45	5.48e-01	9.15e-01	0.1820	-7.89e-02	-6.12e-02	-1.14e-01	-9.79e-02	2.24e-02	3.60e-01	4.77e-01	1.87e-01	2.56e-01	7.95e-01
CELLULAR RESPONSE TO TYPE II INTERFERON	115	3.28e-01	8.01e-01	0.1820	6.44e-02	4.83e-02	8.94e-02	9.49e-02	9.73e-02	2.33e-01	3.71e-01	9.77e-02	7.87e-02	7.13e-02
HISTONE H3 K4 METHYLATION	18	6.90e-01	9.61e-01	0.1810	-3.98e-02	-6.63e-02	-9.60e-02	-1.18e-01	-6.28e-02	7.70e-01	6.26e-01	4.81e-01	3.88e-01	6.45e-01
REGULATION OF CALCIUM ION IMPORT	31	9.14e-01	9.94e-01	0.1810	7.66e-02	9.03e-02	8.76e-02	8.98e-02	5.61e-02	4.60e-01	3.84e-01	3.98e-01	3.87e-01	5.89e-01
REGULATION OF COAGULATION	73	4.41e-01	8.71e-01	0.1810	-8.06e-02	-1.29e-01	-6.53e-02	-7.49e-02	2.42e-03	2.34e-01	5.75e-02	3.35e-01	2.69e-01	9.71e-01
MULTINUCLEAR OSTEOCLAST DIFFERENTIATION	8	9.70e-01	9.97e-01	0.1810	-4.34e-02	-4.88e-02	-1.22e-01	-1.18e-01	-5.50e-03	8.32e-01	8.11e-01	5.52e-01	5.65e-01	9.79e-01
REGULATION OF SYNAPTIC VESICLE RECYCLING	24	6.21e-01	9.43e-01	0.1810	4.85e-02	6.95e-02	1.16e-01	8.90e-02	6.59e-02	6.81e-01	5.56e-01	3.26e-01	4.50e-01	5.76e-01
AMIDE BIOSYNTHETIC PROCESS	938	8.68e-16	2.19e-13	0.1810	6.65e-02	-3.73e-02	1.16e-01	1.16e-01	9.68e-03	5.52e-04	5.30e-02	1.53e-09	1.83e-09	6.15e-01
REGULATION OF LIPASE ACTIVITY	77	3.45e-01	8.16e-01	0.1810	-9.86e-02	-6.03e-02	-1.06e-01	-8.97e-02	-1.28e-02	1.35e-01	3.60e-01	1.07e-01	1.74e-01	8.46e-01
TRANS SYNAPTIC SIGNALING BY LIPID	7	8.01e-01	9.82e-01	0.1810	-4.11e-02	1.44e-01	-1.01e-02	-2.88e-02	-9.68e-02	8.51e-01	5.09e-01	9.63e-01	8.95e-01	6.57e-01
UTERUS MORPHOGENESIS	6	9.79e-01	9.97e-01	0.1810	-2.73e-02	1.04e-01	-9.58e-02	-7.32e-02	-8.14e-02	9.08e-01	6.58e-01	6.85e-01	7.56e-01	7.30e-01
ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT	6	9.90e-01	9.98e-01	0.1810	7.63e-02	1.48e-01	5.02e-02	4.75e-02	1.82e-02	7.46e-01	5.31e-01	8.31e-01	8.40e-01	9.38e-01
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	61	3.77e-01	8.36e-01	0.1810	-6.15e-02	3.91e-02	-1.20e-01	-1.13e-01	-1.34e-02	4.06e-01	5.97e-01	1.05e-01	1.25e-01	8.56e-01
RESPONSE TO NICOTINE	49	4.19e-01	8.59e-01	0.1810	5.02e-02	8.62e-02	1.05e-01	1.04e-01	3.02e-02	5.43e-01	2.97e-01	2.02e-01	2.09e-01	7.15e-01
HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE	32	1.69e-01	6.37e-01	0.1810	9.95e-02	-6.80e-02	8.36e-02	1.06e-01	1.78e-03	3.30e-01	5.06e-01	4.13e-01	3.01e-01	9.86e-01
PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE	11	6.16e-01	9.39e-01	0.1810	1.53e-01	8.84e-02	2.60e-03	-5.49e-03	-3.80e-02	3.80e-01	6.12e-01	9.88e-01	9.75e-01	8.27e-01
POSITIVE REGULATION OF MIRNA METABOLIC PROCESS	60	1.18e-01	5.49e-01	0.1810	3.83e-02	-1.15e-01	6.79e-02	5.96e-02	9.83e-02	6.08e-01	1.22e-01	3.63e-01	4.25e-01	1.88e-01
REGULATION OF SYNAPSE MATURATION	20	9.11e-01	9.94e-01	0.1810	1.31e-01	9.16e-02	5.72e-02	6.22e-02	4.71e-03	3.12e-01	4.78e-01	6.58e-01	6.30e-01	9.71e-01
REGULATION OF RESPONSE TO FOOD	14	3.41e-02	2.79e-01	0.1810	1.48e-01	2.31e-02	8.29e-02	1.48e-02	5.45e-02	3.37e-01	8.81e-01	5.91e-01	9.24e-01	7.24e-01
REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	6	9.84e-01	9.98e-01	0.1800	-6.00e-02	-7.84e-02	2.43e-02	2.90e-03	1.49e-01	7.99e-01	7.40e-01	9.18e-01	9.90e-01	5.27e-01
REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	15	8.26e-01	9.83e-01	0.1800	-3.64e-02	1.03e-01	-8.06e-02	-9.22e-02	-7.46e-02	8.07e-01	4.89e-01	5.89e-01	5.36e-01	6.17e-01
POSITIVE REGULATION OF ANOIKIS	6	7.14e-01	9.68e-01	0.1800	-1.02e-01	-4.30e-02	9.43e-02	9.79e-02	4.20e-02	6.65e-01	8.55e-01	6.89e-01	6.78e-01	8.59e-01
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	31	2.83e-01	7.62e-01	0.1800	7.05e-02	-1.08e-01	9.00e-02	7.99e-02	3.78e-02	4.97e-01	2.99e-01	3.86e-01	4.42e-01	7.16e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	45	8.01e-01	9.82e-01	0.1800	-9.43e-02	-8.94e-02	-7.68e-02	-8.47e-02	5.03e-02	2.74e-01	2.99e-01	3.73e-01	3.26e-01	5.60e-01
REGULATION OF MALE GONAD DEVELOPMENT	8	9.52e-01	9.97e-01	0.1800	9.96e-02	6.43e-02	1.70e-02	3.86e-02	-1.29e-01	6.26e-01	7.53e-01	9.34e-01	8.50e-01	5.28e-01
RESPONSE TO PLATELET DERIVED GROWTH FACTOR	21	9.15e-01	9.94e-01	0.1800	-9.60e-02	-1.81e-02	-1.00e-01	-1.13e-01	-7.99e-03	4.46e-01	8.86e-01	4.27e-01	3.69e-01	9.49e-01
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	124	2.67e-01	7.48e-01	0.1800	7.92e-02	4.68e-02	1.11e-01	9.81e-02	4.48e-02	1.27e-01	3.68e-01	3.25e-02	5.93e-02	3.89e-01
POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE	46	6.18e-02	3.97e-01	0.1800	-7.26e-02	7.82e-02	-8.73e-02	-1.04e-01	5.07e-02	3.94e-01	3.59e-01	3.06e-01	2.21e-01	5.52e-01
REGULATION OF BROWN FAT CELL DIFFERENTIATION	24	8.33e-02	4.59e-01	0.1800	1.61e-02	-1.24e-01	-9.53e-02	-8.48e-02	2.07e-02	8.92e-01	2.92e-01	4.19e-01	4.72e-01	8.60e-01
POSITIVE REGULATION OF RESPIRATORY BURST	7	8.54e-01	9.88e-01	0.1800	1.20e-02	1.78e-01	-2.99e-03	1.85e-02	1.90e-02	9.56e-01	4.16e-01	9.89e-01	9.32e-01	9.30e-01
POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	21	4.53e-01	8.77e-01	0.1800	-5.10e-02	-1.27e-01	-6.47e-02	-9.67e-02	1.54e-02	6.86e-01	3.15e-01	6.08e-01	4.43e-01	9.03e-01
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS	41	4.08e-01	8.51e-01	0.1800	-8.67e-02	-7.03e-02	-1.66e-02	-1.62e-02	1.39e-01	3.37e-01	4.36e-01	8.54e-01	8.58e-01	1.24e-01
PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX	18	6.47e-01	9.51e-01	0.1800	-6.63e-02	8.61e-02	-7.15e-02	-5.42e-02	-1.11e-01	6.26e-01	5.27e-01	5.99e-01	6.91e-01	4.13e-01
OLEFINIC COMPOUND BIOSYNTHETIC PROCESS	28	7.87e-01	9.81e-01	0.1800	-1.05e-01	-3.84e-02	-7.77e-02	-6.78e-02	-9.59e-02	3.38e-01	7.25e-01	4.77e-01	5.35e-01	3.80e-01
MYELOID DENDRITIC CELL ACTIVATION	29	6.01e-01	9.33e-01	0.1790	9.55e-02	6.54e-02	1.42e-02	2.86e-02	-1.33e-01	3.73e-01	5.42e-01	8.95e-01	7.90e-01	2.14e-01
POSITIVE REGULATION OF NEUTROPHIL MIGRATION	30	9.29e-02	4.86e-01	0.1790	2.82e-02	-3.58e-02	-7.07e-02	-5.20e-02	1.50e-01	7.89e-01	7.35e-01	5.02e-01	6.22e-01	1.56e-01
ANIMAL ORGAN MATURATION	30	4.20e-01	8.59e-01	0.1790	-3.57e-02	1.23e-01	-6.39e-02	-5.10e-02	-9.49e-02	7.35e-01	2.43e-01	5.45e-01	6.28e-01	3.68e-01
TETRAPYRROLE BIOSYNTHETIC PROCESS	31	6.08e-01	9.35e-01	0.1790	3.22e-02	-9.43e-02	7.69e-02	5.93e-02	1.13e-01	7.57e-01	3.64e-01	4.59e-01	5.68e-01	2.77e-01
RETINAL ROD CELL DIFFERENTIATION	14	6.83e-01	9.61e-01	0.1790	1.42e-01	3.97e-02	3.50e-02	5.29e-02	7.98e-02	3.58e-01	7.97e-01	8.21e-01	7.32e-01	6.05e-01
REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	16	8.86e-01	9.91e-01	0.1790	6.69e-02	1.63e-01	2.23e-02	2.36e-02	1.35e-04	6.43e-01	2.59e-01	8.77e-01	8.70e-01	9.99e-01
REGULATION OF GLOMERULAR FILTRATION	8	9.62e-01	9.97e-01	0.1790	2.97e-02	1.34e-01	-4.60e-02	-1.96e-02	-1.03e-01	8.84e-01	5.11e-01	8.22e-01	9.24e-01	6.14e-01
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	27	9.56e-01	9.97e-01	0.1790	8.26e-02	1.22e-02	1.03e-01	1.05e-01	5.84e-02	4.58e-01	9.13e-01	3.55e-01	3.44e-01	5.99e-01
NERVOUS SYSTEM PROCESS	1405	8.73e-16	2.19e-13	0.1790	-1.02e-01	-1.93e-02	-1.02e-01	-1.03e-01	-2.21e-03	1.21e-10	2.26e-01	1.29e-10	8.02e-11	8.89e-01
POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	7	8.57e-01	9.88e-01	0.1790	-1.40e-01	-5.15e-02	2.06e-03	-2.10e-02	9.59e-02	5.20e-01	8.14e-01	9.92e-01	9.23e-01	6.60e-01
REGULATION OF CHONDROCYTE DIFFERENTIATION	52	8.63e-01	9.88e-01	0.1790	-1.08e-01	-8.83e-02	-7.40e-02	-7.93e-02	-2.85e-02	1.79e-01	2.71e-01	3.56e-01	3.23e-01	7.22e-01
HORMONE METABOLIC PROCESS	233	1.08e-01	5.26e-01	0.1790	-9.96e-02	-9.75e-02	-7.74e-02	-7.94e-02	1.55e-02	8.81e-03	1.03e-02	4.19e-02	3.67e-02	6.83e-01
NEURON REMODELING	15	7.43e-01	9.74e-01	0.1790	1.08e-02	1.30e-01	-1.06e-02	-2.76e-02	-1.19e-01	9.42e-01	3.85e-01	9.44e-01	8.53e-01	4.25e-01
REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	219	4.80e-03	7.91e-02	0.1790	5.78e-02	-5.41e-02	1.11e-01	1.03e-01	5.22e-02	1.41e-01	1.67e-01	4.82e-03	8.31e-03	1.83e-01
POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY	8	8.85e-01	9.91e-01	0.1790	-5.76e-02	-1.12e-02	5.37e-02	2.76e-02	1.58e-01	7.78e-01	9.56e-01	7.93e-01	8.92e-01	4.40e-01
CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION	51	3.32e-01	8.04e-01	0.1790	-7.66e-02	-9.97e-03	-9.54e-02	-1.03e-01	7.82e-02	3.44e-01	9.02e-01	2.38e-01	2.01e-01	3.34e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	118	3.03e-01	7.75e-01	0.1790	-8.95e-02	-6.76e-02	-8.74e-02	-1.03e-01	-3.23e-02	9.29e-02	2.05e-01	1.01e-01	5.33e-02	5.45e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE	437	1.82e-05	9.52e-04	0.1790	6.50e-02	-3.66e-02	1.12e-01	1.02e-01	5.71e-02	1.97e-02	1.89e-01	5.51e-05	2.57e-04	4.08e-02
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION	18	9.23e-01	9.95e-01	0.1790	8.40e-02	1.32e-01	-6.35e-03	3.59e-03	-8.51e-02	5.37e-01	3.31e-01	9.63e-01	9.79e-01	5.32e-01
INFLAMMASOME MEDIATED SIGNALING PATHWAY	39	6.93e-01	9.61e-01	0.1780	-8.53e-02	-1.09e-01	-2.05e-02	-2.37e-02	1.08e-01	3.57e-01	2.39e-01	8.24e-01	7.98e-01	2.42e-01
REGULATION OF NEURON APOPTOTIC PROCESS	224	9.57e-03	1.26e-01	0.1780	9.45e-02	-3.48e-03	8.97e-02	8.81e-02	8.41e-02	1.48e-02	9.29e-01	2.07e-02	2.31e-02	3.01e-02
NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	61	7.17e-01	9.68e-01	0.1780	-8.67e-02	-6.03e-02	-9.43e-02	-1.07e-01	-1.93e-02	2.41e-01	4.16e-01	2.03e-01	1.49e-01	7.94e-01
REGULATION OF GLUCOSE IMPORT	58	3.80e-01	8.37e-01	0.1780	-6.84e-02	-8.61e-02	-6.92e-02	-5.59e-02	-1.09e-01	3.68e-01	2.57e-01	3.62e-01	4.62e-01	1.52e-01
MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	15	5.31e-01	9.07e-01	0.1780	-1.68e-02	8.46e-02	-4.52e-02	-6.76e-02	1.33e-01	9.10e-01	5.70e-01	7.62e-01	6.51e-01	3.72e-01
GLOMERULAR EPITHELIAL CELL DIFFERENTIATION	21	8.36e-01	9.85e-01	0.1780	-1.05e-01	-7.92e-02	-6.62e-02	-5.29e-02	-8.57e-02	4.05e-01	5.30e-01	5.99e-01	6.75e-01	4.97e-01
CALCIUM ION TRANSPORT INTO CYTOSOL	28	4.81e-01	8.91e-01	0.1780	-1.04e-02	-4.49e-02	-3.63e-02	-3.09e-02	1.66e-01	9.24e-01	6.81e-01	7.40e-01	7.77e-01	1.30e-01
NEGATIVE REGULATION OF NEURON DIFFERENTIATION	72	5.76e-02	3.81e-01	0.1780	8.88e-02	-3.60e-02	8.58e-02	6.72e-02	1.04e-01	1.93e-01	5.97e-01	2.08e-01	3.24e-01	1.29e-01
CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	31	1.33e-01	5.80e-01	0.1780	9.95e-02	-9.55e-02	7.11e-02	7.15e-02	5.09e-02	3.38e-01	3.57e-01	4.93e-01	4.91e-01	6.24e-01
DORSAL VENTRAL NEURAL TUBE PATTERNING	24	1.84e-01	6.56e-01	0.1780	2.22e-02	-1.36e-01	7.82e-02	3.40e-02	7.35e-02	8.51e-01	2.47e-01	5.07e-01	7.73e-01	5.33e-01
IMMATURE T CELL PROLIFERATION	12	8.60e-01	9.88e-01	0.1780	-5.56e-02	-8.50e-02	-8.29e-02	-1.10e-01	-4.98e-02	7.39e-01	6.10e-01	6.19e-01	5.10e-01	7.65e-01
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	58	3.82e-01	8.38e-01	0.1780	3.72e-02	-7.46e-03	1.17e-01	9.32e-02	8.95e-02	6.24e-01	9.22e-01	1.24e-01	2.20e-01	2.38e-01
POSITIVE REGULATION OF SYNAPSE MATURATION	9	8.41e-01	9.85e-01	0.1780	2.83e-02	1.75e-01	-9.20e-03	1.67e-02	1.50e-04	8.83e-01	3.64e-01	9.62e-01	9.31e-01	9.99e-01
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS	18	6.57e-01	9.54e-01	0.1780	-1.27e-03	1.30e-01	-3.69e-02	-5.46e-02	-1.02e-01	9.93e-01	3.40e-01	7.86e-01	6.88e-01	4.53e-01
DIGESTION	128	4.69e-02	3.38e-01	0.1780	-7.00e-02	5.42e-02	-9.16e-02	-9.26e-02	-8.29e-02	1.71e-01	2.89e-01	7.35e-02	7.03e-02	1.05e-01
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	47	5.98e-01	9.33e-01	0.1780	-9.37e-02	-3.20e-02	-1.02e-01	-9.65e-02	4.54e-02	2.66e-01	7.04e-01	2.24e-01	2.53e-01	5.90e-01
MEIOTIC CHROMOSOME SEPARATION	8	9.54e-01	9.97e-01	0.1780	8.62e-02	1.19e-01	1.92e-02	4.94e-03	-9.81e-02	6.73e-01	5.59e-01	9.25e-01	9.81e-01	6.31e-01
POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	6	6.64e-01	9.54e-01	0.1780	5.12e-02	-1.49e-01	-3.94e-02	-1.36e-02	-7.03e-02	8.28e-01	5.26e-01	8.67e-01	9.54e-01	7.66e-01
PROTEIN DNA COMPLEX ORGANIZATION	796	7.60e-12	1.30e-09	0.1780	9.55e-02	2.73e-02	1.08e-01	9.74e-02	-2.36e-02	4.59e-06	1.91e-01	1.99e-07	2.93e-06	2.57e-01
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS	158	2.55e-02	2.37e-01	0.1780	8.66e-02	-1.69e-02	8.28e-02	7.94e-02	1.03e-01	6.02e-02	7.13e-01	7.25e-02	8.48e-02	2.52e-02
INDUCTION OF POSITIVE CHEMOTAXIS	13	9.61e-01	9.97e-01	0.1780	-1.28e-01	-1.01e-01	-4.81e-02	-5.22e-02	-3.87e-04	4.25e-01	5.29e-01	7.64e-01	7.44e-01	9.98e-01
PROTEIN LOCALIZATION TO VACUOLE	85	2.04e-01	6.84e-01	0.1780	-7.19e-02	-1.52e-01	4.03e-03	-1.11e-02	5.54e-02	2.52e-01	1.53e-02	9.49e-01	8.59e-01	3.77e-01
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION	121	7.22e-03	1.05e-01	0.1780	-5.12e-02	-1.51e-01	-3.26e-02	-4.96e-02	5.14e-02	3.31e-01	4.16e-03	5.36e-01	3.46e-01	3.29e-01
CELLULAR RESPONSE TO AMYLOID BETA	45	9.19e-02	4.83e-01	0.1780	-7.71e-02	-8.10e-02	-8.46e-02	-5.41e-02	9.46e-02	3.71e-01	3.47e-01	3.26e-01	5.30e-01	2.72e-01
NLS BEARING PROTEIN IMPORT INTO NUCLEUS	19	7.54e-01	9.75e-01	0.1770	4.25e-02	1.04e-01	2.41e-02	1.05e-02	-1.35e-01	7.49e-01	4.34e-01	8.56e-01	9.37e-01	3.08e-01
MESODERMAL CELL DIFFERENTIATION	34	4.76e-02	3.41e-01	0.1770	5.09e-02	-1.33e-01	2.53e-02	7.50e-03	1.03e-01	6.07e-01	1.80e-01	7.98e-01	9.40e-01	2.99e-01
SPINDLE ORGANIZATION	194	1.47e-02	1.64e-01	0.1770	8.37e-02	-1.56e-02	1.13e-01	1.03e-01	2.74e-02	4.44e-02	7.07e-01	6.56e-03	1.31e-02	5.11e-01
NEGATIVE REGULATION OF VASCULAR PERMEABILITY	18	9.40e-01	9.97e-01	0.1770	-1.15e-01	-3.14e-02	-8.82e-02	-8.54e-02	-4.65e-02	3.98e-01	8.18e-01	5.17e-01	5.30e-01	7.32e-01
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	31	5.14e-01	9.01e-01	0.1770	-8.48e-02	-1.16e-05	-1.12e-01	-9.41e-02	5.34e-02	4.14e-01	1.00e+00	2.80e-01	3.64e-01	6.07e-01
LONG TERM SYNAPTIC DEPRESSION	30	9.32e-01	9.97e-01	0.1770	6.89e-02	4.94e-02	1.05e-01	9.62e-02	6.33e-02	5.14e-01	6.39e-01	3.20e-01	3.62e-01	5.49e-01
POSITIVE REGULATION OF AMIDE METABOLIC PROCESS	155	1.32e-02	1.55e-01	0.1770	3.91e-02	-6.30e-02	1.10e-01	1.12e-01	3.60e-02	4.00e-01	1.76e-01	1.78e-02	1.63e-02	4.39e-01
ENDODERMAL CELL FATE COMMITMENT	15	4.89e-01	8.92e-01	0.1770	-5.48e-02	-1.34e-01	-3.75e-02	-8.16e-02	-4.81e-02	7.13e-01	3.67e-01	8.01e-01	5.84e-01	7.47e-01
INDOLE CONTAINING COMPOUND METABOLIC PROCESS	22	9.58e-01	9.97e-01	0.1770	-9.07e-02	-9.03e-02	-8.99e-02	-8.19e-02	-1.46e-02	4.61e-01	4.64e-01	4.65e-01	5.06e-01	9.05e-01
HEART TRABECULA FORMATION	15	6.94e-01	9.61e-01	0.1770	2.07e-02	-3.26e-02	4.48e-02	3.05e-02	-1.64e-01	8.89e-01	8.27e-01	7.64e-01	8.38e-01	2.71e-01
PROTEIN O LINKED MANNOSYLATION	17	7.11e-01	9.67e-01	0.1770	-1.02e-01	-6.97e-02	-2.72e-02	-1.86e-02	-1.22e-01	4.67e-01	6.19e-01	8.46e-01	8.94e-01	3.82e-01
TISSUE REMODELING	179	1.37e-01	5.89e-01	0.1770	-7.50e-02	-6.00e-02	-1.04e-01	-1.06e-01	-7.07e-03	8.36e-02	1.66e-01	1.61e-02	1.47e-02	8.70e-01
RESPONSE TO PH	41	2.88e-01	7.66e-01	0.1770	7.44e-02	1.34e-01	6.49e-03	3.12e-02	8.30e-02	4.10e-01	1.39e-01	9.43e-01	7.30e-01	3.58e-01
PHOSPHATIDYLINOSITOL MEDIATED SIGNALING	26	8.24e-01	9.83e-01	0.1770	-2.95e-02	8.68e-02	-8.69e-02	-8.47e-02	-9.03e-02	7.95e-01	4.43e-01	4.43e-01	4.55e-01	4.25e-01
GERM CELL PROLIFERATION	10	1.50e-01	6.12e-01	0.1770	1.43e-01	6.70e-02	-1.61e-02	-6.34e-02	-4.66e-02	4.35e-01	7.14e-01	9.30e-01	7.28e-01	7.98e-01
NEGATIVE REGULATION OF GLUCONEOGENESIS	18	8.04e-01	9.82e-01	0.1770	-8.43e-02	4.50e-02	-1.12e-01	-9.55e-02	-2.15e-02	5.36e-01	7.41e-01	4.10e-01	4.83e-01	8.75e-01
CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY	8	8.69e-01	9.88e-01	0.1770	-5.17e-02	-2.11e-03	-9.33e-03	1.15e-02	-1.68e-01	8.00e-01	9.92e-01	9.64e-01	9.55e-01	4.09e-01
PHOSPHOLIPID HOMEOSTASIS	16	7.67e-01	9.75e-01	0.1770	-3.08e-02	-1.56e-01	5.44e-02	5.59e-02	3.20e-03	8.31e-01	2.81e-01	7.07e-01	6.99e-01	9.82e-01
CELL RECOGNITION	153	5.74e-04	1.58e-02	0.1770	5.58e-02	1.61e-01	1.89e-02	4.04e-02	-6.66e-03	2.33e-01	5.65e-04	6.87e-01	3.89e-01	8.87e-01
NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	13	7.54e-01	9.75e-01	0.1770	-4.40e-02	6.84e-02	-8.39e-02	-1.13e-01	-6.91e-02	7.84e-01	6.69e-01	6.00e-01	4.80e-01	6.66e-01
CHROMOSOME LOCALIZATION	117	7.08e-02	4.27e-01	0.1770	8.24e-02	-6.10e-03	1.11e-01	1.06e-01	-2.69e-02	1.24e-01	9.09e-01	3.78e-02	4.70e-02	6.15e-01
REGULATION OF THYMOCYTE APOPTOTIC PROCESS	14	5.50e-01	9.15e-01	0.1770	3.87e-02	1.19e-01	8.87e-02	5.12e-02	7.10e-02	8.02e-01	4.41e-01	5.65e-01	7.40e-01	6.46e-01
POSITIVE REGULATION OF PLATELET AGGREGATION	11	4.84e-01	8.91e-01	0.1770	4.12e-02	-5.87e-02	-6.29e-02	-7.62e-02	1.28e-01	8.13e-01	7.36e-01	7.18e-01	6.62e-01	4.64e-01
EPIGENETIC REGULATION OF GENE EXPRESSION	210	1.92e-02	1.98e-01	0.1770	9.96e-02	4.55e-02	1.00e-01	9.23e-02	-2.53e-02	1.29e-02	2.56e-01	1.24e-02	2.11e-02	5.27e-01
PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS	24	4.19e-01	8.59e-01	0.1760	-6.90e-02	-2.61e-02	-1.20e-01	-8.70e-02	6.15e-02	5.59e-01	8.25e-01	3.10e-01	4.61e-01	6.02e-01
REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	15	7.92e-01	9.81e-01	0.1760	1.12e-01	1.28e-01	-1.05e-02	2.52e-02	-3.83e-02	4.53e-01	3.91e-01	9.44e-01	8.66e-01	7.97e-01
DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM	85	1.37e-03	3.14e-02	0.1760	1.35e-02	6.43e-02	-1.24e-01	-9.85e-02	3.95e-02	8.30e-01	3.05e-01	4.73e-02	1.16e-01	5.29e-01
RESPONSE TO ESTRADIOL	111	7.51e-02	4.40e-01	0.1760	1.03e-02	-1.00e-01	8.23e-02	6.61e-02	9.90e-02	8.52e-01	6.85e-02	1.34e-01	2.29e-01	7.15e-02
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I	8	8.51e-01	9.88e-01	0.1760	1.04e-01	1.40e-02	8.96e-02	5.33e-02	9.58e-02	6.10e-01	9.45e-01	6.61e-01	7.94e-01	6.39e-01
PROTEIN CONTAINING COMPLEX ASSEMBLY	1523	3.88e-16	1.08e-13	0.1760	8.26e-02	3.64e-03	1.11e-01	1.09e-01	8.20e-03	6.94e-08	8.12e-01	4.82e-13	1.19e-12	5.92e-01
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	132	3.27e-04	1.03e-02	0.1760	8.92e-02	-4.41e-02	9.72e-02	7.21e-02	8.05e-02	7.69e-02	3.82e-01	5.39e-02	1.53e-01	1.10e-01
STRIATUM DEVELOPMENT	20	5.19e-01	9.03e-01	0.1760	1.94e-02	1.55e-02	-2.06e-02	-4.46e-02	-1.67e-01	8.80e-01	9.05e-01	8.73e-01	7.30e-01	1.95e-01
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION	48	5.48e-01	9.15e-01	0.1760	-4.92e-03	-1.04e-01	6.55e-02	5.16e-02	1.15e-01	9.53e-01	2.11e-01	4.32e-01	5.36e-01	1.70e-01
EMBRYONIC HEART TUBE DEVELOPMENT	83	1.68e-02	1.81e-01	0.1760	7.32e-02	-8.42e-02	8.59e-02	7.12e-02	7.77e-02	2.49e-01	1.85e-01	1.76e-01	2.62e-01	2.21e-01
METANEPHRIC TUBULE FORMATION	6	9.21e-01	9.95e-01	0.1760	-3.41e-02	-2.93e-02	5.28e-02	1.04e-02	1.61e-01	8.85e-01	9.01e-01	8.23e-01	9.65e-01	4.94e-01
REGULATION OF ANIMAL ORGAN FORMATION	27	2.95e-01	7.71e-01	0.1760	-4.81e-02	-1.48e-01	2.09e-03	-3.87e-02	7.21e-02	6.66e-01	1.83e-01	9.85e-01	7.28e-01	5.17e-01
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	26	5.93e-01	9.32e-01	0.1760	-5.06e-02	9.22e-02	-1.06e-01	-9.14e-02	-1.74e-02	6.55e-01	4.16e-01	3.50e-01	4.20e-01	8.78e-01
TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER	12	8.80e-01	9.89e-01	0.1760	3.41e-02	1.13e-01	3.74e-02	5.29e-02	-1.13e-01	8.38e-01	5.00e-01	8.23e-01	7.51e-01	4.96e-01
POSITIVE REGULATION OF PEPTIDASE ACTIVITY	167	3.09e-02	2.64e-01	0.1760	4.17e-02	-6.06e-02	7.53e-02	7.18e-02	1.21e-01	3.52e-01	1.76e-01	9.30e-02	1.10e-01	7.01e-03
COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	24	7.05e-01	9.65e-01	0.1760	7.61e-02	1.09e-02	1.15e-01	9.64e-02	-4.92e-02	5.19e-01	9.27e-01	3.30e-01	4.14e-01	6.76e-01
ACTIN NUCLEATION	55	6.63e-01	9.54e-01	0.1760	3.45e-02	-2.15e-02	8.12e-02	7.04e-02	1.33e-01	6.58e-01	7.83e-01	2.98e-01	3.66e-01	8.87e-02
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	9	7.21e-01	9.69e-01	0.1750	-5.79e-04	-1.57e-01	-3.67e-02	-5.10e-02	-4.80e-02	9.98e-01	4.16e-01	8.49e-01	7.91e-01	8.03e-01
RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI	9	8.18e-01	9.83e-01	0.1750	-2.80e-02	-1.49e-01	-1.47e-02	-4.02e-02	-7.75e-02	8.85e-01	4.39e-01	9.39e-01	8.34e-01	6.87e-01
ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION	5	9.53e-01	9.97e-01	0.1750	-3.29e-02	-1.61e-01	-2.83e-02	-5.10e-02	-1.50e-02	8.99e-01	5.32e-01	9.13e-01	8.43e-01	9.54e-01
VESICLE FUSION TO PLASMA MEMBRANE	24	6.50e-01	9.51e-01	0.1750	-1.16e-02	-4.80e-02	8.40e-02	9.53e-02	1.10e-01	9.22e-01	6.84e-01	4.76e-01	4.19e-01	3.49e-01
REGULATION OF PROTEIN NEDDYLATION	19	5.11e-01	9.00e-01	0.1750	-7.27e-03	-1.26e-01	1.03e-01	6.55e-02	1.06e-02	9.56e-01	3.44e-01	4.39e-01	6.21e-01	9.36e-01
PROSTATE GLAND GROWTH	10	8.86e-01	9.91e-01	0.1750	7.44e-02	1.20e-01	-7.81e-02	-5.40e-02	-4.35e-02	6.84e-01	5.13e-01	6.69e-01	7.68e-01	8.12e-01
REGULATION OF KIDNEY DEVELOPMENT	32	4.16e-01	8.56e-01	0.1750	2.61e-02	-9.20e-02	8.92e-02	5.74e-02	1.02e-01	7.98e-01	3.68e-01	3.82e-01	5.74e-01	3.20e-01
GLUTAMATE METABOLIC PROCESS	32	8.53e-01	9.88e-01	0.1750	-8.28e-02	-8.78e-02	-8.10e-02	-9.77e-02	-4.79e-03	4.17e-01	3.90e-01	4.28e-01	3.39e-01	9.63e-01
MRNA METABOLIC PROCESS	743	9.71e-11	1.43e-08	0.1750	7.98e-02	-2.46e-03	1.11e-01	1.07e-01	-2.03e-02	2.14e-04	9.09e-01	2.39e-07	6.07e-07	3.46e-01
NEGATIVE REGULATION OF EXOCYTOSIS	32	6.18e-01	9.41e-01	0.1750	-3.24e-02	-1.52e-01	4.34e-02	3.13e-02	6.11e-02	7.51e-01	1.37e-01	6.71e-01	7.59e-01	5.49e-01
POSITIVE REGULATION OF ENDOCYTIC RECYCLING	8	9.92e-01	9.99e-01	0.1750	-3.33e-02	5.16e-02	-7.74e-02	-7.58e-02	-1.23e-01	8.70e-01	8.00e-01	7.05e-01	7.11e-01	5.47e-01
POSITIVE REGULATION OF PROTEIN DEACETYLATION	10	5.22e-01	9.04e-01	0.1750	1.80e-02	1.04e-01	5.69e-02	1.01e-01	-7.80e-02	9.21e-01	5.71e-01	7.55e-01	5.79e-01	6.69e-01
GAMMA AMINOBUTYRIC ACID IMPORT	6	8.76e-01	9.88e-01	0.1750	-1.25e-01	-7.93e-02	1.30e-03	1.81e-02	9.21e-02	5.97e-01	7.37e-01	9.96e-01	9.39e-01	6.96e-01
POSITIVE REGULATION OF AMYLOID BETA FORMATION	20	3.14e-01	7.86e-01	0.1750	-1.35e-01	-7.98e-02	-5.99e-02	-2.92e-02	3.81e-02	2.94e-01	5.37e-01	6.43e-01	8.21e-01	7.68e-01
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY	45	2.68e-01	7.48e-01	0.1750	-3.95e-02	-7.50e-02	-9.51e-02	-9.61e-02	7.15e-02	6.47e-01	3.84e-01	2.70e-01	2.65e-01	4.06e-01
PROGESTERONE RECEPTOR SIGNALING PATHWAY	11	9.10e-01	9.94e-01	0.1750	-6.14e-02	-9.02e-02	-1.59e-02	-4.57e-02	1.28e-01	7.24e-01	6.04e-01	9.27e-01	7.93e-01	4.64e-01
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	52	4.90e-01	8.93e-01	0.1750	-6.77e-02	2.90e-03	-1.03e-01	-1.19e-01	-3.57e-02	3.98e-01	9.71e-01	2.00e-01	1.39e-01	6.56e-01
AMINO ACID TRANSMEMBRANE TRANSPORT	93	1.72e-01	6.44e-01	0.1750	1.08e-01	1.33e-01	1.17e-02	2.89e-02	-1.33e-02	7.14e-02	2.69e-02	8.45e-01	6.30e-01	8.25e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE	33	7.46e-02	4.40e-01	0.1750	1.15e-02	-7.07e-02	-1.16e-01	-1.08e-01	-1.58e-02	9.09e-01	4.82e-01	2.50e-01	2.82e-01	8.75e-01
SURFACTANT HOMEOSTASIS	17	1.20e-01	5.52e-01	0.1740	-8.78e-02	-4.67e-02	-3.93e-02	1.08e-02	1.37e-01	5.31e-01	7.39e-01	7.79e-01	9.38e-01	3.27e-01
REGULATION OF ERYTHROCYTE DIFFERENTIATION	44	2.53e-01	7.37e-01	0.1740	4.85e-02	-1.02e-01	9.32e-02	7.51e-02	5.70e-02	5.78e-01	2.40e-01	2.85e-01	3.89e-01	5.13e-01
POSITIVE REGULATION OF MACROAUTOPHAGY	71	2.55e-01	7.38e-01	0.1740	-7.54e-02	-1.43e-01	-3.48e-02	-5.38e-02	-1.12e-02	2.72e-01	3.74e-02	6.12e-01	4.33e-01	8.70e-01
PEPTIDE METABOLIC PROCESS	930	4.33e-16	1.16e-13	0.1740	5.87e-02	-4.25e-02	1.12e-01	1.12e-01	3.53e-03	2.39e-03	2.78e-02	7.62e-09	6.78e-09	8.55e-01
METHYLGLYOXAL METABOLIC PROCESS	6	9.74e-01	9.97e-01	0.1740	-1.21e-01	-1.04e-01	6.25e-03	-4.92e-03	7.02e-02	6.09e-01	6.60e-01	9.79e-01	9.83e-01	7.66e-01
LAYER FORMATION IN CEREBRAL CORTEX	14	8.65e-01	9.88e-01	0.1740	-6.72e-02	3.85e-02	-6.91e-02	-9.04e-02	-1.06e-01	6.63e-01	8.03e-01	6.54e-01	5.58e-01	4.91e-01
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS	38	6.31e-01	9.47e-01	0.1740	-8.25e-02	-1.38e-01	4.78e-04	-2.37e-02	6.18e-02	3.79e-01	1.41e-01	9.96e-01	8.01e-01	5.10e-01
POSITIVE REGULATION OF WOUND HEALING	61	6.66e-01	9.55e-01	0.1740	-9.36e-02	-1.17e-01	-4.27e-02	-4.83e-02	6.01e-02	2.06e-01	1.14e-01	5.64e-01	5.14e-01	4.17e-01
NEUROBLAST DIVISION	13	6.75e-01	9.59e-01	0.1740	3.11e-02	2.41e-02	9.52e-02	6.62e-02	-1.23e-01	8.46e-01	8.80e-01	5.52e-01	6.80e-01	4.41e-01
PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS	50	2.68e-01	7.48e-01	0.1740	-2.94e-02	-1.51e-01	2.54e-02	6.03e-03	7.61e-02	7.19e-01	6.44e-02	7.56e-01	9.41e-01	3.52e-01
INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	53	1.07e-01	5.25e-01	0.1740	-4.94e-03	-1.53e-01	6.53e-02	4.66e-02	1.84e-02	9.50e-01	5.40e-02	4.11e-01	5.58e-01	8.17e-01
NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	18	3.22e-01	7.96e-01	0.1740	5.22e-02	4.68e-02	-4.45e-02	-6.61e-03	1.52e-01	7.01e-01	7.31e-01	7.44e-01	9.61e-01	2.63e-01
NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	13	7.54e-01	9.75e-01	0.1740	-7.25e-02	-1.55e-01	-1.28e-02	1.09e-02	2.33e-02	6.51e-01	3.33e-01	9.36e-01	9.46e-01	8.84e-01
NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY	22	5.61e-01	9.20e-01	0.1740	1.09e-03	-1.57e-01	2.49e-02	2.32e-02	6.58e-02	9.93e-01	2.02e-01	8.40e-01	8.50e-01	5.93e-01
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	15	7.61e-01	9.75e-01	0.1740	4.53e-02	1.57e-01	2.56e-02	1.44e-02	5.03e-02	7.61e-01	2.92e-01	8.63e-01	9.23e-01	7.36e-01
REGULATION OF TOLERANCE INDUCTION	19	5.27e-01	9.06e-01	0.1740	-7.24e-03	2.13e-02	1.07e-01	7.37e-02	1.13e-01	9.56e-01	8.72e-01	4.18e-01	5.78e-01	3.95e-01
NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	5	8.75e-01	9.88e-01	0.1730	-9.55e-02	-1.07e-01	-3.16e-02	-9.20e-02	-8.31e-03	7.12e-01	6.79e-01	9.03e-01	7.22e-01	9.74e-01
POSITIVE REGULATION OF COAGULATION	30	6.37e-01	9.48e-01	0.1730	-1.44e-02	-1.38e-01	4.18e-02	2.68e-02	9.19e-02	8.91e-01	1.92e-01	6.92e-01	7.99e-01	3.84e-01
NEGATIVE REGULATION OF CIRCADIAN RHYTHM	11	9.03e-01	9.94e-01	0.1730	-5.16e-03	-2.18e-02	1.22e-01	1.04e-01	6.36e-02	9.76e-01	9.00e-01	4.85e-01	5.52e-01	7.15e-01
POSITIVE REGULATION OF PLASMINOGEN ACTIVATION	8	9.80e-01	9.97e-01	0.1730	4.40e-02	-6.34e-02	6.39e-02	5.58e-02	1.30e-01	8.30e-01	7.56e-01	7.54e-01	7.85e-01	5.24e-01
FIBROBLAST GROWTH FACTOR PRODUCTION	9	9.68e-01	9.97e-01	0.1730	1.09e-01	7.63e-02	2.81e-02	4.24e-02	-9.85e-02	5.71e-01	6.92e-01	8.84e-01	8.26e-01	6.09e-01
NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	14	9.07e-01	9.94e-01	0.1730	7.89e-03	-2.94e-02	1.20e-01	1.01e-01	6.80e-02	9.59e-01	8.49e-01	4.38e-01	5.15e-01	6.59e-01
INNATE IMMUNE RESPONSE IN MUCOSA	26	2.06e-02	2.06e-01	0.1730	1.39e-01	5.83e-02	-1.17e-02	5.30e-02	-6.57e-02	2.20e-01	6.07e-01	9.18e-01	6.40e-01	5.62e-01
GLIAL CELL MIGRATION	58	7.34e-01	9.73e-01	0.1730	-8.62e-02	-5.66e-03	-1.03e-01	-1.05e-01	-2.90e-02	2.56e-01	9.41e-01	1.73e-01	1.68e-01	7.03e-01
POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	33	3.10e-01	7.83e-01	0.1730	-5.17e-02	-9.01e-02	-1.02e-01	-7.66e-02	5.39e-02	6.08e-01	3.70e-01	3.11e-01	4.46e-01	5.92e-01
SMOOTHENED SIGNALING PATHWAY	140	5.77e-03	9.10e-02	0.1730	1.23e-01	2.36e-02	8.80e-02	7.97e-02	-5.25e-03	1.17e-02	6.30e-01	7.21e-02	1.03e-01	9.15e-01
REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	12	1.56e-01	6.18e-01	0.1730	-8.02e-02	1.12e-01	6.83e-02	6.66e-02	-4.10e-02	6.30e-01	5.00e-01	6.82e-01	6.89e-01	8.06e-01
RESPONSE TO NERVE GROWTH FACTOR	47	6.46e-01	9.50e-01	0.1730	-7.22e-02	-1.26e-01	-4.15e-02	-5.47e-02	6.24e-02	3.92e-01	1.34e-01	6.23e-01	5.17e-01	4.59e-01
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	23	6.85e-01	9.61e-01	0.1730	4.38e-02	-6.58e-02	3.50e-02	3.85e-02	1.44e-01	7.16e-01	5.85e-01	7.71e-01	7.49e-01	2.31e-01
INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	5	8.74e-01	9.88e-01	0.1730	-1.35e-01	5.59e-02	-6.68e-02	-6.02e-02	1.73e-02	6.00e-01	8.29e-01	7.96e-01	8.16e-01	9.47e-01
NEUTROPHIL MIGRATION	121	2.72e-04	9.03e-03	0.1730	4.61e-03	-4.89e-02	-3.65e-02	-2.12e-02	1.60e-01	9.30e-01	3.53e-01	4.88e-01	6.86e-01	2.36e-03
MITOCHONDRIAL FISSION	40	1.73e-01	6.44e-01	0.1730	-3.70e-02	-1.48e-01	-3.83e-02	-5.82e-02	-3.94e-02	6.85e-01	1.05e-01	6.75e-01	5.24e-01	6.66e-01
MYOTUBE CELL DEVELOPMENT	40	5.28e-01	9.06e-01	0.1720	3.77e-03	2.07e-02	-1.01e-01	-9.48e-02	-1.01e-01	9.67e-01	8.21e-01	2.71e-01	3.00e-01	2.69e-01
REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	33	3.79e-01	8.37e-01	0.1720	6.57e-02	1.33e-01	-7.15e-02	-4.88e-02	-1.16e-02	5.14e-01	1.85e-01	4.77e-01	6.28e-01	9.08e-01
PROTEIN LOCALIZATION TO CELL LEADING EDGE	5	7.30e-01	9.71e-01	0.1720	-1.41e-01	-3.63e-02	2.15e-02	-4.09e-02	7.99e-02	5.85e-01	8.88e-01	9.34e-01	8.74e-01	7.57e-01
REGULATION OF FAT CELL PROLIFERATION	10	9.69e-01	9.97e-01	0.1720	-7.60e-02	-8.38e-02	-8.15e-02	-7.00e-02	7.33e-02	6.77e-01	6.46e-01	6.56e-01	7.01e-01	6.88e-01
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS	38	4.31e-01	8.67e-01	0.1720	9.99e-02	5.81e-02	1.99e-02	3.67e-02	-1.21e-01	2.87e-01	5.36e-01	8.32e-01	6.95e-01	1.98e-01
REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS	30	8.07e-01	9.82e-01	0.1720	3.53e-02	-5.65e-02	7.80e-02	6.32e-02	1.23e-01	7.38e-01	5.92e-01	4.60e-01	5.49e-01	2.43e-01
NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION	41	5.50e-01	9.15e-01	0.1720	-4.78e-02	-5.76e-02	-1.04e-01	-1.13e-01	-2.06e-02	5.96e-01	5.23e-01	2.49e-01	2.09e-01	8.20e-01
BLASTODERM SEGMENTATION	24	2.70e-01	7.50e-01	0.1720	1.75e-02	1.11e-01	-5.95e-02	-7.93e-02	8.45e-02	8.82e-01	3.45e-01	6.14e-01	5.01e-01	4.74e-01
DIET INDUCED THERMOGENESIS	13	5.01e-01	8.98e-01	0.1720	-6.82e-02	-9.53e-02	2.93e-02	5.46e-02	-1.10e-01	6.70e-01	5.52e-01	8.55e-01	7.33e-01	4.92e-01
LEUKOCYTE APOPTOTIC PROCESS	118	1.68e-01	6.36e-01	0.1720	3.38e-02	-2.69e-02	1.05e-01	8.73e-02	9.53e-02	5.26e-01	6.14e-01	4.84e-02	1.01e-01	7.38e-02
MACROPHAGE MIGRATION	61	3.32e-01	8.04e-01	0.1720	-4.76e-02	-3.01e-02	-1.21e-01	-1.01e-01	-4.13e-02	5.20e-01	6.85e-01	1.02e-01	1.74e-01	5.77e-01
VACUOLAR LOCALIZATION	82	1.08e-01	5.25e-01	0.1720	-1.01e-02	-1.34e-01	3.69e-02	2.77e-02	9.67e-02	8.74e-01	3.57e-02	5.64e-01	6.64e-01	1.30e-01
DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING	6	9.82e-01	9.97e-01	0.1720	5.34e-02	3.43e-02	2.65e-03	1.46e-02	-1.59e-01	8.21e-01	8.84e-01	9.91e-01	9.51e-01	5.00e-01
DENDRITIC CELL MIGRATION	32	2.41e-01	7.26e-01	0.1720	9.40e-02	6.13e-02	-9.98e-03	4.90e-03	1.30e-01	3.57e-01	5.49e-01	9.22e-01	9.62e-01	2.04e-01
MAINTENANCE OF CELL NUMBER	179	1.16e-03	2.80e-02	0.1720	7.09e-02	-5.11e-02	1.10e-01	9.14e-02	3.82e-02	1.02e-01	2.38e-01	1.14e-02	3.50e-02	3.78e-01
FEEDING BEHAVIOR	102	1.86e-01	6.57e-01	0.1720	-6.00e-02	-7.79e-02	-8.77e-02	-9.95e-02	-4.70e-02	2.95e-01	1.74e-01	1.26e-01	8.26e-02	4.12e-01
PHOSPHATIDYLGLYCEROL METABOLIC PROCESS	33	1.58e-01	6.20e-01	0.1720	7.01e-02	1.18e-01	-4.03e-02	-6.29e-03	9.49e-02	4.86e-01	2.42e-01	6.89e-01	9.50e-01	3.45e-01
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	21	7.78e-01	9.79e-01	0.1720	1.67e-02	5.11e-02	9.14e-02	8.65e-02	1.04e-01	8.95e-01	6.85e-01	4.69e-01	4.93e-01	4.11e-01
PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING	14	7.67e-01	9.75e-01	0.1720	4.29e-02	9.80e-02	-9.71e-02	-6.11e-02	-6.93e-02	7.81e-01	5.25e-01	5.29e-01	6.92e-01	6.53e-01
POSITIVE REGULATION OF TORC1 SIGNALING	50	2.12e-01	6.91e-01	0.1720	-2.27e-02	-1.55e-01	5.19e-02	3.31e-02	3.30e-02	7.81e-01	5.79e-02	5.25e-01	6.86e-01	6.87e-01
EMBRYONIC EYE MORPHOGENESIS	35	3.69e-01	8.31e-01	0.1710	-8.36e-03	-1.25e-01	-9.37e-03	-1.47e-02	1.16e-01	9.32e-01	2.00e-01	9.24e-01	8.81e-01	2.36e-01
REGULATION OF PROTEIN EXPORT FROM NUCLEUS	32	1.71e-01	6.41e-01	0.1710	9.68e-02	-4.90e-02	1.07e-01	7.83e-02	-2.19e-03	3.43e-01	6.31e-01	2.94e-01	4.43e-01	9.83e-01
POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	16	5.66e-01	9.23e-01	0.1710	-1.34e-02	-2.77e-02	1.05e-01	8.95e-02	-9.70e-02	9.26e-01	8.48e-01	4.67e-01	5.35e-01	5.02e-01
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	75	2.11e-01	6.90e-01	0.1710	-5.71e-02	-8.06e-02	-7.22e-02	-7.22e-02	9.59e-02	3.93e-01	2.27e-01	2.79e-01	2.80e-01	1.51e-01
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	35	6.81e-01	9.61e-01	0.1710	-4.76e-02	-5.34e-02	-4.58e-02	-5.45e-02	-1.38e-01	6.26e-01	5.84e-01	6.39e-01	5.77e-01	1.56e-01
RESPONSE TO ACID CHEMICAL	132	2.57e-01	7.39e-01	0.1710	7.19e-02	8.42e-03	1.12e-01	1.01e-01	3.72e-02	1.54e-01	8.67e-01	2.63e-02	4.51e-02	4.60e-01
REGULATION OF DENDRITE MORPHOGENESIS	57	4.22e-01	8.61e-01	0.1710	-9.53e-02	-7.09e-03	-9.32e-02	-1.03e-01	2.95e-02	2.13e-01	9.26e-01	2.24e-01	1.77e-01	7.00e-01
CARDIAC VENTRICLE MORPHOGENESIS	72	5.89e-02	3.86e-01	0.1710	-1.97e-02	-1.54e-01	5.72e-02	4.11e-02	1.59e-02	7.72e-01	2.37e-02	4.01e-01	5.47e-01	8.16e-01
NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION	23	7.84e-01	9.81e-01	0.1710	8.19e-02	9.68e-02	1.27e-02	6.38e-03	-1.14e-01	4.96e-01	4.22e-01	9.16e-01	9.58e-01	3.43e-01
MYELOID LEUKOCYTE MIGRATION	233	2.16e-05	1.10e-03	0.1710	-4.78e-02	-6.84e-02	-1.00e-01	-8.94e-02	6.57e-02	2.09e-01	7.20e-02	8.31e-03	1.87e-02	8.38e-02
DOPAMINE BIOSYNTHETIC PROCESS	12	9.04e-01	9.94e-01	0.1710	-1.43e-02	-4.75e-02	5.09e-02	6.54e-02	1.41e-01	9.32e-01	7.76e-01	7.60e-01	6.95e-01	3.96e-01
RESPONSE TO THYROID HORMONE	28	2.66e-01	7.47e-01	0.1710	-1.68e-02	-1.53e-01	-3.65e-02	-2.70e-02	-5.90e-02	8.78e-01	1.60e-01	7.38e-01	8.05e-01	5.89e-01
GLUTAMATERGIC NEURON DIFFERENTIATION	15	8.79e-01	9.89e-01	0.1710	1.06e-01	6.32e-02	6.54e-02	9.71e-02	2.09e-02	4.79e-01	6.71e-01	6.61e-01	5.15e-01	8.88e-01
PURINE RIBONUCLEOSIDE METABOLIC PROCESS	20	8.62e-01	9.88e-01	0.1710	-6.41e-02	-1.42e-01	-3.56e-02	-4.02e-02	-4.74e-02	6.20e-01	2.73e-01	7.83e-01	7.56e-01	7.14e-01
PLASMA LIPOPROTEIN PARTICLE CLEARANCE	54	8.48e-02	4.65e-01	0.1710	-9.86e-02	1.11e-03	-1.02e-01	-7.08e-02	-6.45e-02	2.10e-01	9.89e-01	1.96e-01	3.68e-01	4.12e-01
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	60	1.43e-01	6.01e-01	0.1710	-4.87e-02	-2.08e-02	-1.25e-01	-9.37e-02	-4.51e-02	5.14e-01	7.81e-01	9.44e-02	2.09e-01	5.45e-01
GLYCOPROTEIN CATABOLIC PROCESS	33	7.66e-01	9.75e-01	0.1710	-9.87e-02	-1.16e-01	-2.53e-02	-4.87e-02	5.58e-02	3.27e-01	2.51e-01	8.01e-01	6.29e-01	5.79e-01
SKELETAL MUSCLE TISSUE REGENERATION	37	8.20e-01	9.83e-01	0.1710	-1.16e-01	-6.64e-02	-6.80e-02	-7.78e-02	2.33e-02	2.20e-01	4.85e-01	4.74e-01	4.13e-01	8.06e-01
ACTIN FILAMENT SEVERING	16	6.87e-01	9.61e-01	0.1710	-1.63e-02	-1.15e-01	-5.86e-02	-5.43e-02	9.68e-02	9.10e-01	4.27e-01	6.85e-01	7.07e-01	5.03e-01
HEMATOPOIETIC STEM CELL HOMEOSTASIS	20	6.43e-01	9.50e-01	0.1710	-1.89e-02	-3.47e-02	-3.34e-02	-5.18e-02	1.54e-01	8.84e-01	7.88e-01	7.96e-01	6.88e-01	2.32e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	23	7.81e-01	9.81e-01	0.1710	2.56e-02	1.43e-01	-2.26e-02	-2.04e-02	-8.51e-02	8.32e-01	2.37e-01	8.51e-01	8.66e-01	4.80e-01
ACTIN FILAMENT DEPOLYMERIZATION	58	7.88e-01	9.81e-01	0.1710	-1.03e-01	-8.16e-02	-7.00e-02	-8.28e-02	9.86e-03	1.75e-01	2.83e-01	3.56e-01	2.75e-01	8.97e-01
GANGLIOSIDE BIOSYNTHETIC PROCESS	17	9.23e-01	9.95e-01	0.1710	9.87e-02	1.35e-02	8.18e-02	7.19e-02	8.56e-02	4.81e-01	9.23e-01	5.59e-01	6.08e-01	5.41e-01
ENDODERMAL CELL DIFFERENTIATION	48	3.26e-01	7.98e-01	0.1710	-3.62e-02	-3.02e-02	-9.10e-02	-1.09e-01	-8.14e-02	6.64e-01	7.17e-01	2.75e-01	1.90e-01	3.29e-01
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	95	1.52e-01	6.14e-01	0.1700	-5.93e-02	-1.30e-01	-3.76e-02	-3.66e-02	7.67e-02	3.18e-01	2.87e-02	5.26e-01	5.37e-01	1.97e-01
REGULATION OF GLYCOGEN METABOLIC PROCESS	36	5.85e-01	9.28e-01	0.1700	4.41e-02	-6.63e-02	8.11e-02	6.14e-02	1.11e-01	6.47e-01	4.91e-01	4.00e-01	5.24e-01	2.49e-01
POSITIVE REGULATION OF SYNAPSE ASSEMBLY	56	6.19e-01	9.42e-01	0.1700	-8.59e-02	4.02e-05	-1.04e-01	-1.03e-01	1.98e-03	2.66e-01	1.00e+00	1.77e-01	1.81e-01	9.80e-01
POSITIVE REGULATION OF AXON EXTENSION	33	5.27e-01	9.06e-01	0.1700	-4.76e-02	9.08e-02	-8.91e-02	-9.51e-02	-3.79e-02	6.36e-01	3.67e-01	3.76e-01	3.44e-01	7.06e-01
REGULATION OF CYTOPLASMIC TRANSPORT	29	7.87e-01	9.81e-01	0.1700	-7.73e-02	-1.25e-01	-4.60e-02	-6.59e-02	-2.70e-02	4.71e-01	2.42e-01	6.68e-01	5.39e-01	8.01e-01
REGULATION OF VESICLE SIZE	19	5.15e-01	9.01e-01	0.1700	1.70e-02	-1.48e-01	4.91e-02	2.45e-02	6.14e-02	8.98e-01	2.65e-01	7.11e-01	8.53e-01	6.43e-01
SPONTANEOUS SYNAPTIC TRANSMISSION	14	6.08e-01	9.35e-01	0.1700	-1.35e-01	1.40e-02	-5.69e-02	-6.56e-02	5.46e-02	3.82e-01	9.28e-01	7.12e-01	6.71e-01	7.24e-01
CELLULAR RESPONSE TO STEROL DEPLETION	16	7.84e-01	9.81e-01	0.1700	-4.54e-02	-1.24e-01	-4.63e-02	-2.94e-02	9.20e-02	7.53e-01	3.91e-01	7.49e-01	8.39e-01	5.24e-01
SEROTONIN TRANSPORT	20	7.97e-01	9.81e-01	0.1700	-9.63e-02	1.88e-02	-7.32e-02	-8.92e-02	-7.70e-02	4.56e-01	8.84e-01	5.71e-01	4.90e-01	5.51e-01
TRANSMISSION OF NERVE IMPULSE	68	1.63e-01	6.27e-01	0.1700	-5.39e-02	-3.29e-02	-9.56e-02	-8.74e-02	9.00e-02	4.42e-01	6.38e-01	1.73e-01	2.12e-01	1.99e-01
RECEPTOR CLUSTERING	53	8.23e-01	9.83e-01	0.1700	-1.01e-01	-7.10e-02	-7.71e-02	-8.30e-02	2.81e-02	2.03e-01	3.71e-01	3.32e-01	2.96e-01	7.23e-01
REGULATION OF HEART GROWTH	68	8.66e-02	4.68e-01	0.1700	-3.31e-02	-1.13e-01	-5.86e-02	-6.58e-02	-8.53e-02	6.37e-01	1.08e-01	4.03e-01	3.48e-01	2.24e-01
EMBRYONIC SKELETAL JOINT MORPHOGENESIS	11	5.14e-01	9.01e-01	0.1700	3.84e-02	-1.65e-01	-4.11e-03	-7.08e-03	1.19e-02	8.25e-01	3.44e-01	9.81e-01	9.68e-01	9.46e-01
NEGATIVE REGULATION OF ENDOCYTOSIS	76	6.34e-01	9.48e-01	0.1700	-9.01e-02	-1.18e-01	-5.56e-02	-5.72e-02	1.90e-02	1.74e-01	7.51e-02	4.02e-01	3.89e-01	7.74e-01
POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	26	8.76e-01	9.88e-01	0.1700	9.16e-02	5.65e-02	5.35e-02	5.66e-02	1.06e-01	4.19e-01	6.18e-01	6.37e-01	6.18e-01	3.52e-01
CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	12	8.97e-01	9.93e-01	0.1700	-2.34e-02	4.71e-02	-1.11e-01	-1.14e-01	2.53e-02	8.88e-01	7.78e-01	5.06e-01	4.93e-01	8.80e-01
PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	715	4.31e-11	6.72e-09	0.1690	6.89e-02	-4.74e-02	1.04e-01	9.38e-02	4.63e-02	1.68e-03	3.07e-02	2.33e-06	1.91e-05	3.48e-02
CHROMATIN REMODELING	579	2.02e-08	2.00e-06	0.1690	9.24e-02	2.23e-02	1.01e-01	9.17e-02	-3.20e-02	1.45e-04	3.60e-01	3.22e-05	1.61e-04	1.88e-01
CELLULAR RESPONSE TO INORGANIC SUBSTANCE	220	6.95e-02	4.22e-01	0.1690	6.38e-02	7.51e-03	8.02e-02	7.39e-02	1.12e-01	1.03e-01	8.48e-01	4.03e-02	5.89e-02	4.08e-03
BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS	36	2.30e-01	7.13e-01	0.1690	7.16e-02	-9.71e-02	6.96e-02	6.15e-02	7.38e-02	4.57e-01	3.13e-01	4.70e-01	5.23e-01	4.43e-01
PROTEIN AUTO ADP RIBOSYLATION	11	8.98e-01	9.93e-01	0.1690	-9.85e-02	-7.78e-02	-1.08e-02	-1.66e-02	-1.12e-01	5.72e-01	6.55e-01	9.50e-01	9.24e-01	5.21e-01
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	5	9.77e-01	9.97e-01	0.1690	3.09e-03	9.71e-02	-7.70e-02	-9.47e-02	-6.52e-02	9.90e-01	7.07e-01	7.66e-01	7.14e-01	8.01e-01
METANEPHROS DEVELOPMENT	91	1.59e-02	1.74e-01	0.1690	4.23e-02	-8.60e-02	5.53e-02	3.65e-02	1.23e-01	4.85e-01	1.56e-01	3.62e-01	5.48e-01	4.33e-02
REGULATION OF STEM CELL POPULATION MAINTENANCE	71	1.81e-01	6.56e-01	0.1690	7.56e-02	1.06e-02	1.17e-01	9.20e-02	2.23e-02	2.71e-01	8.77e-01	8.70e-02	1.80e-01	7.46e-01
REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	9	9.41e-01	9.97e-01	0.1690	9.75e-02	1.24e-01	-3.85e-02	-1.53e-02	-4.48e-02	6.12e-01	5.20e-01	8.42e-01	9.37e-01	8.16e-01
AMINO ACID BETAINE TRANSPORT	13	6.25e-01	9.44e-01	0.1690	1.28e-01	6.04e-02	-2.79e-02	-8.84e-03	-8.71e-02	4.23e-01	7.06e-01	8.62e-01	9.56e-01	5.86e-01
REGULATION OF ATP METABOLIC PROCESS	22	9.15e-01	9.94e-01	0.1690	4.13e-02	1.27e-02	6.39e-02	7.17e-02	1.32e-01	7.37e-01	9.18e-01	6.04e-01	5.60e-01	2.84e-01
SPINAL CORD MOTOR NEURON DIFFERENTIATION	28	5.85e-02	3.85e-01	0.1690	8.88e-02	-1.09e-01	7.70e-02	5.10e-02	-1.25e-02	4.16e-01	3.17e-01	4.80e-01	6.40e-01	9.09e-01
NEUROPEPTIDE SIGNALING PATHWAY	102	3.00e-01	7.73e-01	0.1690	-6.08e-02	-4.66e-02	-1.04e-01	-1.08e-01	-6.29e-03	2.89e-01	4.16e-01	6.95e-02	5.85e-02	9.13e-01
REGULATION OF OXIDATIVE PHOSPHORYLATION	21	4.96e-01	8.96e-01	0.1690	-4.70e-02	-8.02e-02	4.66e-02	4.65e-02	-1.25e-01	7.09e-01	5.25e-01	7.12e-01	7.12e-01	3.23e-01
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	28	2.74e-01	7.56e-01	0.1690	2.08e-02	-1.55e-01	4.95e-02	3.58e-02	1.40e-02	8.49e-01	1.55e-01	6.50e-01	7.43e-01	8.98e-01
REGULATION OF NEUROTRANSMITTER SECRETION	76	3.97e-01	8.45e-01	0.1690	-9.38e-02	-8.77e-02	-3.62e-02	-4.77e-02	9.15e-02	1.57e-01	1.86e-01	5.85e-01	4.72e-01	1.68e-01
HINDBRAIN DEVELOPMENT	149	5.30e-02	3.62e-01	0.1690	7.42e-02	-3.49e-02	8.69e-02	8.14e-02	8.70e-02	1.18e-01	4.61e-01	6.72e-02	8.65e-02	6.68e-02
VITAMIN METABOLIC PROCESS	107	2.87e-01	7.66e-01	0.1690	6.36e-02	-3.76e-02	9.51e-02	9.25e-02	7.34e-02	2.55e-01	5.02e-01	8.91e-02	9.82e-02	1.90e-01
METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT	5	6.66e-01	9.55e-01	0.1690	8.82e-02	-9.92e-02	-2.05e-02	-4.33e-02	-9.23e-02	7.33e-01	7.01e-01	9.37e-01	8.67e-01	7.21e-01
NEGATIVE CHEMOTAXIS	46	3.47e-01	8.18e-01	0.1690	-7.73e-02	3.17e-02	-9.51e-02	-1.02e-01	4.39e-02	3.64e-01	7.10e-01	2.65e-01	2.29e-01	6.07e-01
RIBONUCLEOSIDE CATABOLIC PROCESS	20	5.07e-01	8.99e-01	0.1690	-7.28e-02	2.51e-02	-1.22e-01	-8.59e-02	1.15e-02	5.73e-01	8.46e-01	3.44e-01	5.06e-01	9.29e-01
ENGULFMENT OF APOPTOTIC CELL	15	9.86e-02	5.02e-01	0.1680	-4.17e-02	-1.47e-02	6.85e-02	1.20e-01	8.62e-02	7.80e-01	9.21e-01	6.46e-01	4.23e-01	5.63e-01
GMP BIOSYNTHETIC PROCESS	13	7.68e-01	9.75e-01	0.1680	1.42e-02	-5.42e-02	1.01e-01	1.22e-01	1.36e-02	9.29e-01	7.35e-01	5.30e-01	4.46e-01	9.32e-01
REGULATION OF LIPID CATABOLIC PROCESS	60	4.73e-01	8.86e-01	0.1680	1.67e-03	3.27e-02	-5.24e-02	-4.12e-02	-1.51e-01	9.82e-01	6.61e-01	4.82e-01	5.81e-01	4.29e-02
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	103	2.68e-01	7.48e-01	0.1680	-7.07e-02	-2.57e-02	-1.06e-01	-1.04e-01	2.80e-02	2.15e-01	6.52e-01	6.40e-02	6.92e-02	6.24e-01
REGULATION OF HISTONE MODIFICATION	36	4.25e-01	8.63e-01	0.1680	-4.13e-02	-9.71e-02	-9.70e-02	-8.54e-02	2.03e-02	6.68e-01	3.13e-01	3.14e-01	3.75e-01	8.33e-01
INTERLEUKIN 1 PRODUCTION	123	3.45e-02	2.81e-01	0.1680	-5.57e-02	-7.81e-02	-6.73e-02	-6.23e-02	1.03e-01	2.86e-01	1.35e-01	1.98e-01	2.33e-01	4.82e-02
POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	6	9.77e-01	9.97e-01	0.1680	1.15e-01	9.17e-02	1.48e-02	2.85e-02	7.49e-02	6.26e-01	6.97e-01	9.50e-01	9.04e-01	7.51e-01
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	81	5.91e-01	9.31e-01	0.1680	7.28e-02	1.98e-02	1.07e-01	1.05e-01	6.27e-03	2.58e-01	7.58e-01	9.59e-02	1.02e-01	9.22e-01
PROTEIN LOCALIZATION TO CILIUM	70	4.18e-01	8.58e-01	0.1680	1.09e-01	7.00e-02	5.90e-02	6.18e-02	-6.36e-02	1.13e-01	3.11e-01	3.94e-01	3.71e-01	3.58e-01
THYROID GLAND DEVELOPMENT	31	5.91e-01	9.31e-01	0.1680	-2.29e-02	-2.41e-02	-1.08e-01	-1.14e-01	-4.88e-02	8.25e-01	8.16e-01	2.99e-01	2.70e-01	6.38e-01
MUSCLE ADAPTATION	117	1.20e-01	5.53e-01	0.1680	8.58e-03	7.51e-02	-7.30e-02	-5.51e-02	-1.19e-01	8.73e-01	1.60e-01	1.72e-01	3.04e-01	2.64e-02
OLIGODENDROCYTE DEVELOPMENT	44	1.02e-01	5.10e-01	0.1680	1.09e-01	6.18e-03	5.74e-02	3.85e-02	1.08e-01	2.13e-01	9.43e-01	5.10e-01	6.59e-01	2.16e-01
HORMONE MEDIATED SIGNALING PATHWAY	185	5.48e-02	3.68e-01	0.1680	-8.31e-02	-1.02e-01	-6.44e-02	-8.21e-02	6.02e-03	5.11e-02	1.71e-02	1.31e-01	5.40e-02	8.88e-01
NEUTROPHIL HOMEOSTASIS	20	7.84e-01	9.81e-01	0.1680	-3.83e-02	-6.60e-02	-1.12e-01	-9.87e-02	-5.52e-03	7.67e-01	6.10e-01	3.85e-01	4.45e-01	9.66e-01
PRESYNAPTIC ACTIVE ZONE ORGANIZATION	8	9.81e-01	9.97e-01	0.1680	-5.16e-02	-1.25e-01	2.56e-02	2.50e-03	9.61e-02	8.01e-01	5.41e-01	9.00e-01	9.90e-01	6.38e-01
LEFT RIGHT AXIS SPECIFICATION	13	9.33e-01	9.97e-01	0.1680	-7.48e-02	-1.44e-01	8.83e-03	-1.68e-02	3.90e-02	6.40e-01	3.70e-01	9.56e-01	9.17e-01	8.08e-01
LIPID LOCALIZATION	496	2.21e-03	4.42e-02	0.1680	-8.68e-02	-3.09e-02	-1.00e-01	-9.71e-02	-1.25e-02	9.35e-04	2.38e-01	1.31e-04	2.12e-04	6.32e-01
MITOTIC CELL CYCLE	900	5.15e-13	9.94e-11	0.1680	6.11e-02	-4.16e-02	1.08e-01	9.44e-02	4.45e-02	1.85e-03	3.41e-02	3.42e-08	1.54e-06	2.35e-02
POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS	13	8.53e-01	9.88e-01	0.1680	-2.11e-02	1.80e-03	-4.07e-03	-2.24e-02	1.65e-01	8.95e-01	9.91e-01	9.80e-01	8.89e-01	3.04e-01
MULTICELLULAR ORGANISMAL MOVEMENT	57	2.47e-01	7.32e-01	0.1680	8.66e-02	1.23e-01	9.77e-04	1.71e-02	7.14e-02	2.58e-01	1.07e-01	9.90e-01	8.23e-01	3.51e-01
RESPONSE TO TUMOR NECROSIS FACTOR	248	1.09e-01	5.27e-01	0.1680	7.61e-02	7.31e-02	7.80e-02	8.51e-02	6.01e-02	3.89e-02	4.73e-02	3.44e-02	2.11e-02	1.03e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE	16	9.53e-01	9.97e-01	0.1670	6.41e-02	7.70e-02	8.45e-02	9.86e-02	3.35e-02	6.57e-01	5.94e-01	5.58e-01	4.95e-01	8.17e-01
CELL CELL JUNCTION ASSEMBLY	152	2.84e-01	7.62e-01	0.1670	-9.76e-02	-3.30e-02	-9.11e-02	-9.46e-02	-1.26e-02	3.77e-02	4.83e-01	5.26e-02	4.40e-02	7.88e-01
REGULATION OF STRIATED MUSCLE CONTRACTION	92	2.00e-01	6.80e-01	0.1670	9.09e-02	1.34e-01	1.41e-02	3.63e-02	-1.82e-02	1.32e-01	2.66e-02	8.15e-01	5.48e-01	7.63e-01
TRIGLYCERIDE CATABOLIC PROCESS	27	7.42e-01	9.73e-01	0.1670	6.18e-02	1.47e-01	1.90e-02	3.85e-02	-2.60e-02	5.79e-01	1.86e-01	8.65e-01	7.29e-01	8.15e-01
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS	25	8.48e-01	9.87e-01	0.1670	6.60e-02	-1.11e-02	5.68e-02	5.63e-02	1.31e-01	5.68e-01	9.24e-01	6.23e-01	6.26e-01	2.58e-01
GLYCOSIDE METABOLIC PROCESS	20	7.50e-01	9.75e-01	0.1670	-8.16e-02	5.71e-02	-8.44e-02	-7.21e-02	-7.56e-02	5.28e-01	6.59e-01	5.13e-01	5.77e-01	5.58e-01
PROTEIN LOCALIZATION TO MICROTUBULE	17	7.26e-01	9.71e-01	0.1670	1.32e-01	4.29e-02	7.01e-02	5.51e-02	2.84e-02	3.47e-01	7.59e-01	6.17e-01	6.94e-01	8.40e-01
PEPTIDYL LYSINE DEACETYLATION	6	8.67e-01	9.88e-01	0.1670	-3.58e-02	-2.89e-02	1.07e-01	8.06e-02	-8.90e-02	8.79e-01	9.03e-01	6.51e-01	7.32e-01	7.06e-01
ENDOPLASMIC RETICULUM ORGANIZATION	96	3.27e-02	2.73e-01	0.1670	3.61e-03	-1.30e-01	7.72e-02	6.45e-02	3.08e-02	9.51e-01	2.80e-02	1.91e-01	2.75e-01	6.02e-01
VESICLE TRANSPORT ALONG MICROTUBULE	45	5.02e-01	8.98e-01	0.1670	-1.21e-03	-7.07e-04	8.18e-02	6.76e-02	1.29e-01	9.89e-01	9.93e-01	3.42e-01	4.32e-01	1.34e-01
COMPLEMENT ACTIVATION	58	3.13e-03	5.72e-02	0.1670	-6.47e-02	5.72e-02	-7.03e-02	-4.20e-02	1.17e-01	3.94e-01	4.51e-01	3.55e-01	5.80e-01	1.23e-01
REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	23	4.24e-01	8.62e-01	0.1670	-7.66e-02	-9.27e-02	8.52e-02	7.34e-02	2.77e-02	5.25e-01	4.42e-01	4.80e-01	5.42e-01	8.18e-01
ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	24	2.42e-01	7.26e-01	0.1670	7.13e-03	-1.83e-03	-6.80e-02	-3.62e-02	1.48e-01	9.52e-01	9.88e-01	5.64e-01	7.59e-01	2.10e-01
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	49	3.28e-01	8.00e-01	0.1670	4.26e-02	-8.81e-02	5.78e-02	5.12e-02	1.11e-01	6.06e-01	2.86e-01	4.84e-01	5.35e-01	1.79e-01
CARDIAC SEPTUM MORPHOGENESIS	72	3.59e-02	2.88e-01	0.1670	-3.25e-02	-1.56e-01	3.42e-02	5.30e-03	3.70e-02	6.34e-01	2.24e-02	6.15e-01	9.38e-01	5.88e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE	260	2.13e-02	2.12e-01	0.1670	7.75e-02	-1.04e-03	1.03e-01	1.04e-01	1.45e-02	3.15e-02	9.77e-01	4.14e-03	3.73e-03	6.88e-01
CELLULAR RESPONSE TO ALCOHOL	99	2.10e-01	6.89e-01	0.1670	-4.34e-02	-3.55e-02	-1.10e-01	-1.08e-01	-2.91e-02	4.56e-01	5.42e-01	5.89e-02	6.28e-02	6.17e-01
POSITIVE REGULATION OF LIPID KINASE ACTIVITY	26	8.84e-01	9.91e-01	0.1670	-5.32e-02	2.22e-02	-1.15e-01	-1.03e-01	-2.49e-02	6.39e-01	8.45e-01	3.11e-01	3.63e-01	8.26e-01
REGULATION OF FATTY ACID OXIDATION	33	7.16e-01	9.68e-01	0.1670	-3.20e-02	-3.74e-02	-6.46e-02	-7.47e-02	-1.25e-01	7.50e-01	7.10e-01	5.21e-01	4.57e-01	2.15e-01
I KAPPAB PHOSPHORYLATION	15	6.70e-01	9.57e-01	0.1670	-6.90e-03	1.55e-01	-4.29e-02	-3.29e-02	2.62e-02	9.63e-01	2.98e-01	7.74e-01	8.25e-01	8.60e-01
CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION	10	9.45e-01	9.97e-01	0.1660	-6.80e-02	-5.21e-02	-3.79e-02	-2.93e-02	1.34e-01	7.10e-01	7.75e-01	8.36e-01	8.73e-01	4.61e-01
PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION	7	7.41e-01	9.73e-01	0.1660	-3.78e-02	3.17e-02	-1.66e-02	-6.74e-02	-1.43e-01	8.62e-01	8.85e-01	9.40e-01	7.58e-01	5.13e-01
MEMORY	120	3.24e-01	7.96e-01	0.1660	4.79e-02	-2.21e-02	9.51e-02	9.86e-02	7.82e-02	3.65e-01	6.76e-01	7.18e-02	6.21e-02	1.39e-01
QUATERNARY AMMONIUM GROUP TRANSPORT	29	5.29e-01	9.07e-01	0.1660	9.77e-02	1.08e-01	-3.36e-02	-2.85e-02	-6.75e-02	3.62e-01	3.15e-01	7.54e-01	7.91e-01	5.29e-01
REGULATION OF MICROTUBULE POLYMERIZATION	59	4.12e-01	8.54e-01	0.1660	-5.69e-02	-1.39e-01	-3.61e-02	-4.37e-02	4.42e-02	4.50e-01	6.55e-02	6.31e-01	5.62e-01	5.57e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	155	8.29e-03	1.14e-01	0.1660	-7.22e-03	-1.25e-01	3.58e-02	3.30e-02	9.77e-02	8.77e-01	7.29e-03	4.42e-01	4.78e-01	3.58e-02
RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR	9	9.62e-01	9.97e-01	0.1660	4.17e-02	1.04e-01	5.90e-02	5.86e-02	-8.95e-02	8.28e-01	5.88e-01	7.59e-01	7.61e-01	6.42e-01
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS	297	2.02e-02	2.04e-01	0.1660	7.33e-02	7.61e-02	7.08e-02	8.09e-02	6.96e-02	2.98e-02	2.41e-02	3.59e-02	1.65e-02	3.91e-02
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA	287	4.09e-02	3.09e-01	0.1660	-8.55e-02	-1.06e-01	-6.04e-02	-6.58e-02	3.12e-02	1.27e-02	1.95e-03	7.82e-02	5.50e-02	3.64e-01
ARTERY MORPHOGENESIS	81	2.75e-01	7.56e-01	0.1660	6.88e-02	-4.98e-02	9.38e-02	9.29e-02	5.38e-02	2.84e-01	4.39e-01	1.44e-01	1.48e-01	4.03e-01
CYCLIC NUCLEOTIDE CATABOLIC PROCESS	14	9.18e-01	9.95e-01	0.1660	-6.21e-02	5.44e-02	-1.02e-01	-1.01e-01	7.46e-03	6.87e-01	7.24e-01	5.10e-01	5.11e-01	9.61e-01
POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	126	6.90e-02	4.21e-01	0.1660	2.74e-02	-6.04e-02	4.74e-02	4.60e-02	1.37e-01	5.95e-01	2.42e-01	3.58e-01	3.73e-01	7.98e-03
REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	10	7.62e-01	9.75e-01	0.1660	-8.73e-02	-3.98e-02	4.31e-02	4.89e-03	1.28e-01	6.33e-01	8.27e-01	8.14e-01	9.79e-01	4.83e-01
ETHANOL OXIDATION	9	9.72e-01	9.97e-01	0.1660	8.94e-02	1.05e-01	3.79e-02	6.40e-02	5.34e-02	6.42e-01	5.85e-01	8.44e-01	7.40e-01	7.82e-01
REGULATION OF GERMINAL CENTER FORMATION	8	8.19e-01	9.83e-01	0.1660	-3.89e-02	-1.41e-01	-3.85e-02	-5.85e-03	-6.80e-02	8.49e-01	4.91e-01	8.51e-01	9.77e-01	7.39e-01
POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	132	6.49e-02	4.06e-01	0.1660	1.64e-02	-8.92e-02	7.99e-02	8.01e-02	7.99e-02	7.46e-01	7.68e-02	1.13e-01	1.12e-01	1.13e-01
CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY	11	8.60e-01	9.88e-01	0.1660	2.09e-02	-7.04e-02	9.53e-02	1.10e-01	-2.72e-02	9.05e-01	6.86e-01	5.84e-01	5.26e-01	8.76e-01
NEGATIVE REGULATION OF TISSUE REMODELING	21	5.27e-01	9.06e-01	0.1650	8.28e-02	-2.65e-02	3.36e-02	2.39e-02	1.35e-01	5.11e-01	8.33e-01	7.90e-01	8.50e-01	2.86e-01
MITOCHONDRION DISTRIBUTION	16	3.50e-01	8.18e-01	0.1650	-6.52e-02	1.01e-01	-2.74e-02	-6.18e-02	-9.10e-02	6.52e-01	4.83e-01	8.49e-01	6.69e-01	5.28e-01
REGULATION OF GLUCOSE METABOLIC PROCESS	99	4.52e-01	8.76e-01	0.1650	-4.99e-02	-4.14e-02	-9.88e-02	-9.44e-02	-6.68e-02	3.91e-01	4.77e-01	8.94e-02	1.04e-01	2.51e-01
REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	22	2.50e-01	7.33e-01	0.1650	1.91e-02	1.56e-01	-1.78e-02	1.95e-02	4.18e-02	8.77e-01	2.04e-01	8.85e-01	8.74e-01	7.34e-01
ISOTYPE SWITCHING TO IGA ISOTYPES	8	7.45e-01	9.75e-01	0.1650	-3.69e-02	-6.33e-02	9.14e-02	1.16e-01	-1.28e-02	8.57e-01	7.56e-01	6.54e-01	5.71e-01	9.50e-01
REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE	17	7.00e-01	9.63e-01	0.1650	-3.21e-02	5.65e-02	-3.13e-02	-5.66e-02	-1.37e-01	8.19e-01	6.87e-01	8.23e-01	6.86e-01	3.27e-01
NCRNA TRANSCRIPTION	134	2.55e-02	2.37e-01	0.1650	8.46e-02	-4.01e-02	9.61e-02	9.24e-02	2.60e-02	9.10e-02	4.23e-01	5.46e-02	6.47e-02	6.04e-01
POLYOL METABOLIC PROCESS	103	5.26e-01	9.05e-01	0.1650	-1.07e-01	-7.40e-02	-6.66e-02	-7.62e-02	1.93e-03	6.03e-02	1.95e-01	2.43e-01	1.82e-01	9.73e-01
MOTILE CILIUM ASSEMBLY	64	5.75e-01	9.26e-01	0.1650	-6.84e-02	-4.82e-02	-9.49e-02	-9.98e-02	3.42e-02	3.44e-01	5.05e-01	1.89e-01	1.67e-01	6.37e-01
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT	9	8.47e-01	9.87e-01	0.1650	2.60e-02	-1.03e-01	9.32e-02	6.62e-02	-5.30e-02	8.92e-01	5.93e-01	6.28e-01	7.31e-01	7.83e-01
RISC COMPLEX ASSEMBLY	10	6.23e-01	9.43e-01	0.1650	-9.18e-03	-1.46e-01	6.51e-02	1.81e-02	-3.20e-02	9.60e-01	4.23e-01	7.22e-01	9.21e-01	8.61e-01
CRANIAL NERVE DEVELOPMENT	61	1.44e-01	6.01e-01	0.1650	1.02e-01	-5.61e-03	5.47e-02	5.45e-02	1.04e-01	1.70e-01	9.40e-01	4.60e-01	4.61e-01	1.61e-01
MULTI MULTICELLULAR ORGANISM PROCESS	203	1.95e-01	6.73e-01	0.1650	9.20e-02	4.01e-02	7.73e-02	8.31e-02	6.44e-02	2.38e-02	3.25e-01	5.76e-02	4.12e-02	1.14e-01
RESPONSE TO PROTOZOAN	31	9.15e-01	9.94e-01	0.1640	-4.64e-02	-2.92e-02	-7.78e-02	-7.16e-02	-1.13e-01	6.55e-01	7.78e-01	4.54e-01	4.90e-01	2.74e-01
TOOTH MINERALIZATION	28	8.39e-01	9.85e-01	0.1640	-8.84e-02	6.23e-04	-8.98e-02	-1.04e-01	-2.04e-02	4.18e-01	9.95e-01	4.11e-01	3.43e-01	8.52e-01
RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL	10	8.62e-01	9.88e-01	0.1640	-3.73e-02	2.26e-03	-8.03e-02	-1.12e-01	-8.08e-02	8.38e-01	9.90e-01	6.60e-01	5.38e-01	6.58e-01
NUCLEOTIDE SUGAR METABOLIC PROCESS	37	4.25e-01	8.63e-01	0.1640	8.12e-02	-3.52e-02	1.01e-01	8.85e-02	-3.34e-02	3.93e-01	7.11e-01	2.87e-01	3.52e-01	7.25e-01
METANEPHRIC S SHAPED BODY MORPHOGENESIS	5	1.25e-01	5.65e-01	0.1640	-3.22e-02	-6.31e-02	-2.33e-02	-1.45e-01	-1.91e-02	9.01e-01	8.07e-01	9.28e-01	5.74e-01	9.41e-01
SODIUM INDEPENDENT ORGANIC ANION TRANSPORT	15	8.20e-01	9.83e-01	0.1640	-1.14e-01	-4.13e-02	-6.17e-02	-5.15e-02	7.57e-02	4.43e-01	7.82e-01	6.79e-01	7.30e-01	6.12e-01
REGULATION OF LAMELLIPODIUM MORPHOGENESIS	11	9.00e-01	9.94e-01	0.1640	-2.62e-03	4.89e-02	-1.20e-01	-1.01e-01	-6.61e-04	9.88e-01	7.79e-01	4.90e-01	5.63e-01	9.97e-01
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	18	6.09e-01	9.35e-01	0.1640	5.00e-02	-6.05e-02	4.12e-03	1.43e-02	1.43e-01	7.14e-01	6.57e-01	9.76e-01	9.16e-01	2.92e-01
SYNAPTIC VESICLE MEMBRANE ORGANIZATION	27	7.50e-01	9.75e-01	0.1640	-1.90e-02	-4.78e-02	5.08e-02	5.78e-02	1.36e-01	8.64e-01	6.68e-01	6.48e-01	6.03e-01	2.22e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	10	8.15e-01	9.83e-01	0.1640	9.52e-02	1.84e-02	2.15e-03	7.37e-03	1.32e-01	6.02e-01	9.20e-01	9.91e-01	9.68e-01	4.69e-01
ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	152	1.64e-01	6.28e-01	0.1640	-6.78e-02	-5.32e-02	-9.86e-02	-9.71e-02	1.92e-02	1.49e-01	2.58e-01	3.59e-02	3.88e-02	6.83e-01
PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE	5	9.77e-01	9.97e-01	0.1640	-4.98e-02	-1.38e-01	-2.81e-02	-5.70e-02	3.82e-02	8.47e-01	5.94e-01	9.13e-01	8.25e-01	8.82e-01
POSITIVE REGULATION OF NUCLEAR DIVISION	60	1.87e-01	6.58e-01	0.1640	1.33e-01	8.34e-02	3.22e-02	3.58e-02	-8.85e-03	7.56e-02	2.64e-01	6.67e-01	6.32e-01	9.06e-01
POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	17	9.64e-01	9.97e-01	0.1640	5.47e-02	3.61e-02	6.00e-02	5.59e-02	1.26e-01	6.96e-01	7.96e-01	6.69e-01	6.90e-01	3.68e-01
MRNA 3 END PROCESSING	49	1.02e-01	5.10e-01	0.1640	-3.64e-02	-1.00e-01	9.01e-02	7.32e-02	-4.60e-02	6.59e-01	2.26e-01	2.75e-01	3.76e-01	5.78e-01
LABYRINTHINE LAYER DEVELOPMENT	43	8.60e-01	9.88e-01	0.1640	4.18e-02	9.81e-03	8.72e-02	7.85e-02	1.06e-01	6.36e-01	9.11e-01	3.23e-01	3.73e-01	2.28e-01
REGULATION OF MUSCLE CELL DIFFERENTIATION	155	2.98e-01	7.72e-01	0.1640	-5.94e-02	-5.18e-02	-9.24e-02	-9.38e-02	-5.78e-02	2.02e-01	2.66e-01	4.71e-02	4.38e-02	2.14e-01
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION	93	3.99e-01	8.45e-01	0.1640	9.94e-02	5.31e-02	8.78e-02	7.93e-02	-1.27e-02	9.76e-02	3.76e-01	1.43e-01	1.86e-01	8.32e-01
REGULATION OF BONE MINERALIZATION	76	1.32e-01	5.77e-01	0.1640	-4.74e-02	-1.42e-01	-4.42e-02	-4.82e-02	-8.79e-03	4.75e-01	3.19e-02	5.05e-01	4.68e-01	8.95e-01
REGULATION OF NEURON DIFFERENTIATION	192	5.07e-07	3.86e-05	0.1640	4.65e-02	-1.01e-01	6.77e-02	4.17e-02	9.04e-02	2.66e-01	1.60e-02	1.06e-01	3.19e-01	3.07e-02
POSITIVE REGULATION OF B CELL PROLIFERATION	43	3.92e-01	8.41e-01	0.1640	-1.57e-02	-3.27e-02	1.05e-01	9.07e-02	7.87e-02	8.59e-01	7.10e-01	2.33e-01	3.04e-01	3.72e-01
RESPONSE TO COCAINE	47	6.32e-01	9.47e-01	0.1630	1.24e-02	-8.90e-02	8.14e-02	6.86e-02	8.55e-02	8.83e-01	2.91e-01	3.34e-01	4.16e-01	3.10e-01
PROTEOGLYCAN METABOLIC PROCESS	86	1.04e-01	5.14e-01	0.1630	-9.69e-02	-6.50e-02	-6.09e-02	-9.12e-02	-3.24e-02	1.20e-01	2.98e-01	3.29e-01	1.44e-01	6.03e-01
NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	38	2.31e-01	7.14e-01	0.1630	-4.59e-03	-1.41e-01	2.19e-02	3.83e-02	7.04e-02	9.61e-01	1.34e-01	8.15e-01	6.83e-01	4.52e-01
POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY	14	9.44e-01	9.97e-01	0.1630	-5.56e-02	-5.96e-02	-3.54e-02	-4.16e-02	1.31e-01	7.18e-01	7.00e-01	8.18e-01	7.87e-01	3.98e-01
PROTEIN TARGETING	316	1.57e-03	3.41e-02	0.1630	5.35e-02	-4.32e-02	9.97e-02	8.76e-02	6.58e-02	1.02e-01	1.87e-01	2.31e-03	7.41e-03	4.43e-02
REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	26	6.50e-01	9.51e-01	0.1630	8.26e-02	-4.98e-02	9.22e-02	7.66e-02	5.48e-02	4.66e-01	6.61e-01	4.16e-01	4.99e-01	6.29e-01
REGULATION OF MONOATOMIC ANION TRANSPORT	16	7.90e-01	9.81e-01	0.1630	3.79e-03	9.11e-02	-9.35e-02	-9.47e-02	2.50e-02	9.79e-01	5.28e-01	5.17e-01	5.12e-01	8.63e-01
ENDOSOMAL VESICLE FUSION	12	9.76e-01	9.97e-01	0.1630	-5.15e-02	-8.70e-02	-7.85e-02	-7.51e-02	-6.80e-02	7.57e-01	6.02e-01	6.38e-01	6.52e-01	6.83e-01
PRE MIRNA PROCESSING	17	6.52e-01	9.52e-01	0.1630	7.87e-03	3.76e-03	-8.30e-02	-1.02e-01	-9.60e-02	9.55e-01	9.79e-01	5.54e-01	4.66e-01	4.93e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT	66	7.67e-01	9.75e-01	0.1630	1.02e-01	7.35e-02	6.84e-02	6.79e-02	3.74e-02	1.50e-01	3.02e-01	3.37e-01	3.40e-01	5.99e-01
NUCLEAR TRANSPORT	314	6.47e-04	1.73e-02	0.1630	6.72e-02	-2.83e-02	1.06e-01	9.84e-02	1.56e-02	4.06e-02	3.89e-01	1.18e-03	2.71e-03	6.35e-01
EXPORT ACROSS PLASMA MEMBRANE	78	5.63e-01	9.21e-01	0.1630	-1.02e-01	-4.28e-02	-8.50e-02	-8.31e-02	1.16e-02	1.18e-01	5.13e-01	1.94e-01	2.04e-01	8.59e-01
REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS	11	9.63e-01	9.97e-01	0.1630	3.14e-02	-8.73e-02	8.45e-02	8.66e-02	5.76e-02	8.57e-01	6.16e-01	6.27e-01	6.19e-01	7.41e-01
CONVERGENT EXTENSION	15	5.73e-01	9.26e-01	0.1630	1.30e-01	7.37e-02	-9.88e-03	-1.29e-02	-6.20e-02	3.82e-01	6.21e-01	9.47e-01	9.31e-01	6.78e-01
RESPONSE TO FATTY ACID	55	5.46e-01	9.15e-01	0.1630	-6.98e-02	-9.38e-02	-5.35e-02	-7.06e-02	-7.06e-02	3.71e-01	2.29e-01	4.92e-01	3.65e-01	3.65e-01
REGULATION OF JNK CASCADE	130	3.09e-01	7.83e-01	0.1630	-6.06e-02	-2.62e-02	-1.05e-01	-1.05e-01	-1.47e-02	2.33e-01	6.06e-01	3.96e-02	3.90e-02	7.73e-01
POLYSACCHARIDE CATABOLIC PROCESS	21	8.94e-01	9.92e-01	0.1630	8.24e-02	1.04e-01	6.44e-02	5.16e-02	-4.50e-02	5.13e-01	4.09e-01	6.09e-01	6.83e-01	7.21e-01
MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	29	4.62e-01	8.80e-01	0.1630	-6.33e-02	-5.58e-02	-5.22e-02	-8.32e-02	9.85e-02	5.55e-01	6.03e-01	6.27e-01	4.38e-01	3.59e-01
ORGANELLE FUSION	156	4.21e-02	3.14e-01	0.1630	3.05e-02	-7.79e-02	8.90e-02	7.73e-02	7.44e-02	5.11e-01	9.32e-02	5.49e-02	9.56e-02	1.09e-01
TOR SIGNALING	158	2.83e-02	2.52e-01	0.1630	-1.18e-02	-1.08e-01	7.16e-02	5.81e-02	7.76e-02	7.97e-01	1.87e-02	1.20e-01	2.08e-01	9.24e-02
RESPONSE TO TYPE II INTERFERON	137	3.77e-01	8.36e-01	0.1630	6.40e-02	4.92e-02	7.67e-02	8.33e-02	8.41e-02	1.96e-01	3.20e-01	1.21e-01	9.24e-02	8.91e-02
PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	7	7.43e-01	9.74e-01	0.1620	3.82e-02	-1.55e-01	1.92e-04	-1.33e-02	-2.56e-02	8.61e-01	4.77e-01	9.99e-01	9.51e-01	9.07e-01
VIRAL PROCESS	414	3.12e-03	5.71e-02	0.1620	7.52e-02	5.72e-03	1.03e-01	9.53e-02	3.12e-02	8.61e-03	8.42e-01	3.14e-04	8.74e-04	2.77e-01
LENS FIBER CELL DEVELOPMENT	14	9.35e-01	9.97e-01	0.1620	-2.20e-02	-3.65e-02	3.83e-02	4.14e-02	1.46e-01	8.86e-01	8.13e-01	8.04e-01	7.89e-01	3.43e-01
GLUTATHIONE METABOLIC PROCESS	52	6.15e-01	9.39e-01	0.1620	7.12e-02	-2.27e-02	1.00e-01	1.03e-01	7.53e-03	3.74e-01	7.77e-01	2.11e-01	1.97e-01	9.25e-01
PRIMARY ALCOHOL BIOSYNTHETIC PROCESS	14	6.25e-01	9.44e-01	0.1620	-1.26e-01	2.46e-03	-5.29e-02	-4.67e-02	7.43e-02	4.15e-01	9.87e-01	7.32e-01	7.62e-01	6.30e-01
BODY FLUID SECRETION	87	4.99e-01	8.97e-01	0.1620	-9.90e-02	-6.40e-02	-7.44e-02	-7.29e-02	3.99e-02	1.10e-01	3.02e-01	2.30e-01	2.40e-01	5.20e-01
NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS	272	2.46e-03	4.80e-02	0.1620	7.19e-02	-3.48e-02	9.70e-02	9.73e-02	3.28e-02	4.13e-02	3.23e-01	5.87e-03	5.74e-03	3.52e-01
SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	20	9.36e-01	9.97e-01	0.1620	9.45e-02	1.03e-01	2.52e-02	2.76e-02	-7.29e-02	4.64e-01	4.24e-01	8.45e-01	8.31e-01	5.72e-01
REGULATION OF NEURONAL SYNAPTIC PLASTICITY	53	5.21e-01	9.03e-01	0.1620	-7.47e-03	-6.88e-02	7.80e-02	8.00e-02	9.51e-02	9.25e-01	3.86e-01	3.26e-01	3.14e-01	2.31e-01
ERYTHROCYTE HOMEOSTASIS	135	1.07e-02	1.34e-01	0.1620	8.41e-02	-4.65e-02	8.05e-02	7.48e-02	7.07e-02	9.14e-02	3.51e-01	1.06e-01	1.33e-01	1.56e-01
METANEPHRIC GLOMERULUS DEVELOPMENT	16	8.54e-01	9.88e-01	0.1620	-2.63e-02	-1.24e-02	-8.22e-02	-1.01e-01	-9.17e-02	8.55e-01	9.32e-01	5.69e-01	4.83e-01	5.26e-01
CYTOSOLIC TRANSPORT	176	6.56e-02	4.09e-01	0.1620	-8.28e-02	-1.20e-01	-3.82e-02	-5.63e-02	1.63e-02	5.81e-02	5.86e-03	3.82e-01	1.98e-01	7.10e-01
MACROMOLECULE METHYLATION	197	6.27e-03	9.53e-02	0.1620	3.60e-02	-5.32e-02	1.10e-01	9.59e-02	2.70e-02	3.83e-01	1.98e-01	7.64e-03	2.02e-02	5.13e-01
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT	5	9.91e-01	9.98e-01	0.1620	-4.43e-02	-6.72e-02	-8.08e-02	-7.66e-02	8.55e-02	8.64e-01	7.95e-01	7.54e-01	7.67e-01	7.40e-01
REGULATION OF CHEMOTAXIS	221	4.33e-03	7.30e-02	0.1620	-6.16e-02	-7.13e-02	-7.28e-02	-6.93e-02	8.47e-02	1.14e-01	6.76e-02	6.23e-02	7.56e-02	3.01e-02
TYPE I INTERFERON PRODUCTION	115	1.54e-01	6.16e-01	0.1620	5.88e-02	-3.92e-02	1.04e-01	9.11e-02	4.40e-02	2.76e-01	4.67e-01	5.29e-02	9.15e-02	4.15e-01
WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	12	9.17e-01	9.95e-01	0.1620	-6.91e-02	-1.21e-01	-3.99e-02	-6.86e-02	-2.05e-02	6.78e-01	4.68e-01	8.11e-01	6.81e-01	9.02e-01
RENAL FILTRATION	25	7.12e-01	9.67e-01	0.1620	3.32e-02	1.46e-01	-9.39e-03	7.99e-03	-5.88e-02	7.74e-01	2.05e-01	9.35e-01	9.45e-01	6.11e-01
REGULATION OF GENE SILENCING BY REGULATORY NCRNA	29	6.65e-01	9.54e-01	0.1620	1.01e-01	3.95e-02	4.41e-02	5.31e-02	-9.77e-02	3.45e-01	7.13e-01	6.81e-01	6.20e-01	3.63e-01
CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT	23	9.79e-01	9.97e-01	0.1620	-8.18e-02	-7.78e-02	-6.73e-02	-7.47e-02	-5.70e-02	4.97e-01	5.18e-01	5.76e-01	5.35e-01	6.36e-01
LEUKOCYTE MEDIATED IMMUNITY	380	1.38e-03	3.15e-02	0.1620	7.20e-02	6.02e-02	5.66e-02	6.62e-02	9.86e-02	1.60e-02	4.40e-02	5.81e-02	2.66e-02	9.69e-04
SKIN EPIDERMIS DEVELOPMENT	125	6.44e-02	4.05e-01	0.1620	-5.98e-02	-1.21e-01	-5.31e-02	-6.72e-02	2.25e-02	2.48e-01	1.93e-02	3.05e-01	1.94e-01	6.65e-01
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	42	8.62e-01	9.88e-01	0.1620	7.76e-02	3.37e-03	8.08e-02	7.76e-02	8.66e-02	3.84e-01	9.70e-01	3.65e-01	3.84e-01	3.31e-01
REGULATION OF MUSCLE HYPERTROPHY	69	7.94e-01	9.81e-01	0.1620	-5.83e-02	-3.51e-02	-8.21e-02	-7.88e-02	-9.22e-02	4.02e-01	6.14e-01	2.38e-01	2.57e-01	1.85e-01
PINOCYTOSIS	22	5.38e-01	9.12e-01	0.1610	-2.60e-03	-1.38e-01	4.80e-02	5.41e-02	-4.37e-02	9.83e-01	2.64e-01	6.97e-01	6.61e-01	7.23e-01
NEGATIVE REGULATION OF TOR SIGNALING	72	2.30e-01	7.13e-01	0.1610	-8.38e-03	-1.15e-01	7.76e-02	6.87e-02	4.39e-02	9.02e-01	9.02e-02	2.55e-01	3.14e-01	5.20e-01
GLUCOSE IMPORT	75	6.31e-02	4.02e-01	0.1610	-8.47e-03	-1.90e-02	-3.43e-02	-1.14e-02	-1.56e-01	8.99e-01	7.76e-01	6.08e-01	8.65e-01	1.95e-02
TACHYKININ RECEPTOR SIGNALING PATHWAY	8	9.92e-01	9.99e-01	0.1610	-9.29e-02	-7.10e-02	-4.97e-02	-5.71e-02	8.15e-02	6.49e-01	7.28e-01	8.08e-01	7.80e-01	6.90e-01
STEM CELL DIVISION	30	2.95e-01	7.71e-01	0.1610	-2.70e-02	-1.04e-01	4.03e-03	-3.34e-02	1.15e-01	7.98e-01	3.22e-01	9.70e-01	7.52e-01	2.75e-01
TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	17	4.99e-01	8.97e-01	0.1610	-1.39e-01	1.30e-03	-4.52e-02	-6.89e-02	4.72e-03	3.22e-01	9.93e-01	7.47e-01	6.23e-01	9.73e-01
SUPPRESSION OF VIRAL RELEASE BY HOST	15	8.45e-01	9.86e-01	0.1610	2.17e-02	-1.14e-01	8.62e-02	7.03e-02	1.73e-02	8.85e-01	4.47e-01	5.63e-01	6.37e-01	9.08e-01
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	62	5.51e-01	9.16e-01	0.1610	7.49e-03	-8.35e-02	6.86e-02	5.82e-02	1.04e-01	9.19e-01	2.55e-01	3.50e-01	4.28e-01	1.55e-01
CARDIAC MUSCLE CELL PROLIFERATION	57	1.95e-01	6.71e-01	0.1610	-4.24e-02	-1.30e-01	-5.31e-02	-6.65e-02	-1.24e-02	5.80e-01	9.04e-02	4.88e-01	3.85e-01	8.72e-01
POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	23	4.94e-01	8.96e-01	0.1610	1.78e-02	1.04e-01	3.58e-02	1.59e-02	1.15e-01	8.82e-01	3.86e-01	7.66e-01	8.95e-01	3.39e-01
NECROPTOTIC PROCESS	45	5.91e-01	9.31e-01	0.1610	5.10e-02	1.16e-01	4.61e-02	4.87e-02	-7.42e-02	5.54e-01	1.80e-01	5.93e-01	5.72e-01	3.89e-01
POSITIVE REGULATION OF LIPID TRANSPORT	86	5.16e-01	9.02e-01	0.1610	-8.35e-02	-8.21e-02	-8.03e-02	-7.23e-02	2.36e-02	1.81e-01	1.88e-01	1.98e-01	2.46e-01	7.06e-01
INTEGRIN MEDIATED SIGNALING PATHWAY	110	7.10e-01	9.67e-01	0.1610	-7.49e-02	-2.73e-02	-9.29e-02	-9.24e-02	-4.92e-02	1.74e-01	6.20e-01	9.22e-02	9.41e-02	3.73e-01
NEGATIVE REGULATION OF CATECHOLAMINE SECRETION	13	7.64e-01	9.75e-01	0.1610	-9.18e-02	-6.58e-02	-5.56e-02	-9.89e-02	-1.73e-02	5.66e-01	6.81e-01	7.29e-01	5.37e-01	9.14e-01
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	895	2.23e-17	7.31e-15	0.1610	7.39e-02	-4.68e-02	9.83e-02	8.38e-02	3.97e-02	1.77e-04	1.76e-02	5.93e-07	2.09e-05	4.37e-02
PRESYNAPTIC MEMBRANE ORGANIZATION	6	9.28e-01	9.95e-01	0.1610	-1.10e-01	6.78e-03	-3.22e-02	-5.03e-02	1.01e-01	6.42e-01	9.77e-01	8.91e-01	8.31e-01	6.67e-01
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	122	6.14e-01	9.38e-01	0.1610	-7.92e-02	-5.27e-02	-9.18e-02	-9.10e-02	-1.17e-02	1.31e-01	3.15e-01	7.97e-02	8.27e-02	8.24e-01
CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM	5	6.50e-01	9.51e-01	0.1610	2.96e-02	4.34e-03	5.95e-02	1.30e-01	6.70e-02	9.09e-01	9.87e-01	8.18e-01	6.14e-01	7.95e-01
HISTONE METHYLATION	35	7.77e-01	9.78e-01	0.1610	-6.71e-02	-5.48e-02	-8.58e-02	-1.04e-01	-1.50e-02	4.92e-01	5.75e-01	3.79e-01	2.88e-01	8.78e-01
REGULATION OF RESPIRATORY BURST	16	9.79e-01	9.97e-01	0.1610	-3.58e-02	4.45e-02	-8.78e-02	-8.45e-02	-8.82e-02	8.04e-01	7.58e-01	5.43e-01	5.59e-01	5.42e-01
CHONDROCYTE PROLIFERATION	24	5.37e-01	9.12e-01	0.1610	-3.94e-02	-1.09e-01	5.38e-03	-1.74e-02	-1.10e-01	7.38e-01	3.57e-01	9.64e-01	8.83e-01	3.49e-01
NEUTROPHIL CHEMOTAXIS	102	2.76e-03	5.23e-02	0.1610	1.66e-02	-3.82e-02	-3.08e-02	-1.77e-02	1.51e-01	7.72e-01	5.05e-01	5.91e-01	7.57e-01	8.35e-03
POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	33	4.90e-01	8.93e-01	0.1610	1.01e-01	1.23e-01	-2.05e-02	-1.58e-02	5.18e-03	3.18e-01	2.23e-01	8.39e-01	8.76e-01	9.59e-01
REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION	155	8.39e-03	1.15e-01	0.1610	2.30e-02	-9.89e-02	7.11e-02	5.49e-02	8.62e-02	6.21e-01	3.35e-02	1.27e-01	2.38e-01	6.39e-02
MYELOID LEUKOCYTE MEDIATED IMMUNITY	107	1.15e-02	1.40e-01	0.1610	-2.96e-02	-1.25e-01	-5.10e-02	-5.12e-02	6.44e-02	5.97e-01	2.58e-02	3.62e-01	3.60e-01	2.50e-01
NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	9	4.96e-01	8.96e-01	0.1610	-1.44e-02	-1.02e-01	-3.41e-02	-8.90e-02	7.78e-02	9.40e-01	5.95e-01	8.59e-01	6.44e-01	6.86e-01
SCHWANN CELL DEVELOPMENT	30	7.23e-01	9.70e-01	0.1610	-8.88e-02	1.70e-02	-6.48e-02	-6.97e-02	-9.25e-02	4.00e-01	8.72e-01	5.39e-01	5.09e-01	3.80e-01
MAST CELL MEDIATED IMMUNITY	55	2.98e-01	7.72e-01	0.1610	-3.68e-02	-1.15e-01	-4.28e-02	-3.95e-02	8.80e-02	6.37e-01	1.39e-01	5.83e-01	6.12e-01	2.59e-01
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	41	2.66e-01	7.47e-01	0.1600	6.35e-02	1.11e-01	3.62e-02	1.49e-02	8.82e-02	4.82e-01	2.18e-01	6.88e-01	8.69e-01	3.28e-01
IRON ION TRANSPORT	53	6.66e-01	9.55e-01	0.1600	-5.27e-02	-8.00e-02	-7.94e-02	-8.40e-02	-5.64e-02	5.07e-01	3.14e-01	3.17e-01	2.90e-01	4.77e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	186	3.18e-02	2.69e-01	0.1600	1.16e-02	-7.78e-02	5.57e-02	5.27e-02	1.17e-01	7.84e-01	6.74e-02	1.90e-01	2.15e-01	6.03e-03
CEREBROSPINAL FLUID CIRCULATION	15	9.67e-01	9.97e-01	0.1600	-9.99e-02	-8.94e-02	-3.89e-02	-4.76e-02	-6.27e-02	5.03e-01	5.49e-01	7.94e-01	7.50e-01	6.74e-01
POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	33	5.61e-01	9.20e-01	0.1600	3.40e-02	-7.28e-02	6.45e-02	4.22e-02	1.15e-01	7.36e-01	4.69e-01	5.21e-01	6.75e-01	2.52e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	20	7.16e-01	9.68e-01	0.1600	-2.50e-02	-1.54e-01	1.39e-02	2.09e-02	2.80e-02	8.46e-01	2.34e-01	9.14e-01	8.71e-01	8.29e-01
REGULATION OF MUSCLE ADAPTATION	92	1.77e-01	6.47e-01	0.1600	1.80e-02	9.47e-02	-6.88e-02	-4.73e-02	-9.69e-02	7.66e-01	1.16e-01	2.54e-01	4.33e-01	1.08e-01
REGULATION OF PROTEIN DEPHOSPHORYLATION	75	3.70e-01	8.31e-01	0.1600	-4.97e-03	-9.83e-02	5.66e-02	5.54e-02	9.84e-02	9.41e-01	1.41e-01	3.96e-01	4.07e-01	1.40e-01
NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS	19	7.67e-01	9.75e-01	0.1600	1.05e-01	-8.11e-03	9.28e-02	7.61e-02	1.18e-02	4.28e-01	9.51e-01	4.84e-01	5.66e-01	9.29e-01
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	6	9.89e-01	9.98e-01	0.1600	-1.81e-03	-2.30e-02	-6.03e-02	-5.64e-02	-1.35e-01	9.94e-01	9.22e-01	7.98e-01	8.11e-01	5.66e-01
GLIAL CELL ACTIVATION	57	5.47e-01	9.15e-01	0.1600	-7.92e-02	-8.46e-02	-8.14e-02	-6.77e-02	3.10e-02	3.01e-01	2.69e-01	2.88e-01	3.77e-01	6.86e-01
POSITIVE REGULATION OF VACUOLE ORGANIZATION	23	8.48e-01	9.87e-01	0.1600	-4.62e-03	-8.27e-02	9.26e-02	7.28e-02	6.94e-02	9.69e-01	4.92e-01	4.42e-01	5.46e-01	5.64e-01
MICROVILLUS ORGANIZATION	28	5.44e-01	9.15e-01	0.1600	-1.43e-02	1.25e-02	-3.60e-02	-4.46e-02	1.48e-01	8.96e-01	9.09e-01	7.41e-01	6.83e-01	1.75e-01
NEUROFILAMENT CYTOSKELETON ORGANIZATION	10	8.73e-01	9.88e-01	0.1600	3.65e-03	-1.46e-01	5.44e-02	3.44e-02	6.73e-03	9.84e-01	4.24e-01	7.66e-01	8.50e-01	9.71e-01
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS	26	2.79e-01	7.58e-01	0.1600	2.41e-02	-1.19e-01	-6.99e-03	-1.88e-02	1.02e-01	8.32e-01	2.94e-01	9.51e-01	8.68e-01	3.68e-01
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	26	8.48e-01	9.87e-01	0.1600	-7.61e-02	9.12e-04	-8.75e-02	-6.97e-02	-8.50e-02	5.02e-01	9.94e-01	4.40e-01	5.38e-01	4.53e-01
NERVE GROWTH FACTOR SIGNALING PATHWAY	13	8.15e-01	9.82e-01	0.1600	-4.49e-02	-1.19e-01	8.03e-02	4.58e-02	2.81e-02	7.79e-01	4.58e-01	6.16e-01	7.75e-01	8.61e-01
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	71	2.02e-02	2.04e-01	0.1600	1.25e-02	-9.32e-02	7.92e-03	-1.46e-02	1.28e-01	8.55e-01	1.75e-01	9.08e-01	8.31e-01	6.22e-02
MAMMARY GLAND MORPHOGENESIS	42	4.20e-01	8.59e-01	0.1600	-2.49e-02	-1.40e-01	3.51e-02	1.35e-02	6.20e-02	7.80e-01	1.16e-01	6.94e-01	8.79e-01	4.87e-01
REGULATION OF T CELL MEDIATED IMMUNITY	95	3.26e-01	7.98e-01	0.1600	4.80e-02	6.34e-02	5.87e-02	6.10e-02	1.09e-01	4.19e-01	2.85e-01	3.22e-01	3.04e-01	6.53e-02
REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	60	5.48e-01	9.15e-01	0.1600	-5.81e-02	-1.26e-01	-2.72e-02	-3.11e-02	6.78e-02	4.36e-01	9.24e-02	7.15e-01	6.77e-01	3.64e-01
DENDRITE MORPHOGENESIS	129	1.80e-01	6.52e-01	0.1600	-9.00e-02	-2.60e-02	-8.44e-02	-9.41e-02	2.64e-02	7.75e-02	6.10e-01	9.79e-02	6.49e-02	6.04e-01
EPITHELIAL TO MESENCHYMAL TRANSITION	176	6.11e-03	9.37e-02	0.1590	-2.72e-02	-1.27e-01	5.91e-02	4.22e-02	5.65e-02	5.34e-01	3.55e-03	1.76e-01	3.34e-01	1.96e-01
OSTEOCLAST DIFFERENTIATION	103	4.54e-01	8.78e-01	0.1590	-8.78e-02	-2.80e-02	-9.54e-02	-8.84e-02	-3.96e-03	1.24e-01	6.24e-01	9.44e-02	1.21e-01	9.45e-01
RETINAL METABOLIC PROCESS	18	9.52e-01	9.97e-01	0.1590	-6.43e-02	-9.54e-02	-3.51e-02	-3.74e-02	9.77e-02	6.37e-01	4.83e-01	7.97e-01	7.84e-01	4.73e-01
VESTIBULOCOCHLEAR NERVE DEVELOPMENT	11	8.16e-01	9.83e-01	0.1590	5.47e-02	1.20e-01	-5.51e-02	-6.96e-02	-1.10e-03	7.53e-01	4.89e-01	7.51e-01	6.89e-01	9.95e-01
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT	6	6.58e-01	9.54e-01	0.1590	-6.99e-02	1.41e-01	1.80e-02	-1.38e-02	-7.17e-03	7.67e-01	5.49e-01	9.39e-01	9.53e-01	9.76e-01
ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER	14	9.13e-01	9.94e-01	0.1590	8.68e-02	-1.07e-03	8.09e-02	6.19e-02	8.63e-02	5.74e-01	9.94e-01	6.00e-01	6.89e-01	5.76e-01
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	15	8.89e-01	9.91e-01	0.1590	-6.24e-03	-7.01e-02	7.46e-02	4.41e-02	1.14e-01	9.67e-01	6.39e-01	6.17e-01	7.68e-01	4.46e-01
INOSINE METABOLIC PROCESS	5	9.07e-01	9.94e-01	0.1590	-7.20e-02	1.83e-02	-1.20e-01	-7.00e-02	-2.27e-02	7.81e-01	9.43e-01	6.42e-01	7.86e-01	9.30e-01
ARACHIDONIC ACID METABOLIC PROCESS	56	1.46e-01	6.04e-01	0.1590	1.06e-02	1.27e-01	1.67e-02	1.95e-02	-9.17e-02	8.91e-01	1.00e-01	8.29e-01	8.01e-01	2.35e-01
INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE	132	2.66e-04	8.89e-03	0.1590	1.73e-02	1.44e-01	-1.64e-02	-3.70e-03	6.34e-02	7.31e-01	4.31e-03	7.45e-01	9.41e-01	2.08e-01
INTERLEUKIN 4 PRODUCTION	32	7.30e-01	9.71e-01	0.1590	-3.45e-02	-7.48e-02	-2.44e-02	-2.76e-02	1.31e-01	7.35e-01	4.64e-01	8.11e-01	7.87e-01	2.00e-01
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	134	2.51e-01	7.35e-01	0.1590	-6.82e-02	-8.20e-02	-8.39e-02	-7.43e-02	-3.64e-02	1.73e-01	1.01e-01	9.37e-02	1.37e-01	4.66e-01
NEURAL RETINA DEVELOPMENT	78	2.10e-01	6.89e-01	0.1590	1.04e-01	4.84e-02	4.96e-02	4.69e-02	8.66e-02	1.13e-01	4.60e-01	4.48e-01	4.74e-01	1.86e-01
STEM CELL DIFFERENTIATION	240	2.74e-06	1.73e-04	0.1590	4.76e-02	-7.02e-02	8.00e-02	5.34e-02	9.37e-02	2.04e-01	6.10e-02	3.27e-02	1.54e-01	1.24e-02
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	164	1.23e-02	1.46e-01	0.1590	-4.70e-02	1.69e-02	-9.23e-02	-1.09e-01	-4.82e-02	2.99e-01	7.08e-01	4.14e-02	1.60e-02	2.87e-01
HISTONE H4 ACETYLATION	11	1.27e-01	5.68e-01	0.1590	9.42e-02	1.10e-01	5.54e-02	-1.81e-02	2.70e-02	5.88e-01	5.26e-01	7.50e-01	9.17e-01	8.77e-01
CELLULAR COMPONENT MAINTENANCE	72	8.38e-01	9.85e-01	0.1590	-8.96e-02	-8.49e-02	-6.39e-02	-7.04e-02	-3.03e-02	1.89e-01	2.13e-01	3.48e-01	3.02e-01	6.57e-01
T HELPER 1 TYPE IMMUNE RESPONSE	48	8.37e-01	9.85e-01	0.1590	-8.84e-02	-9.83e-02	-4.54e-02	-4.97e-02	5.61e-02	2.89e-01	2.39e-01	5.87e-01	5.51e-01	5.01e-01
REGULATION OF INTRACELLULAR LIPID TRANSPORT	10	6.56e-01	9.53e-01	0.1590	-9.58e-02	-2.17e-02	1.24e-02	-3.46e-02	1.19e-01	6.00e-01	9.05e-01	9.46e-01	8.50e-01	5.15e-01
EMBRYONIC HEART TUBE MORPHOGENESIS	70	2.42e-02	2.30e-01	0.1580	6.48e-02	-9.22e-02	7.19e-02	5.42e-02	6.53e-02	3.48e-01	1.82e-01	2.98e-01	4.33e-01	3.44e-01
REGULATION OF NERVOUS SYSTEM PROCESS	114	2.88e-02	2.54e-01	0.1580	-6.43e-02	9.90e-03	-9.66e-02	-8.52e-02	6.48e-02	2.36e-01	8.55e-01	7.47e-02	1.16e-01	2.32e-01
PLATELET MORPHOGENESIS	22	5.53e-01	9.16e-01	0.1580	-1.40e-02	-4.24e-02	-6.96e-02	-8.28e-02	1.06e-01	9.10e-01	7.30e-01	5.72e-01	5.01e-01	3.87e-01
PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	28	3.66e-01	8.30e-01	0.1580	-2.27e-02	-9.28e-02	-6.66e-02	-8.55e-02	6.43e-02	8.35e-01	3.95e-01	5.42e-01	4.33e-01	5.56e-01
AROMATIC AMINO ACID METABOLIC PROCESS	31	7.37e-01	9.73e-01	0.1580	-5.21e-02	-1.05e-01	-6.57e-02	-5.96e-02	5.78e-02	6.16e-01	3.10e-01	5.26e-01	5.66e-01	5.78e-01
PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY	5	9.20e-01	9.95e-01	0.1580	-1.32e-02	-1.21e-01	-4.50e-02	-7.45e-02	-5.04e-02	9.59e-01	6.38e-01	8.62e-01	7.73e-01	8.45e-01
REGULATION OF DIGESTIVE SYSTEM PROCESS	37	7.90e-01	9.81e-01	0.1580	-5.49e-02	6.58e-03	-8.98e-02	-1.04e-01	-5.61e-02	5.63e-01	9.45e-01	3.44e-01	2.76e-01	5.55e-01
AUTOPHAGY OF MITOCHONDRION	90	2.96e-01	7.71e-01	0.1580	-6.03e-02	-1.20e-01	-5.47e-02	-5.55e-02	-3.00e-02	3.23e-01	4.92e-02	3.70e-01	3.63e-01	6.23e-01
NEURON RECOGNITION	45	8.27e-01	9.83e-01	0.1580	-9.64e-02	-9.82e-02	-3.63e-02	-4.83e-02	4.90e-02	2.63e-01	2.54e-01	6.74e-01	5.75e-01	5.70e-01
POSTSYNAPTIC MEMBRANE ORGANIZATION	35	9.19e-01	9.95e-01	0.1580	-1.03e-01	-9.33e-02	-5.13e-02	-5.41e-02	7.37e-03	2.91e-01	3.40e-01	5.99e-01	5.80e-01	9.40e-01
BILE ACID SECRETION	12	3.08e-01	7.82e-01	0.1580	-9.71e-02	9.05e-03	-1.10e-01	-5.15e-02	2.69e-02	5.60e-01	9.57e-01	5.11e-01	7.57e-01	8.72e-01
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	22	6.93e-01	9.61e-01	0.1580	6.08e-03	-9.25e-02	-7.26e-03	-8.08e-03	1.27e-01	9.61e-01	4.52e-01	9.53e-01	9.48e-01	3.01e-01
CELLULAR RESPONSE TO UV	87	3.42e-02	2.79e-01	0.1580	1.31e-02	-9.79e-02	8.92e-02	5.90e-02	6.09e-02	8.33e-01	1.14e-01	1.50e-01	3.41e-01	3.26e-01
NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	16	9.12e-01	9.94e-01	0.1580	-2.47e-02	-1.02e-03	-4.85e-02	-3.00e-02	-1.45e-01	8.64e-01	9.94e-01	7.37e-01	8.35e-01	3.15e-01
MAINTENANCE OF PROTEIN LOCATION	85	3.65e-01	8.29e-01	0.1580	-5.19e-02	-1.08e-01	-1.30e-02	-1.79e-02	1.01e-01	4.08e-01	8.66e-02	8.35e-01	7.75e-01	1.08e-01
IMMUNOGLOBULIN V D J RECOMBINATION	8	2.80e-01	7.58e-01	0.1580	1.40e-01	5.64e-02	8.07e-03	-4.43e-02	3.16e-03	4.92e-01	7.82e-01	9.68e-01	8.28e-01	9.88e-01
CHOLESTEROL STORAGE	25	9.54e-01	9.97e-01	0.1580	3.71e-02	1.02e-02	7.19e-02	6.90e-02	1.16e-01	7.48e-01	9.30e-01	5.34e-01	5.50e-01	3.15e-01
REGULATION OF PHOSPHATASE ACTIVITY	59	6.19e-01	9.42e-01	0.1580	-6.39e-02	-1.05e-01	-7.89e-03	-2.08e-02	9.66e-02	3.96e-01	1.65e-01	9.17e-01	7.83e-01	1.99e-01
OTOLITH DEVELOPMENT	10	9.08e-01	9.94e-01	0.1580	-1.02e-01	-1.05e-02	-4.24e-02	-5.13e-02	9.98e-02	5.77e-01	9.54e-01	8.16e-01	7.79e-01	5.85e-01
INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION	35	7.02e-01	9.64e-01	0.1580	5.89e-02	3.29e-02	3.37e-02	3.16e-02	1.35e-01	5.47e-01	7.36e-01	7.30e-01	7.47e-01	1.68e-01
CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	47	2.34e-01	7.18e-01	0.1580	1.06e-01	1.08e-01	2.98e-02	1.28e-02	-3.03e-02	2.08e-01	2.02e-01	7.23e-01	8.79e-01	7.19e-01
RESPONSE TO PROSTAGLANDIN E	23	6.90e-01	9.61e-01	0.1580	3.05e-02	8.51e-02	-4.96e-03	-4.45e-03	1.29e-01	8.00e-01	4.80e-01	9.67e-01	9.71e-01	2.85e-01
GENERATION OF PRECURSOR METABOLITES AND ENERGY	470	1.25e-07	1.07e-05	0.1580	9.21e-02	-1.52e-02	9.19e-02	8.74e-02	-2.34e-03	6.18e-04	5.73e-01	6.40e-04	1.16e-03	9.31e-01
REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	43	7.11e-01	9.67e-01	0.1570	-7.96e-02	-3.79e-02	-6.01e-02	-5.10e-02	-1.04e-01	3.66e-01	6.67e-01	4.96e-01	5.62e-01	2.38e-01
HEPATICOBILIARY SYSTEM DEVELOPMENT	140	6.97e-02	4.23e-01	0.1570	3.74e-03	-9.37e-02	7.28e-02	5.80e-02	8.54e-02	9.39e-01	5.55e-02	1.37e-01	2.36e-01	8.10e-02
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	43	6.75e-01	9.59e-01	0.1570	2.10e-02	4.41e-02	-6.12e-02	-5.35e-02	-1.26e-01	8.12e-01	6.17e-01	4.87e-01	5.44e-01	1.54e-01
POSITIVE REGULATION OF CYTOKINESIS	43	4.07e-01	8.51e-01	0.1570	-7.02e-02	-3.06e-02	-6.47e-02	-9.35e-02	-7.73e-02	4.26e-01	7.29e-01	4.63e-01	2.89e-01	3.81e-01
POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	18	9.70e-01	9.97e-01	0.1570	-9.76e-02	-9.13e-02	-3.84e-02	-4.73e-02	5.61e-02	4.73e-01	5.03e-01	7.78e-01	7.28e-01	6.81e-01
RESCUE OF STALLED RIBOSOME	29	4.05e-01	8.50e-01	0.1570	-4.72e-03	-1.29e-01	4.90e-02	3.69e-02	-6.49e-02	9.65e-01	2.28e-01	6.48e-01	7.31e-01	5.45e-01
NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS	15	8.37e-01	9.85e-01	0.1570	-6.14e-03	-1.16e-01	5.47e-02	6.94e-02	5.85e-02	9.67e-01	4.37e-01	7.14e-01	6.42e-01	6.95e-01
BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION	14	7.49e-01	9.75e-01	0.1570	1.03e-01	-1.17e-02	6.61e-02	9.77e-02	6.02e-03	5.05e-01	9.40e-01	6.69e-01	5.27e-01	9.69e-01
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	24	7.54e-01	9.75e-01	0.1570	3.71e-02	3.67e-02	2.07e-02	1.27e-02	-1.46e-01	7.53e-01	7.56e-01	8.61e-01	9.15e-01	2.15e-01
AMINO ACID BIOSYNTHETIC PROCESS	74	1.07e-01	5.24e-01	0.1570	3.08e-02	-9.43e-02	9.32e-02	7.81e-02	7.97e-03	6.47e-01	1.61e-01	1.66e-01	2.46e-01	9.06e-01
RESPONSE TO LEUKEMIA INHIBITORY FACTOR	101	8.17e-02	4.56e-01	0.1570	1.44e-02	-9.67e-02	7.90e-02	8.27e-02	4.47e-02	8.03e-01	9.30e-02	1.70e-01	1.51e-01	4.38e-01
INTRACELLULAR MRNA LOCALIZATION	13	8.12e-01	9.82e-01	0.1570	-1.33e-01	-5.33e-02	-4.74e-02	-3.86e-02	1.78e-02	4.06e-01	7.39e-01	7.67e-01	8.10e-01	9.12e-01
REGULATORY NCRNA PROCESSING	84	2.49e-01	7.33e-01	0.1570	2.39e-02	4.44e-02	-2.34e-02	-2.39e-02	-1.45e-01	7.05e-01	4.82e-01	7.11e-01	7.05e-01	2.18e-02
DETECTION OF BACTERIUM	16	9.61e-01	9.97e-01	0.1570	-5.68e-02	-4.48e-02	-6.35e-02	-5.15e-02	-1.13e-01	6.94e-01	7.56e-01	6.60e-01	7.22e-01	4.35e-01
COPULATION	19	8.74e-01	9.88e-01	0.1570	-2.04e-02	-1.21e-01	6.97e-02	5.71e-02	3.78e-02	8.78e-01	3.61e-01	5.99e-01	6.66e-01	7.75e-01
REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	22	3.17e-01	7.89e-01	0.1570	-1.04e-01	3.78e-02	-3.38e-02	-4.79e-02	9.42e-02	3.98e-01	7.59e-01	7.84e-01	6.98e-01	4.44e-01
SUBSTANTIA NIGRA DEVELOPMENT	40	4.05e-01	8.50e-01	0.1570	-1.24e-02	-9.44e-02	9.51e-02	6.71e-02	4.45e-02	8.92e-01	3.02e-01	2.98e-01	4.63e-01	6.26e-01
NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION	15	8.91e-01	9.92e-01	0.1570	4.25e-02	2.26e-02	9.33e-02	1.13e-01	2.86e-02	7.76e-01	8.80e-01	5.32e-01	4.49e-01	8.48e-01
POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	19	4.00e-01	8.45e-01	0.1570	8.51e-02	6.81e-02	8.20e-02	4.17e-02	-6.51e-02	5.21e-01	6.08e-01	5.36e-01	7.53e-01	6.23e-01
DISTAL CONVOLUTED TUBULE DEVELOPMENT	5	8.19e-01	9.83e-01	0.1570	7.56e-02	-7.61e-02	8.14e-02	3.77e-02	-7.07e-02	7.70e-01	7.68e-01	7.53e-01	8.84e-01	7.84e-01
CELLULAR RESPONSE TO LEUCINE	12	6.86e-01	9.61e-01	0.1570	4.27e-02	-1.06e-02	3.23e-03	-2.34e-02	-1.49e-01	7.98e-01	9.50e-01	9.85e-01	8.88e-01	3.73e-01
RESPONSE TO TOXIC SUBSTANCE	249	1.31e-01	5.76e-01	0.1570	4.74e-02	7.54e-03	8.17e-02	7.67e-02	9.82e-02	1.98e-01	8.38e-01	2.65e-02	3.71e-02	7.59e-03
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	19	6.49e-01	9.51e-01	0.1570	2.36e-02	-1.05e-01	2.37e-03	4.56e-03	1.13e-01	8.58e-01	4.27e-01	9.86e-01	9.73e-01	3.92e-01
ACETYL COA BIOSYNTHETIC PROCESS	16	5.31e-01	9.07e-01	0.1560	4.78e-03	-8.35e-02	1.04e-01	6.46e-02	-5.03e-02	9.74e-01	5.63e-01	4.72e-01	6.54e-01	7.28e-01
REGULATION OF NATURAL KILLER CELL ACTIVATION	42	7.27e-01	9.71e-01	0.1560	7.26e-02	1.27e-01	2.36e-02	3.10e-02	3.74e-02	4.15e-01	1.53e-01	7.91e-01	7.28e-01	6.75e-01
SULFATE TRANSPORT	17	8.88e-01	9.91e-01	0.1560	-9.52e-02	-5.57e-02	-8.83e-02	-6.62e-02	-6.86e-03	4.97e-01	6.91e-01	5.29e-01	6.37e-01	9.61e-01
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS	32	5.86e-01	9.29e-01	0.1560	-9.23e-02	-7.91e-02	2.99e-03	4.10e-03	9.75e-02	3.66e-01	4.38e-01	9.77e-01	9.68e-01	3.40e-01
NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	34	8.25e-01	9.83e-01	0.1560	-1.02e-01	-1.52e-02	-8.18e-02	-8.21e-02	-1.14e-02	3.01e-01	8.78e-01	4.09e-01	4.07e-01	9.09e-01
PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	28	5.18e-01	9.03e-01	0.1560	7.71e-02	1.31e-01	-2.13e-02	1.09e-02	2.46e-02	4.80e-01	2.30e-01	8.45e-01	9.20e-01	8.22e-01
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	52	6.23e-01	9.44e-01	0.1560	-5.35e-02	5.26e-02	-7.37e-02	-7.16e-02	-8.99e-02	5.05e-01	5.12e-01	3.58e-01	3.72e-01	2.62e-01
MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY	6	8.95e-01	9.93e-01	0.1560	-3.10e-02	-1.34e-01	-1.92e-02	-6.00e-02	3.60e-02	8.95e-01	5.69e-01	9.35e-01	7.99e-01	8.79e-01
REGULATION OF DENDRITE DEVELOPMENT	91	3.10e-01	7.83e-01	0.1560	-9.63e-02	-2.09e-02	-7.96e-02	-8.48e-02	3.11e-02	1.12e-01	7.30e-01	1.90e-01	1.62e-01	6.08e-01
REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	57	5.24e-01	9.05e-01	0.1560	1.72e-02	7.50e-03	9.44e-02	9.37e-02	7.84e-02	8.22e-01	9.22e-01	2.18e-01	2.21e-01	3.06e-01
FEMALE GENITALIA DEVELOPMENT	19	5.44e-01	9.15e-01	0.1560	3.19e-03	-4.19e-02	-1.85e-03	-2.85e-02	-1.47e-01	9.81e-01	7.52e-01	9.89e-01	8.30e-01	2.67e-01
NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	21	4.61e-01	8.80e-01	0.1560	-1.38e-02	-8.61e-02	-8.43e-02	-5.39e-02	-8.10e-02	9.13e-01	4.95e-01	5.03e-01	6.69e-01	5.20e-01
SMOOTH MUSCLE CELL MIGRATION	86	8.07e-01	9.82e-01	0.1550	-7.54e-02	-6.60e-02	-8.34e-02	-8.25e-02	-1.96e-02	2.27e-01	2.90e-01	1.81e-01	1.86e-01	7.54e-01
RETINOIC ACID RECEPTOR SIGNALING PATHWAY	32	3.50e-01	8.18e-01	0.1550	-4.04e-02	-1.19e-01	-4.50e-02	-7.29e-02	3.30e-02	6.93e-01	2.45e-01	6.60e-01	4.75e-01	7.46e-01
MEMBRANE DISASSEMBLY	11	9.73e-01	9.97e-01	0.1550	-1.40e-02	9.84e-03	-5.15e-02	-6.07e-02	-1.32e-01	9.36e-01	9.55e-01	7.67e-01	7.27e-01	4.47e-01
AMINOGLYCAN CATABOLIC PROCESS	33	8.49e-01	9.87e-01	0.1550	-7.92e-02	-5.13e-02	-9.10e-02	-7.35e-02	-3.91e-02	4.31e-01	6.10e-01	3.65e-01	4.65e-01	6.97e-01
NEGATIVE REGULATION OF MITOTIC CELL CYCLE	241	4.23e-03	7.17e-02	0.1550	4.25e-02	-3.63e-02	1.07e-01	8.97e-02	3.85e-02	2.56e-01	3.31e-01	4.19e-03	1.65e-02	3.03e-01
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	97	2.16e-01	6.98e-01	0.1550	-3.63e-02	-3.96e-02	-1.04e-01	-9.60e-02	-3.35e-02	5.36e-01	5.00e-01	7.59e-02	1.02e-01	5.68e-01
MUSCLE CELL MIGRATION	100	6.99e-01	9.62e-01	0.1550	-7.91e-02	-8.79e-02	-6.60e-02	-7.31e-02	-2.00e-02	1.72e-01	1.29e-01	2.54e-01	2.06e-01	7.29e-01
CELLULAR RESPONSE TO LEPTIN STIMULUS	17	8.18e-01	9.83e-01	0.1550	8.78e-02	-3.10e-02	7.11e-02	5.78e-02	8.36e-02	5.31e-01	8.25e-01	6.12e-01	6.80e-01	5.51e-01
RESPIRATORY SYSTEM PROCESS	37	6.53e-01	9.52e-01	0.1550	-1.53e-03	8.22e-02	-8.68e-02	-6.34e-02	-7.58e-02	9.87e-01	3.87e-01	3.61e-01	5.05e-01	4.25e-01
REGULATION OF AUTOPHAGOSOME ASSEMBLY	42	4.26e-01	8.64e-01	0.1550	-3.76e-03	-1.09e-01	8.51e-02	6.29e-02	2.97e-02	9.66e-01	2.22e-01	3.40e-01	4.80e-01	7.39e-01
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	57	7.52e-01	9.75e-01	0.1550	-7.89e-02	-9.35e-02	-3.94e-02	-4.95e-02	7.02e-02	3.03e-01	2.22e-01	6.07e-01	5.18e-01	3.60e-01
RESPIRATORY BURST	33	9.71e-01	9.97e-01	0.1550	6.36e-02	2.12e-02	8.49e-02	8.73e-02	6.75e-02	5.27e-01	8.33e-01	3.99e-01	3.86e-01	5.02e-01
POSITIVE REGULATION OF FATTY ACID OXIDATION	14	9.81e-01	9.97e-01	0.1540	7.37e-02	9.25e-02	2.79e-02	3.85e-02	-8.72e-02	6.33e-01	5.49e-01	8.57e-01	8.03e-01	5.72e-01
CELL MATRIX ADHESION	232	7.93e-02	4.52e-01	0.1540	-5.83e-02	4.13e-03	-1.00e-01	-9.96e-02	-2.24e-02	1.26e-01	9.14e-01	8.64e-03	8.98e-03	5.56e-01
MAINTENANCE OF PROTEIN LOCATION IN CELL	60	3.18e-01	7.89e-01	0.1540	3.54e-02	-8.58e-02	5.19e-02	5.08e-02	9.96e-02	6.35e-01	2.50e-01	4.86e-01	4.96e-01	1.82e-01
REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	45	6.95e-01	9.61e-01	0.1540	6.76e-03	-7.08e-02	3.82e-02	3.54e-02	1.27e-01	9.37e-01	4.11e-01	6.57e-01	6.81e-01	1.42e-01
B CELL RECEPTOR SIGNALING PATHWAY	61	3.80e-02	2.98e-01	0.1540	-1.05e-03	6.08e-02	1.02e-01	9.22e-02	3.32e-02	9.89e-01	4.11e-01	1.67e-01	2.13e-01	6.54e-01
RESPONSE TO ESTROGEN	66	3.65e-01	8.29e-01	0.1540	-3.71e-02	-1.18e-01	-1.59e-02	-1.65e-02	8.93e-02	6.02e-01	9.78e-02	8.23e-01	8.17e-01	2.10e-01
LYMPHOCYTE ANERGY	7	3.47e-01	8.18e-01	0.1540	-8.90e-02	1.08e-01	5.40e-02	-2.26e-03	-3.59e-02	6.83e-01	6.21e-01	8.04e-01	9.92e-01	8.69e-01
POSITIVE REGULATION OF VASCULOGENESIS	12	7.54e-01	9.75e-01	0.1540	-3.11e-03	-1.25e-01	7.29e-02	4.02e-02	-3.25e-02	9.85e-01	4.52e-01	6.62e-01	8.10e-01	8.45e-01
AMINO SUGAR METABOLIC PROCESS	40	7.96e-01	9.81e-01	0.1540	5.90e-02	5.93e-02	5.71e-02	4.87e-02	1.05e-01	5.18e-01	5.16e-01	5.32e-01	5.94e-01	2.49e-01
REACTIVE NITROGEN SPECIES METABOLIC PROCESS	76	6.47e-01	9.51e-01	0.1540	-7.63e-02	-1.06e-01	-3.68e-02	-4.15e-02	6.07e-02	2.50e-01	1.12e-01	5.79e-01	5.31e-01	3.60e-01
POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	109	1.51e-01	6.13e-01	0.1540	-2.66e-02	-1.24e-01	3.88e-02	3.03e-02	7.25e-02	6.31e-01	2.56e-02	4.84e-01	5.84e-01	1.91e-01
PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION	13	9.09e-01	9.94e-01	0.1540	-1.92e-02	8.99e-02	-9.62e-02	-7.62e-02	-1.31e-02	9.04e-01	5.74e-01	5.48e-01	6.34e-01	9.35e-01
REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	18	5.64e-01	9.22e-01	0.1540	4.93e-02	7.30e-02	1.06e-01	6.75e-02	1.04e-02	7.17e-01	5.92e-01	4.36e-01	6.20e-01	9.39e-01
RESPONSE TO UV	147	4.98e-03	8.13e-02	0.1540	3.74e-02	-8.39e-02	9.08e-02	6.97e-02	4.62e-02	4.34e-01	7.91e-02	5.74e-02	1.45e-01	3.34e-01
REGULATION OF SYNAPTIC VESICLE CYCLE	12	7.43e-01	9.74e-01	0.1540	1.90e-02	2.94e-03	-8.82e-02	-7.22e-02	1.01e-01	9.09e-01	9.86e-01	5.97e-01	6.65e-01	5.43e-01
G0 TO G1 TRANSITION	36	4.60e-02	3.35e-01	0.1540	5.97e-02	2.06e-03	1.21e-01	7.09e-02	-2.15e-02	5.35e-01	9.83e-01	2.10e-01	4.62e-01	8.24e-01
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT	85	2.47e-01	7.32e-01	0.1540	-3.83e-02	-9.07e-02	-2.42e-02	-3.20e-02	1.11e-01	5.41e-01	1.48e-01	7.00e-01	6.10e-01	7.71e-02
RESPONSE TO MURAMYL DIPEPTIDE	20	3.90e-01	8.41e-01	0.1540	8.39e-02	-4.12e-02	3.29e-03	1.88e-02	1.20e-01	5.16e-01	7.50e-01	9.80e-01	8.84e-01	3.51e-01
CELLULAR RESPONSE TO RADIATION	170	6.61e-02	4.11e-01	0.1540	7.03e-02	-7.10e-04	9.61e-02	7.89e-02	5.67e-02	1.14e-01	9.87e-01	3.07e-02	7.59e-02	2.02e-01
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	33	4.13e-01	8.54e-01	0.1540	-6.63e-03	1.02e-01	-9.37e-02	-6.52e-02	-1.21e-02	9.47e-01	3.11e-01	3.52e-01	5.17e-01	9.04e-01
REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	26	9.25e-01	9.95e-01	0.1540	3.06e-02	2.92e-03	9.68e-02	8.30e-02	8.00e-02	7.87e-01	9.79e-01	3.93e-01	4.64e-01	4.80e-01
NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	36	1.30e-01	5.74e-01	0.1540	1.20e-02	1.01e-01	-5.12e-02	-8.22e-02	-6.25e-02	9.01e-01	2.95e-01	5.95e-01	3.94e-01	5.16e-01
THIOESTER BIOSYNTHETIC PROCESS	43	5.72e-01	9.26e-01	0.1540	-3.47e-02	-1.31e-01	3.01e-02	1.09e-02	6.58e-02	6.94e-01	1.39e-01	7.33e-01	9.01e-01	4.56e-01
POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING	12	3.86e-01	8.40e-01	0.1530	-7.39e-02	-9.08e-03	5.41e-02	7.54e-02	-9.69e-02	6.57e-01	9.57e-01	7.46e-01	6.51e-01	5.61e-01
POSITIVE REGULATION OF MUSCLE HYPERTROPHY	36	9.42e-01	9.97e-01	0.1530	-5.85e-02	-3.29e-03	-7.49e-02	-7.60e-02	-9.33e-02	5.43e-01	9.73e-01	4.36e-01	4.30e-01	3.32e-01
EMBRYONIC HINDLIMB MORPHOGENESIS	27	1.98e-01	6.77e-01	0.1530	9.41e-03	-1.40e-01	5.54e-02	1.78e-02	1.94e-02	9.33e-01	2.07e-01	6.19e-01	8.73e-01	8.62e-01
TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB	7	9.92e-01	9.99e-01	0.1530	-8.21e-02	-5.19e-02	-6.58e-02	-5.99e-02	7.83e-02	7.07e-01	8.12e-01	7.63e-01	7.84e-01	7.20e-01
PANCREAS DEVELOPMENT	78	6.57e-03	9.77e-02	0.1530	9.34e-03	-1.35e-01	3.43e-02	6.95e-03	6.29e-02	8.87e-01	3.93e-02	6.00e-01	9.15e-01	3.37e-01
CELL CELL ADHESION MEDIATED BY INTEGRIN	17	7.38e-01	9.73e-01	0.1530	8.78e-03	6.82e-02	-1.42e-02	-2.73e-02	1.33e-01	9.50e-01	6.27e-01	9.19e-01	8.46e-01	3.41e-01
TONGUE MORPHOGENESIS	10	6.88e-01	9.61e-01	0.1530	-4.16e-02	-5.02e-02	-4.57e-02	-9.32e-02	-9.19e-02	8.20e-01	7.83e-01	8.02e-01	6.10e-01	6.15e-01
METANEPHROS MORPHOGENESIS	30	6.48e-01	9.51e-01	0.1530	-7.74e-02	-8.19e-02	-5.55e-02	-8.66e-02	-1.29e-02	4.63e-01	4.37e-01	5.99e-01	4.12e-01	9.03e-01
DNA SYNTHESIS INVOLVED IN DNA REPAIR	39	4.29e-01	8.66e-01	0.1530	-3.89e-02	-1.32e-01	4.50e-02	4.45e-02	-2.10e-02	6.74e-01	1.53e-01	6.27e-01	6.31e-01	8.20e-01
PROTEIN CONTAINING COMPLEX DISASSEMBLY	241	1.32e-02	1.54e-01	0.1530	5.63e-02	-2.57e-02	1.02e-01	8.69e-02	4.11e-02	1.32e-01	4.91e-01	6.56e-03	2.01e-02	2.72e-01
BRANCHED CHAIN AMINO ACID METABOLIC PROCESS	26	7.01e-01	9.63e-01	0.1530	1.46e-02	-8.46e-02	4.42e-02	2.26e-02	1.16e-01	8.97e-01	4.55e-01	6.96e-01	8.42e-01	3.05e-01
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS	11	9.69e-01	9.97e-01	0.1530	3.87e-02	1.37e-01	-2.20e-02	-9.25e-03	-5.04e-02	8.24e-01	4.32e-01	8.99e-01	9.58e-01	7.72e-01
CAMP BIOSYNTHETIC PROCESS	10	9.56e-01	9.97e-01	0.1530	-8.47e-03	1.11e-01	-7.68e-02	-5.88e-02	-4.00e-02	9.63e-01	5.43e-01	6.74e-01	7.47e-01	8.27e-01
RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	31	5.08e-01	9.00e-01	0.1530	-2.71e-02	-1.33e-01	-1.37e-02	-1.42e-04	6.86e-02	7.94e-01	2.00e-01	8.95e-01	9.99e-01	5.09e-01
SYNAPSE PRUNING	14	7.33e-01	9.72e-01	0.1530	-1.32e-02	1.47e-01	-3.25e-02	-1.98e-02	-8.26e-03	9.32e-01	3.41e-01	8.33e-01	8.98e-01	9.57e-01
NEGATIVE REGULATION OF AMINE TRANSPORT	28	6.27e-01	9.45e-01	0.1530	2.87e-03	-1.06e-01	4.79e-02	2.28e-02	9.62e-02	9.79e-01	3.32e-01	6.61e-01	8.34e-01	3.78e-01
PROSTATE GLAND MORPHOGENESIS	27	1.40e-01	5.95e-01	0.1530	9.15e-02	-7.94e-02	7.65e-02	5.12e-02	-1.24e-02	4.11e-01	4.75e-01	4.91e-01	6.45e-01	9.11e-01
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	10	8.25e-01	9.83e-01	0.1530	-1.25e-03	1.32e-01	-3.46e-02	-5.28e-02	4.34e-02	9.95e-01	4.70e-01	8.50e-01	7.72e-01	8.12e-01
REGULATION OF B CELL APOPTOTIC PROCESS	20	7.66e-01	9.75e-01	0.1530	1.77e-02	-1.20e-01	6.60e-02	5.06e-02	4.01e-02	8.91e-01	3.52e-01	6.10e-01	6.95e-01	7.56e-01
ENDOCRINE SYSTEM DEVELOPMENT	137	1.70e-03	3.58e-02	0.1530	-1.54e-02	-1.39e-01	1.26e-02	-6.56e-03	5.86e-02	7.55e-01	4.89e-03	7.99e-01	8.95e-01	2.36e-01
TORC2 SIGNALING	12	9.46e-01	9.97e-01	0.1520	-4.45e-02	-5.87e-02	-5.92e-02	-7.92e-02	-8.97e-02	7.90e-01	7.25e-01	7.22e-01	6.35e-01	5.91e-01
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	170	1.06e-02	1.33e-01	0.1520	-9.11e-02	-9.43e-02	-4.67e-02	-3.35e-02	5.24e-02	4.05e-02	3.39e-02	2.94e-01	4.52e-01	2.39e-01
REGULATION OF DNA METHYLATION	20	7.37e-01	9.73e-01	0.1520	-1.07e-01	-9.81e-02	8.26e-03	-3.36e-03	-4.54e-02	4.07e-01	4.47e-01	9.49e-01	9.79e-01	7.25e-01
FERTILIZATION	194	8.27e-03	1.14e-01	0.1520	6.61e-02	1.34e-01	6.90e-03	2.73e-02	-1.40e-02	1.12e-01	1.32e-03	8.68e-01	5.11e-01	7.37e-01
NEUROMUSCULAR PROCESS CONTROLLING POSTURE	18	8.80e-01	9.89e-01	0.1520	-5.17e-02	-1.19e-01	-2.65e-02	-1.45e-02	7.34e-02	7.04e-01	3.81e-01	8.46e-01	9.15e-01	5.90e-01
REGULATION OF CHOLESTEROL METABOLIC PROCESS	40	3.88e-01	8.40e-01	0.1520	-7.85e-03	5.36e-02	-9.88e-02	-9.10e-02	4.68e-02	9.32e-01	5.58e-01	2.80e-01	3.19e-01	6.08e-01
INTRACELLULAR PHOSPHATE ION HOMEOSTASIS	10	9.32e-01	9.97e-01	0.1520	-2.71e-03	8.31e-02	-3.06e-02	-4.70e-03	-1.24e-01	9.88e-01	6.49e-01	8.67e-01	9.79e-01	4.99e-01
SHORT TERM MEMORY	10	8.83e-01	9.91e-01	0.1520	5.46e-02	1.84e-02	5.62e-02	8.64e-02	-9.59e-02	7.65e-01	9.20e-01	7.58e-01	6.36e-01	6.00e-01
DENDRITIC SPINE DEVELOPMENT	86	1.18e-01	5.49e-01	0.1520	-1.09e-01	-9.25e-03	-7.49e-02	-7.24e-02	1.85e-02	8.08e-02	8.82e-01	2.30e-01	2.46e-01	7.67e-01
MODULATION BY SYMBIONT OF ENTRY INTO HOST	55	7.38e-01	9.73e-01	0.1520	7.78e-02	1.16e-01	4.26e-02	4.01e-02	8.67e-03	3.18e-01	1.35e-01	5.85e-01	6.07e-01	9.11e-01
REGULATION OF PIGMENTATION	17	7.67e-01	9.75e-01	0.1520	2.24e-02	-1.22e-01	3.52e-02	2.52e-02	7.63e-02	8.73e-01	3.83e-01	8.02e-01	8.57e-01	5.86e-01
CARDIOLIPIN BIOSYNTHETIC PROCESS	7	5.53e-01	9.16e-01	0.1520	8.94e-02	-1.11e-01	-3.48e-02	-9.45e-03	3.75e-02	6.82e-01	6.10e-01	8.73e-01	9.65e-01	8.64e-01
LUNG EPITHELIUM DEVELOPMENT	44	2.36e-01	7.19e-01	0.1520	-1.79e-02	-9.95e-02	-7.02e-02	-5.64e-02	-6.90e-02	8.37e-01	2.54e-01	4.21e-01	5.17e-01	4.28e-01
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	162	5.38e-01	9.13e-01	0.1520	-7.36e-02	-2.99e-02	-8.87e-02	-8.46e-02	-4.18e-02	1.06e-01	5.12e-01	5.14e-02	6.31e-02	3.59e-01
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION	175	7.44e-05	3.00e-03	0.1520	4.24e-02	-8.74e-02	5.43e-02	3.41e-02	9.76e-02	3.34e-01	4.60e-02	2.15e-01	4.36e-01	2.59e-02
REGULATION OF EXECUTION PHASE OF APOPTOSIS	17	8.50e-01	9.88e-01	0.1520	-1.24e-02	-3.82e-02	3.11e-03	7.80e-03	-1.46e-01	9.30e-01	7.85e-01	9.82e-01	9.56e-01	2.96e-01
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	29	8.62e-01	9.88e-01	0.1520	-7.01e-02	-7.91e-02	-8.78e-03	-1.30e-02	1.08e-01	5.13e-01	4.61e-01	9.35e-01	9.04e-01	3.15e-01
REGULATION OF DEFENSE RESPONSE TO BACTERIUM	20	8.59e-01	9.88e-01	0.1520	-6.91e-02	-1.20e-02	-9.83e-02	-8.11e-02	4.34e-02	5.93e-01	9.26e-01	4.47e-01	5.30e-01	7.37e-01
POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION	10	9.72e-01	9.97e-01	0.1520	5.92e-02	9.78e-02	-4.48e-02	-2.29e-02	-8.62e-02	7.46e-01	5.92e-01	8.06e-01	9.00e-01	6.37e-01
DOPAMINE SECRETION	41	2.09e-01	6.86e-01	0.1520	-6.10e-03	6.52e-02	1.57e-02	-3.88e-03	1.36e-01	9.46e-01	4.70e-01	8.62e-01	9.66e-01	1.32e-01
RESPONSE TO ALKALOID	90	3.93e-01	8.42e-01	0.1520	3.19e-02	-5.49e-02	8.59e-02	7.17e-02	8.02e-02	6.01e-01	3.68e-01	1.59e-01	2.40e-01	1.88e-01
NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	6	9.18e-01	9.95e-01	0.1520	-2.06e-02	6.99e-02	-7.36e-02	-1.03e-01	4.08e-02	9.30e-01	7.67e-01	7.55e-01	6.62e-01	8.63e-01
POSITIVE REGULATION OF RECEPTOR RECYCLING	14	9.54e-01	9.97e-01	0.1520	-5.75e-02	-2.62e-02	-8.34e-02	-7.97e-02	7.52e-02	7.10e-01	8.65e-01	5.89e-01	6.05e-01	6.26e-01
MITOCHONDRIAL DEPOLARIZATION	22	6.06e-01	9.34e-01	0.1520	-1.86e-02	-1.10e-01	-1.48e-02	-1.11e-03	-1.02e-01	8.80e-01	3.74e-01	9.04e-01	9.93e-01	4.08e-01
MITOPHAGY	34	6.97e-01	9.62e-01	0.1510	-3.96e-02	-1.33e-01	2.24e-02	2.54e-02	5.07e-02	6.90e-01	1.80e-01	8.21e-01	7.98e-01	6.09e-01
DNA METHYLATION	47	6.28e-01	9.45e-01	0.1510	-3.47e-03	-3.17e-02	8.72e-02	7.08e-02	9.64e-02	9.67e-01	7.07e-01	3.01e-01	4.01e-01	2.53e-01
REGULATION OF B CELL ACTIVATION	124	3.28e-01	8.01e-01	0.1510	1.93e-02	-3.51e-02	8.75e-02	8.39e-02	8.14e-02	7.10e-01	5.00e-01	9.26e-02	1.06e-01	1.18e-01
PHAGOSOME LYSOSOME FUSION	13	7.51e-01	9.75e-01	0.1510	-4.39e-03	-9.93e-03	-3.46e-02	-6.50e-02	-1.32e-01	9.78e-01	9.51e-01	8.29e-01	6.85e-01	4.10e-01
INORGANIC ANION TRANSPORT	162	2.69e-03	5.14e-02	0.1510	-6.08e-02	2.89e-02	-1.04e-01	-8.42e-02	2.22e-02	1.82e-01	5.26e-01	2.26e-02	6.43e-02	6.27e-01
PROGESTERONE METABOLIC PROCESS	16	4.14e-01	8.54e-01	0.1510	-3.26e-02	1.37e-01	-2.13e-02	5.85e-03	-5.09e-02	8.21e-01	3.43e-01	8.83e-01	9.68e-01	7.24e-01
REGULATION OF REPRODUCTIVE PROCESS	201	2.38e-01	7.22e-01	0.1510	9.36e-02	6.69e-02	7.05e-02	6.80e-02	-6.92e-03	2.22e-02	1.02e-01	8.50e-02	9.63e-02	8.66e-01
MESENCHYMAL STEM CELL DIFFERENTIATION	12	8.84e-01	9.91e-01	0.1510	-1.77e-03	6.87e-02	-7.95e-03	1.55e-02	-1.34e-01	9.92e-01	6.80e-01	9.62e-01	9.26e-01	4.23e-01
TRNA METHYLATION	40	2.47e-01	7.32e-01	0.1510	3.36e-03	-1.04e-01	3.58e-02	3.10e-02	-9.86e-02	9.71e-01	2.54e-01	6.95e-01	7.35e-01	2.80e-01
MINERALOCORTICOID METABOLIC PROCESS	14	7.47e-01	9.75e-01	0.1510	-1.32e-01	-1.98e-02	-5.28e-02	-4.59e-02	-1.60e-02	3.94e-01	8.98e-01	7.32e-01	7.66e-01	9.17e-01
HINDBRAIN MATURATION	5	6.32e-01	9.47e-01	0.1510	1.45e-01	-4.96e-03	1.03e-02	-2.47e-02	-3.46e-02	5.76e-01	9.85e-01	9.68e-01	9.24e-01	8.93e-01
PHOSPHOLIPID CATABOLIC PROCESS	55	7.29e-01	9.71e-01	0.1510	-5.37e-02	2.86e-03	-1.03e-01	-8.84e-02	-3.86e-02	4.90e-01	9.71e-01	1.86e-01	2.57e-01	6.20e-01
REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE	9	8.86e-01	9.91e-01	0.1510	7.99e-02	6.77e-02	-1.75e-02	9.63e-03	1.07e-01	6.78e-01	7.25e-01	9.28e-01	9.60e-01	5.78e-01
REGULATION OF JUN KINASE ACTIVITY	44	2.26e-01	7.08e-01	0.1510	8.25e-02	4.19e-02	-3.06e-02	-1.16e-02	-1.15e-01	3.43e-01	6.31e-01	7.25e-01	8.94e-01	1.87e-01
POSITIVE REGULATION OF GLIAL CELL PROLIFERATION	19	9.66e-01	9.97e-01	0.1510	1.06e-01	8.49e-02	4.32e-02	4.83e-02	1.26e-02	4.24e-01	5.22e-01	7.45e-01	7.16e-01	9.25e-01
POSITIVE REGULATION OF CHOLESTEROL EFFLUX	27	1.87e-01	6.58e-01	0.1510	-9.45e-02	-1.04e-01	-3.68e-02	-4.53e-04	4.20e-02	3.96e-01	3.52e-01	7.40e-01	9.97e-01	7.05e-01
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	36	9.26e-01	9.95e-01	0.1510	9.08e-02	4.94e-02	7.97e-02	7.52e-02	-9.02e-03	3.46e-01	6.08e-01	4.08e-01	4.35e-01	9.25e-01
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	41	2.48e-01	7.33e-01	0.1510	-7.78e-03	8.38e-02	1.61e-03	-2.52e-03	1.25e-01	9.31e-01	3.53e-01	9.86e-01	9.78e-01	1.66e-01
PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS	9	8.16e-01	9.83e-01	0.1510	1.21e-02	-1.40e-01	-2.30e-02	-9.88e-03	4.89e-02	9.50e-01	4.67e-01	9.05e-01	9.59e-01	7.99e-01
SPROUTING ANGIOGENESIS	183	1.71e-01	6.42e-01	0.1510	-8.86e-02	-6.36e-02	-7.80e-02	-6.83e-02	-8.87e-03	3.86e-02	1.38e-01	6.87e-02	1.11e-01	8.36e-01
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS	91	8.15e-02	4.56e-01	0.1510	-6.64e-02	-2.01e-03	-9.94e-02	-7.12e-02	-5.79e-02	2.73e-01	9.74e-01	1.01e-01	2.41e-01	3.39e-01
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS	102	6.15e-01	9.39e-01	0.1510	-6.01e-02	-2.43e-02	-9.49e-02	-9.60e-02	-1.73e-02	2.94e-01	6.72e-01	9.77e-02	9.38e-02	7.63e-01
CELLULAR RESPONSE TO COLD	13	9.25e-01	9.95e-01	0.1510	-4.06e-02	-1.34e-01	-3.08e-02	-3.99e-02	-2.39e-02	8.00e-01	4.03e-01	8.48e-01	8.03e-01	8.81e-01
POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	5	7.99e-01	9.81e-01	0.1510	8.24e-02	2.72e-02	1.19e-02	-3.27e-02	-1.18e-01	7.50e-01	9.16e-01	9.63e-01	8.99e-01	6.47e-01
REGULATION OF PROTEIN AUTOPHOSPHORYLATION	39	8.49e-01	9.87e-01	0.1510	1.99e-02	-5.49e-02	7.75e-02	6.47e-02	9.54e-02	8.30e-01	5.53e-01	4.02e-01	4.84e-01	3.03e-01
NEUTRAL AMINO ACID TRANSPORT	54	3.75e-01	8.36e-01	0.1510	1.03e-01	8.15e-02	4.66e-03	1.14e-02	-7.29e-02	1.91e-01	3.00e-01	9.53e-01	8.85e-01	3.54e-01
RESPONSE TO ANGIOTENSIN	35	5.99e-01	9.33e-01	0.1510	-4.00e-02	-1.26e-01	-5.26e-02	-4.95e-02	-7.62e-03	6.82e-01	1.98e-01	5.90e-01	6.12e-01	9.38e-01
NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY	46	5.90e-01	9.31e-01	0.1510	-5.28e-02	-1.34e-02	-9.56e-02	-8.74e-02	5.43e-02	5.36e-01	8.75e-01	2.62e-01	3.05e-01	5.24e-01
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION	11	8.99e-01	9.93e-01	0.1510	7.95e-02	1.22e-01	1.50e-03	3.78e-02	1.24e-02	6.48e-01	4.85e-01	9.93e-01	8.28e-01	9.43e-01
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	95	2.67e-01	7.48e-01	0.1500	-5.79e-02	-1.28e-01	-3.38e-02	-3.95e-02	-1.41e-02	3.29e-01	3.11e-02	5.69e-01	5.05e-01	8.12e-01
REGULATION OF LEUKOCYTE MIGRATION	218	1.72e-02	1.84e-01	0.1500	-6.21e-02	-7.55e-02	-7.60e-02	-6.80e-02	5.13e-02	1.14e-01	5.48e-02	5.31e-02	8.34e-02	1.92e-01
REGULATION OF MITOTIC CELL CYCLE	509	7.26e-07	5.31e-05	0.1500	6.09e-02	-2.90e-02	1.01e-01	8.44e-02	2.76e-02	1.86e-02	2.63e-01	1.01e-04	1.11e-03	2.87e-01
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	34	8.34e-01	9.85e-01	0.1500	-6.45e-02	-9.82e-02	-5.76e-02	-7.38e-02	2.08e-03	5.15e-01	3.22e-01	5.61e-01	4.56e-01	9.83e-01
GLIAL CELL PROLIFERATION	54	5.30e-01	9.07e-01	0.1500	-4.78e-02	-8.75e-02	-6.32e-02	-6.95e-02	6.15e-02	5.43e-01	2.66e-01	4.22e-01	3.77e-01	4.34e-01
TUBULIN DEACETYLATION	19	6.94e-01	9.61e-01	0.1500	1.60e-02	-8.30e-02	6.90e-02	3.40e-02	9.74e-02	9.04e-01	5.31e-01	6.03e-01	7.97e-01	4.62e-01
PROTEIN LIPID COMPLEX ORGANIZATION	54	3.89e-01	8.40e-01	0.1500	-6.43e-02	-2.64e-02	-9.26e-02	-6.59e-02	-6.92e-02	4.14e-01	7.37e-01	2.39e-01	4.03e-01	3.79e-01
CORONARY VASCULATURE DEVELOPMENT	48	5.92e-01	9.32e-01	0.1500	2.12e-02	-2.79e-02	4.13e-02	2.69e-02	1.37e-01	8.00e-01	7.38e-01	6.21e-01	7.47e-01	9.96e-02
METHYLATION	262	3.06e-03	5.61e-02	0.1500	5.32e-02	-3.97e-02	9.98e-02	8.77e-02	2.11e-02	1.38e-01	2.69e-01	5.39e-03	1.45e-02	5.56e-01
TONGUE DEVELOPMENT	20	2.89e-01	7.67e-01	0.1500	1.07e-01	-3.31e-02	8.05e-02	5.01e-02	-2.97e-02	4.06e-01	7.98e-01	5.33e-01	6.98e-01	8.18e-01
NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS	17	3.61e-01	8.25e-01	0.1500	1.21e-02	-9.61e-02	5.36e-02	9.46e-02	3.62e-02	9.31e-01	4.93e-01	7.02e-01	5.00e-01	7.96e-01
PREPULSE INHIBITION	13	5.16e-01	9.02e-01	0.1500	3.17e-02	5.54e-02	-3.53e-02	-7.49e-02	-1.07e-01	8.43e-01	7.30e-01	8.26e-01	6.40e-01	5.03e-01
ADRENERGIC RECEPTOR SIGNALING PATHWAY	32	9.39e-01	9.97e-01	0.1500	-8.29e-02	-6.89e-02	-6.18e-02	-7.72e-02	-3.18e-02	4.17e-01	5.00e-01	5.45e-01	4.49e-01	7.55e-01
REGULATION OF NOTCH SIGNALING PATHWAY	94	1.50e-01	6.11e-01	0.1500	-5.50e-02	-1.01e-01	-5.77e-02	-7.61e-02	6.66e-03	3.56e-01	9.03e-02	3.34e-01	2.02e-01	9.11e-01
REGULATION OF CD40 SIGNALING PATHWAY	6	8.09e-01	9.82e-01	0.1500	1.16e-01	8.08e-04	1.83e-03	4.54e-02	8.29e-02	6.23e-01	9.97e-01	9.94e-01	8.47e-01	7.25e-01
MALONYL COA METABOLIC PROCESS	6	9.93e-01	9.99e-01	0.1500	3.71e-02	1.78e-02	7.02e-02	4.97e-02	1.15e-01	8.75e-01	9.40e-01	7.66e-01	8.33e-01	6.25e-01
POSITIVE REGULATION OF AMYLOID BETA CLEARANCE	8	7.99e-01	9.81e-01	0.1500	-5.61e-02	-1.06e-01	-2.51e-02	1.48e-02	8.48e-02	7.83e-01	6.05e-01	9.02e-01	9.42e-01	6.78e-01
ANDROGEN METABOLIC PROCESS	29	6.76e-01	9.59e-01	0.1500	-5.13e-02	5.24e-02	-9.36e-02	-8.39e-02	3.42e-02	6.32e-01	6.25e-01	3.83e-01	4.34e-01	7.50e-01
REGULATION OF PROTEIN SUMOYLATION	21	9.32e-01	9.97e-01	0.1500	4.45e-02	4.11e-02	9.65e-02	9.67e-02	-4.64e-03	7.24e-01	7.44e-01	4.44e-01	4.43e-01	9.71e-01
DETECTION OF ABIOTIC STIMULUS	133	1.55e-03	3.40e-02	0.1490	-3.21e-03	1.22e-01	-6.44e-02	-4.98e-02	2.70e-02	9.49e-01	1.48e-02	1.99e-01	3.21e-01	5.91e-01
ORGANELLE MEMBRANE FUSION	118	1.01e-01	5.09e-01	0.1490	1.82e-02	-8.88e-02	8.11e-02	6.74e-02	5.44e-02	7.32e-01	9.55e-02	1.28e-01	2.06e-01	3.07e-01
TAXIS	447	2.96e-05	1.44e-03	0.1490	-5.78e-02	-5.74e-02	-8.31e-02	-7.66e-02	5.37e-02	3.60e-02	3.75e-02	2.60e-03	5.48e-03	5.16e-02
GAS TRANSPORT	22	3.43e-01	8.14e-01	0.1490	-6.93e-02	3.83e-03	6.59e-02	4.54e-02	1.05e-01	5.74e-01	9.75e-01	5.93e-01	7.12e-01	3.93e-01
MITOTIC CELL CYCLE PROCESS	748	1.72e-10	2.49e-08	0.1490	5.15e-02	-4.68e-02	9.83e-02	8.44e-02	2.56e-02	1.66e-02	2.94e-02	4.69e-06	8.42e-05	2.34e-01
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT	13	9.05e-01	9.94e-01	0.1490	-8.37e-02	-1.06e-01	-2.43e-02	-5.82e-02	-7.20e-03	6.01e-01	5.08e-01	8.79e-01	7.16e-01	9.64e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	71	1.32e-01	5.79e-01	0.1490	-7.33e-02	2.61e-02	-1.00e-01	-7.82e-02	-3.20e-03	2.85e-01	7.03e-01	1.43e-01	2.55e-01	9.63e-01
UNSATURATED FATTY ACID METABOLIC PROCESS	110	2.07e-01	6.84e-01	0.1490	4.99e-02	7.38e-02	8.12e-02	8.37e-02	-2.68e-02	3.66e-01	1.81e-01	1.41e-01	1.29e-01	6.27e-01
DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM	98	1.95e-03	3.99e-02	0.1490	3.96e-02	8.38e-02	-6.14e-03	2.56e-02	1.14e-01	4.98e-01	1.52e-01	9.16e-01	6.61e-01	5.13e-02
REGULATORY T CELL DIFFERENTIATION	39	5.55e-01	9.17e-01	0.1490	2.23e-02	7.31e-02	5.63e-02	6.21e-02	9.68e-02	8.10e-01	4.30e-01	5.43e-01	5.02e-01	2.96e-01
POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	11	6.24e-01	9.44e-01	0.1490	4.04e-03	1.15e-01	8.13e-02	4.69e-02	1.63e-02	9.81e-01	5.11e-01	6.41e-01	7.88e-01	9.26e-01
REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	169	1.55e-02	1.71e-01	0.1490	1.97e-02	-8.45e-02	8.77e-02	7.23e-02	4.18e-02	6.59e-01	5.80e-02	4.91e-02	1.05e-01	3.48e-01
NEGATIVE REGULATION OF STEM CELL PROLIFERATION	26	8.26e-01	9.83e-01	0.1490	-8.45e-03	-8.79e-02	2.34e-02	8.08e-03	1.17e-01	9.41e-01	4.38e-01	8.36e-01	9.43e-01	3.00e-01
SKELETAL MUSCLE ORGAN DEVELOPMENT	169	9.12e-02	4.81e-01	0.1490	7.44e-02	2.73e-02	7.18e-02	5.86e-02	8.55e-02	9.53e-02	5.41e-01	1.07e-01	1.88e-01	5.51e-02
DOPAMINE TRANSPORT	55	2.03e-01	6.83e-01	0.1490	4.57e-02	1.28e-01	2.14e-02	7.69e-03	5.53e-02	5.57e-01	9.94e-02	7.84e-01	9.21e-01	4.78e-01
NEGATIVE REGULATION OF LOCOMOTION	395	8.43e-03	1.15e-01	0.1490	-7.83e-02	-6.44e-02	-7.17e-02	-6.99e-02	4.28e-02	7.58e-03	2.81e-02	1.44e-02	1.71e-02	1.44e-01
NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	5	9.62e-01	9.97e-01	0.1490	6.37e-02	8.23e-02	-8.74e-02	-5.86e-02	-1.43e-02	8.05e-01	7.50e-01	7.35e-01	8.20e-01	9.56e-01
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	48	5.18e-01	9.03e-01	0.1490	3.89e-02	-4.52e-02	3.88e-02	3.11e-02	1.27e-01	6.41e-01	5.88e-01	6.41e-01	7.09e-01	1.29e-01
ENDODERM DEVELOPMENT	81	1.11e-01	5.34e-01	0.1490	-3.31e-02	-4.41e-02	-7.48e-02	-9.40e-02	-6.80e-02	6.06e-01	4.93e-01	2.45e-01	1.43e-01	2.90e-01
REGULATION OF GRANULOCYTE CHEMOTAXIS	50	7.70e-02	4.48e-01	0.1490	-1.87e-02	-2.29e-02	-1.04e-01	-7.57e-02	6.84e-02	8.19e-01	7.79e-01	2.04e-01	3.54e-01	4.03e-01
TORC1 SIGNALING	96	3.55e-02	2.86e-01	0.1490	2.62e-02	-8.53e-02	9.41e-02	7.10e-02	1.47e-02	6.57e-01	1.49e-01	1.11e-01	2.29e-01	8.03e-01
MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE	19	3.95e-02	3.05e-01	0.1480	-1.15e-01	1.50e-02	3.99e-02	6.36e-02	5.50e-02	3.87e-01	9.10e-01	7.63e-01	6.31e-01	6.78e-01
REGULATION OF ANIMAL ORGAN MORPHOGENESIS	121	5.68e-02	3.78e-01	0.1480	4.84e-03	-8.45e-02	4.17e-02	2.31e-02	1.12e-01	9.27e-01	1.08e-01	4.28e-01	6.61e-01	3.31e-02
REGULATION OF MICROTUBULE DEPOLYMERIZATION	26	2.12e-01	6.91e-01	0.1480	8.53e-02	-6.48e-02	5.43e-02	2.93e-02	8.19e-02	4.51e-01	5.67e-01	6.32e-01	7.96e-01	4.70e-01
NEURON PROJECTION ARBORIZATION	31	5.11e-01	9.00e-01	0.1480	-5.50e-02	-8.76e-02	1.80e-02	-1.77e-02	1.03e-01	5.96e-01	3.99e-01	8.62e-01	8.64e-01	3.20e-01
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	170	2.99e-01	7.73e-01	0.1480	-7.09e-02	-8.80e-02	-6.25e-02	-7.04e-02	1.84e-02	1.11e-01	4.77e-02	1.60e-01	1.13e-01	6.79e-01
CALCIUM ION TRANSPORT	427	1.14e-06	7.86e-05	0.1480	5.31e-02	1.26e-01	1.47e-02	1.96e-02	5.11e-02	5.98e-02	7.58e-06	6.01e-01	4.88e-01	7.02e-02
POSITIVE REGULATION OF STRESS FIBER ASSEMBLY	51	7.29e-01	9.71e-01	0.1480	-5.22e-02	-2.76e-03	-9.95e-02	-9.59e-02	1.19e-02	5.19e-01	9.73e-01	2.19e-01	2.36e-01	8.83e-01
REGULATION OF DEPHOSPHORYLATION	101	4.11e-01	8.53e-01	0.1480	-6.49e-02	-1.17e-01	-3.84e-03	-1.25e-02	6.32e-02	2.59e-01	4.30e-02	9.47e-01	8.28e-01	2.72e-01
B CELL PROLIFERATION	98	6.78e-02	4.18e-01	0.1480	-1.21e-01	-5.54e-02	-3.72e-02	-5.28e-02	1.61e-03	3.80e-02	3.44e-01	5.25e-01	3.66e-01	9.78e-01
CIRCADIAN REGULATION OF GENE EXPRESSION	66	3.81e-01	8.38e-01	0.1480	-4.98e-02	-1.30e-01	-2.44e-02	-3.81e-02	2.54e-02	4.84e-01	6.88e-02	7.32e-01	5.92e-01	7.21e-01
EYE PHOTORECEPTOR CELL DIFFERENTIATION	47	4.47e-01	8.74e-01	0.1480	-4.03e-02	2.25e-02	-9.26e-02	-8.55e-02	6.26e-02	6.33e-01	7.90e-01	2.72e-01	3.10e-01	4.58e-01
VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	34	5.40e-01	9.13e-01	0.1480	-4.88e-02	3.49e-02	-7.35e-02	-7.30e-02	8.72e-02	6.22e-01	7.24e-01	4.58e-01	4.62e-01	3.79e-01
STRESS INDUCED PREMATURE SENESCENCE	8	9.49e-01	9.97e-01	0.1480	-8.08e-02	-9.72e-02	-3.13e-02	-6.85e-02	-1.58e-02	6.92e-01	6.34e-01	8.78e-01	7.37e-01	9.38e-01
REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION	14	9.04e-01	9.94e-01	0.1480	-8.57e-02	-9.53e-02	-2.47e-02	-5.55e-02	-4.23e-02	5.79e-01	5.37e-01	8.73e-01	7.19e-01	7.84e-01
REGULATION OF MICROTUBULE BASED PROCESS	248	1.02e-02	1.30e-01	0.1480	4.95e-02	-4.57e-02	8.53e-02	7.22e-02	6.96e-02	1.79e-01	2.15e-01	2.07e-02	5.01e-02	5.91e-02
POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION	7	9.83e-01	9.97e-01	0.1480	9.71e-02	1.50e-02	4.44e-02	5.48e-02	8.49e-02	6.57e-01	9.45e-01	8.39e-01	8.02e-01	6.97e-01
NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS	1217	8.01e-19	3.77e-16	0.1480	5.55e-02	-5.57e-02	9.08e-02	7.81e-02	3.61e-02	1.12e-03	1.06e-03	9.49e-08	4.51e-06	3.41e-02
REGULATION OF PROTEIN DEPOLYMERIZATION	82	5.14e-01	9.01e-01	0.1480	-7.29e-02	-9.30e-02	-5.26e-02	-7.02e-02	1.19e-02	2.54e-01	1.45e-01	4.10e-01	2.72e-01	8.52e-01
AORTA MORPHOGENESIS	38	1.57e-01	6.19e-01	0.1480	1.11e-01	-4.21e-02	5.57e-02	6.68e-02	6.47e-03	2.35e-01	6.53e-01	5.52e-01	4.76e-01	9.45e-01
POSITIVE REGULATION OF CHEMOTAXIS	140	9.50e-03	1.25e-01	0.1480	-1.84e-02	-7.15e-02	-2.69e-02	-1.72e-02	1.24e-01	7.08e-01	1.44e-01	5.83e-01	7.25e-01	1.15e-02
FOAM CELL DIFFERENTIATION	41	5.39e-01	9.13e-01	0.1480	1.75e-02	1.20e-01	-5.52e-02	-3.31e-02	-5.51e-02	8.46e-01	1.85e-01	5.41e-01	7.14e-01	5.41e-01
MICROTUBULE ORGANIZING CENTER LOCALIZATION	32	7.17e-01	9.68e-01	0.1480	-9.84e-02	-1.05e-01	-1.46e-03	-2.56e-02	2.19e-02	3.36e-01	3.05e-01	9.89e-01	8.02e-01	8.30e-01
AXIS SPECIFICATION	91	2.68e-02	2.45e-01	0.1480	8.53e-02	-2.56e-02	8.46e-02	6.19e-02	5.34e-02	1.59e-01	6.72e-01	1.63e-01	3.08e-01	3.79e-01
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	14	9.61e-01	9.97e-01	0.1470	7.98e-02	-1.95e-02	8.71e-02	8.59e-02	-6.56e-03	6.05e-01	8.99e-01	5.73e-01	5.78e-01	9.66e-01
ANTERIOR HEAD DEVELOPMENT	7	7.92e-01	9.81e-01	0.1470	6.98e-02	1.97e-02	2.48e-02	-1.30e-02	-1.25e-01	7.49e-01	9.28e-01	9.10e-01	9.53e-01	5.66e-01
REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	10	8.20e-01	9.83e-01	0.1470	-2.22e-02	-3.21e-02	7.55e-02	3.05e-02	1.17e-01	9.03e-01	8.61e-01	6.79e-01	8.67e-01	5.23e-01
REGULATION OF GLIAL CELL DIFFERENTIATION	78	2.22e-01	7.04e-01	0.1470	4.62e-02	-7.71e-02	6.52e-02	6.62e-02	7.06e-02	4.81e-01	2.39e-01	3.19e-01	3.12e-01	2.81e-01
CELL PROLIFERATION IN BONE MARROW	10	6.38e-01	9.49e-01	0.1470	1.80e-02	-8.11e-03	6.96e-02	2.42e-02	-1.26e-01	9.21e-01	9.65e-01	7.03e-01	8.95e-01	4.90e-01
GANGLIOSIDE CATABOLIC PROCESS	7	9.66e-01	9.97e-01	0.1470	-4.40e-02	-6.73e-02	8.85e-02	7.53e-02	4.15e-02	8.40e-01	7.58e-01	6.85e-01	7.30e-01	8.49e-01
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	42	7.69e-01	9.75e-01	0.1470	5.35e-02	-4.52e-02	9.20e-02	8.54e-02	3.19e-02	5.48e-01	6.13e-01	3.02e-01	3.38e-01	7.21e-01
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	76	3.00e-01	7.73e-01	0.1470	1.11e-02	9.31e-02	-7.80e-02	-7.25e-02	-3.88e-02	8.67e-01	1.60e-01	2.40e-01	2.75e-01	5.58e-01
PHAGOLYSOSOME ASSEMBLY	17	7.12e-01	9.67e-01	0.1470	-1.83e-02	-9.19e-03	-4.54e-02	-7.48e-02	-1.16e-01	8.96e-01	9.48e-01	7.46e-01	5.93e-01	4.06e-01
ORGANIC HYDROXY COMPOUND TRANSPORT	302	1.76e-01	6.47e-01	0.1470	-7.22e-02	-1.85e-02	-8.62e-02	-8.63e-02	-3.42e-02	3.09e-02	5.81e-01	9.94e-03	9.90e-03	3.07e-01
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	67	1.66e-01	6.33e-01	0.1470	3.02e-02	8.99e-02	3.91e-02	5.41e-02	9.02e-02	6.69e-01	2.03e-01	5.80e-01	4.43e-01	2.02e-01
CELL CYCLE PHASE TRANSITION	551	5.66e-08	5.19e-06	0.1470	5.40e-02	-3.38e-02	1.01e-01	8.37e-02	1.85e-02	3.02e-02	1.75e-01	5.07e-05	7.80e-04	4.57e-01
REGULATION OF RNA EXPORT FROM NUCLEUS	13	9.51e-01	9.97e-01	0.1470	3.65e-02	-4.70e-02	1.01e-01	7.85e-02	4.09e-02	8.20e-01	7.69e-01	5.28e-01	6.24e-01	7.98e-01
MITOTIC CELL CYCLE PHASE TRANSITION	452	1.09e-06	7.64e-05	0.1470	4.33e-02	-4.73e-02	9.97e-02	8.10e-02	3.08e-02	1.15e-01	8.49e-02	2.78e-04	3.14e-03	2.61e-01
REGULATION OF OSTEOCLAST DIFFERENTIATION	68	5.05e-01	8.99e-01	0.1470	-9.44e-02	-7.42e-02	-5.81e-02	-4.89e-02	3.74e-02	1.78e-01	2.90e-01	4.08e-01	4.86e-01	5.94e-01
REFLEX	21	8.09e-01	9.82e-01	0.1470	-5.95e-03	-8.74e-02	2.26e-02	5.18e-04	1.16e-01	9.62e-01	4.88e-01	8.58e-01	9.97e-01	3.59e-01
DENDRITIC SPINE MORPHOGENESIS	51	5.21e-01	9.03e-01	0.1470	-9.55e-02	-6.96e-03	-7.94e-02	-7.42e-02	2.41e-02	2.38e-01	9.31e-01	3.27e-01	3.60e-01	7.66e-01
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION	21	9.34e-01	9.97e-01	0.1470	-3.31e-02	-1.14e-01	3.63e-02	2.87e-02	7.22e-02	7.93e-01	3.64e-01	7.73e-01	8.20e-01	5.67e-01
REGULATION OF CATECHOLAMINE METABOLIC PROCESS	18	4.38e-01	8.69e-01	0.1470	1.17e-01	-1.82e-02	2.53e-02	3.15e-02	-7.70e-02	3.91e-01	8.94e-01	8.53e-01	8.17e-01	5.72e-01
POSITIVE REGULATION OF HEART RATE	27	9.29e-01	9.95e-01	0.1470	8.00e-02	3.51e-02	7.54e-02	9.03e-02	-9.21e-03	4.72e-01	7.52e-01	4.98e-01	4.17e-01	9.34e-01
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	60	6.26e-01	9.44e-01	0.1470	-5.50e-02	1.36e-02	-9.92e-02	-9.19e-02	5.85e-03	4.61e-01	8.55e-01	1.84e-01	2.18e-01	9.38e-01
MESONEPHROS DEVELOPMENT	99	1.62e-01	6.26e-01	0.1470	3.79e-02	-3.52e-02	7.18e-02	5.04e-02	1.06e-01	5.14e-01	5.45e-01	2.17e-01	3.86e-01	6.96e-02
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	59	3.78e-01	8.36e-01	0.1470	-6.82e-02	-1.15e-01	3.77e-03	-7.54e-03	-5.93e-02	3.65e-01	1.26e-01	9.60e-01	9.20e-01	4.31e-01
CENTRIOLE ASSEMBLY	47	5.18e-01	9.03e-01	0.1460	-3.73e-02	-8.53e-02	6.64e-02	4.31e-02	8.07e-02	6.58e-01	3.12e-01	4.31e-01	6.09e-01	3.38e-01
REGULATION OF ACTION POTENTIAL	55	4.44e-01	8.73e-01	0.1460	-7.62e-02	1.71e-02	-9.43e-02	-7.66e-02	-2.46e-02	3.29e-01	8.26e-01	2.27e-01	3.26e-01	7.52e-01
MESENCHYMAL TO EPITHELIAL TRANSITION	18	9.11e-01	9.94e-01	0.1460	-9.41e-02	-1.08e-01	1.06e-02	-5.66e-03	2.65e-02	4.90e-01	4.26e-01	9.38e-01	9.67e-01	8.46e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS	127	1.02e-01	5.10e-01	0.1460	3.54e-02	-4.21e-02	9.82e-02	9.35e-02	-2.84e-03	4.91e-01	4.13e-01	5.60e-02	6.89e-02	9.56e-01
T HELPER 1 CELL DIFFERENTIATION	23	8.62e-01	9.88e-01	0.1460	-5.42e-02	-1.26e-01	3.05e-02	2.93e-02	2.94e-02	6.52e-01	2.97e-01	8.00e-01	8.08e-01	8.07e-01
COPII COATED VESICLE BUDDING	42	3.14e-01	7.86e-01	0.1460	-6.60e-03	-1.24e-01	4.64e-02	4.89e-02	-3.79e-02	9.41e-01	1.65e-01	6.03e-01	5.84e-01	6.71e-01
PROTEIN LOCALIZATION TO ORGANELLE	917	1.16e-11	1.95e-09	0.1460	5.34e-02	-3.71e-02	9.78e-02	8.51e-02	1.84e-02	6.06e-03	5.68e-02	4.99e-07	1.23e-05	3.45e-01
PROTEIN LOCALIZATION TO LYSOSOME	57	3.96e-01	8.44e-01	0.1460	-3.24e-02	-1.24e-01	5.06e-02	3.16e-02	3.69e-02	6.72e-01	1.05e-01	5.09e-01	6.80e-01	6.30e-01
ORGANELLE DISASSEMBLY	137	1.01e-02	1.29e-01	0.1460	1.61e-02	-1.16e-01	6.08e-02	5.33e-02	3.24e-02	7.45e-01	1.89e-02	2.19e-01	2.81e-01	5.12e-01
AMP BIOSYNTHETIC PROCESS	12	8.42e-01	9.86e-01	0.1460	4.24e-02	4.66e-02	7.59e-02	1.06e-01	-2.08e-02	7.99e-01	7.80e-01	6.49e-01	5.26e-01	9.01e-01
REGULATION OF ORGAN GROWTH	93	1.06e-01	5.23e-01	0.1460	-4.16e-02	-1.25e-01	-3.51e-02	-4.61e-02	-2.65e-02	4.88e-01	3.77e-02	5.59e-01	4.42e-01	6.59e-01
ASSOCIATIVE LEARNING	84	5.19e-01	9.03e-01	0.1460	6.67e-02	8.28e-03	8.11e-02	6.67e-02	7.60e-02	2.90e-01	8.96e-01	1.99e-01	2.91e-01	2.29e-01
EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT	6	9.89e-01	9.98e-01	0.1460	3.57e-02	7.90e-02	-7.38e-02	-7.03e-02	-5.85e-02	8.80e-01	7.38e-01	7.54e-01	7.66e-01	8.04e-01
NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS	1436	2.42e-20	1.40e-17	0.1460	5.52e-02	-5.40e-02	8.89e-02	7.80e-02	3.68e-02	4.58e-04	6.02e-04	1.68e-08	7.28e-07	1.95e-02
WATER TRANSPORT	28	1.95e-01	6.71e-01	0.1460	-5.66e-02	7.13e-02	-3.37e-02	-1.61e-02	1.08e-01	6.04e-01	5.14e-01	7.58e-01	8.83e-01	3.23e-01
NEGATIVE REGULATION OF CILIUM ASSEMBLY	18	6.03e-01	9.34e-01	0.1460	-6.34e-02	-8.86e-02	-3.69e-02	-7.85e-02	-4.34e-02	6.41e-01	5.15e-01	7.86e-01	5.64e-01	7.50e-01
POSITIVE REGULATION OF TOR SIGNALING	65	3.79e-01	8.36e-01	0.1460	-2.17e-02	-1.23e-01	3.24e-02	1.80e-02	6.50e-02	7.63e-01	8.54e-02	6.51e-01	8.02e-01	3.65e-01
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	144	9.91e-03	1.28e-01	0.1460	-8.51e-02	-7.60e-02	-5.74e-02	-3.89e-02	5.86e-02	7.80e-02	1.15e-01	2.34e-01	4.20e-01	2.25e-01
ALPHA BETA T CELL ACTIVATION	169	1.48e-01	6.07e-01	0.1460	5.71e-02	9.77e-02	5.70e-02	5.90e-02	4.13e-02	2.00e-01	2.84e-02	2.01e-01	1.86e-01	3.55e-01
NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	153	6.23e-01	9.44e-01	0.1460	-7.90e-02	-5.09e-02	-7.28e-02	-7.98e-02	-2.72e-02	9.15e-02	2.77e-01	1.20e-01	8.85e-02	5.62e-01
SPHINGOMYELIN CATABOLIC PROCESS	8	9.28e-01	9.95e-01	0.1460	1.07e-01	7.38e-03	2.89e-02	4.70e-02	8.14e-02	5.99e-01	9.71e-01	8.87e-01	8.18e-01	6.90e-01
MEMBRANE DOCKING	91	1.54e-01	6.16e-01	0.1450	3.24e-02	-7.37e-02	9.09e-02	7.42e-02	3.04e-02	5.93e-01	2.25e-01	1.34e-01	2.21e-01	6.16e-01
REGULATION OF NUCLEAR DIVISION	146	9.59e-02	4.94e-01	0.1450	6.33e-02	2.48e-02	8.57e-02	7.90e-02	-5.41e-02	1.87e-01	6.05e-01	7.37e-02	9.94e-02	2.59e-01
REGULATION OF PLASMA MEMBRANE ORGANIZATION	16	7.21e-01	9.70e-01	0.1450	1.13e-01	7.62e-02	-2.43e-02	1.36e-03	-4.55e-02	4.36e-01	5.98e-01	8.66e-01	9.92e-01	7.53e-01
REGULATION OF AMINE METABOLIC PROCESS	31	9.31e-01	9.96e-01	0.1450	1.02e-01	5.85e-02	5.81e-02	6.21e-02	-6.47e-03	3.25e-01	5.73e-01	5.75e-01	5.50e-01	9.50e-01
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	21	9.27e-01	9.95e-01	0.1450	-5.15e-02	-2.19e-03	-1.02e-01	-8.89e-02	8.57e-03	6.83e-01	9.86e-01	4.17e-01	4.81e-01	9.46e-01
SYNAPTIC VESICLE EXOCYTOSIS	91	2.98e-01	7.73e-01	0.1450	-6.03e-02	-8.99e-02	2.84e-02	1.25e-02	9.16e-02	3.20e-01	1.38e-01	6.39e-01	8.36e-01	1.31e-01
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	225	2.57e-01	7.40e-01	0.1450	-7.75e-02	-8.36e-02	-5.76e-02	-6.25e-02	2.89e-02	4.52e-02	3.07e-02	1.36e-01	1.06e-01	4.55e-01
HEART VALVE MORPHOGENESIS	60	4.63e-01	8.81e-01	0.1450	-4.85e-02	-1.13e-01	-3.93e-02	-4.92e-02	-4.31e-02	5.16e-01	1.29e-01	5.99e-01	5.10e-01	5.63e-01
INTERLEUKIN 6 PRODUCTION	165	1.07e-01	5.25e-01	0.1450	-5.39e-02	-5.37e-02	-9.08e-02	-8.23e-02	1.47e-02	2.32e-01	2.34e-01	4.41e-02	6.82e-02	7.44e-01
PROTEIN TRIMERIZATION	17	8.52e-01	9.88e-01	0.1450	-1.36e-02	-7.54e-02	-2.44e-02	-1.26e-02	1.20e-01	9.23e-01	5.91e-01	8.62e-01	9.28e-01	3.92e-01
REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION	8	9.21e-01	9.95e-01	0.1450	-2.94e-02	-5.33e-02	4.84e-02	7.11e-02	9.95e-02	8.85e-01	7.94e-01	8.13e-01	7.28e-01	6.26e-01
GRANULOCYTE MIGRATION	148	2.38e-04	8.08e-03	0.1450	-1.37e-02	-3.67e-02	-6.64e-02	-4.70e-02	1.13e-01	7.74e-01	4.40e-01	1.63e-01	3.23e-01	1.76e-02
DENDRITE ARBORIZATION	10	9.76e-01	9.97e-01	0.1450	-6.84e-02	-7.71e-02	-2.99e-02	-5.38e-02	8.06e-02	7.08e-01	6.73e-01	8.70e-01	7.68e-01	6.59e-01
MIDBRAIN DEVELOPMENT	86	8.86e-02	4.73e-01	0.1450	-3.28e-02	-1.38e-01	-3.60e-03	-1.96e-02	1.77e-02	5.99e-01	2.66e-02	9.54e-01	7.53e-01	7.76e-01
PALLIUM DEVELOPMENT	183	1.94e-04	6.91e-03	0.1450	2.80e-03	-1.14e-01	6.83e-02	4.21e-02	3.71e-02	9.48e-01	7.59e-03	1.11e-01	3.26e-01	3.86e-01
T CELL DIFFERENTIATION	301	2.42e-02	2.30e-01	0.1450	5.81e-02	5.39e-02	8.90e-02	7.77e-02	2.61e-02	8.30e-02	1.08e-01	7.92e-03	2.04e-02	4.36e-01
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	21	8.98e-01	9.93e-01	0.1450	-6.89e-02	-7.97e-02	5.86e-04	3.46e-03	9.89e-02	5.85e-01	5.27e-01	9.96e-01	9.78e-01	4.33e-01
RESPONSE TO HYDROGEN PEROXIDE	96	2.28e-01	7.12e-01	0.1450	3.07e-02	-5.28e-02	8.30e-02	6.23e-02	7.98e-02	6.03e-01	3.71e-01	1.60e-01	2.91e-01	1.76e-01
HYDROCARBON METABOLIC PROCESS	7	9.71e-01	9.97e-01	0.1440	1.03e-01	9.68e-02	-2.21e-02	-6.09e-03	-1.81e-02	6.36e-01	6.57e-01	9.19e-01	9.78e-01	9.34e-01
CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	20	4.43e-01	8.72e-01	0.1440	1.34e-02	1.22e-01	-3.45e-02	-6.45e-02	-1.90e-02	9.17e-01	3.43e-01	7.89e-01	6.18e-01	8.83e-01
NOSE DEVELOPMENT	16	6.74e-01	9.59e-01	0.1440	1.49e-02	-8.39e-02	-4.60e-02	-4.86e-02	-9.55e-02	9.18e-01	5.61e-01	7.50e-01	7.36e-01	5.08e-01
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	109	1.89e-01	6.61e-01	0.1440	-4.05e-02	-1.19e-01	3.71e-02	2.16e-02	5.71e-02	4.65e-01	3.22e-02	5.04e-01	6.97e-01	3.03e-01
POSITIVE REGULATION OF EXOCYTOSIS	74	4.84e-01	8.91e-01	0.1440	-4.23e-02	-1.10e-01	8.12e-03	8.26e-03	8.21e-02	5.29e-01	1.01e-01	9.04e-01	9.02e-01	2.22e-01
MONOACYLGLYCEROL BIOSYNTHETIC PROCESS	5	9.53e-01	9.97e-01	0.1440	-4.96e-02	9.78e-02	-5.98e-02	-3.12e-02	-6.50e-02	8.48e-01	7.05e-01	8.17e-01	9.04e-01	8.01e-01
ENDOCYTOSIS	684	3.76e-03	6.50e-02	0.1440	-7.59e-02	-5.31e-02	-7.70e-02	-7.86e-02	1.02e-02	7.07e-04	1.78e-02	5.92e-04	4.55e-04	6.49e-01
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY	98	6.53e-01	9.52e-01	0.1440	-7.02e-02	-3.55e-02	-8.32e-02	-8.64e-02	1.49e-02	2.30e-01	5.43e-01	1.55e-01	1.39e-01	7.99e-01
REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	34	8.27e-01	9.83e-01	0.1440	-6.17e-02	-7.53e-02	1.24e-02	4.44e-03	1.06e-01	5.33e-01	4.47e-01	9.00e-01	9.64e-01	2.87e-01
NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	14	5.62e-01	9.20e-01	0.1440	1.29e-02	7.17e-02	-7.04e-02	-1.02e-01	6.95e-03	9.34e-01	6.42e-01	6.48e-01	5.07e-01	9.64e-01
METENCEPHALON DEVELOPMENT	107	2.69e-01	7.50e-01	0.1440	9.10e-02	6.65e-03	6.58e-02	6.87e-02	5.85e-02	1.04e-01	9.05e-01	2.40e-01	2.20e-01	2.96e-01
REGULATION OF HEART RATE	99	5.09e-01	9.00e-01	0.1440	6.46e-02	6.93e-02	4.78e-02	5.67e-02	7.93e-02	2.66e-01	2.34e-01	4.11e-01	3.29e-01	1.73e-01
REGULATION OF STEROID BIOSYNTHETIC PROCESS	79	6.25e-01	9.44e-01	0.1440	-6.52e-02	-6.61e-02	-7.60e-02	-7.11e-02	3.61e-02	3.16e-01	3.10e-01	2.43e-01	2.74e-01	5.79e-01
CRANIAL SKELETAL SYSTEM DEVELOPMENT	70	2.91e-02	2.56e-01	0.1440	3.44e-02	-9.79e-02	6.99e-02	4.00e-02	5.91e-02	6.19e-01	1.56e-01	3.12e-01	5.62e-01	3.92e-01
LEUCINE TRANSPORT	10	7.98e-01	9.81e-01	0.1440	1.10e-01	2.70e-02	2.54e-02	1.06e-02	-8.42e-02	5.46e-01	8.82e-01	8.90e-01	9.54e-01	6.45e-01
GLAND MORPHOGENESIS	120	1.71e-01	6.42e-01	0.1440	-4.57e-02	-1.22e-01	1.03e-03	-1.24e-02	5.93e-02	3.87e-01	2.06e-02	9.84e-01	8.14e-01	2.62e-01
INNERVATION	26	7.60e-01	9.75e-01	0.1440	-4.61e-02	-1.25e-01	1.33e-02	7.92e-03	-5.11e-02	6.84e-01	2.68e-01	9.07e-01	9.44e-01	6.52e-01
COLLAGEN FIBRIL ORGANIZATION	63	6.82e-01	9.61e-01	0.1440	-3.04e-03	6.86e-02	-6.38e-02	-5.25e-02	-9.56e-02	9.67e-01	3.46e-01	3.81e-01	4.71e-01	1.89e-01
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	52	4.58e-01	8.79e-01	0.1440	3.25e-02	-6.81e-02	8.12e-02	8.94e-02	2.02e-02	6.85e-01	3.95e-01	3.11e-01	2.65e-01	8.01e-01
CYTOSKELETON DEPENDENT CYTOKINESIS	113	6.20e-02	3.98e-01	0.1440	-4.08e-02	-8.33e-02	-2.89e-02	-4.37e-02	-9.66e-02	4.54e-01	1.26e-01	5.96e-01	4.22e-01	7.60e-02
ENDOSOME TO LYSOSOME TRANSPORT	70	3.62e-01	8.26e-01	0.1440	5.56e-02	-2.91e-02	8.73e-02	9.15e-02	-2.73e-02	4.21e-01	6.74e-01	2.07e-01	1.85e-01	6.93e-01
REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	62	5.93e-01	9.32e-01	0.1440	7.09e-02	-1.07e-02	8.16e-02	6.82e-02	6.48e-02	3.34e-01	8.84e-01	2.67e-01	3.53e-01	3.77e-01
RIBONUCLEOSIDE METABOLIC PROCESS	34	9.12e-01	9.94e-01	0.1440	-6.97e-02	-5.89e-02	-8.21e-02	-6.86e-02	-2.96e-02	4.82e-01	5.52e-01	4.07e-01	4.89e-01	7.65e-01
REGULATION OF CALCIUM ION TRANSPORT	241	3.51e-03	6.19e-02	0.1440	6.44e-02	1.18e-01	7.52e-03	1.23e-02	4.76e-02	8.49e-02	1.54e-03	8.41e-01	7.42e-01	2.03e-01
NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY	12	3.80e-01	8.37e-01	0.1430	-4.59e-02	-5.65e-02	-2.17e-02	3.14e-02	-1.18e-01	7.83e-01	7.35e-01	8.97e-01	8.51e-01	4.80e-01
INTRACELLULAR PH REDUCTION	51	2.07e-01	6.84e-01	0.1430	1.04e-01	5.62e-02	3.74e-02	2.43e-02	-6.78e-02	1.99e-01	4.87e-01	6.44e-01	7.64e-01	4.02e-01
CADMIUM ION TRANSMEMBRANE TRANSPORT	6	6.92e-01	9.61e-01	0.1430	8.84e-02	-8.60e-02	5.54e-03	-2.22e-02	6.95e-02	7.08e-01	7.15e-01	9.81e-01	9.25e-01	7.68e-01
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	239	4.19e-02	3.13e-01	0.1430	4.10e-02	3.30e-02	4.87e-02	5.30e-02	1.12e-01	2.74e-01	3.80e-01	1.95e-01	1.58e-01	2.80e-03
PROTEIN ACETYLATION	97	2.05e-01	6.84e-01	0.1430	9.11e-02	1.87e-02	7.55e-02	6.91e-02	-3.76e-02	1.21e-01	7.50e-01	1.99e-01	2.40e-01	5.22e-01
GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE	6	7.55e-01	9.75e-01	0.1430	3.60e-02	-1.14e-01	1.32e-02	-3.05e-02	7.15e-02	8.79e-01	6.29e-01	9.55e-01	8.97e-01	7.62e-01
AXON GUIDANCE	223	4.29e-02	3.19e-01	0.1430	-7.45e-02	-5.58e-02	-6.24e-02	-7.76e-02	4.39e-02	5.52e-02	1.51e-01	1.08e-01	4.58e-02	2.58e-01
POSITIVE REGULATION OF DEPHOSPHORYLATION	51	4.70e-01	8.84e-01	0.1430	-2.13e-02	-7.89e-02	7.39e-02	7.58e-02	5.11e-02	7.92e-01	3.30e-01	3.61e-01	3.49e-01	5.28e-01
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	13	6.38e-01	9.49e-01	0.1430	5.71e-02	-2.59e-02	1.10e-01	6.55e-02	-1.33e-02	7.21e-01	8.72e-01	4.93e-01	6.83e-01	9.34e-01
SENSORY PERCEPTION OF TEMPERATURE STIMULUS	27	6.21e-01	9.43e-01	0.1430	-3.96e-02	6.53e-03	-2.57e-02	-1.53e-02	1.34e-01	7.21e-01	9.53e-01	8.17e-01	8.91e-01	2.28e-01
TERTIARY ALCOHOL METABOLIC PROCESS	22	4.32e-01	8.68e-01	0.1430	-2.77e-02	1.34e-01	-3.37e-02	-1.64e-02	-1.51e-02	8.22e-01	2.75e-01	7.85e-01	8.94e-01	9.03e-01
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	14	7.47e-01	9.75e-01	0.1430	-7.09e-02	1.55e-02	-6.48e-03	-2.98e-02	1.19e-01	6.46e-01	9.20e-01	9.67e-01	8.47e-01	4.39e-01
ANDROGEN RECEPTOR SIGNALING PATHWAY	45	3.88e-01	8.40e-01	0.1430	-5.07e-03	9.49e-02	-4.14e-02	-5.73e-02	-8.02e-02	9.53e-01	2.71e-01	6.31e-01	5.06e-01	3.52e-01
ACTOMYOSIN STRUCTURE ORGANIZATION	205	7.35e-02	4.36e-01	0.1430	-5.54e-02	3.05e-02	-9.13e-02	-8.60e-02	-2.58e-02	1.71e-01	4.52e-01	2.42e-02	3.38e-02	5.24e-01
DORSAL VENTRAL PATTERN FORMATION	97	1.24e-03	2.94e-02	0.1430	8.34e-02	-7.37e-02	6.59e-02	5.07e-02	3.30e-02	1.56e-01	2.10e-01	2.62e-01	3.88e-01	5.75e-01
REGULATION OF ISOMERASE ACTIVITY	8	6.84e-01	9.61e-01	0.1430	7.14e-02	-6.01e-02	-1.35e-02	-3.32e-02	-1.02e-01	7.26e-01	7.69e-01	9.47e-01	8.71e-01	6.17e-01
DEDIFFERENTIATION	11	4.55e-01	8.78e-01	0.1430	8.17e-02	-3.44e-02	-6.65e-02	-4.64e-02	7.72e-02	6.39e-01	8.43e-01	7.03e-01	7.90e-01	6.57e-01
ANIMAL ORGAN FORMATION	66	2.55e-02	2.37e-01	0.1430	1.32e-02	-9.80e-02	7.14e-02	3.27e-02	6.65e-02	8.53e-01	1.69e-01	3.16e-01	6.46e-01	3.50e-01
ENDOSOME ORGANIZATION	93	3.97e-02	3.05e-01	0.1430	2.21e-02	-1.04e-01	7.26e-02	5.17e-02	3.31e-02	7.12e-01	8.28e-02	2.26e-01	3.89e-01	5.82e-01
POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION	8	9.73e-01	9.97e-01	0.1430	6.97e-02	1.15e-01	-3.82e-02	-2.43e-02	1.74e-02	7.33e-01	5.75e-01	8.51e-01	9.05e-01	9.32e-01
VESICLE DOCKING	64	3.60e-01	8.25e-01	0.1430	4.13e-02	-5.72e-02	9.46e-02	7.93e-02	9.89e-03	5.68e-01	4.29e-01	1.90e-01	2.72e-01	8.91e-01
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS	28	1.91e-01	6.65e-01	0.1430	5.26e-02	-5.58e-02	7.45e-02	3.12e-02	8.90e-02	6.30e-01	6.09e-01	4.95e-01	7.75e-01	4.15e-01
REGULATION OF ENDOCYTOSIS	284	5.89e-02	3.86e-01	0.1420	-7.10e-02	-7.11e-02	-6.33e-02	-6.24e-02	4.78e-02	3.95e-02	3.91e-02	6.64e-02	7.02e-02	1.66e-01
SPERM FLAGELLUM ASSEMBLY	39	6.88e-01	9.61e-01	0.1420	-7.26e-02	-5.14e-04	-9.13e-02	-7.06e-02	-4.10e-02	4.33e-01	9.96e-01	3.24e-01	4.46e-01	6.57e-01
MITOTIC CYTOKINESIS	85	3.87e-02	3.01e-01	0.1420	-8.81e-03	-8.09e-02	-9.26e-03	-2.18e-02	-1.14e-01	8.88e-01	1.97e-01	8.83e-01	7.28e-01	6.85e-02
REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	13	2.96e-01	7.72e-01	0.1420	5.32e-02	-9.79e-02	-5.21e-02	-7.02e-02	1.27e-02	7.40e-01	5.41e-01	7.45e-01	6.61e-01	9.37e-01
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	107	4.93e-01	8.95e-01	0.1420	-7.23e-02	-9.80e-02	-2.91e-02	-4.21e-02	5.26e-02	1.96e-01	7.98e-02	6.03e-01	4.52e-01	3.47e-01
BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	51	8.85e-02	4.73e-01	0.1420	-6.77e-02	-3.50e-02	-4.73e-02	-2.09e-02	1.08e-01	4.03e-01	6.65e-01	5.59e-01	7.97e-01	1.81e-01
REGULATION OF CELL JUNCTION ASSEMBLY	199	2.15e-01	6.95e-01	0.1420	-8.11e-02	-5.96e-02	-6.23e-02	-7.40e-02	2.71e-02	4.86e-02	1.47e-01	1.30e-01	7.19e-02	5.10e-01
POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT	12	5.75e-01	9.26e-01	0.1420	-4.22e-02	2.77e-02	9.93e-02	7.85e-02	-4.03e-02	8.00e-01	8.68e-01	5.51e-01	6.38e-01	8.09e-01
ACETYL COA METABOLIC PROCESS	31	5.87e-01	9.29e-01	0.1420	6.41e-03	-2.98e-02	-7.24e-03	-1.89e-02	-1.37e-01	9.51e-01	7.74e-01	9.44e-01	8.55e-01	1.86e-01
RESPONSE TO PAIN	34	8.70e-01	9.88e-01	0.1420	-8.70e-02	-2.17e-02	-7.11e-02	-7.87e-02	2.98e-02	3.80e-01	8.26e-01	4.73e-01	4.27e-01	7.64e-01
MUCUS SECRETION	18	5.66e-01	9.23e-01	0.1420	-9.03e-02	3.40e-02	-4.78e-02	-3.84e-02	8.42e-02	5.07e-01	8.03e-01	7.25e-01	7.78e-01	5.36e-01
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	277	6.12e-03	9.37e-02	0.1420	-3.73e-02	4.71e-02	-8.99e-02	-8.95e-02	-2.03e-02	2.85e-01	1.77e-01	9.99e-03	1.04e-02	5.61e-01
NEURON CELLULAR HOMEOSTASIS	59	7.85e-01	9.81e-01	0.1420	9.95e-02	6.30e-02	5.13e-02	5.84e-02	-1.33e-02	1.86e-01	4.03e-01	4.95e-01	4.38e-01	8.60e-01
ANGIOGENESIS INVOLVED IN WOUND HEALING	31	8.55e-02	4.67e-01	0.1420	8.78e-02	-4.08e-02	4.68e-02	8.94e-02	-2.24e-02	3.97e-01	6.94e-01	6.52e-01	3.89e-01	8.29e-01
ALPHA BETA T CELL DIFFERENTIATION	119	5.48e-01	9.15e-01	0.1420	5.24e-02	5.39e-02	7.44e-02	7.94e-02	5.07e-02	3.24e-01	3.10e-01	1.61e-01	1.34e-01	3.40e-01
CHROMOSOME SEGREGATION	409	5.04e-05	2.22e-03	0.1420	6.21e-02	-1.02e-02	9.73e-02	8.04e-02	1.26e-02	3.12e-02	7.25e-01	7.29e-04	5.27e-03	6.62e-01
AMIDE METABOLIC PROCESS	1223	3.08e-13	6.26e-11	0.1420	4.79e-02	-3.90e-02	9.05e-02	8.90e-02	1.06e-02	4.80e-03	2.18e-02	9.88e-08	1.58e-07	5.31e-01
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	75	4.31e-01	8.68e-01	0.1410	5.21e-02	8.99e-02	5.49e-02	4.49e-02	6.47e-02	4.36e-01	1.78e-01	4.11e-01	5.01e-01	3.33e-01
PURINE NUCLEOSIDE METABOLIC PROCESS	25	8.14e-01	9.82e-01	0.1410	-1.42e-02	-1.24e-01	3.31e-02	3.47e-02	4.68e-02	9.02e-01	2.84e-01	7.75e-01	7.64e-01	6.86e-01
AXO DENDRITIC TRANSPORT	74	5.57e-01	9.18e-01	0.1410	-1.58e-03	-6.17e-02	7.94e-02	6.98e-02	7.07e-02	9.81e-01	3.59e-01	2.38e-01	2.99e-01	2.93e-01
HISTONE H3 K9 METHYLATION	5	9.92e-01	9.99e-01	0.1410	5.86e-02	-4.16e-02	7.78e-02	9.34e-02	6.01e-03	8.20e-01	8.72e-01	7.63e-01	7.18e-01	9.81e-01
TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING	12	1.83e-01	6.56e-01	0.1410	-9.54e-02	1.70e-02	-6.17e-02	3.29e-04	-8.24e-02	5.67e-01	9.19e-01	7.12e-01	9.98e-01	6.21e-01
METANEPHRIC COLLECTING DUCT DEVELOPMENT	10	9.78e-01	9.97e-01	0.1410	8.07e-02	1.14e-01	-7.41e-03	-7.12e-03	-1.51e-02	6.58e-01	5.31e-01	9.68e-01	9.69e-01	9.34e-01
PHOSPHOLIPID TRANSLOCATION	50	7.96e-01	9.81e-01	0.1410	-6.02e-02	1.67e-02	-9.19e-02	-8.63e-02	-1.06e-02	4.61e-01	8.38e-01	2.61e-01	2.91e-01	8.96e-01
CELLULAR EXTRAVASATION	71	2.26e-01	7.08e-01	0.1410	-4.94e-02	-7.16e-02	-7.98e-02	-6.20e-02	4.64e-02	4.72e-01	2.97e-01	2.45e-01	3.67e-01	4.99e-01
PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING	6	8.57e-01	9.88e-01	0.1410	4.20e-02	1.28e-01	-1.03e-03	-4.12e-02	1.13e-02	8.59e-01	5.88e-01	9.97e-01	8.61e-01	9.62e-01
HINDLIMB MORPHOGENESIS	35	1.96e-01	6.73e-01	0.1410	3.57e-02	-1.07e-01	6.09e-02	3.05e-02	5.11e-02	7.15e-01	2.75e-01	5.33e-01	7.55e-01	6.01e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	34	8.50e-01	9.88e-01	0.1410	-2.04e-02	-9.95e-03	-9.15e-02	-8.86e-02	-5.62e-02	8.37e-01	9.20e-01	3.56e-01	3.71e-01	5.71e-01
POSITIVE REGULATION OF PROTEIN ACETYLATION	24	5.47e-01	9.15e-01	0.1410	5.66e-02	-9.61e-02	4.71e-02	5.56e-02	4.62e-02	6.31e-01	4.15e-01	6.90e-01	6.37e-01	6.95e-01
OOGENESIS	108	3.64e-01	8.27e-01	0.1410	-5.85e-02	-4.16e-02	-5.14e-02	-6.50e-02	-8.87e-02	2.94e-01	4.55e-01	3.56e-01	2.43e-01	1.11e-01
LYMPHOCYTE HOMEOSTASIS	72	7.34e-01	9.73e-01	0.1410	2.90e-02	6.39e-04	8.84e-02	8.13e-02	6.79e-02	6.70e-01	9.93e-01	1.94e-01	2.33e-01	3.19e-01
CELLULAR RESPONSE TO STRESS	1871	3.51e-17	1.06e-14	0.1410	3.99e-02	-4.80e-02	8.41e-02	7.34e-02	5.94e-02	4.19e-03	5.77e-04	1.62e-09	1.43e-07	2.08e-05
LIPOPROTEIN BIOSYNTHETIC PROCESS	91	2.24e-01	7.05e-01	0.1410	-4.99e-02	-1.30e-01	2.04e-03	4.95e-03	1.90e-02	4.11e-01	3.19e-02	9.73e-01	9.35e-01	7.55e-01
VESICLE TETHERING	31	4.83e-01	8.91e-01	0.1400	-6.08e-02	-1.20e-01	1.11e-02	-2.15e-02	-3.38e-02	5.58e-01	2.49e-01	9.15e-01	8.36e-01	7.45e-01
NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	26	8.16e-01	9.83e-01	0.1400	4.74e-02	4.51e-02	4.96e-02	7.07e-02	8.93e-02	6.76e-01	6.90e-01	6.61e-01	5.32e-01	4.31e-01
FLUID TRANSPORT	37	4.91e-01	8.94e-01	0.1400	3.28e-02	1.14e-01	-1.61e-03	1.39e-02	7.35e-02	7.30e-01	2.29e-01	9.87e-01	8.84e-01	4.39e-01
LIMB BUD FORMATION	9	8.60e-01	9.88e-01	0.1400	6.07e-02	-5.64e-02	2.47e-02	1.74e-02	-1.09e-01	7.53e-01	7.69e-01	8.98e-01	9.28e-01	5.71e-01
REGULATION OF PHOSPHOLIPID TRANSLOCATION	6	8.97e-01	9.93e-01	0.1400	-7.86e-02	6.71e-02	-3.12e-02	-2.23e-02	8.66e-02	7.39e-01	7.76e-01	8.95e-01	9.25e-01	7.13e-01
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY	38	3.64e-01	8.27e-01	0.1400	4.54e-02	-8.01e-02	7.92e-02	5.41e-02	4.46e-02	6.28e-01	3.93e-01	3.98e-01	5.64e-01	6.34e-01
ERYTHROCYTE DEVELOPMENT	37	5.94e-01	9.32e-01	0.1400	1.56e-02	-9.90e-02	2.98e-02	2.23e-02	9.07e-02	8.69e-01	2.97e-01	7.54e-01	8.15e-01	3.40e-01
OUTFLOW TRACT MORPHOGENESIS	82	7.23e-03	1.05e-01	0.1400	1.47e-02	-1.19e-01	5.93e-02	2.76e-02	3.21e-02	8.18e-01	6.28e-02	3.53e-01	6.65e-01	6.15e-01
NEPHRON MORPHOGENESIS	77	8.39e-02	4.62e-01	0.1400	3.91e-02	-2.90e-02	7.06e-02	4.00e-02	1.03e-01	5.53e-01	6.60e-01	2.84e-01	5.44e-01	1.17e-01
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY	51	5.23e-01	9.04e-01	0.1400	-1.87e-02	-5.48e-02	-2.57e-03	-1.73e-02	1.26e-01	8.18e-01	4.98e-01	9.75e-01	8.30e-01	1.19e-01
PIGMENT BIOSYNTHETIC PROCESS	51	6.63e-01	9.54e-01	0.1400	-3.67e-02	-9.71e-02	3.25e-04	-1.46e-02	9.27e-02	6.50e-01	2.30e-01	9.97e-01	8.57e-01	2.52e-01
BLASTOCYST DEVELOPMENT	114	5.20e-01	9.03e-01	0.1400	8.43e-02	2.20e-02	7.55e-02	7.06e-02	3.60e-02	1.20e-01	6.85e-01	1.64e-01	1.93e-01	5.07e-01
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION	67	5.96e-02	3.88e-01	0.1400	1.01e-01	-3.18e-02	6.17e-02	5.47e-02	3.88e-02	1.52e-01	6.53e-01	3.83e-01	4.39e-01	5.83e-01
NUCLEOSIDE METABOLIC PROCESS	53	6.04e-01	9.34e-01	0.1400	-5.61e-02	-9.90e-02	-5.38e-02	-4.34e-02	4.28e-02	4.80e-01	2.12e-01	4.98e-01	5.84e-01	5.90e-01
POSITIVE REGULATION OF B CELL DIFFERENTIATION	14	8.74e-01	9.88e-01	0.1400	4.32e-02	-6.76e-02	6.99e-02	8.01e-02	-4.26e-02	7.80e-01	6.61e-01	6.50e-01	6.04e-01	7.83e-01
SULFUR COMPOUND BIOSYNTHETIC PROCESS	150	8.17e-02	4.56e-01	0.1400	-7.14e-02	-1.12e-01	-6.80e-03	-1.89e-02	-3.88e-02	1.31e-01	1.83e-02	8.86e-01	6.90e-01	4.12e-01
TRIPARTITE REGIONAL SUBDIVISION	19	4.83e-01	8.91e-01	0.1400	5.62e-03	6.46e-02	-5.55e-02	-8.25e-02	7.33e-02	9.66e-01	6.26e-01	6.75e-01	5.34e-01	5.80e-01
MEMBRANE RAFT ASSEMBLY	11	9.73e-01	9.97e-01	0.1390	9.91e-02	8.28e-02	4.05e-02	3.09e-02	1.35e-02	5.69e-01	6.34e-01	8.16e-01	8.59e-01	9.38e-01
MICROTUBULE POLYMERIZATION	91	4.07e-01	8.51e-01	0.1390	-5.17e-02	-1.07e-01	-5.19e-02	-5.09e-02	-2.44e-03	3.94e-01	7.78e-02	3.92e-01	4.01e-01	9.68e-01
PEPTIDYL CYSTEINE MODIFICATION	41	4.46e-01	8.73e-01	0.1390	3.31e-02	-5.67e-02	5.94e-02	8.06e-02	7.12e-02	7.14e-01	5.30e-01	5.10e-01	3.72e-01	4.30e-01
STARTLE RESPONSE	26	4.21e-01	8.60e-01	0.1390	-2.91e-02	-5.84e-02	-6.51e-02	-9.46e-02	4.39e-02	7.97e-01	6.06e-01	5.65e-01	4.04e-01	6.98e-01
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	16	3.86e-01	8.40e-01	0.1390	8.28e-02	-6.93e-02	-3.63e-03	-8.03e-04	-8.77e-02	5.67e-01	6.31e-01	9.80e-01	9.96e-01	5.44e-01
ALPHA BETA T CELL PROLIFERATION	43	5.36e-01	9.11e-01	0.1390	2.62e-02	1.18e-01	-5.20e-02	-4.35e-02	5.69e-03	7.66e-01	1.79e-01	5.55e-01	6.22e-01	9.49e-01
REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	29	8.51e-01	9.88e-01	0.1390	-2.17e-02	-9.26e-02	6.83e-02	5.47e-02	5.15e-02	8.40e-01	3.88e-01	5.24e-01	6.10e-01	6.31e-01
RESPONSE TO MUSCLE STRETCH	24	5.65e-01	9.23e-01	0.1390	-8.72e-03	5.79e-02	4.76e-02	3.81e-02	-1.10e-01	9.41e-01	6.24e-01	6.87e-01	7.47e-01	3.49e-01
IMMATURE B CELL DIFFERENTIATION	12	4.74e-01	8.86e-01	0.1390	-4.42e-02	-7.93e-02	3.26e-03	-5.27e-02	-9.11e-02	7.91e-01	6.34e-01	9.84e-01	7.52e-01	5.85e-01
RESPONSE TO TYPE I INTERFERON	84	8.24e-01	9.83e-01	0.1390	7.36e-02	5.81e-02	7.18e-02	6.53e-02	3.31e-02	2.44e-01	3.58e-01	2.56e-01	3.01e-01	5.99e-01
ACTIN FILAMENT BUNDLE ORGANIZATION	160	1.77e-01	6.47e-01	0.1390	-5.58e-02	2.74e-02	-8.84e-02	-8.55e-02	-1.70e-02	2.23e-01	5.50e-01	5.37e-02	6.19e-02	7.10e-01
MUCOCILIARY CLEARANCE	8	7.50e-01	9.75e-01	0.1390	-1.14e-01	-1.97e-02	2.48e-02	3.06e-02	6.54e-02	5.76e-01	9.23e-01	9.03e-01	8.81e-01	7.49e-01
ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT	127	7.79e-03	1.09e-01	0.1390	6.35e-02	-6.38e-02	7.53e-02	7.03e-02	-2.37e-02	2.17e-01	2.14e-01	1.43e-01	1.71e-01	6.45e-01
INFLAMMATORY RESPONSE TO WOUNDING	27	6.45e-01	9.50e-01	0.1390	1.30e-02	3.86e-02	8.11e-02	9.38e-02	4.72e-02	9.07e-01	7.29e-01	4.66e-01	3.99e-01	6.71e-01
POSITIVE REGULATION OF STEROID METABOLIC PROCESS	27	6.76e-01	9.59e-01	0.1390	2.68e-02	6.11e-02	-1.90e-02	-8.02e-03	1.20e-01	8.09e-01	5.82e-01	8.64e-01	9.42e-01	2.81e-01
POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS	100	3.59e-01	8.25e-01	0.1390	-5.54e-02	-1.11e-01	-3.49e-02	-3.14e-02	4.09e-02	3.38e-01	5.56e-02	5.46e-01	5.88e-01	4.80e-01
MOLTING CYCLE	113	5.50e-01	9.15e-01	0.1390	-6.07e-02	-6.66e-02	-7.02e-02	-7.86e-02	2.03e-03	2.65e-01	2.22e-01	1.98e-01	1.49e-01	9.70e-01
NEGATIVE REGULATION OF MUSCLE CONTRACTION	23	5.19e-01	9.03e-01	0.1390	5.29e-02	-6.76e-02	4.53e-02	6.19e-02	-7.70e-02	6.60e-01	5.75e-01	7.07e-01	6.07e-01	5.23e-01
NUCLEAR CHROMOSOME SEGREGATION	307	3.57e-03	6.26e-02	0.1390	6.02e-02	-4.91e-03	9.46e-02	8.12e-02	2.80e-04	6.96e-02	8.82e-01	4.37e-03	1.44e-02	9.93e-01
LONG TERM MEMORY	36	7.31e-01	9.72e-01	0.1380	3.42e-02	-6.45e-02	8.40e-02	8.23e-02	4.69e-04	7.23e-01	5.03e-01	3.83e-01	3.93e-01	9.96e-01
MATURE B CELL DIFFERENTIATION	35	6.85e-01	9.61e-01	0.1380	-7.11e-03	5.29e-02	-3.22e-03	-1.03e-02	-1.27e-01	9.42e-01	5.88e-01	9.74e-01	9.16e-01	1.93e-01
REGULATION OF SMOOTH MUSCLE CONTRACTION	61	5.26e-01	9.05e-01	0.1380	-4.26e-02	-8.25e-02	-7.20e-02	-6.13e-02	-3.98e-02	5.65e-01	2.65e-01	3.31e-01	4.08e-01	5.91e-01
REGULATION OF HORMONE BIOSYNTHETIC PROCESS	24	2.35e-01	7.19e-01	0.1380	-4.45e-02	-8.03e-02	8.11e-02	2.77e-02	5.80e-02	7.06e-01	4.96e-01	4.92e-01	8.14e-01	6.23e-01
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	52	8.12e-01	9.82e-01	0.1380	-9.07e-02	-4.13e-02	-6.21e-02	-6.63e-02	3.08e-02	2.58e-01	6.06e-01	4.38e-01	4.08e-01	7.01e-01
CELLULAR RESPONSE TO GONADOTROPIN STIMULUS	17	8.30e-01	9.84e-01	0.1380	-9.56e-04	-2.39e-02	-2.21e-02	-3.98e-02	-1.28e-01	9.95e-01	8.64e-01	8.75e-01	7.76e-01	3.59e-01
COLLATERAL SPROUTING IN ABSENCE OF INJURY	5	9.74e-01	9.97e-01	0.1380	-9.73e-02	-6.47e-02	-3.13e-02	-1.10e-02	6.62e-02	7.06e-01	8.02e-01	9.03e-01	9.66e-01	7.98e-01
STEROID METABOLIC PROCESS	315	7.91e-02	4.52e-01	0.1380	-6.58e-02	-2.58e-02	-8.67e-02	-8.13e-02	-5.77e-04	4.46e-02	4.32e-01	8.12e-03	1.31e-02	9.86e-01
NEGATIVE REGULATION OF MAP KINASE ACTIVITY	50	1.53e-01	6.16e-01	0.1380	6.06e-02	-4.73e-02	5.06e-02	4.35e-02	-9.35e-02	4.59e-01	5.62e-01	5.36e-01	5.95e-01	2.53e-01
REGULATION OF CELL MATURATION	20	7.37e-01	9.73e-01	0.1380	-4.36e-02	-1.02e-01	6.71e-02	4.33e-02	-2.18e-02	7.36e-01	4.31e-01	6.04e-01	7.38e-01	8.66e-01
FEAR RESPONSE	43	8.37e-01	9.85e-01	0.1380	4.42e-02	3.19e-02	8.25e-02	6.69e-02	6.96e-02	6.16e-01	7.17e-01	3.49e-01	4.48e-01	4.29e-01
REGULATION OF B CELL PROLIFERATION	63	2.99e-01	7.73e-01	0.1380	-1.09e-01	-7.12e-02	-1.16e-02	-2.39e-02	3.89e-02	1.36e-01	3.29e-01	8.74e-01	7.43e-01	5.93e-01
NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	189	2.36e-03	4.68e-02	0.1380	5.73e-03	-7.89e-02	8.91e-02	6.73e-02	1.90e-02	8.92e-01	6.15e-02	3.47e-02	1.11e-01	6.52e-01
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	31	3.49e-01	8.18e-01	0.1380	-1.22e-02	9.61e-02	-5.10e-02	-3.00e-02	7.85e-02	9.07e-01	3.54e-01	6.23e-01	7.73e-01	4.49e-01
MEMBRANE RAFT ORGANIZATION	26	9.74e-01	9.97e-01	0.1380	8.94e-02	4.98e-02	6.54e-02	6.49e-02	-7.81e-03	4.30e-01	6.60e-01	5.64e-01	5.67e-01	9.45e-01
LYMPH NODE DEVELOPMENT	18	6.78e-01	9.60e-01	0.1380	6.54e-02	2.35e-04	9.26e-02	6.14e-02	-4.89e-02	6.31e-01	9.99e-01	4.96e-01	6.52e-01	7.20e-01
OLFACTORY LOBE DEVELOPMENT	36	1.55e-01	6.17e-01	0.1380	2.42e-02	-1.33e-01	2.72e-02	9.31e-03	-4.94e-04	8.02e-01	1.68e-01	7.77e-01	9.23e-01	9.96e-01
HEART GROWTH	94	1.69e-01	6.37e-01	0.1380	-2.27e-02	-5.92e-02	-7.22e-02	-7.69e-02	-6.23e-02	7.03e-01	3.21e-01	2.27e-01	1.98e-01	2.97e-01
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	185	1.33e-01	5.81e-01	0.1380	-5.33e-02	-5.32e-02	-7.66e-02	-8.11e-02	2.96e-02	2.11e-01	2.12e-01	7.24e-02	5.71e-02	4.87e-01
SMAD PROTEIN SIGNAL TRANSDUCTION	83	3.32e-01	8.04e-01	0.1380	-4.40e-02	-1.10e-01	-4.90e-02	-4.66e-02	2.12e-02	4.88e-01	8.45e-02	4.40e-01	4.63e-01	7.39e-01
METANEPHRIC RENAL VESICLE MORPHOGENESIS	14	8.46e-01	9.87e-01	0.1380	-5.08e-02	1.82e-02	-5.07e-04	-1.62e-02	-1.26e-01	7.42e-01	9.06e-01	9.97e-01	9.16e-01	4.16e-01
POST EMBRYONIC DEVELOPMENT	91	4.28e-01	8.65e-01	0.1380	-4.79e-02	-1.13e-01	8.20e-03	6.71e-03	6.06e-02	4.30e-01	6.15e-02	8.92e-01	9.12e-01	3.18e-01
REGULATION OF VASCULAR PERMEABILITY	50	9.28e-01	9.95e-01	0.1370	-5.71e-02	-2.29e-02	-8.20e-02	-7.26e-02	-5.59e-02	4.85e-01	7.80e-01	3.16e-01	3.74e-01	4.94e-01
NEGATIVE REGULATION OF PROTEIN SUMOYLATION	8	8.95e-01	9.93e-01	0.1370	-5.31e-02	5.86e-02	9.56e-03	7.83e-03	-1.12e-01	7.95e-01	7.74e-01	9.63e-01	9.69e-01	5.84e-01
CORPUS CALLOSUM DEVELOPMENT	26	8.24e-01	9.83e-01	0.1370	4.71e-02	1.18e-01	-4.32e-02	-2.85e-02	-8.90e-03	6.77e-01	2.98e-01	7.03e-01	8.01e-01	9.37e-01
ACTIVATION OF GTPASE ACTIVITY	96	1.89e-02	1.96e-01	0.1370	-2.06e-02	2.28e-02	-6.83e-02	-8.45e-02	7.84e-02	7.27e-01	6.99e-01	2.47e-01	1.53e-01	1.84e-01
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	65	6.74e-01	9.59e-01	0.1370	-3.96e-02	-1.38e-02	-7.05e-02	-5.49e-02	-9.54e-02	5.81e-01	8.47e-01	3.26e-01	4.44e-01	1.83e-01
REGULATION OF CELL CYCLE	1070	2.30e-12	4.12e-10	0.1370	6.55e-02	-1.90e-02	8.96e-02	7.70e-02	1.44e-02	2.93e-04	2.93e-01	7.26e-07	2.08e-05	4.26e-01
REGULATION OF ANOIKIS	24	9.82e-01	9.97e-01	0.1370	8.88e-02	6.15e-02	5.48e-02	6.20e-02	-1.74e-02	4.52e-01	6.02e-01	6.42e-01	5.99e-01	8.83e-01
RETROGRADE AXONAL TRANSPORT	21	9.21e-01	9.95e-01	0.1370	-9.80e-02	-7.67e-02	-3.55e-02	-3.16e-02	-3.24e-02	4.37e-01	5.43e-01	7.78e-01	8.02e-01	7.97e-01
WATER SOLUBLE VITAMIN METABOLIC PROCESS	58	4.08e-01	8.51e-01	0.1370	2.75e-02	-8.97e-02	7.12e-02	6.73e-02	2.03e-02	7.17e-01	2.38e-01	3.49e-01	3.75e-01	7.89e-01
SYNAPTIC MEMBRANE ADHESION	25	1.09e-01	5.27e-01	0.1370	-2.18e-02	-1.01e-02	-5.70e-02	-1.07e-01	-5.94e-02	8.50e-01	9.31e-01	6.22e-01	3.55e-01	6.07e-01
REGULATION OF NON MOTILE CILIUM ASSEMBLY	11	6.64e-01	9.54e-01	0.1370	-1.12e-01	-9.47e-04	-2.62e-02	-6.91e-02	2.94e-02	5.22e-01	9.96e-01	8.80e-01	6.92e-01	8.66e-01
LEUKOCYTE TETHERING OR ROLLING	34	2.08e-01	6.85e-01	0.1370	-2.26e-02	-8.74e-02	-6.16e-02	-3.08e-02	7.64e-02	8.20e-01	3.78e-01	5.34e-01	7.56e-01	4.41e-01
LUNG VASCULATURE DEVELOPMENT	8	8.97e-01	9.93e-01	0.1370	-9.15e-03	-1.12e-01	1.65e-02	-1.98e-02	7.39e-02	9.64e-01	5.84e-01	9.36e-01	9.23e-01	7.17e-01
REGULATION OF STEROID METABOLIC PROCESS	101	2.60e-01	7.43e-01	0.1370	-5.78e-02	-4.51e-02	-6.90e-02	-6.03e-02	7.02e-02	3.16e-01	4.34e-01	2.31e-01	2.95e-01	2.23e-01
REGULATION OF ICOSANOID SECRETION	20	9.56e-01	9.97e-01	0.1370	-6.98e-02	-3.33e-02	-8.29e-02	-7.11e-02	2.83e-02	5.89e-01	7.97e-01	5.21e-01	5.82e-01	8.27e-01
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS	44	2.01e-02	2.04e-01	0.1370	6.13e-02	-9.34e-02	6.95e-02	3.34e-02	1.51e-02	4.82e-01	2.84e-01	4.25e-01	7.01e-01	8.62e-01
NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS	54	2.91e-01	7.67e-01	0.1370	-8.37e-03	-1.11e-01	4.08e-02	1.52e-02	6.65e-02	9.15e-01	1.59e-01	6.04e-01	8.47e-01	3.98e-01
OLIGODENDROCYTE DIFFERENTIATION	102	6.97e-02	4.23e-01	0.1370	7.47e-02	-2.45e-02	5.73e-02	4.59e-02	8.40e-02	1.92e-01	6.69e-01	3.17e-01	4.23e-01	1.43e-01
NATURAL KILLER CELL DEGRANULATION	11	8.74e-01	9.88e-01	0.1360	3.90e-02	7.75e-02	4.80e-02	7.97e-02	4.92e-02	8.23e-01	6.56e-01	7.83e-01	6.47e-01	7.77e-01
INNER CELL MASS CELL DIFFERENTIATION	8	4.36e-01	8.69e-01	0.1360	5.78e-02	-1.08e-01	3.95e-03	-4.35e-02	4.02e-02	7.77e-01	5.96e-01	9.85e-01	8.31e-01	8.44e-01
RESPONSE TO INTERLEUKIN 17	17	9.67e-01	9.97e-01	0.1360	-1.82e-02	6.07e-02	-7.28e-02	-5.67e-02	-7.78e-02	8.97e-01	6.65e-01	6.03e-01	6.86e-01	5.78e-01
REGULATION OF MONONUCLEAR CELL MIGRATION	119	1.51e-01	6.13e-01	0.1360	-6.11e-02	-7.95e-02	-6.79e-02	-5.33e-02	3.29e-02	2.50e-01	1.34e-01	2.01e-01	3.15e-01	5.35e-01
DENDRITE SELF AVOIDANCE	14	8.78e-01	9.89e-01	0.1360	-9.99e-02	2.38e-02	-5.99e-02	-6.10e-02	-2.70e-02	5.18e-01	8.77e-01	6.98e-01	6.93e-01	8.61e-01
POSITIVE REGULATION OF SODIUM ION TRANSPORT	29	2.78e-01	7.58e-01	0.1360	1.54e-02	-8.97e-02	-6.46e-02	-5.21e-02	-5.83e-02	8.86e-01	4.03e-01	5.47e-01	6.27e-01	5.87e-01
MESODERM DEVELOPMENT	124	1.07e-02	1.34e-01	0.1360	5.82e-02	-7.37e-02	6.11e-02	5.03e-02	5.89e-02	2.63e-01	1.56e-01	2.40e-01	3.33e-01	2.57e-01
CARBOHYDRATE TRANSPORT	154	2.70e-01	7.50e-01	0.1360	-5.06e-02	-3.20e-02	-7.58e-02	-6.17e-02	-7.35e-02	2.79e-01	4.93e-01	1.04e-01	1.86e-01	1.15e-01
CGMP METABOLIC PROCESS	16	9.75e-01	9.97e-01	0.1360	4.99e-02	8.22e-02	6.96e-02	6.48e-02	-1.55e-02	7.30e-01	5.69e-01	6.30e-01	6.53e-01	9.15e-01
ROOF OF MOUTH DEVELOPMENT	90	9.41e-02	4.90e-01	0.1360	6.66e-02	-4.75e-02	7.77e-02	6.08e-02	4.58e-02	2.75e-01	4.36e-01	2.02e-01	3.18e-01	4.53e-01
POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	30	9.28e-01	9.95e-01	0.1360	6.66e-02	6.31e-02	4.15e-02	5.14e-02	-7.57e-02	5.28e-01	5.50e-01	6.94e-01	6.26e-01	4.73e-01
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION	113	2.31e-01	7.14e-01	0.1360	6.63e-02	-1.47e-02	8.91e-02	7.69e-02	7.25e-03	2.23e-01	7.87e-01	1.02e-01	1.58e-01	8.94e-01
REGULATION OF PROTEIN CATABOLIC PROCESS	340	1.18e-03	2.83e-02	0.1360	2.64e-02	-6.66e-02	8.17e-02	7.03e-02	4.23e-02	4.03e-01	3.49e-02	9.65e-03	2.60e-02	1.80e-01
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY	22	9.67e-01	9.97e-01	0.1360	5.84e-02	5.29e-02	8.02e-02	7.29e-02	-2.36e-02	6.35e-01	6.67e-01	5.15e-01	5.54e-01	8.48e-01
MAST CELL MIGRATION	13	8.82e-01	9.91e-01	0.1360	-2.07e-02	9.38e-03	-8.29e-02	-1.00e-01	3.26e-02	8.97e-01	9.53e-01	6.05e-01	5.31e-01	8.39e-01
STRIATED MUSCLE CELL PROLIFERATION	80	1.20e-01	5.54e-01	0.1360	-2.47e-02	-1.28e-01	-7.90e-03	-2.27e-02	2.84e-02	7.03e-01	4.71e-02	9.03e-01	7.25e-01	6.61e-01
POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	9	9.74e-01	9.97e-01	0.1360	-5.49e-04	-2.78e-02	-4.68e-02	-5.46e-02	-1.12e-01	9.98e-01	8.85e-01	8.08e-01	7.77e-01	5.61e-01
COENZYME A BIOSYNTHETIC PROCESS	11	7.14e-01	9.68e-01	0.1360	1.07e-01	2.67e-03	6.82e-02	3.55e-02	3.27e-02	5.39e-01	9.88e-01	6.95e-01	8.38e-01	8.51e-01
DIAPHRAGM DEVELOPMENT	8	7.44e-01	9.74e-01	0.1360	-5.00e-02	2.34e-02	-2.50e-02	-7.38e-02	9.66e-02	8.07e-01	9.09e-01	9.03e-01	7.18e-01	6.36e-01
REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	19	8.91e-01	9.92e-01	0.1360	4.70e-02	6.97e-02	7.84e-02	6.15e-02	-3.81e-02	7.23e-01	5.99e-01	5.54e-01	6.42e-01	7.74e-01
REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	40	8.15e-01	9.82e-01	0.1360	-2.44e-02	-9.95e-02	4.94e-02	3.83e-02	6.32e-02	7.90e-01	2.76e-01	5.89e-01	6.75e-01	4.89e-01
REGULATION OF CELL MORPHOGENESIS	233	2.38e-01	7.22e-01	0.1360	-6.34e-02	-1.57e-02	-8.32e-02	-8.49e-02	-4.62e-03	9.56e-02	6.81e-01	2.87e-02	2.56e-02	9.03e-01
REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	16	9.11e-01	9.94e-01	0.1360	-6.88e-02	-4.71e-02	-5.33e-02	-8.14e-02	-4.47e-02	6.34e-01	7.44e-01	7.12e-01	5.73e-01	7.57e-01
BASE EXCISION REPAIR	42	3.09e-01	7.83e-01	0.1360	4.11e-02	-7.86e-02	5.87e-02	5.54e-02	-6.35e-02	6.45e-01	3.78e-01	5.10e-01	5.35e-01	4.76e-01
RESPONSE TO DSRNA	53	6.07e-01	9.35e-01	0.1360	2.86e-02	-7.24e-02	7.65e-02	6.29e-02	5.00e-02	7.18e-01	3.62e-01	3.35e-01	4.28e-01	5.29e-01
RETINOIC ACID METABOLIC PROCESS	33	8.99e-01	9.93e-01	0.1350	-1.17e-02	-7.50e-02	3.13e-02	2.26e-02	1.05e-01	9.07e-01	4.56e-01	7.56e-01	8.22e-01	2.95e-01
CHOLINE TRANSPORT	9	9.55e-01	9.97e-01	0.1350	4.01e-02	5.19e-02	-5.86e-02	-6.60e-02	-7.91e-02	8.35e-01	7.88e-01	7.61e-01	7.32e-01	6.81e-01
NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY	28	3.31e-01	8.03e-01	0.1350	-4.22e-02	1.18e-01	-4.14e-02	-2.97e-02	6.07e-04	6.99e-01	2.79e-01	7.05e-01	7.86e-01	9.96e-01
POSITIVE REGULATION OF AMINO ACID TRANSPORT	22	5.91e-01	9.31e-01	0.1350	3.98e-02	9.96e-02	2.61e-02	2.33e-04	7.83e-02	7.46e-01	4.19e-01	8.32e-01	9.98e-01	5.25e-01
POSITIVE REGULATION OF PROTEIN MATURATION	27	9.29e-01	9.95e-01	0.1350	5.51e-02	1.20e-01	1.03e-03	7.66e-03	-2.94e-02	6.20e-01	2.81e-01	9.93e-01	9.45e-01	7.92e-01
MESENCHYME DEVELOPMENT	311	2.13e-04	7.43e-03	0.1350	-3.94e-03	-9.94e-02	4.85e-02	2.99e-02	7.18e-02	9.05e-01	2.56e-03	1.41e-01	3.65e-01	2.95e-02
JNK CASCADE	157	4.15e-01	8.55e-01	0.1350	-5.23e-02	-2.73e-02	-8.31e-02	-8.76e-02	-1.51e-02	2.58e-01	5.55e-01	7.24e-02	5.81e-02	7.43e-01
NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS	46	5.22e-01	9.04e-01	0.1350	3.19e-02	-8.46e-02	5.47e-02	4.26e-02	7.26e-02	7.08e-01	3.21e-01	5.21e-01	6.17e-01	3.94e-01
MONOSACCHARIDE CATABOLIC PROCESS	49	3.62e-01	8.26e-01	0.1350	-2.31e-02	-3.77e-02	-9.65e-02	-8.01e-02	2.36e-02	7.80e-01	6.48e-01	2.42e-01	3.32e-01	7.75e-01
NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	66	1.21e-02	1.45e-01	0.1350	5.57e-02	-4.16e-02	9.58e-02	5.44e-02	3.55e-02	4.34e-01	5.59e-01	1.78e-01	4.45e-01	6.18e-01
REGULATION OF EPITHELIAL CELL MIGRATION	282	2.04e-02	2.05e-01	0.1350	-7.70e-02	-7.02e-02	-6.21e-02	-5.18e-02	2.83e-02	2.60e-02	4.24e-02	7.28e-02	1.34e-01	4.14e-01
MAST CELL ACTIVATION	67	3.91e-01	8.41e-01	0.1350	-2.90e-02	-1.14e-01	-1.64e-02	-2.43e-02	5.92e-02	6.81e-01	1.07e-01	8.16e-01	7.31e-01	4.02e-01
CENTROSOME DUPLICATION	74	4.86e-01	8.92e-01	0.1350	-6.49e-02	-1.16e-01	1.30e-02	-2.43e-03	1.95e-02	3.35e-01	8.47e-02	8.47e-01	9.71e-01	7.72e-01
NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	24	9.13e-01	9.94e-01	0.1350	6.21e-02	4.26e-02	6.17e-02	4.51e-02	8.17e-02	5.98e-01	7.18e-01	6.01e-01	7.02e-01	4.88e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN	47	6.01e-01	9.33e-01	0.1350	2.15e-02	1.23e-01	-1.13e-02	-6.30e-03	-4.99e-02	7.99e-01	1.46e-01	8.93e-01	9.40e-01	5.54e-01
EPITHELIAL STRUCTURE MAINTENANCE	33	8.88e-01	9.91e-01	0.1350	-7.42e-03	6.72e-02	-6.40e-02	-6.63e-02	-7.15e-02	9.41e-01	5.04e-01	5.24e-01	5.10e-01	4.77e-01
RESPONSE TO CALCIUM ION	140	1.96e-01	6.73e-01	0.1350	9.53e-03	-3.27e-02	4.26e-02	2.99e-02	1.20e-01	8.46e-01	5.04e-01	3.84e-01	5.42e-01	1.46e-02
CLEAVAGE FURROW FORMATION	7	8.39e-01	9.85e-01	0.1350	-8.35e-02	-3.80e-02	-3.81e-02	-9.11e-02	-2.44e-04	7.02e-01	8.62e-01	8.62e-01	6.76e-01	9.99e-01
POSITIVE REGULATION OF RUFFLE ASSEMBLY	15	3.19e-01	7.91e-01	0.1350	-6.49e-02	1.12e-01	2.08e-02	-7.06e-04	3.27e-02	6.63e-01	4.55e-01	8.89e-01	9.96e-01	8.26e-01
MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING	7	9.50e-01	9.97e-01	0.1350	-3.04e-02	-1.18e-01	-1.86e-02	-4.84e-02	2.33e-02	8.89e-01	5.88e-01	9.32e-01	8.25e-01	9.15e-01
EPITHELIAL CELL CELL ADHESION	15	8.40e-01	9.85e-01	0.1350	-1.53e-02	-4.73e-02	-4.11e-03	1.57e-02	-1.24e-01	9.18e-01	7.51e-01	9.78e-01	9.16e-01	4.06e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	93	7.14e-02	4.29e-01	0.1350	-2.78e-02	-5.64e-02	-4.59e-02	-6.31e-02	8.99e-02	6.43e-01	3.47e-01	4.45e-01	2.93e-01	1.34e-01
POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS	27	2.52e-01	7.36e-01	0.1350	5.00e-02	6.82e-04	-5.49e-02	-3.04e-02	1.08e-01	6.53e-01	9.95e-01	6.22e-01	7.84e-01	3.31e-01
MYELIN MAINTENANCE	17	8.66e-01	9.88e-01	0.1350	1.03e-01	8.52e-02	-1.07e-02	3.83e-03	-1.24e-02	4.63e-01	5.43e-01	9.39e-01	9.78e-01	9.29e-01
GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT	11	9.54e-01	9.97e-01	0.1340	-2.33e-02	-4.23e-02	4.39e-02	1.62e-02	1.16e-01	8.93e-01	8.08e-01	8.01e-01	9.26e-01	5.04e-01
NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING	21	9.35e-01	9.97e-01	0.1340	-2.30e-02	-6.31e-02	5.12e-02	5.33e-02	8.99e-02	8.55e-01	6.17e-01	6.85e-01	6.73e-01	4.76e-01
POSITIVE REGULATION OF MYOBLAST FUSION	16	8.32e-01	9.85e-01	0.1340	-1.04e-01	8.60e-03	-4.47e-02	-5.24e-02	-5.01e-02	4.73e-01	9.53e-01	7.57e-01	7.17e-01	7.29e-01
ASTROCYTE DEVELOPMENT	42	2.47e-01	7.32e-01	0.1340	-8.03e-02	-5.41e-02	-7.70e-02	-4.59e-02	2.49e-02	3.68e-01	5.44e-01	3.88e-01	6.07e-01	7.80e-01
MALE MEIOTIC NUCLEAR DIVISION	54	7.11e-01	9.67e-01	0.1340	-5.20e-02	-2.38e-02	-7.94e-02	-9.08e-02	1.48e-02	5.08e-01	7.63e-01	3.13e-01	2.49e-01	8.51e-01
RESPONSE TO FIBROBLAST GROWTH FACTOR	116	5.82e-01	9.28e-01	0.1340	6.29e-02	8.74e-03	8.50e-02	8.22e-02	1.67e-03	2.42e-01	8.71e-01	1.14e-01	1.26e-01	9.75e-01
POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	31	5.71e-01	9.26e-01	0.1340	-2.03e-04	3.28e-02	-9.12e-02	-7.76e-02	5.06e-02	9.98e-01	7.52e-01	3.79e-01	4.54e-01	6.26e-01
PIGMENTATION	108	2.40e-01	7.24e-01	0.1340	2.75e-02	-4.43e-02	4.94e-02	3.54e-02	1.08e-01	6.21e-01	4.26e-01	3.75e-01	5.25e-01	5.35e-02
MYOTUBE DIFFERENTIATION	127	5.40e-01	9.13e-01	0.1340	-5.53e-02	1.11e-02	-8.22e-02	-8.38e-02	-3.18e-02	2.82e-01	8.28e-01	1.10e-01	1.03e-01	5.37e-01
RESPONSE TO METAL ION	346	1.40e-02	1.59e-01	0.1340	3.29e-02	-2.25e-02	5.03e-02	4.48e-02	1.09e-01	2.93e-01	4.72e-01	1.08e-01	1.52e-01	5.07e-04
REGULATION OF PEPTIDASE ACTIVITY	299	3.18e-02	2.69e-01	0.1340	3.22e-02	-3.51e-02	5.27e-02	5.14e-02	1.01e-01	3.39e-01	2.97e-01	1.17e-01	1.26e-01	2.57e-03
PHOTORECEPTOR CELL DEVELOPMENT	49	5.01e-01	8.98e-01	0.1340	5.12e-02	1.04e-01	-1.29e-02	-5.00e-03	6.58e-02	5.35e-01	2.08e-01	8.76e-01	9.52e-01	4.26e-01
SYNAPTIC VESICLE UNCOATING	6	8.45e-01	9.86e-01	0.1340	8.38e-02	5.66e-03	1.65e-02	-1.68e-02	1.02e-01	7.22e-01	9.81e-01	9.44e-01	9.43e-01	6.67e-01
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS	24	9.39e-01	9.97e-01	0.1340	8.65e-02	7.18e-02	5.25e-02	4.35e-02	-2.55e-02	4.63e-01	5.43e-01	6.56e-01	7.12e-01	8.29e-01
REGULATION OF SENSORY PERCEPTION	17	9.22e-01	9.95e-01	0.1340	-2.07e-03	2.52e-02	8.42e-03	8.49e-03	1.31e-01	9.88e-01	8.57e-01	9.52e-01	9.52e-01	3.50e-01
ICOSANOID SECRETION	46	7.56e-01	9.75e-01	0.1340	6.97e-02	1.03e-01	1.63e-02	3.23e-02	3.42e-02	4.14e-01	2.27e-01	8.48e-01	7.05e-01	6.88e-01
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	94	3.77e-01	8.36e-01	0.1340	-4.94e-02	-1.21e-01	-1.08e-02	-1.97e-02	1.44e-02	4.08e-01	4.18e-02	8.57e-01	7.42e-01	8.10e-01
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM	35	9.14e-01	9.94e-01	0.1340	6.31e-02	8.21e-02	3.99e-02	5.22e-02	5.32e-02	5.18e-01	4.00e-01	6.83e-01	5.93e-01	5.86e-01
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	151	5.48e-01	9.15e-01	0.1340	-6.65e-02	-6.38e-02	-6.40e-02	-7.17e-02	1.22e-02	1.58e-01	1.76e-01	1.75e-01	1.29e-01	7.96e-01
RESPONSE TO TEMPERATURE STIMULUS	165	4.31e-01	8.67e-01	0.1340	8.15e-02	3.93e-02	6.05e-02	7.05e-02	3.22e-02	7.09e-02	3.83e-01	1.80e-01	1.18e-01	4.75e-01
PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION	6	8.67e-01	9.88e-01	0.1340	6.01e-02	-4.97e-02	5.01e-02	8.26e-03	9.59e-02	7.99e-01	8.33e-01	8.32e-01	9.72e-01	6.84e-01
EYE PHOTORECEPTOR CELL DEVELOPMENT	34	5.09e-01	9.00e-01	0.1340	1.37e-02	6.67e-02	-5.79e-02	-4.77e-02	8.70e-02	8.90e-01	5.01e-01	5.59e-01	6.31e-01	3.80e-01
POSITIVE REGULATION OF PROTEOLYSIS	340	1.01e-02	1.29e-01	0.1340	1.20e-02	-6.53e-02	5.37e-02	5.22e-02	8.84e-02	7.03e-01	3.84e-02	8.85e-02	9.83e-02	5.09e-03
DNA MODIFICATION	99	2.88e-01	7.66e-01	0.1330	1.36e-02	-3.98e-02	9.33e-02	8.23e-02	2.26e-02	8.15e-01	4.94e-01	1.09e-01	1.57e-01	6.98e-01
MESENCHYMAL CELL PROLIFERATION	43	3.99e-01	8.45e-01	0.1330	-3.15e-02	-1.13e-01	-1.12e-02	-3.06e-02	-5.48e-02	7.21e-01	2.01e-01	8.99e-01	7.29e-01	5.34e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	42	5.76e-01	9.26e-01	0.1330	-5.84e-02	-1.17e-01	1.22e-02	1.94e-02	1.64e-03	5.13e-01	1.88e-01	8.91e-01	8.28e-01	9.85e-01
POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION	10	9.81e-01	9.97e-01	0.1330	3.40e-02	-6.22e-02	7.74e-02	5.92e-02	5.66e-02	8.52e-01	7.33e-01	6.72e-01	7.46e-01	7.57e-01
APOPTOTIC CELL CLEARANCE	47	1.15e-01	5.43e-01	0.1330	4.52e-02	1.15e-01	-3.76e-02	5.18e-03	-3.34e-02	5.92e-01	1.74e-01	6.56e-01	9.51e-01	6.92e-01
REGULATION OF MITOCHONDRION ORGANIZATION	147	4.36e-02	3.22e-01	0.1330	-6.99e-03	-1.08e-01	1.69e-02	1.19e-02	7.40e-02	8.84e-01	2.33e-02	7.24e-01	8.03e-01	1.21e-01
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY	132	2.20e-01	7.00e-01	0.1330	3.41e-02	-5.74e-02	7.34e-02	6.21e-02	6.32e-02	4.99e-01	2.55e-01	1.45e-01	2.18e-01	2.10e-01
REGULATION OF CELLULAR KETONE METABOLIC PROCESS	139	4.73e-01	8.86e-01	0.1330	-4.26e-02	-4.75e-02	-6.75e-02	-6.95e-02	-6.50e-02	3.86e-01	3.34e-01	1.70e-01	1.57e-01	1.86e-01
MICROTUBULE DEPOLYMERIZATION	42	4.35e-01	8.69e-01	0.1330	9.40e-02	4.13e-02	5.44e-02	3.57e-02	5.38e-02	2.92e-01	6.43e-01	5.42e-01	6.89e-01	5.47e-01
GDP METABOLIC PROCESS	9	7.93e-01	9.81e-01	0.1330	-2.29e-02	1.29e-02	7.01e-02	3.61e-02	-1.04e-01	9.05e-01	9.47e-01	7.16e-01	8.51e-01	5.90e-01
REGULATION OF CARDIAC CONDUCTION	26	8.36e-01	9.85e-01	0.1330	4.37e-02	1.05e-01	-5.26e-02	-4.03e-02	-1.55e-02	7.00e-01	3.52e-01	6.43e-01	7.22e-01	8.91e-01
REGULATION OF ADAPTIVE IMMUNE RESPONSE	201	1.72e-01	6.44e-01	0.1330	3.10e-02	1.47e-02	5.93e-02	6.46e-02	9.35e-02	4.48e-01	7.19e-01	1.47e-01	1.14e-01	2.22e-02
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	133	3.31e-01	8.03e-01	0.1330	-5.22e-02	-7.91e-02	-3.68e-02	-4.03e-02	7.51e-02	2.99e-01	1.15e-01	4.63e-01	4.22e-01	1.35e-01
NON CANONICAL WNT SIGNALING PATHWAY	66	4.23e-01	8.61e-01	0.1330	-4.09e-02	-6.28e-02	-1.94e-02	-3.80e-02	1.01e-01	5.66e-01	3.78e-01	7.85e-01	5.94e-01	1.57e-01
ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS	1764	6.11e-20	3.28e-17	0.1330	4.07e-02	-5.54e-02	8.08e-02	7.79e-02	1.64e-02	4.54e-03	1.10e-04	1.67e-08	5.39e-08	2.54e-01
VITAMIN TRANSPORT	52	3.00e-01	7.73e-01	0.1320	-1.69e-02	-2.50e-02	-1.00e-01	-7.64e-02	-2.70e-02	8.33e-01	7.55e-01	2.10e-01	3.41e-01	7.37e-01
REGULATION OF AEROBIC RESPIRATION	30	7.00e-01	9.63e-01	0.1320	3.69e-02	-3.90e-02	6.52e-02	6.74e-02	-7.65e-02	7.27e-01	7.12e-01	5.36e-01	5.23e-01	4.68e-01
AXONEME ASSEMBLY	92	3.56e-01	8.22e-01	0.1320	5.14e-02	8.72e-02	-2.95e-02	-1.09e-02	-7.92e-02	3.94e-01	1.48e-01	6.25e-01	8.57e-01	1.89e-01
CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY	155	2.03e-02	2.05e-01	0.1320	6.21e-02	1.12e-01	-2.43e-02	1.06e-03	-2.37e-02	1.82e-01	1.62e-02	6.02e-01	9.82e-01	6.11e-01
RESPONSE TO ISCHEMIA	62	2.65e-01	7.47e-01	0.1320	9.07e-03	-1.07e-01	1.92e-02	2.38e-02	7.16e-02	9.02e-01	1.47e-01	7.94e-01	7.46e-01	3.30e-01
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS	72	6.59e-01	9.54e-01	0.1320	8.19e-02	2.34e-02	6.86e-02	6.83e-02	-2.93e-02	2.30e-01	7.31e-01	3.14e-01	3.16e-01	6.67e-01
NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	22	4.14e-01	8.54e-01	0.1320	3.47e-02	5.85e-02	-8.78e-02	-4.19e-02	-5.83e-02	7.78e-01	6.35e-01	4.76e-01	7.34e-01	6.36e-01
REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION	101	4.82e-01	8.91e-01	0.1320	-5.80e-02	1.68e-02	-8.01e-02	-8.52e-02	-1.24e-02	3.14e-01	7.71e-01	1.64e-01	1.39e-01	8.29e-01
REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT	21	5.96e-01	9.33e-01	0.1320	-2.28e-02	-8.02e-03	9.03e-02	8.61e-02	-3.62e-02	8.57e-01	9.49e-01	4.74e-01	4.94e-01	7.74e-01
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	22	4.72e-01	8.85e-01	0.1320	3.20e-02	1.02e-01	-7.21e-02	-3.01e-02	-2.22e-03	7.95e-01	4.09e-01	5.58e-01	8.07e-01	9.86e-01
GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS	26	6.33e-01	9.48e-01	0.1320	5.24e-02	2.79e-02	-1.49e-02	-1.53e-02	1.16e-01	6.44e-01	8.05e-01	8.95e-01	8.93e-01	3.06e-01
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS	93	2.09e-07	1.73e-05	0.1320	4.34e-02	-1.22e-01	1.36e-02	-2.31e-02	3.08e-03	4.70e-01	4.24e-02	8.20e-01	7.01e-01	9.59e-01
L GLUTAMATE TRANSMEMBRANE TRANSPORT	28	6.87e-01	9.61e-01	0.1320	5.33e-02	1.05e-01	-2.77e-02	-7.03e-03	5.20e-02	6.26e-01	3.35e-01	8.00e-01	9.49e-01	6.34e-01
DEVELOPMENTAL PIGMENTATION	47	6.68e-01	9.56e-01	0.1320	-3.69e-02	-8.95e-02	2.89e-03	-1.70e-02	8.80e-02	6.62e-01	2.88e-01	9.73e-01	8.40e-01	2.97e-01
REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	6	9.54e-01	9.97e-01	0.1320	5.71e-02	2.59e-02	-7.86e-02	-6.74e-02	-5.24e-02	8.09e-01	9.12e-01	7.39e-01	7.75e-01	8.24e-01
AXONAL TRANSPORT OF MITOCHONDRION	16	5.75e-01	9.26e-01	0.1320	-1.71e-02	-5.15e-02	1.42e-02	-2.40e-02	-1.17e-01	9.06e-01	7.22e-01	9.22e-01	8.68e-01	4.18e-01
POSITIVE REGULATION OF MITOTIC CELL CYCLE	122	6.94e-02	4.22e-01	0.1320	8.75e-02	2.95e-03	7.60e-02	6.28e-02	1.57e-03	9.52e-02	9.55e-01	1.47e-01	2.31e-01	9.76e-01
INTRACELLULAR PROTEIN TRANSPORT	838	5.84e-09	6.76e-07	0.1320	2.87e-02	-6.19e-02	8.14e-02	7.14e-02	3.14e-02	1.59e-01	2.31e-03	6.19e-05	4.44e-04	1.23e-01
CELL JUNCTION MAINTENANCE	45	9.16e-01	9.94e-01	0.1320	-5.89e-02	-6.79e-02	-6.53e-02	-6.46e-02	2.90e-02	4.94e-01	4.31e-01	4.48e-01	4.54e-01	7.36e-01
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	74	4.09e-01	8.52e-01	0.1320	-6.98e-02	-5.81e-02	-3.46e-03	-5.65e-03	9.52e-02	2.99e-01	3.88e-01	9.59e-01	9.33e-01	1.57e-01
REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	18	4.37e-01	8.69e-01	0.1320	-4.63e-02	8.03e-02	-3.25e-02	-6.99e-02	-5.29e-02	7.34e-01	5.56e-01	8.11e-01	6.08e-01	6.98e-01
STEM CELL DEVELOPMENT	87	8.58e-02	4.67e-01	0.1320	7.79e-03	-4.43e-02	2.42e-03	-1.55e-02	1.23e-01	9.00e-01	4.75e-01	9.69e-01	8.03e-01	4.80e-02
NOREPINEPHRINE TRANSPORT	22	4.08e-01	8.51e-01	0.1320	-3.69e-02	-8.06e-03	-9.67e-03	-4.96e-02	-1.15e-01	7.65e-01	9.48e-01	9.37e-01	6.87e-01	3.49e-01
RESPONSE TO INTERLEUKIN 1	134	2.70e-01	7.50e-01	0.1310	6.41e-02	8.12e-02	2.73e-02	3.01e-02	7.03e-02	2.00e-01	1.05e-01	5.85e-01	5.48e-01	1.60e-01
INTERMEMBRANE LIPID TRANSFER	54	7.00e-01	9.63e-01	0.1310	-5.39e-02	-1.14e-01	-2.25e-02	-2.19e-02	-2.15e-02	4.93e-01	1.49e-01	7.75e-01	7.80e-01	7.84e-01
COCHLEA DEVELOPMENT	46	3.47e-01	8.18e-01	0.1310	9.49e-02	-1.30e-02	6.82e-02	5.78e-02	-1.09e-02	2.66e-01	8.79e-01	4.24e-01	4.98e-01	8.98e-01
CELLULAR RESPONSE TO ALKALOID	35	9.48e-01	9.97e-01	0.1310	3.03e-02	-3.20e-02	6.18e-02	5.62e-02	9.14e-02	7.56e-01	7.43e-01	5.27e-01	5.65e-01	3.49e-01
MYOBLAST DIFFERENTIATION	109	5.23e-01	9.04e-01	0.1310	2.46e-02	-2.70e-02	8.16e-02	6.87e-02	6.73e-02	6.57e-01	6.26e-01	1.41e-01	2.15e-01	2.25e-01
NEUROTRANSMITTER SECRETION	138	2.13e-01	6.93e-01	0.1310	-5.23e-02	-6.99e-02	1.78e-02	8.25e-03	9.62e-02	2.89e-01	1.56e-01	7.19e-01	8.67e-01	5.11e-02
SISTER CHROMATID COHESION	53	4.00e-01	8.45e-01	0.1310	-3.71e-02	-1.09e-01	2.72e-02	1.70e-02	-5.51e-02	6.41e-01	1.71e-01	7.32e-01	8.31e-01	4.88e-01
REGULATION OF NUCLEOTIDE EXCISION REPAIR	28	1.89e-01	6.61e-01	0.1310	3.25e-02	2.11e-02	1.09e-01	6.19e-02	6.55e-04	7.66e-01	8.46e-01	3.17e-01	5.71e-01	9.95e-01
REGULATION OF CELL CYCLE CHECKPOINT	45	5.84e-01	9.28e-01	0.1310	4.80e-03	-4.88e-02	9.14e-02	8.01e-02	-5.13e-03	9.56e-01	5.71e-01	2.89e-01	3.53e-01	9.53e-01
CYCLIC NUCLEOTIDE MEDIATED SIGNALING	80	6.08e-01	9.35e-01	0.1310	-8.42e-02	-6.92e-02	-4.91e-02	-4.30e-02	3.25e-02	1.93e-01	2.85e-01	4.47e-01	5.06e-01	6.15e-01
CARBOHYDRATE TRANSMEMBRANE TRANSPORT	132	3.25e-01	7.98e-01	0.1310	-3.57e-02	-5.25e-03	-7.03e-02	-5.47e-02	-8.91e-02	4.78e-01	9.17e-01	1.63e-01	2.78e-01	7.71e-02
DRINKING BEHAVIOR	8	8.57e-01	9.88e-01	0.1310	2.02e-02	8.42e-03	-2.45e-02	-5.51e-02	1.14e-01	9.21e-01	9.67e-01	9.05e-01	7.87e-01	5.76e-01
POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION	17	6.91e-01	9.61e-01	0.1310	-8.06e-02	-8.19e-03	-2.18e-02	-5.43e-02	8.45e-02	5.65e-01	9.53e-01	8.76e-01	6.98e-01	5.46e-01
PROTEIN MONOUBIQUITINATION	41	4.70e-01	8.85e-01	0.1310	-2.51e-02	-9.78e-02	1.46e-02	-1.37e-02	8.08e-02	7.81e-01	2.78e-01	8.71e-01	8.80e-01	3.71e-01
RNA STABILIZATION	66	4.34e-01	8.69e-01	0.1310	6.98e-03	-5.50e-02	2.60e-02	1.03e-02	1.15e-01	9.22e-01	4.40e-01	7.14e-01	8.85e-01	1.06e-01
NEURAL PRECURSOR CELL PROLIFERATION	163	7.18e-02	4.31e-01	0.1310	2.26e-02	-7.81e-02	6.43e-02	5.37e-02	5.87e-02	6.19e-01	8.51e-02	1.56e-01	2.37e-01	1.96e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	69	8.45e-01	9.86e-01	0.1310	4.90e-02	6.01e-03	8.72e-02	8.04e-02	2.41e-02	4.82e-01	9.31e-01	2.10e-01	2.48e-01	7.29e-01
REGULATION OF T HELPER CELL DIFFERENTIATION	42	8.14e-01	9.82e-01	0.1310	4.96e-02	-8.05e-04	3.86e-02	4.62e-02	1.05e-01	5.78e-01	9.93e-01	6.65e-01	6.04e-01	2.40e-01
KETONE BIOSYNTHETIC PROCESS	48	5.64e-01	9.22e-01	0.1310	-2.79e-03	-8.06e-02	7.17e-02	7.30e-02	8.33e-03	9.73e-01	3.34e-01	3.90e-01	3.82e-01	9.20e-01
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	89	2.02e-01	6.82e-01	0.1300	-1.53e-02	-9.88e-04	2.10e-02	2.74e-02	1.25e-01	8.03e-01	9.87e-01	7.32e-01	6.55e-01	4.18e-02
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL	198	2.27e-03	4.53e-02	0.1300	2.88e-02	1.15e-01	-5.39e-03	9.48e-04	5.50e-02	4.84e-01	5.45e-03	8.96e-01	9.82e-01	1.82e-01
NEGATIVE REGULATION OF CELL CYCLE	391	1.20e-04	4.54e-03	0.1300	3.75e-02	-3.96e-02	9.07e-02	7.47e-02	1.45e-02	2.04e-01	1.79e-01	2.08e-03	1.12e-02	6.23e-01
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	62	7.08e-01	9.65e-01	0.1300	-9.26e-02	-4.93e-02	-4.71e-02	-5.09e-02	3.43e-02	2.07e-01	5.02e-01	5.21e-01	4.88e-01	6.40e-01
MIRNA CATABOLIC PROCESS	18	8.70e-01	9.88e-01	0.1300	4.17e-03	-4.81e-02	-1.21e-02	-2.31e-02	1.18e-01	9.76e-01	7.24e-01	9.29e-01	8.65e-01	3.86e-01
SPERM MOTILITY	127	7.30e-03	1.05e-01	0.1300	4.27e-02	1.12e-01	-4.44e-02	-1.25e-02	-1.96e-02	4.06e-01	2.87e-02	3.88e-01	8.08e-01	7.03e-01
HAIR CELL DIFFERENTIATION	53	7.35e-01	9.73e-01	0.1300	-6.74e-02	-2.41e-02	-6.33e-02	-6.28e-02	6.24e-02	3.96e-01	7.61e-01	4.25e-01	4.29e-01	4.32e-01
EMBRYONIC BODY MORPHOGENESIS	11	9.37e-01	9.97e-01	0.1300	8.96e-03	-1.11e-01	1.73e-02	2.48e-02	5.98e-02	9.59e-01	5.23e-01	9.21e-01	8.87e-01	7.31e-01
REGULATION OF TELOMERASE ACTIVITY	48	5.80e-01	9.27e-01	0.1300	4.08e-02	-4.84e-02	8.56e-02	7.35e-02	-1.41e-02	6.25e-01	5.62e-01	3.05e-01	3.78e-01	8.66e-01
FACIAL NERVE MORPHOGENESIS	9	9.76e-01	9.97e-01	0.1300	4.01e-02	-2.18e-02	2.15e-02	1.25e-02	1.19e-01	8.35e-01	9.10e-01	9.11e-01	9.48e-01	5.35e-01
REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	28	3.68e-01	8.30e-01	0.1300	2.73e-02	8.73e-02	-1.69e-02	1.68e-02	8.94e-02	8.03e-01	4.24e-01	8.77e-01	8.78e-01	4.13e-01
POSITIVE REGULATION OF ORGANIC ACID TRANSPORT	44	6.37e-01	9.48e-01	0.1300	-3.94e-02	2.30e-03	-7.56e-02	-8.53e-02	4.87e-02	6.51e-01	9.79e-01	3.86e-01	3.28e-01	5.76e-01
RECEPTOR METABOLIC PROCESS	71	6.21e-01	9.43e-01	0.1300	-6.01e-02	-6.44e-02	-6.80e-03	-1.15e-02	9.47e-02	3.82e-01	3.48e-01	9.21e-01	8.67e-01	1.68e-01
RESPONSE TO LEAD ION	19	9.40e-01	9.97e-01	0.1300	7.58e-02	6.24e-02	6.79e-02	5.00e-02	1.25e-02	5.67e-01	6.38e-01	6.08e-01	7.06e-01	9.25e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION	7	9.88e-01	9.98e-01	0.1300	4.12e-02	9.14e-02	4.44e-02	6.27e-02	3.08e-02	8.50e-01	6.75e-01	8.39e-01	7.74e-01	8.88e-01
NEGATIVE REGULATION OF GLUCOSE IMPORT	16	2.07e-01	6.84e-01	0.1300	2.01e-02	-8.11e-02	-7.67e-02	-2.35e-02	-5.91e-02	8.89e-01	5.75e-01	5.95e-01	8.71e-01	6.83e-01
REGULATION OF SYNAPSE ASSEMBLY	104	5.27e-01	9.06e-01	0.1300	-7.90e-02	-4.49e-02	-5.33e-02	-6.40e-02	4.11e-02	1.64e-01	4.29e-01	3.48e-01	2.59e-01	4.69e-01
POSTSYNAPTIC DENSITY ASSEMBLY	21	4.23e-01	8.61e-01	0.1300	-3.13e-02	-2.25e-02	-3.52e-03	-4.65e-02	1.15e-01	8.04e-01	8.59e-01	9.78e-01	7.12e-01	3.62e-01
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	65	7.74e-01	9.77e-01	0.1300	4.86e-02	-1.54e-02	8.09e-02	6.79e-02	5.57e-02	4.98e-01	8.30e-01	2.59e-01	3.44e-01	4.37e-01
PEPTIDYL SERINE AUTOPHOSPHORYLATION	8	3.16e-01	7.88e-01	0.1300	2.73e-02	5.91e-02	-2.67e-02	-9.78e-02	-4.83e-02	8.94e-01	7.72e-01	8.96e-01	6.32e-01	8.13e-01
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	240	6.49e-02	4.06e-01	0.1300	-5.08e-02	-2.79e-02	-7.83e-02	-7.74e-02	3.69e-02	1.75e-01	4.56e-01	3.67e-02	3.88e-02	3.25e-01
RESPONSE TO INORGANIC SUBSTANCE	510	5.72e-03	9.05e-02	0.1300	4.63e-02	4.02e-03	5.67e-02	5.06e-02	9.44e-02	7.37e-02	8.77e-01	2.84e-02	5.06e-02	2.61e-04
LEYDIG CELL DIFFERENTIATION	9	7.98e-01	9.81e-01	0.1300	1.02e-01	6.04e-03	4.48e-02	1.94e-02	-6.29e-02	5.95e-01	9.75e-01	8.16e-01	9.20e-01	7.44e-01
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	53	6.49e-01	9.51e-01	0.1300	-8.15e-02	-5.30e-02	-4.55e-02	-6.76e-02	2.69e-02	3.05e-01	5.05e-01	5.67e-01	3.94e-01	7.35e-01
IMPORT ACROSS PLASMA MEMBRANE	202	1.54e-03	3.40e-02	0.1300	2.20e-02	1.23e-01	-2.78e-02	-1.48e-02	1.41e-02	5.89e-01	2.59e-03	4.96e-01	7.17e-01	7.31e-01
PROTEIN CATABOLIC PROCESS	930	1.71e-09	2.19e-07	0.1300	5.00e-02	-4.20e-02	8.10e-02	7.11e-02	3.02e-02	9.80e-03	2.98e-02	2.82e-05	2.37e-04	1.18e-01
REGULATION OF STEM CELL PROLIFERATION	91	4.12e-01	8.54e-01	0.1300	-2.63e-02	-1.05e-01	1.94e-02	7.74e-03	6.82e-02	6.64e-01	8.38e-02	7.49e-01	8.99e-01	2.61e-01
AXONAL TRANSPORT	62	7.42e-01	9.74e-01	0.1290	-8.44e-03	-5.44e-02	5.56e-02	4.24e-02	9.39e-02	9.09e-01	4.59e-01	4.49e-01	5.63e-01	2.01e-01
CALCIUM ION TRANSMEMBRANE TRANSPORT	338	7.96e-06	4.51e-04	0.1290	2.63e-02	1.20e-01	-1.32e-02	-8.48e-03	3.79e-02	4.06e-01	1.52e-04	6.76e-01	7.89e-01	2.31e-01
CELLULAR RESPONSE TO CALCIUM ION	84	5.84e-01	9.28e-01	0.1290	2.10e-02	-1.02e-02	4.65e-02	3.58e-02	1.13e-01	7.40e-01	8.72e-01	4.61e-01	5.71e-01	7.36e-02
RESPONSE TO INSULIN	262	1.36e-01	5.86e-01	0.1290	-5.78e-02	-8.99e-02	-4.80e-02	-5.46e-02	-5.15e-03	1.07e-01	1.23e-02	1.81e-01	1.28e-01	8.86e-01
MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS	10	8.85e-01	9.91e-01	0.1290	-1.30e-02	-1.23e-01	3.12e-02	1.98e-03	-2.25e-02	9.43e-01	5.02e-01	8.64e-01	9.91e-01	9.02e-01
POSITIVE REGULATION OF AMINE TRANSPORT	39	6.14e-01	9.39e-01	0.1290	2.65e-02	2.37e-02	6.27e-02	3.80e-02	1.00e-01	7.75e-01	7.98e-01	4.98e-01	6.81e-01	2.78e-01
PROTEIN PALMITOYLATION	28	8.97e-01	9.93e-01	0.1290	-4.91e-02	-1.00e-01	-3.13e-02	-2.75e-02	-4.97e-02	6.53e-01	3.58e-01	7.74e-01	8.01e-01	6.49e-01
PROTEIN LOCALIZATION TO POSTSYNAPSE	40	6.84e-01	9.61e-01	0.1290	3.75e-02	4.10e-02	8.86e-02	6.74e-02	3.49e-02	6.81e-01	6.53e-01	3.32e-01	4.61e-01	7.02e-01
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	62	8.24e-01	9.83e-01	0.1290	4.12e-02	-2.89e-02	7.94e-02	7.97e-02	3.86e-02	5.75e-01	6.94e-01	2.80e-01	2.77e-01	5.99e-01
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS	198	2.48e-02	2.34e-01	0.1290	-3.60e-02	-1.19e-01	2.48e-02	1.89e-02	1.62e-02	3.83e-01	3.91e-03	5.48e-01	6.46e-01	6.94e-01
PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	16	8.13e-01	9.82e-01	0.1290	-2.52e-02	7.45e-03	-5.67e-02	-3.50e-02	1.07e-01	8.62e-01	9.59e-01	6.95e-01	8.08e-01	4.57e-01
FIBROBLAST ACTIVATION	15	9.85e-01	9.98e-01	0.1290	3.40e-02	-2.67e-02	4.34e-02	4.60e-02	1.04e-01	8.20e-01	8.58e-01	7.71e-01	7.58e-01	4.86e-01
CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION	6	9.64e-01	9.97e-01	0.1290	1.90e-02	3.07e-02	3.81e-02	1.12e-02	-1.17e-01	9.36e-01	8.96e-01	8.72e-01	9.62e-01	6.19e-01
POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	50	5.49e-01	9.15e-01	0.1290	3.78e-02	1.09e-01	1.25e-03	8.03e-03	5.77e-02	6.44e-01	1.84e-01	9.88e-01	9.22e-01	4.80e-01
LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	34	2.04e-01	6.83e-01	0.1290	-8.07e-03	1.17e-01	-1.91e-02	1.19e-02	-4.84e-02	9.35e-01	2.38e-01	8.47e-01	9.04e-01	6.25e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	12	9.35e-01	9.97e-01	0.1290	1.36e-02	1.02e-01	7.76e-03	2.50e-02	-7.29e-02	9.35e-01	5.40e-01	9.63e-01	8.81e-01	6.62e-01
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	99	6.85e-03	1.01e-01	0.1290	2.16e-02	-7.20e-02	-1.49e-02	-2.09e-02	-1.01e-01	7.11e-01	2.16e-01	7.97e-01	7.20e-01	8.11e-02
REGULATION OF LYSOSOME ORGANIZATION	12	9.83e-01	9.97e-01	0.1290	-8.67e-02	-5.09e-02	-3.67e-02	-5.34e-02	-4.75e-02	6.03e-01	7.60e-01	8.26e-01	7.49e-01	7.76e-01
LEPTIN MEDIATED SIGNALING PATHWAY	10	8.50e-01	9.88e-01	0.1290	2.72e-02	-6.87e-02	7.53e-02	3.46e-02	6.51e-02	8.82e-01	7.07e-01	6.80e-01	8.50e-01	7.22e-01
PROTEIN CATABOLIC PROCESS IN THE VACUOLE	22	9.93e-01	9.99e-01	0.1290	6.93e-02	3.68e-02	5.92e-02	6.49e-02	5.17e-02	5.74e-01	7.65e-01	6.31e-01	5.98e-01	6.75e-01
REGULATION OF VASCULOGENESIS	16	8.58e-01	9.88e-01	0.1280	-1.34e-02	-6.47e-02	7.74e-02	6.13e-02	-4.87e-02	9.26e-01	6.54e-01	5.92e-01	6.71e-01	7.36e-01
MICROTUBULE BUNDLE FORMATION	121	2.16e-01	6.97e-01	0.1280	7.62e-02	8.78e-02	4.70e-03	2.57e-02	-4.77e-02	1.48e-01	9.52e-02	9.29e-01	6.25e-01	3.65e-01
CARDIAC CHAMBER MORPHOGENESIS	127	1.76e-02	1.87e-01	0.1280	2.39e-03	-1.04e-01	5.81e-02	3.47e-02	3.31e-02	9.63e-01	4.33e-02	2.58e-01	4.99e-01	5.20e-01
CELL DIVISION	614	4.82e-08	4.48e-06	0.1280	3.47e-02	-5.54e-02	8.40e-02	6.76e-02	2.36e-02	1.42e-01	1.91e-02	3.76e-04	4.22e-03	3.18e-01
NEGATIVE REGULATION OF RNA CATABOLIC PROCESS	78	6.32e-01	9.47e-01	0.1280	-1.71e-02	-6.16e-02	2.61e-02	1.63e-02	1.07e-01	7.94e-01	3.47e-01	6.90e-01	8.03e-01	1.03e-01
RESPONSE TO ORGANOPHOSPHORUS	121	3.83e-01	8.39e-01	0.1280	-5.03e-02	-7.35e-02	-4.05e-02	-4.90e-02	6.69e-02	3.40e-01	1.63e-01	4.41e-01	3.51e-01	2.04e-01
POLYOL BIOSYNTHETIC PROCESS	62	6.36e-01	9.48e-01	0.1280	-8.99e-02	-7.52e-02	-1.98e-02	-3.72e-02	3.05e-02	2.21e-01	3.06e-01	7.88e-01	6.13e-01	6.78e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL	42	8.69e-02	4.68e-01	0.1280	1.63e-02	-8.80e-02	-6.72e-02	-5.34e-02	3.24e-02	8.55e-01	3.24e-01	4.51e-01	5.49e-01	7.17e-01
GLYCOLIPID BIOSYNTHETIC PROCESS	72	5.43e-01	9.15e-01	0.1280	4.25e-02	-5.47e-02	7.26e-02	6.34e-02	4.82e-02	5.33e-01	4.23e-01	2.87e-01	3.52e-01	4.80e-01
REGULATION OF REGULATED SECRETORY PATHWAY	117	2.65e-01	7.47e-01	0.1280	-3.38e-02	-8.94e-02	-2.42e-02	-2.84e-02	7.67e-02	5.27e-01	9.49e-02	6.52e-01	5.96e-01	1.52e-01
PROTEIN LOCALIZATION TO NUCLEUS	305	1.43e-03	3.24e-02	0.1280	4.98e-02	-2.43e-02	8.41e-02	7.50e-02	-2.53e-02	1.35e-01	4.65e-01	1.15e-02	2.43e-02	4.46e-01
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	41	8.41e-01	9.85e-01	0.1280	-6.21e-02	2.79e-02	-7.49e-02	-7.62e-02	-1.83e-02	4.91e-01	7.57e-01	4.07e-01	3.99e-01	8.39e-01
MRNA POLYADENYLATION	24	8.70e-01	9.88e-01	0.1280	-6.59e-02	-9.00e-02	-2.50e-02	-4.99e-02	-2.86e-02	5.76e-01	4.45e-01	8.32e-01	6.72e-01	8.09e-01
POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION	971	7.36e-06	4.23e-04	0.1280	-6.41e-02	-4.65e-03	-7.45e-02	-6.48e-02	-4.99e-02	7.22e-04	8.06e-01	8.42e-05	6.24e-04	8.40e-03
NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY	389	6.38e-02	4.03e-01	0.1280	4.74e-02	-5.10e-03	8.34e-02	7.67e-02	3.52e-02	1.08e-01	8.63e-01	4.73e-03	9.44e-03	2.34e-01
CELLULAR RESPONSE TO CHEMICAL STRESS	307	1.78e-03	3.72e-02	0.1280	2.69e-02	-6.56e-02	7.22e-02	5.65e-02	5.38e-02	4.18e-01	4.81e-02	2.96e-02	8.84e-02	1.05e-01
LOCOMOTOR RHYTHM	15	7.94e-01	9.81e-01	0.1280	-1.79e-02	-2.49e-02	-7.47e-02	-9.82e-02	1.25e-02	9.04e-01	8.67e-01	6.17e-01	5.10e-01	9.33e-01
PROTEIN LOCALIZATION TO AXON	9	9.56e-01	9.97e-01	0.1280	1.00e-02	4.20e-02	5.85e-02	4.50e-02	-9.49e-02	9.58e-01	8.27e-01	7.61e-01	8.15e-01	6.22e-01
POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	9	9.80e-01	9.97e-01	0.1280	-4.08e-02	-1.05e-01	-3.08e-02	-1.77e-02	4.86e-02	8.32e-01	5.86e-01	8.73e-01	9.27e-01	8.01e-01
REGULATION OF VACUOLE ORGANIZATION	53	3.39e-01	8.08e-01	0.1280	-4.45e-04	-8.83e-02	7.48e-02	4.88e-02	2.23e-02	9.96e-01	2.66e-01	3.46e-01	5.39e-01	7.79e-01
SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT	40	7.56e-01	9.75e-01	0.1280	4.39e-02	4.40e-02	4.49e-02	6.29e-02	8.02e-02	6.31e-01	6.30e-01	6.23e-01	4.91e-01	3.80e-01
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	98	3.05e-01	7.77e-01	0.1270	1.61e-02	-8.19e-02	6.66e-02	5.76e-02	3.91e-02	7.83e-01	1.61e-01	2.55e-01	3.24e-01	5.03e-01
STEM CELL PROLIFERATION	120	1.16e-01	5.44e-01	0.1270	9.34e-03	-9.08e-02	4.37e-02	2.97e-02	7.16e-02	8.60e-01	8.58e-02	4.08e-01	5.75e-01	1.76e-01
ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION	6	9.92e-01	9.99e-01	0.1270	2.93e-02	1.05e-01	-4.63e-02	-4.53e-02	6.78e-03	9.01e-01	6.55e-01	8.44e-01	8.48e-01	9.77e-01
DEHYDROASCORBIC ACID TRANSPORT	9	8.70e-01	9.88e-01	0.1270	6.01e-02	-6.93e-03	-1.64e-02	1.09e-02	1.10e-01	7.55e-01	9.71e-01	9.32e-01	9.55e-01	5.67e-01
PHOSPHOLIPID TRANSPORT	101	7.36e-01	9.73e-01	0.1270	-7.73e-02	-5.54e-02	-5.93e-02	-5.68e-02	2.05e-02	1.79e-01	3.36e-01	3.03e-01	3.24e-01	7.22e-01
EATING BEHAVIOR	37	5.11e-01	9.00e-01	0.1270	-2.99e-02	-4.83e-02	-5.74e-02	-8.11e-02	-5.57e-02	7.53e-01	6.11e-01	5.46e-01	3.93e-01	5.58e-01
RESPONSE TO FLUID SHEAR STRESS	34	8.92e-01	9.92e-01	0.1270	-4.15e-02	-6.12e-02	-7.01e-02	-7.58e-02	7.42e-03	6.75e-01	5.37e-01	4.79e-01	4.44e-01	9.40e-01
VASODILATION	46	3.50e-01	8.18e-01	0.1270	6.53e-02	-3.46e-02	6.03e-02	8.01e-02	-2.61e-02	4.44e-01	6.85e-01	4.79e-01	3.48e-01	7.59e-01
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	44	8.80e-01	9.89e-01	0.1270	-5.82e-02	-4.21e-02	-7.50e-02	-6.03e-02	-4.19e-02	5.04e-01	6.29e-01	3.90e-01	4.89e-01	6.31e-01
REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	12	9.88e-01	9.98e-01	0.1270	-1.27e-04	-4.27e-02	7.88e-02	7.31e-02	5.27e-02	9.99e-01	7.98e-01	6.37e-01	6.61e-01	7.52e-01
NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	32	9.05e-01	9.94e-01	0.1270	-8.04e-03	-2.15e-02	3.79e-02	3.76e-02	1.13e-01	9.37e-01	8.33e-01	7.11e-01	7.13e-01	2.68e-01
APOPTOTIC PROCESS	1856	1.60e-12	3.02e-10	0.1270	5.77e-02	-2.19e-02	7.62e-02	7.14e-02	3.78e-02	3.76e-05	1.17e-01	5.16e-08	3.39e-07	6.92e-03
CELLULAR RESPONSE TO HYDROGEN PEROXIDE	65	3.35e-01	8.05e-01	0.1270	3.96e-02	-5.33e-02	7.97e-02	5.73e-02	4.58e-02	5.81e-01	4.57e-01	2.67e-01	4.25e-01	5.23e-01
ACTIN FILAMENT BASED PROCESS	774	1.57e-04	5.77e-03	0.1270	-5.03e-02	-7.68e-05	-8.23e-02	-8.26e-02	-2.82e-03	1.73e-02	9.97e-01	9.68e-05	9.24e-05	8.94e-01
PARTURITION	14	7.62e-01	9.75e-01	0.1270	-1.47e-02	8.92e-02	5.43e-03	-1.99e-02	-8.68e-02	9.24e-01	5.63e-01	9.72e-01	8.97e-01	5.74e-01
APOPTOTIC SIGNALING PATHWAY	600	2.18e-04	7.53e-03	0.1270	4.36e-02	-4.09e-02	7.45e-02	6.86e-02	4.74e-02	6.78e-02	8.70e-02	1.81e-03	4.08e-03	4.72e-02
RESPONSE TO RETINOIC ACID	105	5.09e-01	9.00e-01	0.1270	2.61e-02	-4.64e-02	4.94e-02	4.62e-02	9.31e-02	6.44e-01	4.11e-01	3.82e-01	4.13e-01	9.91e-02
DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS	102	1.25e-01	5.65e-01	0.1270	-4.44e-02	-8.29e-02	-4.77e-02	-6.87e-02	-1.49e-02	4.38e-01	1.48e-01	4.05e-01	2.30e-01	7.95e-01
RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	14	8.67e-01	9.88e-01	0.1270	-2.26e-03	-1.56e-03	-5.93e-02	-7.10e-02	8.66e-02	9.88e-01	9.92e-01	7.01e-01	6.46e-01	5.75e-01
RESPONSE TO INSECTICIDE	6	7.43e-01	9.74e-01	0.1270	9.85e-02	-1.33e-02	-1.04e-02	-3.84e-02	6.77e-02	6.76e-01	9.55e-01	9.65e-01	8.71e-01	7.74e-01
PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS	8	9.85e-01	9.98e-01	0.1270	-5.01e-02	-8.88e-02	-1.62e-03	-1.80e-02	-7.28e-02	8.06e-01	6.63e-01	9.94e-01	9.30e-01	7.21e-01
REGULATION OF MESENCHYMAL CELL PROLIFERATION	32	6.06e-01	9.34e-01	0.1270	-1.70e-02	-8.46e-02	-2.31e-02	-3.79e-02	-8.12e-02	8.68e-01	4.07e-01	8.21e-01	7.10e-01	4.27e-01
ACTIVATION OF PROTEIN KINASE ACTIVITY	86	7.71e-01	9.76e-01	0.1260	6.71e-02	2.28e-02	5.37e-02	5.41e-02	7.17e-02	2.82e-01	7.15e-01	3.89e-01	3.85e-01	2.50e-01
REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	46	5.00e-01	8.98e-01	0.1260	3.05e-04	1.76e-02	1.28e-02	2.67e-02	1.22e-01	9.97e-01	8.36e-01	8.81e-01	7.54e-01	1.53e-01
RESPONSE TO VITAMIN A	15	5.75e-01	9.26e-01	0.1260	6.82e-02	-9.58e-02	3.35e-02	1.99e-02	2.48e-02	6.47e-01	5.20e-01	8.22e-01	8.94e-01	8.68e-01
REGULATION OF MONOCYTE CHEMOTAXIS	27	1.09e-01	5.28e-01	0.1260	1.07e-01	1.94e-02	2.89e-03	5.33e-02	-3.61e-02	3.36e-01	8.61e-01	9.79e-01	6.32e-01	7.46e-01
REGULATION OF AXONOGENESIS	145	4.23e-02	3.15e-01	0.1260	-2.73e-02	2.34e-02	-7.84e-02	-8.57e-02	3.42e-02	5.71e-01	6.26e-01	1.03e-01	7.48e-02	4.78e-01
HETEROCHROMATIN ORGANIZATION	89	4.58e-01	8.79e-01	0.1260	-6.82e-02	-9.91e-02	6.94e-03	-1.09e-02	3.61e-02	2.66e-01	1.06e-01	9.10e-01	8.59e-01	5.56e-01
RENAL PROTEIN ABSORPTION	7	9.96e-01	1.00e+00	0.1260	-3.33e-02	6.15e-02	-5.97e-02	-5.95e-02	-6.25e-02	8.79e-01	7.78e-01	7.84e-01	7.85e-01	7.74e-01
ENDOCHONDRAL BONE MORPHOGENESIS	59	6.14e-01	9.38e-01	0.1260	7.20e-02	-1.38e-02	5.59e-02	5.28e-02	6.79e-02	3.39e-01	8.54e-01	4.57e-01	4.83e-01	3.67e-01
INNER EAR RECEPTOR CELL DEVELOPMENT	46	6.79e-01	9.60e-01	0.1260	-1.75e-02	-1.24e-02	-7.99e-03	-1.45e-02	1.23e-01	8.38e-01	8.84e-01	9.25e-01	8.65e-01	1.48e-01
ACTION POTENTIAL	139	1.89e-01	6.61e-01	0.1260	-5.98e-02	-2.39e-02	-6.45e-02	-5.95e-02	6.35e-02	2.23e-01	6.27e-01	1.89e-01	2.25e-01	1.96e-01
NEGATIVE REGULATION OF PROGRAMMED CELL DEATH	881	1.10e-06	7.68e-05	0.1260	5.37e-02	-3.01e-02	7.58e-02	6.91e-02	3.98e-02	6.83e-03	1.29e-01	1.34e-04	4.99e-04	4.49e-02
RETROGRADE TRANS SYNAPTIC SIGNALING	10	9.83e-01	9.97e-01	0.1260	2.99e-02	7.04e-02	6.09e-02	4.90e-02	6.26e-02	8.70e-01	7.00e-01	7.39e-01	7.88e-01	7.32e-01
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	102	5.09e-01	9.00e-01	0.1260	-5.23e-02	1.14e-02	-7.99e-02	-8.08e-02	9.06e-03	3.61e-01	8.42e-01	1.63e-01	1.59e-01	8.74e-01
TYROSINE METABOLIC PROCESS	17	8.75e-01	9.88e-01	0.1260	-1.96e-02	-6.51e-03	-8.92e-02	-7.15e-02	4.82e-02	8.89e-01	9.63e-01	5.24e-01	6.10e-01	7.31e-01
GOLGI VESICLE TRANSPORT	284	1.45e-02	1.63e-01	0.1260	-4.84e-02	-9.30e-02	-2.83e-02	-3.67e-02	-5.18e-02	1.60e-01	7.00e-03	4.12e-01	2.87e-01	1.33e-01
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE	48	3.32e-01	8.04e-01	0.1260	2.05e-02	-9.87e-02	6.05e-02	4.41e-02	-7.22e-03	8.06e-01	2.37e-01	4.69e-01	5.97e-01	9.31e-01
AXONOGENESIS INVOLVED IN INNERVATION	9	9.92e-01	9.99e-01	0.1260	-7.76e-02	-4.62e-02	-4.01e-02	-5.85e-02	-5.12e-02	6.87e-01	8.10e-01	8.35e-01	7.61e-01	7.90e-01
RESPONSE TO AMINE	45	6.50e-01	9.51e-01	0.1260	-2.20e-02	-9.88e-02	4.23e-02	2.02e-02	5.79e-02	7.99e-01	2.51e-01	6.23e-01	8.14e-01	5.02e-01
HEART FORMATION	33	1.01e-01	5.08e-01	0.1260	-1.90e-02	-1.16e-01	1.94e-02	-2.80e-02	3.02e-02	8.50e-01	2.51e-01	8.47e-01	7.81e-01	7.64e-01
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	62	7.81e-01	9.81e-01	0.1260	-7.43e-02	-1.08e-03	-6.93e-02	-6.47e-02	-3.53e-02	3.11e-01	9.88e-01	3.45e-01	3.78e-01	6.30e-01
MACROPHAGE ACTIVATION	109	3.16e-01	7.88e-01	0.1250	-5.80e-02	-6.89e-02	-4.61e-02	-3.66e-02	6.45e-02	2.96e-01	2.14e-01	4.06e-01	5.09e-01	2.44e-01
POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION	45	4.64e-01	8.81e-01	0.1250	-1.92e-02	-1.17e-01	1.79e-02	2.31e-02	-2.68e-02	8.24e-01	1.73e-01	8.36e-01	7.89e-01	7.56e-01
PROTEIN K63 LINKED UBIQUITINATION	56	9.33e-01	9.97e-01	0.1250	5.37e-02	5.85e-02	6.70e-02	6.31e-02	3.10e-02	4.87e-01	4.49e-01	3.86e-01	4.14e-01	6.88e-01
RESPONSE TO PROSTAGLANDIN	31	9.05e-01	9.94e-01	0.1250	-1.93e-02	6.18e-02	-7.68e-02	-6.84e-02	-3.13e-02	8.53e-01	5.51e-01	4.60e-01	5.10e-01	7.63e-01
REGULATION OF CELLULAR RESPONSE TO STRESS	629	1.26e-04	4.73e-03	0.1250	3.43e-02	-4.69e-02	7.35e-02	6.46e-02	5.27e-02	1.42e-01	4.46e-02	1.64e-03	5.66e-03	2.41e-02
RUFFLE ORGANIZATION	57	6.87e-01	9.61e-01	0.1250	-6.53e-02	5.73e-03	-6.96e-02	-8.04e-02	9.70e-03	3.93e-01	9.40e-01	3.63e-01	2.94e-01	8.99e-01
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS	30	2.73e-01	7.55e-01	0.1250	4.71e-02	-1.10e-01	1.35e-02	1.45e-02	3.21e-02	6.55e-01	2.98e-01	8.98e-01	8.91e-01	7.61e-01
NEGATIVE REGULATION OF CELL CYCLE PROCESS	307	7.21e-05	2.98e-03	0.1250	2.22e-02	-4.41e-02	9.07e-02	7.07e-02	-6.61e-03	5.04e-01	1.84e-01	6.29e-03	3.30e-02	8.42e-01
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	210	2.08e-01	6.85e-01	0.1250	-5.74e-02	-1.00e-01	-1.43e-02	-2.35e-02	4.02e-02	1.51e-01	1.24e-02	7.21e-01	5.57e-01	3.15e-01
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	115	8.51e-01	9.88e-01	0.1250	-7.19e-02	-5.85e-02	-5.74e-02	-6.16e-02	2.11e-03	1.83e-01	2.78e-01	2.88e-01	2.54e-01	9.69e-01
CARTILAGE DEVELOPMENT	199	1.52e-01	6.13e-01	0.1250	-4.04e-02	-6.46e-02	-5.51e-02	-6.10e-02	-5.57e-02	3.26e-01	1.16e-01	1.80e-01	1.38e-01	1.76e-01
RESPONSE TO OSMOTIC STRESS	79	7.65e-01	9.75e-01	0.1250	2.20e-02	-2.53e-02	5.66e-02	4.76e-02	9.51e-02	7.35e-01	6.97e-01	3.84e-01	4.65e-01	1.44e-01
CONVERGENT EXTENSION INVOLVED IN GASTRULATION	9	9.32e-01	9.97e-01	0.1250	3.73e-02	3.70e-03	-3.49e-02	-4.82e-02	-1.03e-01	8.47e-01	9.85e-01	8.56e-01	8.02e-01	5.91e-01
NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	49	5.40e-01	9.13e-01	0.1250	7.19e-02	6.86e-02	5.71e-04	1.26e-02	7.47e-02	3.84e-01	4.06e-01	9.94e-01	8.78e-01	3.65e-01
REGULATION OF GTPASE ACTIVITY	288	2.08e-04	7.35e-03	0.1250	-4.65e-02	7.88e-03	-6.60e-02	-8.11e-02	4.95e-02	1.75e-01	8.18e-01	5.40e-02	1.78e-02	1.48e-01
REGULATION OF CELL CYCLE PHASE TRANSITION	439	1.58e-06	1.04e-04	0.1250	4.39e-02	-3.12e-02	8.79e-02	6.97e-02	-1.11e-02	1.15e-01	2.63e-01	1.59e-03	1.23e-02	6.91e-01
LYMPH VESSEL DEVELOPMENT	31	9.90e-01	9.98e-01	0.1250	-5.48e-02	-4.38e-02	-6.05e-02	-6.12e-02	-5.70e-02	5.97e-01	6.73e-01	5.60e-01	5.55e-01	5.83e-01
CAVEOLIN MEDIATED ENDOCYTOSIS	11	9.90e-01	9.98e-01	0.1250	5.58e-02	9.67e-02	1.05e-02	2.93e-02	-4.62e-02	7.49e-01	5.79e-01	9.52e-01	8.67e-01	7.91e-01
RESPONSE TO CATECHOLAMINE	86	2.55e-01	7.38e-01	0.1250	-3.10e-02	-3.65e-02	-3.96e-02	-5.23e-02	9.47e-02	6.19e-01	5.58e-01	5.26e-01	4.02e-01	1.29e-01
RENAL VESICLE DEVELOPMENT	18	9.78e-01	9.97e-01	0.1250	-7.44e-02	-5.07e-02	-3.57e-02	-4.82e-02	-6.20e-02	5.84e-01	7.09e-01	7.93e-01	7.23e-01	6.49e-01
REGULATION OF TAU PROTEIN KINASE ACTIVITY	13	9.37e-01	9.97e-01	0.1250	5.38e-02	1.91e-02	-2.45e-02	-1.87e-02	-1.07e-01	7.37e-01	9.05e-01	8.78e-01	9.07e-01	5.06e-01
REGULATION OF ALPHA BETA T CELL ACTIVATION	109	3.38e-01	8.08e-01	0.1250	3.61e-02	7.86e-02	4.32e-02	4.67e-02	6.35e-02	5.15e-01	1.56e-01	4.36e-01	3.99e-01	2.52e-01
POTASSIUM ION HOMEOSTASIS	34	8.41e-01	9.85e-01	0.1250	3.50e-02	1.10e-01	-1.13e-02	-1.50e-02	-4.36e-02	7.24e-01	2.68e-01	9.09e-01	8.80e-01	6.60e-01
BRADYKININ CATABOLIC PROCESS	7	9.58e-01	9.97e-01	0.1250	-9.11e-02	1.97e-02	-4.29e-02	-6.37e-02	3.09e-02	6.76e-01	9.28e-01	8.44e-01	7.70e-01	8.88e-01
CERAMIDE BIOSYNTHETIC PROCESS	68	5.79e-01	9.27e-01	0.1250	1.39e-02	-7.86e-02	5.54e-02	4.41e-02	6.42e-02	8.43e-01	2.62e-01	4.29e-01	5.29e-01	3.60e-01
REGULATION OF RECEPTOR BINDING	17	8.87e-01	9.91e-01	0.1250	-5.54e-02	-8.14e-02	4.87e-02	2.12e-02	5.46e-02	6.92e-01	5.61e-01	7.28e-01	8.80e-01	6.97e-01
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS	29	8.90e-01	9.91e-01	0.1250	-4.27e-02	-9.86e-02	-4.76e-03	2.22e-03	6.27e-02	6.91e-01	3.58e-01	9.65e-01	9.84e-01	5.59e-01
NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION	11	9.78e-01	9.97e-01	0.1240	-3.63e-02	-1.15e-01	-3.23e-03	-5.33e-03	-2.88e-02	8.35e-01	5.08e-01	9.85e-01	9.76e-01	8.69e-01
ALDITOL METABOLIC PROCESS	21	9.95e-01	9.99e-01	0.1240	7.65e-02	5.98e-02	5.16e-02	5.79e-02	-7.85e-03	5.44e-01	6.35e-01	6.82e-01	6.46e-01	9.50e-01
NEUROTRANSMITTER METABOLIC PROCESS	25	5.29e-01	9.07e-01	0.1240	1.06e-01	6.08e-02	-1.91e-02	-1.04e-02	-4.51e-03	3.57e-01	5.99e-01	8.69e-01	9.28e-01	9.69e-01
REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	106	1.11e-01	5.34e-01	0.1240	-3.55e-02	-4.38e-02	-6.05e-02	-4.66e-02	8.05e-02	5.28e-01	4.35e-01	2.82e-01	4.07e-01	1.52e-01
REGULATION OF SYNAPTIC VESICLE PRIMING	7	9.63e-01	9.97e-01	0.1240	-2.73e-03	-2.17e-02	4.19e-02	1.95e-02	-1.13e-01	9.90e-01	9.21e-01	8.48e-01	9.29e-01	6.03e-01
POSITIVE REGULATION OF LIPID LOCALIZATION	111	5.50e-01	9.15e-01	0.1240	-6.52e-02	-5.05e-02	-6.97e-02	-5.98e-02	1.48e-02	2.35e-01	3.58e-01	2.04e-01	2.76e-01	7.88e-01
CELLULAR RESPONSE TO ETHER	6	9.95e-01	9.99e-01	0.1240	-1.54e-02	-4.40e-02	6.79e-02	6.90e-02	6.26e-02	9.48e-01	8.52e-01	7.73e-01	7.70e-01	7.91e-01
POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	35	2.65e-01	7.47e-01	0.1240	2.30e-02	-8.97e-02	-2.68e-02	-3.07e-02	7.22e-02	8.14e-01	3.58e-01	7.84e-01	7.54e-01	4.59e-01
CELL DIFFERENTIATION IN HINDBRAIN	21	9.64e-01	9.97e-01	0.1240	-5.01e-02	-8.87e-02	3.18e-03	-1.36e-02	6.99e-02	6.91e-01	4.82e-01	9.80e-01	9.14e-01	5.79e-01
NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS	26	9.16e-01	9.94e-01	0.1240	-4.06e-02	-7.20e-02	-3.91e-02	-5.15e-02	-6.66e-02	7.20e-01	5.25e-01	7.30e-01	6.50e-01	5.57e-01
REGULATION OF TORC2 SIGNALING	6	9.53e-01	9.97e-01	0.1240	8.18e-02	-5.83e-02	5.22e-02	4.38e-02	-2.66e-02	7.29e-01	8.05e-01	8.25e-01	8.53e-01	9.10e-01
REGULATION OF ENDOCYTIC RECYCLING	20	9.63e-01	9.97e-01	0.1240	6.58e-02	1.02e-01	-7.14e-04	1.67e-02	-1.85e-02	6.10e-01	4.28e-01	9.96e-01	8.97e-01	8.86e-01
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS	11	8.54e-01	9.88e-01	0.1240	-6.92e-02	-9.44e-03	2.05e-02	3.01e-03	-1.01e-01	6.91e-01	9.57e-01	9.06e-01	9.86e-01	5.64e-01
CHONDROCYTE DEVELOPMENT	32	2.54e-01	7.37e-01	0.1240	5.54e-02	-8.46e-02	2.57e-02	1.02e-02	6.66e-02	5.88e-01	4.08e-01	8.01e-01	9.21e-01	5.14e-01
REGULATION OF NEURON PROJECTION ARBORIZATION	14	9.62e-01	9.97e-01	0.1240	-5.09e-02	-4.71e-02	-4.90e-02	-6.85e-02	5.94e-02	7.42e-01	7.60e-01	7.51e-01	6.57e-01	7.01e-01
MACROAUTOPHAGY	317	6.13e-05	2.62e-03	0.1240	3.31e-02	-7.80e-02	6.90e-02	5.72e-02	1.40e-02	3.11e-01	1.69e-02	3.47e-02	7.97e-02	6.69e-01
SERTOLI CELL DEVELOPMENT	12	7.57e-01	9.75e-01	0.1240	8.66e-02	5.81e-02	5.73e-02	2.20e-02	-2.78e-02	6.04e-01	7.27e-01	7.31e-01	8.95e-01	8.67e-01
APPENDAGE DEVELOPMENT	177	3.14e-05	1.51e-03	0.1240	-4.59e-03	-1.20e-01	8.70e-03	-1.57e-02	2.35e-02	9.16e-01	5.70e-03	8.42e-01	7.18e-01	5.90e-01
EYE MORPHOGENESIS	159	1.16e-01	5.45e-01	0.1240	-4.02e-02	-4.72e-02	-5.14e-02	-4.81e-02	8.11e-02	3.82e-01	3.04e-01	2.64e-01	2.95e-01	7.74e-02
REGULATION OF VASOCONSTRICTION	61	6.49e-01	9.51e-01	0.1240	1.46e-02	2.81e-02	-5.45e-02	-5.38e-02	-9.22e-02	8.43e-01	7.04e-01	4.61e-01	4.67e-01	2.13e-01
NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY	69	6.36e-01	9.48e-01	0.1240	-4.93e-02	1.36e-02	-7.86e-02	-7.70e-02	2.56e-02	4.79e-01	8.45e-01	2.59e-01	2.69e-01	7.13e-01
CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	70	9.00e-01	9.94e-01	0.1240	-6.19e-02	-7.64e-02	-4.96e-02	-5.27e-02	2.11e-02	3.71e-01	2.69e-01	4.73e-01	4.46e-01	7.60e-01
POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	28	2.01e-01	6.81e-01	0.1240	-1.21e-01	-7.73e-03	1.04e-03	-1.83e-02	-1.97e-02	2.69e-01	9.44e-01	9.92e-01	8.67e-01	8.57e-01
NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	33	5.30e-01	9.07e-01	0.1240	-7.18e-02	-4.15e-02	3.01e-02	5.88e-03	8.67e-02	4.75e-01	6.80e-01	7.65e-01	9.53e-01	3.89e-01
MESENCHYMAL CELL DIFFERENTIATION	256	8.15e-03	1.13e-01	0.1240	-2.81e-02	-1.01e-01	2.93e-02	1.07e-02	5.86e-02	4.38e-01	5.54e-03	4.20e-01	7.68e-01	1.07e-01
MAST CELL CHEMOTAXIS	10	9.75e-01	9.97e-01	0.1240	3.21e-02	7.59e-02	-5.08e-02	-5.73e-02	-5.16e-02	8.60e-01	6.78e-01	7.81e-01	7.54e-01	7.77e-01
INFLAMMATORY RESPONSE	851	7.26e-04	1.91e-02	0.1240	-5.92e-02	-3.75e-02	-7.35e-02	-6.96e-02	1.22e-02	3.34e-03	6.30e-02	2.71e-04	5.66e-04	5.45e-01
PROTEIN LOCALIZATION TO CELL SURFACE	65	9.04e-01	9.94e-01	0.1240	-6.31e-02	-8.49e-02	-4.46e-02	-4.49e-02	8.88e-03	3.79e-01	2.36e-01	5.34e-01	5.31e-01	9.02e-01
CARDIAC VENTRICLE DEVELOPMENT	127	1.11e-01	5.34e-01	0.1240	-1.06e-02	-1.02e-01	4.29e-02	2.58e-02	4.75e-02	8.36e-01	4.72e-02	4.03e-01	6.15e-01	3.55e-01
PURINE CONTAINING COMPOUND SALVAGE	14	8.38e-01	9.85e-01	0.1240	2.86e-02	-6.73e-02	-6.15e-03	-4.45e-03	-9.93e-02	8.53e-01	6.63e-01	9.68e-01	9.77e-01	5.20e-01
EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION	312	4.15e-03	7.09e-02	0.1240	-3.96e-02	3.69e-02	-7.83e-02	-7.79e-02	1.11e-02	2.29e-01	2.62e-01	1.73e-02	1.79e-02	7.36e-01
RHYTHMIC PROCESS	287	2.41e-02	2.30e-01	0.1230	-5.42e-02	-9.62e-02	-2.87e-02	-4.39e-02	1.71e-02	1.14e-01	5.03e-03	4.03e-01	2.00e-01	6.19e-01
EMBRYONIC SKELETAL JOINT DEVELOPMENT	15	8.14e-01	9.82e-01	0.1230	3.11e-02	-1.11e-01	2.97e-02	3.22e-02	6.70e-03	8.35e-01	4.57e-01	8.42e-01	8.29e-01	9.64e-01
FATTY ACID BETA OXIDATION	74	4.11e-01	8.53e-01	0.1230	-2.21e-02	-3.40e-02	-3.04e-02	-4.28e-02	-1.04e-01	7.43e-01	6.13e-01	6.52e-01	5.24e-01	1.22e-01
VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	27	7.44e-01	9.74e-01	0.1230	-3.07e-02	4.86e-02	-4.99e-02	-5.14e-02	8.23e-02	7.82e-01	6.62e-01	6.54e-01	6.44e-01	4.59e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN	38	8.27e-01	9.83e-01	0.1230	-2.31e-02	7.32e-02	-6.36e-02	-6.25e-02	-3.69e-02	8.05e-01	4.35e-01	4.97e-01	5.05e-01	6.94e-01
POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION	21	9.01e-01	9.94e-01	0.1230	-5.04e-02	-2.86e-02	-6.13e-02	-8.41e-02	-3.17e-02	6.90e-01	8.21e-01	6.27e-01	5.05e-01	8.01e-01
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	134	3.57e-01	8.22e-01	0.1230	1.02e-02	-6.44e-02	5.32e-02	4.34e-02	7.88e-02	8.38e-01	1.98e-01	2.88e-01	3.86e-01	1.15e-01
AORTA DEVELOPMENT	65	2.84e-01	7.62e-01	0.1230	8.95e-02	-9.92e-03	4.91e-02	4.74e-02	4.91e-02	2.12e-01	8.90e-01	4.94e-01	5.09e-01	4.94e-01
AROMATIC AMINO ACID TRANSPORT	9	9.67e-01	9.97e-01	0.1230	9.89e-03	7.84e-02	5.92e-02	5.59e-02	4.78e-02	9.59e-01	6.84e-01	7.59e-01	7.71e-01	8.04e-01
REGULATION OF INCLUSION BODY ASSEMBLY	17	5.88e-01	9.30e-01	0.1230	-2.67e-02	-6.54e-02	-5.71e-02	-1.75e-02	-8.12e-02	8.49e-01	6.41e-01	6.84e-01	9.00e-01	5.62e-01
VASCULAR ENDOTHELIAL CELL PROLIFERATION	49	3.92e-01	8.41e-01	0.1230	9.95e-04	8.47e-02	-3.32e-02	-3.36e-02	7.58e-02	9.90e-01	3.05e-01	6.88e-01	6.84e-01	3.59e-01
INORGANIC ANION TRANSMEMBRANE TRANSPORT	125	2.41e-02	2.30e-01	0.1230	-4.50e-02	3.66e-02	-8.70e-02	-6.39e-02	1.01e-02	3.85e-01	4.79e-01	9.30e-02	2.17e-01	8.45e-01
POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION	13	9.24e-01	9.95e-01	0.1230	4.10e-03	6.23e-02	4.44e-02	4.45e-02	-8.52e-02	9.80e-01	6.97e-01	7.82e-01	7.81e-01	5.95e-01
IMPORT INTO NUCLEUS	163	9.50e-02	4.92e-01	0.1230	4.03e-02	-2.73e-02	7.96e-02	7.55e-02	-2.66e-02	3.74e-01	5.48e-01	7.96e-02	9.60e-02	5.58e-01
POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	26	8.09e-01	9.82e-01	0.1230	-1.41e-02	-6.62e-02	7.89e-02	5.51e-02	3.56e-02	9.01e-01	5.59e-01	4.86e-01	6.27e-01	7.53e-01
GLYCOSYLATION	215	6.11e-02	3.96e-01	0.1230	-4.37e-02	-1.08e-01	-1.24e-02	-2.39e-02	2.90e-02	2.70e-01	6.41e-03	7.55e-01	5.46e-01	4.63e-01
REGULATION OF INFLAMMATORY RESPONSE	410	6.82e-02	4.19e-01	0.1230	-5.82e-02	-5.53e-02	-6.37e-02	-6.30e-02	2.45e-02	4.30e-02	5.45e-02	2.70e-02	2.85e-02	3.95e-01
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION	777	6.15e-08	5.58e-06	0.1230	2.69e-02	-5.47e-02	7.96e-02	6.74e-02	2.15e-02	2.02e-01	9.45e-03	1.60e-04	1.39e-03	3.07e-01
AXON EXTENSION	111	2.19e-01	7.00e-01	0.1230	2.25e-02	8.60e-02	-5.17e-02	-5.36e-02	-4.01e-02	6.82e-01	1.18e-01	3.47e-01	3.29e-01	4.65e-01
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	6	8.69e-01	9.88e-01	0.1230	-3.53e-02	-2.61e-02	1.36e-02	-3.94e-02	1.07e-01	8.81e-01	9.12e-01	9.54e-01	8.67e-01	6.51e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	14	9.73e-01	9.97e-01	0.1230	-7.99e-02	-7.44e-02	-1.31e-02	-1.69e-02	-5.14e-02	6.05e-01	6.30e-01	9.32e-01	9.13e-01	7.39e-01
FOLIC ACID TRANSPORT	10	8.21e-01	9.83e-01	0.1230	7.79e-02	-2.45e-02	3.79e-03	3.22e-02	8.54e-02	6.70e-01	8.93e-01	9.83e-01	8.60e-01	6.40e-01
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	67	5.98e-01	9.33e-01	0.1230	-5.54e-02	-4.39e-02	-6.49e-02	-5.39e-02	5.40e-02	4.33e-01	5.34e-01	3.59e-01	4.46e-01	4.45e-01
TRANSPORT OF VIRUS	21	9.01e-01	9.94e-01	0.1230	4.71e-02	3.47e-02	6.73e-02	5.23e-02	-6.58e-02	7.09e-01	7.83e-01	5.93e-01	6.78e-01	6.02e-01
RESPONSE TO LAMINAR FLUID SHEAR STRESS	14	9.92e-01	9.99e-01	0.1220	8.54e-02	5.71e-02	3.97e-02	5.19e-02	1.26e-02	5.80e-01	7.11e-01	7.97e-01	7.36e-01	9.35e-01
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION	32	4.90e-01	8.93e-01	0.1220	7.52e-02	7.52e-02	-2.19e-02	-2.68e-02	4.98e-02	4.61e-01	4.61e-01	8.30e-01	7.93e-01	6.26e-01
INSULIN METABOLIC PROCESS	16	9.47e-01	9.97e-01	0.1220	-2.01e-02	-9.73e-02	2.53e-03	-1.36e-02	7.01e-02	8.89e-01	5.00e-01	9.86e-01	9.25e-01	6.28e-01
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	45	4.86e-01	8.92e-01	0.1220	-9.88e-03	-9.84e-02	-2.75e-02	-2.74e-02	6.04e-02	9.09e-01	2.53e-01	7.49e-01	7.50e-01	4.83e-01
ENDOTHELIUM DEVELOPMENT	143	2.86e-01	7.65e-01	0.1220	3.37e-02	-5.07e-02	5.48e-02	5.53e-02	7.16e-02	4.86e-01	2.95e-01	2.58e-01	2.54e-01	1.39e-01
REGULATION OF SALIVA SECRETION	7	9.22e-01	9.95e-01	0.1220	1.85e-02	7.40e-02	-1.58e-02	-4.43e-02	8.28e-02	9.33e-01	7.35e-01	9.42e-01	8.39e-01	7.04e-01
REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT	5	9.98e-01	1.00e+00	0.1220	2.76e-02	1.01e-02	8.91e-02	7.78e-02	-5.71e-03	9.15e-01	9.69e-01	7.30e-01	7.63e-01	9.82e-01
REGULATION OF CELL SUBSTRATE ADHESION	213	1.87e-01	6.58e-01	0.1220	-5.45e-02	-5.37e-02	-5.91e-02	-6.96e-02	2.60e-02	1.70e-01	1.77e-01	1.37e-01	8.00e-02	5.13e-01
REGULATION OF MUSCLE ORGAN DEVELOPMENT	23	8.23e-01	9.83e-01	0.1220	3.86e-02	2.17e-02	-3.60e-02	-4.04e-02	-9.98e-02	7.49e-01	8.57e-01	7.65e-01	7.37e-01	4.07e-01
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	79	3.96e-01	8.45e-01	0.1220	-3.11e-02	-4.85e-02	-6.48e-02	-7.05e-02	4.85e-02	6.33e-01	4.56e-01	3.19e-01	2.79e-01	4.56e-01
PHAGOSOME MATURATION	28	3.01e-01	7.73e-01	0.1220	5.27e-02	-2.48e-03	-6.40e-02	-6.96e-02	-5.55e-02	6.29e-01	9.82e-01	5.58e-01	5.24e-01	6.11e-01
RESPONSE TO VIRUS	422	8.13e-02	4.56e-01	0.1220	3.93e-02	-1.84e-02	7.28e-02	6.93e-02	5.30e-02	1.66e-01	5.17e-01	1.03e-02	1.46e-02	6.16e-02
GRANULOCYTE CHEMOTAXIS	125	2.76e-03	5.23e-02	0.1220	4.54e-03	-2.09e-02	-6.00e-02	-4.07e-02	9.52e-02	9.30e-01	6.87e-01	2.46e-01	4.32e-01	6.59e-02
MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS	73	7.38e-01	9.73e-01	0.1220	6.35e-02	7.33e-02	4.26e-02	5.91e-02	7.95e-03	3.48e-01	2.79e-01	5.30e-01	3.82e-01	9.06e-01
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE	151	7.10e-03	1.04e-01	0.1220	4.15e-02	-6.88e-02	4.71e-02	3.11e-02	7.16e-02	3.78e-01	1.45e-01	3.18e-01	5.09e-01	1.29e-01
CEREBELLAR GRANULAR LAYER MORPHOGENESIS	8	9.94e-01	9.99e-01	0.1220	-5.27e-03	5.08e-02	-8.05e-02	-7.22e-02	-2.12e-02	9.79e-01	8.03e-01	6.93e-01	7.24e-01	9.17e-01
POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW	6	5.52e-01	9.16e-01	0.1210	-8.93e-02	-5.54e-03	5.20e-02	-1.96e-02	-6.05e-02	7.05e-01	9.81e-01	8.25e-01	9.34e-01	7.97e-01
REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT	8	9.99e-01	1.00e+00	0.1210	-6.88e-02	-8.33e-02	-3.00e-02	-3.86e-02	2.60e-02	7.36e-01	6.83e-01	8.83e-01	8.50e-01	8.98e-01
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY	5	8.80e-01	9.89e-01	0.1210	-1.40e-02	-9.78e-02	-1.52e-02	-6.50e-02	2.25e-02	9.57e-01	7.05e-01	9.53e-01	8.01e-01	9.30e-01
DE NOVO AMP BIOSYNTHETIC PROCESS	8	7.67e-01	9.75e-01	0.1210	-3.87e-02	5.19e-02	-1.32e-02	2.76e-02	-9.79e-02	8.50e-01	7.99e-01	9.48e-01	8.93e-01	6.32e-01
RECEPTOR INTERNALIZATION	123	4.06e-01	8.50e-01	0.1210	-5.45e-02	-7.19e-02	-9.04e-03	-2.31e-02	7.72e-02	2.97e-01	1.69e-01	8.63e-01	6.58e-01	1.39e-01
CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS	122	4.01e-01	8.46e-01	0.1210	-4.88e-02	-3.86e-02	-6.72e-02	-7.88e-02	1.04e-02	3.52e-01	4.62e-01	2.00e-01	1.33e-01	8.43e-01
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE	24	1.08e-02	1.35e-01	0.1210	-8.89e-02	6.21e-02	-4.46e-02	8.70e-03	2.96e-02	4.51e-01	5.98e-01	7.05e-01	9.41e-01	8.02e-01
REGULATION OF PHOSPHOLIPASE ACTIVITY	58	8.80e-01	9.89e-01	0.1210	-6.28e-02	-5.53e-02	-5.26e-02	-5.11e-02	4.80e-02	4.08e-01	4.66e-01	4.88e-01	5.01e-01	5.27e-01
GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	75	7.53e-01	9.75e-01	0.1210	3.13e-02	-4.54e-02	5.90e-02	5.72e-02	6.99e-02	6.39e-01	4.97e-01	3.77e-01	3.91e-01	2.95e-01
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	23	6.15e-01	9.39e-01	0.1210	8.23e-03	-8.25e-02	-4.48e-02	-3.57e-02	6.70e-02	9.46e-01	4.93e-01	7.10e-01	7.67e-01	5.78e-01
PATTERN SPECIFICATION PROCESS	457	4.26e-15	1.03e-12	0.1210	4.81e-02	-8.68e-02	5.43e-02	3.23e-02	2.68e-02	7.77e-02	1.46e-03	4.65e-02	2.36e-01	3.26e-01
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE	220	1.99e-02	2.03e-01	0.1210	2.23e-02	1.68e-02	1.50e-02	2.37e-02	1.14e-01	5.68e-01	6.67e-01	7.02e-01	5.44e-01	3.56e-03
CELLULAR RESPONSE TO OXIDATIVE STRESS	248	7.96e-03	1.11e-01	0.1210	1.46e-02	-7.58e-02	6.47e-02	4.86e-02	4.51e-02	6.93e-01	3.97e-02	7.92e-02	1.87e-01	2.22e-01
METANEPHRIC EPITHELIUM DEVELOPMENT	29	8.43e-01	9.86e-01	0.1210	-1.54e-02	8.80e-03	-8.42e-02	-8.16e-02	2.18e-02	8.86e-01	9.35e-01	4.33e-01	4.47e-01	8.39e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	84	1.97e-01	6.75e-01	0.1210	-3.35e-02	-2.95e-02	-6.09e-02	-7.77e-02	5.29e-02	5.95e-01	6.40e-01	3.35e-01	2.18e-01	4.02e-01
NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	15	9.95e-01	9.99e-01	0.1200	-5.37e-02	-4.15e-02	-6.42e-02	-7.45e-02	-1.56e-02	7.19e-01	7.81e-01	6.67e-01	6.17e-01	9.16e-01
CALCIUM MEDIATED SIGNALING	203	2.31e-02	2.23e-01	0.1200	4.86e-02	7.09e-02	1.19e-02	2.61e-02	7.94e-02	2.32e-01	8.15e-02	7.69e-01	5.22e-01	5.13e-02
CARBOHYDRATE DERIVATIVE TRANSPORT	83	7.31e-01	9.71e-01	0.1200	-6.88e-02	-5.87e-02	-5.84e-02	-5.01e-02	2.01e-02	2.78e-01	3.55e-01	3.58e-01	4.30e-01	7.52e-01
ACIDIC AMINO ACID TRANSPORT	65	6.71e-01	9.58e-01	0.1200	3.86e-02	2.45e-02	2.29e-02	2.71e-02	1.06e-01	5.90e-01	7.32e-01	7.50e-01	7.05e-01	1.41e-01
ENDOTHELIAL CELL DEVELOPMENT	65	6.52e-01	9.52e-01	0.1200	-2.76e-02	-1.07e-01	1.30e-02	9.59e-03	4.49e-02	7.00e-01	1.36e-01	8.57e-01	8.94e-01	5.31e-01
C21 STEROID HORMONE METABOLIC PROCESS	36	8.70e-02	4.68e-01	0.1200	-6.25e-02	9.82e-02	-2.78e-02	-1.13e-02	-3.85e-03	5.16e-01	3.08e-01	7.73e-01	9.07e-01	9.68e-01
POSITIVE REGULATION OF PROTEIN SECRETION	142	4.03e-01	8.48e-01	0.1200	-4.68e-02	-7.73e-02	-5.75e-02	-5.42e-02	4.81e-03	3.36e-01	1.12e-01	2.37e-01	2.65e-01	9.21e-01
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	93	8.71e-02	4.68e-01	0.1200	5.87e-02	1.03e-02	5.46e-03	2.05e-02	1.02e-01	3.28e-01	8.64e-01	9.27e-01	7.32e-01	8.85e-02
SUBSTRATE ADHESION DEPENDENT CELL SPREADING	99	4.61e-01	8.80e-01	0.1200	-3.51e-02	-8.35e-02	-2.67e-02	-2.70e-02	6.91e-02	5.46e-01	1.51e-01	6.46e-01	6.43e-01	2.35e-01
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS	217	1.57e-05	8.36e-04	0.1200	-3.36e-02	-1.03e-01	-1.91e-02	-4.86e-02	-7.46e-03	3.93e-01	9.25e-03	6.28e-01	2.17e-01	8.50e-01
CEREBRAL CORTEX DEVELOPMENT	121	7.70e-03	1.09e-01	0.1200	-5.94e-04	-1.04e-01	4.45e-02	1.60e-02	3.77e-02	9.91e-01	4.87e-02	3.98e-01	7.61e-01	4.74e-01
VESICLE MEDIATED CHOLESTEROL TRANSPORT	9	9.89e-01	9.98e-01	0.1200	-8.98e-04	2.43e-02	-7.24e-02	-7.83e-02	-4.95e-02	9.96e-01	9.00e-01	7.07e-01	6.84e-01	7.97e-01
ECTOPIC GERM CELL PROGRAMMED CELL DEATH	17	8.17e-01	9.83e-01	0.1200	2.19e-02	-1.72e-02	-7.39e-02	-7.24e-02	-5.38e-02	8.76e-01	9.02e-01	5.98e-01	6.06e-01	7.01e-01
PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS	32	9.17e-01	9.95e-01	0.1200	-3.11e-02	-1.03e-01	1.95e-02	1.53e-02	4.66e-02	7.61e-01	3.13e-01	8.49e-01	8.81e-01	6.48e-01
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY	167	4.03e-01	8.48e-01	0.1200	2.58e-02	-3.16e-02	6.11e-02	5.14e-02	7.94e-02	5.65e-01	4.81e-01	1.73e-01	2.52e-01	7.66e-02
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	26	8.49e-01	9.87e-01	0.1200	6.48e-03	4.64e-02	3.13e-03	-4.29e-04	1.10e-01	9.54e-01	6.82e-01	9.78e-01	9.97e-01	3.31e-01
AMINO ACID TRANSPORT	142	2.67e-01	7.48e-01	0.1200	7.45e-02	8.87e-02	8.77e-03	1.78e-02	2.26e-02	1.25e-01	6.81e-02	8.57e-01	7.14e-01	6.42e-01
NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	22	5.80e-01	9.27e-01	0.1200	1.97e-02	9.40e-03	9.50e-02	5.60e-02	4.07e-02	8.73e-01	9.39e-01	4.41e-01	6.50e-01	7.41e-01
PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	46	8.35e-01	9.85e-01	0.1200	-4.28e-02	-5.09e-02	1.32e-02	4.63e-03	9.83e-02	6.16e-01	5.50e-01	8.77e-01	9.57e-01	2.49e-01
REGULATION OF PROGRAMMED NECROTIC CELL DEATH	36	8.79e-01	9.89e-01	0.1190	-1.30e-02	2.13e-02	-1.66e-02	-1.81e-02	-1.14e-01	8.92e-01	8.25e-01	8.63e-01	8.51e-01	2.36e-01
TOLL LIKE RECEPTOR SIGNALING PATHWAY	67	7.63e-01	9.75e-01	0.1190	-5.81e-02	-5.41e-02	-3.09e-02	-4.10e-02	7.31e-02	4.11e-01	4.43e-01	6.62e-01	5.62e-01	3.01e-01
IRON ION TRANSMEMBRANE TRANSPORT	27	8.02e-01	9.82e-01	0.1190	9.58e-02	6.46e-02	5.37e-03	2.45e-02	-1.71e-02	3.89e-01	5.61e-01	9.61e-01	8.26e-01	8.78e-01
SODIUM ION TRANSMEMBRANE TRANSPORT	169	1.12e-02	1.39e-01	0.1190	1.77e-02	1.01e-01	-4.01e-02	-2.89e-02	3.50e-02	6.92e-01	2.28e-02	3.69e-01	5.17e-01	4.33e-01
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	159	4.08e-01	8.51e-01	0.1190	-5.38e-02	-8.75e-02	-2.26e-02	-3.31e-02	4.60e-02	2.42e-01	5.69e-02	6.22e-01	4.72e-01	3.17e-01
DIGESTIVE TRACT MORPHOGENESIS	48	4.62e-01	8.80e-01	0.1190	-4.12e-02	-1.06e-01	-9.95e-03	-3.46e-02	-1.12e-02	6.22e-01	2.06e-01	9.05e-01	6.78e-01	8.93e-01
REGULATION OF AMINO ACID TRANSPORT	41	8.63e-01	9.88e-01	0.1190	5.98e-02	2.01e-02	4.24e-02	3.54e-02	8.50e-02	5.08e-01	8.23e-01	6.39e-01	6.95e-01	3.46e-01
POSITIVE REGULATION OF CALCIUM ION TRANSPORT	113	5.41e-02	3.65e-01	0.1190	1.10e-03	7.07e-02	-2.42e-02	-2.41e-02	9.00e-02	9.84e-01	1.94e-01	6.57e-01	6.58e-01	9.85e-02
REGULATION OF CIRCADIAN RHYTHM	110	4.50e-01	8.76e-01	0.1190	-3.82e-02	-6.80e-02	-9.97e-03	-2.15e-02	8.71e-02	4.89e-01	2.18e-01	8.57e-01	6.97e-01	1.14e-01
DETECTION OF MECHANICAL STIMULUS	53	1.74e-01	6.46e-01	0.1190	-1.46e-02	1.05e-01	-2.93e-02	-1.55e-02	4.37e-02	8.54e-01	1.87e-01	7.12e-01	8.45e-01	5.82e-01
NEGATIVE REGULATION OF OSSIFICATION	37	7.67e-01	9.75e-01	0.1190	-2.36e-02	-7.99e-02	-4.37e-02	-4.79e-02	-5.56e-02	8.04e-01	4.00e-01	6.46e-01	6.14e-01	5.59e-01
REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	12	9.55e-01	9.97e-01	0.1190	-2.66e-02	-4.63e-03	6.01e-02	4.58e-02	8.80e-02	8.73e-01	9.78e-01	7.19e-01	7.83e-01	5.98e-01
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	1193	3.35e-23	2.56e-20	0.1190	5.39e-02	-6.14e-02	6.49e-02	5.03e-02	2.76e-02	1.70e-03	3.51e-04	1.59e-04	3.42e-03	1.09e-01
POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	185	4.70e-01	8.84e-01	0.1190	7.69e-02	2.96e-02	5.94e-02	6.19e-02	5.33e-03	7.12e-02	4.87e-01	1.64e-01	1.46e-01	9.00e-01
NEGATIVE REGULATION OF FIBRINOLYSIS	13	9.87e-01	9.98e-01	0.1190	6.34e-02	-1.87e-02	6.36e-02	5.62e-02	5.10e-02	6.92e-01	9.07e-01	6.91e-01	7.26e-01	7.50e-01
PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	221	1.25e-01	5.65e-01	0.1190	-3.79e-02	-6.94e-02	-8.38e-03	-1.75e-02	8.68e-02	3.31e-01	7.54e-02	8.30e-01	6.55e-01	2.62e-02
KERATINOCYTE PROLIFERATION	59	4.66e-01	8.83e-01	0.1190	2.95e-02	1.13e-01	1.64e-02	9.13e-03	-9.13e-03	6.95e-01	1.32e-01	8.28e-01	9.03e-01	9.03e-01
GLUCAN BIOSYNTHETIC PROCESS	44	5.68e-01	9.24e-01	0.1190	2.38e-02	-7.57e-02	4.97e-02	3.07e-02	6.65e-02	7.85e-01	3.85e-01	5.69e-01	7.25e-01	4.46e-01
MYELOID CELL HOMEOSTASIS	166	6.13e-03	9.37e-02	0.1190	4.72e-02	-6.92e-02	4.20e-02	3.55e-02	6.39e-02	2.94e-01	1.24e-01	3.51e-01	4.30e-01	1.55e-01
GENITALIA DEVELOPMENT	46	5.82e-01	9.28e-01	0.1190	-2.30e-02	-5.34e-02	-4.27e-02	-5.87e-02	-7.39e-02	7.87e-01	5.31e-01	6.17e-01	4.91e-01	3.86e-01
SPHINGOLIPID CATABOLIC PROCESS	32	7.39e-01	9.73e-01	0.1190	-1.58e-02	-5.74e-02	-7.62e-02	-6.70e-02	-1.62e-02	8.77e-01	5.74e-01	4.55e-01	5.12e-01	8.74e-01
NEGATIVE REGULATION OF AXONOGENESIS	60	9.14e-02	4.81e-01	0.1190	5.13e-02	6.22e-02	-4.86e-03	-2.52e-02	8.33e-02	4.92e-01	4.04e-01	9.48e-01	7.36e-01	2.65e-01
RIBOSE PHOSPHATE METABOLIC PROCESS	361	3.46e-03	6.14e-02	0.1190	3.94e-02	-4.51e-02	7.32e-02	7.13e-02	8.08e-03	1.99e-01	1.41e-01	1.69e-02	2.00e-02	7.92e-01
ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE	41	4.79e-02	3.42e-01	0.1190	8.81e-02	3.91e-02	-5.53e-02	-2.19e-02	3.52e-02	3.29e-01	6.65e-01	5.40e-01	8.08e-01	6.96e-01
SOMITE DEVELOPMENT	82	1.38e-01	5.91e-01	0.1190	5.63e-02	-5.41e-02	6.61e-02	4.92e-02	3.41e-02	3.78e-01	3.97e-01	3.01e-01	4.41e-01	5.93e-01
MUSCLE ATROPHY	10	9.94e-01	9.99e-01	0.1190	8.78e-02	3.63e-02	4.60e-02	4.90e-02	-2.26e-02	6.31e-01	8.42e-01	8.01e-01	7.88e-01	9.01e-01
VENTRICULAR SYSTEM DEVELOPMENT	32	7.81e-01	9.81e-01	0.1190	-2.10e-02	-9.13e-02	2.49e-02	1.56e-03	6.82e-02	8.37e-01	3.71e-01	8.07e-01	9.88e-01	5.04e-01
REGULATION OF MIRNA TRANSCRIPTION	69	1.08e-01	5.25e-01	0.1190	1.78e-02	-1.08e-01	2.12e-02	8.52e-03	3.84e-02	7.98e-01	1.20e-01	7.61e-01	9.03e-01	5.82e-01
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	185	3.67e-01	8.30e-01	0.1190	-6.16e-02	-6.84e-02	-2.65e-02	-3.17e-02	6.22e-02	1.48e-01	1.09e-01	5.34e-01	4.57e-01	1.45e-01
ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION	40	7.94e-01	9.81e-01	0.1180	2.43e-02	-4.48e-02	7.98e-02	7.04e-02	-9.77e-03	7.90e-01	6.24e-01	3.82e-01	4.41e-01	9.15e-01
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	23	8.66e-01	9.88e-01	0.1180	-1.53e-02	-1.42e-02	-8.29e-02	-7.41e-02	3.52e-02	8.99e-01	9.06e-01	4.91e-01	5.39e-01	7.70e-01
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION	58	5.12e-01	9.00e-01	0.1180	8.36e-02	5.32e-02	2.41e-02	2.00e-02	5.65e-02	2.71e-01	4.83e-01	7.51e-01	7.92e-01	4.57e-01
VESICLE ORGANIZATION	351	5.55e-04	1.56e-02	0.1180	1.85e-02	-8.31e-02	5.21e-02	4.34e-02	4.58e-02	5.51e-01	7.46e-03	9.34e-02	1.63e-01	1.40e-01
HEART TRABECULA MORPHOGENESIS	32	6.35e-01	9.48e-01	0.1180	-2.08e-02	-6.65e-02	1.13e-02	-7.53e-03	-9.43e-02	8.39e-01	5.15e-01	9.12e-01	9.41e-01	3.56e-01
ORGANIC CATION TRANSPORT	62	3.56e-01	8.22e-01	0.1180	4.07e-02	3.53e-02	-1.46e-02	-2.52e-02	-1.01e-01	5.80e-01	6.30e-01	8.42e-01	7.31e-01	1.70e-01
PROTEIN LOCALIZATION TO SYNAPSE	73	4.55e-01	8.78e-01	0.1180	3.10e-03	-8.21e-03	6.72e-02	4.66e-02	8.46e-02	9.64e-01	9.03e-01	3.21e-01	4.92e-01	2.11e-01
TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	183	3.79e-01	8.37e-01	0.1180	-6.30e-02	-5.30e-02	-4.30e-02	-4.96e-02	5.32e-02	1.42e-01	2.16e-01	3.15e-01	2.48e-01	2.15e-01
TELENCEPHALON DEVELOPMENT	268	3.27e-04	1.03e-02	0.1180	4.00e-03	-9.19e-02	4.82e-02	2.69e-02	4.91e-02	9.10e-01	9.62e-03	1.74e-01	4.49e-01	1.67e-01
NEGATIVE REGULATION OF PEPTIDE SECRETION	44	5.46e-01	9.15e-01	0.1180	8.30e-02	4.88e-02	9.11e-03	1.14e-02	6.65e-02	3.41e-01	5.75e-01	9.17e-01	8.96e-01	4.45e-01
PEPTIDYL LYSINE ACETYLATION	64	1.63e-01	6.28e-01	0.1180	4.87e-02	-6.11e-02	6.91e-02	4.57e-02	3.04e-02	5.00e-01	3.98e-01	3.39e-01	5.27e-01	6.74e-01
NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS	329	4.60e-01	8.80e-01	0.1180	-6.72e-02	-4.70e-02	-5.84e-02	-5.82e-02	-1.89e-02	3.60e-02	1.43e-01	6.85e-02	6.97e-02	5.56e-01
REGULATION OF MITOTIC CENTROSOME SEPARATION	9	7.98e-01	9.81e-01	0.1180	6.54e-02	-6.44e-02	-2.73e-03	-1.51e-02	7.22e-02	7.34e-01	7.38e-01	9.89e-01	9.37e-01	7.08e-01
OLIGOSACCHARIDE BIOSYNTHETIC PROCESS	29	6.98e-01	9.62e-01	0.1180	-6.63e-04	1.13e-02	-9.28e-02	-7.01e-02	-1.42e-02	9.95e-01	9.16e-01	3.87e-01	5.14e-01	8.95e-01
ICOSANOID METABOLIC PROCESS	118	1.89e-01	6.62e-01	0.1180	-4.54e-02	2.50e-02	-5.30e-02	-3.74e-02	-8.34e-02	3.94e-01	6.39e-01	3.20e-01	4.83e-01	1.18e-01
OLIGOSACCHARIDE CATABOLIC PROCESS	17	8.94e-01	9.93e-01	0.1180	-5.72e-02	4.08e-02	-5.34e-02	-6.16e-02	4.75e-02	6.83e-01	7.71e-01	7.03e-01	6.60e-01	7.34e-01
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	107	5.47e-01	9.15e-01	0.1180	-8.16e-02	-5.09e-02	-3.56e-02	-4.29e-02	3.85e-02	1.45e-01	3.63e-01	5.24e-01	4.44e-01	4.92e-01
POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY	31	8.07e-01	9.82e-01	0.1180	-3.50e-02	-1.11e-01	-1.50e-03	-1.91e-02	3.28e-03	7.36e-01	2.87e-01	9.88e-01	8.54e-01	9.75e-01
REGULATION OF GLIOGENESIS	106	2.04e-01	6.84e-01	0.1180	7.38e-03	-8.65e-02	4.08e-02	2.58e-02	6.28e-02	8.96e-01	1.24e-01	4.68e-01	6.46e-01	2.64e-01
PURINE RIBONUCLEOSIDE CATABOLIC PROCESS	6	9.73e-01	9.97e-01	0.1180	-6.17e-02	-5.43e-02	-6.13e-02	-3.20e-02	4.77e-02	7.93e-01	8.18e-01	7.95e-01	8.92e-01	8.40e-01
ONE CARBON METABOLIC PROCESS	37	6.45e-01	9.50e-01	0.1180	9.67e-02	1.90e-02	3.49e-02	4.55e-02	-2.85e-02	3.09e-01	8.41e-01	7.13e-01	6.32e-01	7.64e-01
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	272	2.33e-01	7.18e-01	0.1180	-7.03e-02	-2.86e-02	-6.04e-02	-6.46e-02	1.52e-02	4.60e-02	4.17e-01	8.66e-02	6.65e-02	6.65e-01
POSITIVE REGULATION OF SECRETION	305	5.34e-02	3.62e-01	0.1180	-4.46e-02	-8.94e-02	-3.39e-02	-3.82e-02	3.49e-02	1.81e-01	7.22e-03	3.08e-01	2.51e-01	2.94e-01
VESICLE CARGO LOADING	29	4.84e-01	8.91e-01	0.1170	-1.97e-02	-1.06e-01	-4.25e-02	-1.88e-02	-3.83e-03	8.55e-01	3.23e-01	6.92e-01	8.61e-01	9.72e-01
POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	17	4.26e-01	8.64e-01	0.1170	5.26e-02	-6.71e-02	4.15e-02	2.96e-03	6.92e-02	7.07e-01	6.32e-01	7.67e-01	9.83e-01	6.21e-01
VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS	47	5.99e-01	9.33e-01	0.1170	-5.48e-02	-9.12e-02	2.68e-02	1.63e-02	-3.85e-02	5.16e-01	2.79e-01	7.51e-01	8.46e-01	6.48e-01
NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	24	8.42e-01	9.85e-01	0.1170	1.48e-03	-2.92e-02	1.74e-02	2.56e-02	-1.09e-01	9.90e-01	8.04e-01	8.82e-01	8.28e-01	3.54e-01
HEART VALVE FORMATION	15	8.83e-01	9.91e-01	0.1170	9.51e-02	3.91e-02	5.32e-03	8.32e-03	-5.54e-02	5.24e-01	7.93e-01	9.72e-01	9.56e-01	7.10e-01
CARDIAC MUSCLE CELL CONTRACTION	72	6.95e-01	9.61e-01	0.1170	-4.19e-02	5.65e-03	-7.55e-02	-7.51e-02	2.43e-02	5.39e-01	9.34e-01	2.68e-01	2.70e-01	7.21e-01
NUCLEUS ORGANIZATION	142	6.06e-01	9.34e-01	0.1170	6.20e-02	9.30e-03	6.44e-02	7.16e-02	2.21e-02	2.02e-01	8.48e-01	1.85e-01	1.41e-01	6.49e-01
POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION	43	3.56e-01	8.22e-01	0.1170	2.27e-02	2.27e-02	8.43e-02	5.17e-02	5.37e-02	7.97e-01	7.97e-01	3.39e-01	5.58e-01	5.42e-01
REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	343	4.74e-05	2.12e-03	0.1170	3.08e-02	-4.37e-02	8.29e-02	6.29e-02	-2.94e-03	3.26e-01	1.65e-01	8.35e-03	4.53e-02	9.25e-01
APPENDAGE MORPHOGENESIS	142	4.05e-05	1.87e-03	0.1170	3.41e-03	-1.13e-01	-2.10e-03	-2.79e-02	6.30e-03	9.44e-01	1.97e-02	9.66e-01	5.67e-01	8.97e-01
BROWN FAT CELL DIFFERENTIATION	53	4.61e-02	3.35e-01	0.1170	8.95e-02	-5.75e-02	2.83e-02	3.87e-02	-3.14e-03	2.59e-01	4.69e-01	7.22e-01	6.26e-01	9.68e-01
NEUTRAL LIPID CATABOLIC PROCESS	37	8.63e-01	9.88e-01	0.1170	8.92e-03	7.34e-02	-3.15e-02	-1.54e-02	-8.31e-02	9.25e-01	4.40e-01	7.40e-01	8.71e-01	3.82e-01
PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	7	9.72e-01	9.97e-01	0.1170	-1.81e-02	-2.40e-02	7.26e-02	7.43e-02	-4.36e-02	9.34e-01	9.12e-01	7.40e-01	7.33e-01	8.42e-01
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	25	5.11e-01	9.00e-01	0.1170	5.07e-02	-3.45e-02	-2.39e-03	-1.24e-02	-9.83e-02	6.60e-01	7.65e-01	9.83e-01	9.15e-01	3.95e-01
NEURAL CREST CELL DIFFERENTIATION	93	1.52e-01	6.13e-01	0.1170	-5.29e-04	-5.67e-02	1.36e-03	-1.59e-02	1.01e-01	9.93e-01	3.45e-01	9.82e-01	7.91e-01	9.34e-02
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH	157	5.05e-01	8.99e-01	0.1160	-5.30e-02	-3.96e-02	-6.25e-02	-7.26e-02	-2.78e-03	2.52e-01	3.92e-01	1.76e-01	1.16e-01	9.52e-01
POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	16	7.73e-01	9.77e-01	0.1160	3.91e-02	-3.73e-02	-1.49e-02	-2.42e-02	9.92e-02	7.87e-01	7.96e-01	9.18e-01	8.67e-01	4.92e-01
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY	29	9.76e-01	9.97e-01	0.1160	-6.78e-02	-7.04e-02	-3.49e-02	-4.85e-02	2.12e-02	5.28e-01	5.12e-01	7.45e-01	6.51e-01	8.43e-01
NEUROINFLAMMATORY RESPONSE	82	6.40e-01	9.49e-01	0.1160	-5.92e-02	-4.30e-02	-6.15e-02	-5.23e-02	4.09e-02	3.54e-01	5.01e-01	3.36e-01	4.13e-01	5.22e-01
SERINE FAMILY AMINO ACID METABOLIC PROCESS	37	6.32e-01	9.47e-01	0.1160	-6.82e-03	-1.75e-02	7.75e-02	8.28e-02	1.77e-02	9.43e-01	8.54e-01	4.15e-01	3.84e-01	8.52e-01
GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS	34	4.42e-01	8.72e-01	0.1160	2.72e-02	-1.59e-02	6.92e-02	3.32e-02	8.15e-02	7.84e-01	8.73e-01	4.85e-01	7.38e-01	4.11e-01
REGULATION OF NCRNA TRANSCRIPTION	91	8.07e-02	4.55e-01	0.1160	4.75e-02	-7.60e-02	5.61e-02	4.61e-02	1.42e-02	4.34e-01	2.10e-01	3.55e-01	4.47e-01	8.15e-01
GMP METABOLIC PROCESS	25	8.53e-01	9.88e-01	0.1160	-5.14e-04	-3.51e-02	7.87e-02	7.50e-02	-2.14e-02	9.96e-01	7.62e-01	4.96e-01	5.16e-01	8.53e-01
VACUOLAR TRANSPORT	163	2.93e-01	7.69e-01	0.1160	-5.18e-02	-9.84e-02	-1.65e-02	-2.29e-02	-1.82e-02	2.54e-01	3.01e-02	7.17e-01	6.14e-01	6.89e-01
GLYCEROLIPID CATABOLIC PROCESS	64	4.20e-01	8.59e-01	0.1160	-2.81e-02	5.72e-02	-7.52e-02	-5.42e-02	-2.88e-02	6.97e-01	4.29e-01	2.98e-01	4.54e-01	6.90e-01
LYTIC VACUOLE ORGANIZATION	103	2.02e-01	6.82e-01	0.1160	3.34e-02	-2.80e-02	6.58e-02	6.08e-02	-5.95e-02	5.58e-01	6.24e-01	2.48e-01	2.86e-01	2.96e-01
NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS	27	6.53e-01	9.52e-01	0.1160	-3.38e-03	8.93e-02	1.94e-02	3.01e-02	-6.48e-02	9.76e-01	4.22e-01	8.62e-01	7.87e-01	5.60e-01
LEUKOCYTE MIGRATION	383	6.16e-04	1.66e-02	0.1160	-3.31e-02	-4.00e-02	-7.50e-02	-6.49e-02	2.95e-02	2.67e-01	1.79e-01	1.17e-02	2.93e-02	3.21e-01
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	55	8.36e-01	9.85e-01	0.1160	7.84e-03	4.56e-02	-5.79e-02	-5.56e-02	-6.93e-02	9.20e-01	5.58e-01	4.58e-01	4.75e-01	3.74e-01
POSTSYNAPTIC CYTOSKELETON ORGANIZATION	17	9.57e-01	9.97e-01	0.1160	8.80e-02	1.71e-02	4.39e-02	5.65e-02	1.51e-02	5.30e-01	9.03e-01	7.54e-01	6.87e-01	9.14e-01
PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	64	1.78e-01	6.48e-01	0.1160	-3.31e-02	-5.09e-02	7.81e-02	5.16e-02	3.04e-02	6.47e-01	4.81e-01	2.80e-01	4.75e-01	6.74e-01
PARAXIAL MESODERM MORPHOGENESIS	10	9.29e-01	9.95e-01	0.1160	-6.08e-02	-2.74e-03	-1.68e-02	-4.50e-02	-8.58e-02	7.39e-01	9.88e-01	9.27e-01	8.05e-01	6.38e-01
PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	20	8.38e-01	9.85e-01	0.1160	3.84e-02	-3.36e-02	6.15e-02	8.20e-02	-1.58e-02	7.66e-01	7.95e-01	6.34e-01	5.26e-01	9.03e-01
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION	100	1.39e-01	5.94e-01	0.1160	-2.38e-02	-7.10e-02	-6.65e-02	-5.15e-02	-2.57e-02	6.81e-01	2.20e-01	2.51e-01	3.74e-01	6.57e-01
MRNA TRANSCRIPTION	47	4.52e-01	8.76e-01	0.1150	2.82e-02	-5.99e-02	5.51e-02	4.53e-02	-6.21e-02	7.38e-01	4.77e-01	5.13e-01	5.91e-01	4.62e-01
INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION	45	7.20e-01	9.69e-01	0.1150	-5.13e-02	-3.78e-03	-5.85e-02	-5.11e-02	6.82e-02	5.52e-01	9.65e-01	4.97e-01	5.53e-01	4.29e-01
ASTROCYTE DIFFERENTIATION	84	5.53e-01	9.16e-01	0.1150	3.14e-02	-4.06e-02	3.78e-02	4.29e-02	8.61e-02	6.19e-01	5.20e-01	5.50e-01	4.97e-01	1.72e-01
REGULATION OF MYOBLAST DIFFERENTIATION	72	7.83e-01	9.81e-01	0.1150	-1.00e-02	-4.00e-02	3.99e-02	3.09e-02	9.52e-02	8.83e-01	5.57e-01	5.58e-01	6.50e-01	1.62e-01
REGULATION OF FEVER GENERATION	9	9.25e-01	9.95e-01	0.1150	-3.91e-02	-1.06e-01	-1.53e-02	1.09e-02	-1.26e-02	8.39e-01	5.81e-01	9.37e-01	9.55e-01	9.48e-01
IMP BIOSYNTHETIC PROCESS	10	9.86e-01	9.98e-01	0.1150	-4.65e-02	-1.04e-01	-5.19e-03	4.09e-03	1.57e-02	7.99e-01	5.68e-01	9.77e-01	9.82e-01	9.31e-01
NEUROTRANSMITTER TRANSPORT	198	4.01e-01	8.46e-01	0.1150	4.01e-02	3.31e-02	4.69e-02	4.33e-02	8.08e-02	3.31e-01	4.21e-01	2.55e-01	2.94e-01	5.00e-02
CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS	302	2.39e-01	7.24e-01	0.1150	-4.90e-02	-6.37e-02	-5.59e-02	-5.97e-02	-1.20e-02	1.43e-01	5.70e-02	9.46e-02	7.43e-02	7.19e-01
REGULATION OF APOPTOTIC SIGNALING PATHWAY	381	3.70e-03	6.43e-02	0.1150	1.41e-02	-7.12e-02	5.96e-02	5.08e-02	4.32e-02	6.37e-01	1.70e-02	4.56e-02	8.88e-02	1.48e-01
REGULATION OF SISTER CHROMATID COHESION	15	7.94e-01	9.81e-01	0.1150	1.11e-02	-1.11e-01	-2.27e-02	-1.84e-02	7.72e-04	9.41e-01	4.57e-01	8.79e-01	9.02e-01	9.96e-01
MACROPHAGE CHEMOTAXIS	41	5.50e-01	9.15e-01	0.1150	-1.70e-02	-4.78e-02	-7.00e-02	-4.73e-02	-5.95e-02	8.51e-01	5.96e-01	4.38e-01	6.00e-01	5.09e-01
GANGLIOSIDE METABOLIC PROCESS	28	9.87e-01	9.98e-01	0.1150	3.33e-02	-2.17e-02	6.34e-02	6.22e-02	6.15e-02	7.61e-01	8.42e-01	5.62e-01	5.69e-01	5.74e-01
RESPONSE TO ETHANOL	117	5.88e-01	9.29e-01	0.1150	-4.60e-02	-8.63e-02	-2.19e-02	-2.98e-02	4.80e-02	3.90e-01	1.07e-01	6.83e-01	5.78e-01	3.70e-01
STRIATED MUSCLE CELL DIFFERENTIATION	298	4.18e-01	8.58e-01	0.1150	-5.03e-02	-1.39e-02	-6.98e-02	-7.13e-02	-2.35e-02	1.35e-01	6.79e-01	3.82e-02	3.42e-02	4.85e-01
POSITIVE REGULATION OF GROWTH	240	7.68e-02	4.48e-01	0.1150	-3.51e-02	-4.23e-02	-6.78e-02	-7.45e-02	-4.69e-03	3.50e-01	2.59e-01	7.02e-02	4.68e-02	9.00e-01
TRABECULA FORMATION	26	6.22e-01	9.43e-01	0.1150	-1.12e-02	-4.98e-02	6.04e-02	3.65e-02	-7.49e-02	9.21e-01	6.61e-01	5.94e-01	7.47e-01	5.08e-01
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS	419	9.19e-04	2.28e-02	0.1150	1.10e-02	-7.93e-02	4.89e-02	4.08e-02	5.22e-02	7.00e-01	5.34e-03	8.60e-02	1.52e-01	6.68e-02
EMBRYONIC NEUROCRANIUM MORPHOGENESIS	8	9.81e-01	9.97e-01	0.1150	7.63e-04	5.47e-02	-6.48e-02	-7.21e-02	2.82e-02	9.97e-01	7.89e-01	7.51e-01	7.24e-01	8.90e-01
MELANIN METABOLIC PROCESS	24	8.25e-01	9.83e-01	0.1150	-6.58e-02	-1.98e-02	-1.07e-02	-2.97e-02	8.64e-02	5.77e-01	8.66e-01	9.28e-01	8.01e-01	4.64e-01
OSTEOBLAST DIFFERENTIATION	249	8.49e-02	4.65e-01	0.1150	1.34e-02	-4.80e-02	4.37e-02	3.25e-02	8.79e-02	7.15e-01	1.92e-01	2.35e-01	3.78e-01	1.69e-02
POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS	382	3.68e-01	8.30e-01	0.1150	-6.13e-02	-5.27e-02	-5.02e-02	-5.34e-02	-3.55e-02	3.97e-02	7.67e-02	9.17e-02	7.31e-02	2.34e-01
PHOSPHOLIPID EFFLUX	14	1.53e-01	6.15e-01	0.1150	-5.40e-02	4.82e-03	8.81e-03	6.50e-02	-7.70e-02	7.27e-01	9.75e-01	9.54e-01	6.74e-01	6.18e-01
POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION	316	2.35e-01	7.19e-01	0.1150	5.39e-02	5.73e-02	6.11e-02	5.53e-02	1.30e-02	9.93e-02	7.98e-02	6.17e-02	9.07e-02	6.90e-01
ENDOTHELIAL CELL APOPTOTIC PROCESS	67	8.61e-01	9.88e-01	0.1150	-5.07e-02	1.95e-02	-6.59e-02	-6.22e-02	-4.47e-02	4.73e-01	7.83e-01	3.51e-01	3.79e-01	5.27e-01
REGULATION OF CELL CYCLE PROCESS	713	1.21e-08	1.32e-06	0.1150	4.78e-02	-2.92e-02	7.76e-02	6.28e-02	-6.24e-03	2.97e-02	1.84e-01	4.10e-04	4.26e-03	7.76e-01
REGULATION OF PROTEIN MATURATION	68	9.57e-01	9.97e-01	0.1150	5.17e-02	4.10e-02	5.48e-02	5.39e-02	5.34e-02	4.61e-01	5.59e-01	4.34e-01	4.42e-01	4.46e-01
REGULATION OF CARDIAC MUSCLE CONTRACTION	73	8.72e-01	9.88e-01	0.1150	6.54e-02	7.80e-02	2.02e-02	2.75e-02	-3.99e-02	3.34e-01	2.49e-01	7.65e-01	6.85e-01	5.55e-01
REGULATION OF NUCLEOTIDE METABOLIC PROCESS	45	5.25e-01	9.05e-01	0.1140	-1.07e-03	-1.63e-02	-2.29e-02	-7.60e-03	1.11e-01	9.90e-01	8.50e-01	7.90e-01	9.30e-01	1.99e-01
LENS DEVELOPMENT IN CAMERA TYPE EYE	85	5.76e-01	9.26e-01	0.1140	-4.00e-02	-8.62e-02	-1.23e-02	-2.70e-02	5.63e-02	5.24e-01	1.69e-01	8.45e-01	6.68e-01	3.70e-01
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY	223	1.65e-03	3.52e-02	0.1140	3.91e-02	-6.92e-02	6.30e-02	5.27e-02	-4.48e-03	3.15e-01	7.50e-02	1.05e-01	1.75e-01	9.08e-01
INTERSTRAND CROSS LINK REPAIR	37	9.27e-01	9.95e-01	0.1140	5.89e-02	3.69e-02	7.04e-02	5.72e-02	3.86e-03	5.35e-01	6.98e-01	4.58e-01	5.47e-01	9.68e-01
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION	335	7.00e-02	4.23e-01	0.1140	-5.46e-02	-2.49e-02	-6.31e-02	-7.26e-02	1.40e-02	8.56e-02	4.33e-01	4.70e-02	2.23e-02	6.59e-01
FEVER GENERATION	11	9.53e-01	9.97e-01	0.1140	2.45e-02	2.92e-02	-6.78e-02	-4.11e-02	-7.29e-02	8.88e-01	8.67e-01	6.97e-01	8.14e-01	6.75e-01
NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	146	6.90e-01	9.61e-01	0.1140	-6.04e-02	-4.75e-02	-5.40e-02	-5.91e-02	2.75e-02	2.08e-01	3.22e-01	2.60e-01	2.18e-01	5.66e-01
REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	53	9.08e-01	9.94e-01	0.1140	6.78e-02	4.88e-02	3.94e-02	4.46e-02	-5.00e-02	3.93e-01	5.39e-01	6.19e-01	5.75e-01	5.29e-01
MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	23	5.09e-01	9.00e-01	0.1140	-1.63e-02	9.66e-03	-2.01e-02	-5.37e-02	9.68e-02	8.92e-01	9.36e-01	8.67e-01	6.56e-01	4.22e-01
NEGATIVE REGULATION OF HEMOPOIESIS	115	4.85e-01	8.92e-01	0.1140	-6.30e-02	-9.21e-02	-7.75e-03	-2.16e-02	-4.51e-03	2.43e-01	8.78e-02	8.86e-01	6.89e-01	9.33e-01
NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	21	9.58e-01	9.97e-01	0.1140	5.55e-02	1.30e-02	6.07e-02	7.57e-02	-1.83e-02	6.60e-01	9.18e-01	6.30e-01	5.48e-01	8.84e-01
ESTABLISHMENT OF MITOCHONDRION LOCALIZATION	27	2.79e-01	7.58e-01	0.1140	3.46e-02	-2.34e-02	8.35e-02	4.23e-02	-4.99e-02	7.56e-01	8.33e-01	4.53e-01	7.04e-01	6.54e-01
DETOXIFICATION	153	5.33e-01	9.09e-01	0.1140	3.04e-02	-2.45e-02	5.99e-02	5.09e-02	7.26e-02	5.16e-01	6.01e-01	2.01e-01	2.77e-01	1.21e-01
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	80	1.87e-01	6.58e-01	0.1140	-1.87e-03	8.38e-02	-3.24e-02	-3.35e-02	6.13e-02	9.77e-01	1.95e-01	6.16e-01	6.04e-01	3.43e-01
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	167	6.37e-02	4.03e-01	0.1140	3.23e-02	1.04e-01	-2.06e-02	-1.70e-02	1.95e-02	4.71e-01	2.04e-02	6.46e-01	7.05e-01	6.63e-01
PROTEIN KINASE A SIGNALING	37	4.36e-01	8.69e-01	0.1140	-3.79e-02	5.27e-02	8.44e-03	1.87e-03	-9.30e-02	6.90e-01	5.79e-01	9.29e-01	9.84e-01	3.28e-01
BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	310	2.44e-01	7.29e-01	0.1140	4.51e-02	-6.93e-03	5.87e-02	5.44e-02	6.67e-02	1.72e-01	8.34e-01	7.56e-02	9.94e-02	4.33e-02
CELL JUNCTION ASSEMBLY	423	9.61e-02	4.94e-01	0.1140	-6.53e-02	-3.72e-02	-5.53e-02	-6.34e-02	1.44e-02	2.13e-02	1.89e-01	5.11e-02	2.53e-02	6.12e-01
SERINE FAMILY AMINO ACID CATABOLIC PROCESS	14	7.65e-01	9.75e-01	0.1140	-5.44e-02	4.81e-02	-7.61e-02	-4.29e-02	-3.76e-03	7.25e-01	7.55e-01	6.22e-01	7.81e-01	9.81e-01
POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	8	9.98e-01	1.00e+00	0.1140	1.92e-02	-5.18e-02	4.69e-02	4.62e-02	7.42e-02	9.25e-01	8.00e-01	8.18e-01	8.21e-01	7.16e-01
TOLERANCE INDUCTION	29	5.09e-01	9.00e-01	0.1140	-7.94e-02	-7.30e-03	9.44e-03	-9.95e-03	7.97e-02	4.59e-01	9.46e-01	9.30e-01	9.26e-01	4.57e-01
NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	65	9.02e-01	9.94e-01	0.1140	-7.12e-02	-6.35e-02	-4.12e-02	-3.95e-02	2.27e-02	3.21e-01	3.76e-01	5.65e-01	5.82e-01	7.52e-01
REGULATION OF HUMORAL IMMUNE RESPONSE	47	9.23e-02	4.84e-01	0.1140	-5.98e-02	1.97e-02	5.74e-05	1.72e-02	9.29e-02	4.78e-01	8.16e-01	9.99e-01	8.38e-01	2.71e-01
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS	122	2.90e-01	7.67e-01	0.1140	-7.37e-02	-4.56e-02	-2.02e-02	-2.39e-02	6.63e-02	1.60e-01	3.84e-01	7.00e-01	6.48e-01	2.06e-01
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	48	7.10e-01	9.67e-01	0.1130	-1.84e-02	-3.17e-02	-3.01e-03	6.12e-03	1.07e-01	8.26e-01	7.04e-01	9.71e-01	9.41e-01	1.99e-01
CELL FATE COMMITMENT	279	1.34e-08	1.41e-06	0.1130	3.81e-02	-8.53e-02	4.56e-02	2.08e-02	4.02e-02	2.73e-01	1.42e-02	1.90e-01	5.50e-01	2.47e-01
HUMORAL IMMUNE RESPONSE	238	7.66e-06	4.37e-04	0.1130	1.88e-02	8.99e-02	-6.18e-03	1.91e-02	6.32e-02	6.18e-01	1.69e-02	8.70e-01	6.12e-01	9.30e-02
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	82	1.94e-01	6.71e-01	0.1130	-3.95e-02	3.69e-02	-3.98e-02	-4.55e-02	7.91e-02	5.37e-01	5.63e-01	5.33e-01	4.77e-01	2.15e-01
STRIATED MUSCLE CONTRACTION	175	1.02e-01	5.10e-01	0.1130	4.91e-02	9.97e-02	-1.81e-02	-8.36e-03	9.42e-03	2.63e-01	2.29e-02	6.80e-01	8.49e-01	8.30e-01
EMBRYONIC APPENDAGE MORPHOGENESIS	119	4.51e-05	2.06e-03	0.1130	2.45e-02	-1.05e-01	2.84e-02	-3.30e-03	2.08e-02	6.44e-01	4.84e-02	5.92e-01	9.50e-01	6.95e-01
NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	11	9.11e-01	9.94e-01	0.1130	9.24e-03	2.11e-02	-6.94e-02	-8.41e-02	2.00e-02	9.58e-01	9.04e-01	6.90e-01	6.29e-01	9.08e-01
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	89	6.32e-02	4.02e-01	0.1130	3.54e-02	-8.10e-02	3.37e-02	1.94e-02	5.89e-02	5.64e-01	1.87e-01	5.82e-01	7.52e-01	3.36e-01
CEREBELLAR GRANULAR LAYER DEVELOPMENT	12	9.98e-01	1.00e+00	0.1130	-5.37e-02	7.40e-03	-6.75e-02	-6.90e-02	-2.28e-02	7.47e-01	9.65e-01	6.86e-01	6.79e-01	8.91e-01
SMOOTH MUSCLE CELL PROLIFERATION	160	1.24e-01	5.63e-01	0.1130	-3.24e-02	-4.73e-02	-5.57e-02	-6.38e-02	4.82e-02	4.79e-01	3.02e-01	2.24e-01	1.63e-01	2.93e-01
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE	71	6.64e-01	9.54e-01	0.1130	2.46e-02	9.84e-02	-2.17e-02	-2.00e-02	-4.04e-02	7.20e-01	1.52e-01	7.52e-01	7.71e-01	5.56e-01
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	118	3.73e-01	8.34e-01	0.1130	-8.52e-02	-3.50e-02	-4.56e-02	-4.46e-02	1.50e-02	1.10e-01	5.12e-01	3.92e-01	4.03e-01	7.78e-01
ESTABLISHMENT OF SKIN BARRIER	33	6.58e-01	9.54e-01	0.1130	-1.25e-02	-9.36e-02	-3.32e-02	-4.13e-02	-3.24e-02	9.01e-01	3.52e-01	7.41e-01	6.81e-01	7.47e-01
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	147	2.85e-03	5.34e-02	0.1130	1.72e-02	-5.90e-02	8.13e-03	-1.27e-02	9.36e-02	7.19e-01	2.17e-01	8.65e-01	7.91e-01	5.02e-02
REGULATION OF HEART CONTRACTION	199	2.61e-01	7.44e-01	0.1130	7.57e-02	7.51e-02	2.21e-02	2.54e-02	1.55e-02	6.55e-02	6.76e-02	5.92e-01	5.36e-01	7.06e-01
REGULATION OF EXOCYTOSIS	178	3.29e-01	8.02e-01	0.1130	-3.21e-02	-7.91e-02	2.14e-02	1.37e-02	6.93e-02	4.60e-01	6.87e-02	6.22e-01	7.52e-01	1.11e-01
CGMP MEDIATED SIGNALING	30	3.61e-01	8.25e-01	0.1130	-2.22e-02	8.18e-02	4.43e-02	4.50e-02	3.94e-02	8.34e-01	4.38e-01	6.75e-01	6.69e-01	7.09e-01
RENAL TUBULE DEVELOPMENT	99	8.30e-02	4.59e-01	0.1130	3.85e-02	-1.18e-02	4.09e-02	1.74e-02	9.56e-02	5.09e-01	8.40e-01	4.82e-01	7.65e-01	1.00e-01
REGULATION OF NEUROINFLAMMATORY RESPONSE	41	9.15e-01	9.94e-01	0.1130	-1.87e-02	-5.44e-02	8.67e-03	6.04e-03	9.64e-02	8.36e-01	5.47e-01	9.24e-01	9.47e-01	2.86e-01
RUFFLE ASSEMBLY	45	7.65e-01	9.75e-01	0.1130	-7.25e-02	-2.56e-02	-4.64e-02	-6.55e-02	1.82e-02	4.00e-01	7.66e-01	5.90e-01	4.47e-01	8.33e-01
POSITIVE REGULATION OF TOLERANCE INDUCTION	11	7.78e-01	9.79e-01	0.1130	-1.54e-02	5.92e-02	7.58e-02	4.38e-02	3.59e-02	9.29e-01	7.34e-01	6.64e-01	8.01e-01	8.37e-01
RETINA LAYER FORMATION	23	9.66e-01	9.97e-01	0.1130	-3.27e-02	-7.30e-02	-2.23e-02	-3.00e-02	6.99e-02	7.86e-01	5.45e-01	8.53e-01	8.04e-01	5.61e-01
ORGANOPHOSPHATE ESTER TRANSPORT	147	8.18e-01	9.83e-01	0.1130	-6.15e-02	-2.75e-02	-5.73e-02	-5.62e-02	-4.10e-02	1.98e-01	5.65e-01	2.30e-01	2.40e-01	3.90e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	91	4.00e-01	8.45e-01	0.1130	4.13e-02	9.65e-03	3.60e-02	3.69e-02	-9.05e-02	4.95e-01	8.74e-01	5.52e-01	5.43e-01	1.36e-01
GLYCOPROTEIN BIOSYNTHETIC PROCESS	291	9.15e-02	4.82e-01	0.1120	-5.75e-02	-8.42e-02	-2.28e-02	-3.48e-02	-2.27e-02	9.12e-02	1.34e-02	5.04e-01	3.07e-01	5.06e-01
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	28	8.34e-01	9.85e-01	0.1120	-1.59e-02	-3.56e-02	-7.07e-02	-7.80e-02	-5.78e-03	8.84e-01	7.44e-01	5.17e-01	4.75e-01	9.58e-01
SODIUM ION EXPORT ACROSS PLASMA MEMBRANE	15	9.79e-01	9.97e-01	0.1120	6.25e-02	8.27e-02	1.19e-02	3.05e-02	2.86e-02	6.75e-01	5.79e-01	9.36e-01	8.38e-01	8.48e-01
MALE MEIOSIS I	27	8.41e-01	9.85e-01	0.1120	-2.25e-02	2.24e-02	8.39e-04	-4.86e-03	1.08e-01	8.40e-01	8.41e-01	9.94e-01	9.65e-01	3.33e-01
REGULATION OF ACTIN FILAMENT LENGTH	149	5.72e-01	9.26e-01	0.1120	-6.40e-02	-4.10e-02	-5.13e-02	-6.42e-02	-7.83e-03	1.78e-01	3.88e-01	2.79e-01	1.76e-01	8.69e-01
ACTIN POLYMERIZATION OR DEPOLYMERIZATION	186	3.90e-01	8.40e-01	0.1120	-5.80e-02	-3.28e-02	-5.76e-02	-6.92e-02	5.98e-03	1.73e-01	4.40e-01	1.75e-01	1.03e-01	8.88e-01
RESPONSE TO VITAMIN	82	5.02e-02	3.50e-01	0.1120	2.11e-02	-1.07e-01	1.81e-02	8.61e-03	1.63e-02	7.41e-01	9.37e-02	7.77e-01	8.93e-01	7.99e-01
PROSTATE GLAND DEVELOPMENT	49	1.58e-01	6.20e-01	0.1120	1.37e-02	-1.09e-01	1.67e-02	-4.44e-03	1.45e-02	8.68e-01	1.87e-01	8.40e-01	9.57e-01	8.61e-01
GLAND DEVELOPMENT	429	5.01e-04	1.45e-02	0.1120	-1.43e-02	-9.22e-02	2.55e-02	1.18e-02	5.54e-02	6.10e-01	1.05e-03	3.65e-01	6.74e-01	4.91e-02
REGULATION OF PROTEOLYSIS	588	8.46e-03	1.15e-01	0.1120	2.52e-02	-3.80e-02	5.43e-02	4.97e-02	7.11e-02	2.96e-01	1.16e-01	2.43e-02	3.95e-02	3.21e-03
REGULATION OF HEAT GENERATION	12	9.28e-01	9.95e-01	0.1120	2.10e-02	-5.60e-02	3.78e-02	6.12e-02	6.16e-02	9.00e-01	7.37e-01	8.21e-01	7.13e-01	7.12e-01
REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY	8	9.59e-01	9.97e-01	0.1120	-1.07e-02	-7.74e-02	3.03e-02	4.81e-02	-5.66e-02	9.58e-01	7.05e-01	8.82e-01	8.14e-01	7.82e-01
POSITIVE REGULATION OF LYMPHOCYTE MIGRATION	40	6.56e-01	9.53e-01	0.1120	2.43e-02	-2.26e-02	-2.38e-03	9.20e-03	1.06e-01	7.90e-01	8.04e-01	9.79e-01	9.20e-01	2.44e-01
CAMERA TYPE EYE MORPHOGENESIS	130	2.12e-01	6.91e-01	0.1120	-6.97e-03	-4.87e-02	-1.12e-02	-1.05e-02	9.94e-02	8.91e-01	3.38e-01	8.26e-01	8.37e-01	5.04e-02
NEGATIVE REGULATION OF AXON EXTENSION	43	3.29e-01	8.02e-01	0.1120	3.89e-02	8.75e-02	-1.96e-02	-3.79e-02	3.91e-02	6.59e-01	3.21e-01	8.24e-01	6.68e-01	6.57e-01
EYE PIGMENTATION	5	9.71e-01	9.97e-01	0.1120	1.90e-03	-4.03e-02	-6.12e-02	-8.34e-02	-1.38e-02	9.94e-01	8.76e-01	8.13e-01	7.47e-01	9.57e-01
POSITIVE REGULATION OF T CELL MIGRATION	33	5.73e-01	9.26e-01	0.1120	-6.86e-03	-3.32e-02	-6.37e-02	-4.58e-02	7.21e-02	9.46e-01	7.42e-01	5.26e-01	6.49e-01	4.74e-01
PIGMENT CELL DIFFERENTIATION	35	5.07e-01	8.99e-01	0.1120	-2.63e-03	-8.66e-02	9.67e-03	-1.58e-02	6.81e-02	9.78e-01	3.75e-01	9.21e-01	8.71e-01	4.85e-01
MUSCLE CELL DEVELOPMENT	191	5.56e-01	9.18e-01	0.1120	-2.42e-02	2.94e-03	-6.26e-02	-6.12e-02	-6.52e-02	5.64e-01	9.44e-01	1.36e-01	1.45e-01	1.20e-01
ADAPTIVE IMMUNE RESPONSE	449	3.81e-04	1.16e-02	0.1120	2.82e-02	7.68e-02	4.26e-02	4.63e-02	4.28e-02	3.06e-01	5.30e-03	1.21e-01	9.24e-02	1.20e-01
NEURON MIGRATION	167	5.21e-02	3.58e-01	0.1120	7.99e-02	2.64e-02	5.83e-02	4.46e-02	-2.47e-03	7.48e-02	5.56e-01	1.94e-01	3.20e-01	9.56e-01
FOREBRAIN DEVELOPMENT	392	4.91e-07	3.77e-05	0.1120	-9.32e-03	-1.01e-01	2.66e-02	3.61e-03	3.74e-02	7.51e-01	5.74e-04	3.66e-01	9.02e-01	2.04e-01
NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	6	8.27e-01	9.83e-01	0.1120	9.86e-03	4.26e-02	-4.07e-02	-8.69e-02	3.66e-02	9.67e-01	8.57e-01	8.63e-01	7.13e-01	8.77e-01
NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	12	8.84e-01	9.91e-01	0.1110	-7.66e-02	-8.19e-03	-2.47e-02	-5.62e-02	-5.22e-02	6.46e-01	9.61e-01	8.82e-01	7.36e-01	7.54e-01
REGULATION OF RESPONSE TO WOUNDING	166	5.58e-01	9.19e-01	0.1110	-5.29e-02	-3.81e-02	-6.79e-02	-5.94e-02	-6.43e-03	2.39e-01	3.98e-01	1.31e-01	1.87e-01	8.86e-01
ANTERIOR POSTERIOR PATTERN SPECIFICATION	209	3.18e-09	3.90e-07	0.1110	5.88e-02	-8.36e-02	3.40e-02	1.17e-02	2.61e-02	1.43e-01	3.72e-02	3.97e-01	7.71e-01	5.15e-01
RESPONSE TO PARATHYROID HORMONE	10	9.83e-01	9.97e-01	0.1110	4.70e-02	9.21e-03	4.22e-02	5.78e-02	-7.07e-02	7.97e-01	9.60e-01	8.17e-01	7.52e-01	6.99e-01
GLOMERULAR EPITHELIUM DEVELOPMENT	24	8.70e-01	9.88e-01	0.1110	-7.20e-02	-4.98e-02	-3.30e-02	-1.92e-02	-5.74e-02	5.42e-01	6.73e-01	7.80e-01	8.71e-01	6.26e-01
RNA DESTABILIZATION	163	7.99e-01	9.82e-01	0.1110	-5.76e-02	-1.82e-02	-6.41e-02	-6.33e-02	-2.50e-02	2.04e-01	6.89e-01	1.58e-01	1.63e-01	5.82e-01
REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	24	6.98e-01	9.62e-01	0.1110	5.49e-02	-5.03e-02	4.67e-02	6.80e-02	1.28e-03	6.41e-01	6.70e-01	6.92e-01	5.64e-01	9.91e-01
REGULATION OF CATION CHANNEL ACTIVITY	115	5.90e-01	9.31e-01	0.1110	-3.18e-02	2.61e-02	-7.54e-02	-6.82e-02	-1.78e-02	5.56e-01	6.29e-01	1.62e-01	2.06e-01	7.42e-01
PROTEIN ACTIVATION CASCADE	17	9.12e-01	9.94e-01	0.1110	-6.92e-02	-5.70e-02	1.16e-02	-1.46e-02	6.28e-02	6.21e-01	6.84e-01	9.34e-01	9.17e-01	6.54e-01
GRANULOCYTE DIFFERENTIATION	40	7.65e-01	9.75e-01	0.1110	-4.12e-03	-5.92e-03	-8.04e-02	-7.26e-02	-2.30e-02	9.64e-01	9.48e-01	3.79e-01	4.27e-01	8.01e-01
REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	21	9.39e-01	9.97e-01	0.1110	-7.78e-02	-4.95e-02	-4.82e-02	-3.43e-02	-1.75e-02	5.37e-01	6.95e-01	7.02e-01	7.86e-01	8.90e-01
CELLULAR RESPONSE TO ESTRADIOL STIMULUS	37	7.04e-01	9.65e-01	0.1110	-1.10e-02	-1.07e-01	2.03e-02	5.39e-03	1.80e-02	9.08e-01	2.61e-01	8.30e-01	9.55e-01	8.50e-01
REGULATION OF CARBOHYDRATE METABOLIC PROCESS	181	5.83e-01	9.28e-01	0.1110	-4.63e-02	-4.04e-02	-6.39e-02	-6.66e-02	1.56e-03	2.83e-01	3.48e-01	1.38e-01	1.22e-01	9.71e-01
NEUROMUSCULAR PROCESS CONTROLLING BALANCE	51	7.28e-01	9.71e-01	0.1110	7.69e-02	7.47e-02	2.32e-02	1.54e-02	-1.25e-03	3.42e-01	3.56e-01	7.74e-01	8.49e-01	9.88e-01
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	45	8.71e-01	9.88e-01	0.1110	-3.77e-02	-5.77e-02	-2.23e-02	-2.73e-02	-7.92e-02	6.62e-01	5.03e-01	7.96e-01	7.51e-01	3.58e-01
NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS	567	3.81e-05	1.77e-03	0.1110	4.81e-02	-3.68e-02	6.52e-02	6.57e-02	-2.84e-03	5.00e-02	1.34e-01	7.90e-03	7.50e-03	9.08e-01
INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	31	7.17e-01	9.68e-01	0.1110	-4.45e-03	6.44e-02	-3.14e-02	-2.14e-02	8.14e-02	9.66e-01	5.35e-01	7.63e-01	8.36e-01	4.33e-01
POSITIVE REGULATION OF RNA METABOLIC PROCESS	1810	1.82e-23	1.71e-20	0.1110	5.04e-02	-4.31e-02	6.68e-02	5.27e-02	2.43e-02	3.70e-04	2.32e-03	2.37e-06	2.00e-04	8.56e-02
POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	149	1.20e-01	5.52e-01	0.1110	1.88e-02	5.28e-02	6.67e-03	7.83e-03	9.48e-02	6.93e-01	2.66e-01	8.88e-01	8.69e-01	4.59e-02
ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION	5	9.76e-01	9.97e-01	0.1110	-4.06e-02	1.96e-02	2.03e-02	-4.22e-03	-9.88e-02	8.75e-01	9.39e-01	9.37e-01	9.87e-01	7.02e-01
VACUOLE ORGANIZATION	219	2.20e-02	2.16e-01	0.1110	4.00e-02	-3.72e-02	6.72e-02	6.15e-02	-3.04e-02	3.08e-01	3.42e-01	8.64e-02	1.16e-01	4.38e-01
CYTOKINETIC PROCESS	42	5.93e-01	9.32e-01	0.1100	2.76e-02	-8.22e-02	4.76e-02	4.75e-02	-1.24e-02	7.57e-01	3.56e-01	5.94e-01	5.94e-01	8.90e-01
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	55	4.56e-01	8.78e-01	0.1100	-8.69e-02	-4.50e-02	-1.65e-02	-1.32e-02	4.67e-02	2.65e-01	5.64e-01	8.32e-01	8.66e-01	5.49e-01
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT	138	7.65e-01	9.75e-01	0.1100	-3.75e-02	-1.85e-02	-6.96e-02	-6.39e-02	-3.88e-02	4.47e-01	7.07e-01	1.58e-01	1.95e-01	4.32e-01
AMEBOIDAL TYPE CELL MIGRATION	478	1.14e-02	1.39e-01	0.1100	-5.36e-02	-5.11e-02	-5.05e-02	-4.52e-02	4.55e-02	4.47e-02	5.56e-02	5.85e-02	9.04e-02	8.80e-02
NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS	27	9.27e-01	9.95e-01	0.1100	-3.72e-03	-1.70e-02	-6.39e-02	-5.78e-02	-6.66e-02	9.73e-01	8.78e-01	5.66e-01	6.03e-01	5.49e-01
CYTOKINESIS	178	3.00e-02	2.60e-01	0.1100	-3.10e-02	-6.87e-02	-2.54e-03	-1.67e-02	-7.85e-02	4.75e-01	1.14e-01	9.53e-01	7.01e-01	7.06e-02
PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS	85	5.66e-01	9.23e-01	0.1100	-3.50e-02	-1.02e-01	1.74e-02	9.44e-03	1.15e-02	5.76e-01	1.05e-01	7.81e-01	8.80e-01	8.54e-01
AORTIC VALVE MORPHOGENESIS	38	6.42e-01	9.50e-01	0.1100	-9.95e-03	-1.08e-01	-5.51e-03	6.27e-04	1.40e-02	9.15e-01	2.47e-01	9.53e-01	9.95e-01	8.81e-01
DOPAMINE METABOLIC PROCESS	35	7.84e-01	9.81e-01	0.1100	7.19e-02	4.32e-03	2.99e-02	4.23e-02	6.49e-02	4.62e-01	9.65e-01	7.59e-01	6.65e-01	5.07e-01
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	53	6.85e-01	9.61e-01	0.1100	6.78e-03	-1.98e-02	1.74e-02	2.96e-02	1.02e-01	9.32e-01	8.03e-01	8.26e-01	7.09e-01	1.99e-01
METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT	25	8.86e-01	9.91e-01	0.1100	-6.23e-03	1.90e-02	-7.43e-02	-7.64e-02	1.64e-02	9.57e-01	8.69e-01	5.20e-01	5.08e-01	8.87e-01
NEGATIVE REGULATION OF IMMUNE RESPONSE	199	1.84e-01	6.56e-01	0.1100	-1.66e-02	-2.97e-02	4.32e-02	3.51e-02	8.80e-02	6.87e-01	4.70e-01	2.93e-01	3.93e-01	3.22e-02
SUBPALLIUM DEVELOPMENT	26	3.57e-01	8.22e-01	0.1100	6.90e-02	-5.59e-02	5.45e-02	2.91e-02	-1.75e-02	5.42e-01	6.22e-01	6.30e-01	7.97e-01	8.77e-01
PROTEIN ACYLATION	134	1.73e-01	6.45e-01	0.1090	6.13e-02	-9.80e-03	6.32e-02	5.60e-02	-3.18e-02	2.20e-01	8.45e-01	2.07e-01	2.63e-01	5.26e-01
REGULATION OF MACROPHAGE CHEMOTAXIS	28	7.24e-01	9.70e-01	0.1090	-4.58e-02	-4.68e-02	-7.38e-02	-4.63e-02	-1.02e-02	6.75e-01	6.68e-01	4.99e-01	6.71e-01	9.26e-01
POSITIVE REGULATION OF MYOBLAST PROLIFERATION	14	9.83e-01	9.97e-01	0.1090	3.24e-02	9.88e-03	6.89e-02	6.23e-02	-4.67e-02	8.34e-01	9.49e-01	6.55e-01	6.86e-01	7.62e-01
REGULATION OF RESPONSE TO CYTOKINE STIMULUS	175	6.42e-01	9.50e-01	0.1090	2.55e-02	-1.08e-02	5.31e-02	4.98e-02	7.66e-02	5.61e-01	8.05e-01	2.25e-01	2.55e-01	8.05e-02
CELLULAR RESPONSE TO SALT	192	1.83e-01	6.56e-01	0.1090	4.82e-02	2.63e-02	3.60e-02	2.82e-02	8.25e-02	2.49e-01	5.30e-01	3.90e-01	5.01e-01	4.88e-02
NAIL DEVELOPMENT	11	7.30e-01	9.71e-01	0.1090	-4.50e-02	-8.34e-02	3.04e-03	-4.59e-02	-2.82e-02	7.96e-01	6.32e-01	9.86e-01	7.92e-01	8.71e-01
NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	80	8.72e-01	9.88e-01	0.1090	-5.44e-02	-8.55e-02	-1.98e-02	-2.60e-02	2.35e-02	4.00e-01	1.86e-01	7.59e-01	6.88e-01	7.17e-01
PROGRAMMED NECROTIC CELL DEATH	56	9.12e-01	9.94e-01	0.1090	4.46e-02	6.89e-02	4.70e-02	5.25e-02	-1.33e-02	5.64e-01	3.72e-01	5.43e-01	4.96e-01	8.64e-01
NEGATIVE REGULATION OF ORGANELLE ASSEMBLY	42	8.00e-01	9.82e-01	0.1090	4.27e-02	-8.44e-03	7.65e-02	5.64e-02	3.07e-02	6.32e-01	9.25e-01	3.91e-01	5.27e-01	7.30e-01
POSITIVE REGULATION OF ORGANELLE ASSEMBLY	82	7.93e-01	9.81e-01	0.1090	-3.61e-02	-7.82e-02	8.57e-04	-4.94e-03	6.63e-02	5.72e-01	2.21e-01	9.89e-01	9.38e-01	3.00e-01
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT	126	5.79e-09	6.76e-07	0.1090	5.31e-02	-9.06e-02	1.96e-02	-1.66e-02	-1.18e-02	3.03e-01	7.89e-02	7.04e-01	7.48e-01	8.18e-01
CARDIAC MUSCLE CELL ACTION POTENTIAL	72	6.92e-01	9.61e-01	0.1090	-4.51e-02	-2.39e-02	-5.22e-02	-6.19e-02	5.15e-02	5.08e-01	7.25e-01	4.43e-01	3.63e-01	4.50e-01
ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY	41	5.86e-01	9.29e-01	0.1090	-3.70e-02	6.31e-03	3.36e-02	2.63e-02	9.27e-02	6.82e-01	9.44e-01	7.10e-01	7.71e-01	3.04e-01
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	139	4.56e-01	8.78e-01	0.1090	2.56e-02	-3.39e-02	6.82e-02	5.52e-02	4.78e-02	6.03e-01	4.90e-01	1.65e-01	2.61e-01	3.31e-01
POSITIVE REGULATION OF CELL GROWTH	153	2.53e-01	7.37e-01	0.1080	-3.19e-02	-4.12e-02	-6.33e-02	-7.02e-02	1.00e-02	4.96e-01	3.79e-01	1.76e-01	1.34e-01	8.30e-01
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	28	4.98e-01	8.97e-01	0.1080	3.73e-02	7.52e-02	-3.84e-02	-5.04e-03	5.66e-02	7.33e-01	4.91e-01	7.25e-01	9.63e-01	6.04e-01
FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS	9	7.65e-01	9.75e-01	0.1080	-4.22e-02	9.62e-02	3.12e-03	2.61e-02	-6.98e-05	8.26e-01	6.17e-01	9.87e-01	8.92e-01	1.00e+00
SECRETORY GRANULE ORGANIZATION	63	5.10e-01	9.00e-01	0.1080	-1.53e-02	-2.98e-02	-6.92e-02	-6.68e-02	3.69e-02	8.34e-01	6.82e-01	3.42e-01	3.59e-01	6.12e-01
ACTIN FILAMENT BASED MOVEMENT	128	1.58e-01	6.20e-01	0.1080	-3.56e-03	7.74e-02	-5.90e-02	-4.72e-02	4.24e-04	9.45e-01	1.30e-01	2.49e-01	3.57e-01	9.93e-01
PROTEIN TARGETING TO MEMBRANE	120	7.57e-01	9.75e-01	0.1080	6.04e-02	3.67e-03	6.15e-02	6.00e-02	2.58e-02	2.53e-01	9.45e-01	2.44e-01	2.57e-01	6.26e-01
MECHANORECEPTOR DIFFERENTIATION	68	6.96e-01	9.61e-01	0.1080	-8.20e-03	-3.64e-02	-2.49e-03	-7.17e-03	1.01e-01	9.07e-01	6.04e-01	9.72e-01	9.19e-01	1.49e-01
RESPONSE TO AMINO ACID STARVATION	53	8.85e-01	9.91e-01	0.1080	3.75e-02	3.40e-02	7.19e-02	6.13e-02	1.42e-02	6.36e-01	6.69e-01	3.65e-01	4.40e-01	8.58e-01
INTERLEUKIN 2 PRODUCTION	60	6.54e-01	9.53e-01	0.1080	5.67e-02	4.78e-02	8.20e-03	1.25e-02	7.73e-02	4.48e-01	5.22e-01	9.12e-01	8.67e-01	3.00e-01
POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	25	9.22e-01	9.95e-01	0.1080	1.28e-02	1.29e-04	2.21e-02	7.91e-03	1.05e-01	9.12e-01	9.99e-01	8.48e-01	9.45e-01	3.64e-01
RIBONUCLEOTIDE CATABOLIC PROCESS	48	8.83e-01	9.91e-01	0.1080	-4.31e-02	-2.14e-02	-6.06e-02	-6.84e-02	3.20e-02	6.06e-01	7.98e-01	4.68e-01	4.12e-01	7.02e-01
CELL CYCLE	1738	2.34e-17	7.34e-15	0.1080	4.64e-02	-3.05e-02	7.09e-02	5.62e-02	2.00e-02	1.28e-03	3.42e-02	8.68e-07	9.68e-05	1.65e-01
NEURON MATURATION	47	7.08e-01	9.65e-01	0.1080	5.39e-02	4.48e-02	6.49e-02	4.63e-02	-2.04e-02	5.23e-01	5.95e-01	4.41e-01	5.83e-01	8.09e-01
G QUADRUPLEX DNA UNWINDING	7	9.51e-01	9.97e-01	0.1080	-3.90e-02	5.71e-02	-1.29e-02	-4.02e-02	-7.14e-02	8.58e-01	7.94e-01	9.53e-01	8.54e-01	7.43e-01
DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	11	9.87e-01	9.98e-01	0.1080	-4.17e-02	-4.93e-02	-6.22e-02	-4.79e-02	3.65e-02	8.11e-01	7.77e-01	7.21e-01	7.83e-01	8.34e-01
MIRNA PROCESSING	45	7.92e-01	9.81e-01	0.1080	3.29e-02	2.61e-02	3.96e-02	3.30e-02	-8.51e-02	7.03e-01	7.62e-01	6.46e-01	7.02e-01	3.24e-01
ZYMOGEN ACTIVATION	57	8.75e-01	9.88e-01	0.1080	-4.83e-02	-5.63e-02	-5.79e-02	-4.94e-02	1.87e-02	5.28e-01	4.62e-01	4.50e-01	5.19e-01	8.07e-01
REGULATION OF BMP SIGNALING PATHWAY	115	9.74e-02	4.98e-01	0.1080	-9.87e-03	-3.22e-02	-6.18e-02	-7.31e-02	-3.66e-02	8.55e-01	5.50e-01	2.52e-01	1.75e-01	4.98e-01
REGULATION OF KERATINOCYTE PROLIFERATION	47	8.39e-01	9.85e-01	0.1080	2.91e-02	8.90e-02	8.35e-03	4.64e-03	-5.27e-02	7.30e-01	2.91e-01	9.21e-01	9.56e-01	5.32e-01
POSITIVE REGULATION OF MACROPHAGE MIGRATION	26	2.77e-01	7.57e-01	0.1080	3.26e-02	1.65e-02	-1.87e-02	2.39e-02	9.68e-02	7.74e-01	8.85e-01	8.69e-01	8.33e-01	3.93e-01
ACTIVIN RECEPTOR SIGNALING PATHWAY	44	5.81e-01	9.28e-01	0.1080	2.98e-02	-6.54e-04	-3.42e-02	-3.79e-02	-9.02e-02	7.32e-01	9.94e-01	6.95e-01	6.63e-01	3.01e-01
NADPH REGENERATION	21	3.89e-01	8.40e-01	0.1080	-2.14e-05	-6.38e-02	-4.21e-02	-7.60e-02	-2.37e-03	1.00e+00	6.13e-01	7.39e-01	5.46e-01	9.85e-01
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	172	3.49e-01	8.18e-01	0.1080	-2.11e-02	4.47e-02	-5.61e-02	-5.93e-02	-5.02e-02	6.32e-01	3.12e-01	2.05e-01	1.80e-01	2.56e-01
DNA LIGATION INVOLVED IN DNA REPAIR	5	7.69e-01	9.75e-01	0.1080	4.98e-02	-7.99e-02	3.57e-02	-1.80e-02	-3.37e-02	8.47e-01	7.57e-01	8.90e-01	9.44e-01	8.96e-01
CELLULAR RESPONSE TO HORMONE STIMULUS	589	1.36e-02	1.57e-01	0.1080	-4.65e-02	-6.84e-02	-4.40e-02	-5.20e-02	-1.02e-02	5.40e-02	4.54e-03	6.82e-02	3.11e-02	6.73e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	29	4.99e-01	8.97e-01	0.1080	7.04e-02	-3.53e-02	1.49e-02	2.14e-02	-6.84e-02	5.11e-01	7.42e-01	8.89e-01	8.42e-01	5.24e-01
FEMALE GAMETE GENERATION	158	2.79e-01	7.58e-01	0.1080	-3.76e-02	-2.78e-02	-4.33e-02	-5.71e-02	-6.51e-02	4.15e-01	5.46e-01	3.48e-01	2.16e-01	1.58e-01
NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	111	7.66e-01	9.75e-01	0.1080	-5.82e-02	-1.95e-02	-6.33e-02	-5.45e-02	-2.84e-02	2.89e-01	7.23e-01	2.49e-01	3.21e-01	6.05e-01
RESPONSE TO DOPAMINE	70	3.85e-01	8.40e-01	0.1070	-1.51e-02	-2.64e-02	-3.13e-02	-4.47e-02	8.75e-02	8.27e-01	7.02e-01	6.51e-01	5.18e-01	2.06e-01
POSTSYNAPSE ASSEMBLY	35	7.67e-01	9.75e-01	0.1070	4.49e-02	3.14e-02	4.84e-02	2.72e-02	7.40e-02	6.46e-01	7.48e-01	6.20e-01	7.81e-01	4.49e-01
LOCOMOTORY BEHAVIOR	198	1.46e-02	1.63e-01	0.1070	-3.35e-02	-7.16e-02	-3.39e-02	-5.35e-02	3.54e-02	4.16e-01	8.21e-02	4.10e-01	1.94e-01	3.91e-01
REGULATION OF ACTIN FILAMENT BASED PROCESS	362	2.47e-01	7.32e-01	0.1070	-5.42e-02	-1.60e-02	-6.14e-02	-6.69e-02	-8.72e-03	7.67e-02	6.01e-01	4.48e-02	2.88e-02	7.76e-01
INCLUSION BODY ASSEMBLY	23	8.26e-01	9.83e-01	0.1070	4.60e-02	1.59e-02	5.28e-02	7.92e-02	7.14e-03	7.03e-01	8.95e-01	6.61e-01	5.11e-01	9.53e-01
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION	337	1.79e-02	1.90e-01	0.1070	8.81e-04	-4.85e-02	6.52e-02	5.00e-02	4.82e-02	9.78e-01	1.26e-01	3.96e-02	1.14e-01	1.28e-01
COPPER ION TRANSPORT	15	9.72e-01	9.97e-01	0.1070	-2.76e-02	-1.00e-01	1.46e-02	5.63e-03	-1.95e-02	8.53e-01	5.02e-01	9.22e-01	9.70e-01	8.96e-01
HETEROTYPIC CELL CELL ADHESION	61	7.59e-01	9.75e-01	0.1070	-3.26e-02	-6.19e-02	-3.18e-02	-2.66e-02	6.92e-02	6.59e-01	4.03e-01	6.68e-01	7.20e-01	3.50e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	19	9.02e-01	9.94e-01	0.1070	5.22e-02	8.15e-02	-3.76e-02	-1.21e-02	-2.07e-02	6.93e-01	5.38e-01	7.77e-01	9.27e-01	8.76e-01
RESPONSE TO SALT	352	1.90e-02	1.96e-01	0.1070	3.61e-02	-1.11e-03	3.91e-02	2.87e-02	8.78e-02	2.45e-01	9.71e-01	2.07e-01	3.54e-01	4.67e-03
ORGANELLE FISSION	480	1.35e-03	3.13e-02	0.1070	5.10e-02	-1.62e-02	6.91e-02	6.06e-02	-5.73e-03	5.55e-02	5.42e-01	9.49e-03	2.29e-02	8.30e-01
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	70	7.64e-01	9.75e-01	0.1060	2.95e-02	4.01e-02	5.27e-02	6.15e-02	4.78e-02	6.69e-01	5.61e-01	4.46e-01	3.74e-01	4.89e-01
REGULATED EXOCYTOSIS	216	2.24e-01	7.05e-01	0.1060	-2.22e-02	-6.24e-02	2.04e-03	-4.78e-04	8.32e-02	5.74e-01	1.14e-01	9.59e-01	9.90e-01	3.51e-02
SYNAPTIC TRANSMISSION CHOLINERGIC	31	4.62e-01	8.80e-01	0.1060	-7.55e-03	9.49e-02	7.09e-03	-1.50e-02	-4.43e-02	9.42e-01	3.61e-01	9.46e-01	8.85e-01	6.69e-01
REGULATION OF MEMBRANE DEPOLARIZATION	45	7.28e-01	9.71e-01	0.1060	1.06e-02	1.31e-02	-6.53e-02	-4.75e-02	-6.70e-02	9.02e-01	8.79e-01	4.48e-01	5.81e-01	4.37e-01
FEMALE SEX DIFFERENTIATION	117	3.94e-02	3.05e-01	0.1060	-2.96e-02	-7.28e-02	-3.19e-02	-5.59e-02	-3.08e-02	5.81e-01	1.74e-01	5.51e-01	2.96e-01	5.65e-01
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	269	9.01e-02	4.78e-01	0.1060	-2.78e-02	1.60e-03	-6.31e-02	-7.23e-02	-3.58e-02	4.33e-01	9.64e-01	7.49e-02	4.11e-02	3.12e-01
MORPHOGENESIS OF A POLARIZED EPITHELIUM	89	7.11e-01	9.67e-01	0.1060	-4.17e-02	-5.64e-02	-2.32e-02	-3.33e-02	6.84e-02	4.96e-01	3.58e-01	7.05e-01	5.87e-01	2.65e-01
REGULATION OF ORGANIC ACID TRANSPORT	75	6.98e-01	9.62e-01	0.1060	-3.33e-02	-4.94e-02	-3.70e-02	-4.42e-02	6.60e-02	6.18e-01	4.59e-01	5.80e-01	5.08e-01	3.23e-01
REGULATION OF LEUKOCYTE CHEMOTAXIS	120	3.95e-02	3.05e-01	0.1060	5.58e-03	-1.79e-02	-4.50e-02	-3.22e-02	8.85e-02	9.16e-01	7.35e-01	3.95e-01	5.43e-01	9.41e-02
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION	52	6.79e-01	9.60e-01	0.1060	2.97e-02	-2.10e-02	6.47e-02	4.25e-02	6.26e-02	7.11e-01	7.93e-01	4.20e-01	5.96e-01	4.35e-01
MEMBRANE LIPID BIOSYNTHETIC PROCESS	148	2.24e-01	7.05e-01	0.1060	-5.28e-03	-8.95e-02	3.06e-02	2.80e-02	3.81e-02	9.12e-01	6.02e-02	5.21e-01	5.57e-01	4.23e-01
RESPONSE TO PURINE CONTAINING COMPOUND	137	6.88e-01	9.61e-01	0.1060	-5.00e-02	-6.66e-02	-3.65e-02	-4.48e-02	3.02e-02	3.13e-01	1.78e-01	4.61e-01	3.65e-01	5.42e-01
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT	80	4.71e-01	8.85e-01	0.1060	2.02e-02	-3.60e-02	7.45e-02	5.42e-02	3.14e-02	7.54e-01	5.78e-01	2.49e-01	4.02e-01	6.27e-01
BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS	48	7.68e-01	9.75e-01	0.1060	5.56e-02	7.24e-02	8.13e-03	4.19e-03	5.25e-02	5.05e-01	3.85e-01	9.22e-01	9.60e-01	5.29e-01
GLYCOPROTEIN METABOLIC PROCESS	358	5.07e-02	3.53e-01	0.1060	-5.64e-02	-7.81e-02	-2.15e-02	-3.56e-02	-1.25e-02	6.66e-02	1.11e-02	4.85e-01	2.48e-01	6.85e-01
POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	141	6.95e-01	9.61e-01	0.1060	-3.12e-02	3.89e-03	-7.15e-02	-6.70e-02	-2.41e-02	5.23e-01	9.36e-01	1.43e-01	1.70e-01	6.21e-01
REACTIVE OXYGEN SPECIES METABOLIC PROCESS	218	2.12e-01	6.91e-01	0.1060	2.78e-02	-3.30e-02	5.77e-02	4.54e-02	6.23e-02	4.79e-01	4.02e-01	1.42e-01	2.48e-01	1.13e-01
ERBB SIGNALING PATHWAY	123	6.63e-01	9.54e-01	0.1050	-4.05e-02	-5.09e-02	-5.52e-02	-5.79e-02	2.12e-02	4.38e-01	3.29e-01	2.90e-01	2.68e-01	6.85e-01
RESPONSE TO VITAMIN D	36	5.06e-01	8.99e-01	0.1050	2.99e-02	-5.31e-02	7.17e-02	4.50e-02	-1.35e-02	7.56e-01	5.81e-01	4.57e-01	6.41e-01	8.89e-01
ACUTE INFLAMMATORY RESPONSE	104	2.26e-01	7.08e-01	0.1050	-1.79e-02	1.88e-02	-6.16e-02	-5.24e-02	6.18e-02	7.52e-01	7.40e-01	2.78e-01	3.56e-01	2.76e-01
DENDRITE DEVELOPMENT	219	1.84e-01	6.56e-01	0.1050	-6.02e-02	-8.89e-03	-5.40e-02	-6.16e-02	2.51e-02	1.25e-01	8.21e-01	1.69e-01	1.16e-01	5.23e-01
TETRAHYDROFOLATE INTERCONVERSION	9	9.93e-01	9.99e-01	0.1050	-5.20e-03	-9.16e-02	1.70e-02	1.05e-02	4.71e-02	9.78e-01	6.34e-01	9.30e-01	9.57e-01	8.07e-01
NUCLEOBASE CONTAINING COMPOUND TRANSPORT	206	5.98e-01	9.33e-01	0.1050	5.48e-02	7.48e-03	6.19e-02	6.32e-02	1.16e-02	1.75e-01	8.53e-01	1.25e-01	1.18e-01	7.73e-01
NEGATIVE REGULATION OF PROTEIN BINDING	77	6.14e-01	9.38e-01	0.1050	-3.26e-02	-7.42e-02	2.74e-02	3.16e-02	5.19e-02	6.21e-01	2.60e-01	6.78e-01	6.32e-01	4.31e-01
REGULATION OF WOUND HEALING	129	6.03e-01	9.34e-01	0.1050	-5.01e-02	-4.83e-02	-5.77e-02	-4.95e-02	1.98e-02	3.26e-01	3.43e-01	2.58e-01	3.32e-01	6.98e-01
UROGENITAL SYSTEM DEVELOPMENT	66	1.23e-01	5.61e-01	0.1050	2.70e-02	-8.99e-02	3.52e-02	1.55e-02	2.62e-02	7.04e-01	2.07e-01	6.21e-01	8.28e-01	7.12e-01
NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	95	7.41e-01	9.73e-01	0.1050	-3.95e-02	-1.17e-02	-6.45e-02	-7.15e-02	1.94e-03	5.06e-01	8.44e-01	2.77e-01	2.29e-01	9.74e-01
PROTEIN DEACETYLATION	51	9.55e-01	9.97e-01	0.1050	2.36e-02	-1.76e-03	6.75e-02	6.05e-02	4.68e-02	7.71e-01	9.83e-01	4.04e-01	4.55e-01	5.63e-01
CELL CHEMOTAXIS	309	9.03e-04	2.26e-02	0.1050	-1.88e-02	-3.33e-02	-5.86e-02	-4.83e-02	6.10e-02	5.70e-01	3.14e-01	7.64e-02	1.44e-01	6.49e-02
SPHINGOLIPID BIOSYNTHETIC PROCESS	110	5.70e-01	9.26e-01	0.1050	-2.65e-02	-8.93e-02	1.49e-02	6.27e-03	4.49e-02	6.31e-01	1.06e-01	7.87e-01	9.09e-01	4.16e-01
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	7	9.71e-01	9.97e-01	0.1050	-3.28e-02	8.34e-02	-4.03e-02	-2.11e-02	-2.90e-02	8.81e-01	7.02e-01	8.53e-01	9.23e-01	8.94e-01
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	23	8.02e-01	9.82e-01	0.1050	7.39e-02	1.67e-02	1.32e-02	3.43e-02	6.19e-02	5.40e-01	8.90e-01	9.13e-01	7.76e-01	6.07e-01
RECEPTOR LOCALIZATION TO SYNAPSE	57	6.33e-01	9.48e-01	0.1040	5.85e-03	2.92e-02	6.77e-02	6.45e-02	3.58e-02	9.39e-01	7.03e-01	3.77e-01	3.99e-01	6.40e-01
TERPENOID BIOSYNTHETIC PROCESS	16	7.48e-01	9.75e-01	0.1040	2.22e-02	-7.15e-02	-4.72e-02	-4.95e-02	-2.50e-02	8.78e-01	6.20e-01	7.44e-01	7.32e-01	8.63e-01
POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	60	4.99e-01	8.97e-01	0.1040	-3.87e-02	-1.68e-02	-4.73e-02	-6.99e-02	-4.46e-02	6.04e-01	8.22e-01	5.26e-01	3.49e-01	5.50e-01
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	37	2.52e-01	7.35e-01	0.1040	5.64e-02	-6.15e-02	1.95e-02	3.26e-03	5.96e-02	5.53e-01	5.17e-01	8.37e-01	9.73e-01	5.31e-01
PROCESS UTILIZING AUTOPHAGIC MECHANISM	552	2.21e-05	1.11e-03	0.1040	3.94e-03	-8.68e-02	3.77e-02	2.96e-02	3.18e-02	8.74e-01	4.82e-04	1.29e-01	2.35e-01	2.01e-01
POSITIVE REGULATION OF CELLULAR EXTRAVASATION	15	9.84e-01	9.98e-01	0.1040	-2.16e-02	-1.41e-02	2.05e-02	1.95e-02	9.70e-02	8.85e-01	9.25e-01	8.91e-01	8.96e-01	5.16e-01
UV PROTECTION	12	7.96e-01	9.81e-01	0.1040	9.12e-02	-2.85e-02	3.19e-02	2.01e-02	-1.77e-02	5.85e-01	8.64e-01	8.48e-01	9.04e-01	9.16e-01
PLATELET AGGREGATION	71	6.34e-01	9.48e-01	0.1040	3.72e-02	-4.07e-02	3.70e-02	3.20e-02	7.35e-02	5.88e-01	5.54e-01	5.90e-01	6.41e-01	2.84e-01
PROTEIN AUTOPHOSPHORYLATION	189	3.24e-01	7.96e-01	0.1040	-3.10e-03	4.16e-02	-5.36e-02	-5.56e-02	-5.58e-02	9.41e-01	3.24e-01	2.04e-01	1.88e-01	1.85e-01
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	224	7.37e-01	9.73e-01	0.1040	-5.09e-02	-4.02e-02	-5.68e-02	-5.79e-02	-4.28e-03	1.89e-01	3.00e-01	1.43e-01	1.35e-01	9.12e-01
DNA DEALKYLATION	37	8.93e-01	9.92e-01	0.1040	-7.28e-02	-3.14e-02	-4.00e-02	-3.31e-02	-4.26e-02	4.44e-01	7.41e-01	6.74e-01	7.27e-01	6.54e-01
POSITIVE REGULATION OF MAPK CASCADE	467	2.51e-03	4.86e-02	0.1040	-3.04e-02	-4.07e-02	-4.37e-02	-4.35e-02	6.62e-02	2.61e-01	1.31e-01	1.05e-01	1.07e-01	1.42e-02
POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	15	9.27e-01	9.95e-01	0.1040	4.16e-03	6.30e-02	4.68e-02	3.90e-02	-5.53e-02	9.78e-01	6.73e-01	7.54e-01	7.94e-01	7.11e-01
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	58	2.35e-01	7.19e-01	0.1040	-4.05e-02	2.73e-03	2.17e-02	2.55e-02	-8.94e-02	5.94e-01	9.71e-01	7.75e-01	7.37e-01	2.39e-01
PURINE CONTAINING COMPOUND METABOLIC PROCESS	460	8.26e-03	1.14e-01	0.1040	4.71e-02	-2.40e-02	6.33e-02	6.28e-02	3.49e-03	8.34e-02	3.78e-01	1.99e-02	2.10e-02	8.98e-01
SULFUR COMPOUND METABOLIC PROCESS	295	8.27e-02	4.59e-01	0.1040	-4.36e-02	-8.55e-02	-1.60e-02	-2.29e-02	-2.75e-02	1.98e-01	1.16e-02	6.37e-01	4.98e-01	4.16e-01
MACROMOLECULE CATABOLIC PROCESS	1346	3.22e-09	3.90e-07	0.1040	3.53e-02	-4.17e-02	6.35e-02	5.55e-02	2.54e-02	2.98e-02	1.02e-02	9.18e-05	6.32e-04	1.17e-01
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	24	9.91e-01	9.99e-01	0.1040	-6.16e-02	-7.78e-02	-1.82e-02	-2.14e-02	1.05e-02	6.02e-01	5.10e-01	8.77e-01	8.56e-01	9.29e-01
SPERMATID DIFFERENTIATION	202	5.60e-03	8.89e-02	0.1040	1.06e-02	7.29e-02	-4.83e-02	-3.25e-02	4.38e-02	7.94e-01	7.42e-02	2.36e-01	4.25e-01	2.83e-01
MODIFIED AMINO ACID TRANSPORT	47	5.02e-01	8.98e-01	0.1040	3.99e-02	4.94e-02	-6.30e-02	-4.18e-02	-3.13e-02	6.36e-01	5.58e-01	4.55e-01	6.20e-01	7.11e-01
TRANSITION METAL ION TRANSPORT	93	2.91e-01	7.67e-01	0.1030	1.70e-02	-8.09e-02	3.23e-02	2.33e-02	4.78e-02	7.77e-01	1.77e-01	5.91e-01	6.97e-01	4.26e-01
POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT	202	4.07e-02	3.08e-01	0.1030	1.57e-02	4.83e-02	-5.19e-03	-2.01e-03	8.99e-02	7.00e-01	2.37e-01	8.99e-01	9.61e-01	2.76e-02
EMBRYONIC AXIS SPECIFICATION	39	6.53e-01	9.52e-01	0.1030	4.50e-02	9.24e-03	3.43e-02	1.43e-02	8.48e-02	6.27e-01	9.20e-01	7.11e-01	8.77e-01	3.60e-01
INTRACELLULAR TRANSPORT	1513	3.57e-10	4.98e-08	0.1030	3.39e-02	-3.86e-02	6.44e-02	5.38e-02	3.14e-02	2.75e-02	1.20e-02	2.77e-05	4.66e-04	4.14e-02
RESPONSE TO ABIOTIC STIMULUS	1079	2.06e-03	4.17e-02	0.1030	4.48e-02	-7.75e-03	5.39e-02	5.33e-02	5.32e-02	1.28e-02	6.67e-01	2.75e-03	3.12e-03	3.17e-03
SUPEROXIDE METABOLIC PROCESS	66	9.34e-01	9.97e-01	0.1030	-5.51e-02	-5.58e-02	-3.47e-02	-3.72e-02	4.36e-02	4.39e-01	4.33e-01	6.26e-01	6.01e-01	5.40e-01
RETROGRADE TRANSPORT ENDOSOME TO GOLGI	95	2.03e-01	6.83e-01	0.1030	-1.37e-02	-9.78e-02	-5.32e-03	-1.87e-02	2.24e-02	8.17e-01	9.94e-02	9.29e-01	7.52e-01	7.06e-01
RESPONSE TO ALDOSTERONE	16	8.51e-01	9.88e-01	0.1030	6.35e-02	4.08e-02	-3.54e-02	-4.03e-02	-4.53e-02	6.60e-01	7.78e-01	8.06e-01	7.80e-01	7.54e-01
LIPOPROTEIN METABOLIC PROCESS	129	5.73e-01	9.26e-01	0.1030	-5.31e-02	-7.35e-02	-3.17e-02	-2.59e-02	-2.71e-02	2.97e-01	1.50e-01	5.34e-01	6.12e-01	5.95e-01
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION	91	8.57e-01	9.88e-01	0.1030	-5.62e-02	-3.19e-02	-5.15e-02	-5.23e-02	3.25e-02	3.54e-01	5.99e-01	3.96e-01	3.88e-01	5.92e-01
EMBRYONIC ORGAN DEVELOPMENT	446	7.20e-07	5.31e-05	0.1030	4.45e-02	-5.28e-02	4.74e-02	3.25e-02	5.05e-02	1.07e-01	5.59e-02	8.58e-02	2.39e-01	6.76e-02
REGULATION OF PROGRAMMED CELL DEATH	1469	1.89e-08	1.90e-06	0.1030	3.97e-02	-3.58e-02	5.80e-02	5.32e-02	3.95e-02	1.09e-02	2.15e-02	1.96e-04	6.41e-04	1.13e-02
MIRNA METABOLIC PROCESS	101	1.50e-01	6.11e-01	0.1030	-1.75e-02	-9.11e-02	-1.99e-02	-3.47e-02	2.00e-02	7.61e-01	1.14e-01	7.30e-01	5.46e-01	7.29e-01
SYNAPTIC VESICLE RECYCLING	76	5.18e-01	9.03e-01	0.1030	-6.99e-02	-2.96e-02	-2.06e-02	-3.46e-02	5.67e-02	2.92e-01	6.56e-01	7.56e-01	6.03e-01	3.92e-01
NATURAL KILLER CELL ACTIVATION	93	3.86e-01	8.40e-01	0.1030	2.04e-02	1.01e-01	2.13e-05	3.00e-03	4.12e-03	7.34e-01	9.34e-02	1.00e+00	9.60e-01	9.45e-01
EPITHELIAL CELL MORPHOGENESIS	29	9.73e-01	9.97e-01	0.1030	5.21e-02	8.79e-02	7.25e-04	8.17e-03	-5.99e-03	6.27e-01	4.12e-01	9.95e-01	9.39e-01	9.55e-01
POSITIVE REGULATION OF TELOMERASE ACTIVITY	33	8.45e-01	9.86e-01	0.1030	1.71e-02	-5.60e-02	6.30e-02	5.21e-02	-2.10e-02	8.65e-01	5.78e-01	5.31e-01	6.05e-01	8.35e-01
LEUKOCYTE CHEMOTAXIS	233	7.39e-05	3.00e-03	0.1030	1.23e-02	-1.47e-02	-5.96e-02	-4.60e-02	6.70e-02	7.46e-01	6.99e-01	1.17e-01	2.27e-01	7.79e-02
IN UTERO EMBRYONIC DEVELOPMENT	383	1.17e-01	5.46e-01	0.1030	4.11e-02	-1.63e-02	6.63e-02	6.16e-02	1.95e-02	1.68e-01	5.85e-01	2.59e-02	3.85e-02	5.12e-01
EPITHELIAL CELL APOPTOTIC PROCESS	143	7.89e-01	9.81e-01	0.1030	3.48e-02	1.49e-02	6.46e-02	5.77e-02	3.96e-02	4.72e-01	7.58e-01	1.82e-01	2.33e-01	4.14e-01
MYELOID CELL DEVELOPMENT	80	7.62e-01	9.75e-01	0.1020	-3.03e-02	-4.73e-02	-5.51e-02	-6.09e-02	-2.48e-02	6.39e-01	4.65e-01	3.95e-01	3.47e-01	7.02e-01
CELLULAR RESPONSE TO VITAMIN D	21	9.45e-01	9.97e-01	0.1020	-4.58e-02	-8.58e-02	9.41e-04	-2.16e-02	2.40e-02	7.16e-01	4.96e-01	9.94e-01	8.64e-01	8.49e-01
NOTCH SIGNALING PATHWAY	174	3.40e-02	2.79e-01	0.1020	-1.61e-02	-7.57e-02	-8.25e-03	-2.55e-02	6.15e-02	7.13e-01	8.48e-02	8.51e-01	5.61e-01	1.62e-01
POSITIVE REGULATION OF GLUTAMATE SECRETION	11	7.20e-01	9.69e-01	0.1020	-1.44e-03	2.27e-02	-3.19e-02	-7.20e-02	6.14e-02	9.93e-01	8.96e-01	8.55e-01	6.79e-01	7.24e-01
REGULATION OF EXTENT OF CELL GROWTH	101	2.08e-01	6.85e-01	0.1020	-1.05e-02	2.22e-02	-5.89e-02	-6.67e-02	4.42e-02	8.55e-01	7.00e-01	3.07e-01	2.47e-01	4.43e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	37	9.90e-01	9.98e-01	0.1020	-6.15e-02	-2.51e-02	-4.91e-02	-5.27e-02	-2.86e-02	5.17e-01	7.92e-01	6.05e-01	5.79e-01	7.63e-01
CANONICAL WNT SIGNALING PATHWAY	302	1.43e-01	6.01e-01	0.1020	2.58e-03	-4.96e-02	4.88e-02	3.83e-02	6.42e-02	9.38e-01	1.38e-01	1.45e-01	2.52e-01	5.51e-02
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	51	7.90e-01	9.81e-01	0.1020	3.43e-02	6.23e-02	-4.78e-02	-3.78e-02	-4.06e-02	6.72e-01	4.42e-01	5.55e-01	6.40e-01	6.16e-01
POSITIVE REGULATION OF HYDROLASE ACTIVITY	484	2.21e-03	4.42e-02	0.1020	-7.27e-03	-3.30e-02	4.35e-03	-3.63e-03	9.62e-02	7.84e-01	2.14e-01	8.70e-01	8.91e-01	2.90e-04
PROTEIN PROCESSING	233	3.35e-01	8.06e-01	0.1020	2.40e-02	-1.72e-02	3.58e-02	3.72e-02	8.28e-02	5.27e-01	6.50e-01	3.47e-01	3.28e-01	2.94e-02
SEQUESTERING OF CALCIUM ION	138	8.00e-02	4.53e-01	0.1020	6.40e-03	8.54e-02	-2.60e-02	-2.77e-02	4.00e-02	8.97e-01	8.33e-02	5.98e-01	5.74e-01	4.17e-01
POSITIVE REGULATION OF EXOSOMAL SECRETION	15	6.83e-01	9.61e-01	0.1020	-1.16e-02	2.58e-02	5.24e-02	7.85e-02	-2.58e-02	9.38e-01	8.62e-01	7.25e-01	5.99e-01	8.63e-01
REGULATION OF MONOATOMIC ION TRANSPORT	545	1.14e-05	6.24e-04	0.1020	2.35e-02	6.81e-02	-8.28e-03	-4.12e-03	7.12e-02	3.47e-01	6.51e-03	7.41e-01	8.69e-01	4.47e-03
POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION	15	8.80e-01	9.89e-01	0.1020	-5.83e-02	-1.51e-02	-1.76e-02	-4.74e-02	6.44e-02	6.96e-01	9.19e-01	9.06e-01	7.51e-01	6.66e-01
EAR DEVELOPMENT	218	5.01e-02	3.50e-01	0.1020	1.05e-02	-6.07e-02	3.15e-02	1.75e-02	7.23e-02	7.89e-01	1.22e-01	4.23e-01	6.56e-01	6.57e-02
MEMBRANE RAFT LOCALIZATION	8	9.97e-01	1.00e+00	0.1010	-2.87e-02	-7.87e-02	-4.17e-02	-3.81e-02	-9.56e-03	8.88e-01	7.00e-01	8.38e-01	8.52e-01	9.63e-01
REPLACEMENT OSSIFICATION	30	9.57e-01	9.97e-01	0.1010	-3.74e-02	-3.59e-02	-3.92e-02	-4.69e-02	6.23e-02	7.23e-01	7.34e-01	7.10e-01	6.57e-01	5.55e-01
REGULATION OF ADENYLATE CYCLASE ACTIVITY	44	6.86e-01	9.61e-01	0.1010	4.96e-02	-3.64e-02	4.55e-02	3.27e-02	5.80e-02	5.69e-01	6.76e-01	6.02e-01	7.07e-01	5.06e-01
PROLINE METABOLIC PROCESS	10	9.09e-01	9.94e-01	0.1010	-2.79e-02	-6.52e-02	2.65e-02	4.95e-02	-4.57e-02	8.79e-01	7.21e-01	8.84e-01	7.86e-01	8.02e-01
NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	140	2.35e-01	7.19e-01	0.1010	-3.19e-02	-4.33e-02	-3.90e-02	-2.96e-02	7.05e-02	5.14e-01	3.77e-01	4.26e-01	5.46e-01	1.50e-01
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT	182	4.94e-02	3.47e-01	0.1010	-1.74e-02	-5.35e-02	-5.32e-02	-4.72e-02	4.50e-02	6.85e-01	2.13e-01	2.16e-01	2.72e-01	2.95e-01
LIPID STORAGE	93	6.51e-01	9.52e-01	0.1010	-3.47e-02	-5.37e-02	-4.44e-02	-3.98e-02	5.09e-02	5.63e-01	3.71e-01	4.60e-01	5.07e-01	3.96e-01
POSITIVE REGULATION OF CELL DIVISION	89	5.03e-01	8.98e-01	0.1010	-4.60e-02	-8.20e-02	-9.23e-03	-2.68e-02	-2.41e-02	4.53e-01	1.81e-01	8.80e-01	6.62e-01	6.95e-01
MELANOCYTE DIFFERENTIATION	24	9.95e-01	9.99e-01	0.1010	-4.52e-02	-5.58e-02	-4.98e-02	-5.05e-02	5.28e-03	7.01e-01	6.36e-01	6.73e-01	6.68e-01	9.64e-01
REGULATION OF MYOBLAST FUSION	21	9.80e-01	9.97e-01	0.1010	-5.20e-02	1.48e-02	-4.43e-02	-5.12e-02	-5.19e-02	6.80e-01	9.06e-01	7.25e-01	6.85e-01	6.81e-01
NEUTRAL LIPID METABOLIC PROCESS	128	6.33e-01	9.48e-01	0.1010	-4.18e-02	-7.30e-03	-5.94e-02	-4.68e-02	-5.15e-02	4.14e-01	8.87e-01	2.46e-01	3.61e-01	3.14e-01
REGULATION OF AXON EXTENSION	85	4.23e-01	8.61e-01	0.1010	-7.49e-04	5.52e-02	-5.67e-02	-6.24e-02	6.02e-04	9.90e-01	3.79e-01	3.66e-01	3.20e-01	9.92e-01
POSITIVE REGULATION OF NEUROGENESIS	228	5.21e-01	9.04e-01	0.1010	-5.85e-02	-3.25e-02	-4.82e-02	-5.39e-02	2.11e-02	1.28e-01	3.98e-01	2.10e-01	1.61e-01	5.82e-01
C21 STEROID HORMONE BIOSYNTHETIC PROCESS	20	6.42e-01	9.50e-01	0.1010	-2.75e-02	4.68e-02	3.26e-02	4.59e-02	-6.36e-02	8.32e-01	7.17e-01	8.01e-01	7.22e-01	6.23e-01
RESPONSE TO OXIDATIVE STRESS	384	2.40e-03	4.74e-02	0.1010	9.60e-04	-7.89e-02	4.26e-02	2.95e-02	3.53e-02	9.74e-01	7.94e-03	1.52e-01	3.21e-01	2.35e-01
PEPTIDYL SERINE MODIFICATION	291	2.99e-02	2.60e-01	0.1010	-4.43e-02	-3.18e-02	-4.96e-02	-6.68e-02	-1.55e-02	1.93e-01	3.51e-01	1.45e-01	4.98e-02	6.49e-01
POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	65	1.02e-01	5.10e-01	0.1010	-3.79e-03	-2.25e-02	-7.92e-02	-5.11e-02	2.69e-02	9.58e-01	7.54e-01	2.69e-01	4.76e-01	7.08e-01
REGULATION OF ACTIN NUCLEATION	38	9.63e-01	9.97e-01	0.1010	-4.11e-02	-8.59e-02	-6.21e-03	-8.49e-03	3.07e-02	6.61e-01	3.59e-01	9.47e-01	9.28e-01	7.43e-01
REGULATION OF HORMONE LEVELS	522	1.90e-01	6.64e-01	0.1010	-4.66e-02	-4.45e-02	-5.30e-02	-5.62e-02	2.38e-03	6.86e-02	8.19e-02	3.82e-02	2.79e-02	9.26e-01
ENDOSOMAL TRANSPORT	242	5.74e-02	3.80e-01	0.1010	-2.61e-02	-8.83e-02	-1.40e-02	-2.33e-02	2.99e-02	4.84e-01	1.80e-02	7.07e-01	5.33e-01	4.23e-01
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION	121	5.68e-01	9.24e-01	0.1010	-4.17e-02	-4.84e-02	-3.36e-02	-4.43e-02	5.42e-02	4.29e-01	3.58e-01	5.23e-01	3.99e-01	3.03e-01
FAS SIGNALING PATHWAY	8	2.37e-01	7.20e-01	0.1000	2.27e-02	6.93e-02	-5.98e-02	3.20e-02	-1.34e-02	9.11e-01	7.34e-01	7.69e-01	8.76e-01	9.48e-01
REGULATION OF RESPONSE TO TUMOR CELL	22	7.47e-01	9.75e-01	0.1000	-1.28e-02	3.30e-02	7.24e-02	5.40e-02	2.62e-02	9.17e-01	7.89e-01	5.57e-01	6.61e-01	8.31e-01
REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	13	9.91e-01	9.98e-01	0.1000	-5.65e-02	-4.45e-03	-6.47e-02	-5.17e-02	-4.13e-03	7.24e-01	9.78e-01	6.86e-01	7.47e-01	9.79e-01
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	73	6.99e-01	9.62e-01	0.1000	1.49e-02	1.72e-02	8.52e-03	1.07e-02	9.68e-02	8.26e-01	8.00e-01	9.00e-01	8.74e-01	1.53e-01
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	24	6.75e-01	9.59e-01	0.1000	-2.36e-02	6.40e-02	3.01e-02	3.04e-02	5.99e-02	8.41e-01	5.88e-01	7.98e-01	7.97e-01	6.11e-01
TISSUE MIGRATION	364	1.39e-02	1.59e-01	0.1000	-4.89e-02	-5.71e-02	-4.07e-02	-3.02e-02	4.30e-02	1.09e-01	6.14e-02	1.83e-01	3.22e-01	1.59e-01
LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE	52	6.26e-01	9.44e-01	0.1000	-4.44e-02	-5.50e-02	-4.22e-02	-2.51e-02	5.15e-02	5.80e-01	4.92e-01	5.98e-01	7.54e-01	5.21e-01
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	228	3.16e-01	7.89e-01	0.1000	-3.90e-02	-4.78e-02	-5.11e-02	-5.76e-02	1.76e-02	3.10e-01	2.14e-01	1.84e-01	1.34e-01	6.48e-01
POSITIVE REGULATION OF AUTOPHAGY	143	2.95e-01	7.71e-01	0.1000	-3.99e-02	-8.60e-02	-1.05e-03	-1.22e-02	-2.99e-02	4.11e-01	7.57e-02	9.83e-01	8.01e-01	5.37e-01
NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC	107	4.62e-01	8.80e-01	0.1000	-4.50e-02	-8.86e-02	6.09e-03	-9.16e-03	-5.89e-03	4.21e-01	1.13e-01	9.13e-01	8.70e-01	9.16e-01
REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY	7	9.60e-01	9.97e-01	0.1000	6.16e-04	-7.32e-02	6.16e-02	2.59e-02	1.40e-02	9.98e-01	7.37e-01	7.78e-01	9.06e-01	9.49e-01
RENAL SYSTEM DEVELOPMENT	316	5.98e-03	9.22e-02	0.1000	4.20e-02	-3.06e-02	5.19e-02	3.75e-02	5.68e-02	1.99e-01	3.50e-01	1.13e-01	2.52e-01	8.25e-02
CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS	20	9.95e-01	9.99e-01	0.1000	4.25e-02	6.26e-02	4.23e-02	4.62e-02	-1.92e-02	7.42e-01	6.28e-01	7.43e-01	7.20e-01	8.82e-01
CELL MORPHOGENESIS	914	3.92e-04	1.18e-02	0.1000	-4.18e-02	-3.94e-02	-5.29e-02	-6.24e-02	3.85e-03	3.19e-02	4.33e-02	6.68e-03	1.37e-03	8.43e-01
CARDIAC CHAMBER DEVELOPMENT	168	5.16e-02	3.57e-01	0.1000	1.81e-02	-6.68e-02	5.23e-02	3.42e-02	3.61e-02	6.86e-01	1.35e-01	2.42e-01	4.45e-01	4.20e-01
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	48	4.78e-01	8.88e-01	0.0999	-4.28e-03	2.58e-02	2.67e-02	4.33e-02	8.19e-02	9.59e-01	7.57e-01	7.49e-01	6.04e-01	3.26e-01
LIPID MODIFICATION	185	2.97e-01	7.72e-01	0.0998	-4.23e-02	-4.80e-02	-3.69e-02	-5.06e-02	-4.40e-02	3.21e-01	2.60e-01	3.87e-01	2.35e-01	3.02e-01
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1192	5.59e-04	1.56e-02	0.0998	-4.47e-02	-5.96e-02	-4.10e-02	-4.58e-02	2.51e-02	9.25e-03	5.30e-04	1.71e-02	7.76e-03	1.44e-01
ASTROCYTE ACTIVATION	25	3.70e-01	8.31e-01	0.0997	-4.83e-02	5.64e-02	-5.80e-02	-2.39e-02	2.24e-02	6.76e-01	6.26e-01	6.16e-01	8.36e-01	8.46e-01
REGULATION OF OSSIFICATION	116	1.94e-01	6.70e-01	0.0997	-1.23e-02	-9.81e-02	-2.37e-03	-8.47e-03	9.47e-03	8.19e-01	6.80e-02	9.65e-01	8.75e-01	8.60e-01
RESPONSE TO FORSKOLIN	14	9.69e-01	9.97e-01	0.0996	-3.93e-02	-6.00e-02	4.84e-02	4.55e-02	1.92e-02	7.99e-01	6.97e-01	7.54e-01	7.68e-01	9.01e-01
LONG CHAIN FATTY ACID METABOLIC PROCESS	104	2.99e-01	7.73e-01	0.0996	-4.81e-02	1.44e-02	-1.90e-02	-2.21e-02	-8.09e-02	3.97e-01	8.00e-01	7.38e-01	6.97e-01	1.54e-01
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM	29	9.61e-01	9.97e-01	0.0995	1.45e-02	6.51e-02	-4.86e-02	-3.70e-02	-4.16e-02	8.93e-01	5.44e-01	6.50e-01	7.30e-01	6.99e-01
RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	54	8.84e-01	9.91e-01	0.0995	-3.42e-02	-7.84e-02	-3.20e-02	-3.53e-02	-1.77e-02	6.64e-01	3.19e-01	6.84e-01	6.54e-01	8.22e-01
IMPORT INTO CELL	900	2.49e-03	4.85e-02	0.0995	-4.53e-02	-7.92e-03	-6.24e-02	-6.12e-02	1.19e-02	2.12e-02	6.87e-01	1.50e-03	1.83e-03	5.46e-01
LUNG MORPHOGENESIS	54	3.04e-01	7.76e-01	0.0995	4.49e-02	-7.28e-02	3.65e-02	3.20e-02	-1.51e-02	5.69e-01	3.55e-01	6.42e-01	6.84e-01	8.48e-01
POSITIVE REGULATION OF NEUROBLAST PROLIFERATION	37	9.56e-01	9.97e-01	0.0994	-4.65e-02	-8.18e-02	3.96e-03	3.12e-03	3.17e-02	6.24e-01	3.89e-01	9.67e-01	9.74e-01	7.38e-01
REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	431	1.67e-04	6.10e-03	0.0994	1.94e-02	6.90e-02	-1.18e-02	-7.33e-03	6.74e-02	4.89e-01	1.40e-02	6.75e-01	7.94e-01	1.63e-02
VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE	145	9.24e-01	9.95e-01	0.0994	-5.47e-02	-4.05e-02	-4.68e-02	-4.94e-02	-2.46e-02	2.55e-01	4.00e-01	3.30e-01	3.05e-01	6.09e-01
VASOCONSTRICTION	80	7.54e-01	9.75e-01	0.0993	5.59e-03	2.73e-02	-5.49e-02	-5.37e-02	-5.64e-02	9.31e-01	6.73e-01	3.96e-01	4.06e-01	3.83e-01
NEURON PROJECTION ORGANIZATION	85	7.53e-01	9.75e-01	0.0992	-6.39e-02	-3.75e-03	-5.40e-02	-4.92e-02	-2.01e-02	3.08e-01	9.52e-01	3.89e-01	4.33e-01	7.49e-01
REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	12	9.90e-01	9.98e-01	0.0991	1.30e-02	-7.11e-02	4.10e-02	4.38e-02	3.17e-02	9.38e-01	6.70e-01	8.06e-01	7.93e-01	8.49e-01
POSITIVE REGULATION OF CILIUM ASSEMBLY	28	9.35e-01	9.97e-01	0.0991	-5.92e-03	-4.05e-02	1.34e-02	-1.53e-03	8.92e-02	9.57e-01	7.11e-01	9.02e-01	9.89e-01	4.14e-01
TRABECULA MORPHOGENESIS	47	6.04e-01	9.34e-01	0.0991	-4.30e-02	-4.43e-02	-5.85e-03	-2.79e-02	-7.21e-02	6.10e-01	5.99e-01	9.45e-01	7.41e-01	3.92e-01
POSITIVE REGULATION OF CELL MATRIX ADHESION	56	6.10e-01	9.36e-01	0.0991	2.20e-02	3.53e-02	-1.39e-02	-1.76e-02	8.71e-02	7.76e-01	6.47e-01	8.57e-01	8.20e-01	2.60e-01
VENTRICULAR SEPTUM DEVELOPMENT	74	3.93e-01	8.42e-01	0.0991	-2.79e-02	-9.38e-02	6.67e-03	-1.34e-02	-4.53e-03	6.78e-01	1.63e-01	9.21e-01	8.43e-01	9.46e-01
MORPHOGENESIS OF A BRANCHING STRUCTURE	195	1.89e-02	1.96e-01	0.0990	1.26e-02	-7.13e-02	2.56e-02	1.02e-02	6.17e-02	7.62e-01	8.61e-02	5.38e-01	8.06e-01	1.37e-01
RESPONSE TO RADIATION	410	6.37e-02	4.03e-01	0.0990	4.17e-02	-1.21e-02	5.63e-02	4.67e-02	5.07e-02	1.48e-01	6.74e-01	5.05e-02	1.05e-01	7.80e-02
INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	62	9.41e-01	9.97e-01	0.0989	5.68e-02	5.33e-02	3.43e-02	3.35e-02	-3.78e-02	4.39e-01	4.68e-01	6.40e-01	6.49e-01	6.07e-01
BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS	1629	4.77e-03	7.90e-02	0.0989	4.33e-02	2.30e-02	5.28e-02	5.61e-02	3.78e-02	3.54e-03	1.21e-01	3.75e-04	1.57e-04	1.10e-02
NUCLEOBASE CATABOLIC PROCESS	10	1.00e+00	1.00e+00	0.0989	-3.76e-02	-5.31e-03	-4.72e-02	-5.09e-02	-5.92e-02	8.37e-01	9.77e-01	7.96e-01	7.80e-01	7.46e-01
PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING	24	9.86e-01	9.98e-01	0.0988	5.58e-02	6.99e-02	2.17e-02	3.59e-02	-3.17e-03	6.36e-01	5.53e-01	8.54e-01	7.61e-01	9.79e-01
REGULATION OF PROTEIN BINDING	140	6.54e-01	9.53e-01	0.0988	-5.18e-02	-8.00e-02	-1.33e-02	-2.17e-02	-6.31e-03	2.90e-01	1.02e-01	7.85e-01	6.58e-01	8.98e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	87	7.44e-01	9.74e-01	0.0988	7.30e-02	6.01e-02	1.59e-02	2.38e-02	-2.71e-03	2.39e-01	3.33e-01	7.97e-01	7.01e-01	9.65e-01
POSTSYNAPTIC SPECIALIZATION ASSEMBLY	26	6.48e-01	9.51e-01	0.0987	-2.16e-02	1.51e-03	-7.39e-03	-3.68e-02	8.87e-02	8.49e-01	9.89e-01	9.48e-01	7.45e-01	4.34e-01
REGULATION OF ORGANELLE ASSEMBLY	232	3.81e-02	2.99e-01	0.0986	-4.74e-03	-7.65e-02	4.33e-02	2.64e-02	3.57e-02	9.01e-01	4.47e-02	2.56e-01	4.88e-01	3.48e-01
NEURON PROJECTION EXTENSION	168	1.44e-01	6.02e-01	0.0986	-7.10e-03	4.69e-02	-5.75e-02	-6.38e-02	-1.02e-02	8.74e-01	2.94e-01	1.99e-01	1.54e-01	8.20e-01
POSITIVE REGULATION OF INFLAMMATORY RESPONSE	149	4.14e-01	8.54e-01	0.0986	-1.20e-02	-3.78e-02	2.75e-03	-4.26e-03	9.01e-02	8.01e-01	4.26e-01	9.54e-01	9.29e-01	5.75e-02
BIOMINERAL TISSUE DEVELOPMENT	165	3.42e-01	8.12e-01	0.0985	-3.15e-02	-7.66e-02	-3.51e-02	-3.89e-02	-1.00e-02	4.85e-01	8.93e-02	4.37e-01	3.89e-01	8.24e-01
TRANSCYTOSIS	20	9.86e-01	9.98e-01	0.0985	-4.65e-02	-8.67e-02	1.16e-03	-1.85e-03	-4.66e-03	7.19e-01	5.02e-01	9.93e-01	9.89e-01	9.71e-01
POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST	14	9.46e-01	9.97e-01	0.0983	5.00e-02	-1.44e-03	-5.65e-03	8.67e-03	-8.40e-02	7.46e-01	9.93e-01	9.71e-01	9.55e-01	5.86e-01
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	59	3.92e-01	8.41e-01	0.0983	3.85e-02	-5.36e-02	5.47e-02	4.05e-02	-2.62e-02	6.09e-01	4.77e-01	4.68e-01	5.91e-01	7.27e-01
CIRCADIAN RHYTHM	196	1.40e-01	5.95e-01	0.0983	-2.75e-02	-5.81e-02	-2.38e-02	-3.58e-02	6.06e-02	5.06e-01	1.61e-01	5.65e-01	3.88e-01	1.43e-01
MUSCLE CELL PROLIFERATION	230	1.88e-02	1.96e-01	0.0983	-1.72e-02	-6.73e-02	-2.98e-02	-3.98e-02	4.86e-02	6.54e-01	7.87e-02	4.36e-01	2.98e-01	2.04e-01
CELLULAR COMPONENT DISASSEMBLY	480	2.89e-03	5.36e-02	0.0982	3.04e-02	-4.86e-02	5.38e-02	4.56e-02	3.74e-02	2.53e-01	6.84e-02	4.36e-02	8.73e-02	1.60e-01
B CELL ACTIVATION	263	3.07e-01	7.81e-01	0.0982	1.87e-02	-5.03e-03	6.43e-02	5.48e-02	4.61e-02	6.02e-01	8.88e-01	7.26e-02	1.26e-01	1.98e-01
REGULATION OF CELLULAR RESPONSE TO HEAT	16	9.98e-01	1.00e+00	0.0981	5.19e-02	7.11e-02	2.73e-02	3.29e-02	7.38e-03	7.19e-01	6.23e-01	8.50e-01	8.20e-01	9.59e-01
NEGATIVE REGULATION OF CELL GROWTH	177	4.83e-02	3.42e-01	0.0981	7.40e-02	-1.46e-04	4.88e-02	4.03e-02	1.17e-02	8.95e-02	9.97e-01	2.63e-01	3.55e-01	7.89e-01
MESODERM MORPHOGENESIS	76	5.83e-02	3.84e-01	0.0980	1.84e-02	-9.19e-02	5.08e-03	-1.20e-02	2.56e-02	7.81e-01	1.66e-01	9.39e-01	8.57e-01	7.00e-01
SECOND MESSENGER MEDIATED SIGNALING	298	2.13e-02	2.12e-01	0.0980	3.27e-02	5.21e-02	7.96e-03	1.80e-02	7.37e-02	3.31e-01	1.22e-01	8.13e-01	5.94e-01	2.86e-02
PROTEIN DESTABILIZATION	46	8.30e-01	9.84e-01	0.0979	-3.08e-02	-7.51e-02	4.29e-02	3.16e-02	1.25e-02	7.17e-01	3.78e-01	6.15e-01	7.10e-01	8.83e-01
ORGANIC ACID TRANSMEMBRANE TRANSPORT	146	4.37e-01	8.69e-01	0.0979	2.14e-02	5.78e-02	-4.30e-02	-4.01e-02	-4.82e-02	6.55e-01	2.28e-01	3.69e-01	4.03e-01	3.14e-01
DEVELOPMENTAL CELL GROWTH	226	1.62e-01	6.26e-01	0.0979	-2.10e-02	3.50e-03	-6.51e-02	-6.97e-02	-5.92e-03	5.86e-01	9.28e-01	9.20e-02	7.10e-02	8.78e-01
REGULATION OF MACROAUTOPHAGY	150	9.45e-03	1.25e-01	0.0978	8.54e-03	-8.34e-02	4.52e-02	2.20e-02	2.96e-03	8.57e-01	7.80e-02	3.39e-01	6.41e-01	9.50e-01
STEROID HORMONE MEDIATED SIGNALING PATHWAY	132	4.16e-01	8.56e-01	0.0978	-4.25e-02	-7.89e-02	-1.71e-02	-3.31e-02	1.17e-02	3.99e-01	1.17e-01	7.35e-01	5.12e-01	8.17e-01
POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	12	9.85e-01	9.98e-01	0.0977	-2.01e-02	-9.23e-02	6.06e-04	1.64e-03	-2.49e-02	9.04e-01	5.80e-01	9.97e-01	9.92e-01	8.81e-01
CYTOKINE PRODUCTION	840	8.81e-02	4.72e-01	0.0976	-5.01e-02	-3.55e-02	-5.33e-02	-5.39e-02	4.25e-03	1.37e-02	8.06e-02	8.70e-03	7.96e-03	8.34e-01
RESPONSE TO CAMP	82	6.13e-01	9.38e-01	0.0976	2.19e-03	-1.69e-02	-6.72e-03	-7.11e-03	9.56e-02	9.73e-01	7.92e-01	9.16e-01	9.11e-01	1.35e-01
UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS	14	8.68e-01	9.88e-01	0.0976	4.25e-02	2.31e-02	2.63e-02	-1.26e-03	8.06e-02	7.83e-01	8.81e-01	8.65e-01	9.93e-01	6.02e-01
ACTIVATED T CELL PROLIFERATION	47	9.56e-01	9.97e-01	0.0975	-5.95e-02	-6.51e-02	-2.21e-02	-3.43e-02	-7.05e-03	4.80e-01	4.40e-01	7.93e-01	6.84e-01	9.33e-01
CELL JUNCTION DISASSEMBLY	27	6.53e-01	9.52e-01	0.0975	-3.90e-02	3.03e-02	1.88e-02	-4.33e-04	8.19e-02	7.26e-01	7.86e-01	8.66e-01	9.97e-01	4.61e-01
REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	23	6.84e-01	9.61e-01	0.0974	5.42e-02	4.49e-02	-5.10e-03	-2.35e-02	6.29e-02	6.53e-01	7.09e-01	9.66e-01	8.45e-01	6.01e-01
POSITIVE REGULATION OF GTPASE ACTIVITY	225	5.67e-04	1.57e-02	0.0974	-7.76e-03	2.90e-02	-3.52e-02	-5.28e-02	6.75e-02	8.41e-01	4.53e-01	3.63e-01	1.73e-01	8.08e-02
DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM	112	1.06e-01	5.23e-01	0.0974	2.22e-02	8.67e-02	-3.24e-02	-1.04e-02	1.75e-02	6.85e-01	1.13e-01	5.53e-01	8.49e-01	7.49e-01
SODIUM ION TRANSPORT	235	6.48e-02	4.06e-01	0.0973	2.47e-02	7.87e-02	-4.10e-02	-3.05e-02	-7.81e-03	5.14e-01	3.77e-02	2.79e-01	4.21e-01	8.37e-01
RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM	51	6.63e-01	9.54e-01	0.0973	-1.37e-02	-5.91e-02	4.42e-02	3.85e-02	-4.84e-02	8.66e-01	4.66e-01	5.85e-01	6.34e-01	5.50e-01
CATECHOL CONTAINING COMPOUND METABOLIC PROCESS	50	7.66e-01	9.75e-01	0.0972	2.28e-02	-4.81e-02	1.60e-02	1.93e-02	7.74e-02	7.80e-01	5.56e-01	8.45e-01	8.13e-01	3.44e-01
BEHAVIORAL RESPONSE TO ETHANOL	10	9.69e-01	9.97e-01	0.0972	2.21e-02	7.06e-02	-5.84e-04	-1.69e-02	6.07e-02	9.04e-01	6.99e-01	9.97e-01	9.26e-01	7.40e-01
MEMBRANE DEPOLARIZATION	78	5.64e-01	9.22e-01	0.0971	4.95e-02	7.65e-02	-1.48e-02	6.21e-03	-2.94e-02	4.50e-01	2.43e-01	8.22e-01	9.24e-01	6.53e-01
INNATE IMMUNE RESPONSE	912	2.59e-02	2.40e-01	0.0971	3.71e-02	2.77e-02	4.77e-02	5.22e-02	4.78e-02	5.73e-02	1.56e-01	1.46e-02	7.51e-03	1.44e-02
REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	31	8.73e-01	9.88e-01	0.0970	3.83e-03	5.40e-03	3.80e-02	5.11e-02	7.29e-02	9.71e-01	9.58e-01	7.14e-01	6.23e-01	4.82e-01
MYELOID LEUKOCYTE DIFFERENTIATION	227	6.16e-01	9.40e-01	0.0970	-4.34e-02	-4.18e-02	-5.38e-02	-5.27e-02	1.01e-02	2.60e-01	2.78e-01	1.62e-01	1.71e-01	7.93e-01
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM	451	2.80e-02	2.51e-01	0.0969	-1.26e-02	3.88e-02	-6.08e-02	-5.91e-02	-2.35e-02	6.46e-01	1.57e-01	2.70e-02	3.16e-02	3.92e-01
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES	149	1.78e-01	6.49e-01	0.0969	1.98e-02	-5.47e-02	5.99e-02	4.42e-02	2.16e-02	6.77e-01	2.49e-01	2.07e-01	3.51e-01	6.48e-01
RELAXATION OF MUSCLE	33	9.38e-01	9.97e-01	0.0968	-2.72e-02	-7.22e-02	-4.17e-02	-4.06e-02	6.71e-03	7.87e-01	4.73e-01	6.79e-01	6.87e-01	9.47e-01
LOCOMOTION	1266	3.77e-04	1.16e-02	0.0968	-4.31e-02	-4.20e-02	-5.22e-02	-5.01e-02	2.29e-02	9.82e-03	1.20e-02	1.78e-03	2.72e-03	1.71e-01
DEFENSE RESPONSE TO BACTERIUM	302	1.51e-04	5.57e-03	0.0968	4.32e-02	6.82e-02	-2.21e-02	-1.59e-04	4.86e-02	1.97e-01	4.14e-02	5.09e-01	9.96e-01	1.46e-01
HOMOLOGOUS RECOMBINATION	65	2.35e-01	7.19e-01	0.0967	5.80e-02	7.05e-02	2.85e-02	5.30e-03	1.31e-02	4.19e-01	3.26e-01	6.91e-01	9.41e-01	8.55e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	34	7.70e-01	9.76e-01	0.0966	-5.78e-02	9.69e-03	-5.40e-02	-4.03e-02	3.69e-02	5.60e-01	9.22e-01	5.86e-01	6.84e-01	7.10e-01
HEMOSTASIS	220	2.84e-01	7.62e-01	0.0966	-3.31e-02	-4.40e-02	-5.22e-02	-5.96e-02	-2.39e-03	3.97e-01	2.60e-01	1.82e-01	1.27e-01	9.51e-01
NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS	116	6.12e-01	9.37e-01	0.0966	-4.41e-02	-8.48e-02	-1.22e-03	-1.31e-02	4.63e-03	4.12e-01	1.15e-01	9.82e-01	8.07e-01	9.31e-01
REPRODUCTIVE SYSTEM DEVELOPMENT	289	1.52e-06	1.02e-04	0.0965	-1.72e-02	-9.06e-02	9.26e-04	-2.74e-02	7.54e-03	6.15e-01	8.01e-03	9.78e-01	4.24e-01	8.25e-01
ATRIOVENTRICULAR VALVE DEVELOPMENT	29	6.72e-01	9.58e-01	0.0965	4.32e-02	-3.62e-02	4.34e-02	2.67e-02	-5.94e-02	6.87e-01	7.36e-01	6.86e-01	8.03e-01	5.80e-01
NEGATIVE REGULATION OF CELL MATURATION	8	9.82e-01	9.97e-01	0.0963	-4.87e-02	-5.45e-02	5.09e-02	3.62e-02	-5.34e-03	8.11e-01	7.89e-01	8.03e-01	8.59e-01	9.79e-01
VESICLE TARGETING	65	3.15e-01	7.87e-01	0.0963	2.46e-02	-1.62e-02	3.56e-02	1.81e-02	-8.25e-02	7.32e-01	8.21e-01	6.19e-01	8.00e-01	2.50e-01
LUNG SACCULE DEVELOPMENT	10	9.21e-01	9.95e-01	0.0962	8.28e-02	-1.59e-02	3.72e-02	2.40e-02	-1.33e-02	6.50e-01	9.31e-01	8.39e-01	8.95e-01	9.42e-01
KERATINOCYTE DIFFERENTIATION	174	1.09e-02	1.36e-01	0.0962	4.94e-04	9.55e-02	-2.60e-03	6.82e-03	8.20e-03	9.91e-01	2.97e-02	9.53e-01	8.77e-01	8.52e-01
POSITIVE REGULATION OF WNT SIGNALING PATHWAY	138	5.10e-01	9.00e-01	0.0962	-6.39e-02	-5.93e-02	-1.96e-02	-3.55e-02	4.04e-03	1.95e-01	2.29e-01	6.91e-01	4.72e-01	9.35e-01
HORMONE CATABOLIC PROCESS	11	7.40e-01	9.73e-01	0.0959	-5.31e-02	-5.70e-02	-2.42e-03	-5.23e-02	-1.98e-02	7.61e-01	7.43e-01	9.89e-01	7.64e-01	9.09e-01
LEUKOCYTE HOMEOSTASIS	103	7.94e-01	9.81e-01	0.0959	-3.84e-03	-2.54e-02	3.87e-02	3.16e-02	7.78e-02	9.46e-01	6.56e-01	4.98e-01	5.80e-01	1.73e-01
REGULATION OF FAT CELL DIFFERENTIATION	140	3.83e-02	2.99e-01	0.0959	5.77e-02	-3.04e-02	1.98e-02	2.49e-02	6.27e-02	2.39e-01	5.35e-01	6.85e-01	6.11e-01	2.00e-01
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS	39	8.63e-01	9.88e-01	0.0958	-2.82e-03	-8.27e-02	1.35e-02	1.63e-02	4.34e-02	9.76e-01	3.72e-01	8.84e-01	8.60e-01	6.39e-01
LACTATE METABOLIC PROCESS	18	9.68e-01	9.97e-01	0.0958	6.24e-02	6.38e-02	-7.65e-03	-9.47e-03	-3.25e-02	6.47e-01	6.39e-01	9.55e-01	9.45e-01	8.11e-01
POSITIVE REGULATION OF LEUKOCYTE MIGRATION	142	1.50e-02	1.67e-01	0.0957	-1.64e-04	-3.80e-02	-4.50e-02	-2.72e-02	7.03e-02	9.97e-01	4.34e-01	3.55e-01	5.75e-01	1.48e-01
RESPONSE TO GONADOTROPIN	27	8.24e-01	9.83e-01	0.0956	3.82e-02	3.95e-02	-2.08e-02	-3.32e-02	-6.77e-02	7.31e-01	7.23e-01	8.51e-01	7.65e-01	5.42e-01
CILIUM MOVEMENT	194	6.51e-02	4.07e-01	0.0955	4.72e-02	8.06e-02	-1.34e-02	8.11e-03	-1.23e-02	2.57e-01	5.29e-02	7.47e-01	8.45e-01	7.67e-01
OSTEOCLAST FUSION	6	9.97e-01	1.00e+00	0.0955	1.38e-02	9.01e-02	2.99e-04	-4.44e-03	-2.82e-02	9.53e-01	7.02e-01	9.99e-01	9.85e-01	9.05e-01
RESPONSE TO ANTIBIOTIC	36	8.89e-01	9.91e-01	0.0955	1.36e-02	-1.34e-02	-8.64e-03	-4.30e-03	-9.31e-02	8.87e-01	8.90e-01	9.28e-01	9.64e-01	3.34e-01
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	12	9.60e-01	9.97e-01	0.0955	5.77e-02	5.80e-02	-2.66e-02	-3.26e-02	-2.57e-02	7.29e-01	7.28e-01	8.73e-01	8.45e-01	8.78e-01
REGULATION OF MAP KINASE ACTIVITY	140	2.48e-01	7.33e-01	0.0954	-2.15e-02	-8.26e-02	-2.86e-02	-2.84e-02	-1.35e-02	6.61e-01	9.16e-02	5.59e-01	5.61e-01	7.83e-01
HEAD MORPHOGENESIS	35	9.75e-01	9.97e-01	0.0953	-1.83e-02	-1.01e-02	-4.58e-02	-5.06e-02	-6.32e-02	8.51e-01	9.17e-01	6.39e-01	6.05e-01	5.17e-01
REGULATION OF PROTEIN POLYMERIZATION	195	6.50e-01	9.51e-01	0.0952	-4.38e-02	-4.58e-02	-4.52e-02	-5.36e-02	-1.16e-02	2.91e-01	2.70e-01	2.76e-01	1.97e-01	7.79e-01
EXOCYTIC PROCESS	82	4.42e-01	8.72e-01	0.0952	-2.35e-02	-6.49e-02	3.00e-02	2.57e-02	-5.23e-02	7.12e-01	3.10e-01	6.38e-01	6.87e-01	4.13e-01
REGULATION OF MEMBRANE LIPID DISTRIBUTION	60	8.38e-01	9.85e-01	0.0952	-4.89e-02	-1.19e-02	-4.18e-02	-4.17e-02	5.51e-02	5.12e-01	8.73e-01	5.75e-01	5.76e-01	4.61e-01
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY	234	4.95e-01	8.96e-01	0.0950	-5.59e-02	-3.80e-02	-3.83e-02	-4.59e-02	2.97e-02	1.41e-01	3.17e-01	3.13e-01	2.26e-01	4.33e-01
CELLULAR RESPONSE TO PEPTIDE	367	1.24e-01	5.63e-01	0.0950	-3.34e-02	-5.18e-02	-5.24e-02	-4.97e-02	4.27e-04	2.72e-01	8.83e-02	8.47e-02	1.02e-01	9.89e-01
CELLULAR COMPONENT MORPHOGENESIS	753	5.41e-04	1.52e-02	0.0949	-3.93e-02	-2.37e-02	-5.09e-02	-6.06e-02	2.50e-02	6.64e-02	2.68e-01	1.73e-02	4.61e-03	2.43e-01
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	129	4.89e-01	8.92e-01	0.0949	-3.38e-02	-8.02e-02	-2.09e-02	-3.12e-02	3.43e-03	5.08e-01	1.16e-01	6.82e-01	5.40e-01	9.46e-01
POSITIVE REGULATION OF CELL CYCLE CHECKPOINT	18	8.68e-01	9.88e-01	0.0948	-6.44e-02	2.86e-02	-1.53e-02	-2.04e-02	-5.80e-02	6.36e-01	8.34e-01	9.10e-01	8.81e-01	6.70e-01
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	168	1.08e-01	5.25e-01	0.0948	-3.40e-02	7.43e-03	-6.82e-02	-5.18e-02	2.10e-02	4.47e-01	8.68e-01	1.27e-01	2.47e-01	6.38e-01
PROTEIN CONTAINING COMPLEX REMODELING	36	1.46e-01	6.04e-01	0.0947	1.99e-02	1.17e-02	-2.52e-02	1.66e-02	8.68e-02	8.37e-01	9.03e-01	7.93e-01	8.63e-01	3.68e-01
STEROID HORMONE BIOSYNTHETIC PROCESS	44	6.54e-01	9.53e-01	0.0947	-5.79e-03	8.54e-02	-3.50e-02	-2.03e-02	1.32e-03	9.47e-01	3.27e-01	6.88e-01	8.16e-01	9.88e-01
RESPONSE TO COLD	43	6.09e-01	9.35e-01	0.0946	4.73e-02	-4.78e-02	3.84e-02	4.88e-02	-2.39e-02	5.91e-01	5.88e-01	6.63e-01	5.80e-01	7.86e-01
MEMBRANE REPOLARIZATION	52	6.94e-01	9.61e-01	0.0940	-3.40e-02	1.66e-02	-3.78e-02	-4.86e-02	6.01e-02	6.72e-01	8.36e-01	6.37e-01	5.44e-01	4.53e-01
NEGATIVE REGULATION OF GENE EXPRESSION	1479	2.74e-03	5.22e-02	0.0940	-4.68e-02	-1.26e-02	-5.49e-02	-4.96e-02	-3.17e-02	2.59e-03	4.18e-01	4.08e-04	1.41e-03	4.14e-02
CELL AGGREGATION	23	7.17e-01	9.68e-01	0.0940	4.43e-03	-5.32e-02	-3.68e-02	-1.14e-02	-6.70e-02	9.71e-01	6.58e-01	7.60e-01	9.25e-01	5.78e-01
BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST	206	6.84e-01	9.61e-01	0.0939	5.32e-02	1.53e-02	5.46e-02	5.26e-02	1.54e-03	1.88e-01	7.05e-01	1.77e-01	1.93e-01	9.70e-01
G1 TO G0 TRANSITION	19	9.80e-01	9.97e-01	0.0938	5.80e-02	1.47e-02	4.18e-02	3.77e-02	-4.53e-02	6.62e-01	9.11e-01	7.52e-01	7.76e-01	7.33e-01
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	90	6.02e-01	9.34e-01	0.0938	-4.47e-03	-2.46e-02	4.32e-02	2.56e-02	7.51e-02	9.42e-01	6.87e-01	4.78e-01	6.74e-01	2.18e-01
PIGMENT METABOLIC PROCESS	74	7.51e-01	9.75e-01	0.0938	-3.74e-02	-4.26e-02	-6.86e-03	-1.92e-03	7.43e-02	5.78e-01	5.26e-01	9.19e-01	9.77e-01	2.69e-01
GLOMERULUS VASCULATURE MORPHOGENESIS	6	9.57e-01	9.97e-01	0.0938	7.72e-03	5.74e-02	-2.20e-02	-5.25e-02	4.68e-02	9.74e-01	8.08e-01	9.26e-01	8.24e-01	8.43e-01
RECEPTOR MEDIATED ENDOCYTOSIS	254	7.26e-01	9.71e-01	0.0937	-4.72e-02	-3.76e-02	-5.01e-02	-5.09e-02	6.25e-03	1.95e-01	3.03e-01	1.69e-01	1.62e-01	8.64e-01
REGULATION OF VESICLE MEDIATED TRANSPORT	507	1.56e-01	6.17e-01	0.0937	-4.73e-02	-6.23e-02	-2.22e-02	-2.61e-02	3.85e-02	6.79e-02	1.63e-02	3.91e-01	3.15e-01	1.38e-01
GLUCOSE 6 PHOSPHATE METABOLIC PROCESS	27	4.05e-01	8.50e-01	0.0937	-5.48e-03	1.55e-03	-3.62e-02	-6.95e-02	5.09e-02	9.61e-01	9.89e-01	7.45e-01	5.32e-01	6.47e-01
TEMPERATURE HOMEOSTASIS	181	2.05e-01	6.84e-01	0.0936	-1.61e-02	-7.83e-02	-1.02e-02	-9.96e-03	4.64e-02	7.08e-01	6.90e-02	8.13e-01	8.17e-01	2.82e-01
EMBRYONIC ORGAN MORPHOGENESIS	292	2.39e-07	1.94e-05	0.0934	3.30e-02	-7.86e-02	2.18e-02	4.17e-03	3.12e-02	3.32e-01	2.09e-02	5.22e-01	9.02e-01	3.59e-01
SNRNA TRANSCRIPTION BY RNA POLYMERASE III	8	8.00e-01	9.82e-01	0.0933	4.79e-02	-7.11e-02	-3.47e-02	3.93e-04	-1.25e-02	8.14e-01	7.28e-01	8.65e-01	9.98e-01	9.51e-01
CELL CYCLE G1 S PHASE TRANSITION	264	8.04e-03	1.11e-01	0.0933	4.47e-03	-6.54e-02	5.30e-02	3.35e-02	2.18e-02	9.01e-01	6.72e-02	1.38e-01	3.49e-01	5.43e-01
POST TRANSLATIONAL PROTEIN MODIFICATION	999	7.96e-08	6.97e-06	0.0933	1.83e-02	-4.92e-02	6.01e-02	4.77e-02	8.28e-03	3.27e-01	8.45e-03	1.31e-03	1.07e-02	6.58e-01
TYROSINE PHOSPHORYLATION OF STAT PROTEIN	81	9.16e-01	9.94e-01	0.0933	-3.12e-02	-1.50e-02	-5.26e-02	-4.35e-02	-5.33e-02	6.28e-01	8.15e-01	4.13e-01	4.99e-01	4.07e-01
RESPONSE TO AMPHETAMINE	29	5.46e-01	9.15e-01	0.0932	-7.81e-03	-7.20e-02	-1.66e-02	-4.30e-02	-3.63e-02	9.42e-01	5.02e-01	8.77e-01	6.89e-01	7.35e-01
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	18	9.02e-01	9.94e-01	0.0932	6.74e-02	-3.47e-02	3.59e-02	3.56e-02	1.93e-02	6.21e-01	7.99e-01	7.92e-01	7.94e-01	8.87e-01
REGULATION OF HIPPO SIGNALING	25	9.24e-01	9.95e-01	0.0931	-5.62e-02	-1.24e-02	-2.49e-02	-2.08e-02	6.56e-02	6.26e-01	9.14e-01	8.30e-01	8.57e-01	5.70e-01
MYOBLAST FUSION	47	3.44e-01	8.14e-01	0.0931	-1.74e-02	8.62e-02	9.35e-03	1.42e-02	2.54e-02	8.36e-01	3.07e-01	9.12e-01	8.67e-01	7.63e-01
CELLULAR RESPONSE TO ABIOTIC STIMULUS	318	2.84e-01	7.63e-01	0.0929	3.94e-02	-1.05e-02	4.81e-02	4.23e-02	5.36e-02	2.27e-01	7.48e-01	1.40e-01	1.95e-01	1.00e-01
SMOOTH MUSCLE CELL DIFFERENTIATION	72	2.00e-01	6.80e-01	0.0928	3.40e-02	-7.88e-02	2.38e-02	2.43e-02	-1.01e-02	6.18e-01	2.48e-01	7.27e-01	7.22e-01	8.82e-01
RECEPTOR RECYCLING	46	9.53e-01	9.97e-01	0.0927	5.39e-03	-1.14e-02	2.70e-02	2.07e-02	8.54e-02	9.50e-01	8.94e-01	7.51e-01	8.08e-01	3.16e-01
REGULATION OF LYMPHOCYTE DIFFERENTIATION	206	2.42e-01	7.26e-01	0.0927	3.01e-02	2.44e-02	6.52e-02	5.24e-02	9.99e-03	4.56e-01	5.47e-01	1.07e-01	1.94e-01	8.05e-01
BIOGENIC AMINE METABOLIC PROCESS	87	7.34e-01	9.73e-01	0.0927	-1.72e-02	-6.99e-02	-4.45e-03	-4.51e-03	5.80e-02	7.82e-01	2.60e-01	9.43e-01	9.42e-01	3.49e-01
NEGATIVE REGULATION OF WOUND HEALING	72	7.10e-01	9.67e-01	0.0927	-3.68e-02	-3.03e-02	-6.10e-02	-4.71e-02	1.95e-02	5.89e-01	6.57e-01	3.71e-01	4.89e-01	7.75e-01
PEPTIDYL LYSINE MODIFICATION	204	2.62e-02	2.42e-01	0.0926	1.89e-02	-6.21e-02	4.57e-02	3.77e-02	-2.92e-02	6.41e-01	1.26e-01	2.60e-01	3.53e-01	4.73e-01
NEGATIVE REGULATION OF PHOSPHORYLATION	321	1.60e-03	3.44e-02	0.0926	2.05e-02	-7.14e-02	4.06e-02	2.91e-02	2.38e-02	5.27e-01	2.78e-02	2.11e-01	3.70e-01	4.63e-01
REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	103	7.95e-01	9.81e-01	0.0926	4.45e-02	7.99e-02	5.84e-03	1.34e-02	-2.33e-03	4.35e-01	1.61e-01	9.18e-01	8.14e-01	9.67e-01
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	83	6.86e-01	9.61e-01	0.0924	-3.60e-02	-1.82e-02	-2.48e-02	-2.21e-02	7.62e-02	5.71e-01	7.75e-01	6.96e-01	7.28e-01	2.30e-01
GLOMERULUS MORPHOGENESIS	9	9.13e-01	9.94e-01	0.0922	-4.10e-03	6.98e-02	-1.37e-02	-4.33e-02	3.95e-02	9.83e-01	7.17e-01	9.43e-01	8.22e-01	8.37e-01
CELLULAR ALDEHYDE METABOLIC PROCESS	70	9.07e-01	9.94e-01	0.0922	-5.02e-02	-6.83e-02	-1.88e-02	-1.84e-02	-2.51e-02	4.68e-01	3.23e-01	7.86e-01	7.90e-01	7.16e-01
ANOIKIS	33	9.88e-01	9.98e-01	0.0922	-2.43e-02	-1.73e-02	-3.62e-02	-3.35e-02	-7.20e-02	8.09e-01	8.63e-01	7.19e-01	7.39e-01	4.74e-01
HEPATOCYTE APOPTOTIC PROCESS	21	9.40e-01	9.97e-01	0.0922	-6.24e-03	8.29e-03	2.15e-02	3.87e-03	8.90e-02	9.61e-01	9.48e-01	8.65e-01	9.75e-01	4.80e-01
RESPONSE TO LUTEINIZING HORMONE	7	9.96e-01	1.00e+00	0.0922	1.68e-02	-3.83e-02	5.12e-02	4.47e-02	-4.60e-02	9.39e-01	8.61e-01	8.14e-01	8.38e-01	8.33e-01
MEMBRANE LIPID CATABOLIC PROCESS	38	8.51e-01	9.88e-01	0.0921	-2.01e-02	-4.79e-02	-5.73e-02	-4.29e-02	-2.60e-02	8.30e-01	6.10e-01	5.41e-01	6.48e-01	7.82e-01
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	6	8.30e-01	9.84e-01	0.0921	-1.68e-03	-5.49e-03	4.35e-02	-1.47e-02	7.96e-02	9.94e-01	9.81e-01	8.54e-01	9.50e-01	7.36e-01
MALE SEX DIFFERENTIATION	163	6.39e-03	9.58e-02	0.0921	-2.22e-02	-6.69e-02	-2.07e-02	-4.55e-02	-3.16e-02	6.24e-01	1.40e-01	6.48e-01	3.16e-01	4.86e-01
REGULATION OF ENDOTHELIAL CELL MIGRATION	220	2.93e-02	2.56e-01	0.0920	-5.26e-02	-4.75e-02	-3.78e-02	-2.22e-02	3.91e-02	1.79e-01	2.25e-01	3.34e-01	5.71e-01	3.18e-01
GLUTAMATE RECEPTOR SIGNALING PATHWAY	47	7.93e-01	9.81e-01	0.0920	6.00e-03	8.33e-02	-1.29e-02	-1.88e-02	-3.10e-02	9.43e-01	3.23e-01	8.79e-01	8.24e-01	7.13e-01
CEREBELLAR CORTEX FORMATION	24	9.79e-01	9.97e-01	0.0920	-2.14e-02	-4.65e-02	-1.44e-02	-2.19e-02	7.18e-02	8.56e-01	6.93e-01	9.03e-01	8.53e-01	5.43e-01
NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT	24	9.73e-01	9.97e-01	0.0920	-3.10e-02	-6.91e-02	-6.42e-03	-2.13e-02	4.71e-02	7.92e-01	5.58e-01	9.57e-01	8.57e-01	6.89e-01
POSITIVE REGULATION OF CATABOLIC PROCESS	575	7.30e-02	4.34e-01	0.0919	-4.70e-02	-7.12e-02	-1.96e-02	-2.44e-02	-1.42e-02	5.42e-02	3.53e-03	4.22e-01	3.16e-01	5.60e-01
REGULATION OF HAIR CYCLE	28	9.42e-01	9.97e-01	0.0919	1.28e-02	3.41e-02	-5.76e-02	-5.59e-02	-2.60e-02	9.07e-01	7.55e-01	5.98e-01	6.08e-01	8.12e-01
CELL VOLUME HOMEOSTASIS	34	8.26e-01	9.83e-01	0.0919	-3.21e-02	4.34e-02	-1.13e-02	-1.11e-02	-7.27e-02	7.46e-01	6.61e-01	9.09e-01	9.11e-01	4.63e-01
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	47	8.23e-01	9.83e-01	0.0918	3.81e-02	-3.77e-02	3.45e-02	4.29e-02	5.03e-02	6.52e-01	6.55e-01	6.83e-01	6.11e-01	5.51e-01
POSITIVE REGULATION OF PROTEIN GLYCOSYLATION	8	8.78e-01	9.88e-01	0.0918	3.48e-02	5.20e-02	-3.73e-02	1.14e-02	-5.46e-02	8.65e-01	7.99e-01	8.55e-01	9.56e-01	7.89e-01
CELL CYCLE PROCESS	1248	1.29e-11	2.11e-09	0.0916	3.28e-02	-3.52e-02	6.21e-02	4.67e-02	6.30e-03	5.10e-02	3.62e-02	2.24e-04	5.46e-03	7.08e-01
REGULATION OF METAL ION TRANSPORT	381	7.44e-03	1.07e-01	0.0916	3.30e-02	6.11e-02	-4.90e-03	3.99e-04	5.95e-02	2.69e-01	4.05e-02	8.69e-01	9.89e-01	4.62e-02
CEREBELLAR PURKINJE CELL LAYER FORMATION	14	9.73e-01	9.97e-01	0.0915	-1.92e-02	-3.23e-02	3.58e-02	1.23e-02	7.44e-02	9.01e-01	8.34e-01	8.17e-01	9.36e-01	6.30e-01
REGULATION OF ERBB SIGNALING PATHWAY	70	9.67e-01	9.97e-01	0.0915	4.99e-02	2.16e-02	4.60e-02	4.19e-02	3.92e-02	4.70e-01	7.54e-01	5.06e-01	5.44e-01	5.71e-01
REGULATION OF LOCOMOTION	1082	1.11e-02	1.37e-01	0.0914	-4.38e-02	-4.13e-02	-4.72e-02	-4.62e-02	1.94e-02	1.49e-02	2.17e-02	8.77e-03	1.03e-02	2.81e-01
INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE	8	9.32e-01	9.97e-01	0.0914	2.58e-02	-6.69e-02	-3.50e-02	-4.46e-02	2.02e-04	9.00e-01	7.43e-01	8.64e-01	8.27e-01	9.99e-01
PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	40	8.86e-01	9.91e-01	0.0912	2.75e-02	-2.31e-03	4.72e-02	4.11e-02	-6.04e-02	7.63e-01	9.80e-01	6.06e-01	6.53e-01	5.09e-01
POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION	69	2.03e-01	6.82e-01	0.0912	8.32e-03	-4.86e-02	-3.30e-02	-1.50e-02	6.77e-02	9.05e-01	4.85e-01	6.36e-01	8.29e-01	3.31e-01
REGULATION OF MIRNA METABOLIC PROCESS	83	2.75e-01	7.56e-01	0.0912	7.09e-03	-8.67e-02	1.76e-02	4.93e-03	2.05e-02	9.11e-01	1.72e-01	7.82e-01	9.38e-01	7.47e-01
LEARNING	145	6.95e-01	9.61e-01	0.0912	2.39e-02	-9.08e-03	4.16e-02	3.27e-02	6.97e-02	6.20e-01	8.50e-01	3.87e-01	4.97e-01	1.47e-01
EXECUTION PHASE OF APOPTOSIS	74	6.93e-01	9.61e-01	0.0911	4.51e-02	-3.57e-02	5.06e-02	4.75e-02	1.33e-02	5.02e-01	5.95e-01	4.52e-01	4.79e-01	8.43e-01
RESPONSE TO BACTERIUM	668	1.04e-02	1.32e-01	0.0911	5.06e-02	4.46e-02	2.30e-02	3.19e-02	4.71e-02	2.58e-02	4.94e-02	3.11e-01	1.60e-01	3.80e-02
PHOTORECEPTOR CELL DIFFERENTIATION	63	6.01e-01	9.33e-01	0.0911	1.49e-02	5.10e-02	-4.19e-02	-3.71e-02	4.84e-02	8.38e-01	4.84e-01	5.65e-01	6.10e-01	5.06e-01
NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	71	6.77e-01	9.59e-01	0.0911	-1.15e-02	-8.67e-02	4.42e-03	5.04e-03	2.46e-02	8.67e-01	2.07e-01	9.49e-01	9.41e-01	7.20e-01
MUSCLE CELL CELLULAR HOMEOSTASIS	21	8.56e-01	9.88e-01	0.0911	3.04e-02	8.23e-03	4.22e-02	2.08e-02	-7.14e-02	8.09e-01	9.48e-01	7.38e-01	8.69e-01	5.71e-01
NEGATIVE REGULATION OF BINDING	119	5.09e-01	9.00e-01	0.0911	-2.00e-02	-5.17e-02	3.96e-02	4.17e-02	4.38e-02	7.07e-01	3.30e-01	4.56e-01	4.32e-01	4.10e-01
BEHAVIORAL RESPONSE TO COCAINE	14	9.32e-01	9.97e-01	0.0909	5.46e-03	-6.73e-02	4.96e-02	2.21e-02	2.74e-02	9.72e-01	6.63e-01	7.48e-01	8.86e-01	8.59e-01
MYELOID LEUKOCYTE ACTIVATION	236	1.12e-01	5.35e-01	0.0909	-2.00e-02	-6.56e-02	-2.98e-02	-2.95e-02	4.24e-02	5.96e-01	8.25e-02	4.31e-01	4.35e-01	2.62e-01
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	65	5.87e-01	9.29e-01	0.0909	9.63e-03	-1.10e-02	-5.80e-02	-5.33e-02	-4.28e-02	8.93e-01	8.79e-01	4.19e-01	4.57e-01	5.50e-01
REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE	12	9.48e-01	9.97e-01	0.0909	7.73e-02	2.72e-02	-3.86e-03	1.10e-02	3.75e-02	6.43e-01	8.71e-01	9.82e-01	9.48e-01	8.22e-01
REGULATION OF NEUROTRANSMITTER TRANSPORT	92	8.12e-01	9.82e-01	0.0909	-4.20e-02	-3.75e-02	-1.56e-02	-2.09e-02	6.64e-02	4.87e-01	5.34e-01	7.96e-01	7.29e-01	2.71e-01
CELL PART MORPHOGENESIS	644	4.55e-04	1.35e-02	0.0908	-3.55e-02	-4.09e-02	-3.81e-02	-5.12e-02	3.52e-02	1.24e-01	7.64e-02	9.90e-02	2.66e-02	1.28e-01
REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	28	5.31e-01	9.07e-01	0.0907	-7.35e-02	7.40e-03	4.92e-03	-1.85e-02	4.90e-02	5.01e-01	9.46e-01	9.64e-01	8.65e-01	6.54e-01
POSITIVE REGULATION OF LOCOMOTION	589	5.89e-03	9.19e-02	0.0907	-3.15e-02	-4.70e-02	-4.91e-02	-4.35e-02	2.70e-02	1.91e-01	5.12e-02	4.19e-02	7.09e-02	2.64e-01
ISOPRENOID BIOSYNTHETIC PROCESS	29	2.52e-01	7.35e-01	0.0907	6.77e-02	-5.20e-02	-2.31e-02	-1.92e-02	-5.85e-03	5.28e-01	6.28e-01	8.30e-01	8.58e-01	9.57e-01
ERK1 AND ERK2 CASCADE	335	1.89e-02	1.96e-01	0.0907	7.96e-03	8.03e-03	1.92e-03	9.12e-03	8.95e-02	8.02e-01	8.00e-01	9.52e-01	7.74e-01	4.85e-03
REGULATION OF TRANSFERASE ACTIVITY	673	2.34e-04	7.97e-03	0.0906	3.84e-02	-3.49e-02	5.50e-02	4.98e-02	4.52e-03	8.94e-02	1.22e-01	1.50e-02	2.76e-02	8.41e-01
NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	133	2.94e-01	7.71e-01	0.0906	5.60e-02	2.61e-02	2.30e-02	1.61e-02	6.00e-02	2.65e-01	6.03e-01	6.48e-01	7.48e-01	2.32e-01
SEGMENTATION	99	1.95e-02	2.01e-01	0.0906	2.88e-02	-4.68e-02	2.34e-02	-3.57e-03	6.81e-02	6.20e-01	4.21e-01	6.87e-01	9.51e-01	2.42e-01
PEPTIDYL TYROSINE MODIFICATION	271	7.14e-01	9.68e-01	0.0905	-3.61e-02	-6.36e-03	-5.72e-02	-5.42e-02	-2.53e-02	3.06e-01	8.57e-01	1.05e-01	1.25e-01	4.73e-01
REGULATION OF SPROUTING ANGIOGENESIS	62	6.06e-01	9.34e-01	0.0905	-3.68e-02	4.44e-02	-5.47e-02	-4.29e-02	6.19e-03	6.17e-01	5.45e-01	4.56e-01	5.59e-01	9.33e-01
SELECTIVE AUTOPHAGY	92	5.98e-01	9.33e-01	0.0905	3.99e-02	-3.62e-02	5.38e-02	4.55e-02	1.76e-02	5.08e-01	5.48e-01	3.72e-01	4.51e-01	7.70e-01
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	85	5.34e-01	9.09e-01	0.0903	9.81e-03	-5.08e-03	-5.41e-02	-4.55e-02	-5.50e-02	8.76e-01	9.35e-01	3.88e-01	4.69e-01	3.80e-01
POSITIVE REGULATION OF BINDING	121	3.17e-01	7.89e-01	0.0902	2.43e-02	-4.64e-02	5.69e-02	4.55e-02	-8.72e-03	6.44e-01	3.78e-01	2.79e-01	3.88e-01	8.68e-01
PROTEIN CONTAINING COMPLEX LOCALIZATION	178	2.78e-01	7.58e-01	0.0902	3.00e-02	1.26e-02	6.61e-02	5.15e-02	6.67e-03	4.90e-01	7.72e-01	1.28e-01	2.36e-01	8.78e-01
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	15	9.70e-01	9.97e-01	0.0902	8.71e-03	6.31e-02	-3.89e-02	-4.57e-02	2.15e-02	9.53e-01	6.72e-01	7.94e-01	7.59e-01	8.85e-01
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	51	9.78e-01	9.97e-01	0.0901	-3.84e-02	-7.32e-03	-5.98e-02	-5.32e-02	-1.38e-02	6.35e-01	9.28e-01	4.60e-01	5.11e-01	8.65e-01
REGULATION OF LYASE ACTIVITY	57	7.93e-01	9.81e-01	0.0901	4.73e-02	-1.79e-02	2.83e-02	2.98e-02	6.23e-02	5.37e-01	8.15e-01	7.11e-01	6.97e-01	4.16e-01
RAC PROTEIN SIGNAL TRANSDUCTION	41	8.97e-01	9.93e-01	0.0901	-5.18e-02	-5.64e-02	-2.21e-04	-1.89e-02	4.36e-02	5.66e-01	5.32e-01	9.98e-01	8.34e-01	6.29e-01
ACTIN MEDIATED CELL CONTRACTION	101	3.60e-01	8.25e-01	0.0900	1.18e-02	6.71e-02	-3.43e-02	-2.53e-02	4.06e-02	8.38e-01	2.44e-01	5.52e-01	6.61e-01	4.80e-01
RESPONSE TO PEPTIDE HORMONE	415	1.57e-01	6.20e-01	0.0900	-3.58e-02	-6.62e-02	-3.33e-02	-3.56e-02	-7.84e-03	2.11e-01	2.07e-02	2.44e-01	2.13e-01	7.84e-01
REGULATION OF HAIR FOLLICLE DEVELOPMENT	19	8.38e-01	9.85e-01	0.0900	1.41e-02	-6.98e-02	2.72e-03	-1.59e-02	5.26e-02	9.15e-01	5.98e-01	9.84e-01	9.04e-01	6.91e-01
T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	10	9.09e-01	9.94e-01	0.0900	-2.37e-02	1.88e-02	-4.10e-02	-7.38e-02	-7.62e-03	8.97e-01	9.18e-01	8.23e-01	6.86e-01	9.67e-01
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	149	5.48e-01	9.15e-01	0.0898	5.04e-02	7.09e-04	5.63e-02	4.85e-02	-5.63e-04	2.88e-01	9.88e-01	2.35e-01	3.07e-01	9.91e-01
CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION	29	8.87e-01	9.91e-01	0.0898	2.70e-02	5.93e-02	-2.92e-02	-1.72e-02	5.17e-02	8.01e-01	5.81e-01	7.85e-01	8.73e-01	6.30e-01
GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	39	9.34e-01	9.97e-01	0.0897	-3.10e-02	-4.42e-02	-2.60e-02	-1.75e-02	-6.45e-02	7.38e-01	6.33e-01	7.79e-01	8.50e-01	4.86e-01
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	165	3.96e-02	3.05e-01	0.0897	1.08e-02	8.99e-04	-4.44e-02	-3.75e-02	6.75e-02	8.11e-01	9.84e-01	3.25e-01	4.06e-01	1.35e-01
ESTABLISHMENT OF CELL POLARITY	153	9.19e-01	9.95e-01	0.0895	-4.79e-02	-5.08e-02	-3.74e-02	-4.14e-02	-3.98e-03	3.07e-01	2.79e-01	4.24e-01	3.76e-01	9.32e-01
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT	58	9.36e-01	9.97e-01	0.0892	2.14e-02	-2.56e-02	5.89e-02	5.68e-02	1.19e-02	7.78e-01	7.36e-01	4.38e-01	4.55e-01	8.75e-01
REGULATION OF MULTICELLULAR ORGANISM GROWTH	63	8.77e-01	9.88e-01	0.0891	9.64e-04	-6.48e-02	2.77e-02	2.29e-02	4.94e-02	9.89e-01	3.73e-01	7.04e-01	7.53e-01	4.97e-01
TISSUE MORPHOGENESIS	620	1.48e-05	7.94e-04	0.0891	-1.87e-02	-6.46e-02	-3.03e-02	-4.06e-02	2.90e-02	4.26e-01	6.00e-03	1.98e-01	8.41e-02	2.18e-01
POSITIVE REGULATION OF CELL CYCLE PROCESS	251	8.59e-02	4.67e-01	0.0890	5.09e-02	-1.34e-02	5.47e-02	4.62e-02	-3.19e-03	1.65e-01	7.15e-01	1.35e-01	2.07e-01	9.31e-01
POSTSYNAPSE ORGANIZATION	179	8.88e-01	9.91e-01	0.0888	-4.43e-02	-1.25e-02	-5.03e-02	-5.26e-02	-2.18e-02	3.06e-01	7.73e-01	2.45e-01	2.25e-01	6.14e-01
SMALL MOLECULE CATABOLIC PROCESS	366	4.50e-02	3.30e-01	0.0888	-1.53e-02	-2.86e-02	-5.79e-02	-5.44e-02	-2.29e-02	6.16e-01	3.48e-01	5.69e-02	7.39e-02	4.51e-01
LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS	26	6.21e-01	9.43e-01	0.0888	-6.85e-02	-2.58e-02	3.62e-02	3.04e-02	-1.72e-02	5.45e-01	8.20e-01	7.50e-01	7.89e-01	8.80e-01
SPINDLE LOCALIZATION	62	9.24e-01	9.95e-01	0.0887	3.28e-02	-2.61e-03	5.68e-02	5.78e-02	-1.48e-02	6.55e-01	9.72e-01	4.39e-01	4.31e-01	8.40e-01
NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	50	7.67e-01	9.75e-01	0.0887	6.22e-03	-1.42e-02	7.84e-04	-1.15e-02	8.66e-02	9.39e-01	8.62e-01	9.92e-01	8.88e-01	2.90e-01
BLOOD COAGULATION FIBRIN CLOT FORMATION	14	9.76e-01	9.97e-01	0.0887	1.76e-03	1.36e-02	6.26e-02	4.52e-02	4.13e-02	9.91e-01	9.30e-01	6.85e-01	7.69e-01	7.89e-01
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	30	9.88e-01	9.98e-01	0.0886	-4.19e-02	-3.18e-02	-4.01e-02	-4.65e-02	3.63e-02	6.91e-01	7.63e-01	7.04e-01	6.59e-01	7.31e-01
PROTEIN HETEROOLIGOMERIZATION	28	9.20e-01	9.95e-01	0.0886	-6.63e-02	-1.54e-02	-3.87e-02	-3.09e-02	2.76e-02	5.44e-01	8.87e-01	7.23e-01	7.77e-01	8.00e-01
SEX DIFFERENTIATION	266	8.21e-05	3.27e-03	0.0886	-1.83e-02	-7.70e-02	-1.25e-02	-3.70e-02	-7.46e-03	6.07e-01	3.07e-02	7.25e-01	2.99e-01	8.34e-01
REGULATION OF TRANSPORTER ACTIVITY	253	2.21e-01	7.01e-01	0.0885	-2.21e-02	3.02e-02	-5.91e-02	-4.73e-02	-2.66e-02	5.44e-01	4.08e-01	1.06e-01	1.95e-01	4.66e-01
ANIMAL ORGAN MORPHOGENESIS	1014	1.86e-07	1.55e-05	0.0885	-2.28e-02	-6.96e-02	-1.65e-02	-2.86e-02	3.70e-02	2.19e-01	1.75e-04	3.75e-01	1.23e-01	4.62e-02
CELL SUBSTRATE ADHESION	344	1.43e-01	6.00e-01	0.0884	-3.11e-02	8.54e-04	-5.68e-02	-5.63e-02	2.13e-02	3.21e-01	9.78e-01	7.04e-02	7.25e-02	4.96e-01
NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION	164	7.88e-01	9.81e-01	0.0884	-4.04e-02	-5.37e-02	-3.39e-02	-3.73e-02	2.76e-02	3.72e-01	2.35e-01	4.54e-01	4.10e-01	5.41e-01
CELLULAR RESPONSE TO OSMOTIC STRESS	51	8.24e-01	9.83e-01	0.0884	-1.44e-02	-5.58e-02	5.17e-03	-1.06e-02	6.60e-02	8.58e-01	4.91e-01	9.49e-01	8.96e-01	4.15e-01
LAMELLIPODIUM ASSEMBLY	67	5.71e-01	9.26e-01	0.0884	-7.60e-03	-6.28e-03	-7.62e-04	-1.72e-02	8.62e-02	9.14e-01	9.29e-01	9.91e-01	8.07e-01	2.23e-01
MORPHOGENESIS OF AN EPITHELIUM	505	4.21e-05	1.93e-03	0.0884	-1.33e-02	-7.02e-02	-1.86e-02	-3.05e-02	3.80e-02	6.10e-01	6.93e-03	4.74e-01	2.41e-01	1.44e-01
POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	61	7.59e-02	4.43e-01	0.0884	2.29e-02	-7.36e-02	-3.44e-02	-1.36e-02	2.24e-02	7.57e-01	3.20e-01	6.42e-01	8.54e-01	7.62e-01
REGULATION OF MRNA METABOLIC PROCESS	339	3.90e-01	8.40e-01	0.0884	3.36e-02	-5.31e-04	5.91e-02	5.61e-02	6.08e-03	2.88e-01	9.87e-01	6.12e-02	7.59e-02	8.47e-01
PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL	107	1.16e-01	5.44e-01	0.0884	-3.67e-02	-6.80e-02	3.04e-02	6.15e-03	-2.95e-02	5.12e-01	2.24e-01	5.88e-01	9.12e-01	5.98e-01
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS	259	5.84e-02	3.85e-01	0.0883	-2.55e-03	5.45e-03	-3.70e-03	3.00e-03	8.80e-02	9.44e-01	8.80e-01	9.18e-01	9.34e-01	1.47e-02
RESPONSE TO KETONE	198	1.00e-01	5.06e-01	0.0883	-1.19e-02	-8.47e-02	5.17e-03	-4.71e-03	2.10e-02	7.73e-01	3.99e-02	9.00e-01	9.09e-01	6.10e-01
UTERUS DEVELOPMENT	23	5.32e-01	9.07e-01	0.0883	3.10e-02	-7.33e-02	2.86e-02	1.57e-03	-2.53e-02	7.97e-01	5.43e-01	8.12e-01	9.90e-01	8.33e-01
REGULATION OF DEVELOPMENTAL GROWTH	311	1.30e-01	5.74e-01	0.0883	-3.21e-02	-5.63e-02	-3.34e-02	-4.28e-02	2.53e-02	3.30e-01	8.75e-02	3.11e-01	1.94e-01	4.43e-01
DEFENSE RESPONSE TO OTHER ORGANISM	1153	2.00e-02	2.03e-01	0.0882	3.83e-02	2.82e-02	4.20e-02	4.80e-02	3.80e-02	2.82e-02	1.06e-01	1.60e-02	6.00e-03	2.94e-02
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION	60	4.38e-01	8.69e-01	0.0882	2.72e-03	-5.41e-02	-2.75e-02	-1.38e-02	6.25e-02	9.71e-01	4.69e-01	7.13e-01	8.53e-01	4.03e-01
REGULATION OF NEURON PROJECTION DEVELOPMENT	431	8.87e-02	4.73e-01	0.0882	-3.58e-02	-2.99e-02	-4.38e-02	-4.98e-02	3.46e-02	2.03e-01	2.87e-01	1.18e-01	7.61e-02	2.17e-01
PROTEIN SUMOYLATION	64	6.40e-01	9.49e-01	0.0881	-2.07e-03	-6.61e-02	2.83e-02	2.57e-02	-4.40e-02	9.77e-01	3.61e-01	6.96e-01	7.22e-01	5.42e-01
CELL JUNCTION ORGANIZATION	716	6.15e-02	3.97e-01	0.0881	-5.23e-02	-2.20e-02	-4.46e-02	-4.78e-02	1.65e-02	1.72e-02	3.16e-01	4.18e-02	2.92e-02	4.51e-01
REGULATION OF MUSCLE SYSTEM PROCESS	239	1.12e-01	5.35e-01	0.0881	2.48e-02	5.24e-02	-4.44e-02	-3.01e-02	-3.90e-02	5.09e-01	1.63e-01	2.37e-01	4.23e-01	2.99e-01
NEPHRON DEVELOPMENT	152	4.53e-01	8.77e-01	0.0881	3.48e-02	-7.38e-04	3.99e-02	2.79e-02	6.47e-02	4.59e-01	9.87e-01	3.96e-01	5.53e-01	1.69e-01
REGULATION OF LONG TERM SYNAPTIC POTENTIATION	46	7.88e-01	9.81e-01	0.0881	-3.64e-02	-1.66e-02	1.37e-02	1.71e-02	7.53e-02	6.69e-01	8.45e-01	8.72e-01	8.41e-01	3.77e-01
REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI	7	9.86e-01	9.98e-01	0.0881	-1.53e-02	4.87e-03	-3.63e-02	-6.05e-02	-5.02e-02	9.44e-01	9.82e-01	8.68e-01	7.82e-01	8.18e-01
NEGATIVE REGULATION OF GROWTH	233	1.53e-01	6.15e-01	0.0880	5.67e-02	-8.30e-03	4.93e-02	4.38e-02	1.02e-02	1.36e-01	8.27e-01	1.95e-01	2.50e-01	7.89e-01
REGULATION OF MRNA EXPORT FROM NUCLEUS	7	9.91e-01	9.98e-01	0.0879	6.49e-02	-5.57e-03	4.55e-02	3.03e-02	2.22e-02	7.66e-01	9.80e-01	8.35e-01	8.90e-01	9.19e-01
POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	192	3.64e-01	8.27e-01	0.0879	-3.95e-02	-3.74e-02	-6.90e-03	-1.82e-02	6.62e-02	3.45e-01	3.71e-01	8.69e-01	6.64e-01	1.14e-01
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS	614	4.26e-04	1.28e-02	0.0879	1.28e-02	-6.13e-02	4.57e-02	3.76e-02	1.69e-02	5.89e-01	9.43e-03	5.29e-02	1.11e-01	4.76e-01
MYELOID DENDRITIC CELL CYTOKINE PRODUCTION	8	8.45e-01	9.86e-01	0.0877	7.05e-02	-1.81e-02	4.71e-02	1.06e-02	-8.08e-03	7.30e-01	9.29e-01	8.18e-01	9.59e-01	9.68e-01
NEGATIVE REGULATION OF PROTEOLYSIS	213	6.54e-01	9.53e-01	0.0875	2.58e-02	-2.25e-02	4.28e-02	4.26e-02	5.32e-02	5.17e-01	5.72e-01	2.81e-01	2.84e-01	1.81e-01
WOUND HEALING	407	2.51e-01	7.35e-01	0.0875	-3.34e-02	-4.27e-02	-4.86e-02	-4.83e-02	4.05e-03	2.47e-01	1.39e-01	9.25e-02	9.46e-02	8.88e-01
REGULATION OF ACTIN FILAMENT ORGANIZATION	259	6.56e-01	9.53e-01	0.0874	-4.86e-02	-2.69e-02	-4.44e-02	-5.06e-02	6.21e-03	1.78e-01	4.56e-01	2.19e-01	1.61e-01	8.63e-01
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	371	5.08e-03	8.25e-02	0.0874	3.15e-03	-7.69e-02	2.38e-02	1.51e-02	3.02e-02	9.17e-01	1.10e-02	4.30e-01	6.17e-01	3.18e-01
REGULATION OF RUFFLE ASSEMBLY	32	6.01e-01	9.33e-01	0.0873	-4.59e-02	6.62e-03	-2.45e-02	-5.28e-02	4.57e-02	6.53e-01	9.48e-01	8.11e-01	6.05e-01	6.55e-01
NUCLEOBASE METABOLIC PROCESS	38	8.34e-01	9.85e-01	0.0872	-2.49e-02	-7.73e-02	1.27e-02	2.38e-02	1.70e-02	7.90e-01	4.10e-01	8.93e-01	7.99e-01	8.56e-01
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT	21	9.10e-01	9.94e-01	0.0872	3.96e-02	-1.47e-02	4.23e-02	6.32e-02	-7.15e-03	7.53e-01	9.07e-01	7.37e-01	6.16e-01	9.55e-01
CATECHOLAMINE SECRETION	60	2.12e-01	6.91e-01	0.0871	-5.04e-02	-2.41e-02	-1.51e-02	-4.82e-02	4.39e-02	5.00e-01	7.47e-01	8.40e-01	5.19e-01	5.57e-01
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	51	9.52e-01	9.97e-01	0.0871	-3.27e-02	-2.59e-02	-5.80e-02	-4.97e-02	3.29e-03	6.86e-01	7.49e-01	4.74e-01	5.39e-01	9.68e-01
REGULATION OF HYDROLASE ACTIVITY	741	1.95e-03	3.99e-02	0.0871	-2.01e-02	-3.74e-02	-9.87e-03	-1.58e-02	7.37e-02	3.52e-01	8.31e-02	6.47e-01	4.65e-01	6.30e-04
REGULATION OF LIPID BIOSYNTHETIC PROCESS	180	4.72e-01	8.85e-01	0.0869	-2.63e-02	-4.71e-02	-4.96e-02	-4.67e-02	3.41e-03	5.43e-01	2.76e-01	2.51e-01	2.80e-01	9.37e-01
NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS	83	5.45e-01	9.15e-01	0.0869	1.69e-02	-3.97e-02	2.77e-02	1.25e-02	6.90e-02	7.91e-01	5.32e-01	6.62e-01	8.44e-01	2.77e-01
FOREBRAIN CELL MIGRATION	64	8.95e-01	9.93e-01	0.0869	-2.80e-02	-7.27e-02	1.55e-02	4.28e-03	3.50e-02	6.99e-01	3.15e-01	8.30e-01	9.53e-01	6.28e-01
GOLGI ORGANIZATION	141	3.34e-01	8.05e-01	0.0869	7.84e-03	-7.03e-02	2.14e-02	1.77e-02	4.21e-02	8.72e-01	1.50e-01	6.61e-01	7.17e-01	3.88e-01
NEGATIVE REGULATION OF SECRETION	164	1.75e-01	6.47e-01	0.0868	-1.52e-02	-3.70e-02	-1.97e-02	-3.24e-02	6.71e-02	7.36e-01	4.14e-01	6.64e-01	4.74e-01	1.38e-01
RESPONSE TO AXON INJURY	79	2.27e-01	7.10e-01	0.0868	-1.26e-02	-3.58e-02	-5.43e-02	-3.36e-02	4.49e-02	8.46e-01	5.82e-01	4.04e-01	6.05e-01	4.90e-01
EXTRINSIC APOPTOTIC SIGNALING PATHWAY	221	1.43e-01	6.01e-01	0.0867	4.73e-02	-2.99e-02	4.40e-02	4.44e-02	2.19e-02	2.25e-01	4.44e-01	2.60e-01	2.55e-01	5.75e-01
MAINTENANCE OF LOCATION	335	1.59e-01	6.20e-01	0.0866	-3.45e-02	-2.37e-02	-3.78e-02	-3.85e-02	5.33e-02	2.78e-01	4.55e-01	2.34e-01	2.26e-01	9.39e-02
NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	49	9.26e-01	9.95e-01	0.0866	2.58e-02	1.01e-02	4.81e-02	3.42e-02	5.70e-02	7.55e-01	9.03e-01	5.60e-01	6.79e-01	4.90e-01
IRIS MORPHOGENESIS	10	9.90e-01	9.98e-01	0.0865	7.19e-02	2.32e-02	1.54e-02	1.82e-02	-3.49e-02	6.94e-01	8.99e-01	9.33e-01	9.21e-01	8.48e-01
CELLULAR RESPONSE TO KETONE	97	4.75e-01	8.86e-01	0.0865	-2.04e-02	-3.78e-02	-7.54e-03	-2.07e-02	-7.18e-02	7.28e-01	5.21e-01	8.98e-01	7.24e-01	2.21e-01
ACTIN FILAMENT ORGANIZATION	443	1.13e-01	5.37e-01	0.0864	-3.95e-02	-1.24e-02	-4.84e-02	-5.35e-02	2.36e-02	1.54e-01	6.54e-01	8.09e-02	5.35e-02	3.94e-01
POSITIVE REGULATION OF MUSCLE CONTRACTION	46	9.72e-01	9.97e-01	0.0863	5.91e-02	5.47e-02	1.68e-02	2.40e-02	9.77e-03	4.88e-01	5.21e-01	8.44e-01	7.79e-01	9.09e-01
NEGATIVE REGULATION OF CATABOLIC PROCESS	323	1.82e-01	6.56e-01	0.0862	4.17e-02	-6.88e-03	4.21e-02	3.50e-02	5.13e-02	1.97e-01	8.32e-01	1.93e-01	2.79e-01	1.13e-01
NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	140	5.75e-01	9.26e-01	0.0861	-2.96e-02	-7.13e-02	-1.53e-02	-1.84e-02	-2.96e-02	5.45e-01	1.45e-01	7.55e-01	7.07e-01	5.45e-01
NEURONAL STEM CELL POPULATION MAINTENANCE	23	6.95e-01	9.61e-01	0.0861	6.18e-02	-3.58e-02	4.22e-02	2.29e-02	-2.71e-03	6.08e-01	7.66e-01	7.26e-01	8.49e-01	9.82e-01
REGULATION OF PLATELET AGGREGATION	27	7.61e-01	9.75e-01	0.0861	3.36e-02	1.53e-02	-5.60e-02	-5.30e-02	1.00e-02	7.62e-01	8.91e-01	6.14e-01	6.34e-01	9.28e-01
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS	502	8.46e-02	4.65e-01	0.0861	-2.12e-02	-4.46e-02	1.72e-02	1.04e-02	6.75e-02	4.17e-01	8.69e-02	5.08e-01	6.89e-01	9.55e-03
REGULATION OF EPIDERMIS DEVELOPMENT	66	1.36e-01	5.86e-01	0.0860	1.82e-02	-4.65e-02	3.98e-02	7.73e-03	5.72e-02	7.98e-01	5.14e-01	5.76e-01	9.13e-01	4.22e-01
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	595	4.07e-02	3.08e-01	0.0860	-3.19e-02	-4.47e-02	-1.37e-02	-1.87e-02	6.20e-02	1.84e-01	6.23e-02	5.68e-01	4.36e-01	9.72e-03
REGULATION OF CYTOKINESIS	87	3.10e-01	7.83e-01	0.0859	-7.94e-03	-5.72e-02	3.11e-02	1.49e-02	-5.34e-02	8.98e-01	3.57e-01	6.16e-01	8.10e-01	3.89e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	61	8.20e-01	9.83e-01	0.0859	8.21e-03	1.92e-03	-2.22e-03	6.59e-03	-8.52e-02	9.12e-01	9.79e-01	9.76e-01	9.29e-01	2.50e-01
MUSCLE CELL DIFFERENTIATION	407	5.20e-01	9.03e-01	0.0859	-3.42e-02	-2.65e-02	-4.78e-02	-5.09e-02	-2.50e-02	2.37e-01	3.59e-01	9.80e-02	7.79e-02	3.86e-01
GERM CELL DEVELOPMENT	345	1.55e-01	6.17e-01	0.0858	-9.73e-03	3.51e-02	-5.53e-02	-5.19e-02	-1.69e-02	7.56e-01	2.62e-01	7.75e-02	9.74e-02	5.90e-01
REGULATION OF NEUROBLAST PROLIFERATION	53	9.39e-01	9.97e-01	0.0858	-3.44e-02	-7.82e-02	3.67e-03	-2.92e-03	6.97e-03	6.65e-01	3.25e-01	9.63e-01	9.71e-01	9.30e-01
POSITIVE REGULATION OF TRANSLATIONAL INITIATION	24	9.68e-01	9.97e-01	0.0858	5.65e-02	6.84e-03	3.11e-02	3.93e-02	-4.01e-02	6.32e-01	9.54e-01	7.92e-01	7.39e-01	7.34e-01
POSITIVE REGULATION OF STEROL TRANSPORT	38	4.71e-01	8.85e-01	0.0857	-5.65e-02	-2.78e-02	-3.85e-02	-1.30e-02	4.17e-02	5.47e-01	7.67e-01	6.81e-01	8.90e-01	6.57e-01
NADP METABOLIC PROCESS	41	6.77e-02	4.17e-01	0.0857	6.35e-02	-5.41e-02	8.90e-04	-1.92e-02	3.93e-03	4.82e-01	5.49e-01	9.92e-01	8.31e-01	9.65e-01
INTERFERON ALPHA PRODUCTION	27	7.84e-01	9.81e-01	0.0856	3.29e-02	5.51e-02	8.97e-03	-1.24e-02	-5.46e-02	7.67e-01	6.20e-01	9.36e-01	9.11e-01	6.24e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	31	7.69e-01	9.76e-01	0.0856	-1.15e-03	4.52e-02	-4.19e-02	-5.93e-02	9.16e-04	9.91e-01	6.63e-01	6.86e-01	5.67e-01	9.93e-01
SKELETAL SYSTEM MORPHOGENESIS	226	1.11e-04	4.30e-03	0.0856	3.47e-02	-6.72e-02	3.01e-02	1.18e-02	2.36e-02	3.69e-01	8.18e-02	4.35e-01	7.60e-01	5.41e-01
LYMPHOCYTE ACTIVATION	759	3.60e-02	2.88e-01	0.0855	3.74e-02	3.69e-02	4.93e-02	4.15e-02	1.99e-02	7.95e-02	8.38e-02	2.07e-02	5.14e-02	3.50e-01
MEMBRANE ORGANIZATION	777	5.26e-04	1.49e-02	0.0854	-1.17e-02	-7.12e-02	2.99e-02	2.77e-02	2.05e-02	5.79e-01	7.28e-04	1.56e-01	1.88e-01	3.31e-01
REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	368	6.24e-01	9.44e-01	0.0854	-4.37e-02	-4.50e-02	-3.82e-02	-4.34e-02	-4.37e-03	1.50e-01	1.38e-01	2.08e-01	1.53e-01	8.86e-01
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	33	9.52e-01	9.97e-01	0.0854	4.87e-02	-1.81e-03	3.94e-02	4.13e-02	-4.08e-02	6.29e-01	9.86e-01	6.95e-01	6.81e-01	6.85e-01
POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	31	9.92e-01	9.99e-01	0.0854	-3.13e-02	-3.42e-02	-4.90e-02	-5.22e-02	-2.22e-03	7.63e-01	7.41e-01	6.37e-01	6.15e-01	9.83e-01
REGULATION OF XENOPHAGY	9	9.13e-01	9.94e-01	0.0853	3.86e-02	-6.02e-02	-2.31e-02	-3.10e-02	-2.57e-02	8.41e-01	7.54e-01	9.04e-01	8.72e-01	8.94e-01
HEART MORPHOGENESIS	262	1.22e-02	1.46e-01	0.0853	4.91e-04	-7.21e-02	3.60e-02	1.83e-02	2.10e-02	9.89e-01	4.46e-02	3.15e-01	6.10e-01	5.58e-01
SECONDARY METABOLIC PROCESS	55	1.11e-01	5.34e-01	0.0853	-4.75e-02	6.17e-02	1.75e-02	1.37e-02	2.67e-02	5.42e-01	4.29e-01	8.23e-01	8.60e-01	7.32e-01
REGULATION OF T CELL MIGRATION	47	9.22e-01	9.95e-01	0.0852	-2.00e-02	-8.98e-03	-6.32e-02	-5.11e-02	-1.30e-02	8.13e-01	9.15e-01	4.53e-01	5.44e-01	8.78e-01
MONOATOMIC CATION TRANSMEMBRANE TRANSPORT	814	6.41e-06	3.71e-04	0.0852	1.80e-02	6.75e-02	-1.48e-03	-3.36e-04	4.87e-02	3.84e-01	1.06e-03	9.43e-01	9.87e-01	1.82e-02
NEGATIVE REGULATION OF KINASE ACTIVITY	190	5.78e-03	9.10e-02	0.0851	3.30e-02	-6.68e-02	3.23e-02	2.27e-02	-1.17e-02	4.32e-01	1.12e-01	4.43e-01	5.90e-01	7.81e-01
SERTOLI CELL DIFFERENTIATION	17	4.58e-01	8.79e-01	0.0851	6.56e-03	7.61e-03	1.46e-02	-3.29e-02	7.65e-02	9.63e-01	9.57e-01	9.17e-01	8.14e-01	5.85e-01
CARDIAC SEPTUM DEVELOPMENT	108	1.29e-01	5.72e-01	0.0849	1.40e-03	-7.85e-02	2.56e-02	4.74e-03	1.92e-02	9.80e-01	1.59e-01	6.46e-01	9.32e-01	7.31e-01
ADAPTIVE THERMOGENESIS	165	2.70e-01	7.50e-01	0.0849	-2.77e-03	-7.01e-02	2.31e-03	3.34e-04	4.78e-02	9.51e-01	1.20e-01	9.59e-01	9.94e-01	2.89e-01
REGULATION OF CYCLASE ACTIVITY	53	8.41e-01	9.85e-01	0.0848	6.46e-02	1.12e-02	2.72e-02	3.03e-02	3.52e-02	4.16e-01	8.87e-01	7.32e-01	7.03e-01	6.57e-01
CONNECTIVE TISSUE DEVELOPMENT	278	1.61e-01	6.25e-01	0.0847	-2.33e-02	-5.18e-02	-3.54e-02	-4.19e-02	-3.06e-02	5.04e-01	1.37e-01	3.09e-01	2.29e-01	3.81e-01
REGULATION OF MONOOXYGENASE ACTIVITY	42	3.76e-01	8.36e-01	0.0845	7.83e-03	6.94e-02	-2.87e-02	1.14e-03	3.79e-02	9.30e-01	4.36e-01	7.47e-01	9.90e-01	6.71e-01
PROTEIN EXPORT FROM NUCLEUS	59	6.46e-01	9.50e-01	0.0845	1.75e-02	-6.67e-02	3.69e-02	2.93e-02	-1.26e-02	8.16e-01	3.76e-01	6.24e-01	6.97e-01	8.67e-01
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	215	2.40e-01	7.24e-01	0.0843	4.23e-02	-1.87e-02	5.38e-02	4.50e-02	6.62e-03	2.85e-01	6.36e-01	1.74e-01	2.55e-01	8.67e-01
REGULATION OF CELL PROJECTION ORGANIZATION	661	2.21e-02	2.16e-01	0.0842	-3.75e-02	-3.02e-02	-4.26e-02	-5.16e-02	1.71e-02	1.00e-01	1.85e-01	6.19e-02	2.35e-02	4.53e-01
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS	193	3.05e-01	7.76e-01	0.0842	4.34e-03	-2.35e-02	7.22e-03	-3.11e-04	8.04e-02	9.17e-01	5.74e-01	8.63e-01	9.94e-01	5.40e-02
POSITIVE REGULATION OF LIPID METABOLIC PROCESS	139	8.04e-01	9.82e-01	0.0842	-1.62e-02	-4.40e-03	-5.43e-02	-4.78e-02	-3.97e-02	7.41e-01	9.29e-01	2.69e-01	3.31e-01	4.19e-01
LIPOSACCHARIDE METABOLIC PROCESS	106	5.40e-01	9.13e-01	0.0841	5.13e-03	-7.08e-02	2.05e-02	2.09e-02	3.45e-02	9.27e-01	2.08e-01	7.15e-01	7.10e-01	5.39e-01
SENSORY ORGAN MORPHOGENESIS	272	2.14e-01	6.95e-01	0.0841	-2.36e-02	-4.45e-02	-2.72e-02	-3.21e-02	5.26e-02	5.02e-01	2.07e-01	4.41e-01	3.62e-01	1.35e-01
POLYSACCHARIDE BIOSYNTHETIC PROCESS	64	6.03e-01	9.34e-01	0.0841	-1.18e-03	-7.14e-02	9.14e-03	-5.46e-03	4.32e-02	9.87e-01	3.23e-01	8.99e-01	9.40e-01	5.50e-01
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL	28	9.80e-01	9.97e-01	0.0841	-3.86e-02	-1.28e-02	-3.57e-02	-3.52e-02	5.39e-02	7.24e-01	9.06e-01	7.44e-01	7.47e-01	6.22e-01
LIPID IMPORT INTO CELL	20	8.10e-01	9.82e-01	0.0841	2.79e-02	6.27e-02	5.60e-03	-1.84e-02	4.46e-02	8.29e-01	6.28e-01	9.65e-01	8.87e-01	7.30e-01
VESICLE BUDDING FROM MEMBRANE	81	4.30e-01	8.67e-01	0.0840	3.60e-02	-4.61e-02	3.56e-02	4.27e-02	-2.34e-02	5.76e-01	4.73e-01	5.80e-01	5.07e-01	7.15e-01
HEAT GENERATION	17	7.70e-01	9.76e-01	0.0839	3.86e-02	-1.54e-02	3.12e-02	6.56e-02	6.84e-03	7.83e-01	9.13e-01	8.24e-01	6.40e-01	9.61e-01
REGULATION OF CANONICAL WNT SIGNALING PATHWAY	249	4.37e-01	8.69e-01	0.0838	-5.28e-03	-4.50e-02	3.62e-02	2.70e-02	5.41e-02	8.86e-01	2.21e-01	3.25e-01	4.63e-01	1.41e-01
CORPUS CALLOSUM MORPHOGENESIS	6	9.63e-01	9.97e-01	0.0838	-7.90e-03	6.28e-04	-3.38e-02	-6.61e-02	3.80e-02	9.73e-01	9.98e-01	8.86e-01	7.79e-01	8.72e-01
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS	541	3.02e-01	7.74e-01	0.0837	-3.54e-02	-2.95e-02	-5.03e-02	-4.85e-02	-8.56e-04	1.59e-01	2.41e-01	4.51e-02	5.37e-02	9.73e-01
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION	150	5.61e-01	9.20e-01	0.0837	-4.32e-02	-1.80e-02	-3.89e-02	-4.99e-02	2.82e-02	3.61e-01	7.03e-01	4.10e-01	2.91e-01	5.51e-01
CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS	22	8.60e-01	9.88e-01	0.0836	1.97e-02	7.88e-02	2.00e-03	-1.75e-02	-9.50e-03	8.73e-01	5.22e-01	9.87e-01	8.87e-01	9.39e-01
REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	53	4.78e-01	8.89e-01	0.0835	2.73e-02	3.12e-02	1.39e-02	-7.07e-03	7.09e-02	7.31e-01	6.95e-01	8.61e-01	9.29e-01	3.72e-01
ALCOHOL METABOLIC PROCESS	355	4.05e-01	8.50e-01	0.0835	-3.58e-02	-3.02e-02	-5.14e-02	-4.43e-02	-1.33e-02	2.46e-01	3.29e-01	9.59e-02	1.52e-01	6.66e-01
NEGATIVE REGULATION OF CELL ADHESION	300	5.64e-01	9.22e-01	0.0835	-4.46e-02	-2.50e-02	-4.32e-02	-4.44e-02	2.27e-02	1.84e-01	4.57e-01	1.98e-01	1.86e-01	5.00e-01
INTRACELLULAR IRON ION HOMEOSTASIS	66	8.35e-01	9.85e-01	0.0835	-2.01e-02	-8.05e-02	5.56e-04	3.83e-04	9.19e-03	7.78e-01	2.58e-01	9.94e-01	9.96e-01	8.97e-01
AUTOPHAGOSOME ORGANIZATION	115	3.45e-01	8.16e-01	0.0835	2.03e-02	-5.67e-02	4.24e-02	3.58e-02	-1.59e-02	7.06e-01	2.93e-01	4.32e-01	5.07e-01	7.68e-01
NEGATIVE REGULATION OF HYDROLASE ACTIVITY	204	6.48e-01	9.51e-01	0.0833	-4.35e-02	-5.84e-02	-1.08e-02	-1.12e-02	3.74e-02	2.84e-01	1.51e-01	7.90e-01	7.83e-01	3.57e-01
DEFENSE RESPONSE TO SYMBIONT	325	4.64e-01	8.81e-01	0.0833	2.85e-02	-1.22e-02	5.52e-02	5.16e-02	1.64e-02	3.77e-01	7.04e-01	8.73e-02	1.10e-01	6.11e-01
ESTABLISHMENT OF TISSUE POLARITY	67	6.27e-01	9.45e-01	0.0832	-7.78e-03	-4.05e-02	4.22e-03	-1.37e-02	7.08e-02	9.12e-01	5.66e-01	9.52e-01	8.46e-01	3.16e-01
SPECIFICATION OF SYMMETRY	136	1.58e-01	6.20e-01	0.0832	4.02e-02	-3.88e-02	4.74e-02	3.68e-02	-1.37e-02	4.18e-01	4.34e-01	3.39e-01	4.59e-01	7.83e-01
REGULATION OF MEMBRANE POTENTIAL	423	8.73e-03	1.17e-01	0.0831	-3.97e-02	-3.85e-03	-2.65e-02	-2.48e-02	6.33e-02	1.61e-01	8.92e-01	3.49e-01	3.82e-01	2.56e-02
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	106	2.28e-01	7.11e-01	0.0831	3.15e-02	-4.97e-02	4.19e-02	3.17e-02	-2.63e-02	5.75e-01	3.77e-01	4.56e-01	5.73e-01	6.40e-01
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	28	9.07e-01	9.94e-01	0.0831	-3.32e-03	6.58e-02	-3.23e-02	-1.38e-02	-3.64e-02	9.76e-01	5.46e-01	7.68e-01	8.99e-01	7.39e-01
REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	382	5.03e-02	3.50e-01	0.0831	-2.34e-02	-7.04e-02	-2.41e-02	-2.81e-02	5.13e-03	4.32e-01	1.81e-02	4.19e-01	3.46e-01	8.63e-01
REGULATION OF PROTEIN SECRETION	261	5.12e-01	9.00e-01	0.0830	-2.83e-02	-2.71e-02	-5.23e-02	-5.11e-02	2.74e-03	4.31e-01	4.51e-01	1.45e-01	1.55e-01	9.39e-01
DEPHOSPHORYLATION	288	4.65e-01	8.83e-01	0.0829	-3.77e-02	-6.54e-02	-9.03e-03	-1.69e-02	2.83e-02	2.71e-01	5.61e-02	7.92e-01	6.21e-01	4.09e-01
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION	543	5.04e-03	8.21e-02	0.0829	-3.05e-02	-2.91e-02	-4.01e-02	-5.15e-02	2.88e-02	2.25e-01	2.46e-01	1.10e-01	4.00e-02	2.52e-01
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS	124	3.12e-01	7.85e-01	0.0828	-8.13e-03	-3.87e-02	5.60e-02	4.41e-02	-1.48e-02	8.76e-01	4.57e-01	2.82e-01	3.96e-01	7.77e-01
STEROL BIOSYNTHETIC PROCESS	63	2.56e-01	7.39e-01	0.0828	7.70e-02	1.90e-02	-1.08e-02	-3.94e-03	-2.09e-02	2.91e-01	7.94e-01	8.83e-01	9.57e-01	7.74e-01
REGULATION OF INNATE IMMUNE RESPONSE	407	1.22e-01	5.58e-01	0.0828	-8.42e-03	-1.74e-02	3.63e-02	2.97e-02	6.54e-02	7.71e-01	5.47e-01	2.08e-01	3.03e-01	2.36e-02
GLUTAMINE TRANSPORT	9	9.80e-01	9.97e-01	0.0828	3.46e-02	-2.97e-02	2.69e-02	1.37e-02	-6.21e-02	8.57e-01	8.77e-01	8.89e-01	9.43e-01	7.47e-01
MUSCLE SYSTEM PROCESS	438	4.80e-02	3.42e-01	0.0828	-1.38e-02	1.96e-02	-5.96e-02	-5.22e-02	-2.74e-03	6.20e-01	4.82e-01	3.26e-02	6.12e-02	9.22e-01
MONONUCLEAR CELL DIFFERENTIATION	464	9.29e-02	4.86e-01	0.0828	3.73e-02	3.80e-02	4.89e-02	3.90e-02	1.02e-02	1.68e-01	1.61e-01	7.12e-02	1.50e-01	7.08e-01
EXOCRINE SYSTEM DEVELOPMENT	45	9.59e-01	9.97e-01	0.0827	5.41e-02	3.62e-02	2.29e-02	3.44e-02	3.00e-02	5.30e-01	6.75e-01	7.90e-01	6.90e-01	7.27e-01
MEIOTIC CELL CYCLE PROCESS	210	3.54e-01	8.22e-01	0.0826	4.99e-02	3.83e-02	3.66e-02	2.82e-02	-2.71e-02	2.12e-01	3.39e-01	3.60e-01	4.81e-01	4.98e-01
NEUROMUSCULAR PROCESS	159	1.59e-01	6.20e-01	0.0825	5.74e-02	5.29e-02	-8.71e-03	-7.59e-03	2.42e-02	2.12e-01	2.50e-01	8.50e-01	8.69e-01	5.98e-01
CELL MATURATION	191	4.38e-01	8.69e-01	0.0824	-4.18e-03	-4.28e-02	1.17e-02	3.22e-03	6.93e-02	9.21e-01	3.08e-01	7.80e-01	9.39e-01	9.87e-02
NEGATIVE ADAPTATION OF SIGNALING PATHWAY	18	8.42e-01	9.85e-01	0.0824	6.99e-02	7.49e-03	-3.72e-03	-6.56e-03	4.22e-02	6.08e-01	9.56e-01	9.78e-01	9.62e-01	7.57e-01
POTASSIUM ION TRANSPORT	234	3.72e-02	2.94e-01	0.0824	-9.97e-03	4.28e-02	-8.58e-03	-1.17e-02	6.81e-02	7.93e-01	2.59e-01	8.21e-01	7.58e-01	7.27e-02
ORGANELLE TRANSPORT ALONG MICROTUBULE	84	7.55e-01	9.75e-01	0.0823	-3.68e-02	-5.54e-02	-2.11e-03	-1.88e-02	4.46e-02	5.59e-01	3.80e-01	9.73e-01	7.66e-01	4.80e-01
DICARBOXYLIC ACID TRANSPORT	98	5.97e-01	9.33e-01	0.0822	1.64e-02	4.07e-02	2.72e-03	1.09e-02	6.86e-02	7.79e-01	4.86e-01	9.63e-01	8.52e-01	2.41e-01
PROTEIN METHYLATION	75	7.68e-01	9.75e-01	0.0821	-8.24e-03	-6.95e-02	2.11e-02	8.92e-03	3.62e-02	9.02e-01	2.98e-01	7.52e-01	8.94e-01	5.88e-01
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY	126	6.44e-01	9.50e-01	0.0821	-6.17e-03	-2.78e-02	1.66e-02	2.26e-02	7.17e-02	9.05e-01	5.90e-01	7.48e-01	6.62e-01	1.65e-01
REGULATION OF SYSTEM PROCESS	539	3.46e-02	2.82e-01	0.0818	-1.81e-02	6.77e-03	-5.87e-02	-5.35e-02	1.68e-03	4.72e-01	7.88e-01	1.97e-02	3.36e-02	9.47e-01
CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	284	6.82e-01	9.61e-01	0.0818	3.59e-02	1.12e-02	5.11e-02	5.16e-02	5.97e-04	2.98e-01	7.45e-01	1.38e-01	1.35e-01	9.86e-01
CELLULAR RESPONSE TO MANGANESE ION	10	9.64e-01	9.97e-01	0.0814	3.32e-03	-6.75e-02	5.64e-03	-1.37e-02	-4.30e-02	9.85e-01	7.12e-01	9.75e-01	9.40e-01	8.14e-01
VESICLE CYTOSKELETAL TRAFFICKING	68	7.03e-01	9.65e-01	0.0814	-5.28e-02	-2.96e-03	-2.17e-02	-2.85e-02	5.05e-02	4.51e-01	9.66e-01	7.57e-01	6.85e-01	4.72e-01
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	76	1.26e-01	5.67e-01	0.0814	7.25e-03	1.94e-02	-2.20e-02	5.32e-03	7.54e-02	9.13e-01	7.70e-01	7.40e-01	9.36e-01	2.56e-01
INTRACELLULAR STEROL TRANSPORT	35	7.73e-01	9.77e-01	0.0814	3.62e-02	5.04e-02	-3.29e-02	-4.08e-02	5.30e-03	7.11e-01	6.06e-01	7.36e-01	6.76e-01	9.57e-01
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	65	7.35e-01	9.73e-01	0.0814	3.82e-02	-1.63e-02	1.79e-02	1.43e-02	6.61e-02	5.94e-01	8.20e-01	8.03e-01	8.42e-01	3.57e-01
PROTEIN COMPLEX OLIGOMERIZATION	249	6.75e-01	9.59e-01	0.0812	3.11e-02	-8.44e-03	4.37e-02	3.85e-02	4.64e-02	3.98e-01	8.19e-01	2.35e-01	2.95e-01	2.07e-01
NEGATIVE REGULATION OF PROTEIN SECRETION	71	8.14e-01	9.82e-01	0.0812	-2.41e-02	-3.57e-02	-3.89e-02	-4.80e-02	3.02e-02	7.26e-01	6.03e-01	5.71e-01	4.85e-01	6.60e-01
GLIAL CELL DIFFERENTIATION	246	4.13e-01	8.54e-01	0.0811	2.01e-02	-3.80e-02	3.45e-02	3.34e-02	4.92e-02	5.86e-01	3.05e-01	3.51e-01	3.67e-01	1.84e-01
PROTEOLYSIS	1554	7.47e-03	1.07e-01	0.0810	2.86e-02	-9.24e-03	4.21e-02	3.94e-02	4.84e-02	6.00e-02	5.43e-01	5.56e-03	9.50e-03	1.43e-03
REGULATION OF CELLULAR RESPIRATION	46	9.51e-01	9.97e-01	0.0810	1.96e-02	-1.03e-02	5.41e-02	5.45e-02	-1.34e-02	8.18e-01	9.03e-01	5.26e-01	5.23e-01	8.75e-01
KIDNEY MORPHOGENESIS	94	1.67e-01	6.33e-01	0.0809	-1.75e-04	-4.28e-02	3.43e-02	6.28e-03	5.92e-02	9.98e-01	4.74e-01	5.65e-01	9.16e-01	3.21e-01
STRESS FIBER ASSEMBLY	108	7.96e-01	9.81e-01	0.0809	-2.47e-02	1.61e-02	-5.27e-02	-5.31e-02	8.71e-03	6.58e-01	7.73e-01	3.44e-01	3.41e-01	8.76e-01
EXOCYTOSIS	331	4.00e-01	8.45e-01	0.0808	-3.70e-02	-5.35e-02	-1.06e-03	-4.73e-03	4.76e-02	2.47e-01	9.42e-02	9.73e-01	8.82e-01	1.36e-01
NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	11	9.65e-01	9.97e-01	0.0807	2.34e-02	-2.34e-02	-2.06e-02	2.37e-04	-7.07e-02	8.93e-01	8.93e-01	9.06e-01	9.99e-01	6.85e-01
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	34	8.12e-01	9.82e-01	0.0807	6.11e-04	-6.17e-02	-1.89e-02	-2.86e-02	3.92e-02	9.95e-01	5.34e-01	8.49e-01	7.73e-01	6.93e-01
CYCLIC NUCLEOTIDE METABOLIC PROCESS	40	9.78e-01	9.97e-01	0.0805	-3.85e-02	8.45e-03	-5.07e-02	-4.79e-02	7.73e-03	6.73e-01	9.26e-01	5.79e-01	6.00e-01	9.33e-01
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS	564	1.26e-02	1.50e-01	0.0805	1.91e-02	-4.17e-02	4.90e-02	4.35e-02	9.04e-03	4.39e-01	9.01e-02	4.64e-02	7.74e-02	7.13e-01
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT	31	9.81e-01	9.97e-01	0.0805	-1.22e-02	-4.86e-02	-5.82e-03	-8.37e-03	6.22e-02	9.07e-01	6.39e-01	9.55e-01	9.36e-01	5.49e-01
PROTEIN HOMOOLIGOMERIZATION	188	4.19e-01	8.59e-01	0.0804	2.52e-02	-1.38e-02	2.42e-02	1.73e-02	6.90e-02	5.51e-01	7.44e-01	5.66e-01	6.83e-01	1.03e-01
PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS	10	9.70e-01	9.97e-01	0.0804	-1.35e-02	1.06e-02	-5.04e-02	-2.69e-02	5.39e-02	9.41e-01	9.54e-01	7.83e-01	8.83e-01	7.68e-01
POSITIVE REGULATION OF LIPASE ACTIVITY	59	4.51e-01	8.76e-01	0.0804	-3.75e-02	-2.77e-02	-4.03e-02	-1.85e-02	4.82e-02	6.18e-01	7.12e-01	5.93e-01	8.05e-01	5.22e-01
MONOATOMIC CATION TRANSPORT	997	5.82e-05	2.52e-03	0.0804	2.70e-02	6.73e-02	5.19e-03	5.52e-03	3.38e-02	1.49e-01	3.21e-04	7.81e-01	7.68e-01	7.05e-02
PROTEIN DEPHOSPHORYLATION	194	4.72e-01	8.85e-01	0.0802	8.92e-03	-4.97e-02	3.19e-02	2.45e-02	4.76e-02	8.30e-01	2.33e-01	4.44e-01	5.56e-01	2.52e-01
MICROTUBULE NUCLEATION	43	5.48e-01	9.15e-01	0.0802	5.50e-02	-1.58e-02	1.60e-03	-6.46e-04	5.62e-02	5.33e-01	8.58e-01	9.85e-01	9.94e-01	5.24e-01
NEGATIVE REGULATION OF CELL ACTIVATION	217	5.98e-01	9.33e-01	0.0801	-2.81e-02	-3.42e-02	-4.70e-02	-4.58e-02	1.23e-02	4.75e-01	3.85e-01	2.33e-01	2.45e-01	7.54e-01
APICAL PROTEIN LOCALIZATION	14	9.11e-01	9.94e-01	0.0801	2.53e-02	3.86e-02	4.94e-02	1.96e-02	3.82e-02	8.70e-01	8.03e-01	7.49e-01	8.99e-01	8.04e-01
REGULATION OF MYELINATION	45	7.40e-01	9.73e-01	0.0801	-1.74e-02	2.80e-02	-1.29e-02	-2.55e-03	7.18e-02	8.40e-01	7.45e-01	8.81e-01	9.76e-01	4.05e-01
RESPONSE TO PEPTIDE	502	5.23e-02	3.58e-01	0.0800	-2.62e-02	-6.06e-02	-3.16e-02	-3.01e-02	1.14e-02	3.14e-01	2.00e-02	2.26e-01	2.48e-01	6.62e-01
RHO PROTEIN SIGNAL TRANSDUCTION	128	8.11e-01	9.82e-01	0.0799	-1.81e-02	-1.66e-02	-4.30e-02	-4.73e-02	-4.12e-02	7.23e-01	7.46e-01	4.01e-01	3.55e-01	4.20e-01
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS	889	2.20e-02	2.16e-01	0.0799	-3.04e-02	-2.60e-02	-4.67e-02	-4.97e-02	1.21e-02	1.25e-01	1.88e-01	1.82e-02	1.20e-02	5.41e-01
SYNCYTIUM FORMATION	65	6.30e-01	9.46e-01	0.0799	-2.66e-02	5.82e-02	-3.73e-02	-2.83e-02	-1.02e-02	7.10e-01	4.17e-01	6.03e-01	6.93e-01	8.86e-01
DOSAGE COMPENSATION	27	3.38e-01	8.08e-01	0.0798	3.61e-02	-4.32e-02	-2.63e-02	-4.87e-02	1.22e-02	7.46e-01	6.98e-01	8.13e-01	6.62e-01	9.13e-01
REGULATION OF CELL SHAPE	134	8.05e-01	9.82e-01	0.0797	-1.09e-02	3.55e-02	-4.82e-02	-4.39e-02	-2.70e-02	8.28e-01	4.78e-01	3.36e-01	3.80e-01	5.89e-01
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	26	9.90e-01	9.98e-01	0.0796	-2.24e-03	-8.20e-03	1.22e-02	1.07e-02	7.74e-02	9.84e-01	9.42e-01	9.14e-01	9.25e-01	4.94e-01
ENDODERM FORMATION	57	2.30e-01	7.14e-01	0.0796	2.93e-02	-8.37e-03	-8.78e-03	-2.94e-02	-6.68e-02	7.02e-01	9.13e-01	9.09e-01	7.01e-01	3.83e-01
STEROL METABOLIC PROCESS	150	1.77e-01	6.47e-01	0.0795	1.51e-02	1.57e-02	-5.64e-02	-5.14e-02	-5.08e-03	7.50e-01	7.40e-01	2.33e-01	2.78e-01	9.14e-01
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS	108	9.17e-01	9.95e-01	0.0795	-4.34e-02	-1.36e-02	-4.56e-02	-3.88e-02	-2.58e-02	4.36e-01	8.06e-01	4.13e-01	4.86e-01	6.44e-01
ALPHA AMINO ACID METABOLIC PROCESS	197	4.13e-01	8.54e-01	0.0794	1.26e-02	-4.63e-02	4.04e-02	4.32e-02	2.23e-02	7.60e-01	2.62e-01	3.29e-01	2.95e-01	5.89e-01
POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	23	8.77e-01	9.88e-01	0.0793	1.15e-02	4.34e-02	-3.63e-02	-5.11e-02	1.83e-02	9.24e-01	7.19e-01	7.63e-01	6.72e-01	8.79e-01
SYNAPTIC TRANSMISSION GLUTAMATERGIC	106	5.70e-01	9.26e-01	0.0793	2.73e-02	5.76e-02	2.28e-02	1.25e-02	3.93e-02	6.28e-01	3.05e-01	6.85e-01	8.24e-01	4.85e-01
PROTEIN LOCALIZATION TO CELL JUNCTION	102	5.48e-01	9.15e-01	0.0792	-5.12e-02	-3.62e-02	5.18e-03	-9.69e-03	4.72e-02	3.72e-01	5.27e-01	9.28e-01	8.66e-01	4.11e-01
ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS	242	6.62e-01	9.54e-01	0.0792	-3.64e-02	-3.05e-02	-3.84e-02	-4.04e-02	3.01e-02	3.29e-01	4.14e-01	3.04e-01	2.79e-01	4.20e-01
POSITIVE REGULATION OF VASOCONSTRICTION	30	9.23e-01	9.95e-01	0.0792	4.91e-02	5.64e-02	-7.63e-03	-1.44e-02	-2.04e-02	6.42e-01	5.93e-01	9.42e-01	8.91e-01	8.47e-01
PROTEIN POLYUBIQUITINATION	219	1.51e-01	6.13e-01	0.0791	4.73e-03	-5.48e-02	3.96e-02	2.44e-02	3.26e-02	9.04e-01	1.62e-01	3.12e-01	5.34e-01	4.05e-01
MEMBRANE LIPID METABOLIC PROCESS	208	2.48e-01	7.33e-01	0.0791	-6.95e-03	-6.99e-02	2.95e-03	3.54e-03	3.60e-02	8.63e-01	8.21e-02	9.42e-01	9.30e-01	3.70e-01
MONONUCLEAR CELL MIGRATION	199	2.84e-02	2.52e-01	0.0790	-7.69e-03	-2.22e-02	-5.26e-02	-3.69e-02	3.96e-02	8.52e-01	5.90e-01	2.01e-01	3.70e-01	3.36e-01
REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT	299	7.95e-02	4.53e-01	0.0789	2.79e-02	5.08e-02	-6.74e-03	-4.30e-03	5.30e-02	4.07e-01	1.31e-01	8.41e-01	8.98e-01	1.15e-01
SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	13	9.26e-01	9.95e-01	0.0789	-1.15e-02	-6.80e-02	3.48e-02	5.42e-03	-1.52e-02	9.43e-01	6.71e-01	8.28e-01	9.73e-01	9.24e-01
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT	189	3.35e-01	8.05e-01	0.0789	3.42e-02	-2.53e-02	5.12e-02	4.13e-02	9.16e-03	4.17e-01	5.49e-01	2.25e-01	3.27e-01	8.28e-01
PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT	24	9.42e-01	9.97e-01	0.0788	1.32e-03	-2.00e-02	-4.00e-02	-3.52e-02	5.46e-02	9.91e-01	8.65e-01	7.34e-01	7.66e-01	6.44e-01
CELL CELL SIGNALING BY WNT	441	1.07e-01	5.23e-01	0.0788	-9.67e-03	-4.24e-02	3.61e-02	2.49e-02	4.90e-02	7.28e-01	1.27e-01	1.94e-01	3.71e-01	7.78e-02
CERAMIDE METABOLIC PROCESS	106	7.15e-01	9.68e-01	0.0787	-1.80e-02	-6.82e-02	-1.08e-02	-1.63e-02	2.90e-02	7.49e-01	2.25e-01	8.47e-01	7.72e-01	6.06e-01
VASCULAR TRANSPORT	84	6.35e-01	9.48e-01	0.0787	7.51e-03	5.59e-02	-3.55e-02	-2.79e-02	3.11e-02	9.05e-01	3.76e-01	5.74e-01	6.59e-01	6.22e-01
COGNITION	304	2.39e-01	7.23e-01	0.0787	4.21e-03	-3.61e-02	3.71e-02	2.49e-02	5.36e-02	9.00e-01	2.78e-01	2.66e-01	4.56e-01	1.08e-01
REGULATION OF LIPID METABOLIC PROCESS	329	6.04e-01	9.34e-01	0.0785	-3.19e-02	-3.61e-02	-4.48e-02	-4.17e-02	-1.02e-02	3.19e-01	2.61e-01	1.62e-01	1.94e-01	7.51e-01
CELL ADHESION	1467	6.74e-04	1.79e-02	0.0785	-2.80e-02	5.07e-03	-5.12e-02	-5.23e-02	1.55e-03	7.31e-02	7.45e-01	1.02e-03	8.05e-04	9.21e-01
TRIGLYCERIDE METABOLIC PROCESS	102	7.03e-01	9.65e-01	0.0783	-2.46e-02	-7.36e-04	-3.98e-02	-2.55e-02	-5.74e-02	6.67e-01	9.90e-01	4.87e-01	6.57e-01	3.16e-01
PROTEIN HOMOTETRAMERIZATION	57	7.57e-01	9.75e-01	0.0783	6.70e-02	3.24e-02	1.73e-02	1.34e-02	-1.10e-02	3.82e-01	6.73e-01	8.21e-01	8.61e-01	8.86e-01
CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	37	8.71e-01	9.88e-01	0.0783	-2.54e-03	4.03e-02	-1.77e-02	-2.58e-02	5.94e-02	9.79e-01	6.72e-01	8.52e-01	7.86e-01	5.32e-01
CARDIAC MUSCLE TISSUE REGENERATION	8	9.60e-01	9.97e-01	0.0782	-1.16e-03	-6.62e-02	-1.29e-02	-3.84e-02	-8.98e-03	9.95e-01	7.46e-01	9.50e-01	8.51e-01	9.65e-01
SYNAPTIC VESICLE CLUSTERING	15	9.55e-01	9.97e-01	0.0781	-6.09e-03	7.62e-02	9.08e-03	1.20e-03	1.32e-02	9.67e-01	6.09e-01	9.51e-01	9.94e-01	9.29e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	37	9.78e-01	9.97e-01	0.0780	1.34e-02	1.98e-02	1.61e-02	1.58e-02	7.07e-02	8.88e-01	8.35e-01	8.65e-01	8.68e-01	4.57e-01
HOMOTYPIC CELL CELL ADHESION	93	8.11e-01	9.82e-01	0.0778	8.97e-03	-3.87e-02	1.30e-02	1.15e-02	6.46e-02	8.81e-01	5.19e-01	8.28e-01	8.48e-01	2.82e-01
MONOATOMIC ION TRANSMEMBRANE TRANSPORT	975	7.19e-07	5.31e-05	0.0777	9.90e-03	6.82e-02	-8.29e-03	-6.32e-03	3.44e-02	6.01e-01	3.12e-04	6.61e-01	7.38e-01	6.90e-02
RESPONSE TO CORTICOSTEROID	143	3.61e-01	8.25e-01	0.0777	5.12e-02	-9.47e-03	4.45e-02	3.64e-02	-4.56e-03	2.91e-01	8.45e-01	3.59e-01	4.52e-01	9.25e-01
CYTOKINE MEDIATED SIGNALING PATHWAY	488	6.21e-02	3.98e-01	0.0776	2.83e-02	2.95e-02	1.18e-02	1.57e-02	6.29e-02	2.83e-01	2.65e-01	6.56e-01	5.52e-01	1.73e-02
EPITHELIAL TUBE MORPHOGENESIS	326	7.29e-04	1.91e-02	0.0774	4.02e-02	-3.59e-02	2.83e-02	1.59e-02	4.53e-02	2.13e-01	2.66e-01	3.80e-01	6.23e-01	1.60e-01
CALCIUM ION HOMEOSTASIS	320	1.69e-01	6.37e-01	0.0772	3.11e-02	4.70e-02	1.16e-02	8.60e-03	5.09e-02	3.39e-01	1.49e-01	7.22e-01	7.91e-01	1.18e-01
REGULATION OF GLYCOGEN CATABOLIC PROCESS	7	8.25e-01	9.83e-01	0.0772	6.09e-02	2.53e-02	1.44e-02	-2.79e-02	-2.50e-02	7.80e-01	9.08e-01	9.47e-01	8.98e-01	9.09e-01
REGULATION OF ACTIN FILAMENT BASED MOVEMENT	39	6.97e-01	9.62e-01	0.0772	3.51e-02	6.16e-02	-2.48e-02	1.03e-03	1.80e-02	7.04e-01	5.06e-01	7.89e-01	9.91e-01	8.46e-01
T CELL MIGRATION	68	8.44e-01	9.86e-01	0.0772	7.92e-04	4.13e-02	-4.97e-02	-4.21e-02	2.47e-03	9.91e-01	5.56e-01	4.78e-01	5.48e-01	9.72e-01
RESPONSE TO CARBOHYDRATE	225	7.74e-02	4.49e-01	0.0772	-9.26e-03	-5.79e-02	-2.19e-02	-2.92e-02	-3.45e-02	8.11e-01	1.35e-01	5.71e-01	4.51e-01	3.73e-01
HEAD DEVELOPMENT	726	3.49e-08	3.33e-06	0.0771	1.18e-02	-6.13e-02	2.56e-02	8.43e-03	3.63e-02	5.88e-01	4.91e-03	2.39e-01	6.99e-01	9.58e-02
PROTEIN POLYMERIZATION	272	6.77e-01	9.59e-01	0.0770	-3.43e-02	-3.65e-02	-3.83e-02	-4.35e-02	8.29e-03	3.30e-01	3.01e-01	2.77e-01	2.17e-01	8.14e-01
ORGANONITROGEN COMPOUND CATABOLIC PROCESS	1269	9.23e-07	6.61e-05	0.0769	3.07e-02	-3.74e-02	4.34e-02	3.70e-02	1.80e-02	6.55e-02	2.50e-02	9.38e-03	2.67e-02	2.82e-01
ENDOTHELIAL CELL PROLIFERATION	197	4.38e-01	8.69e-01	0.0769	-3.40e-02	1.86e-03	-4.61e-02	-4.10e-02	3.07e-02	4.10e-01	9.64e-01	2.64e-01	3.21e-01	4.57e-01
REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	14	9.24e-01	9.95e-01	0.0769	5.27e-02	-3.50e-02	1.01e-03	5.14e-03	4.34e-02	7.33e-01	8.21e-01	9.95e-01	9.73e-01	7.78e-01
REGULATION OF WNT SIGNALING PATHWAY	325	2.92e-01	7.68e-01	0.0768	-6.87e-03	-3.90e-02	3.64e-02	2.58e-02	4.84e-02	8.31e-01	2.26e-01	2.60e-01	4.25e-01	1.33e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	48	9.20e-01	9.95e-01	0.0768	-2.92e-02	3.69e-02	-4.23e-02	-4.36e-02	9.22e-04	7.27e-01	6.58e-01	6.12e-01	6.01e-01	9.91e-01
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	286	1.40e-01	5.95e-01	0.0767	-2.14e-02	-5.41e-02	-3.09e-02	-3.91e-02	-3.29e-03	5.34e-01	1.15e-01	3.68e-01	2.55e-01	9.24e-01
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	45	3.10e-01	7.83e-01	0.0767	2.68e-02	-4.48e-02	-4.37e-02	-2.28e-02	-2.69e-02	7.56e-01	6.03e-01	6.12e-01	7.91e-01	7.55e-01
REGULATION OF SECRETION	603	6.90e-02	4.21e-01	0.0765	-2.89e-02	-3.93e-02	-3.10e-02	-3.64e-02	3.46e-02	2.25e-01	9.95e-02	1.94e-01	1.26e-01	1.47e-01
VESICLE MEDIATED TRANSPORT IN SYNAPSE	208	3.56e-01	8.22e-01	0.0765	-2.66e-02	-3.31e-02	1.41e-02	9.08e-04	6.21e-02	5.09e-01	4.11e-01	7.26e-01	9.82e-01	1.23e-01
NEURAL TUBE DEVELOPMENT	160	1.14e-01	5.39e-01	0.0765	2.99e-02	-3.02e-02	2.06e-02	7.80e-03	5.97e-02	5.15e-01	5.10e-01	6.52e-01	8.65e-01	1.93e-01
RENAL WATER ABSORPTION	6	8.95e-01	9.93e-01	0.0765	-5.68e-02	-3.44e-02	2.18e-02	-3.06e-02	4.97e-03	8.10e-01	8.84e-01	9.26e-01	8.97e-01	9.83e-01
LAMELLIPODIUM ORGANIZATION	86	5.24e-01	9.05e-01	0.0764	-1.15e-02	-1.52e-02	-1.57e-02	-3.06e-02	6.55e-02	8.53e-01	8.07e-01	8.02e-01	6.24e-01	2.93e-01
CELL ADHESION MEDIATED BY INTEGRIN	86	7.05e-01	9.65e-01	0.0763	6.88e-03	-2.82e-03	-1.29e-02	-1.44e-02	7.35e-02	9.12e-01	9.64e-01	8.36e-01	8.18e-01	2.39e-01
MITOCHONDRION LOCALIZATION	46	7.98e-01	9.81e-01	0.0763	2.71e-02	2.51e-02	1.02e-02	-3.37e-03	-6.59e-02	7.51e-01	7.68e-01	9.04e-01	9.68e-01	4.39e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION	166	1.71e-01	6.41e-01	0.0762	3.46e-03	2.65e-02	1.53e-02	2.74e-02	6.41e-02	9.39e-01	5.55e-01	7.33e-01	5.42e-01	1.54e-01
SULFUR COMPOUND TRANSPORT	53	7.18e-01	9.69e-01	0.0762	3.74e-02	3.52e-02	2.46e-02	4.69e-02	-1.91e-02	6.37e-01	6.57e-01	7.57e-01	5.55e-01	8.10e-01
VESICLE MEDIATED TRANSPORT	1468	1.03e-02	1.31e-01	0.0761	-3.66e-02	-5.11e-02	-2.38e-02	-2.91e-02	2.07e-02	1.89e-02	1.04e-03	1.28e-01	6.17e-02	1.83e-01
POSITIVE REGULATION OF INSULIN SECRETION	83	8.28e-01	9.83e-01	0.0761	-1.85e-02	-5.21e-02	-3.41e-02	-3.69e-02	-1.48e-02	7.70e-01	4.12e-01	5.92e-01	5.61e-01	8.16e-01
CARDIAC MUSCLE CELL DIFFERENTIATION	129	7.65e-01	9.75e-01	0.0760	-2.55e-02	-6.63e-02	-1.55e-02	-2.02e-02	8.71e-03	6.16e-01	1.93e-01	7.61e-01	6.92e-01	8.64e-01
REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC	8	8.69e-01	9.88e-01	0.0759	-6.11e-02	3.14e-03	2.79e-02	-1.19e-02	-3.31e-02	7.65e-01	9.88e-01	8.91e-01	9.53e-01	8.71e-01
T HELPER 17 TYPE IMMUNE RESPONSE	46	9.52e-01	9.97e-01	0.0759	2.47e-02	5.05e-02	1.29e-02	2.02e-02	4.49e-02	7.72e-01	5.53e-01	8.80e-01	8.12e-01	5.98e-01
HIPPO SIGNALING	42	9.63e-01	9.97e-01	0.0759	-2.70e-02	-2.54e-02	1.61e-02	1.36e-02	6.28e-02	7.62e-01	7.76e-01	8.57e-01	8.79e-01	4.82e-01
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	315	3.34e-02	2.76e-01	0.0758	1.02e-02	5.86e-02	3.13e-02	3.22e-02	1.36e-02	7.55e-01	7.35e-02	3.40e-01	3.26e-01	6.78e-01
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	57	8.72e-01	9.88e-01	0.0757	1.10e-02	4.34e-02	2.17e-03	-1.61e-04	6.11e-02	8.86e-01	5.71e-01	9.77e-01	9.98e-01	4.25e-01
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING	659	1.04e-05	5.82e-04	0.0757	4.27e-02	-2.84e-02	3.94e-02	2.83e-02	2.74e-02	6.15e-02	2.14e-01	8.44e-02	2.16e-01	2.30e-01
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	278	9.85e-03	1.28e-01	0.0757	8.73e-03	-5.74e-02	1.48e-03	-6.93e-04	-4.85e-02	8.02e-01	9.96e-02	9.66e-01	9.84e-01	1.64e-01
NEGATIVE REGULATION OF MOLECULAR FUNCTION	754	5.71e-02	3.79e-01	0.0757	-3.25e-02	-6.61e-02	-5.70e-03	-9.36e-03	1.32e-02	1.28e-01	1.99e-03	7.90e-01	6.62e-01	5.36e-01
PURINE NUCLEOBASE METABOLIC PROCESS	19	9.64e-01	9.97e-01	0.0756	4.37e-02	3.69e-02	1.79e-02	4.01e-02	2.30e-02	7.42e-01	7.81e-01	8.93e-01	7.62e-01	8.62e-01
REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	138	7.85e-01	9.81e-01	0.0756	-3.32e-02	-6.54e-02	-9.70e-04	-1.04e-02	1.47e-02	5.00e-01	1.84e-01	9.84e-01	8.33e-01	7.65e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	30	8.78e-01	9.89e-01	0.0754	-3.51e-03	-3.49e-02	-1.17e-02	-2.82e-02	5.94e-02	9.73e-01	7.41e-01	9.11e-01	7.89e-01	5.73e-01
NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	76	6.63e-01	9.54e-01	0.0754	-2.27e-02	-3.59e-02	-3.21e-02	-4.72e-02	2.50e-02	7.32e-01	5.89e-01	6.28e-01	4.76e-01	7.07e-01
NON MOTILE CILIUM ASSEMBLY	63	4.17e-01	8.57e-01	0.0754	-9.49e-03	-1.07e-02	-3.59e-02	-5.72e-02	-3.04e-02	8.96e-01	8.84e-01	6.22e-01	4.32e-01	6.76e-01
ADAPTATION OF SIGNALING PATHWAY	20	9.02e-01	9.94e-01	0.0753	5.78e-02	2.69e-02	-2.94e-02	-2.19e-02	-1.62e-02	6.55e-01	8.35e-01	8.20e-01	8.65e-01	9.00e-01
REGULATION OF EXOSOMAL SECRETION	19	9.27e-01	9.95e-01	0.0753	-1.38e-02	-1.94e-02	3.41e-02	4.97e-02	3.83e-02	9.17e-01	8.84e-01	7.97e-01	7.07e-01	7.72e-01
ADULT BEHAVIOR	141	2.74e-02	2.47e-01	0.0752	1.78e-02	3.34e-03	-4.44e-02	-5.72e-02	-9.62e-03	7.15e-01	9.45e-01	3.63e-01	2.41e-01	8.44e-01
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	140	5.48e-01	9.15e-01	0.0752	1.62e-02	-2.01e-03	2.16e-02	2.16e-02	-6.68e-02	7.41e-01	9.67e-01	6.60e-01	6.59e-01	1.72e-01
XENOBIOTIC METABOLIC PROCESS	123	1.97e-01	6.74e-01	0.0752	-6.22e-02	1.45e-02	-2.38e-02	-2.86e-02	-1.38e-02	2.33e-01	7.81e-01	6.49e-01	5.84e-01	7.92e-01
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY	54	6.65e-01	9.55e-01	0.0752	5.60e-02	-2.02e-02	2.88e-02	2.33e-02	2.70e-02	4.77e-01	7.97e-01	7.14e-01	7.67e-01	7.32e-01
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	223	8.33e-01	9.85e-01	0.0751	-3.85e-02	-5.38e-02	-2.00e-02	-2.25e-02	1.89e-02	3.22e-01	1.66e-01	6.06e-01	5.63e-01	6.27e-01
VASCULOGENESIS	81	8.87e-01	9.91e-01	0.0751	4.55e-02	2.67e-02	3.92e-02	3.13e-02	-1.85e-02	4.79e-01	6.77e-01	5.42e-01	6.27e-01	7.73e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION	126	5.83e-01	9.28e-01	0.0749	5.34e-03	-2.06e-03	1.32e-02	2.26e-02	6.99e-02	9.18e-01	9.68e-01	7.98e-01	6.61e-01	1.75e-01
REGULATION OF AUTOPHAGY	338	1.91e-02	1.97e-01	0.0748	-2.79e-03	-6.46e-02	2.01e-02	5.70e-03	3.14e-02	9.30e-01	4.13e-02	5.24e-01	8.57e-01	3.21e-01
OLIGOSACCHARIDE METABOLIC PROCESS	65	7.26e-01	9.71e-01	0.0748	1.57e-02	3.15e-02	-4.72e-02	-4.28e-02	1.73e-02	8.27e-01	6.61e-01	5.10e-01	5.51e-01	8.09e-01
REGULATION OF DENDRITIC CELL DIFFERENTIATION	14	9.39e-01	9.97e-01	0.0748	3.30e-02	3.67e-02	-2.26e-02	-3.67e-02	3.60e-02	8.31e-01	8.12e-01	8.83e-01	8.12e-01	8.16e-01
RESPONSE TO ORGANIC CYCLIC COMPOUND	876	3.82e-05	1.77e-03	0.0748	-5.84e-04	-6.15e-02	1.19e-02	2.80e-03	4.08e-02	9.77e-01	2.01e-03	5.50e-01	8.88e-01	4.03e-02
CELLULAR RESPONSE TO RETINOIC ACID	67	8.63e-01	9.88e-01	0.0748	4.47e-02	-7.37e-03	2.87e-02	2.56e-02	4.54e-02	5.27e-01	9.17e-01	6.84e-01	7.17e-01	5.21e-01
RESPONSE TO NITROGEN COMPOUND	1083	3.36e-04	1.05e-02	0.0748	-1.28e-02	-5.91e-02	-1.54e-03	-6.40e-03	4.35e-02	4.77e-01	1.02e-03	9.32e-01	7.22e-01	1.56e-02
MONOSACCHARIDE BIOSYNTHETIC PROCESS	96	8.42e-01	9.85e-01	0.0747	2.02e-02	4.94e-02	-2.35e-02	-2.52e-02	-3.94e-02	7.33e-01	4.03e-01	6.90e-01	6.70e-01	5.04e-01
NEGATIVE REGULATION OF CATALYTIC ACTIVITY	462	4.82e-02	3.42e-01	0.0747	9.29e-03	-5.44e-02	3.33e-02	2.91e-02	2.39e-02	7.32e-01	4.51e-02	2.19e-01	2.83e-01	3.79e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	107	7.06e-01	9.65e-01	0.0746	-3.86e-02	-2.49e-02	-5.25e-03	-1.69e-02	5.61e-02	4.91e-01	6.56e-01	9.25e-01	7.63e-01	3.16e-01
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	23	9.81e-01	9.97e-01	0.0746	2.09e-02	4.33e-03	4.92e-02	3.25e-02	4.03e-02	8.62e-01	9.71e-01	6.83e-01	7.87e-01	7.38e-01
REGULATION OF OXIDOREDUCTASE ACTIVITY	77	7.18e-01	9.69e-01	0.0745	4.36e-02	5.42e-02	2.47e-03	2.04e-02	1.71e-02	5.08e-01	4.11e-01	9.70e-01	7.57e-01	7.95e-01
SCHWANN CELL DIFFERENTIATION	38	8.60e-01	9.88e-01	0.0745	-5.99e-02	-9.68e-03	-1.66e-02	-1.41e-02	-3.74e-02	5.23e-01	9.18e-01	8.59e-01	8.80e-01	6.90e-01
FATTY ACID BIOSYNTHETIC PROCESS	160	3.50e-01	8.18e-01	0.0745	-3.00e-03	-7.11e-02	1.49e-02	1.56e-02	4.78e-03	9.48e-01	1.21e-01	7.46e-01	7.34e-01	9.17e-01
REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	117	7.20e-01	9.69e-01	0.0745	-2.55e-02	-6.35e-02	1.02e-02	-3.04e-03	2.74e-02	6.34e-01	2.35e-01	8.49e-01	9.55e-01	6.09e-01
AMINO ACID METABOLIC PROCESS	278	2.55e-01	7.38e-01	0.0744	1.32e-02	-4.45e-02	3.84e-02	4.07e-02	1.59e-02	7.05e-01	2.02e-01	2.70e-01	2.43e-01	6.47e-01
CELLULAR RESPONSE TO NUTRIENT	45	9.04e-01	9.94e-01	0.0743	4.54e-02	8.98e-03	2.48e-02	2.04e-02	-4.85e-02	5.98e-01	9.17e-01	7.73e-01	8.12e-01	5.74e-01
EXTRACELLULAR TRANSPORT	45	9.73e-01	9.97e-01	0.0742	-3.67e-02	-5.90e-02	-7.00e-03	-1.93e-02	1.61e-02	6.70e-01	4.94e-01	9.35e-01	8.23e-01	8.52e-01
NEGATIVE REGULATION OF AUTOPHAGY	86	5.86e-01	9.29e-01	0.0741	2.02e-02	1.77e-02	-1.52e-02	-1.85e-02	6.48e-02	7.47e-01	7.77e-01	8.08e-01	7.67e-01	2.99e-01
GLYCOSYL COMPOUND METABOLIC PROCESS	79	7.16e-01	9.68e-01	0.0741	-2.52e-02	-4.47e-02	-3.69e-02	-2.45e-02	2.99e-02	6.99e-01	4.93e-01	5.71e-01	7.06e-01	6.46e-01
REGULATION OF POTASSIUM ION TRANSPORT	99	7.62e-01	9.75e-01	0.0741	-2.47e-02	-4.79e-03	-1.84e-02	-1.79e-02	6.48e-02	6.71e-01	9.34e-01	7.51e-01	7.59e-01	2.65e-01
REGULATION OF SMALL MOLECULE METABOLIC PROCESS	325	4.19e-01	8.59e-01	0.0740	-2.17e-02	-2.73e-02	-4.75e-02	-4.40e-02	-8.58e-03	5.01e-01	3.97e-01	1.41e-01	1.73e-01	7.90e-01
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	41	6.34e-01	9.48e-01	0.0740	1.11e-02	-7.00e-02	-1.62e-02	-4.46e-03	-1.31e-02	9.02e-01	4.38e-01	8.58e-01	9.61e-01	8.85e-01
POSITIVE REGULATION OF DEFENSE RESPONSE	463	1.52e-01	6.13e-01	0.0738	-2.57e-02	-3.26e-02	3.86e-03	-3.89e-03	6.08e-02	3.44e-01	2.30e-01	8.87e-01	8.86e-01	2.49e-02
OLEFINIC COMPOUND METABOLIC PROCESS	157	3.81e-01	8.38e-01	0.0738	-1.28e-02	4.50e-02	-1.84e-02	-9.09e-03	-5.32e-02	7.82e-01	3.30e-01	6.90e-01	8.44e-01	2.50e-01
THIOESTER METABOLIC PROCESS	89	8.23e-01	9.83e-01	0.0737	-3.51e-02	-6.09e-02	1.88e-02	9.35e-03	6.81e-03	5.67e-01	3.21e-01	7.59e-01	8.79e-01	9.12e-01
POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	51	6.87e-01	9.61e-01	0.0737	5.18e-03	6.43e-02	-4.53e-03	-2.00e-02	-2.91e-02	9.49e-01	4.27e-01	9.55e-01	8.05e-01	7.20e-01
MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT	8	9.99e-01	1.00e+00	0.0735	3.56e-02	3.26e-02	1.28e-02	2.16e-02	4.95e-02	8.62e-01	8.73e-01	9.50e-01	9.16e-01	8.08e-01
NEGATIVE REGULATION OF CELL CELL ADHESION	198	7.86e-01	9.81e-01	0.0734	-3.21e-02	-4.06e-02	-2.06e-02	-2.37e-02	4.16e-02	4.37e-01	3.24e-01	6.17e-01	5.66e-01	3.13e-01
POSITIVE REGULATION OF TRANSPORTER ACTIVITY	89	9.08e-01	9.94e-01	0.0734	3.31e-02	5.76e-02	8.72e-03	1.96e-02	-2.28e-02	5.89e-01	3.48e-01	8.87e-01	7.50e-01	7.10e-01
RESPONSE TO GROWTH HORMONE	36	9.72e-01	9.97e-01	0.0734	3.41e-02	5.86e-02	8.86e-04	-4.64e-03	-2.78e-02	7.23e-01	5.43e-01	9.93e-01	9.62e-01	7.73e-01
REGULATION OF INTRACELLULAR TRANSPORT	321	2.10e-01	6.87e-01	0.0734	3.02e-02	-2.47e-02	4.66e-02	3.89e-02	1.33e-02	3.51e-01	4.47e-01	1.51e-01	2.31e-01	6.82e-01
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN	354	1.33e-01	5.80e-01	0.0733	3.19e-02	-1.33e-03	1.46e-02	1.66e-02	6.22e-02	3.02e-01	9.66e-01	6.36e-01	5.91e-01	4.44e-02
ENSHEATHMENT OF NEURONS	143	8.25e-01	9.83e-01	0.0733	1.50e-02	1.11e-02	2.19e-02	1.88e-02	6.47e-02	7.58e-01	8.18e-01	6.51e-01	6.99e-01	1.82e-01
REGULATION OF MUSCLE CONTRACTION	163	2.16e-01	6.97e-01	0.0731	3.91e-02	5.16e-02	-2.92e-02	-1.23e-02	-1.23e-02	3.89e-01	2.55e-01	5.20e-01	7.86e-01	7.86e-01
PROSTANOID METABOLIC PROCESS	50	8.72e-01	9.88e-01	0.0731	4.86e-04	-5.66e-02	2.96e-02	3.48e-02	-7.55e-03	9.95e-01	4.89e-01	7.18e-01	6.70e-01	9.26e-01
VISUAL BEHAVIOR	55	9.69e-01	9.97e-01	0.0730	4.05e-02	4.41e-02	2.25e-02	1.78e-02	-3.04e-02	6.03e-01	5.72e-01	7.73e-01	8.20e-01	6.97e-01
POSITIVE REGULATION OF FILOPODIUM ASSEMBLY	28	8.57e-01	9.88e-01	0.0730	2.88e-02	3.03e-02	2.54e-03	-1.39e-02	5.81e-02	7.92e-01	7.81e-01	9.81e-01	8.99e-01	5.95e-01
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	44	6.93e-01	9.61e-01	0.0729	3.18e-02	3.43e-02	4.94e-02	2.62e-02	0.00e+00	7.15e-01	6.94e-01	5.71e-01	7.64e-01	1.00e+00
REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	64	8.20e-01	9.83e-01	0.0729	1.65e-02	5.94e-02	-2.34e-02	-2.65e-02	1.63e-02	8.20e-01	4.11e-01	7.46e-01	7.14e-01	8.22e-01
REGULATION OF ORGANELLE ORGANIZATION	1151	1.07e-06	7.58e-05	0.0728	3.74e-03	-5.19e-02	3.59e-02	2.17e-02	2.88e-02	8.30e-01	2.95e-03	3.97e-02	2.14e-01	9.93e-02
ORGANIC ANION TRANSPORT	429	1.63e-01	6.27e-01	0.0728	-2.30e-02	1.38e-02	-4.83e-02	-4.58e-02	1.23e-02	4.14e-01	6.25e-01	8.59e-02	1.04e-01	6.61e-01
REGULATION OF NERVOUS SYSTEM DEVELOPMENT	445	1.14e-01	5.39e-01	0.0728	-2.30e-02	-4.03e-02	-1.52e-02	-2.39e-02	4.84e-02	4.04e-01	1.45e-01	5.82e-01	3.88e-01	8.00e-02
REGULATION OF OSTEOBLAST DIFFERENTIATION	144	5.87e-01	9.29e-01	0.0726	-8.79e-03	-4.61e-02	-1.50e-03	-1.05e-02	5.43e-02	8.55e-01	3.39e-01	9.75e-01	8.28e-01	2.60e-01
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	39	9.69e-01	9.97e-01	0.0725	3.41e-02	-8.39e-04	3.49e-02	3.38e-02	-4.16e-02	7.13e-01	9.93e-01	7.06e-01	7.15e-01	6.53e-01
BONE MINERALIZATION	116	1.16e-01	5.44e-01	0.0725	1.27e-02	-6.47e-02	-2.07e-02	-2.12e-02	-5.37e-03	8.13e-01	2.28e-01	7.00e-01	6.94e-01	9.20e-01
MALE GAMETE GENERATION	571	7.51e-02	4.40e-01	0.0725	7.02e-04	1.94e-02	-4.65e-02	-4.28e-02	-2.98e-02	9.77e-01	4.28e-01	5.75e-02	8.05e-02	2.23e-01
GASTRULATION	188	9.58e-03	1.26e-01	0.0725	1.52e-02	-6.91e-02	1.45e-02	-9.75e-04	6.30e-03	7.18e-01	1.02e-01	7.32e-01	9.82e-01	8.82e-01
POSITIVE REGULATION OF ORGANELLE ORGANIZATION	496	2.00e-02	2.03e-01	0.0723	1.99e-02	-4.48e-02	3.37e-02	2.66e-02	3.15e-02	4.47e-01	8.75e-02	1.99e-01	3.11e-01	2.30e-01
SPHINGOLIPID METABOLIC PROCESS	162	6.09e-01	9.36e-01	0.0723	-7.06e-03	-5.17e-02	-7.32e-04	-4.03e-03	4.99e-02	8.77e-01	2.56e-01	9.87e-01	9.29e-01	2.73e-01
REGULATION OF RESPONSE TO OXIDATIVE STRESS	31	8.36e-01	9.85e-01	0.0723	-5.76e-03	7.09e-02	1.26e-02	3.05e-03	1.49e-03	9.56e-01	4.95e-01	9.04e-01	9.77e-01	9.89e-01
LYSOSOMAL TRANSPORT	128	5.02e-01	8.98e-01	0.0722	4.65e-05	-5.32e-02	3.04e-02	2.64e-02	-2.77e-02	9.99e-01	2.99e-01	5.52e-01	6.06e-01	5.88e-01
RESPONSE TO REACTIVE OXYGEN SPECIES	196	2.87e-01	7.66e-01	0.0722	2.05e-02	-3.09e-02	4.94e-02	3.59e-02	1.05e-02	6.21e-01	4.56e-01	2.33e-01	3.86e-01	8.00e-01
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	113	7.05e-01	9.65e-01	0.0721	-6.01e-03	8.47e-03	-2.01e-03	3.01e-04	7.14e-02	9.12e-01	8.76e-01	9.70e-01	9.96e-01	1.90e-01
DEMETHYLATION	51	9.15e-01	9.94e-01	0.0721	-4.48e-02	-1.52e-02	-1.48e-02	-1.33e-02	-5.07e-02	5.80e-01	8.51e-01	8.55e-01	8.70e-01	5.31e-01
TISSUE HOMEOSTASIS	264	3.71e-01	8.31e-01	0.0721	-1.95e-02	-2.41e-02	-4.27e-02	-4.11e-02	2.68e-02	5.85e-01	5.01e-01	2.32e-01	2.50e-01	4.53e-01
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	558	1.64e-01	6.28e-01	0.0720	6.15e-03	-3.91e-02	3.16e-02	3.15e-02	4.03e-02	8.04e-01	1.14e-01	2.01e-01	2.03e-01	1.04e-01
CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	89	7.38e-01	9.73e-01	0.0720	-3.21e-02	-2.89e-02	-1.07e-02	-2.81e-03	5.65e-02	6.01e-01	6.37e-01	8.62e-01	9.64e-01	3.57e-01
EMBRYO DEVELOPMENT	1094	1.72e-09	2.19e-07	0.0720	2.88e-02	-4.38e-02	3.12e-02	1.98e-02	3.27e-02	1.08e-01	1.44e-02	8.14e-02	2.69e-01	6.80e-02
REGULATION OF EMBRYONIC DEVELOPMENT	89	1.37e-01	5.87e-01	0.0720	5.08e-02	-3.93e-02	2.72e-02	1.47e-02	9.89e-03	4.07e-01	5.22e-01	6.58e-01	8.11e-01	8.72e-01
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	392	1.01e-01	5.09e-01	0.0718	-2.00e-02	-5.31e-02	-2.63e-02	-3.25e-02	1.37e-02	4.96e-01	7.08e-02	3.72e-01	2.69e-01	6.41e-01
CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS	170	7.08e-01	9.65e-01	0.0718	-2.70e-02	-5.28e-02	-2.57e-02	-2.17e-02	2.24e-02	5.43e-01	2.35e-01	5.63e-01	6.25e-01	6.14e-01
REGULATION OF VASCULATURE DEVELOPMENT	337	5.67e-01	9.23e-01	0.0716	-2.76e-02	-1.45e-02	-4.82e-02	-4.28e-02	-2.61e-03	3.85e-01	6.47e-01	1.28e-01	1.77e-01	9.34e-01
GENERATION OF NEURONS	1421	8.26e-09	9.14e-07	0.0716	-1.32e-02	-4.90e-02	-7.88e-03	-2.09e-02	4.53e-02	4.05e-01	1.98e-03	6.19e-01	1.87e-01	4.18e-03
MONOCARBOXYLIC ACID TRANSPORT	174	4.62e-01	8.80e-01	0.0716	-4.18e-02	1.45e-02	-3.67e-02	-4.05e-02	1.30e-02	3.41e-01	7.41e-01	4.03e-01	3.56e-01	7.67e-01
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION	170	6.09e-01	9.36e-01	0.0715	-3.48e-02	-2.93e-02	-3.31e-02	-2.58e-02	3.58e-02	4.34e-01	5.10e-01	4.56e-01	5.62e-01	4.20e-01
REGULATION OF AMIDE METABOLIC PROCESS	570	3.70e-02	2.93e-01	0.0715	-2.48e-02	-6.34e-02	1.50e-02	1.43e-02	6.45e-03	3.10e-01	9.61e-03	5.40e-01	5.61e-01	7.92e-01
RESPONSE TO ELECTRICAL STIMULUS	44	7.38e-01	9.73e-01	0.0715	3.61e-03	-6.33e-02	-2.66e-02	-1.96e-02	9.59e-04	9.67e-01	4.68e-01	7.60e-01	8.22e-01	9.91e-01
REGULATION OF CELLULAR COMPONENT BIOGENESIS	956	2.49e-02	2.34e-01	0.0715	-3.47e-02	-5.49e-02	-6.07e-03	-1.55e-02	2.46e-02	6.91e-02	3.99e-03	7.50e-01	4.17e-01	1.98e-01
PHOSPHATIDYLCHOLINE METABOLIC PROCESS	74	2.67e-01	7.48e-01	0.0714	3.67e-02	3.51e-02	-4.33e-02	-1.99e-02	1.61e-02	5.85e-01	6.02e-01	5.20e-01	7.67e-01	8.11e-01
RESPONSE TO HORMONE	841	6.22e-03	9.48e-02	0.0713	-2.28e-02	-6.05e-02	-1.61e-02	-2.26e-02	1.20e-02	2.61e-01	2.89e-03	4.29e-01	2.65e-01	5.55e-01
FACE MORPHOGENESIS	30	9.70e-01	9.97e-01	0.0713	4.87e-02	4.36e-02	1.15e-02	4.88e-03	-2.55e-02	6.44e-01	6.79e-01	9.13e-01	9.63e-01	8.09e-01
PURINE CONTAINING COMPOUND CATABOLIC PROCESS	57	7.87e-01	9.81e-01	0.0710	3.31e-02	-6.97e-03	2.10e-02	9.04e-03	5.80e-02	6.65e-01	9.27e-01	7.84e-01	9.06e-01	4.48e-01
CARDIOLIPIN ACYL CHAIN REMODELING	5	9.98e-01	1.00e+00	0.0709	-4.13e-04	-3.76e-02	-3.54e-02	-4.46e-02	1.94e-02	9.99e-01	8.84e-01	8.91e-01	8.63e-01	9.40e-01
DIGESTIVE SYSTEM DEVELOPMENT	142	2.88e-01	7.66e-01	0.0709	-5.97e-03	-5.67e-02	-1.05e-02	-2.19e-02	3.45e-02	9.02e-01	2.44e-01	8.29e-01	6.53e-01	4.78e-01
POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	36	9.61e-01	9.97e-01	0.0709	-4.48e-02	-4.27e-02	1.35e-02	9.93e-03	3.02e-02	6.42e-01	6.58e-01	8.88e-01	9.18e-01	7.54e-01
NEGATIVE REGULATION OF MACROPHAGE ACTIVATION	18	9.68e-01	9.97e-01	0.0708	5.52e-02	4.20e-02	-1.33e-02	3.38e-03	3.34e-03	6.85e-01	7.58e-01	9.22e-01	9.80e-01	9.80e-01
REGULATION OF DEFENSE RESPONSE	786	6.63e-02	4.11e-01	0.0708	-2.96e-02	-3.20e-02	-1.91e-02	-2.29e-02	4.71e-02	1.57e-01	1.27e-01	3.62e-01	2.76e-01	2.46e-02
ENDOTHELIAL CELL MIGRATION	270	5.22e-02	3.58e-01	0.0708	-3.66e-02	-3.86e-02	-2.43e-02	-1.07e-02	3.84e-02	3.00e-01	2.75e-01	4.92e-01	7.62e-01	2.78e-01
REGULATION OF LYMPHOCYTE ACTIVATION	491	2.35e-01	7.19e-01	0.0708	2.83e-02	4.34e-02	3.50e-02	2.95e-02	1.52e-02	2.83e-01	9.93e-02	1.84e-01	2.64e-01	5.65e-01
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	55	5.96e-01	9.33e-01	0.0707	5.82e-02	1.34e-03	5.54e-03	2.00e-02	3.44e-02	4.56e-01	9.86e-01	9.43e-01	7.98e-01	6.59e-01
CENTRAL NERVOUS SYSTEM DEVELOPMENT	972	1.35e-08	1.41e-06	0.0706	2.34e-02	-4.42e-02	2.92e-02	1.53e-02	3.74e-02	2.17e-01	1.95e-02	1.24e-01	4.18e-01	4.84e-02
POSITIVE REGULATION OF CELL CYCLE	319	3.13e-02	2.66e-01	0.0705	4.56e-02	-1.51e-02	4.05e-02	3.05e-02	1.00e-02	1.62e-01	6.43e-01	2.13e-01	3.50e-01	7.59e-01
REGULATION OF PROTEIN DEACETYLATION	31	9.99e-01	1.00e+00	0.0705	2.63e-02	2.20e-02	3.88e-02	3.53e-02	3.23e-02	8.00e-01	8.32e-01	7.08e-01	7.34e-01	7.56e-01
NEUROMUSCULAR JUNCTION DEVELOPMENT	50	9.12e-01	9.94e-01	0.0705	2.76e-02	6.32e-02	-8.60e-03	6.88e-03	-9.38e-03	7.35e-01	4.39e-01	9.16e-01	9.33e-01	9.09e-01
NEURON DEVELOPMENT	1091	1.87e-04	6.71e-03	0.0705	-2.17e-02	-3.45e-02	-2.51e-02	-3.40e-02	3.91e-02	2.27e-01	5.45e-02	1.62e-01	5.79e-02	2.91e-02
REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	403	3.64e-01	8.28e-01	0.0705	-2.88e-02	-6.04e-02	-3.52e-03	-1.03e-02	1.91e-02	3.20e-01	3.74e-02	9.03e-01	7.23e-01	5.10e-01
TETRAPYRROLE METABOLIC PROCESS	58	9.11e-01	9.94e-01	0.0704	-1.25e-02	-6.54e-02	1.61e-02	1.53e-02	-5.32e-03	8.69e-01	3.89e-01	8.32e-01	8.41e-01	9.44e-01
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS	1247	2.77e-04	9.12e-03	0.0703	-2.22e-03	-5.70e-02	2.44e-02	1.96e-02	2.67e-02	8.95e-01	6.98e-04	1.48e-01	2.44e-01	1.13e-01
PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS	83	3.20e-01	7.93e-01	0.0703	3.45e-02	-5.31e-02	2.14e-02	1.26e-02	1.77e-02	5.87e-01	4.03e-01	7.36e-01	8.43e-01	7.81e-01
POSITIVE REGULATION OF TRANSPORT	859	2.92e-02	2.56e-01	0.0702	-2.10e-02	-4.78e-02	-1.29e-02	-1.64e-02	4.21e-02	2.95e-01	1.74e-02	5.20e-01	4.13e-01	3.61e-02
SOMITOGENESIS	64	2.90e-01	7.67e-01	0.0702	4.44e-02	-3.91e-02	3.14e-02	1.33e-02	1.66e-02	5.39e-01	5.89e-01	6.64e-01	8.54e-01	8.18e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	48	7.49e-01	9.75e-01	0.0702	1.16e-02	5.18e-02	-2.12e-02	-3.59e-02	-1.93e-02	8.90e-01	5.35e-01	8.00e-01	6.67e-01	8.17e-01
RESPONSE TO ENDOGENOUS STIMULUS	1700	4.61e-05	2.09e-03	0.0702	-2.23e-02	-5.25e-02	-1.62e-02	-2.26e-02	2.99e-02	1.26e-01	3.14e-04	2.65e-01	1.21e-01	4.00e-02
FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS	26	9.96e-01	1.00e+00	0.0701	-1.96e-02	-5.57e-02	1.72e-02	1.46e-02	3.03e-02	8.63e-01	6.23e-01	8.79e-01	8.97e-01	7.89e-01
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	97	9.18e-01	9.95e-01	0.0700	-2.83e-02	-5.19e-02	-2.08e-02	-2.84e-02	1.29e-02	6.30e-01	3.77e-01	7.24e-01	6.28e-01	8.26e-01
CARDIOCYTE DIFFERENTIATION	163	6.75e-01	9.59e-01	0.0699	2.30e-03	-5.11e-02	1.77e-02	1.49e-02	4.18e-02	9.60e-01	2.61e-01	6.97e-01	7.43e-01	3.57e-01
EMBRYONIC MORPHOGENESIS	604	2.38e-09	2.98e-07	0.0698	2.18e-02	-6.00e-02	1.84e-02	1.46e-03	2.11e-02	3.59e-01	1.17e-02	4.40e-01	9.51e-01	3.75e-01
TOLL SIGNALING PATHWAY	10	8.37e-01	9.85e-01	0.0698	-2.73e-02	5.67e-02	1.73e-02	-1.94e-02	1.50e-02	8.81e-01	7.56e-01	9.25e-01	9.15e-01	9.35e-01
REGULATION OF RESPONSE TO EXTERNAL STIMULUS	1087	5.32e-03	8.54e-02	0.0698	-2.34e-02	-2.93e-02	-2.45e-02	-2.77e-02	4.58e-02	1.93e-01	1.03e-01	1.73e-01	1.22e-01	1.08e-02
EPIDERMAL CELL DIFFERENTIATION	242	3.96e-02	3.05e-01	0.0696	-7.28e-03	5.75e-02	-1.61e-02	-7.89e-03	3.42e-02	8.45e-01	1.24e-01	6.65e-01	8.33e-01	3.59e-01
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	1069	3.16e-02	2.68e-01	0.0696	-2.98e-02	-4.57e-02	-2.30e-02	-2.91e-02	2.22e-02	9.96e-02	1.16e-02	2.04e-01	1.08e-01	2.20e-01
DEVELOPMENTAL MATURATION	318	2.18e-01	7.00e-01	0.0695	3.04e-02	-1.25e-03	3.31e-02	2.26e-02	4.80e-02	3.51e-01	9.69e-01	3.10e-01	4.88e-01	1.41e-01
MEIOTIC CELL CYCLE	276	1.18e-01	5.49e-01	0.0695	3.77e-02	3.45e-02	2.28e-02	1.21e-02	-3.93e-02	2.81e-01	3.23e-01	5.15e-01	7.29e-01	2.62e-01
POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	27	9.98e-01	1.00e+00	0.0694	-1.13e-02	1.27e-03	-2.35e-02	-2.19e-02	-6.04e-02	9.19e-01	9.91e-01	8.33e-01	8.44e-01	5.87e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION	208	6.65e-01	9.54e-01	0.0694	-1.68e-02	-5.40e-02	1.48e-02	6.47e-03	3.68e-02	6.76e-01	1.80e-01	7.13e-01	8.72e-01	3.60e-01
NEPHRON EPITHELIUM DEVELOPMENT	115	5.98e-01	9.33e-01	0.0693	1.45e-02	-1.66e-02	2.32e-02	9.44e-03	6.08e-02	7.88e-01	7.58e-01	6.67e-01	8.61e-01	2.60e-01
POSITIVE REGULATION OF IMMUNE RESPONSE	700	8.33e-03	1.14e-01	0.0693	1.97e-03	1.76e-02	2.67e-02	2.90e-02	5.42e-02	9.29e-01	4.26e-01	2.28e-01	1.91e-01	1.46e-02
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	14	9.24e-01	9.95e-01	0.0693	-6.59e-03	1.17e-02	-3.29e-02	-5.81e-02	-1.29e-02	9.66e-01	9.40e-01	8.31e-01	7.07e-01	9.34e-01
METANEPHRIC NEPHRON MORPHOGENESIS	24	8.25e-01	9.83e-01	0.0693	-2.85e-02	-5.36e-02	1.72e-03	-2.84e-02	1.76e-02	8.09e-01	6.50e-01	9.88e-01	8.10e-01	8.81e-01
NEGATIVE REGULATION OF JNK CASCADE	37	8.96e-01	9.93e-01	0.0692	5.92e-02	2.39e-02	9.03e-03	2.50e-02	6.56e-04	5.33e-01	8.01e-01	9.24e-01	7.92e-01	9.94e-01
CARBOHYDRATE BIOSYNTHETIC PROCESS	206	5.83e-01	9.28e-01	0.0691	-1.40e-02	-1.58e-02	-4.40e-02	-4.71e-02	-1.31e-02	7.29e-01	6.96e-01	2.76e-01	2.43e-01	7.45e-01
RESPONSE TO NUTRIENT	147	3.17e-01	7.89e-01	0.0691	-4.68e-03	-6.84e-02	7.33e-03	-2.35e-03	-3.73e-03	9.22e-01	1.52e-01	8.78e-01	9.61e-01	9.38e-01
ENERGY RESERVE METABOLIC PROCESS	84	2.48e-01	7.33e-01	0.0690	5.98e-02	1.80e-02	8.29e-03	-2.87e-03	-2.81e-02	3.44e-01	7.76e-01	8.96e-01	9.64e-01	6.56e-01
MONOATOMIC ION TRANSPORT	1196	1.27e-05	6.94e-04	0.0689	1.49e-02	6.10e-02	-7.97e-03	-5.26e-03	2.67e-02	3.85e-01	3.76e-04	6.42e-01	7.59e-01	1.20e-01
RESPONSE TO ACTIVITY	72	9.80e-01	9.97e-01	0.0687	-2.55e-02	-1.09e-02	-4.42e-02	-4.43e-02	5.45e-03	7.08e-01	8.73e-01	5.16e-01	5.16e-01	9.36e-01
POSITIVE REGULATION OF REPRODUCTIVE PROCESS	83	8.64e-01	9.88e-01	0.0687	4.61e-02	4.60e-02	3.77e-03	4.02e-03	2.13e-02	4.68e-01	4.69e-01	9.53e-01	9.49e-01	7.38e-01
REGULATION OF CELL SIZE	176	7.12e-01	9.67e-01	0.0686	-2.62e-02	2.39e-03	-4.00e-02	-4.79e-02	-1.11e-02	5.49e-01	9.56e-01	3.60e-01	2.73e-01	8.00e-01
REGULATION OF NEUROGENESIS	373	9.27e-02	4.85e-01	0.0686	-7.41e-03	-4.07e-02	3.92e-04	-9.82e-03	5.39e-02	8.06e-01	1.77e-01	9.90e-01	7.45e-01	7.40e-02
GLYCEROLIPID BIOSYNTHETIC PROCESS	236	7.75e-01	9.77e-01	0.0686	-3.55e-02	-5.20e-02	-1.46e-02	-2.08e-02	-1.01e-02	3.48e-01	1.69e-01	7.00e-01	5.82e-01	7.90e-01
MICROTUBULE ORGANIZING CENTER ORGANIZATION	150	2.06e-01	6.84e-01	0.0686	-1.17e-02	-6.14e-02	2.61e-02	8.01e-03	-7.21e-03	8.05e-01	1.94e-01	5.81e-01	8.65e-01	8.79e-01
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	57	9.57e-01	9.97e-01	0.0686	-1.43e-02	-1.72e-02	-4.35e-02	-4.69e-02	-1.07e-02	8.52e-01	8.22e-01	5.70e-01	5.41e-01	8.89e-01
RESPONSE TO ALCOHOL	246	4.00e-01	8.45e-01	0.0685	-1.67e-02	-3.88e-02	-3.19e-02	-3.37e-02	2.77e-02	6.52e-01	2.95e-01	3.89e-01	3.63e-01	4.55e-01
NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING	6	9.78e-01	9.97e-01	0.0685	2.86e-02	-5.63e-02	2.66e-02	1.15e-03	1.80e-04	9.03e-01	8.11e-01	9.10e-01	9.96e-01	9.99e-01
NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION	44	9.52e-01	9.97e-01	0.0685	-2.63e-03	-6.17e-02	2.28e-02	1.71e-02	8.54e-03	9.76e-01	4.79e-01	7.94e-01	8.45e-01	9.22e-01
MEMBRANE FUSION	174	5.45e-01	9.15e-01	0.0684	-9.60e-03	-5.89e-02	2.51e-02	2.21e-02	-1.51e-03	8.27e-01	1.80e-01	5.67e-01	6.16e-01	9.73e-01
ENDOMEMBRANE SYSTEM ORGANIZATION	568	1.96e-02	2.01e-01	0.0684	7.66e-03	-5.47e-02	2.44e-02	2.38e-02	2.15e-02	7.55e-01	2.59e-02	3.19e-01	3.31e-01	3.81e-01
LONG CHAIN FATTY ACID TRANSPORT	66	8.67e-01	9.88e-01	0.0683	-5.67e-02	-1.35e-02	-2.08e-02	-2.87e-02	-3.51e-03	4.26e-01	8.50e-01	7.70e-01	6.87e-01	9.61e-01
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS	200	3.26e-01	7.98e-01	0.0682	4.35e-02	-6.06e-03	3.89e-02	3.19e-02	-1.39e-02	2.89e-01	8.83e-01	3.43e-01	4.37e-01	7.35e-01
SYNAPTIC SIGNALING	747	7.48e-02	4.40e-01	0.0682	-3.36e-02	-1.66e-02	-3.24e-02	-3.83e-02	2.70e-02	1.18e-01	4.41e-01	1.32e-01	7.47e-02	2.08e-01
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS	147	6.79e-01	9.60e-01	0.0681	-1.10e-02	-2.64e-02	-2.81e-02	-3.37e-02	-4.36e-02	8.17e-01	5.81e-01	5.57e-01	4.81e-01	3.62e-01
PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS	42	9.19e-01	9.95e-01	0.0681	3.22e-03	-5.93e-02	1.34e-02	2.02e-02	2.29e-02	9.71e-01	5.06e-01	8.81e-01	8.21e-01	7.98e-01
REGULATION OF RECEPTOR RECYCLING	25	9.29e-01	9.95e-01	0.0681	-1.46e-02	3.57e-02	2.62e-02	2.54e-02	4.25e-02	8.99e-01	7.57e-01	8.21e-01	8.26e-01	7.13e-01
BLOOD VESSEL REMODELING	46	9.84e-01	9.98e-01	0.0680	-3.82e-02	-4.57e-02	-1.45e-02	-2.57e-02	1.45e-02	6.54e-01	5.92e-01	8.65e-01	7.63e-01	8.65e-01
SUPRAMOLECULAR FIBER ORGANIZATION	811	2.18e-02	2.14e-01	0.0678	-2.30e-02	1.96e-02	-4.48e-02	-4.08e-02	4.24e-03	2.66e-01	3.43e-01	3.02e-02	4.83e-02	8.37e-01
EPITHELIAL CELL DEVELOPMENT	208	4.70e-01	8.84e-01	0.0677	-8.97e-03	-4.63e-02	-6.93e-03	-1.26e-02	4.64e-02	8.24e-01	2.49e-01	8.63e-01	7.54e-01	2.49e-01
NEGATIVE REGULATION OF TRANSPORT	452	4.26e-01	8.64e-01	0.0676	-2.77e-02	-4.57e-02	-2.30e-02	-2.73e-02	2.10e-02	3.13e-01	9.56e-02	4.03e-01	3.19e-01	4.45e-01
CELLULAR RESPONSE TO NITROGEN COMPOUND	662	8.05e-02	4.54e-01	0.0675	-2.20e-02	-3.81e-02	-2.60e-02	-2.97e-02	3.28e-02	3.35e-01	9.44e-02	2.54e-01	1.93e-01	1.50e-01
REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	10	6.88e-01	9.61e-01	0.0675	-4.63e-02	3.12e-02	2.30e-02	-2.59e-02	-1.55e-02	8.00e-01	8.64e-01	9.00e-01	8.87e-01	9.32e-01
GAMETE GENERATION	724	3.08e-02	2.64e-01	0.0675	-5.30e-03	7.02e-04	-4.15e-02	-4.37e-02	-2.99e-02	8.08e-01	9.74e-01	5.69e-02	4.53e-02	1.71e-01
KIDNEY EPITHELIUM DEVELOPMENT	145	4.45e-01	8.73e-01	0.0674	1.74e-02	-2.14e-02	2.44e-02	1.07e-02	5.54e-02	7.18e-01	6.57e-01	6.12e-01	8.23e-01	2.49e-01
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION	180	1.44e-01	6.02e-01	0.0673	4.56e-02	4.05e-02	9.93e-03	-1.26e-03	2.66e-02	2.91e-01	3.48e-01	8.18e-01	9.77e-01	5.38e-01
CLATHRIN COAT ASSEMBLY	17	8.34e-01	9.85e-01	0.0673	1.42e-02	-2.07e-03	-3.36e-02	-5.65e-02	3.17e-05	9.19e-01	9.88e-01	8.10e-01	6.87e-01	1.00e+00
RESPONSE TO LIPID	893	3.49e-04	1.08e-02	0.0672	1.86e-02	-3.73e-02	1.89e-02	1.36e-02	4.73e-02	3.45e-01	5.86e-02	3.39e-01	4.89e-01	1.64e-02
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	100	8.91e-01	9.92e-01	0.0672	2.51e-02	6.18e-02	-2.81e-03	4.97e-03	-5.90e-03	6.65e-01	2.85e-01	9.61e-01	9.32e-01	9.19e-01
SULFUR COMPOUND CATABOLIC PROCESS	35	8.22e-01	9.83e-01	0.0671	-2.37e-02	3.36e-02	1.94e-02	1.80e-02	4.60e-02	8.08e-01	7.31e-01	8.42e-01	8.54e-01	6.38e-01
REGULATION OF CELL DIVISION	177	1.72e-01	6.44e-01	0.0670	2.80e-02	-3.35e-02	3.85e-02	2.73e-02	-1.87e-02	5.20e-01	4.42e-01	3.77e-01	5.30e-01	6.69e-01
BODY MORPHOGENESIS	46	9.70e-01	9.97e-01	0.0668	-1.18e-02	-3.44e-02	-3.07e-02	-3.26e-02	-3.38e-02	8.90e-01	6.87e-01	7.18e-01	7.02e-01	6.92e-01
POSITIVE REGULATION OF HORMONE SECRETION	139	3.01e-01	7.73e-01	0.0668	-3.88e-03	-5.39e-02	-2.04e-02	-2.84e-02	1.79e-02	9.37e-01	2.73e-01	6.78e-01	5.63e-01	7.15e-01
REGULATION OF SYNAPTIC PLASTICITY	204	5.82e-01	9.28e-01	0.0668	1.70e-02	3.38e-02	2.89e-02	3.51e-02	3.10e-02	6.76e-01	4.06e-01	4.77e-01	3.88e-01	4.45e-01
REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	16	8.93e-01	9.92e-01	0.0666	-4.52e-02	4.02e-02	-3.17e-03	-2.23e-02	-1.67e-02	7.54e-01	7.81e-01	9.83e-01	8.77e-01	9.08e-01
HEPOXILIN METABOLIC PROCESS	9	9.94e-01	9.99e-01	0.0665	-4.49e-02	-3.30e-02	1.85e-02	1.77e-02	-2.58e-02	8.16e-01	8.64e-01	9.24e-01	9.27e-01	8.93e-01
POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	93	6.39e-01	9.49e-01	0.0665	3.40e-02	-2.03e-02	3.91e-02	2.97e-02	-2.11e-02	5.71e-01	7.35e-01	5.15e-01	6.21e-01	7.25e-01
HEART VALVE DEVELOPMENT	72	6.14e-01	9.39e-01	0.0664	2.35e-03	-6.46e-02	6.04e-03	-4.15e-03	-1.34e-02	9.73e-01	3.44e-01	9.29e-01	9.51e-01	8.44e-01
RESPONSE TO CYTOKINE	906	4.26e-01	8.64e-01	0.0664	3.09e-02	4.19e-03	3.58e-02	3.64e-02	2.88e-02	1.15e-01	8.31e-01	6.75e-02	6.32e-02	1.42e-01
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS	480	4.48e-01	8.74e-01	0.0663	-3.26e-02	-3.37e-02	-2.32e-02	-2.90e-02	2.88e-02	2.21e-01	2.06e-01	3.84e-01	2.77e-01	2.80e-01
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS	89	8.62e-01	9.88e-01	0.0663	-5.61e-03	-5.85e-03	1.48e-02	4.90e-03	6.39e-02	9.27e-01	9.24e-01	8.09e-01	9.36e-01	2.97e-01
REGULATION OF LAMELLIPODIUM ASSEMBLY	37	7.74e-01	9.77e-01	0.0663	-4.14e-02	-2.40e-02	2.39e-02	5.88e-04	3.91e-02	6.63e-01	8.00e-01	8.02e-01	9.95e-01	6.81e-01
ENTRY INTO HOST	159	8.27e-01	9.83e-01	0.0663	3.36e-02	3.12e-02	3.48e-02	2.84e-02	-1.63e-02	4.65e-01	4.97e-01	4.48e-01	5.36e-01	7.23e-01
INTRACELLULAR LIPID TRANSPORT	50	5.65e-01	9.23e-01	0.0662	3.78e-02	1.37e-02	-2.34e-02	-3.36e-02	-3.30e-02	6.44e-01	8.67e-01	7.75e-01	6.81e-01	6.86e-01
REGULATION OF IMMUNE EFFECTOR PROCESS	375	1.29e-01	5.72e-01	0.0662	-1.02e-02	3.51e-03	-5.50e-04	2.36e-03	6.53e-02	7.34e-01	9.07e-01	9.85e-01	9.38e-01	3.00e-02
MUSCLE CONTRACTION	338	5.18e-02	3.58e-01	0.0662	1.26e-02	3.68e-02	-3.60e-02	-2.84e-02	2.76e-02	6.91e-01	2.44e-01	2.55e-01	3.70e-01	3.84e-01
POSITIVE REGULATION OF GENE EXPRESSION	1130	1.41e-02	1.60e-01	0.0661	1.24e-02	-3.15e-02	2.48e-02	2.27e-02	4.58e-02	4.82e-01	7.41e-02	1.59e-01	1.98e-01	9.36e-03
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	68	5.83e-01	9.28e-01	0.0661	3.35e-03	-5.70e-02	1.04e-02	-6.54e-03	3.10e-02	9.62e-01	4.16e-01	8.82e-01	9.26e-01	6.59e-01
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	198	3.70e-02	2.93e-01	0.0657	-8.55e-03	-5.49e-02	2.41e-02	4.04e-03	-2.52e-02	8.36e-01	1.83e-01	5.58e-01	9.22e-01	5.41e-01
PROTEIN TETRAMERIZATION	88	9.70e-01	9.97e-01	0.0655	4.45e-02	3.86e-02	1.79e-02	1.81e-02	-1.34e-02	4.70e-01	5.32e-01	7.71e-01	7.70e-01	8.28e-01
MAPK CASCADE	746	4.62e-02	3.35e-01	0.0655	-1.87e-02	-3.08e-02	-2.42e-02	-2.60e-02	4.16e-02	3.85e-01	1.52e-01	2.60e-01	2.26e-01	5.33e-02
REGULATION OF SMOOTHENED SIGNALING PATHWAY	84	5.55e-01	9.17e-01	0.0655	4.63e-02	-3.81e-03	3.35e-02	2.21e-02	-2.26e-02	4.63e-01	9.52e-01	5.95e-01	7.26e-01	7.20e-01
MULTICELLULAR ORGANISM REPRODUCTION	876	3.42e-02	2.79e-01	0.0654	-8.86e-03	-1.01e-03	-4.18e-02	-4.33e-02	-2.41e-02	6.56e-01	9.59e-01	3.59e-02	2.95e-02	2.25e-01
NEGATIVE REGULATION OF CELL DEVELOPMENT	275	5.16e-02	3.57e-01	0.0654	7.52e-03	-4.88e-02	1.68e-02	2.81e-03	3.94e-02	8.30e-01	1.64e-01	6.32e-01	9.36e-01	2.61e-01
REGULATION OF HORMONE SECRETION	248	4.28e-01	8.65e-01	0.0654	-1.27e-02	-1.78e-02	-4.10e-02	-4.53e-02	-8.02e-03	7.31e-01	6.30e-01	2.66e-01	2.19e-01	8.28e-01
POSITIVE REGULATION OF PROGRAMMED CELL DEATH	546	3.96e-02	3.05e-01	0.0653	5.08e-03	-4.51e-02	7.73e-03	6.88e-03	4.58e-02	8.39e-01	7.14e-02	7.57e-01	7.83e-01	6.73e-02
REGULATION OF TRANSMEMBRANE TRANSPORT	561	4.84e-03	7.91e-02	0.0653	2.55e-03	4.69e-02	-2.26e-02	-1.65e-02	3.57e-02	9.18e-01	5.77e-02	3.60e-01	5.03e-01	1.48e-01
ACTIVATION OF INNATE IMMUNE RESPONSE	263	8.48e-01	9.87e-01	0.0652	-3.76e-02	-3.51e-02	-2.07e-02	-2.38e-02	2.48e-02	2.94e-01	3.27e-01	5.64e-01	5.07e-01	4.88e-01
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	101	7.85e-02	4.51e-01	0.0652	1.61e-02	-4.23e-02	-1.89e-02	-3.47e-02	-2.54e-02	7.80e-01	4.63e-01	7.43e-01	5.47e-01	6.59e-01
LYMPHOCYTE MIGRATION	117	5.34e-01	9.09e-01	0.0652	1.76e-02	3.30e-02	-1.14e-02	5.73e-04	5.22e-02	7.43e-01	5.38e-01	8.32e-01	9.91e-01	3.30e-01
REGULATION OF APPETITE	19	2.74e-01	7.56e-01	0.0652	5.98e-03	-1.02e-02	-1.04e-02	-6.12e-02	1.60e-02	9.64e-01	9.38e-01	9.38e-01	6.44e-01	9.04e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION	1622	6.56e-07	4.94e-05	0.0652	9.21e-03	-4.65e-02	3.47e-02	2.59e-02	1.12e-02	5.36e-01	1.78e-03	1.99e-02	8.20e-02	4.54e-01
FACE DEVELOPMENT	49	8.13e-01	9.82e-01	0.0650	2.90e-02	2.06e-02	-3.81e-03	-1.51e-02	-5.21e-02	7.25e-01	8.03e-01	9.63e-01	8.55e-01	5.28e-01
CELL MOTILITY	1721	1.23e-03	2.93e-02	0.0649	-2.21e-02	-1.90e-02	-4.06e-02	-3.83e-02	1.59e-02	1.27e-01	1.91e-01	5.04e-03	8.24e-03	2.74e-01
HEART PROCESS	245	4.75e-01	8.86e-01	0.0649	4.02e-02	5.04e-02	1.45e-03	3.59e-04	7.84e-03	2.79e-01	1.75e-01	9.69e-01	9.92e-01	8.33e-01
REGULATION OF BINDING	253	5.14e-01	9.01e-01	0.0649	1.04e-02	-3.40e-02	4.04e-02	3.60e-02	4.54e-03	7.76e-01	3.51e-01	2.69e-01	3.25e-01	9.01e-01
EXPORT FROM CELL	870	1.99e-01	6.78e-01	0.0649	-2.82e-02	-3.71e-02	-2.80e-02	-2.87e-02	2.08e-02	1.58e-01	6.31e-02	1.61e-01	1.51e-01	2.99e-01
AMINE METABOLIC PROCESS	107	7.67e-01	9.75e-01	0.0649	9.75e-03	-2.46e-02	6.90e-03	1.40e-02	5.71e-02	8.62e-01	6.60e-01	9.02e-01	8.02e-01	3.07e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	70	9.59e-01	9.97e-01	0.0648	3.89e-02	3.99e-02	1.41e-02	2.47e-02	1.67e-02	5.73e-01	5.64e-01	8.38e-01	7.21e-01	8.09e-01
GLIAL CELL DEVELOPMENT	118	7.68e-01	9.75e-01	0.0647	-1.48e-02	-2.87e-02	-2.11e-02	-1.53e-02	4.97e-02	7.81e-01	5.90e-01	6.92e-01	7.74e-01	3.51e-01
ORGANIC ACID BIOSYNTHETIC PROCESS	321	7.45e-02	4.40e-01	0.0647	1.97e-03	-6.08e-02	1.76e-02	1.21e-02	-5.91e-03	9.52e-01	6.11e-02	5.88e-01	7.08e-01	8.55e-01
INTERNAL PROTEIN AMINO ACID ACETYLATION	53	4.76e-01	8.86e-01	0.0647	5.54e-02	-5.32e-03	2.86e-02	1.13e-02	1.18e-02	4.85e-01	9.47e-01	7.19e-01	8.86e-01	8.82e-01
CELLULAR RESPONSE TO VITAMIN	28	9.91e-01	9.98e-01	0.0646	1.15e-02	2.62e-02	-3.10e-02	-3.27e-02	-3.64e-02	9.16e-01	8.11e-01	7.76e-01	7.65e-01	7.39e-01
HORMONE BIOSYNTHETIC PROCESS	65	8.84e-01	9.91e-01	0.0644	4.40e-03	3.97e-02	-7.13e-03	-7.66e-03	4.94e-02	9.51e-01	5.80e-01	9.21e-01	9.15e-01	4.91e-01
EPITHELIAL CELL PROLIFERATION	468	2.23e-01	7.04e-01	0.0644	-1.49e-02	-5.25e-02	-4.79e-03	-8.45e-03	3.27e-02	5.80e-01	5.16e-02	8.59e-01	7.54e-01	2.25e-01
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	161	9.58e-01	9.97e-01	0.0643	-1.84e-02	2.69e-03	-4.03e-02	-3.65e-02	-2.89e-02	6.86e-01	9.53e-01	3.78e-01	4.25e-01	5.26e-01
REGULATION OF IMMUNE RESPONSE	875	2.92e-02	2.56e-01	0.0643	4.35e-03	7.57e-03	2.55e-02	2.78e-02	5.13e-02	8.27e-01	7.04e-01	2.01e-01	1.63e-01	9.96e-03
CARDIAC CONDUCTION	94	6.03e-01	9.34e-01	0.0643	1.43e-02	2.19e-02	-2.07e-02	-2.62e-02	4.83e-02	8.11e-01	7.14e-01	7.28e-01	6.61e-01	4.19e-01
RECEPTOR SIGNALING PATHWAY VIA STAT	182	9.45e-01	9.97e-01	0.0642	-3.39e-02	-8.78e-03	-3.30e-02	-3.08e-02	-2.94e-02	4.30e-01	8.38e-01	4.43e-01	4.73e-01	4.94e-01
HEMATOPOIETIC STEM CELL MIGRATION	8	9.14e-01	9.94e-01	0.0641	5.25e-02	1.87e-02	-1.54e-02	2.62e-02	8.69e-03	7.97e-01	9.27e-01	9.40e-01	8.98e-01	9.66e-01
POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	8	9.99e-01	1.00e+00	0.0641	-2.82e-02	-1.91e-02	-6.19e-03	-1.90e-02	5.05e-02	8.90e-01	9.26e-01	9.76e-01	9.26e-01	8.05e-01
FATTY ACID CATABOLIC PROCESS	104	8.97e-01	9.93e-01	0.0641	3.47e-02	2.19e-02	2.67e-02	2.22e-02	-3.49e-02	5.41e-01	7.00e-01	6.38e-01	6.96e-01	5.39e-01
NEUROBLAST PROLIFERATION	80	9.52e-01	9.97e-01	0.0639	-2.14e-02	-5.89e-02	-4.21e-03	-8.06e-03	8.49e-03	7.41e-01	3.62e-01	9.48e-01	9.01e-01	8.96e-01
ANTIGEN PROCESSING AND PRESENTATION	112	9.46e-01	9.97e-01	0.0638	3.07e-02	2.85e-02	2.96e-02	3.78e-02	3.94e-03	5.74e-01	6.03e-01	5.89e-01	4.90e-01	9.43e-01
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	698	3.94e-01	8.43e-01	0.0638	-2.48e-02	-3.34e-02	-3.32e-02	-3.39e-02	-9.24e-03	2.64e-01	1.33e-01	1.35e-01	1.27e-01	6.77e-01
T CELL ACTIVATION	542	7.28e-02	4.34e-01	0.0637	2.14e-02	4.40e-02	3.01e-02	2.25e-02	1.58e-02	3.94e-01	7.97e-02	2.31e-01	3.70e-01	5.30e-01
TERPENOID METABOLIC PROCESS	96	9.20e-01	9.95e-01	0.0636	-2.35e-02	-4.62e-04	-2.90e-02	-2.05e-02	-4.72e-02	6.91e-01	9.94e-01	6.23e-01	7.28e-01	4.24e-01
LAMELLIPODIUM MORPHOGENESIS	18	9.44e-01	9.97e-01	0.0636	5.28e-02	2.87e-02	-1.03e-02	-1.74e-02	-4.10e-03	6.98e-01	8.33e-01	9.40e-01	8.98e-01	9.76e-01
HORMONE TRANSPORT	311	5.07e-01	8.99e-01	0.0635	-1.63e-02	-1.65e-02	-3.87e-02	-4.30e-02	-1.23e-02	6.21e-01	6.16e-01	2.40e-01	1.92e-01	7.09e-01
REGULATION OF CATALYTIC ACTIVITY	1430	2.16e-04	7.49e-03	0.0635	2.17e-02	-2.47e-02	2.66e-02	2.05e-02	4.27e-02	1.69e-01	1.18e-01	9.21e-02	1.94e-01	6.77e-03
CARDIAC MUSCLE CONTRACTION	131	8.11e-01	9.82e-01	0.0635	2.58e-02	5.56e-02	-1.13e-02	-1.13e-02	-4.03e-03	6.10e-01	2.71e-01	8.24e-01	8.23e-01	9.36e-01
CELLULAR RESPONSE TO MECHANICAL STIMULUS	69	7.78e-01	9.79e-01	0.0634	5.75e-03	-4.18e-02	9.67e-03	2.13e-02	4.12e-02	9.34e-01	5.48e-01	8.90e-01	7.60e-01	5.54e-01
VASCULAR PROCESS IN CIRCULATORY SYSTEM	261	5.51e-01	9.16e-01	0.0633	-2.26e-02	-1.78e-02	-4.40e-02	-3.50e-02	-4.57e-03	5.29e-01	6.21e-01	2.21e-01	3.30e-01	8.99e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	58	9.07e-01	9.94e-01	0.0633	2.30e-02	5.67e-02	-2.43e-03	1.06e-02	1.18e-02	7.62e-01	4.55e-01	9.74e-01	8.89e-01	8.76e-01
METANEPHRIC NEPHRON DEVELOPMENT	40	4.70e-01	8.84e-01	0.0632	7.91e-03	-3.17e-02	-1.75e-02	-4.16e-02	2.99e-02	9.31e-01	7.29e-01	8.49e-01	6.49e-01	7.43e-01
POSITIVE REGULATION OF PHOSPHORYLATION	636	4.49e-01	8.75e-01	0.0632	-2.48e-02	-3.49e-02	-3.08e-02	-3.25e-02	-1.20e-02	2.85e-01	1.33e-01	1.84e-01	1.61e-01	6.05e-01
REGULATION OF SIGNALING RECEPTOR ACTIVITY	104	1.75e-01	6.47e-01	0.0631	-5.10e-02	5.29e-04	1.20e-02	1.29e-02	3.27e-02	3.69e-01	9.93e-01	8.32e-01	8.21e-01	5.64e-01
DICARBOXYLIC ACID METABOLIC PROCESS	92	9.26e-01	9.95e-01	0.0631	3.09e-02	2.71e-02	-3.19e-03	2.05e-03	-4.77e-02	6.09e-01	6.53e-01	9.58e-01	9.73e-01	4.29e-01
NEGATIVE REGULATION OF T CELL PROLIFERATION	68	9.03e-01	9.94e-01	0.0628	-1.72e-02	1.03e-02	-2.12e-02	-1.94e-02	5.21e-02	8.06e-01	8.84e-01	7.62e-01	7.82e-01	4.58e-01
PROTEIN LOCALIZATION TO EXTRACELLULAR REGION	364	4.31e-01	8.67e-01	0.0626	-1.91e-02	-3.33e-02	-3.47e-02	-3.33e-02	1.17e-02	5.31e-01	2.75e-01	2.56e-01	2.75e-01	7.02e-01
MACROMOLECULE DEACYLATION	63	8.87e-01	9.91e-01	0.0626	4.73e-03	-2.29e-02	4.69e-02	3.29e-02	9.51e-03	9.48e-01	7.53e-01	5.20e-01	6.52e-01	8.96e-01
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS	954	2.41e-02	2.30e-01	0.0626	6.51e-03	-4.12e-02	2.81e-02	2.35e-02	2.89e-02	7.33e-01	3.11e-02	1.41e-01	2.20e-01	1.31e-01
NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS	24	9.11e-01	9.94e-01	0.0625	1.29e-02	-3.77e-02	4.30e-02	2.12e-02	-5.12e-03	9.13e-01	7.49e-01	7.15e-01	8.58e-01	9.65e-01
NEGATIVE REGULATION OF DEFENSE RESPONSE	308	3.38e-01	8.08e-01	0.0623	-9.41e-03	-2.20e-02	-4.11e-03	1.20e-03	5.74e-02	7.76e-01	5.07e-01	9.01e-01	9.71e-01	8.33e-02
REGULATION OF LAMELLIPODIUM ORGANIZATION	49	8.96e-01	9.93e-01	0.0622	-3.95e-02	-1.32e-02	-1.38e-02	-2.92e-02	3.30e-02	6.33e-01	8.73e-01	8.67e-01	7.23e-01	6.90e-01
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	692	1.43e-01	6.00e-01	0.0622	5.34e-03	-3.17e-02	3.59e-02	2.89e-02	2.66e-02	8.11e-01	1.55e-01	1.07e-01	1.95e-01	2.33e-01
REGULATION OF CELL ADHESION	775	9.80e-02	5.00e-01	0.0621	-2.54e-02	-8.98e-03	-3.51e-02	-3.97e-02	1.80e-02	2.30e-01	6.70e-01	9.64e-02	5.97e-02	3.93e-01
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	65	5.30e-01	9.07e-01	0.0621	1.79e-02	-2.66e-02	3.40e-02	1.11e-02	3.93e-02	8.03e-01	7.10e-01	6.35e-01	8.77e-01	5.84e-01
MEIOSIS I CELL CYCLE PROCESS	133	4.40e-01	8.70e-01	0.0620	2.81e-02	5.09e-02	1.89e-02	5.41e-03	8.96e-03	5.76e-01	3.11e-01	7.07e-01	9.14e-01	8.58e-01
REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	171	8.40e-01	9.85e-01	0.0619	2.13e-02	5.59e-02	4.55e-04	1.39e-03	-1.61e-02	6.31e-01	2.07e-01	9.92e-01	9.75e-01	7.17e-01
AXON DEVELOPMENT	481	7.27e-03	1.05e-01	0.0619	-8.27e-03	-1.99e-02	-2.13e-02	-3.22e-02	4.33e-02	7.56e-01	4.55e-01	4.23e-01	2.26e-01	1.04e-01
PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS	49	9.29e-01	9.95e-01	0.0618	1.17e-02	-4.57e-02	1.71e-02	2.37e-02	2.72e-02	8.87e-01	5.80e-01	8.35e-01	7.74e-01	7.42e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	29	9.44e-01	9.97e-01	0.0617	-2.77e-02	3.38e-02	-3.26e-02	-2.26e-02	1.79e-02	7.96e-01	7.53e-01	7.61e-01	8.33e-01	8.67e-01
STRIATED MUSCLE TISSUE DEVELOPMENT	260	2.75e-01	7.56e-01	0.0617	-1.54e-02	-5.57e-02	-9.86e-03	-1.90e-02	-2.21e-03	6.69e-01	1.22e-01	7.84e-01	5.97e-01	9.51e-01
POSITIVE REGULATION OF CATALYTIC ACTIVITY	900	4.67e-03	7.74e-02	0.0616	1.07e-02	-2.67e-02	1.18e-02	5.82e-03	5.29e-02	5.85e-01	1.75e-01	5.47e-01	7.67e-01	7.11e-03
REGULATION OF CILIUM ASSEMBLY	93	4.80e-01	8.91e-01	0.0616	-1.86e-02	-3.79e-02	-1.85e-02	-3.73e-02	-1.66e-02	7.56e-01	5.28e-01	7.58e-01	5.34e-01	7.82e-01
POSITIVE REGULATION OF CELL ACTIVATION	378	8.55e-01	9.88e-01	0.0615	2.85e-02	1.48e-02	3.66e-02	3.27e-02	1.86e-02	3.41e-01	6.20e-01	2.22e-01	2.74e-01	5.36e-01
SKELETAL SYSTEM DEVELOPMENT	509	1.11e-03	2.73e-02	0.0613	-6.62e-03	-5.58e-02	-8.73e-03	-2.03e-02	-1.06e-02	7.98e-01	3.10e-02	7.36e-01	4.33e-01	6.81e-01
MAINTENANCE OF LOCATION IN CELL	225	5.28e-01	9.06e-01	0.0613	-6.66e-03	-1.85e-03	-1.22e-02	-1.39e-02	5.80e-02	8.63e-01	9.62e-01	7.52e-01	7.20e-01	1.34e-01
REGULATION OF BLOOD CIRCULATION	247	4.59e-01	8.80e-01	0.0612	3.70e-02	4.70e-02	-8.62e-03	-7.89e-03	-5.93e-03	3.16e-01	2.04e-01	8.16e-01	8.31e-01	8.73e-01
MORPHOGENESIS OF EMBRYONIC EPITHELIUM	150	2.11e-01	6.89e-01	0.0612	1.51e-02	-4.31e-02	1.89e-02	3.72e-03	3.59e-02	7.50e-01	3.63e-01	6.89e-01	9.37e-01	4.47e-01
RESPONSE TO STEROID HORMONE	318	5.48e-02	3.68e-01	0.0610	1.46e-02	-4.87e-02	2.56e-02	1.53e-02	1.57e-02	6.54e-01	1.35e-01	4.32e-01	6.40e-01	6.29e-01
GLYCOSPHINGOLIPID METABOLIC PROCESS	62	9.33e-01	9.97e-01	0.0610	8.54e-03	-2.70e-02	1.58e-02	6.21e-03	5.13e-02	9.07e-01	7.14e-01	8.30e-01	9.33e-01	4.85e-01
MAINTENANCE OF SYNAPSE STRUCTURE	25	9.99e-01	1.00e+00	0.0608	-3.26e-02	-4.49e-02	-1.16e-02	-1.23e-02	-1.83e-02	7.78e-01	6.98e-01	9.20e-01	9.15e-01	8.74e-01
NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT	125	8.99e-01	9.93e-01	0.0608	-1.92e-02	-1.16e-02	-3.67e-02	-3.97e-02	1.63e-02	7.11e-01	8.23e-01	4.79e-01	4.43e-01	7.53e-01
MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	129	2.44e-01	7.29e-01	0.0607	2.96e-02	-4.54e-02	1.03e-02	7.15e-03	2.43e-02	5.62e-01	3.73e-01	8.39e-01	8.89e-01	6.34e-01
NEUROGENESIS	1648	1.04e-07	8.97e-06	0.0607	-7.32e-03	-4.08e-02	-3.54e-04	-1.22e-02	4.27e-02	6.21e-01	5.80e-03	9.81e-01	4.09e-01	3.88e-03
FAT CELL DIFFERENTIATION	243	1.13e-02	1.39e-01	0.0607	4.83e-02	-2.52e-02	8.70e-03	1.22e-02	2.22e-02	1.95e-01	4.98e-01	8.15e-01	7.44e-01	5.52e-01
POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	353	3.61e-01	8.25e-01	0.0606	-4.05e-02	-2.35e-02	-8.80e-03	-1.36e-02	3.50e-02	1.92e-01	4.48e-01	7.76e-01	6.62e-01	2.58e-01
REGULATION OF PROTEIN TARGETING TO MEMBRANE	32	1.00e+00	1.00e+00	0.0606	-2.63e-02	-5.49e-03	-3.59e-02	-3.41e-02	-2.23e-02	7.96e-01	9.57e-01	7.25e-01	7.39e-01	8.27e-01
RESPONSE TO OXYGEN CONTAINING COMPOUND	1742	5.51e-05	2.41e-03	0.0605	-8.96e-03	-4.10e-02	-8.33e-03	-1.22e-02	4.10e-02	5.34e-01	4.44e-03	5.63e-01	3.96e-01	4.45e-03
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	462	2.31e-01	7.14e-01	0.0605	-1.54e-02	-1.68e-02	-2.11e-02	-2.05e-02	4.77e-02	5.71e-01	5.37e-01	4.36e-01	4.51e-01	7.89e-02
POSITIVE REGULATION OF CELL DIFFERENTIATION	854	1.28e-04	4.78e-03	0.0604	-9.56e-03	-4.29e-02	-1.90e-02	-2.87e-02	2.29e-02	6.35e-01	3.31e-02	3.46e-01	1.55e-01	2.55e-01
VESICLE LOCALIZATION	208	8.14e-01	9.82e-01	0.0603	1.97e-02	3.97e-03	4.08e-02	3.23e-02	2.29e-02	6.24e-01	9.21e-01	3.10e-01	4.23e-01	5.69e-01
CELLULAR LIPID CATABOLIC PROCESS	220	8.45e-01	9.86e-01	0.0602	1.41e-03	1.52e-02	-2.60e-02	-2.09e-02	-4.78e-02	9.71e-01	6.98e-01	5.06e-01	5.94e-01	2.22e-01
HOMEOSTASIS OF NUMBER OF CELLS	299	1.82e-01	6.56e-01	0.0601	1.98e-02	-4.07e-02	2.22e-02	1.76e-02	2.77e-02	5.57e-01	2.26e-01	5.08e-01	6.01e-01	4.10e-01
REGULATION OF CYTOSKELETON ORGANIZATION	493	2.00e-01	6.80e-01	0.0601	-2.57e-02	-4.13e-02	-1.40e-02	-2.44e-02	2.14e-02	3.28e-01	1.17e-01	5.93e-01	3.54e-01	4.15e-01
OSSIFICATION	425	2.03e-01	6.82e-01	0.0601	7.58e-04	-3.85e-02	3.83e-03	1.38e-04	4.60e-02	9.79e-01	1.73e-01	8.92e-01	9.96e-01	1.04e-01
POSITIVE REGULATION OF T CELL PROLIFERATION	100	7.77e-01	9.78e-01	0.0600	2.92e-02	3.92e-02	-7.16e-03	3.42e-03	3.39e-02	6.13e-01	4.98e-01	9.02e-01	9.53e-01	5.58e-01
RETINA DEVELOPMENT IN CAMERA TYPE EYE	156	5.04e-01	8.98e-01	0.0600	2.54e-02	2.56e-02	-2.97e-02	-2.87e-02	-2.44e-02	5.84e-01	5.81e-01	5.22e-01	5.36e-01	5.99e-01
ALPHA AMINO ACID CATABOLIC PROCESS	89	8.76e-01	9.88e-01	0.0599	-1.51e-02	-5.25e-02	-1.80e-02	-1.33e-02	1.01e-02	8.05e-01	3.92e-01	7.69e-01	8.28e-01	8.69e-01
REGULATION OF KERATINOCYTE DIFFERENTIATION	40	9.80e-02	5.00e-01	0.0596	-3.24e-02	-1.47e-02	2.72e-02	-1.92e-02	-3.43e-02	7.23e-01	8.72e-01	7.66e-01	8.34e-01	7.07e-01
ORGANELLE LOCALIZATION	588	8.30e-02	4.59e-01	0.0595	1.16e-02	-3.18e-02	3.77e-02	3.11e-02	2.18e-03	6.30e-01	1.88e-01	1.18e-01	1.97e-01	9.28e-01
CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	138	9.46e-01	9.97e-01	0.0595	-1.61e-03	-2.28e-02	2.13e-02	1.65e-02	4.78e-02	9.74e-01	6.43e-01	6.65e-01	7.37e-01	3.32e-01
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	293	6.83e-01	9.61e-01	0.0595	-6.09e-03	-3.93e-02	2.29e-02	2.24e-02	3.06e-02	8.58e-01	2.47e-01	5.01e-01	5.10e-01	3.68e-01
GLIOGENESIS	329	4.65e-01	8.82e-01	0.0593	-1.41e-02	-4.72e-02	-2.02e-03	-8.82e-03	3.18e-02	6.59e-01	1.41e-01	9.50e-01	7.83e-01	3.21e-01
REGULATION OF CATABOLIC PROCESS	1028	9.11e-04	2.26e-02	0.0593	-3.17e-04	-4.93e-02	2.49e-02	1.53e-02	1.53e-02	9.86e-01	7.54e-03	1.77e-01	4.05e-01	4.07e-01
PROTEIN LOCALIZATION TO PLASMA MEMBRANE	278	8.07e-01	9.82e-01	0.0593	-1.01e-02	2.36e-02	-2.67e-02	-2.32e-02	-4.01e-02	7.71e-01	4.99e-01	4.44e-01	5.06e-01	2.50e-01
RESPONSE TO GROWTH FACTOR	730	4.04e-02	3.07e-01	0.0591	-1.75e-02	-4.82e-02	-1.05e-02	-1.85e-02	2.03e-02	4.20e-01	2.66e-02	6.29e-01	3.94e-01	3.50e-01
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS	983	2.98e-03	5.47e-02	0.0591	1.40e-04	-5.05e-02	2.37e-02	1.94e-02	3.25e-03	9.94e-01	7.38e-03	2.08e-01	3.04e-01	8.63e-01
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS	1310	2.54e-05	1.27e-03	0.0590	-9.03e-03	-4.04e-02	-1.65e-02	-2.34e-02	3.08e-02	5.83e-01	1.40e-02	3.16e-01	1.55e-01	6.12e-02
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT	204	3.72e-01	8.32e-01	0.0590	-1.05e-02	2.97e-02	-1.34e-02	-1.22e-02	4.65e-02	7.96e-01	4.64e-01	7.42e-01	7.64e-01	2.53e-01
GLUCAN METABOLIC PROCESS	73	6.73e-01	9.59e-01	0.0589	4.49e-02	4.52e-03	3.09e-02	1.70e-02	1.36e-02	5.07e-01	9.47e-01	6.48e-01	8.01e-01	8.41e-01
AMYLOID FIBRIL FORMATION	38	7.58e-01	9.75e-01	0.0589	-4.96e-02	2.74e-02	-9.14e-03	-9.74e-03	8.58e-03	5.97e-01	7.70e-01	9.22e-01	9.17e-01	9.27e-01
HEMOPOIESIS	914	1.38e-02	1.57e-01	0.0588	3.00e-02	-1.19e-02	3.33e-02	2.59e-02	2.52e-02	1.25e-01	5.42e-01	8.75e-02	1.84e-01	1.96e-01
EMBRYONIC PATTERN SPECIFICATION	69	5.04e-01	8.98e-01	0.0588	2.13e-02	-1.05e-02	-1.56e-02	-2.64e-02	4.42e-02	7.59e-01	8.81e-01	8.23e-01	7.04e-01	5.26e-01
PLASMA MEMBRANE ORGANIZATION	161	5.55e-01	9.17e-01	0.0587	2.09e-02	3.74e-02	-1.36e-02	2.03e-03	-3.76e-02	6.48e-01	4.12e-01	7.66e-01	9.65e-01	4.10e-01
SENSORY PERCEPTION OF MECHANICAL STIMULUS	179	4.04e-01	8.49e-01	0.0586	5.59e-03	5.03e-02	1.01e-02	1.60e-02	2.28e-02	8.97e-01	2.46e-01	8.16e-01	7.12e-01	5.99e-01
SEMI LUNAR VALVE DEVELOPMENT	47	8.24e-01	9.83e-01	0.0585	1.20e-02	-4.64e-02	-1.48e-02	-1.13e-02	-2.80e-02	8.87e-01	5.82e-01	8.61e-01	8.94e-01	7.40e-01
ESTABLISHMENT OF ORGANELLE LOCALIZATION	454	2.61e-01	7.44e-01	0.0585	1.45e-02	-2.85e-02	3.69e-02	3.20e-02	3.54e-03	5.96e-01	2.97e-01	1.78e-01	2.42e-01	8.97e-01
CARBOHYDRATE METABOLIC PROCESS	541	5.46e-02	3.67e-01	0.0584	-1.03e-02	-2.93e-02	-3.21e-02	-3.70e-02	-7.15e-03	6.82e-01	2.44e-01	2.02e-01	1.41e-01	7.76e-01
CELLULAR RESPONSE TO EXTERNAL STIMULUS	329	2.60e-01	7.43e-01	0.0582	1.67e-03	-4.74e-02	8.52e-03	3.09e-03	3.24e-02	9.59e-01	1.39e-01	7.90e-01	9.23e-01	3.12e-01
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	71	1.31e-01	5.77e-01	0.0582	5.09e-02	-2.02e-02	1.04e-02	-7.48e-03	1.47e-02	4.58e-01	7.69e-01	8.80e-01	9.13e-01	8.30e-01
TUBE FORMATION	149	4.06e-01	8.50e-01	0.0581	6.28e-03	-3.69e-02	1.51e-02	7.18e-04	4.17e-02	8.95e-01	4.36e-01	7.50e-01	9.88e-01	3.79e-01
REGULATION OF GLIAL CELL PROLIFERATION	37	7.43e-01	9.74e-01	0.0580	-1.17e-02	-2.14e-02	-1.04e-02	-3.45e-02	3.84e-02	9.02e-01	8.22e-01	9.13e-01	7.17e-01	6.86e-01
TRANSPORT ALONG MICROTUBULE	164	6.59e-01	9.54e-01	0.0580	2.36e-02	-3.88e-03	4.14e-02	2.90e-02	1.53e-02	6.03e-01	9.32e-01	3.60e-01	5.22e-01	7.35e-01
SENSORY ORGAN DEVELOPMENT	578	9.73e-03	1.27e-01	0.0578	1.93e-03	-3.39e-02	-4.81e-03	-1.25e-02	4.48e-02	9.37e-01	1.63e-01	8.43e-01	6.06e-01	6.59e-02
NEGATIVE REGULATION OF HORMONE SECRETION	65	5.51e-01	9.16e-01	0.0577	1.71e-02	-1.24e-03	-3.29e-02	-4.24e-02	1.25e-02	8.12e-01	9.86e-01	6.46e-01	5.55e-01	8.62e-01
POSITIVE REGULATION OF MOLECULAR FUNCTION	1221	5.47e-03	8.72e-02	0.0577	2.21e-02	-1.34e-02	2.68e-02	1.96e-02	3.94e-02	1.93e-01	4.30e-01	1.14e-01	2.49e-01	2.03e-02
EPITHELIAL CELL DIFFERENTIATION	722	2.80e-01	7.58e-01	0.0577	-1.75e-02	-3.06e-02	7.03e-03	5.02e-03	4.48e-02	4.22e-01	1.62e-01	7.48e-01	8.18e-01	4.01e-02
CIRCULATORY SYSTEM PROCESS	577	1.13e-01	5.37e-01	0.0577	-9.91e-03	-6.04e-03	-3.91e-02	-3.86e-02	1.32e-02	6.84e-01	8.04e-01	1.08e-01	1.13e-01	5.88e-01
REGULATION OF RESPONSE TO STRESS	1437	2.34e-02	2.26e-01	0.0577	4.71e-03	-3.07e-02	2.26e-02	1.79e-02	3.92e-02	7.65e-01	5.16e-02	1.51e-01	2.56e-01	1.29e-02
REGULATION OF CELLULAR COMPONENT SIZE	350	3.24e-01	7.96e-01	0.0576	-2.44e-02	-1.27e-02	-3.02e-02	-4.06e-02	6.50e-04	4.32e-01	6.83e-01	3.31e-01	1.92e-01	9.83e-01
POSITIVE REGULATION OF CYTOKINE PRODUCTION	483	4.77e-01	8.87e-01	0.0576	-2.43e-02	-1.24e-02	-3.03e-02	-3.14e-02	2.59e-02	3.60e-01	6.40e-01	2.54e-01	2.37e-01	3.30e-01
AMINE TRANSPORT	106	6.46e-01	9.50e-01	0.0575	2.35e-02	1.02e-02	2.56e-02	1.08e-02	4.33e-02	6.76e-01	8.56e-01	6.49e-01	8.47e-01	4.41e-01
REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	129	9.66e-01	9.97e-01	0.0575	3.12e-02	4.63e-02	8.82e-03	9.71e-03	-4.51e-03	5.41e-01	3.64e-01	8.63e-01	8.49e-01	9.29e-01
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	44	7.61e-01	9.75e-01	0.0574	2.28e-02	-2.29e-03	-2.22e-02	-3.04e-02	3.68e-02	7.94e-01	9.79e-01	7.99e-01	7.27e-01	6.73e-01
ADIPOSE TISSUE DEVELOPMENT	57	9.99e-01	1.00e+00	0.0574	-2.51e-02	-2.13e-02	-2.99e-02	-3.08e-02	-1.91e-02	7.43e-01	7.81e-01	6.96e-01	6.88e-01	8.03e-01
NUCLEOTIDE EXCISION REPAIR	83	1.81e-01	6.56e-01	0.0573	-2.77e-02	-4.37e-02	1.34e-02	-1.68e-02	-1.24e-02	6.63e-01	4.92e-01	8.33e-01	7.91e-01	8.46e-01
RESPONSE TO XENOBIOTIC STIMULUS	424	6.22e-01	9.43e-01	0.0573	-5.93e-03	-2.39e-02	2.51e-02	2.13e-02	3.99e-02	8.34e-01	3.98e-01	3.75e-01	4.53e-01	1.59e-01
BEHAVIOR	629	6.44e-03	9.63e-02	0.0572	-9.03e-03	-3.25e-02	-1.55e-02	-2.55e-02	3.52e-02	6.99e-01	1.64e-01	5.08e-01	2.75e-01	1.31e-01
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	341	2.00e-01	6.80e-01	0.0571	-1.71e-02	-3.66e-02	-2.29e-02	-3.31e-02	4.24e-03	5.87e-01	2.46e-01	4.68e-01	2.94e-01	8.93e-01
PYRUVATE METABOLIC PROCESS	112	7.58e-01	9.75e-01	0.0571	1.61e-02	-2.46e-02	3.95e-03	8.82e-03	4.80e-02	7.69e-01	6.53e-01	9.42e-01	8.72e-01	3.80e-01
LIGAND GATED ION CHANNEL SIGNALING PATHWAY	31	9.93e-01	9.99e-01	0.0571	-6.77e-03	-1.59e-04	-4.01e-02	-4.00e-02	-2.09e-04	9.48e-01	9.99e-01	6.99e-01	7.00e-01	9.98e-01
REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	113	4.78e-01	8.89e-01	0.0571	-2.13e-02	4.10e-02	-1.10e-02	-1.01e-02	3.01e-02	6.95e-01	4.52e-01	8.40e-01	8.53e-01	5.81e-01
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	113	9.76e-01	9.97e-01	0.0569	2.34e-02	2.33e-02	3.12e-02	2.60e-02	2.25e-02	6.68e-01	6.69e-01	5.67e-01	6.33e-01	6.79e-01
REGULATION OF LYMPHOCYTE MIGRATION	66	9.38e-01	9.97e-01	0.0569	-2.38e-02	-1.62e-02	-2.77e-02	-1.97e-02	3.55e-02	7.38e-01	8.20e-01	6.97e-01	7.82e-01	6.18e-01
RESPONSE TO MINERALOCORTICOID	33	9.22e-01	9.95e-01	0.0568	4.15e-03	-3.70e-02	-2.53e-02	-3.20e-02	-1.34e-02	9.67e-01	7.13e-01	8.01e-01	7.50e-01	8.94e-01
CELLULAR KETONE METABOLIC PROCESS	220	8.65e-01	9.88e-01	0.0568	-1.71e-02	-2.99e-02	-2.35e-02	-2.31e-02	-3.08e-02	6.62e-01	4.45e-01	5.48e-01	5.54e-01	4.32e-01
INTRACELLULAR RECEPTOR SIGNALING PATHWAY	338	3.04e-01	7.76e-01	0.0567	-1.16e-02	-4.07e-02	6.12e-05	-1.01e-02	3.65e-02	7.14e-01	1.99e-01	9.98e-01	7.51e-01	2.49e-01
RESPONSE TO WOUNDING	538	1.18e-01	5.49e-01	0.0566	-1.26e-02	-3.51e-02	-2.65e-02	-2.34e-02	2.37e-02	6.17e-01	1.63e-01	2.93e-01	3.53e-01	3.47e-01
POSITIVE REGULATION OF HEMOPOIESIS	181	9.52e-01	9.97e-01	0.0566	3.32e-02	6.39e-03	3.23e-02	3.19e-02	1.58e-03	4.41e-01	8.82e-01	4.54e-01	4.59e-01	9.71e-01
RESPONSE TO MONOSACCHARIDE	201	9.90e-02	5.03e-01	0.0566	1.85e-02	-3.25e-02	-2.89e-03	-8.94e-03	-4.14e-02	6.51e-01	4.26e-01	9.44e-01	8.27e-01	3.12e-01
REGULATION OF LIPID KINASE ACTIVITY	38	9.88e-01	9.98e-01	0.0565	2.38e-02	4.90e-02	-8.71e-04	-3.23e-03	1.48e-02	7.99e-01	6.02e-01	9.93e-01	9.73e-01	8.75e-01
RESPIRATORY SYSTEM DEVELOPMENT	207	1.95e-01	6.73e-01	0.0564	2.27e-02	-3.58e-03	-1.61e-02	-1.99e-02	-4.47e-02	5.73e-01	9.29e-01	6.90e-01	6.22e-01	2.67e-01
MONOSACCHARIDE METABOLIC PROCESS	249	2.23e-01	7.04e-01	0.0563	1.68e-02	-1.12e-02	-1.97e-02	-1.69e-02	-4.57e-02	6.48e-01	7.61e-01	5.92e-01	6.46e-01	2.15e-01
CELLULAR RESPONSE TO BIOTIC STIMULUS	255	5.43e-01	9.15e-01	0.0562	1.58e-02	-4.28e-03	4.42e-03	3.42e-03	5.35e-02	6.65e-01	9.06e-01	9.03e-01	9.25e-01	1.41e-01
CELLULAR RESPONSE TO STARVATION	171	6.95e-01	9.61e-01	0.0561	-1.75e-02	-5.27e-02	4.89e-03	-5.19e-03	4.61e-03	6.93e-01	2.35e-01	9.12e-01	9.07e-01	9.17e-01
PLATELET ACTIVATION	128	6.43e-01	9.50e-01	0.0561	-3.70e-03	-3.15e-02	-2.58e-02	-3.15e-02	-2.20e-02	9.42e-01	5.39e-01	6.15e-01	5.39e-01	6.67e-01
NEGATIVE REGULATION OF BLOOD PRESSURE	46	8.57e-01	9.88e-01	0.0560	2.40e-02	-1.60e-02	3.37e-02	1.58e-02	3.03e-02	7.78e-01	8.51e-01	6.93e-01	8.53e-01	7.22e-01
EPITHELIUM DEVELOPMENT	1206	1.26e-02	1.49e-01	0.0559	-1.04e-02	-3.81e-02	-1.61e-03	-7.60e-03	3.89e-02	5.44e-01	2.60e-02	9.25e-01	6.57e-01	2.29e-02
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	54	8.92e-01	9.92e-01	0.0559	-6.83e-03	-5.15e-02	1.21e-02	1.87e-04	-1.68e-02	9.31e-01	5.13e-01	8.78e-01	9.98e-01	8.30e-01
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY	617	7.89e-01	9.81e-01	0.0558	-2.78e-02	-2.70e-02	-2.80e-02	-2.85e-02	3.64e-03	2.38e-01	2.53e-01	2.34e-01	2.27e-01	8.77e-01
LIPID BIOSYNTHETIC PROCESS	707	1.70e-01	6.41e-01	0.0556	-1.71e-02	-4.78e-02	-1.29e-02	-1.53e-02	1.09e-02	4.38e-01	3.04e-02	5.59e-01	4.88e-01	6.21e-01
RESPONSE TO MECHANICAL STIMULUS	209	6.48e-01	9.51e-01	0.0556	2.30e-02	2.74e-02	1.40e-02	2.42e-02	3.21e-02	5.66e-01	4.95e-01	7.27e-01	5.47e-01	4.23e-01
REGULATION OF GROWTH	589	1.13e-02	1.39e-01	0.0556	-4.00e-03	-5.33e-02	-1.00e-03	-8.66e-03	1.26e-02	8.68e-01	2.72e-02	9.67e-01	7.19e-01	6.01e-01
PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	31	9.66e-01	9.97e-01	0.0555	1.80e-02	-4.43e-03	-1.19e-02	-1.37e-02	4.91e-02	8.63e-01	9.66e-01	9.09e-01	8.95e-01	6.36e-01
RESPONSE TO BMP	170	1.29e-01	5.72e-01	0.0553	6.98e-03	-2.02e-02	-2.89e-02	-3.96e-02	-1.41e-02	8.75e-01	6.49e-01	5.16e-01	3.73e-01	7.51e-01
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	462	3.80e-01	8.37e-01	0.0553	-2.63e-02	-1.62e-02	-2.14e-02	-2.84e-02	2.90e-02	3.32e-01	5.50e-01	4.31e-01	2.96e-01	2.86e-01
REGENERATION	181	9.40e-01	9.97e-01	0.0551	-3.43e-02	-1.64e-02	-2.97e-02	-2.65e-02	3.10e-03	4.26e-01	7.03e-01	4.91e-01	5.39e-01	9.43e-01
NEGATIVE REGULATION OF SIGNALING	1399	5.96e-03	9.21e-02	0.0550	8.67e-03	-3.19e-02	2.30e-02	1.68e-02	3.34e-02	5.86e-01	4.53e-02	1.49e-01	2.93e-01	3.59e-02
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	142	3.77e-01	8.36e-01	0.0549	2.60e-02	-1.79e-02	-5.89e-03	-3.28e-05	4.45e-02	5.92e-01	7.13e-01	9.04e-01	9.99e-01	3.60e-01
REGULATION OF PROTEIN MODIFICATION PROCESS	1251	4.64e-05	2.09e-03	0.0548	8.57e-03	-4.67e-02	2.08e-02	1.36e-02	1.15e-02	6.10e-01	5.48e-03	2.16e-01	4.17e-01	4.93e-01
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	983	1.01e-01	5.09e-01	0.0547	-1.72e-02	-3.23e-02	-1.90e-02	-1.92e-02	3.04e-02	3.60e-01	8.63e-02	3.13e-01	3.08e-01	1.06e-01
MUSCLE TISSUE DEVELOPMENT	422	2.64e-02	2.43e-01	0.0547	1.10e-02	-3.99e-02	1.24e-02	2.09e-03	3.35e-02	6.97e-01	1.59e-01	6.63e-01	9.41e-01	2.38e-01
SENSORY SYSTEM DEVELOPMENT	394	9.85e-02	5.02e-01	0.0545	-5.57e-03	-1.65e-02	-2.74e-02	-3.34e-02	2.84e-02	8.50e-01	5.73e-01	3.50e-01	2.56e-01	3.34e-01
ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS	560	1.80e-01	6.52e-01	0.0544	-1.23e-04	-4.63e-02	1.61e-02	1.28e-02	1.97e-02	9.96e-01	6.09e-02	5.14e-01	6.04e-01	4.25e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	60	8.02e-01	9.82e-01	0.0543	1.04e-02	1.31e-02	-1.59e-02	-2.88e-02	-3.99e-02	8.89e-01	8.61e-01	8.31e-01	7.00e-01	5.93e-01
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	67	9.86e-01	9.98e-01	0.0542	-3.12e-02	-4.13e-02	-1.30e-02	-9.38e-03	2.70e-03	6.59e-01	5.59e-01	8.54e-01	8.94e-01	9.69e-01
RETINA MORPHOGENESIS IN CAMERA TYPE EYE	63	9.38e-01	9.97e-01	0.0540	9.90e-03	1.93e-03	-1.02e-02	-5.72e-03	5.18e-02	8.92e-01	9.79e-01	8.88e-01	9.37e-01	4.77e-01
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY	979	3.75e-01	8.36e-01	0.0540	-2.21e-02	-2.97e-02	-2.71e-02	-2.85e-02	1.65e-03	2.42e-01	1.16e-01	1.51e-01	1.31e-01	9.30e-01
SYNAPSE ASSEMBLY	185	6.46e-01	9.50e-01	0.0540	-3.30e-03	-1.17e-02	8.01e-03	-2.42e-03	5.19e-02	9.38e-01	7.84e-01	8.51e-01	9.55e-01	2.23e-01
ENERGY HOMEOSTASIS	76	9.90e-01	9.98e-01	0.0539	1.45e-02	-6.52e-03	3.78e-02	3.33e-02	1.09e-02	8.27e-01	9.22e-01	5.69e-01	6.16e-01	8.69e-01
REGULATION OF RESPONSE TO BIOTIC STIMULUS	492	2.94e-01	7.70e-01	0.0539	-2.31e-02	-1.81e-02	8.00e-03	4.49e-03	4.43e-02	3.81e-01	4.93e-01	7.61e-01	8.64e-01	9.24e-02
MEIOTIC CHROMOSOME SEGREGATION	90	4.12e-01	8.54e-01	0.0539	-1.64e-02	1.57e-02	-7.91e-03	-2.80e-02	-3.92e-02	7.88e-01	7.96e-01	8.97e-01	6.46e-01	5.20e-01
SECRETION	926	1.77e-01	6.47e-01	0.0539	-1.97e-02	-2.25e-02	-2.51e-02	-2.54e-02	2.70e-02	3.10e-01	2.45e-01	1.95e-01	1.91e-01	1.63e-01
LIPID CATABOLIC PROCESS	329	8.75e-01	9.88e-01	0.0539	-8.26e-03	1.55e-02	-3.05e-02	-2.79e-02	-2.98e-02	7.97e-01	6.29e-01	3.42e-01	3.84e-01	3.54e-01
PROTEIN LOCALIZATION TO GOLGI APPARATUS	29	8.44e-01	9.86e-01	0.0535	3.61e-02	-2.00e-02	-1.86e-02	-4.32e-03	-2.83e-02	7.37e-01	8.52e-01	8.63e-01	9.68e-01	7.92e-01
NEURAL TUBE FORMATION	103	8.05e-01	9.82e-01	0.0535	4.08e-02	1.22e-02	1.84e-02	1.23e-02	2.37e-02	4.74e-01	8.31e-01	7.47e-01	8.30e-01	6.78e-01
ORGANIC ACID TRANSPORT	341	4.62e-01	8.80e-01	0.0535	-1.15e-02	3.02e-02	-3.07e-02	-2.94e-02	3.17e-03	7.16e-01	3.38e-01	3.31e-01	3.50e-01	9.20e-01
PHOSPHATIDYLINOSITOL METABOLIC PROCESS	147	6.37e-01	9.48e-01	0.0532	-2.87e-02	-3.89e-02	1.04e-02	-1.61e-03	-1.96e-02	5.48e-01	4.16e-01	8.27e-01	9.73e-01	6.82e-01
REGULATION OF CELL PROJECTION ASSEMBLY	220	2.31e-01	7.15e-01	0.0531	-2.63e-02	-2.42e-02	-1.78e-02	-3.49e-02	2.54e-03	5.01e-01	5.35e-01	6.49e-01	3.73e-01	9.48e-01
ADULT LOCOMOTORY BEHAVIOR	80	2.97e-01	7.72e-01	0.0531	2.75e-02	-2.13e-02	-2.08e-02	-2.95e-02	1.76e-02	6.71e-01	7.42e-01	7.48e-01	6.48e-01	7.86e-01
ORGANOPHOSPHATE CATABOLIC PROCESS	142	9.22e-01	9.95e-01	0.0530	-1.63e-02	-1.26e-02	-3.05e-02	-3.13e-02	2.17e-02	7.37e-01	7.95e-01	5.30e-01	5.20e-01	6.55e-01
MONOAMINE TRANSPORT	86	1.77e-01	6.47e-01	0.0528	5.20e-03	4.75e-02	1.23e-02	-1.24e-02	-1.42e-02	9.34e-01	4.46e-01	8.43e-01	8.42e-01	8.20e-01
NEGATIVE REGULATION OF RESPONSE TO WOUNDING	94	8.20e-01	9.83e-01	0.0528	-1.69e-02	2.28e-03	-4.11e-02	-2.81e-02	5.02e-03	7.77e-01	9.69e-01	4.91e-01	6.38e-01	9.33e-01
HETEROCYCLE CATABOLIC PROCESS	518	2.06e-01	6.84e-01	0.0528	3.18e-03	-4.41e-02	1.90e-02	1.58e-02	1.51e-02	9.01e-01	8.61e-02	4.60e-01	5.38e-01	5.56e-01
CELLULAR RESPONSE TO LIGHT STIMULUS	114	5.03e-01	8.98e-01	0.0528	-4.59e-03	-4.09e-02	2.39e-02	5.04e-03	2.21e-02	9.32e-01	4.50e-01	6.59e-01	9.26e-01	6.83e-01
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	151	4.06e-01	8.50e-01	0.0528	1.09e-02	-5.07e-02	8.77e-03	3.30e-03	-1.91e-03	8.17e-01	2.82e-01	8.52e-01	9.44e-01	9.68e-01
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND	1249	3.64e-03	6.35e-02	0.0527	-1.17e-02	-3.30e-02	-1.82e-02	-2.33e-02	2.61e-02	4.87e-01	4.96e-02	2.80e-01	1.66e-01	1.21e-01
REGULATION OF BODY FLUID LEVELS	351	6.91e-01	9.61e-01	0.0527	-1.69e-02	-1.55e-02	-3.18e-02	-3.45e-02	7.08e-03	5.87e-01	6.18e-01	3.06e-01	2.67e-01	8.20e-01
STEROID BIOSYNTHETIC PROCESS	177	5.75e-01	9.26e-01	0.0525	-1.01e-03	-5.49e-03	-3.00e-02	-2.49e-02	3.47e-02	9.81e-01	9.00e-01	4.91e-01	5.68e-01	4.26e-01
INORGANIC ION HOMEOSTASIS	515	3.17e-01	7.89e-01	0.0524	1.86e-02	1.86e-02	7.85e-03	5.64e-03	4.43e-02	4.70e-01	4.70e-01	7.60e-01	8.27e-01	8.55e-02
POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	264	8.52e-01	9.88e-01	0.0523	2.29e-02	3.94e-02	1.61e-02	1.42e-02	1.40e-02	5.22e-01	2.71e-01	6.53e-01	6.91e-01	6.95e-01
POSITIVE REGULATION OF LIPID STORAGE	27	9.43e-01	9.97e-01	0.0521	-1.92e-02	2.69e-02	-3.57e-02	-1.82e-02	3.78e-03	8.63e-01	8.09e-01	7.48e-01	8.70e-01	9.73e-01
FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE	12	8.73e-01	9.88e-01	0.0521	-2.43e-03	4.55e-02	2.21e-02	-1.22e-02	2.32e-04	9.88e-01	7.85e-01	8.95e-01	9.42e-01	9.99e-01
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS	231	2.47e-01	7.32e-01	0.0519	-3.09e-04	1.51e-02	-2.76e-02	-3.63e-02	1.96e-02	9.94e-01	6.92e-01	4.70e-01	3.41e-01	6.08e-01
CARBOHYDRATE PHOSPHORYLATION	22	9.84e-01	9.98e-01	0.0516	3.33e-02	7.07e-03	-1.53e-02	-8.83e-03	-3.46e-02	7.87e-01	9.54e-01	9.01e-01	9.43e-01	7.79e-01
ANATOMICAL STRUCTURE MATURATION	253	4.84e-01	8.91e-01	0.0516	-3.01e-03	-1.59e-02	2.81e-03	-6.94e-03	4.84e-02	9.34e-01	6.63e-01	9.39e-01	8.49e-01	1.85e-01
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS	267	3.23e-01	7.96e-01	0.0514	8.29e-03	-3.85e-02	1.41e-02	5.35e-03	2.94e-02	8.16e-01	2.78e-01	6.91e-01	8.80e-01	4.08e-01
FATTY ACID TRANSPORT	115	8.23e-01	9.83e-01	0.0514	-2.91e-02	2.14e-02	-2.43e-02	-2.73e-02	1.38e-03	5.89e-01	6.92e-01	6.53e-01	6.13e-01	9.80e-01
FORMATION OF PRIMARY GERM LAYER	126	4.13e-02	3.10e-01	0.0514	2.70e-02	-4.04e-02	3.67e-03	-1.34e-02	-9.31e-03	6.01e-01	4.33e-01	9.43e-01	7.95e-01	8.57e-01
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS	61	8.04e-01	9.82e-01	0.0513	2.59e-02	-2.27e-02	1.17e-02	1.86e-03	3.62e-02	7.27e-01	7.59e-01	8.75e-01	9.80e-01	6.24e-01
ESTABLISHMENT OF SPINDLE ORIENTATION	42	9.43e-01	9.97e-01	0.0513	-8.99e-03	-2.12e-02	2.22e-02	1.07e-02	-3.86e-02	9.20e-01	8.12e-01	8.03e-01	9.05e-01	6.65e-01
PEPTIDYL AMINO ACID MODIFICATION	893	3.38e-02	2.79e-01	0.0513	-1.47e-02	-4.62e-02	-6.96e-03	-1.33e-02	-7.40e-03	4.57e-01	1.92e-02	7.24e-01	5.00e-01	7.07e-01
CELL PROJECTION ORGANIZATION	1547	1.22e-03	2.90e-02	0.0512	-1.88e-02	-2.34e-02	-2.31e-02	-3.17e-02	1.36e-02	2.17e-01	1.24e-01	1.29e-01	3.73e-02	3.70e-01
REGULATION OF LEUKOCYTE PROLIFERATION	257	8.68e-01	9.88e-01	0.0511	-2.30e-02	-1.42e-02	-2.41e-02	-2.68e-02	2.41e-02	5.26e-01	6.94e-01	5.06e-01	4.59e-01	5.05e-01
ACTIVATION OF IMMUNE RESPONSE	502	1.12e-01	5.37e-01	0.0511	7.04e-05	2.50e-02	2.31e-02	2.27e-02	3.07e-02	9.98e-01	3.38e-01	3.76e-01	3.83e-01	2.39e-01
REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	133	8.67e-01	9.88e-01	0.0509	1.45e-02	3.31e-02	4.53e-04	-1.46e-03	3.58e-02	7.74e-01	5.10e-01	9.93e-01	9.77e-01	4.76e-01
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	82	9.00e-01	9.94e-01	0.0509	5.29e-03	2.44e-02	1.76e-02	2.47e-02	3.23e-02	9.34e-01	7.03e-01	7.83e-01	6.99e-01	6.13e-01
ORGANOPHOSPHATE METABOLIC PROCESS	917	2.44e-02	2.32e-01	0.0508	1.31e-02	-3.19e-02	2.70e-02	2.55e-02	-3.45e-03	5.00e-01	1.01e-01	1.65e-01	1.90e-01	8.59e-01
HISTONE MODIFICATION	106	2.59e-01	7.42e-01	0.0508	4.40e-02	7.70e-03	1.81e-02	1.99e-03	1.61e-02	4.34e-01	8.91e-01	7.48e-01	9.72e-01	7.74e-01
POSITIVE REGULATION OF PEPTIDE SECRETION	110	9.34e-01	9.97e-01	0.0508	-1.09e-02	-1.54e-02	-1.19e-02	-1.66e-02	4.25e-02	8.43e-01	7.80e-01	8.29e-01	7.64e-01	4.42e-01
REGULATION OF HEMOPOIESIS	406	3.25e-01	7.98e-01	0.0508	1.89e-02	-1.72e-02	3.19e-02	2.69e-02	-1.35e-02	5.12e-01	5.52e-01	2.70e-01	3.53e-01	6.41e-01
SECONDARY PALATE DEVELOPMENT	26	9.96e-01	1.00e+00	0.0507	-8.06e-03	7.30e-03	-8.82e-03	-1.04e-02	4.76e-02	9.43e-01	9.49e-01	9.38e-01	9.27e-01	6.74e-01
CYTOSKELETON ORGANIZATION	1446	1.28e-01	5.72e-01	0.0506	-2.01e-02	-1.06e-03	-3.24e-02	-3.25e-02	6.46e-03	2.00e-01	9.46e-01	3.90e-02	3.82e-02	6.81e-01
EAR MORPHOGENESIS	124	4.85e-01	8.92e-01	0.0504	2.99e-03	-4.80e-02	6.00e-03	-6.50e-03	1.25e-02	9.54e-01	3.56e-01	9.08e-01	9.00e-01	8.10e-01
ENTERIC NERVOUS SYSTEM DEVELOPMENT	12	9.99e-01	1.00e+00	0.0504	-1.03e-02	2.62e-02	-2.98e-02	-2.54e-02	1.49e-02	9.51e-01	8.75e-01	8.58e-01	8.79e-01	9.29e-01
POSITIVE REGULATION OF CELL DEVELOPMENT	426	8.09e-01	9.82e-01	0.0503	-2.31e-02	-1.79e-02	-2.55e-02	-3.07e-02	-9.17e-03	4.14e-01	5.27e-01	3.67e-01	2.77e-01	7.46e-01
POSITIVE REGULATION OF SIGNALING	1731	2.70e-02	2.46e-01	0.0502	-1.77e-02	-2.89e-02	-1.63e-02	-2.01e-02	2.66e-02	2.21e-01	4.56e-02	2.59e-01	1.64e-01	6.59e-02
SALIVARY GLAND DEVELOPMENT	33	9.89e-01	9.98e-01	0.0502	-2.27e-02	1.37e-02	-3.40e-02	-2.53e-02	4.90e-03	8.21e-01	8.92e-01	7.36e-01	8.01e-01	9.61e-01
REGULATION OF BLOOD PRESSURE	175	4.16e-01	8.57e-01	0.0502	1.24e-02	-3.57e-03	-3.55e-02	-3.23e-02	-6.89e-03	7.78e-01	9.35e-01	4.17e-01	4.62e-01	8.75e-01
IMMUNE RESPONSE REGULATING SIGNALING PATHWAY	461	3.47e-01	8.18e-01	0.0502	7.50e-03	2.81e-02	2.25e-02	2.28e-02	2.54e-02	7.82e-01	3.01e-01	4.09e-01	4.01e-01	3.51e-01
REGULATION OF EPITHELIAL CELL PROLIFERATION	395	6.53e-01	9.52e-01	0.0501	-1.35e-02	-4.24e-02	-3.80e-03	-6.18e-03	2.19e-02	6.45e-01	1.48e-01	8.97e-01	8.33e-01	4.55e-01
SMALL MOLECULE BIOSYNTHETIC PROCESS	579	1.41e-01	5.99e-01	0.0500	2.53e-04	-4.56e-02	1.53e-02	1.30e-02	4.82e-03	9.92e-01	6.09e-02	5.30e-01	5.93e-01	8.43e-01
PROTEIN HETEROTETRAMERIZATION	15	9.99e-01	1.00e+00	0.0500	3.48e-03	1.54e-02	-1.26e-03	-5.39e-03	4.71e-02	9.81e-01	9.18e-01	9.93e-01	9.71e-01	7.52e-01
POSITIVE REGULATION OF GLIOGENESIS	68	9.35e-01	9.97e-01	0.0499	3.64e-03	-3.92e-02	1.70e-02	1.97e-02	-1.62e-02	9.59e-01	5.76e-01	8.08e-01	7.79e-01	8.17e-01
REGULATION OF PEPTIDE TRANSPORT	195	5.96e-01	9.33e-01	0.0499	1.57e-02	3.26e-02	-1.34e-02	-1.57e-02	2.74e-02	7.06e-01	4.32e-01	7.48e-01	7.05e-01	5.09e-01
LYMPH VESSEL MORPHOGENESIS	23	9.91e-01	9.98e-01	0.0498	-3.33e-02	1.99e-02	-2.32e-02	-2.08e-02	-1.79e-03	7.82e-01	8.69e-01	8.47e-01	8.63e-01	9.88e-01
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT	32	3.79e-01	8.36e-01	0.0498	3.98e-02	-9.95e-03	2.42e-02	-8.93e-03	1.17e-02	6.97e-01	9.22e-01	8.13e-01	9.30e-01	9.09e-01
NEGATIVE REGULATION OF RESPONSE TO STIMULUS	1676	2.02e-02	2.04e-01	0.0496	2.26e-03	-3.01e-02	1.48e-02	1.05e-02	3.50e-02	8.78e-01	4.00e-02	3.14e-01	4.73e-01	1.72e-02
MICROTUBULE BASED TRANSPORT	204	6.22e-01	9.43e-01	0.0495	1.62e-02	-1.33e-02	3.55e-02	2.39e-02	1.36e-02	6.90e-01	7.43e-01	3.82e-01	5.57e-01	7.37e-01
REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	87	9.72e-01	9.97e-01	0.0495	-5.41e-03	-2.90e-02	1.55e-02	7.19e-03	3.59e-02	9.31e-01	6.40e-01	8.02e-01	9.08e-01	5.63e-01
PHOSPHOLIPID BIOSYNTHETIC PROCESS	244	4.80e-01	8.91e-01	0.0494	-1.31e-02	-4.32e-02	1.70e-02	6.73e-03	-7.92e-03	7.24e-01	2.45e-01	6.47e-01	8.56e-01	8.31e-01
RENAL SYSTEM VASCULATURE DEVELOPMENT	32	9.67e-01	9.97e-01	0.0493	2.73e-02	-9.49e-03	6.04e-04	-2.25e-03	3.99e-02	7.89e-01	9.26e-01	9.95e-01	9.82e-01	6.96e-01
TRANSMEMBRANE TRANSPORT	1481	4.84e-04	1.41e-02	0.0493	6.15e-03	4.23e-02	-8.39e-03	-5.25e-03	2.25e-02	6.92e-01	6.49e-03	5.89e-01	7.35e-01	1.47e-01
MUSCLE ORGAN DEVELOPMENT	342	1.85e-01	6.56e-01	0.0492	1.30e-02	-1.26e-02	1.57e-02	4.19e-03	4.28e-02	6.79e-01	6.90e-01	6.18e-01	8.94e-01	1.74e-01
REGULATION OF GLYCOLYTIC PROCESS	50	9.14e-01	9.94e-01	0.0491	8.58e-03	8.33e-03	-2.15e-02	-2.84e-02	3.16e-02	9.16e-01	9.19e-01	7.92e-01	7.28e-01	6.99e-01
CELLULAR CATABOLIC PROCESS	1537	6.45e-04	1.73e-02	0.0491	-6.49e-03	-4.79e-02	1.22e-03	-3.40e-03	7.94e-03	6.71e-01	1.70e-03	9.36e-01	8.24e-01	6.03e-01
REGULATION OF T CELL ACTIVATION	369	1.81e-01	6.56e-01	0.0491	8.41e-03	4.67e-02	9.80e-03	3.27e-03	7.23e-03	7.82e-01	1.23e-01	7.46e-01	9.14e-01	8.11e-01
CELLULAR RESPONSE TO ACID CHEMICAL	86	9.55e-01	9.97e-01	0.0491	-2.06e-02	-4.41e-02	4.39e-03	-4.91e-03	5.95e-04	7.42e-01	4.80e-01	9.44e-01	9.37e-01	9.92e-01
REGULATION OF TRANSPORT	1711	2.92e-03	5.39e-02	0.0489	-7.94e-03	-1.39e-02	-1.38e-02	-1.61e-02	4.11e-02	5.85e-01	3.37e-01	3.44e-01	2.67e-01	4.69e-03
INNER EAR MORPHOGENESIS	104	4.07e-01	8.50e-01	0.0489	3.61e-03	-2.57e-02	-2.04e-02	-3.39e-02	-1.21e-02	9.49e-01	6.50e-01	7.20e-01	5.50e-01	8.31e-01
PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	285	4.36e-01	8.69e-01	0.0489	-1.20e-02	5.11e-03	-3.77e-02	-2.75e-02	6.38e-03	7.28e-01	8.82e-01	2.73e-01	4.25e-01	8.53e-01
FILOPODIUM ASSEMBLY	66	8.89e-01	9.91e-01	0.0488	-3.71e-03	3.69e-02	-5.77e-03	-1.31e-02	2.83e-02	9.58e-01	6.04e-01	9.35e-01	8.54e-01	6.91e-01
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND	528	6.99e-02	4.23e-01	0.0488	-1.10e-03	-4.33e-02	4.46e-03	-3.80e-03	2.17e-02	9.66e-01	8.90e-02	8.61e-01	8.81e-01	3.93e-01
OXIDATIVE DEMETHYLATION	14	9.78e-01	9.97e-01	0.0488	-7.18e-03	4.57e-02	2.24e-03	-1.47e-02	-3.80e-03	9.63e-01	7.67e-01	9.88e-01	9.24e-01	9.80e-01
RESPONSE TO EXTRACELLULAR STIMULUS	501	6.66e-02	4.13e-01	0.0486	3.83e-03	-4.22e-02	5.56e-03	-1.38e-03	2.32e-02	8.83e-01	1.06e-01	8.31e-01	9.58e-01	3.75e-01
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS	200	7.61e-01	9.75e-01	0.0486	-2.34e-02	-4.13e-02	6.50e-03	-2.43e-03	-7.57e-03	5.69e-01	3.14e-01	8.74e-01	9.53e-01	8.54e-01
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS	217	4.78e-01	8.89e-01	0.0485	9.25e-03	-4.34e-02	8.66e-03	6.11e-03	1.66e-02	8.14e-01	2.71e-01	8.26e-01	8.77e-01	6.74e-01
ENDOCYTIC RECYCLING	83	9.92e-01	9.99e-01	0.0482	-1.87e-02	-3.07e-02	-2.38e-02	-2.14e-02	-1.46e-03	7.68e-01	6.28e-01	7.07e-01	7.36e-01	9.82e-01
REGULATION OF CELLULAR CATABOLIC PROCESS	686	2.29e-01	7.13e-01	0.0481	-1.52e-02	-4.33e-02	-2.70e-03	-9.40e-03	1.03e-02	4.96e-01	5.31e-02	9.04e-01	6.75e-01	6.46e-01
SIGNAL RELEASE	467	5.77e-01	9.26e-01	0.0480	-1.96e-02	-2.32e-02	-1.41e-02	-2.02e-02	2.78e-02	4.69e-01	3.89e-01	6.02e-01	4.54e-01	3.04e-01
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	17	9.56e-01	9.97e-01	0.0479	3.04e-02	1.18e-02	-7.45e-04	-1.71e-02	-3.07e-02	8.28e-01	9.33e-01	9.96e-01	9.03e-01	8.27e-01
CELLULAR HOMEOSTASIS	782	3.30e-01	8.02e-01	0.0477	2.47e-02	5.34e-03	1.68e-02	1.47e-02	3.37e-02	2.41e-01	7.99e-01	4.25e-01	4.85e-01	1.09e-01
CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS	25	9.99e-01	1.00e+00	0.0476	2.60e-02	3.00e-02	-1.60e-03	-1.78e-03	-2.63e-02	8.22e-01	7.95e-01	9.89e-01	9.88e-01	8.20e-01
REGULATION OF CELL GROWTH	399	2.55e-02	2.37e-01	0.0476	1.89e-02	-4.03e-02	1.20e-02	5.64e-03	1.03e-02	5.17e-01	1.67e-01	6.80e-01	8.47e-01	7.23e-01
BONE DEVELOPMENT	204	9.63e-01	9.97e-01	0.0475	-2.37e-02	-3.20e-02	-1.40e-02	-1.90e-02	1.08e-02	5.59e-01	4.31e-01	7.31e-01	6.40e-01	7.90e-01
LIPID OXIDATION	112	6.62e-01	9.54e-01	0.0474	1.59e-03	-9.35e-03	1.96e-02	7.19e-03	-4.14e-02	9.77e-01	8.64e-01	7.20e-01	8.95e-01	4.49e-01
POSITIVE REGULATION OF CELL ADHESION	467	2.98e-01	7.73e-01	0.0473	-1.17e-02	-1.06e-02	-1.87e-02	-2.47e-02	3.21e-02	6.64e-01	6.94e-01	4.90e-01	3.60e-01	2.34e-01
MULTICELLULAR ORGANISM GROWTH	144	9.11e-01	9.94e-01	0.0473	-6.55e-03	-4.46e-02	7.21e-03	5.88e-03	1.09e-02	8.92e-01	3.56e-01	8.81e-01	9.03e-01	8.21e-01
AMIDE TRANSPORT	344	5.98e-01	9.33e-01	0.0472	2.19e-02	1.94e-02	3.65e-03	3.50e-03	3.68e-02	4.86e-01	5.37e-01	9.07e-01	9.11e-01	2.41e-01
LOCALIZATION WITHIN MEMBRANE	657	7.64e-01	9.75e-01	0.0471	1.62e-02	-7.90e-03	2.96e-02	2.79e-02	1.52e-02	4.79e-01	7.30e-01	1.95e-01	2.22e-01	5.06e-01
DEVELOPMENTAL GROWTH	633	3.85e-01	8.40e-01	0.0470	-1.42e-02	-1.51e-02	-2.60e-02	-3.13e-02	-1.13e-02	5.43e-01	5.17e-01	2.64e-01	1.79e-01	6.27e-01
REGULATION OF KINASE ACTIVITY	565	2.16e-02	2.14e-01	0.0470	1.91e-02	-3.39e-02	1.98e-02	1.52e-02	-8.42e-03	4.38e-01	1.68e-01	4.21e-01	5.37e-01	7.32e-01
INTRACELLULAR GLUCOSE HOMEOSTASIS	153	5.56e-01	9.18e-01	0.0465	9.65e-03	-2.65e-02	-8.57e-03	-1.23e-02	-3.38e-02	8.37e-01	5.71e-01	8.55e-01	7.93e-01	4.71e-01
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	1718	6.14e-02	3.97e-01	0.0462	-4.08e-03	-2.80e-02	7.98e-03	4.44e-03	3.53e-02	7.79e-01	5.36e-02	5.82e-01	7.60e-01	1.48e-02
REGULATION OF MUSCLE TISSUE DEVELOPMENT	45	9.02e-01	9.94e-01	0.0460	2.82e-02	-2.92e-02	3.09e-03	4.18e-03	2.11e-02	7.43e-01	7.35e-01	9.71e-01	9.61e-01	8.06e-01
CELL PROJECTION ASSEMBLY	589	3.68e-01	8.31e-01	0.0460	-1.52e-02	-1.20e-02	-2.43e-02	-3.12e-02	-1.33e-02	5.28e-01	6.19e-01	3.14e-01	1.96e-01	5.81e-01
ORGANIC ACID METABOLIC PROCESS	937	2.22e-01	7.03e-01	0.0460	-1.63e-02	-4.00e-02	-9.16e-03	-8.76e-03	-9.19e-03	3.96e-01	3.79e-02	6.35e-01	6.49e-01	6.33e-01
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	128	8.03e-01	9.82e-01	0.0459	-5.09e-03	-3.57e-02	-1.22e-02	-1.87e-02	1.76e-02	9.21e-01	4.86e-01	8.12e-01	7.15e-01	7.32e-01
PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	28	9.99e-01	1.00e+00	0.0459	-1.09e-04	1.64e-02	-3.05e-02	-2.89e-02	-7.98e-03	9.99e-01	8.80e-01	7.80e-01	7.91e-01	9.42e-01
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH	108	7.96e-01	9.81e-01	0.0454	3.15e-03	-2.98e-02	-8.23e-03	-1.45e-02	2.98e-02	9.55e-01	5.92e-01	8.82e-01	7.95e-01	5.92e-01
REGULATION OF ANATOMICAL STRUCTURE SIZE	486	7.56e-01	9.75e-01	0.0454	-1.90e-02	-2.27e-02	-2.19e-02	-2.66e-02	-7.82e-05	4.73e-01	3.92e-01	4.08e-01	3.15e-01	9.98e-01
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION	918	5.46e-03	8.72e-02	0.0451	-2.51e-03	-1.51e-02	-2.58e-02	-3.19e-02	-1.09e-02	8.97e-01	4.37e-01	1.85e-01	1.01e-01	5.74e-01
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	54	9.83e-01	9.97e-01	0.0450	9.75e-03	-2.03e-02	2.40e-02	2.08e-02	-2.27e-02	9.01e-01	7.96e-01	7.61e-01	7.91e-01	7.73e-01
REGULATION OF PH	96	9.18e-01	9.95e-01	0.0450	2.26e-02	3.06e-02	1.30e-02	4.91e-03	-1.95e-02	7.02e-01	6.04e-01	8.25e-01	9.34e-01	7.41e-01
REGULATION OF DEFENSE RESPONSE TO VIRUS	93	6.44e-01	9.50e-01	0.0450	3.15e-02	-3.25e-03	-1.04e-02	-2.13e-03	3.01e-02	5.99e-01	9.57e-01	8.63e-01	9.72e-01	6.16e-01
BONE TRABECULA FORMATION	10	9.60e-01	9.97e-01	0.0448	-3.44e-02	4.39e-03	1.92e-02	-9.71e-03	1.85e-02	8.51e-01	9.81e-01	9.16e-01	9.58e-01	9.20e-01
POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	34	9.62e-01	9.97e-01	0.0446	-2.45e-02	-3.19e-02	1.07e-02	-5.39e-03	-1.49e-02	8.04e-01	7.47e-01	9.14e-01	9.57e-01	8.80e-01
HEART DEVELOPMENT	598	5.86e-02	3.85e-01	0.0446	3.67e-03	-3.64e-02	1.66e-02	6.46e-03	1.82e-02	8.78e-01	1.28e-01	4.89e-01	7.87e-01	4.46e-01
SEXUAL REPRODUCTION	989	9.98e-02	5.06e-01	0.0445	1.86e-02	2.36e-02	-1.15e-02	-1.23e-02	-2.82e-02	3.22e-01	2.08e-01	5.42e-01	5.12e-01	1.33e-01
LONG TERM SYNAPTIC POTENTIATION	102	5.58e-01	9.19e-01	0.0444	-6.76e-03	4.00e-02	-5.95e-03	6.55e-03	1.57e-02	9.06e-01	4.85e-01	9.17e-01	9.09e-01	7.84e-01
LIPID METABOLIC PROCESS	1354	7.31e-01	9.72e-01	0.0444	-2.18e-02	-1.50e-02	-2.53e-02	-2.44e-02	-5.55e-03	1.77e-01	3.55e-01	1.18e-01	1.32e-01	7.32e-01
REGULATION OF MRNA CATABOLIC PROCESS	240	9.89e-01	9.98e-01	0.0442	-2.60e-02	-2.39e-02	-1.87e-02	-1.89e-02	1.79e-03	4.87e-01	5.24e-01	6.18e-01	6.14e-01	9.62e-01
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY	47	9.76e-01	9.97e-01	0.0442	2.27e-03	3.88e-02	1.33e-02	1.53e-02	-5.76e-03	9.79e-01	6.45e-01	8.75e-01	8.56e-01	9.46e-01
PROTEIN DEPOLYMERIZATION	112	6.54e-01	9.53e-01	0.0440	-1.04e-02	-2.77e-02	-1.64e-03	-1.75e-02	2.74e-02	8.49e-01	6.12e-01	9.76e-01	7.49e-01	6.17e-01
CELL ACTIVATION	1064	2.05e-01	6.84e-01	0.0440	1.74e-02	8.81e-03	2.45e-02	1.76e-02	2.54e-02	3.36e-01	6.27e-01	1.78e-01	3.31e-01	1.62e-01
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS	1213	1.21e-01	5.55e-01	0.0440	-1.21e-02	-5.20e-03	-2.75e-02	-2.95e-02	1.13e-02	4.78e-01	7.60e-01	1.06e-01	8.33e-02	5.06e-01
GLOMERULUS DEVELOPMENT	68	9.98e-01	1.00e+00	0.0439	8.79e-03	-8.51e-03	2.19e-02	1.85e-02	3.08e-02	9.00e-01	9.03e-01	7.55e-01	7.92e-01	6.60e-01
POSITIVE REGULATION OF TRANSFERASE ACTIVITY	401	6.09e-01	9.35e-01	0.0438	2.14e-02	-1.73e-02	2.27e-02	2.32e-02	1.06e-02	4.62e-01	5.51e-01	4.36e-01	4.26e-01	7.16e-01
EPITHELIAL TUBE FORMATION	136	4.86e-01	8.92e-01	0.0437	4.75e-03	-3.04e-02	3.47e-03	-1.02e-02	2.92e-02	9.24e-01	5.41e-01	9.44e-01	8.38e-01	5.57e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	26	9.95e-01	9.99e-01	0.0437	-2.44e-02	2.88e-03	-1.01e-02	-1.87e-02	-2.93e-02	8.29e-01	9.80e-01	9.29e-01	8.69e-01	7.96e-01
CELL CELL SIGNALING	1630	1.32e-02	1.55e-01	0.0436	-1.55e-02	-1.14e-02	-1.72e-02	-2.31e-02	2.65e-02	2.98e-01	4.43e-01	2.47e-01	1.19e-01	7.44e-02
REGULATION OF TUBE SIZE	142	6.58e-01	9.54e-01	0.0434	-9.29e-04	-4.21e-02	-4.32e-03	3.35e-03	-9.08e-03	9.85e-01	3.87e-01	9.29e-01	9.45e-01	8.52e-01
REGULATION OF FILOPODIUM ASSEMBLY	48	9.42e-01	9.97e-01	0.0432	-1.18e-02	2.53e-02	-3.06e-03	-1.23e-02	3.05e-02	8.87e-01	7.62e-01	9.71e-01	8.83e-01	7.14e-01
REGULATION OF PROTEIN IMPORT INTO NUCLEUS	57	9.60e-01	9.97e-01	0.0432	1.62e-03	-2.77e-02	1.57e-03	-4.34e-03	-3.29e-02	9.83e-01	7.18e-01	9.84e-01	9.55e-01	6.68e-01
CARBOHYDRATE HOMEOSTASIS	248	5.79e-01	9.27e-01	0.0432	3.50e-02	9.38e-03	1.22e-02	9.81e-03	-1.74e-02	3.42e-01	7.99e-01	7.40e-01	7.90e-01	6.37e-01
DENDRITIC CELL DIFFERENTIATION	45	9.87e-01	9.98e-01	0.0431	2.31e-02	1.64e-02	-1.34e-02	-1.26e-02	-2.67e-02	7.89e-01	8.49e-01	8.77e-01	8.84e-01	7.56e-01
POSITIVE REGULATION OF LYASE ACTIVITY	39	9.51e-01	9.97e-01	0.0431	1.06e-02	-3.33e-02	-1.19e-02	-1.42e-02	1.70e-02	9.09e-01	7.19e-01	8.97e-01	8.78e-01	8.54e-01
REGULATION OF SODIUM ION TRANSPORT	80	5.07e-01	8.99e-01	0.0426	1.70e-02	-1.98e-02	-2.99e-02	-1.44e-02	6.29e-03	7.93e-01	7.60e-01	6.44e-01	8.24e-01	9.23e-01
MYELOID CELL DIFFERENTIATION	413	1.35e-01	5.83e-01	0.0425	2.88e-02	-1.83e-02	1.16e-02	1.20e-02	1.90e-02	3.15e-01	5.24e-01	6.86e-01	6.75e-01	5.08e-01
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	54	9.44e-01	9.97e-01	0.0425	7.88e-03	3.48e-02	-2.09e-02	-7.64e-03	6.19e-03	9.20e-01	6.58e-01	7.91e-01	9.23e-01	9.37e-01
CELL CELL ADHESION	922	1.82e-01	6.56e-01	0.0424	-1.51e-02	-1.52e-03	-2.33e-02	-2.81e-02	1.52e-02	4.36e-01	9.37e-01	2.29e-01	1.49e-01	4.34e-01
NEGATIVE REGULATION OF MAPK CASCADE	164	9.39e-01	9.97e-01	0.0422	1.88e-02	2.35e-02	-1.33e-02	-9.00e-03	-2.49e-02	6.77e-01	6.04e-01	7.70e-01	8.42e-01	5.81e-01
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	57	7.97e-01	9.81e-01	0.0422	1.33e-04	3.31e-02	1.73e-02	1.24e-03	1.97e-02	9.99e-01	6.66e-01	8.21e-01	9.87e-01	7.97e-01
BLOOD VESSEL MORPHOGENESIS	679	5.63e-01	9.22e-01	0.0422	-1.42e-02	-2.36e-02	-1.92e-02	-1.80e-02	1.82e-02	5.28e-01	2.93e-01	3.94e-01	4.25e-01	4.20e-01
ISOPRENOID METABOLIC PROCESS	130	9.38e-01	9.97e-01	0.0420	1.56e-02	1.39e-03	1.40e-02	1.89e-02	-3.11e-02	7.59e-01	9.78e-01	7.82e-01	7.10e-01	5.40e-01
IMMUNE EFFECTOR PROCESS	612	7.45e-02	4.40e-01	0.0420	-2.13e-03	2.88e-02	-6.69e-03	-1.09e-03	2.98e-02	9.28e-01	2.24e-01	7.78e-01	9.63e-01	2.08e-01
PEPTIDE TRANSPORT	254	7.22e-01	9.70e-01	0.0420	4.24e-03	2.89e-02	-1.95e-02	-2.07e-02	1.00e-02	9.07e-01	4.28e-01	5.92e-01	5.69e-01	7.83e-01
TUBE MORPHOGENESIS	915	1.59e-01	6.21e-01	0.0419	-8.65e-03	-2.84e-02	-1.23e-02	-1.58e-02	2.17e-02	6.57e-01	1.45e-01	5.28e-01	4.17e-01	2.65e-01
MICROTUBULE CYTOSKELETON ORGANIZATION	628	3.91e-01	8.41e-01	0.0419	5.21e-03	-2.72e-02	2.15e-02	1.53e-02	1.70e-02	8.23e-01	2.45e-01	3.57e-01	5.11e-01	4.67e-01
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS	778	1.45e-01	6.03e-01	0.0416	-4.37e-03	-4.02e-02	9.46e-04	-2.51e-03	9.49e-03	8.36e-01	5.62e-02	9.64e-01	9.05e-01	6.52e-01
REGULATION OF MYELOID CELL DIFFERENTIATION	206	4.12e-01	8.54e-01	0.0416	2.26e-02	-2.31e-02	4.86e-03	7.38e-03	-2.47e-02	5.76e-01	5.68e-01	9.04e-01	8.55e-01	5.42e-01
ORGANIC ACID CATABOLIC PROCESS	246	2.50e-01	7.33e-01	0.0415	2.15e-02	-3.08e-03	-1.15e-02	-1.59e-02	-2.95e-02	5.62e-01	9.34e-01	7.55e-01	6.68e-01	4.26e-01
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	102	8.93e-01	9.92e-01	0.0415	-2.79e-02	-2.47e-02	1.56e-02	8.25e-03	4.85e-03	6.26e-01	6.67e-01	7.86e-01	8.86e-01	9.33e-01
NEGATIVE REGULATION OF CELL DIFFERENTIATION	686	7.68e-02	4.48e-01	0.0413	1.43e-02	-2.67e-02	2.16e-02	1.43e-02	1.07e-02	5.24e-01	2.33e-01	3.34e-01	5.23e-01	6.33e-01
GLUCOSE METABOLIC PROCESS	183	7.47e-01	9.75e-01	0.0413	8.13e-03	-1.44e-02	-1.51e-02	-1.20e-02	-3.25e-02	8.49e-01	7.37e-01	7.25e-01	7.79e-01	4.48e-01
SKIN DEVELOPMENT	311	6.05e-01	9.34e-01	0.0409	2.48e-03	3.85e-02	-9.64e-03	-3.18e-03	-8.75e-03	9.40e-01	2.43e-01	7.70e-01	9.23e-01	7.91e-01
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS	19	7.92e-01	9.81e-01	0.0409	4.70e-03	-1.00e-02	-9.61e-03	2.33e-02	3.02e-02	9.72e-01	9.40e-01	9.42e-01	8.60e-01	8.20e-01
RNA CATABOLIC PROCESS	349	6.24e-01	9.44e-01	0.0408	2.66e-03	-3.40e-02	1.76e-02	1.38e-02	1.10e-03	9.32e-01	2.75e-01	5.73e-01	6.58e-01	9.72e-01
MONOATOMIC ION HOMEOSTASIS	581	3.42e-01	8.12e-01	0.0408	1.03e-02	1.33e-02	4.26e-04	-2.64e-03	3.70e-02	6.70e-01	5.85e-01	9.86e-01	9.13e-01	1.27e-01
ORGAN GROWTH	168	3.17e-01	7.89e-01	0.0406	1.48e-02	-3.15e-02	-1.12e-02	-1.54e-02	-8.99e-03	7.40e-01	4.82e-01	8.03e-01	7.31e-01	8.41e-01
TUBE DEVELOPMENT	1121	1.96e-02	2.01e-01	0.0405	-4.47e-03	-3.10e-02	-7.68e-03	-1.33e-02	2.06e-02	8.00e-01	7.96e-02	6.64e-01	4.52e-01	2.45e-01
POSITIVE REGULATION OF MRNA METABOLIC PROCESS	190	9.79e-01	9.97e-01	0.0405	-2.25e-02	-2.01e-02	-1.04e-02	-1.22e-02	-2.18e-02	5.93e-01	6.33e-01	8.05e-01	7.73e-01	6.05e-01
REGULATION OF EPITHELIAL CELL DIFFERENTIATION	169	3.27e-01	7.99e-01	0.0403	2.86e-03	-2.71e-02	-1.44e-02	-2.57e-02	-3.41e-03	9.49e-01	5.43e-01	7.47e-01	5.64e-01	9.39e-01
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1620	2.26e-02	2.20e-01	0.0402	-8.66e-03	-1.93e-02	-1.69e-02	-2.04e-02	2.15e-02	5.61e-01	1.95e-01	2.56e-01	1.71e-01	1.48e-01
LEUKOCYTE PROLIFERATION	334	8.25e-01	9.83e-01	0.0399	-1.98e-02	-9.18e-03	-1.11e-02	-1.53e-02	2.75e-02	5.33e-01	7.73e-01	7.27e-01	6.32e-01	3.88e-01
ODONTOGENESIS	126	9.58e-01	9.97e-01	0.0398	-9.87e-03	-2.72e-02	-1.74e-02	-2.11e-02	-2.01e-04	8.48e-01	5.98e-01	7.35e-01	6.83e-01	9.97e-01
MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS	781	1.81e-01	6.55e-01	0.0396	6.55e-03	-2.50e-02	3.12e-03	2.44e-03	2.98e-02	7.56e-01	2.35e-01	8.82e-01	9.08e-01	1.56e-01
CELLULAR RESPONSE TO LIPID	592	3.77e-02	2.96e-01	0.0396	1.54e-02	-2.71e-02	1.11e-02	3.82e-03	2.15e-02	5.22e-01	2.61e-01	6.44e-01	8.74e-01	3.72e-01
REGULATION OF PROTEIN GLYCOSYLATION	12	7.48e-01	9.75e-01	0.0394	-1.13e-02	1.72e-02	-1.41e-02	2.93e-02	-8.06e-03	9.46e-01	9.18e-01	9.33e-01	8.60e-01	9.61e-01
REGULATION OF HOMOTYPIC CELL CELL ADHESION	34	9.44e-01	9.97e-01	0.0393	2.30e-02	-5.72e-03	-1.58e-02	-1.98e-02	1.85e-02	8.16e-01	9.54e-01	8.73e-01	8.42e-01	8.52e-01
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE	204	7.73e-01	9.77e-01	0.0393	-1.25e-02	-1.80e-02	2.31e-02	2.28e-02	3.34e-03	7.59e-01	6.57e-01	5.70e-01	5.74e-01	9.34e-01
INTERFERON MEDIATED SIGNALING PATHWAY	102	9.77e-01	9.97e-01	0.0390	-1.68e-03	2.17e-04	2.46e-02	1.92e-02	2.34e-02	9.77e-01	9.97e-01	6.68e-01	7.38e-01	6.83e-01
REGULATION OF INSULIN SECRETION	161	8.77e-01	9.88e-01	0.0389	1.25e-02	2.06e-02	-2.27e-02	-2.05e-02	4.07e-04	7.85e-01	6.51e-01	6.20e-01	6.53e-01	9.93e-01
RESPONSE TO STARVATION	208	8.99e-01	9.94e-01	0.0389	-8.84e-03	-3.41e-02	-2.42e-03	-7.58e-03	1.46e-02	8.26e-01	3.97e-01	9.52e-01	8.50e-01	7.17e-01
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT	1424	6.54e-03	9.75e-02	0.0388	-6.42e-03	-3.34e-02	-8.54e-03	-1.45e-02	8.24e-03	6.85e-01	3.49e-02	5.89e-01	3.61e-01	6.02e-01
CARDIAC CELL DEVELOPMENT	92	9.69e-01	9.97e-01	0.0383	-1.86e-03	-2.22e-02	-1.68e-02	-1.64e-02	-2.06e-02	9.75e-01	7.13e-01	7.80e-01	7.86e-01	7.33e-01
POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY	274	8.43e-01	9.86e-01	0.0383	-8.12e-03	-2.65e-02	-1.86e-02	-1.88e-02	1.26e-04	8.17e-01	4.51e-01	5.95e-01	5.93e-01	9.97e-01
AMINO ACID CATABOLIC PROCESS	109	8.67e-01	9.88e-01	0.0382	4.15e-03	-2.13e-02	-2.29e-02	-1.96e-02	-8.87e-03	9.40e-01	7.01e-01	6.79e-01	7.24e-01	8.73e-01
HOMEOSTATIC PROCESS	1660	5.94e-02	3.88e-01	0.0381	7.16e-03	-1.34e-02	5.03e-03	3.27e-03	3.44e-02	6.27e-01	3.62e-01	7.33e-01	8.25e-01	1.96e-02
MICROTUBULE BASED PROCESS	901	7.24e-01	9.70e-01	0.0379	1.44e-02	-8.35e-03	2.20e-02	1.96e-02	1.72e-02	4.63e-01	6.71e-01	2.63e-01	3.19e-01	3.82e-01
SMALL MOLECULE METABOLIC PROCESS	1783	8.91e-04	2.26e-02	0.0379	2.99e-03	-3.29e-02	5.98e-03	6.77e-03	-1.61e-02	8.34e-01	2.09e-02	6.75e-01	6.35e-01	2.58e-01
ODONTOGENESIS OF DENTIN CONTAINING TOOTH	90	9.94e-01	9.99e-01	0.0378	8.92e-03	-1.85e-02	2.14e-02	1.79e-02	1.52e-02	8.84e-01	7.62e-01	7.26e-01	7.69e-01	8.03e-01
DEFENSE RESPONSE	1744	5.42e-02	3.65e-01	0.0375	1.16e-02	1.71e-02	6.08e-03	1.09e-02	2.86e-02	4.19e-01	2.34e-01	6.73e-01	4.50e-01	4.70e-02
MRNA CATABOLIC PROCESS	295	7.35e-01	9.73e-01	0.0374	-2.14e-04	-3.15e-02	1.34e-02	1.06e-02	-1.07e-02	9.95e-01	3.52e-01	6.93e-01	7.54e-01	7.52e-01
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION	180	9.56e-01	9.97e-01	0.0372	-8.10e-03	-9.81e-03	-2.38e-02	-2.54e-02	2.84e-03	8.51e-01	8.20e-01	5.81e-01	5.57e-01	9.48e-01
REGULATION OF PHOSPHORUS METABOLIC PROCESS	1136	5.85e-03	9.15e-02	0.0370	6.89e-04	-3.67e-02	2.14e-03	-3.57e-03	-3.38e-03	9.69e-01	3.71e-02	9.03e-01	8.39e-01	8.48e-01
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	72	8.90e-01	9.91e-01	0.0370	-1.16e-02	3.23e-02	8.70e-04	4.73e-03	1.29e-02	8.65e-01	6.35e-01	9.90e-01	9.45e-01	8.50e-01
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS	1014	6.54e-01	9.53e-01	0.0370	1.14e-02	1.42e-02	1.56e-02	1.77e-02	2.19e-02	5.40e-01	4.43e-01	4.02e-01	3.41e-01	2.37e-01
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION	159	9.53e-01	9.97e-01	0.0366	1.82e-02	7.73e-03	4.36e-03	8.08e-03	2.94e-02	6.93e-01	8.66e-01	9.24e-01	8.61e-01	5.22e-01
ORGANELLE ASSEMBLY	961	8.70e-02	4.68e-01	0.0366	1.91e-02	-8.21e-03	2.44e-02	1.75e-02	-1.28e-03	3.17e-01	6.67e-01	1.99e-01	3.58e-01	9.46e-01
POSITIVE REGULATION OF CYCLASE ACTIVITY	38	9.77e-01	9.97e-01	0.0365	4.74e-03	-3.18e-02	-5.84e-03	-1.17e-02	-1.13e-02	9.60e-01	7.34e-01	9.50e-01	9.00e-01	9.04e-01
REGULATION OF PHOSPHORYLATION	1011	4.45e-03	7.50e-02	0.0362	7.57e-03	-3.26e-02	9.77e-03	3.44e-03	-9.11e-03	6.84e-01	7.91e-02	5.99e-01	8.53e-01	6.24e-01
POSITIVE REGULATION OF KINASE ACTIVITY	328	8.87e-01	9.91e-01	0.0359	-8.91e-03	-1.74e-02	-2.22e-02	-2.03e-02	-1.06e-04	7.81e-01	5.88e-01	4.89e-01	5.27e-01	9.97e-01
EPIDERMIS DEVELOPMENT	375	5.03e-01	8.98e-01	0.0359	7.56e-03	2.80e-02	-2.70e-03	4.76e-03	2.03e-02	8.02e-01	3.52e-01	9.29e-01	8.74e-01	4.99e-01
T CELL PROLIFERATION	204	9.23e-01	9.95e-01	0.0358	7.81e-03	1.94e-02	1.74e-04	-1.07e-03	2.91e-02	8.48e-01	6.34e-01	9.97e-01	9.79e-01	4.74e-01
POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	231	3.55e-01	8.22e-01	0.0357	1.80e-02	-2.81e-02	-9.51e-04	-2.34e-03	1.25e-02	6.38e-01	4.62e-01	9.80e-01	9.51e-01	7.44e-01
GLYCOLYTIC PROCESS	85	8.70e-01	9.88e-01	0.0353	1.78e-02	-8.68e-04	-1.67e-02	-9.73e-03	2.37e-02	7.77e-01	9.89e-01	7.91e-01	8.77e-01	7.06e-01
MICROTUBULE BASED MOVEMENT	401	9.15e-01	9.94e-01	0.0353	2.15e-02	2.68e-02	1.51e-03	6.08e-03	-5.11e-03	4.60e-01	3.57e-01	9.59e-01	8.35e-01	8.61e-01
REGULATION OF CELL DIFFERENTIATION	1558	9.04e-04	2.26e-02	0.0352	1.03e-03	-3.17e-02	1.59e-03	-5.66e-03	1.42e-02	9.46e-01	3.69e-02	9.17e-01	7.09e-01	3.50e-01
POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	104	7.79e-01	9.79e-01	0.0348	-1.60e-03	-7.93e-03	1.31e-02	-1.99e-03	3.11e-02	9.77e-01	8.89e-01	8.18e-01	9.72e-01	5.83e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION	458	3.25e-01	7.96e-01	0.0347	4.27e-04	-3.38e-02	-2.97e-03	-6.82e-03	-1.80e-03	9.87e-01	2.15e-01	9.13e-01	8.02e-01	9.47e-01
POSITIVE REGULATION OF CELL CELL ADHESION	311	8.68e-01	9.88e-01	0.0345	1.67e-02	2.03e-02	4.24e-03	2.03e-03	2.18e-02	6.12e-01	5.38e-01	8.98e-01	9.51e-01	5.08e-01
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	24	9.99e-01	1.00e+00	0.0342	1.69e-02	2.85e-02	7.40e-03	1.60e-03	-3.43e-03	8.86e-01	8.09e-01	9.50e-01	9.89e-01	9.77e-01
POSITIVE REGULATION OF PROTEIN POLYMERIZATION	89	8.23e-01	9.83e-01	0.0341	2.15e-02	1.97e-02	-7.36e-03	-1.59e-02	1.53e-03	7.26e-01	7.48e-01	9.05e-01	7.95e-01	9.80e-01
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	312	4.56e-01	8.78e-01	0.0339	1.82e-02	-2.50e-02	9.55e-03	9.56e-03	2.58e-03	5.79e-01	4.47e-01	7.72e-01	7.71e-01	9.38e-01
REGULATION OF IMMUNE SYSTEM PROCESS	1465	7.35e-01	9.73e-01	0.0338	7.62e-03	-1.09e-03	1.65e-02	1.70e-02	2.28e-02	6.25e-01	9.44e-01	2.90e-01	2.76e-01	1.43e-01
RESPONSE TO LIGHT STIMULUS	302	6.64e-01	9.54e-01	0.0338	5.57e-03	-2.15e-02	9.83e-03	2.28e-03	2.33e-02	8.68e-01	5.20e-01	7.69e-01	9.46e-01	4.85e-01
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS	945	7.88e-02	4.52e-01	0.0332	2.24e-03	-3.19e-02	6.10e-03	8.32e-04	6.63e-03	9.07e-01	9.65e-02	7.51e-01	9.65e-01	7.30e-01
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	140	9.76e-01	9.97e-01	0.0331	-2.38e-03	-1.05e-02	-2.11e-02	-1.93e-02	-1.27e-02	9.61e-01	8.31e-01	6.66e-01	6.93e-01	7.96e-01
REGULATION OF CELL CELL ADHESION	479	7.22e-01	9.70e-01	0.0327	-1.06e-02	-1.70e-03	-8.33e-03	-1.23e-02	2.71e-02	6.90e-01	9.49e-01	7.55e-01	6.44e-01	3.10e-01
CILIUM ORGANIZATION	410	5.52e-01	9.16e-01	0.0327	4.50e-03	1.25e-03	-1.13e-02	-1.65e-02	-2.55e-02	8.76e-01	9.65e-01	6.95e-01	5.67e-01	3.76e-01
PROTEIN PHOSPHORYLATION	1275	7.69e-03	1.09e-01	0.0327	-4.40e-03	-2.32e-02	-9.28e-03	-1.69e-02	-1.18e-02	7.92e-01	1.63e-01	5.77e-01	3.10e-01	4.79e-01
VASCULATURE DEVELOPMENT	794	4.92e-01	8.94e-01	0.0323	-3.36e-03	-1.66e-02	-8.40e-03	-6.73e-03	2.53e-02	8.72e-01	4.26e-01	6.87e-01	7.47e-01	2.26e-01
CIRCULATORY SYSTEM DEVELOPMENT	1175	4.89e-01	8.92e-01	0.0323	-6.00e-03	-1.95e-02	-4.24e-03	-5.94e-03	2.39e-02	7.29e-01	2.59e-01	8.06e-01	7.32e-01	1.68e-01
FATTY ACID METABOLIC PROCESS	388	8.68e-01	9.88e-01	0.0320	-8.07e-03	-6.65e-04	-3.19e-03	-1.57e-03	-3.07e-02	7.85e-01	9.82e-01	9.14e-01	9.58e-01	2.99e-01
CELL GROWTH	476	4.77e-02	3.41e-01	0.0314	1.36e-02	-2.71e-02	-2.51e-03	-7.98e-03	1.34e-03	6.12e-01	3.11e-01	9.25e-01	7.65e-01	9.60e-01
CARBOHYDRATE CATABOLIC PROCESS	155	8.10e-01	9.82e-01	0.0312	2.03e-03	-1.70e-02	-1.54e-02	-2.08e-02	-3.63e-03	9.65e-01	7.15e-01	7.41e-01	6.55e-01	9.38e-01
REGULATION OF CELL DEVELOPMENT	815	4.33e-02	3.20e-01	0.0302	2.03e-03	-2.93e-02	6.19e-03	-2.37e-03	3.16e-03	9.21e-01	1.56e-01	7.64e-01	9.09e-01	8.78e-01
GLYCEROLIPID METABOLIC PROCESS	372	9.55e-01	9.97e-01	0.0302	-1.04e-02	3.56e-03	-2.13e-02	-1.73e-02	-6.19e-03	7.30e-01	9.06e-01	4.81e-01	5.66e-01	8.38e-01
SYNAPSE ORGANIZATION	449	7.47e-01	9.75e-01	0.0294	-3.89e-03	1.26e-02	-1.17e-03	-2.21e-03	2.62e-02	8.88e-01	6.46e-01	9.66e-01	9.36e-01	3.41e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	70	9.55e-01	9.97e-01	0.0294	9.84e-03	-4.97e-03	-1.38e-02	-5.89e-03	2.28e-02	8.87e-01	9.43e-01	8.42e-01	9.32e-01	7.42e-01
RAS PROTEIN SIGNAL TRANSDUCTION	319	5.84e-01	9.28e-01	0.0288	-1.38e-02	-2.11e-02	1.76e-03	-9.48e-03	1.01e-02	6.73e-01	5.17e-01	9.57e-01	7.71e-01	7.56e-01
ALCOHOL BIOSYNTHETIC PROCESS	139	9.88e-01	9.98e-01	0.0281	-3.71e-03	-1.16e-02	-9.23e-03	-1.07e-02	2.10e-02	9.40e-01	8.13e-01	8.51e-01	8.27e-01	6.69e-01
POLYSACCHARIDE METABOLIC PROCESS	96	7.51e-01	9.75e-01	0.0280	1.32e-02	-1.24e-02	-1.01e-02	-1.87e-02	1.25e-03	8.23e-01	8.34e-01	8.64e-01	7.51e-01	9.83e-01
MONOCARBOXYLIC ACID CATABOLIC PROCESS	128	5.67e-01	9.23e-01	0.0279	1.51e-02	-1.01e-02	1.35e-02	-2.26e-04	-1.62e-02	7.68e-01	8.44e-01	7.92e-01	9.96e-01	7.51e-01
OOCYTE DIFFERENTIATION	64	8.62e-01	9.88e-01	0.0278	7.74e-03	-1.67e-02	9.60e-03	-4.44e-03	-1.80e-02	9.15e-01	8.17e-01	8.94e-01	9.51e-01	8.03e-01
REGULATION OF CELLULAR LOCALIZATION	946	1.36e-01	5.86e-01	0.0270	4.25e-03	-2.32e-02	1.19e-02	5.05e-03	1.43e-03	8.25e-01	2.26e-01	5.36e-01	7.92e-01	9.40e-01
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	515	2.41e-01	7.26e-01	0.0269	7.15e-03	-2.28e-02	-4.34e-03	-7.95e-03	-8.14e-03	7.81e-01	3.75e-01	8.66e-01	7.57e-01	7.52e-01
GROWTH	887	4.07e-02	3.08e-01	0.0265	3.09e-03	-2.42e-02	-2.62e-03	-9.22e-03	-4.39e-03	8.76e-01	2.22e-01	8.95e-01	6.41e-01	8.24e-01
REGULATION OF LEUKOCYTE DIFFERENTIATION	315	7.40e-01	9.73e-01	0.0258	-1.84e-02	-1.64e-02	4.66e-03	-3.92e-03	-4.13e-03	5.74e-01	6.16e-01	8.87e-01	9.05e-01	9.00e-01
B CELL DIFFERENTIATION	144	7.36e-01	9.73e-01	0.0256	-1.32e-02	1.30e-02	6.20e-03	-3.90e-03	-1.61e-02	7.84e-01	7.88e-01	8.98e-01	9.36e-01	7.39e-01
NAD METABOLIC PROCESS	42	9.98e-01	1.00e+00	0.0255	2.02e-02	1.06e-02	-2.51e-03	-1.85e-03	1.09e-02	8.21e-01	9.05e-01	9.78e-01	9.83e-01	9.03e-01
INSULIN SECRETION	193	9.25e-01	9.95e-01	0.0255	6.70e-03	7.50e-03	-1.54e-02	-1.72e-02	3.79e-03	8.72e-01	8.57e-01	7.11e-01	6.81e-01	9.28e-01
CELLULAR RESPONSE TO XENOBIOTIC STIMULUS	189	8.15e-01	9.82e-01	0.0252	-1.78e-02	1.25e-02	-3.77e-04	-2.83e-03	1.25e-02	6.73e-01	7.68e-01	9.93e-01	9.47e-01	7.66e-01
POSITIVE REGULATION OF CELL POPULATION PROLIFERATION	1217	1.67e-01	6.34e-01	0.0249	-3.57e-04	-1.97e-02	-1.93e-03	-6.94e-03	1.35e-02	9.83e-01	2.48e-01	9.10e-01	6.83e-01	4.28e-01
PROTEIN LOCALIZATION TO CELL PERIPHERY	336	9.84e-01	9.98e-01	0.0246	7.47e-03	1.48e-02	6.36e-03	5.90e-03	-1.60e-02	8.14e-01	6.41e-01	8.41e-01	8.53e-01	6.14e-01
PHOSPHORYLATION	1528	1.38e-02	1.57e-01	0.0243	-2.35e-03	-2.14e-02	-2.84e-03	-1.02e-02	-3.93e-03	8.78e-01	1.63e-01	8.53e-01	5.03e-01	7.97e-01
MONOCARBOXYLIC ACID METABOLIC PROCESS	612	9.88e-01	9.98e-01	0.0239	-1.04e-02	-1.41e-02	-1.12e-02	-1.17e-02	9.18e-04	6.61e-01	5.52e-01	6.37e-01	6.20e-01	9.69e-01
CHEMICAL HOMEOSTASIS	996	6.07e-01	9.35e-01	0.0238	1.73e-03	5.76e-04	-6.19e-03	-7.00e-03	2.18e-02	9.26e-01	9.75e-01	7.41e-01	7.08e-01	2.44e-01
GLYCEROPHOSPHOLIPID METABOLIC PROCESS	286	9.99e-01	1.00e+00	0.0231	-1.10e-02	-9.07e-03	-1.30e-02	-1.24e-02	-3.02e-03	7.48e-01	7.92e-01	7.06e-01	7.19e-01	9.30e-01
SMOOTH MUSCLE CONTRACTION	109	9.34e-01	9.97e-01	0.0231	2.16e-02	3.36e-03	-7.22e-03	-1.27e-03	1.69e-03	6.97e-01	9.52e-01	8.96e-01	9.82e-01	9.76e-01
NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	38	9.80e-01	9.97e-01	0.0230	-4.39e-03	-1.69e-02	-3.23e-03	8.72e-03	-1.16e-02	9.63e-01	8.57e-01	9.73e-01	9.26e-01	9.01e-01
PHOSPHOLIPID METABOLIC PROCESS	364	9.85e-01	9.98e-01	0.0229	-5.12e-03	-1.98e-02	3.24e-03	1.13e-03	9.67e-03	8.67e-01	5.16e-01	9.15e-01	9.70e-01	7.51e-01
REGULATION OF CELL ACTIVATION	630	7.93e-01	9.81e-01	0.0225	4.75e-03	4.01e-03	7.78e-03	2.81e-03	1.99e-02	8.39e-01	8.64e-01	7.39e-01	9.04e-01	3.93e-01
LEUKOCYTE CELL CELL ADHESION	403	9.32e-01	9.97e-01	0.0217	-4.46e-03	6.13e-03	-1.06e-02	-1.30e-02	1.14e-02	8.78e-01	8.33e-01	7.15e-01	6.55e-01	6.94e-01
MUSCLE STRUCTURE DEVELOPMENT	677	1.87e-01	6.57e-01	0.0203	5.90e-03	-8.26e-03	3.82e-03	-4.85e-03	1.65e-02	7.94e-01	7.14e-01	8.65e-01	8.30e-01	4.64e-01
LEUKOCYTE DIFFERENTIATION	597	6.95e-01	9.61e-01	0.0193	6.39e-03	5.14e-03	1.40e-02	7.15e-03	7.59e-03	7.90e-01	8.30e-01	5.60e-01	7.65e-01	7.51e-01
REGULATION OF TRANS SYNAPTIC SIGNALING	469	9.23e-01	9.95e-01	0.0183	-3.03e-03	8.01e-03	3.75e-03	1.31e-03	1.57e-02	9.10e-01	7.66e-01	8.89e-01	9.61e-01	5.61e-01
REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS	81	9.03e-01	9.94e-01	0.0182	-1.01e-02	1.08e-02	3.71e-03	-8.62e-03	5.13e-03	8.75e-01	8.67e-01	9.54e-01	8.93e-01	9.36e-01
NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION	904	4.24e-01	8.62e-01	0.0174	1.48e-02	4.20e-03	-2.77e-03	-3.99e-03	6.58e-03	4.51e-01	8.30e-01	8.88e-01	8.39e-01	7.37e-01
POSTSYNAPTIC SPECIALIZATION ORGANIZATION	41	9.81e-01	9.97e-01	0.0169	-3.71e-04	-8.79e-03	1.41e-02	9.43e-04	-2.94e-03	9.97e-01	9.22e-01	8.76e-01	9.92e-01	9.74e-01
REPRODUCTION	1419	1.03e-01	5.14e-01	0.0164	1.31e-02	4.35e-03	-4.55e-03	-7.58e-03	4.50e-04	4.09e-01	7.84e-01	7.74e-01	6.32e-01	9.77e-01
CELLULAR LIPID METABOLIC PROCESS	972	9.83e-01	9.97e-01	0.0159	-4.76e-03	-9.37e-03	-6.63e-03	-6.57e-03	-7.40e-03	8.02e-01	6.21e-01	7.26e-01	7.28e-01	6.96e-01
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT	201	8.14e-01	9.82e-01	0.0120	1.82e-03	2.09e-03	7.29e-03	-2.91e-03	8.71e-03	9.65e-01	9.59e-01	8.59e-01	9.43e-01	8.31e-01

---

Detailed Gene set reports

CELLULAR RESPONSE TO NITROSATIVE STRESS

CELLULAR RESPONSE TO NITROSATIVE STRESS

metric	value
setSize	6
pMANOVA	0.0308
p.adjustMANOVA	0.264
s.dist	1.34
s.ADOS	0.619
s.diagnosis	0.273
s.iIQ	0.691
s.iLang	0.668
s.motor	0.646
p.ADOS	0.00859
p.diagnosis	0.247
p.iIQ	0.00337
p.iLang	0.00461
p.motor	0.00613

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
DDIT3	1478	1365
DNAJA1	1377	1386
ATM	645	484
STOX1	652	433

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ATG5	-9446	-6175	-6873	-7683	-1576
ATM	1643	1113	645	484	-6743
DDIT3	1857	-3287	1478	1365	-380
DNAJA1	-332	-4398	1377	1386	-21
PARK7	-648	-1224	-2131	-1710	-1331
STOX1	1205	657	652	433	441

---

---

PROTEIN POLYUFMYLATION

PROTEIN POLYUFMYLATION

metric	value
setSize	5
pMANOVA	0.0266
p.adjustMANOVA	0.244
s.dist	1.34
s.ADOS	0.67
s.diagnosis	0.222
s.iIQ	0.804
s.iLang	0.798
s.motor	0.055
p.ADOS	0.00948
p.diagnosis	0.389
p.iIQ	0.00184
p.iLang	0.002
p.motor	0.831

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
UFL1	2254	2401
UFM1	1488	1715
UFC1	1185	1303

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
DDRGK1	822	588	-309	491	-6225
UBA5	-7677	-12182	-2344	-3439	-1906
UFC1	2881	5262	1185	1303	-16671
UFL1	2842	2702	2254	2401	-14997
UFM1	-826	-10290	1488	1715	-1134

---

---

MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE

MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE

metric	value
setSize	5
pMANOVA	0.0111
p.adjustMANOVA	0.137
s.dist	1.3
s.ADOS	-0.565
s.diagnosis	0.111
s.iIQ	-0.74
s.iLang	-0.767
s.motor	-0.474
p.ADOS	0.0287
p.diagnosis	0.666
p.iIQ	0.00416
p.iLang	0.00297
p.motor	0.0662

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
TERB1	-17733	-18075
SPDYA	-17908	-17671
TERB2	-18012	-17532
SUN1	-15763	-16003
MAJIN	-15276	-14471

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
MAJIN	-15003	-10002	-14471	-15276	-12778
SPDYA	-15787	-7315	-17671	-17908	-10697
SUN1	-11694	410	-16003	-15763	-13492
TERB1	-11359	524	-18075	-17733	-16936
TERB2	-16900	-3718	-17532	-18012	-16518

---

---

TELOMERE TETHERING AT NUCLEAR PERIPHERY

TELOMERE TETHERING AT NUCLEAR PERIPHERY

metric	value
setSize	6
pMANOVA	0.00789
p.adjustMANOVA	0.11
s.dist	1.27
s.ADOS	-0.539
s.diagnosis	0.0863
s.iIQ	-0.742
s.iLang	-0.759
s.motor	-0.434
p.ADOS	0.0223
p.diagnosis	0.714
p.iIQ	0.00165
p.iLang	0.00129
p.motor	0.0655

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
TERB1	-17733	-18075
SPDYA	-17908	-17671
TERB2	-18012	-17532
NUP98	-16383	-16854
SUN1	-15763	-16003
MAJIN	-15276	-14471

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
MAJIN	-15003	-10002	-14471	-15276	-12778
NUP98	-12389	-5695	-16854	-16383	-11391
SPDYA	-15787	-7315	-17671	-17908	-10697
SUN1	-11694	410	-16003	-15763	-13492
TERB1	-11359	524	-18075	-17733	-16936
TERB2	-16900	-3718	-17532	-18012	-16518

---

---

MRNA 3 SPLICE SITE RECOGNITION

MRNA 3 SPLICE SITE RECOGNITION

metric	value
setSize	6
pMANOVA	0.0534
p.adjustMANOVA	0.362
s.dist	1.27
s.ADOS	0.616
s.diagnosis	0.168
s.iIQ	0.694
s.iLang	0.692
s.motor	0.489
p.ADOS	0.00902
p.diagnosis	0.477
p.iIQ	0.00323
p.iLang	0.00332
p.motor	0.038

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
ISY1	1095	1686

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ISY1	1869	-2093	1095	1686	-3873
SF1	-1910	-3032	-1201	-1569	-385
SF3A1	-3908	-6152	-2444	-2799	-3767
SF3A2	-65	-983	-138	384	-1062
SF3A3	-1913	-4523	-1429	-1510	-8144
SLU7	-55	-3580	-519	-290	-2880

---

---

NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION

NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION

metric	value
setSize	6
pMANOVA	0.0607
p.adjustMANOVA	0.394
s.dist	1.26
s.ADOS	-0.656
s.diagnosis	-0.665
s.iIQ	-0.589
s.iLang	-0.604
s.motor	-0.109
p.ADOS	0.00541
p.diagnosis	0.00479
p.iIQ	0.0125
p.iLang	0.0104
p.motor	0.644

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
MIR29B1	-15010	-18773
MIR146A	-15019	-17985
MIR19B1	-12534	-17591
MIR19A	-14153	-15116
MIR199A1	-10190	-13585
CD200	-9099	-7900

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CD200	-7900	-9099	-6941	-7563	-5678
MIR146A	-17985	-15019	-16741	-17856	1390
MIR199A1	-13585	-10190	-16020	-15203	-4594
MIR19A	-15116	-14153	-12924	-12453	-17617
MIR19B1	-17591	-12534	-18294	-18390	-18008
MIR29B1	-18773	-15010	-19481	-19283	-15570

---

---

ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C

ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C

metric	value
setSize	6
pMANOVA	0.111
p.adjustMANOVA	0.534
s.dist	1.26
s.ADOS	0.656
s.diagnosis	0.4
s.iIQ	0.67
s.iLang	0.674
s.motor	0.311
p.ADOS	0.00542
p.diagnosis	0.0898
p.iIQ	0.00447
p.iLang	0.00425
p.motor	0.187

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
CASP9	2126	2005
CYCS	246	59

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
APAF1	-52	-1092	-46	86	-2757
BAX	-7629	-9462	-4021	-3658	-3006
BOK	454	2968	-3975	-4246	-18265
CASP9	1562	-5050	2005	2126	1591
CYCS	2344	4452	59	246	-7014
DIABLO	14	3346	-269	121	-2554

---

---

RESPONSE TO YEAST

RESPONSE TO YEAST

metric	value
setSize	7
pMANOVA	0.00202
p.adjustMANOVA	0.041
s.dist	1.22
s.ADOS	-0.486
s.diagnosis	-0.564
s.iIQ	-0.678
s.iLang	-0.681
s.motor	-0.0316
p.ADOS	0.0258
p.diagnosis	0.00982
p.iIQ	0.00189
p.iLang	0.00181
p.motor	0.885

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
CLEC6A	-18956	-19216
CLEC7A	-18106	-18174
MPO	-17536	-18405
ELANE	-16150	-17597
CRK	-16208	-16508
PTX3	-13066	-10713
PLCG2	-11817	-11792

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CLEC6A	-18527	-9762	-19216	-18956	-19651
CLEC7A	-18008	-16092	-18174	-18106	-2187
CRK	-12974	-11004	-16508	-16208	-11052
ELANE	-5258	-11599	-17597	-16150	-9418
MPO	-10233	-14512	-18405	-17536	-1924
PLCG2	-11902	-2846	-11792	-11817	-8127
PTX3	-16000	-14955	-10713	-13066	-11697

---

---

DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY

DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY

metric	value
setSize	6
pMANOVA	0.0183
p.adjustMANOVA	0.192
s.dist	1.21
s.ADOS	0.536
s.diagnosis	-0.00841
s.iIQ	0.629
s.iLang	0.657
s.motor	0.587
p.ADOS	0.0229
p.diagnosis	0.972
p.iIQ	0.0076
p.iLang	0.00534
p.motor	0.0127

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
RBBP4	1710	1461
ASF1B	1423	1629
ASF1A	150	637

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ASF1A	1331	4693	637	150	50
ASF1B	-5077	-12504	1629	1423	828
CHAF1A	-3131	-10095	-3021	-1431	-513
CHAF1B	-4215	-1305	-10042	-7926	-16818
NASP	-447	-5806	359	-400	971
RBBP4	272	-7111	1461	1710	1931

---

---

INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY

INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY

metric	value
setSize	6
pMANOVA	0.0694
p.adjustMANOVA	0.422
s.dist	1.19
s.ADOS	-0.607
s.diagnosis	-0.535
s.iIQ	-0.609
s.iLang	-0.626
s.motor	0.0454
p.ADOS	0.01
p.diagnosis	0.0232
p.iIQ	0.00982
p.iLang	0.00795
p.motor	0.847

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
IL5RA	-18285	-18169
CSF2RB	-17684	-17653
IL5	-15904	-15706
LYN	-16268	-15342
JAK2	-14785	-14918
STAT5A	-9254	-9932

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CSF2RB	-17558	-15126	-17653	-17684	-8530
IL5	-16897	-6153	-15706	-15904	-16645
IL5RA	-18245	-15847	-18169	-18285	-11328
JAK2	-14473	-9001	-14918	-14785	-5784
LYN	-16395	-14393	-15342	-16268	-5528
STAT5A	-4141	-6820	-9932	-9254	-1946

---

---

POSITIVE REGULATION OF HYPERSENSITIVITY

POSITIVE REGULATION OF HYPERSENSITIVITY

metric	value
setSize	5
pMANOVA	0.0902
p.adjustMANOVA	0.478
s.dist	1.17
s.ADOS	0.528
s.diagnosis	0.607
s.iIQ	0.519
s.iLang	0.543
s.motor	0.395
p.ADOS	0.0407
p.diagnosis	0.0187
p.iIQ	0.0445
p.iLang	0.0355
p.motor	0.126

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	iLang
FCGR1A	2448	2741

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
C3	-4136	131	-6035	-6296	-6894
CCR7	-1124	4255	-1929	-1968	-5512
FCGR1A	2716	2448	2629	2741	2001
HLA-E	-2768	187	-1443	-1003	-3912
ZP3	-4521	482	-6856	-5206	-7667

---

---

FUSED ANTRUM STAGE

FUSED ANTRUM STAGE

metric	value
setSize	6
pMANOVA	0.042
p.adjustMANOVA	0.314
s.dist	1.16
s.ADOS	-0.609
s.diagnosis	-0.735
s.iIQ	-0.409
s.iLang	-0.46
s.motor	-0.223
p.ADOS	0.00983
p.diagnosis	0.00182
p.iIQ	0.0825
p.iLang	0.0509
p.motor	0.344

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
TNFAIP6	-15946	-17730
PTX3	-14955	-16000
NPR2	-14351	-16313
BMPR1B	-10543	-14676
NPPC	-15131	-10037
EREG	-9759	-13045

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BMPR1B	-14676	-10543	-16257	-16593	-11336
EREG	-13045	-9759	-15584	-16229	-19186
NPPC	-10037	-15131	-34	-56	-384
NPR2	-16313	-14351	-17869	-17580	-11361
PTX3	-16000	-14955	-10713	-13066	-11697
TNFAIP6	-17730	-15946	-17941	-17603	-13738

---

---

INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY

INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY

metric	value
setSize	6
pMANOVA	0.0419
p.adjustMANOVA	0.313
s.dist	1.13
s.ADOS	-0.565
s.diagnosis	-0.665
s.iIQ	-0.487
s.iLang	-0.494
s.motor	0.184
p.ADOS	0.0165
p.diagnosis	0.00477
p.iIQ	0.039
p.iLang	0.0363
p.motor	0.435

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
CSF2RB	-15126	-17558
FCER1G	-15932	-16511
SYK	-15285	-16222
IL3	-13870	-15990
JAK2	-9001	-14473
STAT5A	-6820	-4141

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CSF2RB	-17558	-15126	-17653	-17684	-8530
FCER1G	-16511	-15932	-18172	-17940	-5976
IL3	-15990	-13870	-16933	-17057	-8486
JAK2	-14473	-9001	-14918	-14785	-5784
STAT5A	-4141	-6820	-9932	-9254	-1946
SYK	-16222	-15285	-5947	-6636	-9783

---

---

RESPONSE TO PROSTAGLANDIN D

RESPONSE TO PROSTAGLANDIN D

metric	value
setSize	5
pMANOVA	0.137
p.adjustMANOVA	0.589
s.dist	1.11
s.ADOS	-0.591
s.diagnosis	-0.306
s.iIQ	-0.526
s.iLang	-0.508
s.motor	-0.511
p.ADOS	0.022
p.diagnosis	0.236
p.iIQ	0.0416
p.iLang	0.0492
p.motor	0.0477

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	ADOS	iIQ
PTGFR	-17368	-17714
AKR1C3	-17322	-16252
AKR1C2	-15771	-15907
TNC	-11815	-11799
PTGDR	-9936	-10159

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
AKR1C2	-15771	-3687	-15907	-15298	-12195
AKR1C3	-17322	-13555	-16252	-16137	-16901
PTGDR	-9936	-10319	-10159	-10811	-16811
PTGFR	-17368	-13525	-17714	-18230	-16962
TNC	-11815	-2264	-11799	-9788	-9609

---

---

RNA GUANINE N7 METHYLATION

RNA GUANINE N7 METHYLATION

metric	value
setSize	6
pMANOVA	0.152
p.adjustMANOVA	0.613
s.dist	1.11
s.ADOS	0.557
s.diagnosis	0.372
s.iIQ	0.625
s.iLang	0.613
s.motor	0.0995
p.ADOS	0.0181
p.diagnosis	0.115
p.iIQ	0.00804
p.iLang	0.00929
p.motor	0.673

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
RAMAC	2194	2283
RNMT	1969	1919
TRMT112	1419	1323

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BUD23	-157	154	-3934	-2913	-6765
METTL1	-3922	-520	-4565	-4903	-16941
RAMAC	3027	5390	2194	2283	-15186
RNMT	2428	3283	1969	1919	-5902
TRMT112	-1127	-6635	1419	1323	1236
WDR4	-10149	-8402	-6359	-7090	-2587

---

---

NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS

NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS

metric	value
setSize	6
pMANOVA	0.0691
p.adjustMANOVA	0.421
s.dist	1.11
s.ADOS	-0.569
s.diagnosis	-0.663
s.iIQ	-0.417
s.iLang	-0.466
s.motor	-0.261
p.ADOS	0.0158
p.diagnosis	0.0049
p.iIQ	0.0772
p.iLang	0.048
p.motor	0.268

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
SPI1	-15876	-16834
IL10	-15071	-14102
NFX1	-12380	-13179
HDAC2	-13474	-11411
TAF7	-10693	-13239
PF4	-8396	-16403

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
HDAC2	-11411	-13474	-5680	-7324	-4109
IL10	-14102	-15071	-13445	-14357	-6013
NFX1	-13179	-12380	-8618	-9219	-8961
PF4	-16403	-8396	-17510	-17759	-15005
SPI1	-16834	-15876	-17633	-17495	-16688
TAF7	-13239	-10693	-15998	-15363	-19461

---

---

PROTEIN UFMYLATION

PROTEIN UFMYLATION

metric	value
setSize	6
pMANOVA	0.0476
p.adjustMANOVA	0.341
s.dist	1.11
s.ADOS	0.567
s.diagnosis	0.109
s.iIQ	0.67
s.iLang	0.651
s.motor	0.123
p.ADOS	0.0162
p.diagnosis	0.645
p.iIQ	0.00448
p.iLang	0.00573
p.motor	0.601

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
UFL1	2254	2401
UFM1	1488	1715
UFC1	1185	1303

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CDK5RAP3	-7274	-10390	-8526	-9306	-3626
DDRGK1	822	588	-309	491	-6225
UBA5	-7677	-12182	-2344	-3439	-1906
UFC1	2881	5262	1185	1303	-16671
UFL1	2842	2702	2254	2401	-14997
UFM1	-826	-10290	1488	1715	-1134

---

---

PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY

PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY

metric	value
setSize	6
pMANOVA	0.00396
p.adjustMANOVA	0.0679
s.dist	1.1
s.ADOS	0.394
s.diagnosis	0.616
s.iIQ	0.428
s.iLang	0.474
s.motor	0.512
p.ADOS	0.0942
p.diagnosis	0.00897
p.iIQ	0.0692
p.iLang	0.0445
p.motor	0.0299

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	motor
HLA-A	2949	1052
SERPINB4	3385	410

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
HLA-A	-3722	2949	451	-74	1052
HLA-B	-3284	4012	-1919	-619	-5929
HLA-E	-2768	187	-1443	-1003	-3912
HLA-G	-7459	-2113	-11428	-10928	-9278
SERPINB4	1878	3385	-504	-259	410
SERPINB9	-5402	1187	-7561	-5823	-921

---

---

POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS

POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS

metric	value
setSize	7
pMANOVA	0.0297
p.adjustMANOVA	0.26
s.dist	1.1
s.ADOS	0.469
s.diagnosis	0.55
s.iIQ	0.498
s.iLang	0.508
s.motor	0.414
p.ADOS	0.0316
p.diagnosis	0.0118
p.iIQ	0.0226
p.iLang	0.0199
p.motor	0.0579

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	iLang
FCGR1A	2448	2741

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
C3	-4136	131	-6035	-6296	-6894
CCR7	-1124	4255	-1929	-1968	-5512
CNR1	-7912	-252	-4968	-5695	-6009
FCGR1A	2716	2448	2629	2741	2001
HLA-E	-2768	187	-1443	-1003	-3912
PARK7	-648	-1224	-2131	-1710	-1331
ZP3	-4521	482	-6856	-5206	-7667

---

---

NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS

NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS

metric	value
setSize	5
pMANOVA	0.159
p.adjustMANOVA	0.62
s.dist	1.09
s.ADOS	-0.598
s.diagnosis	-0.15
s.iIQ	-0.595
s.iLang	-0.607
s.motor	-0.284
p.ADOS	0.0206
p.diagnosis	0.561
p.iIQ	0.0212
p.iLang	0.0188
p.motor	0.271

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	ADOS
MIR548P	-19405	-18613
MIR30C1	-17867	-14852
SIRT1	-16578	-15635
FBXW7	-15381	-15444
SIK1	-6526	-8028

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
FBXW7	-15444	-7696	-14258	-15381	-7849
MIR30C1	-14852	411	-17906	-17867	-16651
MIR548P	-18613	-12710	-19562	-19405	-19722
SIK1	-8028	-3543	-7069	-6526	-7675
SIRT1	-15635	-11119	-16891	-16578	-7923

---

---

NEGATIVE REGULATION OF MYOBLAST PROLIFERATION

NEGATIVE REGULATION OF MYOBLAST PROLIFERATION

metric	value
setSize	9
pMANOVA	0.013
p.adjustMANOVA	0.153
s.dist	1.06
s.ADOS	-0.504
s.diagnosis	-0.0905
s.iIQ	-0.597
s.iLang	-0.64
s.motor	-0.32
p.ADOS	0.00886
p.diagnosis	0.638
p.iIQ	0.00193
p.iLang	0.000876
p.motor	0.0964

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
MSTN	-19450	-19513
MIR133A1	-19381	-19441
MIR10A	-19004	-18924
MIR133B	-18098	-17866
MIR204	-15411	-13624
MYOD1	-14942	-13633
MIR1-1	-12118	-12691
MIR499A	-12574	-9953
MIR134	-8773	-10726

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
MIR1-1	-16066	-4247	-12691	-12118	-11647
MIR10A	-17975	-16265	-18924	-19004	-18239
MIR133A1	-18318	-9371	-19441	-19381	-19366
MIR133B	-14665	198	-17866	-18098	-19058
MIR134	-8394	2523	-10726	-8773	-10410
MIR204	-2908	-4316	-13624	-15411	1862
MIR499A	-11396	2204	-9953	-12574	-4424
MSTN	-18738	-14287	-19513	-19450	-18906
MYOD1	-12726	-12861	-13633	-14942	-11088

---

---

U4 SNRNA 3 END PROCESSING

U4 SNRNA 3 END PROCESSING

metric	value
setSize	8
pMANOVA	0.00187
p.adjustMANOVA	0.039
s.dist	1.06
s.ADOS	0.591
s.diagnosis	0.187
s.iIQ	0.614
s.iLang	0.579
s.motor	-0.134
p.ADOS	0.00378
p.diagnosis	0.359
p.iIQ	0.00265
p.iLang	0.00459
p.motor	0.512

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	ADOS
EXOSC8	2182	2527
EXOSC5	1902	1591
EXOSC6	156	2617

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
EXOSC2	-9794	-11873	-7163	-8334	-10463
EXOSC3	-346	-581	-4064	-3758	-19282
EXOSC4	-4004	-11109	-1431	-2186	-11278
EXOSC5	1591	-6744	1902	1924	-13532
EXOSC6	2617	5131	156	669	-16554
EXOSC7	1001	3358	-1568	-1520	-11545
EXOSC8	2527	-215	2182	2304	572
EXOSC9	-3748	-3360	-3374	-4692	-249

---

---

ANTRAL OVARIAN FOLLICLE GROWTH

ANTRAL OVARIAN FOLLICLE GROWTH

metric	value
setSize	11
pMANOVA	0.0136
p.adjustMANOVA	0.157
s.dist	1.05
s.ADOS	-0.549
s.diagnosis	-0.524
s.iIQ	-0.444
s.iLang	-0.472
s.motor	-0.335
p.ADOS	0.0016
p.diagnosis	0.00263
p.iIQ	0.0108
p.iLang	0.00666
p.motor	0.0543

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	ADOS	diagnosis
TNFAIP6	-17730	-15946
PTX3	-16000	-14955
NPR2	-16313	-14351
SCAPER	-17940	-11358
GAS2	-15612	-12128
GPR149	-15586	-10885
BMPR1B	-14676	-10543
NPPC	-10037	-15131
EREG	-13045	-9759
ESR1	-12248	-7446

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BMPR1B	-14676	-10543	-16257	-16593	-11336
EREG	-13045	-9759	-15584	-16229	-19186
ESR1	-12248	-7446	-13455	-13350	-17801
GAS2	-15612	-12128	-14466	-15544	-12057
GPR149	-15586	-10885	-16000	-16206	-16781
NPPC	-10037	-15131	-34	-56	-384
NPR2	-16313	-14351	-17869	-17580	-11361
PTX3	-16000	-14955	-10713	-13066	-11697
SCAPER	-17940	-11358	-18782	-18779	-15838
TNFAIP6	-17730	-15946	-17941	-17603	-13738
ZP3	-4521	482	-6856	-5206	-7667

---

---

POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS

POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS

metric	value
setSize	5
pMANOVA	0.0913
p.adjustMANOVA	0.481
s.dist	1.05
s.ADOS	0.377
s.diagnosis	0.292
s.iIQ	0.454
s.iLang	0.428
s.motor	0.695
p.ADOS	0.144
p.diagnosis	0.258
p.iIQ	0.0786
p.iLang	0.0977
p.motor	0.00709

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	motor	iIQ
CCL4	674	2436

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CCL3	-4185	-12306	-540	-1300	853
CCL4	3154	5781	2436	2601	674
CCL5	2670	5355	2288	2485	-1149
CCL7	-1619	4987	-2293	-2907	-7379
XCL1	-18296	-13855	-19122	-19029	1732

---

---

REGULATION OF FEMALE RECEPTIVITY

REGULATION OF FEMALE RECEPTIVITY

metric	value
setSize	7
pMANOVA	0.0106
p.adjustMANOVA	0.133
s.dist	1.05
s.ADOS	-0.463
s.diagnosis	-0.533
s.iIQ	-0.51
s.iLang	-0.58
s.motor	0.0621
p.ADOS	0.034
p.diagnosis	0.0146
p.iIQ	0.0194
p.iLang	0.0079
p.motor	0.776

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	diagnosis
DRD5	-17559	-15319
PPP1R1B	-16712	-14757
THRB	-13969	-13907
AVP	-17764	-10509
AVPR1A	-8047	-14370
NCOA1	-16779	-6447
THRA	-13135	-3086

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
AVP	-16483	-10509	-17621	-17764	-17761
AVPR1A	-4833	-14370	-5553	-8047	-4591
DRD5	-16320	-15319	-17388	-17559	-686
NCOA1	-15669	-6447	-16618	-16779	-4660
PPP1R1B	-15392	-14757	-16468	-16712	-5829
THRA	-6305	-3086	-12592	-13135	-17383
THRB	-16052	-13907	-13078	-13969	-5838

---

---

SENSORY PERCEPTION OF SWEET TASTE

SENSORY PERCEPTION OF SWEET TASTE

metric	value
setSize	7
pMANOVA	0.0635
p.adjustMANOVA	0.403
s.dist	1.04
s.ADOS	-0.351
s.diagnosis	-0.0532
s.iIQ	-0.556
s.iLang	-0.513
s.motor	-0.623
p.ADOS	0.108
p.diagnosis	0.808
p.iIQ	0.0109
p.iLang	0.0187
p.motor	0.00431

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	motor	iIQ
GNAT3	-18998	-19397
RGS21	-19019	-19373
CALHM1	-17556	-15149
TAS1R3	-14832	-16592
TAS1R2	-15378	-13426
ITPR3	-11641	-11822
REEP2	-12739	-7126

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CALHM1	-11198	2694	-15149	-14277	-17556
GNAT3	-18594	-12449	-19397	-19349	-18998
ITPR3	-10463	-5895	-11822	-11222	-11641
REEP2	-12797	-14758	-7126	-7559	-12739
RGS21	-18848	-15506	-19373	-19384	-19019
TAS1R2	-2012	3107	-13426	-11276	-15378
TAS1R3	-8429	1834	-16592	-15714	-14832

---

---

NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS

NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS

metric	value
setSize	5
pMANOVA	0.316
p.adjustMANOVA	0.788
s.dist	1.03
s.ADOS	0.436
s.diagnosis	0.124
s.iIQ	0.564
s.iLang	0.555
s.motor	0.487
p.ADOS	0.0915
p.diagnosis	0.632
p.iIQ	0.0289
p.iLang	0.0316
p.motor	0.0594

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
ORMDL2	2050	2075
ORMDL1	1211	1265

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ORMDL1	1523	1131	1211	1265	-321
ORMDL2	1870	965	2050	2075	-782
ORMDL3	-2964	-346	-5136	-3664	-13579
PRKAA1	-7027	-12637	-1037	-2298	920
SPHK1	-8401	-8538	-8184	-8436	-3120

---

---

PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY

PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY

metric	value
setSize	7
pMANOVA	0.154
p.adjustMANOVA	0.616
s.dist	1.03
s.ADOS	0.547
s.diagnosis	0.248
s.iIQ	0.534
s.iLang	0.564
s.motor	0.301
p.ADOS	0.0121
p.diagnosis	0.257
p.iIQ	0.0144
p.iLang	0.0097
p.motor	0.169

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	ADOS

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ALDOB	-940	337	265	725	712
ATP6V1B1	-1737	1014	-2755	-1634	-12719
CCDC115	-573	-3476	-673	-720	1005
PIP4P1	-441	-8332	1506	1308	1250
TM9SF4	-9667	-12383	-9925	-8688	204
TMEM199	-594	1027	-1003	-1765	-10725
TMEM9	1657	4286	-5331	-3969	-17887

---

---

PROTEIN UNFOLDING

PROTEIN UNFOLDING

metric	value
setSize	5
pMANOVA	0.09
p.adjustMANOVA	0.477
s.dist	1.02
s.ADOS	0.314
s.diagnosis	0.0869
s.iIQ	0.635
s.iLang	0.659
s.motor	0.326
p.ADOS	0.225
p.diagnosis	0.737
p.iIQ	0.0139
p.iLang	0.0107
p.motor	0.207

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ANGPTL4	-546	914	-272	77	-1882
ERP29	-11810	-14130	-206	-1133	-4708
HSP90AA1	-3616	-4660	-988	-395	-10677
PEX1	894	3262	-763	-843	-5653
PEX6	-6722	-6851	-4909	-2953	-2933

---

---

POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS

POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS

metric	value
setSize	12
pMANOVA	0.000604
p.adjustMANOVA	0.0164
s.dist	1.02
s.ADOS	0.406
s.diagnosis	0.51
s.iIQ	0.458
s.iLang	0.486
s.motor	0.417
p.ADOS	0.015
p.diagnosis	0.0022
p.iIQ	0.00605
p.iLang	0.00359
p.motor	0.0124

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	iLang
FCGR1A	2448	2741
CD28	3874	1730
LTA	5692	1038

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
C3	-4136	131	-6035	-6296	-6894
CCR7	-1124	4255	-1929	-1968	-5512
CD28	891	3874	1957	1730	-1442
CD81	-11714	-274	-8332	-9239	-8804
CNR1	-7912	-252	-4968	-5695	-6009
FCGR1A	2716	2448	2629	2741	2001
HLA-E	-2768	187	-1443	-1003	-3912
KARS1	-6513	-10417	-4302	-3907	-7451
LTA	1888	5692	983	1038	-2798
PARK7	-648	-1224	-2131	-1710	-1331
TNF	-6209	181	-10489	-6329	-66
ZP3	-4521	482	-6856	-5206	-7667

---

---

LIMB JOINT MORPHOGENESIS

LIMB JOINT MORPHOGENESIS

metric	value
setSize	5
pMANOVA	0.22
p.adjustMANOVA	0.7
s.dist	1.02
s.ADOS	-0.461
s.diagnosis	-0.517
s.iIQ	-0.513
s.iLang	-0.504
s.motor	-0.215
p.ADOS	0.0743
p.diagnosis	0.0454
p.iIQ	0.0472
p.iLang	0.0509
p.motor	0.405

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	iIQ
COL3A1	-15556	-18309
OSR1	-13652	-14302
EXT1	-11155	-12961
OSR2	-10405	-8378
CTNNB1	-4318	-17130

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
COL3A1	-18374	-15556	-18309	-18401	-16787
CTNNB1	-14509	-4318	-17130	-16767	-13982
EXT1	-12491	-11155	-12961	-12638	-9795
OSR1	-12951	-13652	-14302	-13942	-6932
OSR2	-6618	-10405	-8378	-8299	-8478

---

---

CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE

CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE

metric	value
setSize	7
pMANOVA	0.0777
p.adjustMANOVA	0.45
s.dist	1.02
s.ADOS	-0.398
s.diagnosis	0.0073
s.iIQ	-0.623
s.iLang	-0.618
s.motor	-0.323
p.ADOS	0.0682
p.diagnosis	0.973
p.iIQ	0.00431
p.iLang	0.00461
p.motor	0.138

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
TERB1	-18075	-17733
SPDYA	-17671	-17908
TERB2	-17532	-18012
SUN1	-16003	-15763
MAJIN	-14471	-15276
IFFO1	-13709	-13307
LMNA	-10656	-8973

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
IFFO1	-7712	-11495	-13709	-13307	-4024
LMNA	-7561	-4662	-10656	-8973	-12361
MAJIN	-15003	-10002	-14471	-15276	-12778
SPDYA	-15787	-7315	-17671	-17908	-10697
SUN1	-11694	410	-16003	-15763	-13492
TERB1	-11359	524	-18075	-17733	-16936
TERB2	-16900	-3718	-17532	-18012	-16518

---

---

NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE

NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE

metric	value
setSize	5
pMANOVA	0.0728
p.adjustMANOVA	0.434
s.dist	1.02
s.ADOS	0.546
s.diagnosis	0.0883
s.iIQ	0.577
s.iLang	0.625
s.motor	0.0358
p.ADOS	0.0344
p.diagnosis	0.732
p.iIQ	0.0254
p.iLang	0.0155
p.motor	0.89

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
UFL1	2401	2254

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BFAR	-6158	-7805	-5701	-4359	-7491
DDRGK1	822	588	-309	491	-6225
DNAJB9	-416	-2509	-2074	-1972	-11270
HSPA5	-5941	-14363	-4541	-3707	-2020
UFL1	2842	2702	2254	2401	-14997

---

---

LEUKOTRIENE B4 METABOLIC PROCESS

LEUKOTRIENE B4 METABOLIC PROCESS

metric	value
setSize	5
pMANOVA	0.117
p.adjustMANOVA	0.546
s.dist	1.01
s.ADOS	0.563
s.diagnosis	0.649
s.iIQ	0.295
s.iLang	0.382
s.motor	-0.225
p.ADOS	0.0294
p.diagnosis	0.012
p.iIQ	0.254
p.iLang	0.139
p.motor	0.384

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
CYP4A11	5762	3063
CYP4F2	5444	1973

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CYP4A11	3063	5762	1503	1503	-16825
CYP4F12	-784	4085	-6685	-5248	1280
CYP4F2	1973	5444	446	362	-11058
CYP4F3	-34	-251	-5208	-2864	-14546
PTGR1	-12156	-5199	-16178	-14420	-15369

---

---

NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION

NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION

metric	value
setSize	5
pMANOVA	0.368
p.adjustMANOVA	0.831
s.dist	1
s.ADOS	0.504
s.diagnosis	0.198
s.iIQ	0.552
s.iLang	0.575
s.motor	0.28
p.ADOS	0.051
p.diagnosis	0.443
p.iIQ	0.0326
p.iLang	0.026
p.motor	0.278

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
UBQLN4	2318	2337
PHF23	897	729

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CLEC16A	-7087	-900	-12086	-10877	-7895
PHF23	-3813	-14069	729	897	1453
RUBCN	-538	-3111	-509	-317	-1286
TMEM39A	-2703	-1452	-2260	-1965	-15595
UBQLN4	2940	4268	2337	2318	-5061

---

---

POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION

POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION

metric	value
setSize	5
pMANOVA	0.236
p.adjustMANOVA	0.719
s.dist	1
s.ADOS	0.458
s.diagnosis	0.174
s.iIQ	0.565
s.iLang	0.509
s.motor	0.433
p.ADOS	0.0764
p.diagnosis	0.499
p.iIQ	0.0287
p.iLang	0.0486
p.motor	0.0937

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	iLang
UBB	2340	2432
PEF1	541	261

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BIRC2	-2632	-1793	-3145	-3039	724
FANCM	-2915	-5845	-2761	-4266	-6203
PDCD6	-9946	-2646	-8037	-8995	-7240
PEF1	-964	-6520	541	261	-6745
UBB	2677	215	2340	2432	-420

---

---

DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM

DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM

metric	value
setSize	6
pMANOVA	0.0533
p.adjustMANOVA	0.362
s.dist	1
s.ADOS	-0.441
s.diagnosis	-0.552
s.iIQ	-0.486
s.iLang	-0.496
s.motor	0.15
p.ADOS	0.0614
p.diagnosis	0.0193
p.iIQ	0.0392
p.iLang	0.0353
p.motor	0.525

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	iLang
DEFA1	-15613	-17762
DEFA1B	-15613	-17762
DEFA3	-15613	-17762
DEFA5	-10809	-13379
DEFA4	-14416	-7358

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
DEFA1	-18490	-15613	-17184	-17762	-6268
DEFA1B	-18490	-15613	-17184	-17762	-6268
DEFA3	-18490	-15613	-17184	-17762	-6268
DEFA4	198	-14416	-9446	-7358	1400
DEFA5	-15055	-10809	-11889	-13379	-9591
DEFA6	-6270	3629	-10637	-9498	-15783

---

---

THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION

THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION

metric	value
setSize	6
pMANOVA	0.0907
p.adjustMANOVA	0.48
s.dist	0.999
s.ADOS	-0.552
s.diagnosis	-0.59
s.iIQ	-0.331
s.iLang	-0.371
s.motor	0.313
p.ADOS	0.0192
p.diagnosis	0.0123
p.iIQ	0.16
p.iLang	0.116
p.motor	0.185

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
FGF2	-15275	-17086
BMP2	-14419	-15764
GATA2	-14020	-12968
LHX3	-10975	-13592
FGF8	-10761	-13055
WNT4	-5579	-11563

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BMP2	-15764	-14419	-10898	-11972	-10345
FGF2	-17086	-15275	-14938	-15699	434
FGF8	-13055	-10761	-10084	-10686	813
GATA2	-12968	-14020	-12065	-12273	-8202
LHX3	-13592	-10975	-15032	-14708	-7973
WNT4	-11563	-5579	-10151	-9813	-6624

---

---

PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS

PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS

metric	value
setSize	5
pMANOVA	0.284
p.adjustMANOVA	0.762
s.dist	0.994
s.ADOS	0.546
s.diagnosis	0.208
s.iIQ	0.557
s.iLang	0.571
s.motor	0.0975
p.ADOS	0.0345
p.diagnosis	0.42
p.iIQ	0.0309
p.iLang	0.0269
p.motor	0.706

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
NUDT15	549	298

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ADA	-7976	-2569	-7140	-5723	-3631
ITPA	-2347	-4252	-4154	-4826	-17346
NUDT15	2001	1351	298	549	-1659
NUDT16	775	-3693	-544	0	-15716
SAMHD1	-1320	-5534	51	-146	-214

---

---

VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY

VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY

metric	value
setSize	5
pMANOVA	0.387
p.adjustMANOVA	0.84
s.dist	0.989
s.ADOS	0.462
s.diagnosis	0.23
s.iIQ	0.511
s.iLang	0.537
s.motor	0.403
p.ADOS	0.0733
p.diagnosis	0.373
p.iIQ	0.048
p.iLang	0.0377
p.motor	0.118

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
ALDOB	725	265

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ALDOB	-940	337	265	725	712
ATP6V1B1	-1737	1014	-2755	-1634	-12719
CCDC115	-573	-3476	-673	-720	1005
TM9SF4	-9667	-12383	-9925	-8688	204
TMEM199	-594	1027	-1003	-1765	-10725

---

---

INDUCTION OF BACTERIAL AGGLUTINATION

INDUCTION OF BACTERIAL AGGLUTINATION

metric	value
setSize	6
pMANOVA	0.145
p.adjustMANOVA	0.603
s.dist	0.989
s.ADOS	-0.545
s.diagnosis	-0.566
s.iIQ	-0.425
s.iLang	-0.414
s.motor	0.0908
p.ADOS	0.0207
p.diagnosis	0.0164
p.iIQ	0.0713
p.iLang	0.0791
p.motor	0.7

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	ADOS
RNASE2	-16175	-18379
FGB	-15459	-18844
RNASE3	-16147	-16802
SPON2	-12977	-14307
DMBT1	-4212	-11147
FGA	-4407	-4097

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
DMBT1	-11147	-4212	-8396	-8821	857
FGA	-4097	-4407	1402	1479	1534
FGB	-18844	-15459	-19290	-19105	-16859
RNASE2	-18379	-16175	-19184	-19068	-19059
RNASE3	-16802	-16147	-19237	-18819	1060
SPON2	-14307	-12977	-14746	-13699	-14255

---

---

REGULATION OF MACROPHAGE FUSION

REGULATION OF MACROPHAGE FUSION

metric	value
setSize	5
pMANOVA	0.156
p.adjustMANOVA	0.618
s.dist	0.988
s.ADOS	-0.476
s.diagnosis	-0.509
s.iIQ	-0.514
s.iLang	-0.466
s.motor	-0.0975
p.ADOS	0.0652
p.diagnosis	0.0489
p.iIQ	0.0464
p.iLang	0.0709
p.motor	0.706

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	diagnosis
TYROBP	-17778	-15577
OCSTAMP	-15718	-15406
DCSTAMP	-16988	-11496
ADAM9	-12757	-11472
TREM2	-7931	-681

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ADAM9	-14793	-11472	-12757	-14028	-7939
DCSTAMP	-16456	-11496	-16988	-16763	-14721
OCSTAMP	-13287	-15406	-15718	-15565	-11983
TREM2	-4731	-681	-7931	-4025	550
TYROBP	-16520	-15577	-17778	-17568	-15330

---

---

REGULATION OF LIPID TRANSPORTER ACTIVITY

REGULATION OF LIPID TRANSPORTER ACTIVITY

metric	value
setSize	6
pMANOVA	0.00646
p.adjustMANOVA	0.0965
s.dist	0.984
s.ADOS	-0.482
s.diagnosis	-0.214
s.iIQ	-0.555
s.iLang	-0.435
s.motor	-0.439
p.ADOS	0.0407
p.diagnosis	0.364
p.iIQ	0.0186
p.iLang	0.0649
p.motor	0.0626

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iIQ	ADOS
APOA2	-17731	-18150
MIR30C1	-17906	-14852
PPARG	-13794	-15408
ADIPOQ	-13550	-13699
PRKCD	-14010	-9662
MIR34A	-11129	-7601

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
ADIPOQ	-13699	-8444	-13550	-11726	-15515
APOA2	-18150	-15993	-17731	-16702	-13694
MIR30C1	-14852	411	-17906	-17867	-16651
MIR34A	-7601	-2079	-11129	-6379	-13372
PPARG	-15408	-14956	-13794	-14163	-5951
PRKCD	-9662	-4820	-14010	-12607	-16949

---

---

EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY

EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY

metric	value
setSize	6
pMANOVA	0.28
p.adjustMANOVA	0.758
s.dist	0.983
s.ADOS	0.543
s.diagnosis	0.506
s.iIQ	0.418
s.iLang	0.444
s.motor	0.207
p.ADOS	0.0212
p.diagnosis	0.0317
p.iIQ	0.0761
p.iLang	0.0596
p.motor	0.381

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	ADOS	diagnosis
JUNB	2457	4142
TLE6	1385	2194
CITED2	1809	211

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CITED2	1809	211	1814	1935	-1332
EMP2	-10368	-3932	-6598	-6067	-9879
JUNB	2457	4142	-576	-17	-2202
NODAL	-3393	-2444	-9801	-9106	-12316
SP3	-2701	2112	-5538	-5949	-13112
TLE6	1385	2194	-2386	-1483	-145

---

---

PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN

PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN

metric	value
setSize	16
pMANOVA	1.65e-05
p.adjustMANOVA	0.000866
s.dist	0.981
s.ADOS	0.546
s.diagnosis	0.354
s.iIQ	0.446
s.iLang	0.485
s.motor	-0.323
p.ADOS	0.000157
p.diagnosis	0.0141
p.iIQ	0.00202
p.iLang	0.000775
p.motor	0.0251

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	ADOS	iLang
H4C1	2980	2418
H4C8	2724	2349
H2AC4	2306	2398
H4C3	2067	2070
H4C5	1669	2120
H4C12	3143	621
H4C16	1970	768
H4C2	703	1458

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CENPA	-11251	-14285	-9865	-11719	-6941
H2AC4	2306	766	2068	2398	-19578
H2AC8	-7894	-6582	-2047	-1531	-13890
H2BC11	1458	2231	-6194	-3373	-13365
H4C1	2980	4828	2219	2418	-3195
H4C11	-18911	-16119	-19457	-19403	-17655
H4C12	3143	5673	-1712	621	-17454
H4C13	-3956	-1425	-12160	-8146	-17358
H4C16	1970	3242	-153	768	-19397
H4C2	703	-2784	1089	1458	-7165
H4C3	2067	1346	1807	2070	-19333
H4C4	-1551	-3082	-4351	-4564	-16462
H4C5	1669	2028	1514	2120	-14156
H4C6	-4778	-2363	-9876	-11489	-635
H4C8	2724	3401	2144	2349	-3197
H4C9	863	2064	-1723	-1817	-8626

---

---

MELANOCYTE PROLIFERATION

MELANOCYTE PROLIFERATION

metric	value
setSize	5
pMANOVA	0.172
p.adjustMANOVA	0.644
s.dist	0.98
s.ADOS	-0.438
s.diagnosis	-0.57
s.iIQ	-0.435
s.iLang	-0.477
s.motor	-0.167
p.ADOS	0.0898
p.diagnosis	0.0274
p.iIQ	0.0923
p.iLang	0.065
p.motor	0.518

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	diagnosis	iLang
OR51E2	-15609	-19130
FAP	-15784	-18608
CLEC12B	-7257	-15837
WNT5A	-8864	-12035
TBX2	-10520	-2905

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CLEC12B	-12367	-7257	-15674	-15837	-2748
FAP	-18536	-15784	-18765	-18608	-13072
OR51E2	-18612	-15609	-19228	-19130	-18983
TBX2	-4427	-10520	-2095	-2905	-2458
WNT5A	-9730	-8864	-10980	-12035	-16023

---

---

POSITIVE REGULATION OF DNA LIGATION

POSITIVE REGULATION OF DNA LIGATION

metric	value
setSize	5
pMANOVA	0.136
p.adjustMANOVA	0.586
s.dist	0.979
s.ADOS	0.409
s.diagnosis	0.0439
s.iIQ	0.601
s.iLang	0.637
s.motor	0.151
p.ADOS	0.114
p.diagnosis	0.865
p.iIQ	0.0199
p.iLang	0.0136
p.motor	0.56

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	iLang	iIQ
APLF	1335	952
RAD51	556	130

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
APLF	1551	99	952	1335	-7286
HMGB1	-6375	-10896	-2172	-2274	-4546
PARP3	-5976	-8543	-3574	-2617	620
RAD51	1872	2442	130	556	-17320
XRCC1	-7584	-6960	-4390	-3489	-7071

---

---

SENSORY PERCEPTION OF UMAMI TASTE

SENSORY PERCEPTION OF UMAMI TASTE

metric	value
setSize	7
pMANOVA	0.0738
p.adjustMANOVA	0.437
s.dist	0.979
s.ADOS	-0.356
s.diagnosis	0.0624
s.iIQ	-0.537
s.iLang	-0.497
s.motor	-0.541
p.ADOS	0.103
p.diagnosis	0.775
p.iIQ	0.0139
p.iLang	0.0227
p.motor	0.0132

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	motor	iIQ
GNAT3	-18998	-19397
RGS21	-19019	-19373
CALHM1	-17556	-15149
TAS1R3	-14832	-16592
GNAT1	-12387	-15873
ITPR3	-11641	-11822
TAS1R1	-9317	-3196

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
CALHM1	-11198	2694	-15149	-14277	-17556
GNAT1	-12933	-4346	-15873	-14846	-12387
GNAT3	-18594	-12449	-19397	-19349	-18998
ITPR3	-10463	-5895	-11822	-11222	-11641
RGS21	-18848	-15506	-19373	-19384	-19019
TAS1R1	-2256	1703	-3196	-2737	-9317
TAS1R3	-8429	1834	-16592	-15714	-14832

---

---

PROTEIN IMPORT INTO PEROXISOME MEMBRANE

PROTEIN IMPORT INTO PEROXISOME MEMBRANE

metric	value
setSize	6
pMANOVA	0.109
p.adjustMANOVA	0.529
s.dist	0.976
s.ADOS	0.616
s.diagnosis	0.399
s.iIQ	0.44
s.iLang	0.451
s.motor	-0.131
p.ADOS	0.00899
p.diagnosis	0.0905
p.iIQ	0.0618
p.iLang	0.0556
p.motor	0.577

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	ADOS	iLang
PEX3	2590	1728
PEX26	2041	255

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
PEX16	-736	647	-5237	-3972	-18102
PEX19	2266	3375	-953	-1258	-10912
PEX26	2041	1244	-350	255	-8651
PEX3	2590	4211	1706	1728	-3486
PEX5	-4341	-6799	-10363	-10028	-13544
RAB8B	-7786	-7569	-6412	-6924	-6879

---

---

NEGATIVE REGULATION OF MIRNA PROCESSING

NEGATIVE REGULATION OF MIRNA PROCESSING

metric	value
setSize	9
pMANOVA	0.0617
p.adjustMANOVA	0.397
s.dist	0.976
s.ADOS	0.602
s.diagnosis	0.349
s.iIQ	0.467
s.iLang	0.493
s.motor	0.0918
p.ADOS	0.00177
p.diagnosis	0.0702
p.iIQ	0.0152
p.iLang	0.0105
p.motor	0.633

Warning: Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).
Removed 396 rows containing missing values (`geom_tile()`).

Top 20 genes

Gene	ADOS	iLang
BCDIN3D	982	299

Click HERE to show all gene set members

All member genes

	ADOS	diagnosis	iIQ	iLang	motor
BCDIN3D	982	-2269	-158	299	-3212
HOXB-AS3	1590	4989	-7337	-4156	-14564
IL6	-2504	-2889	-5204	-6110	161
LIN28A	-2229	-1242	-8252	-10045	-2357
LIN28B	-1	-1902	102	232	-1384
STAT3	-370	2177	-1687	-1668	-6058
TP53	-2272	-1095	-3379	-2803	-15784
ZC3H10	-2945	-3490	-3750	-1785	-18981
ZMPSTE24	-2627	-6690	-36	-137	-7808

---

---

Here is the session info with all the versions of packages used.

sessionInfo()

## R version 4.3.2 (2023-10-31)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] stats4    parallel  stats     graphics  grDevices utils     datasets 
## [8] methods   base     
## 
## other attached packages:
##  [1] pkgload_1.3.3                                      
##  [2] GGally_2.2.0                                       
##  [3] ggplot2_3.4.4                                      
##  [4] reshape2_1.4.4                                     
##  [5] beeswarm_0.4.0                                     
##  [6] gtools_3.9.5                                       
##  [7] tibble_3.2.1                                       
##  [8] dplyr_1.1.4                                        
##  [9] echarts4r_0.4.5                                    
## [10] gplots_3.1.3                                       
## [11] HGNChelper_0.8.1                                   
## [12] eulerr_7.0.0                                       
## [13] kableExtra_1.3.4                                   
## [14] data.table_1.14.10                                 
## [15] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [16] minfi_1.48.0                                       
## [17] bumphunter_1.44.0                                  
## [18] locfit_1.5-9.8                                     
## [19] iterators_1.0.14                                   
## [20] foreach_1.5.2                                      
## [21] Biostrings_2.70.1                                  
## [22] XVector_0.42.0                                     
## [23] SummarizedExperiment_1.32.0                        
## [24] Biobase_2.62.0                                     
## [25] MatrixGenerics_1.14.0                              
## [26] matrixStats_1.2.0                                  
## [27] GenomicRanges_1.54.1                               
## [28] GenomeInfoDb_1.38.5                                
## [29] IRanges_2.36.0                                     
## [30] S4Vectors_0.40.2                                   
## [31] BiocGenerics_0.48.1                                
## [32] mitch_1.15.2                                       
## [33] limma_3.58.1                                       
## 
## loaded via a namespace (and not attached):
##   [1] splines_4.3.2             later_1.3.2              
##   [3] BiocIO_1.12.0             bitops_1.0-7             
##   [5] filelock_1.0.3            preprocessCore_1.64.0    
##   [7] XML_3.99-0.16             lifecycle_1.0.4          
##   [9] lattice_0.22-5            MASS_7.3-60              
##  [11] base64_2.0.1              scrime_1.3.5             
##  [13] magrittr_2.0.3            sass_0.4.8               
##  [15] rmarkdown_2.25            jquerylib_0.1.4          
##  [17] yaml_2.3.8                httpuv_1.6.13            
##  [19] doRNG_1.8.6               askpass_1.2.0            
##  [21] DBI_1.2.0                 RColorBrewer_1.1-3       
##  [23] abind_1.4-5               zlibbioc_1.48.0          
##  [25] quadprog_1.5-8            rvest_1.0.3              
##  [27] purrr_1.0.2               RCurl_1.98-1.14          
##  [29] rappdirs_0.3.3            GenomeInfoDbData_1.2.11  
##  [31] genefilter_1.84.0         annotate_1.80.0          
##  [33] svglite_2.1.3             DelayedMatrixStats_1.24.0
##  [35] codetools_0.2-19          DelayedArray_0.28.0      
##  [37] xml2_1.3.6                tidyselect_1.2.0         
##  [39] farver_2.1.1              beanplot_1.3.1           
##  [41] BiocFileCache_2.10.1      illuminaio_0.44.0        
##  [43] webshot_0.5.5             jsonlite_1.8.8           
##  [45] GenomicAlignments_1.38.1  multtest_2.58.0          
##  [47] ellipsis_0.3.2            survival_3.5-7           
##  [49] systemfonts_1.0.5         tools_4.3.2              
##  [51] progress_1.2.3            Rcpp_1.0.12              
##  [53] glue_1.7.0                gridExtra_2.3            
##  [55] SparseArray_1.2.3         xfun_0.41                
##  [57] HDF5Array_1.30.0          withr_2.5.2              
##  [59] fastmap_1.1.1             rhdf5filters_1.14.1      
##  [61] fansi_1.0.6               openssl_2.1.1            
##  [63] caTools_1.18.2            digest_0.6.33            
##  [65] R6_2.5.1                  mime_0.12                
##  [67] colorspace_2.1-0          biomaRt_2.58.0           
##  [69] RSQLite_2.3.4             utf8_1.2.4               
##  [71] tidyr_1.3.0               generics_0.1.3           
##  [73] rtracklayer_1.62.0        prettyunits_1.2.0        
##  [75] httr_1.4.7                htmlwidgets_1.6.4        
##  [77] S4Arrays_1.2.0            ggstats_0.5.1            
##  [79] pkgconfig_2.0.3           gtable_0.3.4             
##  [81] blob_1.2.4                siggenes_1.76.0          
##  [83] htmltools_0.5.7           scales_1.3.0             
##  [85] png_0.1-8                 knitr_1.45               
##  [87] rstudioapi_0.15.0         tzdb_0.4.0               
##  [89] rjson_0.2.21              nlme_3.1-164             
##  [91] curl_5.2.0                cachem_1.0.8             
##  [93] rhdf5_2.46.1              stringr_1.5.1            
##  [95] KernSmooth_2.23-22        AnnotationDbi_1.64.1     
##  [97] restfulr_0.0.15           GEOquery_2.70.0          
##  [99] pillar_1.9.0              grid_4.3.2               
## [101] reshape_0.8.9             vctrs_0.6.5              
## [103] promises_1.2.1            dbplyr_2.4.0             
## [105] xtable_1.8-4              evaluate_0.23            
## [107] readr_2.1.5               GenomicFeatures_1.54.1   
## [109] cli_3.6.2                 compiler_4.3.2           
## [111] Rsamtools_2.18.0          rlang_1.1.3              
## [113] crayon_1.5.2              rngtools_1.5.2           
## [115] labeling_0.4.3            nor1mix_1.3-2            
## [117] mclust_6.0.1              plyr_1.8.9               
## [119] stringi_1.8.3             viridisLite_0.4.2        
## [121] BiocParallel_1.36.0       munsell_0.5.0            
## [123] Matrix_1.6-4              hms_1.1.3                
## [125] sparseMatrixStats_1.14.0  bit64_4.0.5              
## [127] Rhdf5lib_1.24.1           KEGGREST_1.42.0          
## [129] statmod_1.5.0             shiny_1.8.0              
## [131] highr_0.10                memoise_2.0.1            
## [133] bslib_0.6.1               bit_4.0.5

END of report